data_6ztg_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6ztg _Structure_validation_residue.Date_analyzed 2020-11-14 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.875 -0.417 . . . . 15.06 109.875 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.656 ' CE1' ' HG3' ' A' ' 194' ' ' LYS . 5.4 m-85 -137.55 156.51 48.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.162 0.43 . . . . 14.83 112.162 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.508 ' CG2' HD22 ' A' ' 187' ' ' LEU . 2.5 m -152.5 151.33 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.348 -0.842 . . . . 10.79 109.717 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.438 HG13 ' HA3' ' A' ' 212' ' ' GLY . 60.2 t -110.82 110.92 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 10.43 111.423 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.597 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 54.6 tt0 -84.85 113.52 21.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.516 -0.311 . . . . 12.54 111.688 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' A' ' 211' ' ' SER . 0.0 OUTLIER -92.01 -34.55 14.38 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.989 0.423 . . . . 11.88 110.341 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.62 174.21 25.69 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.189 -1.005 . . . . 11.9 112.855 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.503 ' HB2' HE22 ' A' ' 147' ' ' GLN . . . -170.76 103.39 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.636 -0.505 . . . . 13.47 109.636 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.81 157.07 43.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.304 0.573 . . . . 14.03 110.695 -175.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 86.1 mttt -98.12 14.3 28.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.134 -0.939 . . . . 17.87 110.612 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.426 ' OD1' ' HG3' ' A' ' 156' ' ' LYS . 4.1 t-20 -112.73 106.22 14.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.564 -0.744 . . . . 16.68 109.348 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.72 -26.48 68.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.901 0.381 . . . . 14.47 111.426 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.72 -38.87 76.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.539 0.685 . . . . 16.57 110.044 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.43 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 68.8 mttm -79.27 -33.44 43.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.671 -1.149 . . . . 16.69 110.292 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 79.6 t -58.02 -44.58 87.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.63 -0.714 . . . . 12.92 110.288 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -62.11 -30.43 71.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.299 -0.864 . . . . 15.83 110.823 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 163' ' ' LYS . 24.4 mt-10 -69.39 -61.95 1.58 Allowed 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 120.906 0.384 . . . . 15.97 110.167 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 27.8 mt -51.5 -46.22 35.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.045 -0.979 . . . . 12.6 111.143 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.8 t -73.11 -34.51 45.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.724 -0.671 . . . . 12.54 110.288 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.8 -32.4 82.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.786 -0.721 . . . . 14.8 112.117 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 159' ' ' GLU . 48.7 mmtt -67.78 -51.05 53.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.266 0.555 . . . . 16.37 109.657 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 188' ' ' VAL . 20.9 mt -87.03 -56.01 3.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.899 1.074 . . . . 12.99 113.899 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -70.13 -29.27 66.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.69 -0.855 . . . . 15.56 108.69 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.7 -24.98 76.03 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.834 -1.076 . . . . 16.6 111.851 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.74 -5.05 59.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.213 0.53 . . . . 16.55 110.549 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.0 24.77 16.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.797 -0.716 . . . . 15.88 113.261 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -94.04 155.39 17.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.307 0.554 . . . . 15.6 110.783 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -71.63 98.24 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.621 -0.511 . . . . 14.31 109.621 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.472 HG21 ' HB3' ' A' ' 164' ' ' LEU . 6.7 t -133.17 125.69 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-N 115.589 -0.732 . . . . 11.04 111.123 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.478 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -135.33 175.24 9.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.265 -0.879 . . . . 11.47 110.602 176.306 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.4 p -117.09 -175.91 2.88 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.844 -1.071 . . . . 11.83 111.926 -169.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.78 153.65 5.62 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.633 -0.712 . . . . 12.84 111.598 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -42.13 -67.15 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.065 3.177 . . . . 15.06 115.19 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.1 m -76.55 -63.08 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.768 0.655 . . . . 16.97 112.768 -167.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.1 m -169.42 130.33 1.01 Allowed Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 112.226 0.454 . . . . 16.04 112.226 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.415 ' HB3' HG22 ' A' ' 184' ' ' THR . 50.1 Cg_exo -63.28 124.6 14.12 Favored 'Trans proline' 0 CA--C 1.519 -0.265 0 C-N-CA 122.771 2.314 . . . . 14.22 111.927 162.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.9 p -153.45 153.51 8.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.557 -0.534 . . . . 16.46 109.557 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -70.44 122.09 18.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.979 -0.555 . . . . 17.05 110.73 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.46 -26.45 14.71 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.621 -0.718 . . . . 17.2 112.407 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 13.2 mptt -108.18 156.28 19.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.961 0.41 . . . . 19.02 110.677 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.9 tp -71.2 117.28 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.681 -0.69 . . . . 15.32 111.462 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 178' ' ' PRO . 38.0 m -111.54 112.45 24.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.635 -0.711 . . . . 13.03 110.188 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 91.1 mtt180 -86.84 144.99 26.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.923 -0.581 . . . . 14.44 109.571 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.615 ' C ' HD12 ' A' ' 187' ' ' LEU . 5.2 mm -113.11 124.05 69.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.297 -0.631 . . . . 11.02 109.297 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.615 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.6 mp -129.15 129.08 44.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.487 0.661 . . . . 10.32 111.241 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.515 ' CG2' HD12 ' A' ' 164' ' ' LEU . 39.8 t -100.58 142.18 16.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.991 -1.004 . . . . 10.0 110.401 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.15 49.96 11.5 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.34 -0.845 . . . . 9.94 113.932 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.462 ' HA ' HG13 ' A' ' 145' ' ' VAL . 13.7 Cg_endo -63.77 124.83 14.28 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 CA-C-N 119.915 1.857 . . . . 11.15 110.273 168.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.94 150.35 13.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.91 -0.586 . . . . 12.77 109.593 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.493 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -91.32 -9.3 45.47 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.919 -0.582 . . . . 15.0 110.944 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.3 t -97.37 102.32 14.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.173 0.511 . . . . 14.58 110.312 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.656 ' HG3' ' CE1' ' A' ' 144' ' ' TYR . 19.8 ttmt -64.54 -42.85 95.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.702 -0.681 . . . . 16.29 110.204 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.77 -51.91 67.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.127 0.489 . . . . 15.6 111.208 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -63.53 -51.47 65.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.602 -0.726 . . . . 14.36 111.431 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 200' ' ' SER . 0.1 OUTLIER -87.01 -37.71 17.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.014 0.746 . . . . 12.11 113.014 -169.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.522 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 14.5 tmtt? -80.95 -20.51 41.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.499 0.666 . . . . 14.96 109.69 -168.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -82.84 -12.43 79.83 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.312 -1.115 . . . . 13.32 110.312 172.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 32.0 m -90.39 -7.62 52.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.825 -0.688 . . . . 12.31 112.547 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 15.8 mt -59.33 -36.58 75.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.592 0.234 . . . . 12.72 111.392 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -56.97 -46.69 90.92 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.909 -0.663 . . . . 14.66 112.189 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.37 -16.87 41.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.686 0.279 . . . . 14.54 110.701 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 207' ' ' LEU . 2.6 tp -66.66 -26.95 67.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.048 0.451 . . . . 12.55 110.502 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.532 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 70.6 mmtt -61.08 -17.58 53.28 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.198 -0.455 . . . . 16.12 110.524 172.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -39.74 12.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.349 0.595 . . . . 16.98 109.521 170.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 204' ' ' LEU . 84.5 mt -61.85 -52.95 62.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.227 -0.897 . . . . 14.15 111.642 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 23.0 p -99.96 -47.5 4.99 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.314 -0.555 . . . . 13.54 110.244 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.35 5.31 71.89 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.576 -0.738 . . . . 14.79 112.793 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.1 mp -95.64 158.47 15.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.18 -0.674 . . . . 13.52 109.18 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 19.4 t -76.5 93.44 3.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.085 0.469 . . . . 14.87 110.527 -173.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -114.12 140.8 16.6 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.713 -0.676 . . . . 12.22 113.264 -176.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 p -105.81 146.73 12.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.135 0.493 . . . . 14.04 110.265 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 5.5 p -73.17 114.01 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.153 -0.93 . . . . 12.89 111.406 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.53 141.75 51.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.028 -0.533 . . . . 14.23 110.202 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -81.49 126.94 7.65 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.246 -0.978 . . . . 14.09 111.603 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.463 ' H ' ' HA ' ' A' ' 144' ' ' TYR . 4.8 t80 . . . . . 0 C--N 1.316 -0.868 0 C-N-CA 124.075 0.95 . . . . 14.24 110.561 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.572 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 108.904 -0.776 . . . . 15.06 108.904 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.599 ' CE1' ' HD3' ' A' ' 194' ' ' LYS . 7.6 m-85 -144.74 155.85 43.76 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.879 0.325 . . . . 14.83 111.879 -175.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.514 ' CG1' ' HB3' ' A' ' 187' ' ' LEU . 2.4 t -149.62 159.94 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.882 -0.784 . . . . 10.79 108.882 173.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.445 ' O ' HD11 ' A' ' 148' ' ' LEU . 58.4 t -101.0 110.02 26.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 O-C-N 122.069 -0.394 . . . . 10.43 110.803 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -86.74 108.92 18.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.569 -0.287 . . . . 12.54 111.051 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.577 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -83.97 -40.55 18.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.228 0.537 . . . . 11.88 109.953 -176.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.38 165.85 28.22 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.544 -0.836 . . . . 11.9 112.526 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -156.75 101.22 1.96 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.512 -0.551 . . . . 13.47 109.512 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.468 HD11 ' C ' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -119.57 159.25 24.71 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.38 0.609 . . . . 14.03 110.028 -174.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 39.3 mttm -101.56 24.49 9.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.888 -1.153 . . . . 17.87 107.888 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -136.37 110.86 8.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.724 -1.58 . . . . 16.68 109.114 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.76 -19.12 62.75 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.204 0.446 . . . . 14.47 112.204 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -64.32 -31.34 72.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.663 0.744 . . . . 16.57 109.563 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.418 ' O ' HG13 ' A' ' 160' ' ' ILE . 3.8 tmtm? -77.87 -38.62 45.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.396 -1.275 . . . . 16.69 109.026 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.4 t -56.44 -42.74 75.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.955 -1.021 . . . . 12.92 110.517 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -58.68 -29.6 66.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.581 -0.736 . . . . 15.83 112.146 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.511 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 8.5 mm-40 -79.56 -60.81 2.21 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.6 -0.519 . . . . 15.97 109.6 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 156' ' ' LYS . 11.4 mt -50.97 -44.3 27.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.278 -0.874 . . . . 12.6 110.673 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 84.9 t -76.49 -37.3 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.659 -0.7 . . . . 12.54 110.376 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.17 -28.79 71.29 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.669 -0.777 . . . . 14.8 112.053 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.511 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 1.0 OUTLIER -71.29 -52.27 19.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.66 0.266 . . . . 16.37 111.071 177.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.507 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 3.8 mm? -86.0 -55.59 3.87 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.043 0.386 . . . . 12.99 112.043 -175.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 24.5 ttt180 -61.7 -42.99 99.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.456 0.646 . . . . 15.56 109.82 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.82 -11.2 62.59 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.824 -1.08 . . . . 16.6 112.973 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.62 -2.19 22.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 16.55 110.714 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.94 56.13 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.233 -0.508 . . . . 15.88 113.569 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -82.58 155.44 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.241 -0.564 . . . . 15.6 110.369 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -71.4 104.39 3.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.74 0.781 . . . . 14.31 110.211 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.19 141.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 114.454 -1.248 . . . . 11.04 109.48 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.474 ' HH ' HD21 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.37 175.49 9.55 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.635 0.731 . . . . 11.47 110.635 169.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.1 p -120.75 -173.96 2.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.625 -1.17 . . . . 11.83 112.294 -168.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.59 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -50.21 151.12 3.83 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 115.161 -0.927 . . . . 12.84 112.982 -177.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -23.9 -70.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 1 C-N-CA 126.093 4.529 . . . . 15.06 115.281 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.1 m -88.95 -62.12 1.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.242 -0.583 . . . . 16.97 112.313 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 97.6 m -167.58 132.08 1.53 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 111.453 0.168 . . . . 16.04 111.453 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.404 ' HB3' HG23 ' A' ' 184' ' ' THR . 73.4 Cg_exo -56.75 125.76 20.06 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.54 2.16 . . . . 14.22 111.741 166.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.494 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.3 p -148.71 160.26 6.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.643 -0.503 . . . . 16.46 109.643 -174.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -72.55 133.47 44.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.527 -0.306 . . . . 17.05 110.739 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.08 -25.61 11.8 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.213 -0.518 . . . . 17.2 114.116 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.494 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.3 OUTLIER -102.94 168.06 9.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.36 0.58 . . . . 19.02 110.67 -176.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.6 tp -76.29 110.5 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.973 0.892 . . . . 15.32 111.766 -174.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 178' ' ' PRO . 48.8 m -104.9 107.59 18.64 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.496 -0.775 . . . . 13.03 109.464 173.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.59 ' H ' ' HB3' ' A' ' 174' ' ' SER . 6.4 ptm180 -90.42 133.71 34.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.408 -0.815 . . . . 14.44 109.675 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.549 ' C ' HD11 ' A' ' 187' ' ' LEU . 3.3 mm -104.91 122.52 58.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.76 -0.459 . . . . 11.02 109.76 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.549 HD11 ' C ' ' A' ' 186' ' ' ILE . 5.1 mp -129.68 126.46 38.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.258 0.552 . . . . 10.32 111.153 -174.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.507 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 38.5 t -102.38 134.77 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.474 -0.784 . . . . 10.0 110.997 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.06 49.86 4.83 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.001 -1.0 . . . . 9.94 113.66 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.46 ' N ' HG13 ' A' ' 145' ' ' VAL . 10.2 Cg_endo -58.86 125.09 17.22 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 119.441 1.621 . . . . 11.15 110.698 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -152.19 151.73 31.36 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.458 -0.497 . . . . 12.77 110.393 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -92.06 -7.0 49.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.824 -0.625 . . . . 15.0 111.706 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.4 p -118.29 104.98 11.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.341 0.591 . . . . 14.58 111.375 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.599 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 36.7 ttpt -58.47 -51.89 67.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.693 -1.139 . . . . 16.29 110.787 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.11 -44.97 83.75 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.158 -0.474 . . . . 15.6 111.191 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.447 ' HZ2' ' HB2' ' A' ' 196' ' ' LYS . 3.2 ttmp? -62.63 -48.28 80.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.745 -0.661 . . . . 14.36 111.017 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.558 ' O ' HD11 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -77.73 -20.39 53.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 12.11 110.935 -175.007 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.442 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.7 tptm -65.31 -39.02 91.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.516 0.674 . . . . 14.96 109.917 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -79.14 -12.43 84.04 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.498 -1.041 . . . . 13.32 110.498 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 59.0 m -84.08 -10.69 57.63 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.823 -0.689 . . . . 12.31 111.82 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 29.6 mt -64.77 -34.72 79.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.833 0.349 . . . . 12.72 110.995 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -61.68 -39.06 96.91 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.793 -0.718 . . . . 14.66 112.401 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.484 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 10.3 pt-20 -86.26 -22.2 26.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.876 0.369 . . . . 14.54 110.99 177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.6 tp -74.83 -31.47 61.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 12.55 111.272 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.571 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 20.2 ptmt -68.17 -15.09 63.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.111 0.481 . . . . 16.12 110.382 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.9 -30.67 17.71 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.177 0.513 . . . . 16.98 109.982 171.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 91.3 mt -76.44 -51.89 10.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.793 -0.64 . . . . 14.15 111.527 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.434 ' HB3' HD11 ' A' ' 164' ' ' LEU . 44.3 p -95.56 -43.93 7.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.354 0.597 . . . . 13.54 110.213 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.571 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 70.01 3.85 46.05 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 114.899 -1.046 . . . . 14.79 112.579 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.44 153.3 18.01 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 109.572 -0.529 . . . . 13.52 109.572 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 24.2 t -85.33 107.25 17.25 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.01 -0.541 . . . . 14.87 110.53 -175.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -127.48 163.27 21.29 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.346 -0.93 . . . . 12.22 113.435 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.87 145.8 12.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.039 -0.58 . . . . 14.04 109.748 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.61 104.85 3.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.104 -0.702 . . . . 12.89 109.104 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 92.8 mmm -117.06 141.8 47.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.168 -0.469 . . . . 14.23 110.447 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.21 155.09 51.31 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.494 -0.86 . . . . 14.09 111.698 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.572 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 10.9 t80 . . . . . 0 C--N 1.309 -1.185 0 C-N-CA 123.082 0.553 . . . . 14.24 110.286 -169.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 110.125 -0.324 . . . . 15.06 110.125 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.529 ' CD2' ' HG3' ' A' ' 194' ' ' LYS . 4.7 m-85 -143.03 158.44 43.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.17 -0.468 . . . . 14.83 111.685 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 190' ' ' PRO . 2.2 m -151.77 152.82 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.715 -0.675 . . . . 10.79 110.633 -176.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 60.3 t -108.73 108.35 25.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 120.862 0.363 . . . . 10.43 111.262 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -85.26 108.94 18.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.54 -0.3 . . . . 12.54 110.871 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.549 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -84.92 -36.64 21.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.138 0.494 . . . . 11.88 109.924 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.34 164.15 28.38 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.583 -0.818 . . . . 11.9 112.674 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -161.21 101.21 1.23 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.02 0.438 . . . . 13.47 109.822 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.8 168.37 18.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.293 0.568 . . . . 14.03 110.586 -174.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -100.39 -5.6 26.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.866 -1.061 . . . . 17.87 109.837 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -105.45 106.58 17.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.122 -0.945 . . . . 16.68 109.844 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.13 -19.42 65.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.798 -0.637 . . . . 14.47 111.266 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.93 -29.78 70.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.516 0.674 . . . . 16.57 110.24 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -89.85 -27.23 20.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.149 -0.932 . . . . 16.69 109.327 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 74.2 t -60.7 -35.62 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.441 -0.799 . . . . 12.92 109.922 173.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.17 -26.81 66.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.437 -0.802 . . . . 15.83 111.59 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.469 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 3.9 mm-40 -70.95 -62.78 1.27 Allowed 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.48 -0.563 . . . . 15.97 109.48 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.563 HD13 HD13 ' A' ' 186' ' ' ILE . 13.8 mt -54.78 -46.49 74.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.622 -1.172 . . . . 12.6 110.514 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.48 HG22 HD12 ' A' ' 186' ' ' ILE . 85.0 t -72.04 -42.88 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.592 -0.731 . . . . 12.54 110.668 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.49 -27.77 66.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.627 -0.797 . . . . 14.8 111.804 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.469 ' HD2' ' O ' ' A' ' 159' ' ' GLU . 15.7 mttp -72.56 -57.93 3.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.491 -0.355 . . . . 16.37 111.021 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.411 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 3.7 mm? -82.87 -56.28 3.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.275 0.472 . . . . 12.99 112.275 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -62.53 -38.25 89.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.445 0.641 . . . . 15.56 109.7 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.08 -28.61 73.81 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.839 -1.073 . . . . 16.6 112.695 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.96 2.03 56.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.998 0.428 . . . . 16.55 110.879 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.83 23.59 55.32 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.979 -0.629 . . . . 15.88 113.313 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -85.66 154.59 21.57 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.645 -0.327 . . . . 15.6 110.22 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -68.52 99.34 0.96 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.366 0.603 . . . . 14.31 109.986 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.5 p -143.99 139.34 25.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 114.96 -1.018 . . . . 11.04 109.949 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.23 176.89 8.39 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.48 0.657 . . . . 11.47 110.508 172.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 p -126.49 -175.28 3.34 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.959 -1.019 . . . . 11.83 111.689 -169.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.471 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 2.9 p -52.24 149.51 9.81 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 115.94 -0.573 . . . . 12.84 111.876 -176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -34.53 -58.07 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.797 3.664 . . . . 15.06 115.341 -171.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 31.7 t -87.91 -64.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.458 -0.897 . . . . 16.97 112.212 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 55.5 m -169.03 134.0 1.33 Allowed Pre-proline 0 CA--C 1.53 0.196 0 O-C-N 122.389 -0.195 . . . . 16.04 111.282 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.488 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 72.5 Cg_exo -59.52 123.27 12.98 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.245 1.963 . . . . 14.22 111.58 165.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 8.6 p -153.92 159.87 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 109.767 -0.457 . . . . 16.46 109.767 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -80.51 122.42 27.0 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.935 -0.394 . . . . 17.05 109.935 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 110.02 -26.48 13.78 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.766 -0.652 . . . . 17.2 112.155 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.444 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.5 OUTLIER -106.93 158.44 17.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.411 -0.588 . . . . 19.02 109.411 175.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.6 tp -74.56 122.24 27.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.524 0.678 . . . . 15.32 111.156 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 56.0 m -111.34 105.0 13.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.81 -0.632 . . . . 13.03 110.202 174.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.471 ' H ' ' HB3' ' A' ' 174' ' ' SER . 97.3 mtt180 -84.03 138.05 33.28 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.984 -0.747 . . . . 14.44 108.984 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.563 HD13 HD13 ' A' ' 160' ' ' ILE . 4.2 mt -115.58 122.13 68.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.332 -0.618 . . . . 11.02 109.332 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 186' ' ' ILE . 3.8 mp -128.79 127.08 41.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.7 -0.682 . . . . 10.32 111.171 -168.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.445 HG23 HD21 ' A' ' 148' ' ' LEU . 50.5 t -100.7 143.13 14.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.034 -0.985 . . . . 10.0 110.418 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.99 48.43 7.71 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.192 -0.913 . . . . 9.94 113.76 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.468 ' HA ' ' CG1' ' A' ' 145' ' ' VAL . 18.7 Cg_endo -66.24 123.62 11.45 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 CA-C-N 119.831 1.815 . . . . 11.15 110.568 172.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.1 158.55 36.6 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.548 -0.751 . . . . 12.77 109.386 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.47 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -92.6 -19.54 21.81 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.66 -0.7 . . . . 15.0 110.707 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 35.6 p -91.96 90.93 7.63 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.582 0.706 . . . . 14.58 110.863 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 144' ' ' TYR . 27.7 ttpt -52.68 -51.88 58.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.562 -1.199 . . . . 16.29 110.905 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -57.71 -45.61 85.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.765 -0.652 . . . . 15.6 111.242 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -75.45 -38.03 59.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.903 -0.589 . . . . 14.36 111.591 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.475 HD23 ' CB ' ' A' ' 144' ' ' TYR . 0.1 OUTLIER -79.09 -20.07 49.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.263 0.554 . . . . 12.11 110.246 -178.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.423 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 54.1 tptt -64.97 -40.73 95.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.587 0.708 . . . . 14.96 110.219 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.24 -12.57 84.48 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.169 -0.923 . . . . 13.32 110.797 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 58.5 m -85.53 -9.04 57.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.716 -0.742 . . . . 12.31 112.236 -176.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.557 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 31.2 mt -65.91 -38.53 88.96 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.733 0.301 . . . . 12.72 111.361 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.34 -38.29 96.18 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.738 -0.744 . . . . 14.66 112.279 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.491 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 11.4 pt-20 -82.16 -18.63 42.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.096 0.474 . . . . 14.54 110.16 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 17.0 tp -74.02 -30.86 62.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.197 -0.456 . . . . 12.55 110.244 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 85.1 mttt -64.33 -19.96 65.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.284 0.564 . . . . 16.12 109.727 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.59 -29.99 18.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.512 -0.767 . . . . 16.98 110.288 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 82.4 mt -78.58 -53.04 7.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.827 -0.624 . . . . 14.15 111.701 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.408 ' HB3' HD12 ' A' ' 164' ' ' LEU . 68.4 p -94.71 -44.0 8.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.418 0.628 . . . . 13.54 110.46 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 67.46 13.85 63.6 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.727 -1.124 . . . . 14.79 112.286 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.423 HD12 HG22 ' A' ' 160' ' ' ILE . 85.3 mt -103.85 152.72 21.58 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.188 -0.671 . . . . 13.52 109.188 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 10.9 t -88.69 108.84 19.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.106 0.479 . . . . 14.87 110.448 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -125.71 161.04 20.22 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.327 -0.939 . . . . 12.22 113.216 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.7 p -102.09 144.01 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.216 0.532 . . . . 14.04 110.433 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.78 105.8 8.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.26 -0.882 . . . . 12.89 110.263 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 84.2 mmm -115.35 148.64 39.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.931 -0.577 . . . . 14.23 110.404 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -78.26 132.65 11.94 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.225 -0.988 . . . . 14.09 111.698 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.619 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 7.3 t80 . . . . . 0 C--N 1.312 -1.064 0 C-N-CA 123.297 0.639 . . . . 14.24 109.607 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.723 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 109.535 -0.542 . . . . 15.06 109.535 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.688 ' CE2' ' HB2' ' A' ' 194' ' ' LYS . 4.4 m-85 -136.76 140.16 42.36 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 111.745 0.276 . . . . 14.83 111.745 -174.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.543 ' CG1' ' HB3' ' A' ' 187' ' ' LEU . 3.2 t -148.91 163.79 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.229 -0.656 . . . . 10.79 109.229 171.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.439 ' H ' HG11 ' A' ' 145' ' ' VAL . 40.1 t -105.54 113.26 41.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 O-C-N 121.787 -0.571 . . . . 10.43 111.267 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.51 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 49.6 tt0 -86.01 116.83 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.636 -0.256 . . . . 12.54 111.551 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.511 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -93.35 -35.09 13.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.088 0.47 . . . . 11.88 110.21 -178.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -147.25 169.38 28.25 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.454 -0.879 . . . . 11.9 112.569 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -163.58 105.39 0.96 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.865 -0.791 . . . . 13.47 108.865 177.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -138.91 159.36 42.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.21 0.529 . . . . 14.03 110.909 -171.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 183' ' ' ILE . 9.2 mmmm -96.93 -3.46 41.76 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.12 -0.945 . . . . 17.87 110.162 -174.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -111.91 115.87 29.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.371 -0.832 . . . . 16.68 110.338 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.6 65.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 14.47 111.007 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.14 -32.4 69.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.669 0.747 . . . . 16.57 110.199 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.416 ' HB3' HD22 ' A' ' 151' ' ' LEU . 32.5 mmtp -89.47 -31.27 17.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.739 -1.119 . . . . 16.69 110.368 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.9 t -61.89 -40.99 89.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.488 -0.778 . . . . 12.92 110.135 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -54.83 -36.38 64.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.078 -0.964 . . . . 15.83 111.056 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 18.5 mt-10 -69.13 -60.78 2.12 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.174 0.511 . . . . 15.97 110.057 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 210' ' ' LEU . 7.9 mt -56.03 -45.19 80.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.074 -0.966 . . . . 12.6 110.971 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.3 t -74.74 -41.22 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.758 -0.656 . . . . 12.54 110.451 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.95 -28.54 66.27 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.547 -0.835 . . . . 14.8 111.763 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 159' ' ' GLU . 15.5 mttp -73.74 -56.73 4.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.612 0.244 . . . . 16.37 111.41 177.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.56 -51.73 7.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.093 0.405 . . . . 12.99 112.093 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -65.84 -41.59 91.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.246 0.546 . . . . 15.56 109.653 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.23 -24.16 76.05 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.369 -0.832 . . . . 16.6 112.745 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.87 4.55 52.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.034 0.445 . . . . 16.55 110.877 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.61 25.11 47.88 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.956 -0.64 . . . . 15.88 113.54 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -89.65 160.12 16.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.159 0.48 . . . . 15.6 110.252 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.96 102.7 8.44 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.554 0.692 . . . . 14.31 109.379 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.84 139.8 27.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.753 -1.112 . . . . 11.04 109.87 -173.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.71 176.32 8.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.686 0.755 . . . . 11.47 110.723 172.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.5 p -123.3 -172.63 2.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.46 -1.245 . . . . 11.83 112.239 -167.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.643 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 0.9 OUTLIER -49.51 158.6 0.78 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.345 -0.843 . . . . 12.84 112.864 -177.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -47.36 -54.29 5.28 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.608 2.872 . . . . 15.06 113.904 -170.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.9 m -88.19 -64.09 1.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.705 -0.798 . . . . 16.97 112.227 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 42.1 m -169.26 137.93 1.63 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 122.336 0.255 . . . . 16.04 110.534 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.411 ' HB3' HG21 ' A' ' 184' ' ' THR . 76.1 Cg_exo -59.83 123.56 13.51 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.213 1.942 . . . . 14.22 111.306 165.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 12.2 p -154.66 159.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 116.177 -0.465 . . . . 16.46 110.487 -174.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -80.85 127.0 32.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.18 -0.464 . . . . 17.05 110.745 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 100.45 -16.45 57.87 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.981 -0.628 . . . . 17.2 112.221 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.499 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 8.5 mptt -120.84 162.5 19.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.787 -0.449 . . . . 19.02 109.787 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 152' ' ' LYS . 9.7 tp -73.38 120.11 21.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.69 0.757 . . . . 15.32 111.771 -172.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.483 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 37.8 m -113.16 105.37 13.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.432 -0.804 . . . . 13.03 109.747 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.643 ' H ' ' HB3' ' A' ' 174' ' ' SER . 15.8 ptt180 -88.18 136.25 33.06 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.362 -0.836 . . . . 14.44 109.584 176.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.531 ' C ' HD12 ' A' ' 187' ' ' LEU . 4.1 mm -110.39 123.1 65.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.677 -0.49 . . . . 11.02 109.677 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.543 ' HB3' ' CG1' ' A' ' 145' ' ' VAL . 4.5 mp -130.11 132.42 46.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.463 0.649 . . . . 10.32 111.441 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.436 HG21 HD23 ' A' ' 148' ' ' LEU . 26.4 t -107.57 132.72 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.053 -0.976 . . . . 10.0 111.015 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.22 49.78 4.32 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.174 -0.921 . . . . 9.94 113.58 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.493 ' HA ' ' CG2' ' A' ' 145' ' ' VAL . 9.3 Cg_endo -59.71 126.11 19.64 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 CA-C-N 119.515 1.657 . . . . 11.15 111.367 173.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -157.63 167.75 29.23 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.124 -0.695 . . . . 12.77 109.124 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -107.89 5.95 26.87 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.029 0.442 . . . . 15.0 110.706 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 48.1 m -120.4 107.37 12.83 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.153 -0.476 . . . . 14.58 111.254 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.688 ' HB2' ' CE2' ' A' ' 144' ' ' TYR . 35.1 ttpt -66.67 -40.4 88.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.81 -0.632 . . . . 16.29 110.023 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -62.49 -39.7 94.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.686 -0.688 . . . . 15.6 110.857 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -51.22 36.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.626 -0.715 . . . . 14.36 110.493 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -74.06 -18.85 60.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.484 . . . . 12.11 110.725 -175.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.532 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 17.4 tppt? -62.93 -39.57 95.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.197 0.522 . . . . 14.96 110.325 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.02 -17.38 79.85 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.09 -1.204 . . . . 13.32 110.09 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 31.0 m -79.39 -8.92 59.44 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.564 -0.818 . . . . 12.31 112.037 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 13.8 mt -70.81 -37.33 73.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.936 0.398 . . . . 12.72 110.378 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.23 -25.32 71.05 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.648 -0.981 . . . . 14.66 110.648 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.591 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 41.6 mt-10 -86.39 -24.43 25.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.941 -0.629 . . . . 14.54 110.534 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.0 tp -60.3 -48.25 82.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.425 -0.352 . . . . 12.55 111.103 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.56 ' HB3' ' HZ2' ' A' ' 205' ' ' LYS . 0.5 OUTLIER -59.0 -21.21 58.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 16.12 111.396 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -38.65 13.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 16.98 110.436 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 93.1 mt -72.75 -51.85 17.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.073 -0.512 . . . . 14.15 111.615 -176.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 64.7 p -101.87 -43.32 5.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.222 0.534 . . . . 13.54 110.919 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.39 6.18 74.84 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.908 -0.877 . . . . 14.79 110.908 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.434 HD12 HG22 ' A' ' 160' ' ' ILE . 60.3 mt -97.74 157.91 15.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.787 -0.449 . . . . 13.52 109.787 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 17.7 p -81.12 95.61 6.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.011 0.434 . . . . 14.87 111.315 -176.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -108.23 142.34 15.95 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.727 -0.749 . . . . 12.22 114.127 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.1 142.39 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.526 -0.546 . . . . 14.04 109.526 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.38 107.02 4.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.109 -0.496 . . . . 12.89 110.512 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 23.9 mmt -109.0 141.54 40.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.741 -0.663 . . . . 14.23 109.817 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.55 107.34 2.34 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.169 -1.015 . . . . 14.09 111.748 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.723 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 6.1 t80 . . . . . 0 C--N 1.308 -1.212 0 CA-C-N 113.147 -1.526 . . . . 14.24 111.066 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.563 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 CA--C 1.518 -0.263 0 N-CA-C 109.133 -0.691 . . . . 15.06 109.133 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.583 ' CE2' ' HD3' ' A' ' 194' ' ' LYS . 4.3 m-85 -143.47 155.43 44.36 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.487 0.551 . . . . 14.83 112.487 -175.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.542 HG11 ' N ' ' A' ' 190' ' ' PRO . 2.5 t -148.39 167.07 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.252 -1.018 . . . . 10.79 108.252 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 59.0 t -107.62 112.85 41.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 O-C-N 121.686 -0.633 . . . . 10.43 111.31 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.544 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 48.9 tt0 -84.52 114.54 22.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.355 -0.384 . . . . 12.54 111.381 -176.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' A' ' 211' ' ' SER . 0.0 OUTLIER -96.45 -33.07 12.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.391 0.615 . . . . 11.88 110.169 -178.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.29 168.39 27.18 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.47 -0.786 . . . . 11.9 112.169 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -170.93 101.49 0.22 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.0 -0.741 . . . . 13.47 109.0 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.81 164.65 35.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.86 -0.609 . . . . 14.03 110.785 -173.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 32.4 mtmm -101.6 15.32 29.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.128 -0.942 . . . . 17.87 110.389 -173.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -109.87 105.14 14.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.153 -0.93 . . . . 16.68 108.96 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.36 -22.13 63.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.199 -0.455 . . . . 14.47 111.682 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.48 -38.22 89.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.928 0.871 . . . . 16.57 109.292 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -75.43 -29.79 59.83 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.309 -1.314 . . . . 16.69 110.119 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 89.3 t -63.29 -40.84 90.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.627 -0.715 . . . . 12.92 109.867 172.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -64.17 -22.23 66.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.644 -0.707 . . . . 15.83 111.954 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.689 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 14.5 mt-10 -78.0 -62.9 1.53 Allowed 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.143 -0.688 . . . . 15.97 109.143 176.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.413 HD13 HG13 ' A' ' 186' ' ' ILE . 10.3 mt -54.48 -48.47 69.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.599 -0.728 . . . . 12.6 110.949 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.85 -40.01 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.762 -0.654 . . . . 12.54 110.555 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.88 -28.91 72.66 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.462 -0.875 . . . . 14.8 112.138 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.689 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.6 mptp? -80.95 -49.3 11.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.4 0.148 . . . . 16.37 111.4 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.87 -55.85 4.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 12.99 111.484 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.414 ' HB2' ' CG1' ' A' ' 171' ' ' VAL . 69.0 ttt180 -66.89 -40.8 87.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.249 0.547 . . . . 15.56 110.313 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.76 -19.87 73.69 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.222 -0.899 . . . . 16.6 112.66 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.05 -5.59 57.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.808 0.337 . . . . 16.55 110.916 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.71 24.97 12.36 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.651 -0.785 . . . . 15.88 112.806 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -94.8 148.3 22.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.933 -0.395 . . . . 15.6 109.933 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -76.67 96.55 4.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.164 -0.68 . . . . 14.31 109.164 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 165' ' ' ARG . 7.4 p -142.62 143.74 25.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.404 -0.816 . . . . 11.04 109.456 -176.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -139.08 176.49 8.66 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.69 0.757 . . . . 11.47 110.85 176.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 20.2 p -113.93 -176.4 2.89 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.477 -1.238 . . . . 11.83 111.004 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.414 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.5 OUTLIER -53.16 141.33 40.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 O-C-N 123.166 0.291 . . . . 12.84 110.778 178.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -40.14 -47.49 4.05 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 124.484 3.456 . . . . 15.06 115.553 -169.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.3 m -85.44 -63.68 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.522 -0.871 . . . . 16.97 112.696 -171.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 98.8 m -168.49 129.94 1.14 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 118.375 0.534 . . . . 16.04 112.096 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.406 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 74.7 Cg_exo -62.63 123.97 13.31 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.519 2.146 . . . . 14.22 111.713 161.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.488 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 7.7 p -154.01 159.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.63 -0.507 . . . . 16.46 109.63 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -81.47 129.15 34.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.967 0.413 . . . . 17.05 110.721 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 104.81 -25.79 24.43 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.058 -0.591 . . . . 17.2 112.376 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.488 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 2.8 mptp? -114.35 157.69 22.48 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.557 -0.534 . . . . 19.02 109.557 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.82 109.93 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.594 0.711 . . . . 15.32 111.815 -173.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.414 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 54.0 m -101.79 111.39 23.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.786 -0.643 . . . . 13.03 109.562 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 74.1 mtp180 -92.22 139.57 30.48 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.39 -0.823 . . . . 14.44 109.755 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.5 ' C ' HD13 ' A' ' 187' ' ' LEU . 4.1 mm -109.6 118.86 57.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.251 -0.648 . . . . 11.02 109.251 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 5.2 mp -129.81 120.88 25.72 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.386 0.612 . . . . 10.32 111.386 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.429 HG21 ' CD2' ' A' ' 148' ' ' LEU . 38.0 t -95.38 136.02 27.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.508 -0.769 . . . . 10.0 110.822 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.46 47.9 5.52 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.316 -0.856 . . . . 9.94 113.943 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.542 ' N ' HG11 ' A' ' 145' ' ' VAL . 11.5 Cg_endo -61.36 126.21 18.74 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 CA-C-N 119.732 1.766 . . . . 11.15 110.998 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -155.04 154.56 32.66 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.512 -0.475 . . . . 12.77 110.376 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -95.02 -4.51 46.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.649 -0.705 . . . . 15.0 111.312 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.1 m -112.5 100.57 8.85 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.487 0.661 . . . . 14.58 110.431 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.583 ' HD3' ' CE2' ' A' ' 144' ' ' TYR . 22.1 ttpp -55.66 -59.78 4.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.461 -1.245 . . . . 16.29 112.011 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.13 -27.96 68.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.686 -0.688 . . . . 15.6 111.81 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -72.51 -37.8 68.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.423 0.63 . . . . 14.36 110.154 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 200' ' ' SER . 0.2 OUTLIER -85.55 -23.52 27.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.791 -0.64 . . . . 12.11 110.444 -175.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.542 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 36.8 mttt -74.66 -32.77 62.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.054 0.454 . . . . 14.96 110.634 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -73.81 -12.63 80.88 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.965 -1.254 . . . . 13.32 109.965 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 47.7 m -90.67 -8.89 48.73 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.365 -0.917 . . . . 12.31 112.24 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 22.7 mt -66.14 -33.37 75.61 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.186 -0.321 . . . . 12.72 110.989 -175.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.81 -44.16 97.28 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.807 -0.711 . . . . 14.66 111.94 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.62 -17.93 34.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.635 0.255 . . . . 14.54 111.037 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 24.5 tp -70.15 -29.32 66.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.05 0.453 . . . . 12.55 109.996 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 61.3 mttp -60.92 -22.66 64.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.61 -0.723 . . . . 16.12 110.861 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.57 -35.34 30.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.291 0.567 . . . . 16.98 109.754 174.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 82.2 mt -75.45 -52.47 10.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.417 -0.81 . . . . 14.15 111.453 -175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 31.9 p -98.64 -45.07 6.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.031 0.444 . . . . 13.54 110.717 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 60.59 21.79 58.31 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.598 -0.728 . . . . 14.79 111.868 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 79.8 mt -98.47 158.09 15.81 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.126 -0.694 . . . . 13.52 109.126 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 16.9 p -73.72 92.61 2.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.822 0.344 . . . . 14.87 110.756 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -111.33 146.33 17.76 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.486 -0.864 . . . . 12.22 114.256 -174.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 49.1 t -117.01 140.97 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.356 -0.979 . . . . 14.04 108.356 170.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . 0.4 HG21 ' HE2' ' A' ' 198' ' ' LYS . 6.3 p -76.14 106.51 6.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.792 0.806 . . . . 12.89 110.314 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 23.0 mmt -113.18 145.99 40.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.152 -0.931 . . . . 14.23 110.797 -174.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.7 139.53 27.64 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.628 -0.796 . . . . 14.09 112.861 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.563 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 9.2 t80 . . . . . 0 C--N 1.315 -0.894 0 C-N-CA 124.332 1.053 . . . . 14.24 110.123 -175.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.523 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 120.27 0.081 . . . . 15.06 110.939 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.672 ' CB ' HD22 ' A' ' 197' ' ' LEU . 3.6 m-85 -146.79 160.66 41.99 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.333 0.396 . . . . 14.83 111.783 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 217' ' ' TYR . 2.5 t -151.12 165.58 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 108.811 -0.811 . . . . 10.79 108.811 173.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 47.7 t -106.57 113.6 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.379 0.536 . . . . 10.43 111.524 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.457 ' OE1' ' HD2' ' A' ' 185' ' ' ARG . 48.5 tt0 -89.86 109.09 20.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.815 0.302 . . . . 12.54 111.815 -175.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.536 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -86.8 -36.04 18.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.29 0.566 . . . . 11.88 110.059 -177.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.59 170.18 26.29 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.603 -0.808 . . . . 11.9 112.456 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.67 107.59 0.39 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.468 -0.568 . . . . 13.47 109.468 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.89 43.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.392 0.615 . . . . 14.03 110.614 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 30.7 mtmm -97.82 8.24 45.04 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.951 -1.022 . . . . 17.87 109.94 -176.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.507 ' HA ' ' OE1' ' A' ' 180' ' ' GLN . 18.0 m120 -106.85 106.17 16.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.022 -0.99 . . . . 16.68 109.692 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.44 -26.17 68.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.067 -0.515 . . . . 14.47 111.067 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.61 -38.82 78.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.64 0.733 . . . . 16.57 109.969 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 160' ' ' ILE . 65.6 mttm -86.16 -17.92 33.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.783 -1.099 . . . . 16.69 110.305 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 71.8 t -68.49 -44.14 83.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.063 -0.717 . . . . 12.92 109.063 170.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -63.1 -29.07 70.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.894 -1.048 . . . . 15.83 111.98 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.4 -48.48 15.4 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.641 -0.424 . . . . 15.97 110.866 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 156' ' ' LYS . 24.8 mt -60.17 -46.87 94.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.545 0.688 . . . . 12.6 109.713 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.438 HG12 ' CB ' ' A' ' 165' ' ' ARG . 43.4 t -63.85 -33.72 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.729 -1.123 . . . . 12.54 110.349 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.69 -34.6 82.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.209 -0.519 . . . . 14.8 112.616 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -70.45 -52.23 23.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.4 . . . . 16.37 110.662 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.529 HD13 ' CG2' ' A' ' 188' ' ' VAL . 2.8 mt -87.87 -58.31 2.62 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.518 0.933 . . . . 12.99 113.518 -172.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.438 ' CB ' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -62.73 -37.04 85.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.394 0.616 . . . . 15.56 109.411 -176.227 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.08 -25.68 74.11 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.111 -0.95 . . . . 16.6 112.197 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.7 -2.98 58.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.948 0.404 . . . . 16.55 110.599 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.46 25.49 33.01 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.836 -0.697 . . . . 15.88 113.104 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -89.61 153.18 20.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.02 0.41 . . . . 15.6 110.462 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.52 100.48 1.42 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.198 0.523 . . . . 14.31 109.833 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.37 140.65 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.124 -0.944 . . . . 11.04 109.828 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.504 ' HH ' HD21 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.83 176.69 8.59 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.575 0.702 . . . . 11.47 110.935 172.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 20.3 p -122.47 -174.35 2.89 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.656 -1.156 . . . . 11.83 111.034 -171.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 67.4 m -51.83 142.29 25.26 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-O 121.218 0.533 . . . . 12.84 110.818 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 82.8 Cg_exo -49.22 -38.2 41.0 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 124.008 3.139 . . . . 15.06 115.179 -168.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 t -87.91 -65.68 0.99 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.813 -0.755 . . . . 16.97 112.261 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 70.7 m -170.17 128.5 0.81 Allowed Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 122.368 0.267 . . . . 16.04 110.94 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.46 ' HB3' HG21 ' A' ' 184' ' ' THR . 72.9 Cg_exo -60.02 121.88 10.52 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 121.848 1.699 . . . . 14.22 111.342 163.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.7 p -155.77 159.92 2.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.809 0.338 . . . . 16.46 110.538 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' A' ' 153' ' ' ASN . 9.2 mm100 -68.85 120.99 15.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.052 -0.522 . . . . 17.05 111.489 177.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.23 -26.22 17.58 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.805 -0.634 . . . . 17.2 112.798 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 13.6 mptt -103.07 154.65 19.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.977 -0.379 . . . . 19.02 109.977 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.7 tp -73.9 109.28 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.897 0.856 . . . . 15.32 110.836 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.46 HG21 ' HB3' ' A' ' 178' ' ' PRO . 29.2 m -101.91 107.06 18.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.605 0.717 . . . . 13.03 110.072 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.457 ' HD2' ' OE1' ' A' ' 147' ' ' GLN . 47.5 mtm180 -87.76 141.06 28.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.993 -1.003 . . . . 14.44 110.254 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.5 ' C ' HD11 ' A' ' 187' ' ' LEU . 4.4 mm -108.74 118.35 56.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.781 -0.822 . . . . 11.02 108.781 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.504 HD21 ' HH ' ' A' ' 172' ' ' TYR . 4.8 mp -128.9 130.85 47.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.487 0.661 . . . . 10.32 111.141 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.529 ' CG2' HD13 ' A' ' 164' ' ' LEU . 43.9 t -107.24 136.52 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.102 -0.953 . . . . 10.0 111.079 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 83.37 46.3 6.17 Favored Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 114.751 -1.113 . . . . 9.94 113.432 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.46 ' N ' HG12 ' A' ' 145' ' ' VAL . 10.9 Cg_endo -60.91 124.38 14.82 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 CA-C-N 119.674 1.737 . . . . 11.15 110.599 175.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -149.89 151.32 33.25 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.21 -0.663 . . . . 12.77 109.21 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.502 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -84.8 -11.91 54.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.367 -0.833 . . . . 15.0 111.581 -174.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.7 m -120.84 113.25 19.88 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.089 0.471 . . . . 14.58 110.954 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.638 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 20.8 ptmt -61.33 -36.29 79.75 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.504 -0.771 . . . . 16.29 111.305 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.35 -43.0 99.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.256 -0.429 . . . . 15.6 111.589 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -70.4 -39.01 74.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 14.36 110.531 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.672 HD22 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -84.37 -16.82 41.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.534 -0.757 . . . . 12.11 110.906 -176.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.417 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 0.8 OUTLIER -60.43 -34.96 74.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.661 0.743 . . . . 14.96 110.387 173.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.59 -12.87 81.12 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.712 -1.131 . . . . 13.32 110.494 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.499 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 69.7 m -82.2 -12.67 57.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.795 -0.702 . . . . 12.31 111.637 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 11.0 mt -69.44 -36.94 77.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.071 0.462 . . . . 12.72 109.934 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.09 -27.31 70.29 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.676 -0.773 . . . . 14.66 111.188 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.574 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 49.6 mt-10 -82.81 -27.32 30.99 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 110.142 -0.318 . . . . 14.54 110.142 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.76 -48.32 81.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.459 . . . . 12.55 111.621 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -56.76 -22.15 33.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.079 -0.51 . . . . 16.12 110.973 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -45.52 9.38 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.816 -0.629 . . . . 16.98 110.162 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 96.3 mt -65.3 -52.39 54.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.975 -0.557 . . . . 14.15 111.694 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.438 ' HB3' HD21 ' A' ' 164' ' ' LEU . 70.1 p -100.05 -44.76 5.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.282 0.563 . . . . 13.54 110.558 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.47 7.84 69.65 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.264 -0.88 . . . . 14.79 111.095 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.13 155.32 17.52 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.466 -0.568 . . . . 13.52 109.466 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 26.3 t -89.03 108.0 19.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.497 -0.319 . . . . 14.87 110.438 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -129.2 158.04 21.9 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.508 -0.853 . . . . 12.22 113.316 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.96 145.12 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.187 0.518 . . . . 14.04 109.997 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.88 110.18 5.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.47 -0.786 . . . . 12.89 110.227 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 93.4 mmm -117.88 141.23 48.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.848 -0.615 . . . . 14.23 110.569 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -66.9 152.73 52.76 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.777 -0.725 . . . . 14.09 112.158 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.523 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 10.9 t80 . . . . . 0 C--N 1.313 -1.009 0 C-N-CA 122.781 0.432 . . . . 14.24 109.954 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 217' ' ' TYR . . . . . . . . 0 CA--C 1.51 -0.58 0 N-CA-C 109.635 -0.506 . . . . 15.06 109.635 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.504 ' HA ' ' H ' ' A' ' 217' ' ' TYR . 3.3 m-85 -135.79 152.76 51.42 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.109 0.48 . . . . 14.83 111.863 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.459 ' CG2' ' HA ' ' A' ' 190' ' ' PRO . 0.9 OUTLIER -152.91 145.69 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.166 -0.925 . . . . 10.79 109.922 -174.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 44.4 t -112.26 108.13 24.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-N 118.424 0.556 . . . . 10.43 111.035 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -88.11 111.08 21.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.491 -0.322 . . . . 12.54 111.334 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.547 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -86.42 -38.87 16.92 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.225 0.536 . . . . 11.88 109.721 -178.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.45 167.51 26.99 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.488 -0.863 . . . . 11.9 112.523 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -168.89 101.68 0.39 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.037 -0.727 . . . . 13.47 109.037 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.16 163.98 37.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.905 -0.589 . . . . 14.03 110.571 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 90.8 mttt -99.22 2.45 45.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.041 -0.981 . . . . 17.87 110.221 -173.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -93.37 98.64 11.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.78 -1.1 . . . . 16.68 108.68 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.85 -20.65 63.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.059 0.457 . . . . 14.47 111.193 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.14 -28.94 64.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.732 0.777 . . . . 16.57 109.183 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -80.49 -34.06 36.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.515 -1.22 . . . . 16.69 108.768 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.402 HG11 HG22 ' A' ' 184' ' ' THR . 75.3 t -58.46 -36.61 59.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.085 -0.961 . . . . 12.92 109.806 172.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -62.02 -33.19 73.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.273 -0.876 . . . . 15.83 112.202 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.01 -35.86 28.42 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.051 -0.66 . . . . 15.97 110.996 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.504 HD11 HD12 ' A' ' 186' ' ' ILE . 14.0 mt -66.22 -47.45 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 12.6 109.437 176.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.59 -38.41 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.868 -1.06 . . . . 12.54 110.838 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -57.75 -30.23 62.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.016 -0.611 . . . . 14.8 112.4 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -70.61 -59.03 3.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.231 0.539 . . . . 16.37 111.081 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.31 -59.79 2.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.709 -0.678 . . . . 12.99 112.101 -173.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.427 ' C ' ' HD3' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -64.05 -37.03 85.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.352 0.596 . . . . 15.56 109.632 -177.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.27 -19.48 77.48 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.043 -0.981 . . . . 16.6 112.691 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -97.42 -13.76 21.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.792 0.329 . . . . 16.55 110.758 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.5 24.92 9.68 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.703 -0.761 . . . . 15.88 113.177 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 207' ' ' LEU . 34.1 m-85 -88.26 158.38 18.49 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.793 -0.239 . . . . 15.6 110.536 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -67.39 97.68 0.58 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.374 0.607 . . . . 14.31 110.08 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.6 p -144.96 137.81 21.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.146 -0.934 . . . . 11.04 110.168 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.52 ' HH ' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -142.12 176.72 8.74 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.454 0.645 . . . . 11.47 110.706 171.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.1 p -118.63 -177.05 3.22 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.785 -1.098 . . . . 11.83 110.713 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.1 OUTLIER -53.4 140.53 45.39 Favored Pre-proline 0 C--N 1.327 -0.405 0 O-C-N 123.256 0.347 . . . . 12.84 111.117 179.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -20.17 -67.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 1 C-N-CA 126.361 4.707 . . . . 15.06 116.048 -172.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.8 m -86.31 -61.66 1.69 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.981 0.734 . . . . 16.97 112.981 -170.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -166.69 133.8 2.02 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 122.021 -0.425 . . . . 16.04 111.795 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.416 ' HB3' HG22 ' A' ' 184' ' ' THR . 54.4 Cg_exo -60.97 125.02 16.1 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.716 2.277 . . . . 14.22 111.46 163.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.45 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 6.0 p -146.41 159.56 10.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.148 -0.686 . . . . 16.46 109.148 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -81.18 122.22 27.11 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.855 0.36 . . . . 17.05 110.862 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.13 -23.98 22.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 17.2 112.614 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.45 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 11.3 mptt -111.5 161.35 16.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.944 0.402 . . . . 19.02 110.327 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.6 tp -71.05 110.42 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.868 0.842 . . . . 15.32 112.114 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.462 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 62.1 m -99.34 106.46 18.56 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.583 -0.735 . . . . 13.03 109.715 172.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 89.8 mtt180 -89.22 136.76 32.84 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.452 -0.794 . . . . 14.44 109.159 176.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.515 ' C ' HD22 ' A' ' 187' ' ' LEU . 2.8 mt -117.2 116.21 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 121.172 0.51 . . . . 11.02 109.696 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.52 HD11 ' HH ' ' A' ' 172' ' ' TYR . 0.1 OUTLIER -128.9 128.07 43.06 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.153 -0.931 . . . . 10.32 111.278 -172.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.461 HG21 HD21 ' A' ' 148' ' ' LEU . 43.1 t -99.91 149.17 5.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.287 -1.324 . . . . 10.0 110.403 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 71.07 46.67 42.28 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 115.277 -0.874 . . . . 9.94 113.895 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.459 ' HA ' ' CG2' ' A' ' 145' ' ' VAL . 19.2 Cg_endo -67.49 124.73 12.39 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 CA-C-N 119.903 1.851 . . . . 11.15 110.401 172.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -160.37 150.09 17.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.888 -0.596 . . . . 12.77 109.963 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -91.13 -6.34 53.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.497 -0.774 . . . . 15.0 110.58 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.539 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 43.2 t -100.44 103.87 15.25 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.087 -0.506 . . . . 14.58 110.274 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 198' ' ' LYS . 32.0 ttpt -60.56 -43.26 97.47 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.451 -0.795 . . . . 16.29 109.642 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.62 -55.49 30.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.217 -0.901 . . . . 15.6 112.398 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -65.51 -41.31 93.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.962 0.41 . . . . 14.36 111.147 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.539 ' HB3' ' O ' ' A' ' 193' ' ' SER . 0.2 OUTLIER -81.22 -18.29 46.62 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.103 -0.499 . . . . 12.11 110.849 -176.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 20.8 tptm -56.52 -55.34 34.95 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.684 0.754 . . . . 14.96 110.885 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -71.48 -13.18 74.05 Favored Glycine 0 CA--C 1.504 -0.64 0 CA-C-N 114.589 -1.187 . . . . 13.32 110.64 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 204' ' ' LEU . 72.9 m -78.45 -12.87 60.03 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.657 -0.771 . . . . 12.31 111.517 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 23.1 mt -76.66 -40.18 49.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.848 0.356 . . . . 12.72 110.477 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.1 -36.45 88.57 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.857 -0.687 . . . . 14.66 111.528 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.519 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 15.4 pt-20 -86.25 -16.89 36.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.888 0.375 . . . . 14.54 110.481 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 200' ' ' SER . 15.4 tp -71.34 -33.18 69.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.644 0.259 . . . . 12.55 111.166 -173.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.593 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 19.1 pttp -62.96 -16.16 58.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.186 0.517 . . . . 16.12 110.344 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.407 ' HG2' ' N ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -90.11 -42.02 11.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.811 -0.631 . . . . 16.98 110.081 170.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.8 mt -68.87 -52.79 25.93 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.788 -0.642 . . . . 14.15 111.505 -175.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 16.7 t -92.49 -44.11 8.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.433 0.635 . . . . 13.54 109.56 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 71.31 -2.13 22.52 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 114.837 -1.074 . . . . 14.79 112.164 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 53.3 mt -92.62 150.31 20.79 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.538 -0.541 . . . . 13.52 109.538 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 19.5 m -85.68 111.84 20.47 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.093 0.473 . . . . 14.87 110.59 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -130.51 163.83 23.11 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.479 -0.867 . . . . 12.22 112.491 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.9 p -100.29 135.39 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.348 0.594 . . . . 14.04 110.472 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 45.9 t -79.71 104.94 8.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.87 -1.059 . . . . 12.89 109.492 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 97.0 mmm -117.24 146.7 43.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.665 -0.698 . . . . 14.23 110.457 -175.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.64 106.33 2.16 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.41 -0.9 . . . . 14.09 111.733 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.504 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 9.3 t80 . . . . . 0 C--N 1.316 -0.849 0 C-N-CA 123.446 0.699 . . . . 14.24 110.517 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.705 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.424 -0.584 . . . . 15.06 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.695 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 5.2 m-85 -143.7 141.94 30.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.261 0.224 . . . . 14.83 111.086 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 187' ' ' LEU . 2.4 t -150.98 162.02 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 109.625 -0.509 . . . . 10.79 109.625 171.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 27.7 t -104.01 117.57 49.75 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 O-C-N 122.21 -0.306 . . . . 10.43 111.129 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.505 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 6.1 tt0 -91.02 111.4 22.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.649 0.24 . . . . 12.54 111.649 -176.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.529 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -94.47 -34.55 12.67 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.215 0.531 . . . . 11.88 110.313 -177.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.51 162.07 27.97 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.671 -0.776 . . . . 11.9 111.923 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -165.38 101.76 0.72 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.758 -0.46 . . . . 13.47 109.758 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.54 163.14 33.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.544 0.687 . . . . 14.03 111.127 -173.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 43.2 mttm -98.47 13.47 31.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.641 -1.163 . . . . 17.87 109.722 -177.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -117.64 104.01 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.31 -0.859 . . . . 16.68 110.277 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -22.71 67.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.204 0.526 . . . . 14.47 110.802 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.02 -37.94 55.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.063 -0.972 . . . . 16.57 111.002 175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -89.64 -31.89 17.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.929 -1.032 . . . . 16.69 110.351 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.417 HG13 HG21 ' A' ' 184' ' ' THR . 82.8 t -55.1 -44.31 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.831 -0.622 . . . . 12.92 110.783 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -58.6 -30.4 67.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.575 -0.739 . . . . 15.83 111.468 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.47 -56.43 4.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.829 -0.434 . . . . 15.97 109.829 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.4 mt -54.76 -40.71 53.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.295 -0.866 . . . . 12.6 110.601 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.6 t -73.83 -44.0 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.852 -0.613 . . . . 12.54 110.737 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.69 -32.4 73.93 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.633 -0.794 . . . . 14.8 111.861 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -67.41 -59.92 3.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.645 0.26 . . . . 16.37 111.214 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 208' ' ' SER . 2.1 mm? -85.98 -57.02 3.2 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.58 0.585 . . . . 12.99 112.58 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.46 ' HD3' ' O ' ' A' ' 165' ' ' ARG . 0.8 OUTLIER -64.45 -35.52 81.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.408 0.623 . . . . 15.56 109.549 -178.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.95 -15.22 76.18 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.349 -0.841 . . . . 16.6 112.313 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -96.17 7.25 46.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.295 0.569 . . . . 16.55 110.342 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.44 15.72 58.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.766 -0.652 . . . . 15.88 113.051 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.439 ' CE1' ' HB3' ' A' ' 207' ' ' LEU . 53.1 m-85 -91.65 148.06 22.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 117.031 0.415 . . . . 15.6 110.574 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.407 ' HB3' ' HD2' ' A' ' 190' ' ' PRO . 22.9 mmm180 -62.56 98.98 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 14.31 110.512 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 165' ' ' ARG . 10.2 t -133.83 133.46 56.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.038 0.447 . . . . 11.04 110.969 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -138.36 175.21 9.77 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.447 -0.797 . . . . 11.47 110.375 170.465 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 22.7 p -115.22 -176.11 2.84 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.878 -1.055 . . . . 11.83 111.173 -172.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.572 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.1 OUTLIER -53.51 143.51 36.75 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 123.16 0.288 . . . . 12.84 111.411 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -25.47 -57.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 1 C-N-CA 126.009 4.473 . . . . 15.06 116.239 -174.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.3 m -87.19 -64.34 1.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.682 -0.807 . . . . 16.97 113.0 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.5 m -170.38 135.57 1.16 Allowed Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 117.857 0.299 . . . . 16.04 111.68 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.414 ' HB3' HG21 ' A' ' 184' ' ' THR . 76.0 Cg_exo -60.13 124.76 15.91 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.139 2.559 . . . . 14.22 112.507 166.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.465 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.1 p -153.51 158.48 3.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.911 -0.586 . . . . 16.46 109.609 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.22 134.67 36.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.392 -0.367 . . . . 17.05 110.347 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 95.27 -25.9 22.03 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.85 -0.691 . . . . 17.2 112.422 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.528 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 9.8 mptt -106.95 168.94 8.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.18 -0.674 . . . . 19.02 109.18 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 10.3 tp -77.53 111.29 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.871 0.843 . . . . 15.32 111.84 -173.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.572 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 37.4 m -105.31 109.93 22.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.463 -0.79 . . . . 13.03 109.18 170.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.542 ' O ' ' HA ' ' A' ' 173' ' ' THR . 36.5 mtt180 -94.68 145.89 24.54 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.597 -0.729 . . . . 14.44 110.2 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.491 ' O ' HD21 ' A' ' 148' ' ' LEU . 3.0 mm -110.37 119.66 59.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.699 -0.852 . . . . 11.02 108.699 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.534 ' HB3' ' CG1' ' A' ' 145' ' ' VAL . 6.1 mp -128.79 131.37 47.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.376 0.608 . . . . 10.32 110.887 -175.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.426 ' CG1' HD13 ' A' ' 204' ' ' LEU . 39.8 t -104.01 133.74 47.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.995 -1.002 . . . . 10.0 110.845 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.75 47.64 5.83 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 114.907 -1.042 . . . . 9.94 113.731 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.459 ' N ' HG13 ' A' ' 145' ' ' VAL . 10.9 Cg_endo -60.79 125.56 17.51 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 CA-C-N 119.629 1.715 . . . . 11.15 110.888 174.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -159.25 168.1 27.33 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.932 -0.576 . . . . 12.77 109.583 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.9 13.69 27.43 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.296 0.569 . . . . 15.0 109.776 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 22.8 t -118.43 109.47 16.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.885 -0.598 . . . . 14.58 111.373 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.69 ' HB2' ' CZ ' ' A' ' 144' ' ' TYR . 38.3 ttpt -69.91 -42.35 73.45 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.67 -0.863 . . . . 16.29 108.67 171.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -56.6 -40.63 75.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 15.6 111.652 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -79.72 -48.25 13.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.374 -0.376 . . . . 14.36 111.196 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -79.66 -20.76 45.89 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.884 0.328 . . . . 12.11 111.884 -171.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.497 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 29.2 tptp -67.4 -44.6 78.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.236 0.541 . . . . 14.96 109.714 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.28 -13.62 76.84 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.678 -0.692 . . . . 13.32 111.547 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 73.9 m -75.32 -24.01 57.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.519 0.2 . . . . 12.31 111.367 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 15.8 mt -61.49 -31.14 71.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.349 . . . . 12.72 110.878 -175.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.48 -46.11 94.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.565 -0.826 . . . . 14.66 111.924 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.499 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 12.6 pt-20 -86.83 -19.64 28.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.429 . . . . 14.54 111.111 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.426 HD13 ' CG1' ' A' ' 188' ' ' VAL . 14.9 tp -68.63 -35.75 77.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.3 -0.409 . . . . 12.55 111.62 -172.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.433 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 6.3 ptpp? -64.37 -16.31 62.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.825 0.345 . . . . 16.12 110.765 174.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.42 -35.5 15.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.117 0.484 . . . . 16.98 110.04 172.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 82.5 mt -74.96 -53.18 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 14.15 111.36 -176.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.485 ' HA ' HD12 ' A' ' 164' ' ' LEU . 3.4 m -94.86 -43.68 8.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 13.54 110.592 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 71.35 1.02 40.92 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.318 -0.856 . . . . 14.79 112.383 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 59.5 mt -84.37 154.48 22.83 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.341 -0.615 . . . . 13.52 109.341 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 23.3 m -77.17 93.49 3.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.86 0.362 . . . . 14.87 110.104 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -111.13 136.54 13.67 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.641 -0.79 . . . . 12.22 113.348 -175.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.92 138.4 25.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.038 -0.727 . . . . 14.04 109.038 174.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 6.6 p -79.23 108.1 12.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.736 0.779 . . . . 12.89 109.378 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 67.2 mtt -122.42 152.52 40.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.369 -0.832 . . . . 14.23 110.13 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -75.26 143.61 30.89 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.004 -1.094 . . . . 14.09 111.616 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.705 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 4.3 t80 . . . . . 0 C--N 1.304 -1.384 0 CA-C-N 114.217 -0.992 . . . . 14.24 109.617 -170.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.75 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 110.387 -0.227 . . . . 15.06 110.387 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.672 ' CE2' ' HE3' ' A' ' 194' ' ' LYS . 36.6 m-85 -142.28 142.9 32.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.549 0.34 . . . . 14.83 111.67 -172.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.488 ' CG2' ' HA ' ' A' ' 190' ' ' PRO . 3.4 t -148.74 164.4 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 109.371 -0.603 . . . . 10.79 109.371 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.419 ' H ' HG11 ' A' ' 145' ' ' VAL . 40.1 t -101.17 107.84 22.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 122.055 -0.403 . . . . 10.43 111.373 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.536 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 40.2 tt0 -78.68 115.94 18.71 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 122.617 0.367 . . . . 12.54 111.129 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.524 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -93.74 -33.31 13.66 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.424 0.631 . . . . 11.88 109.778 177.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.68 168.51 27.39 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.402 -0.817 . . . . 11.9 112.423 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -168.41 100.47 0.42 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.488 -0.93 . . . . 13.47 108.488 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.18 160.77 42.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.661 -0.7 . . . . 14.03 110.799 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 44.7 mtpt -99.35 -6.64 27.49 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.948 -1.024 . . . . 17.87 110.262 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.535 ' ND2' ' HG3' ' A' ' 156' ' ' LYS . 36.2 t30 -90.96 106.5 18.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.527 -0.76 . . . . 16.68 109.691 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.01 -21.38 64.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.969 -0.56 . . . . 14.47 111.697 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -59.52 -35.08 73.5 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.774 0.797 . . . . 16.57 109.878 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.535 ' HG3' ' ND2' ' A' ' 153' ' ' ASN . 28.3 mtpp -83.67 -33.35 25.24 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.561 -1.2 . . . . 16.69 110.753 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' A' ' 178' ' ' PRO . 89.7 t -57.48 -39.14 67.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.404 0.621 . . . . 12.92 109.662 173.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -60.78 -30.32 69.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.106 -0.952 . . . . 15.83 111.743 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.6 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 6.0 mm-40 -77.24 -61.65 1.91 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.185 -0.672 . . . . 15.97 109.185 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 156' ' ' LYS . 12.3 mt -49.41 -46.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.357 -0.838 . . . . 12.6 110.793 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.3 t -73.75 -41.42 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.463 -0.789 . . . . 12.54 110.602 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.66 -28.88 70.61 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.611 -0.804 . . . . 14.8 112.137 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.6 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.6 mptp? -72.7 -52.44 15.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.703 0.287 . . . . 16.37 111.183 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.5 mm? -86.39 -55.86 3.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.272 0.471 . . . . 12.99 112.272 -176.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -63.45 -40.28 96.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.223 0.535 . . . . 15.56 109.752 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.68 -23.98 73.98 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.02 -0.991 . . . . 16.6 112.517 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.18 0.85 56.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.867 0.365 . . . . 16.55 110.723 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.56 17.3 58.76 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.927 -0.654 . . . . 15.88 113.237 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -83.86 153.85 23.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.979 0.39 . . . . 15.6 111.036 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.15 99.33 2.79 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.284 -0.636 . . . . 14.31 109.284 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.66 141.7 27.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 114.904 -1.044 . . . . 11.04 109.255 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.7 176.41 8.72 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.994 0.902 . . . . 11.47 111.31 170.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 14.2 p -123.34 -173.73 2.79 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.817 -1.538 . . . . 11.83 109.886 -171.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.454 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 19.5 m -50.01 137.58 19.97 Favored Pre-proline 0 C--O 1.234 0.278 0 N-CA-C 109.737 -0.468 . . . . 12.84 109.737 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -37.44 -50.38 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 124.572 3.515 . . . . 15.06 115.399 -167.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.0 t -82.93 -60.41 2.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.116 -0.634 . . . . 16.97 112.471 -172.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.3 m -166.81 135.43 2.24 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 117.891 0.314 . . . . 16.04 111.608 -175.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.448 ' HB3' HG12 ' A' ' 157' ' ' VAL . 34.4 Cg_exo -62.24 124.62 14.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.266 1.977 . . . . 14.22 111.063 165.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.453 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.8 p -153.57 154.56 7.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 110.084 -0.339 . . . . 16.46 110.084 -176.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -82.92 141.59 32.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.123 0.487 . . . . 17.05 110.887 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.93 -17.07 59.33 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.698 -0.683 . . . . 17.2 111.921 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 10.2 mptt -123.78 156.8 35.42 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.353 -0.61 . . . . 19.02 109.353 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.414 ' O ' HG21 ' A' ' 183' ' ' ILE . 7.7 tp -71.46 109.07 3.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.554 0.692 . . . . 15.32 111.049 -174.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.454 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 32.6 m -103.49 106.77 17.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.813 0.816 . . . . 13.03 110.438 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.492 ' HG2' ' CD1' ' A' ' 187' ' ' LEU . 22.1 ttp180 -85.39 133.29 34.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.317 -1.31 . . . . 14.44 109.367 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.448 ' C ' HD13 ' A' ' 187' ' ' LEU . 2.0 mm -112.98 118.6 58.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.057 -0.72 . . . . 11.02 109.057 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.492 ' CD1' ' HG2' ' A' ' 185' ' ' ARG . 1.5 mp -131.33 132.64 44.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.396 0.617 . . . . 10.32 111.278 -172.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.432 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 42.3 t -104.9 134.44 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.217 -0.902 . . . . 10.0 111.009 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 84.57 50.41 4.24 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.443 -0.799 . . . . 9.94 113.739 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.488 ' HA ' ' CG2' ' A' ' 145' ' ' VAL . 5.3 Cg_endo -55.88 125.51 19.32 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 119.277 1.538 . . . . 11.15 111.424 174.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -152.47 169.01 23.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.657 -0.702 . . . . 12.77 109.23 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.47 -1.88 22.63 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.81 0.338 . . . . 15.0 111.086 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 70.5 m -121.11 110.15 15.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.863 0.363 . . . . 14.58 111.351 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.672 ' HE3' ' CE2' ' A' ' 144' ' ' TYR . 37.5 ttmt -65.13 -53.44 45.13 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.968 -0.56 . . . . 16.29 110.014 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -51.34 -40.26 58.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.264 -0.88 . . . . 15.6 111.647 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -74.7 -42.07 59.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 14.36 110.947 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 197' ' ' LEU . 0.2 OUTLIER -78.56 -20.25 51.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.022 0.439 . . . . 12.11 110.19 -177.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.454 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.4 tptm -67.06 -39.58 86.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.423 0.63 . . . . 14.96 110.305 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.75 -12.17 84.04 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.303 -1.119 . . . . 13.32 110.303 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 71.5 m -90.26 -9.29 48.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.528 -0.836 . . . . 12.31 112.454 -175.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.506 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 18.2 mt -65.2 -35.79 82.15 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.774 -0.37 . . . . 12.72 110.908 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.96 -44.08 97.52 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.915 -0.66 . . . . 14.66 112.331 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 200' ' ' SER . 11.1 pt-20 -81.06 -18.5 46.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.936 0.398 . . . . 14.54 110.457 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.95 -32.17 71.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 12.55 109.958 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 25.2 mtpp -62.0 -19.84 63.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.572 -0.74 . . . . 16.12 110.37 173.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -40.01 13.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.174 0.511 . . . . 16.98 109.719 172.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.75 -52.54 59.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.63 -0.714 . . . . 14.15 111.339 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 164' ' ' LEU . 62.8 p -103.84 -46.95 4.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.999 0.428 . . . . 13.54 110.802 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 82.27 -6.18 69.13 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.789 -0.641 . . . . 14.79 111.8 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.404 HD23 HG22 ' A' ' 160' ' ' ILE . 9.0 mp -86.61 158.37 19.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.82 -0.437 . . . . 13.52 109.82 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 16.1 m -80.13 94.73 6.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.851 -0.613 . . . . 14.87 110.594 -175.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -111.83 148.55 18.12 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.591 -0.814 . . . . 12.22 113.45 -176.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.4 141.97 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.963 0.411 . . . . 14.04 109.932 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.31 106.77 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.689 0.757 . . . . 12.89 110.372 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 96.6 mmm -117.87 168.55 10.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.464 -0.789 . . . . 14.23 110.376 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -84.76 151.31 26.17 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.356 -0.926 . . . . 14.09 112.462 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.75 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 3.9 t80 . . . . . 0 C--N 1.311 -1.085 0 CA-C-N 114.418 -0.891 . . . . 14.24 109.582 -171.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.629 ' HB2' ' CD2' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 110.449 -0.204 . . . . 15.06 110.449 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.657 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 37.9 m-85 -136.91 143.72 43.11 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.555 -0.293 . . . . 14.83 111.569 -173.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.518 ' CG1' ' HA ' ' A' ' 190' ' ' PRO . 3.0 m -151.39 160.73 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.301 0.64 . . . . 10.79 110.036 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 12.4 t -114.59 122.04 67.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 120.754 -0.378 . . . . 10.43 110.021 176.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.514 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 27.2 tt0 -92.8 97.02 10.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.594 0.235 . . . . 12.54 110.917 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.724 HD11 ' N ' ' A' ' 212' ' ' GLY . 0.3 OUTLIER -83.41 -27.88 29.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.344 0.592 . . . . 11.88 109.691 -177.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.17 162.26 28.15 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.402 -0.904 . . . . 11.9 112.34 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.96 101.52 0.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.779 -0.452 . . . . 13.47 109.779 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.92 158.7 43.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.329 0.585 . . . . 14.03 110.748 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -99.45 4.97 46.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.096 -0.957 . . . . 17.87 109.808 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -105.88 116.72 32.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.887 -1.051 . . . . 16.68 109.74 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -73.48 -23.45 60.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.169 -0.469 . . . . 14.47 112.17 -174.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.84 -35.31 79.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.891 0.853 . . . . 16.57 109.411 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.577 ' O ' HG13 ' A' ' 160' ' ' ILE . 32.3 mmtp -76.08 -38.55 56.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.127 -1.397 . . . . 16.69 110.205 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.431 HG13 HG21 ' A' ' 184' ' ' THR . 93.3 t -57.28 -47.69 83.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.307 0.575 . . . . 12.92 110.325 176.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -59.16 -35.56 73.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.986 -1.006 . . . . 15.83 111.985 -174.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.65 -39.25 27.64 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.626 -0.43 . . . . 15.97 111.65 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 156' ' ' LYS . 29.2 mt -62.7 -49.29 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.549 0.69 . . . . 12.6 109.523 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 91.8 t -66.08 -36.2 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.891 -1.05 . . . . 12.54 109.788 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -56.97 -32.67 62.72 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 14.8 112.187 176.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -71.8 -62.26 1.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.321 . . . . 16.37 111.452 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.02 -50.38 12.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.119 -0.491 . . . . 12.99 112.113 -172.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 3.9 tmt_? -64.84 -43.42 93.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.353 -0.61 . . . . 15.56 109.353 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.01 -27.23 73.36 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.043 -0.981 . . . . 16.6 112.874 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.27 -8.4 59.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.989 0.423 . . . . 16.55 110.625 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.21 19.82 27.21 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.053 -0.594 . . . . 15.88 113.197 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.571 ' CE1' ' HB3' ' A' ' 207' ' ' LEU . 42.7 m-85 -88.22 157.13 18.88 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 117.23 0.515 . . . . 15.6 110.713 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -77.75 100.64 6.34 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.521 0.677 . . . . 14.31 109.279 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.6 p -142.06 137.98 30.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.687 -1.142 . . . . 11.04 109.477 -174.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.49 176.56 8.68 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.539 0.685 . . . . 11.47 110.585 174.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 10.0 p -121.82 -173.97 2.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.722 -1.126 . . . . 11.83 111.191 -169.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 74.7 m -50.45 143.05 14.27 Favored Pre-proline 0 C--O 1.236 0.35 0 O-C-N 123.465 0.478 . . . . 12.84 110.634 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -45.01 -45.43 14.18 Favored 'Trans proline' 0 CA--C 1.527 0.175 0 C-N-CA 124.006 3.138 . . . . 15.06 114.863 -170.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.2 p -86.97 -63.79 1.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.882 -0.727 . . . . 16.97 112.848 -172.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.9 m -168.54 130.04 1.14 Allowed Pre-proline 0 C--O 1.234 0.278 0 O-C-N 122.464 -0.148 . . . . 16.04 111.202 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.446 ' HB3' HG21 ' A' ' 184' ' ' THR . 78.2 Cg_exo -61.45 122.43 11.08 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.116 1.877 . . . . 14.22 111.493 162.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.43 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 4.3 p -155.35 161.68 2.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.849 -0.426 . . . . 16.46 109.849 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -75.25 124.41 27.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.77 0.319 . . . . 17.05 110.681 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.16 -26.06 16.37 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.094 -0.574 . . . . 17.2 112.577 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.43 ' HD3' ' CG1' ' A' ' 179' ' ' VAL . 0.8 OUTLIER -107.16 154.61 20.94 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.703 -0.48 . . . . 19.02 109.703 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.421 ' O ' HG21 ' A' ' 183' ' ' ILE . 8.1 tp -72.79 109.89 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.513 0.673 . . . . 15.32 111.071 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 178' ' ' PRO . 31.4 m -98.8 109.41 22.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.624 0.726 . . . . 13.03 109.974 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 76.9 mtm180 -95.01 134.25 37.89 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.922 -1.036 . . . . 14.44 109.941 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.5 mm -102.56 106.9 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 109.722 -0.473 . . . . 11.02 109.722 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.51 ' HB2' ' CE2' ' A' ' 172' ' ' TYR . 6.1 mp -110.85 114.84 28.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.582 0.706 . . . . 10.32 110.841 -174.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.415 ' HB ' HD21 ' A' ' 148' ' ' LEU . 41.9 t -95.08 140.89 15.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.856 -1.065 . . . . 10.0 110.001 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 77.55 45.85 10.54 Favored Glycine 0 N--CA 1.434 -1.495 0 CA-C-N 115.292 -0.867 . . . . 9.94 114.139 174.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.518 ' HA ' ' CG1' ' A' ' 145' ' ' VAL . 11.4 Cg_endo -61.92 126.38 18.72 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 CA-C-N 119.762 1.781 . . . . 11.15 110.83 171.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -161.54 167.87 24.62 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.987 -0.552 . . . . 12.77 109.721 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -103.9 7.49 36.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.255 -0.43 . . . . 15.0 110.427 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 36.4 t -120.6 116.57 25.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.918 -0.583 . . . . 14.58 110.921 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.635 ' HB2' ' CD2' ' A' ' 144' ' ' TYR . 31.5 ttmt -70.92 -47.75 57.33 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.022 -0.733 . . . . 16.29 109.022 172.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -46.24 -57.46 4.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.704 -1.134 . . . . 15.6 111.639 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -70.7 -39.66 73.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.459 -0.791 . . . . 14.36 111.995 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -82.39 -30.99 29.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.645 0.239 . . . . 12.11 111.645 -174.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.563 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 13.3 tmtt? -79.32 -29.98 42.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.218 -0.66 . . . . 14.96 109.218 -177.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.51 -12.03 83.96 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.022 -1.231 . . . . 13.32 110.022 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 46.3 m -91.09 -8.07 49.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.592 -0.804 . . . . 12.31 112.272 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 23.2 mt -66.96 -35.12 79.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.922 -0.311 . . . . 12.72 111.244 -174.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -58.58 -42.95 96.35 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.735 -0.745 . . . . 14.66 111.905 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 200' ' ' SER . 10.7 pt-20 -83.62 -18.34 38.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.07 0.462 . . . . 14.54 110.412 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.423 ' HG ' ' HG ' ' A' ' 208' ' ' SER . 21.1 tp -69.36 -27.65 65.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.143 -0.481 . . . . 12.55 110.049 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.472 ' HZ1' ' HB3' ' A' ' 205' ' ' LYS . 6.5 mtpm? -63.48 -20.88 65.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.786 -0.643 . . . . 16.12 110.496 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.84 -35.97 16.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.715 -0.476 . . . . 16.98 109.715 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.571 ' HB3' ' CE1' ' A' ' 169' ' ' TYR . 81.9 mt -73.41 -53.09 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.613 -0.722 . . . . 14.15 111.681 -175.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.423 ' HG ' ' HG ' ' A' ' 204' ' ' LEU . 71.2 p -95.04 -42.64 8.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.271 0.557 . . . . 13.54 110.68 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 70.2 5.79 55.07 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.167 -0.924 . . . . 14.79 111.694 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 148' ' ' LEU . 96.1 mt -89.86 162.8 15.29 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.594 0.758 . . . . 13.52 109.84 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 66.1 m -102.24 99.89 10.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.13 0.419 . . . . 14.87 112.13 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.724 ' N ' HD11 ' A' ' 148' ' ' LEU . . . -116.55 157.43 15.05 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.303 -0.951 . . . . 12.22 114.559 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.76 146.15 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.779 -0.711 . . . . 14.04 109.796 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 24.0 t -74.53 117.69 19.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.857 -0.611 . . . . 12.89 110.057 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 87.6 mtp -128.83 153.81 47.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.089 -0.505 . . . . 14.23 110.277 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -86.71 111.1 3.59 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.308 -0.949 . . . . 14.09 112.208 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.657 ' HB3' ' N ' ' A' ' 144' ' ' TYR . 5.2 t80 . . . . . 0 C--N 1.312 -1.027 0 C-N-CA 124.688 1.195 . . . . 14.24 110.472 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.505 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 110.041 -0.355 . . . . 15.06 110.041 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.661 ' CD1' ' HG3' ' A' ' 194' ' ' LYS . 5.4 m-85 -146.72 159.82 43.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.685 0.279 . . . . 14.83 111.454 -177.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 190' ' ' PRO . 2.3 t -149.32 158.83 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.719 -0.845 . . . . 10.79 108.719 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.45 HG12 ' HA3' ' A' ' 212' ' ' GLY . 42.9 t -100.89 106.33 19.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 O-C-N 122.081 -0.387 . . . . 10.43 111.047 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.537 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 28.3 tt0 -78.85 110.23 13.85 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.526 0.331 . . . . 12.54 111.311 -177.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.539 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -87.94 -37.92 16.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.306 0.574 . . . . 11.88 109.568 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.3 164.28 28.02 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.374 -0.917 . . . . 11.9 112.559 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -164.43 104.25 0.84 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.695 -0.854 . . . . 13.47 108.695 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.99 166.19 24.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.956 -0.566 . . . . 14.03 110.406 -173.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 48.5 mtpt -102.77 -6.53 22.51 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.042 -0.981 . . . . 17.87 110.355 -174.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -99.38 109.68 22.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.556 -0.747 . . . . 16.68 109.61 173.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.0 -19.55 65.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.065 -0.516 . . . . 14.47 111.494 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.12 -35.51 75.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.813 0.816 . . . . 16.57 109.965 174.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.5 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.12 -26.98 33.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.564 -1.198 . . . . 16.69 110.12 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.528 ' HA ' HD12 ' A' ' 186' ' ' ILE . 69.5 t -66.0 -39.16 83.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.675 -0.693 . . . . 12.92 110.413 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -68.05 -23.5 64.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.816 -0.629 . . . . 15.83 111.349 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.56 -61.85 1.7 Allowed 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.367 -0.605 . . . . 15.97 109.367 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.557 HD12 HD11 ' A' ' 186' ' ' ILE . 18.2 mt -53.74 -43.89 57.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.582 -1.19 . . . . 12.6 110.274 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 0.3 OUTLIER -72.63 -37.11 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.601 -0.727 . . . . 12.54 110.197 -177.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -66.0 -29.76 75.65 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.768 -0.73 . . . . 14.8 111.505 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -70.23 -51.3 31.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.875 0.369 . . . . 16.37 110.152 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.456 HD13 ' CG2' ' A' ' 188' ' ' VAL . 16.3 mt -88.84 -59.26 2.28 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.133 0.79 . . . . 12.99 113.133 -173.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 55.2 ttp180 -60.86 -37.42 82.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.453 0.644 . . . . 15.56 109.768 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.2 -18.86 78.29 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.907 -1.042 . . . . 16.6 112.266 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -95.67 -0.93 51.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.881 0.372 . . . . 16.55 110.624 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.48 25.8 45.65 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.653 -0.784 . . . . 15.88 113.14 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -92.49 154.85 18.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.952 0.376 . . . . 15.6 110.968 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -67.55 104.23 1.54 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.426 0.631 . . . . 14.31 109.773 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.46 137.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.019 -0.991 . . . . 11.04 109.858 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.413 ' CE1' HG22 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -140.17 175.25 9.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.899 0.857 . . . . 11.47 111.211 169.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 15.0 p -121.96 -175.42 3.1 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.98 -1.464 . . . . 11.83 110.384 -172.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.429 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 7.3 m -50.38 125.6 20.44 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 109.115 -0.698 . . . . 12.84 109.115 173.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 89.6 Cg_exo -45.41 -35.51 11.99 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.349 3.366 . . . . 15.06 115.337 -167.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.9 p -79.85 -62.63 1.63 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.017 -0.673 . . . . 16.97 111.816 -175.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.2 m -167.68 135.01 1.87 Allowed Pre-proline 0 C--N 1.329 -0.298 0 C-N-CA 122.183 0.193 . . . . 16.04 110.771 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.01 123.2 11.53 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.634 1.556 . . . . 14.22 110.107 161.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.5 p -154.22 156.72 4.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.484 -0.487 . . . . 16.46 111.197 -172.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -81.78 133.82 35.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.82 -0.627 . . . . 17.05 110.875 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 99.81 -22.95 38.04 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.881 -0.599 . . . . 17.2 112.471 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 9.1 mptt -115.04 160.67 19.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.445 -0.576 . . . . 19.02 109.445 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 183' ' ' ILE . 9.1 tp -74.16 109.82 7.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.735 0.778 . . . . 15.32 111.28 -174.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 40.0 m -104.22 106.58 17.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.649 0.738 . . . . 13.03 110.208 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 173' ' ' THR . 31.1 ttm180 -86.77 136.58 32.94 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.637 -1.165 . . . . 14.44 109.54 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.557 HD11 HD12 ' A' ' 160' ' ' ILE . 3.6 mt -121.61 120.61 62.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.375 -0.602 . . . . 11.02 109.375 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.521 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -130.54 143.56 50.83 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.356 -0.838 . . . . 10.32 110.406 -169.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' A' ' 148' ' ' LEU . 42.5 t -107.69 136.23 43.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.461 -0.79 . . . . 10.0 111.31 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 81.94 48.74 5.64 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.736 -1.12 . . . . 9.94 113.533 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.51 ' N ' HG12 ' A' ' 145' ' ' VAL . 9.9 Cg_endo -58.94 125.2 17.51 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 CA-C-N 119.472 1.636 . . . . 11.15 110.292 174.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 5.3 t70 -150.93 163.05 39.62 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 120.397 -0.521 . . . . 12.77 110.295 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -103.22 -4.17 24.72 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.304 -0.862 . . . . 15.0 111.281 -176.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 42.8 m -114.79 99.41 7.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.371 0.605 . . . . 14.58 110.449 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.661 ' HG3' ' CD1' ' A' ' 144' ' ' TYR . 25.3 ttpt -59.67 -54.51 45.58 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 114.984 -1.007 . . . . 16.29 111.881 -174.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.93 -40.88 97.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.004 0.43 . . . . 15.6 110.838 -172.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.39 -44.28 96.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 14.36 110.551 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -79.08 -22.54 45.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.049 -0.523 . . . . 12.11 110.567 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.437 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.3 tptm -69.15 -35.74 76.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.403 0.62 . . . . 14.96 109.92 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.02 -11.34 85.48 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.573 -1.011 . . . . 13.32 110.573 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 65.5 m -90.27 -8.96 49.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.89 -0.655 . . . . 12.31 112.624 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.51 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 18.4 mt -64.39 -34.52 78.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.001 -0.28 . . . . 12.72 111.409 -174.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.06 -42.92 96.41 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.831 -0.699 . . . . 14.66 112.135 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -79.31 -18.53 52.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 14.54 110.282 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.425 HD13 HD11 ' A' ' 207' ' ' LEU . 3.4 tp -76.27 -26.88 56.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.116 -0.493 . . . . 12.55 110.607 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 92.7 mttt -61.37 -22.47 64.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.145 0.498 . . . . 16.12 110.256 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -30.74 26.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.314 0.578 . . . . 16.98 109.58 173.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.425 HD11 HD13 ' A' ' 204' ' ' LEU . 88.9 mt -75.33 -53.76 8.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.503 -0.771 . . . . 14.15 111.84 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 p -99.58 -48.05 4.89 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.499 -0.481 . . . . 13.54 110.721 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 77.45 -0.64 68.62 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.706 -0.679 . . . . 14.79 112.675 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.14 158.1 17.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.328 -0.619 . . . . 13.52 109.328 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 35.8 m -84.06 102.57 12.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.159 -0.473 . . . . 14.87 110.877 -175.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -122.43 150.06 16.95 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.28 -0.962 . . . . 12.22 113.61 -175.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.97 144.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.497 -0.557 . . . . 14.04 109.497 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.88 105.85 2.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.655 0.74 . . . . 12.89 109.767 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 98.0 mmm -119.27 139.72 51.45 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.677 -0.692 . . . . 14.23 110.674 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -68.92 155.42 53.54 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.587 -0.733 . . . . 14.09 112.425 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.505 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 16.0 t80 . . . . . 0 C--N 1.311 -1.071 0 CA-C-N 115.124 -0.538 . . . . 14.24 110.364 -171.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.594 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.784 -0.451 . . . . 15.06 109.784 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.55 ' CB ' HD22 ' A' ' 197' ' ' LEU . 3.8 m-85 -144.45 159.96 41.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.851 0.357 . . . . 14.83 111.743 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.535 ' CG2' HD21 ' A' ' 187' ' ' LEU . 2.4 m -151.17 153.05 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.57 -0.741 . . . . 10.79 109.989 -176.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 61.0 t -106.45 111.17 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.582 -0.447 . . . . 10.43 110.593 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -88.4 105.49 17.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.238 -0.437 . . . . 12.54 110.769 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.517 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -83.72 -37.03 23.23 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.351 0.596 . . . . 11.88 109.987 -175.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.18 161.93 27.87 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.261 -0.881 . . . . 11.9 111.846 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -162.63 104.66 1.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.573 -0.529 . . . . 13.47 109.573 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.423 HD13 ' CB ' ' A' ' 156' ' ' LYS . 1.5 pt? -153.26 165.64 35.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.309 0.576 . . . . 14.03 111.058 -176.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 82.3 mttt -98.44 7.1 46.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.255 -0.884 . . . . 17.87 110.914 -172.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -99.64 97.13 8.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.478 -0.783 . . . . 16.68 109.877 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.98 -27.29 68.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.326 0.584 . . . . 14.47 110.246 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.07 -37.22 66.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.931 -1.031 . . . . 16.57 110.551 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 66.1 mttm -90.5 -25.81 20.09 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.181 -0.918 . . . . 16.69 110.691 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 184' ' ' THR . 69.7 t -57.84 -40.46 76.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.437 0.637 . . . . 12.92 109.636 173.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -61.05 -33.4 73.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 15.83 112.183 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 12.6 pt-20 -83.91 -22.84 31.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.463 -0.495 . . . . 15.97 111.633 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 156' ' ' LYS . 16.8 mt -81.05 -49.68 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.345 0.593 . . . . 12.6 109.448 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 45.8 t -69.62 -32.71 53.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.26 -0.882 . . . . 12.54 110.449 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -56.74 -31.97 61.3 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.907 -0.664 . . . . 14.8 112.342 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -73.54 -62.13 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.781 0.324 . . . . 16.37 111.172 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 208' ' ' SER . 3.6 mm? -72.32 -50.37 27.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.085 0.402 . . . . 12.99 112.085 -173.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 31.2 ttm180 -64.13 -47.24 80.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.394 0.616 . . . . 15.56 110.098 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.23 -34.79 90.86 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.916 -1.038 . . . . 16.6 113.047 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -80.14 -7.39 58.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.973 0.416 . . . . 16.55 110.718 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.24 24.73 15.76 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.878 -0.677 . . . . 15.88 113.222 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -93.85 152.69 18.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.75 -0.463 . . . . 15.6 109.75 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -73.35 103.88 4.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.475 0.655 . . . . 14.31 110.162 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.78 139.1 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.832 -1.076 . . . . 11.04 110.051 -173.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -141.3 176.92 8.46 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.507 0.67 . . . . 11.47 110.806 171.213 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.2 p -113.55 -176.34 2.88 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.841 -1.072 . . . . 11.83 111.193 -172.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.82 149.74 16.06 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.405 -0.361 . . . . 12.84 111.111 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -39.32 -53.86 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.347 3.365 . . . . 15.06 115.674 -170.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.4 m -87.17 -64.71 1.11 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 119.515 -0.874 . . . . 16.97 113.133 -169.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.8 m -169.13 135.72 1.46 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 118.228 0.467 . . . . 16.04 111.346 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.429 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 44.7 Cg_exo -65.74 123.95 12.08 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.577 2.184 . . . . 14.22 112.012 162.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.68 158.57 3.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.637 -0.505 . . . . 16.46 109.637 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.63 128.21 35.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.722 0.296 . . . . 17.05 110.54 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.6 -26.17 25.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.097 -0.573 . . . . 17.2 112.3 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.7 OUTLIER -102.67 154.76 18.83 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.716 -0.476 . . . . 19.02 109.716 178.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 183' ' ' ILE . 7.8 tp -73.38 109.65 5.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.6 0.714 . . . . 15.32 111.082 -175.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 178' ' ' PRO . 50.9 m -99.34 119.32 37.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 13.03 109.804 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 60.8 mtt-85 -101.23 140.17 35.89 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.71 -0.677 . . . . 14.44 109.789 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.584 ' C ' HD13 ' A' ' 187' ' ' LEU . 2.1 mm -107.07 120.31 58.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.95 -0.759 . . . . 11.02 108.95 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.584 HD13 ' C ' ' A' ' 186' ' ' ILE . 4.6 mp -128.77 121.86 29.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.521 0.677 . . . . 10.32 111.152 -173.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.441 HG23 HD22 ' A' ' 148' ' ' LEU . 40.3 t -101.44 142.99 15.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.465 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.401 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 77.46 48.33 8.18 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.276 -0.875 . . . . 9.94 113.77 174.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.521 ' HA ' ' CG1' ' A' ' 145' ' ' VAL . 13.6 Cg_endo -64.44 123.99 12.63 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 CA-C-N 119.667 1.734 . . . . 11.15 110.62 171.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -156.75 147.85 22.04 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.841 -0.618 . . . . 12.77 109.78 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.594 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -88.68 -4.97 58.42 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.788 -0.642 . . . . 15.0 111.971 -175.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 75.6 m -115.86 92.05 3.79 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.297 0.57 . . . . 14.58 110.608 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.41 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 30.4 ttpt -52.7 -48.4 66.63 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 114.726 -1.125 . . . . 16.29 111.016 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -55.57 -38.99 70.09 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.102 0.408 . . . . 15.6 112.102 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -74.65 -41.75 59.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.006 0.431 . . . . 14.36 110.539 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.55 HD22 ' CB ' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -81.19 -19.66 42.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.119 0.485 . . . . 12.11 110.69 -175.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 28.1 tptp -66.16 -38.13 87.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.371 0.605 . . . . 14.96 110.31 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.21 -12.5 82.21 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.51 -1.036 . . . . 13.32 110.51 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 75.5 m -83.74 -8.71 59.19 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.7 -0.75 . . . . 12.31 111.895 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 20.2 mt -67.2 -36.35 81.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.965 0.412 . . . . 12.72 110.6 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.08 95.97 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.709 -0.678 . . . . 14.66 112.322 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.43 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 10.9 pt-20 -85.74 -18.41 33.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.902 0.382 . . . . 14.54 110.807 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.4 tp -71.81 -35.05 69.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.558 -0.292 . . . . 12.55 111.196 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.42 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 0.1 OUTLIER -65.63 -15.3 62.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.11 0.481 . . . . 16.12 110.432 174.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -31.89 21.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.868 -0.606 . . . . 16.98 109.658 172.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.0 mt -81.92 -52.47 7.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.612 -0.722 . . . . 14.15 111.646 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.421 ' HB3' HD12 ' A' ' 164' ' ' LEU . 61.5 p -94.0 -43.79 8.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.218 0.533 . . . . 13.54 110.618 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 72.94 -1.04 41.92 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.082 -0.963 . . . . 14.79 112.288 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.58 155.34 18.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.188 -0.671 . . . . 13.52 109.188 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.2 t -92.07 109.0 20.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.967 0.413 . . . . 14.87 110.258 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -126.27 156.13 19.65 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.136 -1.03 . . . . 12.22 113.729 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 p -103.63 147.56 9.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.208 -0.496 . . . . 14.04 110.036 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.7 106.06 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 12.89 110.478 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 24.5 mmt -113.26 143.86 43.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.859 -0.61 . . . . 14.23 110.104 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -75.18 136.42 20.38 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.227 -0.987 . . . . 14.09 111.874 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.53 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 8.8 t80 . . . . . 0 C--N 1.313 -1.009 0 CA-C-O 121.476 0.655 . . . . 14.24 110.052 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.639 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.444 -0.744 0 N-CA-C 109.669 -0.493 . . . . 15.06 109.669 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.626 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 16.1 m-85 -137.23 144.89 43.02 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.454 0.168 . . . . 14.83 111.233 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 190' ' ' PRO . 3.2 m -151.3 164.81 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 122.932 0.493 . . . . 10.79 110.827 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 44.4 t -114.72 108.98 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.778 0.323 . . . . 10.43 111.021 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -84.84 111.55 19.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.541 -0.3 . . . . 12.54 110.796 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.534 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -91.29 -35.32 14.52 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.327 0.584 . . . . 11.88 109.804 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.39 166.52 27.66 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.667 -0.778 . . . . 11.9 112.475 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -167.33 101.31 0.51 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.117 -0.697 . . . . 13.47 109.117 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.71 159.32 42.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.323 0.582 . . . . 14.03 110.978 -171.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 181' ' ' GLY . 5.0 mmmm -98.02 5.29 48.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.892 -1.049 . . . . 17.87 110.027 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -112.61 106.67 15.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.979 -1.01 . . . . 16.68 110.041 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.5 -22.09 64.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.205 -0.452 . . . . 14.47 111.838 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.09 -35.52 73.54 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.814 0.816 . . . . 16.57 110.129 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 97.8 mttt -86.62 -25.71 24.76 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.609 -1.178 . . . . 16.69 110.289 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.0 t -61.61 -45.26 99.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.92 -0.582 . . . . 12.92 110.154 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -60.72 -33.83 73.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.628 -0.714 . . . . 15.83 112.007 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 15.7 pt-20 -78.25 -36.82 46.44 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.589 -0.444 . . . . 15.97 111.214 -175.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 156' ' ' LYS . 20.6 mt -72.02 -46.67 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.666 0.746 . . . . 12.6 109.756 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.97 -34.3 69.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.738 -1.119 . . . . 12.54 110.519 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.44 -27.0 67.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 14.8 112.281 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -71.99 -54.79 8.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.112 0.482 . . . . 16.37 111.068 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.47 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 4.3 mm? -85.7 -62.78 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 12.99 112.38 -174.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -63.18 -37.22 86.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.28 0.562 . . . . 15.56 109.925 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.71 -17.29 79.14 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.015 -0.993 . . . . 16.6 112.522 -176.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -100.71 -6.7 24.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.785 0.326 . . . . 16.55 110.982 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.87 25.66 19.39 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.382 -0.914 . . . . 15.88 113.153 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -93.72 150.91 20.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.3 0.55 . . . . 15.6 109.799 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 102.83 2.12 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.669 0.747 . . . . 14.31 110.058 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.83 144.23 24.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.342 -1.299 . . . . 11.04 109.337 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.63 177.18 8.2 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.768 0.794 . . . . 11.47 110.862 170.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 17.8 p -124.65 -175.17 3.2 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.173 -1.376 . . . . 11.83 110.0 -171.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 62.4 m -50.62 128.53 26.06 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.931 -0.308 . . . . 12.84 110.385 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -15.7 -63.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.583 1 C-N-CA 126.908 5.072 . . . . 15.06 117.047 -175.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.417 ' C ' ' HG1' ' A' ' 177' ' ' THR . 43.5 t -83.81 -63.29 1.38 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.574 -0.851 . . . . 16.97 112.487 -172.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.417 ' HG1' ' C ' ' A' ' 176' ' ' SER . 65.1 m -168.22 134.24 1.6 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 117.62 0.191 . . . . 16.04 110.919 -176.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -60.68 124.67 15.5 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.383 2.056 . . . . 14.22 111.86 165.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.503 ' CG2' ' HB2' ' A' ' 182' ' ' LYS . 32.2 m -137.58 160.75 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 109.042 -0.725 . . . . 16.46 109.042 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.48 120.87 22.3 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.26 -0.427 . . . . 17.05 110.317 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . 0.423 ' O ' ' HE2' ' A' ' 152' ' ' LYS . . . 109.47 -26.45 14.69 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.966 -0.635 . . . . 17.2 113.106 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.503 ' HB2' ' CG2' ' A' ' 179' ' ' VAL . 4.3 mptp? -101.11 163.61 12.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.032 0.444 . . . . 19.02 110.884 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.403 HG21 ' O ' ' A' ' 183' ' ' ILE . 7.6 tp -73.13 108.03 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.835 0.826 . . . . 15.32 110.88 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 52.5 m -101.39 107.27 18.56 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.604 0.716 . . . . 13.03 109.758 175.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 81.5 mtt180 -86.92 138.54 31.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.782 -1.099 . . . . 14.44 109.579 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.472 ' O ' HD22 ' A' ' 148' ' ' LEU . 3.6 mm -110.5 116.8 53.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.49 -0.93 . . . . 11.02 108.49 177.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 172' ' ' TYR . 4.6 mp -129.27 128.83 44.01 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.478 0.656 . . . . 10.32 110.987 -173.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.47 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 54.8 t -104.01 142.39 17.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.903 -1.044 . . . . 10.0 110.423 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.83 49.87 7.45 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.262 -0.881 . . . . 9.94 113.308 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.509 ' HA ' HG12 ' A' ' 145' ' ' VAL . 11.2 Cg_endo -62.44 125.72 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 CA-C-N 119.548 1.674 . . . . 11.15 110.522 172.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -159.7 169.0 24.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.565 -0.743 . . . . 12.77 109.373 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . . . -110.99 5.22 20.15 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.479 0.657 . . . . 15.0 110.237 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.1 m -120.68 103.2 8.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.545 -0.752 . . . . 14.58 111.396 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.613 ' HB2' ' CE1' ' A' ' 144' ' ' TYR . 37.5 ttpt -64.11 -47.96 77.96 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.775 -0.648 . . . . 16.29 109.982 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -57.09 -33.49 67.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.005 -0.543 . . . . 15.6 111.453 -177.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -75.42 -54.19 7.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.052 -0.522 . . . . 14.36 110.023 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.645 ' O ' HD11 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -72.85 -19.52 61.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.079 -0.509 . . . . 12.11 111.044 -173.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.458 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 2.0 mmmm -63.91 -33.67 76.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.526 0.679 . . . . 14.96 110.918 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.74 -12.75 81.04 Favored Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.415 -1.074 . . . . 13.32 110.415 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 74.0 m -83.71 -8.72 59.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.601 -0.799 . . . . 12.31 111.994 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 9.6 mt -71.84 -38.45 70.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.805 0.335 . . . . 12.72 110.632 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.54 -24.7 68.04 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.669 -0.972 . . . . 14.66 110.669 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.555 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 43.8 mt-10 -86.64 -24.2 25.4 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.175 -0.513 . . . . 14.54 110.328 174.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.01 -46.29 89.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.415 -0.357 . . . . 12.55 111.106 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -21.95 46.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.13 -0.486 . . . . 16.12 111.06 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -41.03 11.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.076 -0.511 . . . . 16.98 110.938 174.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.8 mt -67.9 -52.39 36.89 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.144 0.497 . . . . 14.15 111.437 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 66.0 p -104.23 -38.07 7.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.942 -0.572 . . . . 13.54 110.748 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.39 -0.55 54.3 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.103 -0.799 . . . . 14.79 111.103 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 58.7 mt -97.47 154.13 17.69 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 122.831 0.452 . . . . 13.52 110.336 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.1 m -84.85 107.34 16.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.904 -0.589 . . . . 14.87 110.555 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -127.83 158.8 21.5 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.282 -0.961 . . . . 12.22 113.325 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.49 142.58 21.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.763 -0.458 . . . . 14.04 109.763 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.4 105.53 4.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.077 -0.712 . . . . 12.89 109.077 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 92.8 mmm -114.09 142.39 46.26 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.444 -0.798 . . . . 14.23 109.383 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -69.94 109.08 2.71 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.11 -1.043 . . . . 14.09 111.726 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.639 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 5.4 t80 . . . . . 0 C--N 1.313 -0.998 0 C-N-CA 124.113 0.965 . . . . 14.24 110.457 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.538 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.442 -0.856 0 N-CA-C 108.985 -0.746 . . . . 15.06 108.985 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.584 ' CB ' HD21 ' A' ' 197' ' ' LEU . 5.5 m-85 -145.53 153.79 41.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.515 0.198 . . . . 14.83 110.882 -175.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 190' ' ' PRO . 2.7 t -149.51 161.64 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.622 -0.881 . . . . 10.79 108.622 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' A' ' 212' ' ' GLY . 17.7 t -106.39 108.19 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 122.129 -0.357 . . . . 10.43 111.715 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.544 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 30.0 tt0 -81.5 118.26 22.58 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.615 0.228 . . . . 12.54 111.615 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.519 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -91.62 -36.5 13.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.097 -0.641 . . . . 11.88 109.708 177.082 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.14 161.89 28.14 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.536 -0.84 . . . . 11.9 112.73 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -163.68 100.76 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.022 -0.733 . . . . 13.47 109.022 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.71 167.96 19.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.941 -0.572 . . . . 14.03 110.257 -174.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 4.9 mtpm? -104.83 20.85 18.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.325 -0.852 . . . . 17.87 109.662 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -130.76 118.48 20.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.847 -1.069 . . . . 16.68 109.689 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.42 -22.53 61.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.321 0.489 . . . . 14.47 112.321 -173.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.28 -34.78 78.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.935 0.874 . . . . 16.57 109.466 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.36 -29.27 34.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.338 -1.301 . . . . 16.69 110.093 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.46 ' HA ' HD13 ' A' ' 186' ' ' ILE . 97.8 t -65.82 -39.66 85.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.827 -0.624 . . . . 12.92 109.82 173.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.49 -34.57 72.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.022 -0.99 . . . . 15.83 112.13 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.86 -46.51 29.92 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 120.115 -0.634 . . . . 15.97 111.225 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.543 HD11 HD12 ' A' ' 186' ' ' ILE . 25.2 mt -59.01 -45.95 91.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.444 0.64 . . . . 12.6 109.868 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 82.2 t -68.61 -40.62 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.255 -0.884 . . . . 12.54 110.445 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.35 -34.31 88.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.045 -0.598 . . . . 14.8 112.544 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -73.61 -43.96 58.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.587 0.232 . . . . 16.37 111.046 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.556 HD22 ' CB ' ' A' ' 208' ' ' SER . 8.5 mt -87.03 -59.15 2.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.386 0.884 . . . . 12.99 113.386 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.407 ' HG2' ' HB ' ' A' ' 171' ' ' VAL . 9.8 mtp180 -69.74 -30.05 67.56 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.848 -0.797 . . . . 15.56 108.848 -175.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.41 -31.7 77.52 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 114.633 -1.167 . . . . 16.6 111.57 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.3 -12.05 53.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.927 0.394 . . . . 16.55 110.555 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.0 23.24 13.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.892 -0.671 . . . . 15.88 113.317 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -87.79 152.54 22.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.078 0.439 . . . . 15.6 110.329 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.435 ' HG3' ' HD2' ' A' ' 190' ' ' PRO . 20.6 tpp180 -75.43 97.75 3.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.806 0.812 . . . . 14.31 109.589 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 164' ' ' LEU . 2.6 t -131.96 136.32 56.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.605 -1.18 . . . . 11.04 110.622 -173.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -135.26 174.83 10.18 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.759 0.79 . . . . 11.47 111.089 174.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 7.8 p -127.71 -174.52 3.21 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.165 -1.38 . . . . 11.83 110.809 -169.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.0 m -50.13 135.57 22.33 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 120.836 0.35 . . . . 12.84 110.477 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -38.4 -44.85 2.17 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 124.714 3.609 . . . . 15.06 115.721 -169.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.6 m -87.01 -64.19 1.19 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 119.669 -0.812 . . . . 16.97 112.224 -173.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.7 m -168.52 129.13 1.08 Allowed Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 117.942 0.337 . . . . 16.04 111.861 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.44 ' HB3' HG21 ' A' ' 184' ' ' THR . 86.9 Cg_exo -58.33 125.16 17.61 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.772 2.315 . . . . 14.22 112.096 162.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.478 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.7 p -153.18 156.16 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 109.923 -0.399 . . . . 16.46 109.923 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -81.62 133.56 35.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.797 0.332 . . . . 17.05 110.202 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 102.86 -26.23 24.75 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.031 -0.604 . . . . 17.2 111.668 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -115.06 168.56 9.82 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.448 -0.575 . . . . 19.02 109.448 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 10.1 tp -76.48 126.26 36.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.471 0.653 . . . . 15.32 111.335 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 57.4 m -119.66 105.98 11.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.842 -0.617 . . . . 13.03 110.042 173.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 173' ' ' THR . 97.5 mtt180 -83.8 135.43 34.53 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.268 -0.878 . . . . 14.44 108.959 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.543 HD12 HD11 ' A' ' 160' ' ' ILE . 3.2 mt -119.8 120.5 63.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.577 -0.527 . . . . 11.02 109.577 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 186' ' ' ILE . 3.6 mp -129.16 142.1 50.97 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.344 -0.843 . . . . 10.32 111.114 -169.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.486 HG23 HD21 ' A' ' 148' ' ' LEU . 53.8 t -107.14 131.84 56.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.986 -1.006 . . . . 10.0 110.926 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.86 49.62 4.73 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.19 -0.913 . . . . 9.94 113.783 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.48 ' N ' HG12 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -61.35 124.97 15.78 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 CA-C-N 119.624 1.712 . . . . 11.15 110.854 172.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -159.62 149.14 18.27 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.762 -0.458 . . . . 12.77 109.762 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -89.24 6.14 41.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.968 -0.56 . . . . 15.0 111.145 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 196' ' ' LYS . 22.7 t -118.98 96.32 5.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.253 -0.647 . . . . 14.58 109.253 175.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.464 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 15.9 ptmt -63.03 -35.67 81.01 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.027 -0.988 . . . . 16.29 111.583 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 194' ' ' LYS . 8.5 m-20 -68.69 -44.42 74.01 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.996 0.427 . . . . 15.6 110.628 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 193' ' ' SER . 44.0 tttm -59.42 -44.07 92.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.765 -0.652 . . . . 14.36 110.698 176.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.584 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -82.54 -16.96 46.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.654 -0.703 . . . . 12.11 110.487 -176.307 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.622 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 25.3 tptp -64.57 -34.57 78.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 14.96 110.761 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -82.22 -12.56 80.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.391 -1.084 . . . . 13.32 110.391 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 70.9 m -79.58 -9.2 59.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.655 -0.772 . . . . 12.31 111.498 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 1.8 mt -74.11 -33.38 63.58 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.509 -0.552 . . . . 12.72 109.509 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -61.45 -28.23 69.18 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.551 -1.019 . . . . 14.66 110.551 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.53 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 41.8 mt-10 -85.85 -19.17 31.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.062 -0.569 . . . . 14.54 110.664 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.415 HD23 HG12 ' A' ' 146' ' ' VAL . 4.6 tp -60.59 -45.01 95.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.796 0.332 . . . . 12.55 111.553 -173.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -57.85 -23.88 54.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.302 -0.408 . . . . 16.12 111.224 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.38 -37.89 14.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.338 -0.392 . . . . 16.98 110.466 176.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 89.6 mt -70.9 -51.77 24.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.321 0.581 . . . . 14.15 111.052 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.556 ' CB ' HD22 ' A' ' 164' ' ' LEU . 28.4 t -110.11 -43.94 3.86 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.502 -0.772 . . . . 13.54 111.264 -173.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.34 -0.23 55.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.748 -0.739 . . . . 14.79 111.606 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.14 157.51 15.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.684 -0.487 . . . . 13.52 109.684 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 61.2 m -77.1 95.45 4.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.949 0.405 . . . . 14.87 111.1 -174.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -103.94 138.58 14.13 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.651 -0.704 . . . . 12.22 113.439 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.0 142.03 21.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.298 0.571 . . . . 14.04 110.066 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.6 t -78.68 105.94 8.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.434 -0.803 . . . . 12.89 110.419 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 90.1 mtp -120.31 142.59 48.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.073 -0.512 . . . . 14.23 110.258 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -69.22 136.03 28.12 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.624 -0.798 . . . . 14.09 112.416 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.538 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 10.5 t80 . . . . . 0 C--N 1.31 -1.121 0 CA-C-N 114.396 -0.902 . . . . 14.24 110.102 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.705 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 109.436 -0.579 . . . . 15.06 109.436 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.715 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 5.5 m-85 -138.6 141.12 39.17 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 111.455 0.168 . . . . 14.83 111.455 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 144' ' ' TYR . 2.7 t -149.96 163.07 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 109.317 -0.623 . . . . 10.79 109.317 170.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 59.3 t -103.83 108.85 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 O-C-N 122.304 -0.248 . . . . 10.43 111.528 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.429 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 8.6 tt0 -76.72 111.78 12.59 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.21 0.204 . . . . 12.54 110.899 178.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.526 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -89.02 -35.66 16.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.26 -0.644 . . . . 11.88 109.26 176.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.52 167.61 27.49 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.35 -0.841 . . . . 11.9 112.45 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -165.35 101.27 0.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.123 -0.695 . . . . 13.47 109.123 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 158.08 45.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.669 -0.696 . . . . 14.03 110.499 -173.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 49.9 mttp -96.23 16.73 17.45 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.182 -0.917 . . . . 17.87 110.194 -175.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.407 ' O ' HG21 ' A' ' 157' ' ' VAL . 15.8 m120 -118.56 108.37 14.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.959 -1.019 . . . . 16.68 109.52 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.38 68.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.177 0.513 . . . . 14.47 110.557 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.68 -37.51 78.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.386 -0.824 . . . . 16.57 110.157 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 64.8 mttp -84.6 -23.3 29.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.621 -1.172 . . . . 16.69 110.132 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 186' ' ' ILE . 77.0 t -65.64 -46.34 89.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.789 -0.641 . . . . 12.92 109.967 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -61.53 -29.49 70.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 15.83 112.04 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 14.8 pt-20 -77.4 -43.51 32.41 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.282 -0.567 . . . . 15.97 111.101 -177.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 156' ' ' LYS . 21.7 mt -66.33 -46.73 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.762 0.792 . . . . 12.6 109.469 176.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.43 ' CG1' ' HD2' ' A' ' 165' ' ' ARG . 34.2 t -63.46 -32.9 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.538 -1.21 . . . . 12.54 110.588 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.76 -32.18 73.65 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.009 -0.615 . . . . 14.8 112.35 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -71.31 -53.96 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 16.37 110.967 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.479 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 4.0 mm? -83.84 -51.25 7.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.199 0.815 . . . . 12.99 113.199 -172.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.43 ' HD2' ' CG1' ' A' ' 161' ' ' VAL . 48.1 mtt180 -69.74 -37.52 76.49 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.838 -0.801 . . . . 15.56 108.838 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.87 -32.21 83.46 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 114.601 -1.181 . . . . 16.6 112.4 -175.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.78 -3.64 58.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 16.55 110.833 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.41 25.58 35.83 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 15.88 113.376 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -87.03 160.02 18.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.122 0.461 . . . . 15.6 110.658 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -76.29 97.3 4.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.608 0.718 . . . . 14.31 109.543 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.28 141.26 24.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.909 -1.041 . . . . 11.04 109.635 -174.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.2 176.57 8.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.717 0.77 . . . . 11.47 111.095 175.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.3 p -117.27 -175.22 2.76 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.44 -1.254 . . . . 11.83 110.696 -173.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.2 m -51.76 140.2 29.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 12.84 110.934 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -46.18 -36.77 17.33 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.136 3.224 . . . . 15.06 115.069 -169.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.1 m -87.19 -63.74 1.26 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 119.915 -0.714 . . . . 16.97 112.177 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 98.0 m -168.49 139.55 2.14 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 117.742 0.247 . . . . 16.04 111.19 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.441 ' HA ' ' CG2' ' A' ' 184' ' ' THR . 27.8 Cg_exo -66.55 122.82 10.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 121.786 1.657 . . . . 14.22 110.115 163.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.51 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 7.8 p -153.01 156.79 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.363 -0.535 . . . . 16.46 111.251 -172.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -81.48 128.77 34.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.432 -0.804 . . . . 17.05 110.423 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.09 -25.03 29.79 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.704 -0.76 . . . . 17.2 112.433 176.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.51 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 9.0 mptt -112.32 158.93 19.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.636 -0.505 . . . . 19.02 109.636 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.4 tp -70.83 115.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.486 0.66 . . . . 15.32 111.36 -175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.441 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 36.3 m -112.05 113.18 25.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.648 -0.705 . . . . 13.03 109.826 175.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 21.0 ttm180 -89.49 140.93 29.04 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.04 -0.982 . . . . 14.44 110.112 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.479 ' C ' HD13 ' A' ' 187' ' ' LEU . 3.9 mm -111.21 117.51 55.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.878 -0.786 . . . . 11.02 108.878 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 2.5 mp -130.33 135.02 47.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.306 0.574 . . . . 10.32 111.107 -173.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.479 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 41.1 t -108.59 135.62 46.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.241 -0.89 . . . . 10.0 111.078 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.444 ' O ' HD22 ' A' ' 197' ' ' LEU . . . 82.8 49.3 5.15 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 114.999 -1.0 . . . . 9.94 113.507 175.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.469 ' HA ' ' CG2' ' A' ' 145' ' ' VAL . 11.0 Cg_endo -62.3 125.26 15.92 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 CA-C-N 119.552 1.676 . . . . 11.15 111.136 174.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -157.77 168.17 27.97 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.528 -0.545 . . . . 12.77 109.528 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -104.94 4.77 32.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.581 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 196' ' ' LYS . 21.0 t -120.67 117.7 28.21 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.036 0.446 . . . . 14.58 110.146 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.693 ' HB2' ' CE2' ' A' ' 144' ' ' TYR . 39.0 ttpt -67.8 -41.78 82.6 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-N 115.901 -0.591 . . . . 16.29 109.535 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -57.53 -50.19 73.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.667 0.27 . . . . 15.6 111.033 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 39.0 mtpt -52.85 -60.0 3.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.476 -0.784 . . . . 14.36 111.187 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -76.74 -28.83 55.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.912 -1.04 . . . . 12.11 111.617 -169.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.575 ' HD3' ' O ' ' A' ' 198' ' ' LYS . 12.9 tmtt? -73.45 -31.59 63.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.012 -0.736 . . . . 14.96 109.012 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.73 -12.55 84.36 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.227 -1.149 . . . . 13.32 110.227 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 58.5 m -88.37 -9.87 51.24 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.527 -0.837 . . . . 12.31 111.965 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 20.7 mt -66.28 -36.37 82.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.712 0.291 . . . . 12.72 111.055 -174.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -57.47 -44.25 93.76 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.026 -0.607 . . . . 14.66 111.829 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.417 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 13.0 pt-20 -86.07 -17.1 36.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.892 0.377 . . . . 14.54 110.519 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.462 HD11 ' CG1' ' A' ' 188' ' ' VAL . 15.5 tp -66.22 -31.91 73.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.028 0.442 . . . . 12.55 110.442 -177.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.505 ' HZ1' ' HB3' ' A' ' 205' ' ' LYS . 6.1 mtpm? -58.98 -23.71 62.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.515 -0.766 . . . . 16.12 110.272 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.55 -36.96 15.05 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.863 -0.608 . . . . 16.98 110.236 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 92.6 mt -68.04 -52.65 33.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.043 -0.526 . . . . 14.15 111.5 -176.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 56.0 p -102.03 -44.12 5.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.119 0.485 . . . . 13.54 110.13 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.84 5.48 75.0 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.151 -0.931 . . . . 14.79 111.627 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.55 157.74 16.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 110.113 -0.329 . . . . 13.52 110.113 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.5 t -87.97 105.26 17.34 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.106 -0.497 . . . . 14.87 110.341 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -128.53 160.64 22.21 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.138 -1.03 . . . . 12.22 113.893 -176.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.14 143.53 20.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.137 -0.532 . . . . 14.04 110.026 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.62 105.27 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.38 -0.6 . . . . 12.89 109.38 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 64.1 mtt -120.99 145.96 47.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.019 -0.537 . . . . 14.23 110.226 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -71.91 110.36 3.18 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.365 -0.921 . . . . 14.09 112.803 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.715 ' HB3' ' N ' ' A' ' 144' ' ' TYR . 4.4 t80 . . . . . 0 C--N 1.308 -1.237 0 CA-C-N 113.243 -1.479 . . . . 14.24 110.287 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 108.148 -1.056 . . . . 15.06 108.148 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.539 ' CE1' ' HD3' ' A' ' 194' ' ' LYS . 7.3 m-85 -138.23 153.48 49.12 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.695 0.628 . . . . 14.83 112.695 -176.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.491 ' CG1' ' HA ' ' A' ' 190' ' ' PRO . 2.8 m -151.99 151.97 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 114.842 -1.072 . . . . 10.79 109.76 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 80.5 t -110.79 108.02 24.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 120.3 -0.56 . . . . 10.43 111.434 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.499 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 19.0 tt0 -80.26 114.31 19.07 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.085 -0.507 . . . . 12.54 111.148 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.531 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -93.75 -33.73 13.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.509 0.671 . . . . 11.88 109.555 177.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.3 170.72 26.6 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.666 -0.778 . . . . 11.9 112.359 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -170.34 103.22 0.27 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.02 -0.733 . . . . 13.47 109.02 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.98 153.73 42.55 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.451 0.643 . . . . 14.03 110.435 -174.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 77.4 mttt -89.34 2.96 53.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.046 -0.979 . . . . 17.87 110.438 -175.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -101.82 109.44 21.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.419 -0.81 . . . . 16.68 109.597 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.88 -20.32 63.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.924 -0.58 . . . . 14.47 112.202 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.13 -33.84 76.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 122.1 0.952 . . . . 16.57 109.257 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 160' ' ' ILE . 74.4 mmtt -83.54 -30.07 27.37 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.0 -1.454 . . . . 16.69 110.154 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.453 HG13 ' CD1' ' A' ' 186' ' ' ILE . 77.9 t -57.63 -40.17 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.73 -0.668 . . . . 12.92 110.273 173.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -68.55 -32.62 72.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.264 -0.88 . . . . 15.83 111.969 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.19 -38.09 31.95 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.061 -0.655 . . . . 15.97 111.2 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 156' ' ' LYS . 29.3 mt -63.28 -41.36 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 12.6 109.22 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.79 -35.66 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.01 -0.995 . . . . 12.54 110.17 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.64 -28.54 73.72 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.016 -0.612 . . . . 14.8 112.374 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -72.3 -61.96 1.61 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 16.37 110.977 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.538 ' HB3' HG21 ' A' ' 171' ' ' VAL . 1.8 mm? -79.5 -62.72 1.6 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.927 -0.579 . . . . 12.99 112.188 -175.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' A' ' 165' ' ' ARG . 3.0 tmt_? -61.97 -38.25 87.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.381 -0.6 . . . . 15.56 109.381 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.95 85.22 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.258 -0.883 . . . . 16.6 112.506 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.28 -7.33 59.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.005 0.431 . . . . 16.55 110.523 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.43 25.1 9.58 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.807 -0.711 . . . . 15.88 112.624 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -96.31 145.24 25.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.182 -0.674 . . . . 15.6 109.182 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -70.25 107.32 3.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.611 0.72 . . . . 14.31 110.55 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.538 HG21 ' HB3' ' A' ' 164' ' ' LEU . 11.0 t -138.62 135.71 43.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.773 -1.103 . . . . 11.04 110.324 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -137.85 175.39 9.63 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.78 0.8 . . . . 11.47 110.946 174.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 18.0 p -122.68 -172.68 2.53 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.135 -1.393 . . . . 11.83 110.56 -170.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.6 m -49.61 145.8 7.84 Favored Pre-proline 0 C--O 1.236 0.365 0 O-C-N 123.272 0.357 . . . . 12.84 110.739 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -38.25 -44.94 2.08 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 124.479 3.452 . . . . 15.06 115.302 -170.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.0 p -87.42 -63.53 1.29 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.735 -0.786 . . . . 16.97 113.089 -173.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.1 m -168.07 142.96 2.96 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 117.688 0.222 . . . . 16.04 110.86 -175.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.463 ' HG3' ' OG1' ' A' ' 173' ' ' THR . 25.0 Cg_exo -67.38 123.84 11.34 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.13 1.887 . . . . 14.22 111.066 165.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.418 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.9 p -153.61 156.49 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 120.826 0.346 . . . . 16.46 110.331 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -80.31 128.46 33.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.121 -0.491 . . . . 17.05 110.193 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.17 -26.09 18.11 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.006 -0.616 . . . . 17.2 112.138 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 12.6 mptt -108.08 153.04 23.7 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.618 -0.512 . . . . 19.02 109.618 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.8 tp -69.17 109.58 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.76 0.791 . . . . 15.32 110.874 -176.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 26.8 m -103.57 109.02 20.53 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.956 0.884 . . . . 13.03 110.429 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 173' ' ' THR . 48.3 ttt180 -86.24 134.52 33.76 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.063 -1.426 . . . . 14.44 109.032 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.503 ' C ' HD13 ' A' ' 187' ' ' LEU . 3.7 mm -109.4 117.19 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 N-CA-C 109.183 -0.673 . . . . 11.02 109.183 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.503 HD13 ' C ' ' A' ' 186' ' ' ILE . 2.1 mp -130.17 132.95 46.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.512 0.672 . . . . 10.32 111.034 -173.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.443 HG21 HD21 ' A' ' 148' ' ' LEU . 52.8 t -101.96 137.31 30.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.908 -1.042 . . . . 10.0 110.208 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.97 51.49 5.8 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.344 -0.844 . . . . 9.94 114.071 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.491 ' HA ' ' CG1' ' A' ' 145' ' ' VAL . 18.6 Cg_endo -67.06 125.71 14.02 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 CA-C-N 119.632 1.716 . . . . 11.15 110.813 170.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -157.88 153.63 26.62 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.598 -0.441 . . . . 12.77 110.274 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.405 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -98.83 0.54 44.5 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.948 -0.569 . . . . 15.0 111.473 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 68.8 m -118.48 93.66 4.2 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 121.37 0.605 . . . . 14.58 109.992 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.539 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 35.1 ttpt -57.12 -36.79 71.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.917 -1.038 . . . . 16.29 110.769 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.71 -39.29 80.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.976 0.417 . . . . 15.6 111.53 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -77.54 -42.84 33.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.62 0.724 . . . . 14.36 110.399 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -83.67 -19.19 35.78 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.251 -0.886 . . . . 12.11 110.977 -173.285 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -64.85 -40.12 94.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.193 0.52 . . . . 14.96 110.51 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.47 -13.73 82.92 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 110.328 -1.109 . . . . 13.32 110.328 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 58.4 m -83.35 -11.43 57.65 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.587 -0.807 . . . . 12.31 111.72 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 28.0 mt -66.88 -40.99 87.96 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.878 0.37 . . . . 12.72 110.399 -177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.56 86.28 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.346 -0.931 . . . . 14.66 110.912 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.561 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 45.3 mt-10 -76.89 -26.94 54.74 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 120.81 0.338 . . . . 14.54 110.574 175.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.7 tt -67.41 -38.75 85.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.056 -0.52 . . . . 12.55 110.422 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 82.8 mttt -62.19 -21.02 64.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.392 -0.822 . . . . 16.12 110.261 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -42.31 11.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.676 -0.693 . . . . 16.98 110.281 173.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 96.8 mt -66.9 -51.91 49.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.033 -0.53 . . . . 14.15 111.694 -176.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.409 ' HB3' HD13 ' A' ' 164' ' ' LEU . 71.4 p -100.16 -44.38 5.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.214 0.531 . . . . 13.54 110.821 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.34 12.22 57.86 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.301 -0.863 . . . . 14.79 111.698 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 91.6 mt -91.4 157.75 16.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.912 -0.403 . . . . 13.52 109.912 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 53.9 m -80.6 94.43 6.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.057 0.456 . . . . 14.87 110.777 -178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -124.23 159.82 18.84 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.617 -0.802 . . . . 12.22 113.048 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.2 p -116.17 143.97 24.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.196 0.522 . . . . 14.04 110.541 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.6 t -80.03 106.79 11.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.218 -0.901 . . . . 12.89 110.343 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 24.3 mmt -121.04 155.63 33.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.017 -0.538 . . . . 14.23 110.567 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -82.19 129.62 9.18 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.404 -0.903 . . . . 14.09 111.992 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.471 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 8.6 t80 . . . . . 0 C--N 1.314 -0.964 0 C-N-CA 124.164 0.986 . . . . 14.24 109.975 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.504 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 108.338 -0.986 . . . . 15.06 108.338 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.671 ' CB ' HD22 ' A' ' 197' ' ' LEU . 3.3 m-85 -143.85 152.7 41.51 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.824 -0.351 . . . . 14.83 111.695 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 190' ' ' PRO . 12.5 m -149.2 156.23 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.273 0.629 . . . . 10.79 109.846 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.7 109.55 28.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 O-C-N 121.84 -0.537 . . . . 10.43 111.111 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -86.71 109.55 19.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.566 -0.288 . . . . 12.54 111.478 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.524 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -88.97 -34.86 16.72 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.141 0.496 . . . . 11.88 109.965 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.02 161.56 28.12 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.499 -0.773 . . . . 11.9 112.457 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -161.44 101.49 1.2 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.316 -0.624 . . . . 13.47 109.316 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.75 164.18 28.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.808 -0.633 . . . . 14.03 110.332 -173.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 49.5 mtpt -105.71 0.55 26.36 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.032 -0.985 . . . . 17.87 109.782 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -97.79 108.33 21.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.231 -0.895 . . . . 16.68 109.373 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.53 -21.44 66.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.995 0.426 . . . . 14.47 110.876 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.88 -36.79 70.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.653 0.739 . . . . 16.57 110.036 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 156' ' ' LYS . 2.0 mptp? -83.87 -27.22 28.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.784 -1.098 . . . . 16.69 110.354 -178.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.65 -37.66 76.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.354 0.597 . . . . 12.92 109.801 174.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -68.99 -34.12 74.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.335 -0.848 . . . . 15.83 111.512 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.615 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.7 pt-20 -82.91 -21.35 34.23 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.964 -0.294 . . . . 15.97 111.589 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 156' ' ' LYS . 48.3 mt -85.06 -50.66 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.322 0.582 . . . . 12.6 110.046 174.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.1 -41.74 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.71 -0.677 . . . . 12.54 111.162 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.26 -25.27 62.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.868 -0.682 . . . . 14.8 112.462 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 13.5 mptt -78.09 -61.05 2.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.645 0.259 . . . . 16.37 110.595 176.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.559 HD13 ' HA ' ' A' ' 208' ' ' SER . 2.4 mm? -78.18 -48.47 15.8 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.603 0.594 . . . . 12.99 112.603 -173.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.401 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 41.8 ttt180 -77.87 -26.01 49.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.911 -0.774 . . . . 15.56 108.911 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.15 -25.54 74.46 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.033 -0.985 . . . . 16.6 111.657 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.84 3.96 54.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.054 0.454 . . . . 16.55 110.65 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.87 22.11 47.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.901 -0.666 . . . . 15.88 113.701 174.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -89.11 156.85 18.56 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 117.493 0.647 . . . . 15.6 110.027 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -67.69 96.83 0.58 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.751 -0.463 . . . . 14.31 109.751 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 164' ' ' LEU . 3.6 t -139.09 125.97 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 CA-C-N 115.546 -0.752 . . . . 11.04 110.2 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.63 175.68 9.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.608 -0.723 . . . . 11.47 110.462 173.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.3 p -115.68 -176.36 2.91 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.758 -1.11 . . . . 11.83 111.733 -168.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.584 ' HB2' ' H ' ' A' ' 185' ' ' ARG . 22.9 t -53.03 134.74 48.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.957 -0.565 . . . . 12.84 110.384 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -31.06 -55.31 0.23 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 125.198 3.932 . . . . 15.06 115.542 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.4 t -81.11 -64.39 1.2 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 119.75 -0.78 . . . . 16.97 112.574 -169.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 55.7 m -169.09 130.41 1.06 Allowed Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 118.028 0.376 . . . . 16.04 111.791 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.458 ' HB3' HG23 ' A' ' 184' ' ' THR . 52.3 Cg_exo -65.26 122.62 10.39 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.347 2.032 . . . . 14.22 112.125 162.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.4 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.8 p -154.91 156.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.303 -0.628 . . . . 16.46 109.303 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -77.65 127.75 32.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.07 0.462 . . . . 17.05 110.691 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.02 -26.47 15.3 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.51 -0.768 . . . . 17.2 111.819 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.6 OUTLIER -108.62 167.41 10.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.24 -0.652 . . . . 19.02 109.24 176.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.2 tp -81.51 118.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.553 0.692 . . . . 15.32 111.073 -175.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.458 HG23 ' HB3' ' A' ' 178' ' ' PRO . 28.8 m -111.76 105.19 13.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.729 -0.669 . . . . 13.03 109.896 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.584 ' H ' ' HB2' ' A' ' 174' ' ' SER . 81.0 mtt-85 -84.61 144.44 28.61 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.332 -0.849 . . . . 14.44 110.156 176.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.556 ' C ' HD22 ' A' ' 187' ' ' LEU . 3.0 mm -115.74 117.83 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 108.698 -0.852 . . . . 11.02 108.698 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.556 HD22 ' C ' ' A' ' 186' ' ' ILE . 0.1 OUTLIER -129.94 128.16 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.748 0.785 . . . . 10.32 112.131 -175.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.464 HG23 ' CG2' ' A' ' 171' ' ' VAL . 55.1 t -95.45 146.37 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 114.205 -1.361 . . . . 10.0 110.278 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 72.97 46.61 28.05 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.333 -0.849 . . . . 9.94 114.203 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.543 ' HA ' HG11 ' A' ' 145' ' ' VAL . 11.3 Cg_endo -61.72 125.53 16.89 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 119.83 1.815 . . . . 11.15 110.52 170.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -159.48 154.71 25.26 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.927 -0.578 . . . . 12.77 109.877 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -100.49 2.39 42.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.062 -0.517 . . . . 15.0 111.725 -174.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.11 98.3 6.1 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.563 0.697 . . . . 14.58 110.759 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.46 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 18.4 ptmt -58.88 -39.6 81.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.551 -1.204 . . . . 16.29 112.557 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -67.41 -42.85 82.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.227 0.537 . . . . 15.6 110.393 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -62.9 -41.28 99.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.116 -0.947 . . . . 14.36 110.599 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.671 HD22 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -85.78 -16.79 37.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.865 -0.607 . . . . 12.11 111.085 -177.293 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 4.8 tppp? -64.04 -32.07 73.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.491 0.663 . . . . 14.96 110.023 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -83.88 -13.2 75.56 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.648 -0.981 . . . . 13.32 110.648 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 46.0 m -79.77 -9.17 59.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.008 -0.596 . . . . 12.31 111.523 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 9.8 mt -74.27 -37.25 63.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.939 0.399 . . . . 12.72 110.485 -176.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.41 -34.84 91.03 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.001 -0.618 . . . . 14.66 112.123 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.621 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 11.6 pt-20 -86.1 -19.84 29.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.797 0.332 . . . . 14.54 110.65 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.3 tt -65.25 -42.98 92.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 12.55 111.209 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.434 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 58.8 pttt -61.72 -17.63 56.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.058 -0.519 . . . . 16.12 111.414 176.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -36.83 15.4 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.901 0.381 . . . . 16.98 109.993 172.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.6 mt -68.84 -52.16 32.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 14.15 110.6 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.559 ' HA ' HD13 ' A' ' 164' ' ' LEU . 3.8 m -101.92 -43.38 5.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.654 -0.703 . . . . 13.54 111.298 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 75.13 -2.45 51.41 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.554 -0.748 . . . . 14.79 111.816 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 40.7 mt -80.02 149.49 30.72 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.084 -0.71 . . . . 13.52 109.084 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.2 t -89.7 104.86 17.39 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.73 -0.47 . . . . 14.87 109.73 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -125.53 157.08 19.53 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.416 -0.897 . . . . 12.22 113.492 -174.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.96 143.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.109 0.48 . . . . 14.04 110.276 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 43.5 t -77.83 106.14 7.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.303 -0.862 . . . . 12.89 109.955 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 22.7 mmt -115.73 146.78 41.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.765 -0.652 . . . . 14.23 110.209 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -74.13 134.34 18.18 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.445 -0.883 . . . . 14.09 111.621 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.504 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 7.9 t80 . . . . . 0 C--N 1.308 -1.227 0 CA-C-O 121.536 0.684 . . . . 14.24 110.26 -175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 110.386 -0.228 . . . . 15.06 110.386 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.694 ' CD1' ' HG3' ' A' ' 194' ' ' LYS . 7.1 m-85 -144.17 156.99 44.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.802 0.297 . . . . 14.83 111.802 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.504 HG11 ' N ' ' A' ' 190' ' ' PRO . 2.2 t -151.07 161.03 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.303 -0.999 . . . . 10.79 108.303 170.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.426 HG11 ' HA3' ' A' ' 212' ' ' GLY . 96.1 t -106.76 110.17 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.909 -0.494 . . . . 10.43 111.574 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.567 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 26.5 tt0 -81.14 115.5 20.59 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.785 -0.189 . . . . 12.54 111.39 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 211' ' ' SER . 0.0 OUTLIER -94.76 -33.4 12.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.385 0.612 . . . . 11.88 110.298 -179.148 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.24 163.73 28.38 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.535 -0.84 . . . . 11.9 112.468 -175.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.498 ' C ' HD13 ' A' ' 151' ' ' LEU . . . -161.6 100.02 1.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.356 -0.609 . . . . 13.47 109.356 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.529 HD23 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -127.61 163.24 24.65 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.263 0.554 . . . . 14.03 109.796 -174.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 22.0 mtpp -102.61 -9.42 20.13 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.943 -1.026 . . . . 17.87 109.37 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -94.63 111.54 23.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.909 -1.042 . . . . 16.68 109.301 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.75 -18.34 62.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.148 0.425 . . . . 14.47 112.148 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.4 -34.83 77.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.905 0.859 . . . . 16.57 109.978 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -83.55 -17.75 40.74 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.623 -1.171 . . . . 16.69 110.124 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.547 ' HA ' HD13 ' A' ' 186' ' ' ILE . 67.4 t -76.18 -33.84 24.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.701 -0.682 . . . . 12.92 109.244 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.89 -37.6 81.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.415 -0.812 . . . . 15.83 111.054 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.693 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.8 pt-20 -75.41 -26.67 58.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.729 0.3 . . . . 15.97 111.49 -175.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.514 ' HB ' HD12 ' A' ' 186' ' ' ILE . 69.1 mt -85.09 -49.07 16.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.149 0.499 . . . . 12.6 110.317 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.45 -46.58 69.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.83 -0.623 . . . . 12.54 111.156 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.53 62.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.958 -0.639 . . . . 14.8 112.568 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.693 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 2.1 mptm? -85.93 -57.08 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.683 0.278 . . . . 16.37 110.896 177.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 208' ' ' SER . 2.5 mm? -79.63 -56.84 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.167 0.432 . . . . 12.99 112.167 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.512 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 68.3 ttt180 -64.6 -39.6 94.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 15.56 109.983 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.25 -25.74 71.28 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.254 -0.885 . . . . 16.6 112.698 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.46 -7.3 58.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.929 0.395 . . . . 16.55 110.517 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.3 2.42 29.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.782 -0.723 . . . . 15.88 113.284 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -79.52 151.9 30.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.039 0.419 . . . . 15.6 110.479 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -70.23 99.06 1.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.868 -0.605 . . . . 14.31 110.316 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 165' ' ' ARG . 13.7 t -132.06 132.61 61.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.106 0.479 . . . . 11.04 111.298 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.405 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -137.29 174.86 10.15 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.331 -0.849 . . . . 11.47 110.226 170.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 18.0 p -118.6 -176.57 3.11 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.964 -1.016 . . . . 11.83 111.849 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.428 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.2 OUTLIER -52.99 148.77 13.3 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.85 -0.614 . . . . 12.84 111.867 -178.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -23.93 -65.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.556 1 C-N-CA 125.969 4.446 . . . . 15.06 115.838 -176.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.6 m -88.56 -62.77 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.294 0.85 . . . . 16.97 113.294 -170.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.0 m -166.82 132.67 1.81 Allowed Pre-proline 0 C--O 1.234 0.285 0 N-CA-C 112.449 0.537 . . . . 16.04 112.449 -171.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.44 ' HB3' HG22 ' A' ' 184' ' ' THR . 53.0 Cg_exo -63.48 124.78 14.33 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.971 2.447 . . . . 14.22 111.6 162.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.4 p -152.14 158.46 4.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.42 -0.354 . . . . 16.46 110.261 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -80.49 120.06 23.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.315 -0.402 . . . . 17.05 110.81 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.96 -22.51 25.42 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.98 -0.629 . . . . 17.2 112.72 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.515 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.1 OUTLIER -114.79 163.55 15.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.992 0.425 . . . . 19.02 110.062 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 10.1 tp -71.01 120.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.623 -0.717 . . . . 15.32 111.761 -173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 56.8 m -114.05 105.87 13.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.754 -0.657 . . . . 13.03 109.704 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -83.41 141.16 31.93 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.509 -0.769 . . . . 14.44 108.991 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.547 HD13 ' HA ' ' A' ' 157' ' ' VAL . 3.4 mt -120.91 123.57 70.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.443 -0.577 . . . . 11.02 109.443 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.445 ' HG ' ' HA ' ' A' ' 147' ' ' GLN . 4.0 mp -128.73 135.92 49.87 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.324 -0.853 . . . . 10.32 110.661 -170.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.435 HG21 HD22 ' A' ' 148' ' ' LEU . 25.0 t -104.17 133.4 48.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.239 -0.892 . . . . 10.0 110.835 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.02 47.37 5.3 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.0 -1.0 . . . . 9.94 114.043 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.504 ' N ' HG11 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -61.02 125.1 16.25 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 CA-C-N 119.68 1.74 . . . . 11.15 111.414 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -156.05 147.69 22.88 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.105 -0.498 . . . . 12.77 110.176 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -89.34 -8.99 52.08 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.559 -0.746 . . . . 15.0 111.267 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.4 t -100.67 94.44 6.1 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.449 -0.574 . . . . 14.58 109.449 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.694 ' HG3' ' CD1' ' A' ' 144' ' ' TYR . 18.1 ttmt -54.1 -41.08 67.88 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.142 -0.935 . . . . 16.29 110.101 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.07 -53.41 54.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 15.6 111.827 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -62.88 -46.21 88.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.138 0.494 . . . . 14.36 111.164 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.492 ' O ' HD11 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -76.27 -20.76 57.04 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.841 -0.618 . . . . 12.11 110.864 -176.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 57.0 tptt -65.92 -39.25 90.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.448 0.642 . . . . 14.96 109.728 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.49 -11.3 85.43 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 114.984 -1.007 . . . . 13.32 110.667 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 75.2 m -88.23 -8.97 54.45 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.101 -0.549 . . . . 12.31 112.377 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 33.1 mt -68.34 -37.28 80.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.799 0.333 . . . . 12.72 110.956 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.05 -43.8 96.71 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.926 -0.654 . . . . 14.66 111.882 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.445 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 13.6 pt-20 -83.47 -18.03 39.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.795 0.331 . . . . 14.54 110.935 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.409 HD12 HD13 ' A' ' 207' ' ' LEU . 15.2 tp -74.44 -34.74 63.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.086 0.47 . . . . 12.55 110.306 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 7.6 mtmp? -66.82 -15.63 63.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.775 -0.648 . . . . 16.12 110.015 174.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.01 -36.01 17.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.851 -0.613 . . . . 16.98 109.413 172.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 66.3 mt -68.88 -51.4 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.787 -0.642 . . . . 14.15 111.127 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' SER . . . . . 0.447 ' HA ' HD13 ' A' ' 164' ' ' LEU . 22.2 p -102.67 -47.82 4.31 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.383 -0.527 . . . . 13.54 111.139 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 75.37 -0.17 60.6 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.824 -0.626 . . . . 14.79 112.183 -176.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 148' ' ' LEU . 7.3 mp -74.92 158.98 32.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 110.048 -0.353 . . . . 13.52 110.048 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 57.1 p -77.09 93.35 3.86 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.082 -0.508 . . . . 14.87 110.44 -175.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -112.78 137.63 14.38 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.349 -0.929 . . . . 12.22 114.279 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 16.9 t -101.75 137.94 27.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.287 -0.634 . . . . 14.04 109.287 173.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 5.3 p -75.56 105.65 4.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.622 0.725 . . . . 12.89 109.936 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 91.2 mmm -117.35 133.79 55.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.869 -0.605 . . . . 14.23 110.546 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -67.74 139.31 34.71 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.526 -0.845 . . . . 14.09 111.546 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.497 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 9.9 t80 . . . . . 0 C--N 1.312 -1.031 0 C-N-CA 123.703 0.801 . . . . 14.24 110.423 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.531 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 110.253 -0.277 . . . . 15.06 110.253 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.451 ' HB3' HD23 ' A' ' 197' ' ' LEU . 3.3 m-85 -128.6 156.15 43.83 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.813 0.672 . . . . 14.83 112.813 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 190' ' ' PRO . 2.7 t -150.49 165.75 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 108.983 -0.747 . . . . 10.79 108.983 174.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 43.9 t -105.59 113.05 41.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 O-C-N 121.75 -0.594 . . . . 10.43 110.8 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.437 ' OE1' ' HD3' ' A' ' 185' ' ' ARG . 6.4 tt0 -87.72 105.16 17.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.715 -0.221 . . . . 12.54 111.161 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.536 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -85.66 -36.27 20.39 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.343 0.592 . . . . 11.88 110.198 -176.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.47 169.59 26.4 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.251 -0.976 . . . . 11.9 112.674 -173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.32 101.27 0.35 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.288 -0.634 . . . . 13.47 109.288 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.75 154.63 47.46 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.402 0.62 . . . . 14.03 110.724 -173.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 40.6 mtmt -95.44 -3.19 47.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.88 -1.055 . . . . 17.87 109.899 -176.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -97.92 104.15 16.15 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.025 . . . . 16.68 109.362 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.77 -19.01 65.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.371 0.605 . . . . 14.47 110.551 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -59.93 -34.34 73.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.235 -0.893 . . . . 16.57 110.189 174.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -90.42 -29.12 18.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.727 -1.124 . . . . 16.69 110.405 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 93.3 t -58.48 -38.73 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.368 0.604 . . . . 12.92 109.819 173.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -59.75 -29.48 68.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.148 -0.933 . . . . 15.83 111.243 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.74 -62.69 1.4 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.217 0.532 . . . . 15.97 110.03 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.6 mt -55.25 -43.51 71.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.885 -1.052 . . . . 12.6 110.757 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.5 t -74.59 -40.19 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.689 -0.687 . . . . 12.54 110.455 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.26 -33.95 86.33 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.373 -0.918 . . . . 14.8 111.487 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -68.23 -57.43 6.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.411 -0.394 . . . . 16.37 111.497 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -85.3 -52.35 5.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.353 0.501 . . . . 12.99 112.353 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -68.31 -37.59 80.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.15 0.5 . . . . 15.56 110.221 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.09 -23.9 77.63 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.41 -0.814 . . . . 16.6 112.552 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.5 1.39 55.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.951 0.405 . . . . 16.55 110.755 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.29 23.46 34.36 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.83 -0.7 . . . . 15.88 113.396 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -89.92 154.42 19.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.955 0.378 . . . . 15.6 110.208 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 170' ' ' ARG . 8.8 mpt_? -76.55 98.34 4.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.238 -0.653 . . . . 14.31 109.238 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.97 142.01 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.155 -0.929 . . . . 11.04 109.016 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.628 ' HH ' ' HD2' ' A' ' 217' ' ' TYR . 0.1 OUTLIER -138.98 176.8 8.38 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.554 0.693 . . . . 11.47 110.712 174.152 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 23.6 p -111.21 -175.95 2.83 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.508 -1.223 . . . . 11.83 111.353 -171.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.3 OUTLIER -53.81 148.94 18.22 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.212 -0.449 . . . . 12.84 111.031 176.599 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -32.09 -61.38 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 125.126 3.884 . . . . 15.06 115.337 -173.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.1 m -87.32 -63.0 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.371 0.878 . . . . 16.97 113.371 -168.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.7 m -167.82 129.22 1.2 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 118.434 0.561 . . . . 16.04 112.356 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.407 ' HB3' HG22 ' A' ' 184' ' ' THR . 72.1 Cg_exo -59.36 124.27 15.19 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.541 2.16 . . . . 14.22 111.705 163.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.3 p -153.32 160.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 109.646 -0.502 . . . . 16.46 109.646 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -80.13 122.57 26.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.457 -0.338 . . . . 17.05 110.56 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.75 -25.77 18.05 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.888 -0.672 . . . . 17.2 112.555 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.476 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.3 OUTLIER -109.35 160.7 15.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.784 -0.451 . . . . 19.02 109.784 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.406 HG21 ' O ' ' A' ' 183' ' ' ILE . 8.0 tp -73.19 109.4 5.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.747 0.784 . . . . 15.32 111.555 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.473 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 56.9 m -100.05 112.53 24.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.449 -0.796 . . . . 13.03 109.625 174.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 46.1 mtt180 -93.61 144.77 25.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.691 -0.686 . . . . 14.44 109.938 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.486 ' C ' HD11 ' A' ' 187' ' ' LEU . 5.2 mm -114.85 120.41 64.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.108 -0.701 . . . . 11.02 109.108 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.486 HD11 ' C ' ' A' ' 186' ' ' ILE . 4.9 mp -129.42 123.01 30.55 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.208 0.528 . . . . 10.32 111.041 -174.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.419 HG22 ' CD2' ' A' ' 148' ' ' LEU . 33.6 t -99.58 134.97 36.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.625 -0.716 . . . . 10.0 111.159 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 84.5 47.98 5.2 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.96 -1.018 . . . . 9.94 113.555 173.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.515 ' N ' HG12 ' A' ' 145' ' ' VAL . 12.7 Cg_endo -62.74 125.82 16.88 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 119.476 1.638 . . . . 11.15 110.511 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -157.26 152.4 26.06 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.325 -0.55 . . . . 12.77 110.586 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -88.74 2.62 53.11 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.608 -0.724 . . . . 15.0 111.34 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 18.2 t -118.32 97.81 5.96 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.367 0.603 . . . . 14.58 109.685 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.445 ' HZ2' ' CG ' ' A' ' 195' ' ' ASP . 2.9 ptmm? -57.42 -40.5 78.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.899 -1.046 . . . . 16.29 111.821 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . 0.445 ' CG ' ' HZ2' ' A' ' 194' ' ' LYS . 12.2 m-20 -71.75 -46.89 57.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.803 0.335 . . . . 15.6 111.461 -176.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -59.55 -37.21 77.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.316 0.579 . . . . 14.36 110.243 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -84.21 -24.18 30.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.749 -0.659 . . . . 12.11 110.412 -178.241 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.566 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 14.1 tmtt? -74.82 -34.46 62.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.313 0.578 . . . . 14.96 109.652 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.17 -13.28 82.89 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.157 -1.177 . . . . 13.32 110.157 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 45.5 m -90.17 -8.59 50.82 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.354 -0.923 . . . . 12.31 111.934 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 24.3 mt -65.31 -35.21 80.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.671 0.272 . . . . 12.72 111.043 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.2 -42.62 97.28 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.791 -0.718 . . . . 14.66 111.851 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 200' ' ' SER . 9.9 pt-20 -85.91 -19.7 30.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.664 0.268 . . . . 14.54 110.584 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 19.9 tp -68.65 -28.63 67.06 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.112 0.482 . . . . 12.55 110.085 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.532 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 90.8 mttt -60.92 -16.68 44.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.41 -0.814 . . . . 16.12 110.568 173.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -89.91 -43.01 10.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.42 -0.355 . . . . 16.98 110.424 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.13 -55.52 31.5 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.51 0.671 . . . . 14.15 112.204 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 55.9 p -97.38 -44.19 6.97 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.134 -0.939 . . . . 13.54 110.854 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 72.62 1.93 54.57 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.536 -0.756 . . . . 14.79 111.802 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.408 ' HB2' ' HG ' ' A' ' 148' ' ' LEU . 70.5 mt -85.53 152.14 23.4 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.738 -0.468 . . . . 13.52 109.738 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 p -90.32 104.84 17.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.256 -0.429 . . . . 14.87 110.591 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -130.32 160.7 23.09 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.148 -1.025 . . . . 12.22 114.142 -173.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.2 t -101.45 140.59 19.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.917 -0.641 . . . . 14.04 109.383 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.01 105.15 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.732 0.777 . . . . 12.89 109.614 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.415 ' HA ' ' HE2' ' A' ' 215' ' ' MET . 1.8 mmt -122.07 168.85 11.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.48 -0.782 . . . . 14.23 110.564 -172.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -83.48 163.46 40.79 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.476 -0.868 . . . . 14.09 112.934 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.628 ' HD2' ' HH ' ' A' ' 172' ' ' TYR . 6.9 t80 . . . . . 0 C--N 1.318 -0.8 0 C-N-CA 123.845 0.858 . . . . 14.24 110.166 -174.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.47 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 CA--C 1.509 -0.597 0 N-CA-C 110.37 -0.233 . . . . 15.06 110.37 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.511 ' HA ' ' H ' ' A' ' 217' ' ' TYR . 10.0 m-85 -143.95 151.17 39.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.912 0.387 . . . . 14.83 111.336 -177.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' A' ' 187' ' ' LEU . 2.3 t -146.81 153.11 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.58 -1.267 . . . . 10.79 107.58 170.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 17.1 t -98.23 121.73 49.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.304 -0.559 . . . . 10.43 110.815 -176.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.474 ' HG3' ' CG ' ' A' ' 185' ' ' ARG . 3.5 tt0 -83.98 101.73 11.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.579 -0.156 . . . . 12.54 110.579 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 212' ' ' GLY . 0.5 OUTLIER -87.58 -26.5 23.07 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.191 -0.67 . . . . 11.88 109.191 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -149.7 158.29 27.6 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.347 -0.842 . . . . 11.9 112.039 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.499 ' C ' HD12 ' A' ' 151' ' ' LEU . . . -157.48 101.25 1.85 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.391 -0.596 . . . . 13.47 109.391 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.55 HD21 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -125.72 150.65 47.52 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.461 0.648 . . . . 14.03 110.296 -171.231 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 2.6 mttt -93.85 -1.84 54.29 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.738 -1.119 . . . . 17.87 108.431 176.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -104.87 107.27 18.15 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.205 -1.361 . . . . 16.68 109.238 175.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.76 -16.83 59.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.165 0.507 . . . . 14.47 111.022 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -54.98 -35.32 64.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.092 -0.958 . . . . 16.57 111.062 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.496 ' O ' HG13 ' A' ' 160' ' ' ILE . 83.6 tttt -90.53 -31.84 16.57 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.61 -0.723 . . . . 16.69 110.48 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.473 HG11 ' CD1' ' A' ' 186' ' ' ILE . 88.2 t -54.72 -43.26 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.239 -0.437 . . . . 12.92 110.472 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -62.0 -34.38 76.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.674 -0.694 . . . . 15.83 111.737 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.81 -59.05 2.9 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 120.911 0.386 . . . . 15.97 110.016 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 156' ' ' LYS . 21.8 mt -52.39 -45.07 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.846 -1.07 . . . . 12.6 110.788 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 89.6 t -71.16 -43.02 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.74 -0.663 . . . . 12.54 110.366 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.26 68.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.609 -0.805 . . . . 14.8 112.037 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -73.42 -61.79 1.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.257 0.223 . . . . 16.37 111.254 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -78.36 -45.8 21.6 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.415 0.524 . . . . 12.99 112.415 -174.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.481 ' HB2' ' CG1' ' A' ' 171' ' ' VAL . 25.8 ttm180 -65.17 -47.47 76.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.106 -0.702 . . . . 15.56 109.106 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.67 -20.59 68.3 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.048 -0.978 . . . . 16.6 113.456 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.2 -12.43 49.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.001 0.429 . . . . 16.55 110.385 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.41 20.86 11.32 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.937 -0.649 . . . . 15.88 113.222 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -95.74 154.91 16.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 117.337 0.568 . . . . 15.6 110.611 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -76.08 106.71 7.84 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.67 0.748 . . . . 14.31 110.151 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 165' ' ' ARG . 9.3 p -143.07 138.15 26.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.391 -1.277 . . . . 11.04 109.141 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.493 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.37 176.18 8.98 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.35 0.595 . . . . 11.47 110.583 171.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 24.8 p -105.78 -177.33 3.33 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.915 -1.039 . . . . 11.83 110.064 -174.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.23 142.73 36.96 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.305 -0.258 . . . . 12.84 110.305 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -38.92 -47.12 2.81 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 124.25 3.3 . . . . 15.06 115.145 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.402 ' C ' ' HG1' ' A' ' 177' ' ' THR . 16.9 t -85.74 -61.98 1.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 120.231 -0.588 . . . . 16.97 112.41 -171.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 176' ' ' SER . 99.8 m -167.65 137.66 2.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.607 0.595 . . . . 16.04 112.607 -173.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.423 ' HB3' HG22 ' A' ' 184' ' ' THR . 30.6 Cg_exo -67.14 125.23 13.24 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.765 2.31 . . . . 14.22 111.315 160.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 8.8 p -145.63 152.33 14.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.092 0.472 . . . . 16.46 110.6 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -81.78 123.52 28.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 17.05 111.101 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 100.2 -12.1 60.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.836 -0.697 . . . . 17.2 112.612 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.556 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -123.31 161.5 24.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.301 -0.629 . . . . 19.02 109.301 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 183' ' ' ILE . 8.8 tp -66.3 111.57 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.622 0.725 . . . . 15.32 111.858 -172.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 178' ' ' PRO . 87.4 m -109.2 117.16 33.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.372 -0.603 . . . . 13.03 109.372 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.474 ' CG ' ' HG3' ' A' ' 147' ' ' GLN . 25.2 ttm180 -93.92 140.05 30.17 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.503 -0.771 . . . . 14.44 110.171 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.482 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.9 mm -109.31 115.53 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.417 -0.586 . . . . 11.02 109.417 176.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 4.8 mp -121.57 118.02 28.22 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.554 0.692 . . . . 10.32 110.824 -171.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.423 ' CG1' HD11 ' A' ' 204' ' ' LEU . 27.7 t -95.71 135.3 30.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 114.834 -1.075 . . . . 10.0 110.61 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.19 48.93 5.49 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.248 -0.887 . . . . 9.94 113.627 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.514 ' N ' HG11 ' A' ' 145' ' ' VAL . 12.3 Cg_endo -63.84 125.3 15.11 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 CA-C-N 119.525 1.663 . . . . 11.15 111.05 174.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -156.88 161.12 39.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.001 -0.545 . . . . 12.77 110.102 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -102.73 0.09 32.41 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.943 -0.571 . . . . 15.0 111.363 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 28.5 p -113.61 95.91 5.59 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.575 0.702 . . . . 14.58 110.13 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.435 ' HG3' ' CD2' ' A' ' 144' ' ' TYR . 31.6 ttpt -56.7 -53.62 55.58 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.062 -0.972 . . . . 16.29 111.146 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -61.76 -32.04 72.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.833 0.349 . . . . 15.6 111.686 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -73.39 -41.83 62.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.098 0.475 . . . . 14.36 110.539 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -82.66 -19.86 37.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.246 0.546 . . . . 12.11 110.649 -178.123 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.409 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 55.7 tptt -67.15 -36.39 81.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.835 -0.621 . . . . 14.96 110.455 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.61 -12.25 83.11 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.43 -1.068 . . . . 13.32 110.43 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 67.2 m -84.66 -8.08 59.0 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.873 -0.664 . . . . 12.31 111.902 -176.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 14.6 mt -70.58 -36.33 73.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 12.72 110.611 -177.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.7 92.65 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.987 -0.625 . . . . 14.66 112.219 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.411 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 12.8 pt-20 -85.79 -17.34 36.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.955 0.407 . . . . 14.54 110.441 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.423 HD11 ' CG1' ' A' ' 188' ' ' VAL . 17.6 tp -69.14 -34.91 75.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.278 -0.419 . . . . 12.55 111.438 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -63.72 -16.06 60.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.955 0.407 . . . . 16.12 110.604 173.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.44 ' N ' ' HD3' ' A' ' 205' ' ' LYS . 0.8 OUTLIER -88.93 -36.39 15.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.058 -0.519 . . . . 16.98 109.687 172.697 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 93.1 mt -71.47 -52.31 19.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.661 -0.699 . . . . 14.15 111.499 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 63.0 p -98.14 -43.6 6.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.397 0.618 . . . . 13.54 111.04 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.34 0.01 55.97 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.241 -0.89 . . . . 14.79 111.322 -174.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.626 ' C ' HD11 ' A' ' 148' ' ' LEU . 97.1 mt -80.0 162.23 24.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.701 -0.851 . . . . 13.52 108.701 175.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.0 m -111.41 109.46 19.44 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.201 0.445 . . . . 14.87 112.201 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.734 ' N ' HD13 ' A' ' 148' ' ' LEU . . . -121.9 173.67 15.87 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.844 -0.693 . . . . 12.22 114.17 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.4 p -117.1 146.39 21.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.839 -0.68 . . . . 14.04 109.267 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 25.6 t -82.35 115.33 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.905 -0.589 . . . . 12.89 110.505 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 74.8 mtp -125.96 149.83 48.47 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.123 0.487 . . . . 14.23 110.67 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.39 128.56 9.41 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.706 -0.759 . . . . 14.09 112.549 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.511 ' H ' ' HA ' ' A' ' 144' ' ' TYR . 8.1 t80 . . . . . 0 C--N 1.311 -1.071 0 CA-C-N 114.574 -0.813 . . . . 14.24 109.083 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 121.602 0.715 . . . . 18.39 110.207 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.634 ' O ' ' HA ' ' A' ' 69' ' ' GLU . . . -130.33 159.99 22.92 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.691 -0.686 . . . . 17.97 111.713 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -78.01 -20.43 52.55 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.152 -0.684 . . . . 17.74 109.152 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -132.37 105.48 7.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.125 -0.943 . . . . 20.18 109.57 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 26.3 tptp -62.35 -49.9 73.74 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.084 -0.71 . . . . 17.66 109.084 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.542 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 31.8 t-80 165.05 -65.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.514 -1.291 . . . . 19.78 107.514 174.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.511 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 31.9 t80 -175.59 100.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.693 -1.14 . . . . 18.96 108.248 173.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.511 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 74.8 mt-30 72.87 178.65 0.23 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.821 0.701 . . . . 18.6 110.002 -171.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.92 113.81 25.37 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.924 -0.399 . . . . 16.78 109.924 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -95.0 140.13 30.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.398 0.618 . . . . 18.42 111.23 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -147.04 -39.24 0.2 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.31 -0.859 . . . . 17.92 109.063 172.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.67 137.94 37.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.483 -0.78 . . . . 19.75 110.148 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.11 64.31 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.661 0.601 . . . . 20.62 112.042 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 pt -125.81 78.2 69.62 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.0 -0.545 . . . . 19.92 110.235 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.21 56.18 3.12 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.175 2.583 . . . . 21.71 112.09 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 60.25 32.12 20.69 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.718 -0.674 . . . . 23.06 110.402 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.576 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 96.0 t -87.87 -50.81 0.42 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.376 -0.829 . . . . 21.55 111.235 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 7.2 Cg_exo -75.2 173.6 14.23 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 121.618 1.545 . . . . 20.17 111.148 173.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.68 -46.86 87.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.207 0.527 . . . . 21.45 110.337 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.08 -31.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.842 -0.617 . . . . 18.83 110.959 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.23 -75.35 1.57 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.377 -0.689 . . . . 17.72 111.377 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.84 125.54 23.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.117 -0.327 . . . . 16.95 110.117 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -64.64 120.36 12.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.202 -0.454 . . . . 18.58 111.062 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.465 ' O ' HD21 ' A' ' 63' ' ' LEU . 16.6 t70 -76.73 111.61 12.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 18.17 109.673 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.34 145.98 41.23 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.78 -0.646 . . . . 18.88 111.858 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 73.9 Cg_endo -77.73 -30.21 3.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.431 2.754 . . . . 19.87 114.237 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -174.34 112.04 0.16 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.443 -0.344 . . . . 21.1 111.188 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.5 ptp 176.63 -46.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.599 0.562 . . . . 22.59 110.332 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.541 ' HB3' ' HD3' ' A' ' 57' ' ' PRO . 60.1 ttp -144.25 -49.07 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.369 -0.378 . . . . 24.05 110.997 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 56' ' ' MET . 3.8 Cg_exo -78.52 94.05 1.08 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.787 1.658 . . . . 20.94 110.798 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.404 ' HB1' ' CB ' ' A' ' 62' ' ' ALA . . . 64.95 179.61 0.18 Allowed 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.917 0.76 . . . . 20.49 110.785 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.93 151.51 44.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.98 0.419 . . . . 21.67 111.967 -174.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.4 m 70.94 -75.7 0.07 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.091 -0.959 . . . . 22.84 111.84 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.587 ' HA ' HE22 ' A' ' 61' ' ' GLN . 0.0 OUTLIER -122.96 72.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.635 0.731 . . . . 22.15 110.223 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.404 ' CB ' ' HB1' ' A' ' 58' ' ' ALA . . . -92.5 -25.11 18.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.585 -0.734 . . . . 19.92 109.917 175.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 51' ' ' ASP . 44.0 tp -141.47 102.75 6.0 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.363 -0.835 . . . . 19.88 110.049 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -49.57 -39.72 45.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.26 2.64 . . . . 18.74 112.137 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m 61.81 91.64 0.06 Allowed 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.571 0.544 . . . . 17.84 111.465 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.62 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 7.8 tp-100 -91.44 -50.22 0.32 Allowed Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 120.813 -0.355 . . . . 19.1 110.391 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 66' ' ' GLN . 2.0 Cg_endo -87.25 153.07 8.06 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.482 2.121 . . . . 17.47 110.279 167.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.25 -19.18 66.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.079 2.519 . . . . 17.99 113.531 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 12.1 tp10 62.51 -81.61 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.842 0.714 . . . . 18.7 111.017 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.89 -59.71 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.981 -0.628 . . . . 17.72 111.96 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 66.43 -71.06 0.1 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.369 0.668 . . . . 18.19 110.841 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -170.71 -55.05 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.89 -0.596 . . . . 17.96 109.849 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 67.36 -74.33 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.186 0.929 . . . . 19.85 111.153 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.53 -62.84 0.09 Allowed 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.324 -0.991 . . . . 19.68 108.324 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.6 t -96.59 91.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.078 -0.712 . . . . 17.87 109.078 172.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -66.55 -57.94 6.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.39 -0.823 . . . . 20.34 110.525 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.53 -75.67 0.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.309 -0.405 . . . . 18.81 110.716 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.61 52.17 1.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.959 -0.638 . . . . 17.66 111.528 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -98.97 122.48 42.28 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.105 -0.331 . . . . 17.87 110.105 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 67.04 -77.79 0.04 OUTLIER 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.961 0.788 . . . . 18.04 110.822 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 50.46 51.87 15.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.173 0.511 . . . . 17.53 111.199 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.33 123.89 22.64 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.848 -0.614 . . . . 16.64 111.004 -174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.8 129.17 33.54 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.887 2.391 . . . . 17.64 111.881 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 m -84.06 -32.08 25.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.141 -0.481 . . . . 17.42 111.313 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -84.08 -51.85 6.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.812 0.339 . . . . 18.62 110.684 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -83.82 115.16 58.37 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.005 -0.543 . . . . 17.79 110.833 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.88 -31.07 25.49 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.57 2.18 . . . . 19.23 111.585 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.27 92.94 1.01 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.652 -0.703 . . . . 17.96 109.825 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.5 m -59.51 -36.11 75.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.999 -0.546 . . . . 18.63 111.738 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 pt -77.87 -7.22 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.855 0.317 . . . . 19.36 111.855 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -113.94 -38.08 4.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.08 0.467 . . . . 19.41 110.878 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.93 -156.02 0.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.857 -0.61 . . . . 18.96 109.764 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.496 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER 68.07 -140.4 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.581 -0.282 . . . . 18.95 111.088 176.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.405 ' H ' ' HB3' ' A' ' 93' ' ' ASN . 22.1 t-20 -75.6 2.75 11.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.24 0.543 . . . . 20.53 111.403 -173.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.8 m -60.34 -35.43 75.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.918 -0.583 . . . . 21.4 110.391 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -142.53 30.72 1.51 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.973 -0.558 . . . . 21.26 110.351 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 63.83 88.53 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.178 -0.919 . . . . 22.65 111.369 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -119.8 88.39 39.75 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.701 -0.681 . . . . 19.45 109.916 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -91.24 133.99 1.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.49 2.793 . . . . 18.97 112.445 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.497 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 7.4 mp0 -84.14 -51.33 0.6 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.445 -0.343 . . . . 17.53 111.89 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 100' ' ' GLU . 25.7 Cg_exo -64.3 -47.71 5.68 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.013 1.809 . . . . 17.77 112.483 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -123.48 79.03 54.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.435 -0.348 . . . . 18.07 110.815 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.54 140.42 91.16 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.05 2.5 . . . . 16.56 112.301 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.6 m -82.16 67.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.402 0.62 . . . . 17.5 111.042 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.75 144.95 88.96 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.537 -0.756 . . . . 16.11 111.125 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.434 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 56.3 Cg_exo -48.15 -51.29 10.3 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.881 2.387 . . . . 16.19 114.684 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 108' ' ' LYS . 46.8 Cg_exo -55.92 162.97 6.3 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.207 1.938 . . . . 16.43 113.31 -176.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 107' ' ' PRO . 75.4 mmtt 76.05 118.92 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.428 -0.806 . . . . 17.91 110.784 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.97 116.57 4.38 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.708 2.272 . . . . 15.31 112.047 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -140.31 118.65 8.4 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.82 -0.627 . . . . 15.37 110.639 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.02 165.04 17.46 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.387 2.058 . . . . 14.26 112.042 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.72 51.0 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 122.306 1.05 . . . . 15.75 108.993 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 61.35 85.49 0.17 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 114.211 -1.359 . . . . 16.84 110.35 -173.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.44 156.81 58.27 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.174 2.583 . . . . 15.51 112.087 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.81 58.17 5.92 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.133 2.556 . . . . 16.04 112.182 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 40.7 ttmt -70.66 -52.86 10.15 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.972 -0.558 . . . . 19.25 111.667 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 116' ' ' LYS . 29.9 Cg_endo -63.33 -33.24 71.18 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.163 1.909 . . . . 17.04 112.401 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.83 128.9 4.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 17.71 109.889 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 119' ' ' VAL . 5.7 p -115.52 101.74 12.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.385 0.612 . . . . 19.09 110.499 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 54.61 55.44 7.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.833 . . . . 20.88 110.718 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.2 113.26 49.31 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.792 -0.64 . . . . 18.89 109.801 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.79 117.33 4.94 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.428 2.085 . . . . 20.92 111.76 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.81 114.2 1.97 Allowed 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.443 2.095 . . . . 21.13 111.518 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.477 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . . . -61.97 -50.38 81.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.961 -0.563 . . . . 21.37 110.382 176.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 124' ' ' ALA . 90.5 Cg_endo -86.44 142.2 7.04 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.575 1.516 . . . . 21.41 110.731 167.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -86.31 110.69 33.32 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.576 0.227 . . . . 22.17 110.399 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.75 139.77 15.97 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.446 2.097 . . . . 20.33 112.001 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -125.99 76.03 71.59 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.101 -0.5 . . . . 20.48 110.154 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 130' ' ' LYS . 2.6 Cg_exo -76.03 76.28 3.85 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.857 2.371 . . . . 21.43 111.074 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 129' ' ' PRO . 36.4 mtmm 70.2 115.69 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.26 0 O-C-N 124.026 0.829 . . . . 23.44 110.293 -173.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.17 133.11 46.23 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.777 2.318 . . . . 21.1 111.783 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 m -82.58 47.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.598 0.713 . . . . 20.15 111.491 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.9 m -89.8 17.62 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.193 -0.912 . . . . 21.3 110.26 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.85 -174.87 2.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.064 -0.971 . . . . 21.3 108.945 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 52.4 mt-10 -77.48 -81.32 0.09 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.513 -0.475 . . . . 20.74 109.768 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 135' ' ' GLU . 67.5 mttm 76.89 117.61 0.06 Allowed 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 124.089 0.868 . . . . 18.17 109.986 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 65.49 -82.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.851 -1.068 . . . . 17.35 108.516 -164.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . . . 174.55 145.08 0.21 Allowed Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 123.921 0.763 . . . . 19.41 110.103 170.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 138' ' ' ALA . 12.5 Cg_exo -70.19 110.64 2.69 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.78 2.32 . . . . 20.18 111.271 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 28.0 m 76.87 -20.03 0.39 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.638 0.586 . . . . 18.05 111.17 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 139' ' ' PRO . . . -75.06 -76.54 0.74 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.122 -0.561 . . . . 18.56 112.368 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -104.06 58.08 0.72 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.432 0.634 . . . . 19.74 110.777 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . -78.32 165.32 24.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.115 -0.948 . . . . 15.06 109.875 177.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.656 ' CE1' ' HG3' ' A' ' 194' ' ' LYS . 5.4 m-85 -137.55 156.51 48.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.162 0.43 . . . . 14.83 112.162 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.508 ' CG2' HD22 ' A' ' 187' ' ' LEU . 2.5 m -152.5 151.33 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.348 -0.842 . . . . 10.79 109.717 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.438 HG13 ' HA3' ' A' ' 212' ' ' GLY . 60.2 t -110.82 110.92 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 10.43 111.423 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.597 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 54.6 tt0 -84.85 113.52 21.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.516 -0.311 . . . . 12.54 111.688 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' A' ' 211' ' ' SER . 0.0 OUTLIER -92.01 -34.55 14.38 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.989 0.423 . . . . 11.88 110.341 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.62 174.21 25.69 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.189 -1.005 . . . . 11.9 112.855 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.503 ' HB2' HE22 ' A' ' 147' ' ' GLN . . . -170.76 103.39 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.636 -0.505 . . . . 13.47 109.636 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.81 157.07 43.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.304 0.573 . . . . 14.03 110.695 -175.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 86.1 mttt -98.12 14.3 28.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.134 -0.939 . . . . 17.87 110.612 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.426 ' OD1' ' HG3' ' A' ' 156' ' ' LYS . 4.1 t-20 -112.73 106.22 14.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.564 -0.744 . . . . 16.68 109.348 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.72 -26.48 68.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.901 0.381 . . . . 14.47 111.426 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.72 -38.87 76.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.539 0.685 . . . . 16.57 110.044 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.43 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 68.8 mttm -79.27 -33.44 43.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.671 -1.149 . . . . 16.69 110.292 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 79.6 t -58.02 -44.58 87.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.63 -0.714 . . . . 12.92 110.288 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -62.11 -30.43 71.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.299 -0.864 . . . . 15.83 110.823 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 163' ' ' LYS . 24.4 mt-10 -69.39 -61.95 1.58 Allowed 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 120.906 0.384 . . . . 15.97 110.167 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 27.8 mt -51.5 -46.22 35.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.045 -0.979 . . . . 12.6 111.143 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.8 t -73.11 -34.51 45.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.724 -0.671 . . . . 12.54 110.288 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.8 -32.4 82.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.786 -0.721 . . . . 14.8 112.117 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 159' ' ' GLU . 48.7 mmtt -67.78 -51.05 53.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.266 0.555 . . . . 16.37 109.657 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 188' ' ' VAL . 20.9 mt -87.03 -56.01 3.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.899 1.074 . . . . 12.99 113.899 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -70.13 -29.27 66.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.69 -0.855 . . . . 15.56 108.69 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.7 -24.98 76.03 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.834 -1.076 . . . . 16.6 111.851 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.74 -5.05 59.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.213 0.53 . . . . 16.55 110.549 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.0 24.77 16.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.797 -0.716 . . . . 15.88 113.261 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -94.04 155.39 17.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.307 0.554 . . . . 15.6 110.783 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -71.63 98.24 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.621 -0.511 . . . . 14.31 109.621 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.472 HG21 ' HB3' ' A' ' 164' ' ' LEU . 6.7 t -133.17 125.69 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-N 115.589 -0.732 . . . . 11.04 111.123 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.478 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -135.33 175.24 9.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.265 -0.879 . . . . 11.47 110.602 176.306 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.4 p -117.09 -175.91 2.88 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.844 -1.071 . . . . 11.83 111.926 -169.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.78 153.65 5.62 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.633 -0.712 . . . . 12.84 111.598 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -42.13 -67.15 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.065 3.177 . . . . 15.06 115.19 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.1 m -76.55 -63.08 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.768 0.655 . . . . 16.97 112.768 -167.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.1 m -169.42 130.33 1.01 Allowed Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 112.226 0.454 . . . . 16.04 112.226 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.415 ' HB3' HG22 ' A' ' 184' ' ' THR . 50.1 Cg_exo -63.28 124.6 14.12 Favored 'Trans proline' 0 CA--C 1.519 -0.265 0 C-N-CA 122.771 2.314 . . . . 14.22 111.927 162.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.9 p -153.45 153.51 8.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.557 -0.534 . . . . 16.46 109.557 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -70.44 122.09 18.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.979 -0.555 . . . . 17.05 110.73 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.46 -26.45 14.71 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.621 -0.718 . . . . 17.2 112.407 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 13.2 mptt -108.18 156.28 19.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.961 0.41 . . . . 19.02 110.677 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.9 tp -71.2 117.28 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.681 -0.69 . . . . 15.32 111.462 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 178' ' ' PRO . 38.0 m -111.54 112.45 24.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.635 -0.711 . . . . 13.03 110.188 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 91.1 mtt180 -86.84 144.99 26.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.923 -0.581 . . . . 14.44 109.571 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.615 ' C ' HD12 ' A' ' 187' ' ' LEU . 5.2 mm -113.11 124.05 69.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.297 -0.631 . . . . 11.02 109.297 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.615 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.6 mp -129.15 129.08 44.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.487 0.661 . . . . 10.32 111.241 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.515 ' CG2' HD12 ' A' ' 164' ' ' LEU . 39.8 t -100.58 142.18 16.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.991 -1.004 . . . . 10.0 110.401 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.15 49.96 11.5 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.34 -0.845 . . . . 9.94 113.932 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.462 ' HA ' HG13 ' A' ' 145' ' ' VAL . 13.7 Cg_endo -63.77 124.83 14.28 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 CA-C-N 119.915 1.857 . . . . 11.15 110.273 168.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -162.94 150.35 13.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.91 -0.586 . . . . 12.77 109.593 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.493 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -91.32 -9.3 45.47 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.919 -0.582 . . . . 15.0 110.944 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.3 t -97.37 102.32 14.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.173 0.511 . . . . 14.58 110.312 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.656 ' HG3' ' CE1' ' A' ' 144' ' ' TYR . 19.8 ttmt -64.54 -42.85 95.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.702 -0.681 . . . . 16.29 110.204 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.77 -51.91 67.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.127 0.489 . . . . 15.6 111.208 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -63.53 -51.47 65.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.602 -0.726 . . . . 14.36 111.431 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 200' ' ' SER . 0.1 OUTLIER -87.01 -37.71 17.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.014 0.746 . . . . 12.11 113.014 -169.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.522 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 14.5 tmtt? -80.95 -20.51 41.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.499 0.666 . . . . 14.96 109.69 -168.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -82.84 -12.43 79.83 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.312 -1.115 . . . . 13.32 110.312 172.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 32.0 m -90.39 -7.62 52.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.825 -0.688 . . . . 12.31 112.547 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 15.8 mt -59.33 -36.58 75.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.592 0.234 . . . . 12.72 111.392 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -56.97 -46.69 90.92 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.909 -0.663 . . . . 14.66 112.189 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.37 -16.87 41.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.686 0.279 . . . . 14.54 110.701 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.424 ' HA ' ' HB2' ' A' ' 207' ' ' LEU . 2.6 tp -66.66 -26.95 67.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.048 0.451 . . . . 12.55 110.502 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.532 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 70.6 mmtt -61.08 -17.58 53.28 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.198 -0.455 . . . . 16.12 110.524 172.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -39.74 12.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.349 0.595 . . . . 16.98 109.521 170.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 204' ' ' LEU . 84.5 mt -61.85 -52.95 62.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.227 -0.897 . . . . 14.15 111.642 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 23.0 p -99.96 -47.5 4.99 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.314 -0.555 . . . . 13.54 110.244 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.35 5.31 71.89 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.576 -0.738 . . . . 14.79 112.793 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.1 mp -95.64 158.47 15.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.18 -0.674 . . . . 13.52 109.18 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 19.4 t -76.5 93.44 3.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.085 0.469 . . . . 14.87 110.527 -173.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -114.12 140.8 16.6 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.713 -0.676 . . . . 12.22 113.264 -176.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 p -105.81 146.73 12.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.135 0.493 . . . . 14.04 110.265 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 5.5 p -73.17 114.01 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.153 -0.93 . . . . 12.89 111.406 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.53 141.75 51.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.028 -0.533 . . . . 14.23 110.202 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -81.49 126.94 7.65 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.246 -0.978 . . . . 14.09 111.603 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.539 ' CZ ' ' HG3' ' A' ' 219' ' ' PRO . 4.8 t80 -85.81 131.67 34.26 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.075 0.95 . . . . 14.24 110.561 -175.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 p -131.37 91.84 33.86 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.527 -0.546 . . . . 16.73 109.527 172.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.539 ' HG3' ' CZ ' ' A' ' 217' ' ' TYR . 37.9 Cg_exo -53.69 153.31 19.38 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 123.321 2.681 . . . . 17.42 114.218 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 C--O 1.251 1.153 0 CA-C-N 115.186 -0.915 . . . . 19.69 109.609 177.736 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.613 0.245 . . . . 18.39 111.134 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.84 143.62 14.52 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.133 -1.032 . . . . 17.97 112.973 -173.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.4 pm0 -93.73 8.67 40.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.337 0.589 . . . . 17.74 110.178 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -92.7 130.1 38.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.553 -0.749 . . . . 20.18 109.552 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -64.94 -15.45 62.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.327 0.491 . . . . 17.66 112.327 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -63.29 -23.93 67.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.153 0.502 . . . . 19.78 109.896 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -110.31 131.01 55.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.952 -0.567 . . . . 18.96 109.857 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -89.32 126.89 35.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.092 -0.336 . . . . 18.6 110.092 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.86 144.73 56.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 16.78 109.835 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.535 ' HG2' ' H ' ' A' ' 39' ' ' ALA . 27.9 tt0 -117.17 124.55 49.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.073 0.463 . . . . 18.42 111.845 -171.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -102.81 5.52 38.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.774 -0.648 . . . . 17.92 110.413 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.535 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -81.43 -76.69 0.24 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.215 -0.448 . . . . 19.75 111.74 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.76 -16.15 49.04 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.208 -0.197 . . . . 20.62 111.138 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.5 pt 37.12 67.76 1.74 Allowed Pre-proline 0 N--CA 1.472 0.674 0 O-C-N 124.223 0.952 . . . . 19.92 112.525 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.49 61.1 5.97 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.169 2.579 . . . . 21.71 111.941 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 mp 63.86 17.97 10.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.508 -0.769 . . . . 23.06 111.08 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.565 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 90.8 t -85.13 -67.5 0.18 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 21.55 110.43 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.565 ' CD ' ' HB ' ' A' ' 44' ' ' VAL . 56.7 Cg_endo -71.95 92.82 0.71 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.174 1.25 . . . . 20.17 110.594 172.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -77.95 53.33 1.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.768 -0.651 . . . . 21.45 110.753 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.26 9.23 0.64 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.339 -0.846 . . . . 18.83 110.093 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.89 -153.49 38.24 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.835 -0.698 . . . . 17.72 112.212 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.43 116.13 17.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.858 0.361 . . . . 16.95 110.445 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -134.78 44.79 2.61 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.651 0.739 . . . . 18.58 109.473 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -92.34 108.12 19.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.614 -0.721 . . . . 18.17 110.801 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -88.66 137.6 30.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.516 -0.765 . . . . 18.88 108.944 172.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -42.0 136.26 3.59 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.185 2.59 . . . . 19.87 112.75 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -76.91 42.9 0.33 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.83 0.678 . . . . 21.1 112.83 -169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -82.27 -39.85 22.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.215 -0.661 . . . . 22.59 109.215 171.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.538 ' HB3' ' HD3' ' A' ' 57' ' ' PRO . 49.9 ttm -120.19 -50.66 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 24.05 111.304 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.538 ' HD3' ' HB3' ' A' ' 56' ' ' MET . 89.1 Cg_exo -50.73 111.71 0.6 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.712 2.274 . . . . 20.94 113.267 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 70.12 -0.32 2.83 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.931 -1.031 . . . . 20.49 111.859 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.37 -86.08 0.33 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.593 -0.276 . . . . 21.67 110.457 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.406 HG23 ' HA ' ' A' ' 56' ' ' MET . 9.0 t -91.72 -5.45 53.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.041 0.448 . . . . 22.84 110.314 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -141.06 114.18 8.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.941 -0.572 . . . . 22.15 109.632 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.93 145.31 56.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.23 -0.441 . . . . 19.92 111.299 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.2 mt -95.93 107.24 33.12 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.993 -0.549 . . . . 19.88 110.044 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.61 9.66 4.01 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.67 2.247 . . . . 18.74 112.257 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 p -70.48 -77.39 0.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 17.84 110.723 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 42.82 81.61 0.24 Allowed Pre-proline 0 N--CA 1.469 0.517 0 O-C-N 124.102 0.876 . . . . 19.1 112.236 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.4 111.28 0.67 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.081 2.521 . . . . 17.47 112.275 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.13 127.41 10.57 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.604 2.203 . . . . 17.99 112.581 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -106.22 -43.78 4.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.471 -0.937 . . . . 18.7 108.471 170.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.24 131.8 15.59 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.308 -0.86 . . . . 17.72 111.418 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 72.33 2.87 4.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.522 0.729 . . . . 18.19 111.508 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.73 -16.68 18.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.876 0.37 . . . . 17.96 110.435 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -72.94 81.61 1.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.799 -0.637 . . . . 19.85 109.752 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 67.57 177.57 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.669 -0.696 . . . . 19.68 111.044 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.2 t 67.28 -79.43 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.058 -0.519 . . . . 17.87 110.549 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mtm-85 54.1 40.15 31.36 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.249 0.547 . . . . 20.34 111.41 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.96 -163.74 0.87 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.877 -0.601 . . . . 18.81 110.341 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.06 89.59 0.4 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.021 -0.609 . . . . 17.66 112.337 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -112.22 172.5 6.88 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.342 -0.614 . . . . 17.87 109.342 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.09 8.95 21.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.868 0.365 . . . . 18.04 111.629 -173.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.75 -36.38 75.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 17.53 109.96 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.68 97.21 36.21 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.763 -0.653 . . . . 16.64 110.093 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.99 -30.89 80.06 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.995 2.464 . . . . 17.64 112.429 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 m 72.71 -45.53 0.62 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.779 0.832 . . . . 17.42 112.245 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.12 149.5 29.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.915 0.388 . . . . 18.62 110.611 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -79.46 131.85 63.92 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.851 -0.613 . . . . 17.79 110.414 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.22 -27.54 85.08 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.207 2.604 . . . . 19.23 112.414 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.39 63.1 7.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.289 0.566 . . . . 17.96 109.578 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 m -69.5 126.38 29.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.295 -0.866 . . . . 18.63 110.864 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.13 -44.44 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 19.36 111.106 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.56 81.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.378 0.423 . . . . 19.41 111.672 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.46 83.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.872 -0.604 . . . . 18.96 111.682 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -103.29 26.0 8.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.273 0.558 . . . . 18.95 109.891 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 57.03 37.99 29.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.589 -0.732 . . . . 20.53 111.689 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.0 t -70.07 -24.1 63.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.458 . . . . 21.4 110.415 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -111.37 3.16 18.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.611 0.719 . . . . 21.26 109.168 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 60.24 93.49 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 114.482 -1.235 . . . . 22.65 111.346 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.435 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 42.7 tt0 -68.07 -50.37 31.47 Favored Pre-proline 0 CA--C 1.539 0.558 0 N-CA-C 111.938 0.347 . . . . 19.45 111.938 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 98' ' ' GLU . 5.1 Cg_exo -77.78 57.76 6.18 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.59 2.194 . . . . 18.97 112.658 -176.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -93.46 143.39 26.58 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.063 -0.517 . . . . 17.53 110.105 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.76 3.41 3.27 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.894 2.396 . . . . 17.77 112.421 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.36 88.07 13.1 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.553 . . . . 18.07 110.223 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.91 143.38 85.37 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.787 2.324 . . . . 16.56 111.868 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 p -76.96 90.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.816 0.817 . . . . 17.5 110.503 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.97 144.35 9.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.144 -0.935 . . . . 16.11 109.804 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.59 152.63 76.66 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.649 2.233 . . . . 16.19 111.581 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.52 43.72 0.96 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.051 2.501 . . . . 16.43 112.819 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 109' ' ' PRO . 62.0 tttp -96.26 -57.56 0.19 Allowed Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.106 -0.497 . . . . 17.91 111.588 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.485 ' HD2' ' H ' ' A' ' 108' ' ' LYS . 10.0 Cg_endo -54.31 131.62 46.15 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.115 1.877 . . . . 15.31 112.361 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.423 ' HD3' ' HD2' ' A' ' 111' ' ' PRO . 4.2 tppp? -150.32 129.04 6.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.015 -0.539 . . . . 15.37 109.837 -176.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.423 ' HD2' ' HD3' ' A' ' 110' ' ' LYS . 26.1 Cg_endo -64.48 137.68 56.3 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.422 2.081 . . . . 14.26 112.192 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.8 t -90.51 51.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.865 0.841 . . . . 15.75 110.226 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 56.28 80.52 0.29 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.175 -1.375 . . . . 16.84 111.992 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.11 134.82 28.12 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.22 1.947 . . . . 15.51 111.028 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.11 129.64 18.65 Favored 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 122.383 2.055 . . . . 16.04 112.549 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -106.21 103.65 46.23 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.361 -0.381 . . . . 19.25 110.119 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 121' ' ' ALA . 14.9 Cg_exo -69.35 -52.11 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.695 2.263 . . . . 17.04 111.188 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -142.9 29.3 1.51 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.831 -0.622 . . . . 17.71 110.65 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 t 69.75 152.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.82 -0.627 . . . . 19.09 111.224 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 46.5 mm-40 68.84 34.59 3.23 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.118 0.567 . . . . 20.88 110.913 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HB2' ' HD2' ' A' ' 117' ' ' PRO . . . -85.14 112.85 46.61 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.931 -0.577 . . . . 18.89 111.504 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 120' ' ' GLU . 41.8 Cg_endo -93.48 137.53 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.179 2.586 . . . . 20.92 112.153 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.58 58.92 6.05 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.769 2.313 . . . . 21.13 112.34 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.52 ' H ' ' HD2' ' A' ' 125' ' ' PRO . . . -140.96 -57.36 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.938 -0.574 . . . . 21.37 111.317 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.52 ' HD2' ' H ' ' A' ' 124' ' ' ALA . 19.9 Cg_endo -61.48 -34.75 85.23 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 121.907 1.738 . . . . 21.41 111.718 175.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -127.15 94.65 38.46 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.902 -0.59 . . . . 22.17 109.649 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.61 151.75 74.92 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.766 2.311 . . . . 20.33 111.578 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.05 121.81 85.7 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.051 0.453 . . . . 20.48 110.753 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -88.53 -148.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.72 2.28 . . . . 21.43 110.931 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 130' ' ' LYS . 3.9 mppt? -85.29 133.81 41.84 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.312 -0.625 . . . . 23.44 109.312 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.97 111.69 1.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.256 1.971 . . . . 21.1 111.12 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.6 m -86.73 52.68 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.772 0.796 . . . . 20.15 110.941 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.1 m -75.5 151.96 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.096 -0.956 . . . . 21.3 110.146 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 69.39 -75.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.681 0.613 . . . . 21.3 111.218 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 138' ' ' ALA . 6.8 tp10 -170.7 174.48 4.95 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.382 -0.599 . . . . 20.74 109.382 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -140.16 -36.27 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.34 . . . . 18.17 111.121 -175.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.7 3.39 31.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.209 0.528 . . . . 17.35 110.164 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.47 ' H ' ' HG3' ' A' ' 135' ' ' GLU . . . 68.19 141.92 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 114.534 -1.212 . . . . 19.41 111.927 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.69 -51.17 10.86 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.374 2.716 . . . . 20.18 113.917 -171.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 57.9 p -124.96 7.57 8.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.929 0.395 . . . . 18.05 110.869 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.07 -65.94 2.01 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.983 -0.627 . . . . 18.56 112.074 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -125.57 53.77 1.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.202 0.525 . . . . 19.74 110.366 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.572 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -73.01 163.2 28.53 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.904 -0.776 . . . . 15.06 108.904 175.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.599 ' CE1' ' HD3' ' A' ' 194' ' ' LYS . 7.6 m-85 -144.74 155.85 43.76 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.879 0.325 . . . . 14.83 111.879 -175.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.514 ' CG1' ' HB3' ' A' ' 187' ' ' LEU . 2.4 t -149.62 159.94 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.882 -0.784 . . . . 10.79 108.882 173.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.445 ' O ' HD11 ' A' ' 148' ' ' LEU . 58.4 t -101.0 110.02 26.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 O-C-N 122.069 -0.394 . . . . 10.43 110.803 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -86.74 108.92 18.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.569 -0.287 . . . . 12.54 111.051 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.577 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -83.97 -40.55 18.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.228 0.537 . . . . 11.88 109.953 -176.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.38 165.85 28.22 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.544 -0.836 . . . . 11.9 112.526 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -156.75 101.22 1.96 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.512 -0.551 . . . . 13.47 109.512 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.468 HD11 ' C ' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -119.57 159.25 24.71 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.38 0.609 . . . . 14.03 110.028 -174.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 39.3 mttm -101.56 24.49 9.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.888 -1.153 . . . . 17.87 107.888 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -136.37 110.86 8.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.724 -1.58 . . . . 16.68 109.114 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.76 -19.12 62.75 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.204 0.446 . . . . 14.47 112.204 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -64.32 -31.34 72.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.663 0.744 . . . . 16.57 109.563 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.418 ' O ' HG13 ' A' ' 160' ' ' ILE . 3.8 tmtm? -77.87 -38.62 45.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.396 -1.275 . . . . 16.69 109.026 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.4 t -56.44 -42.74 75.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.955 -1.021 . . . . 12.92 110.517 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -58.68 -29.6 66.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.581 -0.736 . . . . 15.83 112.146 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.511 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 8.5 mm-40 -79.56 -60.81 2.21 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.6 -0.519 . . . . 15.97 109.6 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 156' ' ' LYS . 11.4 mt -50.97 -44.3 27.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.278 -0.874 . . . . 12.6 110.673 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 84.9 t -76.49 -37.3 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.659 -0.7 . . . . 12.54 110.376 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.17 -28.79 71.29 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.669 -0.777 . . . . 14.8 112.053 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.511 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 1.0 OUTLIER -71.29 -52.27 19.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.66 0.266 . . . . 16.37 111.071 177.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.507 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 3.8 mm? -86.0 -55.59 3.87 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.043 0.386 . . . . 12.99 112.043 -175.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 24.5 ttt180 -61.7 -42.99 99.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.456 0.646 . . . . 15.56 109.82 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.82 -11.2 62.59 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.824 -1.08 . . . . 16.6 112.973 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.62 -2.19 22.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 16.55 110.714 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.94 56.13 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.233 -0.508 . . . . 15.88 113.569 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -82.58 155.44 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.241 -0.564 . . . . 15.6 110.369 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -71.4 104.39 3.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.74 0.781 . . . . 14.31 110.211 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.19 141.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 114.454 -1.248 . . . . 11.04 109.48 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.474 ' HH ' HD21 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.37 175.49 9.55 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.635 0.731 . . . . 11.47 110.635 169.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 7.1 p -120.75 -173.96 2.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.625 -1.17 . . . . 11.83 112.294 -168.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.59 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -50.21 151.12 3.83 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 115.161 -0.927 . . . . 12.84 112.982 -177.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -23.9 -70.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 1 C-N-CA 126.093 4.529 . . . . 15.06 115.281 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.1 m -88.95 -62.12 1.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.242 -0.583 . . . . 16.97 112.313 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 97.6 m -167.58 132.08 1.53 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 111.453 0.168 . . . . 16.04 111.453 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.404 ' HB3' HG23 ' A' ' 184' ' ' THR . 73.4 Cg_exo -56.75 125.76 20.06 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.54 2.16 . . . . 14.22 111.741 166.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.494 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.3 p -148.71 160.26 6.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.643 -0.503 . . . . 16.46 109.643 -174.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -72.55 133.47 44.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.527 -0.306 . . . . 17.05 110.739 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.08 -25.61 11.8 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.213 -0.518 . . . . 17.2 114.116 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.494 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.3 OUTLIER -102.94 168.06 9.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.36 0.58 . . . . 19.02 110.67 -176.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.6 tp -76.29 110.5 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.973 0.892 . . . . 15.32 111.766 -174.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 178' ' ' PRO . 48.8 m -104.9 107.59 18.64 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.496 -0.775 . . . . 13.03 109.464 173.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.59 ' H ' ' HB3' ' A' ' 174' ' ' SER . 6.4 ptm180 -90.42 133.71 34.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.408 -0.815 . . . . 14.44 109.675 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.549 ' C ' HD11 ' A' ' 187' ' ' LEU . 3.3 mm -104.91 122.52 58.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.76 -0.459 . . . . 11.02 109.76 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.549 HD11 ' C ' ' A' ' 186' ' ' ILE . 5.1 mp -129.68 126.46 38.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.258 0.552 . . . . 10.32 111.153 -174.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.507 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 38.5 t -102.38 134.77 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.474 -0.784 . . . . 10.0 110.997 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.06 49.86 4.83 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.001 -1.0 . . . . 9.94 113.66 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.46 ' N ' HG13 ' A' ' 145' ' ' VAL . 10.2 Cg_endo -58.86 125.09 17.22 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 119.441 1.621 . . . . 11.15 110.698 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -152.19 151.73 31.36 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.458 -0.497 . . . . 12.77 110.393 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -92.06 -7.0 49.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.824 -0.625 . . . . 15.0 111.706 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.4 p -118.29 104.98 11.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.341 0.591 . . . . 14.58 111.375 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.599 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 36.7 ttpt -58.47 -51.89 67.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.693 -1.139 . . . . 16.29 110.787 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.11 -44.97 83.75 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.158 -0.474 . . . . 15.6 111.191 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.447 ' HZ2' ' HB2' ' A' ' 196' ' ' LYS . 3.2 ttmp? -62.63 -48.28 80.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.745 -0.661 . . . . 14.36 111.017 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.558 ' O ' HD11 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -77.73 -20.39 53.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 12.11 110.935 -175.007 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.442 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.7 tptm -65.31 -39.02 91.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.516 0.674 . . . . 14.96 109.917 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -79.14 -12.43 84.04 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.498 -1.041 . . . . 13.32 110.498 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 59.0 m -84.08 -10.69 57.63 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.823 -0.689 . . . . 12.31 111.82 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 29.6 mt -64.77 -34.72 79.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.833 0.349 . . . . 12.72 110.995 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -61.68 -39.06 96.91 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.793 -0.718 . . . . 14.66 112.401 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.484 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 10.3 pt-20 -86.26 -22.2 26.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.876 0.369 . . . . 14.54 110.99 177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.6 tp -74.83 -31.47 61.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 12.55 111.272 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.571 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 20.2 ptmt -68.17 -15.09 63.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.111 0.481 . . . . 16.12 110.382 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.9 -30.67 17.71 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.177 0.513 . . . . 16.98 109.982 171.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 91.3 mt -76.44 -51.89 10.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.793 -0.64 . . . . 14.15 111.527 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.434 ' HB3' HD11 ' A' ' 164' ' ' LEU . 44.3 p -95.56 -43.93 7.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.354 0.597 . . . . 13.54 110.213 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.571 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 70.01 3.85 46.05 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 114.899 -1.046 . . . . 14.79 112.579 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.44 153.3 18.01 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 109.572 -0.529 . . . . 13.52 109.572 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 24.2 t -85.33 107.25 17.25 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.01 -0.541 . . . . 14.87 110.53 -175.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -127.48 163.27 21.29 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.346 -0.93 . . . . 12.22 113.435 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.87 145.8 12.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.039 -0.58 . . . . 14.04 109.748 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.61 104.85 3.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.104 -0.702 . . . . 12.89 109.104 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 92.8 mmm -117.06 141.8 47.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.168 -0.469 . . . . 14.23 110.447 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.21 155.09 51.31 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.494 -0.86 . . . . 14.09 111.698 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.572 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 10.9 t80 -132.03 132.06 43.05 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.082 0.553 . . . . 14.24 110.286 -169.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 31.5 m -146.71 93.4 4.88 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 109.161 -0.681 . . . . 16.73 109.161 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.04 147.23 79.43 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.735 2.29 . . . . 17.42 113.223 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 C--O 1.244 0.805 0 CA-C-N 115.368 -0.833 . . . . 19.69 110.933 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 10.0 p-10 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.485 -0.561 . . . . 18.39 109.485 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' N ' ' HB2' ' A' ' 69' ' ' GLU . . . -136.33 -98.11 0.52 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.187 -1.006 . . . . 17.97 113.271 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -115.76 -88.17 0.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.23 0.456 . . . . 17.74 112.23 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -142.16 168.85 18.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.631 0.253 . . . . 20.18 111.26 -173.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 1.9 mptm? 59.73 -92.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.463 -0.79 . . . . 17.66 111.44 -177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 20.3 t-160 168.72 -55.23 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.691 -0.855 . . . . 19.78 108.691 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.498 ' HB2' ' O ' ' A' ' 33' ' ' HIS . 2.3 t80 170.84 -67.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.235 -0.893 . . . . 18.96 108.891 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.449 ' HG2' ' HB2' ' A' ' 38' ' ' PHE . 52.8 tt0 57.37 65.84 1.27 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.797 0.808 . . . . 18.6 109.229 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.63 118.5 13.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.715 -1.13 . . . . 16.78 112.311 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 55.9 43.35 27.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.416 -0.811 . . . . 18.42 112.695 173.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.449 ' HB2' ' HG2' ' A' ' 35' ' ' GLN . 52.4 m-85 -113.88 56.23 0.71 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.385 0.612 . . . . 17.92 109.87 174.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.72 25.5 11.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.547 -0.751 . . . . 19.75 111.001 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.3 -14.74 60.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.315 0.578 . . . . 20.62 110.317 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -127.59 65.04 65.65 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.567 -0.742 . . . . 19.92 110.779 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.06 65.03 8.39 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.271 1.981 . . . . 21.71 111.769 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mp 61.94 23.48 13.83 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.453 -0.794 . . . . 23.06 111.324 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.403 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 99.3 t -80.35 -57.06 0.66 Allowed Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.24 -0.436 . . . . 21.55 110.851 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.403 ' CD ' ' HB ' ' A' ' 44' ' ' VAL . 25.6 Cg_endo -64.07 -59.34 0.2 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.546 1.497 . . . . 20.17 111.267 174.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -175.37 -69.25 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.974 -0.557 . . . . 21.45 110.071 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.31 39.35 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.017 -0.538 . . . . 18.83 110.83 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.9 57.32 3.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.776 -0.726 . . . . 17.72 112.962 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.1 145.31 56.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.883 0.373 . . . . 16.95 110.841 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -67.37 106.05 1.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.641 . . . . 18.58 110.81 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -96.68 121.48 38.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.264 0.554 . . . . 18.17 110.414 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -86.12 129.87 52.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.737 -0.665 . . . . 18.88 110.513 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.08 -7.34 21.18 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.977 2.451 . . . . 19.87 113.162 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -112.12 144.31 41.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.549 -0.296 . . . . 21.1 110.707 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 43.0 tpp 66.98 -77.11 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.518 -0.765 . . . . 22.59 112.322 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 91.0 mtp -143.67 129.05 9.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.718 0.294 . . . . 24.05 110.846 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 79.3 Cg_endo -85.07 163.48 11.57 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.864 2.376 . . . . 20.94 112.339 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.87 4.55 4.03 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.112 -0.494 . . . . 20.49 111.603 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.23 84.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.916 -0.402 . . . . 21.67 109.916 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 t -99.19 -32.01 11.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.074 -0.512 . . . . 22.84 110.908 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 57' ' ' PRO . 19.3 pt20 -106.15 49.78 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.057 0.456 . . . . 22.15 111.165 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.45 150.94 34.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.17 -0.468 . . . . 19.92 110.709 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.7 mp 66.34 103.92 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.397 0 O-C-N 123.747 0.654 . . . . 19.88 110.85 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.49 145.47 79.77 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.056 2.504 . . . . 18.74 112.562 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.483 ' OG1' ' HD2' ' A' ' 67' ' ' PRO . 6.9 t -155.35 168.12 28.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.323 -0.398 . . . . 17.84 110.416 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.441 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 63.3 tt0 -78.23 -48.26 1.99 Allowed Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 119.096 -0.478 . . . . 19.1 111.923 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.483 ' HD2' ' OG1' ' A' ' 65' ' ' THR . 36.6 Cg_exo -36.49 114.42 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 123.547 2.831 . . . . 17.47 113.928 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -88.41 145.52 5.98 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.838 2.359 . . . . 17.99 113.342 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.472 ' HB2' ' N ' ' A' ' 29' ' ' GLY . 15.1 mm-40 60.91 110.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.927 -1.033 . . . . 18.7 112.309 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.66 95.02 0.68 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.667 -0.697 . . . . 17.72 112.695 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . . . -110.35 52.02 0.74 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.19 0.519 . . . . 18.19 110.218 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -153.8 -49.67 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.883 -0.598 . . . . 17.96 111.419 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 60.82 38.65 17.84 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.157 0.98 . . . . 19.85 108.917 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -119.13 -175.9 3.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.634 -1.166 . . . . 19.68 110.062 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.5 m 38.87 52.79 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 124.295 0.997 . . . . 17.87 111.787 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -112.38 -33.43 6.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.263 -0.88 . . . . 20.34 110.73 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.91 -87.16 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.96 0.355 . . . . 18.81 111.96 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.29 76.96 0.39 Allowed Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.362 -0.695 . . . . 17.66 111.362 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.49 146.31 31.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.88 0.372 . . . . 17.87 110.254 -174.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.02 -8.27 57.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.993 -0.548 . . . . 18.04 110.987 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.02 40.1 15.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.105 -0.952 . . . . 17.53 111.176 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.85 95.23 6.31 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.846 -0.616 . . . . 16.64 110.788 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.71 112.57 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.767 2.311 . . . . 17.64 111.828 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 m -122.26 15.29 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 17.42 111.312 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -104.46 -63.75 1.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.28 0.562 . . . . 18.62 109.711 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 19.8 t70 -83.82 138.3 40.56 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.037 -0.727 . . . . 17.79 109.037 175.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 86' ' ' ASP . 42.6 Cg_exo -57.87 -20.04 42.19 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.997 2.464 . . . . 19.23 113.343 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 68.51 -59.93 0.44 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.631 0.772 . . . . 17.96 111.501 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.1 t -154.14 145.84 23.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.044 -0.525 . . . . 18.63 109.669 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.25 158.47 33.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.522 -0.547 . . . . 19.36 109.522 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.14 36.5 25.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.407 0.622 . . . . 19.41 109.997 -173.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.83 62.08 0.7 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 18.96 109.887 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.623 ' HA ' ' OE1' ' A' ' 98' ' ' GLU . 15.9 m120 -81.85 115.98 21.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.444 -0.798 . . . . 18.95 110.324 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 95' ' ' THR . 4.5 m-20 64.75 -154.97 0.29 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.782 0.676 . . . . 20.53 110.597 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.434 ' H ' ' HB3' ' A' ' 94' ' ' ASN . 54.8 m 74.65 -49.13 0.66 Allowed 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.34 0.4 . . . . 21.4 110.665 -176.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -113.55 21.21 15.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.401 -0.363 . . . . 21.26 111.029 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 70.18 83.11 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.316 0.579 . . . . 22.65 111.021 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.623 ' OE1' ' HA ' ' A' ' 93' ' ' ASN . 48.7 tt0 -80.76 -52.85 0.87 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.88 -0.6 . . . . 19.45 111.345 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 98' ' ' GLU . 6.0 Cg_exo -79.44 85.44 1.85 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.363 2.042 . . . . 18.97 112.325 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 64.42 79.85 0.24 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.691 -0.686 . . . . 17.53 111.695 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.07 -24.19 33.1 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.559 2.173 . . . . 17.77 112.406 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.462 ' HB1' ' HD3' ' A' ' 103' ' ' PRO . . . -119.77 -52.29 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.16 0.43 . . . . 18.07 112.16 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.462 ' HD3' ' HB1' ' A' ' 102' ' ' ALA . 1.9 Cg_endo -81.82 70.07 7.36 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.06 1.84 . . . . 16.56 111.846 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 t -77.34 110.78 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.257 -0.883 . . . . 17.5 110.365 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 56.41 65.39 4.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 O-C-N 123.816 0.698 . . . . 16.11 110.459 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 103' ' ' PRO . 61.5 Cg_endo -72.47 134.53 22.67 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.604 2.202 . . . . 16.19 112.363 -174.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.65 10.81 3.52 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.647 2.232 . . . . 16.43 111.949 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.8 tptm 68.61 110.03 0.03 OUTLIER Pre-proline 0 N--CA 1.462 0.128 0 CA-C-N 114.762 -1.108 . . . . 17.91 111.165 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.36 78.31 0.33 Allowed 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.705 2.27 . . . . 15.31 111.564 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -71.45 129.57 88.63 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.817 -0.629 . . . . 15.37 110.844 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.26 -175.83 2.17 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.149 2.566 . . . . 14.26 112.158 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.9 p -87.93 46.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.633 1.206 . . . . 15.75 109.502 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.531 ' HB2' ' HD3' ' A' ' 114' ' ' PRO . 52.5 mm-40 -96.4 -50.18 0.24 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.267 -1.333 . . . . 16.84 111.445 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 113' ' ' GLU . 50.6 Cg_exo -54.0 -51.99 9.42 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 121.813 1.676 . . . . 15.51 113.915 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.62 107.66 0.91 Allowed 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 121.788 1.658 . . . . 16.04 112.336 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -79.43 127.64 77.9 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 19.25 110.788 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.87 -54.19 0.23 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.961 2.44 . . . . 17.04 110.275 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? 70.27 157.67 0.17 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.498 -0.774 . . . . 17.71 112.038 172.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.26 167.33 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.969 -0.56 . . . . 19.09 109.596 170.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 42.6 44.8 3.78 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.796 0.808 . . . . 20.88 111.133 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.86 146.41 52.3 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.009 -0.996 . . . . 18.89 109.876 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.73 110.7 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.199 1.933 . . . . 20.92 111.285 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -84.5 -1.02 9.58 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.553 2.169 . . . . 21.13 112.387 -176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 68.91 158.4 0.15 Allowed Pre-proline 0 C--O 1.235 0.325 0 O-C-N 124.246 0.966 . . . . 21.37 111.629 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 126' ' ' LYS . 28.3 Cg_endo -63.88 119.95 7.16 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.365 2.044 . . . . 21.41 110.313 171.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 125' ' ' PRO . 48.8 mtmt 66.23 92.41 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 108.727 -0.842 . . . . 22.17 108.727 -170.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.74 157.24 33.65 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.073 2.515 . . . . 20.33 113.254 -170.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -51.38 116.43 7.63 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 115.177 -0.92 . . . . 20.48 111.104 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -75.91 -28.03 8.09 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.666 2.244 . . . . 21.43 112.745 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.465 ' HD2' ' CD ' ' A' ' 134' ' ' GLU . 86.2 mttt -110.75 161.56 24.29 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.119 -0.491 . . . . 23.44 109.944 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.41 -178.24 2.12 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.343 2.029 . . . . 21.1 111.026 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 m -75.74 49.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.495 0.664 . . . . 20.15 111.595 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 133' ' ' VAL . 11.8 p -100.83 6.39 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.225 1.012 . . . . 21.3 109.275 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.465 ' CD ' ' HD2' ' A' ' 130' ' ' LYS . 41.9 mt-10 -116.31 18.27 15.3 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.552 -1.204 . . . . 21.3 109.817 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 61.42 -90.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.725 -0.67 . . . . 20.74 111.454 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.24 78.83 1.8 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.219 -0.66 . . . . 18.17 109.219 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 192' ' ' ALA . . . 53.45 30.91 11.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.344 0.592 . . . . 17.35 110.6 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . . . 67.91 137.57 0.05 OUTLIER Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 114.455 -1.248 . . . . 19.41 112.079 -176.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.437 ' O ' ' HB ' ' A' ' 140' ' ' THR . 17.3 Cg_exo -64.6 117.53 4.59 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.799 2.333 . . . . 20.18 111.586 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 33.1 m 78.56 -17.44 0.58 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 123.522 0.514 . . . . 18.05 111.558 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -68.55 -75.86 0.48 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.966 -0.635 . . . . 18.56 112.655 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 137' ' ' ALA . 68.5 mttm -102.68 42.9 1.11 Allowed 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.843 -0.21 . . . . 19.74 111.071 -177.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 217' ' ' TYR . . . -77.62 153.3 33.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.424 -0.511 . . . . 15.06 110.125 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.529 ' CD2' ' HG3' ' A' ' 194' ' ' LYS . 4.7 m-85 -143.03 158.44 43.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.17 -0.468 . . . . 14.83 111.685 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 190' ' ' PRO . 2.2 m -151.77 152.82 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.715 -0.675 . . . . 10.79 110.633 -176.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 60.3 t -108.73 108.35 25.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 120.862 0.363 . . . . 10.43 111.262 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -85.26 108.94 18.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.54 -0.3 . . . . 12.54 110.871 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.549 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -84.92 -36.64 21.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.138 0.494 . . . . 11.88 109.924 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.34 164.15 28.38 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.583 -0.818 . . . . 11.9 112.674 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -161.21 101.21 1.23 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.02 0.438 . . . . 13.47 109.822 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.8 168.37 18.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.293 0.568 . . . . 14.03 110.586 -174.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -100.39 -5.6 26.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.866 -1.061 . . . . 17.87 109.837 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -105.45 106.58 17.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.122 -0.945 . . . . 16.68 109.844 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.13 -19.42 65.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.798 -0.637 . . . . 14.47 111.266 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.93 -29.78 70.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.516 0.674 . . . . 16.57 110.24 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -89.85 -27.23 20.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.149 -0.932 . . . . 16.69 109.327 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 74.2 t -60.7 -35.62 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.441 -0.799 . . . . 12.92 109.922 173.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.17 -26.81 66.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.437 -0.802 . . . . 15.83 111.59 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.469 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 3.9 mm-40 -70.95 -62.78 1.27 Allowed 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.48 -0.563 . . . . 15.97 109.48 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.563 HD13 HD13 ' A' ' 186' ' ' ILE . 13.8 mt -54.78 -46.49 74.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.622 -1.172 . . . . 12.6 110.514 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.48 HG22 HD12 ' A' ' 186' ' ' ILE . 85.0 t -72.04 -42.88 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.592 -0.731 . . . . 12.54 110.668 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.49 -27.77 66.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.627 -0.797 . . . . 14.8 111.804 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.469 ' HD2' ' O ' ' A' ' 159' ' ' GLU . 15.7 mttp -72.56 -57.93 3.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.491 -0.355 . . . . 16.37 111.021 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.411 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 3.7 mm? -82.87 -56.28 3.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.275 0.472 . . . . 12.99 112.275 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -62.53 -38.25 89.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.445 0.641 . . . . 15.56 109.7 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.08 -28.61 73.81 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.839 -1.073 . . . . 16.6 112.695 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.96 2.03 56.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.998 0.428 . . . . 16.55 110.879 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.83 23.59 55.32 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.979 -0.629 . . . . 15.88 113.313 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -85.66 154.59 21.57 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.645 -0.327 . . . . 15.6 110.22 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -68.52 99.34 0.96 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.366 0.603 . . . . 14.31 109.986 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.5 p -143.99 139.34 25.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 114.96 -1.018 . . . . 11.04 109.949 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.23 176.89 8.39 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.48 0.657 . . . . 11.47 110.508 172.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 p -126.49 -175.28 3.34 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.959 -1.019 . . . . 11.83 111.689 -169.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.471 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 2.9 p -52.24 149.51 9.81 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 115.94 -0.573 . . . . 12.84 111.876 -176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -34.53 -58.07 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.797 3.664 . . . . 15.06 115.341 -171.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 31.7 t -87.91 -64.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.458 -0.897 . . . . 16.97 112.212 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 55.5 m -169.03 134.0 1.33 Allowed Pre-proline 0 CA--C 1.53 0.196 0 O-C-N 122.389 -0.195 . . . . 16.04 111.282 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.488 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 72.5 Cg_exo -59.52 123.27 12.98 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.245 1.963 . . . . 14.22 111.58 165.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 8.6 p -153.92 159.87 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 109.767 -0.457 . . . . 16.46 109.767 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -80.51 122.42 27.0 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.935 -0.394 . . . . 17.05 109.935 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 110.02 -26.48 13.78 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.766 -0.652 . . . . 17.2 112.155 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.444 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.5 OUTLIER -106.93 158.44 17.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.411 -0.588 . . . . 19.02 109.411 175.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.6 tp -74.56 122.24 27.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.524 0.678 . . . . 15.32 111.156 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 56.0 m -111.34 105.0 13.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.81 -0.632 . . . . 13.03 110.202 174.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.471 ' H ' ' HB3' ' A' ' 174' ' ' SER . 97.3 mtt180 -84.03 138.05 33.28 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.984 -0.747 . . . . 14.44 108.984 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.563 HD13 HD13 ' A' ' 160' ' ' ILE . 4.2 mt -115.58 122.13 68.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.332 -0.618 . . . . 11.02 109.332 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 186' ' ' ILE . 3.8 mp -128.79 127.08 41.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.7 -0.682 . . . . 10.32 111.171 -168.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.445 HG23 HD21 ' A' ' 148' ' ' LEU . 50.5 t -100.7 143.13 14.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.034 -0.985 . . . . 10.0 110.418 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.99 48.43 7.71 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.192 -0.913 . . . . 9.94 113.76 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.468 ' HA ' ' CG1' ' A' ' 145' ' ' VAL . 18.7 Cg_endo -66.24 123.62 11.45 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 CA-C-N 119.831 1.815 . . . . 11.15 110.568 172.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.1 158.55 36.6 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.548 -0.751 . . . . 12.77 109.386 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.507 ' O ' ' HB1' ' A' ' 137' ' ' ALA . . . -92.6 -19.54 21.81 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.66 -0.7 . . . . 15.0 110.707 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 35.6 p -91.96 90.93 7.63 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.582 0.706 . . . . 14.58 110.863 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.529 ' HG3' ' CD2' ' A' ' 144' ' ' TYR . 27.7 ttpt -52.68 -51.88 58.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.562 -1.199 . . . . 16.29 110.905 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -57.71 -45.61 85.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.765 -0.652 . . . . 15.6 111.242 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -75.45 -38.03 59.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.903 -0.589 . . . . 14.36 111.591 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.475 HD23 ' CB ' ' A' ' 144' ' ' TYR . 0.1 OUTLIER -79.09 -20.07 49.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.263 0.554 . . . . 12.11 110.246 -178.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.423 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 54.1 tptt -64.97 -40.73 95.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.587 0.708 . . . . 14.96 110.219 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.24 -12.57 84.48 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.169 -0.923 . . . . 13.32 110.797 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 58.5 m -85.53 -9.04 57.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.716 -0.742 . . . . 12.31 112.236 -176.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.557 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 31.2 mt -65.91 -38.53 88.96 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.733 0.301 . . . . 12.72 111.361 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.34 -38.29 96.18 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.738 -0.744 . . . . 14.66 112.279 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.491 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 11.4 pt-20 -82.16 -18.63 42.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.096 0.474 . . . . 14.54 110.16 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 17.0 tp -74.02 -30.86 62.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.197 -0.456 . . . . 12.55 110.244 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 85.1 mttt -64.33 -19.96 65.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.284 0.564 . . . . 16.12 109.727 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.59 -29.99 18.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.512 -0.767 . . . . 16.98 110.288 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 82.4 mt -78.58 -53.04 7.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.827 -0.624 . . . . 14.15 111.701 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.408 ' HB3' HD12 ' A' ' 164' ' ' LEU . 68.4 p -94.71 -44.0 8.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.418 0.628 . . . . 13.54 110.46 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 67.46 13.85 63.6 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.727 -1.124 . . . . 14.79 112.286 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.423 HD12 HG22 ' A' ' 160' ' ' ILE . 85.3 mt -103.85 152.72 21.58 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.188 -0.671 . . . . 13.52 109.188 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 10.9 t -88.69 108.84 19.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.106 0.479 . . . . 14.87 110.448 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -125.71 161.04 20.22 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.327 -0.939 . . . . 12.22 113.216 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.7 p -102.09 144.01 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.216 0.532 . . . . 14.04 110.433 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.78 105.8 8.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.26 -0.882 . . . . 12.89 110.263 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 84.2 mmm -115.35 148.64 39.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.931 -0.577 . . . . 14.23 110.404 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -78.26 132.65 11.94 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.225 -0.988 . . . . 14.09 111.698 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.619 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 7.3 t80 -97.83 133.38 42.41 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.297 0.639 . . . . 14.24 109.607 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.4 t -147.2 93.05 4.77 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 109.167 -0.679 . . . . 16.73 109.167 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.61 145.62 97.5 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.451 2.101 . . . . 17.42 112.65 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.397 -0.811 . . . . 19.69 110.3 179.716 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.805 0.336 . . . . 18.39 110.552 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.58 -140.17 7.25 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.909 -0.877 . . . . 17.97 110.909 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -82.51 61.6 5.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.832 0.348 . . . . 17.74 110.771 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -140.52 30.95 1.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 20.18 110.649 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -110.62 -70.25 0.82 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.165 -0.47 . . . . 17.66 110.136 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 177.2 156.74 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 19.78 109.899 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -81.75 -67.57 0.77 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.76 0.314 . . . . 18.96 110.396 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -142.05 42.87 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.781 0.8 . . . . 18.6 109.528 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -76.88 -26.53 54.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.446 -0.797 . . . . 16.78 111.375 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.95 9.81 11.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.962 0.411 . . . . 18.42 110.956 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -76.04 -78.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.859 -0.61 . . . . 17.92 110.711 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.91 123.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 O-C-N 123.82 0.7 . . . . 19.75 111.197 -173.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.73 62.28 2.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.062 0.458 . . . . 20.62 111.01 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.8 mt 59.66 81.73 0.24 Allowed Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.307 -0.86 . . . . 19.92 110.676 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.515 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 94.7 Cg_endo -84.77 61.02 6.02 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.649 2.233 . . . . 21.71 109.887 175.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 11.2 mp 67.39 20.62 9.9 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.118 -0.946 . . . . 23.06 109.42 -171.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.09 80.8 40.41 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 115.288 -0.869 . . . . 21.55 110.35 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -73.35 87.25 1.08 Allowed 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.518 2.145 . . . . 20.17 111.527 175.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -125.9 -75.52 0.59 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.907 -0.588 . . . . 21.45 110.017 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -167.44 -53.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.268 0.556 . . . . 18.83 110.328 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.21 -85.09 1.56 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.67 -0.695 . . . . 17.72 112.574 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -79.4 160.89 26.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.143 0.497 . . . . 16.95 110.673 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -133.18 29.2 4.04 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.813 -0.81 . . . . 18.58 108.813 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -97.43 171.95 8.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.293 -0.867 . . . . 18.17 110.708 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.576 ' OE2' ' HD2' ' A' ' 53' ' ' PRO . 6.1 tp10 -61.66 146.33 90.49 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.945 -0.761 . . . . 18.88 108.945 173.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.576 ' HD2' ' OE2' ' A' ' 52' ' ' GLU . 13.4 Cg_exo -34.32 -62.85 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.006 3.138 . . . . 19.87 113.279 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -86.55 133.95 33.69 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.43 -0.582 . . . . 21.1 109.43 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 51.8 ttp -71.3 79.46 0.73 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.968 -0.56 . . . . 22.59 111.804 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 25.9 ttt -160.16 67.76 2.77 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.861 -0.609 . . . . 24.05 109.375 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.89 2.4 8.28 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.916 2.411 . . . . 20.94 113.474 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.11 22.38 12.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.63 0.253 . . . . 20.49 111.271 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.95 -57.6 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.368 . . . . 21.67 110.8 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.1 t -100.59 6.54 44.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.432 0.634 . . . . 22.84 110.107 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 62.09 45.22 7.31 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.008 -0.996 . . . . 22.15 111.193 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.64 -20.7 61.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.613 -0.721 . . . . 19.92 110.753 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.7 mp -103.62 133.15 20.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.732 -0.667 . . . . 19.88 109.95 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.3 134.38 36.05 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.66 2.24 . . . . 18.74 111.518 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.2 p -75.25 73.0 2.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.3 0.572 . . . . 17.84 111.243 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 3.8 pt20 -70.12 122.7 87.01 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.815 -0.63 . . . . 19.1 110.212 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 66' ' ' GLN . 23.5 Cg_exo -63.43 147.76 93.14 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.608 2.206 . . . . 17.47 111.783 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -59.33 134.52 59.36 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.378 2.052 . . . . 17.99 110.844 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.52 -39.49 88.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.378 -0.828 . . . . 18.7 111.532 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.57 -61.14 4.74 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.317 -0.713 . . . . 17.72 111.317 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.02 97.74 1.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 122.235 0.214 . . . . 18.19 110.607 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 67.46 -175.06 0.19 Allowed 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.718 0.636 . . . . 17.96 111.687 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -137.33 131.05 31.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.894 -0.594 . . . . 19.85 109.629 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -78.63 56.56 1.86 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 19.68 111.435 -174.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 m -118.58 93.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.567 0.698 . . . . 17.87 111.071 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -74.45 -29.8 61.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.628 -0.714 . . . . 20.34 110.126 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.81 113.58 7.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.694 -0.684 . . . . 18.81 110.084 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.79 -43.14 68.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.934 -0.65 . . . . 17.66 112.186 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -89.08 -13.68 38.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.992 0.425 . . . . 17.87 110.318 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.16 27.71 17.22 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.248 -0.887 . . . . 18.04 110.818 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.19 93.51 8.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.688 -0.687 . . . . 17.53 110.715 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.49 94.1 46.72 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 16.64 110.324 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.76 106.26 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.854 2.37 . . . . 17.64 111.964 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.6 p -136.57 40.98 2.58 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.182 -0.917 . . . . 17.42 110.293 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.1 tp -109.43 129.33 55.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.693 -0.685 . . . . 18.62 110.782 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -83.68 125.68 72.87 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.161 -0.472 . . . . 17.79 110.152 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.27 -6.38 19.07 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.83 2.353 . . . . 19.23 114.092 -174.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.81 -13.14 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.749 -0.38 . . . . 17.96 111.338 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.1 p -76.92 -80.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.624 -0.262 . . . . 18.63 111.061 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.8 mt 54.58 31.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.685 0.755 . . . . 19.36 110.322 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.31 27.71 12.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.095 -0.957 . . . . 19.41 112.15 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -94.03 99.93 12.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 18.96 110.773 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -163.02 162.77 26.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.764 -0.653 . . . . 18.95 109.899 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 63.56 22.84 13.36 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.485 0.49 . . . . 20.53 111.372 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.9 p -70.99 -41.01 71.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.659 0.742 . . . . 21.4 109.643 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.94 21.06 17.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.934 -1.03 . . . . 21.26 108.911 173.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 58.06 34.16 23.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 114.526 -1.216 . . . . 22.65 111.518 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 58.41 83.11 0.22 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 114.864 -1.062 . . . . 19.45 111.576 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.28 91.33 0.33 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.127 2.551 . . . . 18.97 111.944 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 67.64 139.39 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 115.626 -0.715 . . . . 17.53 111.582 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.01 55.28 4.94 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.674 2.249 . . . . 17.77 111.744 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -72.96 128.8 87.42 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 18.07 110.595 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 18.9 Cg_exo -67.58 79.51 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.685 2.257 . . . . 16.56 112.042 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.9 m -90.81 15.69 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 121.7 0.762 . . . . 17.5 110.497 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -139.55 109.97 7.41 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.762 -1.108 . . . . 16.11 109.927 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.25 155.22 70.14 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.626 2.217 . . . . 16.19 111.923 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.55 3.4 4.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.929 2.42 . . . . 16.43 112.077 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -126.98 148.35 65.29 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.476 -0.783 . . . . 17.91 109.217 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.73 7.94 2.53 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.613 2.209 . . . . 15.31 112.688 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.1 tttp 55.19 68.96 2.2 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-N 114.648 -1.16 . . . . 15.37 110.78 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.33 134.92 54.62 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.458 2.105 . . . . 14.26 112.251 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -82.68 54.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.597 1.189 . . . . 15.75 109.994 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.85 -52.78 39.45 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 114.541 -1.209 . . . . 16.84 110.61 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.15 135.69 25.5 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.487 1.458 . . . . 15.51 111.121 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 61.09 5.65 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.806 2.337 . . . . 16.04 112.417 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -104.66 127.19 29.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.962 -0.563 . . . . 19.25 110.821 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 16.4 Cg_exo -69.61 134.33 28.03 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.366 2.044 . . . . 17.04 110.323 169.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 49.4 mmtm 70.49 123.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.654 0.596 . . . . 17.71 110.69 -175.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.2 m -69.3 -11.68 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.971 0.415 . . . . 19.09 111.093 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.27 13.09 20.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 20.88 110.816 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.67 146.07 97.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 18.89 110.594 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.18 125.83 20.36 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.99 2.46 . . . . 20.92 112.22 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.12 -40.34 85.52 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.296 2.664 . . . . 21.13 112.029 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.404 ' O ' ' HD2' ' A' ' 127' ' ' PRO . . . -113.09 126.26 28.5 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.914 -0.585 . . . . 21.37 109.693 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.42 49.18 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.904 2.403 . . . . 21.41 112.054 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.477 ' H ' ' HD2' ' A' ' 127' ' ' PRO . 16.7 tppt? -98.24 -52.45 0.21 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.03 -0.532 . . . . 22.17 111.412 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.477 ' HD2' ' H ' ' A' ' 126' ' ' LYS . 56.5 Cg_endo -70.25 73.64 1.58 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.988 1.792 . . . . 20.33 112.349 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 30.6 tt0 -64.25 136.12 96.62 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 115.84 -0.618 . . . . 20.48 109.46 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 128' ' ' GLU . 19.2 Cg_exo -67.5 57.24 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.318 2.679 . . . . 21.43 114.132 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -134.51 115.76 12.68 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.172 -0.677 . . . . 23.44 109.172 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.72 121.92 9.42 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.369 2.046 . . . . 21.1 111.847 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.6 p -74.96 78.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 122.461 1.124 . . . . 20.15 110.544 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.1 m -83.04 -179.38 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.841 -1.072 . . . . 21.3 110.671 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 67.07 168.12 0.24 Allowed 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.635 0.584 . . . . 21.3 110.108 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -81.47 68.24 7.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.343 -0.614 . . . . 20.74 109.343 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -100.38 -57.83 2.03 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.368 -0.833 . . . . 18.17 109.191 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.14 -50.18 72.91 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.456 -1.313 . . . . 17.35 107.456 166.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 65.48 152.83 0.12 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.55 -1.204 . . . . 19.41 110.996 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 192' ' ' ALA . 8.3 Cg_exo -73.51 39.7 0.5 Allowed 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.624 2.216 . . . . 20.18 113.401 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 12.9 t 175.65 -14.87 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.931 0.345 . . . . 18.05 111.931 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -81.61 -89.41 0.61 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.452 -0.88 . . . . 18.56 111.814 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -93.42 80.43 4.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.188 -1.042 . . . . 19.74 108.188 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.723 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -91.17 165.56 13.41 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.27 -0.877 . . . . 15.06 109.535 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.688 ' CE2' ' HB2' ' A' ' 194' ' ' LYS . 4.4 m-85 -136.76 140.16 42.36 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 111.745 0.276 . . . . 14.83 111.745 -174.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.543 ' CG1' ' HB3' ' A' ' 187' ' ' LEU . 3.2 t -148.91 163.79 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.229 -0.656 . . . . 10.79 109.229 171.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.439 ' H ' HG11 ' A' ' 145' ' ' VAL . 40.1 t -105.54 113.26 41.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 O-C-N 121.787 -0.571 . . . . 10.43 111.267 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.51 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 49.6 tt0 -86.01 116.83 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.636 -0.256 . . . . 12.54 111.551 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.511 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -93.35 -35.09 13.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.088 0.47 . . . . 11.88 110.21 -178.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -147.25 169.38 28.25 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.454 -0.879 . . . . 11.9 112.569 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -163.58 105.39 0.96 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.865 -0.791 . . . . 13.47 108.865 177.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -138.91 159.36 42.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.21 0.529 . . . . 14.03 110.909 -171.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 183' ' ' ILE . 9.2 mmmm -96.93 -3.46 41.76 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.12 -0.945 . . . . 17.87 110.162 -174.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -111.91 115.87 29.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.371 -0.832 . . . . 16.68 110.338 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.6 65.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 14.47 111.007 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.14 -32.4 69.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.669 0.747 . . . . 16.57 110.199 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.416 ' HB3' HD22 ' A' ' 151' ' ' LEU . 32.5 mmtp -89.47 -31.27 17.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.739 -1.119 . . . . 16.69 110.368 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 94.9 t -61.89 -40.99 89.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.488 -0.778 . . . . 12.92 110.135 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -54.83 -36.38 64.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.078 -0.964 . . . . 15.83 111.056 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 18.5 mt-10 -69.13 -60.78 2.12 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.174 0.511 . . . . 15.97 110.057 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 210' ' ' LEU . 7.9 mt -56.03 -45.19 80.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.074 -0.966 . . . . 12.6 110.971 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.3 t -74.74 -41.22 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.758 -0.656 . . . . 12.54 110.451 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.95 -28.54 66.27 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.547 -0.835 . . . . 14.8 111.763 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 159' ' ' GLU . 15.5 mttp -73.74 -56.73 4.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.612 0.244 . . . . 16.37 111.41 177.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.56 -51.73 7.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.093 0.405 . . . . 12.99 112.093 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -65.84 -41.59 91.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.246 0.546 . . . . 15.56 109.653 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.23 -24.16 76.05 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.369 -0.832 . . . . 16.6 112.745 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.87 4.55 52.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.034 0.445 . . . . 16.55 110.877 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.61 25.11 47.88 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.956 -0.64 . . . . 15.88 113.54 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -89.65 160.12 16.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.159 0.48 . . . . 15.6 110.252 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.96 102.7 8.44 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.554 0.692 . . . . 14.31 109.379 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.84 139.8 27.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.753 -1.112 . . . . 11.04 109.87 -173.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.71 176.32 8.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.686 0.755 . . . . 11.47 110.723 172.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.5 p -123.3 -172.63 2.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.46 -1.245 . . . . 11.83 112.239 -167.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.643 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 0.9 OUTLIER -49.51 158.6 0.78 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.345 -0.843 . . . . 12.84 112.864 -177.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -47.36 -54.29 5.28 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.608 2.872 . . . . 15.06 113.904 -170.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.9 m -88.19 -64.09 1.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.705 -0.798 . . . . 16.97 112.227 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 42.1 m -169.26 137.93 1.63 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 122.336 0.255 . . . . 16.04 110.534 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.411 ' HB3' HG21 ' A' ' 184' ' ' THR . 76.1 Cg_exo -59.83 123.56 13.51 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.213 1.942 . . . . 14.22 111.306 165.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 12.2 p -154.66 159.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 116.177 -0.465 . . . . 16.46 110.487 -174.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -80.85 127.0 32.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.18 -0.464 . . . . 17.05 110.745 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 100.45 -16.45 57.87 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.981 -0.628 . . . . 17.2 112.221 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.499 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 8.5 mptt -120.84 162.5 19.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.787 -0.449 . . . . 19.02 109.787 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 152' ' ' LYS . 9.7 tp -73.38 120.11 21.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.69 0.757 . . . . 15.32 111.771 -172.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.483 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 37.8 m -113.16 105.37 13.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.432 -0.804 . . . . 13.03 109.747 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.643 ' H ' ' HB3' ' A' ' 174' ' ' SER . 15.8 ptt180 -88.18 136.25 33.06 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.362 -0.836 . . . . 14.44 109.584 176.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.531 ' C ' HD12 ' A' ' 187' ' ' LEU . 4.1 mm -110.39 123.1 65.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.677 -0.49 . . . . 11.02 109.677 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.543 ' HB3' ' CG1' ' A' ' 145' ' ' VAL . 4.5 mp -130.11 132.42 46.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.463 0.649 . . . . 10.32 111.441 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.436 HG21 HD23 ' A' ' 148' ' ' LEU . 26.4 t -107.57 132.72 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.053 -0.976 . . . . 10.0 111.015 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.22 49.78 4.32 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.174 -0.921 . . . . 9.94 113.58 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.493 ' HA ' ' CG2' ' A' ' 145' ' ' VAL . 9.3 Cg_endo -59.71 126.11 19.64 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 CA-C-N 119.515 1.657 . . . . 11.15 111.367 173.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -157.63 167.75 29.23 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.124 -0.695 . . . . 12.77 109.124 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 139' ' ' PRO . . . -107.89 5.95 26.87 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.029 0.442 . . . . 15.0 110.706 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 48.1 m -120.4 107.37 12.83 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.153 -0.476 . . . . 14.58 111.254 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.688 ' HB2' ' CE2' ' A' ' 144' ' ' TYR . 35.1 ttpt -66.67 -40.4 88.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.81 -0.632 . . . . 16.29 110.023 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -62.49 -39.7 94.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.686 -0.688 . . . . 15.6 110.857 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -51.22 36.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.626 -0.715 . . . . 14.36 110.493 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -74.06 -18.85 60.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.484 . . . . 12.11 110.725 -175.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.532 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 17.4 tppt? -62.93 -39.57 95.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.197 0.522 . . . . 14.96 110.325 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.02 -17.38 79.85 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.09 -1.204 . . . . 13.32 110.09 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 31.0 m -79.39 -8.92 59.44 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.564 -0.818 . . . . 12.31 112.037 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 13.8 mt -70.81 -37.33 73.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.936 0.398 . . . . 12.72 110.378 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.23 -25.32 71.05 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.648 -0.981 . . . . 14.66 110.648 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.591 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 41.6 mt-10 -86.39 -24.43 25.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.941 -0.629 . . . . 14.54 110.534 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.0 tp -60.3 -48.25 82.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.425 -0.352 . . . . 12.55 111.103 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.56 ' HB3' ' HZ2' ' A' ' 205' ' ' LYS . 0.5 OUTLIER -59.0 -21.21 58.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 16.12 111.396 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -38.65 13.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 16.98 110.436 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 93.1 mt -72.75 -51.85 17.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.073 -0.512 . . . . 14.15 111.615 -176.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 64.7 p -101.87 -43.32 5.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.222 0.534 . . . . 13.54 110.919 -176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.39 6.18 74.84 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.908 -0.877 . . . . 14.79 110.908 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.434 HD12 HG22 ' A' ' 160' ' ' ILE . 60.3 mt -97.74 157.91 15.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.787 -0.449 . . . . 13.52 109.787 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 17.7 p -81.12 95.61 6.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.011 0.434 . . . . 14.87 111.315 -176.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -108.23 142.34 15.95 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.727 -0.749 . . . . 12.22 114.127 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.1 142.39 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.526 -0.546 . . . . 14.04 109.526 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.38 107.02 4.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.109 -0.496 . . . . 12.89 110.512 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 23.9 mmt -109.0 141.54 40.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.741 -0.663 . . . . 14.23 109.817 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.55 107.34 2.34 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.169 -1.015 . . . . 14.09 111.748 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.723 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 6.1 t80 -63.85 133.66 53.76 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.147 -1.526 . . . . 14.24 111.066 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.9 p -141.89 91.91 7.99 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.229 -0.442 . . . . 16.73 110.246 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.35 133.47 28.4 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.306 2.004 . . . . 17.42 112.16 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--O 1.251 1.165 0 CA-C-N 115.608 -0.724 . . . . 19.69 111.247 178.043 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.507 0.194 . . . . 18.39 110.789 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.33 -72.48 1.12 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.292 -0.956 . . . . 17.97 113.017 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 58.25 54.48 5.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.407 0.622 . . . . 17.74 110.085 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -70.42 87.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.911 -1.04 . . . . 20.18 110.864 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -158.09 120.33 3.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.071 -0.513 . . . . 17.66 110.231 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -90.36 148.74 22.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.172 -0.467 . . . . 19.78 110.175 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -79.15 53.34 1.44 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.173 -0.467 . . . . 18.96 110.882 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -89.32 -44.4 10.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.034 -0.53 . . . . 18.6 109.771 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -137.02 176.89 8.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.398 -0.819 . . . . 16.78 109.803 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -86.75 -42.82 13.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.679 0.276 . . . . 18.42 111.241 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -146.29 26.5 1.19 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.041 0.386 . . . . 17.92 112.041 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.46 -16.65 30.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.361 . . . . 19.75 111.003 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.615 ' O ' ' HD3' ' A' ' 42' ' ' PRO . . . -107.21 114.1 27.93 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.871 -0.418 . . . . 20.62 109.871 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.416 HD11 ' N ' ' A' ' 41' ' ' ILE . 3.9 mp -102.5 96.27 7.14 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.176 -0.465 . . . . 19.92 109.85 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 40' ' ' ALA . 1.6 Cg_endo -83.54 61.16 6.95 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.968 2.445 . . . . 21.71 110.565 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.413 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 11.1 mp 63.51 29.06 15.41 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.282 -0.872 . . . . 23.06 109.995 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.403 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 28.9 t -127.55 69.92 75.95 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 115.534 -0.757 . . . . 21.55 110.813 178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.413 ' HD3' ' C ' ' A' ' 43' ' ' LEU . 3.1 Cg_exo -84.01 -5.56 10.46 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.918 2.412 . . . . 20.17 111.559 172.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.67 -35.92 79.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.495 -0.775 . . . . 21.45 110.902 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.18 169.48 22.89 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.865 -0.607 . . . . 18.83 109.697 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.84 -92.93 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.508 -0.853 . . . . 17.72 111.803 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -100.74 165.49 11.35 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.095 -0.705 . . . . 16.95 109.095 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -59.99 -40.53 89.48 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.562 -0.533 . . . . 18.58 109.562 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -99.36 153.04 19.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.685 -0.689 . . . . 18.17 109.792 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -78.61 145.42 67.15 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.633 -0.258 . . . . 18.88 110.736 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.41 72.67 2.89 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.1 2.534 . . . . 19.87 111.974 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.401 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 24.7 t70 -135.01 160.28 38.82 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.799 -0.637 . . . . 21.1 109.383 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.2 ttt -63.34 -25.39 68.27 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.169 0.293 . . . . 22.59 111.342 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 17.2 ptp -159.02 68.9 3.37 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.955 0.407 . . . . 24.05 111.051 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 54' ' ' ASP . 67.1 Cg_endo -83.38 -20.69 4.77 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.478 2.119 . . . . 20.94 112.024 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.23 92.04 1.91 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.57 -0.741 . . . . 20.49 109.361 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.88 -63.73 1.0 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 21.67 111.666 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.2 t -98.23 -23.47 15.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.848 0.356 . . . . 22.84 110.993 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -87.89 61.12 6.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.418 0.628 . . . . 22.15 110.27 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.71 14.82 24.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.742 -0.663 . . . . 19.92 110.358 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -81.59 117.14 67.07 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.206 -0.664 . . . . 19.88 109.206 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.34 108.06 1.11 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.551 2.167 . . . . 18.74 112.454 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 m -76.33 -22.69 54.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.329 0.585 . . . . 17.84 110.096 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -115.98 87.49 19.02 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.752 -0.658 . . . . 19.1 109.349 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.43 131.8 5.72 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.396 2.064 . . . . 17.47 112.899 -176.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.51 127.75 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.67 2.247 . . . . 17.99 111.798 173.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -84.42 166.97 16.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.246 -0.434 . . . . 18.7 110.466 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.8 129.32 13.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.972 -0.632 . . . . 17.72 112.3 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 60.81 41.26 14.92 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.093 0.557 . . . . 18.19 111.353 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.15 60.1 2.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.293 0.568 . . . . 17.96 110.958 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -124.27 52.31 1.51 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.041 -0.527 . . . . 19.85 110.434 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.91 -47.32 80.83 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.402 -0.817 . . . . 19.68 110.039 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 m -109.58 132.13 58.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.528 -0.76 . . . . 17.87 109.883 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -133.55 -61.39 0.81 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.223 -0.444 . . . . 20.34 110.01 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.93 98.24 8.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.114 -0.494 . . . . 18.81 110.394 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.85 -141.87 7.12 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.805 -0.712 . . . . 17.66 111.994 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -131.7 19.17 4.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.898 0.38 . . . . 17.87 110.246 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 56.76 41.54 28.01 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.339 -0.846 . . . . 18.04 111.729 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.51 31.4 1.54 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.177 0.513 . . . . 17.53 110.524 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.96 135.07 91.86 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 16.64 111.071 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.41 131.92 26.04 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.665 2.243 . . . . 17.64 112.117 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.1 m 64.87 35.29 8.55 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.335 -0.848 . . . . 17.42 111.056 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.8 tp -80.41 -21.09 42.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.018 -0.537 . . . . 18.62 109.703 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -61.46 128.08 89.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.497 -0.774 . . . . 17.79 109.953 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.66 -6.05 16.57 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.912 2.408 . . . . 19.23 113.547 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 67.19 94.66 0.07 Allowed 'General case' 0 N--CA 1.462 0.162 0 O-C-N 123.894 0.746 . . . . 17.96 111.196 -177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.6 p -80.31 67.98 6.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.4 0.619 . . . . 18.63 111.146 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.8 pt -99.67 24.42 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.761 -0.654 . . . . 19.36 110.701 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.6 -44.38 0.55 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.664 0.786 . . . . 19.41 111.52 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 71.84 -56.53 0.64 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.816 0.847 . . . . 18.96 111.984 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -77.78 -35.21 51.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.471 -0.331 . . . . 18.95 111.138 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.478 ' C ' ' H ' ' A' ' 96' ' ' GLU . 87.3 m-20 -67.17 176.58 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.772 -0.195 . . . . 20.53 110.943 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.1 p 67.49 -36.16 0.28 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.931 1.292 . . . . 21.4 111.03 -171.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 94' ' ' ASN . 6.7 mm-40 -90.07 -5.58 56.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.208 0.528 . . . . 21.26 109.865 172.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 24.1 t80 61.54 47.98 6.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.754 -1.112 . . . . 22.65 109.886 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 63.05 97.75 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 114.991 -1.004 . . . . 19.45 111.611 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -79.79 96.64 1.05 Allowed 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.188 2.592 . . . . 18.97 111.972 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -81.65 152.39 69.53 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.033 -0.53 . . . . 17.53 110.14 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.87 46.36 1.9 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.95 2.433 . . . . 17.77 112.591 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.469 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -88.35 -50.82 0.4 Allowed Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 18.07 111.672 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 102' ' ' ALA . 37.0 Cg_endo -66.73 89.67 0.29 Allowed 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.165 1.91 . . . . 16.56 112.376 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.4 m -94.03 115.36 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 116.039 -0.528 . . . . 17.5 110.367 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.72 116.03 12.88 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 16.11 111.058 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.89 131.89 48.85 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.026 2.484 . . . . 16.19 112.359 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.48 137.55 60.51 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.908 2.405 . . . . 16.43 112.563 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.494 ' HG2' ' H ' ' A' ' 110' ' ' LYS . 41.5 ttmt -68.1 121.2 79.13 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 17.91 110.16 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -84.12 16.04 2.02 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.884 2.389 . . . . 15.31 112.765 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.494 ' H ' ' HG2' ' A' ' 108' ' ' LYS . 88.5 tttt 68.94 130.77 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 115.522 -0.763 . . . . 15.37 111.228 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.73 138.22 84.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.535 2.157 . . . . 14.26 111.684 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -88.26 49.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 122.162 0.982 . . . . 15.75 110.081 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -170.33 81.59 0.58 Allowed Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.12 -1.4 . . . . 16.84 110.104 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.88 125.85 20.51 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.005 2.47 . . . . 15.51 112.187 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.99 54.19 4.77 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 123.224 2.616 . . . . 16.04 112.327 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.4 tttm 57.4 80.57 0.28 Allowed Pre-proline 0 C--O 1.233 0.198 0 CA-C-N 115.645 -0.707 . . . . 19.25 110.402 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.31 -16.27 47.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.621 2.214 . . . . 17.04 111.799 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.12 75.29 9.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.803 -0.635 . . . . 17.71 110.197 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.4 t -92.66 -51.44 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.681 -0.69 . . . . 19.09 109.899 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.452 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 9.0 pt-20 -101.32 1.97 39.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 20.88 110.4 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.06 111.32 35.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.65 -0.705 . . . . 18.89 111.122 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 120' ' ' GLU . 88.9 Cg_endo -91.87 142.27 2.64 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.045 2.497 . . . . 20.92 112.174 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.01 -11.45 19.69 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.473 2.115 . . . . 21.13 111.607 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.48 153.37 26.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.501 -0.772 . . . . 21.37 109.228 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.68 -55.64 3.8 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.694 2.263 . . . . 21.41 112.552 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt 64.2 107.45 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.234 0 O-C-N 123.749 0.656 . . . . 22.17 111.538 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.23 57.49 4.07 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.755 2.303 . . . . 20.33 112.462 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -76.32 123.07 87.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.885 -0.598 . . . . 20.48 110.453 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.12 126.69 21.69 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.82 2.347 . . . . 21.43 111.645 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -69.99 -39.91 11.81 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 112.926 0.713 . . . . 23.44 112.926 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -71.04 84.49 0.86 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.761 1.641 . . . . 21.1 111.54 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.411 HG21 ' HD3' ' A' ' 136' ' ' LYS . 5.2 p -89.17 76.17 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.254 1.026 . . . . 20.15 110.281 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.4 t -100.02 -3.9 9.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.944 0.878 . . . . 21.3 109.901 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -109.94 174.47 5.85 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.58 -1.191 . . . . 21.3 110.541 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -67.26 -62.38 1.45 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.05 -0.352 . . . . 20.74 110.05 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HD3' HG21 ' A' ' 132' ' ' VAL . 29.7 mtpp 75.1 -48.7 0.64 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.975 0.797 . . . . 18.17 111.701 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.51 -21.98 57.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.312 -0.404 . . . . 17.35 110.061 175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 73.02 146.55 0.12 Allowed Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 114.829 -1.078 . . . . 19.41 111.607 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' A' ' 192' ' ' ALA . 71.5 Cg_exo -49.64 -60.95 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.348 2.698 . . . . 20.18 114.043 -173.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.2 m -109.44 0.88 19.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.258 0.551 . . . . 18.05 110.549 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.27 -61.65 2.59 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.805 -0.712 . . . . 18.56 111.98 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -130.91 58.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.196 0.522 . . . . 19.74 110.772 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.563 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -71.37 165.32 23.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.442 -0.799 . . . . 15.06 109.133 173.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.583 ' CE2' ' HD3' ' A' ' 194' ' ' LYS . 4.3 m-85 -143.47 155.43 44.36 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.487 0.551 . . . . 14.83 112.487 -175.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.542 HG11 ' N ' ' A' ' 190' ' ' PRO . 2.5 t -148.39 167.07 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.252 -1.018 . . . . 10.79 108.252 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 59.0 t -107.62 112.85 41.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 O-C-N 121.686 -0.633 . . . . 10.43 111.31 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.544 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 48.9 tt0 -84.52 114.54 22.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.355 -0.384 . . . . 12.54 111.381 -176.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' A' ' 211' ' ' SER . 0.0 OUTLIER -96.45 -33.07 12.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.391 0.615 . . . . 11.88 110.169 -178.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.29 168.39 27.18 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.47 -0.786 . . . . 11.9 112.169 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -170.93 101.49 0.22 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.0 -0.741 . . . . 13.47 109.0 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.81 164.65 35.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.86 -0.609 . . . . 14.03 110.785 -173.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 32.4 mtmm -101.6 15.32 29.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.128 -0.942 . . . . 17.87 110.389 -173.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -109.87 105.14 14.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.153 -0.93 . . . . 16.68 108.96 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.36 -22.13 63.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.199 -0.455 . . . . 14.47 111.682 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.48 -38.22 89.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.928 0.871 . . . . 16.57 109.292 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -75.43 -29.79 59.83 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.309 -1.314 . . . . 16.69 110.119 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 89.3 t -63.29 -40.84 90.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.627 -0.715 . . . . 12.92 109.867 172.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -64.17 -22.23 66.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.644 -0.707 . . . . 15.83 111.954 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.689 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 14.5 mt-10 -78.0 -62.9 1.53 Allowed 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.143 -0.688 . . . . 15.97 109.143 176.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.413 HD13 HG13 ' A' ' 186' ' ' ILE . 10.3 mt -54.48 -48.47 69.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.599 -0.728 . . . . 12.6 110.949 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.85 -40.01 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.762 -0.654 . . . . 12.54 110.555 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.88 -28.91 72.66 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.462 -0.875 . . . . 14.8 112.138 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.689 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.6 mptp? -80.95 -49.3 11.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.4 0.148 . . . . 16.37 111.4 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.87 -55.85 4.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 12.99 111.484 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.414 ' HB2' ' CG1' ' A' ' 171' ' ' VAL . 69.0 ttt180 -66.89 -40.8 87.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.249 0.547 . . . . 15.56 110.313 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.76 -19.87 73.69 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.222 -0.899 . . . . 16.6 112.66 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.05 -5.59 57.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.808 0.337 . . . . 16.55 110.916 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.71 24.97 12.36 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.651 -0.785 . . . . 15.88 112.806 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -94.8 148.3 22.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.933 -0.395 . . . . 15.6 109.933 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -76.67 96.55 4.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.164 -0.68 . . . . 14.31 109.164 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 165' ' ' ARG . 7.4 p -142.62 143.74 25.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.404 -0.816 . . . . 11.04 109.456 -176.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -139.08 176.49 8.66 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.69 0.757 . . . . 11.47 110.85 176.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 20.2 p -113.93 -176.4 2.89 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.477 -1.238 . . . . 11.83 111.004 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.414 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.5 OUTLIER -53.16 141.33 40.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 O-C-N 123.166 0.291 . . . . 12.84 110.778 178.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -40.14 -47.49 4.05 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 124.484 3.456 . . . . 15.06 115.553 -169.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.3 m -85.44 -63.68 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.522 -0.871 . . . . 16.97 112.696 -171.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 98.8 m -168.49 129.94 1.14 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 118.375 0.534 . . . . 16.04 112.096 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.406 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 74.7 Cg_exo -62.63 123.97 13.31 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.519 2.146 . . . . 14.22 111.713 161.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.488 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 7.7 p -154.01 159.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.63 -0.507 . . . . 16.46 109.63 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -81.47 129.15 34.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.967 0.413 . . . . 17.05 110.721 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 104.81 -25.79 24.43 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.058 -0.591 . . . . 17.2 112.376 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.488 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 2.8 mptp? -114.35 157.69 22.48 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.557 -0.534 . . . . 19.02 109.557 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.82 109.93 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.594 0.711 . . . . 15.32 111.815 -173.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.414 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 54.0 m -101.79 111.39 23.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.786 -0.643 . . . . 13.03 109.562 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 74.1 mtp180 -92.22 139.57 30.48 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.39 -0.823 . . . . 14.44 109.755 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.5 ' C ' HD13 ' A' ' 187' ' ' LEU . 4.1 mm -109.6 118.86 57.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.251 -0.648 . . . . 11.02 109.251 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 5.2 mp -129.81 120.88 25.72 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.386 0.612 . . . . 10.32 111.386 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.429 HG21 ' CD2' ' A' ' 148' ' ' LEU . 38.0 t -95.38 136.02 27.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.508 -0.769 . . . . 10.0 110.822 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.46 47.9 5.52 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.316 -0.856 . . . . 9.94 113.943 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.542 ' N ' HG11 ' A' ' 145' ' ' VAL . 11.5 Cg_endo -61.36 126.21 18.74 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 CA-C-N 119.732 1.766 . . . . 11.15 110.998 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -155.04 154.56 32.66 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.512 -0.475 . . . . 12.77 110.376 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 139' ' ' PRO . . . -95.02 -4.51 46.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.649 -0.705 . . . . 15.0 111.312 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.1 m -112.5 100.57 8.85 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.487 0.661 . . . . 14.58 110.431 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.583 ' HD3' ' CE2' ' A' ' 144' ' ' TYR . 22.1 ttpp -55.66 -59.78 4.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.461 -1.245 . . . . 16.29 112.011 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.13 -27.96 68.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.686 -0.688 . . . . 15.6 111.81 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -72.51 -37.8 68.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.423 0.63 . . . . 14.36 110.154 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 200' ' ' SER . 0.2 OUTLIER -85.55 -23.52 27.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.791 -0.64 . . . . 12.11 110.444 -175.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.542 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 36.8 mttt -74.66 -32.77 62.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.054 0.454 . . . . 14.96 110.634 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -73.81 -12.63 80.88 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.965 -1.254 . . . . 13.32 109.965 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 47.7 m -90.67 -8.89 48.73 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.365 -0.917 . . . . 12.31 112.24 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 22.7 mt -66.14 -33.37 75.61 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.186 -0.321 . . . . 12.72 110.989 -175.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.81 -44.16 97.28 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.807 -0.711 . . . . 14.66 111.94 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.62 -17.93 34.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.635 0.255 . . . . 14.54 111.037 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 24.5 tp -70.15 -29.32 66.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.05 0.453 . . . . 12.55 109.996 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 61.3 mttp -60.92 -22.66 64.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.61 -0.723 . . . . 16.12 110.861 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.57 -35.34 30.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.291 0.567 . . . . 16.98 109.754 174.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 82.2 mt -75.45 -52.47 10.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.417 -0.81 . . . . 14.15 111.453 -175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 31.9 p -98.64 -45.07 6.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.031 0.444 . . . . 13.54 110.717 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 60.59 21.79 58.31 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.598 -0.728 . . . . 14.79 111.868 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 79.8 mt -98.47 158.09 15.81 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.126 -0.694 . . . . 13.52 109.126 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 16.9 p -73.72 92.61 2.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.822 0.344 . . . . 14.87 110.756 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -111.33 146.33 17.76 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.486 -0.864 . . . . 12.22 114.256 -174.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 49.1 t -117.01 140.97 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.356 -0.979 . . . . 14.04 108.356 170.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.4 HG21 ' HE2' ' A' ' 198' ' ' LYS . 6.3 p -76.14 106.51 6.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.792 0.806 . . . . 12.89 110.314 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 23.0 mmt -113.18 145.99 40.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.152 -0.931 . . . . 14.23 110.797 -174.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.7 139.53 27.64 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.628 -0.796 . . . . 14.09 112.861 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.563 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 9.2 t80 -106.54 126.12 51.87 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.332 1.053 . . . . 14.24 110.123 -175.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 16.8 p -136.33 92.78 15.26 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 120.808 0.337 . . . . 16.73 110.582 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.559 ' HG3' ' CZ ' ' A' ' 217' ' ' TYR . 14.5 Cg_exo -63.15 120.15 7.5 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.374 2.049 . . . . 17.42 111.925 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.243 -0.884 . . . . 19.69 109.418 -176.752 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.806 -0.442 . . . . 18.39 109.806 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 35' ' ' GLN . . . 144.5 -11.34 1.98 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.312 -0.946 . . . . 17.97 113.16 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 68.61 -66.22 0.25 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.258 0.623 . . . . 17.74 110.893 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -99.29 -69.24 0.77 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.297 -0.631 . . . . 20.18 109.297 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -128.32 -69.31 0.73 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.968 -0.56 . . . . 17.66 110.681 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -168.17 -3.32 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.779 0.323 . . . . 19.78 111.805 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -79.35 -9.08 59.51 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.002 -0.436 . . . . 18.96 111.444 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.516 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 27.3 mt-30 -138.56 166.3 24.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.464 -0.569 . . . . 18.6 109.464 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' HA ' ' OG1' ' A' ' 65' ' ' THR . 3.1 m-20 56.11 78.03 0.22 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.898 0.749 . . . . 16.78 112.22 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.526 ' HG2' ' H ' ' A' ' 38' ' ' PHE . 21.0 tt0 -129.12 170.36 13.62 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.61 -0.885 . . . . 18.42 108.61 176.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.526 ' H ' ' HG2' ' A' ' 37' ' ' GLU . 81.6 m-85 -75.08 39.11 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.349 . . . . 17.92 111.742 -176.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 37' ' ' GLU . . . -110.86 -10.76 14.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.238 0.542 . . . . 19.75 109.983 177.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.71 132.47 39.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.585 -0.734 . . . . 20.62 110.447 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.418 HG23 ' HG2' ' A' ' 45' ' ' PRO . 14.0 pt -134.07 79.93 55.26 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.173 0.511 . . . . 19.92 111.259 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -76.74 51.88 3.51 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.591 2.194 . . . . 21.71 111.045 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 60.76 32.67 20.21 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.741 -0.663 . . . . 23.06 110.41 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.618 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 89.2 t -110.25 -62.96 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.932 -0.576 . . . . 21.55 112.337 -176.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 5.8 Cg_exo -81.92 126.31 5.07 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.329 2.019 . . . . 20.17 112.4 -172.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -86.8 105.7 17.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.062 -0.517 . . . . 21.45 110.822 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 53.07 52.32 14.0 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.997 -0.547 . . . . 18.83 111.12 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -142.99 31.72 1.96 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.638 -0.791 . . . . 17.72 112.265 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.36 138.92 36.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.01 0.433 . . . . 16.95 110.558 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -109.74 49.12 0.85 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.782 0.801 . . . . 18.58 108.846 171.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.98 127.65 43.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.974 -1.012 . . . . 18.17 109.638 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -78.12 113.06 30.09 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.571 -0.286 . . . . 18.88 110.291 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.4 30.06 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.837 2.358 . . . . 19.87 112.782 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -141.33 -60.95 0.48 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.469 -0.332 . . . . 21.1 111.395 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.467 ' HG3' ' N ' ' A' ' 56' ' ' MET . 24.8 ptp -70.27 -54.29 13.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.902 0.334 . . . . 22.59 111.902 -175.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.467 ' N ' ' HG3' ' A' ' 55' ' ' MET . 57.4 mtt -161.55 76.05 2.36 Favored Pre-proline 0 CA--C 1.517 -0.321 0 N-CA-C 109.555 -0.535 . . . . 24.05 109.555 -173.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.9 124.3 6.11 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.07 1.846 . . . . 20.94 111.46 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 68.23 -53.6 0.53 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.359 -0.837 . . . . 20.49 110.96 -171.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 56.83 65.59 1.37 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.128 0.489 . . . . 21.67 110.071 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.6 m 62.12 52.37 3.27 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.222 -0.899 . . . . 22.84 109.757 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 67.7 131.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.831 -1.077 . . . . 22.15 111.442 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 63' ' ' LEU . . . -87.43 37.49 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 19.92 110.671 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.5 mm? 68.78 140.5 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.285 -0.87 . . . . 19.88 111.195 -177.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.59 83.31 0.67 Allowed 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.327 2.018 . . . . 18.74 111.84 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.409 ' OG1' ' HA ' ' A' ' 36' ' ' ASP . 29.6 m -75.36 117.58 17.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.897 -0.592 . . . . 17.84 110.775 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.525 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 34.9 tt0 -177.82 -52.32 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 115.905 -0.589 . . . . 19.1 111.614 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' A' ' 66' ' ' GLN . 75.6 Cg_exo -50.88 -50.18 14.64 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.322 2.014 . . . . 17.47 115.011 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.26 142.92 34.53 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.489 1.459 . . . . 17.99 113.504 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 65.87 -89.14 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.048 -0.978 . . . . 18.7 112.628 171.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.9 55.44 5.32 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.516 -0.85 . . . . 17.72 111.547 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.36 143.32 40.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.573 0.225 . . . . 18.19 111.047 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -175.94 -60.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.819 -0.628 . . . . 17.96 110.141 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -112.26 79.24 1.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.709 -0.678 . . . . 19.85 110.34 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.33 -8.41 53.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.524 . . . . 19.68 110.303 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.0 p -91.24 127.67 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.872 -0.604 . . . . 17.87 109.543 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -126.38 -19.75 4.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.142 -0.481 . . . . 20.34 111.229 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.56 54.3 3.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.103 0.478 . . . . 18.81 110.185 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.29 -106.9 1.97 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.598 -0.728 . . . . 17.66 112.218 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -173.49 -60.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.218 -0.66 . . . . 17.87 109.218 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -158.7 36.79 0.22 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.274 -0.876 . . . . 18.04 109.668 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.54 67.38 8.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.741 -0.663 . . . . 17.53 111.381 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.84 89.12 45.14 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.935 -0.575 . . . . 16.64 109.886 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.94 79.23 1.33 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.167 2.578 . . . . 17.64 112.445 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.6 m 71.68 132.34 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.624 -0.716 . . . . 17.42 111.498 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.425 ' N ' HD23 ' A' ' 85' ' ' LEU . 3.2 mm? -98.62 3.6 47.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.767 -0.651 . . . . 18.62 110.347 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.49 111.5 21.41 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.536 -0.757 . . . . 17.79 110.973 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.15 -42.06 0.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.694 2.263 . . . . 19.23 112.062 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.26 -61.3 1.84 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.289 -0.414 . . . . 17.96 110.992 -176.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.7 t -100.26 58.63 0.98 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.555 0.693 . . . . 18.63 110.615 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.8 tp -66.77 -25.68 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.672 -0.695 . . . . 19.36 109.81 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.61 142.04 40.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.67 -0.695 . . . . 19.41 110.378 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.32 166.63 24.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.228 -0.442 . . . . 18.96 110.088 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.63 68.5 6.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.887 0.375 . . . . 18.95 110.211 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -177.9 -159.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.34 -0.846 . . . . 20.53 109.389 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 66.6 p 65.67 -53.33 0.37 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.007 1.323 . . . . 21.4 112.11 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -119.18 20.47 12.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.628 0.252 . . . . 21.26 110.516 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 60.72 69.91 0.65 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.631 -0.713 . . . . 22.65 110.749 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 67.18 112.04 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.185 -0.916 . . . . 19.45 111.116 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -71.79 69.7 2.89 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.973 2.449 . . . . 18.97 113.292 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -95.08 133.86 25.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.622 -0.51 . . . . 17.53 109.622 172.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.53 108.56 1.86 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.69 2.26 . . . . 17.77 112.583 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.64 131.64 94.26 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.813 -0.631 . . . . 18.07 110.805 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.39 72.95 3.44 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.707 2.272 . . . . 16.56 111.638 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.3 m -86.82 39.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.061 -0.518 . . . . 17.5 111.248 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.51 122.34 76.84 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.98 -0.555 . . . . 16.11 110.749 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.23 109.64 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.254 2.636 . . . . 16.19 112.577 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.4 -55.46 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.937 2.425 . . . . 16.43 112.649 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.475 ' HB3' ' HD3' ' A' ' 109' ' ' PRO . 88.1 tttt -76.2 -50.26 2.97 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 112.431 0.53 . . . . 17.91 112.431 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 108' ' ' LYS . 31.9 Cg_exo -60.49 -21.58 68.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.065 1.844 . . . . 15.31 113.241 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -112.62 103.81 55.67 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.081 -0.34 . . . . 15.37 110.081 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.77 107.92 1.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.085 1.857 . . . . 14.26 111.738 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.9 p -80.87 53.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 122.726 1.251 . . . . 15.75 110.088 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.513 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 49.1 mt-10 -94.73 136.97 22.58 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.611 -1.177 . . . . 16.84 110.147 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HB2' ' HD2' ' A' ' 117' ' ' PRO . 72.1 Cg_endo -80.01 100.07 1.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.75 2.3 . . . . 15.51 111.125 172.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 16.3 Cg_exo -67.21 -38.09 16.55 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.893 2.395 . . . . 16.04 113.728 -170.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 27.5 ttpp -77.05 -48.68 2.54 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.544 0.572 . . . . 19.25 112.544 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 11.2 Cg_exo -73.4 -34.89 5.4 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.178 1.918 . . . . 17.04 112.174 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -102.4 85.88 2.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.999 -0.546 . . . . 17.71 110.326 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.7 m -97.85 -23.17 4.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 19.09 110.876 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.87 125.61 36.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.371 -0.377 . . . . 20.88 110.625 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.69 120.2 74.85 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.697 -0.683 . . . . 18.89 111.254 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.472 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 53.4 Cg_exo -53.04 -44.44 48.79 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.447 2.765 . . . . 20.92 114.203 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 122' ' ' PRO . 40.2 Cg_endo -67.66 -15.84 45.43 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 121.75 1.633 . . . . 21.13 112.845 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -125.34 77.43 68.23 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.868 0.366 . . . . 21.37 110.887 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.467 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 74.2 Cg_endo -80.77 -172.92 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.427 2.085 . . . . 21.41 112.234 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.432 ' O ' ' HD2' ' A' ' 129' ' ' PRO . 52.9 tptt -52.26 -43.11 89.96 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 113.03 0.752 . . . . 22.17 113.03 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.4 -14.7 31.43 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.29 1.993 . . . . 20.33 114.386 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.577 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . 16.3 tp10 -78.6 -55.68 1.01 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.234 0.457 . . . . 20.48 112.234 -175.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 128' ' ' GLU . 19.1 Cg_endo -94.81 87.0 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.412 2.074 . . . . 21.43 111.778 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -117.52 83.09 16.42 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.376 -0.374 . . . . 23.44 111.511 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 129' ' ' PRO . 8.5 Cg_endo -90.77 11.75 2.55 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.973 2.449 . . . . 21.1 112.144 176.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.2 t 51.72 33.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 112.921 -1.945 . . . . 20.15 110.207 -173.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.405 HG11 ' N ' ' A' ' 134' ' ' GLU . 40.8 t 65.5 158.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 114.255 -1.339 . . . . 21.3 110.835 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.405 ' N ' HG11 ' A' ' 133' ' ' VAL . 21.3 mt-10 78.02 -77.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.335 0.654 . . . . 21.3 111.743 172.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -161.59 144.45 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.087 0.47 . . . . 20.74 111.141 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -129.67 -48.05 1.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.774 -0.824 . . . . 18.17 108.774 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.54 ' CB ' ' HG2' ' A' ' 194' ' ' LYS . . . -91.78 5.32 50.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.917 -0.583 . . . . 17.35 110.74 173.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 70.48 160.05 0.16 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.136 -0.938 . . . . 19.41 111.976 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.43 ' O ' ' HB ' ' A' ' 140' ' ' THR . 2.8 Cg_exo -78.39 92.6 1.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.963 2.442 . . . . 20.18 111.727 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.6 ' N ' ' HB3' ' A' ' 192' ' ' ALA . 36.2 m 84.11 140.55 0.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.627 -0.715 . . . . 18.05 111.049 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 117.08 -67.83 0.31 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.621 -0.991 . . . . 18.56 110.621 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -99.75 54.13 0.93 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.798 0.809 . . . . 19.74 109.262 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.523 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -87.27 163.01 17.1 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.61 -1.177 . . . . 15.06 110.939 -175.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.672 ' CB ' HD22 ' A' ' 197' ' ' LEU . 3.6 m-85 -146.79 160.66 41.99 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.333 0.396 . . . . 14.83 111.783 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 217' ' ' TYR . 2.5 t -151.12 165.58 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 108.811 -0.811 . . . . 10.79 108.811 173.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 47.7 t -106.57 113.6 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.379 0.536 . . . . 10.43 111.524 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.457 ' OE1' ' HD2' ' A' ' 185' ' ' ARG . 48.5 tt0 -89.86 109.09 20.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.815 0.302 . . . . 12.54 111.815 -175.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.536 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -86.8 -36.04 18.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.29 0.566 . . . . 11.88 110.059 -177.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.59 170.18 26.29 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.603 -0.808 . . . . 11.9 112.456 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.67 107.59 0.39 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.468 -0.568 . . . . 13.47 109.468 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.89 43.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.392 0.615 . . . . 14.03 110.614 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 30.7 mtmm -97.82 8.24 45.04 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.951 -1.022 . . . . 17.87 109.94 -176.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.507 ' HA ' ' OE1' ' A' ' 180' ' ' GLN . 18.0 m120 -106.85 106.17 16.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.022 -0.99 . . . . 16.68 109.692 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.44 -26.17 68.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.067 -0.515 . . . . 14.47 111.067 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.61 -38.82 78.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.64 0.733 . . . . 16.57 109.969 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 160' ' ' ILE . 65.6 mttm -86.16 -17.92 33.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.783 -1.099 . . . . 16.69 110.305 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 71.8 t -68.49 -44.14 83.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.063 -0.717 . . . . 12.92 109.063 170.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -63.1 -29.07 70.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.894 -1.048 . . . . 15.83 111.98 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.4 -48.48 15.4 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.641 -0.424 . . . . 15.97 110.866 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 156' ' ' LYS . 24.8 mt -60.17 -46.87 94.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.545 0.688 . . . . 12.6 109.713 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.438 HG12 ' CB ' ' A' ' 165' ' ' ARG . 43.4 t -63.85 -33.72 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.729 -1.123 . . . . 12.54 110.349 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.69 -34.6 82.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.209 -0.519 . . . . 14.8 112.616 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -70.45 -52.23 23.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.4 . . . . 16.37 110.662 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.529 HD13 ' CG2' ' A' ' 188' ' ' VAL . 2.8 mt -87.87 -58.31 2.62 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.518 0.933 . . . . 12.99 113.518 -172.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.438 ' CB ' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -62.73 -37.04 85.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.394 0.616 . . . . 15.56 109.411 -176.227 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.08 -25.68 74.11 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.111 -0.95 . . . . 16.6 112.197 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.7 -2.98 58.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.948 0.404 . . . . 16.55 110.599 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.46 25.49 33.01 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.836 -0.697 . . . . 15.88 113.104 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -89.61 153.18 20.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.02 0.41 . . . . 15.6 110.462 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.52 100.48 1.42 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.198 0.523 . . . . 14.31 109.833 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.37 140.65 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.124 -0.944 . . . . 11.04 109.828 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.504 ' HH ' HD21 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.83 176.69 8.59 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.575 0.702 . . . . 11.47 110.935 172.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 20.3 p -122.47 -174.35 2.89 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.656 -1.156 . . . . 11.83 111.034 -171.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 67.4 m -51.83 142.29 25.26 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-O 121.218 0.533 . . . . 12.84 110.818 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 82.8 Cg_exo -49.22 -38.2 41.0 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 124.008 3.139 . . . . 15.06 115.179 -168.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 t -87.91 -65.68 0.99 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.813 -0.755 . . . . 16.97 112.261 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 70.7 m -170.17 128.5 0.81 Allowed Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 122.368 0.267 . . . . 16.04 110.94 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.46 ' HB3' HG21 ' A' ' 184' ' ' THR . 72.9 Cg_exo -60.02 121.88 10.52 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 121.848 1.699 . . . . 14.22 111.342 163.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.7 p -155.77 159.92 2.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.809 0.338 . . . . 16.46 110.538 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' A' ' 153' ' ' ASN . 9.2 mm100 -68.85 120.99 15.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.052 -0.522 . . . . 17.05 111.489 177.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.23 -26.22 17.58 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.805 -0.634 . . . . 17.2 112.798 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 13.6 mptt -103.07 154.65 19.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.977 -0.379 . . . . 19.02 109.977 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.7 tp -73.9 109.28 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.897 0.856 . . . . 15.32 110.836 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.46 HG21 ' HB3' ' A' ' 178' ' ' PRO . 29.2 m -101.91 107.06 18.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.605 0.717 . . . . 13.03 110.072 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.457 ' HD2' ' OE1' ' A' ' 147' ' ' GLN . 47.5 mtm180 -87.76 141.06 28.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.993 -1.003 . . . . 14.44 110.254 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.5 ' C ' HD11 ' A' ' 187' ' ' LEU . 4.4 mm -108.74 118.35 56.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.781 -0.822 . . . . 11.02 108.781 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.504 HD21 ' HH ' ' A' ' 172' ' ' TYR . 4.8 mp -128.9 130.85 47.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.487 0.661 . . . . 10.32 111.141 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.529 ' CG2' HD13 ' A' ' 164' ' ' LEU . 43.9 t -107.24 136.52 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.102 -0.953 . . . . 10.0 111.079 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 83.37 46.3 6.17 Favored Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 114.751 -1.113 . . . . 9.94 113.432 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.46 ' N ' HG12 ' A' ' 145' ' ' VAL . 10.9 Cg_endo -60.91 124.38 14.82 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 CA-C-N 119.674 1.737 . . . . 11.15 110.599 175.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -149.89 151.32 33.25 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.21 -0.663 . . . . 12.77 109.21 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.6 ' HB3' ' N ' ' A' ' 140' ' ' THR . . . -84.8 -11.91 54.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.367 -0.833 . . . . 15.0 111.581 -174.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.7 m -120.84 113.25 19.88 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.089 0.471 . . . . 14.58 110.954 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.638 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 20.8 ptmt -61.33 -36.29 79.75 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.504 -0.771 . . . . 16.29 111.305 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.35 -43.0 99.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.256 -0.429 . . . . 15.6 111.589 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -70.4 -39.01 74.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 14.36 110.531 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.672 HD22 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -84.37 -16.82 41.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.534 -0.757 . . . . 12.11 110.906 -176.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.417 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 0.8 OUTLIER -60.43 -34.96 74.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.661 0.743 . . . . 14.96 110.387 173.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.59 -12.87 81.12 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.712 -1.131 . . . . 13.32 110.494 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.499 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 69.7 m -82.2 -12.67 57.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.795 -0.702 . . . . 12.31 111.637 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 11.0 mt -69.44 -36.94 77.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.071 0.462 . . . . 12.72 109.934 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.09 -27.31 70.29 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.676 -0.773 . . . . 14.66 111.188 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.574 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 49.6 mt-10 -82.81 -27.32 30.99 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 110.142 -0.318 . . . . 14.54 110.142 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.76 -48.32 81.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.459 . . . . 12.55 111.621 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -56.76 -22.15 33.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.079 -0.51 . . . . 16.12 110.973 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -45.52 9.38 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.816 -0.629 . . . . 16.98 110.162 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 96.3 mt -65.3 -52.39 54.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.975 -0.557 . . . . 14.15 111.694 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.438 ' HB3' HD21 ' A' ' 164' ' ' LEU . 70.1 p -100.05 -44.76 5.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.282 0.563 . . . . 13.54 110.558 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.47 7.84 69.65 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.264 -0.88 . . . . 14.79 111.095 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.13 155.32 17.52 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.466 -0.568 . . . . 13.52 109.466 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 26.3 t -89.03 108.0 19.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.497 -0.319 . . . . 14.87 110.438 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -129.2 158.04 21.9 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.508 -0.853 . . . . 12.22 113.316 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.96 145.12 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.187 0.518 . . . . 14.04 109.997 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.88 110.18 5.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.47 -0.786 . . . . 12.89 110.227 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 93.4 mmm -117.88 141.23 48.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.848 -0.615 . . . . 14.23 110.569 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -66.9 152.73 52.76 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.777 -0.725 . . . . 14.09 112.158 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.523 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 10.9 t80 -129.43 131.51 46.77 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 122.781 0.432 . . . . 14.24 109.954 -172.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.3 t -143.55 93.19 6.37 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-O 121.535 0.683 . . . . 16.73 109.51 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.33 140.35 19.39 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.603 2.202 . . . . 17.42 112.855 -177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 21.1 m120 . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.502 -0.772 . . . . 19.69 109.58 176.917 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.942 0.401 . . . . 18.39 110.968 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.29 134.46 1.83 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.111 -0.566 . . . . 17.97 111.756 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.03 9.29 17.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.927 0.363 . . . . 17.74 111.582 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -77.42 -31.19 53.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.029 0.442 . . . . 20.18 110.451 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -118.6 -176.31 3.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.047 -0.524 . . . . 17.66 110.061 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -111.69 -103.16 0.4 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.087 -0.338 . . . . 19.78 110.087 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 58.64 -87.49 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.246 0.618 . . . . 18.96 112.056 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -129.56 13.55 5.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.874 0.368 . . . . 18.6 111.122 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.487 ' CG ' ' H1 ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -99.9 54.68 0.93 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.387 . . . . 16.78 111.527 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -177.72 119.62 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.585 -0.734 . . . . 18.42 110.005 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 49' ' ' ASP . 40.5 p90 -58.38 134.67 56.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 17.92 110.921 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.69 -178.35 6.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.162 -0.472 . . . . 19.75 111.184 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.45 68.61 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.32 -0.252 . . . . 20.62 110.32 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm 61.49 73.59 0.57 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.904 -0.589 . . . . 19.92 110.956 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.86 56.89 6.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.399 2.066 . . . . 21.71 111.668 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mp 62.42 33.64 16.09 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.336 -0.847 . . . . 23.06 111.362 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.496 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 89.2 t -80.69 -59.75 0.48 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.14 -0.482 . . . . 21.55 110.248 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.496 ' CD ' ' HB ' ' A' ' 44' ' ' VAL . 56.2 Cg_endo -74.15 179.43 5.79 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.818 1.679 . . . . 20.17 111.498 169.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -87.16 15.13 6.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.397 -0.365 . . . . 21.45 111.504 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.3 -169.18 1.36 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.538 -0.542 . . . . 18.83 109.538 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.35 -154.46 8.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.393 -0.908 . . . . 17.72 111.665 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . 7.9 t0 -102.11 93.02 5.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.029 -0.73 . . . . 16.95 109.029 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 61.19 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.874 0.734 . . . . 18.58 110.949 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -97.67 172.61 7.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.143 -0.48 . . . . 18.17 110.696 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -85.98 131.36 47.08 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.775 -0.648 . . . . 18.88 110.527 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 25.1 Cg_endo -60.96 162.26 19.65 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.843 3.028 . . . . 19.87 113.884 -173.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -74.65 38.39 0.12 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.407 -0.815 . . . . 21.1 112.314 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 65.9 mtt -90.32 -41.3 11.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.888 0.375 . . . . 22.59 110.094 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.499 ' H ' ' CD ' ' A' ' 57' ' ' PRO . 25.5 mmt -132.65 -48.71 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.614 -0.721 . . . . 24.05 111.534 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 53' ' ' PRO . 53.8 Cg_exo -54.19 132.46 50.51 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 122.593 2.196 . . . . 20.94 113.557 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -168.92 -50.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.962 -1.017 . . . . 20.49 110.356 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 64.45 -82.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.424 -0.807 . . . . 21.67 111.765 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.6 p -134.06 51.88 2.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.315 -0.402 . . . . 22.84 110.13 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 64.8 26.22 12.96 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.705 -0.68 . . . . 22.15 110.647 -175.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.92 74.12 2.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 19.92 110.157 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.0 mt -78.45 116.52 59.94 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.515 -0.766 . . . . 19.88 110.579 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -86.25 -9.19 7.29 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.891 2.394 . . . . 18.74 113.189 -176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 p -79.04 63.43 3.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.189 0.519 . . . . 17.84 111.895 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.4 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 16.9 mm-40 -84.31 114.81 57.06 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.985 -0.552 . . . . 19.1 109.558 175.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.63 -52.82 8.01 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.615 2.876 . . . . 17.47 114.378 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.41 149.41 80.53 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.155 1.237 . . . . 17.99 112.238 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 28' ' ' ASP . 32.8 mt-10 75.81 168.03 0.27 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.993 0.808 . . . . 18.7 111.538 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.34 -78.22 0.28 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.931 -0.652 . . . . 17.72 112.29 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -149.44 40.44 0.85 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.273 0.559 . . . . 18.19 110.197 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -134.0 56.02 1.87 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.9 -0.591 . . . . 17.96 110.619 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -111.77 -35.61 5.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.762 -0.654 . . . . 19.85 110.828 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -88.63 61.56 6.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.981 -0.554 . . . . 19.68 109.974 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -92.57 138.4 20.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.863 -0.608 . . . . 17.87 110.933 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -89.46 59.4 4.77 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.294 -0.632 . . . . 20.34 109.294 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.52 80.53 4.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.489 -0.778 . . . . 18.81 110.529 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -153.81 81.43 0.18 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.627 -0.715 . . . . 17.66 111.849 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.49 -35.55 68.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.693 -0.484 . . . . 17.87 109.693 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 49.74 53.62 12.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.333 0.587 . . . . 18.04 110.243 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -142.39 -73.24 0.31 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.337 -0.847 . . . . 17.53 110.65 -175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 45.3 63.88 8.58 Favored Pre-proline 0 N--CA 1.465 0.288 0 O-C-N 123.639 0.587 . . . . 16.64 111.754 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -62.18 -50.26 5.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.543 2.162 . . . . 17.64 112.092 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.8 m 60.81 -90.21 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.83 0.706 . . . . 17.42 111.453 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.92 -14.07 14.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.668 0.271 . . . . 18.62 110.611 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.24 115.35 46.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 17.79 110.683 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.59 -9.62 15.96 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.501 2.134 . . . . 19.23 111.705 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 71.16 -62.53 0.45 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.382 -0.826 . . . . 17.96 111.055 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.6 m -77.91 104.33 8.41 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.824 -0.435 . . . . 18.63 109.824 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.5 mm -75.44 -31.29 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.209 0.528 . . . . 19.36 111.385 -174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.88 27.66 14.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.224 -0.898 . . . . 19.41 112.546 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.9 73.83 0.46 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.903 -0.59 . . . . 18.96 111.604 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -79.13 -7.66 58.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.123 -0.489 . . . . 18.95 111.078 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 17.4 m120 -89.76 19.1 4.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 20.53 111.129 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.5 p -68.13 -48.04 66.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.389 0.614 . . . . 21.4 109.94 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -105.7 5.81 31.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.557 -0.747 . . . . 21.26 109.238 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 94' ' ' ASN . 91.6 m-85 61.27 64.57 1.07 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.753 -1.112 . . . . 22.65 110.229 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 64.24 89.66 0.1 Allowed Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 115.344 -0.844 . . . . 19.45 110.649 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.93 105.6 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.082 2.521 . . . . 18.97 111.999 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.45 136.47 19.18 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.013 0.435 . . . . 17.53 111.055 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.9 160.14 19.13 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.947 2.431 . . . . 17.77 111.762 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.69 112.49 24.85 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.344 -0.389 . . . . 18.07 110.725 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -79.58 132.15 9.78 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.454 2.103 . . . . 16.56 112.42 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.89 73.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 122.251 1.024 . . . . 17.5 110.132 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' A' ' 106' ' ' PRO . . . -89.19 -48.52 0.41 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.199 -0.909 . . . . 16.11 112.386 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 105' ' ' ALA . 27.3 Cg_exo -63.12 118.12 5.03 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.851 1.701 . . . . 16.19 112.145 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.91 121.81 9.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.026 2.484 . . . . 16.43 112.166 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -69.23 -50.02 21.9 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.947 -0.569 . . . . 17.91 111.78 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.16 48.84 2.64 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.025 1.816 . . . . 15.31 112.713 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -95.21 116.2 66.12 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.96 -0.564 . . . . 15.37 110.743 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.95 107.86 2.31 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.285 1.99 . . . . 14.26 111.426 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.7 m -94.31 45.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.755 0.788 . . . . 15.75 110.873 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -131.97 108.6 14.02 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.887 -1.051 . . . . 16.84 110.793 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.34 125.42 9.08 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.754 2.303 . . . . 15.51 111.456 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.63 147.34 76.01 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.262 1.974 . . . . 16.04 111.647 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 63.86 85.43 0.16 Allowed Pre-proline 0 N--CA 1.466 0.333 0 O-C-N 123.613 0.571 . . . . 19.25 110.889 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.47 118.78 5.76 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.701 2.267 . . . . 17.04 111.467 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 64.22 -93.82 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.494 0.664 . . . . 17.71 109.939 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.2 t -133.4 -57.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 114.957 -1.019 . . . . 19.09 109.002 172.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.77 99.35 2.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.002 -0.999 . . . . 20.88 109.024 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.7 111.99 30.65 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.24 -0.436 . . . . 18.89 110.674 -176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.91 160.02 43.96 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.571 2.181 . . . . 20.92 111.511 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.8 -17.02 58.22 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.932 2.421 . . . . 21.13 112.115 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.39 118.03 14.7 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.616 -0.72 . . . . 21.37 109.569 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.457 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 32.4 Cg_exo -58.32 139.27 89.92 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.601 2.201 . . . . 21.41 111.969 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -89.68 110.95 43.09 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.355 -0.384 . . . . 22.17 110.932 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 125' ' ' PRO . 7.8 Cg_exo -72.71 109.19 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.695 2.263 . . . . 20.33 111.336 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -98.22 112.31 61.76 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.906 -0.588 . . . . 20.48 110.327 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.6 -37.52 96.7 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.772 2.315 . . . . 21.43 111.195 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.569 ' HZ1' ' HB3' ' A' ' 130' ' ' LYS . 6.9 ttpm? -123.71 87.49 52.5 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.229 -0.896 . . . . 23.44 108.806 173.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.4 104.66 1.46 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.82 2.346 . . . . 21.1 112.544 -175.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.4 t -81.74 56.19 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.154 0.978 . . . . 20.15 109.025 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 p -133.31 15.24 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.693 -1.14 . . . . 21.3 108.921 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -90.24 -33.71 16.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.759 -1.11 . . . . 21.3 111.088 -175.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.14 81.9 2.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.64 0.734 . . . . 20.74 110.955 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -125.59 83.12 2.13 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.096 -1.076 . . . . 18.17 108.096 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 72.35 36.35 1.06 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.532 -0.914 . . . . 17.35 108.532 -165.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 72.76 143.08 0.09 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 113.971 -1.468 . . . . 19.41 110.759 -175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.77 95.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.156 2.571 . . . . 20.18 112.536 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.9 m 57.67 33.68 23.54 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.701 0.762 . . . . 18.05 110.124 -177.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -93.46 -70.84 1.14 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.525 -0.761 . . . . 18.56 111.246 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 13.1 mptt -98.4 60.99 1.39 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.523 -0.547 . . . . 19.74 109.523 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.504 ' HB1' ' O ' ' A' ' 217' ' ' TYR . . . -72.46 162.47 29.43 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.378 -0.828 . . . . 15.06 109.635 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.504 ' HA ' ' H ' ' A' ' 217' ' ' TYR . 3.3 m-85 -135.79 152.76 51.42 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.109 0.48 . . . . 14.83 111.863 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.459 ' CG2' ' HA ' ' A' ' 190' ' ' PRO . 0.9 OUTLIER -152.91 145.69 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.166 -0.925 . . . . 10.79 109.922 -174.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 44.4 t -112.26 108.13 24.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-N 118.424 0.556 . . . . 10.43 111.035 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -88.11 111.08 21.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.491 -0.322 . . . . 12.54 111.334 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.547 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -86.42 -38.87 16.92 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.225 0.536 . . . . 11.88 109.721 -178.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.45 167.51 26.99 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.488 -0.863 . . . . 11.9 112.523 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -168.89 101.68 0.39 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.037 -0.727 . . . . 13.47 109.037 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.16 163.98 37.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.905 -0.589 . . . . 14.03 110.571 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 90.8 mttt -99.22 2.45 45.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.041 -0.981 . . . . 17.87 110.221 -173.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -93.37 98.64 11.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.78 -1.1 . . . . 16.68 108.68 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.85 -20.65 63.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.059 0.457 . . . . 14.47 111.193 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.14 -28.94 64.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.732 0.777 . . . . 16.57 109.183 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -80.49 -34.06 36.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.515 -1.22 . . . . 16.69 108.768 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.402 HG11 HG22 ' A' ' 184' ' ' THR . 75.3 t -58.46 -36.61 59.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.085 -0.961 . . . . 12.92 109.806 172.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -62.02 -33.19 73.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.273 -0.876 . . . . 15.83 112.202 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.01 -35.86 28.42 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.051 -0.66 . . . . 15.97 110.996 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.504 HD11 HD12 ' A' ' 186' ' ' ILE . 14.0 mt -66.22 -47.45 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 12.6 109.437 176.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.59 -38.41 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.868 -1.06 . . . . 12.54 110.838 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -57.75 -30.23 62.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.016 -0.611 . . . . 14.8 112.4 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -70.61 -59.03 3.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.231 0.539 . . . . 16.37 111.081 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.31 -59.79 2.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.709 -0.678 . . . . 12.99 112.101 -173.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.427 ' C ' ' HD3' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -64.05 -37.03 85.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.352 0.596 . . . . 15.56 109.632 -177.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.27 -19.48 77.48 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.043 -0.981 . . . . 16.6 112.691 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -97.42 -13.76 21.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.792 0.329 . . . . 16.55 110.758 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.5 24.92 9.68 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.703 -0.761 . . . . 15.88 113.177 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 207' ' ' LEU . 34.1 m-85 -88.26 158.38 18.49 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.793 -0.239 . . . . 15.6 110.536 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -67.39 97.68 0.58 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.374 0.607 . . . . 14.31 110.08 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.6 p -144.96 137.81 21.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.146 -0.934 . . . . 11.04 110.168 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.52 ' HH ' HD11 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -142.12 176.72 8.74 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.454 0.645 . . . . 11.47 110.706 171.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.1 p -118.63 -177.05 3.22 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.785 -1.098 . . . . 11.83 110.713 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.1 OUTLIER -53.4 140.53 45.39 Favored Pre-proline 0 C--N 1.327 -0.405 0 O-C-N 123.256 0.347 . . . . 12.84 111.117 179.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -20.17 -67.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 1 C-N-CA 126.361 4.707 . . . . 15.06 116.048 -172.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.8 m -86.31 -61.66 1.69 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.981 0.734 . . . . 16.97 112.981 -170.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -166.69 133.8 2.02 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 122.021 -0.425 . . . . 16.04 111.795 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.416 ' HB3' HG22 ' A' ' 184' ' ' THR . 54.4 Cg_exo -60.97 125.02 16.1 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.716 2.277 . . . . 14.22 111.46 163.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.45 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 6.0 p -146.41 159.56 10.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.148 -0.686 . . . . 16.46 109.148 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -81.18 122.22 27.11 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.855 0.36 . . . . 17.05 110.862 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.13 -23.98 22.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 17.2 112.614 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.45 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 11.3 mptt -111.5 161.35 16.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.944 0.402 . . . . 19.02 110.327 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.6 tp -71.05 110.42 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.868 0.842 . . . . 15.32 112.114 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.462 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 62.1 m -99.34 106.46 18.56 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.583 -0.735 . . . . 13.03 109.715 172.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 89.8 mtt180 -89.22 136.76 32.84 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.452 -0.794 . . . . 14.44 109.159 176.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.515 ' C ' HD22 ' A' ' 187' ' ' LEU . 2.8 mt -117.2 116.21 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 121.172 0.51 . . . . 11.02 109.696 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.52 HD11 ' HH ' ' A' ' 172' ' ' TYR . 0.1 OUTLIER -128.9 128.07 43.06 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.153 -0.931 . . . . 10.32 111.278 -172.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.461 HG21 HD21 ' A' ' 148' ' ' LEU . 43.1 t -99.91 149.17 5.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.287 -1.324 . . . . 10.0 110.403 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 71.07 46.67 42.28 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 115.277 -0.874 . . . . 9.94 113.895 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.459 ' HA ' ' CG2' ' A' ' 145' ' ' VAL . 19.2 Cg_endo -67.49 124.73 12.39 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 CA-C-N 119.903 1.851 . . . . 11.15 110.401 172.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -160.37 150.09 17.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.888 -0.596 . . . . 12.77 109.963 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -91.13 -6.34 53.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.497 -0.774 . . . . 15.0 110.58 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.539 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 43.2 t -100.44 103.87 15.25 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.087 -0.506 . . . . 14.58 110.274 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 198' ' ' LYS . 32.0 ttpt -60.56 -43.26 97.47 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.451 -0.795 . . . . 16.29 109.642 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.62 -55.49 30.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.217 -0.901 . . . . 15.6 112.398 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -65.51 -41.31 93.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.962 0.41 . . . . 14.36 111.147 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.539 ' HB3' ' O ' ' A' ' 193' ' ' SER . 0.2 OUTLIER -81.22 -18.29 46.62 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.103 -0.499 . . . . 12.11 110.849 -176.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 20.8 tptm -56.52 -55.34 34.95 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.684 0.754 . . . . 14.96 110.885 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -71.48 -13.18 74.05 Favored Glycine 0 CA--C 1.504 -0.64 0 CA-C-N 114.589 -1.187 . . . . 13.32 110.64 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 204' ' ' LEU . 72.9 m -78.45 -12.87 60.03 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.657 -0.771 . . . . 12.31 111.517 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 23.1 mt -76.66 -40.18 49.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.848 0.356 . . . . 12.72 110.477 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.1 -36.45 88.57 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.857 -0.687 . . . . 14.66 111.528 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.519 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 15.4 pt-20 -86.25 -16.89 36.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.888 0.375 . . . . 14.54 110.481 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 200' ' ' SER . 15.4 tp -71.34 -33.18 69.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.644 0.259 . . . . 12.55 111.166 -173.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.593 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 19.1 pttp -62.96 -16.16 58.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.186 0.517 . . . . 16.12 110.344 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.407 ' HG2' ' N ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -90.11 -42.02 11.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.811 -0.631 . . . . 16.98 110.081 170.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.8 mt -68.87 -52.79 25.93 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.788 -0.642 . . . . 14.15 111.505 -175.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 16.7 t -92.49 -44.11 8.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.433 0.635 . . . . 13.54 109.56 178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.593 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 71.31 -2.13 22.52 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 114.837 -1.074 . . . . 14.79 112.164 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 53.3 mt -92.62 150.31 20.79 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.538 -0.541 . . . . 13.52 109.538 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 19.5 m -85.68 111.84 20.47 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.093 0.473 . . . . 14.87 110.59 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -130.51 163.83 23.11 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.479 -0.867 . . . . 12.22 112.491 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.9 p -100.29 135.39 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.348 0.594 . . . . 14.04 110.472 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 45.9 t -79.71 104.94 8.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.87 -1.059 . . . . 12.89 109.492 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 97.0 mmm -117.24 146.7 43.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.665 -0.698 . . . . 14.23 110.457 -175.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.64 106.33 2.16 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.41 -0.9 . . . . 14.09 111.733 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.504 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 9.3 t80 -64.59 124.29 21.47 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.446 0.699 . . . . 14.24 110.517 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 29.8 m -138.66 93.64 10.81 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 109.274 -0.639 . . . . 16.73 109.274 174.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.23 153.46 51.2 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.494 2.129 . . . . 17.42 112.29 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 44.3 t30 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.488 -0.768 . . . . 19.69 109.723 178.088 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.578 0.227 . . . . 18.39 110.465 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.44 -87.05 0.18 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.827 -0.702 . . . . 17.97 112.013 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 62.1 -163.56 0.26 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.031 0.532 . . . . 17.74 110.337 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -102.99 -58.69 1.83 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.841 -0.8 . . . . 20.18 108.841 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 166.04 25.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.49 -1.232 . . . . 17.66 107.718 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -81.6 83.44 7.04 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.509 0.671 . . . . 19.78 110.478 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -74.52 113.21 11.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.567 -0.742 . . . . 18.96 110.531 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -129.3 6.81 5.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.553 -0.748 . . . . 18.6 110.149 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -77.43 170.82 15.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.912 -0.585 . . . . 16.78 111.783 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.51 ' OE1' ' HA ' ' A' ' 62' ' ' ALA . 31.1 tt0 73.16 -52.35 0.71 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.127 -0.942 . . . . 18.42 110.416 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -106.94 31.55 5.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.024 0.44 . . . . 17.92 110.417 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.18 -40.56 71.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 19.75 111.164 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.18 -0.01 3.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.973 -0.558 . . . . 20.62 110.619 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.415 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 22.3 pt 33.93 64.45 1.57 Allowed Pre-proline 0 N--CA 1.476 0.854 0 O-C-N 124.192 0.932 . . . . 19.92 113.486 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 41' ' ' ILE . 2.8 Cg_endo -84.88 55.13 4.2 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.85 2.367 . . . . 21.71 111.269 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 mp 60.57 38.7 18.68 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.452 -0.795 . . . . 23.06 110.527 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.515 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 72.9 t -105.48 -66.22 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.779 -0.646 . . . . 21.55 110.458 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.515 ' CD ' ' HB ' ' A' ' 44' ' ' VAL . 92.3 Cg_endo -80.12 118.8 3.75 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.296 1.33 . . . . 20.17 111.505 170.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -69.88 103.3 2.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.363 -0.381 . . . . 21.45 110.247 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.26 39.38 25.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.666 -0.697 . . . . 18.83 110.764 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.15 -18.94 63.73 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.684 -0.689 . . . . 17.72 112.273 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -78.22 127.99 33.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.447 -0.205 . . . . 16.95 110.447 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 64.4 95.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.953 0.783 . . . . 18.58 111.244 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.32 128.63 38.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.059 -0.519 . . . . 18.17 109.972 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 33.0 tt0 -60.25 118.67 35.47 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 18.88 109.994 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 59.4 Cg_endo -71.8 -169.35 0.43 Allowed 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.14 2.56 . . . . 19.87 113.205 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 22.0 m-20 71.28 -174.26 0.17 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.281 -0.872 . . . . 21.1 110.949 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.33 40.58 0.72 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 22.59 111.494 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 25.7 ttt -166.62 78.93 1.06 Allowed Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.223 -0.658 . . . . 24.05 109.223 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 91.7 Cg_endo -78.02 155.91 30.13 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.935 2.423 . . . . 20.94 112.785 -174.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.76 136.08 57.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.611 -1.177 . . . . 20.49 111.171 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.81 17.43 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.206 -0.452 . . . . 21.67 111.22 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -66.62 130.73 44.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.677 -0.49 . . . . 22.84 109.677 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -73.94 -0.7 16.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 22.15 111.608 -175.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.51 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . . . -61.64 -41.93 98.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.256 -0.646 . . . . 19.92 109.256 171.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 92.3 mt 45.36 77.64 0.44 Allowed Pre-proline 0 N--CA 1.464 0.25 0 O-C-N 124.389 1.056 . . . . 19.88 111.967 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.17 -19.56 66.15 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.76 2.307 . . . . 18.74 112.261 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 m -80.71 58.61 3.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.727 0.775 . . . . 17.84 110.796 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.514 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 78.0 mt-30 -93.43 -50.64 0.27 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.726 -0.67 . . . . 19.1 111.014 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.514 ' HD2' ' H ' ' A' ' 66' ' ' GLN . 50.5 Cg_endo -67.82 148.31 76.7 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.92 1.747 . . . . 17.47 112.037 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.83 -11.3 25.67 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.776 2.317 . . . . 17.99 112.395 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -108.73 114.79 28.88 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.632 -0.713 . . . . 18.7 109.667 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 158.79 33.15 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.387 -0.911 . . . . 17.72 113.4 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.78 -60.51 2.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.215 0.531 . . . . 18.19 110.027 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.1 7.85 13.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.829 -0.623 . . . . 17.96 110.142 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.68 115.39 15.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.643 -0.708 . . . . 19.85 110.759 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -112.84 24.48 12.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.185 0.517 . . . . 19.68 110.0 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 t -121.32 47.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 17.87 110.076 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -126.92 5.02 6.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.949 0.404 . . . . 20.34 110.537 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.34 89.08 2.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.884 0.373 . . . . 18.81 110.666 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -163.85 -147.62 5.14 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.442 -0.885 . . . . 17.66 112.445 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.74 -75.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.8 0.333 . . . . 17.87 110.723 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.19 -44.53 9.7 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.635 -0.506 . . . . 18.04 109.635 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 56.33 55.2 6.85 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.405 0.621 . . . . 17.53 111.104 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.04 85.65 3.88 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.122 -0.944 . . . . 16.64 109.709 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -46.79 -52.99 6.76 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.391 2.728 . . . . 17.64 112.132 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.4 p 39.92 -91.31 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.138 0.975 . . . . 17.42 113.292 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.9 tp 64.57 82.78 0.18 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.261 0.553 . . . . 18.62 110.379 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -77.48 115.98 54.02 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.712 -0.676 . . . . 17.79 110.488 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.1 -25.22 36.26 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.247 2.632 . . . . 19.23 112.553 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.75 81.15 1.99 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.949 -0.568 . . . . 17.96 109.84 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -76.5 101.39 5.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.006 -0.543 . . . . 18.63 110.38 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.7 pt -93.02 -16.69 7.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.23 -0.441 . . . . 19.36 111.083 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 68.65 -73.9 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.862 0.726 . . . . 19.41 111.563 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -151.15 177.88 9.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.465 -0.198 . . . . 18.96 110.465 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -134.23 129.6 35.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.561 -0.29 . . . . 18.95 110.967 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.25 24.34 11.37 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.759 -0.655 . . . . 20.53 112.586 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.9 p -84.74 -43.88 13.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.466 0.651 . . . . 21.4 109.53 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -110.47 -17.81 13.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.359 -0.837 . . . . 21.26 109.991 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -80.24 -23.03 41.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.69 0.757 . . . . 22.65 110.791 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -137.86 84.17 22.29 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.084 -0.962 . . . . 19.45 110.805 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -89.41 -79.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.995 2.463 . . . . 18.97 111.252 172.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' H ' ' HD2' ' A' ' 101' ' ' PRO . 40.2 mt-10 -144.16 -54.88 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.72 -0.673 . . . . 17.53 110.503 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.536 ' HD2' ' H ' ' A' ' 100' ' ' GLU . 75.3 Cg_endo -76.88 157.92 34.84 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.661 1.574 . . . . 17.77 112.191 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.451 ' N ' ' HD3' ' A' ' 103' ' ' PRO . . . 51.22 64.17 8.49 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.578 -0.737 . . . . 18.07 112.155 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 102' ' ' ALA . 13.0 Cg_endo -92.79 121.03 0.46 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.914 2.409 . . . . 16.56 111.822 177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.6 m -87.17 29.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.214 0.531 . . . . 17.5 110.937 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.29 119.86 74.74 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.61 -0.723 . . . . 16.11 110.241 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.429 ' O ' ' HD2' ' A' ' 109' ' ' PRO . 56.8 Cg_endo -70.24 150.85 65.92 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.327 2.018 . . . . 16.19 111.835 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.87 47.81 1.55 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.008 2.472 . . . . 16.43 112.707 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.417 ' H ' ' HD2' ' A' ' 109' ' ' PRO . 68.0 mttm -96.23 -56.36 0.2 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.959 -0.564 . . . . 17.91 110.051 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 106' ' ' PRO . 73.5 Cg_endo -75.01 141.29 26.43 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.768 1.646 . . . . 15.31 111.02 171.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -76.0 -48.57 3.52 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.175 -0.466 . . . . 15.37 111.776 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.11 101.21 1.47 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.364 1.376 . . . . 14.26 112.392 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.9 t -89.68 59.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.352 -0.981 . . . . 15.75 108.352 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 68.99 86.3 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.086 -1.415 . . . . 16.84 109.736 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.66 142.76 98.77 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.365 2.71 . . . . 15.51 112.456 -176.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.89 137.44 79.86 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.813 2.342 . . . . 16.04 111.768 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -68.69 120.19 74.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.459 . . . . 19.25 110.255 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.36 70.5 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.925 2.416 . . . . 17.04 112.355 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.07 142.13 47.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.936 -0.574 . . . . 17.71 110.652 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.409 HG11 ' HG3' ' A' ' 142' ' ' LYS . 24.3 m -90.46 -22.98 6.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.262 -0.426 . . . . 19.09 111.566 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -148.98 64.43 1.04 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.513 0.673 . . . . 20.88 110.167 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.17 142.78 93.08 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.126 -0.943 . . . . 18.89 110.934 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.3 112.57 3.03 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.844 2.363 . . . . 20.92 111.883 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.34 52.17 4.21 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.808 2.339 . . . . 21.13 112.228 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.6 -51.98 1.78 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.856 -0.611 . . . . 21.37 111.208 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.47 98.31 0.84 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.481 1.454 . . . . 21.41 110.917 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.443 ' HZ1' ' HB2' ' A' ' 126' ' ' LYS . 4.2 ttmp? 65.86 101.45 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.961 -0.563 . . . . 22.17 109.819 -173.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.416 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 24.4 Cg_exo -62.67 90.88 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.944 2.429 . . . . 20.33 113.498 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -113.39 75.35 2.35 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.73 -0.668 . . . . 20.48 109.768 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 96.2 Cg_endo -92.3 152.36 3.08 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.788 2.326 . . . . 21.43 113.523 -173.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.421 ' HD2' ' HD2' ' A' ' 131' ' ' PRO . 26.9 tptp -137.37 111.47 9.12 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.413 -0.812 . . . . 23.44 109.321 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.421 ' HD2' ' HD2' ' A' ' 130' ' ' LYS . 52.8 Cg_exo -55.57 119.58 6.8 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.449 2.099 . . . . 21.1 111.891 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 m -102.61 45.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.799 0.809 . . . . 20.15 110.053 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.24 154.84 3.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.63 -1.168 . . . . 21.3 108.626 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 66.79 26.35 9.45 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.223 0.535 . . . . 21.3 109.649 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -109.83 149.0 30.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.532 -0.758 . . . . 20.74 110.804 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.476 ' HB2' ' HZ1' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -92.69 -49.05 6.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.802 -0.814 . . . . 18.17 108.802 176.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . -151.82 16.28 0.67 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.081 -0.963 . . . . 17.35 109.472 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 75.75 146.11 0.11 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 114.361 -1.291 . . . . 19.41 111.406 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -47.31 -55.09 4.23 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.763 2.975 . . . . 20.18 114.416 -172.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.9 t -120.76 -16.43 8.2 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.956 -0.298 . . . . 18.05 111.272 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.95 -58.65 11.85 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.973 -0.632 . . . . 18.56 111.843 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.443 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 67.7 mttm -129.95 82.51 2.07 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.196 0.522 . . . . 19.74 110.069 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.705 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -107.43 162.05 14.28 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.826 -0.624 . . . . 15.06 109.424 176.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.695 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 5.2 m-85 -143.7 141.94 30.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.261 0.224 . . . . 14.83 111.086 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 187' ' ' LEU . 2.4 t -150.98 162.02 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 109.625 -0.509 . . . . 10.79 109.625 171.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 27.7 t -104.01 117.57 49.75 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 O-C-N 122.21 -0.306 . . . . 10.43 111.129 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.505 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 6.1 tt0 -91.02 111.4 22.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.649 0.24 . . . . 12.54 111.649 -176.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.529 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -94.47 -34.55 12.67 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.215 0.531 . . . . 11.88 110.313 -177.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.51 162.07 27.97 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.671 -0.776 . . . . 11.9 111.923 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -165.38 101.76 0.72 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.758 -0.46 . . . . 13.47 109.758 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.54 163.14 33.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.544 0.687 . . . . 14.03 111.127 -173.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 43.2 mttm -98.47 13.47 31.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.641 -1.163 . . . . 17.87 109.722 -177.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -117.64 104.01 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.31 -0.859 . . . . 16.68 110.277 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -22.71 67.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.204 0.526 . . . . 14.47 110.802 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.02 -37.94 55.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.063 -0.972 . . . . 16.57 111.002 175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -89.64 -31.89 17.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.929 -1.032 . . . . 16.69 110.351 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.417 HG13 HG21 ' A' ' 184' ' ' THR . 82.8 t -55.1 -44.31 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.831 -0.622 . . . . 12.92 110.783 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -58.6 -30.4 67.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.575 -0.739 . . . . 15.83 111.468 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.47 -56.43 4.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.829 -0.434 . . . . 15.97 109.829 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.4 mt -54.76 -40.71 53.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.295 -0.866 . . . . 12.6 110.601 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.6 t -73.83 -44.0 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.852 -0.613 . . . . 12.54 110.737 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.69 -32.4 73.93 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.633 -0.794 . . . . 14.8 111.861 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -67.41 -59.92 3.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.645 0.26 . . . . 16.37 111.214 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 208' ' ' SER . 2.1 mm? -85.98 -57.02 3.2 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.58 0.585 . . . . 12.99 112.58 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.46 ' HD3' ' O ' ' A' ' 165' ' ' ARG . 0.8 OUTLIER -64.45 -35.52 81.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.408 0.623 . . . . 15.56 109.549 -178.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.95 -15.22 76.18 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.349 -0.841 . . . . 16.6 112.313 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -96.17 7.25 46.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.295 0.569 . . . . 16.55 110.342 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.44 15.72 58.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.766 -0.652 . . . . 15.88 113.051 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.439 ' CE1' ' HB3' ' A' ' 207' ' ' LEU . 53.1 m-85 -91.65 148.06 22.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 117.031 0.415 . . . . 15.6 110.574 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.407 ' HB3' ' HD2' ' A' ' 190' ' ' PRO . 22.9 mmm180 -62.56 98.98 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 14.31 110.512 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 165' ' ' ARG . 10.2 t -133.83 133.46 56.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.038 0.447 . . . . 11.04 110.969 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -138.36 175.21 9.77 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.447 -0.797 . . . . 11.47 110.375 170.465 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 22.7 p -115.22 -176.11 2.84 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.878 -1.055 . . . . 11.83 111.173 -172.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.572 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.1 OUTLIER -53.51 143.51 36.75 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 123.16 0.288 . . . . 12.84 111.411 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -25.47 -57.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 1 C-N-CA 126.009 4.473 . . . . 15.06 116.239 -174.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.3 m -87.19 -64.34 1.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.682 -0.807 . . . . 16.97 113.0 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.5 m -170.38 135.57 1.16 Allowed Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 117.857 0.299 . . . . 16.04 111.68 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.414 ' HB3' HG21 ' A' ' 184' ' ' THR . 76.0 Cg_exo -60.13 124.76 15.91 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.139 2.559 . . . . 14.22 112.507 166.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.465 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.1 p -153.51 158.48 3.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.911 -0.586 . . . . 16.46 109.609 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.22 134.67 36.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.392 -0.367 . . . . 17.05 110.347 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 95.27 -25.9 22.03 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.85 -0.691 . . . . 17.2 112.422 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.528 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 9.8 mptt -106.95 168.94 8.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.18 -0.674 . . . . 19.02 109.18 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 10.3 tp -77.53 111.29 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.871 0.843 . . . . 15.32 111.84 -173.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.572 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 37.4 m -105.31 109.93 22.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.463 -0.79 . . . . 13.03 109.18 170.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.542 ' O ' ' HA ' ' A' ' 173' ' ' THR . 36.5 mtt180 -94.68 145.89 24.54 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.597 -0.729 . . . . 14.44 110.2 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.491 ' O ' HD21 ' A' ' 148' ' ' LEU . 3.0 mm -110.37 119.66 59.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.699 -0.852 . . . . 11.02 108.699 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.534 ' HB3' ' CG1' ' A' ' 145' ' ' VAL . 6.1 mp -128.79 131.37 47.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.376 0.608 . . . . 10.32 110.887 -175.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.426 ' CG1' HD13 ' A' ' 204' ' ' LEU . 39.8 t -104.01 133.74 47.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.995 -1.002 . . . . 10.0 110.845 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.75 47.64 5.83 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 114.907 -1.042 . . . . 9.94 113.731 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.459 ' N ' HG13 ' A' ' 145' ' ' VAL . 10.9 Cg_endo -60.79 125.56 17.51 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 CA-C-N 119.629 1.715 . . . . 11.15 110.888 174.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -159.25 168.1 27.33 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.932 -0.576 . . . . 12.77 109.583 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.9 13.69 27.43 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.296 0.569 . . . . 15.0 109.776 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 22.8 t -118.43 109.47 16.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.885 -0.598 . . . . 14.58 111.373 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.69 ' HB2' ' CZ ' ' A' ' 144' ' ' TYR . 38.3 ttpt -69.91 -42.35 73.45 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.67 -0.863 . . . . 16.29 108.67 171.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -56.6 -40.63 75.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 15.6 111.652 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -79.72 -48.25 13.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.374 -0.376 . . . . 14.36 111.196 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -79.66 -20.76 45.89 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.884 0.328 . . . . 12.11 111.884 -171.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.497 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 29.2 tptp -67.4 -44.6 78.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.236 0.541 . . . . 14.96 109.714 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.28 -13.62 76.84 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.678 -0.692 . . . . 13.32 111.547 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 73.9 m -75.32 -24.01 57.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.519 0.2 . . . . 12.31 111.367 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 15.8 mt -61.49 -31.14 71.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.349 . . . . 12.72 110.878 -175.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.48 -46.11 94.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.565 -0.826 . . . . 14.66 111.924 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.499 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 12.6 pt-20 -86.83 -19.64 28.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.429 . . . . 14.54 111.111 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.426 HD13 ' CG1' ' A' ' 188' ' ' VAL . 14.9 tp -68.63 -35.75 77.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.3 -0.409 . . . . 12.55 111.62 -172.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.433 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 6.3 ptpp? -64.37 -16.31 62.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.825 0.345 . . . . 16.12 110.765 174.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.42 -35.5 15.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.117 0.484 . . . . 16.98 110.04 172.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 82.5 mt -74.96 -53.18 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 14.15 111.36 -176.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.485 ' HA ' HD12 ' A' ' 164' ' ' LEU . 3.4 m -94.86 -43.68 8.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 13.54 110.592 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 71.35 1.02 40.92 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.318 -0.856 . . . . 14.79 112.383 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 59.5 mt -84.37 154.48 22.83 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.341 -0.615 . . . . 13.52 109.341 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 23.3 m -77.17 93.49 3.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.86 0.362 . . . . 14.87 110.104 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -111.13 136.54 13.67 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.641 -0.79 . . . . 12.22 113.348 -175.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.92 138.4 25.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.038 -0.727 . . . . 14.04 109.038 174.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 6.6 p -79.23 108.1 12.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.736 0.779 . . . . 12.89 109.378 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 67.2 mtt -122.42 152.52 40.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.369 -0.832 . . . . 14.23 110.13 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -75.26 143.61 30.89 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.004 -1.094 . . . . 14.09 111.616 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.705 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 4.3 t80 -110.21 133.89 52.78 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.217 -0.992 . . . . 14.24 109.617 -170.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.8 t -147.7 93.66 4.52 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-O 121.229 0.537 . . . . 16.73 110.802 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.444 ' HD3' ' CE1' ' A' ' 217' ' ' TYR . 58.4 Cg_endo -72.71 123.78 9.26 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.244 1.962 . . . . 17.42 111.201 174.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.8 p30 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.377 -0.82 . . . . 19.69 109.77 -179.284 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.883 0.373 . . . . 18.39 110.692 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -115.01 107.25 1.75 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.761 -0.733 . . . . 17.97 111.674 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' HA ' ' HG3' ' A' ' 68' ' ' PRO . 10.9 pt20 -81.08 48.91 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.257 0.551 . . . . 17.74 112.022 -175.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -85.94 -25.22 26.21 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.149 -0.686 . . . . 20.18 109.149 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -86.98 140.06 29.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.303 -0.862 . . . . 17.66 109.709 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -88.47 174.61 8.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.285 -0.416 . . . . 19.78 110.604 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -53.56 -64.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.621 . . . . 18.96 112.178 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -172.94 -64.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.062 0.458 . . . . 18.6 110.294 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -155.41 128.49 8.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.511 -0.768 . . . . 16.78 109.112 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.33 111.36 2.25 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.337 0.589 . . . . 18.42 111.059 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -58.23 118.78 5.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.219 -0.901 . . . . 17.92 111.466 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.79 71.95 3.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.719 -0.673 . . . . 19.75 110.398 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 71.05 -49.5 0.68 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.982 0.801 . . . . 20.62 111.791 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.8 pt 39.27 65.72 3.27 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.249 1.019 . . . . 19.92 112.53 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.14 76.49 4.45 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.137 2.558 . . . . 21.71 112.35 -176.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 62.72 48.86 4.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.427 -0.806 . . . . 23.06 111.519 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 88.9 t -122.44 -62.5 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.322 -0.399 . . . . 21.55 111.343 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 44' ' ' VAL . 59.3 Cg_endo -69.81 150.54 68.02 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.089 1.859 . . . . 20.17 112.816 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -79.49 -28.99 41.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.778 -0.646 . . . . 21.45 110.632 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.77 -168.5 2.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.068 -0.515 . . . . 18.83 110.533 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.77 175.54 19.06 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.991 -0.624 . . . . 17.72 111.669 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.49 95.03 1.02 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.369 0.604 . . . . 16.95 110.303 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -122.31 119.91 32.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.45 -0.796 . . . . 18.58 109.582 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -67.75 134.88 51.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.317 -0.623 . . . . 18.17 109.317 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -85.51 119.41 72.15 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 121.038 0.447 . . . . 18.88 112.149 -172.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.53 -23.51 4.91 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.329 2.019 . . . . 19.87 110.151 167.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -142.17 157.73 44.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.088 -1.415 . . . . 21.1 107.925 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.2 ttt -72.06 80.56 0.94 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.332 0.586 . . . . 22.59 110.815 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.529 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 66.0 mtt -131.85 -49.84 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.616 -0.72 . . . . 24.05 111.214 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 56' ' ' MET . 51.2 Cg_exo -58.9 136.54 74.22 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.862 1.708 . . . . 20.94 111.846 174.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 68.63 -64.97 0.29 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.918 0.761 . . . . 20.49 111.427 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.68 -82.52 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.674 0.79 . . . . 21.67 112.304 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 t -79.74 -16.52 55.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.068 0.461 . . . . 22.84 110.322 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -94.76 130.7 41.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.896 -0.593 . . . . 22.15 110.485 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.58 100.6 12.53 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.862 -0.422 . . . . 19.92 109.862 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.15 101.44 45.06 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.315 -0.402 . . . . 19.88 110.004 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.85 -69.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.631 2.221 . . . . 18.74 111.964 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.0 m -154.03 -63.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 17.84 111.007 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.414 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 25.5 tp60 -130.91 94.66 27.74 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.252 -0.431 . . . . 19.1 110.459 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -96.8 93.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.272 2.648 . . . . 17.47 112.224 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HG3' ' HA ' ' A' ' 30' ' ' GLN . 97.4 Cg_endo -76.11 -23.25 12.2 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.426 2.084 . . . . 17.99 111.924 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -138.91 177.04 8.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.956 -1.02 . . . . 18.7 109.194 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.87 -49.85 4.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.81 -0.709 . . . . 17.72 112.121 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -110.95 8.92 22.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.053 0.454 . . . . 18.19 110.254 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.63 74.53 8.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.903 -0.589 . . . . 17.96 110.811 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -78.43 0.71 24.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.887 -0.597 . . . . 19.85 111.289 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -112.77 91.04 3.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.255 -0.43 . . . . 19.68 109.985 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.5 m -80.97 53.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.469 0.652 . . . . 17.87 111.292 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -69.41 -38.7 78.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.548 -0.751 . . . . 20.34 110.204 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.3 56.1 3.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.616 . . . . 18.81 110.448 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.73 -90.43 0.96 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.845 -0.616 . . . . 17.66 112.212 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -132.12 -8.7 3.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.063 0.459 . . . . 17.87 110.544 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.9 18.77 11.39 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.337 -0.847 . . . . 18.04 110.943 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -155.8 143.99 19.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.715 -0.675 . . . . 17.53 109.649 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.41 ' N ' ' HD3' ' A' ' 83' ' ' PRO . . . 53.52 64.24 7.06 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 123.521 0.513 . . . . 16.64 111.117 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 82' ' ' ALA . 17.9 Cg_exo -66.93 96.42 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.631 2.221 . . . . 17.64 111.053 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -84.52 51.42 2.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.826 -0.624 . . . . 17.42 111.1 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.69 6.82 39.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.957 -0.565 . . . . 18.62 110.096 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.99 120.85 61.26 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.563 -0.744 . . . . 17.79 110.496 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.51 -31.34 94.15 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.137 2.558 . . . . 19.23 111.542 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.01 69.81 1.33 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.765 -0.652 . . . . 17.96 109.775 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 m -66.58 -46.56 75.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.037 -0.528 . . . . 18.63 109.871 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.4 tt -130.12 86.36 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 122.084 0.945 . . . . 19.36 110.16 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.66 156.42 33.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.359 -0.837 . . . . 19.41 110.077 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.87 -52.57 0.68 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.87 0.731 . . . . 18.96 111.576 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -91.11 99.83 12.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.522 0.201 . . . . 18.95 110.614 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 68.33 171.56 0.28 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.914 -0.585 . . . . 20.53 110.681 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.2 m 74.68 -43.83 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.057 0.543 . . . . 21.4 110.878 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -131.07 21.06 4.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.012 -0.54 . . . . 21.26 110.881 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.502 ' CD2' ' HG2' ' A' ' 98' ' ' GLU . 13.9 t80 -130.15 -79.97 0.55 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.448 0.642 . . . . 22.65 110.759 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.502 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 7.7 pt-20 -154.22 142.52 14.29 Favored Pre-proline 0 C--N 1.305 -1.367 0 CA-C-N 114.798 -1.092 . . . . 19.45 109.889 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.76 135.39 59.69 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.643 2.229 . . . . 18.97 112.08 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -101.4 140.71 21.48 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.817 -0.629 . . . . 17.53 110.609 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.68 143.72 99.59 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.695 2.263 . . . . 17.77 111.474 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.09 90.99 30.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.728 0.299 . . . . 18.07 111.142 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.64 92.36 0.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.743 2.296 . . . . 16.56 111.458 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.0 m -84.66 16.16 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.661 0.743 . . . . 17.5 111.047 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.98 141.66 12.72 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 114.817 -1.083 . . . . 16.11 109.083 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.98 116.58 3.23 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.985 2.457 . . . . 16.19 112.881 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.01 -32.54 93.38 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.016 2.477 . . . . 16.43 111.977 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.78 82.67 54.79 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.18 -0.464 . . . . 17.91 110.08 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.05 49.57 2.84 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.919 2.413 . . . . 15.31 111.837 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -153.82 151.06 24.17 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.527 -0.761 . . . . 15.37 109.745 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.25 107.66 1.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.264 1.976 . . . . 14.26 111.139 173.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 m -83.24 50.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.372 0.606 . . . . 15.75 111.16 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 58.51 83.63 0.21 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 114.572 -1.194 . . . . 16.84 111.172 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.62 109.41 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.252 1.968 . . . . 15.51 111.636 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.54 52.89 4.43 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.92 2.413 . . . . 16.04 112.142 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -72.96 117.11 57.01 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.495 -0.775 . . . . 19.25 109.803 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.26 60.17 6.81 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.909 2.406 . . . . 17.04 112.133 -175.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.8 mttm 63.35 -132.17 0.43 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.493 -0.776 . . . . 17.71 110.724 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.3 t 70.27 -67.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 O-C-N 123.57 0.543 . . . . 19.09 111.299 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -105.11 30.59 5.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.864 0.364 . . . . 20.88 110.406 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.35 146.59 99.05 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.469 -0.332 . . . . 18.89 110.56 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.442 ' HB2' ' HD3' ' A' ' 123' ' ' PRO . 71.6 Cg_exo -46.13 -52.63 6.87 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.232 2.622 . . . . 20.92 115.174 -174.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 122' ' ' PRO . 67.9 Cg_endo -84.28 26.56 0.64 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.663 1.575 . . . . 21.13 113.903 -173.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.56 84.69 0.2 Allowed Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 123.074 0.549 . . . . 21.37 111.294 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.86 98.22 1.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.507 2.138 . . . . 21.41 112.754 -173.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 127' ' ' PRO . 87.3 tttt -70.95 -48.66 14.01 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.004 -0.544 . . . . 22.17 110.966 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 126' ' ' LYS . 39.7 Cg_endo -66.27 154.8 72.81 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.012 1.808 . . . . 20.33 112.499 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -97.02 164.27 18.23 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.602 -0.726 . . . . 20.48 110.272 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.49 76.75 0.52 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.979 2.453 . . . . 21.43 112.094 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -161.07 162.13 22.78 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.465 -0.789 . . . . 23.44 108.984 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.95 95.46 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.065 1.843 . . . . 21.1 111.169 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.58 59.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.926 0.869 . . . . 20.15 110.487 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.3 t 63.18 96.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 114.966 -1.015 . . . . 21.3 111.417 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -78.03 -17.08 57.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.764 -0.653 . . . . 21.3 110.419 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.23 171.3 5.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.854 -0.612 . . . . 20.74 109.518 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 136' ' ' LYS . 1.0 OUTLIER -164.52 21.66 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.794 0.806 . . . . 18.17 109.428 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 138' ' ' ALA . . . 176.48 -78.72 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.11 -1.405 . . . . 17.35 108.043 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.566 ' HB2' ' H ' ' A' ' 142' ' ' LYS . . . 174.95 148.76 0.25 Allowed Pre-proline 0 C--N 1.327 -0.385 0 O-C-N 124.683 1.239 . . . . 19.41 109.927 168.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.8 -60.79 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.477 2.118 . . . . 20.18 113.486 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 12.5 p -111.63 -24.62 9.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.101 0.408 . . . . 18.05 112.101 -173.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.5 -74.67 0.75 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.691 -0.766 . . . . 18.56 112.104 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.566 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -89.77 78.3 6.91 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.746 -0.464 . . . . 19.74 109.746 177.093 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.75 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -105.56 162.57 13.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.027 -0.533 . . . . 15.06 110.387 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.672 ' CE2' ' HE3' ' A' ' 194' ' ' LYS . 36.6 m-85 -142.28 142.9 32.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.549 0.34 . . . . 14.83 111.67 -172.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.488 ' CG2' ' HA ' ' A' ' 190' ' ' PRO . 3.4 t -148.74 164.4 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 109.371 -0.603 . . . . 10.79 109.371 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.419 ' H ' HG11 ' A' ' 145' ' ' VAL . 40.1 t -101.17 107.84 22.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 122.055 -0.403 . . . . 10.43 111.373 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.536 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 40.2 tt0 -78.68 115.94 18.71 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 122.617 0.367 . . . . 12.54 111.129 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.524 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -93.74 -33.31 13.66 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.424 0.631 . . . . 11.88 109.778 177.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.68 168.51 27.39 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.402 -0.817 . . . . 11.9 112.423 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -168.41 100.47 0.42 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.488 -0.93 . . . . 13.47 108.488 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.18 160.77 42.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.661 -0.7 . . . . 14.03 110.799 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 44.7 mtpt -99.35 -6.64 27.49 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.948 -1.024 . . . . 17.87 110.262 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.535 ' ND2' ' HG3' ' A' ' 156' ' ' LYS . 36.2 t30 -90.96 106.5 18.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.527 -0.76 . . . . 16.68 109.691 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.01 -21.38 64.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.969 -0.56 . . . . 14.47 111.697 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -59.52 -35.08 73.5 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.774 0.797 . . . . 16.57 109.878 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.535 ' HG3' ' ND2' ' A' ' 153' ' ' ASN . 28.3 mtpp -83.67 -33.35 25.24 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.561 -1.2 . . . . 16.69 110.753 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' A' ' 178' ' ' PRO . 89.7 t -57.48 -39.14 67.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.404 0.621 . . . . 12.92 109.662 173.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -60.78 -30.32 69.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.106 -0.952 . . . . 15.83 111.743 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.6 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 6.0 mm-40 -77.24 -61.65 1.91 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.185 -0.672 . . . . 15.97 109.185 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 156' ' ' LYS . 12.3 mt -49.41 -46.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.357 -0.838 . . . . 12.6 110.793 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.3 t -73.75 -41.42 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.463 -0.789 . . . . 12.54 110.602 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.66 -28.88 70.61 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.611 -0.804 . . . . 14.8 112.137 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.6 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.6 mptp? -72.7 -52.44 15.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.703 0.287 . . . . 16.37 111.183 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.5 mm? -86.39 -55.86 3.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.272 0.471 . . . . 12.99 112.272 -176.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -63.45 -40.28 96.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.223 0.535 . . . . 15.56 109.752 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.68 -23.98 73.98 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.02 -0.991 . . . . 16.6 112.517 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.18 0.85 56.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.867 0.365 . . . . 16.55 110.723 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.56 17.3 58.76 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.927 -0.654 . . . . 15.88 113.237 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -83.86 153.85 23.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.979 0.39 . . . . 15.6 111.036 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.15 99.33 2.79 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.284 -0.636 . . . . 14.31 109.284 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.66 141.7 27.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 114.904 -1.044 . . . . 11.04 109.255 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.7 176.41 8.72 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.994 0.902 . . . . 11.47 111.31 170.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 14.2 p -123.34 -173.73 2.79 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.817 -1.538 . . . . 11.83 109.886 -171.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.454 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 19.5 m -50.01 137.58 19.97 Favored Pre-proline 0 C--O 1.234 0.278 0 N-CA-C 109.737 -0.468 . . . . 12.84 109.737 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -37.44 -50.38 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 124.572 3.515 . . . . 15.06 115.399 -167.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.0 t -82.93 -60.41 2.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.116 -0.634 . . . . 16.97 112.471 -172.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.3 m -166.81 135.43 2.24 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 117.891 0.314 . . . . 16.04 111.608 -175.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.448 ' HB3' HG12 ' A' ' 157' ' ' VAL . 34.4 Cg_exo -62.24 124.62 14.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.266 1.977 . . . . 14.22 111.063 165.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.453 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.8 p -153.57 154.56 7.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 110.084 -0.339 . . . . 16.46 110.084 -176.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -82.92 141.59 32.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.123 0.487 . . . . 17.05 110.887 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.93 -17.07 59.33 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.698 -0.683 . . . . 17.2 111.921 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 10.2 mptt -123.78 156.8 35.42 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.353 -0.61 . . . . 19.02 109.353 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.414 ' O ' HG21 ' A' ' 183' ' ' ILE . 7.7 tp -71.46 109.07 3.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.554 0.692 . . . . 15.32 111.049 -174.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.454 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 32.6 m -103.49 106.77 17.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.813 0.816 . . . . 13.03 110.438 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.492 ' HG2' ' CD1' ' A' ' 187' ' ' LEU . 22.1 ttp180 -85.39 133.29 34.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.317 -1.31 . . . . 14.44 109.367 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.448 ' C ' HD13 ' A' ' 187' ' ' LEU . 2.0 mm -112.98 118.6 58.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.057 -0.72 . . . . 11.02 109.057 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.492 ' CD1' ' HG2' ' A' ' 185' ' ' ARG . 1.5 mp -131.33 132.64 44.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.396 0.617 . . . . 10.32 111.278 -172.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.432 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 42.3 t -104.9 134.44 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.217 -0.902 . . . . 10.0 111.009 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 84.57 50.41 4.24 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.443 -0.799 . . . . 9.94 113.739 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.488 ' HA ' ' CG2' ' A' ' 145' ' ' VAL . 5.3 Cg_endo -55.88 125.51 19.32 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 119.277 1.538 . . . . 11.15 111.424 174.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -152.47 169.01 23.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.657 -0.702 . . . . 12.77 109.23 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.47 -1.88 22.63 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.81 0.338 . . . . 15.0 111.086 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 70.5 m -121.11 110.15 15.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.863 0.363 . . . . 14.58 111.351 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.672 ' HE3' ' CE2' ' A' ' 144' ' ' TYR . 37.5 ttmt -65.13 -53.44 45.13 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.968 -0.56 . . . . 16.29 110.014 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -51.34 -40.26 58.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.264 -0.88 . . . . 15.6 111.647 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -74.7 -42.07 59.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 14.36 110.947 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 197' ' ' LEU . 0.2 OUTLIER -78.56 -20.25 51.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.022 0.439 . . . . 12.11 110.19 -177.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.454 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.4 tptm -67.06 -39.58 86.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.423 0.63 . . . . 14.96 110.305 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.75 -12.17 84.04 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.303 -1.119 . . . . 13.32 110.303 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 71.5 m -90.26 -9.29 48.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.528 -0.836 . . . . 12.31 112.454 -175.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.506 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 18.2 mt -65.2 -35.79 82.15 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.774 -0.37 . . . . 12.72 110.908 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.96 -44.08 97.52 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.915 -0.66 . . . . 14.66 112.331 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 200' ' ' SER . 11.1 pt-20 -81.06 -18.5 46.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.936 0.398 . . . . 14.54 110.457 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.95 -32.17 71.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 12.55 109.958 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 25.2 mtpp -62.0 -19.84 63.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.572 -0.74 . . . . 16.12 110.37 173.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -40.01 13.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.174 0.511 . . . . 16.98 109.719 172.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.75 -52.54 59.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.63 -0.714 . . . . 14.15 111.339 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 164' ' ' LEU . 62.8 p -103.84 -46.95 4.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.999 0.428 . . . . 13.54 110.802 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 82.27 -6.18 69.13 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.789 -0.641 . . . . 14.79 111.8 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.404 HD23 HG22 ' A' ' 160' ' ' ILE . 9.0 mp -86.61 158.37 19.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.82 -0.437 . . . . 13.52 109.82 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 16.1 m -80.13 94.73 6.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.851 -0.613 . . . . 14.87 110.594 -175.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -111.83 148.55 18.12 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.591 -0.814 . . . . 12.22 113.45 -176.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.4 141.97 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.963 0.411 . . . . 14.04 109.932 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.31 106.77 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.689 0.757 . . . . 12.89 110.372 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 96.6 mmm -117.87 168.55 10.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.464 -0.789 . . . . 14.23 110.376 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -84.76 151.31 26.17 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.356 -0.926 . . . . 14.09 112.462 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.75 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 3.9 t80 -123.87 133.01 53.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.418 -0.891 . . . . 14.24 109.582 -171.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 26.5 p -139.84 92.33 9.99 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.396 -0.365 . . . . 16.73 110.204 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.64 120.77 7.53 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.242 1.962 . . . . 17.42 111.501 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 13.7 m120 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.628 -0.701 . . . . 19.69 110.155 -178.73 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.551 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 9.4 p-10 . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 109.903 -0.406 . . . . 18.39 109.903 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.59 -38.94 94.43 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.806 -0.711 . . . . 17.97 111.68 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.472 ' OE1' ' HD2' ' A' ' 68' ' ' PRO . 19.3 tp60 55.61 74.76 0.36 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.601 0.715 . . . . 17.74 110.892 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -122.17 -63.22 1.31 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.533 -0.758 . . . . 20.18 111.194 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -152.29 160.72 43.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.958 -0.386 . . . . 17.66 109.958 -173.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.5 m80 66.98 35.51 4.66 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.889 0.476 . . . . 19.78 111.303 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.549 ' CD2' ' HG2' ' A' ' 35' ' ' GLN . 39.9 p90 -74.41 -29.24 61.43 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.939 -0.305 . . . . 18.96 110.976 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.549 ' HG2' ' CD2' ' A' ' 34' ' ' TYR . 11.5 pt20 -160.29 22.15 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.215 0.531 . . . . 18.6 110.06 173.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.76 -67.78 0.8 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.519 -0.764 . . . . 16.78 110.505 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -148.75 162.45 39.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.639 -0.71 . . . . 18.42 109.271 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -137.85 166.37 24.19 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.782 0.325 . . . . 17.92 110.851 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.52 159.92 25.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.076 -0.511 . . . . 19.75 110.313 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.09 50.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.607 0.242 . . . . 20.62 110.756 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.412 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 22.9 pt 36.63 64.94 2.4 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 124.41 1.069 . . . . 19.92 113.14 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 41' ' ' ILE . 8.3 Cg_exo -72.27 72.96 2.76 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.746 2.297 . . . . 21.71 111.423 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mp 69.08 7.85 6.48 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.5 -0.773 . . . . 23.06 111.526 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.524 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 47.8 t -64.3 -53.89 42.97 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.428 -0.351 . . . . 21.55 111.64 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.524 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 84.0 Cg_endo -80.79 14.49 2.04 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 121.791 1.66 . . . . 20.17 112.073 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 60.62 29.37 18.96 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.385 0.612 . . . . 21.45 110.276 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.99 155.6 39.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.355 -0.839 . . . . 18.83 109.62 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.62 168.55 16.29 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.769 -0.729 . . . . 17.72 112.155 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.87 164.11 21.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.639 -0.134 . . . . 16.95 110.639 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 73.24 -55.71 0.67 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.932 0.77 . . . . 18.58 111.71 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.84 115.17 9.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.852 0.358 . . . . 18.17 110.62 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -86.11 147.36 44.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.15 -0.477 . . . . 18.88 110.922 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.82 141.87 67.19 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.524 2.149 . . . . 19.87 111.716 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -76.91 63.51 2.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.091 0.472 . . . . 21.1 111.512 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.4 mmt -105.75 -33.36 8.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.95 -0.568 . . . . 22.59 109.833 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.508 ' H ' ' HD2' ' A' ' 57' ' ' PRO . 68.4 mtt -146.22 -50.72 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.506 -0.77 . . . . 24.05 111.842 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.508 ' HD2' ' H ' ' A' ' 56' ' ' MET . 84.6 Cg_exo -48.79 121.63 6.89 Favored 'Trans proline' 0 C--N 1.363 1.315 0 C-N-CA 122.374 2.049 . . . . 20.94 112.849 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.26 -26.5 42.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.587 -0.733 . . . . 20.49 110.868 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.58 -71.36 0.12 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.982 0.801 . . . . 21.67 111.745 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.8 t -75.51 124.06 26.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.098 0.475 . . . . 22.84 110.993 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 55.45 42.14 30.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.495 -0.775 . . . . 22.15 110.77 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.74 134.37 37.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.913 -0.585 . . . . 19.92 110.427 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.3 mt -111.97 96.77 35.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.362 -0.381 . . . . 19.88 110.432 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.84 39.97 0.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.741 2.294 . . . . 18.74 112.069 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.1 t -68.29 -30.66 69.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.764 -0.653 . . . . 17.84 110.597 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -108.4 152.84 42.2 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 19.1 109.988 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.78 110.02 2.46 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.736 2.291 . . . . 17.47 111.655 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.472 ' HD2' ' OE1' ' A' ' 30' ' ' GLN . 46.3 Cg_exo -57.37 113.74 1.63 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.035 2.49 . . . . 17.99 112.218 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 20.9 mt-10 66.8 -73.26 0.08 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.625 0.77 . . . . 18.7 111.19 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.55 46.61 14.32 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.709 -0.757 . . . . 17.72 111.36 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.21 86.38 1.97 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.139 0.495 . . . . 18.19 111.368 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.05 58.65 3.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.145 0.497 . . . . 17.96 109.773 176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.57 -1.46 37.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 19.85 111.825 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -89.41 -160.68 0.7 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.651 0.262 . . . . 19.68 110.692 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.9 t -74.25 81.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.216 0.532 . . . . 17.87 110.485 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -74.09 -22.13 59.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.857 -0.61 . . . . 20.34 110.826 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.21 36.33 1.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.167 0.508 . . . . 18.81 110.48 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.85 101.16 2.55 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.948 -0.644 . . . . 17.66 112.083 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -71.57 -64.61 0.89 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.996 0.427 . . . . 17.87 110.082 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.14 -15.15 14.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.955 -0.566 . . . . 18.04 110.014 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.76 40.94 0.93 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.662 -0.699 . . . . 17.53 111.084 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.6 133.61 21.54 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.86 -0.609 . . . . 16.64 110.279 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -88.98 45.57 0.89 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.095 2.53 . . . . 17.64 112.747 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.7 m 58.45 -97.5 0.07 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.002 -0.545 . . . . 17.42 111.538 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.549 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 95.9 mt -133.29 10.9 4.15 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.494 0.187 . . . . 18.62 111.223 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.48 112.01 36.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.627 -0.261 . . . . 17.79 111.461 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 85' ' ' LEU . 24.2 Cg_exo -63.79 -47.23 7.3 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.567 2.178 . . . . 19.23 110.668 172.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 45.72 49.55 11.27 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 124.099 0.874 . . . . 17.96 112.352 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.4 t -163.07 141.05 8.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.08 -0.509 . . . . 18.63 110.128 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.424 ' HA ' ' ND2' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -135.52 22.17 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.069 -0.514 . . . . 19.36 109.617 177.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.66 73.61 3.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.556 -0.747 . . . . 19.41 111.42 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 63.87 54.26 1.8 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.665 -0.698 . . . . 18.96 111.929 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 90' ' ' ILE . 45.4 m-20 -76.79 65.03 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.08 0.466 . . . . 18.95 109.961 176.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -82.43 37.65 0.52 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.49 0.552 . . . . 20.53 112.49 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.1 p -73.21 -33.9 65.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.507 0.67 . . . . 21.4 109.318 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -107.57 17.22 22.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.252 -0.885 . . . . 21.26 108.737 172.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 15.1 t80 62.85 24.02 14.31 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.912 -1.04 . . . . 22.65 111.099 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.465 ' OE2' ' HA ' ' A' ' 101' ' ' PRO . 10.0 pt-20 -155.9 128.32 4.08 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.81 -0.632 . . . . 19.45 109.561 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.09 -23.18 61.0 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.952 2.434 . . . . 18.97 112.864 -175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -154.31 140.78 12.97 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.682 -0.69 . . . . 17.53 109.424 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.465 ' HA ' ' OE2' ' A' ' 98' ' ' GLU . 52.4 Cg_endo -68.12 -18.64 45.55 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.021 2.481 . . . . 17.77 112.79 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.14 142.48 41.27 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.018 -0.537 . . . . 18.07 109.945 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.3 83.42 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.545 2.163 . . . . 16.56 111.534 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.5 p 41.82 47.9 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 122.363 1.077 . . . . 17.5 111.837 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -132.16 91.83 30.8 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.125 -0.943 . . . . 16.11 110.852 -175.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -88.48 103.31 0.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.189 2.592 . . . . 16.19 111.968 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.37 -18.45 34.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.291 1.994 . . . . 16.43 111.726 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 75.3 mmtt -91.44 126.92 52.8 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.825 -0.625 . . . . 17.91 109.825 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 108' ' ' LYS . 6.7 Cg_exo -73.28 54.9 2.89 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.931 2.42 . . . . 15.31 111.706 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -84.12 118.11 70.42 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.733 -0.667 . . . . 15.37 110.571 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.48 123.51 9.56 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.355 2.037 . . . . 14.26 111.627 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.8 p -84.7 49.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 122.584 1.183 . . . . 15.75 110.242 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.636 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 43.9 mt-10 -105.53 -46.91 0.13 Allowed Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.778 -1.101 . . . . 16.84 112.16 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 113' ' ' GLU . 65.3 Cg_endo -97.04 95.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.434 2.089 . . . . 15.51 112.728 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 86.1 Cg_endo -91.2 -177.11 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.769 2.313 . . . . 16.04 111.584 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -131.37 69.48 81.91 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.931 0.396 . . . . 19.25 111.217 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.485 ' HB2' ' OD1' ' A' ' 220' ' ' ASN . 4.0 Cg_exo -79.01 -81.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.065 1.843 . . . . 17.04 110.493 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 56.58 -158.7 0.24 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.953 0.406 . . . . 17.71 110.602 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.7 t -87.01 -19.05 8.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.786 -0.82 . . . . 19.09 108.786 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -90.13 33.59 0.88 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.144 -0.935 . . . . 20.88 110.516 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.34 130.67 93.35 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.676 -0.693 . . . . 18.89 111.418 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 39.3 Cg_exo -59.31 127.85 25.41 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.544 2.162 . . . . 20.92 111.14 174.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 122' ' ' PRO . 15.3 Cg_exo -69.86 52.46 1.03 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.994 2.462 . . . . 21.13 112.663 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.69 118.81 66.45 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.05 -0.523 . . . . 21.37 109.757 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.439 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 12.1 Cg_endo -56.29 117.62 4.3 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.919 2.413 . . . . 21.41 112.39 -175.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -99.91 103.65 23.58 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.539 -0.755 . . . . 22.17 110.151 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.472 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 90.1 Cg_endo -87.25 -161.22 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.858 2.372 . . . . 20.33 110.888 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -114.68 74.13 3.18 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.634 0.254 . . . . 20.48 110.556 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.472 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 93.8 Cg_endo -92.39 -168.3 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.916 2.411 . . . . 21.43 111.72 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -127.41 77.44 75.78 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.764 -0.458 . . . . 23.44 109.764 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.2 96.57 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.97 2.447 . . . . 21.1 111.697 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.6 m -91.39 43.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.767 0.794 . . . . 20.15 110.416 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 134' ' ' GLU . 12.4 p -135.7 163.41 35.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.766 -1.106 . . . . 21.3 109.173 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 133' ' ' VAL . 46.1 mt-10 72.73 -175.08 0.16 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.121 0.569 . . . . 21.3 110.177 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.07 -84.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.727 0.269 . . . . 20.74 111.727 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -139.83 -73.14 0.37 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.826 0.346 . . . . 18.17 110.23 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -97.66 -3.71 38.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.13 -0.486 . . . . 17.35 110.121 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 80.35 142.39 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 114.632 -1.167 . . . . 19.41 111.552 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.33 -57.79 2.14 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.707 2.938 . . . . 20.18 114.155 -172.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.2 t -113.65 -13.61 12.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.861 0.362 . . . . 18.05 110.604 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.09 -51.7 55.82 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.99 -0.624 . . . . 18.56 111.565 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -143.28 94.08 2.57 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.192 -0.67 . . . . 19.74 109.192 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.629 ' HB2' ' CD2' ' A' ' 217' ' ' TYR . . . -108.13 159.87 16.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.86 -0.609 . . . . 15.06 110.449 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.657 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 37.9 m-85 -136.91 143.72 43.11 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.555 -0.293 . . . . 14.83 111.569 -173.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.518 ' CG1' ' HA ' ' A' ' 190' ' ' PRO . 3.0 m -151.39 160.73 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.301 0.64 . . . . 10.79 110.036 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 12.4 t -114.59 122.04 67.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 120.754 -0.378 . . . . 10.43 110.021 176.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.514 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 27.2 tt0 -92.8 97.02 10.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.594 0.235 . . . . 12.54 110.917 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.724 HD11 ' N ' ' A' ' 212' ' ' GLY . 0.3 OUTLIER -83.41 -27.88 29.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.344 0.592 . . . . 11.88 109.691 -177.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.17 162.26 28.15 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.402 -0.904 . . . . 11.9 112.34 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.96 101.52 0.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.779 -0.452 . . . . 13.47 109.779 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.92 158.7 43.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.329 0.585 . . . . 14.03 110.748 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -99.45 4.97 46.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.096 -0.957 . . . . 17.87 109.808 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -105.88 116.72 32.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.887 -1.051 . . . . 16.68 109.74 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -73.48 -23.45 60.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.169 -0.469 . . . . 14.47 112.17 -174.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.84 -35.31 79.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.891 0.853 . . . . 16.57 109.411 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.577 ' O ' HG13 ' A' ' 160' ' ' ILE . 32.3 mmtp -76.08 -38.55 56.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.127 -1.397 . . . . 16.69 110.205 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.431 HG13 HG21 ' A' ' 184' ' ' THR . 93.3 t -57.28 -47.69 83.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.307 0.575 . . . . 12.92 110.325 176.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -59.16 -35.56 73.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.986 -1.006 . . . . 15.83 111.985 -174.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.65 -39.25 27.64 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.626 -0.43 . . . . 15.97 111.65 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 156' ' ' LYS . 29.2 mt -62.7 -49.29 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.549 0.69 . . . . 12.6 109.523 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 91.8 t -66.08 -36.2 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.891 -1.05 . . . . 12.54 109.788 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -56.97 -32.67 62.72 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 14.8 112.187 176.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -71.8 -62.26 1.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.321 . . . . 16.37 111.452 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.02 -50.38 12.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.119 -0.491 . . . . 12.99 112.113 -172.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 3.9 tmt_? -64.84 -43.42 93.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.353 -0.61 . . . . 15.56 109.353 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.01 -27.23 73.36 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.043 -0.981 . . . . 16.6 112.874 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.27 -8.4 59.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.989 0.423 . . . . 16.55 110.625 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.21 19.82 27.21 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.053 -0.594 . . . . 15.88 113.197 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.571 ' CE1' ' HB3' ' A' ' 207' ' ' LEU . 42.7 m-85 -88.22 157.13 18.88 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 117.23 0.515 . . . . 15.6 110.713 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -77.75 100.64 6.34 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.521 0.677 . . . . 14.31 109.279 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.6 p -142.06 137.98 30.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.687 -1.142 . . . . 11.04 109.477 -174.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.49 176.56 8.68 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.539 0.685 . . . . 11.47 110.585 174.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 10.0 p -121.82 -173.97 2.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.722 -1.126 . . . . 11.83 111.191 -169.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 74.7 m -50.45 143.05 14.27 Favored Pre-proline 0 C--O 1.236 0.35 0 O-C-N 123.465 0.478 . . . . 12.84 110.634 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -45.01 -45.43 14.18 Favored 'Trans proline' 0 CA--C 1.527 0.175 0 C-N-CA 124.006 3.138 . . . . 15.06 114.863 -170.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.2 p -86.97 -63.79 1.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.882 -0.727 . . . . 16.97 112.848 -172.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.9 m -168.54 130.04 1.14 Allowed Pre-proline 0 C--O 1.234 0.278 0 O-C-N 122.464 -0.148 . . . . 16.04 111.202 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.446 ' HB3' HG21 ' A' ' 184' ' ' THR . 78.2 Cg_exo -61.45 122.43 11.08 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.116 1.877 . . . . 14.22 111.493 162.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.43 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 4.3 p -155.35 161.68 2.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.849 -0.426 . . . . 16.46 109.849 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -75.25 124.41 27.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.77 0.319 . . . . 17.05 110.681 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.16 -26.06 16.37 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.094 -0.574 . . . . 17.2 112.577 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.43 ' HD3' ' CG1' ' A' ' 179' ' ' VAL . 0.8 OUTLIER -107.16 154.61 20.94 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.703 -0.48 . . . . 19.02 109.703 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.421 ' O ' HG21 ' A' ' 183' ' ' ILE . 8.1 tp -72.79 109.89 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.513 0.673 . . . . 15.32 111.071 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 178' ' ' PRO . 31.4 m -98.8 109.41 22.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.624 0.726 . . . . 13.03 109.974 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 76.9 mtm180 -95.01 134.25 37.89 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.922 -1.036 . . . . 14.44 109.941 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.5 mm -102.56 106.9 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 109.722 -0.473 . . . . 11.02 109.722 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.51 ' HB2' ' CE2' ' A' ' 172' ' ' TYR . 6.1 mp -110.85 114.84 28.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.582 0.706 . . . . 10.32 110.841 -174.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.415 ' HB ' HD21 ' A' ' 148' ' ' LEU . 41.9 t -95.08 140.89 15.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.856 -1.065 . . . . 10.0 110.001 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 77.55 45.85 10.54 Favored Glycine 0 N--CA 1.434 -1.495 0 CA-C-N 115.292 -0.867 . . . . 9.94 114.139 174.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.518 ' HA ' ' CG1' ' A' ' 145' ' ' VAL . 11.4 Cg_endo -61.92 126.38 18.72 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 CA-C-N 119.762 1.781 . . . . 11.15 110.83 171.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -161.54 167.87 24.62 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.987 -0.552 . . . . 12.77 109.721 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -103.9 7.49 36.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.255 -0.43 . . . . 15.0 110.427 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 36.4 t -120.6 116.57 25.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.918 -0.583 . . . . 14.58 110.921 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.635 ' HB2' ' CD2' ' A' ' 144' ' ' TYR . 31.5 ttmt -70.92 -47.75 57.33 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.022 -0.733 . . . . 16.29 109.022 172.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -46.24 -57.46 4.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.704 -1.134 . . . . 15.6 111.639 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -70.7 -39.66 73.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.459 -0.791 . . . . 14.36 111.995 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -82.39 -30.99 29.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.645 0.239 . . . . 12.11 111.645 -174.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.563 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 13.3 tmtt? -79.32 -29.98 42.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.218 -0.66 . . . . 14.96 109.218 -177.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.51 -12.03 83.96 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.022 -1.231 . . . . 13.32 110.022 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 46.3 m -91.09 -8.07 49.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.592 -0.804 . . . . 12.31 112.272 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 23.2 mt -66.96 -35.12 79.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.922 -0.311 . . . . 12.72 111.244 -174.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -58.58 -42.95 96.35 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.735 -0.745 . . . . 14.66 111.905 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 200' ' ' SER . 10.7 pt-20 -83.62 -18.34 38.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.07 0.462 . . . . 14.54 110.412 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.423 ' HG ' ' HG ' ' A' ' 208' ' ' SER . 21.1 tp -69.36 -27.65 65.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.143 -0.481 . . . . 12.55 110.049 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.472 ' HZ1' ' HB3' ' A' ' 205' ' ' LYS . 6.5 mtpm? -63.48 -20.88 65.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.786 -0.643 . . . . 16.12 110.496 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.84 -35.97 16.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.715 -0.476 . . . . 16.98 109.715 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.571 ' HB3' ' CE1' ' A' ' 169' ' ' TYR . 81.9 mt -73.41 -53.09 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.613 -0.722 . . . . 14.15 111.681 -175.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.423 ' HG ' ' HG ' ' A' ' 204' ' ' LEU . 71.2 p -95.04 -42.64 8.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.271 0.557 . . . . 13.54 110.68 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 70.2 5.79 55.07 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.167 -0.924 . . . . 14.79 111.694 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 148' ' ' LEU . 96.1 mt -89.86 162.8 15.29 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.594 0.758 . . . . 13.52 109.84 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 66.1 m -102.24 99.89 10.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.13 0.419 . . . . 14.87 112.13 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.724 ' N ' HD11 ' A' ' 148' ' ' LEU . . . -116.55 157.43 15.05 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.303 -0.951 . . . . 12.22 114.559 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.76 146.15 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.779 -0.711 . . . . 14.04 109.796 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 24.0 t -74.53 117.69 19.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.857 -0.611 . . . . 12.89 110.057 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 87.6 mtp -128.83 153.81 47.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.089 -0.505 . . . . 14.23 110.277 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -86.71 111.1 3.59 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.308 -0.949 . . . . 14.09 112.208 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.657 ' HB3' ' N ' ' A' ' 144' ' ' TYR . 5.2 t80 -63.82 142.71 58.31 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 124.688 1.195 . . . . 14.24 110.472 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 20.5 m -145.78 93.57 5.21 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 110.205 -0.294 . . . . 16.73 110.205 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.565 ' HG3' ' CZ ' ' A' ' 217' ' ' TYR . 19.3 Cg_exo -60.43 118.99 5.92 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.259 1.973 . . . . 17.42 111.373 175.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.485 ' OD1' ' HB2' ' A' ' 117' ' ' PRO . 90.9 m-20 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.475 -0.774 . . . . 19.69 110.68 -175.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.757 0.313 . . . . 18.39 111.147 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -99.91 -110.36 3.16 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.354 -0.927 . . . . 17.97 112.624 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 67.2 -67.31 0.17 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.509 0.723 . . . . 17.74 111.24 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -72.67 -38.25 67.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.277 0.56 . . . . 20.18 110.357 177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 60.95 23.21 13.34 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.806 -1.088 . . . . 17.66 112.65 173.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -73.2 -45.03 58.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.053 -0.721 . . . . 19.78 109.053 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 36' ' ' ASP . 35.4 t80 -153.59 89.75 1.35 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.441 -0.948 . . . . 18.96 108.441 172.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -68.13 -10.4 53.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.791 -0.64 . . . . 18.6 111.999 -174.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 35.9 t70 -89.63 5.45 45.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.45 0.643 . . . . 16.78 110.187 177.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -75.48 86.55 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 18.42 110.162 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.1 t80 57.86 59.47 3.16 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.42 0.629 . . . . 17.92 109.32 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.36 96.73 1.92 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.554 -0.748 . . . . 19.75 111.123 -176.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 68.52 -74.0 0.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.144 0.903 . . . . 20.62 111.199 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.422 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 33.6 mm 54.6 66.07 4.49 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 121.308 0.575 . . . . 19.92 111.367 178.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.422 ' HD3' ' N ' ' A' ' 41' ' ' ILE . 3.6 Cg_exo -81.41 71.84 6.7 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.065 2.51 . . . . 21.71 111.617 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mp 58.79 37.6 24.91 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.467 0.651 . . . . 23.06 109.884 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.479 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 7.7 p -96.88 -29.39 0.26 Allowed Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.41 1.263 . . . . 21.55 114.41 -173.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 44' ' ' VAL . 96.5 Cg_endo -88.96 178.22 2.75 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 121.481 1.454 . . . . 20.17 112.824 -172.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -92.29 -18.44 23.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.886 -0.597 . . . . 21.45 110.977 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.47 -48.22 0.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.301 -0.409 . . . . 18.83 110.846 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.14 -113.57 0.62 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.994 -0.622 . . . . 17.72 111.752 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.06 149.67 29.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.682 -0.488 . . . . 16.95 109.682 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.409 ' N ' ' HD2' ' A' ' 50' ' ' ARG . 4.8 mpt_? -83.18 125.48 31.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.954 0.407 . . . . 18.58 109.992 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -78.83 150.09 32.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 18.17 111.548 -173.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -77.16 133.5 68.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.234 -0.894 . . . . 18.88 111.237 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.86 152.64 52.56 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.951 2.434 . . . . 19.87 112.458 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -77.1 75.38 3.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 21.1 110.74 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 54.9 ttm -165.34 -40.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.512 -0.767 . . . . 22.59 109.826 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.2 tpt -160.88 74.78 2.66 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.797 -0.638 . . . . 24.05 109.475 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.45 123.44 1.86 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.51 2.14 . . . . 20.94 112.35 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.44 88.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.053 -0.976 . . . . 20.49 111.481 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.23 136.24 15.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.145 -0.479 . . . . 21.67 110.347 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.3 p -80.78 -10.09 59.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.168 0.509 . . . . 22.84 111.033 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -109.06 27.73 9.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.056 -0.52 . . . . 22.15 109.833 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.448 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 68.71 171.63 0.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.337 -0.847 . . . . 19.92 111.544 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.2 100.54 5.9 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.637 -0.71 . . . . 19.88 109.161 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 62' ' ' ALA . 96.1 Cg_endo -81.53 40.69 1.02 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.737 2.291 . . . . 18.74 112.75 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m 60.02 78.87 0.25 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.651 -0.704 . . . . 17.84 110.738 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.541 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 50.1 tt0 -67.67 -47.63 44.71 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.007 -0.542 . . . . 19.1 111.305 178.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 66' ' ' GLN . 38.1 Cg_endo -65.55 137.11 49.12 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 121.952 1.768 . . . . 17.47 111.465 174.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.6 114.57 2.19 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.028 1.818 . . . . 17.99 111.384 174.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.74 -53.01 3.69 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.726 -0.842 . . . . 18.7 108.726 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 177.26 164.06 30.29 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.451 -0.795 . . . . 17.72 111.28 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.72 144.15 38.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.034 -0.358 . . . . 18.19 110.034 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.31 103.11 1.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 17.96 110.476 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -70.09 -54.56 12.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.417 0.627 . . . . 19.85 109.74 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -120.96 -77.17 0.58 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.121 -0.945 . . . . 19.68 109.166 175.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.2 m -145.47 143.92 21.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.871 -0.604 . . . . 17.87 109.767 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -111.82 -21.82 11.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.928 0.394 . . . . 20.34 110.232 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.05 167.36 22.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.826 -0.624 . . . . 18.81 110.311 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.33 177.17 32.17 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.978 -0.629 . . . . 17.66 111.7 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -116.84 162.81 17.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.927 -0.397 . . . . 17.87 109.927 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.98 -42.16 99.76 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.579 -0.156 . . . . 18.04 110.579 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 50.03 78.83 0.09 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.633 0.583 . . . . 17.53 111.492 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 112.52 5.06 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 16.64 111.322 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.98 -24.58 8.24 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.485 2.123 . . . . 17.64 113.067 -176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.2 p -136.79 143.03 42.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.756 0.312 . . . . 17.42 111.346 -177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.3 mt -98.03 71.4 2.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.221 -0.659 . . . . 18.62 109.221 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -53.33 120.91 22.88 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.268 -0.878 . . . . 17.79 111.641 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.0 -6.26 18.68 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.954 2.436 . . . . 19.23 112.94 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 69.77 36.9 1.96 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.557 -0.747 . . . . 17.96 111.791 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m 65.36 97.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.662 -0.699 . . . . 18.63 111.743 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.6 mt 67.66 96.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.257 0.551 . . . . 19.36 111.504 175.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.6 -17.14 60.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.117 -0.492 . . . . 19.41 110.651 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.406 ' H ' ' HG2' ' A' ' 98' ' ' GLU . . . 65.07 12.84 8.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.436 -0.802 . . . . 18.96 112.018 176.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.83 165.32 11.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.086 0.469 . . . . 18.95 110.777 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -94.77 36.41 1.18 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.997 -0.547 . . . . 20.53 110.421 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.5 m -84.95 -42.4 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.807 -0.633 . . . . 21.4 109.321 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -122.78 27.27 7.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.354 -0.839 . . . . 21.26 109.511 175.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 46.9 t80 52.65 77.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.989 -1.005 . . . . 22.65 111.215 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 92' ' ' ALA . 6.9 tp10 -115.71 81.59 9.46 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 108.792 -0.818 . . . . 19.45 108.792 174.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.11 -69.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.517 2.145 . . . . 18.97 113.512 -172.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 58.49 69.91 1.34 Allowed Pre-proline 0 N--CA 1.462 0.16 0 O-C-N 123.263 0.352 . . . . 17.53 110.389 -172.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.89 -35.4 67.4 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.518 2.146 . . . . 17.77 112.004 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 50.06 70.99 1.71 Allowed Pre-proline 0 C--O 1.238 0.453 0 O-C-N 123.808 0.693 . . . . 18.07 111.498 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.2 48.39 2.68 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.595 2.197 . . . . 16.56 111.928 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.71 41.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.974 -1.012 . . . . 17.5 111.179 -176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -134.9 87.94 28.71 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.703 -0.68 . . . . 16.11 110.39 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.509 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 73.2 Cg_exo -49.48 -47.68 21.69 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.054 2.503 . . . . 16.19 113.417 176.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 106' ' ' PRO . 13.9 Cg_endo -57.05 127.54 26.19 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.968 1.779 . . . . 16.43 112.249 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -85.3 160.03 55.17 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.586 -0.733 . . . . 17.91 109.979 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.5 74.72 0.81 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.736 2.29 . . . . 15.31 110.83 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -109.84 134.63 20.59 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.335 -0.848 . . . . 15.37 110.338 -172.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.71 147.87 93.51 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.67 2.247 . . . . 14.26 111.848 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.7 m -85.33 54.56 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 121.72 0.772 . . . . 15.75 111.353 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.12 129.34 94.43 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.033 -0.985 . . . . 16.84 110.136 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -57.7 119.09 6.12 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.046 2.498 . . . . 15.51 112.244 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.25 175.81 4.56 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.838 2.358 . . . . 16.04 112.136 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 56.47 71.07 1.25 Allowed Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 116.064 -0.516 . . . . 19.25 109.861 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.58 35.88 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.175 2.583 . . . . 17.04 113.999 -170.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -111.08 40.65 2.0 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.881 0.372 . . . . 17.71 111.145 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.48 -11.63 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.191 0.519 . . . . 19.09 110.502 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.92 16.42 19.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.62 -0.718 . . . . 20.88 110.913 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.48 131.4 86.47 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.601 -0.727 . . . . 18.89 110.022 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.12 120.65 6.42 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.138 2.558 . . . . 20.92 112.073 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.52 102.52 0.09 OUTLIER 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.348 2.699 . . . . 21.13 112.865 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -150.99 99.79 3.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 21.37 110.35 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.68 -32.13 57.88 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.757 2.304 . . . . 21.41 112.709 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -121.12 103.31 42.54 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.973 -0.38 . . . . 22.17 109.973 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.69 142.44 76.9 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.713 2.275 . . . . 20.33 111.459 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 16.0 pt-20 -71.98 141.35 84.11 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.481 . . . . 20.48 110.546 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 128' ' ' GLU . 23.5 Cg_exo -65.55 -18.03 58.44 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.095 2.53 . . . . 21.43 113.149 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -129.47 84.06 63.08 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.742 0.306 . . . . 23.44 111.17 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.25 160.35 49.28 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.746 2.297 . . . . 21.1 111.076 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 t -81.23 50.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.882 0.849 . . . . 20.15 109.977 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.5 t -136.44 83.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.922 -1.035 . . . . 21.3 109.333 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -107.84 -23.47 12.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.592 0.711 . . . . 21.3 109.111 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.7 141.32 58.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.587 -1.188 . . . . 20.74 109.735 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -112.45 -51.39 2.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.026 -0.534 . . . . 18.17 110.131 -173.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.518 ' HB1' ' O ' ' A' ' 192' ' ' ALA . . . -89.39 6.29 41.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.329 0.585 . . . . 17.35 109.57 174.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 74.12 148.71 0.12 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 114.123 -1.399 . . . . 19.41 112.411 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -44.22 -45.62 12.07 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.873 3.048 . . . . 20.18 114.403 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 140' ' ' THR . 7.4 m -130.5 22.34 5.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.405 0.622 . . . . 18.05 110.056 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.63 -79.48 0.72 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.947 -0.861 . . . . 18.56 110.947 178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 137' ' ' ALA . 68.3 mttm -129.27 59.28 1.59 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.333 0.587 . . . . 19.74 109.552 173.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.505 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -73.37 161.0 30.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.272 -0.876 . . . . 15.06 110.041 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.661 ' CD1' ' HG3' ' A' ' 194' ' ' LYS . 5.4 m-85 -146.72 159.82 43.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.685 0.279 . . . . 14.83 111.454 -177.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 190' ' ' PRO . 2.3 t -149.32 158.83 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.719 -0.845 . . . . 10.79 108.719 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.45 HG12 ' HA3' ' A' ' 212' ' ' GLY . 42.9 t -100.89 106.33 19.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 O-C-N 122.081 -0.387 . . . . 10.43 111.047 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.537 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 28.3 tt0 -78.85 110.23 13.85 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.526 0.331 . . . . 12.54 111.311 -177.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.539 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -87.94 -37.92 16.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.306 0.574 . . . . 11.88 109.568 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.3 164.28 28.02 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.374 -0.917 . . . . 11.9 112.559 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -164.43 104.25 0.84 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.695 -0.854 . . . . 13.47 108.695 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.99 166.19 24.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.956 -0.566 . . . . 14.03 110.406 -173.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 48.5 mtpt -102.77 -6.53 22.51 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.042 -0.981 . . . . 17.87 110.355 -174.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -99.38 109.68 22.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.556 -0.747 . . . . 16.68 109.61 173.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.0 -19.55 65.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.065 -0.516 . . . . 14.47 111.494 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.12 -35.51 75.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.813 0.816 . . . . 16.57 109.965 174.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.5 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.12 -26.98 33.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.564 -1.198 . . . . 16.69 110.12 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.528 ' HA ' HD12 ' A' ' 186' ' ' ILE . 69.5 t -66.0 -39.16 83.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.675 -0.693 . . . . 12.92 110.413 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -68.05 -23.5 64.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.816 -0.629 . . . . 15.83 111.349 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.56 -61.85 1.7 Allowed 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.367 -0.605 . . . . 15.97 109.367 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.557 HD12 HD11 ' A' ' 186' ' ' ILE . 18.2 mt -53.74 -43.89 57.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.582 -1.19 . . . . 12.6 110.274 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 0.3 OUTLIER -72.63 -37.11 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.601 -0.727 . . . . 12.54 110.197 -177.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -66.0 -29.76 75.65 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.768 -0.73 . . . . 14.8 111.505 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -70.23 -51.3 31.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.875 0.369 . . . . 16.37 110.152 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.456 HD13 ' CG2' ' A' ' 188' ' ' VAL . 16.3 mt -88.84 -59.26 2.28 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.133 0.79 . . . . 12.99 113.133 -173.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 55.2 ttp180 -60.86 -37.42 82.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.453 0.644 . . . . 15.56 109.768 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.2 -18.86 78.29 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.907 -1.042 . . . . 16.6 112.266 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -95.67 -0.93 51.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.881 0.372 . . . . 16.55 110.624 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.48 25.8 45.65 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.653 -0.784 . . . . 15.88 113.14 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -92.49 154.85 18.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.952 0.376 . . . . 15.6 110.968 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -67.55 104.23 1.54 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.426 0.631 . . . . 14.31 109.773 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.46 137.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.019 -0.991 . . . . 11.04 109.858 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.413 ' CE1' HG22 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -140.17 175.25 9.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.899 0.857 . . . . 11.47 111.211 169.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 15.0 p -121.96 -175.42 3.1 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.98 -1.464 . . . . 11.83 110.384 -172.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.429 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 7.3 m -50.38 125.6 20.44 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 109.115 -0.698 . . . . 12.84 109.115 173.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 89.6 Cg_exo -45.41 -35.51 11.99 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.349 3.366 . . . . 15.06 115.337 -167.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.9 p -79.85 -62.63 1.63 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.017 -0.673 . . . . 16.97 111.816 -175.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.2 m -167.68 135.01 1.87 Allowed Pre-proline 0 C--N 1.329 -0.298 0 C-N-CA 122.183 0.193 . . . . 16.04 110.771 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.01 123.2 11.53 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.634 1.556 . . . . 14.22 110.107 161.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.5 p -154.22 156.72 4.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.484 -0.487 . . . . 16.46 111.197 -172.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -81.78 133.82 35.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.82 -0.627 . . . . 17.05 110.875 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 99.81 -22.95 38.04 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.881 -0.599 . . . . 17.2 112.471 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 9.1 mptt -115.04 160.67 19.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.445 -0.576 . . . . 19.02 109.445 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 183' ' ' ILE . 9.1 tp -74.16 109.82 7.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.735 0.778 . . . . 15.32 111.28 -174.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 40.0 m -104.22 106.58 17.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.649 0.738 . . . . 13.03 110.208 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 173' ' ' THR . 31.1 ttm180 -86.77 136.58 32.94 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.637 -1.165 . . . . 14.44 109.54 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.557 HD11 HD12 ' A' ' 160' ' ' ILE . 3.6 mt -121.61 120.61 62.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.375 -0.602 . . . . 11.02 109.375 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.521 ' N ' HD13 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -130.54 143.56 50.83 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.356 -0.838 . . . . 10.32 110.406 -169.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' A' ' 148' ' ' LEU . 42.5 t -107.69 136.23 43.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.461 -0.79 . . . . 10.0 111.31 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 81.94 48.74 5.64 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.736 -1.12 . . . . 9.94 113.533 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.51 ' N ' HG12 ' A' ' 145' ' ' VAL . 9.9 Cg_endo -58.94 125.2 17.51 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 CA-C-N 119.472 1.636 . . . . 11.15 110.292 174.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 5.3 t70 -150.93 163.05 39.62 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 120.397 -0.521 . . . . 12.77 110.295 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.518 ' O ' ' HB1' ' A' ' 137' ' ' ALA . . . -103.22 -4.17 24.72 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.304 -0.862 . . . . 15.0 111.281 -176.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 42.8 m -114.79 99.41 7.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.371 0.605 . . . . 14.58 110.449 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.661 ' HG3' ' CD1' ' A' ' 144' ' ' TYR . 25.3 ttpt -59.67 -54.51 45.58 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 114.984 -1.007 . . . . 16.29 111.881 -174.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.93 -40.88 97.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.004 0.43 . . . . 15.6 110.838 -172.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.39 -44.28 96.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 14.36 110.551 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -79.08 -22.54 45.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.049 -0.523 . . . . 12.11 110.567 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.437 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.3 tptm -69.15 -35.74 76.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.403 0.62 . . . . 14.96 109.92 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.02 -11.34 85.48 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.573 -1.011 . . . . 13.32 110.573 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 65.5 m -90.27 -8.96 49.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.89 -0.655 . . . . 12.31 112.624 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.51 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 18.4 mt -64.39 -34.52 78.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.001 -0.28 . . . . 12.72 111.409 -174.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.06 -42.92 96.41 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.831 -0.699 . . . . 14.66 112.135 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -79.31 -18.53 52.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 14.54 110.282 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.425 HD13 HD11 ' A' ' 207' ' ' LEU . 3.4 tp -76.27 -26.88 56.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.116 -0.493 . . . . 12.55 110.607 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 92.7 mttt -61.37 -22.47 64.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.145 0.498 . . . . 16.12 110.256 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -30.74 26.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.314 0.578 . . . . 16.98 109.58 173.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.425 HD11 HD13 ' A' ' 204' ' ' LEU . 88.9 mt -75.33 -53.76 8.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.503 -0.771 . . . . 14.15 111.84 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 p -99.58 -48.05 4.89 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.499 -0.481 . . . . 13.54 110.721 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 77.45 -0.64 68.62 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.706 -0.679 . . . . 14.79 112.675 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.14 158.1 17.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.328 -0.619 . . . . 13.52 109.328 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 35.8 m -84.06 102.57 12.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.159 -0.473 . . . . 14.87 110.877 -175.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -122.43 150.06 16.95 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.28 -0.962 . . . . 12.22 113.61 -175.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.97 144.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.497 -0.557 . . . . 14.04 109.497 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.88 105.85 2.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.655 0.74 . . . . 12.89 109.767 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 98.0 mmm -119.27 139.72 51.45 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.677 -0.692 . . . . 14.23 110.674 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -68.92 155.42 53.54 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.587 -0.733 . . . . 14.09 112.425 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.505 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 16.0 t80 -135.06 127.76 31.0 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.124 -0.538 . . . . 14.24 110.364 -171.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.8 p -141.45 92.49 8.18 Favored Pre-proline 0 C--N 1.317 -0.845 0 N-CA-C 109.608 -0.516 . . . . 16.73 109.608 172.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.36 160.79 37.37 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.628 2.218 . . . . 17.42 112.457 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 6.1 t30 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.377 -0.821 . . . . 19.69 109.817 -178.44 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.554 ' H1 ' ' HG3' ' A' ' 69' ' ' GLU . 2.1 p-10 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.653 -0.499 . . . . 18.39 109.653 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.84 -152.29 21.62 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.091 -0.804 . . . . 17.97 111.091 170.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -155.69 -45.25 0.08 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.811 0.305 . . . . 17.74 110.842 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -84.14 -50.77 7.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.003 0.43 . . . . 20.18 110.374 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 37.5 tptt -86.55 133.69 33.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.789 -0.641 . . . . 17.66 109.847 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -144.64 147.24 32.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.241 0.46 . . . . 19.78 112.241 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.411 ' CZ ' ' HA ' ' A' ' 76' ' ' ARG . 95.1 m-85 56.45 41.08 29.29 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.29 -0.868 . . . . 18.96 111.894 175.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -160.38 39.01 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.68 0.752 . . . . 18.6 109.338 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -65.08 144.03 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.248 -0.887 . . . . 16.78 111.303 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -150.35 90.94 1.7 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.849 -0.614 . . . . 18.42 110.244 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -120.03 4.74 10.88 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.675 -0.693 . . . . 17.92 110.353 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.09 -42.2 5.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.624 . . . . 19.75 111.106 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.0 38.8 1.0 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.126 0.489 . . . . 20.62 111.137 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 41' ' ' ILE . 28.2 pt -127.72 90.2 48.76 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 121.353 0.597 . . . . 19.92 110.712 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.76 59.27 4.96 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.134 2.556 . . . . 21.71 111.742 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.3 mp 57.1 32.31 21.48 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.498 -0.774 . . . . 23.06 110.772 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 79.1 t -84.44 -57.19 0.4 Allowed Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.577 -0.738 . . . . 21.55 110.706 177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.462 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 97.0 Cg_endo -77.4 137.0 16.29 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.889 1.726 . . . . 20.17 112.054 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.17 -31.9 11.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.393 0.616 . . . . 21.45 109.523 176.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 84' ' ' SER . . . -105.69 136.76 44.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.512 -0.767 . . . . 18.83 109.041 172.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 53' ' ' PRO . . . 119.8 -22.21 8.74 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.785 -0.926 . . . . 17.72 110.785 -171.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 12.0 t70 -80.57 99.62 8.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.041 -0.726 . . . . 16.95 109.041 175.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 87.7 mtt180 70.69 -56.69 0.61 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.445 0.698 . . . . 18.58 111.473 -175.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -88.24 122.67 32.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.123 -0.49 . . . . 18.17 110.431 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.86 135.5 96.03 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.205 -0.452 . . . . 18.88 111.487 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 96.3 Cg_endo -86.03 53.78 3.28 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.004 2.469 . . . . 19.87 112.104 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.03 172.58 17.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.846 -0.616 . . . . 21.1 109.797 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 47.8 tpp -80.86 82.23 6.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.427 0.632 . . . . 22.59 109.836 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.501 ' H ' ' HD2' ' A' ' 57' ' ' PRO . 47.4 tpp -150.17 -54.4 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.568 -0.742 . . . . 24.05 109.475 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.501 ' HD2' ' H ' ' A' ' 56' ' ' MET . 13.6 Cg_endo -57.44 105.45 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.218 1.945 . . . . 20.94 112.304 172.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.76 116.57 21.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.819 -0.628 . . . . 20.49 110.105 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.71 12.5 16.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.998 -0.546 . . . . 21.67 111.194 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 p -95.26 64.05 2.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.045 0.45 . . . . 22.84 111.04 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 63.58 20.32 12.18 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.565 -0.743 . . . . 22.15 111.966 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.96 -29.52 14.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 19.92 110.01 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.6 mt -125.68 77.75 69.42 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.747 -0.66 . . . . 19.88 111.236 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -82.87 -10.08 10.62 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.932 2.421 . . . . 18.74 110.716 172.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.8 p -107.48 166.54 10.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.022 -0.99 . . . . 17.84 110.017 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.9 116.14 59.01 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.436 -0.579 . . . . 19.1 109.436 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -42.22 123.31 2.59 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.99 3.126 . . . . 17.47 113.2 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -29.86 113.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 1 C-N-CA 125.314 4.01 . . . . 17.99 114.66 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.554 ' HG3' ' H1 ' ' A' ' 28' ' ' ASP . 15.8 tt0 -123.2 -52.85 1.84 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.697 -0.683 . . . . 18.7 109.717 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 74' ' ' GLU . . . 133.69 -151.67 20.25 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.306 -0.861 . . . . 17.72 111.454 -177.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.93 -70.64 0.12 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.708 0.289 . . . . 18.19 110.783 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.12 -69.55 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.397 -0.365 . . . . 17.96 110.636 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -88.21 -16.49 33.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.259 0.552 . . . . 19.85 109.948 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.497 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 38.8 tt0 -97.04 120.89 38.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.897 -0.592 . . . . 19.68 110.547 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.31 138.35 15.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.938 -1.134 . . . . 17.87 107.938 172.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.411 ' HA ' ' CZ ' ' A' ' 34' ' ' TYR . 10.4 ptm180 -146.22 -50.21 0.22 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.556 0.947 . . . . 20.34 113.556 -171.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.85 166.82 22.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.325 0.583 . . . . 18.81 112.293 -168.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.18 113.55 0.53 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.34 -0.845 . . . . 17.66 111.572 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.428 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 33.4 t70 -93.23 150.36 20.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.934 0.397 . . . . 17.87 110.562 -177.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.93 -8.46 58.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.511 -0.768 . . . . 18.04 111.719 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.27 33.45 20.93 Favored 'General case' 0 N--CA 1.461 0.079 0 O-C-N 123.96 0.788 . . . . 17.53 111.501 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.422 ' HB1' ' HD3' ' A' ' 83' ' ' PRO . . . -98.39 -51.79 0.21 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.684 -0.689 . . . . 16.64 112.641 -177.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 6.0 Cg_exo -78.29 57.79 6.38 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.334 2.023 . . . . 17.64 112.801 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.413 ' HA ' ' HB2' ' A' ' 47' ' ' ALA . 29.5 t -75.03 78.66 2.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.072 0.463 . . . . 17.42 110.428 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.418 HD21 ' H ' ' A' ' 85' ' ' LEU . 2.7 pt? -77.69 -35.46 52.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 18.62 110.419 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 6.3 m-20 -83.71 121.62 76.27 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.235 -0.439 . . . . 17.79 110.802 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 86' ' ' ASP . 7.9 Cg_exo -72.95 -8.55 22.45 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.787 2.324 . . . . 19.23 111.814 176.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 68.22 -64.1 0.31 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.611 0.764 . . . . 17.96 110.97 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.6 m -94.16 110.0 21.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.21 -0.663 . . . . 18.63 109.21 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.6 mt -77.26 75.68 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.443 0.639 . . . . 19.36 110.283 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.96 11.1 7.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.484 -0.78 . . . . 19.41 110.475 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 69.9 -66.78 0.26 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.471 -0.786 . . . . 18.96 111.78 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -157.84 161.36 38.33 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.434 -0.58 . . . . 18.95 109.434 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.409 ' ND2' ' H ' ' A' ' 98' ' ' GLU . 2.2 t-20 -80.76 61.83 4.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.298 0.57 . . . . 20.53 111.435 -176.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.447 HG21 ' HG2' ' A' ' 96' ' ' GLU . 3.4 t -87.11 -42.28 13.16 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.886 -0.783 . . . . 21.4 108.886 169.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.447 ' HG2' HG21 ' A' ' 95' ' ' THR . 25.7 mm-40 -107.27 -43.69 4.52 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.295 -0.411 . . . . 21.26 111.076 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.0 t80 178.13 95.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.975 0.416 . . . . 22.65 110.925 -172.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.409 ' H ' ' ND2' ' A' ' 94' ' ' ASN . 33.5 tt0 -95.25 -46.22 0.27 Allowed Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 115.905 -0.589 . . . . 19.45 112.032 176.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.06 75.2 3.31 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.188 1.925 . . . . 18.97 112.847 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.07 -49.67 34.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.016 -0.538 . . . . 17.53 111.532 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.94 45.12 1.6 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.091 1.861 . . . . 17.77 112.509 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.0 138.4 32.04 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 115.944 -0.571 . . . . 18.07 110.685 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.38 78.73 3.56 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.549 2.166 . . . . 16.56 111.272 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.1 m -86.35 46.89 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.626 -0.715 . . . . 17.5 111.293 -177.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.6 87.42 0.13 Allowed Pre-proline 0 C--O 1.232 0.16 0 CA-C-N 115.426 -0.806 . . . . 16.11 111.799 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.79 114.75 3.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.385 2.057 . . . . 16.19 110.396 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.4 -28.27 62.86 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.555 2.17 . . . . 16.43 112.666 -173.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -148.21 91.92 4.7 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.208 -0.451 . . . . 17.91 110.12 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.38 -33.63 57.65 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.369 2.046 . . . . 15.31 111.687 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -140.64 125.86 11.15 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.61 -0.723 . . . . 15.37 110.636 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -74.65 118.28 5.26 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.178 1.918 . . . . 14.26 110.776 170.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.3 p -83.32 52.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 122.667 1.222 . . . . 15.75 110.416 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -86.61 131.26 46.14 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.682 -1.145 . . . . 16.84 109.529 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -56.72 115.45 2.49 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.481 2.12 . . . . 15.51 111.713 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.2 155.97 55.84 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.437 2.091 . . . . 16.04 112.391 -176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -109.22 91.56 9.79 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 19.25 109.572 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -89.74 36.32 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.802 2.335 . . . . 17.04 112.843 -176.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 pttm 45.48 101.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.692 1.197 . . . . 17.71 113.108 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.2 m -62.97 -28.96 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 19.09 111.471 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.21 84.93 2.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.514 0.673 . . . . 20.88 109.889 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.32 116.7 62.4 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.488 -0.778 . . . . 18.89 111.069 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -88.63 166.19 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.981 2.454 . . . . 20.92 111.687 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.56 67.43 6.39 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.598 2.199 . . . . 21.13 111.331 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -135.65 132.11 19.52 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.911 -0.586 . . . . 21.37 110.797 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.08 142.81 88.88 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.737 2.291 . . . . 21.41 111.501 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.529 ' O ' ' HD2' ' A' ' 129' ' ' PRO . 52.1 mtmt -55.57 -38.5 68.68 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 114.812 1.412 . . . . 22.17 114.812 -171.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.88 -23.61 35.06 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.022 1.815 . . . . 20.33 114.581 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.455 ' HB2' ' HD3' ' A' ' 129' ' ' PRO . 30.5 mt-10 -70.62 -52.82 10.33 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 119.006 -0.521 . . . . 20.48 111.979 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 126' ' ' LYS . 77.1 Cg_exo -52.75 103.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.11 1.873 . . . . 21.43 112.225 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -83.32 -43.64 0.84 Allowed Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 112.234 0.457 . . . . 23.44 112.234 -176.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 133' ' ' VAL . 78.0 Cg_exo -54.03 112.96 1.12 Allowed 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.048 1.832 . . . . 21.1 111.917 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.6 m -81.49 36.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.786 0.803 . . . . 20.15 111.91 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 131' ' ' PRO . 10.6 p -131.76 -2.42 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.824 -1.08 . . . . 21.3 109.865 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -100.28 -7.44 24.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.737 -1.119 . . . . 21.3 110.04 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -121.68 -162.16 0.96 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.424 -0.807 . . . . 20.74 109.873 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' ' 136' ' ' LYS . 8.3 mptt -95.36 -75.96 0.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.688 -0.405 . . . . 18.17 110.283 -172.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 192' ' ' ALA . . . -109.79 18.6 20.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.325 -0.398 . . . . 17.35 109.947 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 72.62 151.8 0.14 Allowed Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 114.771 -1.104 . . . . 19.41 111.785 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.01 -18.98 7.8 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 124.272 3.315 . . . . 20.18 114.538 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.7 t -163.99 32.21 0.08 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.591 0.71 . . . . 18.05 109.982 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.6 -79.1 0.85 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.468 -0.872 . . . . 18.56 111.438 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -114.49 69.19 0.71 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.548 -0.538 . . . . 19.74 109.548 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.594 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . -78.38 159.78 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.991 -0.549 . . . . 15.06 109.784 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.55 ' CB ' HD22 ' A' ' 197' ' ' LEU . 3.8 m-85 -144.45 159.96 41.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.851 0.357 . . . . 14.83 111.743 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.535 ' CG2' HD21 ' A' ' 187' ' ' LEU . 2.4 m -151.17 153.05 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.57 -0.741 . . . . 10.79 109.989 -176.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 61.0 t -106.45 111.17 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.582 -0.447 . . . . 10.43 110.593 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -88.4 105.49 17.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.238 -0.437 . . . . 12.54 110.769 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.517 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -83.72 -37.03 23.23 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.351 0.596 . . . . 11.88 109.987 -175.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.18 161.93 27.87 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.261 -0.881 . . . . 11.9 111.846 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -162.63 104.66 1.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.573 -0.529 . . . . 13.47 109.573 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.423 HD13 ' CB ' ' A' ' 156' ' ' LYS . 1.5 pt? -153.26 165.64 35.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.309 0.576 . . . . 14.03 111.058 -176.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 82.3 mttt -98.44 7.1 46.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.255 -0.884 . . . . 17.87 110.914 -172.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -99.64 97.13 8.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.478 -0.783 . . . . 16.68 109.877 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.98 -27.29 68.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.326 0.584 . . . . 14.47 110.246 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.07 -37.22 66.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.931 -1.031 . . . . 16.57 110.551 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 66.1 mttm -90.5 -25.81 20.09 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.181 -0.918 . . . . 16.69 110.691 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 184' ' ' THR . 69.7 t -57.84 -40.46 76.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.437 0.637 . . . . 12.92 109.636 173.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -61.05 -33.4 73.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 15.83 112.183 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 12.6 pt-20 -83.91 -22.84 31.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.463 -0.495 . . . . 15.97 111.633 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 156' ' ' LYS . 16.8 mt -81.05 -49.68 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.345 0.593 . . . . 12.6 109.448 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 45.8 t -69.62 -32.71 53.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.26 -0.882 . . . . 12.54 110.449 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -56.74 -31.97 61.3 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.907 -0.664 . . . . 14.8 112.342 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -73.54 -62.13 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.781 0.324 . . . . 16.37 111.172 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 208' ' ' SER . 3.6 mm? -72.32 -50.37 27.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.085 0.402 . . . . 12.99 112.085 -173.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 31.2 ttm180 -64.13 -47.24 80.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.394 0.616 . . . . 15.56 110.098 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.23 -34.79 90.86 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.916 -1.038 . . . . 16.6 113.047 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -80.14 -7.39 58.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.973 0.416 . . . . 16.55 110.718 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.24 24.73 15.76 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.878 -0.677 . . . . 15.88 113.222 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -93.85 152.69 18.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.75 -0.463 . . . . 15.6 109.75 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -73.35 103.88 4.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.475 0.655 . . . . 14.31 110.162 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.78 139.1 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.832 -1.076 . . . . 11.04 110.051 -173.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -141.3 176.92 8.46 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.507 0.67 . . . . 11.47 110.806 171.213 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.2 p -113.55 -176.34 2.88 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.841 -1.072 . . . . 11.83 111.193 -172.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.82 149.74 16.06 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.405 -0.361 . . . . 12.84 111.111 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -39.32 -53.86 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.347 3.365 . . . . 15.06 115.674 -170.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.4 m -87.17 -64.71 1.11 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 119.515 -0.874 . . . . 16.97 113.133 -169.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.8 m -169.13 135.72 1.46 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 118.228 0.467 . . . . 16.04 111.346 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.429 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 44.7 Cg_exo -65.74 123.95 12.08 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.577 2.184 . . . . 14.22 112.012 162.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.68 158.57 3.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.637 -0.505 . . . . 16.46 109.637 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.63 128.21 35.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.722 0.296 . . . . 17.05 110.54 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.6 -26.17 25.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.097 -0.573 . . . . 17.2 112.3 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.7 OUTLIER -102.67 154.76 18.83 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.716 -0.476 . . . . 19.02 109.716 178.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 183' ' ' ILE . 7.8 tp -73.38 109.65 5.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.6 0.714 . . . . 15.32 111.082 -175.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 178' ' ' PRO . 50.9 m -99.34 119.32 37.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 13.03 109.804 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 60.8 mtt-85 -101.23 140.17 35.89 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.71 -0.677 . . . . 14.44 109.789 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.584 ' C ' HD13 ' A' ' 187' ' ' LEU . 2.1 mm -107.07 120.31 58.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.95 -0.759 . . . . 11.02 108.95 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.584 HD13 ' C ' ' A' ' 186' ' ' ILE . 4.6 mp -128.77 121.86 29.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.521 0.677 . . . . 10.32 111.152 -173.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.441 HG23 HD22 ' A' ' 148' ' ' LEU . 40.3 t -101.44 142.99 15.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.465 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.401 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 77.46 48.33 8.18 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.276 -0.875 . . . . 9.94 113.77 174.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.521 ' HA ' ' CG1' ' A' ' 145' ' ' VAL . 13.6 Cg_endo -64.44 123.99 12.63 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 CA-C-N 119.667 1.734 . . . . 11.15 110.62 171.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -156.75 147.85 22.04 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.841 -0.618 . . . . 12.77 109.78 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.594 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -88.68 -4.97 58.42 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.788 -0.642 . . . . 15.0 111.971 -175.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.421 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 75.6 m -115.86 92.05 3.79 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.297 0.57 . . . . 14.58 110.608 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.41 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 30.4 ttpt -52.7 -48.4 66.63 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 114.726 -1.125 . . . . 16.29 111.016 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -55.57 -38.99 70.09 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.102 0.408 . . . . 15.6 112.102 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -74.65 -41.75 59.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.006 0.431 . . . . 14.36 110.539 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.55 HD22 ' CB ' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -81.19 -19.66 42.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.119 0.485 . . . . 12.11 110.69 -175.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.431 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 28.1 tptp -66.16 -38.13 87.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.371 0.605 . . . . 14.96 110.31 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.21 -12.5 82.21 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.51 -1.036 . . . . 13.32 110.51 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 75.5 m -83.74 -8.71 59.19 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.7 -0.75 . . . . 12.31 111.895 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 20.2 mt -67.2 -36.35 81.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.965 0.412 . . . . 12.72 110.6 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.08 95.97 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.709 -0.678 . . . . 14.66 112.322 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.43 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 10.9 pt-20 -85.74 -18.41 33.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.902 0.382 . . . . 14.54 110.807 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.4 tp -71.81 -35.05 69.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.558 -0.292 . . . . 12.55 111.196 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.42 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 0.1 OUTLIER -65.63 -15.3 62.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.11 0.481 . . . . 16.12 110.432 174.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -31.89 21.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.868 -0.606 . . . . 16.98 109.658 172.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.0 mt -81.92 -52.47 7.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.612 -0.722 . . . . 14.15 111.646 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.421 ' HB3' HD12 ' A' ' 164' ' ' LEU . 61.5 p -94.0 -43.79 8.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.218 0.533 . . . . 13.54 110.618 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 72.94 -1.04 41.92 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.082 -0.963 . . . . 14.79 112.288 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.58 155.34 18.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.188 -0.671 . . . . 13.52 109.188 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.2 t -92.07 109.0 20.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.967 0.413 . . . . 14.87 110.258 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -126.27 156.13 19.65 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.136 -1.03 . . . . 12.22 113.729 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 p -103.63 147.56 9.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.208 -0.496 . . . . 14.04 110.036 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.7 106.06 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 12.89 110.478 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 24.5 mmt -113.26 143.86 43.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.859 -0.61 . . . . 14.23 110.104 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -75.18 136.42 20.38 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.227 -0.987 . . . . 14.09 111.874 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.53 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 8.8 t80 -105.1 130.93 53.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.476 0.655 . . . . 14.24 110.052 -174.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 42.3 m -145.13 94.51 5.29 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 108.378 -0.971 . . . . 16.73 108.378 172.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.78 145.42 98.25 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.917 2.411 . . . . 17.42 113.189 -172.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 . . . . . 0 C--O 1.244 0.769 0 CA-C-O 118.35 -0.833 . . . . 19.69 109.879 179.051 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.97 -0.381 . . . . 18.39 109.97 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.3 147.26 5.47 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.202 -0.999 . . . . 17.97 112.718 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.467 ' CB ' ' HB3' ' A' ' 68' ' ' PRO . 19.9 tp60 74.78 -46.68 0.61 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.903 0.881 . . . . 17.74 112.062 175.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -56.39 -46.61 80.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.48 0.657 . . . . 20.18 110.189 176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -109.35 170.23 8.19 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.284 -1.006 . . . . 17.66 108.284 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -78.53 55.11 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.595 0.712 . . . . 19.78 112.018 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -141.39 132.75 26.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.51 -1.292 . . . . 18.96 107.51 171.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 63.72 27.54 14.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.428 0.632 . . . . 18.6 110.029 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -102.45 -39.41 7.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.274 -0.876 . . . . 16.78 109.742 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -96.59 161.26 13.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.273 -0.876 . . . . 18.42 110.099 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.63 84.81 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.685 -0.689 . . . . 17.92 111.236 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 64.57 -76.34 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.762 0.825 . . . . 19.75 111.523 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . -163.41 141.92 8.01 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.51 -0.922 . . . . 20.62 108.51 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.6 mm -121.79 66.36 20.45 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 120.842 -0.343 . . . . 19.92 111.279 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.528 ' HD3' ' C ' ' A' ' 40' ' ' ALA . 38.5 Cg_endo -96.64 57.82 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.015 2.477 . . . . 21.71 111.286 174.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp 59.67 45.24 13.27 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.681 -0.691 . . . . 23.06 110.508 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.469 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 77.2 t -116.45 -59.99 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.644 -0.707 . . . . 21.55 111.568 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.469 ' HD2' ' H ' ' A' ' 44' ' ' VAL . 40.9 Cg_endo -68.78 119.56 6.54 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 121.636 1.557 . . . . 20.17 112.222 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -76.55 -33.56 58.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.031 -0.531 . . . . 21.45 109.992 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.43 -8.54 57.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.802 -0.635 . . . . 18.83 110.794 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.15 -168.37 46.66 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.044 -0.598 . . . . 17.72 112.494 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.93 127.63 32.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.539 0.209 . . . . 16.95 110.847 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.46 ' HD2' ' OD2' ' A' ' 51' ' ' ASP . 4.9 ttm105 -169.9 -157.36 0.16 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.364 . . . . 18.58 110.68 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.46 ' OD2' ' HD2' ' A' ' 50' ' ' ARG . 8.1 p-10 -70.45 154.46 41.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.642 -0.708 . . . . 18.17 111.145 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -87.27 116.83 67.42 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.49 -0.777 . . . . 18.88 111.119 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.493 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . 38.2 Cg_endo -67.37 -12.3 35.31 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.582 2.188 . . . . 19.87 111.952 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -83.95 -11.85 56.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.774 . . . . 21.1 111.051 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 87.6 mtp -107.34 -81.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 22.59 111.584 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 15.2 tpt -158.0 77.83 3.5 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.217 -0.661 . . . . 24.05 109.217 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.493 ' HG3' ' HA ' ' A' ' 53' ' ' PRO . 35.1 Cg_endo -88.4 39.07 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.33 2.687 . . . . 20.94 113.075 -173.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.13 100.66 13.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.022 -0.535 . . . . 20.49 109.914 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.477 ' O ' ' HB ' ' A' ' 60' ' ' THR . . . -68.8 78.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.039 0.447 . . . . 21.67 111.166 -177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 59' ' ' ALA . 10.8 t 170.29 -28.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.215 -0.902 . . . . 22.84 109.602 -178.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -150.65 38.04 0.67 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.265 0.555 . . . . 22.15 109.828 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.96 139.97 58.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.569 -0.741 . . . . 19.92 110.872 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.4 mt -122.8 79.5 49.26 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 19.88 110.447 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' ' 67' ' ' PRO . 79.7 Cg_endo -93.65 15.04 1.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.957 2.438 . . . . 18.74 112.346 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.02 55.36 2.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.161 0.505 . . . . 17.84 111.323 -175.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.539 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 53.5 tp60 -132.24 -52.49 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.19 -0.459 . . . . 19.1 111.004 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 66' ' ' GLN . 50.9 Cg_exo -53.11 -49.33 17.91 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.497 1.465 . . . . 17.47 112.451 169.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.467 ' HB3' ' CB ' ' A' ' 30' ' ' GLN . 32.7 Cg_endo -66.05 143.94 74.02 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.665 1.576 . . . . 17.99 111.102 170.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.56 150.01 49.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.216 0.531 . . . . 18.7 110.371 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.49 -86.99 0.97 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.352 -0.84 . . . . 17.72 113.154 -171.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 57.68 73.37 0.47 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.249 0.547 . . . . 18.19 109.952 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.26 54.04 2.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.783 -0.644 . . . . 17.96 111.654 -174.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -160.34 65.01 0.33 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.509 0.671 . . . . 19.85 109.814 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -89.73 -5.34 57.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.348 0.594 . . . . 19.68 109.652 176.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.84 156.12 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.103 -0.953 . . . . 17.87 111.149 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 6.9 tpm_? -138.11 -33.73 0.68 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.193 -0.458 . . . . 20.34 110.915 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.39 72.1 7.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.754 0.311 . . . . 18.81 110.893 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.96 -34.83 61.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.006 -0.616 . . . . 17.66 112.403 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.12 -32.65 63.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.982 0.42 . . . . 17.87 110.604 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.6 31.49 21.13 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.353 -0.839 . . . . 18.04 111.375 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.71 69.13 5.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.125 0.488 . . . . 17.53 111.345 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.512 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . . . -84.91 -50.31 0.57 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.203 -0.453 . . . . 16.64 111.806 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 82' ' ' ALA . 27.2 Cg_exo -62.6 115.0 2.63 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 121.903 1.736 . . . . 17.64 111.977 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.5 t -105.32 -169.71 1.64 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.496 -0.775 . . . . 17.42 109.848 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mp 69.84 14.99 7.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.95 0.5 . . . . 18.62 111.316 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -82.9 133.54 48.44 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.189 -0.671 . . . . 17.79 109.189 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.43 -49.61 12.84 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.605 2.203 . . . . 19.23 112.551 -174.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 34.13 64.04 0.38 Allowed 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.484 1.115 . . . . 17.96 112.601 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.8 t -125.22 151.54 45.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.377 -0.374 . . . . 18.63 111.042 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 64.7 mt 70.42 -68.51 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 123.839 0.712 . . . . 19.36 111.356 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.63 114.45 8.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.642 -0.503 . . . . 19.41 109.642 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -129.03 -63.02 0.98 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.297 -0.411 . . . . 18.96 110.989 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 53.8 t30 63.06 90.47 0.08 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.785 0.678 . . . . 18.95 110.34 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.47 46.16 1.31 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.162 -0.472 . . . . 20.53 111.092 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.0 t -73.43 -30.15 63.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.033 -0.531 . . . . 21.4 109.948 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.26 8.85 16.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.61 -0.723 . . . . 21.26 109.142 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.4 t80 58.55 55.31 4.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.27 -1.332 . . . . 22.65 111.045 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -105.64 109.82 63.58 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.268 -0.642 . . . . 19.45 109.268 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.14 71.39 3.6 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.702 2.268 . . . . 18.97 112.395 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.436 ' OE2' ' HD2' ' A' ' 101' ' ' PRO . 8.7 tp10 -87.91 115.81 64.22 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.772 -0.649 . . . . 17.53 109.727 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.436 ' HD2' ' OE2' ' A' ' 100' ' ' GLU . 32.3 Cg_exo -60.37 166.89 8.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.866 2.377 . . . . 17.77 111.996 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.31 115.49 35.25 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.253 -0.43 . . . . 18.07 109.904 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.1 91.48 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.888 2.392 . . . . 16.56 113.052 -172.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.0 p -77.89 55.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.683 1.23 . . . . 17.5 109.834 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . . . -137.81 178.87 1.51 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 114.816 -1.084 . . . . 16.11 110.081 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.583 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 49.5 Cg_exo -42.28 -39.54 6.32 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.013 2.475 . . . . 16.19 115.889 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 106' ' ' PRO . 1.5 Cg_endo -43.76 -30.6 3.0 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 123.24 2.627 . . . . 16.43 114.322 175.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -61.23 127.57 88.29 Favored Pre-proline 0 C--O 1.233 0.193 0 C-N-CA 121.17 -0.212 . . . . 17.91 110.631 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.92 106.08 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.255 2.637 . . . . 15.31 112.887 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.444 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 59.3 pttt -139.99 158.54 67.1 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.463 -0.94 . . . . 15.37 108.463 175.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 110' ' ' LYS . 9.9 Cg_endo -49.99 119.13 4.48 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.753 2.302 . . . . 14.26 112.415 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 7.7 p -81.6 64.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.86 0.838 . . . . 15.75 109.298 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 35.2 mm-40 80.92 126.78 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 114.284 -1.326 . . . . 16.84 110.266 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.04 145.07 65.77 Favored 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 122.758 2.306 . . . . 15.51 111.507 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.61 57.05 2.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.01 2.473 . . . . 16.04 112.888 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.519 ' HZ2' ' HB3' ' A' ' 116' ' ' LYS . 7.1 ttpm? -78.33 -39.66 1.73 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.65 -0.704 . . . . 19.25 110.141 173.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -59.56 120.4 8.21 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 121.139 1.226 . . . . 17.04 110.574 166.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt 67.15 65.19 0.43 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.776 0.673 . . . . 17.71 110.759 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.2 115.2 5.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.644 0.259 . . . . 19.09 110.47 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 59.01 50.92 7.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.775 -0.648 . . . . 20.88 110.506 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -53.79 114.1 5.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 18.89 110.849 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.04 135.28 61.65 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.556 2.171 . . . . 20.92 111.635 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.51 101.5 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.002 2.468 . . . . 21.13 112.294 -177.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.39 147.35 98.17 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.656 -0.702 . . . . 21.37 110.268 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.34 73.98 0.38 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.806 2.337 . . . . 21.41 112.153 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.4 pttp -55.38 112.59 4.35 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.189 -0.914 . . . . 22.17 111.808 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.29 -54.24 1.9 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.246 2.631 . . . . 20.33 112.332 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -143.43 88.06 8.15 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.991 0.424 . . . . 20.48 110.503 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.33 87.7 1.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.533 2.155 . . . . 21.43 111.183 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -64.26 116.81 30.99 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.706 -0.679 . . . . 23.44 110.734 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.29 107.29 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.494 2.13 . . . . 21.1 111.517 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.35 39.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 122.057 0.932 . . . . 20.15 110.526 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -157.53 133.69 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.493 -1.23 . . . . 21.3 109.867 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -154.96 44.32 0.49 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.597 -0.89 . . . . 21.3 108.597 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 57.84 63.44 1.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.095 -0.957 . . . . 20.74 108.784 -166.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.593 ' HB3' ' CB ' ' A' ' 192' ' ' ALA . 67.4 mttm -92.47 87.67 6.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.892 -1.049 . . . . 18.17 109.128 -175.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 56.8 42.12 27.1 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.131 -1.063 . . . . 17.35 108.131 -169.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 72.71 145.67 0.11 Allowed Pre-proline 0 C--N 1.341 0.219 0 CA-C-N 113.903 -1.499 . . . . 19.41 110.46 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -41.26 86.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.704 3.603 . . . . 20.18 114.634 -169.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.483 ' HB ' ' CG ' ' A' ' 219' ' ' PRO . 62.5 p 49.78 32.02 4.95 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.326 -0.852 . . . . 18.05 112.246 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.64 -59.22 1.45 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.783 -0.722 . . . . 18.56 111.449 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -94.78 71.16 3.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.002 0.43 . . . . 19.74 109.887 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.639 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -104.61 158.41 16.52 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.669 -0.493 . . . . 15.06 109.669 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.626 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 16.1 m-85 -137.23 144.89 43.02 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.454 0.168 . . . . 14.83 111.233 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 190' ' ' PRO . 3.2 m -151.3 164.81 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 122.932 0.493 . . . . 10.79 110.827 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 44.4 t -114.72 108.98 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.778 0.323 . . . . 10.43 111.021 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -84.84 111.55 19.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.541 -0.3 . . . . 12.54 110.796 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.534 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -91.29 -35.32 14.52 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.327 0.584 . . . . 11.88 109.804 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.39 166.52 27.66 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.667 -0.778 . . . . 11.9 112.475 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -167.33 101.31 0.51 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.117 -0.697 . . . . 13.47 109.117 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.71 159.32 42.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.323 0.582 . . . . 14.03 110.978 -171.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 181' ' ' GLY . 5.0 mmmm -98.02 5.29 48.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.892 -1.049 . . . . 17.87 110.027 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -112.61 106.67 15.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.979 -1.01 . . . . 16.68 110.041 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.5 -22.09 64.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.205 -0.452 . . . . 14.47 111.838 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.09 -35.52 73.54 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.814 0.816 . . . . 16.57 110.129 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 97.8 mttt -86.62 -25.71 24.76 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.609 -1.178 . . . . 16.69 110.289 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 90.0 t -61.61 -45.26 99.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.92 -0.582 . . . . 12.92 110.154 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -60.72 -33.83 73.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.628 -0.714 . . . . 15.83 112.007 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 15.7 pt-20 -78.25 -36.82 46.44 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.589 -0.444 . . . . 15.97 111.214 -175.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 156' ' ' LYS . 20.6 mt -72.02 -46.67 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.666 0.746 . . . . 12.6 109.756 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.97 -34.3 69.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.738 -1.119 . . . . 12.54 110.519 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.44 -27.0 67.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 14.8 112.281 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -71.99 -54.79 8.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.112 0.482 . . . . 16.37 111.068 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.47 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 4.3 mm? -85.7 -62.78 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 12.99 112.38 -174.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -63.18 -37.22 86.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.28 0.562 . . . . 15.56 109.925 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.71 -17.29 79.14 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.015 -0.993 . . . . 16.6 112.522 -176.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -100.71 -6.7 24.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.785 0.326 . . . . 16.55 110.982 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.87 25.66 19.39 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.382 -0.914 . . . . 15.88 113.153 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -93.72 150.91 20.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.3 0.55 . . . . 15.6 109.799 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 102.83 2.12 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.669 0.747 . . . . 14.31 110.058 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.83 144.23 24.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.342 -1.299 . . . . 11.04 109.337 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.63 177.18 8.2 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.768 0.794 . . . . 11.47 110.862 170.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 17.8 p -124.65 -175.17 3.2 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.173 -1.376 . . . . 11.83 110.0 -171.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 62.4 m -50.62 128.53 26.06 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.931 -0.308 . . . . 12.84 110.385 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -15.7 -63.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.583 1 C-N-CA 126.908 5.072 . . . . 15.06 117.047 -175.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.417 ' C ' ' HG1' ' A' ' 177' ' ' THR . 43.5 t -83.81 -63.29 1.38 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.574 -0.851 . . . . 16.97 112.487 -172.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.417 ' HG1' ' C ' ' A' ' 176' ' ' SER . 65.1 m -168.22 134.24 1.6 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 117.62 0.191 . . . . 16.04 110.919 -176.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -60.68 124.67 15.5 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.383 2.056 . . . . 14.22 111.86 165.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.503 ' CG2' ' HB2' ' A' ' 182' ' ' LYS . 32.2 m -137.58 160.75 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 109.042 -0.725 . . . . 16.46 109.042 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.48 120.87 22.3 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.26 -0.427 . . . . 17.05 110.317 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.423 ' O ' ' HE2' ' A' ' 152' ' ' LYS . . . 109.47 -26.45 14.69 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.966 -0.635 . . . . 17.2 113.106 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.503 ' HB2' ' CG2' ' A' ' 179' ' ' VAL . 4.3 mptp? -101.11 163.61 12.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.032 0.444 . . . . 19.02 110.884 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.403 HG21 ' O ' ' A' ' 183' ' ' ILE . 7.6 tp -73.13 108.03 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.835 0.826 . . . . 15.32 110.88 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 52.5 m -101.39 107.27 18.56 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.604 0.716 . . . . 13.03 109.758 175.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 81.5 mtt180 -86.92 138.54 31.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.782 -1.099 . . . . 14.44 109.579 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.472 ' O ' HD22 ' A' ' 148' ' ' LEU . 3.6 mm -110.5 116.8 53.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.49 -0.93 . . . . 11.02 108.49 177.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 172' ' ' TYR . 4.6 mp -129.27 128.83 44.01 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.478 0.656 . . . . 10.32 110.987 -173.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.47 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 54.8 t -104.01 142.39 17.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.903 -1.044 . . . . 10.0 110.423 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.83 49.87 7.45 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.262 -0.881 . . . . 9.94 113.308 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.509 ' HA ' HG12 ' A' ' 145' ' ' VAL . 11.2 Cg_endo -62.44 125.72 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 CA-C-N 119.548 1.674 . . . . 11.15 110.522 172.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -159.7 169.0 24.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.565 -0.743 . . . . 12.77 109.373 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.593 ' CB ' ' HB3' ' A' ' 136' ' ' LYS . . . -110.99 5.22 20.15 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.479 0.657 . . . . 15.0 110.237 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.1 m -120.68 103.2 8.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.545 -0.752 . . . . 14.58 111.396 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.613 ' HB2' ' CE1' ' A' ' 144' ' ' TYR . 37.5 ttpt -64.11 -47.96 77.96 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.775 -0.648 . . . . 16.29 109.982 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -57.09 -33.49 67.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.005 -0.543 . . . . 15.6 111.453 -177.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -75.42 -54.19 7.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.052 -0.522 . . . . 14.36 110.023 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.645 ' O ' HD11 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -72.85 -19.52 61.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.079 -0.509 . . . . 12.11 111.044 -173.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.458 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 2.0 mmmm -63.91 -33.67 76.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.526 0.679 . . . . 14.96 110.918 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.74 -12.75 81.04 Favored Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.415 -1.074 . . . . 13.32 110.415 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 74.0 m -83.71 -8.72 59.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.601 -0.799 . . . . 12.31 111.994 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 9.6 mt -71.84 -38.45 70.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.805 0.335 . . . . 12.72 110.632 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.54 -24.7 68.04 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.669 -0.972 . . . . 14.66 110.669 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.555 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 43.8 mt-10 -86.64 -24.2 25.4 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.175 -0.513 . . . . 14.54 110.328 174.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.01 -46.29 89.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.415 -0.357 . . . . 12.55 111.106 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -21.95 46.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.13 -0.486 . . . . 16.12 111.06 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -41.03 11.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.076 -0.511 . . . . 16.98 110.938 174.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.8 mt -67.9 -52.39 36.89 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.144 0.497 . . . . 14.15 111.437 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 66.0 p -104.23 -38.07 7.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.942 -0.572 . . . . 13.54 110.748 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.39 -0.55 54.3 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.103 -0.799 . . . . 14.79 111.103 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 58.7 mt -97.47 154.13 17.69 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 122.831 0.452 . . . . 13.52 110.336 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.1 m -84.85 107.34 16.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.904 -0.589 . . . . 14.87 110.555 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -127.83 158.8 21.5 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.282 -0.961 . . . . 12.22 113.325 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.49 142.58 21.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.763 -0.458 . . . . 14.04 109.763 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.4 105.53 4.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.077 -0.712 . . . . 12.89 109.077 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 92.8 mmm -114.09 142.39 46.26 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.444 -0.798 . . . . 14.23 109.383 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -69.94 109.08 2.71 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.11 -1.043 . . . . 14.09 111.726 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.639 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 5.4 t80 -64.38 127.03 29.73 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.113 0.965 . . . . 14.24 110.457 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.4 p -144.58 91.84 6.12 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 115.535 -0.757 . . . . 16.73 109.36 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.483 ' CG ' ' HB ' ' A' ' 140' ' ' THR . 19.0 Cg_endo -61.09 139.04 82.05 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.455 2.103 . . . . 17.42 112.169 -177.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' ' 220' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.457 -0.782 . . . . 19.69 109.691 -177.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 120.766 0.317 . . . . 18.39 110.839 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.17 64.09 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.365 -0.921 . . . . 17.97 112.801 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -77.36 98.6 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.999 -0.371 . . . . 17.74 109.999 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -136.87 121.53 18.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.2 0.524 . . . . 20.18 110.951 178.212 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.5 tptm -96.92 83.65 3.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.665 -0.865 . . . . 17.66 108.665 175.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -111.25 -76.39 0.6 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.15 -0.477 . . . . 19.78 110.673 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -155.37 22.51 0.42 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.946 0.35 . . . . 18.96 111.946 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -104.85 -116.07 0.23 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.507 -0.923 . . . . 18.6 108.507 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 66.38 -70.27 0.11 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.037 0.535 . . . . 16.78 111.604 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 60.04 55.06 3.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.241 0.544 . . . . 18.42 110.717 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -70.09 -49.56 49.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.164 -0.471 . . . . 17.92 110.814 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.06 33.97 5.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.535 -0.302 . . . . 19.75 110.844 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 68.85 -66.53 0.24 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.084 0.865 . . . . 20.62 111.723 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.402 ' O ' HG13 ' A' ' 41' ' ' ILE . 35.7 pt 40.19 71.74 1.16 Allowed Pre-proline 0 N--CA 1.467 0.416 0 C-N-CA 124.12 0.968 . . . . 19.92 112.675 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.38 57.52 4.83 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.268 2.645 . . . . 21.71 111.891 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 60.09 27.67 17.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.547 -0.751 . . . . 23.06 110.898 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.593 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 93.9 t -90.9 -54.77 0.27 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.94 -0.573 . . . . 21.55 111.081 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 30.8 Cg_endo -99.81 -177.95 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.888 2.392 . . . . 20.17 111.592 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -104.23 -1.08 27.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.988 0.423 . . . . 21.45 110.438 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.0 172.79 17.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.653 -0.703 . . . . 18.83 109.272 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.64 57.01 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.302 -0.951 . . . . 17.72 112.419 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.2 94.14 5.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.941 0.4 . . . . 16.95 110.224 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -80.14 -37.7 32.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 18.58 109.831 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -97.7 110.37 22.95 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.1 -1.074 . . . . 18.17 108.1 169.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 54' ' ' ASP . 14.0 tp10 -81.47 114.85 52.8 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.255 -0.43 . . . . 18.88 110.918 -172.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.28 44.51 1.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.904 2.402 . . . . 19.87 111.782 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.509 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 7.5 t70 -84.97 69.31 10.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.761 -0.654 . . . . 21.1 110.109 -177.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 88.4 mtp 70.26 -14.7 0.38 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.515 -0.766 . . . . 22.59 112.246 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.413 ' H ' ' C ' ' A' ' 54' ' ' ASP . 50.1 ttm -171.44 90.64 0.44 Allowed Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 108.953 -0.758 . . . . 24.05 108.953 -175.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -85.39 51.38 2.96 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.84 2.36 . . . . 20.94 112.11 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.18 113.6 6.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.317 -0.856 . . . . 20.49 109.876 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.99 -17.28 13.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.253 -0.43 . . . . 21.67 111.134 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.7 m -86.28 -27.21 24.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.25 0.548 . . . . 22.84 110.112 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -138.84 152.03 47.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.63 -0.714 . . . . 22.15 109.368 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.87 71.08 8.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.183 0.516 . . . . 19.92 110.011 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 98.3 mt -123.17 114.34 29.3 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.8 -0.636 . . . . 19.88 111.429 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.89 78.93 2.74 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.703 2.269 . . . . 18.74 111.119 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -60.76 -20.78 62.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.021 -0.536 . . . . 17.84 111.601 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -61.46 120.01 51.83 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.131 -0.486 . . . . 19.1 110.849 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -103.84 83.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.537 2.825 . . . . 17.47 113.437 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.74 -90.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.563 2.175 . . . . 17.99 112.763 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 67.16 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.825 0.703 . . . . 18.7 111.559 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.14 -159.92 32.45 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.761 -0.733 . . . . 17.72 111.916 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 61.47 49.0 5.47 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.859 0.464 . . . . 18.19 111.405 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 60.62 43.12 13.0 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.395 -0.82 . . . . 17.96 111.519 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 64.24 -90.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.3 -0.863 . . . . 19.85 111.325 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -90.94 91.35 8.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.873 -0.603 . . . . 19.68 109.943 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 p -78.17 106.94 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.278 0.561 . . . . 17.87 111.094 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -175.79 -53.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.829 -0.623 . . . . 20.34 110.529 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.68 137.43 44.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.129 -0.487 . . . . 18.81 111.134 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.02 179.48 45.35 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.228 -0.749 . . . . 17.66 111.228 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -139.55 -75.19 0.36 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.061 0.431 . . . . 17.87 110.706 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -159.09 19.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 18.04 111.234 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.31 -51.92 7.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 17.53 111.008 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.431 ' H ' ' HD2' ' A' ' 83' ' ' PRO . . . -172.26 -50.12 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.153 -0.476 . . . . 16.64 111.632 -176.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HD2' ' H ' ' A' ' 82' ' ' ALA . 92.8 Cg_exo -41.55 107.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 123.207 2.605 . . . . 17.64 113.546 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -124.32 143.16 50.73 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.04 -0.982 . . . . 17.42 109.485 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.28 120.72 13.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.363 -0.38 . . . . 18.62 110.008 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.1 118.88 30.19 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.952 -0.567 . . . . 17.79 111.07 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.28 -14.18 18.56 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.889 2.392 . . . . 19.23 112.784 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.04 -3.77 56.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.006 0.431 . . . . 17.96 110.744 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.0 p 50.12 39.02 18.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.134 -0.939 . . . . 18.63 112.108 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.88 1.65 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.952 -0.567 . . . . 19.36 110.589 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.01 162.21 29.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.509 -0.769 . . . . 19.41 110.733 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.1 68.24 4.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.217 -0.447 . . . . 18.96 111.205 -176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -132.5 -56.41 0.95 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.591 . . . . 18.95 110.045 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -95.26 18.82 11.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.865 -0.607 . . . . 20.53 110.397 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -62.46 -45.7 91.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.545 -0.752 . . . . 21.4 110.934 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -118.29 25.69 10.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.101 0.477 . . . . 21.26 109.848 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.1 t80 57.77 71.03 0.6 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.908 -1.042 . . . . 22.65 111.205 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 63.75 100.33 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.719 -0.673 . . . . 19.45 110.993 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -44.83 106.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.716 2.944 . . . . 18.97 113.58 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.484 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 34.0 tt0 -173.49 -53.36 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.652 -0.704 . . . . 17.53 111.142 -178.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 100' ' ' GLU . 20.2 Cg_endo -60.93 -39.49 60.71 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 122.125 1.883 . . . . 17.77 112.438 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 46.87 76.71 0.52 Allowed Pre-proline 0 C--O 1.234 0.274 0 O-C-N 123.806 0.692 . . . . 18.07 112.502 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.96 116.02 2.87 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.934 2.422 . . . . 16.56 112.292 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.0 m -86.04 82.12 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.074 -0.512 . . . . 17.5 111.075 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.15 83.19 0.21 Allowed Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 115.61 -0.723 . . . . 16.11 111.055 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -52.26 117.05 3.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.292 2.661 . . . . 16.19 112.345 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.3 -20.69 42.47 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.946 2.431 . . . . 16.43 112.635 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -113.47 111.88 49.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.436 -0.347 . . . . 17.91 110.778 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 26.0 Cg_exo -64.37 172.11 7.0 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.953 2.436 . . . . 15.31 111.839 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 109' ' ' PRO . 24.9 mtpp 74.08 141.18 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 123.8 0.687 . . . . 15.37 111.334 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -59.87 146.99 94.37 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.645 2.23 . . . . 14.26 111.606 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.01 46.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.327 0.584 . . . . 15.75 111.874 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 51.21 84.83 0.2 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 114.653 -1.158 . . . . 16.84 111.552 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -67.15 164.13 31.45 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.774 2.316 . . . . 15.51 111.781 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -48.31 -49.31 14.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.585 2.19 . . . . 16.04 112.204 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -122.39 96.28 46.17 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.969 -0.56 . . . . 19.25 110.084 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.18 47.79 2.32 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.008 2.472 . . . . 17.04 111.55 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -160.07 99.96 1.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.468 -0.787 . . . . 17.71 109.278 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.38 90.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.558 0.694 . . . . 19.09 112.009 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -157.6 13.43 0.22 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.852 -1.067 . . . . 20.88 109.136 172.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.9 162.98 62.83 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 114.515 -1.221 . . . . 18.89 110.143 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.411 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 87.4 Cg_exo -41.83 -49.57 5.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.725 2.284 . . . . 20.92 113.552 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 122' ' ' PRO . 27.8 Cg_endo -63.03 111.67 1.46 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 121.778 1.652 . . . . 21.13 111.805 172.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.84 136.99 29.82 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.405 -0.361 . . . . 21.37 111.173 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.4 62.32 8.13 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.756 2.304 . . . . 21.41 112.294 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 32' ' ' LYS . 12.6 mptt -123.26 68.84 38.97 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.975 -0.557 . . . . 22.17 111.183 176.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.01 44.47 1.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.228 1.952 . . . . 20.33 111.091 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.4 ' OE2' ' HG3' ' A' ' 131' ' ' PRO . 39.1 tt0 -163.68 99.41 0.97 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.7 -0.682 . . . . 20.48 110.516 -172.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.95 -55.8 0.29 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.849 2.366 . . . . 21.43 112.161 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -161.5 109.43 1.21 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 23.44 110.483 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.4 ' HG3' ' OE2' ' A' ' 128' ' ' GLU . 27.8 Cg_endo -95.28 179.04 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.339 2.693 . . . . 21.1 112.243 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.5 m -101.05 50.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.357 0.598 . . . . 20.15 109.396 172.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.9 t 57.04 76.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 114.944 -1.025 . . . . 21.3 109.589 -171.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -113.23 120.4 41.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.483 -0.781 . . . . 21.3 111.143 -174.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -108.99 175.47 5.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.674 -0.694 . . . . 20.74 109.882 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -92.33 48.29 1.39 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.894 -0.78 . . . . 18.17 108.894 176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 70.41 -4.12 1.69 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.651 -1.159 . . . . 17.35 111.582 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 64.31 166.72 0.11 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.902 -0.59 . . . . 19.41 110.514 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -71.95 1.07 6.25 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.707 2.271 . . . . 20.18 112.022 176.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 13.0 t 175.73 176.28 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.32 -0.992 . . . . 18.05 108.32 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.06 -64.35 3.35 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.371 -0.919 . . . . 18.56 112.361 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -92.76 38.58 1.02 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.476 0.655 . . . . 19.74 109.455 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.538 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -78.37 163.01 26.04 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.22 -0.9 . . . . 15.06 108.985 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.584 ' CB ' HD21 ' A' ' 197' ' ' LEU . 5.5 m-85 -145.53 153.79 41.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.515 0.198 . . . . 14.83 110.882 -175.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 190' ' ' PRO . 2.7 t -149.51 161.64 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.622 -0.881 . . . . 10.79 108.622 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' A' ' 212' ' ' GLY . 17.7 t -106.39 108.19 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 122.129 -0.357 . . . . 10.43 111.715 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.544 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 30.0 tt0 -81.5 118.26 22.58 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.615 0.228 . . . . 12.54 111.615 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.519 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -91.62 -36.5 13.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.097 -0.641 . . . . 11.88 109.708 177.082 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.14 161.89 28.14 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.536 -0.84 . . . . 11.9 112.73 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -163.68 100.76 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.022 -0.733 . . . . 13.47 109.022 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.71 167.96 19.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.941 -0.572 . . . . 14.03 110.257 -174.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 4.9 mtpm? -104.83 20.85 18.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.325 -0.852 . . . . 17.87 109.662 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -130.76 118.48 20.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.847 -1.069 . . . . 16.68 109.689 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.42 -22.53 61.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.321 0.489 . . . . 14.47 112.321 -173.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.28 -34.78 78.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.935 0.874 . . . . 16.57 109.466 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.36 -29.27 34.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.338 -1.301 . . . . 16.69 110.093 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.46 ' HA ' HD13 ' A' ' 186' ' ' ILE . 97.8 t -65.82 -39.66 85.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.827 -0.624 . . . . 12.92 109.82 173.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.49 -34.57 72.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.022 -0.99 . . . . 15.83 112.13 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.86 -46.51 29.92 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 120.115 -0.634 . . . . 15.97 111.225 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.543 HD11 HD12 ' A' ' 186' ' ' ILE . 25.2 mt -59.01 -45.95 91.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.444 0.64 . . . . 12.6 109.868 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 82.2 t -68.61 -40.62 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.255 -0.884 . . . . 12.54 110.445 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.35 -34.31 88.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.045 -0.598 . . . . 14.8 112.544 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -73.61 -43.96 58.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.587 0.232 . . . . 16.37 111.046 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.556 HD22 ' CB ' ' A' ' 208' ' ' SER . 8.5 mt -87.03 -59.15 2.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.386 0.884 . . . . 12.99 113.386 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.407 ' HG2' ' HB ' ' A' ' 171' ' ' VAL . 9.8 mtp180 -69.74 -30.05 67.56 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.848 -0.797 . . . . 15.56 108.848 -175.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.41 -31.7 77.52 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 114.633 -1.167 . . . . 16.6 111.57 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.3 -12.05 53.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.927 0.394 . . . . 16.55 110.555 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.0 23.24 13.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.892 -0.671 . . . . 15.88 113.317 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -87.79 152.54 22.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.078 0.439 . . . . 15.6 110.329 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.435 ' HG3' ' HD2' ' A' ' 190' ' ' PRO . 20.6 tpp180 -75.43 97.75 3.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.806 0.812 . . . . 14.31 109.589 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 164' ' ' LEU . 2.6 t -131.96 136.32 56.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.605 -1.18 . . . . 11.04 110.622 -173.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -135.26 174.83 10.18 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.759 0.79 . . . . 11.47 111.089 174.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 7.8 p -127.71 -174.52 3.21 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.165 -1.38 . . . . 11.83 110.809 -169.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 58.0 m -50.13 135.57 22.33 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 120.836 0.35 . . . . 12.84 110.477 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -38.4 -44.85 2.17 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 124.714 3.609 . . . . 15.06 115.721 -169.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.6 m -87.01 -64.19 1.19 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 119.669 -0.812 . . . . 16.97 112.224 -173.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.7 m -168.52 129.13 1.08 Allowed Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 117.942 0.337 . . . . 16.04 111.861 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.44 ' HB3' HG21 ' A' ' 184' ' ' THR . 86.9 Cg_exo -58.33 125.16 17.61 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.772 2.315 . . . . 14.22 112.096 162.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.478 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.7 p -153.18 156.16 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 109.923 -0.399 . . . . 16.46 109.923 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -81.62 133.56 35.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.797 0.332 . . . . 17.05 110.202 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 102.86 -26.23 24.75 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.031 -0.604 . . . . 17.2 111.668 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -115.06 168.56 9.82 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.448 -0.575 . . . . 19.02 109.448 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 10.1 tp -76.48 126.26 36.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.471 0.653 . . . . 15.32 111.335 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 57.4 m -119.66 105.98 11.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.842 -0.617 . . . . 13.03 110.042 173.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 173' ' ' THR . 97.5 mtt180 -83.8 135.43 34.53 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.268 -0.878 . . . . 14.44 108.959 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.543 HD12 HD11 ' A' ' 160' ' ' ILE . 3.2 mt -119.8 120.5 63.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.577 -0.527 . . . . 11.02 109.577 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 186' ' ' ILE . 3.6 mp -129.16 142.1 50.97 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.344 -0.843 . . . . 10.32 111.114 -169.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.486 HG23 HD21 ' A' ' 148' ' ' LEU . 53.8 t -107.14 131.84 56.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.986 -1.006 . . . . 10.0 110.926 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.86 49.62 4.73 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.19 -0.913 . . . . 9.94 113.783 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.48 ' N ' HG12 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -61.35 124.97 15.78 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 CA-C-N 119.624 1.712 . . . . 11.15 110.854 172.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -159.62 149.14 18.27 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.762 -0.458 . . . . 12.77 109.762 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -89.24 6.14 41.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.968 -0.56 . . . . 15.0 111.145 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 196' ' ' LYS . 22.7 t -118.98 96.32 5.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.253 -0.647 . . . . 14.58 109.253 175.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.464 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 15.9 ptmt -63.03 -35.67 81.01 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.027 -0.988 . . . . 16.29 111.583 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 194' ' ' LYS . 8.5 m-20 -68.69 -44.42 74.01 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.996 0.427 . . . . 15.6 110.628 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 193' ' ' SER . 44.0 tttm -59.42 -44.07 92.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.765 -0.652 . . . . 14.36 110.698 176.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.584 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -82.54 -16.96 46.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.654 -0.703 . . . . 12.11 110.487 -176.307 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.622 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 25.3 tptp -64.57 -34.57 78.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 14.96 110.761 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -82.22 -12.56 80.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.391 -1.084 . . . . 13.32 110.391 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 70.9 m -79.58 -9.2 59.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.655 -0.772 . . . . 12.31 111.498 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 1.8 mt -74.11 -33.38 63.58 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.509 -0.552 . . . . 12.72 109.509 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -61.45 -28.23 69.18 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.551 -1.019 . . . . 14.66 110.551 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.53 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 41.8 mt-10 -85.85 -19.17 31.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.062 -0.569 . . . . 14.54 110.664 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.415 HD23 HG12 ' A' ' 146' ' ' VAL . 4.6 tp -60.59 -45.01 95.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.796 0.332 . . . . 12.55 111.553 -173.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -57.85 -23.88 54.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.302 -0.408 . . . . 16.12 111.224 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.38 -37.89 14.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.338 -0.392 . . . . 16.98 110.466 176.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 89.6 mt -70.9 -51.77 24.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.321 0.581 . . . . 14.15 111.052 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.556 ' CB ' HD22 ' A' ' 164' ' ' LEU . 28.4 t -110.11 -43.94 3.86 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.502 -0.772 . . . . 13.54 111.264 -173.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.34 -0.23 55.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.748 -0.739 . . . . 14.79 111.606 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.14 157.51 15.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.684 -0.487 . . . . 13.52 109.684 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 61.2 m -77.1 95.45 4.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.949 0.405 . . . . 14.87 111.1 -174.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -103.94 138.58 14.13 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.651 -0.704 . . . . 12.22 113.439 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.0 142.03 21.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.298 0.571 . . . . 14.04 110.066 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.6 t -78.68 105.94 8.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.434 -0.803 . . . . 12.89 110.419 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 90.1 mtp -120.31 142.59 48.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.073 -0.512 . . . . 14.23 110.258 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -69.22 136.03 28.12 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.624 -0.798 . . . . 14.09 112.416 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.538 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 10.5 t80 -100.67 124.61 46.52 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.396 -0.902 . . . . 14.24 110.102 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 5.2 t -142.39 93.32 7.13 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 109.318 -0.623 . . . . 16.73 109.318 175.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -59.36 138.6 85.3 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.744 2.296 . . . . 17.42 112.893 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 33.2 t30 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.398 -0.811 . . . . 19.69 110.18 -179.299 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.421 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 30.3 t70 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.894 0.378 . . . . 18.39 110.349 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.05 153.74 25.54 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.36 -0.924 . . . . 17.97 111.786 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -82.36 65.71 7.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.944 0.402 . . . . 17.74 110.34 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HZ2' ' HB2' ' A' ' 31' ' ' LYS . 9.4 mtmp? 58.73 26.07 14.19 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.544 -0.753 . . . . 20.18 110.946 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -97.61 77.54 2.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.682 -0.69 . . . . 17.66 110.637 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -86.82 95.07 9.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.672 -0.694 . . . . 19.78 110.173 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.5 t80 66.55 36.03 5.15 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.031 -0.986 . . . . 18.96 110.519 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -91.41 -42.06 10.53 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.952 -0.759 . . . . 18.6 108.952 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -153.51 128.82 9.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.017 -0.992 . . . . 16.78 109.585 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -98.77 31.73 2.84 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.986 -0.746 . . . . 18.42 108.986 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 49' ' ' ASP . 7.5 m-30 68.14 -77.09 0.05 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.786 -1.097 . . . . 17.92 109.543 -173.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.18 -76.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.605 0.762 . . . . 19.75 112.942 174.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.83 -5.39 37.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.003 0.372 . . . . 20.62 112.003 -173.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.2 pt -127.2 64.77 62.64 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 111.97 0.359 . . . . 19.92 111.97 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.51 92.03 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.305 2.004 . . . . 21.71 111.666 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.1 mp 61.99 31.35 18.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.701 -0.681 . . . . 23.06 111.145 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.502 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 62.2 t -93.77 -50.86 0.26 Allowed Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 21.55 111.352 177.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.502 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 11.4 Cg_endo -88.03 -67.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.901 1.734 . . . . 20.17 112.499 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -152.67 69.06 0.85 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.028 -0.73 . . . . 21.45 109.028 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 70.18 -67.54 0.23 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.086 -0.961 . . . . 18.83 111.012 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -131.07 -120.71 2.22 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.822 -0.704 . . . . 17.72 112.739 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.437 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 22.8 t0 -80.19 122.06 26.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.971 0.415 . . . . 16.95 111.195 -173.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -166.86 -51.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.17 -0.678 . . . . 18.58 109.17 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -83.94 141.25 31.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.726 -0.67 . . . . 18.17 109.909 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -83.12 119.59 74.43 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.459 -0.337 . . . . 18.88 110.208 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.86 119.75 6.52 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.326 2.018 . . . . 19.87 111.141 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.78 -16.06 36.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 21.1 111.619 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.13 -28.8 69.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.541 -0.3 . . . . 22.59 110.671 176.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.3 tpt -172.84 79.99 0.42 Allowed Pre-proline 0 C--O 1.234 0.281 0 CA-C-O 120.808 0.337 . . . . 24.05 110.708 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -88.79 -167.69 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.852 2.368 . . . . 20.94 111.465 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.23 85.47 1.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.001 0.429 . . . . 20.49 111.308 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.97 156.73 48.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.16 -0.473 . . . . 21.67 110.952 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.4 m 65.35 -81.75 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.16 0.584 . . . . 22.84 111.323 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -89.47 -11.37 43.18 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.649 -0.5 . . . . 22.15 109.649 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.84 -78.55 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 114.892 -1.049 . . . . 19.92 112.04 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.1 mt 63.18 99.73 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.27 0 O-C-N 123.614 0.571 . . . . 19.88 110.222 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.59 132.53 20.63 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.142 2.561 . . . . 18.74 112.451 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 7.2 t -134.81 50.77 2.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.486 0.66 . . . . 17.84 110.877 -176.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.5 pm0 -79.89 108.7 9.77 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.511 . . . . 19.1 109.924 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 65' ' ' THR . 66.7 Cg_endo -83.75 116.89 2.26 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.527 2.151 . . . . 17.47 112.773 -175.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 73.4 Cg_endo -83.81 109.24 1.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.624 2.216 . . . . 17.99 111.02 174.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 68' ' ' PRO . 2.3 mp0 71.14 109.73 0.06 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.825 0.703 . . . . 18.7 110.283 -171.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.35 -34.55 22.86 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.677 -0.773 . . . . 17.72 111.938 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.44 55.29 2.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.05 0.453 . . . . 18.19 110.808 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 28' ' ' ASP . . . -70.77 -53.39 15.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.05 -0.523 . . . . 17.96 110.509 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -96.28 135.39 38.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.758 -0.656 . . . . 19.85 110.171 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -79.08 71.38 5.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.167 0.508 . . . . 19.68 110.128 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 m -72.94 128.55 35.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.639 -0.709 . . . . 17.87 111.241 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -97.12 -47.22 5.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.707 -0.679 . . . . 20.34 109.878 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.62 15.09 2.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.973 -0.558 . . . . 18.81 110.871 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.08 -103.91 0.87 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.818 -0.706 . . . . 17.66 111.526 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -129.14 17.8 6.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.315 -0.624 . . . . 17.87 109.315 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.68 -163.86 0.26 Allowed 'General case' 0 C--O 1.236 0.342 0 CA-C-N 114.914 -1.039 . . . . 18.04 109.882 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.11 31.65 19.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.187 0.518 . . . . 17.53 110.974 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -133.18 131.94 21.97 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.986 -0.552 . . . . 16.64 110.526 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.13 83.82 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.499 2.133 . . . . 17.64 112.312 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 p -103.33 -76.24 0.59 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.105 -0.952 . . . . 17.42 109.909 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -115.55 88.06 2.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.557 -0.905 . . . . 18.62 108.557 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -74.66 130.11 82.27 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.661 -0.7 . . . . 17.79 109.884 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.44 -18.61 49.5 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.867 2.378 . . . . 19.23 112.593 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.32 75.16 0.97 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.93 0.395 . . . . 17.96 110.563 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 m -64.51 -22.0 66.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.283 0.563 . . . . 18.63 110.322 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 24.7 pt -68.96 -16.33 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 19.36 110.912 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.43 35.93 4.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.33 0.586 . . . . 19.41 110.106 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 93' ' ' ASN . . . -73.01 -176.83 2.21 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.475 -0.784 . . . . 18.96 110.698 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 3.6 t-20 72.58 -66.39 0.31 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.092 0.557 . . . . 18.95 110.856 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -81.27 13.14 3.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.37 0.605 . . . . 20.53 111.295 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.8 t -94.83 -11.22 29.25 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.537 -0.756 . . . . 21.4 109.313 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -135.45 -32.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.628 -0.715 . . . . 21.26 111.611 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.469 ' CE1' ' HG2' ' A' ' 99' ' ' PRO . 3.0 t80 -172.25 79.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 22.65 110.172 -174.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.536 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 36.2 tt0 -53.16 -48.67 91.33 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 113.026 0.75 . . . . 19.45 113.026 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 98' ' ' GLU . 16.5 Cg_endo -58.29 -15.59 24.62 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.392 2.061 . . . . 18.97 113.933 -178.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -80.83 119.68 76.79 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.822 -0.436 . . . . 17.53 109.822 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.34 95.56 0.52 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.409 2.073 . . . . 17.77 112.078 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -61.19 130.9 91.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.851 -0.613 . . . . 18.07 110.538 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 54.4 Cg_exo -54.32 99.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.378 2.719 . . . . 16.56 113.154 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.87 112.13 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 121.774 0.797 . . . . 17.5 110.193 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.53 -50.02 90.51 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 114.838 -1.074 . . . . 16.11 112.8 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.09 119.12 5.97 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.571 1.514 . . . . 16.19 111.496 172.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.54 64.5 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.015 2.477 . . . . 16.43 112.683 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.41 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 8.5 mtmp? -80.4 -49.71 1.16 Allowed Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.01 -0.541 . . . . 17.91 111.398 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 108' ' ' LYS . 88.7 Cg_endo -83.73 49.98 3.04 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.786 1.658 . . . . 15.31 112.567 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -93.21 130.72 34.91 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 120.832 0.348 . . . . 15.37 110.24 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.55 129.79 15.16 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.959 2.439 . . . . 14.26 113.119 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.5 p -94.72 40.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 122.819 1.295 . . . . 15.75 109.864 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -67.35 162.27 57.12 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.863 -1.517 . . . . 16.84 109.353 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.1 -49.71 9.67 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.506 2.137 . . . . 15.51 114.11 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.491 ' O ' ' HB3' ' A' ' 123' ' ' PRO . 56.8 Cg_endo -69.89 -17.27 37.08 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 121.729 1.619 . . . . 16.04 112.349 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm 53.41 68.39 2.95 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 122.863 0.465 . . . . 19.25 111.502 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -81.51 107.96 1.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.023 2.482 . . . . 17.04 111.452 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -78.32 77.3 4.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.067 0.46 . . . . 17.71 111.12 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.5 t 69.9 -80.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.109 -0.95 . . . . 19.09 111.524 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -126.5 1.77 6.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.18 0.514 . . . . 20.88 110.483 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.52 132.35 44.96 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.436 -0.802 . . . . 18.89 110.611 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.21 134.33 38.85 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.58 2.187 . . . . 20.92 111.827 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 46.4 Cg_exo -57.81 113.1 1.37 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.762 2.308 . . . . 21.13 112.129 176.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . . . -143.17 141.64 19.88 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.253 -0.43 . . . . 21.37 110.64 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 124' ' ' ALA . 12.5 Cg_exo -70.8 94.35 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.855 2.37 . . . . 21.41 112.023 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -159.49 124.65 2.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.256 -0.429 . . . . 22.17 110.437 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.3 115.95 3.0 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.384 2.056 . . . . 20.33 110.878 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.69 124.51 89.51 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.782 -0.644 . . . . 20.48 111.752 -172.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.01 157.94 46.17 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.369 2.713 . . . . 21.43 112.443 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -157.07 146.34 15.1 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 23.44 110.446 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.43 125.97 10.0 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.237 1.958 . . . . 21.1 111.802 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.1 p -89.39 49.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 122.721 1.248 . . . . 20.15 110.373 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.6 m -86.26 20.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.675 -1.148 . . . . 21.3 110.353 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -129.31 155.67 45.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.404 -0.816 . . . . 21.3 109.756 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -81.08 64.14 5.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.16 0.505 . . . . 20.74 109.933 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -65.06 -68.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.376 -0.829 . . . . 18.17 109.608 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -112.03 9.57 20.39 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.858 -0.793 . . . . 17.35 108.858 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 73.89 148.44 0.12 Allowed Pre-proline 0 C--N 1.34 0.176 0 CA-C-N 114.076 -1.42 . . . . 19.41 110.796 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.88 -7.24 12.69 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.106 2.537 . . . . 20.18 113.135 -175.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 219' ' ' PRO . 9.6 t -155.0 173.19 16.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.297 -0.631 . . . . 18.05 109.297 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.53 -77.29 2.12 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.717 -0.754 . . . . 18.56 111.392 -174.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.54 73.81 2.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.492 0.663 . . . . 19.74 109.455 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.705 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -109.66 164.05 12.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.027 -0.988 . . . . 15.06 109.436 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.715 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 5.5 m-85 -138.6 141.12 39.17 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 111.455 0.168 . . . . 14.83 111.455 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 144' ' ' TYR . 2.7 t -149.96 163.07 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 109.317 -0.623 . . . . 10.79 109.317 170.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 59.3 t -103.83 108.85 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 O-C-N 122.304 -0.248 . . . . 10.43 111.528 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.429 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 8.6 tt0 -76.72 111.78 12.59 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.21 0.204 . . . . 12.54 110.899 178.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.526 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -89.02 -35.66 16.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.26 -0.644 . . . . 11.88 109.26 176.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.52 167.61 27.49 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.35 -0.841 . . . . 11.9 112.45 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -165.35 101.27 0.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.123 -0.695 . . . . 13.47 109.123 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 158.08 45.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.669 -0.696 . . . . 14.03 110.499 -173.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 49.9 mttp -96.23 16.73 17.45 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.182 -0.917 . . . . 17.87 110.194 -175.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.407 ' O ' HG21 ' A' ' 157' ' ' VAL . 15.8 m120 -118.56 108.37 14.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.959 -1.019 . . . . 16.68 109.52 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.38 68.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.177 0.513 . . . . 14.47 110.557 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.68 -37.51 78.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.386 -0.824 . . . . 16.57 110.157 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 64.8 mttp -84.6 -23.3 29.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.621 -1.172 . . . . 16.69 110.132 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.45 HG13 ' CD1' ' A' ' 186' ' ' ILE . 77.0 t -65.64 -46.34 89.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.789 -0.641 . . . . 12.92 109.967 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -61.53 -29.49 70.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 15.83 112.04 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 14.8 pt-20 -77.4 -43.51 32.41 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.282 -0.567 . . . . 15.97 111.101 -177.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 156' ' ' LYS . 21.7 mt -66.33 -46.73 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.762 0.792 . . . . 12.6 109.469 176.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.43 ' CG1' ' HD2' ' A' ' 165' ' ' ARG . 34.2 t -63.46 -32.9 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.538 -1.21 . . . . 12.54 110.588 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.76 -32.18 73.65 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.009 -0.615 . . . . 14.8 112.35 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -71.31 -53.96 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 16.37 110.967 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.479 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 4.0 mm? -83.84 -51.25 7.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.199 0.815 . . . . 12.99 113.199 -172.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.43 ' HD2' ' CG1' ' A' ' 161' ' ' VAL . 48.1 mtt180 -69.74 -37.52 76.49 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.838 -0.801 . . . . 15.56 108.838 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.87 -32.21 83.46 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 114.601 -1.181 . . . . 16.6 112.4 -175.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.78 -3.64 58.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 16.55 110.833 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.41 25.58 35.83 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 15.88 113.376 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -87.03 160.02 18.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.122 0.461 . . . . 15.6 110.658 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -76.29 97.3 4.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.608 0.718 . . . . 14.31 109.543 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.28 141.26 24.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.909 -1.041 . . . . 11.04 109.635 -174.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.2 176.57 8.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.717 0.77 . . . . 11.47 111.095 175.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.3 p -117.27 -175.22 2.76 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.44 -1.254 . . . . 11.83 110.696 -173.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.2 m -51.76 140.2 29.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 12.84 110.934 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -46.18 -36.77 17.33 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.136 3.224 . . . . 15.06 115.069 -169.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.1 m -87.19 -63.74 1.26 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 119.915 -0.714 . . . . 16.97 112.177 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 98.0 m -168.49 139.55 2.14 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 117.742 0.247 . . . . 16.04 111.19 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.441 ' HA ' ' CG2' ' A' ' 184' ' ' THR . 27.8 Cg_exo -66.55 122.82 10.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 121.786 1.657 . . . . 14.22 110.115 163.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.51 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 7.8 p -153.01 156.79 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.363 -0.535 . . . . 16.46 111.251 -172.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -81.48 128.77 34.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.432 -0.804 . . . . 17.05 110.423 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.09 -25.03 29.79 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.704 -0.76 . . . . 17.2 112.433 176.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.51 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 9.0 mptt -112.32 158.93 19.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.636 -0.505 . . . . 19.02 109.636 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.4 tp -70.83 115.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.486 0.66 . . . . 15.32 111.36 -175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.441 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 36.3 m -112.05 113.18 25.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.648 -0.705 . . . . 13.03 109.826 175.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 21.0 ttm180 -89.49 140.93 29.04 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.04 -0.982 . . . . 14.44 110.112 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.479 ' C ' HD13 ' A' ' 187' ' ' LEU . 3.9 mm -111.21 117.51 55.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.878 -0.786 . . . . 11.02 108.878 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 2.5 mp -130.33 135.02 47.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.306 0.574 . . . . 10.32 111.107 -173.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.479 ' CG2' ' HG ' ' A' ' 164' ' ' LEU . 41.1 t -108.59 135.62 46.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.241 -0.89 . . . . 10.0 111.078 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.444 ' O ' HD22 ' A' ' 197' ' ' LEU . . . 82.8 49.3 5.15 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 114.999 -1.0 . . . . 9.94 113.507 175.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.469 ' HA ' ' CG2' ' A' ' 145' ' ' VAL . 11.0 Cg_endo -62.3 125.26 15.92 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 CA-C-N 119.552 1.676 . . . . 11.15 111.136 174.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -157.77 168.17 27.97 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.528 -0.545 . . . . 12.77 109.528 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -104.94 4.77 32.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.581 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 196' ' ' LYS . 21.0 t -120.67 117.7 28.21 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.036 0.446 . . . . 14.58 110.146 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.693 ' HB2' ' CE2' ' A' ' 144' ' ' TYR . 39.0 ttpt -67.8 -41.78 82.6 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-N 115.901 -0.591 . . . . 16.29 109.535 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -57.53 -50.19 73.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.667 0.27 . . . . 15.6 111.033 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 39.0 mtpt -52.85 -60.0 3.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.476 -0.784 . . . . 14.36 111.187 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.0 OUTLIER -76.74 -28.83 55.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.912 -1.04 . . . . 12.11 111.617 -169.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.575 ' HD3' ' O ' ' A' ' 198' ' ' LYS . 12.9 tmtt? -73.45 -31.59 63.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.012 -0.736 . . . . 14.96 109.012 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.73 -12.55 84.36 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.227 -1.149 . . . . 13.32 110.227 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 58.5 m -88.37 -9.87 51.24 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.527 -0.837 . . . . 12.31 111.965 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 20.7 mt -66.28 -36.37 82.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.712 0.291 . . . . 12.72 111.055 -174.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -57.47 -44.25 93.76 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.026 -0.607 . . . . 14.66 111.829 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.417 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 13.0 pt-20 -86.07 -17.1 36.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.892 0.377 . . . . 14.54 110.519 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.462 HD11 ' CG1' ' A' ' 188' ' ' VAL . 15.5 tp -66.22 -31.91 73.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.028 0.442 . . . . 12.55 110.442 -177.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.505 ' HZ1' ' HB3' ' A' ' 205' ' ' LYS . 6.1 mtpm? -58.98 -23.71 62.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.515 -0.766 . . . . 16.12 110.272 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.55 -36.96 15.05 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.863 -0.608 . . . . 16.98 110.236 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 92.6 mt -68.04 -52.65 33.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.043 -0.526 . . . . 14.15 111.5 -176.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 56.0 p -102.03 -44.12 5.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.119 0.485 . . . . 13.54 110.13 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.84 5.48 75.0 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.151 -0.931 . . . . 14.79 111.627 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.55 157.74 16.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 110.113 -0.329 . . . . 13.52 110.113 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.5 t -87.97 105.26 17.34 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.106 -0.497 . . . . 14.87 110.341 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -128.53 160.64 22.21 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.138 -1.03 . . . . 12.22 113.893 -176.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.14 143.53 20.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.137 -0.532 . . . . 14.04 110.026 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.62 105.27 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.38 -0.6 . . . . 12.89 109.38 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 64.1 mtt -120.99 145.96 47.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.019 -0.537 . . . . 14.23 110.226 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -71.91 110.36 3.18 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.365 -0.921 . . . . 14.09 112.803 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.715 ' HB3' ' N ' ' A' ' 144' ' ' TYR . 4.4 t80 -64.05 134.68 55.43 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.243 -1.479 . . . . 14.24 110.287 175.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 27.1 m -147.09 93.34 4.75 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 120.881 -0.328 . . . . 16.73 110.935 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.419 ' HG2' ' OG1' ' A' ' 140' ' ' THR . 57.4 Cg_endo -73.66 118.86 5.64 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.865 1.71 . . . . 17.42 110.847 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 45.5 t30 . . . . . 0 C--O 1.244 0.797 0 CA-C-O 118.54 -0.743 . . . . 19.69 109.744 -176.181 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.699 0.285 . . . . 18.39 111.26 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.521 ' O ' ' HG2' ' A' ' 30' ' ' GLN . . . -97.66 32.38 6.84 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.056 -0.592 . . . . 17.97 113.452 -174.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 2.4 pt20 68.51 141.56 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.079 0.952 . . . . 17.74 112.467 174.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -84.08 118.91 24.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.314 -0.857 . . . . 20.18 109.68 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.522 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -161.57 142.92 11.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.332 0.586 . . . . 17.66 111.586 -174.337 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -79.17 -28.35 42.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.62 -0.718 . . . . 19.78 109.213 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -133.09 -69.52 0.56 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.225 -0.898 . . . . 18.96 109.461 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 175.73 -67.6 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.693 -0.685 . . . . 18.6 109.35 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -112.96 131.83 55.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 16.78 110.094 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -143.95 -53.92 0.35 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.166 -0.47 . . . . 18.42 110.061 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 t80 55.97 73.43 0.43 Allowed 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.853 0.721 . . . . 17.92 109.834 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 70.56 -63.16 0.42 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.108 -0.951 . . . . 19.75 111.112 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -168.26 -62.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.563 -0.289 . . . . 20.62 110.88 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.1 mt 55.57 73.54 0.84 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.825 -0.625 . . . . 19.92 111.067 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.26 46.59 2.14 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.931 2.421 . . . . 21.71 110.587 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mp 59.77 31.62 20.91 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.176 -0.92 . . . . 23.06 110.801 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.471 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 76.5 t -84.96 -58.44 0.35 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.554 -0.748 . . . . 21.55 110.667 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 73.3 Cg_endo -75.79 129.77 11.93 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.416 1.411 . . . . 20.17 111.301 172.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -68.54 -23.44 64.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 21.45 110.732 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.36 58.64 1.33 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.951 -0.568 . . . . 18.83 110.423 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.38 -25.86 60.5 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.743 -0.662 . . . . 17.72 112.104 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.55 95.5 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.785 -0.45 . . . . 16.95 109.785 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -75.35 -39.07 59.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.911 -0.586 . . . . 18.58 110.095 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.1 157.51 15.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.183 -0.673 . . . . 18.17 109.183 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.2 115.11 58.59 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.155 -0.313 . . . . 18.88 110.155 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.85 68.52 5.61 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.893 2.395 . . . . 19.87 112.052 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.76 152.4 26.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.772 -0.649 . . . . 21.1 110.064 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -66.85 -15.96 63.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.116 -0.493 . . . . 22.59 110.971 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 51.7 tpp -153.09 96.0 2.93 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.037 -0.529 . . . . 24.05 109.596 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -66.5 86.43 0.27 Allowed 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.683 2.255 . . . . 20.94 111.797 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 61' ' ' GLN . . . -168.83 131.68 1.34 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.913 -1.494 . . . . 20.49 109.822 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.85 -58.39 0.09 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.16 0.505 . . . . 21.67 109.775 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.9 p -105.8 -31.62 8.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.111 -0.7 . . . . 22.84 109.111 170.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 84.0 mm-40 -133.17 160.09 38.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.042 -0.981 . . . . 22.15 109.098 175.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.47 111.94 24.24 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.564 -0.532 . . . . 19.92 109.564 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.24 114.43 61.12 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.442 -0.344 . . . . 19.88 111.647 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -88.67 48.68 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.846 2.364 . . . . 18.74 111.003 172.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.7 p -81.09 -61.52 1.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.579 -0.737 . . . . 17.84 111.345 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.504 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 35.8 mt-30 -69.26 -53.42 13.43 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 119.501 -0.285 . . . . 19.1 110.414 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.483 ' HA ' ' HB3' ' A' ' 30' ' ' GLN . 94.2 Cg_endo -87.97 103.02 0.48 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.995 1.797 . . . . 17.47 111.401 170.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 66' ' ' GLN . 23.0 Cg_exo -66.16 0.73 2.98 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.17 2.58 . . . . 17.99 113.179 -174.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.63 -57.92 0.63 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.657 -0.497 . . . . 18.7 109.657 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.08 161.97 12.44 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.71 -0.757 . . . . 17.72 111.849 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.28 93.99 3.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.949 0.404 . . . . 18.19 110.75 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.62 -45.5 17.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.262 -0.426 . . . . 17.96 110.149 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 4.3 tp10 65.59 172.86 0.22 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.338 -0.846 . . . . 19.85 110.829 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.534 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 2.5 mp0 63.37 35.4 12.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.494 0.664 . . . . 19.68 109.531 -175.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -93.95 -9.73 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.112 -0.949 . . . . 17.87 110.848 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -63.05 -30.83 71.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.222 -0.445 . . . . 20.34 110.974 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 60.93 -84.28 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.548 0.739 . . . . 18.81 112.012 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.09 130.1 4.34 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.25 -0.74 . . . . 17.66 111.25 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -73.16 107.61 5.58 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.513 -0.18 . . . . 17.87 110.513 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 71.79 -54.47 0.68 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.603 0.761 . . . . 18.04 111.78 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 57.38 56.8 4.81 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.379 0.609 . . . . 17.53 110.437 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.62 158.79 59.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.385 -0.825 . . . . 16.64 110.463 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -48.7 -59.11 1.37 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.864 2.376 . . . . 17.64 112.836 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.463 ' C ' HD11 ' A' ' 85' ' ' LEU . 19.1 p -171.31 -86.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 17.42 110.555 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.463 HD11 ' C ' ' A' ' 84' ' ' SER . 7.0 mp -135.66 50.31 2.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 18.62 110.185 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.47 145.91 99.01 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.593 -0.521 . . . . 17.79 109.593 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 -6.58 18.09 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.633 2.222 . . . . 19.23 113.603 -173.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 62.45 11.52 4.71 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.855 0.462 . . . . 17.96 111.544 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.0 p -146.38 -169.25 3.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.111 -0.495 . . . . 18.63 110.435 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.6 pt -91.29 136.13 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.144 0.497 . . . . 19.36 110.797 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.65 77.83 1.67 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.938 -0.574 . . . . 19.41 109.869 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.87 -28.84 64.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 18.96 110.739 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 65.1 -81.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.487 -0.779 . . . . 18.95 111.944 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.642 ' OD1' ' HA ' ' A' ' 97' ' ' PHE . 62.2 t30 -154.6 24.15 0.46 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.103 0.478 . . . . 20.53 110.414 -176.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.7 t -64.56 -27.77 69.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.032 -0.531 . . . . 21.4 110.985 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -124.72 21.27 8.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.351 . . . . 21.26 110.665 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.642 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 95.4 m-85 65.58 87.1 0.12 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.371 -0.832 . . . . 22.65 111.239 175.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 62.08 101.37 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 115.552 -0.749 . . . . 19.45 111.316 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.0 98.25 0.1 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.535 2.157 . . . . 18.97 111.466 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 58.91 83.61 0.21 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.773 -0.649 . . . . 17.53 110.578 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.58 -8.95 17.25 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.76 2.307 . . . . 17.77 112.833 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -141.46 74.47 23.75 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.498 -0.319 . . . . 18.07 111.084 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.17 120.38 7.26 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.817 2.345 . . . . 16.56 111.64 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -100.99 20.52 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.178 0.436 . . . . 17.5 112.178 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.55 131.19 26.41 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.141 -0.481 . . . . 16.11 110.082 177.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -46.53 117.71 2.18 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.556 2.837 . . . . 16.19 112.477 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.48 -43.71 55.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.807 3.005 . . . . 16.43 113.246 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -106.55 111.16 64.11 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.407 -0.361 . . . . 17.91 110.111 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.15 136.12 26.32 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.211 1.941 . . . . 15.31 111.774 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -94.56 108.07 34.4 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.487 -0.324 . . . . 15.37 110.143 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.46 138.99 17.98 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.38 2.053 . . . . 14.26 112.189 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.23 52.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.27 1.033 . . . . 15.75 109.164 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 62.35 88.6 0.12 Allowed Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 114.28 -1.327 . . . . 16.84 111.386 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.61 145.79 46.56 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.988 2.458 . . . . 15.51 111.884 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.35 150.79 7.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.332 2.688 . . . . 16.04 113.184 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -66.38 115.29 22.43 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.155 -0.93 . . . . 19.25 111.356 -176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -75.41 166.86 27.86 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.714 2.276 . . . . 17.04 110.908 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -115.86 82.59 1.79 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.503 0.668 . . . . 17.71 110.993 -172.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.8 m -98.0 -27.51 3.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.095 -0.957 . . . . 19.09 110.543 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.35 12.96 36.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.544 -0.753 . . . . 20.88 110.18 -177.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.26 133.36 87.51 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.535 -0.757 . . . . 18.89 110.204 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.35 134.25 60.16 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.78 2.32 . . . . 20.92 111.698 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.95 55.11 0.92 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.038 2.492 . . . . 21.13 112.589 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.481 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . . . -79.5 -48.8 1.44 Allowed Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.156 -0.475 . . . . 21.37 111.125 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 124' ' ' ALA . 6.1 Cg_exo -79.22 81.99 2.64 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.224 1.949 . . . . 21.41 111.486 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 128' ' ' GLU . 59.5 tttp -73.99 120.39 81.06 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.013 -0.54 . . . . 22.17 109.691 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.19 -33.62 81.01 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.17 2.58 . . . . 20.33 113.008 -174.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.418 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 34.0 tt0 -153.62 118.59 2.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 121.174 -0.21 . . . . 20.48 110.881 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.22 146.19 15.63 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.783 2.322 . . . . 21.43 111.871 174.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt 55.97 77.69 0.41 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.883 -0.599 . . . . 23.44 111.649 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.73 137.71 46.58 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.38 2.053 . . . . 21.1 111.37 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.467 ' O ' ' HB ' ' A' ' 133' ' ' VAL . 15.7 m -114.36 54.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.041 0.448 . . . . 20.15 110.896 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 132' ' ' VAL . 73.2 t 72.52 111.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.219 -0.9 . . . . 21.3 110.364 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -80.39 148.92 30.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.347 -0.842 . . . . 21.3 111.165 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -57.69 -39.39 77.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.179 -0.919 . . . . 20.74 109.612 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -172.8 -66.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.109 -0.95 . . . . 18.17 108.509 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 142' ' ' LYS . . . -117.11 6.13 12.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.593 -0.73 . . . . 17.35 109.586 173.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 72.65 143.69 0.1 OUTLIER Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 114.741 -1.118 . . . . 19.41 111.398 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.18 -18.17 50.18 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.395 2.73 . . . . 20.18 113.294 -176.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 90.8 m -149.5 122.94 9.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.024 0.44 . . . . 18.05 111.017 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.93 -69.05 0.54 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.585 -0.817 . . . . 18.56 112.055 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 137' ' ' ALA . 0.0 OUTLIER -101.97 28.27 5.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.793 0.806 . . . . 19.74 109.98 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 217' ' ' TYR . . . -76.72 164.2 26.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.61 -1.177 . . . . 15.06 108.148 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.539 ' CE1' ' HD3' ' A' ' 194' ' ' LYS . 7.3 m-85 -138.23 153.48 49.12 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.695 0.628 . . . . 14.83 112.695 -176.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.491 ' CG1' ' HA ' ' A' ' 190' ' ' PRO . 2.8 m -151.99 151.97 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 114.842 -1.072 . . . . 10.79 109.76 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 80.5 t -110.79 108.02 24.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 120.3 -0.56 . . . . 10.43 111.434 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.499 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 19.0 tt0 -80.26 114.31 19.07 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.085 -0.507 . . . . 12.54 111.148 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.531 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -93.75 -33.73 13.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.509 0.671 . . . . 11.88 109.555 177.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.3 170.72 26.6 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.666 -0.778 . . . . 11.9 112.359 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -170.34 103.22 0.27 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.02 -0.733 . . . . 13.47 109.02 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.98 153.73 42.55 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.451 0.643 . . . . 14.03 110.435 -174.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 77.4 mttt -89.34 2.96 53.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.046 -0.979 . . . . 17.87 110.438 -175.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -101.82 109.44 21.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.419 -0.81 . . . . 16.68 109.597 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.88 -20.32 63.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.924 -0.58 . . . . 14.47 112.202 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.13 -33.84 76.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 122.1 0.952 . . . . 16.57 109.257 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 160' ' ' ILE . 74.4 mmtt -83.54 -30.07 27.37 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.0 -1.454 . . . . 16.69 110.154 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.453 HG13 ' CD1' ' A' ' 186' ' ' ILE . 77.9 t -57.63 -40.17 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.73 -0.668 . . . . 12.92 110.273 173.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -68.55 -32.62 72.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.264 -0.88 . . . . 15.83 111.969 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.19 -38.09 31.95 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.061 -0.655 . . . . 15.97 111.2 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 156' ' ' LYS . 29.3 mt -63.28 -41.36 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 12.6 109.22 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.79 -35.66 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.01 -0.995 . . . . 12.54 110.17 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.64 -28.54 73.72 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.016 -0.612 . . . . 14.8 112.374 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -72.3 -61.96 1.61 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 16.37 110.977 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.538 ' HB3' HG21 ' A' ' 171' ' ' VAL . 1.8 mm? -79.5 -62.72 1.6 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.927 -0.579 . . . . 12.99 112.188 -175.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' A' ' 165' ' ' ARG . 3.0 tmt_? -61.97 -38.25 87.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.381 -0.6 . . . . 15.56 109.381 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.95 85.22 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.258 -0.883 . . . . 16.6 112.506 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.28 -7.33 59.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.005 0.431 . . . . 16.55 110.523 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.43 25.1 9.58 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.807 -0.711 . . . . 15.88 112.624 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -96.31 145.24 25.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.182 -0.674 . . . . 15.6 109.182 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -70.25 107.32 3.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.611 0.72 . . . . 14.31 110.55 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.538 HG21 ' HB3' ' A' ' 164' ' ' LEU . 11.0 t -138.62 135.71 43.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.773 -1.103 . . . . 11.04 110.324 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -137.85 175.39 9.63 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.78 0.8 . . . . 11.47 110.946 174.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 18.0 p -122.68 -172.68 2.53 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.135 -1.393 . . . . 11.83 110.56 -170.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.6 m -49.61 145.8 7.84 Favored Pre-proline 0 C--O 1.236 0.365 0 O-C-N 123.272 0.357 . . . . 12.84 110.739 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -38.25 -44.94 2.08 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 124.479 3.452 . . . . 15.06 115.302 -170.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.0 p -87.42 -63.53 1.29 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.735 -0.786 . . . . 16.97 113.089 -173.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.1 m -168.07 142.96 2.96 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 117.688 0.222 . . . . 16.04 110.86 -175.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.463 ' HG3' ' OG1' ' A' ' 173' ' ' THR . 25.0 Cg_exo -67.38 123.84 11.34 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.13 1.887 . . . . 14.22 111.066 165.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.418 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.9 p -153.61 156.49 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 120.826 0.346 . . . . 16.46 110.331 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -80.31 128.46 33.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.121 -0.491 . . . . 17.05 110.193 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.17 -26.09 18.11 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.006 -0.616 . . . . 17.2 112.138 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 12.6 mptt -108.08 153.04 23.7 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.618 -0.512 . . . . 19.02 109.618 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.8 tp -69.17 109.58 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.76 0.791 . . . . 15.32 110.874 -176.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 26.8 m -103.57 109.02 20.53 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.956 0.884 . . . . 13.03 110.429 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 173' ' ' THR . 48.3 ttt180 -86.24 134.52 33.76 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.063 -1.426 . . . . 14.44 109.032 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.503 ' C ' HD13 ' A' ' 187' ' ' LEU . 3.7 mm -109.4 117.19 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 N-CA-C 109.183 -0.673 . . . . 11.02 109.183 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.503 HD13 ' C ' ' A' ' 186' ' ' ILE . 2.1 mp -130.17 132.95 46.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.512 0.672 . . . . 10.32 111.034 -173.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.443 HG21 HD21 ' A' ' 148' ' ' LEU . 52.8 t -101.96 137.31 30.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.908 -1.042 . . . . 10.0 110.208 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.97 51.49 5.8 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.344 -0.844 . . . . 9.94 114.071 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.491 ' HA ' ' CG1' ' A' ' 145' ' ' VAL . 18.6 Cg_endo -67.06 125.71 14.02 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 CA-C-N 119.632 1.716 . . . . 11.15 110.813 170.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -157.88 153.63 26.62 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.598 -0.441 . . . . 12.77 110.274 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.405 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -98.83 0.54 44.5 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.948 -0.569 . . . . 15.0 111.473 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 68.8 m -118.48 93.66 4.2 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 121.37 0.605 . . . . 14.58 109.992 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.539 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 35.1 ttpt -57.12 -36.79 71.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.917 -1.038 . . . . 16.29 110.769 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.71 -39.29 80.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.976 0.417 . . . . 15.6 111.53 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -77.54 -42.84 33.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.62 0.724 . . . . 14.36 110.399 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -83.67 -19.19 35.78 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.251 -0.886 . . . . 12.11 110.977 -173.285 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -64.85 -40.12 94.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.193 0.52 . . . . 14.96 110.51 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.47 -13.73 82.92 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 110.328 -1.109 . . . . 13.32 110.328 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 58.4 m -83.35 -11.43 57.65 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.587 -0.807 . . . . 12.31 111.72 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 28.0 mt -66.88 -40.99 87.96 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.878 0.37 . . . . 12.72 110.399 -177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.56 86.28 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.346 -0.931 . . . . 14.66 110.912 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.561 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 45.3 mt-10 -76.89 -26.94 54.74 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 120.81 0.338 . . . . 14.54 110.574 175.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.7 tt -67.41 -38.75 85.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.056 -0.52 . . . . 12.55 110.422 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 82.8 mttt -62.19 -21.02 64.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.392 -0.822 . . . . 16.12 110.261 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -42.31 11.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.676 -0.693 . . . . 16.98 110.281 173.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 96.8 mt -66.9 -51.91 49.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.033 -0.53 . . . . 14.15 111.694 -176.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.409 ' HB3' HD13 ' A' ' 164' ' ' LEU . 71.4 p -100.16 -44.38 5.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.214 0.531 . . . . 13.54 110.821 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.34 12.22 57.86 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.301 -0.863 . . . . 14.79 111.698 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 91.6 mt -91.4 157.75 16.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.912 -0.403 . . . . 13.52 109.912 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 53.9 m -80.6 94.43 6.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.057 0.456 . . . . 14.87 110.777 -178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -124.23 159.82 18.84 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.617 -0.802 . . . . 12.22 113.048 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.2 p -116.17 143.97 24.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.196 0.522 . . . . 14.04 110.541 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.6 t -80.03 106.79 11.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.218 -0.901 . . . . 12.89 110.343 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 24.3 mmt -121.04 155.63 33.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.017 -0.538 . . . . 14.23 110.567 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -82.19 129.62 9.18 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.404 -0.903 . . . . 14.09 111.992 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.471 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 8.6 t80 -88.72 131.76 34.89 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 124.164 0.986 . . . . 14.24 109.975 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 78.6 m -144.91 92.25 5.83 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 109.506 -0.553 . . . . 16.73 109.506 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.28 140.92 91.12 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.409 2.072 . . . . 17.42 112.082 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.305 -0.855 . . . . 19.69 110.022 -177.888 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.784 0.326 . . . . 18.39 110.893 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.15 59.53 3.48 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.478 -0.868 . . . . 17.97 112.905 -176.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -66.3 126.48 28.89 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.337 -0.616 . . . . 17.74 109.337 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -98.97 139.27 34.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.824 -0.625 . . . . 20.18 111.196 -171.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -83.1 160.3 21.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 17.66 109.942 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -61.99 -57.65 10.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.029 0.443 . . . . 19.78 110.136 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -150.4 -67.89 0.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.91 -0.774 . . . . 18.96 108.91 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 47.15 45.81 16.21 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.986 0.804 . . . . 18.6 111.205 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -80.92 98.56 7.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.399 0.618 . . . . 16.78 110.646 -174.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -117.87 126.44 52.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.564 -0.744 . . . . 18.42 109.918 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -82.57 57.95 3.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.531 0.681 . . . . 17.92 110.363 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.41 39.27 1.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.72 -0.673 . . . . 19.75 110.028 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.4 167.12 29.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.259 -0.882 . . . . 20.62 109.214 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.423 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 17.0 pt 37.52 69.42 1.4 Allowed Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 124.237 0.96 . . . . 19.92 112.484 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.55 79.19 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.166 2.577 . . . . 21.71 112.976 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 60.19 26.54 15.97 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.316 -0.856 . . . . 23.06 111.624 174.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.593 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 96.9 t -89.83 -55.2 0.29 Allowed Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.949 -0.569 . . . . 21.55 111.38 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 6.9 Cg_exo -77.13 149.36 28.34 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.98 1.787 . . . . 20.17 111.453 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -75.39 88.47 2.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.291 0.567 . . . . 21.45 109.643 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -159.7 -33.87 0.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.423 -0.808 . . . . 18.83 110.677 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.85 -60.43 4.88 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.887 -0.673 . . . . 17.72 111.662 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -102.02 178.6 4.56 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.072 -0.714 . . . . 16.95 109.072 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -80.54 171.68 14.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.18 0.514 . . . . 18.58 110.247 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -74.76 164.21 26.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.856 -0.611 . . . . 18.17 109.882 174.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 1.6 pm0 -71.86 149.27 92.63 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.276 -0.42 . . . . 18.88 111.258 -173.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 57.4 Cg_endo -70.69 71.16 2.01 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.978 2.452 . . . . 19.87 113.1 -177.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.432 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 28.8 m-20 -132.24 165.98 22.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.349 -0.612 . . . . 21.1 109.349 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.441 ' HG3' ' HG2' ' A' ' 56' ' ' MET . 15.6 tpt -65.17 109.01 2.05 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.37 0.419 . . . . 22.59 110.81 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.441 ' HG2' ' HG3' ' A' ' 55' ' ' MET . 25.5 ptt? 40.81 73.65 0.84 Allowed Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 124.3 1.04 . . . . 24.05 112.497 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 54' ' ' ASP . 86.9 Cg_endo -90.47 10.35 2.96 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.728 2.285 . . . . 20.94 112.337 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.53 149.76 30.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.979 -0.555 . . . . 20.49 110.305 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.11 -41.57 7.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.113 -0.494 . . . . 21.67 111.087 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.4 m -81.2 -48.06 12.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.313 -0.403 . . . . 22.84 110.522 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -100.27 -159.8 0.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.143 -0.481 . . . . 22.15 109.79 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.35 33.52 6.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.353 0.597 . . . . 19.92 110.311 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.432 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 2.6 tm? -72.35 -46.05 10.47 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.472 -0.785 . . . . 19.88 110.615 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 73.6 Cg_exo -52.69 119.5 6.07 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.933 1.755 . . . . 18.74 111.85 174.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 p -76.32 110.7 11.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.909 -0.587 . . . . 17.84 112.045 -174.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 23.3 mt-30 -66.96 -46.98 54.24 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.341 -0.845 . . . . 19.1 110.985 173.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 66' ' ' GLN . 51.5 Cg_endo -70.02 123.37 9.96 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.128 1.886 . . . . 17.47 112.3 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -70.92 -159.04 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.192 2.594 . . . . 17.99 112.504 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 73.31 -58.23 0.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.713 0.805 . . . . 18.7 112.296 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.3 -54.98 8.16 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.823 -0.703 . . . . 17.72 111.676 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -162.95 153.38 16.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.041 -0.355 . . . . 18.19 110.041 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.12 32.19 0.34 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.917 0.389 . . . . 17.96 110.952 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -124.13 -162.75 1.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.043 -0.526 . . . . 19.85 109.971 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 62.67 44.52 6.6 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.974 0.892 . . . . 19.68 109.357 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.46 140.47 8.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.996 -1.002 . . . . 17.87 109.437 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 73.57 -60.9 0.52 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.37 0.668 . . . . 20.34 111.05 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.16 34.41 4.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.054 0.454 . . . . 18.81 111.092 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.94 110.27 0.45 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.704 -0.76 . . . . 17.66 112.225 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 80' ' ' ALA . 10.3 t70 56.26 -151.36 0.41 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.702 0.401 . . . . 17.87 110.284 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.495 ' H ' ' CG ' ' A' ' 79' ' ' ASP . . . 58.78 29.27 18.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.083 0.468 . . . . 18.04 111.772 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.29 63.29 6.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.222 0.535 . . . . 17.53 110.882 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.17 98.24 25.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.702 -0.681 . . . . 16.64 110.018 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.5 129.51 26.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.969 2.446 . . . . 17.64 112.804 -177.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.3 m -84.82 -24.34 28.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.411 -0.813 . . . . 17.42 110.005 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.6 mt -78.7 -6.96 57.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.512 -0.767 . . . . 18.62 110.627 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.64 115.25 15.57 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 17.79 110.508 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.15 -6.7 18.28 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.019 2.48 . . . . 19.23 112.894 -175.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.92 -61.57 1.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.327 -0.397 . . . . 17.96 110.265 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.8 m 54.26 65.05 1.62 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.611 0.72 . . . . 18.63 109.542 -177.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.9 pt -103.09 61.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.332 -0.849 . . . . 19.36 112.232 -170.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.49 -23.29 40.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.193 -0.458 . . . . 19.41 110.2 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.08 124.22 23.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.651 -0.704 . . . . 18.96 110.788 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.593 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 48.4 m-80 -93.81 109.25 20.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.179 -0.464 . . . . 18.95 110.545 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -96.47 -178.75 4.38 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.976 -0.379 . . . . 20.53 109.976 177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.0 p 60.01 -43.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.898 1.279 . . . . 21.4 112.968 -174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -90.93 -25.7 19.65 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.188 -0.32 . . . . 21.26 111.282 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.593 ' HB3' ' O ' ' A' ' 93' ' ' ASN . 74.5 t80 -128.85 -0.31 5.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.692 0.758 . . . . 22.65 110.949 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -76.53 -45.26 3.33 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.472 -0.785 . . . . 19.45 112.364 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.74 71.35 4.06 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.148 1.899 . . . . 18.97 112.865 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -111.16 91.15 12.73 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.24 -0.437 . . . . 17.53 109.897 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.71 -21.59 9.73 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.547 2.165 . . . . 17.77 112.696 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 49.51 78.86 0.38 Allowed Pre-proline 0 N--CA 1.465 0.321 0 O-C-N 123.403 0.439 . . . . 18.07 111.454 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.27 113.39 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.088 2.525 . . . . 16.56 112.617 -177.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.6 t -82.25 104.99 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.876 -0.602 . . . . 17.5 110.7 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.97 113.3 62.73 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.352 -0.385 . . . . 16.11 110.953 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.18 154.73 46.92 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.751 2.301 . . . . 16.19 112.237 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.84 55.25 4.32 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.067 2.511 . . . . 16.43 112.753 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -167.63 121.01 0.77 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.561 . . . . 17.91 109.854 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.79 -39.06 0.54 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.439 2.093 . . . . 15.31 112.644 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.543 ' H ' ' HD2' ' A' ' 111' ' ' PRO . 62.1 mtpt -144.33 -58.87 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.256 -0.429 . . . . 15.37 111.655 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.543 ' HD2' ' H ' ' A' ' 110' ' ' LYS . 28.6 Cg_endo -62.63 119.25 6.26 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.842 1.695 . . . . 14.26 113.093 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.6 t -92.71 57.35 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.154 -0.684 . . . . 15.75 109.154 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 57.39 86.63 0.16 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.769 -1.105 . . . . 16.84 110.815 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.07 -48.46 20.93 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.415 2.743 . . . . 15.51 114.803 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.6 97.59 0.63 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.601 1.534 . . . . 16.04 112.755 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.569 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 32.1 mmmt -65.3 -51.08 55.74 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.171 -0.468 . . . . 19.25 111.086 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 116' ' ' LYS . 4.5 Cg_exo -77.94 -46.22 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.852 1.701 . . . . 17.04 111.16 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt 54.46 66.92 1.1 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.7 -0.682 . . . . 17.71 110.89 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.4 p -150.48 146.79 16.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.746 -0.661 . . . . 19.09 110.108 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 40.89 50.2 3.04 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.239 0.962 . . . . 20.88 112.231 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.88 135.57 96.36 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.814 -0.63 . . . . 18.89 110.386 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.27 115.14 2.32 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.866 2.377 . . . . 20.92 112.184 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.95 44.57 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.841 2.361 . . . . 21.13 112.111 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.14 142.87 64.46 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.165 -0.47 . . . . 21.37 110.474 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.31 60.26 3.99 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.806 2.337 . . . . 21.41 111.88 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -107.27 131.11 21.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.54 -0.754 . . . . 22.17 110.45 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.53 83.78 1.27 Allowed 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.843 2.362 . . . . 20.33 112.05 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -58.97 131.37 86.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 20.48 111.193 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.27 61.96 6.75 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.952 2.435 . . . . 21.43 112.369 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -138.66 143.43 37.9 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.73 -0.668 . . . . 23.44 109.77 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.82 96.43 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.539 2.159 . . . . 21.1 111.586 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.9 m -82.64 52.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.623 0.725 . . . . 20.15 110.845 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.4 m -83.84 0.79 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.392 -0.822 . . . . 21.3 111.02 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.77 17.23 11.9 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.8 -1.091 . . . . 21.3 108.891 174.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 65.73 -92.26 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.74 -1.118 . . . . 20.74 110.811 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 tttm 178.34 -45.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.024 -1.102 . . . . 18.17 108.024 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -87.3 -76.4 0.37 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.34 -0.846 . . . . 17.35 109.085 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 192' ' ' ALA . . . -177.17 149.45 0.8 Allowed Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.148 -0.933 . . . . 19.41 109.821 173.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.31 -42.59 27.49 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.918 2.412 . . . . 20.18 113.02 -174.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 39.0 p -130.63 23.57 5.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.956 -0.566 . . . . 18.05 110.469 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -125.02 121.79 4.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.969 -0.634 . . . . 18.56 111.86 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.5 mttm 58.15 32.46 22.05 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 122.842 0.457 . . . . 19.74 110.671 -176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.504 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -70.77 162.59 28.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.338 -0.986 . . . . 15.06 108.338 174.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.671 ' CB ' HD22 ' A' ' 197' ' ' LEU . 3.3 m-85 -143.85 152.7 41.51 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.824 -0.351 . . . . 14.83 111.695 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 190' ' ' PRO . 12.5 m -149.2 156.23 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.273 0.629 . . . . 10.79 109.846 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.7 109.55 28.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 O-C-N 121.84 -0.537 . . . . 10.43 111.111 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -86.71 109.55 19.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.566 -0.288 . . . . 12.54 111.478 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.524 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -88.97 -34.86 16.72 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.141 0.496 . . . . 11.88 109.965 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.02 161.56 28.12 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.499 -0.773 . . . . 11.9 112.457 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -161.44 101.49 1.2 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.316 -0.624 . . . . 13.47 109.316 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.75 164.18 28.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.808 -0.633 . . . . 14.03 110.332 -173.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 49.5 mtpt -105.71 0.55 26.36 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.032 -0.985 . . . . 17.87 109.782 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -97.79 108.33 21.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.231 -0.895 . . . . 16.68 109.373 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.53 -21.44 66.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.995 0.426 . . . . 14.47 110.876 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.88 -36.79 70.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.653 0.739 . . . . 16.57 110.036 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 156' ' ' LYS . 2.0 mptp? -83.87 -27.22 28.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.784 -1.098 . . . . 16.69 110.354 -178.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.65 -37.66 76.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.354 0.597 . . . . 12.92 109.801 174.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -68.99 -34.12 74.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.335 -0.848 . . . . 15.83 111.512 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.615 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.7 pt-20 -82.91 -21.35 34.23 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.964 -0.294 . . . . 15.97 111.589 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 156' ' ' LYS . 48.3 mt -85.06 -50.66 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.322 0.582 . . . . 12.6 110.046 174.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.1 -41.74 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.71 -0.677 . . . . 12.54 111.162 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.26 -25.27 62.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.868 -0.682 . . . . 14.8 112.462 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 13.5 mptt -78.09 -61.05 2.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.645 0.259 . . . . 16.37 110.595 176.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.559 HD13 ' HA ' ' A' ' 208' ' ' SER . 2.4 mm? -78.18 -48.47 15.8 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.603 0.594 . . . . 12.99 112.603 -173.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.401 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 41.8 ttt180 -77.87 -26.01 49.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.911 -0.774 . . . . 15.56 108.911 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.15 -25.54 74.46 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.033 -0.985 . . . . 16.6 111.657 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.84 3.96 54.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.054 0.454 . . . . 16.55 110.65 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.87 22.11 47.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.901 -0.666 . . . . 15.88 113.701 174.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -89.11 156.85 18.56 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 117.493 0.647 . . . . 15.6 110.027 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -67.69 96.83 0.58 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.751 -0.463 . . . . 14.31 109.751 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 164' ' ' LEU . 3.6 t -139.09 125.97 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 CA-C-N 115.546 -0.752 . . . . 11.04 110.2 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.63 175.68 9.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.608 -0.723 . . . . 11.47 110.462 173.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.3 p -115.68 -176.36 2.91 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.758 -1.11 . . . . 11.83 111.733 -168.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.584 ' HB2' ' H ' ' A' ' 185' ' ' ARG . 22.9 t -53.03 134.74 48.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.957 -0.565 . . . . 12.84 110.384 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -31.06 -55.31 0.23 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 125.198 3.932 . . . . 15.06 115.542 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.4 t -81.11 -64.39 1.2 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 119.75 -0.78 . . . . 16.97 112.574 -169.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 55.7 m -169.09 130.41 1.06 Allowed Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 118.028 0.376 . . . . 16.04 111.791 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.458 ' HB3' HG23 ' A' ' 184' ' ' THR . 52.3 Cg_exo -65.26 122.62 10.39 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.347 2.032 . . . . 14.22 112.125 162.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.4 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.8 p -154.91 156.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.303 -0.628 . . . . 16.46 109.303 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -77.65 127.75 32.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.07 0.462 . . . . 17.05 110.691 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.02 -26.47 15.3 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.51 -0.768 . . . . 17.2 111.819 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.6 OUTLIER -108.62 167.41 10.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.24 -0.652 . . . . 19.02 109.24 176.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.2 tp -81.51 118.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.553 0.692 . . . . 15.32 111.073 -175.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.458 HG23 ' HB3' ' A' ' 178' ' ' PRO . 28.8 m -111.76 105.19 13.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.729 -0.669 . . . . 13.03 109.896 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.584 ' H ' ' HB2' ' A' ' 174' ' ' SER . 81.0 mtt-85 -84.61 144.44 28.61 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.332 -0.849 . . . . 14.44 110.156 176.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.556 ' C ' HD22 ' A' ' 187' ' ' LEU . 3.0 mm -115.74 117.83 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 108.698 -0.852 . . . . 11.02 108.698 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.556 HD22 ' C ' ' A' ' 186' ' ' ILE . 0.1 OUTLIER -129.94 128.16 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.748 0.785 . . . . 10.32 112.131 -175.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.464 HG23 ' CG2' ' A' ' 171' ' ' VAL . 55.1 t -95.45 146.37 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 114.205 -1.361 . . . . 10.0 110.278 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 72.97 46.61 28.05 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.333 -0.849 . . . . 9.94 114.203 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.543 ' HA ' HG11 ' A' ' 145' ' ' VAL . 11.3 Cg_endo -61.72 125.53 16.89 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 119.83 1.815 . . . . 11.15 110.52 170.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -159.48 154.71 25.26 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.927 -0.578 . . . . 12.77 109.877 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 138' ' ' ALA . . . -100.49 2.39 42.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.062 -0.517 . . . . 15.0 111.725 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.11 98.3 6.1 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.563 0.697 . . . . 14.58 110.759 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.46 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 18.4 ptmt -58.88 -39.6 81.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.551 -1.204 . . . . 16.29 112.557 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -67.41 -42.85 82.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.227 0.537 . . . . 15.6 110.393 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -62.9 -41.28 99.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.116 -0.947 . . . . 14.36 110.599 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.671 HD22 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -85.78 -16.79 37.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.865 -0.607 . . . . 12.11 111.085 -177.293 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 4.8 tppp? -64.04 -32.07 73.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.491 0.663 . . . . 14.96 110.023 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -83.88 -13.2 75.56 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.648 -0.981 . . . . 13.32 110.648 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 46.0 m -79.77 -9.17 59.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.008 -0.596 . . . . 12.31 111.523 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 9.8 mt -74.27 -37.25 63.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.939 0.399 . . . . 12.72 110.485 -176.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.41 -34.84 91.03 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.001 -0.618 . . . . 14.66 112.123 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.621 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 11.6 pt-20 -86.1 -19.84 29.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.797 0.332 . . . . 14.54 110.65 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.3 tt -65.25 -42.98 92.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 12.55 111.209 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.434 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 58.8 pttt -61.72 -17.63 56.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.058 -0.519 . . . . 16.12 111.414 176.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -36.83 15.4 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.901 0.381 . . . . 16.98 109.993 172.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.6 mt -68.84 -52.16 32.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 14.15 110.6 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.559 ' HA ' HD13 ' A' ' 164' ' ' LEU . 3.8 m -101.92 -43.38 5.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.654 -0.703 . . . . 13.54 111.298 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 75.13 -2.45 51.41 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.554 -0.748 . . . . 14.79 111.816 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 40.7 mt -80.02 149.49 30.72 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.084 -0.71 . . . . 13.52 109.084 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.2 t -89.7 104.86 17.39 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.73 -0.47 . . . . 14.87 109.73 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -125.53 157.08 19.53 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.416 -0.897 . . . . 12.22 113.492 -174.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.96 143.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.109 0.48 . . . . 14.04 110.276 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 43.5 t -77.83 106.14 7.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.303 -0.862 . . . . 12.89 109.955 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 22.7 mmt -115.73 146.78 41.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.765 -0.652 . . . . 14.23 110.209 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -74.13 134.34 18.18 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.445 -0.883 . . . . 14.09 111.621 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.504 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 7.9 t80 -100.87 124.32 46.37 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.536 0.684 . . . . 14.24 110.26 -175.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 55.6 m -144.57 93.7 5.71 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 108.873 -0.788 . . . . 16.73 108.873 174.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.4 120.55 8.55 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.743 2.296 . . . . 17.42 112.496 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.1 p30 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.381 -0.819 . . . . 19.69 109.926 -178.042 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 t70 . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.683 0.278 . . . . 18.39 110.555 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.0 -36.12 4.32 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.843 -0.694 . . . . 17.97 112.158 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.52 ' HA ' ' CD1' ' A' ' 34' ' ' TYR . 13.9 pt20 39.86 71.11 0.19 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.074 0.95 . . . . 17.74 112.384 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -123.75 -96.88 0.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.064 -0.398 . . . . 20.18 111.857 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.554 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 24.9 ttmm -73.74 -23.68 59.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.194 0.442 . . . . 17.66 112.194 -169.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -82.79 -1.39 51.57 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.05 -0.26 . . . . 19.78 111.275 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.52 ' CD1' ' HA ' ' A' ' 30' ' ' GLN . 70.5 m-85 -135.06 -40.1 0.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.935 0.346 . . . . 18.96 111.935 -173.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.554 ' OE1' ' HA ' ' A' ' 32' ' ' LYS . 10.3 mm100 55.1 56.73 6.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.235 0.541 . . . . 18.6 110.098 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -92.1 -44.27 8.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.744 . . . . 16.78 112.556 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -87.31 -72.5 0.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.054 -0.258 . . . . 18.42 111.383 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -165.17 118.99 1.24 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.099 0.476 . . . . 17.92 110.386 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.47 161.86 21.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.842 -0.617 . . . . 19.75 110.783 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 62.93 25.91 15.28 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.795 0.685 . . . . 20.62 111.927 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.507 ' O ' HG21 ' A' ' 41' ' ' ILE . 20.2 tt -164.59 65.17 1.2 Allowed Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 122.178 0.99 . . . . 19.92 109.679 177.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.591 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 24.4 Cg_exo -60.92 102.61 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.62 2.88 . . . . 21.71 113.053 -169.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 42' ' ' PRO . 0.6 OUTLIER 55.66 19.32 3.27 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.234 0.959 . . . . 23.06 111.771 174.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.49 ' HB ' ' CG1' ' A' ' 41' ' ' ILE . 93.5 t -83.55 -37.58 0.69 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 112.944 0.72 . . . . 21.55 112.944 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' HD3' HG12 ' A' ' 41' ' ' ILE . 5.2 Cg_exo -69.45 -28.18 27.04 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.224 1.283 . . . . 20.17 111.65 -174.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HB2' ' HZ1' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -170.09 -68.79 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.79 -0.641 . . . . 21.45 109.796 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.91 -26.76 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.223 -0.444 . . . . 18.83 111.182 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.75 -40.57 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.014 -0.834 . . . . 17.72 111.014 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -79.9 159.45 26.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.614 -0.513 . . . . 16.95 109.614 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -103.36 -51.02 3.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.366 0.603 . . . . 18.58 109.658 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -77.01 135.68 38.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.945 -1.025 . . . . 18.17 110.724 -172.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -85.51 115.45 61.51 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.363 -0.38 . . . . 18.88 110.369 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -89.0 88.46 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.095 2.53 . . . . 19.87 112.435 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -155.94 130.98 9.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 21.1 111.22 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.426 ' HG2' ' HG3' ' A' ' 56' ' ' MET . 20.5 ttt 70.49 -71.47 0.13 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.764 0.665 . . . . 22.59 111.793 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.59 ' H ' ' HD2' ' A' ' 57' ' ' PRO . 92.2 mtp -137.13 -53.91 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.172 -0.467 . . . . 24.05 110.569 -177.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.59 ' HD2' ' H ' ' A' ' 56' ' ' MET . 6.8 Cg_endo -48.99 123.93 10.64 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.295 1.997 . . . . 20.94 112.424 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 54.0 30.78 12.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.579 -0.737 . . . . 20.49 112.532 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.56 -62.47 1.49 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.892 0.377 . . . . 21.67 110.801 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.0 t -149.42 126.33 11.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.284 -0.416 . . . . 22.84 110.6 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 60.47 34.46 20.48 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.567 0.699 . . . . 22.15 110.554 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.24 -61.15 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.891 -0.595 . . . . 19.92 110.0 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.78 115.53 65.59 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.663 -0.866 . . . . 19.88 108.663 175.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -58.55 -37.02 96.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.758 2.305 . . . . 18.74 112.066 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.9 p 44.23 48.21 7.79 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.654 0.597 . . . . 17.84 112.239 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -80.55 133.78 55.53 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.077 -0.511 . . . . 19.1 110.064 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -54.72 114.25 1.76 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.832 2.354 . . . . 17.47 112.071 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.24 -4.92 15.69 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.79 2.327 . . . . 17.99 111.866 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -99.83 158.71 15.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.714 -0.676 . . . . 18.7 109.509 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.58 74.97 2.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.94 -0.647 . . . . 17.72 111.71 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.65 -51.83 6.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.121 0.486 . . . . 18.19 110.202 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.19 121.11 24.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.67 -0.695 . . . . 17.96 110.496 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.99 164.02 18.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.89 -0.595 . . . . 19.85 109.476 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -72.14 90.35 1.2 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.078 0.466 . . . . 19.68 111.183 -175.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.26 124.82 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.69 -0.686 . . . . 17.87 110.027 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.597 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -88.76 60.36 5.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.323 0.582 . . . . 20.34 109.813 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -97.97 28.44 3.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 18.81 111.043 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.52 100.15 0.46 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.182 -0.532 . . . . 17.66 111.876 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 59.12 42.75 18.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.541 0.686 . . . . 17.87 110.724 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.91 -8.62 57.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.326 -0.852 . . . . 18.04 110.58 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.64 -13.92 62.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.822 -0.626 . . . . 17.53 110.598 176.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.64 88.57 0.12 Allowed Pre-proline 0 N--CA 1.462 0.153 0 CA-C-N 115.382 -0.826 . . . . 16.64 111.621 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.23 160.61 46.74 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.444 2.096 . . . . 17.64 111.744 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.9 p -81.59 3.73 24.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.326 0.584 . . . . 17.42 110.413 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.12 -164.13 1.13 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.688 -0.687 . . . . 18.62 109.159 177.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.76 116.6 30.66 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.875 0.369 . . . . 17.79 110.781 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.58 -31.32 8.89 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.832 2.354 . . . . 19.23 113.076 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.64 115.03 2.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.171 -0.307 . . . . 17.96 110.171 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -74.52 89.26 2.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.28 0.562 . . . . 18.63 110.703 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.6 pt -111.15 128.59 67.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.609 -0.723 . . . . 19.36 110.647 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.74 140.85 30.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.188 -0.46 . . . . 19.41 110.565 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.12 55.71 2.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.137 0.494 . . . . 18.96 110.607 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 28.7 p30 -70.97 -19.79 62.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.831 -0.622 . . . . 18.95 110.806 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.1 164.08 20.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.006 -0.543 . . . . 20.53 109.682 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.6 m 71.4 -52.53 0.69 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.009 0.818 . . . . 21.4 109.884 -173.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -77.37 -40.68 42.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 21.26 110.439 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.431 ' HB3' ' O ' ' A' ' 93' ' ' ASN . 38.6 t80 -111.98 -79.1 0.58 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.453 -0.499 . . . . 22.65 110.443 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -69.48 110.18 5.89 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 115.188 -0.914 . . . . 19.45 110.238 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.04 -15.98 16.11 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.636 2.224 . . . . 18.97 113.512 -175.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.57 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 6.9 tp10 -56.1 -53.47 63.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 111.653 0.242 . . . . 17.53 111.653 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 6.3 Cg_endo -91.55 31.5 0.32 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.619 2.212 . . . . 17.77 112.451 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.462 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . . . -69.71 -45.1 24.79 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.595 -0.275 . . . . 18.07 111.305 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 102' ' ' ALA . 23.6 Cg_exo -66.59 159.83 48.94 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.8 1.667 . . . . 16.56 111.262 173.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.85 20.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.458 0.647 . . . . 17.5 111.623 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 103' ' ' PRO . . . -152.91 81.53 5.2 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.134 -0.939 . . . . 16.11 109.429 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.14 125.1 16.19 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.71 2.273 . . . . 16.19 112.249 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.93 96.88 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.478 2.118 . . . . 16.43 110.925 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -64.83 131.86 95.29 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.587 -0.733 . . . . 17.91 111.401 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.47 3.31 6.91 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.929 2.419 . . . . 15.31 111.942 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -114.59 79.09 5.33 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 15.37 109.992 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -83.69 136.5 7.34 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.426 2.084 . . . . 14.26 112.304 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -93.99 44.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 122.352 1.072 . . . . 15.75 109.467 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.92 122.38 2.63 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.216 -1.356 . . . . 16.84 110.5 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.32 134.98 13.1 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.37 2.047 . . . . 15.51 112.136 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.52 42.39 1.14 Allowed 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.796 2.331 . . . . 16.04 111.747 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 56.9 tttp -82.55 -48.68 0.84 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.363 -0.835 . . . . 19.25 111.389 -177.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 91.6 Cg_endo -84.97 6.14 5.88 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.002 1.801 . . . . 17.04 111.569 176.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -72.15 149.3 44.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.982 -1.008 . . . . 17.71 110.52 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 20.1 m -76.83 50.9 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.16 0.505 . . . . 19.09 112.268 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -89.83 68.82 7.51 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.689 -0.486 . . . . 20.88 109.689 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.98 122.41 41.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.361 -0.836 . . . . 18.89 111.865 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.31 145.93 61.33 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.69 2.26 . . . . 20.92 111.534 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.82 101.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.864 2.376 . . . . 21.13 111.978 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.475 ' N ' ' HD2' ' A' ' 125' ' ' PRO . . . -69.48 -49.05 23.62 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.839 -0.619 . . . . 21.37 112.246 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 124' ' ' ALA . 40.3 Cg_endo -67.65 85.16 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.062 1.841 . . . . 21.41 112.528 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 127' ' ' PRO . 68.2 mttm -68.36 -50.52 27.89 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.941 -0.572 . . . . 22.17 111.551 178.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 126' ' ' LYS . 61.2 Cg_endo -72.38 81.13 1.54 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.117 1.878 . . . . 20.33 112.102 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 130' ' ' LYS . 10.1 pt-20 -95.35 153.08 39.69 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 20.48 110.968 -177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.74 27.02 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.106 2.538 . . . . 21.43 113.149 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 128' ' ' GLU . 31.2 mmmt -139.29 71.86 39.01 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.888 -0.597 . . . . 23.44 109.616 176.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.93 131.95 35.01 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.544 2.163 . . . . 21.1 111.874 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.28 69.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 122.172 0.987 . . . . 20.15 110.117 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.74 147.03 8.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.37 -0.832 . . . . 21.3 109.949 176.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 40.85 63.09 1.24 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.611 0.764 . . . . 21.3 111.193 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 137' ' ' ALA . 1.1 mp0 -55.42 -62.0 1.96 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.861 -1.063 . . . . 20.74 111.691 -173.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 80.87 -14.87 0.79 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.099 0.874 . . . . 18.17 109.645 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 142' ' ' LYS . . . -132.86 23.21 4.24 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.961 -1.018 . . . . 17.35 109.004 175.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 68.85 158.16 0.15 Allowed Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 114.719 -1.128 . . . . 19.41 111.17 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -43.0 -43.02 9.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.643 2.895 . . . . 20.18 114.174 -174.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.3 t -166.57 23.12 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.269 0.557 . . . . 18.05 110.878 175.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -83.69 -49.21 4.94 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.882 -0.675 . . . . 18.56 112.268 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 137' ' ' ALA . 90.8 mttt -104.34 47.22 0.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.333 0.587 . . . . 19.74 110.06 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . -76.12 165.59 24.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.176 -0.92 . . . . 15.06 110.386 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.694 ' CD1' ' HG3' ' A' ' 194' ' ' LYS . 7.1 m-85 -144.17 156.99 44.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.802 0.297 . . . . 14.83 111.802 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.504 HG11 ' N ' ' A' ' 190' ' ' PRO . 2.2 t -151.07 161.03 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.303 -0.999 . . . . 10.79 108.303 170.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.426 HG11 ' HA3' ' A' ' 212' ' ' GLY . 96.1 t -106.76 110.17 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.909 -0.494 . . . . 10.43 111.574 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.567 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 26.5 tt0 -81.14 115.5 20.59 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.785 -0.189 . . . . 12.54 111.39 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 211' ' ' SER . 0.0 OUTLIER -94.76 -33.4 12.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.385 0.612 . . . . 11.88 110.298 -179.148 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.24 163.73 28.38 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.535 -0.84 . . . . 11.9 112.468 -175.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.498 ' C ' HD13 ' A' ' 151' ' ' LEU . . . -161.6 100.02 1.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.356 -0.609 . . . . 13.47 109.356 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.529 HD23 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -127.61 163.24 24.65 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.263 0.554 . . . . 14.03 109.796 -174.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 22.0 mtpp -102.61 -9.42 20.13 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.943 -1.026 . . . . 17.87 109.37 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -94.63 111.54 23.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.909 -1.042 . . . . 16.68 109.301 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.75 -18.34 62.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.148 0.425 . . . . 14.47 112.148 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.4 -34.83 77.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.905 0.859 . . . . 16.57 109.978 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -83.55 -17.75 40.74 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.623 -1.171 . . . . 16.69 110.124 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.547 ' HA ' HD13 ' A' ' 186' ' ' ILE . 67.4 t -76.18 -33.84 24.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.701 -0.682 . . . . 12.92 109.244 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.89 -37.6 81.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.415 -0.812 . . . . 15.83 111.054 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.693 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.8 pt-20 -75.41 -26.67 58.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.729 0.3 . . . . 15.97 111.49 -175.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.514 ' HB ' HD12 ' A' ' 186' ' ' ILE . 69.1 mt -85.09 -49.07 16.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.149 0.499 . . . . 12.6 110.317 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.45 -46.58 69.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.83 -0.623 . . . . 12.54 111.156 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.53 62.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.958 -0.639 . . . . 14.8 112.568 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.693 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 2.1 mptm? -85.93 -57.08 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.683 0.278 . . . . 16.37 110.896 177.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 208' ' ' SER . 2.5 mm? -79.63 -56.84 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.167 0.432 . . . . 12.99 112.167 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.512 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 68.3 ttt180 -64.6 -39.6 94.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 15.56 109.983 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.25 -25.74 71.28 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.254 -0.885 . . . . 16.6 112.698 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.46 -7.3 58.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.929 0.395 . . . . 16.55 110.517 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.3 2.42 29.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.782 -0.723 . . . . 15.88 113.284 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -79.52 151.9 30.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.039 0.419 . . . . 15.6 110.479 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -70.23 99.06 1.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.868 -0.605 . . . . 14.31 110.316 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 165' ' ' ARG . 13.7 t -132.06 132.61 61.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.106 0.479 . . . . 11.04 111.298 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.405 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -137.29 174.86 10.15 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.331 -0.849 . . . . 11.47 110.226 170.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 18.0 p -118.6 -176.57 3.11 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.964 -1.016 . . . . 11.83 111.849 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.428 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.2 OUTLIER -52.99 148.77 13.3 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.85 -0.614 . . . . 12.84 111.867 -178.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -23.93 -65.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.556 1 C-N-CA 125.969 4.446 . . . . 15.06 115.838 -176.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.6 m -88.56 -62.77 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.294 0.85 . . . . 16.97 113.294 -170.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.0 m -166.82 132.67 1.81 Allowed Pre-proline 0 C--O 1.234 0.285 0 N-CA-C 112.449 0.537 . . . . 16.04 112.449 -171.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.44 ' HB3' HG22 ' A' ' 184' ' ' THR . 53.0 Cg_exo -63.48 124.78 14.33 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.971 2.447 . . . . 14.22 111.6 162.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.4 p -152.14 158.46 4.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.42 -0.354 . . . . 16.46 110.261 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -80.49 120.06 23.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.315 -0.402 . . . . 17.05 110.81 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.96 -22.51 25.42 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.98 -0.629 . . . . 17.2 112.72 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.515 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.1 OUTLIER -114.79 163.55 15.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.992 0.425 . . . . 19.02 110.062 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 10.1 tp -71.01 120.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.623 -0.717 . . . . 15.32 111.761 -173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 56.8 m -114.05 105.87 13.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.754 -0.657 . . . . 13.03 109.704 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -83.41 141.16 31.93 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.509 -0.769 . . . . 14.44 108.991 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.547 HD13 ' HA ' ' A' ' 157' ' ' VAL . 3.4 mt -120.91 123.57 70.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.443 -0.577 . . . . 11.02 109.443 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.445 ' HG ' ' HA ' ' A' ' 147' ' ' GLN . 4.0 mp -128.73 135.92 49.87 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.324 -0.853 . . . . 10.32 110.661 -170.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.435 HG21 HD22 ' A' ' 148' ' ' LEU . 25.0 t -104.17 133.4 48.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.239 -0.892 . . . . 10.0 110.835 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.02 47.37 5.3 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.0 -1.0 . . . . 9.94 114.043 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.504 ' N ' HG11 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -61.02 125.1 16.25 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 CA-C-N 119.68 1.74 . . . . 11.15 111.414 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -156.05 147.69 22.88 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.105 -0.498 . . . . 12.77 110.176 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -89.34 -8.99 52.08 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.559 -0.746 . . . . 15.0 111.267 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.4 t -100.67 94.44 6.1 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.449 -0.574 . . . . 14.58 109.449 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.694 ' HG3' ' CD1' ' A' ' 144' ' ' TYR . 18.1 ttmt -54.1 -41.08 67.88 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.142 -0.935 . . . . 16.29 110.101 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.07 -53.41 54.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 15.6 111.827 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -62.88 -46.21 88.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.138 0.494 . . . . 14.36 111.164 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.492 ' O ' HD11 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -76.27 -20.76 57.04 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.841 -0.618 . . . . 12.11 110.864 -176.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 57.0 tptt -65.92 -39.25 90.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.448 0.642 . . . . 14.96 109.728 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.49 -11.3 85.43 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 114.984 -1.007 . . . . 13.32 110.667 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 75.2 m -88.23 -8.97 54.45 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.101 -0.549 . . . . 12.31 112.377 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 33.1 mt -68.34 -37.28 80.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.799 0.333 . . . . 12.72 110.956 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.05 -43.8 96.71 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.926 -0.654 . . . . 14.66 111.882 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.445 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 13.6 pt-20 -83.47 -18.03 39.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.795 0.331 . . . . 14.54 110.935 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.409 HD12 HD13 ' A' ' 207' ' ' LEU . 15.2 tp -74.44 -34.74 63.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.086 0.47 . . . . 12.55 110.306 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 7.6 mtmp? -66.82 -15.63 63.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.775 -0.648 . . . . 16.12 110.015 174.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.01 -36.01 17.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.851 -0.613 . . . . 16.98 109.413 172.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 66.3 mt -68.88 -51.4 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.787 -0.642 . . . . 14.15 111.127 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.447 ' HA ' HD13 ' A' ' 164' ' ' LEU . 22.2 p -102.67 -47.82 4.31 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.383 -0.527 . . . . 13.54 111.139 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 75.37 -0.17 60.6 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.824 -0.626 . . . . 14.79 112.183 -176.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 148' ' ' LEU . 7.3 mp -74.92 158.98 32.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 110.048 -0.353 . . . . 13.52 110.048 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.625 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 57.1 p -77.09 93.35 3.86 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.082 -0.508 . . . . 14.87 110.44 -175.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -112.78 137.63 14.38 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.349 -0.929 . . . . 12.22 114.279 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 16.9 t -101.75 137.94 27.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.287 -0.634 . . . . 14.04 109.287 173.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 5.3 p -75.56 105.65 4.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.622 0.725 . . . . 12.89 109.936 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 91.2 mmm -117.35 133.79 55.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.869 -0.605 . . . . 14.23 110.546 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -67.74 139.31 34.71 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.526 -0.845 . . . . 14.09 111.546 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.497 ' HB3' ' C ' ' A' ' 143' ' ' ALA . 9.9 t80 -108.98 131.61 54.9 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 123.703 0.801 . . . . 14.24 110.423 -170.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.2 t -146.56 94.75 4.71 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-O 121.091 0.472 . . . . 16.73 109.852 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.9 148.78 77.14 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.258 1.972 . . . . 17.42 111.823 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.695 -0.669 . . . . 19.69 109.959 -179.081 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.543 0.211 . . . . 18.39 110.459 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.42 163.29 29.4 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.747 -0.74 . . . . 17.97 112.14 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 60.25 80.82 0.2 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.426 0.632 . . . . 17.74 111.182 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -76.75 75.64 3.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.627 -0.715 . . . . 20.18 111.084 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.541 ' HG2' ' H ' ' A' ' 34' ' ' TYR . 41.2 ttmt -98.12 154.11 17.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.36 -0.607 . . . . 17.66 109.36 175.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.47 ' HE1' ' O ' ' A' ' 74' ' ' GLU . 85.4 m-70 -129.38 25.73 5.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.957 0.408 . . . . 19.78 111.355 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.541 ' H ' ' HG2' ' A' ' 32' ' ' LYS . 88.1 m-85 -132.92 176.81 8.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.325 -0.398 . . . . 18.96 110.512 -175.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 63.56 33.9 12.99 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.902 0.751 . . . . 18.6 109.473 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.4 t70 73.47 117.7 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.507 -1.224 . . . . 16.78 111.874 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -87.62 34.39 0.71 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.014 -0.539 . . . . 18.42 110.643 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.5 t80 62.35 -76.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.859 0.864 . . . . 17.92 111.447 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.06 141.5 11.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.775 0.321 . . . . 19.75 110.724 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.4 65.2 8.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.202 0.525 . . . . 20.62 110.332 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.417 HD11 ' O ' ' A' ' 47' ' ' ALA . 8.0 pt -121.8 83.1 42.63 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.822 -0.626 . . . . 19.92 111.543 -177.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.79 68.03 7.8 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.754 2.303 . . . . 21.71 111.897 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mp 62.88 34.53 14.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.907 -0.588 . . . . 23.06 111.468 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.57 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 57.9 t -90.69 -52.71 0.3 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.125 -0.488 . . . . 21.55 111.172 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.57 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 5.8 Cg_endo -92.22 172.25 2.46 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.777 2.318 . . . . 20.17 111.651 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -85.15 57.78 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.755 0.788 . . . . 21.45 109.154 174.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.417 ' O ' HD11 ' A' ' 41' ' ' ILE . . . -168.36 137.94 2.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.839 -1.073 . . . . 18.83 109.253 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.11 -128.47 2.74 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.675 -0.774 . . . . 17.72 111.297 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.42 123.08 14.2 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.029 -0.36 . . . . 16.95 110.029 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -164.82 82.96 0.38 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.219 -0.66 . . . . 18.58 109.219 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.27 110.46 0.96 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.638 -0.71 . . . . 18.17 111.45 -172.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -85.48 115.4 61.28 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 109.12 -0.696 . . . . 18.88 109.12 171.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.72 7.18 2.45 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.856 2.371 . . . . 19.87 112.864 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -136.77 67.81 1.44 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.206 0.527 . . . . 21.1 110.355 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.3 ttt -166.68 -70.26 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.452 -0.795 . . . . 22.59 109.942 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.539 ' HB3' ' HD3' ' A' ' 57' ' ' PRO . 38.4 tpp -144.55 -48.57 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.966 -0.561 . . . . 24.05 110.656 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 56' ' ' MET . 14.0 Cg_exo -71.28 122.64 8.87 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.478 1.452 . . . . 20.94 110.712 172.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HB2' ' HB1' ' A' ' 62' ' ' ALA . . . -74.65 -47.51 31.57 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.009 -0.541 . . . . 20.49 110.183 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 177.81 -175.55 0.17 Allowed 'General case' 0 CA--C 1.522 -0.132 0 O-C-N 123.933 0.771 . . . . 21.67 109.663 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -67.23 -19.4 65.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.242 0.544 . . . . 22.84 110.117 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -82.53 -15.38 52.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.826 -0.625 . . . . 22.15 110.5 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 58' ' ' ALA . . . -147.64 87.92 1.66 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.131 -0.486 . . . . 19.92 110.872 -177.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.34 161.13 75.96 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.72 -0.673 . . . . 19.88 109.857 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.442 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 7.4 Cg_exo -73.64 69.76 4.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.775 2.317 . . . . 18.74 112.756 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m 59.57 42.08 17.95 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.387 0.613 . . . . 17.84 111.038 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 64' ' ' PRO . 12.0 pt20 -173.44 74.31 0.39 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.451 -0.795 . . . . 19.1 110.517 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.09 -45.19 37.46 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.305 2.67 . . . . 17.47 114.976 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.62 -46.73 31.37 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.235 1.957 . . . . 17.99 113.098 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -164.11 149.72 10.74 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.365 -0.605 . . . . 18.7 109.365 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 72' ' ' ALA . . . -90.6 58.8 3.36 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.848 -0.614 . . . . 17.72 112.391 -173.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 70.15 -27.78 0.17 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.004 0.742 . . . . 18.19 113.004 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 70' ' ' GLY . . . -75.52 22.82 0.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.539 0.57 . . . . 17.96 112.539 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -83.39 -25.01 31.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.058 -1.09 . . . . 19.85 108.058 172.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' O ' ' HE1' ' A' ' 33' ' ' HIS . 30.0 tt0 -130.55 89.65 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.764 -1.107 . . . . 19.68 109.24 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 t -77.58 95.89 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 17.87 110.866 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -80.28 -41.76 24.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.139 -0.482 . . . . 20.34 110.131 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 66.5 -64.98 0.21 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.006 0.816 . . . . 18.81 112.697 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 82' ' ' ALA . . . -98.72 -130.99 7.08 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.045 -0.597 . . . . 17.66 113.206 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 81' ' ' ALA . 59.3 m-20 58.5 61.33 2.27 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.724 0.41 . . . . 17.87 110.442 -177.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 74.11 -23.64 0.22 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.044 0.84 . . . . 18.04 112.311 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . -75.73 -34.42 60.32 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.713 0.264 . . . . 17.53 111.713 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.457 ' HB2' ' HA2' ' A' ' 78' ' ' GLY . . . -56.47 -54.92 48.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 112.034 0.383 . . . . 16.64 112.034 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.15 -19.66 19.83 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.374 1.382 . . . . 17.64 112.254 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.8 t 69.29 -63.25 0.38 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.461 -0.79 . . . . 17.42 110.4 -175.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.6 mt -113.61 149.7 34.17 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.723 -0.473 . . . . 18.62 109.723 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -79.39 130.14 69.61 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.411 . . . . 17.79 110.918 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.45 -15.61 48.45 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.927 2.418 . . . . 19.23 112.222 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.22 102.62 2.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.05 -0.523 . . . . 17.96 110.807 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.1 p -75.91 -40.76 53.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.151 -0.477 . . . . 18.63 110.994 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 pt -121.43 -47.8 2.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.23 -0.441 . . . . 19.36 110.747 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -171.13 -91.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.328 -0.396 . . . . 19.41 110.332 174.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 174.34 -43.53 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.061 0.458 . . . . 18.96 111.295 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -94.08 47.03 1.19 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.982 -0.553 . . . . 18.95 112.24 -169.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -149.28 77.67 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.597 0.237 . . . . 20.53 110.587 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.8 m -67.19 -51.15 56.98 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.847 -0.797 . . . . 21.4 108.847 172.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -120.18 -26.5 5.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.948 -1.024 . . . . 21.26 108.83 168.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -179.6 -7.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.2 -0.909 . . . . 22.65 110.477 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -149.94 169.13 9.67 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.366 -0.834 . . . . 19.45 108.989 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.35 -64.72 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.981 1.788 . . . . 18.97 112.275 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 103' ' ' PRO . 34.7 tt0 -175.94 133.43 0.43 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 17.53 110.185 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.26 102.9 0.48 Allowed 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.586 2.191 . . . . 17.77 111.608 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 58.78 78.24 0.36 Allowed Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 115.584 -0.734 . . . . 18.07 110.292 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.467 ' HA ' ' OE1' ' A' ' 100' ' ' GLU . 36.3 Cg_exo -62.16 142.64 92.67 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.294 2.663 . . . . 16.56 112.926 -175.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.5 m -93.48 18.31 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 121.438 0.637 . . . . 17.5 111.23 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' A' ' 106' ' ' PRO . . . -70.79 -50.3 13.06 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.24 -0.891 . . . . 16.11 111.982 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 105' ' ' ALA . 37.9 Cg_endo -65.51 156.78 61.75 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.982 1.788 . . . . 16.19 111.958 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.22 -13.02 25.73 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.723 2.282 . . . . 16.43 111.983 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 14.1 mptt -89.29 131.02 41.83 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.688 -0.687 . . . . 17.91 109.719 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 108' ' ' LYS . 35.5 Cg_exo -61.98 103.95 0.31 Allowed 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.729 2.286 . . . . 15.31 112.025 176.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -84.29 -51.05 0.59 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.264 -0.426 . . . . 15.37 111.251 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.7 96.09 0.98 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.666 1.577 . . . . 14.26 112.701 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.8 53.78 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 122.376 1.084 . . . . 15.75 108.907 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.636 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 24.4 mm-40 -65.44 -41.62 51.67 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 113.84 -1.527 . . . . 16.84 112.425 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 113' ' ' GLU . 3.7 Cg_exo -40.87 126.97 2.53 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.968 2.445 . . . . 15.51 112.276 172.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.94 -172.65 1.49 Allowed 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.765 2.31 . . . . 16.04 112.515 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.1 tptt 64.83 71.95 0.52 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 115.765 -0.652 . . . . 19.25 110.48 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -96.57 -4.72 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.624 2.883 . . . . 17.04 111.465 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.3 tptt 60.04 51.66 5.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.264 -1.335 . . . . 17.71 110.722 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 m 37.45 -106.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 115.257 -0.883 . . . . 19.09 112.841 -176.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -113.12 68.87 0.68 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.974 0.416 . . . . 20.88 110.883 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.93 113.47 7.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 18.89 110.779 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' A' ' 123' ' ' PRO . 35.7 Cg_exo -57.79 -50.26 10.92 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.118 2.545 . . . . 20.92 114.032 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 122' ' ' PRO . 81.6 Cg_endo -90.15 40.98 0.44 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.649 1.566 . . . . 21.13 112.259 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.96 128.05 91.99 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.051 -0.522 . . . . 21.37 110.533 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.43 -18.93 66.82 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.759 2.306 . . . . 21.41 112.0 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HZ3' ' HB3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -116.19 108.09 46.48 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.728 -0.669 . . . . 22.17 109.668 177.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.41 -38.75 89.45 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.297 2.665 . . . . 20.33 112.884 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -127.62 90.56 47.96 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.309 -0.405 . . . . 20.48 110.138 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.457 ' O ' ' HD3' ' A' ' 131' ' ' PRO . 7.6 Cg_exo -71.86 -65.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.994 2.463 . . . . 21.43 111.993 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -115.83 85.48 14.55 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.13 -0.693 . . . . 23.44 109.13 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 129' ' ' PRO . 2.6 Cg_exo -75.85 75.89 3.91 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.954 2.436 . . . . 21.1 112.425 -177.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.3 p -89.61 42.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 122.556 1.17 . . . . 20.15 109.292 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.44 136.3 7.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.637 -1.165 . . . . 21.3 110.861 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.88 -169.67 1.56 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.903 -0.589 . . . . 21.3 109.49 173.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.561 ' HG3' ' H ' ' A' ' 136' ' ' LYS . 2.0 pt-20 -47.06 -81.45 0.01 OUTLIER 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.751 0.648 . . . . 20.74 112.751 -174.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.561 ' H ' ' HG3' ' A' ' 135' ' ' GLU . 40.2 ttpt 70.3 -40.01 0.46 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.34 0.656 . . . . 18.17 111.127 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 142' ' ' LYS . . . -68.68 -21.63 64.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.989 -0.55 . . . . 17.35 109.974 172.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 74.82 147.22 0.12 Allowed Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 114.467 -1.242 . . . . 19.41 111.347 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 192' ' ' ALA . 71.5 Cg_exo -51.51 -75.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.1 2.533 . . . . 20.18 113.586 -175.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.3 p -90.12 -11.98 39.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.888 0.375 . . . . 18.05 110.976 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.37 -54.6 31.11 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.18 -0.768 . . . . 18.56 111.18 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 137' ' ' ALA . 58.6 tttm -144.56 79.58 1.61 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.814 0.816 . . . . 19.74 109.698 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.531 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -74.29 169.2 18.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.546 -1.206 . . . . 15.06 110.253 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.451 ' HB3' HD23 ' A' ' 197' ' ' LEU . 3.3 m-85 -128.6 156.15 43.83 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.813 0.672 . . . . 14.83 112.813 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 190' ' ' PRO . 2.7 t -150.49 165.75 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 108.983 -0.747 . . . . 10.79 108.983 174.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 43.9 t -105.59 113.05 41.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 O-C-N 121.75 -0.594 . . . . 10.43 110.8 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.437 ' OE1' ' HD3' ' A' ' 185' ' ' ARG . 6.4 tt0 -87.72 105.16 17.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.715 -0.221 . . . . 12.54 111.161 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.536 ' HA ' ' HA2' ' A' ' 212' ' ' GLY . 0.0 OUTLIER -85.66 -36.27 20.39 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.343 0.592 . . . . 11.88 110.198 -176.224 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.47 169.59 26.4 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.251 -0.976 . . . . 11.9 112.674 -173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.32 101.27 0.35 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.288 -0.634 . . . . 13.47 109.288 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.75 154.63 47.46 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.402 0.62 . . . . 14.03 110.724 -173.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 40.6 mtmt -95.44 -3.19 47.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.88 -1.055 . . . . 17.87 109.899 -176.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -97.92 104.15 16.15 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.025 . . . . 16.68 109.362 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.77 -19.01 65.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.371 0.605 . . . . 14.47 110.551 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -59.93 -34.34 73.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.235 -0.893 . . . . 16.57 110.189 174.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -90.42 -29.12 18.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.727 -1.124 . . . . 16.69 110.405 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 93.3 t -58.48 -38.73 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.368 0.604 . . . . 12.92 109.819 173.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -59.75 -29.48 68.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.148 -0.933 . . . . 15.83 111.243 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.74 -62.69 1.4 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.217 0.532 . . . . 15.97 110.03 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.6 mt -55.25 -43.51 71.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.885 -1.052 . . . . 12.6 110.757 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.5 t -74.59 -40.19 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.689 -0.687 . . . . 12.54 110.455 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.26 -33.95 86.33 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.373 -0.918 . . . . 14.8 111.487 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -68.23 -57.43 6.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.411 -0.394 . . . . 16.37 111.497 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -85.3 -52.35 5.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.353 0.501 . . . . 12.99 112.353 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -68.31 -37.59 80.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.15 0.5 . . . . 15.56 110.221 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.09 -23.9 77.63 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.41 -0.814 . . . . 16.6 112.552 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.5 1.39 55.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.951 0.405 . . . . 16.55 110.755 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.29 23.46 34.36 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.83 -0.7 . . . . 15.88 113.396 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -89.92 154.42 19.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.955 0.378 . . . . 15.6 110.208 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 170' ' ' ARG . 8.8 mpt_? -76.55 98.34 4.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.238 -0.653 . . . . 14.31 109.238 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.97 142.01 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.155 -0.929 . . . . 11.04 109.016 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.628 ' HH ' ' HD2' ' A' ' 217' ' ' TYR . 0.1 OUTLIER -138.98 176.8 8.38 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.554 0.693 . . . . 11.47 110.712 174.152 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 23.6 p -111.21 -175.95 2.83 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.508 -1.223 . . . . 11.83 111.353 -171.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.3 OUTLIER -53.81 148.94 18.22 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.212 -0.449 . . . . 12.84 111.031 176.599 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -32.09 -61.38 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 125.126 3.884 . . . . 15.06 115.337 -173.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.1 m -87.32 -63.0 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.371 0.878 . . . . 16.97 113.371 -168.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.7 m -167.82 129.22 1.2 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 118.434 0.561 . . . . 16.04 112.356 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.407 ' HB3' HG22 ' A' ' 184' ' ' THR . 72.1 Cg_exo -59.36 124.27 15.19 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.541 2.16 . . . . 14.22 111.705 163.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.3 p -153.32 160.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 109.646 -0.502 . . . . 16.46 109.646 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -80.13 122.57 26.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.457 -0.338 . . . . 17.05 110.56 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.75 -25.77 18.05 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.888 -0.672 . . . . 17.2 112.555 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.476 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.3 OUTLIER -109.35 160.7 15.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.784 -0.451 . . . . 19.02 109.784 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.406 HG21 ' O ' ' A' ' 183' ' ' ILE . 8.0 tp -73.19 109.4 5.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.747 0.784 . . . . 15.32 111.555 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.473 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 56.9 m -100.05 112.53 24.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.449 -0.796 . . . . 13.03 109.625 174.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.508 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 46.1 mtt180 -93.61 144.77 25.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.691 -0.686 . . . . 14.44 109.938 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.486 ' C ' HD11 ' A' ' 187' ' ' LEU . 5.2 mm -114.85 120.41 64.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.108 -0.701 . . . . 11.02 109.108 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.486 HD11 ' C ' ' A' ' 186' ' ' ILE . 4.9 mp -129.42 123.01 30.55 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.208 0.528 . . . . 10.32 111.041 -174.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.419 HG22 ' CD2' ' A' ' 148' ' ' LEU . 33.6 t -99.58 134.97 36.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.625 -0.716 . . . . 10.0 111.159 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 84.5 47.98 5.2 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.96 -1.018 . . . . 9.94 113.555 173.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.515 ' N ' HG12 ' A' ' 145' ' ' VAL . 12.7 Cg_endo -62.74 125.82 16.88 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 119.476 1.638 . . . . 11.15 110.511 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -157.26 152.4 26.06 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.325 -0.55 . . . . 12.77 110.586 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.597 ' O ' ' HA ' ' A' ' 139' ' ' PRO . . . -88.74 2.62 53.11 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.608 -0.724 . . . . 15.0 111.34 -175.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 18.2 t -118.32 97.81 5.96 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.367 0.603 . . . . 14.58 109.685 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.445 ' HZ2' ' CG ' ' A' ' 195' ' ' ASP . 2.9 ptmm? -57.42 -40.5 78.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.899 -1.046 . . . . 16.29 111.821 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . 0.445 ' CG ' ' HZ2' ' A' ' 194' ' ' LYS . 12.2 m-20 -71.75 -46.89 57.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.803 0.335 . . . . 15.6 111.461 -176.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -59.55 -37.21 77.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.316 0.579 . . . . 14.36 110.243 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -84.21 -24.18 30.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.749 -0.659 . . . . 12.11 110.412 -178.241 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.566 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 14.1 tmtt? -74.82 -34.46 62.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.313 0.578 . . . . 14.96 109.652 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.17 -13.28 82.89 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.157 -1.177 . . . . 13.32 110.157 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 45.5 m -90.17 -8.59 50.82 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.354 -0.923 . . . . 12.31 111.934 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 24.3 mt -65.31 -35.21 80.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.671 0.272 . . . . 12.72 111.043 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.2 -42.62 97.28 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.791 -0.718 . . . . 14.66 111.851 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 200' ' ' SER . 9.9 pt-20 -85.91 -19.7 30.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.664 0.268 . . . . 14.54 110.584 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 19.9 tp -68.65 -28.63 67.06 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.112 0.482 . . . . 12.55 110.085 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.532 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 90.8 mttt -60.92 -16.68 44.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.41 -0.814 . . . . 16.12 110.568 173.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -89.91 -43.01 10.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.42 -0.355 . . . . 16.98 110.424 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.13 -55.52 31.5 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.51 0.671 . . . . 14.15 112.204 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 55.9 p -97.38 -44.19 6.97 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.134 -0.939 . . . . 13.54 110.854 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 72.62 1.93 54.57 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.536 -0.756 . . . . 14.79 111.802 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.408 ' HB2' ' HG ' ' A' ' 148' ' ' LEU . 70.5 mt -85.53 152.14 23.4 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.738 -0.468 . . . . 13.52 109.738 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 p -90.32 104.84 17.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.256 -0.429 . . . . 14.87 110.591 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -130.32 160.7 23.09 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.148 -1.025 . . . . 12.22 114.142 -173.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.2 t -101.45 140.59 19.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.917 -0.641 . . . . 14.04 109.383 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.01 105.15 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.732 0.777 . . . . 12.89 109.614 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.415 ' HA ' ' HE2' ' A' ' 215' ' ' MET . 1.8 mmt -122.07 168.85 11.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.48 -0.782 . . . . 14.23 110.564 -172.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -83.48 163.46 40.79 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.476 -0.868 . . . . 14.09 112.934 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.628 ' HD2' ' HH ' ' A' ' 172' ' ' TYR . 6.9 t80 -128.67 126.5 40.27 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.845 0.858 . . . . 14.24 110.166 -174.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 89.4 m -146.61 93.37 4.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 116.075 -0.511 . . . . 16.73 109.653 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.9 149.87 60.32 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.702 2.268 . . . . 17.42 112.541 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 47.8 t30 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.843 -0.599 . . . . 19.69 109.791 177.21 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.528 ' O ' ' HE2' ' A' ' 31' ' ' LYS . 28.7 m-20 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.706 -0.479 . . . . 18.39 109.706 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.0 162.75 54.1 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.851 -0.69 . . . . 17.97 112.687 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 65.71 -98.18 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.144 0.577 . . . . 17.74 111.747 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HE2' ' O ' ' A' ' 28' ' ' ASP . 57.6 mtmt 56.17 25.06 8.67 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 122.665 0.386 . . . . 20.18 111.154 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -167.51 -170.94 1.54 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.174 -0.676 . . . . 17.66 109.174 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m80 59.99 42.63 15.71 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.496 0.498 . . . . 19.78 110.771 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.435 ' CE1' ' HB2' ' A' ' 66' ' ' GLN . 52.9 t80 -142.73 57.08 1.42 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.593 0.711 . . . . 18.96 110.065 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -89.49 46.05 1.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.741 0.781 . . . . 18.6 109.653 173.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -84.9 125.37 32.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.899 -1.046 . . . . 16.78 109.83 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -56.11 118.14 4.4 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.698 0.624 . . . . 18.42 110.95 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -73.28 86.75 1.46 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.08 0.467 . . . . 17.92 110.851 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.55 -13.29 26.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.686 -0.688 . . . . 19.75 109.65 175.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.79 -148.34 0.37 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.135 -0.938 . . . . 20.62 109.593 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.419 ' O ' HG21 ' A' ' 41' ' ' ILE . 4.4 mp 60.92 72.71 0.68 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 121.718 0.771 . . . . 19.92 110.411 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -81.18 54.02 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.068 2.512 . . . . 21.71 111.28 175.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 mp 62.24 26.4 15.82 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.39 -0.823 . . . . 23.06 111.336 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.502 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 83.9 t -79.81 -60.65 0.5 Allowed Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.301 -0.409 . . . . 21.55 110.593 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.502 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 96.1 Cg_endo -78.35 59.81 7.24 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.894 1.729 . . . . 20.17 111.537 172.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HB2' ' HZ1' ' A' ' 46' ' ' LYS . 10.2 mtmp? 68.49 167.18 0.26 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.552 -0.749 . . . . 21.45 111.112 -176.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.89 54.21 2.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 18.83 111.675 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.14 -8.93 83.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.903 -0.665 . . . . 17.72 112.052 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -80.55 131.07 35.48 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.409 -0.219 . . . . 16.95 110.409 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 60.59 39.11 18.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.758 -0.656 . . . . 18.58 110.415 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.11 127.67 33.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.634 -0.712 . . . . 18.17 109.286 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 57' ' ' PRO . 12.6 pt-20 -85.5 115.78 62.86 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.245 0.545 . . . . 18.88 112.366 -171.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 57' ' ' PRO . 88.1 Cg_endo -83.77 32.92 0.5 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.012 2.474 . . . . 19.87 112.038 176.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -93.65 -56.34 2.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.145 -0.479 . . . . 21.1 111.354 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 72.2 mtm -85.26 -85.25 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.413 -0.358 . . . . 22.59 111.586 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.538 ' H ' ' HD2' ' A' ' 57' ' ' PRO . 65.6 mtt -122.41 -41.28 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.297 0.48 . . . . 24.05 112.297 -176.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.647 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 88.0 Cg_exo -48.76 125.65 13.2 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.997 1.798 . . . . 20.94 112.168 171.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 66.13 8.99 5.91 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.333 -0.849 . . . . 20.49 111.877 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.97 -39.48 5.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.105 0.479 . . . . 21.67 109.863 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.6 m -80.52 -35.83 34.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 22.84 110.102 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -113.09 179.34 3.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.725 -0.67 . . . . 22.15 109.748 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.81 -80.98 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.852 0.358 . . . . 19.92 111.44 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.8 tp -134.98 89.82 23.33 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.043 0.449 . . . . 19.88 110.192 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -93.43 28.68 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.475 2.784 . . . . 18.74 113.222 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 p -68.25 -58.64 4.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.117 0.484 . . . . 17.84 110.311 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 84.0 mm-40 -135.6 76.26 55.17 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.825 -0.625 . . . . 19.1 109.683 172.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.42 127.76 5.94 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.751 2.301 . . . . 17.47 112.267 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.41 -16.97 44.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.601 2.201 . . . . 17.99 112.306 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -124.56 163.13 22.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.547 -0.751 . . . . 18.7 109.906 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.9 -153.35 17.0 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.646 -0.787 . . . . 17.72 112.295 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 64.43 74.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.286 0.565 . . . . 18.19 110.824 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.8 152.97 20.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.469 -0.787 . . . . 17.96 109.738 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.81 124.76 39.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.632 0.254 . . . . 19.85 110.724 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 71.18 -59.43 0.54 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.462 0.705 . . . . 19.68 111.946 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.87 103.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.194 -0.457 . . . . 17.87 111.186 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? 66.98 17.0 10.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.439 -0.8 . . . . 20.34 111.242 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.85 -28.09 7.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.223 -0.444 . . . . 18.81 111.009 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.73 85.68 0.86 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.82 -0.705 . . . . 17.66 112.357 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -146.82 164.17 33.7 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.566 -0.531 . . . . 17.87 109.566 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.41 57.99 3.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.217 0.532 . . . . 18.04 110.79 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.76 71.79 1.25 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.761 -0.654 . . . . 17.53 110.393 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.34 105.84 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.338 0 O-C-N 123.87 0.731 . . . . 16.64 111.579 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.65 -22.31 59.99 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.994 2.463 . . . . 17.64 112.328 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.3 m 67.26 -176.5 0.2 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.434 -0.803 . . . . 17.42 111.187 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 85' ' ' LEU . 1.9 pt? -142.77 133.68 25.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.345 -0.388 . . . . 18.62 109.971 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -76.07 132.93 72.92 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.974 -0.557 . . . . 17.79 110.975 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.36 -6.39 18.3 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.689 2.259 . . . . 19.23 112.111 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.433 ' C ' ' HG1' ' A' ' 89' ' ' THR . . . 65.04 -85.32 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.422 -0.808 . . . . 17.96 111.425 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.433 ' HG1' ' C ' ' A' ' 88' ' ' ALA . 44.6 p 49.33 -96.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.348 0.659 . . . . 18.63 112.309 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mm -77.64 -36.13 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.146 0.498 . . . . 19.36 110.268 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.716 ' HA ' ' OG1' ' A' ' 95' ' ' THR . . . -104.9 81.96 1.81 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.845 -0.616 . . . . 19.41 110.822 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -99.33 -39.09 8.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.172 -0.467 . . . . 18.96 111.47 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -160.02 -69.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.972 0.415 . . . . 18.95 111.229 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -85.42 54.82 3.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.503 0.668 . . . . 20.53 111.373 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.716 ' OG1' ' HA ' ' A' ' 91' ' ' ALA . 6.9 m -103.26 -24.85 13.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.661 0.743 . . . . 21.4 109.287 172.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -143.13 30.14 1.44 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.769 -1.105 . . . . 21.26 109.301 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 56.18 52.95 9.54 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.752 -1.113 . . . . 22.65 111.48 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -79.74 120.23 79.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 19.45 110.14 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.412 ' C ' ' HD3' ' A' ' 101' ' ' PRO . 62.2 Cg_endo -74.29 147.56 37.46 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.294 1.996 . . . . 18.97 111.571 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.69 71.33 66.79 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 121.054 0.454 . . . . 17.53 110.542 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 99' ' ' PRO . 6.2 Cg_exo -74.05 -58.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.779 2.319 . . . . 17.77 111.719 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.58 116.95 8.5 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.901 -0.59 . . . . 18.07 109.889 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.05 132.79 33.2 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.616 2.21 . . . . 16.56 112.583 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 p -106.94 103.83 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.755 -0.657 . . . . 17.5 110.212 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 49.45 63.7 9.84 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-N 115.366 -0.834 . . . . 16.11 111.048 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.0 138.85 14.82 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.362 2.041 . . . . 16.19 112.891 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.54 -20.53 35.74 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.64 2.227 . . . . 16.43 110.811 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 87.2 tttt -117.88 115.43 36.86 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 114.909 -1.041 . . . . 17.91 108.446 173.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 108' ' ' LYS . 12.6 Cg_exo -70.62 53.5 1.4 Allowed 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.107 2.538 . . . . 15.31 113.259 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -77.0 115.46 48.73 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 15.37 110.274 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.76 117.61 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.147 1.898 . . . . 14.26 111.803 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.2 m -85.23 47.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.784 0.802 . . . . 15.75 110.486 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -139.4 165.33 32.45 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.915 -1.039 . . . . 16.84 110.043 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.83 170.53 1.37 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.811 2.341 . . . . 15.51 112.185 174.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.7 50.95 0.84 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.101 2.534 . . . . 16.04 112.172 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -174.53 69.57 0.3 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.746 -1.116 . . . . 19.25 108.512 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -38.07 -57.96 0.74 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.939 3.093 . . . . 17.04 113.187 -168.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -133.95 15.68 3.9 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.188 -0.671 . . . . 17.71 109.188 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.6 t 66.65 -69.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.167 -0.924 . . . . 19.09 110.235 -171.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.13 57.97 0.66 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.123 -0.49 . . . . 20.88 109.679 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.64 112.67 12.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 18.89 110.573 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.36 117.13 3.69 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.031 2.487 . . . . 20.92 112.512 -176.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.03 165.45 29.75 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.86 2.373 . . . . 21.13 111.645 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 126' ' ' LYS . . . -70.13 141.41 89.01 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.29 -0.633 . . . . 21.37 109.29 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.85 21.25 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.619 2.213 . . . . 21.41 112.554 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 124' ' ' ALA . 12.2 mmmm -139.37 70.42 39.54 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.656 -0.702 . . . . 22.17 110.128 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.1 58.54 6.62 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.981 2.454 . . . . 20.33 111.779 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -73.19 136.27 79.18 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.496 -0.775 . . . . 20.48 110.566 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.04 72.06 2.75 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.738 2.292 . . . . 21.43 112.328 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -87.27 123.43 69.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.715 -0.675 . . . . 23.44 111.035 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.93 127.11 18.7 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.562 2.174 . . . . 21.1 110.97 173.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 m -85.91 51.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.081 0.467 . . . . 20.15 111.912 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 134' ' ' GLU . 31.5 t 66.54 172.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.313 -0.858 . . . . 21.3 110.239 178.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.494 ' N ' HG12 ' A' ' 133' ' ' VAL . 20.5 mt-10 73.39 78.05 0.13 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.33 0.586 . . . . 21.3 110.891 174.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -74.46 158.44 33.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.624 -0.717 . . . . 20.74 109.97 178.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -172.29 -27.85 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.137 -0.69 . . . . 18.17 109.137 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 142' ' ' LYS . . . -115.79 24.08 11.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.147 -0.933 . . . . 17.35 109.851 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 68.23 152.07 0.13 Allowed Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 115.154 -0.93 . . . . 19.41 111.779 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.37 94.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.129 2.553 . . . . 20.18 112.217 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.466 ' HA ' ' HB1' ' A' ' 143' ' ' ALA . 1.4 p 51.48 26.97 3.49 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.886 0.875 . . . . 18.05 112.752 -176.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -83.24 -47.13 5.87 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.743 -0.943 . . . . 18.56 110.743 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 137' ' ' ALA . 46.4 mtmt -127.89 56.93 1.56 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.122 -0.696 . . . . 19.74 109.122 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.47 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -77.32 164.55 25.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.13 -0.941 . . . . 15.06 110.37 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.511 ' HA ' ' H ' ' A' ' 217' ' ' TYR . 10.0 m-85 -143.95 151.17 39.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.912 0.387 . . . . 14.83 111.336 -177.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' A' ' 187' ' ' LEU . 2.3 t -146.81 153.11 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.58 -1.267 . . . . 10.79 107.58 170.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 17.1 t -98.23 121.73 49.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.304 -0.559 . . . . 10.43 110.815 -176.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.474 ' HG3' ' CG ' ' A' ' 185' ' ' ARG . 3.5 tt0 -83.98 101.73 11.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.579 -0.156 . . . . 12.54 110.579 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.734 HD13 ' N ' ' A' ' 212' ' ' GLY . 0.5 OUTLIER -87.58 -26.5 23.07 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.191 -0.67 . . . . 11.88 109.191 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -149.7 158.29 27.6 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.347 -0.842 . . . . 11.9 112.039 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.499 ' C ' HD12 ' A' ' 151' ' ' LEU . . . -157.48 101.25 1.85 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.391 -0.596 . . . . 13.47 109.391 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.55 HD21 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -125.72 150.65 47.52 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.461 0.648 . . . . 14.03 110.296 -171.231 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 2.6 mttt -93.85 -1.84 54.29 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.738 -1.119 . . . . 17.87 108.431 176.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -104.87 107.27 18.15 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.205 -1.361 . . . . 16.68 109.238 175.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.76 -16.83 59.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.165 0.507 . . . . 14.47 111.022 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -54.98 -35.32 64.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.092 -0.958 . . . . 16.57 111.062 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.496 ' O ' HG13 ' A' ' 160' ' ' ILE . 83.6 tttt -90.53 -31.84 16.57 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.61 -0.723 . . . . 16.69 110.48 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.473 HG11 ' CD1' ' A' ' 186' ' ' ILE . 88.2 t -54.72 -43.26 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.239 -0.437 . . . . 12.92 110.472 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -62.0 -34.38 76.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.674 -0.694 . . . . 15.83 111.737 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.81 -59.05 2.9 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 120.911 0.386 . . . . 15.97 110.016 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 156' ' ' LYS . 21.8 mt -52.39 -45.07 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.846 -1.07 . . . . 12.6 110.788 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 89.6 t -71.16 -43.02 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.74 -0.663 . . . . 12.54 110.366 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.26 68.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.609 -0.805 . . . . 14.8 112.037 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -73.42 -61.79 1.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.257 0.223 . . . . 16.37 111.254 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -78.36 -45.8 21.6 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.415 0.524 . . . . 12.99 112.415 -174.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.481 ' HB2' ' CG1' ' A' ' 171' ' ' VAL . 25.8 ttm180 -65.17 -47.47 76.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.106 -0.702 . . . . 15.56 109.106 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.67 -20.59 68.3 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.048 -0.978 . . . . 16.6 113.456 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.2 -12.43 49.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.001 0.429 . . . . 16.55 110.385 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.41 20.86 11.32 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.937 -0.649 . . . . 15.88 113.222 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -95.74 154.91 16.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 117.337 0.568 . . . . 15.6 110.611 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -76.08 106.71 7.84 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.67 0.748 . . . . 14.31 110.151 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 165' ' ' ARG . 9.3 p -143.07 138.15 26.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.391 -1.277 . . . . 11.04 109.141 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.493 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.37 176.18 8.98 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.35 0.595 . . . . 11.47 110.583 171.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 24.8 p -105.78 -177.33 3.33 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.915 -1.039 . . . . 11.83 110.064 -174.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.23 142.73 36.96 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.305 -0.258 . . . . 12.84 110.305 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -38.92 -47.12 2.81 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 124.25 3.3 . . . . 15.06 115.145 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.402 ' C ' ' HG1' ' A' ' 177' ' ' THR . 16.9 t -85.74 -61.98 1.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 120.231 -0.588 . . . . 16.97 112.41 -171.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 176' ' ' SER . 99.8 m -167.65 137.66 2.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.607 0.595 . . . . 16.04 112.607 -173.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.423 ' HB3' HG22 ' A' ' 184' ' ' THR . 30.6 Cg_exo -67.14 125.23 13.24 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.765 2.31 . . . . 14.22 111.315 160.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 8.8 p -145.63 152.33 14.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.092 0.472 . . . . 16.46 110.6 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -81.78 123.52 28.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 17.05 111.101 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 100.2 -12.1 60.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.836 -0.697 . . . . 17.2 112.612 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.556 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -123.31 161.5 24.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.301 -0.629 . . . . 19.02 109.301 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 183' ' ' ILE . 8.8 tp -66.3 111.57 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.622 0.725 . . . . 15.32 111.858 -172.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 178' ' ' PRO . 87.4 m -109.2 117.16 33.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.372 -0.603 . . . . 13.03 109.372 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.474 ' CG ' ' HG3' ' A' ' 147' ' ' GLN . 25.2 ttm180 -93.92 140.05 30.17 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.503 -0.771 . . . . 14.44 110.171 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.482 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.9 mm -109.31 115.53 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.417 -0.586 . . . . 11.02 109.417 176.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 4.8 mp -121.57 118.02 28.22 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.554 0.692 . . . . 10.32 110.824 -171.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.423 ' CG1' HD11 ' A' ' 204' ' ' LEU . 27.7 t -95.71 135.3 30.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 114.834 -1.075 . . . . 10.0 110.61 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.19 48.93 5.49 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.248 -0.887 . . . . 9.94 113.627 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.514 ' N ' HG11 ' A' ' 145' ' ' VAL . 12.3 Cg_endo -63.84 125.3 15.11 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 CA-C-N 119.525 1.663 . . . . 11.15 111.05 174.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -156.88 161.12 39.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.001 -0.545 . . . . 12.77 110.102 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.412 ' HB2' ' H ' ' A' ' 140' ' ' THR . . . -102.73 0.09 32.41 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.943 -0.571 . . . . 15.0 111.363 -176.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 28.5 p -113.61 95.91 5.59 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.575 0.702 . . . . 14.58 110.13 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.435 ' HG3' ' CD2' ' A' ' 144' ' ' TYR . 31.6 ttpt -56.7 -53.62 55.58 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.062 -0.972 . . . . 16.29 111.146 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -61.76 -32.04 72.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.833 0.349 . . . . 15.6 111.686 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -73.39 -41.83 62.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.098 0.475 . . . . 14.36 110.539 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 197' ' ' LEU . 0.1 OUTLIER -82.66 -19.86 37.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.246 0.546 . . . . 12.11 110.649 -178.123 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.409 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 55.7 tptt -67.15 -36.39 81.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.835 -0.621 . . . . 14.96 110.455 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.61 -12.25 83.11 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.43 -1.068 . . . . 13.32 110.43 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 67.2 m -84.66 -8.08 59.0 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.873 -0.664 . . . . 12.31 111.902 -176.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 14.6 mt -70.58 -36.33 73.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 12.72 110.611 -177.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.7 92.65 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.987 -0.625 . . . . 14.66 112.219 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.411 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 12.8 pt-20 -85.79 -17.34 36.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.955 0.407 . . . . 14.54 110.441 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.423 HD11 ' CG1' ' A' ' 188' ' ' VAL . 17.6 tp -69.14 -34.91 75.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.278 -0.419 . . . . 12.55 111.438 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.44 ' HD3' ' N ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -63.72 -16.06 60.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.955 0.407 . . . . 16.12 110.604 173.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.44 ' N ' ' HD3' ' A' ' 205' ' ' LYS . 0.8 OUTLIER -88.93 -36.39 15.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.058 -0.519 . . . . 16.98 109.687 172.697 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 93.1 mt -71.47 -52.31 19.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.661 -0.699 . . . . 14.15 111.499 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 63.0 p -98.14 -43.6 6.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.397 0.618 . . . . 13.54 111.04 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.34 0.01 55.97 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.241 -0.89 . . . . 14.79 111.322 -174.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.626 ' C ' HD11 ' A' ' 148' ' ' LEU . 97.1 mt -80.0 162.23 24.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.701 -0.851 . . . . 13.52 108.701 175.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.0 m -111.41 109.46 19.44 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.201 0.445 . . . . 14.87 112.201 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.734 ' N ' HD13 ' A' ' 148' ' ' LEU . . . -121.9 173.67 15.87 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.844 -0.693 . . . . 12.22 114.17 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.4 p -117.1 146.39 21.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.839 -0.68 . . . . 14.04 109.267 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 25.6 t -82.35 115.33 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.905 -0.589 . . . . 12.89 110.505 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 74.8 mtp -125.96 149.83 48.47 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.123 0.487 . . . . 14.23 110.67 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.39 128.56 9.41 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.706 -0.759 . . . . 14.09 112.549 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.511 ' H ' ' HA ' ' A' ' 144' ' ' TYR . 8.1 t80 -84.55 120.36 26.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.574 -0.813 . . . . 14.24 109.083 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 25.5 m -134.83 91.89 19.83 Favored Pre-proline 0 C--N 1.306 -1.295 0 C-N-CA 120.617 -0.433 . . . . 16.73 110.689 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 217' ' ' TYR . 9.5 Cg_exo -66.96 133.13 30.18 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.244 1.962 . . . . 17.42 111.138 173.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.1 t30 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.856 -0.592 . . . . 19.69 110.009 -178.096 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.499 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.875 -0.417 . . . . 14.65 109.875 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.654 ' CE1' ' HG3' ' A' ' 194' ' ' LYS . 5.4 m-85 -137.55 156.51 48.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.162 0.43 . . . . 14.81 112.162 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.5 m -152.5 151.33 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.348 -0.842 . . . . 10.48 109.717 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.463 HG12 ' HA3' ' A' ' 212' ' ' GLY . 60.2 t -110.82 110.92 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 10.1 111.423 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.608 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 8.0 tt0 -84.85 113.52 21.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.516 -0.311 . . . . 12.0 111.688 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -92.01 -34.55 14.38 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.989 0.423 . . . . 11.880000000000001 110.341 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.62 174.21 25.69 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.189 -1.005 . . . . 11.35 112.855 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -170.76 103.39 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.636 -0.505 . . . . 13.470000000000001 109.636 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.81 157.07 43.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.304 0.573 . . . . 13.52 110.695 -175.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 86.1 mttt -98.12 14.3 28.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.134 -0.939 . . . . 17.600000000000001 110.612 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.432 ' OD1' ' HG3' ' A' ' 156' ' ' LYS . 4.1 t-20 -112.73 106.22 14.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.564 -0.744 . . . . 16.140000000000001 109.348 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.72 -26.48 68.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.901 0.381 . . . . 14.039999999999999 111.426 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.72 -38.87 76.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.539 0.685 . . . . 16.57 110.044 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.443 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 68.8 mttm -79.27 -33.44 43.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.671 -1.149 . . . . 16.399999999999999 110.292 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 184' ' ' THR . 79.6 t -58.02 -44.58 87.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.63 -0.714 . . . . 12.67 110.288 175.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -62.11 -30.43 71.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.299 -0.864 . . . . 15.32 110.823 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.576 ' O ' ' HG2' ' A' ' 163' ' ' LYS . 24.4 mt-10 -69.39 -61.95 1.58 Allowed 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 120.906 0.384 . . . . 15.970000000000001 110.167 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.428 HD12 HG13 ' A' ' 186' ' ' ILE . 27.8 mt -51.5 -46.22 35.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.045 -0.979 . . . . 12.6 111.143 -175.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.8 t -73.11 -34.51 45.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.724 -0.671 . . . . 12.539999999999999 110.288 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.8 -32.4 82.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.786 -0.721 . . . . 14.800000000000001 112.117 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 159' ' ' GLU . 48.7 mmtt -67.78 -51.05 53.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.266 0.555 . . . . 16.050000000000001 109.657 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.622 ' HB3' HG21 ' A' ' 171' ' ' VAL . 20.9 mt -87.03 -56.01 3.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.899 1.074 . . . . 12.99 113.899 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.407 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 47.2 ttp180 -70.13 -29.27 66.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.69 -0.855 . . . . 15.06 108.69 -174.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.7 -24.98 76.03 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.834 -1.076 . . . . 16.600000000000001 111.851 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.74 -5.05 59.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.213 0.53 . . . . 16.140000000000001 110.549 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.0 24.77 16.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.797 -0.716 . . . . 15.119999999999999 113.261 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -94.04 155.39 17.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.307 0.554 . . . . 15.49 110.783 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -71.63 98.24 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.621 -0.511 . . . . 13.869999999999999 109.621 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.799 HG22 HG22 ' A' ' 188' ' ' VAL . 6.7 t -133.17 125.69 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-N 115.589 -0.732 . . . . 10.82 111.123 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -135.33 175.24 9.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.265 -0.879 . . . . 11.130000000000001 110.602 176.306 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.4 p -117.09 -175.91 2.88 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.844 -1.071 . . . . 11.52 111.926 -169.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.78 153.65 5.62 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.633 -0.712 . . . . 12.75 111.598 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -42.13 -67.15 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.065 3.177 . . . . 14.640000000000001 115.19 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.1 m -76.55 -63.08 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.768 0.655 . . . . 16.68 112.768 -167.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.1 m -169.42 130.33 1.01 Allowed Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 112.226 0.454 . . . . 16.039999999999999 112.226 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.515 ' HB3' HG21 ' A' ' 184' ' ' THR . 50.1 Cg_exo -63.28 124.6 14.12 Favored 'Trans proline' 0 CA--C 1.519 -0.265 0 C-N-CA 122.771 2.314 . . . . 14.220000000000001 111.927 162.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.9 p -153.45 153.51 8.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.557 -0.534 . . . . 16.129999999999999 109.557 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -70.44 122.09 18.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.979 -0.555 . . . . 16.699999999999999 110.73 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.46 -26.45 14.71 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.621 -0.718 . . . . 16.98 112.407 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 13.2 mptt -108.18 156.28 19.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.961 0.41 . . . . 18.73 110.677 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.9 tp -71.2 117.28 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.681 -0.69 . . . . 14.82 111.462 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 178' ' ' PRO . 38.0 m -111.54 112.45 24.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.635 -0.711 . . . . 12.779999999999999 110.188 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 91.1 mtt180 -86.84 144.99 26.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.923 -0.581 . . . . 13.98 109.571 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.635 ' C ' HD12 ' A' ' 187' ' ' LEU . 5.2 mm -113.11 124.05 69.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.297 -0.631 . . . . 10.56 109.297 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.6 mp -129.15 129.08 44.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.487 0.661 . . . . 10.1 111.241 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 148' ' ' LEU . 39.8 t -100.58 142.18 16.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.991 -1.004 . . . . 9.7400000000000002 110.401 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.15 49.96 11.5 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.34 -0.845 . . . . 9.7599999999999998 113.932 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.674 ' HA ' HG12 ' A' ' 145' ' ' VAL . 13.7 Cg_endo -63.77 124.83 14.28 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 CA-C-N 119.915 1.857 . . . . 11.15 110.273 168.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.422 ' HB3' HD22 ' A' ' 197' ' ' LEU . 5.9 t70 -162.94 150.35 13.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.91 -0.586 . . . . 12.77 109.593 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.499 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -91.32 -9.3 45.47 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.919 -0.582 . . . . 14.6 110.944 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.3 t -97.37 102.32 14.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.173 0.511 . . . . 14.300000000000001 110.312 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.654 ' HG3' ' CE1' ' A' ' 144' ' ' TYR . 19.8 ttmt -64.54 -42.85 95.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.702 -0.681 . . . . 15.970000000000001 110.204 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.77 -51.91 67.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.127 0.489 . . . . 15.6 111.208 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -63.53 -51.47 65.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.602 -0.726 . . . . 14.220000000000001 111.431 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 191' ' ' ASP . 0.1 OUTLIER -87.01 -37.71 17.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.014 0.746 . . . . 11.949999999999999 113.014 -169.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.53 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 14.5 tmtt? -80.95 -20.51 41.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.499 0.666 . . . . 14.699999999999999 109.69 -168.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -82.84 -12.43 79.83 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.312 -1.115 . . . . 13.09 110.312 172.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 32.0 m -90.39 -7.62 52.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.825 -0.688 . . . . 12.109999999999999 112.547 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 15.8 mt -59.33 -36.58 75.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.592 0.234 . . . . 12.720000000000001 111.392 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -56.97 -46.69 90.92 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.909 -0.663 . . . . 14.66 112.189 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.37 -16.87 41.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.686 0.279 . . . . 13.890000000000001 110.701 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.538 HD12 HD12 ' A' ' 207' ' ' LEU . 2.6 tp -66.66 -26.95 67.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.048 0.451 . . . . 12.550000000000001 110.502 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.546 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 70.6 mmtt -61.08 -17.58 53.28 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.198 -0.455 . . . . 15.83 110.524 172.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -90.32 -39.74 12.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.349 0.595 . . . . 16.969999999999999 109.521 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.538 HD12 HD12 ' A' ' 204' ' ' LEU . 84.5 mt -61.85 -52.95 62.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.227 -0.897 . . . . 13.890000000000001 111.642 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 23.0 p -99.96 -47.5 4.99 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.314 -0.555 . . . . 13.539999999999999 110.244 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.35 5.31 71.89 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.576 -0.738 . . . . 14.67 112.793 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.613 HD22 HD11 ' A' ' 164' ' ' LEU . 9.1 mp -95.64 158.47 15.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.18 -0.674 . . . . 13.039999999999999 109.18 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 19.4 t -76.5 93.44 3.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.085 0.469 . . . . 14.84 110.527 -173.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -114.12 140.8 16.6 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.713 -0.676 . . . . 12.220000000000001 113.264 -176.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 p -105.81 146.73 12.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.135 0.493 . . . . 13.74 110.265 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 5.5 p -73.17 114.01 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.153 -0.93 . . . . 12.890000000000001 111.406 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.53 141.75 51.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.028 -0.533 . . . . 13.800000000000001 110.202 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -81.49 126.94 7.65 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.246 -0.978 . . . . 13.359999999999999 111.603 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.502 ' HB2' HG22 ' A' ' 145' ' ' VAL . 4.8 t80 . . . . . 0 C--N 1.316 -0.868 0 C-N-CA 124.075 0.95 . . . . 14.24 110.561 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.582 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 108.904 -0.776 . . . . 14.65 108.904 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.608 ' CE1' ' HD3' ' A' ' 194' ' ' LYS . 7.6 m-85 -144.74 155.85 43.76 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.879 0.325 . . . . 14.81 111.879 -175.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.775 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.4 t -149.62 159.94 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.882 -0.784 . . . . 10.48 108.882 173.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 58.4 t -101.0 110.02 26.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 O-C-N 122.069 -0.394 . . . . 10.1 110.803 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -86.74 108.92 18.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.569 -0.287 . . . . 12.0 111.051 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.895 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -83.97 -40.55 18.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.228 0.537 . . . . 11.880000000000001 109.953 -176.558 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.38 165.85 28.22 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.544 -0.836 . . . . 11.35 112.526 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.481 ' C ' HD13 ' A' ' 151' ' ' LEU . . . -156.75 101.22 1.96 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.512 -0.551 . . . . 13.470000000000001 109.512 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.481 HD13 ' C ' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -119.57 159.25 24.71 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.38 0.609 . . . . 13.52 110.028 -174.299 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 39.3 mttm -101.56 24.49 9.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.888 -1.153 . . . . 17.600000000000001 107.888 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -136.37 110.86 8.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.724 -1.58 . . . . 16.140000000000001 109.114 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.407 ' HA ' ' CG2' ' A' ' 157' ' ' VAL . . . -70.76 -19.12 62.75 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.204 0.446 . . . . 14.039999999999999 112.204 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -64.32 -31.34 72.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.663 0.744 . . . . 16.57 109.563 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.462 ' HD2' HD11 ' A' ' 160' ' ' ILE . 3.8 tmtm? -77.87 -38.62 45.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.396 -1.275 . . . . 16.399999999999999 109.026 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.407 ' CG2' ' HA ' ' A' ' 154' ' ' ALA . 94.4 t -56.44 -42.74 75.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.955 -1.021 . . . . 12.67 110.517 176.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -58.68 -29.6 66.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.581 -0.736 . . . . 15.32 112.146 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.525 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 8.5 mm-40 -79.56 -60.81 2.21 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.6 -0.519 . . . . 15.970000000000001 109.6 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.462 HD11 ' HD2' ' A' ' 156' ' ' LYS . 11.4 mt -50.97 -44.3 27.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.278 -0.874 . . . . 12.6 110.673 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 84.9 t -76.49 -37.3 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.659 -0.7 . . . . 12.539999999999999 110.376 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.17 -28.79 71.29 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.669 -0.777 . . . . 14.800000000000001 112.053 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 1.0 OUTLIER -71.29 -52.27 19.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.66 0.266 . . . . 16.050000000000001 111.071 177.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.515 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 3.8 mm? -86.0 -55.59 3.87 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.043 0.386 . . . . 12.99 112.043 -175.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 24.5 ttt180 -61.7 -42.99 99.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.456 0.646 . . . . 15.06 109.82 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.82 -11.2 62.59 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.824 -1.08 . . . . 16.600000000000001 112.973 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.62 -2.19 22.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 16.140000000000001 110.714 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.94 56.13 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.233 -0.508 . . . . 15.119999999999999 113.569 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -82.58 155.44 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.241 -0.564 . . . . 15.49 110.369 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 170' ' ' ARG . 36.1 mmt180 -71.4 104.39 3.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.74 0.781 . . . . 13.869999999999999 110.211 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.19 141.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 114.454 -1.248 . . . . 10.82 109.48 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.37 175.49 9.55 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.635 0.731 . . . . 11.130000000000001 110.635 169.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.437 ' HB ' ' HG3' ' A' ' 178' ' ' PRO . 7.1 p -120.75 -173.96 2.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.625 -1.17 . . . . 11.52 112.294 -168.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.632 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -50.21 151.12 3.83 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 115.161 -0.927 . . . . 12.75 112.982 -177.061 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -23.9 -70.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 1 C-N-CA 126.093 4.529 . . . . 14.640000000000001 115.281 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.1 m -88.95 -62.12 1.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.242 -0.583 . . . . 16.68 112.313 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 97.6 m -167.58 132.08 1.53 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 111.453 0.168 . . . . 16.039999999999999 111.453 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.448 ' HB3' HG21 ' A' ' 184' ' ' THR . 73.4 Cg_exo -56.75 125.76 20.06 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.54 2.16 . . . . 14.220000000000001 111.741 166.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.3 p -148.71 160.26 6.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.643 -0.503 . . . . 16.129999999999999 109.643 -174.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -72.55 133.47 44.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.527 -0.306 . . . . 16.699999999999999 110.739 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.08 -25.61 11.8 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.213 -0.518 . . . . 16.98 114.116 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.501 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.3 OUTLIER -102.94 168.06 9.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.36 0.58 . . . . 18.73 110.67 -176.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.6 tp -76.29 110.5 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.973 0.892 . . . . 14.82 111.766 -174.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.448 HG21 ' HB3' ' A' ' 178' ' ' PRO . 48.8 m -104.9 107.59 18.64 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.496 -0.775 . . . . 12.779999999999999 109.464 173.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.632 ' H ' ' HB3' ' A' ' 174' ' ' SER . 6.4 ptm180 -90.42 133.71 34.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.408 -0.815 . . . . 13.98 109.675 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.556 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.3 mm -104.91 122.52 58.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.76 -0.459 . . . . 10.56 109.76 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.556 HD12 ' C ' ' A' ' 186' ' ' ILE . 5.1 mp -129.68 126.46 38.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.258 0.552 . . . . 10.1 111.153 -174.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.895 HG23 HD21 ' A' ' 148' ' ' LEU . 38.5 t -102.38 134.77 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.474 -0.784 . . . . 9.7400000000000002 110.997 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.06 49.86 4.83 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.001 -1.0 . . . . 9.7599999999999998 113.66 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.775 ' HA ' HG22 ' A' ' 145' ' ' VAL . 10.2 Cg_endo -58.86 125.09 17.22 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 119.441 1.621 . . . . 11.15 110.698 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -152.19 151.73 31.36 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.458 -0.497 . . . . 12.77 110.393 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -92.06 -7.0 49.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.824 -0.625 . . . . 14.6 111.706 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.4 p -118.29 104.98 11.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.341 0.591 . . . . 14.300000000000001 111.375 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.608 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 36.7 ttpt -58.47 -51.89 67.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.693 -1.139 . . . . 15.970000000000001 110.787 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.11 -44.97 83.75 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.158 -0.474 . . . . 15.6 111.191 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -62.63 -48.28 80.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.745 -0.661 . . . . 14.220000000000001 111.017 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -77.73 -20.39 53.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 11.949999999999999 110.935 -175.007 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.7 tptm -65.31 -39.02 91.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.516 0.674 . . . . 14.699999999999999 109.917 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -79.14 -12.43 84.04 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.498 -1.041 . . . . 13.09 110.498 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 59.0 m -84.08 -10.69 57.63 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.823 -0.689 . . . . 12.109999999999999 111.82 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 29.6 mt -64.77 -34.72 79.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.833 0.349 . . . . 12.720000000000001 110.995 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -61.68 -39.06 96.91 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.793 -0.718 . . . . 14.66 112.401 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.495 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 10.3 pt-20 -86.26 -22.2 26.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.876 0.369 . . . . 13.890000000000001 110.99 177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.6 tp -74.83 -31.47 61.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 12.550000000000001 111.272 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.582 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 20.2 ptmt -68.17 -15.09 63.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.111 0.481 . . . . 15.83 110.382 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.9 -30.67 17.71 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.177 0.513 . . . . 16.969999999999999 109.982 171.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 91.3 mt -76.44 -51.89 10.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.793 -0.64 . . . . 13.890000000000001 111.527 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.472 ' HB3' HD11 ' A' ' 164' ' ' LEU . 44.3 p -95.56 -43.93 7.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.354 0.597 . . . . 13.539999999999999 110.213 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 70.01 3.85 46.05 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 114.899 -1.046 . . . . 14.67 112.579 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.44 153.3 18.01 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 109.572 -0.529 . . . . 13.039999999999999 109.572 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 24.2 t -85.33 107.25 17.25 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.01 -0.541 . . . . 14.84 110.53 -175.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -127.48 163.27 21.29 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.346 -0.93 . . . . 12.220000000000001 113.435 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.87 145.8 12.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.039 -0.58 . . . . 13.74 109.748 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.61 104.85 3.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.104 -0.702 . . . . 12.890000000000001 109.104 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 92.8 mmm -117.06 141.8 47.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.168 -0.469 . . . . 13.800000000000001 110.447 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.21 155.09 51.31 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.494 -0.86 . . . . 13.359999999999999 111.698 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.704 ' HB2' HG23 ' A' ' 145' ' ' VAL . 10.9 t80 . . . . . 0 C--N 1.309 -1.185 0 C-N-CA 123.082 0.553 . . . . 14.24 110.286 -169.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 110.125 -0.324 . . . . 14.65 110.125 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CD2' ' HG3' ' A' ' 194' ' ' LYS . 4.7 m-85 -143.03 158.44 43.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.17 -0.468 . . . . 14.81 111.685 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.673 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.2 m -151.77 152.82 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.715 -0.675 . . . . 10.48 110.633 -176.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 60.3 t -108.73 108.35 25.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 120.862 0.363 . . . . 10.1 111.262 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -85.26 108.94 18.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.54 -0.3 . . . . 12.0 110.871 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -84.92 -36.64 21.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.138 0.494 . . . . 11.880000000000001 109.924 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.34 164.15 28.38 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.583 -0.818 . . . . 11.35 112.674 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -161.21 101.21 1.23 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.02 0.438 . . . . 13.470000000000001 109.822 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.8 168.37 18.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.293 0.568 . . . . 13.52 110.586 -174.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -100.39 -5.6 26.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.866 -1.061 . . . . 17.600000000000001 109.837 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -105.45 106.58 17.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.122 -0.945 . . . . 16.140000000000001 109.844 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.13 -19.42 65.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.798 -0.637 . . . . 14.039999999999999 111.266 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.93 -29.78 70.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.516 0.674 . . . . 16.57 110.24 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -89.85 -27.23 20.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.149 -0.932 . . . . 16.399999999999999 109.327 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.471 HG11 HG21 ' A' ' 184' ' ' THR . 74.2 t -60.7 -35.62 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.441 -0.799 . . . . 12.67 109.922 173.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.17 -26.81 66.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.437 -0.802 . . . . 15.32 111.59 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.468 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 3.9 mm-40 -70.95 -62.78 1.27 Allowed 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.48 -0.563 . . . . 15.970000000000001 109.48 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.819 HD12 HD12 ' A' ' 186' ' ' ILE . 13.8 mt -54.78 -46.49 74.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.622 -1.172 . . . . 12.6 110.514 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.474 HG23 HD13 ' A' ' 186' ' ' ILE . 85.0 t -72.04 -42.88 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.592 -0.731 . . . . 12.539999999999999 110.668 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.49 -27.77 66.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.627 -0.797 . . . . 14.800000000000001 111.804 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 159' ' ' GLU . 15.7 mttp -72.56 -57.93 3.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.491 -0.355 . . . . 16.050000000000001 111.021 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.7 mm? -82.87 -56.28 3.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.275 0.472 . . . . 12.99 112.275 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -62.53 -38.25 89.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.445 0.641 . . . . 15.06 109.7 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.08 -28.61 73.81 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.839 -1.073 . . . . 16.600000000000001 112.695 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.96 2.03 56.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.998 0.428 . . . . 16.140000000000001 110.879 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.83 23.59 55.32 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.979 -0.629 . . . . 15.119999999999999 113.313 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -85.66 154.59 21.57 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.645 -0.327 . . . . 15.49 110.22 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -68.52 99.34 0.96 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.366 0.603 . . . . 13.869999999999999 109.986 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.5 p -143.99 139.34 25.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 114.96 -1.018 . . . . 10.82 109.949 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.474 ' CE1' HG11 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -140.23 176.89 8.39 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.48 0.657 . . . . 11.130000000000001 110.508 172.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 p -126.49 -175.28 3.34 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.959 -1.019 . . . . 11.52 111.689 -169.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.519 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 2.9 p -52.24 149.51 9.81 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 115.94 -0.573 . . . . 12.75 111.876 -176.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -34.53 -58.07 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.797 3.664 . . . . 14.640000000000001 115.341 -171.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 31.7 t -87.91 -64.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.458 -0.897 . . . . 16.68 112.212 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 55.5 m -169.03 134.0 1.33 Allowed Pre-proline 0 CA--C 1.53 0.196 0 O-C-N 122.389 -0.195 . . . . 16.039999999999999 111.282 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.538 ' HB3' HG21 ' A' ' 184' ' ' THR . 72.5 Cg_exo -59.52 123.27 12.98 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.245 1.963 . . . . 14.220000000000001 111.58 165.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 8.6 p -153.92 159.87 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 109.767 -0.457 . . . . 16.129999999999999 109.767 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.51 122.42 27.0 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.935 -0.394 . . . . 16.699999999999999 109.935 -177.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 110.02 -26.48 13.78 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.766 -0.652 . . . . 16.98 112.155 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.448 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.5 OUTLIER -106.93 158.44 17.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.411 -0.588 . . . . 18.73 109.411 175.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.6 tp -74.56 122.24 27.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.524 0.678 . . . . 14.82 111.156 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 56.0 m -111.34 105.0 13.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.81 -0.632 . . . . 12.779999999999999 110.202 174.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.519 ' H ' ' HB3' ' A' ' 174' ' ' SER . 97.3 mtt180 -84.03 138.05 33.28 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.984 -0.747 . . . . 13.98 108.984 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.819 HD12 HD12 ' A' ' 160' ' ' ILE . 4.2 mt -115.58 122.13 68.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.332 -0.618 . . . . 10.56 109.332 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 186' ' ' ILE . 3.8 mp -128.79 127.08 41.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.7 -0.682 . . . . 10.1 111.171 -168.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 148' ' ' LEU . 50.5 t -100.7 143.13 14.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.034 -0.985 . . . . 9.7400000000000002 110.418 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.99 48.43 7.71 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.192 -0.913 . . . . 9.7599999999999998 113.76 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.673 ' HA ' HG12 ' A' ' 145' ' ' VAL . 18.7 Cg_endo -66.24 123.62 11.45 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 CA-C-N 119.831 1.815 . . . . 11.15 110.568 172.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.1 158.55 36.6 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.548 -0.751 . . . . 12.77 109.386 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.479 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -92.6 -19.54 21.81 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.66 -0.7 . . . . 14.6 110.707 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 35.6 p -91.96 90.93 7.63 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.582 0.706 . . . . 14.300000000000001 110.863 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.52 ' HG3' ' CD2' ' A' ' 144' ' ' TYR . 27.7 ttpt -52.68 -51.88 58.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.562 -1.199 . . . . 15.970000000000001 110.905 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -57.71 -45.61 85.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.765 -0.652 . . . . 15.6 111.242 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -75.45 -38.03 59.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.903 -0.589 . . . . 14.220000000000001 111.591 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.1 OUTLIER -79.09 -20.07 49.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.263 0.554 . . . . 11.949999999999999 110.246 -178.881 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.434 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 54.1 tptt -64.97 -40.73 95.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.587 0.708 . . . . 14.699999999999999 110.219 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.24 -12.57 84.48 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.169 -0.923 . . . . 13.09 110.797 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.433 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 58.5 m -85.53 -9.04 57.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.716 -0.742 . . . . 12.109999999999999 112.236 -176.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.563 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 31.2 mt -65.91 -38.53 88.96 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.733 0.301 . . . . 12.720000000000001 111.361 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.34 -38.29 96.18 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.738 -0.744 . . . . 14.66 112.279 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 11.4 pt-20 -82.16 -18.63 42.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.096 0.474 . . . . 13.890000000000001 110.16 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.438 HD11 HG12 ' A' ' 188' ' ' VAL . 17.0 tp -74.02 -30.86 62.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.197 -0.456 . . . . 12.550000000000001 110.244 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 85.1 mttt -64.33 -19.96 65.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.284 0.564 . . . . 15.83 109.727 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.59 -29.99 18.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.512 -0.767 . . . . 16.969999999999999 110.288 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 82.4 mt -78.58 -53.04 7.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.827 -0.624 . . . . 13.890000000000001 111.701 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 164' ' ' LEU . 68.4 p -94.71 -44.0 8.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.418 0.628 . . . . 13.539999999999999 110.46 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 67.46 13.85 63.6 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.727 -1.124 . . . . 14.67 112.286 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.45 HD13 HG23 ' A' ' 160' ' ' ILE . 85.3 mt -103.85 152.72 21.58 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.188 -0.671 . . . . 13.039999999999999 109.188 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 10.9 t -88.69 108.84 19.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.106 0.479 . . . . 14.84 110.448 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -125.71 161.04 20.22 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.327 -0.939 . . . . 12.220000000000001 113.216 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.7 p -102.09 144.01 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.216 0.532 . . . . 13.74 110.433 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.78 105.8 8.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.26 -0.882 . . . . 12.890000000000001 110.263 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 84.2 mmm -115.35 148.64 39.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.931 -0.577 . . . . 13.800000000000001 110.404 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -78.26 132.65 11.94 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.225 -0.988 . . . . 13.359999999999999 111.698 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.592 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 7.3 t80 . . . . . 0 C--N 1.312 -1.064 0 C-N-CA 123.297 0.639 . . . . 14.24 109.607 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.772 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 109.535 -0.542 . . . . 14.65 109.535 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.695 ' CE2' ' HB2' ' A' ' 194' ' ' LYS . 4.4 m-85 -136.76 140.16 42.36 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 111.745 0.276 . . . . 14.81 111.745 -174.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 1.026 HG23 ' HB2' ' A' ' 217' ' ' TYR . 3.2 t -148.91 163.79 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.229 -0.656 . . . . 10.48 109.229 171.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.489 HG11 HD22 ' A' ' 204' ' ' LEU . 40.1 t -105.54 113.26 41.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 O-C-N 121.787 -0.571 . . . . 10.1 111.267 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.52 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 49.6 tt0 -86.01 116.83 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.636 -0.256 . . . . 12.0 111.551 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.984 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -93.35 -35.09 13.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.088 0.47 . . . . 11.880000000000001 110.21 -178.618 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -147.25 169.38 28.25 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.454 -0.879 . . . . 11.35 112.569 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -163.58 105.39 0.96 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.865 -0.791 . . . . 13.470000000000001 108.865 177.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -138.91 159.36 42.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.21 0.529 . . . . 13.52 110.909 -171.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 9.2 mmmm -96.93 -3.46 41.76 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.12 -0.945 . . . . 17.600000000000001 110.162 -174.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -111.91 115.87 29.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.371 -0.832 . . . . 16.140000000000001 110.338 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.6 65.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 14.039999999999999 111.007 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.14 -32.4 69.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.669 0.747 . . . . 16.57 110.199 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.528 ' HB3' HD22 ' A' ' 151' ' ' LEU . 32.5 mmtp -89.47 -31.27 17.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.739 -1.119 . . . . 16.399999999999999 110.368 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' THR . 94.9 t -61.89 -40.99 89.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.488 -0.778 . . . . 12.67 110.135 175.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -54.83 -36.38 64.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.078 -0.964 . . . . 15.32 111.056 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 18.5 mt-10 -69.13 -60.78 2.12 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.174 0.511 . . . . 15.970000000000001 110.057 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.55 HG23 HD13 ' A' ' 210' ' ' LEU . 7.9 mt -56.03 -45.19 80.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.074 -0.966 . . . . 12.6 110.971 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.3 t -74.74 -41.22 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.758 -0.656 . . . . 12.539999999999999 110.451 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.95 -28.54 66.27 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.547 -0.835 . . . . 14.800000000000001 111.763 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 159' ' ' GLU . 15.5 mttp -73.74 -56.73 4.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.612 0.244 . . . . 16.050000000000001 111.41 177.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.4 mm? -82.56 -51.73 7.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.093 0.405 . . . . 12.99 112.093 -174.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -65.84 -41.59 91.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.246 0.546 . . . . 15.06 109.653 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.23 -24.16 76.05 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.369 -0.832 . . . . 16.600000000000001 112.745 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.87 4.55 52.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.034 0.445 . . . . 16.140000000000001 110.877 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.61 25.11 47.88 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.956 -0.64 . . . . 15.119999999999999 113.54 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -89.65 160.12 16.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.159 0.48 . . . . 15.49 110.252 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.96 102.7 8.44 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.554 0.692 . . . . 13.869999999999999 109.379 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.84 139.8 27.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.753 -1.112 . . . . 10.82 109.87 -173.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.564 ' CE1' HG21 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -138.71 176.32 8.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.686 0.755 . . . . 11.130000000000001 110.723 172.189 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.421 ' HB ' ' HG3' ' A' ' 178' ' ' PRO . 4.5 p -123.3 -172.63 2.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.46 -1.245 . . . . 11.52 112.239 -167.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.669 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 0.9 OUTLIER -49.51 158.6 0.78 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.345 -0.843 . . . . 12.75 112.864 -177.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -47.36 -54.29 5.28 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.608 2.872 . . . . 14.640000000000001 113.904 -170.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.9 m -88.19 -64.09 1.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.705 -0.798 . . . . 16.68 112.227 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 42.1 m -169.26 137.93 1.63 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 122.336 0.255 . . . . 16.039999999999999 110.534 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.475 ' HB3' HG21 ' A' ' 184' ' ' THR . 76.1 Cg_exo -59.83 123.56 13.51 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.213 1.942 . . . . 14.220000000000001 111.306 165.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 12.2 p -154.66 159.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 116.177 -0.465 . . . . 16.129999999999999 110.487 -174.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -80.85 127.0 32.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.18 -0.464 . . . . 16.699999999999999 110.745 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 100.45 -16.45 57.87 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.981 -0.628 . . . . 16.98 112.221 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 8.5 mptt -120.84 162.5 19.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.787 -0.449 . . . . 18.73 109.787 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 152' ' ' LYS . 9.7 tp -73.38 120.11 21.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.69 0.757 . . . . 14.82 111.771 -172.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.482 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 37.8 m -113.16 105.37 13.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.432 -0.804 . . . . 12.779999999999999 109.747 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.669 ' H ' ' HB3' ' A' ' 174' ' ' SER . 15.8 ptt180 -88.18 136.25 33.06 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.362 -0.836 . . . . 13.98 109.584 176.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.537 ' C ' HD12 ' A' ' 187' ' ' LEU . 4.1 mm -110.39 123.1 65.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.677 -0.49 . . . . 10.56 109.677 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.555 ' HB3' ' CG1' ' A' ' 145' ' ' VAL . 4.5 mp -130.11 132.42 46.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.463 0.649 . . . . 10.1 111.441 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.984 HG23 HD21 ' A' ' 148' ' ' LEU . 26.4 t -107.57 132.72 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.053 -0.976 . . . . 9.7400000000000002 111.015 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.22 49.78 4.32 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.174 -0.921 . . . . 9.7599999999999998 113.58 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.929 ' HA ' HG22 ' A' ' 145' ' ' VAL . 9.3 Cg_endo -59.71 126.11 19.64 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 CA-C-N 119.515 1.657 . . . . 11.15 111.367 173.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -157.63 167.75 29.23 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.124 -0.695 . . . . 12.77 109.124 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -107.89 5.95 26.87 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.029 0.442 . . . . 14.6 110.706 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 48.1 m -120.4 107.37 12.83 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.153 -0.476 . . . . 14.300000000000001 111.254 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.695 ' HB2' ' CE2' ' A' ' 144' ' ' TYR . 35.1 ttpt -66.67 -40.4 88.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.81 -0.632 . . . . 15.970000000000001 110.023 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -62.49 -39.7 94.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.686 -0.688 . . . . 15.6 110.857 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -51.22 36.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.626 -0.715 . . . . 14.220000000000001 110.493 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.657 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -74.06 -18.85 60.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.484 . . . . 11.949999999999999 110.725 -175.596 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.54 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 17.4 tppt? -62.93 -39.57 95.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.197 0.522 . . . . 14.699999999999999 110.325 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.02 -17.38 79.85 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.09 -1.204 . . . . 13.09 110.09 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 31.0 m -79.39 -8.92 59.44 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.564 -0.818 . . . . 12.109999999999999 112.037 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 13.8 mt -70.81 -37.33 73.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.936 0.398 . . . . 12.720000000000001 110.378 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.23 -25.32 71.05 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.648 -0.981 . . . . 14.66 110.648 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.605 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 41.6 mt-10 -86.39 -24.43 25.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.941 -0.629 . . . . 13.890000000000001 110.534 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.489 HD22 HG11 ' A' ' 146' ' ' VAL . 3.0 tp -60.3 -48.25 82.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.425 -0.352 . . . . 12.550000000000001 111.103 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.0 -21.21 58.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 15.83 111.396 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -38.65 13.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 16.969999999999999 110.436 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 93.1 mt -72.75 -51.85 17.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.073 -0.512 . . . . 13.890000000000001 111.615 -176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.405 ' HB3' HD11 ' A' ' 164' ' ' LEU . 64.7 p -101.87 -43.32 5.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.222 0.534 . . . . 13.539999999999999 110.919 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.39 6.18 74.84 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.908 -0.877 . . . . 14.67 110.908 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.55 HD13 HG23 ' A' ' 160' ' ' ILE . 60.3 mt -97.74 157.91 15.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.787 -0.449 . . . . 13.039999999999999 109.787 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 17.7 p -81.12 95.61 6.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.011 0.434 . . . . 14.84 111.315 -176.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -108.23 142.34 15.95 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.727 -0.749 . . . . 12.220000000000001 114.127 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.1 142.39 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.526 -0.546 . . . . 13.74 109.526 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.38 107.02 4.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.109 -0.496 . . . . 12.890000000000001 110.512 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 23.9 mmt -109.0 141.54 40.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.741 -0.663 . . . . 13.800000000000001 109.817 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.55 107.34 2.34 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.169 -1.015 . . . . 13.359999999999999 111.748 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 1.026 ' HB2' HG23 ' A' ' 145' ' ' VAL . 6.1 t80 . . . . . 0 C--N 1.308 -1.212 0 CA-C-N 113.147 -1.526 . . . . 14.24 111.066 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.577 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 CA--C 1.518 -0.263 0 N-CA-C 109.133 -0.691 . . . . 14.65 109.133 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.595 ' CE2' ' HD3' ' A' ' 194' ' ' LYS . 4.3 m-85 -143.47 155.43 44.36 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.487 0.551 . . . . 14.81 112.487 -175.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.797 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.5 t -148.39 167.07 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.252 -1.018 . . . . 10.48 108.252 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 59.0 t -107.62 112.85 41.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 O-C-N 121.686 -0.633 . . . . 10.1 111.31 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.555 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 48.9 tt0 -84.52 114.54 22.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.355 -0.384 . . . . 12.0 111.381 -176.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.91 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -96.45 -33.07 12.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.391 0.615 . . . . 11.880000000000001 110.169 -178.81 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.29 168.39 27.18 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.47 -0.786 . . . . 11.35 112.169 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -170.93 101.49 0.22 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.0 -0.741 . . . . 13.470000000000001 109.0 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.81 164.65 35.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.86 -0.609 . . . . 13.52 110.785 -173.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 32.4 mtmm -101.6 15.32 29.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.128 -0.942 . . . . 17.600000000000001 110.389 -173.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -109.87 105.14 14.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.153 -0.93 . . . . 16.140000000000001 108.96 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.36 -22.13 63.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.199 -0.455 . . . . 14.039999999999999 111.682 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.48 -38.22 89.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.928 0.871 . . . . 16.57 109.292 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -75.43 -29.79 59.83 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.309 -1.314 . . . . 16.399999999999999 110.119 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 89.3 t -63.29 -40.84 90.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.627 -0.715 . . . . 12.67 109.867 172.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -64.17 -22.23 66.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.644 -0.707 . . . . 15.32 111.954 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.698 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 14.5 mt-10 -78.0 -62.9 1.53 Allowed 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.143 -0.688 . . . . 15.970000000000001 109.143 176.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.535 HD12 HG13 ' A' ' 186' ' ' ILE . 10.3 mt -54.48 -48.47 69.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.599 -0.728 . . . . 12.6 110.949 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.85 -40.01 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.762 -0.654 . . . . 12.539999999999999 110.555 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.88 -28.91 72.66 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.462 -0.875 . . . . 14.800000000000001 112.138 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.698 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.6 mptp? -80.95 -49.3 11.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.4 0.148 . . . . 16.050000000000001 111.4 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.42 HD21 ' HA ' ' A' ' 208' ' ' SER . 0.7 OUTLIER -79.87 -55.85 4.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 12.99 111.484 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.401 ' HB2' ' CG1' ' A' ' 171' ' ' VAL . 69.0 ttt180 -66.89 -40.8 87.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.249 0.547 . . . . 15.06 110.313 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.76 -19.87 73.69 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.222 -0.899 . . . . 16.600000000000001 112.66 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.05 -5.59 57.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.808 0.337 . . . . 16.140000000000001 110.916 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.71 24.97 12.36 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.651 -0.785 . . . . 15.119999999999999 112.806 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -94.8 148.3 22.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.933 -0.395 . . . . 15.49 109.933 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -76.67 96.55 4.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.164 -0.68 . . . . 13.869999999999999 109.164 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 165' ' ' ARG . 7.4 p -142.62 143.74 25.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.404 -0.816 . . . . 10.82 109.456 -176.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.471 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -139.08 176.49 8.66 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.69 0.757 . . . . 11.130000000000001 110.85 176.267 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 20.2 p -113.93 -176.4 2.89 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.477 -1.238 . . . . 11.52 111.004 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.5 OUTLIER -53.16 141.33 40.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 O-C-N 123.166 0.291 . . . . 12.75 110.778 178.507 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -40.14 -47.49 4.05 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 124.484 3.456 . . . . 14.640000000000001 115.553 -169.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.3 m -85.44 -63.68 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.522 -0.871 . . . . 16.68 112.696 -171.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 98.8 m -168.49 129.94 1.14 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 118.375 0.534 . . . . 16.039999999999999 112.096 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.465 ' HB3' HG21 ' A' ' 184' ' ' THR . 74.7 Cg_exo -62.63 123.97 13.31 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.519 2.146 . . . . 14.220000000000001 111.713 161.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.491 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 7.7 p -154.01 159.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.63 -0.507 . . . . 16.129999999999999 109.63 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -81.47 129.15 34.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.967 0.413 . . . . 16.699999999999999 110.721 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 104.81 -25.79 24.43 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.058 -0.591 . . . . 16.98 112.376 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.491 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 2.8 mptp? -114.35 157.69 22.48 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.557 -0.534 . . . . 18.73 109.557 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.6 tp -69.82 109.93 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.594 0.711 . . . . 14.82 111.815 -173.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 178' ' ' PRO . 54.0 m -101.79 111.39 23.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.786 -0.643 . . . . 12.779999999999999 109.562 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 74.1 mtp180 -92.22 139.57 30.48 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.39 -0.823 . . . . 13.98 109.755 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.535 HG13 HD12 ' A' ' 160' ' ' ILE . 4.1 mm -109.6 118.86 57.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.251 -0.648 . . . . 10.56 109.251 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 186' ' ' ILE . 5.2 mp -129.81 120.88 25.72 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.386 0.612 . . . . 10.1 111.386 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.91 HG23 HD21 ' A' ' 148' ' ' LEU . 38.0 t -95.38 136.02 27.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.508 -0.769 . . . . 9.7400000000000002 110.822 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.46 47.9 5.52 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.316 -0.856 . . . . 9.7599999999999998 113.943 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.772 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.5 Cg_endo -61.36 126.21 18.74 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 CA-C-N 119.732 1.766 . . . . 11.15 110.998 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -155.04 154.56 32.66 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.512 -0.475 . . . . 12.77 110.376 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -95.02 -4.51 46.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.649 -0.705 . . . . 14.6 111.312 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.1 m -112.5 100.57 8.85 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.487 0.661 . . . . 14.300000000000001 110.431 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.595 ' HD3' ' CE2' ' A' ' 144' ' ' TYR . 22.1 ttpp -55.66 -59.78 4.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.461 -1.245 . . . . 15.970000000000001 112.011 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.13 -27.96 68.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.686 -0.688 . . . . 15.6 111.81 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -72.51 -37.8 68.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.423 0.63 . . . . 14.220000000000001 110.154 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -85.55 -23.52 27.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.791 -0.64 . . . . 11.949999999999999 110.444 -175.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.557 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 36.8 mttt -74.66 -32.77 62.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.054 0.454 . . . . 14.699999999999999 110.634 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -73.81 -12.63 80.88 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.965 -1.254 . . . . 13.09 109.965 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 47.7 m -90.67 -8.89 48.73 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.365 -0.917 . . . . 12.109999999999999 112.24 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 22.7 mt -66.14 -33.37 75.61 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.186 -0.321 . . . . 12.720000000000001 110.989 -175.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.81 -44.16 97.28 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.807 -0.711 . . . . 14.66 111.94 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.62 -17.93 34.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.635 0.255 . . . . 13.890000000000001 111.037 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.43 HD12 HD12 ' A' ' 207' ' ' LEU . 24.5 tp -70.15 -29.32 66.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.05 0.453 . . . . 12.550000000000001 109.996 -176.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 61.3 mttp -60.92 -22.66 64.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.61 -0.723 . . . . 15.83 110.861 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.57 -35.34 30.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.291 0.567 . . . . 16.969999999999999 109.754 174.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.43 HD12 HD12 ' A' ' 204' ' ' LEU . 82.2 mt -75.45 -52.47 10.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.417 -0.81 . . . . 13.890000000000001 111.453 -175.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.42 ' HA ' HD21 ' A' ' 164' ' ' LEU . 31.9 p -98.64 -45.07 6.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.031 0.444 . . . . 13.539999999999999 110.717 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 60.59 21.79 58.31 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.598 -0.728 . . . . 14.67 111.868 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.436 ' HB2' ' HG ' ' A' ' 148' ' ' LEU . 79.8 mt -98.47 158.09 15.81 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.126 -0.694 . . . . 13.039999999999999 109.126 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 16.9 p -73.72 92.61 2.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.822 0.344 . . . . 14.84 110.756 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -111.33 146.33 17.76 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.486 -0.864 . . . . 12.220000000000001 114.256 -174.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 49.1 t -117.01 140.97 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.356 -0.979 . . . . 13.74 108.356 170.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.495 HG21 ' HE2' ' A' ' 198' ' ' LYS . 6.3 p -76.14 106.51 6.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.792 0.806 . . . . 12.890000000000001 110.314 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 23.0 mmt -113.18 145.99 40.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.152 -0.931 . . . . 13.800000000000001 110.797 -174.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.7 139.53 27.64 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.628 -0.796 . . . . 13.359999999999999 112.861 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.797 ' HB2' HG23 ' A' ' 145' ' ' VAL . 9.2 t80 . . . . . 0 C--N 1.315 -0.894 0 C-N-CA 124.332 1.053 . . . . 14.24 110.123 -175.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.538 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 120.27 0.081 . . . . 14.65 110.939 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.73 ' CB ' HD21 ' A' ' 197' ' ' LEU . 3.6 m-85 -146.79 160.66 41.99 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.333 0.396 . . . . 14.81 111.783 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.695 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.5 t -151.12 165.58 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 108.811 -0.811 . . . . 10.48 108.811 173.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 47.7 t -106.57 113.6 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.379 0.536 . . . . 10.1 111.524 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.478 ' OE1' ' HD2' ' A' ' 185' ' ' ARG . 48.5 tt0 -89.86 109.09 20.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.815 0.302 . . . . 12.0 111.815 -175.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -86.8 -36.04 18.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.29 0.566 . . . . 11.880000000000001 110.059 -177.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.59 170.18 26.29 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.603 -0.808 . . . . 11.35 112.456 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.67 107.59 0.39 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.468 -0.568 . . . . 13.470000000000001 109.468 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.89 43.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.392 0.615 . . . . 13.52 110.614 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 30.7 mtmm -97.82 8.24 45.04 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.951 -1.022 . . . . 17.600000000000001 109.94 -176.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.507 ' HA ' ' OE1' ' A' ' 180' ' ' GLN . 18.0 m120 -106.85 106.17 16.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.022 -0.99 . . . . 16.140000000000001 109.692 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.44 -26.17 68.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.067 -0.515 . . . . 14.039999999999999 111.067 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.61 -38.82 78.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.64 0.733 . . . . 16.57 109.969 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 160' ' ' ILE . 65.6 mttm -86.16 -17.92 33.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.783 -1.099 . . . . 16.399999999999999 110.305 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.447 HG11 HG21 ' A' ' 184' ' ' THR . 71.8 t -68.49 -44.14 83.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.063 -0.717 . . . . 12.67 109.063 170.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -63.1 -29.07 70.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.894 -1.048 . . . . 15.32 111.98 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.414 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.0 pt-20 -78.4 -48.48 15.4 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.641 -0.424 . . . . 15.970000000000001 110.866 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 156' ' ' LYS . 24.8 mt -60.17 -46.87 94.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.545 0.688 . . . . 12.6 109.713 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.477 HG13 ' CB ' ' A' ' 165' ' ' ARG . 43.4 t -63.85 -33.72 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.729 -1.123 . . . . 12.539999999999999 110.349 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.69 -34.6 82.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.209 -0.519 . . . . 14.800000000000001 112.616 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.1 mptp? -70.45 -52.23 23.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.4 . . . . 16.050000000000001 110.662 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.586 HD13 ' CG2' ' A' ' 188' ' ' VAL . 2.8 mt -87.87 -58.31 2.62 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.518 0.933 . . . . 12.99 113.518 -172.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.477 ' CB ' HG13 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -62.73 -37.04 85.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.394 0.616 . . . . 15.06 109.411 -176.227 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.08 -25.68 74.11 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.111 -0.95 . . . . 16.600000000000001 112.197 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.7 -2.98 58.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.948 0.404 . . . . 16.140000000000001 110.599 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.46 25.49 33.01 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.836 -0.697 . . . . 15.119999999999999 113.104 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -89.61 153.18 20.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.02 0.41 . . . . 15.49 110.462 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.52 100.48 1.42 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.198 0.523 . . . . 13.869999999999999 109.833 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.37 140.65 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.124 -0.944 . . . . 10.82 109.828 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.499 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.83 176.69 8.59 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.575 0.702 . . . . 11.130000000000001 110.935 172.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 20.3 p -122.47 -174.35 2.89 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.656 -1.156 . . . . 11.52 111.034 -171.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 67.4 m -51.83 142.29 25.26 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-O 121.218 0.533 . . . . 12.75 110.818 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 82.8 Cg_exo -49.22 -38.2 41.0 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 124.008 3.139 . . . . 14.640000000000001 115.179 -168.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 t -87.91 -65.68 0.99 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.813 -0.755 . . . . 16.68 112.261 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 70.7 m -170.17 128.5 0.81 Allowed Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 122.368 0.267 . . . . 16.039999999999999 110.94 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.531 ' HB3' HG21 ' A' ' 184' ' ' THR . 72.9 Cg_exo -60.02 121.88 10.52 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 121.848 1.699 . . . . 14.220000000000001 111.342 163.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.7 p -155.77 159.92 2.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.809 0.338 . . . . 16.129999999999999 110.538 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' A' ' 153' ' ' ASN . 9.2 mm100 -68.85 120.99 15.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.052 -0.522 . . . . 16.699999999999999 111.489 177.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.23 -26.22 17.58 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.805 -0.634 . . . . 16.98 112.798 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 13.6 mptt -103.07 154.65 19.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.977 -0.379 . . . . 18.73 109.977 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.7 tp -73.9 109.28 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.897 0.856 . . . . 14.82 110.836 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.531 HG21 ' HB3' ' A' ' 178' ' ' PRO . 29.2 m -101.91 107.06 18.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.605 0.717 . . . . 12.779999999999999 110.072 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.478 ' HD2' ' OE1' ' A' ' 147' ' ' GLN . 47.5 mtm180 -87.76 141.06 28.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.993 -1.003 . . . . 13.98 110.254 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.538 ' O ' HD22 ' A' ' 148' ' ' LEU . 4.4 mm -108.74 118.35 56.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.781 -0.822 . . . . 10.56 108.781 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.8 mp -128.9 130.85 47.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.487 0.661 . . . . 10.1 111.141 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 148' ' ' LEU . 43.9 t -107.24 136.52 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.102 -0.953 . . . . 9.7400000000000002 111.079 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 83.37 46.3 6.17 Favored Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 114.751 -1.113 . . . . 9.7599999999999998 113.432 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.695 ' HA ' HG22 ' A' ' 145' ' ' VAL . 10.9 Cg_endo -60.91 124.38 14.82 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 CA-C-N 119.674 1.737 . . . . 11.15 110.599 175.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -149.89 151.32 33.25 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.21 -0.663 . . . . 12.77 109.21 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.527 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -84.8 -11.91 54.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.367 -0.833 . . . . 14.6 111.581 -174.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.7 m -120.84 113.25 19.88 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.089 0.471 . . . . 14.300000000000001 110.954 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.657 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 20.8 ptmt -61.33 -36.29 79.75 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.504 -0.771 . . . . 15.970000000000001 111.305 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.35 -43.0 99.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.256 -0.429 . . . . 15.6 111.589 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -70.4 -39.01 74.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 14.220000000000001 110.531 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.73 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -84.37 -16.82 41.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.534 -0.757 . . . . 11.949999999999999 110.906 -176.028 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 0.8 OUTLIER -60.43 -34.96 74.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.661 0.743 . . . . 14.699999999999999 110.387 173.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.59 -12.87 81.12 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.712 -1.131 . . . . 13.09 110.494 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 69.7 m -82.2 -12.67 57.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.795 -0.702 . . . . 12.109999999999999 111.637 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 11.0 mt -69.44 -36.94 77.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.071 0.462 . . . . 12.720000000000001 109.934 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.09 -27.31 70.29 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.676 -0.773 . . . . 14.66 111.188 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.585 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 49.6 mt-10 -82.81 -27.32 30.99 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 110.142 -0.318 . . . . 13.890000000000001 110.142 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.76 -48.32 81.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.459 . . . . 12.550000000000001 111.621 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -56.76 -22.15 33.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.079 -0.51 . . . . 15.83 110.973 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -89.44 -45.52 9.38 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.816 -0.629 . . . . 16.969999999999999 110.162 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 96.3 mt -65.3 -52.39 54.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.975 -0.557 . . . . 13.890000000000001 111.694 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.501 ' HB3' HD21 ' A' ' 164' ' ' LEU . 70.1 p -100.05 -44.76 5.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.282 0.563 . . . . 13.539999999999999 110.558 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.47 7.84 69.65 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.264 -0.88 . . . . 14.67 111.095 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.13 155.32 17.52 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.466 -0.568 . . . . 13.039999999999999 109.466 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 26.3 t -89.03 108.0 19.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.497 -0.319 . . . . 14.84 110.438 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -129.2 158.04 21.9 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.508 -0.853 . . . . 12.220000000000001 113.316 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.96 145.12 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.187 0.518 . . . . 13.74 109.997 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.88 110.18 5.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.47 -0.786 . . . . 12.890000000000001 110.227 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 93.4 mmm -117.88 141.23 48.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.848 -0.615 . . . . 13.800000000000001 110.569 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -66.9 152.73 52.76 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.777 -0.725 . . . . 13.359999999999999 112.158 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.68 ' HB2' HG23 ' A' ' 145' ' ' VAL . 10.9 t80 . . . . . 0 C--N 1.313 -1.009 0 C-N-CA 122.781 0.432 . . . . 14.24 109.954 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.513 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . . . . . . 0 CA--C 1.51 -0.58 0 N-CA-C 109.635 -0.506 . . . . 14.65 109.635 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.553 ' HA ' ' H ' ' A' ' 217' ' ' TYR . 3.3 m-85 -135.79 152.76 51.42 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.109 0.48 . . . . 14.81 111.863 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' A' ' 187' ' ' LEU . 0.9 OUTLIER -152.91 145.69 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.166 -0.925 . . . . 10.48 109.922 -174.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 44.4 t -112.26 108.13 24.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-N 118.424 0.556 . . . . 10.1 111.035 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -88.11 111.08 21.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.491 -0.322 . . . . 12.0 111.334 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 1.002 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -86.42 -38.87 16.92 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.225 0.536 . . . . 11.880000000000001 109.721 -178.232 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.45 167.51 26.99 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.488 -0.863 . . . . 11.35 112.523 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -168.89 101.68 0.39 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.037 -0.727 . . . . 13.470000000000001 109.037 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.16 163.98 37.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.905 -0.589 . . . . 13.52 110.571 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 90.8 mttt -99.22 2.45 45.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.041 -0.981 . . . . 17.600000000000001 110.221 -173.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -93.37 98.64 11.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.78 -1.1 . . . . 16.140000000000001 108.68 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.85 -20.65 63.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.059 0.457 . . . . 14.039999999999999 111.193 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.14 -28.94 64.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.732 0.777 . . . . 16.57 109.183 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.403 ' O ' HG13 ' A' ' 160' ' ' ILE . 3.1 tppp? -80.49 -34.06 36.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.515 -1.22 . . . . 16.399999999999999 108.768 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 184' ' ' THR . 75.3 t -58.46 -36.61 59.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.085 -0.961 . . . . 12.67 109.806 172.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -62.02 -33.19 73.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.273 -0.876 . . . . 15.32 112.202 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.01 -35.86 28.42 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.051 -0.66 . . . . 15.970000000000001 110.996 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.738 HD12 HD12 ' A' ' 186' ' ' ILE . 14.0 mt -66.22 -47.45 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 12.6 109.437 176.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.59 -38.41 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.868 -1.06 . . . . 12.539999999999999 110.838 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -57.75 -30.23 62.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.016 -0.611 . . . . 14.800000000000001 112.4 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -70.61 -59.03 3.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.231 0.539 . . . . 16.050000000000001 111.081 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.427 HD11 ' HA ' ' A' ' 208' ' ' SER . 4.1 mm? -81.31 -59.79 2.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.709 -0.678 . . . . 12.99 112.101 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.428 ' HD3' ' C ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -64.05 -37.03 85.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.352 0.596 . . . . 15.06 109.632 -177.056 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.27 -19.48 77.48 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.043 -0.981 . . . . 16.600000000000001 112.691 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -97.42 -13.76 21.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.792 0.329 . . . . 16.140000000000001 110.758 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.5 24.92 9.68 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.703 -0.761 . . . . 15.119999999999999 113.177 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 207' ' ' LEU . 34.1 m-85 -88.26 158.38 18.49 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.793 -0.239 . . . . 15.49 110.536 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -67.39 97.68 0.58 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.374 0.607 . . . . 13.869999999999999 110.08 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.6 p -144.96 137.81 21.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.146 -0.934 . . . . 10.82 110.168 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.578 ' CE2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -142.12 176.72 8.74 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.454 0.645 . . . . 11.130000000000001 110.706 171.586 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.1 p -118.63 -177.05 3.22 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.785 -1.098 . . . . 11.52 110.713 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.1 OUTLIER -53.4 140.53 45.39 Favored Pre-proline 0 C--N 1.327 -0.405 0 O-C-N 123.256 0.347 . . . . 12.75 111.117 179.313 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -20.17 -67.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 1 C-N-CA 126.361 4.707 . . . . 14.640000000000001 116.048 -172.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.8 m -86.31 -61.66 1.69 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.981 0.734 . . . . 16.68 112.981 -170.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -166.69 133.8 2.02 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 122.021 -0.425 . . . . 16.039999999999999 111.795 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.487 ' HB3' HG21 ' A' ' 184' ' ' THR . 54.4 Cg_exo -60.97 125.02 16.1 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.716 2.277 . . . . 14.220000000000001 111.46 163.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 6.0 p -146.41 159.56 10.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.148 -0.686 . . . . 16.129999999999999 109.148 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -81.18 122.22 27.11 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.855 0.36 . . . . 16.699999999999999 110.862 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.13 -23.98 22.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 16.98 112.614 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.455 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 11.3 mptt -111.5 161.35 16.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.944 0.402 . . . . 18.73 110.327 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.6 tp -71.05 110.42 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.868 0.842 . . . . 14.82 112.114 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.487 HG21 ' HB3' ' A' ' 178' ' ' PRO . 62.1 m -99.34 106.46 18.56 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.583 -0.735 . . . . 12.779999999999999 109.715 172.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 89.8 mtt180 -89.22 136.76 32.84 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.452 -0.794 . . . . 13.98 109.159 176.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.738 HD12 HD12 ' A' ' 160' ' ' ILE . 2.8 mt -117.2 116.21 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 121.172 0.51 . . . . 10.56 109.696 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.578 HD12 ' CE2' ' A' ' 172' ' ' TYR . 0.1 OUTLIER -128.9 128.07 43.06 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.153 -0.931 . . . . 10.1 111.278 -172.229 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.002 HG23 HD21 ' A' ' 148' ' ' LEU . 43.1 t -99.91 149.17 5.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.287 -1.324 . . . . 9.7400000000000002 110.403 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 71.07 46.67 42.28 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 115.277 -0.874 . . . . 9.7599999999999998 113.895 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.436 ' HA ' ' CG2' ' A' ' 145' ' ' VAL . 19.2 Cg_endo -67.49 124.73 12.39 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 CA-C-N 119.903 1.851 . . . . 11.15 110.401 172.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -160.37 150.09 17.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.888 -0.596 . . . . 12.77 109.963 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.513 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -91.13 -6.34 53.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.497 -0.774 . . . . 14.6 110.58 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.548 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 43.2 t -100.44 103.87 15.25 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.087 -0.506 . . . . 14.300000000000001 110.274 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 198' ' ' LYS . 32.0 ttpt -60.56 -43.26 97.47 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.451 -0.795 . . . . 15.970000000000001 109.642 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.62 -55.49 30.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.217 -0.901 . . . . 15.6 112.398 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -65.51 -41.31 93.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.962 0.41 . . . . 14.220000000000001 111.147 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.548 ' HB3' ' O ' ' A' ' 193' ' ' SER . 0.2 OUTLIER -81.22 -18.29 46.62 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.103 -0.499 . . . . 11.949999999999999 110.849 -176.059 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 20.8 tptm -56.52 -55.34 34.95 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.684 0.754 . . . . 14.699999999999999 110.885 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -71.48 -13.18 74.05 Favored Glycine 0 CA--C 1.504 -0.64 0 CA-C-N 114.589 -1.187 . . . . 13.09 110.64 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.606 ' O ' ' HB2' ' A' ' 204' ' ' LEU . 72.9 m -78.45 -12.87 60.03 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.657 -0.771 . . . . 12.109999999999999 111.517 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 23.1 mt -76.66 -40.18 49.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.848 0.356 . . . . 12.720000000000001 110.477 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.1 -36.45 88.57 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.857 -0.687 . . . . 14.66 111.528 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.529 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 15.4 pt-20 -86.25 -16.89 36.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.888 0.375 . . . . 13.890000000000001 110.481 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 200' ' ' SER . 15.4 tp -71.34 -33.18 69.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.644 0.259 . . . . 12.550000000000001 111.166 -173.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.601 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 19.1 pttp -62.96 -16.16 58.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.186 0.517 . . . . 15.83 110.344 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -90.11 -42.02 11.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.811 -0.631 . . . . 16.969999999999999 110.081 170.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.8 mt -68.87 -52.79 25.93 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.788 -0.642 . . . . 13.890000000000001 111.505 -175.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.427 ' HA ' HD11 ' A' ' 164' ' ' LEU . 16.7 t -92.49 -44.11 8.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.433 0.635 . . . . 13.539999999999999 109.56 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 71.31 -2.13 22.52 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 114.837 -1.074 . . . . 14.67 112.164 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 53.3 mt -92.62 150.31 20.79 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.538 -0.541 . . . . 13.039999999999999 109.538 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 19.5 m -85.68 111.84 20.47 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.093 0.473 . . . . 14.84 110.59 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -130.51 163.83 23.11 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.479 -0.867 . . . . 12.220000000000001 112.491 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.9 p -100.29 135.39 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.348 0.594 . . . . 13.74 110.472 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 45.9 t -79.71 104.94 8.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.87 -1.059 . . . . 12.890000000000001 109.492 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 97.0 mmm -117.24 146.7 43.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.665 -0.698 . . . . 13.800000000000001 110.457 -175.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.64 106.33 2.16 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.41 -0.9 . . . . 13.359999999999999 111.733 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.553 ' H ' ' HA ' ' A' ' 144' ' ' TYR . 9.3 t80 . . . . . 0 C--N 1.316 -0.849 0 C-N-CA 123.446 0.699 . . . . 14.24 110.517 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.845 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.424 -0.584 . . . . 14.65 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.708 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 5.2 m-85 -143.7 141.94 30.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.261 0.224 . . . . 14.81 111.086 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.797 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.4 t -150.98 162.02 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 109.625 -0.509 . . . . 10.48 109.625 171.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 27.7 t -104.01 117.57 49.75 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 O-C-N 122.21 -0.306 . . . . 10.1 111.129 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.515 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 6.1 tt0 -91.02 111.4 22.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.649 0.24 . . . . 12.0 111.649 -176.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 1.018 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -94.47 -34.55 12.67 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.215 0.531 . . . . 11.880000000000001 110.313 -177.579 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.51 162.07 27.97 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.671 -0.776 . . . . 11.35 111.923 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -165.38 101.76 0.72 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.758 -0.46 . . . . 13.470000000000001 109.758 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.54 163.14 33.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.544 0.687 . . . . 13.52 111.127 -173.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 43.2 mttm -98.47 13.47 31.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.641 -1.163 . . . . 17.600000000000001 109.722 -177.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -117.64 104.01 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.31 -0.859 . . . . 16.140000000000001 110.277 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -22.71 67.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.204 0.526 . . . . 14.039999999999999 110.802 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.02 -37.94 55.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.063 -0.972 . . . . 16.57 111.002 175.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -89.64 -31.89 17.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.929 -1.032 . . . . 16.399999999999999 110.351 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 184' ' ' THR . 82.8 t -55.1 -44.31 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.831 -0.622 . . . . 12.67 110.783 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -58.6 -30.4 67.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.575 -0.739 . . . . 15.32 111.468 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.47 -56.43 4.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.829 -0.434 . . . . 15.970000000000001 109.829 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.413 HD12 HG13 ' A' ' 186' ' ' ILE . 19.4 mt -54.76 -40.71 53.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.295 -0.866 . . . . 12.6 110.601 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.6 t -73.83 -44.0 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.852 -0.613 . . . . 12.539999999999999 110.737 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.69 -32.4 73.93 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.633 -0.794 . . . . 14.800000000000001 111.861 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -67.41 -59.92 3.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.645 0.26 . . . . 16.050000000000001 111.214 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.551 ' HB3' HG21 ' A' ' 171' ' ' VAL . 2.1 mm? -85.98 -57.02 3.2 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.58 0.585 . . . . 12.99 112.58 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 165' ' ' ARG . 0.8 OUTLIER -64.45 -35.52 81.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.408 0.623 . . . . 15.06 109.549 -178.18 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.95 -15.22 76.18 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.349 -0.841 . . . . 16.600000000000001 112.313 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -96.17 7.25 46.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.295 0.569 . . . . 16.140000000000001 110.342 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.44 15.72 58.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.766 -0.652 . . . . 15.119999999999999 113.051 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 207' ' ' LEU . 53.1 m-85 -91.65 148.06 22.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 117.031 0.415 . . . . 15.49 110.574 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.427 ' HB3' ' HD2' ' A' ' 190' ' ' PRO . 22.9 mmm180 -62.56 98.98 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 13.869999999999999 110.512 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.669 HG22 HG22 ' A' ' 188' ' ' VAL . 10.2 t -133.83 133.46 56.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.038 0.447 . . . . 10.82 110.969 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -138.36 175.21 9.77 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.447 -0.797 . . . . 11.130000000000001 110.375 170.465 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 22.7 p -115.22 -176.11 2.84 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.878 -1.055 . . . . 11.52 111.173 -172.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.56 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.1 OUTLIER -53.51 143.51 36.75 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 123.16 0.288 . . . . 12.75 111.411 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -25.47 -57.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 1 C-N-CA 126.009 4.473 . . . . 14.640000000000001 116.239 -174.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.3 m -87.19 -64.34 1.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.682 -0.807 . . . . 16.68 113.0 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.5 m -170.38 135.57 1.16 Allowed Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 117.857 0.299 . . . . 16.039999999999999 111.68 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.462 ' HB3' HG21 ' A' ' 184' ' ' THR . 76.0 Cg_exo -60.13 124.76 15.91 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.139 2.559 . . . . 14.220000000000001 112.507 166.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.1 p -153.51 158.48 3.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.911 -0.586 . . . . 16.129999999999999 109.609 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.22 134.67 36.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.392 -0.367 . . . . 16.699999999999999 110.347 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 95.27 -25.9 22.03 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.85 -0.691 . . . . 16.98 112.422 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 9.8 mptt -106.95 168.94 8.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.18 -0.674 . . . . 18.73 109.18 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.439 HD11 ' HB1' ' A' ' 150' ' ' ALA . 10.3 tp -77.53 111.29 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.871 0.843 . . . . 14.82 111.84 -173.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.56 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 37.4 m -105.31 109.93 22.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.463 -0.79 . . . . 12.779999999999999 109.18 170.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 36.5 mtt180 -94.68 145.89 24.54 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.597 -0.729 . . . . 13.98 110.2 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.539 ' O ' HD22 ' A' ' 148' ' ' LEU . 3.0 mm -110.37 119.66 59.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.699 -0.852 . . . . 10.56 108.699 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.547 ' HB3' ' CG1' ' A' ' 145' ' ' VAL . 6.1 mp -128.79 131.37 47.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.376 0.608 . . . . 10.1 110.887 -175.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.018 HG23 HD21 ' A' ' 148' ' ' LEU . 39.8 t -104.01 133.74 47.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.995 -1.002 . . . . 9.7400000000000002 110.845 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.75 47.64 5.83 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 114.907 -1.042 . . . . 9.7599999999999998 113.731 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.797 ' HA ' HG22 ' A' ' 145' ' ' VAL . 10.9 Cg_endo -60.79 125.56 17.51 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 CA-C-N 119.629 1.715 . . . . 11.15 110.888 174.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -159.25 168.1 27.33 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.932 -0.576 . . . . 12.77 109.583 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . . . -106.9 13.69 27.43 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.296 0.569 . . . . 14.6 109.776 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 22.8 t -118.43 109.47 16.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.885 -0.598 . . . . 14.300000000000001 111.373 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.705 ' HB2' ' CZ ' ' A' ' 144' ' ' TYR . 38.3 ttpt -69.91 -42.35 73.45 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.67 -0.863 . . . . 15.970000000000001 108.67 171.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -56.6 -40.63 75.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 15.6 111.652 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -79.72 -48.25 13.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.374 -0.376 . . . . 14.220000000000001 111.196 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -79.66 -20.76 45.89 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.884 0.328 . . . . 11.949999999999999 111.884 -171.811 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.506 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 29.2 tptp -67.4 -44.6 78.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.236 0.541 . . . . 14.699999999999999 109.714 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.28 -13.62 76.84 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.678 -0.692 . . . . 13.09 111.547 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 73.9 m -75.32 -24.01 57.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.519 0.2 . . . . 12.109999999999999 111.367 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 15.8 mt -61.49 -31.14 71.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.349 . . . . 12.720000000000001 110.878 -175.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.48 -46.11 94.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.565 -0.826 . . . . 14.66 111.924 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 12.6 pt-20 -86.83 -19.64 28.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.429 . . . . 13.890000000000001 111.111 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.432 HD11 ' CG1' ' A' ' 188' ' ' VAL . 14.9 tp -68.63 -35.75 77.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.3 -0.409 . . . . 12.550000000000001 111.62 -172.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.44 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 6.3 ptpp? -64.37 -16.31 62.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.825 0.345 . . . . 15.83 110.765 174.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.42 -35.5 15.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.117 0.484 . . . . 16.969999999999999 110.04 172.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 82.5 mt -74.96 -53.18 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 13.890000000000001 111.36 -176.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.531 ' HA ' HD11 ' A' ' 164' ' ' LEU . 3.4 m -94.86 -43.68 8.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 13.539999999999999 110.592 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 71.35 1.02 40.92 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.318 -0.856 . . . . 14.67 112.383 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 59.5 mt -84.37 154.48 22.83 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.341 -0.615 . . . . 13.039999999999999 109.341 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 23.3 m -77.17 93.49 3.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.86 0.362 . . . . 14.84 110.104 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -111.13 136.54 13.67 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.641 -0.79 . . . . 12.220000000000001 113.348 -175.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.92 138.4 25.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.038 -0.727 . . . . 13.74 109.038 174.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 6.6 p -79.23 108.1 12.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.736 0.779 . . . . 12.890000000000001 109.378 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 67.2 mtt -122.42 152.52 40.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.369 -0.832 . . . . 13.800000000000001 110.13 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -75.26 143.61 30.89 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.004 -1.094 . . . . 13.359999999999999 111.616 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.845 ' CD2' ' HB1' ' A' ' 143' ' ' ALA . 4.3 t80 . . . . . 0 C--N 1.304 -1.384 0 CA-C-N 114.217 -0.992 . . . . 14.24 109.617 -170.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.826 ' HB1' ' CD1' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 110.387 -0.227 . . . . 14.65 110.387 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.683 ' CE2' ' HE3' ' A' ' 194' ' ' LYS . 36.6 m-85 -142.28 142.9 32.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.549 0.34 . . . . 14.81 111.67 -172.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.925 HG22 ' HA ' ' A' ' 190' ' ' PRO . 3.4 t -148.74 164.4 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 109.371 -0.603 . . . . 10.48 109.371 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.461 HG21 HD13 ' A' ' 204' ' ' LEU . 40.1 t -101.17 107.84 22.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 122.055 -0.403 . . . . 10.1 111.373 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.549 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 40.2 tt0 -78.68 115.94 18.71 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 122.617 0.367 . . . . 12.0 111.129 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 1.029 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -93.74 -33.31 13.66 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.424 0.631 . . . . 11.880000000000001 109.778 177.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.68 168.51 27.39 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.402 -0.817 . . . . 11.35 112.423 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -168.41 100.47 0.42 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.488 -0.93 . . . . 13.470000000000001 108.488 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.18 160.77 42.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.661 -0.7 . . . . 13.52 110.799 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 44.7 mtpt -99.35 -6.64 27.49 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.948 -1.024 . . . . 17.600000000000001 110.262 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.538 ' ND2' ' HG3' ' A' ' 156' ' ' LYS . 36.2 t30 -90.96 106.5 18.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.527 -0.76 . . . . 16.140000000000001 109.691 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.01 -21.38 64.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.969 -0.56 . . . . 14.039999999999999 111.697 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -59.52 -35.08 73.5 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.774 0.797 . . . . 16.57 109.878 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.538 ' HG3' ' ND2' ' A' ' 153' ' ' ASN . 28.3 mtpp -83.67 -33.35 25.24 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.561 -1.2 . . . . 16.399999999999999 110.753 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 178' ' ' PRO . 89.7 t -57.48 -39.14 67.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.404 0.621 . . . . 12.67 109.662 173.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -60.78 -30.32 69.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.106 -0.952 . . . . 15.32 111.743 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.614 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 6.0 mm-40 -77.24 -61.65 1.91 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.185 -0.672 . . . . 15.970000000000001 109.185 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 156' ' ' LYS . 12.3 mt -49.41 -46.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.357 -0.838 . . . . 12.6 110.793 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.3 t -73.75 -41.42 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.463 -0.789 . . . . 12.539999999999999 110.602 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.66 -28.88 70.61 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.611 -0.804 . . . . 14.800000000000001 112.137 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.614 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.6 mptp? -72.7 -52.44 15.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.703 0.287 . . . . 16.050000000000001 111.183 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.5 mm? -86.39 -55.86 3.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.272 0.471 . . . . 12.99 112.272 -176.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -63.45 -40.28 96.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.223 0.535 . . . . 15.06 109.752 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.68 -23.98 73.98 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.02 -0.991 . . . . 16.600000000000001 112.517 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.18 0.85 56.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.867 0.365 . . . . 16.140000000000001 110.723 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.56 17.3 58.76 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.927 -0.654 . . . . 15.119999999999999 113.237 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -83.86 153.85 23.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.979 0.39 . . . . 15.49 111.036 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.15 99.33 2.79 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.284 -0.636 . . . . 13.869999999999999 109.284 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.66 141.7 27.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 114.904 -1.044 . . . . 10.82 109.255 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.586 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -138.7 176.41 8.72 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.994 0.902 . . . . 11.130000000000001 111.31 170.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 14.2 p -123.34 -173.73 2.79 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.817 -1.538 . . . . 11.52 109.886 -171.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 19.5 m -50.01 137.58 19.97 Favored Pre-proline 0 C--O 1.234 0.278 0 N-CA-C 109.737 -0.468 . . . . 12.75 109.737 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -37.44 -50.38 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 124.572 3.515 . . . . 14.640000000000001 115.399 -167.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.0 t -82.93 -60.41 2.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.116 -0.634 . . . . 16.68 112.471 -172.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.3 m -166.81 135.43 2.24 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 117.891 0.314 . . . . 16.039999999999999 111.608 -175.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.47 ' HB3' HG11 ' A' ' 157' ' ' VAL . 34.4 Cg_exo -62.24 124.62 14.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.266 1.977 . . . . 14.220000000000001 111.063 165.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.463 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.8 p -153.57 154.56 7.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 110.084 -0.339 . . . . 16.129999999999999 110.084 -176.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -82.92 141.59 32.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.123 0.487 . . . . 16.699999999999999 110.887 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.93 -17.07 59.33 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.698 -0.683 . . . . 16.98 111.921 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 10.2 mptt -123.78 156.8 35.42 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.353 -0.61 . . . . 18.73 109.353 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 183' ' ' ILE . 7.7 tp -71.46 109.07 3.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.554 0.692 . . . . 14.82 111.049 -174.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.448 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 32.6 m -103.49 106.77 17.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.813 0.816 . . . . 12.779999999999999 110.438 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.751 ' HG2' HD11 ' A' ' 187' ' ' LEU . 22.1 ttp180 -85.39 133.29 34.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.317 -1.31 . . . . 13.98 109.367 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.533 ' O ' HD22 ' A' ' 148' ' ' LEU . 2.0 mm -112.98 118.6 58.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.057 -0.72 . . . . 10.56 109.057 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.751 HD11 ' HG2' ' A' ' 185' ' ' ARG . 1.5 mp -131.33 132.64 44.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.396 0.617 . . . . 10.1 111.278 -172.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.029 HG23 HD21 ' A' ' 148' ' ' LEU . 42.3 t -104.9 134.44 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.217 -0.902 . . . . 9.7400000000000002 111.009 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 84.57 50.41 4.24 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.443 -0.799 . . . . 9.7599999999999998 113.739 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.925 ' HA ' HG22 ' A' ' 145' ' ' VAL . 5.3 Cg_endo -55.88 125.51 19.32 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 119.277 1.538 . . . . 11.15 111.424 174.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -152.47 169.01 23.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.657 -0.702 . . . . 12.77 109.23 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.47 -1.88 22.63 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.81 0.338 . . . . 14.6 111.086 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 70.5 m -121.11 110.15 15.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.863 0.363 . . . . 14.300000000000001 111.351 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.683 ' HE3' ' CE2' ' A' ' 144' ' ' TYR . 37.5 ttmt -65.13 -53.44 45.13 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.968 -0.56 . . . . 15.970000000000001 110.014 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -51.34 -40.26 58.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.264 -0.88 . . . . 15.6 111.647 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -74.7 -42.07 59.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 14.220000000000001 110.947 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.2 OUTLIER -78.56 -20.25 51.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.022 0.439 . . . . 11.949999999999999 110.19 -177.469 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.462 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.4 tptm -67.06 -39.58 86.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.423 0.63 . . . . 14.699999999999999 110.305 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.75 -12.17 84.04 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.303 -1.119 . . . . 13.09 110.303 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 71.5 m -90.26 -9.29 48.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.528 -0.836 . . . . 12.109999999999999 112.454 -175.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 18.2 mt -65.2 -35.79 82.15 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.774 -0.37 . . . . 12.720000000000001 110.908 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.96 -44.08 97.52 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.915 -0.66 . . . . 14.66 112.331 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 200' ' ' SER . 11.1 pt-20 -81.06 -18.5 46.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.936 0.398 . . . . 13.890000000000001 110.457 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.461 HD13 HG21 ' A' ' 146' ' ' VAL . 1.2 tt -68.95 -32.17 71.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 12.550000000000001 109.958 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 25.2 mtpp -62.0 -19.84 63.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.572 -0.74 . . . . 15.83 110.37 173.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -40.01 13.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.174 0.511 . . . . 16.969999999999999 109.719 172.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.75 -52.54 59.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.63 -0.714 . . . . 13.890000000000001 111.339 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.495 ' HB3' HD11 ' A' ' 164' ' ' LEU . 62.8 p -103.84 -46.95 4.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.999 0.428 . . . . 13.539999999999999 110.802 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 82.27 -6.18 69.13 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.789 -0.641 . . . . 14.67 111.8 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.0 mp -86.61 158.37 19.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.82 -0.437 . . . . 13.039999999999999 109.82 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 16.1 m -80.13 94.73 6.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.851 -0.613 . . . . 14.84 110.594 -175.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -111.83 148.55 18.12 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.591 -0.814 . . . . 12.220000000000001 113.45 -176.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.4 141.97 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.963 0.411 . . . . 13.74 109.932 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.31 106.77 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.689 0.757 . . . . 12.890000000000001 110.372 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 96.6 mmm -117.87 168.55 10.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.464 -0.789 . . . . 13.800000000000001 110.376 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -84.76 151.31 26.17 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.356 -0.926 . . . . 13.359999999999999 112.462 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.913 ' HB2' HG23 ' A' ' 145' ' ' VAL . 3.9 t80 . . . . . 0 C--N 1.311 -1.085 0 CA-C-N 114.418 -0.891 . . . . 14.24 109.582 -171.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.845 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 110.449 -0.204 . . . . 14.65 110.449 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.67 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 37.9 m-85 -136.91 143.72 43.11 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.555 -0.293 . . . . 14.81 111.569 -173.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 190' ' ' PRO . 3.0 m -151.39 160.73 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.301 0.64 . . . . 10.48 110.036 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 12.4 t -114.59 122.04 67.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 120.754 -0.378 . . . . 10.1 110.021 176.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.529 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 27.2 tt0 -92.8 97.02 10.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.594 0.235 . . . . 12.0 110.917 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.781 HD13 ' N ' ' A' ' 212' ' ' GLY . 0.3 OUTLIER -83.41 -27.88 29.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.344 0.592 . . . . 11.880000000000001 109.691 -177.151 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.17 162.26 28.15 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.402 -0.904 . . . . 11.35 112.34 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.96 101.52 0.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.779 -0.452 . . . . 13.470000000000001 109.779 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.92 158.7 43.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.329 0.585 . . . . 13.52 110.748 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -99.45 4.97 46.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.096 -0.957 . . . . 17.600000000000001 109.808 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.404 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.1 t-20 -105.88 116.72 32.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.887 -1.051 . . . . 16.140000000000001 109.74 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -73.48 -23.45 60.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.169 -0.469 . . . . 14.039999999999999 112.17 -174.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.84 -35.31 79.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.891 0.853 . . . . 16.57 109.411 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.58 ' O ' HG13 ' A' ' 160' ' ' ILE . 32.3 mmtp -76.08 -38.55 56.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.127 -1.397 . . . . 16.399999999999999 110.205 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.528 HG11 HG21 ' A' ' 184' ' ' THR . 93.3 t -57.28 -47.69 83.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.307 0.575 . . . . 12.67 110.325 176.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -59.16 -35.56 73.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.986 -1.006 . . . . 15.32 111.985 -174.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.65 -39.25 27.64 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.626 -0.43 . . . . 15.970000000000001 111.65 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 156' ' ' LYS . 29.2 mt -62.7 -49.29 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.549 0.69 . . . . 12.6 109.523 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 91.8 t -66.08 -36.2 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.891 -1.05 . . . . 12.539999999999999 109.788 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -56.97 -32.67 62.72 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 14.800000000000001 112.187 176.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -71.8 -62.26 1.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.321 . . . . 16.050000000000001 111.452 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.7 mm? -78.02 -50.38 12.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.119 -0.491 . . . . 12.99 112.113 -172.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 3.9 tmt_? -64.84 -43.42 93.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.353 -0.61 . . . . 15.06 109.353 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.01 -27.23 73.36 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.043 -0.981 . . . . 16.600000000000001 112.874 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.27 -8.4 59.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.989 0.423 . . . . 16.140000000000001 110.625 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.21 19.82 27.21 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.053 -0.594 . . . . 15.119999999999999 113.197 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 207' ' ' LEU . 42.7 m-85 -88.22 157.13 18.88 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 117.23 0.515 . . . . 15.49 110.713 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -77.75 100.64 6.34 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.521 0.677 . . . . 13.869999999999999 109.279 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.6 p -142.06 137.98 30.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.687 -1.142 . . . . 10.82 109.477 -174.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.527 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.49 176.56 8.68 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.539 0.685 . . . . 11.130000000000001 110.585 174.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 10.0 p -121.82 -173.97 2.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.722 -1.126 . . . . 11.52 111.191 -169.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 74.7 m -50.45 143.05 14.27 Favored Pre-proline 0 C--O 1.236 0.35 0 O-C-N 123.465 0.478 . . . . 12.75 110.634 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -45.01 -45.43 14.18 Favored 'Trans proline' 0 CA--C 1.527 0.175 0 C-N-CA 124.006 3.138 . . . . 14.640000000000001 114.863 -170.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.2 p -86.97 -63.79 1.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.882 -0.727 . . . . 16.68 112.848 -172.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.9 m -168.54 130.04 1.14 Allowed Pre-proline 0 C--O 1.234 0.278 0 O-C-N 122.464 -0.148 . . . . 16.039999999999999 111.202 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.546 ' HB3' HG21 ' A' ' 184' ' ' THR . 78.2 Cg_exo -61.45 122.43 11.08 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.116 1.877 . . . . 14.220000000000001 111.493 162.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 182' ' ' LYS . 4.3 p -155.35 161.68 2.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.849 -0.426 . . . . 16.129999999999999 109.849 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -75.25 124.41 27.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.77 0.319 . . . . 16.699999999999999 110.681 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.16 -26.06 16.37 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.094 -0.574 . . . . 16.98 112.577 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.445 ' HB2' HG12 ' A' ' 179' ' ' VAL . 0.8 OUTLIER -107.16 154.61 20.94 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.703 -0.48 . . . . 18.73 109.703 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.1 tp -72.79 109.89 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.513 0.673 . . . . 14.82 111.071 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.546 HG21 ' HB3' ' A' ' 178' ' ' PRO . 31.4 m -98.8 109.41 22.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.624 0.726 . . . . 12.779999999999999 109.974 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 76.9 mtm180 -95.01 134.25 37.89 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.922 -1.036 . . . . 13.98 109.941 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.405 ' C ' HD12 ' A' ' 187' ' ' LEU . 4.5 mm -102.56 106.9 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 109.722 -0.473 . . . . 10.56 109.722 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.651 HD23 HG21 ' A' ' 145' ' ' VAL . 6.1 mp -110.85 114.84 28.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.582 0.706 . . . . 10.1 110.841 -174.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 41.9 t -95.08 140.89 15.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.856 -1.065 . . . . 9.7400000000000002 110.001 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 77.55 45.85 10.54 Favored Glycine 0 N--CA 1.434 -1.495 0 CA-C-N 115.292 -0.867 . . . . 9.7599999999999998 114.139 174.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.799 ' HA ' HG12 ' A' ' 145' ' ' VAL . 11.4 Cg_endo -61.92 126.38 18.72 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 CA-C-N 119.762 1.781 . . . . 11.15 110.83 171.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -161.54 167.87 24.62 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.987 -0.552 . . . . 12.77 109.721 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -103.9 7.49 36.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.255 -0.43 . . . . 14.6 110.427 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 36.4 t -120.6 116.57 25.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.918 -0.583 . . . . 14.300000000000001 110.921 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.657 ' HB2' ' CD2' ' A' ' 144' ' ' TYR . 31.5 ttmt -70.92 -47.75 57.33 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.022 -0.733 . . . . 15.970000000000001 109.022 172.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -46.24 -57.46 4.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.704 -1.134 . . . . 15.6 111.639 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -70.7 -39.66 73.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.459 -0.791 . . . . 14.220000000000001 111.995 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.548 HD23 ' HB2' ' A' ' 144' ' ' TYR . 0.1 OUTLIER -82.39 -30.99 29.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.645 0.239 . . . . 11.949999999999999 111.645 -174.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.573 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 13.3 tmtt? -79.32 -29.98 42.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.218 -0.66 . . . . 14.699999999999999 109.218 -177.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.51 -12.03 83.96 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.022 -1.231 . . . . 13.09 110.022 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 46.3 m -91.09 -8.07 49.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.592 -0.804 . . . . 12.109999999999999 112.272 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 23.2 mt -66.96 -35.12 79.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.922 -0.311 . . . . 12.720000000000001 111.244 -174.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -58.58 -42.95 96.35 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.735 -0.745 . . . . 14.66 111.905 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 200' ' ' SER . 10.7 pt-20 -83.62 -18.34 38.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.07 0.462 . . . . 13.890000000000001 110.412 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.36 -27.65 65.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.143 -0.481 . . . . 12.550000000000001 110.049 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 6.5 mtpm? -63.48 -20.88 65.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.786 -0.643 . . . . 15.83 110.496 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.84 -35.97 16.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.715 -0.476 . . . . 16.969999999999999 109.715 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.582 ' HB3' ' CE1' ' A' ' 169' ' ' TYR . 81.9 mt -73.41 -53.09 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.613 -0.722 . . . . 13.890000000000001 111.681 -175.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 164' ' ' LEU . 71.2 p -95.04 -42.64 8.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.271 0.557 . . . . 13.539999999999999 110.68 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 70.2 5.79 55.07 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.167 -0.924 . . . . 14.67 111.694 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.631 ' C ' HD12 ' A' ' 148' ' ' LEU . 96.1 mt -89.86 162.8 15.29 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.594 0.758 . . . . 13.039999999999999 109.84 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 66.1 m -102.24 99.89 10.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.13 0.419 . . . . 14.84 112.13 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.781 ' N ' HD13 ' A' ' 148' ' ' LEU . . . -116.55 157.43 15.05 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.303 -0.951 . . . . 12.220000000000001 114.559 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.76 146.15 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.779 -0.711 . . . . 13.74 109.796 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 24.0 t -74.53 117.69 19.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.857 -0.611 . . . . 12.890000000000001 110.057 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 87.6 mtp -128.83 153.81 47.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.089 -0.505 . . . . 13.800000000000001 110.277 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -86.71 111.1 3.59 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.308 -0.949 . . . . 13.359999999999999 112.208 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.845 ' CD2' ' HB1' ' A' ' 143' ' ' ALA . 5.2 t80 . . . . . 0 C--N 1.312 -1.027 0 C-N-CA 124.688 1.195 . . . . 14.24 110.472 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.516 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 110.041 -0.355 . . . . 14.65 110.041 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.653 ' CD1' ' HG3' ' A' ' 194' ' ' LYS . 5.4 m-85 -146.72 159.82 43.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.685 0.279 . . . . 14.81 111.454 -177.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.725 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.3 t -149.32 158.83 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.719 -0.845 . . . . 10.48 108.719 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.471 HG12 ' HA3' ' A' ' 212' ' ' GLY . 42.9 t -100.89 106.33 19.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 O-C-N 122.081 -0.387 . . . . 10.1 111.047 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.553 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 3.4 tt0 -78.85 110.23 13.85 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.526 0.331 . . . . 12.0 111.311 -177.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 1.013 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -87.94 -37.92 16.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.306 0.574 . . . . 11.880000000000001 109.568 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.3 164.28 28.02 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.374 -0.917 . . . . 11.35 112.559 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -164.43 104.25 0.84 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.695 -0.854 . . . . 13.470000000000001 108.695 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.99 166.19 24.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.956 -0.566 . . . . 13.52 110.406 -173.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 48.5 mtpt -102.77 -6.53 22.51 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.042 -0.981 . . . . 17.600000000000001 110.355 -174.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -99.38 109.68 22.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.556 -0.747 . . . . 16.140000000000001 109.61 173.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.0 -19.55 65.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.065 -0.516 . . . . 14.039999999999999 111.494 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.12 -35.51 75.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.813 0.816 . . . . 16.57 109.965 174.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.519 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.12 -26.98 33.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.564 -1.198 . . . . 16.399999999999999 110.12 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.531 ' HA ' HD11 ' A' ' 186' ' ' ILE . 69.5 t -66.0 -39.16 83.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.675 -0.693 . . . . 12.67 110.413 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.433 ' HA ' HG12 ' A' ' 161' ' ' VAL . 23.3 t-20 -68.05 -23.5 64.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.816 -0.629 . . . . 15.32 111.349 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.56 -61.85 1.7 Allowed 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.367 -0.605 . . . . 15.970000000000001 109.367 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.787 HD12 HD12 ' A' ' 186' ' ' ILE . 18.2 mt -53.74 -43.89 57.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.582 -1.19 . . . . 12.6 110.274 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 158' ' ' ASN . 0.3 OUTLIER -72.63 -37.11 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.601 -0.727 . . . . 12.539999999999999 110.197 -177.259 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -66.0 -29.76 75.65 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.768 -0.73 . . . . 14.800000000000001 111.505 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -70.23 -51.3 31.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.875 0.369 . . . . 16.050000000000001 110.152 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.507 HD13 ' CG2' ' A' ' 188' ' ' VAL . 16.3 mt -88.84 -59.26 2.28 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.133 0.79 . . . . 12.99 113.133 -173.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 55.2 ttp180 -60.86 -37.42 82.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.453 0.644 . . . . 15.06 109.768 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.2 -18.86 78.29 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.907 -1.042 . . . . 16.600000000000001 112.266 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -95.67 -0.93 51.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.881 0.372 . . . . 16.140000000000001 110.624 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.48 25.8 45.65 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.653 -0.784 . . . . 15.119999999999999 113.14 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -92.49 154.85 18.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.952 0.376 . . . . 15.49 110.968 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -67.55 104.23 1.54 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.426 0.631 . . . . 13.869999999999999 109.773 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.46 137.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.019 -0.991 . . . . 10.82 109.858 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.531 ' CE1' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -140.17 175.25 9.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.899 0.857 . . . . 11.130000000000001 111.211 169.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 15.0 p -121.96 -175.42 3.1 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.98 -1.464 . . . . 11.52 110.384 -172.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 7.3 m -50.38 125.6 20.44 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 109.115 -0.698 . . . . 12.75 109.115 173.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 89.6 Cg_exo -45.41 -35.51 11.99 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.349 3.366 . . . . 14.640000000000001 115.337 -167.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.9 p -79.85 -62.63 1.63 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.017 -0.673 . . . . 16.68 111.816 -175.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.2 m -167.68 135.01 1.87 Allowed Pre-proline 0 C--N 1.329 -0.298 0 C-N-CA 122.183 0.193 . . . . 16.039999999999999 110.771 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.01 123.2 11.53 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.634 1.556 . . . . 14.220000000000001 110.107 161.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.5 p -154.22 156.72 4.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.484 -0.487 . . . . 16.129999999999999 111.197 -172.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -81.78 133.82 35.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.82 -0.627 . . . . 16.699999999999999 110.875 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 99.81 -22.95 38.04 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.881 -0.599 . . . . 16.98 112.471 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 9.1 mptt -115.04 160.67 19.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.445 -0.576 . . . . 18.73 109.445 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 183' ' ' ILE . 9.1 tp -74.16 109.82 7.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.735 0.778 . . . . 14.82 111.28 -174.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 40.0 m -104.22 106.58 17.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.649 0.738 . . . . 12.779999999999999 110.208 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.55 ' HG2' HD11 ' A' ' 187' ' ' LEU . 31.1 ttm180 -86.77 136.58 32.94 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.637 -1.165 . . . . 13.98 109.54 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.787 HD12 HD12 ' A' ' 160' ' ' ILE . 3.6 mt -121.61 120.61 62.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.375 -0.602 . . . . 10.56 109.375 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -130.54 143.56 50.83 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.356 -0.838 . . . . 10.1 110.406 -169.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.013 HG23 HD21 ' A' ' 148' ' ' LEU . 42.5 t -107.69 136.23 43.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.461 -0.79 . . . . 9.7400000000000002 111.31 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 81.94 48.74 5.64 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.736 -1.12 . . . . 9.7599999999999998 113.533 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.725 ' HA ' HG22 ' A' ' 145' ' ' VAL . 9.9 Cg_endo -58.94 125.2 17.51 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 CA-C-N 119.472 1.636 . . . . 11.15 110.292 174.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.432 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 5.3 t70 -150.93 163.05 39.62 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 120.397 -0.521 . . . . 12.77 110.295 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -103.22 -4.17 24.72 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.304 -0.862 . . . . 14.6 111.281 -176.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 42.8 m -114.79 99.41 7.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.371 0.605 . . . . 14.300000000000001 110.449 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.653 ' HG3' ' CD1' ' A' ' 144' ' ' TYR . 25.3 ttpt -59.67 -54.51 45.58 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 114.984 -1.007 . . . . 15.970000000000001 111.881 -174.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.93 -40.88 97.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.004 0.43 . . . . 15.6 110.838 -172.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.39 -44.28 96.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 14.220000000000001 110.551 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -79.08 -22.54 45.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.049 -0.523 . . . . 11.949999999999999 110.567 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.3 tptm -69.15 -35.74 76.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.403 0.62 . . . . 14.699999999999999 109.92 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.02 -11.34 85.48 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.573 -1.011 . . . . 13.09 110.573 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 65.5 m -90.27 -8.96 49.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.89 -0.655 . . . . 12.109999999999999 112.624 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 18.4 mt -64.39 -34.52 78.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.001 -0.28 . . . . 12.720000000000001 111.409 -174.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.06 -42.92 96.41 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.831 -0.699 . . . . 14.66 112.135 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -79.31 -18.53 52.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 13.890000000000001 110.282 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.568 HD12 HD12 ' A' ' 207' ' ' LEU . 3.4 tp -76.27 -26.88 56.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.116 -0.493 . . . . 12.550000000000001 110.607 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 92.7 mttt -61.37 -22.47 64.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.145 0.498 . . . . 15.83 110.256 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -30.74 26.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.314 0.578 . . . . 16.969999999999999 109.58 173.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.568 HD12 HD12 ' A' ' 204' ' ' LEU . 88.9 mt -75.33 -53.76 8.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.503 -0.771 . . . . 13.890000000000001 111.84 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 p -99.58 -48.05 4.89 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.499 -0.481 . . . . 13.539999999999999 110.721 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 77.45 -0.64 68.62 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.706 -0.679 . . . . 14.67 112.675 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 164' ' ' LEU . 7.8 mp -90.14 158.1 17.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.328 -0.619 . . . . 13.039999999999999 109.328 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 35.8 m -84.06 102.57 12.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.159 -0.473 . . . . 14.84 110.877 -175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -122.43 150.06 16.95 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.28 -0.962 . . . . 12.220000000000001 113.61 -175.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.97 144.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.497 -0.557 . . . . 13.74 109.497 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.88 105.85 2.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.655 0.74 . . . . 12.890000000000001 109.767 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 98.0 mmm -119.27 139.72 51.45 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.677 -0.692 . . . . 13.800000000000001 110.674 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -68.92 155.42 53.54 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.587 -0.733 . . . . 13.359999999999999 112.425 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.656 ' HB2' HG23 ' A' ' 145' ' ' VAL . 16.0 t80 . . . . . 0 C--N 1.311 -1.071 0 CA-C-N 115.124 -0.538 . . . . 14.24 110.364 -171.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.607 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.784 -0.451 . . . . 14.65 109.784 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.575 ' CB ' HD21 ' A' ' 197' ' ' LEU . 3.8 m-85 -144.45 159.96 41.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.851 0.357 . . . . 14.81 111.743 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.73 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.4 m -151.17 153.05 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.57 -0.741 . . . . 10.48 109.989 -176.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 61.0 t -106.45 111.17 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.582 -0.447 . . . . 10.1 110.593 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -88.4 105.49 17.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.238 -0.437 . . . . 12.0 110.769 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.971 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -83.72 -37.03 23.23 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.351 0.596 . . . . 11.880000000000001 109.987 -175.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.18 161.93 27.87 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.261 -0.881 . . . . 11.35 111.846 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -162.63 104.66 1.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.573 -0.529 . . . . 13.470000000000001 109.573 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 156' ' ' LYS . 1.5 pt? -153.26 165.64 35.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.309 0.576 . . . . 13.52 111.058 -176.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 82.3 mttt -98.44 7.1 46.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.255 -0.884 . . . . 17.600000000000001 110.914 -172.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -99.64 97.13 8.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.478 -0.783 . . . . 16.140000000000001 109.877 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.98 -27.29 68.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.326 0.584 . . . . 14.039999999999999 110.246 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.07 -37.22 66.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.931 -1.031 . . . . 16.57 110.551 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.555 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 66.1 mttm -90.5 -25.81 20.09 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.181 -0.918 . . . . 16.399999999999999 110.691 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' THR . 69.7 t -57.84 -40.46 76.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.437 0.637 . . . . 12.67 109.636 173.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -61.05 -33.4 73.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 15.32 112.183 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 12.6 pt-20 -83.91 -22.84 31.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.463 -0.495 . . . . 15.970000000000001 111.633 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 156' ' ' LYS . 16.8 mt -81.05 -49.68 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.345 0.593 . . . . 12.6 109.448 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 45.8 t -69.62 -32.71 53.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.26 -0.882 . . . . 12.539999999999999 110.449 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -56.74 -31.97 61.3 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.907 -0.664 . . . . 14.800000000000001 112.342 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -73.54 -62.13 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.781 0.324 . . . . 16.050000000000001 111.172 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.6 mm? -72.32 -50.37 27.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.085 0.402 . . . . 12.99 112.085 -173.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 31.2 ttm180 -64.13 -47.24 80.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.394 0.616 . . . . 15.06 110.098 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.23 -34.79 90.86 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.916 -1.038 . . . . 16.600000000000001 113.047 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -80.14 -7.39 58.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.973 0.416 . . . . 16.140000000000001 110.718 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.24 24.73 15.76 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.878 -0.677 . . . . 15.119999999999999 113.222 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -93.85 152.69 18.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.75 -0.463 . . . . 15.49 109.75 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -73.35 103.88 4.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.475 0.655 . . . . 13.869999999999999 110.162 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.78 139.1 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.832 -1.076 . . . . 10.82 110.051 -173.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.46 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -141.3 176.92 8.46 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.507 0.67 . . . . 11.130000000000001 110.806 171.213 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.2 p -113.55 -176.34 2.88 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.841 -1.072 . . . . 11.52 111.193 -172.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.82 149.74 16.06 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.405 -0.361 . . . . 12.75 111.111 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -39.32 -53.86 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.347 3.365 . . . . 14.640000000000001 115.674 -170.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.4 m -87.17 -64.71 1.11 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 119.515 -0.874 . . . . 16.68 113.133 -169.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.8 m -169.13 135.72 1.46 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 118.228 0.467 . . . . 16.039999999999999 111.346 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.549 ' HB3' HG21 ' A' ' 184' ' ' THR . 44.7 Cg_exo -65.74 123.95 12.08 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.577 2.184 . . . . 14.220000000000001 112.012 162.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.68 158.57 3.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.637 -0.505 . . . . 16.129999999999999 109.637 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.63 128.21 35.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.722 0.296 . . . . 16.699999999999999 110.54 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.6 -26.17 25.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.097 -0.573 . . . . 16.98 112.3 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.7 OUTLIER -102.67 154.76 18.83 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.716 -0.476 . . . . 18.73 109.716 178.333 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 183' ' ' ILE . 7.8 tp -73.38 109.65 5.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.6 0.714 . . . . 14.82 111.082 -175.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.549 HG21 ' HB3' ' A' ' 178' ' ' PRO . 50.9 m -99.34 119.32 37.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 12.779999999999999 109.804 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 60.8 mtt-85 -101.23 140.17 35.89 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.71 -0.677 . . . . 13.98 109.789 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.609 ' C ' HD12 ' A' ' 187' ' ' LEU . 2.1 mm -107.07 120.31 58.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.95 -0.759 . . . . 10.56 108.95 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.6 mp -128.77 121.86 29.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.521 0.677 . . . . 10.1 111.152 -173.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.971 HG23 HD21 ' A' ' 148' ' ' LEU . 40.3 t -101.44 142.99 15.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.072 -0.967 . . . . 9.7400000000000002 110.465 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.401 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 77.46 48.33 8.18 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.276 -0.875 . . . . 9.7599999999999998 113.77 174.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.73 ' HA ' HG12 ' A' ' 145' ' ' VAL . 13.6 Cg_endo -64.44 123.99 12.63 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 CA-C-N 119.667 1.734 . . . . 11.15 110.62 171.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -156.75 147.85 22.04 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.841 -0.618 . . . . 12.77 109.78 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.607 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -88.68 -4.97 58.42 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.788 -0.642 . . . . 14.6 111.971 -175.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 75.6 m -115.86 92.05 3.79 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.297 0.57 . . . . 14.300000000000001 110.608 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.427 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 30.4 ttpt -52.7 -48.4 66.63 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 114.726 -1.125 . . . . 15.970000000000001 111.016 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -55.57 -38.99 70.09 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.102 0.408 . . . . 15.6 112.102 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -74.65 -41.75 59.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.006 0.431 . . . . 14.220000000000001 110.539 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.575 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -81.19 -19.66 42.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.119 0.485 . . . . 11.949999999999999 110.69 -175.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.438 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 28.1 tptp -66.16 -38.13 87.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.371 0.605 . . . . 14.699999999999999 110.31 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.21 -12.5 82.21 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.51 -1.036 . . . . 13.09 110.51 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 75.5 m -83.74 -8.71 59.19 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.7 -0.75 . . . . 12.109999999999999 111.895 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 20.2 mt -67.2 -36.35 81.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.965 0.412 . . . . 12.720000000000001 110.6 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.08 95.97 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.709 -0.678 . . . . 14.66 112.322 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.443 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 10.9 pt-20 -85.74 -18.41 33.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.902 0.382 . . . . 13.890000000000001 110.807 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.4 tp -71.81 -35.05 69.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.558 -0.292 . . . . 12.550000000000001 111.196 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.428 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 0.1 OUTLIER -65.63 -15.3 62.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.11 0.481 . . . . 15.83 110.432 174.468 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -31.89 21.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.868 -0.606 . . . . 16.969999999999999 109.658 172.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.0 mt -81.92 -52.47 7.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.612 -0.722 . . . . 13.890000000000001 111.646 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.467 ' HB3' HD11 ' A' ' 164' ' ' LEU . 61.5 p -94.0 -43.79 8.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.218 0.533 . . . . 13.539999999999999 110.618 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 72.94 -1.04 41.92 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.082 -0.963 . . . . 14.67 112.288 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.58 155.34 18.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.188 -0.671 . . . . 13.039999999999999 109.188 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.2 t -92.07 109.0 20.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.967 0.413 . . . . 14.84 110.258 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -126.27 156.13 19.65 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.136 -1.03 . . . . 12.220000000000001 113.729 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 p -103.63 147.56 9.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.208 -0.496 . . . . 13.74 110.036 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.7 106.06 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 12.890000000000001 110.478 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 24.5 mmt -113.26 143.86 43.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.859 -0.61 . . . . 13.800000000000001 110.104 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -75.18 136.42 20.38 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.227 -0.987 . . . . 13.359999999999999 111.874 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.557 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 8.8 t80 . . . . . 0 C--N 1.313 -1.009 0 CA-C-O 121.476 0.655 . . . . 14.24 110.052 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.846 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.444 -0.744 0 N-CA-C 109.669 -0.493 . . . . 14.65 109.669 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.64 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 16.1 m-85 -137.23 144.89 43.02 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.454 0.168 . . . . 14.81 111.233 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 190' ' ' PRO . 3.2 m -151.3 164.81 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 122.932 0.493 . . . . 10.48 110.827 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 44.4 t -114.72 108.98 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.778 0.323 . . . . 10.1 111.021 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.404 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 33.2 tt0 -84.84 111.55 19.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.541 -0.3 . . . . 12.0 110.796 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.996 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -91.29 -35.32 14.52 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.327 0.584 . . . . 11.880000000000001 109.804 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.39 166.52 27.66 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.667 -0.778 . . . . 11.35 112.475 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -167.33 101.31 0.51 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.117 -0.697 . . . . 13.470000000000001 109.117 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.71 159.32 42.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.323 0.582 . . . . 13.52 110.978 -171.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 181' ' ' GLY . 5.0 mmmm -98.02 5.29 48.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.892 -1.049 . . . . 17.600000000000001 110.027 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -112.61 106.67 15.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.979 -1.01 . . . . 16.140000000000001 110.041 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.41 ' HA ' ' CG2' ' A' ' 157' ' ' VAL . . . -61.5 -22.09 64.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.205 -0.452 . . . . 14.039999999999999 111.838 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.09 -35.52 73.54 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.814 0.816 . . . . 16.57 110.129 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.592 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 97.8 mttt -86.62 -25.71 24.76 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.609 -1.178 . . . . 16.399999999999999 110.289 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 184' ' ' THR . 90.0 t -61.61 -45.26 99.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.92 -0.582 . . . . 12.67 110.154 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -60.72 -33.83 73.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.628 -0.714 . . . . 15.32 112.007 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 15.7 pt-20 -78.25 -36.82 46.44 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.589 -0.444 . . . . 15.970000000000001 111.214 -175.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 156' ' ' LYS . 20.6 mt -72.02 -46.67 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.666 0.746 . . . . 12.6 109.756 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.97 -34.3 69.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.738 -1.119 . . . . 12.539999999999999 110.519 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.44 -27.0 67.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 14.800000000000001 112.281 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -71.99 -54.79 8.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.112 0.482 . . . . 16.050000000000001 111.068 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.473 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 4.3 mm? -85.7 -62.78 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 12.99 112.38 -174.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -63.18 -37.22 86.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.28 0.562 . . . . 15.06 109.925 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.71 -17.29 79.14 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.015 -0.993 . . . . 16.600000000000001 112.522 -176.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -100.71 -6.7 24.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.785 0.326 . . . . 16.140000000000001 110.982 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.87 25.66 19.39 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.382 -0.914 . . . . 15.119999999999999 113.153 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -93.72 150.91 20.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.3 0.55 . . . . 15.49 109.799 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 102.83 2.12 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.669 0.747 . . . . 13.869999999999999 110.058 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.83 144.23 24.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.342 -1.299 . . . . 10.82 109.337 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.63 177.18 8.2 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.768 0.794 . . . . 11.130000000000001 110.862 170.485 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 17.8 p -124.65 -175.17 3.2 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.173 -1.376 . . . . 11.52 110.0 -171.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 62.4 m -50.62 128.53 26.06 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.931 -0.308 . . . . 12.75 110.385 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -15.7 -63.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.583 1 C-N-CA 126.908 5.072 . . . . 14.640000000000001 117.047 -175.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.5 t -83.81 -63.29 1.38 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.574 -0.851 . . . . 16.68 112.487 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 65.1 m -168.22 134.24 1.6 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 117.62 0.191 . . . . 16.039999999999999 110.919 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.514 ' HB3' HG21 ' A' ' 184' ' ' THR . 51.9 Cg_exo -60.68 124.67 15.5 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.383 2.056 . . . . 14.220000000000001 111.86 165.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 182' ' ' LYS . 32.2 m -137.58 160.75 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 109.042 -0.725 . . . . 16.129999999999999 109.042 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.48 120.87 22.3 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.26 -0.427 . . . . 16.699999999999999 110.317 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLY . . . . . 0.441 ' O ' ' HE2' ' A' ' 152' ' ' LYS . . . 109.47 -26.45 14.69 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.966 -0.635 . . . . 16.98 113.106 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.508 ' HB2' ' CG2' ' A' ' 179' ' ' VAL . 4.3 mptp? -101.11 163.61 12.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.032 0.444 . . . . 18.73 110.884 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 183' ' ' ILE . 7.6 tp -73.13 108.03 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.835 0.826 . . . . 14.82 110.88 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.514 HG21 ' HB3' ' A' ' 178' ' ' PRO . 52.5 m -101.39 107.27 18.56 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.604 0.716 . . . . 12.779999999999999 109.758 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.519 ' HB3' HD11 ' A' ' 187' ' ' LEU . 81.5 mtt180 -86.92 138.54 31.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.782 -1.099 . . . . 13.98 109.579 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.576 ' O ' HD22 ' A' ' 148' ' ' LEU . 3.6 mm -110.5 116.8 53.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.49 -0.93 . . . . 10.56 108.49 177.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 185' ' ' ARG . 4.6 mp -129.27 128.83 44.01 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.478 0.656 . . . . 10.1 110.987 -173.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.996 HG23 HD21 ' A' ' 148' ' ' LEU . 54.8 t -104.01 142.39 17.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.903 -1.044 . . . . 9.7400000000000002 110.423 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.83 49.87 7.45 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.262 -0.881 . . . . 9.7599999999999998 113.308 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.828 ' HA ' HG12 ' A' ' 145' ' ' VAL . 11.2 Cg_endo -62.44 125.72 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 CA-C-N 119.548 1.674 . . . . 11.15 110.522 172.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -159.7 169.0 24.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.565 -0.743 . . . . 12.77 109.373 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . . . -110.99 5.22 20.15 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.479 0.657 . . . . 14.6 110.237 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.1 m -120.68 103.2 8.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.545 -0.752 . . . . 14.300000000000001 111.396 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.617 ' HB2' ' CE1' ' A' ' 144' ' ' TYR . 37.5 ttpt -64.11 -47.96 77.96 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.775 -0.648 . . . . 15.970000000000001 109.982 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -57.09 -33.49 67.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.005 -0.543 . . . . 15.6 111.453 -177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -75.42 -54.19 7.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.052 -0.522 . . . . 14.220000000000001 110.023 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -72.85 -19.52 61.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.079 -0.509 . . . . 11.949999999999999 111.044 -173.747 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.463 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 2.0 mmmm -63.91 -33.67 76.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.526 0.679 . . . . 14.699999999999999 110.918 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.74 -12.75 81.04 Favored Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.415 -1.074 . . . . 13.09 110.415 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 74.0 m -83.71 -8.72 59.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.601 -0.799 . . . . 12.109999999999999 111.994 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 9.6 mt -71.84 -38.45 70.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.805 0.335 . . . . 12.720000000000001 110.632 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.54 -24.7 68.04 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.669 -0.972 . . . . 14.66 110.669 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.568 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 43.8 mt-10 -86.64 -24.2 25.4 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.175 -0.513 . . . . 13.890000000000001 110.328 174.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.403 ' CD2' HG11 ' A' ' 146' ' ' VAL . 6.0 tp -60.01 -46.29 89.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.415 -0.357 . . . . 12.550000000000001 111.106 -175.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -21.95 46.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.13 -0.486 . . . . 15.83 111.06 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -41.03 11.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.076 -0.511 . . . . 16.969999999999999 110.938 174.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.8 mt -67.9 -52.39 36.89 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.144 0.497 . . . . 13.890000000000001 111.437 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 66.0 p -104.23 -38.07 7.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.942 -0.572 . . . . 13.539999999999999 110.748 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.39 -0.55 54.3 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.103 -0.799 . . . . 14.67 111.103 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 58.7 mt -97.47 154.13 17.69 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 122.831 0.452 . . . . 13.039999999999999 110.336 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.1 m -84.85 107.34 16.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.904 -0.589 . . . . 14.84 110.555 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -127.83 158.8 21.5 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.282 -0.961 . . . . 12.220000000000001 113.325 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.49 142.58 21.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.763 -0.458 . . . . 13.74 109.763 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.4 105.53 4.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.077 -0.712 . . . . 12.890000000000001 109.077 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 92.8 mmm -114.09 142.39 46.26 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.444 -0.798 . . . . 13.800000000000001 109.383 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -69.94 109.08 2.71 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.11 -1.043 . . . . 13.359999999999999 111.726 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.846 ' CD2' ' HB1' ' A' ' 143' ' ' ALA . 5.4 t80 . . . . . 0 C--N 1.313 -0.998 0 C-N-CA 124.113 0.965 . . . . 14.24 110.457 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.554 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.442 -0.856 0 N-CA-C 108.985 -0.746 . . . . 14.65 108.985 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.633 ' CB ' HD21 ' A' ' 197' ' ' LEU . 5.5 m-85 -145.53 153.79 41.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.515 0.198 . . . . 14.81 110.882 -175.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.861 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.7 t -149.51 161.64 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.622 -0.881 . . . . 10.48 108.622 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.548 HG11 HD22 ' A' ' 204' ' ' LEU . 17.7 t -106.39 108.19 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 122.129 -0.357 . . . . 10.1 111.715 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.554 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 30.0 tt0 -81.5 118.26 22.58 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.615 0.228 . . . . 12.0 111.615 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.938 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -91.62 -36.5 13.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.097 -0.641 . . . . 11.880000000000001 109.708 177.082 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.14 161.89 28.14 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.536 -0.84 . . . . 11.35 112.73 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -163.68 100.76 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.022 -0.733 . . . . 13.470000000000001 109.022 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.71 167.96 19.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.941 -0.572 . . . . 13.52 110.257 -174.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 4.9 mtpm? -104.83 20.85 18.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.325 -0.852 . . . . 17.600000000000001 109.662 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.403 ' O ' HG23 ' A' ' 157' ' ' VAL . 25.3 t-20 -130.76 118.48 20.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.847 -1.069 . . . . 16.140000000000001 109.689 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.42 -22.53 61.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.321 0.489 . . . . 14.039999999999999 112.321 -173.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.28 -34.78 78.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.935 0.874 . . . . 16.57 109.466 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.36 -29.27 34.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.338 -1.301 . . . . 16.399999999999999 110.093 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.533 ' HA ' HD11 ' A' ' 186' ' ' ILE . 97.8 t -65.82 -39.66 85.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.827 -0.624 . . . . 12.67 109.82 173.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.49 -34.57 72.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.022 -0.99 . . . . 15.32 112.13 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.86 -46.51 29.92 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 120.115 -0.634 . . . . 15.970000000000001 111.225 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.789 HD12 HD12 ' A' ' 186' ' ' ILE . 25.2 mt -59.01 -45.95 91.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.444 0.64 . . . . 12.6 109.868 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 82.2 t -68.61 -40.62 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.255 -0.884 . . . . 12.539999999999999 110.445 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.35 -34.31 88.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.045 -0.598 . . . . 14.800000000000001 112.544 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -73.61 -43.96 58.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.587 0.232 . . . . 16.050000000000001 111.046 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.643 ' HB3' HG21 ' A' ' 171' ' ' VAL . 8.5 mt -87.03 -59.15 2.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.386 0.884 . . . . 12.99 113.386 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.473 ' HG2' ' HB ' ' A' ' 171' ' ' VAL . 9.8 mtp180 -69.74 -30.05 67.56 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.848 -0.797 . . . . 15.06 108.848 -175.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.41 -31.7 77.52 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 114.633 -1.167 . . . . 16.600000000000001 111.57 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.3 -12.05 53.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.927 0.394 . . . . 16.140000000000001 110.555 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.0 23.24 13.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.892 -0.671 . . . . 15.119999999999999 113.317 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -87.79 152.54 22.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.078 0.439 . . . . 15.49 110.329 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.445 ' HG3' ' HD2' ' A' ' 190' ' ' PRO . 20.6 tpp180 -75.43 97.75 3.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.806 0.812 . . . . 13.869999999999999 109.589 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 188' ' ' VAL . 2.6 t -131.96 136.32 56.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.605 -1.18 . . . . 10.82 110.622 -173.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.424 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -135.26 174.83 10.18 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.759 0.79 . . . . 11.130000000000001 111.089 174.13 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 7.8 p -127.71 -174.52 3.21 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.165 -1.38 . . . . 11.52 110.809 -169.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 58.0 m -50.13 135.57 22.33 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 120.836 0.35 . . . . 12.75 110.477 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 30.5 Cg_exo -38.4 -44.85 2.17 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 124.714 3.609 . . . . 14.640000000000001 115.721 -169.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.6 m -87.01 -64.19 1.19 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 119.669 -0.812 . . . . 16.68 112.224 -173.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.7 m -168.52 129.13 1.08 Allowed Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 117.942 0.337 . . . . 16.039999999999999 111.861 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.522 ' HB3' HG21 ' A' ' 184' ' ' THR . 86.9 Cg_exo -58.33 125.16 17.61 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.772 2.315 . . . . 14.220000000000001 112.096 162.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.484 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.7 p -153.18 156.16 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 109.923 -0.399 . . . . 16.129999999999999 109.923 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -81.62 133.56 35.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.797 0.332 . . . . 16.699999999999999 110.202 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 102.86 -26.23 24.75 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.031 -0.604 . . . . 16.98 111.668 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -115.06 168.56 9.82 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.448 -0.575 . . . . 18.73 109.448 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 10.1 tp -76.48 126.26 36.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.471 0.653 . . . . 14.82 111.335 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.522 HG21 ' HB3' ' A' ' 178' ' ' PRO . 57.4 m -119.66 105.98 11.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.842 -0.617 . . . . 12.779999999999999 110.042 173.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 173' ' ' THR . 97.5 mtt180 -83.8 135.43 34.53 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.268 -0.878 . . . . 13.98 108.959 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.789 HD12 HD12 ' A' ' 160' ' ' ILE . 3.2 mt -119.8 120.5 63.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.577 -0.527 . . . . 10.56 109.577 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 187' ' ' LEU . 3.6 mp -129.16 142.1 50.97 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.344 -0.843 . . . . 10.1 111.114 -169.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.938 HG23 HD21 ' A' ' 148' ' ' LEU . 53.8 t -107.14 131.84 56.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.986 -1.006 . . . . 9.7400000000000002 110.926 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.86 49.62 4.73 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.19 -0.913 . . . . 9.7599999999999998 113.783 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.786 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -61.35 124.97 15.78 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 CA-C-N 119.624 1.712 . . . . 11.15 110.854 172.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -159.62 149.14 18.27 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.762 -0.458 . . . . 12.77 109.762 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -89.24 6.14 41.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.968 -0.56 . . . . 14.6 111.145 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.448 ' HB3' ' HB3' ' A' ' 196' ' ' LYS . 22.7 t -118.98 96.32 5.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.253 -0.647 . . . . 14.300000000000001 109.253 175.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.489 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 15.9 ptmt -63.03 -35.67 81.01 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.027 -0.988 . . . . 15.970000000000001 111.583 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -68.69 -44.42 74.01 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.996 0.427 . . . . 15.6 110.628 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 193' ' ' SER . 44.0 tttm -59.42 -44.07 92.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.765 -0.652 . . . . 14.220000000000001 110.698 176.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.633 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -82.54 -16.96 46.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.654 -0.703 . . . . 11.949999999999999 110.487 -176.307 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.622 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 25.3 tptp -64.57 -34.57 78.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 14.699999999999999 110.761 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -82.22 -12.56 80.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.391 -1.084 . . . . 13.09 110.391 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.516 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 70.9 m -79.58 -9.2 59.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.655 -0.772 . . . . 12.109999999999999 111.498 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 1.8 mt -74.11 -33.38 63.58 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.509 -0.552 . . . . 12.720000000000001 109.509 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -61.45 -28.23 69.18 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.551 -1.019 . . . . 14.66 110.551 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.545 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 41.8 mt-10 -85.85 -19.17 31.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.062 -0.569 . . . . 13.890000000000001 110.664 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.548 HD22 HG11 ' A' ' 146' ' ' VAL . 4.6 tp -60.59 -45.01 95.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.796 0.332 . . . . 12.550000000000001 111.553 -173.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -57.85 -23.88 54.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.302 -0.408 . . . . 15.83 111.224 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.38 -37.89 14.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.338 -0.392 . . . . 16.969999999999999 110.466 176.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 89.6 mt -70.9 -51.77 24.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.321 0.581 . . . . 13.890000000000001 111.052 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.564 ' CB ' HD21 ' A' ' 164' ' ' LEU . 28.4 t -110.11 -43.94 3.86 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.502 -0.772 . . . . 13.539999999999999 111.264 -173.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.34 -0.23 55.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.748 -0.739 . . . . 14.67 111.606 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.14 157.51 15.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.684 -0.487 . . . . 13.039999999999999 109.684 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 61.2 m -77.1 95.45 4.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.949 0.405 . . . . 14.84 111.1 -174.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -103.94 138.58 14.13 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.651 -0.704 . . . . 12.220000000000001 113.439 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.0 142.03 21.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.298 0.571 . . . . 13.74 110.066 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.6 t -78.68 105.94 8.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.434 -0.803 . . . . 12.890000000000001 110.419 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 90.1 mtp -120.31 142.59 48.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.073 -0.512 . . . . 13.800000000000001 110.258 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -69.22 136.03 28.12 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.624 -0.798 . . . . 13.359999999999999 112.416 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.861 ' HB2' HG23 ' A' ' 145' ' ' VAL . 10.5 t80 . . . . . 0 C--N 1.31 -1.121 0 CA-C-N 114.396 -0.902 . . . . 14.24 110.102 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.818 ' HB1' ' CD1' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 109.436 -0.579 . . . . 14.65 109.436 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.729 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 5.5 m-85 -138.6 141.12 39.17 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 111.455 0.168 . . . . 14.81 111.455 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 1.026 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.7 t -149.96 163.07 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 109.317 -0.623 . . . . 10.48 109.317 170.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 59.3 t -103.83 108.85 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 O-C-N 122.304 -0.248 . . . . 10.1 111.528 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.46 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 4.9 tt0 -76.72 111.78 12.59 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.21 0.204 . . . . 12.0 110.899 178.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.966 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -89.02 -35.66 16.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.26 -0.644 . . . . 11.880000000000001 109.26 176.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.52 167.61 27.49 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.35 -0.841 . . . . 11.35 112.45 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -165.35 101.27 0.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.123 -0.695 . . . . 13.470000000000001 109.123 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 158.08 45.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.669 -0.696 . . . . 13.52 110.499 -173.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 49.9 mttp -96.23 16.73 17.45 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.182 -0.917 . . . . 17.600000000000001 110.194 -175.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 157' ' ' VAL . 15.8 m120 -118.56 108.37 14.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.959 -1.019 . . . . 16.140000000000001 109.52 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.38 68.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.177 0.513 . . . . 14.039999999999999 110.557 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.68 -37.51 78.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.386 -0.824 . . . . 16.57 110.157 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 64.8 mttp -84.6 -23.3 29.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.621 -1.172 . . . . 16.399999999999999 110.132 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.46 HG13 ' CD1' ' A' ' 186' ' ' ILE . 77.0 t -65.64 -46.34 89.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.789 -0.641 . . . . 12.67 109.967 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -61.53 -29.49 70.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 15.32 112.04 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 14.8 pt-20 -77.4 -43.51 32.41 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.282 -0.567 . . . . 15.970000000000001 111.101 -177.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.465 HD12 HG13 ' A' ' 186' ' ' ILE . 21.7 mt -66.33 -46.73 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.762 0.792 . . . . 12.6 109.469 176.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.442 ' CG1' ' HD2' ' A' ' 165' ' ' ARG . 34.2 t -63.46 -32.9 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.538 -1.21 . . . . 12.539999999999999 110.588 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.76 -32.18 73.65 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.009 -0.615 . . . . 14.800000000000001 112.35 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -71.31 -53.96 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 16.050000000000001 110.967 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.481 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 4.0 mm? -83.84 -51.25 7.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.199 0.815 . . . . 12.99 113.199 -172.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.456 ' HG3' HG13 ' A' ' 171' ' ' VAL . 48.1 mtt180 -69.74 -37.52 76.49 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.838 -0.801 . . . . 15.06 108.838 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.87 -32.21 83.46 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 114.601 -1.181 . . . . 16.600000000000001 112.4 -175.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.78 -3.64 58.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 16.140000000000001 110.833 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.41 25.58 35.83 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 15.119999999999999 113.376 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.422 ' O ' HG12 ' A' ' 171' ' ' VAL . 35.5 m-85 -87.03 160.02 18.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.122 0.461 . . . . 15.49 110.658 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -76.29 97.3 4.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.608 0.718 . . . . 13.869999999999999 109.543 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.456 HG13 ' HG3' ' A' ' 165' ' ' ARG . 5.7 p -144.28 141.26 24.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.909 -1.041 . . . . 10.82 109.635 -174.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.585 ' CE1' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -140.2 176.57 8.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.717 0.77 . . . . 11.130000000000001 111.095 175.347 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.3 p -117.27 -175.22 2.76 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.44 -1.254 . . . . 11.52 110.696 -173.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.2 m -51.76 140.2 29.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 12.75 110.934 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -46.18 -36.77 17.33 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.136 3.224 . . . . 14.640000000000001 115.069 -169.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.1 m -87.19 -63.74 1.26 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 119.915 -0.714 . . . . 16.68 112.177 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 98.0 m -168.49 139.55 2.14 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 117.742 0.247 . . . . 16.039999999999999 111.19 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.437 ' HB3' HG11 ' A' ' 157' ' ' VAL . 27.8 Cg_exo -66.55 122.82 10.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 121.786 1.657 . . . . 14.220000000000001 110.115 163.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 7.8 p -153.01 156.79 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.363 -0.535 . . . . 16.129999999999999 111.251 -172.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -81.48 128.77 34.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.432 -0.804 . . . . 16.699999999999999 110.423 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.09 -25.03 29.79 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.704 -0.76 . . . . 16.98 112.433 176.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 9.0 mptt -112.32 158.93 19.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.636 -0.505 . . . . 18.73 109.636 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.4 tp -70.83 115.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.486 0.66 . . . . 14.82 111.36 -175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 36.3 m -112.05 113.18 25.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.648 -0.705 . . . . 12.779999999999999 109.826 175.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.551 ' CG ' HD11 ' A' ' 187' ' ' LEU . 21.0 ttm180 -89.49 140.93 29.04 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.04 -0.982 . . . . 13.98 110.112 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.521 ' O ' HD22 ' A' ' 148' ' ' LEU . 3.9 mm -111.21 117.51 55.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.878 -0.786 . . . . 10.56 108.878 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 187' ' ' LEU . 2.5 mp -130.33 135.02 47.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.306 0.574 . . . . 10.1 111.107 -173.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.966 HG23 HD21 ' A' ' 148' ' ' LEU . 41.1 t -108.59 135.62 46.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.241 -0.89 . . . . 9.7400000000000002 111.078 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.442 ' O ' HD22 ' A' ' 197' ' ' LEU . . . 82.8 49.3 5.15 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 114.999 -1.0 . . . . 9.7599999999999998 113.507 175.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.923 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -62.3 125.26 15.92 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 CA-C-N 119.552 1.676 . . . . 11.15 111.136 174.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -157.77 168.17 27.97 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.528 -0.545 . . . . 12.77 109.528 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -104.94 4.77 32.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.116 -0.493 . . . . 14.6 110.581 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 196' ' ' LYS . 21.0 t -120.67 117.7 28.21 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.036 0.446 . . . . 14.300000000000001 110.146 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.696 ' HB2' ' CE2' ' A' ' 144' ' ' TYR . 39.0 ttpt -67.8 -41.78 82.6 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-N 115.901 -0.591 . . . . 15.970000000000001 109.535 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -57.53 -50.19 73.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.667 0.27 . . . . 15.6 111.033 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 39.0 mtpt -52.85 -60.0 3.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.476 -0.784 . . . . 14.220000000000001 111.187 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -76.74 -28.83 55.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.912 -1.04 . . . . 11.949999999999999 111.617 -169.318 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.579 ' HD3' ' O ' ' A' ' 198' ' ' LYS . 12.9 tmtt? -73.45 -31.59 63.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.012 -0.736 . . . . 14.699999999999999 109.012 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.73 -12.55 84.36 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.227 -1.149 . . . . 13.09 110.227 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 58.5 m -88.37 -9.87 51.24 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.527 -0.837 . . . . 12.109999999999999 111.965 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 20.7 mt -66.28 -36.37 82.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.712 0.291 . . . . 12.720000000000001 111.055 -174.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -57.47 -44.25 93.76 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.026 -0.607 . . . . 14.66 111.829 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.429 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 13.0 pt-20 -86.07 -17.1 36.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.892 0.377 . . . . 13.890000000000001 110.519 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.56 HD11 HG12 ' A' ' 188' ' ' VAL . 15.5 tp -66.22 -31.91 73.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.028 0.442 . . . . 12.550000000000001 110.442 -177.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.492 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 6.1 mtpm? -58.98 -23.71 62.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.515 -0.766 . . . . 15.83 110.272 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -36.96 15.05 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.863 -0.608 . . . . 16.969999999999999 110.236 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 92.6 mt -68.04 -52.65 33.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.043 -0.526 . . . . 13.890000000000001 111.5 -176.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.402 ' HB3' HD11 ' A' ' 164' ' ' LEU . 56.0 p -102.03 -44.12 5.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.119 0.485 . . . . 13.539999999999999 110.13 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.84 5.48 75.0 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.151 -0.931 . . . . 14.67 111.627 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.55 157.74 16.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 110.113 -0.329 . . . . 13.039999999999999 110.113 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.5 t -87.97 105.26 17.34 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.106 -0.497 . . . . 14.84 110.341 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -128.53 160.64 22.21 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.138 -1.03 . . . . 12.220000000000001 113.893 -176.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.14 143.53 20.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.137 -0.532 . . . . 13.74 110.026 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.62 105.27 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.38 -0.6 . . . . 12.890000000000001 109.38 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 64.1 mtt -120.99 145.96 47.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.019 -0.537 . . . . 13.800000000000001 110.226 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -71.91 110.36 3.18 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.365 -0.921 . . . . 13.359999999999999 112.803 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 1.026 ' HB2' HG23 ' A' ' 145' ' ' VAL . 4.4 t80 . . . . . 0 C--N 1.308 -1.237 0 CA-C-N 113.243 -1.479 . . . . 14.24 110.287 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 108.148 -1.056 . . . . 14.65 108.148 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.555 ' CE1' ' HD3' ' A' ' 194' ' ' LYS . 7.3 m-85 -138.23 153.48 49.12 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.695 0.628 . . . . 14.81 112.695 -176.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.8 m -151.99 151.97 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 114.842 -1.072 . . . . 10.48 109.76 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 80.5 t -110.79 108.02 24.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 120.3 -0.56 . . . . 10.1 111.434 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.515 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 19.0 tt0 -80.26 114.31 19.07 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.085 -0.507 . . . . 12.0 111.148 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 1.037 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -93.75 -33.73 13.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.509 0.671 . . . . 11.880000000000001 109.555 177.453 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.3 170.72 26.6 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.666 -0.778 . . . . 11.35 112.359 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -170.34 103.22 0.27 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.02 -0.733 . . . . 13.470000000000001 109.02 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.98 153.73 42.55 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.451 0.643 . . . . 13.52 110.435 -174.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 77.4 mttt -89.34 2.96 53.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.046 -0.979 . . . . 17.600000000000001 110.438 -175.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -101.82 109.44 21.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.419 -0.81 . . . . 16.140000000000001 109.597 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.409 ' HA ' ' CG2' ' A' ' 157' ' ' VAL . . . -69.88 -20.32 63.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.924 -0.58 . . . . 14.039999999999999 112.202 -175.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.13 -33.84 76.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 122.1 0.952 . . . . 16.57 109.257 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.482 ' O ' HG13 ' A' ' 160' ' ' ILE . 74.4 mmtt -83.54 -30.07 27.37 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.0 -1.454 . . . . 16.399999999999999 110.154 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.463 HG13 ' CD1' ' A' ' 186' ' ' ILE . 77.9 t -57.63 -40.17 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.73 -0.668 . . . . 12.67 110.273 173.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -68.55 -32.62 72.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.264 -0.88 . . . . 15.32 111.969 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.19 -38.09 31.95 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.061 -0.655 . . . . 15.970000000000001 111.2 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 156' ' ' LYS . 29.3 mt -63.28 -41.36 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 12.6 109.22 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.79 -35.66 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.01 -0.995 . . . . 12.539999999999999 110.17 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.64 -28.54 73.72 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.016 -0.612 . . . . 14.800000000000001 112.374 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -72.3 -61.96 1.61 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 16.050000000000001 110.977 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.719 ' HB3' HG21 ' A' ' 171' ' ' VAL . 1.8 mm? -79.5 -62.72 1.6 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.927 -0.579 . . . . 12.99 112.188 -175.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 165' ' ' ARG . 3.0 tmt_? -61.97 -38.25 87.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.381 -0.6 . . . . 15.06 109.381 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.95 85.22 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.258 -0.883 . . . . 16.600000000000001 112.506 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.28 -7.33 59.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.005 0.431 . . . . 16.140000000000001 110.523 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.43 25.1 9.58 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.807 -0.711 . . . . 15.119999999999999 112.624 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -96.31 145.24 25.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.182 -0.674 . . . . 15.49 109.182 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -70.25 107.32 3.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.611 0.72 . . . . 13.869999999999999 110.55 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 188' ' ' VAL . 11.0 t -138.62 135.71 43.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.773 -1.103 . . . . 10.82 110.324 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -137.85 175.39 9.63 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.78 0.8 . . . . 11.130000000000001 110.946 174.091 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 18.0 p -122.68 -172.68 2.53 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.135 -1.393 . . . . 11.52 110.56 -170.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.6 m -49.61 145.8 7.84 Favored Pre-proline 0 C--O 1.236 0.365 0 O-C-N 123.272 0.357 . . . . 12.75 110.739 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -38.25 -44.94 2.08 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 124.479 3.452 . . . . 14.640000000000001 115.302 -170.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.0 p -87.42 -63.53 1.29 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.735 -0.786 . . . . 16.68 113.089 -173.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.1 m -168.07 142.96 2.96 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 117.688 0.222 . . . . 16.039999999999999 110.86 -175.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.482 ' HG3' ' OG1' ' A' ' 173' ' ' THR . 25.0 Cg_exo -67.38 123.84 11.34 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.13 1.887 . . . . 14.220000000000001 111.066 165.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.427 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.9 p -153.61 156.49 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 120.826 0.346 . . . . 16.129999999999999 110.331 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.401 ' NE2' ' H ' ' A' ' 154' ' ' ALA . 6.2 tp-100 -80.31 128.46 33.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.121 -0.491 . . . . 16.699999999999999 110.193 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.17 -26.09 18.11 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.006 -0.616 . . . . 16.98 112.138 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 12.6 mptt -108.08 153.04 23.7 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.618 -0.512 . . . . 18.73 109.618 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.8 tp -69.17 109.58 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.76 0.791 . . . . 14.82 110.874 -176.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.436 ' HB ' HG21 ' A' ' 157' ' ' VAL . 26.8 m -103.57 109.02 20.53 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.956 0.884 . . . . 12.779999999999999 110.429 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 173' ' ' THR . 48.3 ttt180 -86.24 134.52 33.76 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.063 -1.426 . . . . 13.98 109.032 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.502 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.7 mm -109.4 117.19 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 N-CA-C 109.183 -0.673 . . . . 10.56 109.183 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 187' ' ' LEU . 2.1 mp -130.17 132.95 46.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.512 0.672 . . . . 10.1 111.034 -173.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.037 HG23 HD21 ' A' ' 148' ' ' LEU . 52.8 t -101.96 137.31 30.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.908 -1.042 . . . . 9.7400000000000002 110.208 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.97 51.49 5.8 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.344 -0.844 . . . . 9.7599999999999998 114.071 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.698 ' HA ' HG12 ' A' ' 145' ' ' VAL . 18.6 Cg_endo -67.06 125.71 14.02 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 CA-C-N 119.632 1.716 . . . . 11.15 110.813 170.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -157.88 153.63 26.62 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.598 -0.441 . . . . 12.77 110.274 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.412 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -98.83 0.54 44.5 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.948 -0.569 . . . . 14.6 111.473 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 68.8 m -118.48 93.66 4.2 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 121.37 0.605 . . . . 14.300000000000001 109.992 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.555 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 35.1 ttpt -57.12 -36.79 71.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.917 -1.038 . . . . 15.970000000000001 110.769 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.71 -39.29 80.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.976 0.417 . . . . 15.6 111.53 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -77.54 -42.84 33.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.62 0.724 . . . . 14.220000000000001 110.399 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -83.67 -19.19 35.78 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.251 -0.886 . . . . 11.949999999999999 110.977 -173.285 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -64.85 -40.12 94.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.193 0.52 . . . . 14.699999999999999 110.51 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.47 -13.73 82.92 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 110.328 -1.109 . . . . 13.09 110.328 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.472 ' HB2' ' HA ' ' A' ' 197' ' ' LEU . 58.4 m -83.35 -11.43 57.65 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.587 -0.807 . . . . 12.109999999999999 111.72 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 28.0 mt -66.88 -40.99 87.96 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.878 0.37 . . . . 12.720000000000001 110.399 -177.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.56 86.28 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.346 -0.931 . . . . 14.66 110.912 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.575 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 45.3 mt-10 -76.89 -26.94 54.74 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 120.81 0.338 . . . . 13.890000000000001 110.574 175.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 146' ' ' VAL . 4.7 tt -67.41 -38.75 85.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.056 -0.52 . . . . 12.550000000000001 110.422 -176.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 82.8 mttt -62.19 -21.02 64.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.392 -0.822 . . . . 15.83 110.261 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.16 -42.31 11.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.676 -0.693 . . . . 16.969999999999999 110.281 173.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 96.8 mt -66.9 -51.91 49.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.033 -0.53 . . . . 13.890000000000001 111.694 -176.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.446 ' HB3' HD11 ' A' ' 164' ' ' LEU . 71.4 p -100.16 -44.38 5.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.214 0.531 . . . . 13.539999999999999 110.821 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.34 12.22 57.86 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.301 -0.863 . . . . 14.67 111.698 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 91.6 mt -91.4 157.75 16.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.912 -0.403 . . . . 13.039999999999999 109.912 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 53.9 m -80.6 94.43 6.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.057 0.456 . . . . 14.84 110.777 -178.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -124.23 159.82 18.84 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.617 -0.802 . . . . 12.220000000000001 113.048 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.2 p -116.17 143.97 24.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.196 0.522 . . . . 13.74 110.541 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' VAL . . . . . 0.429 HG21 HD13 ' A' ' 201' ' ' LEU . 39.6 t -80.03 106.79 11.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.218 -0.901 . . . . 12.890000000000001 110.343 -176.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 24.3 mmt -121.04 155.63 33.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.017 -0.538 . . . . 13.800000000000001 110.567 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -82.19 129.62 9.18 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.404 -0.903 . . . . 13.359999999999999 111.992 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.568 ' HB2' HG13 ' A' ' 145' ' ' VAL . 8.6 t80 . . . . . 0 C--N 1.314 -0.964 0 C-N-CA 124.164 0.986 . . . . 14.24 109.975 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.517 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 108.338 -0.986 . . . . 14.65 108.338 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.695 ' CB ' HD21 ' A' ' 197' ' ' LEU . 3.3 m-85 -143.85 152.7 41.51 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.824 -0.351 . . . . 14.81 111.695 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.909 HG12 ' HA ' ' A' ' 190' ' ' PRO . 12.5 m -149.2 156.23 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.273 0.629 . . . . 10.48 109.846 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.411 HG21 HD13 ' A' ' 204' ' ' LEU . 60.9 t -109.7 109.55 28.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 O-C-N 121.84 -0.537 . . . . 10.1 111.111 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -86.71 109.55 19.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.566 -0.288 . . . . 12.0 111.478 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 1.04 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -88.97 -34.86 16.72 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.141 0.496 . . . . 11.880000000000001 109.965 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.02 161.56 28.12 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.499 -0.773 . . . . 11.35 112.457 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -161.44 101.49 1.2 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.316 -0.624 . . . . 13.470000000000001 109.316 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.75 164.18 28.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.808 -0.633 . . . . 13.52 110.332 -173.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 49.5 mtpt -105.71 0.55 26.36 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.032 -0.985 . . . . 17.600000000000001 109.782 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -97.79 108.33 21.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.231 -0.895 . . . . 16.140000000000001 109.373 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.53 -21.44 66.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.995 0.426 . . . . 14.039999999999999 110.876 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.88 -36.79 70.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.653 0.739 . . . . 16.57 110.036 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.524 ' N ' ' HD2' ' A' ' 156' ' ' LYS . 2.0 mptp? -83.87 -27.22 28.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.784 -1.098 . . . . 16.399999999999999 110.354 -178.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.65 -37.66 76.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.354 0.597 . . . . 12.67 109.801 174.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -68.99 -34.12 74.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.335 -0.848 . . . . 15.32 111.512 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.616 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.7 pt-20 -82.91 -21.35 34.23 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.964 -0.294 . . . . 15.970000000000001 111.589 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 156' ' ' LYS . 48.3 mt -85.06 -50.66 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.322 0.582 . . . . 12.6 110.046 174.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.1 -41.74 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.71 -0.677 . . . . 12.539999999999999 111.162 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.26 -25.27 62.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.868 -0.682 . . . . 14.800000000000001 112.462 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.616 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 13.5 mptt -78.09 -61.05 2.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.645 0.259 . . . . 16.050000000000001 110.595 176.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.68 ' HB3' HG21 ' A' ' 171' ' ' VAL . 2.4 mm? -78.18 -48.47 15.8 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.603 0.594 . . . . 12.99 112.603 -173.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.42 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 41.8 ttt180 -77.87 -26.01 49.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.911 -0.774 . . . . 15.06 108.911 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.15 -25.54 74.46 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.033 -0.985 . . . . 16.600000000000001 111.657 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.84 3.96 54.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.054 0.454 . . . . 16.140000000000001 110.65 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.87 22.11 47.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.901 -0.666 . . . . 15.119999999999999 113.701 174.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -89.11 156.85 18.56 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 117.493 0.647 . . . . 15.49 110.027 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.407 ' HB3' ' HD2' ' A' ' 190' ' ' PRO . 24.1 mmt180 -67.69 96.83 0.58 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.751 -0.463 . . . . 13.869999999999999 109.751 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.792 HG22 HG22 ' A' ' 188' ' ' VAL . 3.6 t -139.09 125.97 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 CA-C-N 115.546 -0.752 . . . . 10.82 110.2 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.489 ' CE1' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -138.63 175.68 9.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.608 -0.723 . . . . 11.130000000000001 110.462 173.423 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.3 p -115.68 -176.36 2.91 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.758 -1.11 . . . . 11.52 111.733 -168.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.626 ' HB2' ' H ' ' A' ' 185' ' ' ARG . 22.9 t -53.03 134.74 48.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.957 -0.565 . . . . 12.75 110.384 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -31.06 -55.31 0.23 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 125.198 3.932 . . . . 14.640000000000001 115.542 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.4 t -81.11 -64.39 1.2 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 119.75 -0.78 . . . . 16.68 112.574 -169.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 55.7 m -169.09 130.41 1.06 Allowed Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 118.028 0.376 . . . . 16.039999999999999 111.791 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.558 ' HB3' HG21 ' A' ' 184' ' ' THR . 52.3 Cg_exo -65.26 122.62 10.39 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.347 2.032 . . . . 14.220000000000001 112.125 162.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.408 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.8 p -154.91 156.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.303 -0.628 . . . . 16.129999999999999 109.303 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -77.65 127.75 32.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.07 0.462 . . . . 16.699999999999999 110.691 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.02 -26.47 15.3 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.51 -0.768 . . . . 16.98 111.819 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.6 OUTLIER -108.62 167.41 10.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.24 -0.652 . . . . 18.73 109.24 176.284 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.2 tp -81.51 118.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.553 0.692 . . . . 14.82 111.073 -175.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 178' ' ' PRO . 28.8 m -111.76 105.19 13.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.729 -0.669 . . . . 12.779999999999999 109.896 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.626 ' H ' ' HB2' ' A' ' 174' ' ' SER . 81.0 mtt-85 -84.61 144.44 28.61 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.332 -0.849 . . . . 13.98 110.156 176.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.57 ' C ' HD23 ' A' ' 187' ' ' LEU . 3.0 mm -115.74 117.83 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 108.698 -0.852 . . . . 10.56 108.698 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.57 HD23 ' C ' ' A' ' 186' ' ' ILE . 0.1 OUTLIER -129.94 128.16 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.748 0.785 . . . . 10.1 112.131 -175.237 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.04 HG23 HD21 ' A' ' 148' ' ' LEU . 55.1 t -95.45 146.37 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 114.205 -1.361 . . . . 9.7400000000000002 110.278 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 72.97 46.61 28.05 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.333 -0.849 . . . . 9.7599999999999998 114.203 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.909 ' HA ' HG12 ' A' ' 145' ' ' VAL . 11.3 Cg_endo -61.72 125.53 16.89 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 119.83 1.815 . . . . 11.15 110.52 170.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -159.48 154.71 25.26 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.927 -0.578 . . . . 12.77 109.877 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -100.49 2.39 42.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.062 -0.517 . . . . 14.6 111.725 -174.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.11 98.3 6.1 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.563 0.697 . . . . 14.300000000000001 110.759 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.487 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 18.4 ptmt -58.88 -39.6 81.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.551 -1.204 . . . . 15.970000000000001 112.557 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -67.41 -42.85 82.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.227 0.537 . . . . 15.6 110.393 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -62.9 -41.28 99.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.116 -0.947 . . . . 14.220000000000001 110.599 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.695 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -85.78 -16.79 37.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.865 -0.607 . . . . 11.949999999999999 111.085 -177.293 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 4.8 tppp? -64.04 -32.07 73.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.491 0.663 . . . . 14.699999999999999 110.023 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -83.88 -13.2 75.56 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.648 -0.981 . . . . 13.09 110.648 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 46.0 m -79.77 -9.17 59.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.008 -0.596 . . . . 12.109999999999999 111.523 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 9.8 mt -74.27 -37.25 63.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.939 0.399 . . . . 12.720000000000001 110.485 -176.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.41 -34.84 91.03 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.001 -0.618 . . . . 14.66 112.123 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.63 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 11.6 pt-20 -86.1 -19.84 29.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.797 0.332 . . . . 13.890000000000001 110.65 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 146' ' ' VAL . 5.3 tt -65.25 -42.98 92.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 12.550000000000001 111.209 -175.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.442 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 58.8 pttt -61.72 -17.63 56.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.058 -0.519 . . . . 15.83 111.414 176.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -89.23 -36.83 15.4 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.901 0.381 . . . . 16.969999999999999 109.993 172.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.6 mt -68.84 -52.16 32.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 13.890000000000001 110.6 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.636 ' HA ' HD11 ' A' ' 164' ' ' LEU . 3.8 m -101.92 -43.38 5.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.654 -0.703 . . . . 13.539999999999999 111.298 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 75.13 -2.45 51.41 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.554 -0.748 . . . . 14.67 111.816 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 40.7 mt -80.02 149.49 30.72 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.084 -0.71 . . . . 13.039999999999999 109.084 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.2 t -89.7 104.86 17.39 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.73 -0.47 . . . . 14.84 109.73 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.563 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -125.53 157.08 19.53 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.416 -0.897 . . . . 12.220000000000001 113.492 -174.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.96 143.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.109 0.48 . . . . 13.74 110.276 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 43.5 t -77.83 106.14 7.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.303 -0.862 . . . . 12.890000000000001 109.955 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 22.7 mmt -115.73 146.78 41.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.765 -0.652 . . . . 13.800000000000001 110.209 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -74.13 134.34 18.18 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.445 -0.883 . . . . 13.359999999999999 111.621 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.545 ' HB2' HG13 ' A' ' 145' ' ' VAL . 7.9 t80 . . . . . 0 C--N 1.308 -1.227 0 CA-C-O 121.536 0.684 . . . . 14.24 110.26 -175.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 110.386 -0.228 . . . . 14.65 110.386 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.698 ' CD1' ' HG3' ' A' ' 194' ' ' LYS . 7.1 m-85 -144.17 156.99 44.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.802 0.297 . . . . 14.81 111.802 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.698 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.2 t -151.07 161.03 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.303 -0.999 . . . . 10.48 108.303 170.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.45 HG12 ' HA3' ' A' ' 212' ' ' GLY . 96.1 t -106.76 110.17 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.909 -0.494 . . . . 10.1 111.574 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.577 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 26.5 tt0 -81.14 115.5 20.59 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.785 -0.189 . . . . 12.0 111.39 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 1.035 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -94.76 -33.4 12.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.385 0.612 . . . . 11.880000000000001 110.298 -179.148 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.24 163.73 28.38 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.535 -0.84 . . . . 11.35 112.468 -175.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.53 ' HB1' HD11 ' A' ' 183' ' ' ILE . . . -161.6 100.02 1.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.356 -0.609 . . . . 13.470000000000001 109.356 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -127.61 163.24 24.65 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.263 0.554 . . . . 13.52 109.796 -174.073 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 22.0 mtpp -102.61 -9.42 20.13 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.943 -1.026 . . . . 17.600000000000001 109.37 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -94.63 111.54 23.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.909 -1.042 . . . . 16.140000000000001 109.301 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.75 -18.34 62.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.148 0.425 . . . . 14.039999999999999 112.148 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.4 -34.83 77.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.905 0.859 . . . . 16.57 109.978 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -83.55 -17.75 40.74 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.623 -1.171 . . . . 16.399999999999999 110.124 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.707 ' HA ' HD11 ' A' ' 186' ' ' ILE . 67.4 t -76.18 -33.84 24.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.701 -0.682 . . . . 12.67 109.244 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.89 -37.6 81.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.415 -0.812 . . . . 15.32 111.054 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.688 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.8 pt-20 -75.41 -26.67 58.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.729 0.3 . . . . 15.970000000000001 111.49 -175.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.797 HD12 HD12 ' A' ' 186' ' ' ILE . 69.1 mt -85.09 -49.07 16.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.149 0.499 . . . . 12.6 110.317 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.45 -46.58 69.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.83 -0.623 . . . . 12.539999999999999 111.156 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.53 62.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.958 -0.639 . . . . 14.800000000000001 112.568 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.688 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 2.1 mptm? -85.93 -57.08 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.683 0.278 . . . . 16.050000000000001 110.896 177.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.534 ' HB3' HG21 ' A' ' 171' ' ' VAL . 2.5 mm? -79.63 -56.84 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.167 0.432 . . . . 12.99 112.167 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.531 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 68.3 ttt180 -64.6 -39.6 94.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 15.06 109.983 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.25 -25.74 71.28 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.254 -0.885 . . . . 16.600000000000001 112.698 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.46 -7.3 58.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.929 0.395 . . . . 16.140000000000001 110.517 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.3 2.42 29.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.782 -0.723 . . . . 15.119999999999999 113.284 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -79.52 151.9 30.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.039 0.419 . . . . 15.49 110.479 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -70.23 99.06 1.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.868 -0.605 . . . . 13.869999999999999 110.316 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.701 HG22 HG22 ' A' ' 188' ' ' VAL . 13.7 t -132.06 132.61 61.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.106 0.479 . . . . 10.82 111.298 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.463 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -137.29 174.86 10.15 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.331 -0.849 . . . . 11.130000000000001 110.226 170.751 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 18.0 p -118.6 -176.57 3.11 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.964 -1.016 . . . . 11.52 111.849 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.2 OUTLIER -52.99 148.77 13.3 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.85 -0.614 . . . . 12.75 111.867 -178.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -23.93 -65.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.556 1 C-N-CA 125.969 4.446 . . . . 14.640000000000001 115.838 -176.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.6 m -88.56 -62.77 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.294 0.85 . . . . 16.68 113.294 -170.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.0 m -166.82 132.67 1.81 Allowed Pre-proline 0 C--O 1.234 0.285 0 N-CA-C 112.449 0.537 . . . . 16.039999999999999 112.449 -171.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.526 ' HB3' HG21 ' A' ' 184' ' ' THR . 53.0 Cg_exo -63.48 124.78 14.33 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.971 2.447 . . . . 14.220000000000001 111.6 162.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.4 p -152.14 158.46 4.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.42 -0.354 . . . . 16.129999999999999 110.261 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -80.49 120.06 23.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.315 -0.402 . . . . 16.699999999999999 110.81 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.96 -22.51 25.42 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.98 -0.629 . . . . 16.98 112.72 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -114.79 163.55 15.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.992 0.425 . . . . 18.73 110.062 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.53 HD11 ' HB1' ' A' ' 150' ' ' ALA . 10.1 tp -71.01 120.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.623 -0.717 . . . . 14.82 111.761 -173.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.526 HG21 ' HB3' ' A' ' 178' ' ' PRO . 56.8 m -114.05 105.87 13.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.754 -0.657 . . . . 12.779999999999999 109.704 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 63.5 mtt-85 -83.41 141.16 31.93 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.509 -0.769 . . . . 13.98 108.991 176.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.797 HD12 HD12 ' A' ' 160' ' ' ILE . 3.4 mt -120.91 123.57 70.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.443 -0.577 . . . . 10.56 109.443 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 147' ' ' GLN . 4.0 mp -128.73 135.92 49.87 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.324 -0.853 . . . . 10.1 110.661 -170.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 1.035 HG23 HD21 ' A' ' 148' ' ' LEU . 25.0 t -104.17 133.4 48.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.239 -0.892 . . . . 9.7400000000000002 110.835 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.02 47.37 5.3 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.0 -1.0 . . . . 9.7599999999999998 114.043 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.686 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -61.02 125.1 16.25 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 CA-C-N 119.68 1.74 . . . . 11.15 111.414 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -156.05 147.69 22.88 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.105 -0.498 . . . . 12.77 110.176 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.531 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -89.34 -8.99 52.08 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.559 -0.746 . . . . 14.6 111.267 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.4 t -100.67 94.44 6.1 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.449 -0.574 . . . . 14.300000000000001 109.449 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.698 ' HG3' ' CD1' ' A' ' 144' ' ' TYR . 18.1 ttmt -54.1 -41.08 67.88 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.142 -0.935 . . . . 15.970000000000001 110.101 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.07 -53.41 54.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 15.6 111.827 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -62.88 -46.21 88.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.138 0.494 . . . . 14.220000000000001 111.164 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -76.27 -20.76 57.04 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.841 -0.618 . . . . 11.949999999999999 110.864 -176.228 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 57.0 tptt -65.92 -39.25 90.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.448 0.642 . . . . 14.699999999999999 109.728 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.49 -11.3 85.43 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 114.984 -1.007 . . . . 13.09 110.667 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 204' ' ' LEU . 75.2 m -88.23 -8.97 54.45 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.101 -0.549 . . . . 12.109999999999999 112.377 -175.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 33.1 mt -68.34 -37.28 80.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.799 0.333 . . . . 12.720000000000001 110.956 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.05 -43.8 96.71 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.926 -0.654 . . . . 14.66 111.882 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 13.6 pt-20 -83.47 -18.03 39.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.795 0.331 . . . . 13.890000000000001 110.935 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 207' ' ' LEU . 15.2 tp -74.44 -34.74 63.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.086 0.47 . . . . 12.550000000000001 110.306 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 7.6 mtmp? -66.82 -15.63 63.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.775 -0.648 . . . . 15.83 110.015 174.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.01 -36.01 17.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.851 -0.613 . . . . 16.969999999999999 109.413 172.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 204' ' ' LEU . 66.3 mt -68.88 -51.4 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.787 -0.642 . . . . 13.890000000000001 111.127 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.463 ' HA ' HD11 ' A' ' 164' ' ' LEU . 22.2 p -102.67 -47.82 4.31 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.383 -0.527 . . . . 13.539999999999999 111.139 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 75.37 -0.17 60.6 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.824 -0.626 . . . . 14.67 112.183 -176.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.573 ' HB3' ' HB3' ' A' ' 148' ' ' LEU . 7.3 mp -74.92 158.98 32.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 110.048 -0.353 . . . . 13.039999999999999 110.048 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 57.1 p -77.09 93.35 3.86 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.082 -0.508 . . . . 14.84 110.44 -175.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -112.78 137.63 14.38 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.349 -0.929 . . . . 12.220000000000001 114.279 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 16.9 t -101.75 137.94 27.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.287 -0.634 . . . . 13.74 109.287 173.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 5.3 p -75.56 105.65 4.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.622 0.725 . . . . 12.890000000000001 109.936 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 91.2 mmm -117.35 133.79 55.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.869 -0.605 . . . . 13.800000000000001 110.546 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -67.74 139.31 34.71 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.526 -0.845 . . . . 13.359999999999999 111.546 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.698 ' HB2' HG23 ' A' ' 145' ' ' VAL . 9.9 t80 . . . . . 0 C--N 1.312 -1.031 0 C-N-CA 123.703 0.801 . . . . 14.24 110.423 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.55 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 110.253 -0.277 . . . . 14.65 110.253 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.571 ' HB3' HD21 ' A' ' 197' ' ' LEU . 3.3 m-85 -128.6 156.15 43.83 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.813 0.672 . . . . 14.81 112.813 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.85 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.7 t -150.49 165.75 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 108.983 -0.747 . . . . 10.48 108.983 174.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 43.9 t -105.59 113.05 41.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 O-C-N 121.75 -0.594 . . . . 10.1 110.8 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.442 ' OE1' ' HD3' ' A' ' 185' ' ' ARG . 6.4 tt0 -87.72 105.16 17.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.715 -0.221 . . . . 12.0 111.161 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.931 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -85.66 -36.27 20.39 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.343 0.592 . . . . 11.880000000000001 110.198 -176.224 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.47 169.59 26.4 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.251 -0.976 . . . . 11.35 112.674 -173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.32 101.27 0.35 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.288 -0.634 . . . . 13.470000000000001 109.288 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.75 154.63 47.46 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.402 0.62 . . . . 13.52 110.724 -173.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 40.6 mtmt -95.44 -3.19 47.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.88 -1.055 . . . . 17.600000000000001 109.899 -176.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -97.92 104.15 16.15 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.025 . . . . 16.140000000000001 109.362 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.77 -19.01 65.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.371 0.605 . . . . 14.039999999999999 110.551 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -59.93 -34.34 73.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.235 -0.893 . . . . 16.57 110.189 174.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -90.42 -29.12 18.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.727 -1.124 . . . . 16.399999999999999 110.405 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' THR . 93.3 t -58.48 -38.73 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.368 0.604 . . . . 12.67 109.819 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -59.75 -29.48 68.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.148 -0.933 . . . . 15.32 111.243 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.74 -62.69 1.4 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.217 0.532 . . . . 15.970000000000001 110.03 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.458 HD12 HG13 ' A' ' 186' ' ' ILE . 7.6 mt -55.25 -43.51 71.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.885 -1.052 . . . . 12.6 110.757 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.5 t -74.59 -40.19 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.689 -0.687 . . . . 12.539999999999999 110.455 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.26 -33.95 86.33 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.373 -0.918 . . . . 14.800000000000001 111.487 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -68.23 -57.43 6.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.411 -0.394 . . . . 16.050000000000001 111.497 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -85.3 -52.35 5.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.353 0.501 . . . . 12.99 112.353 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -68.31 -37.59 80.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.15 0.5 . . . . 15.06 110.221 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.09 -23.9 77.63 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.41 -0.814 . . . . 16.600000000000001 112.552 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.5 1.39 55.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.951 0.405 . . . . 16.140000000000001 110.755 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.29 23.46 34.36 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.83 -0.7 . . . . 15.119999999999999 113.396 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -89.92 154.42 19.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.955 0.378 . . . . 15.49 110.208 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.474 ' HD2' ' N ' ' A' ' 170' ' ' ARG . 8.8 mpt_? -76.55 98.34 4.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.238 -0.653 . . . . 13.869999999999999 109.238 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.97 142.01 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.155 -0.929 . . . . 10.82 109.016 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.642 ' HH ' ' HD2' ' A' ' 217' ' ' TYR . 0.1 OUTLIER -138.98 176.8 8.38 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.554 0.693 . . . . 11.130000000000001 110.712 174.152 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 23.6 p -111.21 -175.95 2.83 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.508 -1.223 . . . . 11.52 111.353 -171.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.3 OUTLIER -53.81 148.94 18.22 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.212 -0.449 . . . . 12.75 111.031 176.599 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -32.09 -61.38 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 125.126 3.884 . . . . 14.640000000000001 115.337 -173.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.1 m -87.32 -63.0 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.371 0.878 . . . . 16.68 113.371 -168.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.7 m -167.82 129.22 1.2 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 118.434 0.561 . . . . 16.039999999999999 112.356 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.465 ' HB3' HG21 ' A' ' 184' ' ' THR . 72.1 Cg_exo -59.36 124.27 15.19 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.541 2.16 . . . . 14.220000000000001 111.705 163.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.3 p -153.32 160.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 109.646 -0.502 . . . . 16.129999999999999 109.646 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -80.13 122.57 26.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.457 -0.338 . . . . 16.699999999999999 110.56 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.75 -25.77 18.05 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.888 -0.672 . . . . 16.98 112.555 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -109.35 160.7 15.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.784 -0.451 . . . . 18.73 109.784 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.0 tp -73.19 109.4 5.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.747 0.784 . . . . 14.82 111.555 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 178' ' ' PRO . 56.9 m -100.05 112.53 24.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.449 -0.796 . . . . 12.779999999999999 109.625 174.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 46.1 mtt180 -93.61 144.77 25.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.691 -0.686 . . . . 13.98 109.938 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.519 ' O ' HD22 ' A' ' 148' ' ' LEU . 5.2 mm -114.85 120.41 64.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.108 -0.701 . . . . 10.56 109.108 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.499 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.9 mp -129.42 123.01 30.55 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.208 0.528 . . . . 10.1 111.041 -174.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.931 HG23 HD21 ' A' ' 148' ' ' LEU . 33.6 t -99.58 134.97 36.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.625 -0.716 . . . . 9.7400000000000002 111.159 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 84.5 47.98 5.2 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.96 -1.018 . . . . 9.7599999999999998 113.555 173.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.83 ' HA ' HG22 ' A' ' 145' ' ' VAL . 12.7 Cg_endo -62.74 125.82 16.88 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 119.476 1.638 . . . . 11.15 110.511 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -157.26 152.4 26.06 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.325 -0.55 . . . . 12.77 110.586 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -88.74 2.62 53.11 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.608 -0.724 . . . . 14.6 111.34 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 18.2 t -118.32 97.81 5.96 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.367 0.603 . . . . 14.300000000000001 109.685 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 198' ' ' LYS . 2.9 ptmm? -57.42 -40.5 78.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.899 -1.046 . . . . 15.970000000000001 111.821 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -71.75 -46.89 57.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.803 0.335 . . . . 15.6 111.461 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -59.55 -37.21 77.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.316 0.579 . . . . 14.220000000000001 110.243 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.571 HD21 ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -84.21 -24.18 30.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.749 -0.659 . . . . 11.949999999999999 110.412 -178.241 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 14.1 tmtt? -74.82 -34.46 62.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.313 0.578 . . . . 14.699999999999999 109.652 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.17 -13.28 82.89 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.157 -1.177 . . . . 13.09 110.157 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 45.5 m -90.17 -8.59 50.82 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.354 -0.923 . . . . 12.109999999999999 111.934 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 24.3 mt -65.31 -35.21 80.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.671 0.272 . . . . 12.720000000000001 111.043 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.2 -42.62 97.28 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.791 -0.718 . . . . 14.66 111.851 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 200' ' ' SER . 9.9 pt-20 -85.91 -19.7 30.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.664 0.268 . . . . 13.890000000000001 110.584 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 19.9 tp -68.65 -28.63 67.06 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.112 0.482 . . . . 12.550000000000001 110.085 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.543 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 90.8 mttt -60.92 -16.68 44.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.41 -0.814 . . . . 15.83 110.568 173.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -89.91 -43.01 10.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.42 -0.355 . . . . 16.969999999999999 110.424 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.13 -55.52 31.5 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.51 0.671 . . . . 13.890000000000001 112.204 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 55.9 p -97.38 -44.19 6.97 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.134 -0.939 . . . . 13.539999999999999 110.854 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 72.62 1.93 54.57 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.536 -0.756 . . . . 14.67 111.802 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.446 ' HB2' ' HG ' ' A' ' 148' ' ' LEU . 70.5 mt -85.53 152.14 23.4 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.738 -0.468 . . . . 13.039999999999999 109.738 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 p -90.32 104.84 17.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.256 -0.429 . . . . 14.84 110.591 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -130.32 160.7 23.09 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.148 -1.025 . . . . 12.220000000000001 114.142 -173.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.2 t -101.45 140.59 19.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.917 -0.641 . . . . 13.74 109.383 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.01 105.15 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.732 0.777 . . . . 12.890000000000001 109.614 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 1.8 mmt -122.07 168.85 11.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.48 -0.782 . . . . 13.800000000000001 110.564 -172.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -83.48 163.46 40.79 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.476 -0.868 . . . . 13.359999999999999 112.934 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.85 ' HB2' HG23 ' A' ' 145' ' ' VAL . 6.9 t80 . . . . . 0 C--N 1.318 -0.8 0 C-N-CA 123.845 0.858 . . . . 14.24 110.166 -174.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.485 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 CA--C 1.509 -0.597 0 N-CA-C 110.37 -0.233 . . . . 14.65 110.37 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.557 ' HA ' ' H ' ' A' ' 217' ' ' TYR . 10.0 m-85 -143.95 151.17 39.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.912 0.387 . . . . 14.81 111.336 -177.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.88 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.3 t -146.81 153.11 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.58 -1.267 . . . . 10.48 107.58 170.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 17.1 t -98.23 121.73 49.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.304 -0.559 . . . . 10.1 110.815 -176.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.477 ' HG3' ' CG ' ' A' ' 185' ' ' ARG . 3.5 tt0 -83.98 101.73 11.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.579 -0.156 . . . . 12.0 110.579 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.775 HD13 ' N ' ' A' ' 212' ' ' GLY . 0.5 OUTLIER -87.58 -26.5 23.07 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.191 -0.67 . . . . 11.880000000000001 109.191 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -149.7 158.29 27.6 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.347 -0.842 . . . . 11.35 112.039 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.588 ' HB2' ' HG3' ' A' ' 185' ' ' ARG . . . -157.48 101.25 1.85 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.391 -0.596 . . . . 13.470000000000001 109.391 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -125.72 150.65 47.52 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.461 0.648 . . . . 13.52 110.296 -171.231 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 2.6 mttt -93.85 -1.84 54.29 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.738 -1.119 . . . . 17.600000000000001 108.431 176.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -104.87 107.27 18.15 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.205 -1.361 . . . . 16.140000000000001 109.238 175.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.76 -16.83 59.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.165 0.507 . . . . 14.039999999999999 111.022 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -54.98 -35.32 64.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.092 -0.958 . . . . 16.57 111.062 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.496 ' O ' HG13 ' A' ' 160' ' ' ILE . 83.6 tttt -90.53 -31.84 16.57 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.61 -0.723 . . . . 16.399999999999999 110.48 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.483 HG13 ' CD1' ' A' ' 186' ' ' ILE . 88.2 t -54.72 -43.26 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.239 -0.437 . . . . 12.67 110.472 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -62.0 -34.38 76.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.674 -0.694 . . . . 15.32 111.737 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.81 -59.05 2.9 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 120.911 0.386 . . . . 15.970000000000001 110.016 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 156' ' ' LYS . 21.8 mt -52.39 -45.07 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.846 -1.07 . . . . 12.6 110.788 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.445 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 89.6 t -71.16 -43.02 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.74 -0.663 . . . . 12.539999999999999 110.366 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.26 68.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.609 -0.805 . . . . 14.800000000000001 112.037 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -73.42 -61.79 1.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.257 0.223 . . . . 16.050000000000001 111.254 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 208' ' ' SER . 2.2 mm? -78.36 -45.8 21.6 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.415 0.524 . . . . 12.99 112.415 -174.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.476 ' HB2' ' CG1' ' A' ' 171' ' ' VAL . 25.8 ttm180 -65.17 -47.47 76.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.106 -0.702 . . . . 15.06 109.106 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.67 -20.59 68.3 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.048 -0.978 . . . . 16.600000000000001 113.456 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.2 -12.43 49.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.001 0.429 . . . . 16.140000000000001 110.385 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.41 20.86 11.32 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.937 -0.649 . . . . 15.119999999999999 113.222 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -95.74 154.91 16.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 117.337 0.568 . . . . 15.49 110.611 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -76.08 106.71 7.84 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.67 0.748 . . . . 13.869999999999999 110.151 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 165' ' ' ARG . 9.3 p -143.07 138.15 26.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.391 -1.277 . . . . 10.82 109.141 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.518 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.37 176.18 8.98 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.35 0.595 . . . . 11.130000000000001 110.583 171.484 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 24.8 p -105.78 -177.33 3.33 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.915 -1.039 . . . . 11.52 110.064 -174.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.23 142.73 36.96 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.305 -0.258 . . . . 12.75 110.305 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -38.92 -47.12 2.81 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 124.25 3.3 . . . . 14.640000000000001 115.145 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.9 t -85.74 -61.98 1.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 120.231 -0.588 . . . . 16.68 112.41 -171.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.8 m -167.65 137.66 2.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.607 0.595 . . . . 16.039999999999999 112.607 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.414 ' HB3' HG21 ' A' ' 184' ' ' THR . 30.6 Cg_exo -67.14 125.23 13.24 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.765 2.31 . . . . 14.220000000000001 111.315 160.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.563 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 8.8 p -145.63 152.33 14.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.092 0.472 . . . . 16.129999999999999 110.6 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -81.78 123.52 28.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 16.699999999999999 111.101 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 100.2 -12.1 60.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.836 -0.697 . . . . 16.98 112.612 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.563 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -123.31 161.5 24.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.301 -0.629 . . . . 18.73 109.301 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.8 tp -66.3 111.57 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.622 0.725 . . . . 14.82 111.858 -172.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.414 HG21 ' HB3' ' A' ' 178' ' ' PRO . 87.4 m -109.2 117.16 33.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.372 -0.603 . . . . 12.779999999999999 109.372 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.588 ' HG3' ' HB2' ' A' ' 150' ' ' ALA . 25.2 ttm180 -93.92 140.05 30.17 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.503 -0.771 . . . . 13.98 110.171 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.542 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.9 mm -109.31 115.53 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.417 -0.586 . . . . 10.56 109.417 176.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 4.8 mp -121.57 118.02 28.22 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.554 0.692 . . . . 10.1 110.824 -171.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.44 HG12 HD11 ' A' ' 204' ' ' LEU . 27.7 t -95.71 135.3 30.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 114.834 -1.075 . . . . 9.7400000000000002 110.61 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.19 48.93 5.49 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.248 -0.887 . . . . 9.7599999999999998 113.627 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.718 ' HA ' HG22 ' A' ' 145' ' ' VAL . 12.3 Cg_endo -63.84 125.3 15.11 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 CA-C-N 119.525 1.663 . . . . 11.15 111.05 174.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -156.88 161.12 39.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.001 -0.545 . . . . 12.77 110.102 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -102.73 0.09 32.41 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.943 -0.571 . . . . 14.6 111.363 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 28.5 p -113.61 95.91 5.59 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.575 0.702 . . . . 14.300000000000001 110.13 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.426 ' HG3' ' CD2' ' A' ' 144' ' ' TYR . 31.6 ttpt -56.7 -53.62 55.58 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.062 -0.972 . . . . 15.970000000000001 111.146 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -61.76 -32.04 72.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.833 0.349 . . . . 15.6 111.686 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -73.39 -41.83 62.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.098 0.475 . . . . 14.220000000000001 110.539 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -82.66 -19.86 37.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.246 0.546 . . . . 11.949999999999999 110.649 -178.123 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 55.7 tptt -67.15 -36.39 81.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.835 -0.621 . . . . 14.699999999999999 110.455 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.61 -12.25 83.11 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.43 -1.068 . . . . 13.09 110.43 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 67.2 m -84.66 -8.08 59.0 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.873 -0.664 . . . . 12.109999999999999 111.902 -176.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 14.6 mt -70.58 -36.33 73.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 12.720000000000001 110.611 -177.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.7 92.65 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.987 -0.625 . . . . 14.66 112.219 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.422 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 12.8 pt-20 -85.79 -17.34 36.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.955 0.407 . . . . 13.890000000000001 110.441 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.44 HD11 HG12 ' A' ' 188' ' ' VAL . 17.6 tp -69.14 -34.91 75.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.278 -0.419 . . . . 12.550000000000001 111.438 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -63.72 -16.06 60.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.955 0.407 . . . . 15.83 110.604 173.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.442 ' N ' ' HD3' ' A' ' 205' ' ' LYS . 0.0 OUTLIER -88.93 -36.39 15.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.058 -0.519 . . . . 16.969999999999999 109.687 172.697 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 93.1 mt -71.47 -52.31 19.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.661 -0.699 . . . . 13.890000000000001 111.499 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.412 ' HB3' HD11 ' A' ' 164' ' ' LEU . 63.0 p -98.14 -43.6 6.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.397 0.618 . . . . 13.539999999999999 111.04 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.34 0.01 55.97 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.241 -0.89 . . . . 14.67 111.322 -174.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 148' ' ' LEU . 97.1 mt -80.0 162.23 24.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.701 -0.851 . . . . 13.039999999999999 108.701 175.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.0 m -111.41 109.46 19.44 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.201 0.445 . . . . 14.84 112.201 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.775 ' N ' HD13 ' A' ' 148' ' ' LEU . . . -121.9 173.67 15.87 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.844 -0.693 . . . . 12.220000000000001 114.17 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.4 p -117.1 146.39 21.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.839 -0.68 . . . . 13.74 109.267 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 25.6 t -82.35 115.33 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.905 -0.589 . . . . 12.890000000000001 110.505 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 74.8 mtp -125.96 149.83 48.47 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.123 0.487 . . . . 13.800000000000001 110.67 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.39 128.56 9.41 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.706 -0.759 . . . . 13.359999999999999 112.549 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.88 ' HB2' HG23 ' A' ' 145' ' ' VAL . 8.1 t80 . . . . . 0 C--N 1.311 -1.071 0 CA-C-N 114.574 -0.813 . . . . 14.24 109.083 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 121.602 0.715 . . . . 18.390000000000001 110.207 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 69' ' ' GLU . . . -130.33 159.99 22.92 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.691 -0.686 . . . . 17.77 111.713 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -78.01 -20.43 52.55 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.152 -0.684 . . . . 17.690000000000001 109.152 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -132.37 105.48 7.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.125 -0.943 . . . . 19.93 109.57 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 26.3 tptp -62.35 -49.9 73.74 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.084 -0.71 . . . . 17.43 109.084 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.554 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 31.8 t-80 165.05 -65.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.514 -1.291 . . . . 19.359999999999999 107.514 174.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.507 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 31.9 t80 -175.59 100.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.693 -1.14 . . . . 18.960000000000001 108.248 173.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 74.8 mt-30 72.87 178.65 0.23 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.821 0.701 . . . . 18.239999999999998 110.002 -171.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.92 113.81 25.37 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.924 -0.399 . . . . 16.780000000000001 109.924 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -95.0 140.13 30.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.398 0.618 . . . . 18.420000000000002 111.23 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -147.04 -39.24 0.2 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.31 -0.859 . . . . 17.920000000000002 109.063 172.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.67 137.94 37.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.483 -0.78 . . . . 19.550000000000001 110.148 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.11 64.31 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.661 0.601 . . . . 20.309999999999999 112.042 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 pt -125.81 78.2 69.62 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.0 -0.545 . . . . 19.920000000000002 110.235 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.21 56.18 3.12 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.175 2.583 . . . . 21.640000000000001 112.09 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 60.25 32.12 20.69 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.718 -0.674 . . . . 22.670000000000002 110.402 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.609 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 96.0 t -87.87 -50.81 0.42 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.376 -0.829 . . . . 21.34 111.235 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.609 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 7.2 Cg_exo -75.2 173.6 14.23 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 121.618 1.545 . . . . 20.0 111.148 173.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.68 -46.86 87.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.207 0.527 . . . . 21.079999999999998 110.337 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.08 -31.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.842 -0.617 . . . . 18.800000000000001 110.959 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.23 -75.35 1.57 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.377 -0.689 . . . . 17.510000000000002 111.377 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.84 125.54 23.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.117 -0.327 . . . . 16.949999999999999 110.117 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -64.64 120.36 12.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.202 -0.454 . . . . 18.300000000000001 111.062 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.473 ' O ' HD22 ' A' ' 63' ' ' LEU . 16.6 t70 -76.73 111.61 12.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 18.170000000000002 109.673 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.34 145.98 41.23 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.78 -0.646 . . . . 18.82 111.858 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.425 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 73.9 Cg_endo -77.73 -30.21 3.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.431 2.754 . . . . 19.870000000000001 114.237 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -174.34 112.04 0.16 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.443 -0.344 . . . . 21.100000000000001 111.188 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.5 ptp 176.63 -46.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.599 0.562 . . . . 22.300000000000001 110.332 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.554 ' HB3' ' HD3' ' A' ' 57' ' ' PRO . 60.1 ttp -144.25 -49.07 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.369 -0.378 . . . . 23.850000000000001 110.997 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 56' ' ' MET . 3.8 Cg_exo -78.52 94.05 1.08 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.787 1.658 . . . . 20.670000000000002 110.798 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . . . 64.95 179.61 0.18 Allowed 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.917 0.76 . . . . 20.489999999999998 110.785 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.93 151.51 44.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.98 0.419 . . . . 21.469999999999999 111.967 -174.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.4 m 70.94 -75.7 0.07 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.091 -0.959 . . . . 22.600000000000001 111.84 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -122.96 72.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.635 0.731 . . . . 21.93 110.223 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . . . -92.5 -25.11 18.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.585 -0.734 . . . . 19.73 109.917 175.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 51' ' ' ASP . 44.0 tp -141.47 102.75 6.0 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.363 -0.835 . . . . 19.579999999999998 110.049 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -49.57 -39.72 45.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.26 2.64 . . . . 18.5 112.137 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m 61.81 91.64 0.06 Allowed 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.571 0.544 . . . . 17.609999999999999 111.465 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.642 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 55.7 tp60 -91.44 -50.22 0.32 Allowed Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 120.813 -0.355 . . . . 18.760000000000002 110.391 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 66' ' ' GLN . 2.0 Cg_endo -87.25 153.07 8.06 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.482 2.121 . . . . 17.280000000000001 110.279 167.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.25 -19.18 66.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.079 2.519 . . . . 17.77 113.531 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 12.1 tp10 62.51 -81.61 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.842 0.714 . . . . 18.699999999999999 111.017 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.89 -59.71 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.981 -0.628 . . . . 17.719999999999999 111.96 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 66.43 -71.06 0.1 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.369 0.668 . . . . 18.0 110.841 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -170.71 -55.05 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.89 -0.596 . . . . 17.960000000000001 109.849 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 67.36 -74.33 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.186 0.929 . . . . 19.850000000000001 111.153 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.53 -62.84 0.09 Allowed 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.324 -0.991 . . . . 19.670000000000002 108.324 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.6 t -96.59 91.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.078 -0.712 . . . . 17.739999999999998 109.078 172.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -66.55 -57.94 6.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.39 -0.823 . . . . 19.949999999999999 110.525 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.53 -75.67 0.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.309 -0.405 . . . . 18.390000000000001 110.716 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.61 52.17 1.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.959 -0.638 . . . . 17.66 111.528 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -98.97 122.48 42.28 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.105 -0.331 . . . . 17.68 110.105 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 67.04 -77.79 0.04 OUTLIER 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.961 0.788 . . . . 17.800000000000001 110.822 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 50.46 51.87 15.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.173 0.511 . . . . 17.350000000000001 111.199 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.33 123.89 22.64 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.848 -0.614 . . . . 16.640000000000001 111.004 -174.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.8 129.17 33.54 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.887 2.391 . . . . 17.23 111.881 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 m -84.06 -32.08 25.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.141 -0.481 . . . . 17.34 111.313 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -84.08 -51.85 6.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.812 0.339 . . . . 18.41 110.684 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -83.82 115.16 58.37 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.005 -0.543 . . . . 17.449999999999999 110.833 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.88 -31.07 25.49 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.57 2.18 . . . . 18.890000000000001 111.585 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.27 92.94 1.01 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.652 -0.703 . . . . 17.809999999999999 109.825 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.5 m -59.51 -36.11 75.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.999 -0.546 . . . . 18.629999999999999 111.738 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 pt -77.87 -7.22 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.855 0.317 . . . . 19.100000000000001 111.855 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -113.94 -38.08 4.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.08 0.467 . . . . 19.25 110.878 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.93 -156.02 0.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.857 -0.61 . . . . 18.789999999999999 109.764 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER 68.07 -140.4 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.581 -0.282 . . . . 18.949999999999999 111.088 176.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.419 ' H ' ' HB3' ' A' ' 93' ' ' ASN . 22.1 t-20 -75.6 2.75 11.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.24 0.543 . . . . 20.309999999999999 111.403 -173.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.8 m -60.34 -35.43 75.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.918 -0.583 . . . . 21.399999999999999 110.391 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -142.53 30.72 1.51 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.973 -0.558 . . . . 21.16 110.351 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 63.83 88.53 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.178 -0.919 . . . . 22.18 111.369 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -119.8 88.39 39.75 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.701 -0.681 . . . . 19.449999999999999 109.916 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -91.24 133.99 1.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.49 2.793 . . . . 18.530000000000001 112.445 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.514 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 7.4 mp0 -84.14 -51.33 0.6 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.445 -0.343 . . . . 17.449999999999999 111.89 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 100' ' ' GLU . 25.7 Cg_exo -64.3 -47.71 5.68 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.013 1.809 . . . . 17.420000000000002 112.483 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -123.48 79.03 54.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.435 -0.348 . . . . 17.68 110.815 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.54 140.42 91.16 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.05 2.5 . . . . 16.289999999999999 112.301 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.6 m -82.16 67.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.402 0.62 . . . . 17.260000000000002 111.042 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.75 144.95 88.96 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.537 -0.756 . . . . 15.800000000000001 111.125 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.419 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 56.3 Cg_exo -48.15 -51.29 10.3 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.881 2.387 . . . . 15.92 114.684 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 108' ' ' LYS . 46.8 Cg_exo -55.92 162.97 6.3 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.207 1.938 . . . . 16.149999999999999 113.31 -176.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 107' ' ' PRO . 75.4 mmtt 76.05 118.92 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.428 -0.806 . . . . 17.629999999999999 110.784 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.97 116.57 4.38 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.708 2.272 . . . . 15.039999999999999 112.047 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -140.31 118.65 8.4 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.82 -0.627 . . . . 15.199999999999999 110.639 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.02 165.04 17.46 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.387 2.058 . . . . 14.08 112.042 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.72 51.0 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 122.306 1.05 . . . . 15.279999999999999 108.993 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 61.35 85.49 0.17 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 114.211 -1.359 . . . . 16.84 110.35 -173.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.44 156.81 58.27 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.174 2.583 . . . . 15.51 112.087 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.81 58.17 5.92 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.133 2.556 . . . . 16.039999999999999 112.182 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 40.7 ttmt -70.66 -52.86 10.15 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.972 -0.558 . . . . 18.91 111.667 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 116' ' ' LYS . 29.9 Cg_endo -63.33 -33.24 71.18 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.163 1.909 . . . . 17.039999999999999 112.401 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.83 128.9 4.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 17.52 109.889 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 119' ' ' VAL . 5.7 p -115.52 101.74 12.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.385 0.612 . . . . 18.699999999999999 110.499 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.44 ' HG3' ' HA ' ' A' ' 203' ' ' GLU . 2.3 mp0 54.61 55.44 7.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.833 . . . . 20.879999999999999 110.718 -175.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.2 113.26 49.31 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.792 -0.64 . . . . 18.890000000000001 109.801 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.79 117.33 4.94 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.428 2.085 . . . . 20.43 111.76 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.81 114.2 1.97 Allowed 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.443 2.095 . . . . 21.100000000000001 111.518 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . . . -61.97 -50.38 81.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.961 -0.563 . . . . 21.149999999999999 110.382 176.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 124' ' ' ALA . 90.5 Cg_endo -86.44 142.2 7.04 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.575 1.516 . . . . 21.149999999999999 110.731 167.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -86.31 110.69 33.32 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.576 0.227 . . . . 21.879999999999999 110.399 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.75 139.77 15.97 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.446 2.097 . . . . 20.190000000000001 112.001 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -125.99 76.03 71.59 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.101 -0.5 . . . . 20.48 110.154 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.03 76.28 3.85 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.857 2.371 . . . . 21.170000000000002 111.074 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm 70.2 115.69 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.26 0 O-C-N 124.026 0.829 . . . . 23.18 110.293 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.17 133.11 46.23 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.777 2.318 . . . . 20.780000000000001 111.783 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 m -82.58 47.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.598 0.713 . . . . 19.75 111.491 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.9 m -89.8 17.62 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.193 -0.912 . . . . 21.050000000000001 110.26 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.85 -174.87 2.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.064 -0.971 . . . . 21.300000000000001 108.945 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 52.4 mt-10 -77.48 -81.32 0.09 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.513 -0.475 . . . . 20.739999999999998 109.768 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 135' ' ' GLU . 67.5 mttm 76.89 117.61 0.06 Allowed 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 124.089 0.868 . . . . 17.969999999999999 109.986 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . 65.49 -82.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.851 -1.068 . . . . 17.350000000000001 108.516 -164.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . . . 174.55 145.08 0.21 Allowed Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 123.921 0.763 . . . . 19.100000000000001 110.103 170.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 138' ' ' ALA . 12.5 Cg_exo -70.19 110.64 2.69 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.78 2.32 . . . . 19.350000000000001 111.271 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 28.0 m 76.87 -20.03 0.39 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.638 0.586 . . . . 17.75 111.17 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.06 -76.54 0.74 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.122 -0.561 . . . . 17.960000000000001 112.368 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.466 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 60.8 mttp -104.06 58.08 0.72 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.432 0.634 . . . . 19.420000000000002 110.777 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.499 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . -78.32 165.32 24.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.115 -0.948 . . . . 14.65 109.875 177.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.654 ' CE1' ' HG3' ' A' ' 194' ' ' LYS . 5.4 m-85 -137.55 156.51 48.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.162 0.43 . . . . 14.81 112.162 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.5 m -152.5 151.33 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.348 -0.842 . . . . 10.48 109.717 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.463 HG12 ' HA3' ' A' ' 212' ' ' GLY . 60.2 t -110.82 110.92 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 10.1 111.423 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.608 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 8.0 tt0 -84.85 113.52 21.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.516 -0.311 . . . . 12.0 111.688 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -92.01 -34.55 14.38 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.989 0.423 . . . . 11.880000000000001 110.341 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.62 174.21 25.69 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.189 -1.005 . . . . 11.35 112.855 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -170.76 103.39 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.636 -0.505 . . . . 13.470000000000001 109.636 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.81 157.07 43.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.304 0.573 . . . . 13.52 110.695 -175.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 86.1 mttt -98.12 14.3 28.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.134 -0.939 . . . . 17.600000000000001 110.612 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.432 ' OD1' ' HG3' ' A' ' 156' ' ' LYS . 4.1 t-20 -112.73 106.22 14.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.564 -0.744 . . . . 16.140000000000001 109.348 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.72 -26.48 68.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.901 0.381 . . . . 14.039999999999999 111.426 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.72 -38.87 76.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.539 0.685 . . . . 16.57 110.044 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.443 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 68.8 mttm -79.27 -33.44 43.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.671 -1.149 . . . . 16.399999999999999 110.292 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 184' ' ' THR . 79.6 t -58.02 -44.58 87.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.63 -0.714 . . . . 12.67 110.288 175.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -62.11 -30.43 71.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.299 -0.864 . . . . 15.32 110.823 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.576 ' O ' ' HG2' ' A' ' 163' ' ' LYS . 24.4 mt-10 -69.39 -61.95 1.58 Allowed 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 120.906 0.384 . . . . 15.970000000000001 110.167 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.428 HD12 HG13 ' A' ' 186' ' ' ILE . 27.8 mt -51.5 -46.22 35.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.045 -0.979 . . . . 12.6 111.143 -175.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.8 t -73.11 -34.51 45.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.724 -0.671 . . . . 12.539999999999999 110.288 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.8 -32.4 82.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.786 -0.721 . . . . 14.800000000000001 112.117 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 159' ' ' GLU . 48.7 mmtt -67.78 -51.05 53.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.266 0.555 . . . . 16.050000000000001 109.657 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.622 ' HB3' HG21 ' A' ' 171' ' ' VAL . 20.9 mt -87.03 -56.01 3.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.899 1.074 . . . . 12.99 113.899 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.407 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 47.2 ttp180 -70.13 -29.27 66.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.69 -0.855 . . . . 15.06 108.69 -174.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.7 -24.98 76.03 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.834 -1.076 . . . . 16.600000000000001 111.851 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.74 -5.05 59.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.213 0.53 . . . . 16.140000000000001 110.549 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.0 24.77 16.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.797 -0.716 . . . . 15.119999999999999 113.261 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -94.04 155.39 17.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.307 0.554 . . . . 15.49 110.783 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -71.63 98.24 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.621 -0.511 . . . . 13.869999999999999 109.621 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.799 HG22 HG22 ' A' ' 188' ' ' VAL . 6.7 t -133.17 125.69 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-N 115.589 -0.732 . . . . 10.82 111.123 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -135.33 175.24 9.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.265 -0.879 . . . . 11.130000000000001 110.602 176.306 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.4 p -117.09 -175.91 2.88 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.844 -1.071 . . . . 11.52 111.926 -169.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.78 153.65 5.62 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.633 -0.712 . . . . 12.75 111.598 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -42.13 -67.15 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.065 3.177 . . . . 14.640000000000001 115.19 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.1 m -76.55 -63.08 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.768 0.655 . . . . 16.68 112.768 -167.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.1 m -169.42 130.33 1.01 Allowed Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 112.226 0.454 . . . . 16.039999999999999 112.226 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.515 ' HB3' HG21 ' A' ' 184' ' ' THR . 50.1 Cg_exo -63.28 124.6 14.12 Favored 'Trans proline' 0 CA--C 1.519 -0.265 0 C-N-CA 122.771 2.314 . . . . 14.220000000000001 111.927 162.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.9 p -153.45 153.51 8.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.557 -0.534 . . . . 16.129999999999999 109.557 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -70.44 122.09 18.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.979 -0.555 . . . . 16.699999999999999 110.73 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.46 -26.45 14.71 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.621 -0.718 . . . . 16.98 112.407 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 13.2 mptt -108.18 156.28 19.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.961 0.41 . . . . 18.73 110.677 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.9 tp -71.2 117.28 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.681 -0.69 . . . . 14.82 111.462 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 178' ' ' PRO . 38.0 m -111.54 112.45 24.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.635 -0.711 . . . . 12.779999999999999 110.188 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 91.1 mtt180 -86.84 144.99 26.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.923 -0.581 . . . . 13.98 109.571 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.635 ' C ' HD12 ' A' ' 187' ' ' LEU . 5.2 mm -113.11 124.05 69.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.297 -0.631 . . . . 10.56 109.297 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.6 mp -129.15 129.08 44.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.487 0.661 . . . . 10.1 111.241 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 148' ' ' LEU . 39.8 t -100.58 142.18 16.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.991 -1.004 . . . . 9.7400000000000002 110.401 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.15 49.96 11.5 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.34 -0.845 . . . . 9.7599999999999998 113.932 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.674 ' HA ' HG12 ' A' ' 145' ' ' VAL . 13.7 Cg_endo -63.77 124.83 14.28 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 CA-C-N 119.915 1.857 . . . . 11.15 110.273 168.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.422 ' HB3' HD22 ' A' ' 197' ' ' LEU . 5.9 t70 -162.94 150.35 13.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.91 -0.586 . . . . 12.77 109.593 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.499 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -91.32 -9.3 45.47 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.919 -0.582 . . . . 14.6 110.944 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.3 t -97.37 102.32 14.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.173 0.511 . . . . 14.300000000000001 110.312 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.654 ' HG3' ' CE1' ' A' ' 144' ' ' TYR . 19.8 ttmt -64.54 -42.85 95.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.702 -0.681 . . . . 15.970000000000001 110.204 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.77 -51.91 67.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.127 0.489 . . . . 15.6 111.208 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -63.53 -51.47 65.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.602 -0.726 . . . . 14.220000000000001 111.431 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 191' ' ' ASP . 0.1 OUTLIER -87.01 -37.71 17.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.014 0.746 . . . . 11.949999999999999 113.014 -169.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.53 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 14.5 tmtt? -80.95 -20.51 41.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.499 0.666 . . . . 14.699999999999999 109.69 -168.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -82.84 -12.43 79.83 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.312 -1.115 . . . . 13.09 110.312 172.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 32.0 m -90.39 -7.62 52.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.825 -0.688 . . . . 12.109999999999999 112.547 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 15.8 mt -59.33 -36.58 75.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.592 0.234 . . . . 12.720000000000001 111.392 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -56.97 -46.69 90.92 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.909 -0.663 . . . . 14.66 112.189 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.44 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 11.9 pt-20 -84.37 -16.87 41.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.686 0.279 . . . . 13.890000000000001 110.701 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.538 HD12 HD12 ' A' ' 207' ' ' LEU . 2.6 tp -66.66 -26.95 67.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.048 0.451 . . . . 12.550000000000001 110.502 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.546 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 70.6 mmtt -61.08 -17.58 53.28 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.198 -0.455 . . . . 15.83 110.524 172.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -39.74 12.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.349 0.595 . . . . 16.969999999999999 109.521 170.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.538 HD12 HD12 ' A' ' 204' ' ' LEU . 84.5 mt -61.85 -52.95 62.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.227 -0.897 . . . . 13.890000000000001 111.642 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 23.0 p -99.96 -47.5 4.99 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.314 -0.555 . . . . 13.539999999999999 110.244 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.35 5.31 71.89 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.576 -0.738 . . . . 14.67 112.793 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.613 HD22 HD11 ' A' ' 164' ' ' LEU . 9.1 mp -95.64 158.47 15.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.18 -0.674 . . . . 13.039999999999999 109.18 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 19.4 t -76.5 93.44 3.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.085 0.469 . . . . 14.84 110.527 -173.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -114.12 140.8 16.6 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.713 -0.676 . . . . 12.220000000000001 113.264 -176.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 p -105.81 146.73 12.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.135 0.493 . . . . 13.74 110.265 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 5.5 p -73.17 114.01 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.153 -0.93 . . . . 12.890000000000001 111.406 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.53 141.75 51.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.028 -0.533 . . . . 13.800000000000001 110.202 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -81.49 126.94 7.65 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.246 -0.978 . . . . 13.359999999999999 111.603 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.529 ' CZ ' ' HG3' ' A' ' 219' ' ' PRO . 4.8 t80 -85.81 131.67 34.26 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.075 0.95 . . . . 14.24 110.561 -175.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 p -131.37 91.84 33.86 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.527 -0.546 . . . . 16.510000000000002 109.527 172.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.529 ' HG3' ' CZ ' ' A' ' 217' ' ' TYR . 37.9 Cg_exo -53.69 153.31 19.38 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 123.321 2.681 . . . . 17.420000000000002 114.218 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 C--O 1.251 1.153 0 CA-C-N 115.186 -0.915 . . . . 19.190000000000001 109.609 177.736 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.404 ' HA ' ' HG2' ' A' ' 69' ' ' GLU . 10.0 p-10 . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.613 0.245 . . . . 18.390000000000001 111.134 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.84 143.62 14.52 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.133 -1.032 . . . . 17.77 112.973 -173.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.4 pm0 -93.73 8.67 40.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.337 0.589 . . . . 17.690000000000001 110.178 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -92.7 130.1 38.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.553 -0.749 . . . . 19.93 109.552 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -64.94 -15.45 62.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.327 0.491 . . . . 17.43 112.327 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -63.29 -23.93 67.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.153 0.502 . . . . 19.359999999999999 109.896 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -110.31 131.01 55.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.952 -0.567 . . . . 18.960000000000001 109.857 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -89.32 126.89 35.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.092 -0.336 . . . . 18.239999999999998 110.092 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.86 144.73 56.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 16.780000000000001 109.835 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.613 ' HG2' ' H ' ' A' ' 39' ' ' ALA . 27.9 tt0 -117.17 124.55 49.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.073 0.463 . . . . 18.420000000000002 111.845 -171.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -102.81 5.52 38.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.774 -0.648 . . . . 17.920000000000002 110.413 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.613 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -81.43 -76.69 0.24 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.215 -0.448 . . . . 19.550000000000001 111.74 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.76 -16.15 49.04 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.208 -0.197 . . . . 20.309999999999999 111.138 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.413 HG22 ' HG3' ' A' ' 45' ' ' PRO . 35.5 pt 37.12 67.76 1.74 Allowed Pre-proline 0 N--CA 1.472 0.674 0 O-C-N 124.223 0.952 . . . . 19.920000000000002 112.525 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.49 61.1 5.97 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.169 2.579 . . . . 21.640000000000001 111.941 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 mp 63.86 17.97 10.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.508 -0.769 . . . . 22.670000000000002 111.08 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.578 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 90.8 t -85.13 -67.5 0.18 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 21.34 110.43 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.578 ' CD ' ' HB ' ' A' ' 44' ' ' VAL . 56.7 Cg_endo -71.95 92.82 0.71 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.174 1.25 . . . . 20.0 110.594 172.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -77.95 53.33 1.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.768 -0.651 . . . . 21.079999999999998 110.753 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.26 9.23 0.64 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.339 -0.846 . . . . 18.800000000000001 110.093 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.89 -153.49 38.24 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.835 -0.698 . . . . 17.510000000000002 112.212 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.43 116.13 17.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.858 0.361 . . . . 16.949999999999999 110.445 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -134.78 44.79 2.61 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.651 0.739 . . . . 18.300000000000001 109.473 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -92.34 108.12 19.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.614 -0.721 . . . . 18.170000000000002 110.801 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.421 ' HB3' ' HG2' ' A' ' 57' ' ' PRO . 31.6 tt0 -88.66 137.6 30.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.516 -0.765 . . . . 18.82 108.944 172.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -42.0 136.26 3.59 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.185 2.59 . . . . 19.870000000000001 112.75 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -76.91 42.9 0.33 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.83 0.678 . . . . 21.100000000000001 112.83 -169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -82.27 -39.85 22.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.215 -0.661 . . . . 22.300000000000001 109.215 171.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.565 ' HB3' ' HD3' ' A' ' 57' ' ' PRO . 49.9 ttm -120.19 -50.66 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 23.850000000000001 111.304 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 56' ' ' MET . 89.1 Cg_exo -50.73 111.71 0.6 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.712 2.274 . . . . 20.670000000000002 113.267 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 70.12 -0.32 2.83 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.931 -1.031 . . . . 20.489999999999998 111.859 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.37 -86.08 0.33 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.593 -0.276 . . . . 21.469999999999999 110.457 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 56' ' ' MET . 9.0 t -91.72 -5.45 53.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.041 0.448 . . . . 22.600000000000001 110.314 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -141.06 114.18 8.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.941 -0.572 . . . . 21.93 109.632 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.93 145.31 56.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.23 -0.441 . . . . 19.73 111.299 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.2 mt -95.93 107.24 33.12 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.993 -0.549 . . . . 19.579999999999998 110.044 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.61 9.66 4.01 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.67 2.247 . . . . 18.5 112.257 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 p -70.48 -77.39 0.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 17.609999999999999 110.723 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 42.82 81.61 0.24 Allowed Pre-proline 0 N--CA 1.469 0.517 0 O-C-N 124.102 0.876 . . . . 18.760000000000002 112.236 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.4 111.28 0.67 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.081 2.521 . . . . 17.280000000000001 112.275 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.13 127.41 10.57 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.604 2.203 . . . . 17.77 112.581 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' A' ' 28' ' ' ASP . 17.8 mm-40 -106.22 -43.78 4.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.471 -0.937 . . . . 18.699999999999999 108.471 170.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.24 131.8 15.59 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.308 -0.86 . . . . 17.719999999999999 111.418 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 72.33 2.87 4.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.522 0.729 . . . . 18.0 111.508 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.73 -16.68 18.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.876 0.37 . . . . 17.960000000000001 110.435 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -72.94 81.61 1.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.799 -0.637 . . . . 19.850000000000001 109.752 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 67.57 177.57 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.669 -0.696 . . . . 19.670000000000002 111.044 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.2 t 67.28 -79.43 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.058 -0.519 . . . . 17.739999999999998 110.549 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mtm-85 54.1 40.15 31.36 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.249 0.547 . . . . 19.949999999999999 111.41 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.96 -163.74 0.87 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.877 -0.601 . . . . 18.390000000000001 110.341 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.06 89.59 0.4 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.021 -0.609 . . . . 17.66 112.337 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -112.22 172.5 6.88 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.342 -0.614 . . . . 17.68 109.342 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.09 8.95 21.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.868 0.365 . . . . 17.800000000000001 111.629 -173.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.75 -36.38 75.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 17.350000000000001 109.96 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.68 97.21 36.21 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.763 -0.653 . . . . 16.640000000000001 110.093 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.99 -30.89 80.06 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.995 2.464 . . . . 17.23 112.429 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 m 72.71 -45.53 0.62 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.779 0.832 . . . . 17.34 112.245 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.12 149.5 29.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.915 0.388 . . . . 18.41 110.611 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -79.46 131.85 63.92 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.851 -0.613 . . . . 17.449999999999999 110.414 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.22 -27.54 85.08 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.207 2.604 . . . . 18.890000000000001 112.414 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.39 63.1 7.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.289 0.566 . . . . 17.809999999999999 109.578 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 m -69.5 126.38 29.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.295 -0.866 . . . . 18.629999999999999 110.864 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.13 -44.44 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 19.100000000000001 111.106 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.56 81.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.378 0.423 . . . . 19.25 111.672 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.46 83.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.872 -0.604 . . . . 18.789999999999999 111.682 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -103.29 26.0 8.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.273 0.558 . . . . 18.949999999999999 109.891 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 57.03 37.99 29.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.589 -0.732 . . . . 20.309999999999999 111.689 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.0 t -70.07 -24.1 63.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.458 . . . . 21.399999999999999 110.415 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -111.37 3.16 18.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.611 0.719 . . . . 21.16 109.168 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 60.24 93.49 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 114.482 -1.235 . . . . 22.18 111.346 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.433 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 42.7 tt0 -68.07 -50.37 31.47 Favored Pre-proline 0 CA--C 1.539 0.558 0 N-CA-C 111.938 0.347 . . . . 19.449999999999999 111.938 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 98' ' ' GLU . 5.1 Cg_exo -77.78 57.76 6.18 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.59 2.194 . . . . 18.530000000000001 112.658 -176.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -93.46 143.39 26.58 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.063 -0.517 . . . . 17.449999999999999 110.105 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.76 3.41 3.27 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.894 2.396 . . . . 17.420000000000002 112.421 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.36 88.07 13.1 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.553 . . . . 17.68 110.223 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.91 143.38 85.37 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.787 2.324 . . . . 16.289999999999999 111.868 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 p -76.96 90.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.816 0.817 . . . . 17.260000000000002 110.503 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.97 144.35 9.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.144 -0.935 . . . . 15.800000000000001 109.804 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.401 ' O ' ' HD2' ' A' ' 109' ' ' PRO . 26.7 Cg_endo -62.59 152.63 76.66 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.649 2.233 . . . . 15.92 111.581 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.52 43.72 0.96 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.051 2.501 . . . . 16.149999999999999 112.819 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.559 ' H ' ' HD2' ' A' ' 109' ' ' PRO . 62.0 tttp -96.26 -57.56 0.19 Allowed Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.106 -0.497 . . . . 17.629999999999999 111.588 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.559 ' HD2' ' H ' ' A' ' 108' ' ' LYS . 10.0 Cg_endo -54.31 131.62 46.15 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.115 1.877 . . . . 15.039999999999999 112.361 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.459 ' HD3' ' HD2' ' A' ' 111' ' ' PRO . 4.2 tppp? -150.32 129.04 6.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.015 -0.539 . . . . 15.199999999999999 109.837 -176.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.459 ' HD2' ' HD3' ' A' ' 110' ' ' LYS . 26.1 Cg_endo -64.48 137.68 56.3 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.422 2.081 . . . . 14.08 112.192 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.8 t -90.51 51.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.865 0.841 . . . . 15.279999999999999 110.226 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 56.28 80.52 0.29 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.175 -1.375 . . . . 16.84 111.992 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.11 134.82 28.12 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.22 1.947 . . . . 15.51 111.028 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.11 129.64 18.65 Favored 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 122.383 2.055 . . . . 16.039999999999999 112.549 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -106.21 103.65 46.23 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.361 -0.381 . . . . 18.91 110.119 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 121' ' ' ALA . 14.9 Cg_exo -69.35 -52.11 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.695 2.263 . . . . 17.039999999999999 111.188 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -142.9 29.3 1.51 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.831 -0.622 . . . . 17.52 110.65 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 t 69.75 152.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.82 -0.627 . . . . 18.699999999999999 111.224 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 46.5 mm-40 68.84 34.59 3.23 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.118 0.567 . . . . 20.879999999999999 110.913 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.47 ' HB2' ' HD2' ' A' ' 117' ' ' PRO . . . -85.14 112.85 46.61 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.931 -0.577 . . . . 18.890000000000001 111.504 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 120' ' ' GLU . 41.8 Cg_endo -93.48 137.53 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.179 2.586 . . . . 20.43 112.153 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.58 58.92 6.05 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.769 2.313 . . . . 21.100000000000001 112.34 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.598 ' H ' ' HD2' ' A' ' 125' ' ' PRO . . . -140.96 -57.36 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.938 -0.574 . . . . 21.149999999999999 111.317 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.598 ' HD2' ' H ' ' A' ' 124' ' ' ALA . 19.9 Cg_endo -61.48 -34.75 85.23 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 121.907 1.738 . . . . 21.149999999999999 111.718 175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -127.15 94.65 38.46 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.902 -0.59 . . . . 21.879999999999999 109.649 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.61 151.75 74.92 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.766 2.311 . . . . 20.190000000000001 111.578 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.05 121.81 85.7 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.051 0.453 . . . . 20.48 110.753 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -88.53 -148.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.72 2.28 . . . . 21.170000000000002 110.931 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 130' ' ' LYS . 3.9 mppt? -85.29 133.81 41.84 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.312 -0.625 . . . . 23.18 109.312 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.97 111.69 1.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.256 1.971 . . . . 20.780000000000001 111.12 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.6 m -86.73 52.68 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.772 0.796 . . . . 19.75 110.941 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.1 m -75.5 151.96 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.096 -0.956 . . . . 21.050000000000001 110.146 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 69.39 -75.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.681 0.613 . . . . 21.300000000000001 111.218 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.553 ' HG3' ' H ' ' A' ' 138' ' ' ALA . 6.8 tp10 -170.7 174.48 4.95 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.382 -0.599 . . . . 20.739999999999998 109.382 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -140.16 -36.27 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.34 . . . . 17.969999999999999 111.121 -175.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 193' ' ' SER . . . -104.7 3.39 31.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.209 0.528 . . . . 17.350000000000001 110.164 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.553 ' H ' ' HG3' ' A' ' 135' ' ' GLU . . . 68.19 141.92 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 114.534 -1.212 . . . . 19.100000000000001 111.927 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.69 -51.17 10.86 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.374 2.716 . . . . 19.350000000000001 113.917 -171.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.439 HG22 ' HG2' ' A' ' 219' ' ' PRO . 57.9 p -124.96 7.57 8.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.929 0.395 . . . . 17.75 110.869 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.07 -65.94 2.01 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.983 -0.627 . . . . 17.960000000000001 112.074 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -125.57 53.77 1.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.202 0.525 . . . . 19.420000000000002 110.366 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.582 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -73.01 163.2 28.53 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.904 -0.776 . . . . 14.65 108.904 175.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.608 ' CE1' ' HD3' ' A' ' 194' ' ' LYS . 7.6 m-85 -144.74 155.85 43.76 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.879 0.325 . . . . 14.81 111.879 -175.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.775 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.4 t -149.62 159.94 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.882 -0.784 . . . . 10.48 108.882 173.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 58.4 t -101.0 110.02 26.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 O-C-N 122.069 -0.394 . . . . 10.1 110.803 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -86.74 108.92 18.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.569 -0.287 . . . . 12.0 111.051 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.895 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -83.97 -40.55 18.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.228 0.537 . . . . 11.880000000000001 109.953 -176.558 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.38 165.85 28.22 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.544 -0.836 . . . . 11.35 112.526 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.481 ' C ' HD13 ' A' ' 151' ' ' LEU . . . -156.75 101.22 1.96 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.512 -0.551 . . . . 13.470000000000001 109.512 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.481 HD13 ' C ' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -119.57 159.25 24.71 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.38 0.609 . . . . 13.52 110.028 -174.299 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 39.3 mttm -101.56 24.49 9.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.888 -1.153 . . . . 17.600000000000001 107.888 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -136.37 110.86 8.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.724 -1.58 . . . . 16.140000000000001 109.114 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.407 ' HA ' ' CG2' ' A' ' 157' ' ' VAL . . . -70.76 -19.12 62.75 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.204 0.446 . . . . 14.039999999999999 112.204 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -64.32 -31.34 72.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.663 0.744 . . . . 16.57 109.563 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.462 ' HD2' HD11 ' A' ' 160' ' ' ILE . 3.8 tmtm? -77.87 -38.62 45.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.396 -1.275 . . . . 16.399999999999999 109.026 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.407 ' CG2' ' HA ' ' A' ' 154' ' ' ALA . 94.4 t -56.44 -42.74 75.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.955 -1.021 . . . . 12.67 110.517 176.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -58.68 -29.6 66.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.581 -0.736 . . . . 15.32 112.146 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.525 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 8.5 mm-40 -79.56 -60.81 2.21 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.6 -0.519 . . . . 15.970000000000001 109.6 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.462 HD11 ' HD2' ' A' ' 156' ' ' LYS . 11.4 mt -50.97 -44.3 27.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.278 -0.874 . . . . 12.6 110.673 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 84.9 t -76.49 -37.3 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.659 -0.7 . . . . 12.539999999999999 110.376 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.17 -28.79 71.29 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.669 -0.777 . . . . 14.800000000000001 112.053 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 1.0 OUTLIER -71.29 -52.27 19.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.66 0.266 . . . . 16.050000000000001 111.071 177.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.515 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 3.8 mm? -86.0 -55.59 3.87 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.043 0.386 . . . . 12.99 112.043 -175.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 24.5 ttt180 -61.7 -42.99 99.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.456 0.646 . . . . 15.06 109.82 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.82 -11.2 62.59 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.824 -1.08 . . . . 16.600000000000001 112.973 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.62 -2.19 22.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 16.140000000000001 110.714 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.94 56.13 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.233 -0.508 . . . . 15.119999999999999 113.569 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -82.58 155.44 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.241 -0.564 . . . . 15.49 110.369 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 170' ' ' ARG . 36.1 mmt180 -71.4 104.39 3.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.74 0.781 . . . . 13.869999999999999 110.211 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.19 141.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 114.454 -1.248 . . . . 10.82 109.48 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.37 175.49 9.55 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.635 0.731 . . . . 11.130000000000001 110.635 169.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.437 ' HB ' ' HG3' ' A' ' 178' ' ' PRO . 7.1 p -120.75 -173.96 2.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.625 -1.17 . . . . 11.52 112.294 -168.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.632 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -50.21 151.12 3.83 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 115.161 -0.927 . . . . 12.75 112.982 -177.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -23.9 -70.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 1 C-N-CA 126.093 4.529 . . . . 14.640000000000001 115.281 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.1 m -88.95 -62.12 1.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.242 -0.583 . . . . 16.68 112.313 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 97.6 m -167.58 132.08 1.53 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 111.453 0.168 . . . . 16.039999999999999 111.453 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.448 ' HB3' HG21 ' A' ' 184' ' ' THR . 73.4 Cg_exo -56.75 125.76 20.06 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.54 2.16 . . . . 14.220000000000001 111.741 166.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.3 p -148.71 160.26 6.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.643 -0.503 . . . . 16.129999999999999 109.643 -174.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -72.55 133.47 44.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.527 -0.306 . . . . 16.699999999999999 110.739 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.08 -25.61 11.8 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.213 -0.518 . . . . 16.98 114.116 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.501 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.3 OUTLIER -102.94 168.06 9.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.36 0.58 . . . . 18.73 110.67 -176.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.6 tp -76.29 110.5 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.973 0.892 . . . . 14.82 111.766 -174.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.448 HG21 ' HB3' ' A' ' 178' ' ' PRO . 48.8 m -104.9 107.59 18.64 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.496 -0.775 . . . . 12.779999999999999 109.464 173.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.632 ' H ' ' HB3' ' A' ' 174' ' ' SER . 6.4 ptm180 -90.42 133.71 34.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.408 -0.815 . . . . 13.98 109.675 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.556 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.3 mm -104.91 122.52 58.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.76 -0.459 . . . . 10.56 109.76 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.556 HD12 ' C ' ' A' ' 186' ' ' ILE . 5.1 mp -129.68 126.46 38.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.258 0.552 . . . . 10.1 111.153 -174.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.895 HG23 HD21 ' A' ' 148' ' ' LEU . 38.5 t -102.38 134.77 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.474 -0.784 . . . . 9.7400000000000002 110.997 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.06 49.86 4.83 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.001 -1.0 . . . . 9.7599999999999998 113.66 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.775 ' HA ' HG22 ' A' ' 145' ' ' VAL . 10.2 Cg_endo -58.86 125.09 17.22 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 119.441 1.621 . . . . 11.15 110.698 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -152.19 151.73 31.36 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.458 -0.497 . . . . 12.77 110.393 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -92.06 -7.0 49.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.824 -0.625 . . . . 14.6 111.706 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.418 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 1.4 p -118.29 104.98 11.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.341 0.591 . . . . 14.300000000000001 111.375 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.608 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 36.7 ttpt -58.47 -51.89 67.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.693 -1.139 . . . . 15.970000000000001 110.787 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.11 -44.97 83.75 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.158 -0.474 . . . . 15.6 111.191 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -62.63 -48.28 80.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.745 -0.661 . . . . 14.220000000000001 111.017 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -77.73 -20.39 53.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 11.949999999999999 110.935 -175.007 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.7 tptm -65.31 -39.02 91.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.516 0.674 . . . . 14.699999999999999 109.917 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -79.14 -12.43 84.04 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.498 -1.041 . . . . 13.09 110.498 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 59.0 m -84.08 -10.69 57.63 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.823 -0.689 . . . . 12.109999999999999 111.82 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 29.6 mt -64.77 -34.72 79.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.833 0.349 . . . . 12.720000000000001 110.995 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -61.68 -39.06 96.91 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.793 -0.718 . . . . 14.66 112.401 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.495 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 10.3 pt-20 -86.26 -22.2 26.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.876 0.369 . . . . 13.890000000000001 110.99 177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.6 tp -74.83 -31.47 61.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 12.550000000000001 111.272 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.582 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 20.2 ptmt -68.17 -15.09 63.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.111 0.481 . . . . 15.83 110.382 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.9 -30.67 17.71 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.177 0.513 . . . . 16.969999999999999 109.982 171.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 91.3 mt -76.44 -51.89 10.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.793 -0.64 . . . . 13.890000000000001 111.527 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.472 ' HB3' HD11 ' A' ' 164' ' ' LEU . 44.3 p -95.56 -43.93 7.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.354 0.597 . . . . 13.539999999999999 110.213 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 70.01 3.85 46.05 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 114.899 -1.046 . . . . 14.67 112.579 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.44 153.3 18.01 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 109.572 -0.529 . . . . 13.039999999999999 109.572 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 24.2 t -85.33 107.25 17.25 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.01 -0.541 . . . . 14.84 110.53 -175.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -127.48 163.27 21.29 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.346 -0.93 . . . . 12.220000000000001 113.435 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.87 145.8 12.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.039 -0.58 . . . . 13.74 109.748 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.61 104.85 3.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.104 -0.702 . . . . 12.890000000000001 109.104 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 92.8 mmm -117.06 141.8 47.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.168 -0.469 . . . . 13.800000000000001 110.447 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.21 155.09 51.31 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.494 -0.86 . . . . 13.359999999999999 111.698 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.704 ' HB2' HG23 ' A' ' 145' ' ' VAL . 10.9 t80 -132.03 132.06 43.05 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.082 0.553 . . . . 14.24 110.286 -169.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 31.5 m -146.71 93.4 4.88 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 109.161 -0.681 . . . . 16.510000000000002 109.161 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.439 ' HG2' HG22 ' A' ' 140' ' ' THR . 45.5 Cg_endo -67.04 147.23 79.43 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.735 2.29 . . . . 17.420000000000002 113.223 -173.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 C--O 1.244 0.805 0 CA-C-N 115.368 -0.833 . . . . 19.190000000000001 110.933 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 10.0 p-10 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.485 -0.561 . . . . 18.390000000000001 109.485 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.491 ' N ' ' HB2' ' A' ' 69' ' ' GLU . . . -136.33 -98.11 0.52 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.187 -1.006 . . . . 17.77 113.271 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -115.76 -88.17 0.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.23 0.456 . . . . 17.690000000000001 112.23 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -142.16 168.85 18.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.631 0.253 . . . . 19.93 111.26 -173.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 1.9 mptm? 59.73 -92.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.463 -0.79 . . . . 17.43 111.44 -177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 20.3 t-160 168.72 -55.23 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.691 -0.855 . . . . 19.359999999999999 108.691 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' ' 33' ' ' HIS . 2.3 t80 170.84 -67.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.235 -0.893 . . . . 18.960000000000001 108.891 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.476 ' HG2' ' HB2' ' A' ' 38' ' ' PHE . 52.8 tt0 57.37 65.84 1.27 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.797 0.808 . . . . 18.239999999999998 109.229 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.63 118.5 13.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.715 -1.13 . . . . 16.780000000000001 112.311 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 55.9 43.35 27.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.416 -0.811 . . . . 18.420000000000002 112.695 173.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.476 ' HB2' ' HG2' ' A' ' 35' ' ' GLN . 52.4 m-85 -113.88 56.23 0.71 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.385 0.612 . . . . 17.920000000000002 109.87 174.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.72 25.5 11.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.547 -0.751 . . . . 19.550000000000001 111.001 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.3 -14.74 60.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.315 0.578 . . . . 20.309999999999999 110.317 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -127.59 65.04 65.65 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.567 -0.742 . . . . 19.920000000000002 110.779 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.06 65.03 8.39 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.271 1.981 . . . . 21.640000000000001 111.769 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mp 61.94 23.48 13.83 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.453 -0.794 . . . . 22.670000000000002 111.324 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.417 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 99.3 t -80.35 -57.06 0.66 Allowed Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.24 -0.436 . . . . 21.34 110.851 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.417 ' CD ' ' HB ' ' A' ' 44' ' ' VAL . 25.6 Cg_endo -64.07 -59.34 0.2 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.546 1.497 . . . . 20.0 111.267 174.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -175.37 -69.25 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.974 -0.557 . . . . 21.079999999999998 110.071 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.31 39.35 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.017 -0.538 . . . . 18.800000000000001 110.83 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.9 57.32 3.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.776 -0.726 . . . . 17.510000000000002 112.962 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.1 145.31 56.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.883 0.373 . . . . 16.949999999999999 110.841 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -67.37 106.05 1.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.641 . . . . 18.300000000000001 110.81 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -96.68 121.48 38.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.264 0.554 . . . . 18.170000000000002 110.414 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -86.12 129.87 52.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.737 -0.665 . . . . 18.82 110.513 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.08 -7.34 21.18 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.977 2.451 . . . . 19.870000000000001 113.162 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -112.12 144.31 41.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.549 -0.296 . . . . 21.100000000000001 110.707 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 43.0 tpp 66.98 -77.11 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.518 -0.765 . . . . 22.300000000000001 112.322 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 91.0 mtp -143.67 129.05 9.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.718 0.294 . . . . 23.850000000000001 110.846 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.42 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 79.3 Cg_endo -85.07 163.48 11.57 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.864 2.376 . . . . 20.670000000000002 112.339 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.87 4.55 4.03 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.112 -0.494 . . . . 20.489999999999998 111.603 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.23 84.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.916 -0.402 . . . . 21.469999999999999 109.916 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 t -99.19 -32.01 11.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.074 -0.512 . . . . 22.600000000000001 110.908 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 57' ' ' PRO . 19.3 pt20 -106.15 49.78 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.057 0.456 . . . . 21.93 111.165 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.45 150.94 34.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.17 -0.468 . . . . 19.73 110.709 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 7.7 mp 66.34 103.92 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.397 0 O-C-N 123.747 0.654 . . . . 19.579999999999998 110.85 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 63' ' ' LEU . 13.2 Cg_endo -56.49 145.47 79.77 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.056 2.504 . . . . 18.5 112.562 -174.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.486 ' OG1' ' HD2' ' A' ' 67' ' ' PRO . 6.9 t -155.35 168.12 28.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.323 -0.398 . . . . 17.609999999999999 110.416 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.452 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 63.3 tt0 -78.23 -48.26 1.99 Allowed Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 119.096 -0.478 . . . . 18.760000000000002 111.923 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.486 ' HD2' ' OG1' ' A' ' 65' ' ' THR . 36.6 Cg_exo -36.49 114.42 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 123.547 2.831 . . . . 17.280000000000001 113.928 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -88.41 145.52 5.98 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.838 2.359 . . . . 17.77 113.342 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.491 ' HB2' ' N ' ' A' ' 29' ' ' GLY . 15.1 mm-40 60.91 110.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.927 -1.033 . . . . 18.699999999999999 112.309 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.66 95.02 0.68 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.667 -0.697 . . . . 17.719999999999999 112.695 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 28' ' ' ASP . . . -110.35 52.02 0.74 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.19 0.519 . . . . 18.0 110.218 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -153.8 -49.67 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.883 -0.598 . . . . 17.960000000000001 111.419 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 60.82 38.65 17.84 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.157 0.98 . . . . 19.850000000000001 108.917 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -119.13 -175.9 3.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.634 -1.166 . . . . 19.670000000000002 110.062 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.5 m 38.87 52.79 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 124.295 0.997 . . . . 17.739999999999998 111.787 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -112.38 -33.43 6.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.263 -0.88 . . . . 19.949999999999999 110.73 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.91 -87.16 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.96 0.355 . . . . 18.390000000000001 111.96 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.29 76.96 0.39 Allowed Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.362 -0.695 . . . . 17.66 111.362 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.49 146.31 31.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.88 0.372 . . . . 17.68 110.254 -174.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.02 -8.27 57.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.993 -0.548 . . . . 17.800000000000001 110.987 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.02 40.1 15.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.105 -0.952 . . . . 17.350000000000001 111.176 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.421 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . . . -142.85 95.23 6.31 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.846 -0.616 . . . . 16.640000000000001 110.788 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 82' ' ' ALA . 10.3 Cg_endo -52.71 112.57 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.767 2.311 . . . . 17.23 111.828 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 m -122.26 15.29 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 17.34 111.312 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -104.46 -63.75 1.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.28 0.562 . . . . 18.41 109.711 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 19.8 t70 -83.82 138.3 40.56 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.037 -0.727 . . . . 17.449999999999999 109.037 175.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 86' ' ' ASP . 42.6 Cg_exo -57.87 -20.04 42.19 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.997 2.464 . . . . 18.890000000000001 113.343 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 68.51 -59.93 0.44 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.631 0.772 . . . . 17.809999999999999 111.501 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.1 t -154.14 145.84 23.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.044 -0.525 . . . . 18.629999999999999 109.669 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.25 158.47 33.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.522 -0.547 . . . . 19.100000000000001 109.522 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.14 36.5 25.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.407 0.622 . . . . 19.25 109.997 -173.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.83 62.08 0.7 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 18.789999999999999 109.887 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.637 ' HA ' ' OE1' ' A' ' 98' ' ' GLU . 15.9 m120 -81.85 115.98 21.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.444 -0.798 . . . . 18.949999999999999 110.324 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.422 ' O ' ' HB ' ' A' ' 95' ' ' THR . 4.5 m-20 64.75 -154.97 0.29 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.782 0.676 . . . . 20.309999999999999 110.597 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 94' ' ' ASN . 54.8 m 74.65 -49.13 0.66 Allowed 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.34 0.4 . . . . 21.399999999999999 110.665 -176.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -113.55 21.21 15.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.401 -0.363 . . . . 21.16 111.029 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 70.18 83.11 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.316 0.579 . . . . 22.18 111.021 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.637 ' OE1' ' HA ' ' A' ' 93' ' ' ASN . 48.7 tt0 -80.76 -52.85 0.87 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.88 -0.6 . . . . 19.449999999999999 111.345 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 98' ' ' GLU . 6.0 Cg_exo -79.44 85.44 1.85 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.363 2.042 . . . . 18.530000000000001 112.325 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 64.42 79.85 0.24 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.691 -0.686 . . . . 17.449999999999999 111.695 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.07 -24.19 33.1 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.559 2.173 . . . . 17.420000000000002 112.406 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.482 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . . . -119.77 -52.29 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.16 0.43 . . . . 17.68 112.16 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 102' ' ' ALA . 1.9 Cg_endo -81.82 70.07 7.36 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.06 1.84 . . . . 16.289999999999999 111.846 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 t -77.34 110.78 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.257 -0.883 . . . . 17.260000000000002 110.365 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 56.41 65.39 4.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 O-C-N 123.816 0.698 . . . . 15.800000000000001 110.459 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.47 134.53 22.67 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.604 2.202 . . . . 15.92 112.363 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.65 10.81 3.52 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.647 2.232 . . . . 16.149999999999999 111.949 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.8 tptm 68.61 110.03 0.03 OUTLIER Pre-proline 0 N--CA 1.462 0.128 0 CA-C-N 114.762 -1.108 . . . . 17.629999999999999 111.165 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.36 78.31 0.33 Allowed 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.705 2.27 . . . . 15.039999999999999 111.564 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -71.45 129.57 88.63 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.817 -0.629 . . . . 15.199999999999999 110.844 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.26 -175.83 2.17 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.149 2.566 . . . . 14.08 112.158 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.9 p -87.93 46.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.633 1.206 . . . . 15.279999999999999 109.502 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.559 ' HB2' ' HD3' ' A' ' 114' ' ' PRO . 52.5 mm-40 -96.4 -50.18 0.24 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.267 -1.333 . . . . 16.84 111.445 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 113' ' ' GLU . 50.6 Cg_exo -54.0 -51.99 9.42 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 121.813 1.676 . . . . 15.51 113.915 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 114' ' ' PRO . 36.4 Cg_endo -64.62 107.66 0.91 Allowed 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 121.788 1.658 . . . . 16.039999999999999 112.336 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 30.5 mmmt -79.43 127.64 77.9 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 18.91 110.788 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 116' ' ' LYS . 12.9 Cg_exo -69.87 -54.19 0.23 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.961 2.44 . . . . 17.039999999999999 110.275 174.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? 70.27 157.67 0.17 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.498 -0.774 . . . . 17.52 112.038 172.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.26 167.33 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.969 -0.56 . . . . 18.699999999999999 109.596 170.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 42.6 44.8 3.78 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.796 0.808 . . . . 20.879999999999999 111.133 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.86 146.41 52.3 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.009 -0.996 . . . . 18.890000000000001 109.876 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.73 110.7 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.199 1.933 . . . . 20.43 111.285 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -84.5 -1.02 9.58 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.553 2.169 . . . . 21.100000000000001 112.387 -176.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 68.91 158.4 0.15 Allowed Pre-proline 0 C--O 1.235 0.325 0 O-C-N 124.246 0.966 . . . . 21.149999999999999 111.629 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.88 119.95 7.16 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.365 2.044 . . . . 21.149999999999999 110.313 171.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt 66.23 92.41 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 108.727 -0.842 . . . . 21.879999999999999 108.727 -170.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.74 157.24 33.65 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.073 2.515 . . . . 20.190000000000001 113.254 -170.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -51.38 116.43 7.63 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 115.177 -0.92 . . . . 20.48 111.104 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -75.91 -28.03 8.09 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.666 2.244 . . . . 21.170000000000002 112.745 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.48 ' HD2' ' CD ' ' A' ' 134' ' ' GLU . 86.2 mttt -110.75 161.56 24.29 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.119 -0.491 . . . . 23.18 109.944 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.41 -178.24 2.12 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.343 2.029 . . . . 20.780000000000001 111.026 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 m -75.74 49.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.495 0.664 . . . . 19.75 111.595 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.83 6.39 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.225 1.012 . . . . 21.050000000000001 109.275 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.48 ' CD ' ' HD2' ' A' ' 130' ' ' LYS . 41.9 mt-10 -116.31 18.27 15.3 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.552 -1.204 . . . . 21.300000000000001 109.817 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 61.42 -90.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.725 -0.67 . . . . 20.739999999999998 111.454 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.24 78.83 1.8 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.219 -0.66 . . . . 17.969999999999999 109.219 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.769 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . 53.45 30.91 11.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.344 0.592 . . . . 17.350000000000001 110.6 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . . . 67.91 137.57 0.05 OUTLIER Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 114.455 -1.248 . . . . 19.100000000000001 112.079 -176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.441 ' O ' ' HB ' ' A' ' 140' ' ' THR . 17.3 Cg_exo -64.6 117.53 4.59 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.799 2.333 . . . . 19.350000000000001 111.586 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 33.1 m 78.56 -17.44 0.58 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 123.522 0.514 . . . . 17.75 111.558 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -68.55 -75.86 0.48 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.966 -0.635 . . . . 17.960000000000001 112.655 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.769 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 68.5 mttm -102.68 42.9 1.11 Allowed 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.843 -0.21 . . . . 19.420000000000002 111.071 -177.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 217' ' ' TYR . . . -77.62 153.3 33.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.424 -0.511 . . . . 14.65 110.125 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CD2' ' HG3' ' A' ' 194' ' ' LYS . 4.7 m-85 -143.03 158.44 43.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.17 -0.468 . . . . 14.81 111.685 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.673 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.2 m -151.77 152.82 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.715 -0.675 . . . . 10.48 110.633 -176.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 60.3 t -108.73 108.35 25.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 120.862 0.363 . . . . 10.1 111.262 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -85.26 108.94 18.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.54 -0.3 . . . . 12.0 110.871 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -84.92 -36.64 21.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.138 0.494 . . . . 11.880000000000001 109.924 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.34 164.15 28.38 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.583 -0.818 . . . . 11.35 112.674 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -161.21 101.21 1.23 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.02 0.438 . . . . 13.470000000000001 109.822 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.8 168.37 18.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.293 0.568 . . . . 13.52 110.586 -174.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -100.39 -5.6 26.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.866 -1.061 . . . . 17.600000000000001 109.837 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -105.45 106.58 17.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.122 -0.945 . . . . 16.140000000000001 109.844 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.13 -19.42 65.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.798 -0.637 . . . . 14.039999999999999 111.266 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.93 -29.78 70.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.516 0.674 . . . . 16.57 110.24 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -89.85 -27.23 20.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.149 -0.932 . . . . 16.399999999999999 109.327 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.471 HG11 HG21 ' A' ' 184' ' ' THR . 74.2 t -60.7 -35.62 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.441 -0.799 . . . . 12.67 109.922 173.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.17 -26.81 66.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.437 -0.802 . . . . 15.32 111.59 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.468 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 3.9 mm-40 -70.95 -62.78 1.27 Allowed 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.48 -0.563 . . . . 15.970000000000001 109.48 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.819 HD12 HD12 ' A' ' 186' ' ' ILE . 13.8 mt -54.78 -46.49 74.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.622 -1.172 . . . . 12.6 110.514 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.474 HG23 HD13 ' A' ' 186' ' ' ILE . 85.0 t -72.04 -42.88 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.592 -0.731 . . . . 12.539999999999999 110.668 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.49 -27.77 66.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.627 -0.797 . . . . 14.800000000000001 111.804 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 159' ' ' GLU . 15.7 mttp -72.56 -57.93 3.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.491 -0.355 . . . . 16.050000000000001 111.021 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.7 mm? -82.87 -56.28 3.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.275 0.472 . . . . 12.99 112.275 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -62.53 -38.25 89.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.445 0.641 . . . . 15.06 109.7 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.08 -28.61 73.81 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.839 -1.073 . . . . 16.600000000000001 112.695 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.96 2.03 56.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.998 0.428 . . . . 16.140000000000001 110.879 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.83 23.59 55.32 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.979 -0.629 . . . . 15.119999999999999 113.313 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -85.66 154.59 21.57 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.645 -0.327 . . . . 15.49 110.22 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -68.52 99.34 0.96 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.366 0.603 . . . . 13.869999999999999 109.986 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.5 p -143.99 139.34 25.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 114.96 -1.018 . . . . 10.82 109.949 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.474 ' CE1' HG11 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -140.23 176.89 8.39 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.48 0.657 . . . . 11.130000000000001 110.508 172.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 p -126.49 -175.28 3.34 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.959 -1.019 . . . . 11.52 111.689 -169.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.519 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 2.9 p -52.24 149.51 9.81 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 115.94 -0.573 . . . . 12.75 111.876 -176.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -34.53 -58.07 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.797 3.664 . . . . 14.640000000000001 115.341 -171.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 31.7 t -87.91 -64.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.458 -0.897 . . . . 16.68 112.212 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 55.5 m -169.03 134.0 1.33 Allowed Pre-proline 0 CA--C 1.53 0.196 0 O-C-N 122.389 -0.195 . . . . 16.039999999999999 111.282 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.538 ' HB3' HG21 ' A' ' 184' ' ' THR . 72.5 Cg_exo -59.52 123.27 12.98 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.245 1.963 . . . . 14.220000000000001 111.58 165.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 8.6 p -153.92 159.87 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 109.767 -0.457 . . . . 16.129999999999999 109.767 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.51 122.42 27.0 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.935 -0.394 . . . . 16.699999999999999 109.935 -177.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 110.02 -26.48 13.78 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.766 -0.652 . . . . 16.98 112.155 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.448 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.5 OUTLIER -106.93 158.44 17.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.411 -0.588 . . . . 18.73 109.411 175.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.6 tp -74.56 122.24 27.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.524 0.678 . . . . 14.82 111.156 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 56.0 m -111.34 105.0 13.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.81 -0.632 . . . . 12.779999999999999 110.202 174.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.519 ' H ' ' HB3' ' A' ' 174' ' ' SER . 97.3 mtt180 -84.03 138.05 33.28 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.984 -0.747 . . . . 13.98 108.984 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.819 HD12 HD12 ' A' ' 160' ' ' ILE . 4.2 mt -115.58 122.13 68.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.332 -0.618 . . . . 10.56 109.332 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 186' ' ' ILE . 3.8 mp -128.79 127.08 41.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.7 -0.682 . . . . 10.1 111.171 -168.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 148' ' ' LEU . 50.5 t -100.7 143.13 14.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.034 -0.985 . . . . 9.7400000000000002 110.418 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.99 48.43 7.71 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.192 -0.913 . . . . 9.7599999999999998 113.76 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.673 ' HA ' HG12 ' A' ' 145' ' ' VAL . 18.7 Cg_endo -66.24 123.62 11.45 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 CA-C-N 119.831 1.815 . . . . 11.15 110.568 172.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.1 158.55 36.6 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.548 -0.751 . . . . 12.77 109.386 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 137' ' ' ALA . . . -92.6 -19.54 21.81 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.66 -0.7 . . . . 14.6 110.707 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 35.6 p -91.96 90.93 7.63 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.582 0.706 . . . . 14.300000000000001 110.863 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.52 ' HG3' ' CD2' ' A' ' 144' ' ' TYR . 27.7 ttpt -52.68 -51.88 58.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.562 -1.199 . . . . 15.970000000000001 110.905 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -57.71 -45.61 85.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.765 -0.652 . . . . 15.6 111.242 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -75.45 -38.03 59.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.903 -0.589 . . . . 14.220000000000001 111.591 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.1 OUTLIER -79.09 -20.07 49.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.263 0.554 . . . . 11.949999999999999 110.246 -178.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.434 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 54.1 tptt -64.97 -40.73 95.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.587 0.708 . . . . 14.699999999999999 110.219 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.24 -12.57 84.48 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.169 -0.923 . . . . 13.09 110.797 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.433 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 58.5 m -85.53 -9.04 57.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.716 -0.742 . . . . 12.109999999999999 112.236 -176.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.563 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 31.2 mt -65.91 -38.53 88.96 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.733 0.301 . . . . 12.720000000000001 111.361 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.34 -38.29 96.18 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.738 -0.744 . . . . 14.66 112.279 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 11.4 pt-20 -82.16 -18.63 42.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.096 0.474 . . . . 13.890000000000001 110.16 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.438 HD11 HG12 ' A' ' 188' ' ' VAL . 17.0 tp -74.02 -30.86 62.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.197 -0.456 . . . . 12.550000000000001 110.244 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 85.1 mttt -64.33 -19.96 65.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.284 0.564 . . . . 15.83 109.727 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.59 -29.99 18.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.512 -0.767 . . . . 16.969999999999999 110.288 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 82.4 mt -78.58 -53.04 7.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.827 -0.624 . . . . 13.890000000000001 111.701 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 164' ' ' LEU . 68.4 p -94.71 -44.0 8.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.418 0.628 . . . . 13.539999999999999 110.46 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 67.46 13.85 63.6 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.727 -1.124 . . . . 14.67 112.286 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.45 HD13 HG23 ' A' ' 160' ' ' ILE . 85.3 mt -103.85 152.72 21.58 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.188 -0.671 . . . . 13.039999999999999 109.188 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 10.9 t -88.69 108.84 19.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.106 0.479 . . . . 14.84 110.448 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -125.71 161.04 20.22 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.327 -0.939 . . . . 12.220000000000001 113.216 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.7 p -102.09 144.01 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.216 0.532 . . . . 13.74 110.433 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.78 105.8 8.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.26 -0.882 . . . . 12.890000000000001 110.263 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 84.2 mmm -115.35 148.64 39.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.931 -0.577 . . . . 13.800000000000001 110.404 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -78.26 132.65 11.94 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.225 -0.988 . . . . 13.359999999999999 111.698 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.592 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 7.3 t80 -97.83 133.38 42.41 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.297 0.639 . . . . 14.24 109.607 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.4 t -147.2 93.05 4.77 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 109.167 -0.679 . . . . 16.510000000000002 109.167 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.61 145.62 97.5 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.451 2.101 . . . . 17.420000000000002 112.65 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 52.7 t30 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.397 -0.811 . . . . 19.190000000000001 110.3 179.716 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.805 0.336 . . . . 18.390000000000001 110.552 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.58 -140.17 7.25 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.909 -0.877 . . . . 17.77 110.909 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -82.51 61.6 5.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.832 0.348 . . . . 17.690000000000001 110.771 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -140.52 30.95 1.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 19.93 110.649 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -110.62 -70.25 0.82 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.165 -0.47 . . . . 17.43 110.136 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 177.2 156.74 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 19.359999999999999 109.899 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -81.75 -67.57 0.77 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.76 0.314 . . . . 18.960000000000001 110.396 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -142.05 42.87 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.781 0.8 . . . . 18.239999999999998 109.528 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -76.88 -26.53 54.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.446 -0.797 . . . . 16.780000000000001 111.375 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.95 9.81 11.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.962 0.411 . . . . 18.420000000000002 110.956 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -76.04 -78.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.859 -0.61 . . . . 17.920000000000002 110.711 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.91 123.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 O-C-N 123.82 0.7 . . . . 19.550000000000001 111.197 -173.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.73 62.28 2.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.062 0.458 . . . . 20.309999999999999 111.01 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.8 mt 59.66 81.73 0.24 Allowed Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.307 -0.86 . . . . 19.920000000000002 110.676 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 94.7 Cg_endo -84.77 61.02 6.02 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.649 2.233 . . . . 21.640000000000001 109.887 175.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 11.2 mp 67.39 20.62 9.9 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.118 -0.946 . . . . 22.670000000000002 109.42 -171.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.09 80.8 40.41 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 115.288 -0.869 . . . . 21.34 110.35 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -73.35 87.25 1.08 Allowed 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.518 2.145 . . . . 20.0 111.527 175.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -125.9 -75.52 0.59 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.907 -0.588 . . . . 21.079999999999998 110.017 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -167.44 -53.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.268 0.556 . . . . 18.800000000000001 110.328 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.21 -85.09 1.56 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.67 -0.695 . . . . 17.510000000000002 112.574 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -79.4 160.89 26.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.143 0.497 . . . . 16.949999999999999 110.673 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 50' ' ' ARG . 37.1 ttm180 -133.18 29.2 4.04 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.813 -0.81 . . . . 18.300000000000001 108.813 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -97.43 171.95 8.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.293 -0.867 . . . . 18.170000000000002 110.708 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.587 ' OE2' ' HD2' ' A' ' 53' ' ' PRO . 6.1 tp10 -61.66 146.33 90.49 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.945 -0.761 . . . . 18.82 108.945 173.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.587 ' HD2' ' OE2' ' A' ' 52' ' ' GLU . 13.4 Cg_exo -34.32 -62.85 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.006 3.138 . . . . 19.870000000000001 113.279 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -86.55 133.95 33.69 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.43 -0.582 . . . . 21.100000000000001 109.43 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 51.8 ttp -71.3 79.46 0.73 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.968 -0.56 . . . . 22.300000000000001 111.804 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 25.9 ttt -160.16 67.76 2.77 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.861 -0.609 . . . . 23.850000000000001 109.375 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.89 2.4 8.28 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.916 2.411 . . . . 20.670000000000002 113.474 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.11 22.38 12.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.63 0.253 . . . . 20.489999999999998 111.271 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.95 -57.6 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.368 . . . . 21.469999999999999 110.8 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.1 t -100.59 6.54 44.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.432 0.634 . . . . 22.600000000000001 110.107 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 62.09 45.22 7.31 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.008 -0.996 . . . . 21.93 111.193 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.64 -20.7 61.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.613 -0.721 . . . . 19.73 110.753 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.7 mp -103.62 133.15 20.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.732 -0.667 . . . . 19.579999999999998 109.95 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.3 134.38 36.05 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.66 2.24 . . . . 18.5 111.518 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.2 p -75.25 73.0 2.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.3 0.572 . . . . 17.609999999999999 111.243 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 11.0 pt20 -70.12 122.7 87.01 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.815 -0.63 . . . . 18.760000000000002 110.212 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 66' ' ' GLN . 23.5 Cg_exo -63.43 147.76 93.14 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.608 2.206 . . . . 17.280000000000001 111.783 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -59.33 134.52 59.36 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.378 2.052 . . . . 17.77 110.844 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.52 -39.49 88.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.378 -0.828 . . . . 18.699999999999999 111.532 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.57 -61.14 4.74 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.317 -0.713 . . . . 17.719999999999999 111.317 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.02 97.74 1.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 122.235 0.214 . . . . 18.0 110.607 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 67.46 -175.06 0.19 Allowed 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.718 0.636 . . . . 17.960000000000001 111.687 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -137.33 131.05 31.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.894 -0.594 . . . . 19.850000000000001 109.629 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -78.63 56.56 1.86 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 19.670000000000002 111.435 -174.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 m -118.58 93.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.567 0.698 . . . . 17.739999999999998 111.071 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -74.45 -29.8 61.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.628 -0.714 . . . . 19.949999999999999 110.126 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.81 113.58 7.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.694 -0.684 . . . . 18.390000000000001 110.084 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.79 -43.14 68.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.934 -0.65 . . . . 17.66 112.186 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -89.08 -13.68 38.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.992 0.425 . . . . 17.68 110.318 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.16 27.71 17.22 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.248 -0.887 . . . . 17.800000000000001 110.818 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.19 93.51 8.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.688 -0.687 . . . . 17.350000000000001 110.715 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.49 94.1 46.72 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 16.640000000000001 110.324 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.76 106.26 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.854 2.37 . . . . 17.23 111.964 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.6 p -136.57 40.98 2.58 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.182 -0.917 . . . . 17.34 110.293 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.1 tp -109.43 129.33 55.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.693 -0.685 . . . . 18.41 110.782 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -83.68 125.68 72.87 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.161 -0.472 . . . . 17.449999999999999 110.152 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.27 -6.38 19.07 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.83 2.353 . . . . 18.890000000000001 114.092 -174.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.81 -13.14 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.749 -0.38 . . . . 17.809999999999999 111.338 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.1 p -76.92 -80.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.624 -0.262 . . . . 18.629999999999999 111.061 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.8 mt 54.58 31.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.685 0.755 . . . . 19.100000000000001 110.322 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.31 27.71 12.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.095 -0.957 . . . . 19.25 112.15 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -94.03 99.93 12.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 18.789999999999999 110.773 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -163.02 162.77 26.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.764 -0.653 . . . . 18.949999999999999 109.899 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 63.56 22.84 13.36 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.485 0.49 . . . . 20.309999999999999 111.372 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.9 p -70.99 -41.01 71.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.659 0.742 . . . . 21.399999999999999 109.643 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.94 21.06 17.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.934 -1.03 . . . . 21.16 108.911 173.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 58.06 34.16 23.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 114.526 -1.216 . . . . 22.18 111.518 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 58.41 83.11 0.22 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 114.864 -1.062 . . . . 19.449999999999999 111.576 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.28 91.33 0.33 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.127 2.551 . . . . 18.530000000000001 111.944 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 67.64 139.39 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 115.626 -0.715 . . . . 17.449999999999999 111.582 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.01 55.28 4.94 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.674 2.249 . . . . 17.420000000000002 111.744 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -72.96 128.8 87.42 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 17.68 110.595 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 18.9 Cg_exo -67.58 79.51 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.685 2.257 . . . . 16.289999999999999 112.042 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.9 m -90.81 15.69 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 121.7 0.762 . . . . 17.260000000000002 110.497 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -139.55 109.97 7.41 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.762 -1.108 . . . . 15.800000000000001 109.927 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.25 155.22 70.14 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.626 2.217 . . . . 15.92 111.923 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.55 3.4 4.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.929 2.42 . . . . 16.149999999999999 112.077 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -126.98 148.35 65.29 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.476 -0.783 . . . . 17.629999999999999 109.217 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.73 7.94 2.53 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.613 2.209 . . . . 15.039999999999999 112.688 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.1 tttp 55.19 68.96 2.2 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-N 114.648 -1.16 . . . . 15.199999999999999 110.78 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.33 134.92 54.62 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.458 2.105 . . . . 14.08 112.251 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -82.68 54.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.597 1.189 . . . . 15.279999999999999 109.994 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.85 -52.78 39.45 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 114.541 -1.209 . . . . 16.84 110.61 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.15 135.69 25.5 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.487 1.458 . . . . 15.51 111.121 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 61.09 5.65 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.806 2.337 . . . . 16.039999999999999 112.417 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -104.66 127.19 29.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.962 -0.563 . . . . 18.91 110.821 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 16.4 Cg_exo -69.61 134.33 28.03 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.366 2.044 . . . . 17.039999999999999 110.323 169.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 49.4 mmtm 70.49 123.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.654 0.596 . . . . 17.52 110.69 -175.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.2 m -69.3 -11.68 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.971 0.415 . . . . 18.699999999999999 111.093 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.27 13.09 20.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 20.879999999999999 110.816 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.67 146.07 97.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 18.890000000000001 110.594 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.18 125.83 20.36 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.99 2.46 . . . . 20.43 112.22 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.12 -40.34 85.52 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.296 2.664 . . . . 21.100000000000001 112.029 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.424 ' O ' ' HD2' ' A' ' 127' ' ' PRO . . . -113.09 126.26 28.5 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.914 -0.585 . . . . 21.149999999999999 109.693 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 124' ' ' ALA . 7.8 Cg_exo -73.42 49.18 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.904 2.403 . . . . 21.149999999999999 112.054 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.55 ' H ' ' HD2' ' A' ' 127' ' ' PRO . 16.7 tppt? -98.24 -52.45 0.21 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.03 -0.532 . . . . 21.879999999999999 111.412 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.55 ' HD2' ' H ' ' A' ' 126' ' ' LYS . 56.5 Cg_endo -70.25 73.64 1.58 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.988 1.792 . . . . 20.190000000000001 112.349 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 30.6 tt0 -64.25 136.12 96.62 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 115.84 -0.618 . . . . 20.48 109.46 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 128' ' ' GLU . 19.2 Cg_exo -67.5 57.24 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.318 2.679 . . . . 21.170000000000002 114.132 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -134.51 115.76 12.68 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.172 -0.677 . . . . 23.18 109.172 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.72 121.92 9.42 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.369 2.046 . . . . 20.780000000000001 111.847 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.6 p -74.96 78.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 122.461 1.124 . . . . 19.75 110.544 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.1 m -83.04 -179.38 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.841 -1.072 . . . . 21.050000000000001 110.671 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 67.07 168.12 0.24 Allowed 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.635 0.584 . . . . 21.300000000000001 110.108 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -81.47 68.24 7.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.343 -0.614 . . . . 20.739999999999998 109.343 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -100.38 -57.83 2.03 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.368 -0.833 . . . . 17.969999999999999 109.191 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 142' ' ' LYS . . . -62.14 -50.18 72.91 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.456 -1.313 . . . . 17.350000000000001 107.456 166.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 65.48 152.83 0.12 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.55 -1.204 . . . . 19.100000000000001 110.996 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.487 ' HA ' ' CB ' ' A' ' 192' ' ' ALA . 8.3 Cg_exo -73.51 39.7 0.5 Allowed 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.624 2.216 . . . . 19.350000000000001 113.401 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 12.9 t 175.65 -14.87 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.931 0.345 . . . . 17.75 111.931 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -81.61 -89.41 0.61 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.452 -0.88 . . . . 17.960000000000001 111.814 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . 80.7 tttt -93.42 80.43 4.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.188 -1.042 . . . . 19.420000000000002 108.188 173.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.772 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . -91.17 165.56 13.41 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.27 -0.877 . . . . 14.65 109.535 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.695 ' CE2' ' HB2' ' A' ' 194' ' ' LYS . 4.4 m-85 -136.76 140.16 42.36 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 111.745 0.276 . . . . 14.81 111.745 -174.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 1.026 HG23 ' HB2' ' A' ' 217' ' ' TYR . 3.2 t -148.91 163.79 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.229 -0.656 . . . . 10.48 109.229 171.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.489 HG11 HD22 ' A' ' 204' ' ' LEU . 40.1 t -105.54 113.26 41.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 O-C-N 121.787 -0.571 . . . . 10.1 111.267 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.52 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 49.6 tt0 -86.01 116.83 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.636 -0.256 . . . . 12.0 111.551 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.984 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -93.35 -35.09 13.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.088 0.47 . . . . 11.880000000000001 110.21 -178.618 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -147.25 169.38 28.25 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.454 -0.879 . . . . 11.35 112.569 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -163.58 105.39 0.96 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.865 -0.791 . . . . 13.470000000000001 108.865 177.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -138.91 159.36 42.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.21 0.529 . . . . 13.52 110.909 -171.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 9.2 mmmm -96.93 -3.46 41.76 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.12 -0.945 . . . . 17.600000000000001 110.162 -174.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -111.91 115.87 29.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.371 -0.832 . . . . 16.140000000000001 110.338 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.6 65.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 14.039999999999999 111.007 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.14 -32.4 69.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.669 0.747 . . . . 16.57 110.199 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.528 ' HB3' HD22 ' A' ' 151' ' ' LEU . 32.5 mmtp -89.47 -31.27 17.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.739 -1.119 . . . . 16.399999999999999 110.368 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' THR . 94.9 t -61.89 -40.99 89.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.488 -0.778 . . . . 12.67 110.135 175.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -54.83 -36.38 64.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.078 -0.964 . . . . 15.32 111.056 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 18.5 mt-10 -69.13 -60.78 2.12 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.174 0.511 . . . . 15.970000000000001 110.057 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.55 HG23 HD13 ' A' ' 210' ' ' LEU . 7.9 mt -56.03 -45.19 80.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.074 -0.966 . . . . 12.6 110.971 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.3 t -74.74 -41.22 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.758 -0.656 . . . . 12.539999999999999 110.451 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.95 -28.54 66.27 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.547 -0.835 . . . . 14.800000000000001 111.763 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 159' ' ' GLU . 15.5 mttp -73.74 -56.73 4.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.612 0.244 . . . . 16.050000000000001 111.41 177.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.4 mm? -82.56 -51.73 7.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.093 0.405 . . . . 12.99 112.093 -174.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -65.84 -41.59 91.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.246 0.546 . . . . 15.06 109.653 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.23 -24.16 76.05 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.369 -0.832 . . . . 16.600000000000001 112.745 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.87 4.55 52.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.034 0.445 . . . . 16.140000000000001 110.877 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.61 25.11 47.88 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.956 -0.64 . . . . 15.119999999999999 113.54 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -89.65 160.12 16.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.159 0.48 . . . . 15.49 110.252 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.96 102.7 8.44 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.554 0.692 . . . . 13.869999999999999 109.379 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.84 139.8 27.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.753 -1.112 . . . . 10.82 109.87 -173.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.564 ' CE1' HG21 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -138.71 176.32 8.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.686 0.755 . . . . 11.130000000000001 110.723 172.189 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.421 ' HB ' ' HG3' ' A' ' 178' ' ' PRO . 4.5 p -123.3 -172.63 2.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.46 -1.245 . . . . 11.52 112.239 -167.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.669 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 0.9 OUTLIER -49.51 158.6 0.78 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.345 -0.843 . . . . 12.75 112.864 -177.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -47.36 -54.29 5.28 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.608 2.872 . . . . 14.640000000000001 113.904 -170.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.9 m -88.19 -64.09 1.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.705 -0.798 . . . . 16.68 112.227 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 42.1 m -169.26 137.93 1.63 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 122.336 0.255 . . . . 16.039999999999999 110.534 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.475 ' HB3' HG21 ' A' ' 184' ' ' THR . 76.1 Cg_exo -59.83 123.56 13.51 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.213 1.942 . . . . 14.220000000000001 111.306 165.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 12.2 p -154.66 159.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 116.177 -0.465 . . . . 16.129999999999999 110.487 -174.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -80.85 127.0 32.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.18 -0.464 . . . . 16.699999999999999 110.745 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 100.45 -16.45 57.87 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.981 -0.628 . . . . 16.98 112.221 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 8.5 mptt -120.84 162.5 19.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.787 -0.449 . . . . 18.73 109.787 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 152' ' ' LYS . 9.7 tp -73.38 120.11 21.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.69 0.757 . . . . 14.82 111.771 -172.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.482 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 37.8 m -113.16 105.37 13.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.432 -0.804 . . . . 12.779999999999999 109.747 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.669 ' H ' ' HB3' ' A' ' 174' ' ' SER . 15.8 ptt180 -88.18 136.25 33.06 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.362 -0.836 . . . . 13.98 109.584 176.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.537 ' C ' HD12 ' A' ' 187' ' ' LEU . 4.1 mm -110.39 123.1 65.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.677 -0.49 . . . . 10.56 109.677 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.555 ' HB3' ' CG1' ' A' ' 145' ' ' VAL . 4.5 mp -130.11 132.42 46.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.463 0.649 . . . . 10.1 111.441 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.984 HG23 HD21 ' A' ' 148' ' ' LEU . 26.4 t -107.57 132.72 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.053 -0.976 . . . . 9.7400000000000002 111.015 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.22 49.78 4.32 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.174 -0.921 . . . . 9.7599999999999998 113.58 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.929 ' HA ' HG22 ' A' ' 145' ' ' VAL . 9.3 Cg_endo -59.71 126.11 19.64 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 CA-C-N 119.515 1.657 . . . . 11.15 111.367 173.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -157.63 167.75 29.23 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.124 -0.695 . . . . 12.77 109.124 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.487 ' CB ' ' HA ' ' A' ' 139' ' ' PRO . . . -107.89 5.95 26.87 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.029 0.442 . . . . 14.6 110.706 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 48.1 m -120.4 107.37 12.83 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.153 -0.476 . . . . 14.300000000000001 111.254 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.695 ' HB2' ' CE2' ' A' ' 144' ' ' TYR . 35.1 ttpt -66.67 -40.4 88.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.81 -0.632 . . . . 15.970000000000001 110.023 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -62.49 -39.7 94.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.686 -0.688 . . . . 15.6 110.857 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -51.22 36.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.626 -0.715 . . . . 14.220000000000001 110.493 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.657 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -74.06 -18.85 60.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.484 . . . . 11.949999999999999 110.725 -175.596 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.54 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 17.4 tppt? -62.93 -39.57 95.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.197 0.522 . . . . 14.699999999999999 110.325 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.02 -17.38 79.85 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.09 -1.204 . . . . 13.09 110.09 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 31.0 m -79.39 -8.92 59.44 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.564 -0.818 . . . . 12.109999999999999 112.037 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 13.8 mt -70.81 -37.33 73.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.936 0.398 . . . . 12.720000000000001 110.378 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.23 -25.32 71.05 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.648 -0.981 . . . . 14.66 110.648 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.605 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 41.6 mt-10 -86.39 -24.43 25.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.941 -0.629 . . . . 13.890000000000001 110.534 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.489 HD22 HG11 ' A' ' 146' ' ' VAL . 3.0 tp -60.3 -48.25 82.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.425 -0.352 . . . . 12.550000000000001 111.103 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.0 -21.21 58.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 15.83 111.396 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -38.65 13.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 16.969999999999999 110.436 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 93.1 mt -72.75 -51.85 17.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.073 -0.512 . . . . 13.890000000000001 111.615 -176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.405 ' HB3' HD11 ' A' ' 164' ' ' LEU . 64.7 p -101.87 -43.32 5.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.222 0.534 . . . . 13.539999999999999 110.919 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.39 6.18 74.84 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.908 -0.877 . . . . 14.67 110.908 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.55 HD13 HG23 ' A' ' 160' ' ' ILE . 60.3 mt -97.74 157.91 15.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.787 -0.449 . . . . 13.039999999999999 109.787 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 17.7 p -81.12 95.61 6.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.011 0.434 . . . . 14.84 111.315 -176.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -108.23 142.34 15.95 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.727 -0.749 . . . . 12.220000000000001 114.127 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.1 142.39 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.526 -0.546 . . . . 13.74 109.526 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.38 107.02 4.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.109 -0.496 . . . . 12.890000000000001 110.512 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 23.9 mmt -109.0 141.54 40.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.741 -0.663 . . . . 13.800000000000001 109.817 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.55 107.34 2.34 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.169 -1.015 . . . . 13.359999999999999 111.748 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 1.026 ' HB2' HG23 ' A' ' 145' ' ' VAL . 6.1 t80 -63.85 133.66 53.76 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.147 -1.526 . . . . 14.24 111.066 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.9 p -141.89 91.91 7.99 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.229 -0.442 . . . . 16.510000000000002 110.246 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.35 133.47 28.4 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.306 2.004 . . . . 17.420000000000002 112.16 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--O 1.251 1.165 0 CA-C-N 115.608 -0.724 . . . . 19.190000000000001 111.247 178.043 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.507 0.194 . . . . 18.390000000000001 110.789 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.33 -72.48 1.12 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.292 -0.956 . . . . 17.77 113.017 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 58.25 54.48 5.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.407 0.622 . . . . 17.690000000000001 110.085 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -70.42 87.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.911 -1.04 . . . . 19.93 110.864 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -158.09 120.33 3.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.071 -0.513 . . . . 17.43 110.231 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -90.36 148.74 22.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.172 -0.467 . . . . 19.359999999999999 110.175 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -79.15 53.34 1.44 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.173 -0.467 . . . . 18.960000000000001 110.882 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -89.32 -44.4 10.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.034 -0.53 . . . . 18.239999999999998 109.771 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -137.02 176.89 8.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.398 -0.819 . . . . 16.780000000000001 109.803 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -86.75 -42.82 13.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.679 0.276 . . . . 18.420000000000002 111.241 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -146.29 26.5 1.19 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.041 0.386 . . . . 17.920000000000002 112.041 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.46 -16.65 30.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.361 . . . . 19.550000000000001 111.003 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.617 ' O ' ' HD3' ' A' ' 42' ' ' PRO . . . -107.21 114.1 27.93 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.871 -0.418 . . . . 20.309999999999999 109.871 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 41' ' ' ILE . 3.9 mp -102.5 96.27 7.14 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.176 -0.465 . . . . 19.920000000000002 109.85 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 40' ' ' ALA . 1.6 Cg_endo -83.54 61.16 6.95 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.968 2.445 . . . . 21.640000000000001 110.565 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.425 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 11.1 mp 63.51 29.06 15.41 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.282 -0.872 . . . . 22.670000000000002 109.995 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.9 t -127.55 69.92 75.95 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 115.534 -0.757 . . . . 21.34 110.813 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 43' ' ' LEU . 3.1 Cg_exo -84.01 -5.56 10.46 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.918 2.412 . . . . 20.0 111.559 172.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.67 -35.92 79.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.495 -0.775 . . . . 21.079999999999998 110.902 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.18 169.48 22.89 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.865 -0.607 . . . . 18.800000000000001 109.697 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.84 -92.93 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.508 -0.853 . . . . 17.510000000000002 111.803 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -100.74 165.49 11.35 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.095 -0.705 . . . . 16.949999999999999 109.095 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -59.99 -40.53 89.48 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.562 -0.533 . . . . 18.300000000000001 109.562 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -99.36 153.04 19.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.685 -0.689 . . . . 18.170000000000002 109.792 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 7.6 mm-40 -78.61 145.42 67.15 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.633 -0.258 . . . . 18.82 110.736 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 52' ' ' GLU . 9.9 Cg_exo -72.41 72.67 2.89 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.1 2.534 . . . . 19.870000000000001 111.974 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 24.7 t70 -135.01 160.28 38.82 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.799 -0.637 . . . . 21.100000000000001 109.383 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.2 ttt -63.34 -25.39 68.27 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.169 0.293 . . . . 22.300000000000001 111.342 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 17.2 ptp -159.02 68.9 3.37 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.955 0.407 . . . . 23.850000000000001 111.051 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 54' ' ' ASP . 67.1 Cg_endo -83.38 -20.69 4.77 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.478 2.119 . . . . 20.670000000000002 112.024 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.23 92.04 1.91 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.57 -0.741 . . . . 20.489999999999998 109.361 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.88 -63.73 1.0 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 21.469999999999999 111.666 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.2 t -98.23 -23.47 15.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.848 0.356 . . . . 22.600000000000001 110.993 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -87.89 61.12 6.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.418 0.628 . . . . 21.93 110.27 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.71 14.82 24.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.742 -0.663 . . . . 19.73 110.358 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -81.59 117.14 67.07 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.206 -0.664 . . . . 19.579999999999998 109.206 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.34 108.06 1.11 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.551 2.167 . . . . 18.5 112.454 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 m -76.33 -22.69 54.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.329 0.585 . . . . 17.609999999999999 110.096 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -115.98 87.49 19.02 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.752 -0.658 . . . . 18.760000000000002 109.349 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.43 131.8 5.72 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.396 2.064 . . . . 17.280000000000001 112.899 -176.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.51 127.75 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.67 2.247 . . . . 17.77 111.798 173.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -84.42 166.97 16.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.246 -0.434 . . . . 18.699999999999999 110.466 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.8 129.32 13.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.972 -0.632 . . . . 17.719999999999999 112.3 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 60.81 41.26 14.92 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.093 0.557 . . . . 18.0 111.353 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.15 60.1 2.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.293 0.568 . . . . 17.960000000000001 110.958 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -124.27 52.31 1.51 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.041 -0.527 . . . . 19.850000000000001 110.434 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.91 -47.32 80.83 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.402 -0.817 . . . . 19.670000000000002 110.039 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 m -109.58 132.13 58.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.528 -0.76 . . . . 17.739999999999998 109.883 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -133.55 -61.39 0.81 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.223 -0.444 . . . . 19.949999999999999 110.01 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.93 98.24 8.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.114 -0.494 . . . . 18.390000000000001 110.394 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.85 -141.87 7.12 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.805 -0.712 . . . . 17.66 111.994 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -131.7 19.17 4.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.898 0.38 . . . . 17.68 110.246 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 56.76 41.54 28.01 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.339 -0.846 . . . . 17.800000000000001 111.729 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.51 31.4 1.54 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.177 0.513 . . . . 17.350000000000001 110.524 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.96 135.07 91.86 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 16.640000000000001 111.071 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.41 131.92 26.04 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.665 2.243 . . . . 17.23 112.117 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.1 m 64.87 35.29 8.55 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.335 -0.848 . . . . 17.34 111.056 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.8 tp -80.41 -21.09 42.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.018 -0.537 . . . . 18.41 109.703 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -61.46 128.08 89.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.497 -0.774 . . . . 17.449999999999999 109.953 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.66 -6.05 16.57 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.912 2.408 . . . . 18.890000000000001 113.547 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 67.19 94.66 0.07 Allowed 'General case' 0 N--CA 1.462 0.162 0 O-C-N 123.894 0.746 . . . . 17.809999999999999 111.196 -177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.6 p -80.31 67.98 6.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.4 0.619 . . . . 18.629999999999999 111.146 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.8 pt -99.67 24.42 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.761 -0.654 . . . . 19.100000000000001 110.701 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.6 -44.38 0.55 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.664 0.786 . . . . 19.25 111.52 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 71.84 -56.53 0.64 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.816 0.847 . . . . 18.789999999999999 111.984 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -77.78 -35.21 51.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.471 -0.331 . . . . 18.949999999999999 111.138 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 96' ' ' GLU . 87.3 m-20 -67.17 176.58 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.772 -0.195 . . . . 20.309999999999999 110.943 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.1 p 67.49 -36.16 0.28 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.931 1.292 . . . . 21.399999999999999 111.03 -171.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 94' ' ' ASN . 6.7 mm-40 -90.07 -5.58 56.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.208 0.528 . . . . 21.16 109.865 172.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 24.1 t80 61.54 47.98 6.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.754 -1.112 . . . . 22.18 109.886 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 63.05 97.75 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 114.991 -1.004 . . . . 19.449999999999999 111.611 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -79.79 96.64 1.05 Allowed 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.188 2.592 . . . . 18.530000000000001 111.972 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -81.65 152.39 69.53 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.033 -0.53 . . . . 17.449999999999999 110.14 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.87 46.36 1.9 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.95 2.433 . . . . 17.420000000000002 112.591 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.481 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -88.35 -50.82 0.4 Allowed Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 17.68 111.672 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 102' ' ' ALA . 37.0 Cg_endo -66.73 89.67 0.29 Allowed 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.165 1.91 . . . . 16.289999999999999 112.376 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.4 m -94.03 115.36 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 116.039 -0.528 . . . . 17.260000000000002 110.367 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.72 116.03 12.88 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 15.800000000000001 111.058 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.89 131.89 48.85 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.026 2.484 . . . . 15.92 112.359 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.48 137.55 60.51 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.908 2.405 . . . . 16.149999999999999 112.563 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.577 ' HG2' ' H ' ' A' ' 110' ' ' LYS . 41.5 ttmt -68.1 121.2 79.13 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 17.629999999999999 110.16 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -84.12 16.04 2.02 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.884 2.389 . . . . 15.039999999999999 112.765 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.577 ' H ' ' HG2' ' A' ' 108' ' ' LYS . 88.5 tttt 68.94 130.77 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 115.522 -0.763 . . . . 15.199999999999999 111.228 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.73 138.22 84.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.535 2.157 . . . . 14.08 111.684 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -88.26 49.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 122.162 0.982 . . . . 15.279999999999999 110.081 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -170.33 81.59 0.58 Allowed Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.12 -1.4 . . . . 16.84 110.104 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.88 125.85 20.51 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.005 2.47 . . . . 15.51 112.187 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.99 54.19 4.77 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 123.224 2.616 . . . . 16.039999999999999 112.327 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.4 tttm 57.4 80.57 0.28 Allowed Pre-proline 0 C--O 1.233 0.198 0 CA-C-N 115.645 -0.707 . . . . 18.91 110.402 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.31 -16.27 47.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.621 2.214 . . . . 17.039999999999999 111.799 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.12 75.29 9.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.803 -0.635 . . . . 17.52 110.197 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.4 t -92.66 -51.44 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.681 -0.69 . . . . 18.699999999999999 109.899 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 9.0 pt-20 -101.32 1.97 39.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 20.879999999999999 110.4 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.06 111.32 35.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.65 -0.705 . . . . 18.890000000000001 111.122 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 120' ' ' GLU . 88.9 Cg_endo -91.87 142.27 2.64 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.045 2.497 . . . . 20.43 112.174 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.01 -11.45 19.69 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.473 2.115 . . . . 21.100000000000001 111.607 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.48 153.37 26.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.501 -0.772 . . . . 21.149999999999999 109.228 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.68 -55.64 3.8 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.694 2.263 . . . . 21.149999999999999 112.552 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt 64.2 107.45 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.234 0 O-C-N 123.749 0.656 . . . . 21.879999999999999 111.538 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.23 57.49 4.07 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.755 2.303 . . . . 20.190000000000001 112.462 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -76.32 123.07 87.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.885 -0.598 . . . . 20.48 110.453 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.12 126.69 21.69 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.82 2.347 . . . . 21.170000000000002 111.645 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -69.99 -39.91 11.81 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 112.926 0.713 . . . . 23.18 112.926 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -71.04 84.49 0.86 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.761 1.641 . . . . 20.780000000000001 111.54 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.462 HG23 ' HD3' ' A' ' 136' ' ' LYS . 5.2 p -89.17 76.17 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.254 1.026 . . . . 19.75 110.281 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.4 t -100.02 -3.9 9.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.944 0.878 . . . . 21.050000000000001 109.901 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -109.94 174.47 5.85 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.58 -1.191 . . . . 21.300000000000001 110.541 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -67.26 -62.38 1.45 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.05 -0.352 . . . . 20.739999999999998 110.05 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.462 ' HD3' HG23 ' A' ' 132' ' ' VAL . 29.7 mtpp 75.1 -48.7 0.64 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.975 0.797 . . . . 17.969999999999999 111.701 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.414 ' HB2' ' HE3' ' A' ' 194' ' ' LYS . . . -75.51 -21.98 57.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.312 -0.404 . . . . 17.350000000000001 110.061 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 73.02 146.55 0.12 Allowed Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 114.829 -1.078 . . . . 19.100000000000001 111.607 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.599 ' HA ' ' HB1' ' A' ' 192' ' ' ALA . 71.5 Cg_exo -49.64 -60.95 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.348 2.698 . . . . 19.350000000000001 114.043 -173.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.2 m -109.44 0.88 19.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.258 0.551 . . . . 17.75 110.549 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.27 -61.65 2.59 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.805 -0.712 . . . . 17.960000000000001 111.98 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -130.91 58.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.196 0.522 . . . . 19.420000000000002 110.772 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.577 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -71.37 165.32 23.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.442 -0.799 . . . . 14.65 109.133 173.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.595 ' CE2' ' HD3' ' A' ' 194' ' ' LYS . 4.3 m-85 -143.47 155.43 44.36 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.487 0.551 . . . . 14.81 112.487 -175.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.797 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.5 t -148.39 167.07 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.252 -1.018 . . . . 10.48 108.252 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 59.0 t -107.62 112.85 41.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 O-C-N 121.686 -0.633 . . . . 10.1 111.31 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.555 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 48.9 tt0 -84.52 114.54 22.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.355 -0.384 . . . . 12.0 111.381 -176.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.91 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -96.45 -33.07 12.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.391 0.615 . . . . 11.880000000000001 110.169 -178.81 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.29 168.39 27.18 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.47 -0.786 . . . . 11.35 112.169 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -170.93 101.49 0.22 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.0 -0.741 . . . . 13.470000000000001 109.0 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.81 164.65 35.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.86 -0.609 . . . . 13.52 110.785 -173.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 32.4 mtmm -101.6 15.32 29.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.128 -0.942 . . . . 17.600000000000001 110.389 -173.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -109.87 105.14 14.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.153 -0.93 . . . . 16.140000000000001 108.96 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.36 -22.13 63.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.199 -0.455 . . . . 14.039999999999999 111.682 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.48 -38.22 89.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.928 0.871 . . . . 16.57 109.292 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -75.43 -29.79 59.83 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.309 -1.314 . . . . 16.399999999999999 110.119 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 89.3 t -63.29 -40.84 90.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.627 -0.715 . . . . 12.67 109.867 172.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -64.17 -22.23 66.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.644 -0.707 . . . . 15.32 111.954 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.698 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 14.5 mt-10 -78.0 -62.9 1.53 Allowed 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.143 -0.688 . . . . 15.970000000000001 109.143 176.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.535 HD12 HG13 ' A' ' 186' ' ' ILE . 10.3 mt -54.48 -48.47 69.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.599 -0.728 . . . . 12.6 110.949 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.85 -40.01 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.762 -0.654 . . . . 12.539999999999999 110.555 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.88 -28.91 72.66 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.462 -0.875 . . . . 14.800000000000001 112.138 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.698 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.6 mptp? -80.95 -49.3 11.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.4 0.148 . . . . 16.050000000000001 111.4 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.42 HD21 ' HA ' ' A' ' 208' ' ' SER . 0.7 OUTLIER -79.87 -55.85 4.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 12.99 111.484 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.401 ' HB2' ' CG1' ' A' ' 171' ' ' VAL . 69.0 ttt180 -66.89 -40.8 87.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.249 0.547 . . . . 15.06 110.313 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.76 -19.87 73.69 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.222 -0.899 . . . . 16.600000000000001 112.66 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.05 -5.59 57.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.808 0.337 . . . . 16.140000000000001 110.916 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.71 24.97 12.36 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.651 -0.785 . . . . 15.119999999999999 112.806 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -94.8 148.3 22.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.933 -0.395 . . . . 15.49 109.933 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -76.67 96.55 4.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.164 -0.68 . . . . 13.869999999999999 109.164 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 165' ' ' ARG . 7.4 p -142.62 143.74 25.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.404 -0.816 . . . . 10.82 109.456 -176.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.471 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -139.08 176.49 8.66 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.69 0.757 . . . . 11.130000000000001 110.85 176.267 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 20.2 p -113.93 -176.4 2.89 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.477 -1.238 . . . . 11.52 111.004 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.5 OUTLIER -53.16 141.33 40.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 O-C-N 123.166 0.291 . . . . 12.75 110.778 178.507 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -40.14 -47.49 4.05 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 124.484 3.456 . . . . 14.640000000000001 115.553 -169.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.3 m -85.44 -63.68 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.522 -0.871 . . . . 16.68 112.696 -171.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 98.8 m -168.49 129.94 1.14 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 118.375 0.534 . . . . 16.039999999999999 112.096 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.465 ' HB3' HG21 ' A' ' 184' ' ' THR . 74.7 Cg_exo -62.63 123.97 13.31 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.519 2.146 . . . . 14.220000000000001 111.713 161.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.491 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 7.7 p -154.01 159.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.63 -0.507 . . . . 16.129999999999999 109.63 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -81.47 129.15 34.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.967 0.413 . . . . 16.699999999999999 110.721 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 104.81 -25.79 24.43 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.058 -0.591 . . . . 16.98 112.376 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.491 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 2.8 mptp? -114.35 157.69 22.48 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.557 -0.534 . . . . 18.73 109.557 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.6 tp -69.82 109.93 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.594 0.711 . . . . 14.82 111.815 -173.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 178' ' ' PRO . 54.0 m -101.79 111.39 23.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.786 -0.643 . . . . 12.779999999999999 109.562 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 74.1 mtp180 -92.22 139.57 30.48 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.39 -0.823 . . . . 13.98 109.755 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.535 HG13 HD12 ' A' ' 160' ' ' ILE . 4.1 mm -109.6 118.86 57.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.251 -0.648 . . . . 10.56 109.251 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 186' ' ' ILE . 5.2 mp -129.81 120.88 25.72 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.386 0.612 . . . . 10.1 111.386 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.91 HG23 HD21 ' A' ' 148' ' ' LEU . 38.0 t -95.38 136.02 27.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.508 -0.769 . . . . 9.7400000000000002 110.822 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.46 47.9 5.52 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.316 -0.856 . . . . 9.7599999999999998 113.943 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.772 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.5 Cg_endo -61.36 126.21 18.74 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 CA-C-N 119.732 1.766 . . . . 11.15 110.998 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -155.04 154.56 32.66 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.512 -0.475 . . . . 12.77 110.376 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.599 ' HB1' ' HA ' ' A' ' 139' ' ' PRO . . . -95.02 -4.51 46.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.649 -0.705 . . . . 14.6 111.312 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.1 m -112.5 100.57 8.85 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.487 0.661 . . . . 14.300000000000001 110.431 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.595 ' HD3' ' CE2' ' A' ' 144' ' ' TYR . 22.1 ttpp -55.66 -59.78 4.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.461 -1.245 . . . . 15.970000000000001 112.011 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.13 -27.96 68.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.686 -0.688 . . . . 15.6 111.81 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -72.51 -37.8 68.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.423 0.63 . . . . 14.220000000000001 110.154 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -85.55 -23.52 27.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.791 -0.64 . . . . 11.949999999999999 110.444 -175.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.557 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 36.8 mttt -74.66 -32.77 62.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.054 0.454 . . . . 14.699999999999999 110.634 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -73.81 -12.63 80.88 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.965 -1.254 . . . . 13.09 109.965 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 47.7 m -90.67 -8.89 48.73 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.365 -0.917 . . . . 12.109999999999999 112.24 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 22.7 mt -66.14 -33.37 75.61 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.186 -0.321 . . . . 12.720000000000001 110.989 -175.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.81 -44.16 97.28 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.807 -0.711 . . . . 14.66 111.94 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.62 -17.93 34.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.635 0.255 . . . . 13.890000000000001 111.037 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.43 HD12 HD12 ' A' ' 207' ' ' LEU . 24.5 tp -70.15 -29.32 66.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.05 0.453 . . . . 12.550000000000001 109.996 -176.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 61.3 mttp -60.92 -22.66 64.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.61 -0.723 . . . . 15.83 110.861 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.57 -35.34 30.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.291 0.567 . . . . 16.969999999999999 109.754 174.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.43 HD12 HD12 ' A' ' 204' ' ' LEU . 82.2 mt -75.45 -52.47 10.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.417 -0.81 . . . . 13.890000000000001 111.453 -175.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.42 ' HA ' HD21 ' A' ' 164' ' ' LEU . 31.9 p -98.64 -45.07 6.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.031 0.444 . . . . 13.539999999999999 110.717 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 60.59 21.79 58.31 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.598 -0.728 . . . . 14.67 111.868 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.436 ' HB2' ' HG ' ' A' ' 148' ' ' LEU . 79.8 mt -98.47 158.09 15.81 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.126 -0.694 . . . . 13.039999999999999 109.126 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 16.9 p -73.72 92.61 2.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.822 0.344 . . . . 14.84 110.756 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -111.33 146.33 17.76 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.486 -0.864 . . . . 12.220000000000001 114.256 -174.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 49.1 t -117.01 140.97 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.356 -0.979 . . . . 13.74 108.356 170.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.495 HG21 ' HE2' ' A' ' 198' ' ' LYS . 6.3 p -76.14 106.51 6.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.792 0.806 . . . . 12.890000000000001 110.314 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 23.0 mmt -113.18 145.99 40.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.152 -0.931 . . . . 13.800000000000001 110.797 -174.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.7 139.53 27.64 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.628 -0.796 . . . . 13.359999999999999 112.861 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.797 ' HB2' HG23 ' A' ' 145' ' ' VAL . 9.2 t80 -106.54 126.12 51.87 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.332 1.053 . . . . 14.24 110.123 -175.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 16.8 p -136.33 92.78 15.26 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 120.808 0.337 . . . . 16.510000000000002 110.582 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.565 ' HG3' ' CZ ' ' A' ' 217' ' ' TYR . 14.5 Cg_exo -63.15 120.15 7.5 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.374 2.049 . . . . 17.420000000000002 111.925 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 46.0 t30 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.243 -0.884 . . . . 19.190000000000001 109.418 -176.752 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.806 -0.442 . . . . 18.390000000000001 109.806 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 35' ' ' GLN . . . 144.5 -11.34 1.98 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.312 -0.946 . . . . 17.77 113.16 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 68.61 -66.22 0.25 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.258 0.623 . . . . 17.690000000000001 110.893 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -99.29 -69.24 0.77 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.297 -0.631 . . . . 19.93 109.297 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -128.32 -69.31 0.73 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.968 -0.56 . . . . 17.43 110.681 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -168.17 -3.32 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.779 0.323 . . . . 19.359999999999999 111.805 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -79.35 -9.08 59.51 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.002 -0.436 . . . . 18.960000000000001 111.444 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.522 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 91.7 mt-30 -138.56 166.3 24.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.464 -0.569 . . . . 18.239999999999998 109.464 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.421 ' HA ' ' OG1' ' A' ' 65' ' ' THR . 3.1 m-20 56.11 78.03 0.22 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.898 0.749 . . . . 16.780000000000001 112.22 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.535 ' HG2' ' H ' ' A' ' 38' ' ' PHE . 21.0 tt0 -129.12 170.36 13.62 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.61 -0.885 . . . . 18.420000000000002 108.61 176.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.535 ' H ' ' HG2' ' A' ' 37' ' ' GLU . 81.6 m-85 -75.08 39.11 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.349 . . . . 17.920000000000002 111.742 -176.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -110.86 -10.76 14.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.238 0.542 . . . . 19.550000000000001 109.983 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.71 132.47 39.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.585 -0.734 . . . . 20.309999999999999 110.447 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.46 HG22 ' HG2' ' A' ' 45' ' ' PRO . 14.0 pt -134.07 79.93 55.26 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.173 0.511 . . . . 19.920000000000002 111.259 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -76.74 51.88 3.51 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.591 2.194 . . . . 21.640000000000001 111.045 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 60.76 32.67 20.21 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.741 -0.663 . . . . 22.670000000000002 110.41 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.63 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 89.2 t -110.25 -62.96 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.932 -0.576 . . . . 21.34 112.337 -176.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 5.8 Cg_exo -81.92 126.31 5.07 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.329 2.019 . . . . 20.0 112.4 -172.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -86.8 105.7 17.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.062 -0.517 . . . . 21.079999999999998 110.822 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 53.07 52.32 14.0 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.997 -0.547 . . . . 18.800000000000001 111.12 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -142.99 31.72 1.96 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.638 -0.791 . . . . 17.510000000000002 112.265 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.36 138.92 36.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.01 0.433 . . . . 16.949999999999999 110.558 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -109.74 49.12 0.85 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.782 0.801 . . . . 18.300000000000001 108.846 171.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.98 127.65 43.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.974 -1.012 . . . . 18.170000000000002 109.638 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -78.12 113.06 30.09 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.571 -0.286 . . . . 18.82 110.291 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 91.2 Cg_endo -85.4 30.06 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.837 2.358 . . . . 19.870000000000001 112.782 -175.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -141.33 -60.95 0.48 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.469 -0.332 . . . . 21.100000000000001 111.395 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.478 ' HG3' ' N ' ' A' ' 56' ' ' MET . 24.8 ptp -70.27 -54.29 13.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.902 0.334 . . . . 22.300000000000001 111.902 -175.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.478 ' N ' ' HG3' ' A' ' 55' ' ' MET . 57.4 mtt -161.55 76.05 2.36 Favored Pre-proline 0 CA--C 1.517 -0.321 0 N-CA-C 109.555 -0.535 . . . . 23.850000000000001 109.555 -173.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 53' ' ' PRO . 85.3 Cg_endo -78.9 124.3 6.11 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.07 1.846 . . . . 20.670000000000002 111.46 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 68.23 -53.6 0.53 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.359 -0.837 . . . . 20.489999999999998 110.96 -171.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 56.83 65.59 1.37 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.128 0.489 . . . . 21.469999999999999 110.071 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.6 m 62.12 52.37 3.27 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.222 -0.899 . . . . 22.600000000000001 109.757 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 67.7 131.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.831 -1.077 . . . . 21.93 111.442 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 63' ' ' LEU . . . -87.43 37.49 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 19.73 110.671 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.5 mm? 68.78 140.5 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.285 -0.87 . . . . 19.579999999999998 111.195 -177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.59 83.31 0.67 Allowed 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.327 2.018 . . . . 18.5 111.84 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' A' ' 36' ' ' ASP . 29.6 m -75.36 117.58 17.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.897 -0.592 . . . . 17.609999999999999 110.775 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.541 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 34.9 tt0 -177.82 -52.32 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 115.905 -0.589 . . . . 18.760000000000002 111.614 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 66' ' ' GLN . 75.6 Cg_exo -50.88 -50.18 14.64 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.322 2.014 . . . . 17.280000000000001 115.011 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.26 142.92 34.53 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.489 1.459 . . . . 17.77 113.504 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 65.87 -89.14 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.048 -0.978 . . . . 18.699999999999999 112.628 171.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.9 55.44 5.32 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.516 -0.85 . . . . 17.719999999999999 111.547 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.36 143.32 40.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.573 0.225 . . . . 18.0 111.047 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -175.94 -60.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.819 -0.628 . . . . 17.960000000000001 110.141 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -112.26 79.24 1.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.709 -0.678 . . . . 19.850000000000001 110.34 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.33 -8.41 53.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.524 . . . . 19.670000000000002 110.303 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.0 p -91.24 127.67 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.872 -0.604 . . . . 17.739999999999998 109.543 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -126.38 -19.75 4.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.142 -0.481 . . . . 19.949999999999999 111.229 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.56 54.3 3.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.103 0.478 . . . . 18.390000000000001 110.185 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.29 -106.9 1.97 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.598 -0.728 . . . . 17.66 112.218 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -173.49 -60.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.218 -0.66 . . . . 17.68 109.218 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -158.7 36.79 0.22 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.274 -0.876 . . . . 17.800000000000001 109.668 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.54 67.38 8.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.741 -0.663 . . . . 17.350000000000001 111.381 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.84 89.12 45.14 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.935 -0.575 . . . . 16.640000000000001 109.886 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.94 79.23 1.33 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.167 2.578 . . . . 17.23 112.445 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.6 m 71.68 132.34 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.624 -0.716 . . . . 17.34 111.498 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.405 ' N ' HD22 ' A' ' 85' ' ' LEU . 3.2 mm? -98.62 3.6 47.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.767 -0.651 . . . . 18.41 110.347 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.49 111.5 21.41 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.536 -0.757 . . . . 17.449999999999999 110.973 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.15 -42.06 0.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.694 2.263 . . . . 18.890000000000001 112.062 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.26 -61.3 1.84 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.289 -0.414 . . . . 17.809999999999999 110.992 -176.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.7 t -100.26 58.63 0.98 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.555 0.693 . . . . 18.629999999999999 110.615 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.8 tp -66.77 -25.68 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.672 -0.695 . . . . 19.100000000000001 109.81 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.61 142.04 40.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.67 -0.695 . . . . 19.25 110.378 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.32 166.63 24.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.228 -0.442 . . . . 18.789999999999999 110.088 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.63 68.5 6.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.887 0.375 . . . . 18.949999999999999 110.211 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -177.9 -159.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.34 -0.846 . . . . 20.309999999999999 109.389 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 66.6 p 65.67 -53.33 0.37 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.007 1.323 . . . . 21.399999999999999 112.11 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -119.18 20.47 12.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.628 0.252 . . . . 21.16 110.516 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 60.72 69.91 0.65 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.631 -0.713 . . . . 22.18 110.749 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 67.18 112.04 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.185 -0.916 . . . . 19.449999999999999 111.116 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -71.79 69.7 2.89 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.973 2.449 . . . . 18.530000000000001 113.292 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -95.08 133.86 25.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.622 -0.51 . . . . 17.449999999999999 109.622 172.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.53 108.56 1.86 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.69 2.26 . . . . 17.420000000000002 112.583 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.64 131.64 94.26 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.813 -0.631 . . . . 17.68 110.805 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.39 72.95 3.44 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.707 2.272 . . . . 16.289999999999999 111.638 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.3 m -86.82 39.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.061 -0.518 . . . . 17.260000000000002 111.248 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . . . -83.51 122.34 76.84 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.98 -0.555 . . . . 15.800000000000001 110.749 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 105' ' ' ALA . 37.8 Cg_exo -61.23 109.64 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.254 2.636 . . . . 15.92 112.577 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.4 -55.46 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.937 2.425 . . . . 16.149999999999999 112.649 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.484 ' HB3' ' HD3' ' A' ' 109' ' ' PRO . 88.1 tttt -76.2 -50.26 2.97 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 112.431 0.53 . . . . 17.629999999999999 112.431 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 108' ' ' LYS . 31.9 Cg_exo -60.49 -21.58 68.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.065 1.844 . . . . 15.039999999999999 113.241 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -112.62 103.81 55.67 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.081 -0.34 . . . . 15.199999999999999 110.081 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.77 107.92 1.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.085 1.857 . . . . 14.08 111.738 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.9 p -80.87 53.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 122.726 1.251 . . . . 15.279999999999999 110.088 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.498 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 49.1 mt-10 -94.73 136.97 22.58 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.611 -1.177 . . . . 16.84 110.147 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 117' ' ' PRO . 72.1 Cg_endo -80.01 100.07 1.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.75 2.3 . . . . 15.51 111.125 172.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 16.3 Cg_exo -67.21 -38.09 16.55 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.893 2.395 . . . . 16.039999999999999 113.728 -170.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 27.5 ttpp -77.05 -48.68 2.54 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.544 0.572 . . . . 18.91 112.544 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 11.2 Cg_exo -73.4 -34.89 5.4 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.178 1.918 . . . . 17.039999999999999 112.174 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -102.4 85.88 2.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.999 -0.546 . . . . 17.52 110.326 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.7 m -97.85 -23.17 4.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 18.699999999999999 110.876 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.87 125.61 36.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.371 -0.377 . . . . 20.879999999999999 110.625 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.69 120.2 74.85 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.697 -0.683 . . . . 18.890000000000001 111.254 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.481 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 53.4 Cg_exo -53.04 -44.44 48.79 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.447 2.765 . . . . 20.43 114.203 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 122' ' ' PRO . 40.2 Cg_endo -67.66 -15.84 45.43 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 121.75 1.633 . . . . 21.100000000000001 112.845 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -125.34 77.43 68.23 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.868 0.366 . . . . 21.149999999999999 110.887 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.497 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 74.2 Cg_endo -80.77 -172.92 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.427 2.085 . . . . 21.149999999999999 112.234 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.456 ' O ' ' HD2' ' A' ' 129' ' ' PRO . 52.9 tptt -52.26 -43.11 89.96 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 113.03 0.752 . . . . 21.879999999999999 113.03 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.4 ' HA ' ' HD2' ' A' ' 130' ' ' LYS . 35.9 Cg_exo -60.4 -14.7 31.43 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.29 1.993 . . . . 20.190000000000001 114.386 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.588 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . 16.3 tp10 -78.6 -55.68 1.01 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.234 0.457 . . . . 20.48 112.234 -175.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 128' ' ' GLU . 19.1 Cg_endo -94.81 87.0 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.412 2.074 . . . . 21.170000000000002 111.778 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 127' ' ' PRO . 28.2 mtpp -117.52 83.09 16.42 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.376 -0.374 . . . . 23.18 111.511 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 129' ' ' PRO . 8.5 Cg_endo -90.77 11.75 2.55 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.973 2.449 . . . . 20.780000000000001 112.144 176.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.2 t 51.72 33.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 112.921 -1.945 . . . . 19.75 110.207 -173.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.8 t 65.5 158.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 114.255 -1.339 . . . . 21.050000000000001 110.835 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 78.02 -77.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.335 0.654 . . . . 21.300000000000001 111.743 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -161.59 144.45 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.087 0.47 . . . . 20.739999999999998 111.141 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -129.67 -48.05 1.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.774 -0.824 . . . . 17.969999999999999 108.774 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.573 ' CB ' ' HG2' ' A' ' 194' ' ' LYS . . . -91.78 5.32 50.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.917 -0.583 . . . . 17.350000000000001 110.74 173.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 70.48 160.05 0.16 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.136 -0.938 . . . . 19.100000000000001 111.976 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' A' ' 140' ' ' THR . 2.8 Cg_exo -78.39 92.6 1.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.963 2.442 . . . . 19.350000000000001 111.727 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.64 ' N ' ' HB1' ' A' ' 192' ' ' ALA . 36.2 m 84.11 140.55 0.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.627 -0.715 . . . . 17.75 111.049 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 117.08 -67.83 0.31 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.621 -0.991 . . . . 17.960000000000001 110.621 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -99.75 54.13 0.93 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.798 0.809 . . . . 19.420000000000002 109.262 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.538 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -87.27 163.01 17.1 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.61 -1.177 . . . . 14.65 110.939 -175.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.73 ' CB ' HD21 ' A' ' 197' ' ' LEU . 3.6 m-85 -146.79 160.66 41.99 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.333 0.396 . . . . 14.81 111.783 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.695 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.5 t -151.12 165.58 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 108.811 -0.811 . . . . 10.48 108.811 173.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 47.7 t -106.57 113.6 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.379 0.536 . . . . 10.1 111.524 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.478 ' OE1' ' HD2' ' A' ' 185' ' ' ARG . 48.5 tt0 -89.86 109.09 20.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.815 0.302 . . . . 12.0 111.815 -175.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -86.8 -36.04 18.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.29 0.566 . . . . 11.880000000000001 110.059 -177.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.59 170.18 26.29 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.603 -0.808 . . . . 11.35 112.456 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.67 107.59 0.39 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.468 -0.568 . . . . 13.470000000000001 109.468 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.89 43.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.392 0.615 . . . . 13.52 110.614 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 30.7 mtmm -97.82 8.24 45.04 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.951 -1.022 . . . . 17.600000000000001 109.94 -176.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.507 ' HA ' ' OE1' ' A' ' 180' ' ' GLN . 18.0 m120 -106.85 106.17 16.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.022 -0.99 . . . . 16.140000000000001 109.692 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.44 -26.17 68.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.067 -0.515 . . . . 14.039999999999999 111.067 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.61 -38.82 78.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.64 0.733 . . . . 16.57 109.969 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 160' ' ' ILE . 65.6 mttm -86.16 -17.92 33.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.783 -1.099 . . . . 16.399999999999999 110.305 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.447 HG11 HG21 ' A' ' 184' ' ' THR . 71.8 t -68.49 -44.14 83.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.063 -0.717 . . . . 12.67 109.063 170.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -63.1 -29.07 70.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.894 -1.048 . . . . 15.32 111.98 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.414 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.0 pt-20 -78.4 -48.48 15.4 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.641 -0.424 . . . . 15.970000000000001 110.866 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 156' ' ' LYS . 24.8 mt -60.17 -46.87 94.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.545 0.688 . . . . 12.6 109.713 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.477 HG13 ' CB ' ' A' ' 165' ' ' ARG . 43.4 t -63.85 -33.72 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.729 -1.123 . . . . 12.539999999999999 110.349 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.69 -34.6 82.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.209 -0.519 . . . . 14.800000000000001 112.616 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.1 mptp? -70.45 -52.23 23.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.4 . . . . 16.050000000000001 110.662 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.586 HD13 ' CG2' ' A' ' 188' ' ' VAL . 2.8 mt -87.87 -58.31 2.62 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.518 0.933 . . . . 12.99 113.518 -172.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.477 ' CB ' HG13 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -62.73 -37.04 85.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.394 0.616 . . . . 15.06 109.411 -176.227 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.08 -25.68 74.11 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.111 -0.95 . . . . 16.600000000000001 112.197 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.7 -2.98 58.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.948 0.404 . . . . 16.140000000000001 110.599 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.46 25.49 33.01 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.836 -0.697 . . . . 15.119999999999999 113.104 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -89.61 153.18 20.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.02 0.41 . . . . 15.49 110.462 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.52 100.48 1.42 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.198 0.523 . . . . 13.869999999999999 109.833 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.37 140.65 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.124 -0.944 . . . . 10.82 109.828 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.499 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.83 176.69 8.59 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.575 0.702 . . . . 11.130000000000001 110.935 172.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 20.3 p -122.47 -174.35 2.89 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.656 -1.156 . . . . 11.52 111.034 -171.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 67.4 m -51.83 142.29 25.26 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-O 121.218 0.533 . . . . 12.75 110.818 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 82.8 Cg_exo -49.22 -38.2 41.0 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 124.008 3.139 . . . . 14.640000000000001 115.179 -168.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 t -87.91 -65.68 0.99 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.813 -0.755 . . . . 16.68 112.261 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 70.7 m -170.17 128.5 0.81 Allowed Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 122.368 0.267 . . . . 16.039999999999999 110.94 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.531 ' HB3' HG21 ' A' ' 184' ' ' THR . 72.9 Cg_exo -60.02 121.88 10.52 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 121.848 1.699 . . . . 14.220000000000001 111.342 163.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.7 p -155.77 159.92 2.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.809 0.338 . . . . 16.129999999999999 110.538 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' A' ' 153' ' ' ASN . 9.2 mm100 -68.85 120.99 15.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.052 -0.522 . . . . 16.699999999999999 111.489 177.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.23 -26.22 17.58 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.805 -0.634 . . . . 16.98 112.798 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 13.6 mptt -103.07 154.65 19.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.977 -0.379 . . . . 18.73 109.977 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.7 tp -73.9 109.28 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.897 0.856 . . . . 14.82 110.836 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.531 HG21 ' HB3' ' A' ' 178' ' ' PRO . 29.2 m -101.91 107.06 18.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.605 0.717 . . . . 12.779999999999999 110.072 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.478 ' HD2' ' OE1' ' A' ' 147' ' ' GLN . 47.5 mtm180 -87.76 141.06 28.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.993 -1.003 . . . . 13.98 110.254 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.538 ' O ' HD22 ' A' ' 148' ' ' LEU . 4.4 mm -108.74 118.35 56.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.781 -0.822 . . . . 10.56 108.781 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.8 mp -128.9 130.85 47.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.487 0.661 . . . . 10.1 111.141 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 148' ' ' LEU . 43.9 t -107.24 136.52 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.102 -0.953 . . . . 9.7400000000000002 111.079 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 83.37 46.3 6.17 Favored Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 114.751 -1.113 . . . . 9.7599999999999998 113.432 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.695 ' HA ' HG22 ' A' ' 145' ' ' VAL . 10.9 Cg_endo -60.91 124.38 14.82 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 CA-C-N 119.674 1.737 . . . . 11.15 110.599 175.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -149.89 151.32 33.25 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.21 -0.663 . . . . 12.77 109.21 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.64 ' HB1' ' N ' ' A' ' 140' ' ' THR . . . -84.8 -11.91 54.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.367 -0.833 . . . . 14.6 111.581 -174.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.7 m -120.84 113.25 19.88 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.089 0.471 . . . . 14.300000000000001 110.954 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.657 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 20.8 ptmt -61.33 -36.29 79.75 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.504 -0.771 . . . . 15.970000000000001 111.305 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.35 -43.0 99.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.256 -0.429 . . . . 15.6 111.589 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -70.4 -39.01 74.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 14.220000000000001 110.531 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.73 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -84.37 -16.82 41.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.534 -0.757 . . . . 11.949999999999999 110.906 -176.028 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 0.8 OUTLIER -60.43 -34.96 74.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.661 0.743 . . . . 14.699999999999999 110.387 173.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.59 -12.87 81.12 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.712 -1.131 . . . . 13.09 110.494 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 69.7 m -82.2 -12.67 57.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.795 -0.702 . . . . 12.109999999999999 111.637 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 11.0 mt -69.44 -36.94 77.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.071 0.462 . . . . 12.720000000000001 109.934 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.09 -27.31 70.29 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.676 -0.773 . . . . 14.66 111.188 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.585 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 49.6 mt-10 -82.81 -27.32 30.99 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 110.142 -0.318 . . . . 13.890000000000001 110.142 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.76 -48.32 81.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.459 . . . . 12.550000000000001 111.621 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -56.76 -22.15 33.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.079 -0.51 . . . . 15.83 110.973 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -89.44 -45.52 9.38 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.816 -0.629 . . . . 16.969999999999999 110.162 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 96.3 mt -65.3 -52.39 54.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.975 -0.557 . . . . 13.890000000000001 111.694 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.501 ' HB3' HD21 ' A' ' 164' ' ' LEU . 70.1 p -100.05 -44.76 5.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.282 0.563 . . . . 13.539999999999999 110.558 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.47 7.84 69.65 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.264 -0.88 . . . . 14.67 111.095 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.13 155.32 17.52 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.466 -0.568 . . . . 13.039999999999999 109.466 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 26.3 t -89.03 108.0 19.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.497 -0.319 . . . . 14.84 110.438 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -129.2 158.04 21.9 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.508 -0.853 . . . . 12.220000000000001 113.316 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.96 145.12 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.187 0.518 . . . . 13.74 109.997 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.88 110.18 5.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.47 -0.786 . . . . 12.890000000000001 110.227 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 93.4 mmm -117.88 141.23 48.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.848 -0.615 . . . . 13.800000000000001 110.569 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -66.9 152.73 52.76 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.777 -0.725 . . . . 13.359999999999999 112.158 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.68 ' HB2' HG23 ' A' ' 145' ' ' VAL . 10.9 t80 -129.43 131.51 46.77 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 122.781 0.432 . . . . 14.24 109.954 -172.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.3 t -143.55 93.19 6.37 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-O 121.535 0.683 . . . . 16.510000000000002 109.51 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.33 140.35 19.39 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.603 2.202 . . . . 17.420000000000002 112.855 -177.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 21.1 m120 . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.502 -0.772 . . . . 19.190000000000001 109.58 176.917 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.942 0.401 . . . . 18.390000000000001 110.968 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.29 134.46 1.83 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.111 -0.566 . . . . 17.77 111.756 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.03 9.29 17.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.927 0.363 . . . . 17.690000000000001 111.582 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -77.42 -31.19 53.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.029 0.442 . . . . 19.93 110.451 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -118.6 -176.31 3.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.047 -0.524 . . . . 17.43 110.061 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -111.69 -103.16 0.4 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.087 -0.338 . . . . 19.359999999999999 110.087 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 58.64 -87.49 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.246 0.618 . . . . 18.960000000000001 112.056 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -129.56 13.55 5.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.874 0.368 . . . . 18.239999999999998 111.122 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.9 54.68 0.93 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.387 . . . . 16.780000000000001 111.527 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -177.72 119.62 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.585 -0.734 . . . . 18.420000000000002 110.005 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 49' ' ' ASP . 40.5 p90 -58.38 134.67 56.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 17.920000000000002 110.921 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.69 -178.35 6.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.162 -0.472 . . . . 19.550000000000001 111.184 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.45 68.61 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.32 -0.252 . . . . 20.309999999999999 110.32 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.457 HG23 ' HD2' ' A' ' 45' ' ' PRO . 44.8 mm 61.49 73.59 0.57 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.904 -0.589 . . . . 19.920000000000002 110.956 177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.86 56.89 6.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.399 2.066 . . . . 21.640000000000001 111.668 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mp 62.42 33.64 16.09 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.336 -0.847 . . . . 22.670000000000002 111.362 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 89.2 t -80.69 -59.75 0.48 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.14 -0.482 . . . . 21.34 110.248 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.512 ' CD ' ' HB ' ' A' ' 44' ' ' VAL . 56.2 Cg_endo -74.15 179.43 5.79 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.818 1.679 . . . . 20.0 111.498 169.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -87.16 15.13 6.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.397 -0.365 . . . . 21.079999999999998 111.504 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.3 -169.18 1.36 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.538 -0.542 . . . . 18.800000000000001 109.538 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.35 -154.46 8.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.393 -0.908 . . . . 17.510000000000002 111.665 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . 7.9 t0 -102.11 93.02 5.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.029 -0.73 . . . . 16.949999999999999 109.029 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 61.19 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.874 0.734 . . . . 18.300000000000001 110.949 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -97.67 172.61 7.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.143 -0.48 . . . . 18.170000000000002 110.696 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 6.5 pt-20 -85.98 131.36 47.08 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.775 -0.648 . . . . 18.82 110.527 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 25.1 Cg_endo -60.96 162.26 19.65 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.843 3.028 . . . . 19.870000000000001 113.884 -173.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -74.65 38.39 0.12 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.407 -0.815 . . . . 21.100000000000001 112.314 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 65.9 mtt -90.32 -41.3 11.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.888 0.375 . . . . 22.300000000000001 110.094 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.584 ' H ' ' CD ' ' A' ' 57' ' ' PRO . 25.5 mmt -132.65 -48.71 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.614 -0.721 . . . . 23.850000000000001 111.534 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.584 ' CD ' ' H ' ' A' ' 56' ' ' MET . 53.8 Cg_exo -54.19 132.46 50.51 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 122.593 2.196 . . . . 20.670000000000002 113.557 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -168.92 -50.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.962 -1.017 . . . . 20.489999999999998 110.356 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 64.45 -82.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.424 -0.807 . . . . 21.469999999999999 111.765 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.6 p -134.06 51.88 2.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.315 -0.402 . . . . 22.600000000000001 110.13 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 64.8 26.22 12.96 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.705 -0.68 . . . . 21.93 110.647 -175.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.92 74.12 2.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 19.73 110.157 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.0 mt -78.45 116.52 59.94 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.515 -0.766 . . . . 19.579999999999998 110.579 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -86.25 -9.19 7.29 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.891 2.394 . . . . 18.5 113.189 -176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 p -79.04 63.43 3.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.189 0.519 . . . . 17.609999999999999 111.895 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 16.9 mm-40 -84.31 114.81 57.06 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.985 -0.552 . . . . 18.760000000000002 109.558 175.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.63 -52.82 8.01 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.615 2.876 . . . . 17.280000000000001 114.378 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.41 149.41 80.53 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.155 1.237 . . . . 17.77 112.238 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 28' ' ' ASP . 32.8 mt-10 75.81 168.03 0.27 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.993 0.808 . . . . 18.699999999999999 111.538 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.34 -78.22 0.28 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.931 -0.652 . . . . 17.719999999999999 112.29 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -149.44 40.44 0.85 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.273 0.559 . . . . 18.0 110.197 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -134.0 56.02 1.87 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.9 -0.591 . . . . 17.960000000000001 110.619 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -111.77 -35.61 5.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.762 -0.654 . . . . 19.850000000000001 110.828 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -88.63 61.56 6.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.981 -0.554 . . . . 19.670000000000002 109.974 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -92.57 138.4 20.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.863 -0.608 . . . . 17.739999999999998 110.933 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -89.46 59.4 4.77 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.294 -0.632 . . . . 19.949999999999999 109.294 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.52 80.53 4.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.489 -0.778 . . . . 18.390000000000001 110.529 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -153.81 81.43 0.18 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.627 -0.715 . . . . 17.66 111.849 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.49 -35.55 68.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.693 -0.484 . . . . 17.68 109.693 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 49.74 53.62 12.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.333 0.587 . . . . 17.800000000000001 110.243 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -142.39 -73.24 0.31 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.337 -0.847 . . . . 17.350000000000001 110.65 -175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 45.3 63.88 8.58 Favored Pre-proline 0 N--CA 1.465 0.288 0 O-C-N 123.639 0.587 . . . . 16.640000000000001 111.754 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -62.18 -50.26 5.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.543 2.162 . . . . 17.23 112.092 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.8 m 60.81 -90.21 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.83 0.706 . . . . 17.34 111.453 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.92 -14.07 14.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.668 0.271 . . . . 18.41 110.611 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.24 115.35 46.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 17.449999999999999 110.683 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.59 -9.62 15.96 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.501 2.134 . . . . 18.890000000000001 111.705 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 71.16 -62.53 0.45 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.382 -0.826 . . . . 17.809999999999999 111.055 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.6 m -77.91 104.33 8.41 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.824 -0.435 . . . . 18.629999999999999 109.824 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.5 mm -75.44 -31.29 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.209 0.528 . . . . 19.100000000000001 111.385 -174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.88 27.66 14.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.224 -0.898 . . . . 19.25 112.546 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.9 73.83 0.46 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.903 -0.59 . . . . 18.789999999999999 111.604 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -79.13 -7.66 58.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.123 -0.489 . . . . 18.949999999999999 111.078 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 17.4 m120 -89.76 19.1 4.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 20.309999999999999 111.129 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.5 p -68.13 -48.04 66.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.389 0.614 . . . . 21.399999999999999 109.94 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -105.7 5.81 31.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.557 -0.747 . . . . 21.16 109.238 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 94' ' ' ASN . 91.6 m-85 61.27 64.57 1.07 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.753 -1.112 . . . . 22.18 110.229 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 64.24 89.66 0.1 Allowed Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 115.344 -0.844 . . . . 19.449999999999999 110.649 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.93 105.6 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.082 2.521 . . . . 18.530000000000001 111.999 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.45 136.47 19.18 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.013 0.435 . . . . 17.449999999999999 111.055 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.9 160.14 19.13 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.947 2.431 . . . . 17.420000000000002 111.762 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.69 112.49 24.85 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.344 -0.389 . . . . 17.68 110.725 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -79.58 132.15 9.78 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.454 2.103 . . . . 16.289999999999999 112.42 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.89 73.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 122.251 1.024 . . . . 17.260000000000002 110.132 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.471 ' HB3' ' HD3' ' A' ' 106' ' ' PRO . . . -89.19 -48.52 0.41 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.199 -0.909 . . . . 15.800000000000001 112.386 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 105' ' ' ALA . 27.3 Cg_exo -63.12 118.12 5.03 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.851 1.701 . . . . 15.92 112.145 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.91 121.81 9.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.026 2.484 . . . . 16.149999999999999 112.166 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -69.23 -50.02 21.9 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.947 -0.569 . . . . 17.629999999999999 111.78 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.16 48.84 2.64 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.025 1.816 . . . . 15.039999999999999 112.713 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -95.21 116.2 66.12 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.96 -0.564 . . . . 15.199999999999999 110.743 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.95 107.86 2.31 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.285 1.99 . . . . 14.08 111.426 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.7 m -94.31 45.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.755 0.788 . . . . 15.279999999999999 110.873 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -131.97 108.6 14.02 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.887 -1.051 . . . . 16.84 110.793 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.34 125.42 9.08 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.754 2.303 . . . . 15.51 111.456 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.63 147.34 76.01 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.262 1.974 . . . . 16.039999999999999 111.647 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 63.86 85.43 0.16 Allowed Pre-proline 0 N--CA 1.466 0.333 0 O-C-N 123.613 0.571 . . . . 18.91 110.889 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.47 118.78 5.76 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.701 2.267 . . . . 17.039999999999999 111.467 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 64.22 -93.82 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.494 0.664 . . . . 17.52 109.939 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.2 t -133.4 -57.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 114.957 -1.019 . . . . 18.699999999999999 109.002 172.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.77 99.35 2.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.002 -0.999 . . . . 20.879999999999999 109.024 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.7 111.99 30.65 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.24 -0.436 . . . . 18.890000000000001 110.674 -176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.91 160.02 43.96 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.571 2.181 . . . . 20.43 111.511 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.8 -17.02 58.22 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.932 2.421 . . . . 21.100000000000001 112.115 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.39 118.03 14.7 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.616 -0.72 . . . . 21.149999999999999 109.569 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.454 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 32.4 Cg_exo -58.32 139.27 89.92 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.601 2.201 . . . . 21.149999999999999 111.969 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -89.68 110.95 43.09 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.355 -0.384 . . . . 21.879999999999999 110.932 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 125' ' ' PRO . 7.8 Cg_exo -72.71 109.19 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.695 2.263 . . . . 20.190000000000001 111.336 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -98.22 112.31 61.76 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.906 -0.588 . . . . 20.48 110.327 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.6 -37.52 96.7 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.772 2.315 . . . . 21.170000000000002 111.195 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.43 ' NZ ' ' HB3' ' A' ' 130' ' ' LYS . 6.9 ttpm? -123.71 87.49 52.5 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.229 -0.896 . . . . 23.18 108.806 173.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.4 104.66 1.46 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.82 2.346 . . . . 20.780000000000001 112.544 -175.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.4 t -81.74 56.19 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.154 0.978 . . . . 19.75 109.025 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.403 HG22 ' HE2' ' A' ' 136' ' ' LYS . 11.8 p -133.31 15.24 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.693 -1.14 . . . . 21.050000000000001 108.921 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -90.24 -33.71 16.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.759 -1.11 . . . . 21.300000000000001 111.088 -175.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.14 81.9 2.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.64 0.734 . . . . 20.739999999999998 110.955 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 66.7 mttm -125.59 83.12 2.13 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.096 -1.076 . . . . 17.969999999999999 108.096 173.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . 72.35 36.35 1.06 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.532 -0.914 . . . . 17.350000000000001 108.532 -165.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . . . 72.76 143.08 0.09 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 113.971 -1.468 . . . . 19.100000000000001 110.759 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 138' ' ' ALA . 48.4 Cg_exo -57.77 95.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.156 2.571 . . . . 19.350000000000001 112.536 -176.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.446 ' HA ' ' HB1' ' A' ' 192' ' ' ALA . 3.9 m 57.67 33.68 23.54 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.701 0.762 . . . . 17.75 110.124 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -93.46 -70.84 1.14 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.525 -0.761 . . . . 17.960000000000001 111.246 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 13.1 mptt -98.4 60.99 1.39 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.523 -0.547 . . . . 19.420000000000002 109.523 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.513 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . -72.46 162.47 29.43 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.378 -0.828 . . . . 14.65 109.635 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.553 ' HA ' ' H ' ' A' ' 217' ' ' TYR . 3.3 m-85 -135.79 152.76 51.42 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.109 0.48 . . . . 14.81 111.863 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' A' ' 187' ' ' LEU . 0.9 OUTLIER -152.91 145.69 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.166 -0.925 . . . . 10.48 109.922 -174.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 44.4 t -112.26 108.13 24.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-N 118.424 0.556 . . . . 10.1 111.035 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -88.11 111.08 21.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.491 -0.322 . . . . 12.0 111.334 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 1.002 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -86.42 -38.87 16.92 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.225 0.536 . . . . 11.880000000000001 109.721 -178.232 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.45 167.51 26.99 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.488 -0.863 . . . . 11.35 112.523 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -168.89 101.68 0.39 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.037 -0.727 . . . . 13.470000000000001 109.037 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.16 163.98 37.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.905 -0.589 . . . . 13.52 110.571 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 90.8 mttt -99.22 2.45 45.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.041 -0.981 . . . . 17.600000000000001 110.221 -173.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -93.37 98.64 11.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.78 -1.1 . . . . 16.140000000000001 108.68 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.85 -20.65 63.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.059 0.457 . . . . 14.039999999999999 111.193 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.14 -28.94 64.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.732 0.777 . . . . 16.57 109.183 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.403 ' O ' HG13 ' A' ' 160' ' ' ILE . 3.1 tppp? -80.49 -34.06 36.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.515 -1.22 . . . . 16.399999999999999 108.768 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 184' ' ' THR . 75.3 t -58.46 -36.61 59.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.085 -0.961 . . . . 12.67 109.806 172.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -62.02 -33.19 73.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.273 -0.876 . . . . 15.32 112.202 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.01 -35.86 28.42 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.051 -0.66 . . . . 15.970000000000001 110.996 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.738 HD12 HD12 ' A' ' 186' ' ' ILE . 14.0 mt -66.22 -47.45 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 12.6 109.437 176.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.59 -38.41 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.868 -1.06 . . . . 12.539999999999999 110.838 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -57.75 -30.23 62.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.016 -0.611 . . . . 14.800000000000001 112.4 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -70.61 -59.03 3.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.231 0.539 . . . . 16.050000000000001 111.081 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.427 HD11 ' HA ' ' A' ' 208' ' ' SER . 4.1 mm? -81.31 -59.79 2.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.709 -0.678 . . . . 12.99 112.101 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.428 ' HD3' ' C ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -64.05 -37.03 85.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.352 0.596 . . . . 15.06 109.632 -177.056 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.27 -19.48 77.48 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.043 -0.981 . . . . 16.600000000000001 112.691 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -97.42 -13.76 21.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.792 0.329 . . . . 16.140000000000001 110.758 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.5 24.92 9.68 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.703 -0.761 . . . . 15.119999999999999 113.177 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 207' ' ' LEU . 34.1 m-85 -88.26 158.38 18.49 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.793 -0.239 . . . . 15.49 110.536 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -67.39 97.68 0.58 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.374 0.607 . . . . 13.869999999999999 110.08 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.6 p -144.96 137.81 21.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.146 -0.934 . . . . 10.82 110.168 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.578 ' CE2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -142.12 176.72 8.74 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.454 0.645 . . . . 11.130000000000001 110.706 171.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.1 p -118.63 -177.05 3.22 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.785 -1.098 . . . . 11.52 110.713 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.1 OUTLIER -53.4 140.53 45.39 Favored Pre-proline 0 C--N 1.327 -0.405 0 O-C-N 123.256 0.347 . . . . 12.75 111.117 179.313 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -20.17 -67.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 1 C-N-CA 126.361 4.707 . . . . 14.640000000000001 116.048 -172.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.8 m -86.31 -61.66 1.69 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.981 0.734 . . . . 16.68 112.981 -170.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -166.69 133.8 2.02 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 122.021 -0.425 . . . . 16.039999999999999 111.795 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.487 ' HB3' HG21 ' A' ' 184' ' ' THR . 54.4 Cg_exo -60.97 125.02 16.1 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.716 2.277 . . . . 14.220000000000001 111.46 163.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 6.0 p -146.41 159.56 10.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.148 -0.686 . . . . 16.129999999999999 109.148 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -81.18 122.22 27.11 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.855 0.36 . . . . 16.699999999999999 110.862 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.13 -23.98 22.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 16.98 112.614 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.455 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 11.3 mptt -111.5 161.35 16.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.944 0.402 . . . . 18.73 110.327 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.6 tp -71.05 110.42 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.868 0.842 . . . . 14.82 112.114 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.487 HG21 ' HB3' ' A' ' 178' ' ' PRO . 62.1 m -99.34 106.46 18.56 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.583 -0.735 . . . . 12.779999999999999 109.715 172.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 89.8 mtt180 -89.22 136.76 32.84 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.452 -0.794 . . . . 13.98 109.159 176.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.738 HD12 HD12 ' A' ' 160' ' ' ILE . 2.8 mt -117.2 116.21 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 121.172 0.51 . . . . 10.56 109.696 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.578 HD12 ' CE2' ' A' ' 172' ' ' TYR . 0.1 OUTLIER -128.9 128.07 43.06 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.153 -0.931 . . . . 10.1 111.278 -172.229 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.002 HG23 HD21 ' A' ' 148' ' ' LEU . 43.1 t -99.91 149.17 5.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.287 -1.324 . . . . 9.7400000000000002 110.403 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 71.07 46.67 42.28 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 115.277 -0.874 . . . . 9.7599999999999998 113.895 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.436 ' HA ' ' CG2' ' A' ' 145' ' ' VAL . 19.2 Cg_endo -67.49 124.73 12.39 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 CA-C-N 119.903 1.851 . . . . 11.15 110.401 172.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -160.37 150.09 17.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.888 -0.596 . . . . 12.77 109.963 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.513 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -91.13 -6.34 53.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.497 -0.774 . . . . 14.6 110.58 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.548 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 43.2 t -100.44 103.87 15.25 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.087 -0.506 . . . . 14.300000000000001 110.274 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 198' ' ' LYS . 32.0 ttpt -60.56 -43.26 97.47 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.451 -0.795 . . . . 15.970000000000001 109.642 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.62 -55.49 30.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.217 -0.901 . . . . 15.6 112.398 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -65.51 -41.31 93.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.962 0.41 . . . . 14.220000000000001 111.147 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.548 ' HB3' ' O ' ' A' ' 193' ' ' SER . 0.2 OUTLIER -81.22 -18.29 46.62 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.103 -0.499 . . . . 11.949999999999999 110.849 -176.059 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 20.8 tptm -56.52 -55.34 34.95 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.684 0.754 . . . . 14.699999999999999 110.885 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -71.48 -13.18 74.05 Favored Glycine 0 CA--C 1.504 -0.64 0 CA-C-N 114.589 -1.187 . . . . 13.09 110.64 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.606 ' O ' ' HB2' ' A' ' 204' ' ' LEU . 72.9 m -78.45 -12.87 60.03 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.657 -0.771 . . . . 12.109999999999999 111.517 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 23.1 mt -76.66 -40.18 49.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.848 0.356 . . . . 12.720000000000001 110.477 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.1 -36.45 88.57 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.857 -0.687 . . . . 14.66 111.528 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.529 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 15.4 pt-20 -86.25 -16.89 36.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.888 0.375 . . . . 13.890000000000001 110.481 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 200' ' ' SER . 15.4 tp -71.34 -33.18 69.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.644 0.259 . . . . 12.550000000000001 111.166 -173.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.601 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 19.1 pttp -62.96 -16.16 58.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.186 0.517 . . . . 15.83 110.344 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -90.11 -42.02 11.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.811 -0.631 . . . . 16.969999999999999 110.081 170.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.8 mt -68.87 -52.79 25.93 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.788 -0.642 . . . . 13.890000000000001 111.505 -175.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.427 ' HA ' HD11 ' A' ' 164' ' ' LEU . 16.7 t -92.49 -44.11 8.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.433 0.635 . . . . 13.539999999999999 109.56 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 71.31 -2.13 22.52 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 114.837 -1.074 . . . . 14.67 112.164 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 53.3 mt -92.62 150.31 20.79 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.538 -0.541 . . . . 13.039999999999999 109.538 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 19.5 m -85.68 111.84 20.47 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.093 0.473 . . . . 14.84 110.59 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -130.51 163.83 23.11 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.479 -0.867 . . . . 12.220000000000001 112.491 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.9 p -100.29 135.39 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.348 0.594 . . . . 13.74 110.472 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 45.9 t -79.71 104.94 8.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.87 -1.059 . . . . 12.890000000000001 109.492 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 97.0 mmm -117.24 146.7 43.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.665 -0.698 . . . . 13.800000000000001 110.457 -175.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.64 106.33 2.16 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.41 -0.9 . . . . 13.359999999999999 111.733 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.553 ' H ' ' HA ' ' A' ' 144' ' ' TYR . 9.3 t80 -64.59 124.29 21.47 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.446 0.699 . . . . 14.24 110.517 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 29.8 m -138.66 93.64 10.81 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 109.274 -0.639 . . . . 16.510000000000002 109.274 174.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.23 153.46 51.2 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.494 2.129 . . . . 17.420000000000002 112.29 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 44.3 t30 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.488 -0.768 . . . . 19.190000000000001 109.723 178.088 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.578 0.227 . . . . 18.390000000000001 110.465 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.44 -87.05 0.18 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.827 -0.702 . . . . 17.77 112.013 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 62.1 -163.56 0.26 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.031 0.532 . . . . 17.690000000000001 110.337 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -102.99 -58.69 1.83 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.841 -0.8 . . . . 19.93 108.841 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 166.04 25.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.49 -1.232 . . . . 17.43 107.718 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -81.6 83.44 7.04 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.509 0.671 . . . . 19.359999999999999 110.478 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -74.52 113.21 11.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.567 -0.742 . . . . 18.960000000000001 110.531 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -129.3 6.81 5.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.553 -0.748 . . . . 18.239999999999998 110.149 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -77.43 170.82 15.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.912 -0.585 . . . . 16.780000000000001 111.783 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' A' ' 62' ' ' ALA . 31.1 tt0 73.16 -52.35 0.71 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.127 -0.942 . . . . 18.420000000000002 110.416 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -106.94 31.55 5.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.024 0.44 . . . . 17.920000000000002 110.417 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.18 -40.56 71.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 19.550000000000001 111.164 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.18 -0.01 3.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.973 -0.558 . . . . 20.309999999999999 110.619 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.447 HG21 ' HB2' ' A' ' 49' ' ' ASP . 22.3 pt 33.93 64.45 1.57 Allowed Pre-proline 0 N--CA 1.476 0.854 0 O-C-N 124.192 0.932 . . . . 19.920000000000002 113.486 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 41' ' ' ILE . 2.8 Cg_endo -84.88 55.13 4.2 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.85 2.367 . . . . 21.640000000000001 111.269 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 mp 60.57 38.7 18.68 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.452 -0.795 . . . . 22.670000000000002 110.527 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.534 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 72.9 t -105.48 -66.22 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.779 -0.646 . . . . 21.34 110.458 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.534 ' CD ' ' HB ' ' A' ' 44' ' ' VAL . 92.3 Cg_endo -80.12 118.8 3.75 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.296 1.33 . . . . 20.0 111.505 170.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -69.88 103.3 2.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.363 -0.381 . . . . 21.079999999999998 110.247 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.26 39.38 25.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.666 -0.697 . . . . 18.800000000000001 110.764 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.15 -18.94 63.73 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.684 -0.689 . . . . 17.510000000000002 112.273 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.447 ' HB2' HG21 ' A' ' 41' ' ' ILE . 19.7 t70 -78.22 127.99 33.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.447 -0.205 . . . . 16.949999999999999 110.447 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 64.4 95.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.953 0.783 . . . . 18.300000000000001 111.244 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.32 128.63 38.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.059 -0.519 . . . . 18.170000000000002 109.972 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 33.0 tt0 -60.25 118.67 35.47 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 18.82 109.994 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 59.4 Cg_endo -71.8 -169.35 0.43 Allowed 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.14 2.56 . . . . 19.870000000000001 113.205 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 22.0 m-20 71.28 -174.26 0.17 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.281 -0.872 . . . . 21.100000000000001 110.949 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.33 40.58 0.72 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 22.300000000000001 111.494 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 25.7 ttt -166.62 78.93 1.06 Allowed Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.223 -0.658 . . . . 23.850000000000001 109.223 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 91.7 Cg_endo -78.02 155.91 30.13 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.935 2.423 . . . . 20.670000000000002 112.785 -174.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.76 136.08 57.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.611 -1.177 . . . . 20.489999999999998 111.171 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.81 17.43 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.206 -0.452 . . . . 21.469999999999999 111.22 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -66.62 130.73 44.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.677 -0.49 . . . . 22.600000000000001 109.677 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -73.94 -0.7 16.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 21.93 111.608 -175.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.525 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . . . -61.64 -41.93 98.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.256 -0.646 . . . . 19.73 109.256 171.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.508 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 92.3 mt 45.36 77.64 0.44 Allowed Pre-proline 0 N--CA 1.464 0.25 0 O-C-N 124.389 1.056 . . . . 19.579999999999998 111.967 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.17 -19.56 66.15 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.76 2.307 . . . . 18.5 112.261 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 m -80.71 58.61 3.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.727 0.775 . . . . 17.609999999999999 110.796 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.584 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 78.0 mt-30 -93.43 -50.64 0.27 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.726 -0.67 . . . . 18.760000000000002 111.014 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HD2' ' H ' ' A' ' 66' ' ' GLN . 50.5 Cg_endo -67.82 148.31 76.7 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.92 1.747 . . . . 17.280000000000001 112.037 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.83 -11.3 25.67 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.776 2.317 . . . . 17.77 112.395 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -108.73 114.79 28.88 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.632 -0.713 . . . . 18.699999999999999 109.667 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 158.79 33.15 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.387 -0.911 . . . . 17.719999999999999 113.4 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.78 -60.51 2.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.215 0.531 . . . . 18.0 110.027 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.1 7.85 13.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.829 -0.623 . . . . 17.960000000000001 110.142 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.68 115.39 15.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.643 -0.708 . . . . 19.850000000000001 110.759 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -112.84 24.48 12.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.185 0.517 . . . . 19.670000000000002 110.0 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 t -121.32 47.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 17.739999999999998 110.076 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -126.92 5.02 6.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.949 0.404 . . . . 19.949999999999999 110.537 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.34 89.08 2.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.884 0.373 . . . . 18.390000000000001 110.666 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -163.85 -147.62 5.14 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.442 -0.885 . . . . 17.66 112.445 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.74 -75.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.8 0.333 . . . . 17.68 110.723 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.19 -44.53 9.7 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.635 -0.506 . . . . 17.800000000000001 109.635 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 56.33 55.2 6.85 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.405 0.621 . . . . 17.350000000000001 111.104 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.04 85.65 3.88 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.122 -0.944 . . . . 16.640000000000001 109.709 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -46.79 -52.99 6.76 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.391 2.728 . . . . 17.23 112.132 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.4 p 39.92 -91.31 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.138 0.975 . . . . 17.34 113.292 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.9 tp 64.57 82.78 0.18 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.261 0.553 . . . . 18.41 110.379 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -77.48 115.98 54.02 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.712 -0.676 . . . . 17.449999999999999 110.488 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.1 -25.22 36.26 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.247 2.632 . . . . 18.890000000000001 112.553 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.75 81.15 1.99 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.949 -0.568 . . . . 17.809999999999999 109.84 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -76.5 101.39 5.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.006 -0.543 . . . . 18.629999999999999 110.38 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.7 pt -93.02 -16.69 7.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.23 -0.441 . . . . 19.100000000000001 111.083 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 68.65 -73.9 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.862 0.726 . . . . 19.25 111.563 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -151.15 177.88 9.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.465 -0.198 . . . . 18.789999999999999 110.465 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -134.23 129.6 35.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.561 -0.29 . . . . 18.949999999999999 110.967 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 97' ' ' PHE . 4.4 m-20 58.25 24.34 11.37 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.759 -0.655 . . . . 20.309999999999999 112.586 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.9 p -84.74 -43.88 13.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.466 0.651 . . . . 21.399999999999999 109.53 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -110.47 -17.81 13.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.359 -0.837 . . . . 21.16 109.991 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.421 ' HB3' ' HA ' ' A' ' 94' ' ' ASN . 77.0 t80 -80.24 -23.03 41.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.69 0.757 . . . . 22.18 110.791 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -137.86 84.17 22.29 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.084 -0.962 . . . . 19.449999999999999 110.805 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -89.41 -79.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.995 2.463 . . . . 18.530000000000001 111.252 172.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.636 ' H ' ' HD2' ' A' ' 101' ' ' PRO . 40.2 mt-10 -144.16 -54.88 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.72 -0.673 . . . . 17.449999999999999 110.503 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.636 ' HD2' ' H ' ' A' ' 100' ' ' GLU . 75.3 Cg_endo -76.88 157.92 34.84 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.661 1.574 . . . . 17.420000000000002 112.191 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.449 ' N ' ' HD3' ' A' ' 103' ' ' PRO . . . 51.22 64.17 8.49 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.578 -0.737 . . . . 17.68 112.155 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 102' ' ' ALA . 13.0 Cg_endo -92.79 121.03 0.46 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.914 2.409 . . . . 16.289999999999999 111.822 177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.6 m -87.17 29.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.214 0.531 . . . . 17.260000000000002 110.937 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.29 119.86 74.74 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.61 -0.723 . . . . 15.800000000000001 110.241 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.438 ' O ' ' HD2' ' A' ' 109' ' ' PRO . 56.8 Cg_endo -70.24 150.85 65.92 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.327 2.018 . . . . 15.92 111.835 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.87 47.81 1.55 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.008 2.472 . . . . 16.149999999999999 112.707 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.486 ' H ' ' HD2' ' A' ' 109' ' ' PRO . 68.0 mttm -96.23 -56.36 0.2 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.959 -0.564 . . . . 17.629999999999999 110.051 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 108' ' ' LYS . 73.5 Cg_endo -75.01 141.29 26.43 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.768 1.646 . . . . 15.039999999999999 111.02 171.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -76.0 -48.57 3.52 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.175 -0.466 . . . . 15.199999999999999 111.776 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.11 101.21 1.47 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.364 1.376 . . . . 14.08 112.392 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.9 t -89.68 59.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.352 -0.981 . . . . 15.279999999999999 108.352 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 68.99 86.3 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.086 -1.415 . . . . 16.84 109.736 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 32.4 Cg_exo -58.66 142.76 98.77 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.365 2.71 . . . . 15.51 112.456 -176.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 114' ' ' PRO . 31.5 Cg_exo -58.89 137.44 79.86 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.813 2.342 . . . . 16.039999999999999 111.768 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 5.0 tppp? -68.69 120.19 74.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.459 . . . . 18.91 110.255 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 116' ' ' LYS . 15.3 Cg_exo -69.36 70.5 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.925 2.416 . . . . 17.039999999999999 112.355 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.07 142.13 47.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.936 -0.574 . . . . 17.52 110.652 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.45 HG11 ' HG3' ' A' ' 142' ' ' LYS . 24.3 m -90.46 -22.98 6.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.262 -0.426 . . . . 18.699999999999999 111.566 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 119' ' ' VAL . 10.1 pt-20 -148.98 64.43 1.04 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.513 0.673 . . . . 20.879999999999999 110.167 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -61.17 142.78 93.08 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.126 -0.943 . . . . 18.890000000000001 110.934 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 12.8 Cg_exo -69.3 112.57 3.03 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.844 2.363 . . . . 20.43 111.883 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.34 52.17 4.21 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.808 2.339 . . . . 21.100000000000001 112.228 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.6 -51.98 1.78 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.856 -0.611 . . . . 21.149999999999999 111.208 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.47 98.31 0.84 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.481 1.454 . . . . 21.149999999999999 110.917 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? 65.86 101.45 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.961 -0.563 . . . . 21.879999999999999 109.819 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.426 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 24.4 Cg_exo -62.67 90.88 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.944 2.429 . . . . 20.190000000000001 113.498 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -113.39 75.35 2.35 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.73 -0.668 . . . . 20.48 109.768 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 96.2 Cg_endo -92.3 152.36 3.08 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.788 2.326 . . . . 21.170000000000002 113.523 -173.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.448 ' HD2' ' HD2' ' A' ' 131' ' ' PRO . 26.9 tptp -137.37 111.47 9.12 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.413 -0.812 . . . . 23.18 109.321 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.448 ' HD2' ' HD2' ' A' ' 130' ' ' LYS . 52.8 Cg_exo -55.57 119.58 6.8 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.449 2.099 . . . . 20.780000000000001 111.891 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 m -102.61 45.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.799 0.809 . . . . 19.75 110.053 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.24 154.84 3.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.63 -1.168 . . . . 21.050000000000001 108.626 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 66.79 26.35 9.45 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.223 0.535 . . . . 21.300000000000001 109.649 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -109.83 149.0 30.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.532 -0.758 . . . . 20.739999999999998 110.804 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.404 ' NZ ' ' HB2' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -92.69 -49.05 6.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.802 -0.814 . . . . 17.969999999999999 108.802 176.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . -151.82 16.28 0.67 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.081 -0.963 . . . . 17.350000000000001 109.472 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 75.75 146.11 0.11 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 114.361 -1.291 . . . . 19.100000000000001 111.406 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -47.31 -55.09 4.23 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.763 2.975 . . . . 19.350000000000001 114.416 -172.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.9 t -120.76 -16.43 8.2 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.956 -0.298 . . . . 17.75 111.272 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.95 -58.65 11.85 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.973 -0.632 . . . . 17.960000000000001 111.843 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.641 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 67.7 mttm -129.95 82.51 2.07 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.196 0.522 . . . . 19.420000000000002 110.069 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.845 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . -107.43 162.05 14.28 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.826 -0.624 . . . . 14.65 109.424 176.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.708 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 5.2 m-85 -143.7 141.94 30.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.261 0.224 . . . . 14.81 111.086 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.797 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.4 t -150.98 162.02 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 109.625 -0.509 . . . . 10.48 109.625 171.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 27.7 t -104.01 117.57 49.75 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 O-C-N 122.21 -0.306 . . . . 10.1 111.129 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.515 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 6.1 tt0 -91.02 111.4 22.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.649 0.24 . . . . 12.0 111.649 -176.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 1.018 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -94.47 -34.55 12.67 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.215 0.531 . . . . 11.880000000000001 110.313 -177.579 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.51 162.07 27.97 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.671 -0.776 . . . . 11.35 111.923 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -165.38 101.76 0.72 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.758 -0.46 . . . . 13.470000000000001 109.758 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.54 163.14 33.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.544 0.687 . . . . 13.52 111.127 -173.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 43.2 mttm -98.47 13.47 31.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.641 -1.163 . . . . 17.600000000000001 109.722 -177.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -117.64 104.01 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.31 -0.859 . . . . 16.140000000000001 110.277 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -22.71 67.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.204 0.526 . . . . 14.039999999999999 110.802 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.02 -37.94 55.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.063 -0.972 . . . . 16.57 111.002 175.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -89.64 -31.89 17.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.929 -1.032 . . . . 16.399999999999999 110.351 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 184' ' ' THR . 82.8 t -55.1 -44.31 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.831 -0.622 . . . . 12.67 110.783 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -58.6 -30.4 67.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.575 -0.739 . . . . 15.32 111.468 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.47 -56.43 4.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.829 -0.434 . . . . 15.970000000000001 109.829 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.413 HD12 HG13 ' A' ' 186' ' ' ILE . 19.4 mt -54.76 -40.71 53.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.295 -0.866 . . . . 12.6 110.601 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.6 t -73.83 -44.0 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.852 -0.613 . . . . 12.539999999999999 110.737 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.69 -32.4 73.93 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.633 -0.794 . . . . 14.800000000000001 111.861 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -67.41 -59.92 3.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.645 0.26 . . . . 16.050000000000001 111.214 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.551 ' HB3' HG21 ' A' ' 171' ' ' VAL . 2.1 mm? -85.98 -57.02 3.2 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.58 0.585 . . . . 12.99 112.58 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 165' ' ' ARG . 0.8 OUTLIER -64.45 -35.52 81.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.408 0.623 . . . . 15.06 109.549 -178.18 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.95 -15.22 76.18 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.349 -0.841 . . . . 16.600000000000001 112.313 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -96.17 7.25 46.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.295 0.569 . . . . 16.140000000000001 110.342 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.44 15.72 58.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.766 -0.652 . . . . 15.119999999999999 113.051 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 207' ' ' LEU . 53.1 m-85 -91.65 148.06 22.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 117.031 0.415 . . . . 15.49 110.574 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.427 ' HB3' ' HD2' ' A' ' 190' ' ' PRO . 22.9 mmm180 -62.56 98.98 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 13.869999999999999 110.512 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.669 HG22 HG22 ' A' ' 188' ' ' VAL . 10.2 t -133.83 133.46 56.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.038 0.447 . . . . 10.82 110.969 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -138.36 175.21 9.77 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.447 -0.797 . . . . 11.130000000000001 110.375 170.465 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 22.7 p -115.22 -176.11 2.84 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.878 -1.055 . . . . 11.52 111.173 -172.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.56 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.1 OUTLIER -53.51 143.51 36.75 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 123.16 0.288 . . . . 12.75 111.411 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -25.47 -57.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 1 C-N-CA 126.009 4.473 . . . . 14.640000000000001 116.239 -174.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.3 m -87.19 -64.34 1.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.682 -0.807 . . . . 16.68 113.0 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.5 m -170.38 135.57 1.16 Allowed Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 117.857 0.299 . . . . 16.039999999999999 111.68 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.462 ' HB3' HG21 ' A' ' 184' ' ' THR . 76.0 Cg_exo -60.13 124.76 15.91 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.139 2.559 . . . . 14.220000000000001 112.507 166.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.1 p -153.51 158.48 3.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.911 -0.586 . . . . 16.129999999999999 109.609 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.22 134.67 36.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.392 -0.367 . . . . 16.699999999999999 110.347 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 95.27 -25.9 22.03 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.85 -0.691 . . . . 16.98 112.422 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 9.8 mptt -106.95 168.94 8.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.18 -0.674 . . . . 18.73 109.18 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.439 HD11 ' HB1' ' A' ' 150' ' ' ALA . 10.3 tp -77.53 111.29 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.871 0.843 . . . . 14.82 111.84 -173.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.56 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 37.4 m -105.31 109.93 22.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.463 -0.79 . . . . 12.779999999999999 109.18 170.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 36.5 mtt180 -94.68 145.89 24.54 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.597 -0.729 . . . . 13.98 110.2 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.539 ' O ' HD22 ' A' ' 148' ' ' LEU . 3.0 mm -110.37 119.66 59.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.699 -0.852 . . . . 10.56 108.699 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.547 ' HB3' ' CG1' ' A' ' 145' ' ' VAL . 6.1 mp -128.79 131.37 47.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.376 0.608 . . . . 10.1 110.887 -175.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.018 HG23 HD21 ' A' ' 148' ' ' LEU . 39.8 t -104.01 133.74 47.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.995 -1.002 . . . . 9.7400000000000002 110.845 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.75 47.64 5.83 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 114.907 -1.042 . . . . 9.7599999999999998 113.731 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.797 ' HA ' HG22 ' A' ' 145' ' ' VAL . 10.9 Cg_endo -60.79 125.56 17.51 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 CA-C-N 119.629 1.715 . . . . 11.15 110.888 174.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -159.25 168.1 27.33 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.932 -0.576 . . . . 12.77 109.583 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . . . -106.9 13.69 27.43 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.296 0.569 . . . . 14.6 109.776 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 22.8 t -118.43 109.47 16.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.885 -0.598 . . . . 14.300000000000001 111.373 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.705 ' HB2' ' CZ ' ' A' ' 144' ' ' TYR . 38.3 ttpt -69.91 -42.35 73.45 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.67 -0.863 . . . . 15.970000000000001 108.67 171.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -56.6 -40.63 75.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 15.6 111.652 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -79.72 -48.25 13.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.374 -0.376 . . . . 14.220000000000001 111.196 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -79.66 -20.76 45.89 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.884 0.328 . . . . 11.949999999999999 111.884 -171.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.506 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 29.2 tptp -67.4 -44.6 78.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.236 0.541 . . . . 14.699999999999999 109.714 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.28 -13.62 76.84 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.678 -0.692 . . . . 13.09 111.547 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 73.9 m -75.32 -24.01 57.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.519 0.2 . . . . 12.109999999999999 111.367 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 15.8 mt -61.49 -31.14 71.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.349 . . . . 12.720000000000001 110.878 -175.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.48 -46.11 94.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.565 -0.826 . . . . 14.66 111.924 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 12.6 pt-20 -86.83 -19.64 28.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.429 . . . . 13.890000000000001 111.111 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.432 HD11 ' CG1' ' A' ' 188' ' ' VAL . 14.9 tp -68.63 -35.75 77.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.3 -0.409 . . . . 12.550000000000001 111.62 -172.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.44 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 6.3 ptpp? -64.37 -16.31 62.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.825 0.345 . . . . 15.83 110.765 174.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.42 -35.5 15.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.117 0.484 . . . . 16.969999999999999 110.04 172.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 82.5 mt -74.96 -53.18 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 13.890000000000001 111.36 -176.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.531 ' HA ' HD11 ' A' ' 164' ' ' LEU . 3.4 m -94.86 -43.68 8.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 13.539999999999999 110.592 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 71.35 1.02 40.92 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.318 -0.856 . . . . 14.67 112.383 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 59.5 mt -84.37 154.48 22.83 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.341 -0.615 . . . . 13.039999999999999 109.341 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 23.3 m -77.17 93.49 3.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.86 0.362 . . . . 14.84 110.104 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -111.13 136.54 13.67 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.641 -0.79 . . . . 12.220000000000001 113.348 -175.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.92 138.4 25.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.038 -0.727 . . . . 13.74 109.038 174.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 6.6 p -79.23 108.1 12.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.736 0.779 . . . . 12.890000000000001 109.378 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 67.2 mtt -122.42 152.52 40.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.369 -0.832 . . . . 13.800000000000001 110.13 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -75.26 143.61 30.89 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.004 -1.094 . . . . 13.359999999999999 111.616 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.845 ' CD2' ' HB1' ' A' ' 143' ' ' ALA . 4.3 t80 -110.21 133.89 52.78 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.217 -0.992 . . . . 14.24 109.617 -170.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.8 t -147.7 93.66 4.52 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-O 121.229 0.537 . . . . 16.510000000000002 110.802 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.429 ' HD3' ' CE1' ' A' ' 217' ' ' TYR . 58.4 Cg_endo -72.71 123.78 9.26 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.244 1.962 . . . . 17.420000000000002 111.201 174.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.8 p30 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.377 -0.82 . . . . 19.190000000000001 109.77 -179.284 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.883 0.373 . . . . 18.390000000000001 110.692 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -115.01 107.25 1.75 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.761 -0.733 . . . . 17.77 111.674 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -81.08 48.91 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.257 0.551 . . . . 17.690000000000001 112.022 -175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -85.94 -25.22 26.21 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.149 -0.686 . . . . 19.93 109.149 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -86.98 140.06 29.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.303 -0.862 . . . . 17.43 109.709 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -88.47 174.61 8.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.285 -0.416 . . . . 19.359999999999999 110.604 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -53.56 -64.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.621 . . . . 18.960000000000001 112.178 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -172.94 -64.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.062 0.458 . . . . 18.239999999999998 110.294 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -155.41 128.49 8.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.511 -0.768 . . . . 16.780000000000001 109.112 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.33 111.36 2.25 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.337 0.589 . . . . 18.420000000000002 111.059 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -58.23 118.78 5.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.219 -0.901 . . . . 17.920000000000002 111.466 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.79 71.95 3.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.719 -0.673 . . . . 19.550000000000001 110.398 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 71.05 -49.5 0.68 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.982 0.801 . . . . 20.309999999999999 111.791 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.8 pt 39.27 65.72 3.27 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.249 1.019 . . . . 19.920000000000002 112.53 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.14 76.49 4.45 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.137 2.558 . . . . 21.640000000000001 112.35 -176.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 62.72 48.86 4.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.427 -0.806 . . . . 22.670000000000002 111.519 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.553 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 88.9 t -122.44 -62.5 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.322 -0.399 . . . . 21.34 111.343 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 44' ' ' VAL . 59.3 Cg_endo -69.81 150.54 68.02 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.089 1.859 . . . . 20.0 112.816 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -79.49 -28.99 41.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.778 -0.646 . . . . 21.079999999999998 110.632 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.77 -168.5 2.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.068 -0.515 . . . . 18.800000000000001 110.533 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.77 175.54 19.06 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.991 -0.624 . . . . 17.510000000000002 111.669 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.49 95.03 1.02 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.369 0.604 . . . . 16.949999999999999 110.303 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -122.31 119.91 32.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.45 -0.796 . . . . 18.300000000000001 109.582 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -67.75 134.88 51.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.317 -0.623 . . . . 18.170000000000002 109.317 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 9.4 pt-20 -85.51 119.41 72.15 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 121.038 0.447 . . . . 18.82 112.149 -172.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.53 -23.51 4.91 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.329 2.019 . . . . 19.870000000000001 110.151 167.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 17.2 m-20 -142.17 157.73 44.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.088 -1.415 . . . . 21.100000000000001 107.925 176.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.2 ttt -72.06 80.56 0.94 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.332 0.586 . . . . 22.300000000000001 110.815 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.558 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 66.0 mtt -131.85 -49.84 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.616 -0.72 . . . . 23.850000000000001 111.214 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.558 ' HD3' ' HB2' ' A' ' 56' ' ' MET . 51.2 Cg_exo -58.9 136.54 74.22 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.862 1.708 . . . . 20.670000000000002 111.846 174.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 68.63 -64.97 0.29 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.918 0.761 . . . . 20.489999999999998 111.427 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.68 -82.52 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.674 0.79 . . . . 21.469999999999999 112.304 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 t -79.74 -16.52 55.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.068 0.461 . . . . 22.600000000000001 110.322 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -94.76 130.7 41.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.896 -0.593 . . . . 21.93 110.485 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.58 100.6 12.53 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.862 -0.422 . . . . 19.73 109.862 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.15 101.44 45.06 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.315 -0.402 . . . . 19.579999999999998 110.004 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.85 -69.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.631 2.221 . . . . 18.5 111.964 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.0 m -154.03 -63.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 17.609999999999999 111.007 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.441 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 25.5 tp60 -130.91 94.66 27.74 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.252 -0.431 . . . . 18.760000000000002 110.459 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -96.8 93.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.272 2.648 . . . . 17.280000000000001 112.224 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 66' ' ' GLN . 97.4 Cg_endo -76.11 -23.25 12.2 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.426 2.084 . . . . 17.77 111.924 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -138.91 177.04 8.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.956 -1.02 . . . . 18.699999999999999 109.194 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.87 -49.85 4.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.81 -0.709 . . . . 17.719999999999999 112.121 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -110.95 8.92 22.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.053 0.454 . . . . 18.0 110.254 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.63 74.53 8.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.903 -0.589 . . . . 17.960000000000001 110.811 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -78.43 0.71 24.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.887 -0.597 . . . . 19.850000000000001 111.289 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -112.77 91.04 3.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.255 -0.43 . . . . 19.670000000000002 109.985 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.5 m -80.97 53.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.469 0.652 . . . . 17.739999999999998 111.292 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -69.41 -38.7 78.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.548 -0.751 . . . . 19.949999999999999 110.204 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.3 56.1 3.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.616 . . . . 18.390000000000001 110.448 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.73 -90.43 0.96 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.845 -0.616 . . . . 17.66 112.212 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -132.12 -8.7 3.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.063 0.459 . . . . 17.68 110.544 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.9 18.77 11.39 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.337 -0.847 . . . . 17.800000000000001 110.943 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -155.8 143.99 19.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.715 -0.675 . . . . 17.350000000000001 109.649 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.411 ' N ' ' HD3' ' A' ' 83' ' ' PRO . . . 53.52 64.24 7.06 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 123.521 0.513 . . . . 16.640000000000001 111.117 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 82' ' ' ALA . 17.9 Cg_exo -66.93 96.42 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.631 2.221 . . . . 17.23 111.053 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -84.52 51.42 2.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.826 -0.624 . . . . 17.34 111.1 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.69 6.82 39.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.957 -0.565 . . . . 18.41 110.096 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.99 120.85 61.26 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.563 -0.744 . . . . 17.449999999999999 110.496 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.51 -31.34 94.15 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.137 2.558 . . . . 18.890000000000001 111.542 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.01 69.81 1.33 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.765 -0.652 . . . . 17.809999999999999 109.775 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 m -66.58 -46.56 75.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.037 -0.528 . . . . 18.629999999999999 109.871 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.4 tt -130.12 86.36 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 122.084 0.945 . . . . 19.100000000000001 110.16 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.66 156.42 33.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.359 -0.837 . . . . 19.25 110.077 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.87 -52.57 0.68 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.87 0.731 . . . . 18.789999999999999 111.576 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -91.11 99.83 12.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.522 0.201 . . . . 18.949999999999999 110.614 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.0 t30 68.33 171.56 0.28 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.914 -0.585 . . . . 20.309999999999999 110.681 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.2 m 74.68 -43.83 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.057 0.543 . . . . 21.399999999999999 110.878 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -131.07 21.06 4.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.012 -0.54 . . . . 21.16 110.881 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.517 ' CD2' ' HG2' ' A' ' 98' ' ' GLU . 13.9 t80 -130.15 -79.97 0.55 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.448 0.642 . . . . 22.18 110.759 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.517 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 7.7 pt-20 -154.22 142.52 14.29 Favored Pre-proline 0 C--N 1.305 -1.367 0 CA-C-N 114.798 -1.092 . . . . 19.449999999999999 109.889 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.76 135.39 59.69 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.643 2.229 . . . . 18.530000000000001 112.08 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -101.4 140.71 21.48 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.817 -0.629 . . . . 17.449999999999999 110.609 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.68 143.72 99.59 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.695 2.263 . . . . 17.420000000000002 111.474 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.09 90.99 30.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.728 0.299 . . . . 17.68 111.142 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.64 92.36 0.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.743 2.296 . . . . 16.289999999999999 111.458 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.0 m -84.66 16.16 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.661 0.743 . . . . 17.260000000000002 111.047 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.98 141.66 12.72 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 114.817 -1.083 . . . . 15.800000000000001 109.083 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.98 116.58 3.23 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.985 2.457 . . . . 15.92 112.881 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.01 -32.54 93.38 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.016 2.477 . . . . 16.149999999999999 111.977 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.78 82.67 54.79 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.18 -0.464 . . . . 17.629999999999999 110.08 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.05 49.57 2.84 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.919 2.413 . . . . 15.039999999999999 111.837 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -153.82 151.06 24.17 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.527 -0.761 . . . . 15.199999999999999 109.745 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.25 107.66 1.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.264 1.976 . . . . 14.08 111.139 173.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 m -83.24 50.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.372 0.606 . . . . 15.279999999999999 111.16 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 58.51 83.63 0.21 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 114.572 -1.194 . . . . 16.84 111.172 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.62 109.41 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.252 1.968 . . . . 15.51 111.636 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.54 52.89 4.43 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.92 2.413 . . . . 16.039999999999999 112.142 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -72.96 117.11 57.01 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.495 -0.775 . . . . 18.91 109.803 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.26 60.17 6.81 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.909 2.406 . . . . 17.039999999999999 112.133 -175.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.8 mttm 63.35 -132.17 0.43 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.493 -0.776 . . . . 17.52 110.724 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.3 t 70.27 -67.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 O-C-N 123.57 0.543 . . . . 18.699999999999999 111.299 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -105.11 30.59 5.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.864 0.364 . . . . 20.879999999999999 110.406 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.35 146.59 99.05 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.469 -0.332 . . . . 18.890000000000001 110.56 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.434 ' HB2' ' HD3' ' A' ' 123' ' ' PRO . 71.6 Cg_exo -46.13 -52.63 6.87 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.232 2.622 . . . . 20.43 115.174 -174.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 122' ' ' PRO . 67.9 Cg_endo -84.28 26.56 0.64 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.663 1.575 . . . . 21.100000000000001 113.903 -173.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.56 84.69 0.2 Allowed Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 123.074 0.549 . . . . 21.149999999999999 111.294 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.86 98.22 1.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.507 2.138 . . . . 21.149999999999999 112.754 -173.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 127' ' ' PRO . 87.3 tttt -70.95 -48.66 14.01 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.004 -0.544 . . . . 21.879999999999999 110.966 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 126' ' ' LYS . 39.7 Cg_endo -66.27 154.8 72.81 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.012 1.808 . . . . 20.190000000000001 112.499 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -97.02 164.27 18.23 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.602 -0.726 . . . . 20.48 110.272 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.49 76.75 0.52 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.979 2.453 . . . . 21.170000000000002 112.094 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -161.07 162.13 22.78 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.465 -0.789 . . . . 23.18 108.984 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.95 95.46 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.065 1.843 . . . . 20.780000000000001 111.169 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.58 59.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.926 0.869 . . . . 19.75 110.487 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.3 t 63.18 96.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 114.966 -1.015 . . . . 21.050000000000001 111.417 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -78.03 -17.08 57.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.764 -0.653 . . . . 21.300000000000001 110.419 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.23 171.3 5.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.854 -0.612 . . . . 20.739999999999998 109.518 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.489 ' NZ ' ' HB2' ' A' ' 136' ' ' LYS . 1.0 OUTLIER -164.52 21.66 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.794 0.806 . . . . 17.969999999999999 109.428 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 176.48 -78.72 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.11 -1.405 . . . . 17.350000000000001 108.043 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.638 ' HB3' ' H ' ' A' ' 142' ' ' LYS . . . 174.95 148.76 0.25 Allowed Pre-proline 0 C--N 1.327 -0.385 0 O-C-N 124.683 1.239 . . . . 19.100000000000001 109.927 168.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.8 -60.79 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.477 2.118 . . . . 19.350000000000001 113.486 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.402 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 12.5 p -111.63 -24.62 9.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.101 0.408 . . . . 17.75 112.101 -173.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.5 -74.67 0.75 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.691 -0.766 . . . . 17.960000000000001 112.104 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.638 ' H ' ' HB3' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -89.77 78.3 6.91 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.746 -0.464 . . . . 19.420000000000002 109.746 177.093 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.826 ' HB1' ' CD1' ' A' ' 217' ' ' TYR . . . -105.56 162.57 13.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.027 -0.533 . . . . 14.65 110.387 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.683 ' CE2' ' HE3' ' A' ' 194' ' ' LYS . 36.6 m-85 -142.28 142.9 32.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.549 0.34 . . . . 14.81 111.67 -172.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.925 HG22 ' HA ' ' A' ' 190' ' ' PRO . 3.4 t -148.74 164.4 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 109.371 -0.603 . . . . 10.48 109.371 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.461 HG21 HD13 ' A' ' 204' ' ' LEU . 40.1 t -101.17 107.84 22.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 122.055 -0.403 . . . . 10.1 111.373 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.549 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 40.2 tt0 -78.68 115.94 18.71 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 122.617 0.367 . . . . 12.0 111.129 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 1.029 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -93.74 -33.31 13.66 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.424 0.631 . . . . 11.880000000000001 109.778 177.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.68 168.51 27.39 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.402 -0.817 . . . . 11.35 112.423 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -168.41 100.47 0.42 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.488 -0.93 . . . . 13.470000000000001 108.488 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.18 160.77 42.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.661 -0.7 . . . . 13.52 110.799 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 44.7 mtpt -99.35 -6.64 27.49 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.948 -1.024 . . . . 17.600000000000001 110.262 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.538 ' ND2' ' HG3' ' A' ' 156' ' ' LYS . 36.2 t30 -90.96 106.5 18.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.527 -0.76 . . . . 16.140000000000001 109.691 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.01 -21.38 64.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.969 -0.56 . . . . 14.039999999999999 111.697 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -59.52 -35.08 73.5 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.774 0.797 . . . . 16.57 109.878 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.538 ' HG3' ' ND2' ' A' ' 153' ' ' ASN . 28.3 mtpp -83.67 -33.35 25.24 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.561 -1.2 . . . . 16.399999999999999 110.753 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 178' ' ' PRO . 89.7 t -57.48 -39.14 67.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.404 0.621 . . . . 12.67 109.662 173.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -60.78 -30.32 69.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.106 -0.952 . . . . 15.32 111.743 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.614 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 6.0 mm-40 -77.24 -61.65 1.91 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.185 -0.672 . . . . 15.970000000000001 109.185 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 156' ' ' LYS . 12.3 mt -49.41 -46.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.357 -0.838 . . . . 12.6 110.793 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.3 t -73.75 -41.42 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.463 -0.789 . . . . 12.539999999999999 110.602 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.66 -28.88 70.61 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.611 -0.804 . . . . 14.800000000000001 112.137 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.614 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.6 mptp? -72.7 -52.44 15.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.703 0.287 . . . . 16.050000000000001 111.183 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.5 mm? -86.39 -55.86 3.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.272 0.471 . . . . 12.99 112.272 -176.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -63.45 -40.28 96.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.223 0.535 . . . . 15.06 109.752 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.68 -23.98 73.98 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.02 -0.991 . . . . 16.600000000000001 112.517 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.18 0.85 56.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.867 0.365 . . . . 16.140000000000001 110.723 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.56 17.3 58.76 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.927 -0.654 . . . . 15.119999999999999 113.237 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -83.86 153.85 23.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.979 0.39 . . . . 15.49 111.036 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.15 99.33 2.79 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.284 -0.636 . . . . 13.869999999999999 109.284 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.66 141.7 27.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 114.904 -1.044 . . . . 10.82 109.255 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.586 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -138.7 176.41 8.72 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.994 0.902 . . . . 11.130000000000001 111.31 170.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 14.2 p -123.34 -173.73 2.79 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.817 -1.538 . . . . 11.52 109.886 -171.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 19.5 m -50.01 137.58 19.97 Favored Pre-proline 0 C--O 1.234 0.278 0 N-CA-C 109.737 -0.468 . . . . 12.75 109.737 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -37.44 -50.38 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 124.572 3.515 . . . . 14.640000000000001 115.399 -167.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.0 t -82.93 -60.41 2.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.116 -0.634 . . . . 16.68 112.471 -172.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.3 m -166.81 135.43 2.24 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 117.891 0.314 . . . . 16.039999999999999 111.608 -175.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.47 ' HB3' HG11 ' A' ' 157' ' ' VAL . 34.4 Cg_exo -62.24 124.62 14.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.266 1.977 . . . . 14.220000000000001 111.063 165.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.463 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.8 p -153.57 154.56 7.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 110.084 -0.339 . . . . 16.129999999999999 110.084 -176.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -82.92 141.59 32.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.123 0.487 . . . . 16.699999999999999 110.887 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.93 -17.07 59.33 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.698 -0.683 . . . . 16.98 111.921 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 10.2 mptt -123.78 156.8 35.42 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.353 -0.61 . . . . 18.73 109.353 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 183' ' ' ILE . 7.7 tp -71.46 109.07 3.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.554 0.692 . . . . 14.82 111.049 -174.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.448 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 32.6 m -103.49 106.77 17.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.813 0.816 . . . . 12.779999999999999 110.438 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.751 ' HG2' HD11 ' A' ' 187' ' ' LEU . 22.1 ttp180 -85.39 133.29 34.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.317 -1.31 . . . . 13.98 109.367 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.533 ' O ' HD22 ' A' ' 148' ' ' LEU . 2.0 mm -112.98 118.6 58.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.057 -0.72 . . . . 10.56 109.057 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.751 HD11 ' HG2' ' A' ' 185' ' ' ARG . 1.5 mp -131.33 132.64 44.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.396 0.617 . . . . 10.1 111.278 -172.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.029 HG23 HD21 ' A' ' 148' ' ' LEU . 42.3 t -104.9 134.44 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.217 -0.902 . . . . 9.7400000000000002 111.009 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 84.57 50.41 4.24 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.443 -0.799 . . . . 9.7599999999999998 113.739 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.925 ' HA ' HG22 ' A' ' 145' ' ' VAL . 5.3 Cg_endo -55.88 125.51 19.32 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 119.277 1.538 . . . . 11.15 111.424 174.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -152.47 169.01 23.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.657 -0.702 . . . . 12.77 109.23 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.47 -1.88 22.63 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.81 0.338 . . . . 14.6 111.086 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 70.5 m -121.11 110.15 15.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.863 0.363 . . . . 14.300000000000001 111.351 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.683 ' HE3' ' CE2' ' A' ' 144' ' ' TYR . 37.5 ttmt -65.13 -53.44 45.13 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.968 -0.56 . . . . 15.970000000000001 110.014 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -51.34 -40.26 58.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.264 -0.88 . . . . 15.6 111.647 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -74.7 -42.07 59.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 14.220000000000001 110.947 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.2 OUTLIER -78.56 -20.25 51.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.022 0.439 . . . . 11.949999999999999 110.19 -177.469 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.462 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.4 tptm -67.06 -39.58 86.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.423 0.63 . . . . 14.699999999999999 110.305 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.75 -12.17 84.04 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.303 -1.119 . . . . 13.09 110.303 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 71.5 m -90.26 -9.29 48.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.528 -0.836 . . . . 12.109999999999999 112.454 -175.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 18.2 mt -65.2 -35.79 82.15 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.774 -0.37 . . . . 12.720000000000001 110.908 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.96 -44.08 97.52 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.915 -0.66 . . . . 14.66 112.331 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 200' ' ' SER . 11.1 pt-20 -81.06 -18.5 46.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.936 0.398 . . . . 13.890000000000001 110.457 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.461 HD13 HG21 ' A' ' 146' ' ' VAL . 1.2 tt -68.95 -32.17 71.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 12.550000000000001 109.958 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 25.2 mtpp -62.0 -19.84 63.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.572 -0.74 . . . . 15.83 110.37 173.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -40.01 13.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.174 0.511 . . . . 16.969999999999999 109.719 172.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.75 -52.54 59.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.63 -0.714 . . . . 13.890000000000001 111.339 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.495 ' HB3' HD11 ' A' ' 164' ' ' LEU . 62.8 p -103.84 -46.95 4.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.999 0.428 . . . . 13.539999999999999 110.802 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 82.27 -6.18 69.13 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.789 -0.641 . . . . 14.67 111.8 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.0 mp -86.61 158.37 19.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.82 -0.437 . . . . 13.039999999999999 109.82 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 16.1 m -80.13 94.73 6.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.851 -0.613 . . . . 14.84 110.594 -175.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -111.83 148.55 18.12 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.591 -0.814 . . . . 12.220000000000001 113.45 -176.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.4 141.97 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.963 0.411 . . . . 13.74 109.932 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.31 106.77 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.689 0.757 . . . . 12.890000000000001 110.372 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 96.6 mmm -117.87 168.55 10.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.464 -0.789 . . . . 13.800000000000001 110.376 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -84.76 151.31 26.17 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.356 -0.926 . . . . 13.359999999999999 112.462 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.913 ' HB2' HG23 ' A' ' 145' ' ' VAL . 3.9 t80 -123.87 133.01 53.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.418 -0.891 . . . . 14.24 109.582 -171.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 26.5 p -139.84 92.33 9.99 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.396 -0.365 . . . . 16.510000000000002 110.204 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 140' ' ' THR . 43.9 Cg_endo -69.64 120.77 7.53 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.242 1.962 . . . . 17.420000000000002 111.501 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.628 -0.701 . . . . 19.190000000000001 110.155 -178.73 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 9.4 p-10 . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 109.903 -0.406 . . . . 18.390000000000001 109.903 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.59 -38.94 94.43 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.806 -0.711 . . . . 17.77 111.68 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.495 ' OE1' ' HD2' ' A' ' 68' ' ' PRO . 19.3 tp60 55.61 74.76 0.36 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.601 0.715 . . . . 17.690000000000001 110.892 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -122.17 -63.22 1.31 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.533 -0.758 . . . . 19.93 111.194 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -152.29 160.72 43.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.958 -0.386 . . . . 17.43 109.958 -173.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 66.98 35.51 4.66 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.889 0.476 . . . . 19.359999999999999 111.303 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.556 ' CD2' ' HG2' ' A' ' 35' ' ' GLN . 39.9 p90 -74.41 -29.24 61.43 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.939 -0.305 . . . . 18.960000000000001 110.976 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.556 ' HG2' ' CD2' ' A' ' 34' ' ' TYR . 11.5 pt20 -160.29 22.15 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.215 0.531 . . . . 18.239999999999998 110.06 173.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.76 -67.78 0.8 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.519 -0.764 . . . . 16.780000000000001 110.505 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -148.75 162.45 39.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.639 -0.71 . . . . 18.420000000000002 109.271 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -137.85 166.37 24.19 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.782 0.325 . . . . 17.920000000000002 110.851 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.52 159.92 25.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.076 -0.511 . . . . 19.550000000000001 110.313 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.09 50.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.607 0.242 . . . . 20.309999999999999 110.756 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.411 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 22.9 pt 36.63 64.94 2.4 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 124.41 1.069 . . . . 19.920000000000002 113.14 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 41' ' ' ILE . 8.3 Cg_exo -72.27 72.96 2.76 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.746 2.297 . . . . 21.640000000000001 111.423 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mp 69.08 7.85 6.48 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.5 -0.773 . . . . 22.670000000000002 111.526 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.561 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 47.8 t -64.3 -53.89 42.97 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.428 -0.351 . . . . 21.34 111.64 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.561 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 84.0 Cg_endo -80.79 14.49 2.04 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 121.791 1.66 . . . . 20.0 112.073 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 60.62 29.37 18.96 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.385 0.612 . . . . 21.079999999999998 110.276 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.99 155.6 39.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.355 -0.839 . . . . 18.800000000000001 109.62 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.62 168.55 16.29 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.769 -0.729 . . . . 17.510000000000002 112.155 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.87 164.11 21.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.639 -0.134 . . . . 16.949999999999999 110.639 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 73.24 -55.71 0.67 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.932 0.77 . . . . 18.300000000000001 111.71 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.84 115.17 9.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.852 0.358 . . . . 18.170000000000002 110.62 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.406 ' HB3' ' HG2' ' A' ' 57' ' ' PRO . 35.3 mt-10 -86.11 147.36 44.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.15 -0.477 . . . . 18.82 110.922 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.82 141.87 67.19 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.524 2.149 . . . . 19.870000000000001 111.716 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -76.91 63.51 2.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.091 0.472 . . . . 21.100000000000001 111.512 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.4 mmt -105.75 -33.36 8.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.95 -0.568 . . . . 22.300000000000001 109.833 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.605 ' H ' ' HD2' ' A' ' 57' ' ' PRO . 68.4 mtt -146.22 -50.72 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.506 -0.77 . . . . 23.850000000000001 111.842 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.605 ' HD2' ' H ' ' A' ' 56' ' ' MET . 84.6 Cg_exo -48.79 121.63 6.89 Favored 'Trans proline' 0 C--N 1.363 1.315 0 C-N-CA 122.374 2.049 . . . . 20.670000000000002 112.849 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.26 -26.5 42.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.587 -0.733 . . . . 20.489999999999998 110.868 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.58 -71.36 0.12 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.982 0.801 . . . . 21.469999999999999 111.745 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.8 t -75.51 124.06 26.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.098 0.475 . . . . 22.600000000000001 110.993 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 55.45 42.14 30.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.495 -0.775 . . . . 21.93 110.77 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.74 134.37 37.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.913 -0.585 . . . . 19.73 110.427 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.3 mt -111.97 96.77 35.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.362 -0.381 . . . . 19.579999999999998 110.432 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.84 39.97 0.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.741 2.294 . . . . 18.5 112.069 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 66' ' ' GLN . 4.1 t -68.29 -30.66 69.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.764 -0.653 . . . . 17.609999999999999 110.597 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' A' ' 65' ' ' THR . 48.6 mt-30 -108.4 152.84 42.2 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 18.760000000000002 109.988 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.78 110.02 2.46 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.736 2.291 . . . . 17.280000000000001 111.655 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' OE1' ' A' ' 30' ' ' GLN . 46.3 Cg_exo -57.37 113.74 1.63 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.035 2.49 . . . . 17.77 112.218 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 20.9 mt-10 66.8 -73.26 0.08 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.625 0.77 . . . . 18.699999999999999 111.19 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.55 46.61 14.32 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.709 -0.757 . . . . 17.719999999999999 111.36 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.21 86.38 1.97 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.139 0.495 . . . . 18.0 111.368 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.05 58.65 3.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.145 0.497 . . . . 17.960000000000001 109.773 176.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.57 -1.46 37.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 19.850000000000001 111.825 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -89.41 -160.68 0.7 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.651 0.262 . . . . 19.670000000000002 110.692 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.9 t -74.25 81.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.216 0.532 . . . . 17.739999999999998 110.485 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -74.09 -22.13 59.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.857 -0.61 . . . . 19.949999999999999 110.826 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.21 36.33 1.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.167 0.508 . . . . 18.390000000000001 110.48 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.85 101.16 2.55 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.948 -0.644 . . . . 17.66 112.083 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -71.57 -64.61 0.89 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.996 0.427 . . . . 17.68 110.082 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.14 -15.15 14.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.955 -0.566 . . . . 17.800000000000001 110.014 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.76 40.94 0.93 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.662 -0.699 . . . . 17.350000000000001 111.084 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.6 133.61 21.54 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.86 -0.609 . . . . 16.640000000000001 110.279 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -88.98 45.57 0.89 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.095 2.53 . . . . 17.23 112.747 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.7 m 58.45 -97.5 0.07 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.002 -0.545 . . . . 17.34 111.538 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.55 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 95.9 mt -133.29 10.9 4.15 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.494 0.187 . . . . 18.41 111.223 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.48 112.01 36.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.627 -0.261 . . . . 17.449999999999999 111.461 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 85' ' ' LEU . 24.2 Cg_exo -63.79 -47.23 7.3 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.567 2.178 . . . . 18.890000000000001 110.668 172.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 45.72 49.55 11.27 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 124.099 0.874 . . . . 17.809999999999999 112.352 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.4 t -163.07 141.05 8.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.08 -0.509 . . . . 18.629999999999999 110.128 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.431 ' HA ' ' ND2' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -135.52 22.17 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.069 -0.514 . . . . 19.100000000000001 109.617 177.092 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.66 73.61 3.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.556 -0.747 . . . . 19.25 111.42 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 63.87 54.26 1.8 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.665 -0.698 . . . . 18.789999999999999 111.929 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 90' ' ' ILE . 45.4 m-20 -76.79 65.03 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.08 0.466 . . . . 18.949999999999999 109.961 176.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -82.43 37.65 0.52 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.49 0.552 . . . . 20.309999999999999 112.49 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.1 p -73.21 -33.9 65.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.507 0.67 . . . . 21.399999999999999 109.318 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -107.57 17.22 22.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.252 -0.885 . . . . 21.16 108.737 172.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 15.1 t80 62.85 24.02 14.31 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.912 -1.04 . . . . 22.18 111.099 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.48 ' OE2' ' HA ' ' A' ' 101' ' ' PRO . 10.0 pt-20 -155.9 128.32 4.08 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.81 -0.632 . . . . 19.449999999999999 109.561 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 93' ' ' ASN . 35.4 Cg_endo -65.09 -23.18 61.0 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.952 2.434 . . . . 18.530000000000001 112.864 -175.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -154.31 140.78 12.97 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.682 -0.69 . . . . 17.449999999999999 109.424 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.48 ' HA ' ' OE2' ' A' ' 98' ' ' GLU . 52.4 Cg_endo -68.12 -18.64 45.55 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.021 2.481 . . . . 17.420000000000002 112.79 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.14 142.48 41.27 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.018 -0.537 . . . . 17.68 109.945 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.3 83.42 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.545 2.163 . . . . 16.289999999999999 111.534 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 104' ' ' VAL . 9.5 p 41.82 47.9 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 122.363 1.077 . . . . 17.260000000000002 111.837 -176.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -132.16 91.83 30.8 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.125 -0.943 . . . . 15.800000000000001 110.852 -175.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -88.48 103.31 0.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.189 2.592 . . . . 15.92 111.968 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.37 -18.45 34.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.291 1.994 . . . . 16.149999999999999 111.726 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 75.3 mmtt -91.44 126.92 52.8 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.825 -0.625 . . . . 17.629999999999999 109.825 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 108' ' ' LYS . 6.7 Cg_exo -73.28 54.9 2.89 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.931 2.42 . . . . 15.039999999999999 111.706 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -84.12 118.11 70.42 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.733 -0.667 . . . . 15.199999999999999 110.571 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.48 123.51 9.56 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.355 2.037 . . . . 14.08 111.627 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.8 p -84.7 49.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 122.584 1.183 . . . . 15.279999999999999 110.242 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.649 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 43.9 mt-10 -105.53 -46.91 0.13 Allowed Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.778 -1.101 . . . . 16.84 112.16 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 113' ' ' GLU . 65.3 Cg_endo -97.04 95.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.434 2.089 . . . . 15.51 112.728 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.649 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 86.1 Cg_endo -91.2 -177.11 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.769 2.313 . . . . 16.039999999999999 111.584 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -131.37 69.48 81.91 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.931 0.396 . . . . 18.91 111.217 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.499 ' HB2' ' OD1' ' A' ' 220' ' ' ASN . 4.0 Cg_exo -79.01 -81.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.065 1.843 . . . . 17.039999999999999 110.493 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 56.58 -158.7 0.24 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.953 0.406 . . . . 17.52 110.602 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.7 t -87.01 -19.05 8.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.786 -0.82 . . . . 18.699999999999999 108.786 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -90.13 33.59 0.88 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.144 -0.935 . . . . 20.879999999999999 110.516 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.34 130.67 93.35 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.676 -0.693 . . . . 18.890000000000001 111.418 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 39.3 Cg_exo -59.31 127.85 25.41 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.544 2.162 . . . . 20.43 111.14 174.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 122' ' ' PRO . 15.3 Cg_exo -69.86 52.46 1.03 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.994 2.462 . . . . 21.100000000000001 112.663 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.69 118.81 66.45 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.05 -0.523 . . . . 21.149999999999999 109.757 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.457 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 12.1 Cg_endo -56.29 117.62 4.3 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.919 2.413 . . . . 21.149999999999999 112.39 -175.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -99.91 103.65 23.58 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.539 -0.755 . . . . 21.879999999999999 110.151 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.487 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 90.1 Cg_endo -87.25 -161.22 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.858 2.372 . . . . 20.190000000000001 110.888 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -114.68 74.13 3.18 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.634 0.254 . . . . 20.48 110.556 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.487 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 93.8 Cg_endo -92.39 -168.3 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.916 2.411 . . . . 21.170000000000002 111.72 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -127.41 77.44 75.78 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.764 -0.458 . . . . 23.18 109.764 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.2 96.57 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.97 2.447 . . . . 20.780000000000001 111.697 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.6 m -91.39 43.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.767 0.794 . . . . 19.75 110.416 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 134' ' ' GLU . 12.4 p -135.7 163.41 35.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.766 -1.106 . . . . 21.050000000000001 109.173 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 133' ' ' VAL . 46.1 mt-10 72.73 -175.08 0.16 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.121 0.569 . . . . 21.300000000000001 110.177 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.07 -84.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.727 0.269 . . . . 20.739999999999998 111.727 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -139.83 -73.14 0.37 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.826 0.346 . . . . 17.969999999999999 110.23 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . -97.66 -3.71 38.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.13 -0.486 . . . . 17.350000000000001 110.121 177.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . 80.35 142.39 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 114.632 -1.167 . . . . 19.100000000000001 111.552 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.33 -57.79 2.14 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.707 2.938 . . . . 19.350000000000001 114.155 -172.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.2 t -113.65 -13.61 12.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.861 0.362 . . . . 17.75 110.604 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.09 -51.7 55.82 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.99 -0.624 . . . . 17.960000000000001 111.565 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.474 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 32.9 mtmm -143.28 94.08 2.57 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.192 -0.67 . . . . 19.420000000000002 109.192 175.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.845 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . -108.13 159.87 16.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.86 -0.609 . . . . 14.65 110.449 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.67 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 37.9 m-85 -136.91 143.72 43.11 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.555 -0.293 . . . . 14.81 111.569 -173.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 190' ' ' PRO . 3.0 m -151.39 160.73 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.301 0.64 . . . . 10.48 110.036 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 12.4 t -114.59 122.04 67.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 120.754 -0.378 . . . . 10.1 110.021 176.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.529 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 27.2 tt0 -92.8 97.02 10.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.594 0.235 . . . . 12.0 110.917 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.781 HD13 ' N ' ' A' ' 212' ' ' GLY . 0.3 OUTLIER -83.41 -27.88 29.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.344 0.592 . . . . 11.880000000000001 109.691 -177.151 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.17 162.26 28.15 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.402 -0.904 . . . . 11.35 112.34 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.96 101.52 0.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.779 -0.452 . . . . 13.470000000000001 109.779 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.92 158.7 43.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.329 0.585 . . . . 13.52 110.748 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -99.45 4.97 46.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.096 -0.957 . . . . 17.600000000000001 109.808 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.404 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.1 t-20 -105.88 116.72 32.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.887 -1.051 . . . . 16.140000000000001 109.74 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -73.48 -23.45 60.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.169 -0.469 . . . . 14.039999999999999 112.17 -174.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.84 -35.31 79.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.891 0.853 . . . . 16.57 109.411 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.58 ' O ' HG13 ' A' ' 160' ' ' ILE . 32.3 mmtp -76.08 -38.55 56.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.127 -1.397 . . . . 16.399999999999999 110.205 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.528 HG11 HG21 ' A' ' 184' ' ' THR . 93.3 t -57.28 -47.69 83.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.307 0.575 . . . . 12.67 110.325 176.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -59.16 -35.56 73.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.986 -1.006 . . . . 15.32 111.985 -174.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.65 -39.25 27.64 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.626 -0.43 . . . . 15.970000000000001 111.65 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 156' ' ' LYS . 29.2 mt -62.7 -49.29 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.549 0.69 . . . . 12.6 109.523 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 91.8 t -66.08 -36.2 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.891 -1.05 . . . . 12.539999999999999 109.788 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -56.97 -32.67 62.72 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 14.800000000000001 112.187 176.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -71.8 -62.26 1.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.321 . . . . 16.050000000000001 111.452 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.7 mm? -78.02 -50.38 12.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.119 -0.491 . . . . 12.99 112.113 -172.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 3.9 tmt_? -64.84 -43.42 93.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.353 -0.61 . . . . 15.06 109.353 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.01 -27.23 73.36 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.043 -0.981 . . . . 16.600000000000001 112.874 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.27 -8.4 59.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.989 0.423 . . . . 16.140000000000001 110.625 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.21 19.82 27.21 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.053 -0.594 . . . . 15.119999999999999 113.197 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 207' ' ' LEU . 42.7 m-85 -88.22 157.13 18.88 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 117.23 0.515 . . . . 15.49 110.713 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -77.75 100.64 6.34 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.521 0.677 . . . . 13.869999999999999 109.279 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.6 p -142.06 137.98 30.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.687 -1.142 . . . . 10.82 109.477 -174.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.527 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.49 176.56 8.68 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.539 0.685 . . . . 11.130000000000001 110.585 174.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 10.0 p -121.82 -173.97 2.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.722 -1.126 . . . . 11.52 111.191 -169.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 74.7 m -50.45 143.05 14.27 Favored Pre-proline 0 C--O 1.236 0.35 0 O-C-N 123.465 0.478 . . . . 12.75 110.634 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -45.01 -45.43 14.18 Favored 'Trans proline' 0 CA--C 1.527 0.175 0 C-N-CA 124.006 3.138 . . . . 14.640000000000001 114.863 -170.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.2 p -86.97 -63.79 1.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.882 -0.727 . . . . 16.68 112.848 -172.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.9 m -168.54 130.04 1.14 Allowed Pre-proline 0 C--O 1.234 0.278 0 O-C-N 122.464 -0.148 . . . . 16.039999999999999 111.202 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.546 ' HB3' HG21 ' A' ' 184' ' ' THR . 78.2 Cg_exo -61.45 122.43 11.08 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.116 1.877 . . . . 14.220000000000001 111.493 162.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 182' ' ' LYS . 4.3 p -155.35 161.68 2.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.849 -0.426 . . . . 16.129999999999999 109.849 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -75.25 124.41 27.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.77 0.319 . . . . 16.699999999999999 110.681 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.16 -26.06 16.37 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.094 -0.574 . . . . 16.98 112.577 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.445 ' HB2' HG12 ' A' ' 179' ' ' VAL . 0.8 OUTLIER -107.16 154.61 20.94 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.703 -0.48 . . . . 18.73 109.703 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.1 tp -72.79 109.89 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.513 0.673 . . . . 14.82 111.071 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.546 HG21 ' HB3' ' A' ' 178' ' ' PRO . 31.4 m -98.8 109.41 22.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.624 0.726 . . . . 12.779999999999999 109.974 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 76.9 mtm180 -95.01 134.25 37.89 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.922 -1.036 . . . . 13.98 109.941 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.405 ' C ' HD12 ' A' ' 187' ' ' LEU . 4.5 mm -102.56 106.9 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 109.722 -0.473 . . . . 10.56 109.722 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.651 HD23 HG21 ' A' ' 145' ' ' VAL . 6.1 mp -110.85 114.84 28.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.582 0.706 . . . . 10.1 110.841 -174.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 41.9 t -95.08 140.89 15.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.856 -1.065 . . . . 9.7400000000000002 110.001 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 77.55 45.85 10.54 Favored Glycine 0 N--CA 1.434 -1.495 0 CA-C-N 115.292 -0.867 . . . . 9.7599999999999998 114.139 174.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.799 ' HA ' HG12 ' A' ' 145' ' ' VAL . 11.4 Cg_endo -61.92 126.38 18.72 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 CA-C-N 119.762 1.781 . . . . 11.15 110.83 171.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -161.54 167.87 24.62 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.987 -0.552 . . . . 12.77 109.721 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -103.9 7.49 36.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.255 -0.43 . . . . 14.6 110.427 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 36.4 t -120.6 116.57 25.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.918 -0.583 . . . . 14.300000000000001 110.921 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.657 ' HB2' ' CD2' ' A' ' 144' ' ' TYR . 31.5 ttmt -70.92 -47.75 57.33 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.022 -0.733 . . . . 15.970000000000001 109.022 172.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -46.24 -57.46 4.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.704 -1.134 . . . . 15.6 111.639 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -70.7 -39.66 73.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.459 -0.791 . . . . 14.220000000000001 111.995 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.548 HD23 ' HB2' ' A' ' 144' ' ' TYR . 0.1 OUTLIER -82.39 -30.99 29.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.645 0.239 . . . . 11.949999999999999 111.645 -174.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.573 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 13.3 tmtt? -79.32 -29.98 42.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.218 -0.66 . . . . 14.699999999999999 109.218 -177.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.51 -12.03 83.96 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.022 -1.231 . . . . 13.09 110.022 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 46.3 m -91.09 -8.07 49.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.592 -0.804 . . . . 12.109999999999999 112.272 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 23.2 mt -66.96 -35.12 79.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.922 -0.311 . . . . 12.720000000000001 111.244 -174.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -58.58 -42.95 96.35 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.735 -0.745 . . . . 14.66 111.905 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 200' ' ' SER . 10.7 pt-20 -83.62 -18.34 38.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.07 0.462 . . . . 13.890000000000001 110.412 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.36 -27.65 65.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.143 -0.481 . . . . 12.550000000000001 110.049 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 6.5 mtpm? -63.48 -20.88 65.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.786 -0.643 . . . . 15.83 110.496 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.84 -35.97 16.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.715 -0.476 . . . . 16.969999999999999 109.715 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.582 ' HB3' ' CE1' ' A' ' 169' ' ' TYR . 81.9 mt -73.41 -53.09 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.613 -0.722 . . . . 13.890000000000001 111.681 -175.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 164' ' ' LEU . 71.2 p -95.04 -42.64 8.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.271 0.557 . . . . 13.539999999999999 110.68 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 70.2 5.79 55.07 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.167 -0.924 . . . . 14.67 111.694 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.631 ' C ' HD12 ' A' ' 148' ' ' LEU . 96.1 mt -89.86 162.8 15.29 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.594 0.758 . . . . 13.039999999999999 109.84 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 66.1 m -102.24 99.89 10.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.13 0.419 . . . . 14.84 112.13 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.781 ' N ' HD13 ' A' ' 148' ' ' LEU . . . -116.55 157.43 15.05 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.303 -0.951 . . . . 12.220000000000001 114.559 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.76 146.15 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.779 -0.711 . . . . 13.74 109.796 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 24.0 t -74.53 117.69 19.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.857 -0.611 . . . . 12.890000000000001 110.057 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 87.6 mtp -128.83 153.81 47.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.089 -0.505 . . . . 13.800000000000001 110.277 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -86.71 111.1 3.59 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.308 -0.949 . . . . 13.359999999999999 112.208 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.845 ' CD2' ' HB1' ' A' ' 143' ' ' ALA . 5.2 t80 -63.82 142.71 58.31 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 124.688 1.195 . . . . 14.24 110.472 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 20.5 m -145.78 93.57 5.21 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 110.205 -0.294 . . . . 16.510000000000002 110.205 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.56 ' HG3' ' CZ ' ' A' ' 217' ' ' TYR . 19.3 Cg_exo -60.43 118.99 5.92 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.259 1.973 . . . . 17.420000000000002 111.373 175.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.499 ' OD1' ' HB2' ' A' ' 117' ' ' PRO . 90.9 m-20 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.475 -0.774 . . . . 19.190000000000001 110.68 -175.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.757 0.313 . . . . 18.390000000000001 111.147 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -99.91 -110.36 3.16 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.354 -0.927 . . . . 17.77 112.624 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 67.2 -67.31 0.17 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.509 0.723 . . . . 17.690000000000001 111.24 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -72.67 -38.25 67.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.277 0.56 . . . . 19.93 110.357 177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 60.95 23.21 13.34 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.806 -1.088 . . . . 17.43 112.65 173.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -73.2 -45.03 58.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.053 -0.721 . . . . 19.359999999999999 109.053 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 36' ' ' ASP . 35.4 t80 -153.59 89.75 1.35 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.441 -0.948 . . . . 18.960000000000001 108.441 172.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -68.13 -10.4 53.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.791 -0.64 . . . . 18.239999999999998 111.999 -174.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 35.9 t70 -89.63 5.45 45.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.45 0.643 . . . . 16.780000000000001 110.187 177.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -75.48 86.55 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 18.420000000000002 110.162 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.1 t80 57.86 59.47 3.16 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.42 0.629 . . . . 17.920000000000002 109.32 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.36 96.73 1.92 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.554 -0.748 . . . . 19.550000000000001 111.123 -176.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 68.52 -74.0 0.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.144 0.903 . . . . 20.309999999999999 111.199 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.42 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 33.6 mm 54.6 66.07 4.49 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 121.308 0.575 . . . . 19.920000000000002 111.367 178.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HD3' ' N ' ' A' ' 41' ' ' ILE . 3.6 Cg_exo -81.41 71.84 6.7 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.065 2.51 . . . . 21.640000000000001 111.617 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mp 58.79 37.6 24.91 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.467 0.651 . . . . 22.670000000000002 109.884 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.479 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 7.7 p -96.88 -29.39 0.26 Allowed Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.41 1.263 . . . . 21.34 114.41 -173.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 44' ' ' VAL . 96.5 Cg_endo -88.96 178.22 2.75 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 121.481 1.454 . . . . 20.0 112.824 -172.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -92.29 -18.44 23.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.886 -0.597 . . . . 21.079999999999998 110.977 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.47 -48.22 0.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.301 -0.409 . . . . 18.800000000000001 110.846 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.14 -113.57 0.62 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.994 -0.622 . . . . 17.510000000000002 111.752 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.06 149.67 29.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.682 -0.488 . . . . 16.949999999999999 109.682 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 50' ' ' ARG . 4.8 mpt_? -83.18 125.48 31.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.954 0.407 . . . . 18.300000000000001 109.992 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -78.83 150.09 32.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 18.170000000000002 111.548 -173.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -77.16 133.5 68.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.234 -0.894 . . . . 18.82 111.237 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.86 152.64 52.56 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.951 2.434 . . . . 19.870000000000001 112.458 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -77.1 75.38 3.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 21.100000000000001 110.74 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 54.9 ttm -165.34 -40.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.512 -0.767 . . . . 22.300000000000001 109.826 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.2 tpt -160.88 74.78 2.66 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.797 -0.638 . . . . 23.850000000000001 109.475 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.45 123.44 1.86 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.51 2.14 . . . . 20.670000000000002 112.35 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.44 88.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.053 -0.976 . . . . 20.489999999999998 111.481 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.23 136.24 15.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.145 -0.479 . . . . 21.469999999999999 110.347 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.3 p -80.78 -10.09 59.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.168 0.509 . . . . 22.600000000000001 111.033 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -109.06 27.73 9.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.056 -0.52 . . . . 21.93 109.833 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.462 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 68.71 171.63 0.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.337 -0.847 . . . . 19.73 111.544 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.2 100.54 5.9 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.637 -0.71 . . . . 19.579999999999998 109.161 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 62' ' ' ALA . 96.1 Cg_endo -81.53 40.69 1.02 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.737 2.291 . . . . 18.5 112.75 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m 60.02 78.87 0.25 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.651 -0.704 . . . . 17.609999999999999 110.738 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.551 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 50.1 tt0 -67.67 -47.63 44.71 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.007 -0.542 . . . . 18.760000000000002 111.305 178.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 66' ' ' GLN . 38.1 Cg_endo -65.55 137.11 49.12 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 121.952 1.768 . . . . 17.280000000000001 111.465 174.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.6 114.57 2.19 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.028 1.818 . . . . 17.77 111.384 174.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.74 -53.01 3.69 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.726 -0.842 . . . . 18.699999999999999 108.726 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 177.26 164.06 30.29 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.451 -0.795 . . . . 17.719999999999999 111.28 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.72 144.15 38.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.034 -0.358 . . . . 18.0 110.034 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.31 103.11 1.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 17.960000000000001 110.476 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -70.09 -54.56 12.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.417 0.627 . . . . 19.850000000000001 109.74 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -120.96 -77.17 0.58 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.121 -0.945 . . . . 19.670000000000002 109.166 175.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.2 m -145.47 143.92 21.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.871 -0.604 . . . . 17.739999999999998 109.767 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -111.82 -21.82 11.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.928 0.394 . . . . 19.949999999999999 110.232 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.05 167.36 22.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.826 -0.624 . . . . 18.390000000000001 110.311 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.33 177.17 32.17 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.978 -0.629 . . . . 17.66 111.7 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -116.84 162.81 17.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.927 -0.397 . . . . 17.68 109.927 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.98 -42.16 99.76 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.579 -0.156 . . . . 17.800000000000001 110.579 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 50.03 78.83 0.09 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.633 0.583 . . . . 17.350000000000001 111.492 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 112.52 5.06 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 16.640000000000001 111.322 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.98 -24.58 8.24 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.485 2.123 . . . . 17.23 113.067 -176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.2 p -136.79 143.03 42.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.756 0.312 . . . . 17.34 111.346 -177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.3 mt -98.03 71.4 2.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.221 -0.659 . . . . 18.41 109.221 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -53.33 120.91 22.88 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.268 -0.878 . . . . 17.449999999999999 111.641 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.0 -6.26 18.68 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.954 2.436 . . . . 18.890000000000001 112.94 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 69.77 36.9 1.96 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.557 -0.747 . . . . 17.809999999999999 111.791 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m 65.36 97.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.662 -0.699 . . . . 18.629999999999999 111.743 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.6 mt 67.66 96.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.257 0.551 . . . . 19.100000000000001 111.504 175.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.6 -17.14 60.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.117 -0.492 . . . . 19.25 110.651 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.477 ' H ' ' HG2' ' A' ' 98' ' ' GLU . . . 65.07 12.84 8.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.436 -0.802 . . . . 18.789999999999999 112.018 176.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -106.83 165.32 11.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.086 0.469 . . . . 18.949999999999999 110.777 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -94.77 36.41 1.18 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.997 -0.547 . . . . 20.309999999999999 110.421 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.5 m -84.95 -42.4 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.807 -0.633 . . . . 21.399999999999999 109.321 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -122.78 27.27 7.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.354 -0.839 . . . . 21.16 109.511 175.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 46.9 t80 52.65 77.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.989 -1.005 . . . . 22.18 111.215 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.477 ' HG2' ' H ' ' A' ' 92' ' ' ALA . 6.9 tp10 -115.71 81.59 9.46 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 108.792 -0.818 . . . . 19.449999999999999 108.792 174.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.11 -69.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.517 2.145 . . . . 18.530000000000001 113.512 -172.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 58.49 69.91 1.34 Allowed Pre-proline 0 N--CA 1.462 0.16 0 O-C-N 123.263 0.352 . . . . 17.449999999999999 110.389 -172.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.89 -35.4 67.4 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.518 2.146 . . . . 17.420000000000002 112.004 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 50.06 70.99 1.71 Allowed Pre-proline 0 C--O 1.238 0.453 0 O-C-N 123.808 0.693 . . . . 17.68 111.498 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.2 48.39 2.68 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.595 2.197 . . . . 16.289999999999999 111.928 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.71 41.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.974 -1.012 . . . . 17.260000000000002 111.179 -176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -134.9 87.94 28.71 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.703 -0.68 . . . . 15.800000000000001 110.39 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.515 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 73.2 Cg_exo -49.48 -47.68 21.69 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.054 2.503 . . . . 15.92 113.417 176.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 106' ' ' PRO . 13.9 Cg_endo -57.05 127.54 26.19 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.968 1.779 . . . . 16.149999999999999 112.249 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -85.3 160.03 55.17 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.586 -0.733 . . . . 17.629999999999999 109.979 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.5 74.72 0.81 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.736 2.29 . . . . 15.039999999999999 110.83 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -109.84 134.63 20.59 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.335 -0.848 . . . . 15.199999999999999 110.338 -172.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.71 147.87 93.51 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.67 2.247 . . . . 14.08 111.848 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.7 m -85.33 54.56 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 121.72 0.772 . . . . 15.279999999999999 111.353 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.12 129.34 94.43 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.033 -0.985 . . . . 16.84 110.136 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 40.3 Cg_exo -57.7 119.09 6.12 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.046 2.498 . . . . 15.51 112.244 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 114' ' ' PRO . 22.0 Cg_exo -66.25 175.81 4.56 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.838 2.358 . . . . 16.039999999999999 112.136 177.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 56.47 71.07 1.25 Allowed Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 116.064 -0.516 . . . . 18.91 109.861 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.58 35.88 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.175 2.583 . . . . 17.039999999999999 113.999 -170.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -111.08 40.65 2.0 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.881 0.372 . . . . 17.52 111.145 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.48 -11.63 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.191 0.519 . . . . 18.699999999999999 110.502 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.92 16.42 19.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.62 -0.718 . . . . 20.879999999999999 110.913 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.48 131.4 86.47 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.601 -0.727 . . . . 18.890000000000001 110.022 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 75.6 Cg_exo -50.12 120.65 6.42 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.138 2.558 . . . . 20.43 112.073 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 122' ' ' PRO . 51.8 Cg_exo -55.52 102.52 0.09 OUTLIER 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.348 2.699 . . . . 21.100000000000001 112.865 -177.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.402 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . . . -150.99 99.79 3.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 21.149999999999999 110.35 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 124' ' ' ALA . 32.4 Cg_endo -64.68 -32.13 57.88 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.757 2.304 . . . . 21.149999999999999 112.709 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -121.12 103.31 42.54 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.973 -0.38 . . . . 21.879999999999999 109.973 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.69 142.44 76.9 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.713 2.275 . . . . 20.190000000000001 111.459 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 16.0 pt-20 -71.98 141.35 84.11 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.481 . . . . 20.48 110.546 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 128' ' ' GLU . 23.5 Cg_exo -65.55 -18.03 58.44 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.095 2.53 . . . . 21.170000000000002 113.149 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -129.47 84.06 63.08 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.742 0.306 . . . . 23.18 111.17 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.25 160.35 49.28 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.746 2.297 . . . . 20.780000000000001 111.076 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 t -81.23 50.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.882 0.849 . . . . 19.75 109.977 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.5 t -136.44 83.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.922 -1.035 . . . . 21.050000000000001 109.333 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -107.84 -23.47 12.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.592 0.711 . . . . 21.300000000000001 109.111 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.7 141.32 58.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.587 -1.188 . . . . 20.739999999999998 109.735 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -112.45 -51.39 2.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.026 -0.534 . . . . 17.969999999999999 110.131 -173.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 192' ' ' ALA . . . -89.39 6.29 41.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.329 0.585 . . . . 17.350000000000001 109.57 174.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 74.12 148.71 0.12 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 114.123 -1.399 . . . . 19.100000000000001 112.411 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -44.22 -45.62 12.07 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.873 3.048 . . . . 19.350000000000001 114.403 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.4 m -130.5 22.34 5.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.405 0.622 . . . . 17.75 110.056 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.63 -79.48 0.72 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.947 -0.861 . . . . 17.960000000000001 110.947 178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.437 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 68.3 mttm -129.27 59.28 1.59 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.333 0.587 . . . . 19.420000000000002 109.552 173.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.516 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -73.37 161.0 30.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.272 -0.876 . . . . 14.65 110.041 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.653 ' CD1' ' HG3' ' A' ' 194' ' ' LYS . 5.4 m-85 -146.72 159.82 43.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.685 0.279 . . . . 14.81 111.454 -177.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.725 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.3 t -149.32 158.83 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.719 -0.845 . . . . 10.48 108.719 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.471 HG12 ' HA3' ' A' ' 212' ' ' GLY . 42.9 t -100.89 106.33 19.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 O-C-N 122.081 -0.387 . . . . 10.1 111.047 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.553 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 3.4 tt0 -78.85 110.23 13.85 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.526 0.331 . . . . 12.0 111.311 -177.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 1.013 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -87.94 -37.92 16.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.306 0.574 . . . . 11.880000000000001 109.568 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.3 164.28 28.02 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.374 -0.917 . . . . 11.35 112.559 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -164.43 104.25 0.84 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.695 -0.854 . . . . 13.470000000000001 108.695 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.99 166.19 24.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.956 -0.566 . . . . 13.52 110.406 -173.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 48.5 mtpt -102.77 -6.53 22.51 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.042 -0.981 . . . . 17.600000000000001 110.355 -174.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -99.38 109.68 22.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.556 -0.747 . . . . 16.140000000000001 109.61 173.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.0 -19.55 65.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.065 -0.516 . . . . 14.039999999999999 111.494 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.12 -35.51 75.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.813 0.816 . . . . 16.57 109.965 174.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.519 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.12 -26.98 33.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.564 -1.198 . . . . 16.399999999999999 110.12 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.531 ' HA ' HD11 ' A' ' 186' ' ' ILE . 69.5 t -66.0 -39.16 83.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.675 -0.693 . . . . 12.67 110.413 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.433 ' HA ' HG12 ' A' ' 161' ' ' VAL . 23.3 t-20 -68.05 -23.5 64.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.816 -0.629 . . . . 15.32 111.349 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.56 -61.85 1.7 Allowed 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.367 -0.605 . . . . 15.970000000000001 109.367 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.787 HD12 HD12 ' A' ' 186' ' ' ILE . 18.2 mt -53.74 -43.89 57.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.582 -1.19 . . . . 12.6 110.274 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 158' ' ' ASN . 0.3 OUTLIER -72.63 -37.11 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.601 -0.727 . . . . 12.539999999999999 110.197 -177.259 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -66.0 -29.76 75.65 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.768 -0.73 . . . . 14.800000000000001 111.505 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -70.23 -51.3 31.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.875 0.369 . . . . 16.050000000000001 110.152 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.507 HD13 ' CG2' ' A' ' 188' ' ' VAL . 16.3 mt -88.84 -59.26 2.28 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.133 0.79 . . . . 12.99 113.133 -173.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 55.2 ttp180 -60.86 -37.42 82.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.453 0.644 . . . . 15.06 109.768 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.2 -18.86 78.29 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.907 -1.042 . . . . 16.600000000000001 112.266 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -95.67 -0.93 51.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.881 0.372 . . . . 16.140000000000001 110.624 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.48 25.8 45.65 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.653 -0.784 . . . . 15.119999999999999 113.14 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -92.49 154.85 18.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.952 0.376 . . . . 15.49 110.968 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -67.55 104.23 1.54 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.426 0.631 . . . . 13.869999999999999 109.773 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.46 137.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.019 -0.991 . . . . 10.82 109.858 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.531 ' CE1' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -140.17 175.25 9.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.899 0.857 . . . . 11.130000000000001 111.211 169.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 15.0 p -121.96 -175.42 3.1 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.98 -1.464 . . . . 11.52 110.384 -172.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 7.3 m -50.38 125.6 20.44 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 109.115 -0.698 . . . . 12.75 109.115 173.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 89.6 Cg_exo -45.41 -35.51 11.99 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.349 3.366 . . . . 14.640000000000001 115.337 -167.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.9 p -79.85 -62.63 1.63 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.017 -0.673 . . . . 16.68 111.816 -175.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.2 m -167.68 135.01 1.87 Allowed Pre-proline 0 C--N 1.329 -0.298 0 C-N-CA 122.183 0.193 . . . . 16.039999999999999 110.771 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.01 123.2 11.53 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.634 1.556 . . . . 14.220000000000001 110.107 161.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.5 p -154.22 156.72 4.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.484 -0.487 . . . . 16.129999999999999 111.197 -172.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -81.78 133.82 35.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.82 -0.627 . . . . 16.699999999999999 110.875 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 99.81 -22.95 38.04 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.881 -0.599 . . . . 16.98 112.471 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 9.1 mptt -115.04 160.67 19.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.445 -0.576 . . . . 18.73 109.445 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 183' ' ' ILE . 9.1 tp -74.16 109.82 7.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.735 0.778 . . . . 14.82 111.28 -174.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 40.0 m -104.22 106.58 17.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.649 0.738 . . . . 12.779999999999999 110.208 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.55 ' HG2' HD11 ' A' ' 187' ' ' LEU . 31.1 ttm180 -86.77 136.58 32.94 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.637 -1.165 . . . . 13.98 109.54 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.787 HD12 HD12 ' A' ' 160' ' ' ILE . 3.6 mt -121.61 120.61 62.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.375 -0.602 . . . . 10.56 109.375 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -130.54 143.56 50.83 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.356 -0.838 . . . . 10.1 110.406 -169.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.013 HG23 HD21 ' A' ' 148' ' ' LEU . 42.5 t -107.69 136.23 43.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.461 -0.79 . . . . 9.7400000000000002 111.31 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 81.94 48.74 5.64 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.736 -1.12 . . . . 9.7599999999999998 113.533 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.725 ' HA ' HG22 ' A' ' 145' ' ' VAL . 9.9 Cg_endo -58.94 125.2 17.51 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 CA-C-N 119.472 1.636 . . . . 11.15 110.292 174.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.432 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 5.3 t70 -150.93 163.05 39.62 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 120.397 -0.521 . . . . 12.77 110.295 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 137' ' ' ALA . . . -103.22 -4.17 24.72 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.304 -0.862 . . . . 14.6 111.281 -176.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 42.8 m -114.79 99.41 7.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.371 0.605 . . . . 14.300000000000001 110.449 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.653 ' HG3' ' CD1' ' A' ' 144' ' ' TYR . 25.3 ttpt -59.67 -54.51 45.58 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 114.984 -1.007 . . . . 15.970000000000001 111.881 -174.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.93 -40.88 97.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.004 0.43 . . . . 15.6 110.838 -172.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.39 -44.28 96.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 14.220000000000001 110.551 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -79.08 -22.54 45.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.049 -0.523 . . . . 11.949999999999999 110.567 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.3 tptm -69.15 -35.74 76.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.403 0.62 . . . . 14.699999999999999 109.92 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.02 -11.34 85.48 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.573 -1.011 . . . . 13.09 110.573 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 65.5 m -90.27 -8.96 49.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.89 -0.655 . . . . 12.109999999999999 112.624 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 18.4 mt -64.39 -34.52 78.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.001 -0.28 . . . . 12.720000000000001 111.409 -174.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.06 -42.92 96.41 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.831 -0.699 . . . . 14.66 112.135 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -79.31 -18.53 52.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 13.890000000000001 110.282 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.568 HD12 HD12 ' A' ' 207' ' ' LEU . 3.4 tp -76.27 -26.88 56.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.116 -0.493 . . . . 12.550000000000001 110.607 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 92.7 mttt -61.37 -22.47 64.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.145 0.498 . . . . 15.83 110.256 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -30.74 26.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.314 0.578 . . . . 16.969999999999999 109.58 173.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.568 HD12 HD12 ' A' ' 204' ' ' LEU . 88.9 mt -75.33 -53.76 8.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.503 -0.771 . . . . 13.890000000000001 111.84 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 p -99.58 -48.05 4.89 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.499 -0.481 . . . . 13.539999999999999 110.721 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 77.45 -0.64 68.62 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.706 -0.679 . . . . 14.67 112.675 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 164' ' ' LEU . 7.8 mp -90.14 158.1 17.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.328 -0.619 . . . . 13.039999999999999 109.328 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 35.8 m -84.06 102.57 12.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.159 -0.473 . . . . 14.84 110.877 -175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -122.43 150.06 16.95 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.28 -0.962 . . . . 12.220000000000001 113.61 -175.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.97 144.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.497 -0.557 . . . . 13.74 109.497 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.88 105.85 2.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.655 0.74 . . . . 12.890000000000001 109.767 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 98.0 mmm -119.27 139.72 51.45 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.677 -0.692 . . . . 13.800000000000001 110.674 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -68.92 155.42 53.54 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.587 -0.733 . . . . 13.359999999999999 112.425 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.656 ' HB2' HG23 ' A' ' 145' ' ' VAL . 16.0 t80 -135.06 127.76 31.0 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.124 -0.538 . . . . 14.24 110.364 -171.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.8 p -141.45 92.49 8.18 Favored Pre-proline 0 C--N 1.317 -0.845 0 N-CA-C 109.608 -0.516 . . . . 16.510000000000002 109.608 172.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.36 160.79 37.37 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.628 2.218 . . . . 17.420000000000002 112.457 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 6.1 t30 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.377 -0.821 . . . . 19.190000000000001 109.817 -178.44 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.653 -0.499 . . . . 18.390000000000001 109.653 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.84 -152.29 21.62 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.091 -0.804 . . . . 17.77 111.091 170.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -155.69 -45.25 0.08 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.811 0.305 . . . . 17.690000000000001 110.842 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -84.14 -50.77 7.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.003 0.43 . . . . 19.93 110.374 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 37.5 tptt -86.55 133.69 33.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.789 -0.641 . . . . 17.43 109.847 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -144.64 147.24 32.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.241 0.46 . . . . 19.359999999999999 112.241 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.41 ' CZ ' ' HA ' ' A' ' 76' ' ' ARG . 95.1 m-85 56.45 41.08 29.29 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.29 -0.868 . . . . 18.960000000000001 111.894 175.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -160.38 39.01 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.68 0.752 . . . . 18.239999999999998 109.338 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.416 ' HB3' ' HA3' ' A' ' 78' ' ' GLY . 4.7 p-10 -65.08 144.03 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.248 -0.887 . . . . 16.780000000000001 111.303 -177.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -150.35 90.94 1.7 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.849 -0.614 . . . . 18.420000000000002 110.244 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -120.03 4.74 10.88 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.675 -0.693 . . . . 17.920000000000002 110.353 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.09 -42.2 5.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.624 . . . . 19.550000000000001 111.106 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.0 38.8 1.0 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.126 0.489 . . . . 20.309999999999999 111.137 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 41' ' ' ILE . 28.2 pt -127.72 90.2 48.76 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 121.353 0.597 . . . . 19.920000000000002 110.712 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.76 59.27 4.96 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.134 2.556 . . . . 21.640000000000001 111.742 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.3 mp 57.1 32.31 21.48 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.498 -0.774 . . . . 22.670000000000002 110.772 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.517 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 79.1 t -84.44 -57.19 0.4 Allowed Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.577 -0.738 . . . . 21.34 110.706 177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 97.0 Cg_endo -77.4 137.0 16.29 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.889 1.726 . . . . 20.0 112.054 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.17 -31.9 11.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.393 0.616 . . . . 21.079999999999998 109.523 176.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' A' ' 84' ' ' SER . . . -105.69 136.76 44.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.512 -0.767 . . . . 18.800000000000001 109.041 172.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.446 ' HA2' ' HD3' ' A' ' 53' ' ' PRO . . . 119.8 -22.21 8.74 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.785 -0.926 . . . . 17.510000000000002 110.785 -171.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 12.0 t70 -80.57 99.62 8.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.041 -0.726 . . . . 16.949999999999999 109.041 175.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 87.7 mtt180 70.69 -56.69 0.61 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.445 0.698 . . . . 18.300000000000001 111.473 -175.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -88.24 122.67 32.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.123 -0.49 . . . . 18.170000000000002 110.431 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.86 135.5 96.03 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.205 -0.452 . . . . 18.82 111.487 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.545 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 96.3 Cg_endo -86.03 53.78 3.28 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.004 2.469 . . . . 19.870000000000001 112.104 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.03 172.58 17.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.846 -0.616 . . . . 21.100000000000001 109.797 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 47.8 tpp -80.86 82.23 6.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.427 0.632 . . . . 22.300000000000001 109.836 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.562 ' H ' ' HD2' ' A' ' 57' ' ' PRO . 47.4 tpp -150.17 -54.4 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.568 -0.742 . . . . 23.850000000000001 109.475 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 56' ' ' MET . 13.6 Cg_endo -57.44 105.45 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.218 1.945 . . . . 20.670000000000002 112.304 172.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.76 116.57 21.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.819 -0.628 . . . . 20.489999999999998 110.105 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.71 12.5 16.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.998 -0.546 . . . . 21.469999999999999 111.194 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 p -95.26 64.05 2.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.045 0.45 . . . . 22.600000000000001 111.04 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 63.58 20.32 12.18 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.565 -0.743 . . . . 21.93 111.966 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.96 -29.52 14.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 19.73 110.01 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.6 mt -125.68 77.75 69.42 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.747 -0.66 . . . . 19.579999999999998 111.236 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -82.87 -10.08 10.62 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.932 2.421 . . . . 18.5 110.716 172.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.8 p -107.48 166.54 10.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.022 -0.99 . . . . 17.609999999999999 110.017 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.9 116.14 59.01 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.436 -0.579 . . . . 18.760000000000002 109.436 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -42.22 123.31 2.59 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.99 3.126 . . . . 17.280000000000001 113.2 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -29.86 113.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 1 C-N-CA 125.314 4.01 . . . . 17.77 114.66 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -123.2 -52.85 1.84 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.697 -0.683 . . . . 18.699999999999999 109.717 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 74' ' ' GLU . . . 133.69 -151.67 20.25 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.306 -0.861 . . . . 17.719999999999999 111.454 -177.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.93 -70.64 0.12 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.708 0.289 . . . . 18.0 110.783 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.12 -69.55 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.397 -0.365 . . . . 17.960000000000001 110.636 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -88.21 -16.49 33.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.259 0.552 . . . . 19.850000000000001 109.948 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.51 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 38.8 tt0 -97.04 120.89 38.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.897 -0.592 . . . . 19.670000000000002 110.547 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.31 138.35 15.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.938 -1.134 . . . . 17.739999999999998 107.938 172.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.41 ' HA ' ' CZ ' ' A' ' 34' ' ' TYR . 10.4 ptm180 -146.22 -50.21 0.22 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.556 0.947 . . . . 19.949999999999999 113.556 -171.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.85 166.82 22.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.325 0.583 . . . . 18.390000000000001 112.293 -168.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 36' ' ' ASP . . . 153.18 113.55 0.53 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.34 -0.845 . . . . 17.66 111.572 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.466 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 33.4 t70 -93.23 150.36 20.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.934 0.397 . . . . 17.68 110.562 -177.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.93 -8.46 58.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.511 -0.768 . . . . 17.800000000000001 111.719 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.27 33.45 20.93 Favored 'General case' 0 N--CA 1.461 0.079 0 O-C-N 123.96 0.788 . . . . 17.350000000000001 111.501 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.429 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . . . -98.39 -51.79 0.21 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.684 -0.689 . . . . 16.640000000000001 112.641 -177.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 6.0 Cg_exo -78.29 57.79 6.38 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.334 2.023 . . . . 17.23 112.801 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 29.5 t -75.03 78.66 2.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.072 0.463 . . . . 17.34 110.428 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 85' ' ' LEU . 2.7 pt? -77.69 -35.46 52.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 18.41 110.419 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 6.3 m-20 -83.71 121.62 76.27 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.235 -0.439 . . . . 17.449999999999999 110.802 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 86' ' ' ASP . 7.9 Cg_exo -72.95 -8.55 22.45 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.787 2.324 . . . . 18.890000000000001 111.814 176.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 68.22 -64.1 0.31 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.611 0.764 . . . . 17.809999999999999 110.97 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.6 m -94.16 110.0 21.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.21 -0.663 . . . . 18.629999999999999 109.21 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.6 mt -77.26 75.68 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.443 0.639 . . . . 19.100000000000001 110.283 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.96 11.1 7.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.484 -0.78 . . . . 19.25 110.475 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 69.9 -66.78 0.26 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.471 -0.786 . . . . 18.789999999999999 111.78 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -157.84 161.36 38.33 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.434 -0.58 . . . . 18.949999999999999 109.434 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -80.76 61.83 4.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.298 0.57 . . . . 20.309999999999999 111.435 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.489 HG23 ' HG2' ' A' ' 96' ' ' GLU . 3.4 t -87.11 -42.28 13.16 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.886 -0.783 . . . . 21.399999999999999 108.886 169.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' HG2' HG23 ' A' ' 95' ' ' THR . 25.7 mm-40 -107.27 -43.69 4.52 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.295 -0.411 . . . . 21.16 111.076 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.0 t80 178.13 95.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.975 0.416 . . . . 22.18 110.925 -172.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -95.25 -46.22 0.27 Allowed Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 115.905 -0.589 . . . . 19.449999999999999 112.032 176.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.06 75.2 3.31 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.188 1.925 . . . . 18.530000000000001 112.847 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.408 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 10.9 tp10 -68.07 -49.67 34.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.016 -0.538 . . . . 17.449999999999999 111.532 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 98.1 Cg_endo -76.94 45.12 1.6 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.091 1.861 . . . . 17.420000000000002 112.509 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.0 138.4 32.04 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 115.944 -0.571 . . . . 17.68 110.685 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.38 78.73 3.56 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.549 2.166 . . . . 16.289999999999999 111.272 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 104' ' ' VAL . 11.1 m -86.35 46.89 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.626 -0.715 . . . . 17.260000000000002 111.293 -177.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.6 87.42 0.13 Allowed Pre-proline 0 C--O 1.232 0.16 0 CA-C-N 115.426 -0.806 . . . . 15.800000000000001 111.799 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.79 114.75 3.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.385 2.057 . . . . 15.92 110.396 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.4 -28.27 62.86 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.555 2.17 . . . . 16.149999999999999 112.666 -173.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -148.21 91.92 4.7 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.208 -0.451 . . . . 17.629999999999999 110.12 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.38 -33.63 57.65 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.369 2.046 . . . . 15.039999999999999 111.687 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -140.64 125.86 11.15 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.61 -0.723 . . . . 15.199999999999999 110.636 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -74.65 118.28 5.26 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.178 1.918 . . . . 14.08 110.776 170.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.3 p -83.32 52.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 122.667 1.222 . . . . 15.279999999999999 110.416 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -86.61 131.26 46.14 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.682 -1.145 . . . . 16.84 109.529 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -56.72 115.45 2.49 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.481 2.12 . . . . 15.51 111.713 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.412 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 58.0 Cg_endo -72.2 155.97 55.84 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.437 2.091 . . . . 16.039999999999999 112.391 -176.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -109.22 91.56 9.79 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 18.91 109.572 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 115' ' ' PRO . 61.6 Cg_endo -89.74 36.32 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.802 2.335 . . . . 17.039999999999999 112.843 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 pttm 45.48 101.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.692 1.197 . . . . 17.52 113.108 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.2 m -62.97 -28.96 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 18.699999999999999 111.471 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.21 84.93 2.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.514 0.673 . . . . 20.879999999999999 109.889 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.32 116.7 62.4 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.488 -0.778 . . . . 18.890000000000001 111.069 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -88.63 166.19 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.981 2.454 . . . . 20.43 111.687 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.56 67.43 6.39 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.598 2.199 . . . . 21.100000000000001 111.331 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -135.65 132.11 19.52 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.911 -0.586 . . . . 21.149999999999999 110.797 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.08 142.81 88.88 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.737 2.291 . . . . 21.149999999999999 111.501 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.515 ' O ' ' HD2' ' A' ' 129' ' ' PRO . 52.1 mtmt -55.57 -38.5 68.68 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 114.812 1.412 . . . . 21.879999999999999 114.812 -171.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.88 -23.61 35.06 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.022 1.815 . . . . 20.190000000000001 114.581 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.5 ' HB2' ' HD3' ' A' ' 129' ' ' PRO . 30.5 mt-10 -70.62 -52.82 10.33 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 119.006 -0.521 . . . . 20.48 111.979 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 126' ' ' LYS . 77.1 Cg_exo -52.75 103.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.11 1.873 . . . . 21.170000000000002 112.225 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.401 ' HB2' ' HD3' ' A' ' 131' ' ' PRO . 24.7 mtpp -83.32 -43.64 0.84 Allowed Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 112.234 0.457 . . . . 23.18 112.234 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' A' ' 130' ' ' LYS . 78.0 Cg_exo -54.03 112.96 1.12 Allowed 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.048 1.832 . . . . 20.780000000000001 111.917 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.6 m -81.49 36.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.786 0.803 . . . . 19.75 111.91 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 10.6 p -131.76 -2.42 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.824 -1.08 . . . . 21.050000000000001 109.865 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -100.28 -7.44 24.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.737 -1.119 . . . . 21.300000000000001 110.04 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -121.68 -162.16 0.96 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.424 -0.807 . . . . 20.739999999999998 109.873 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 136' ' ' LYS . 8.3 mptt -95.36 -75.96 0.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.688 -0.405 . . . . 17.969999999999999 110.283 -172.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' A' ' 193' ' ' SER . . . -109.79 18.6 20.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.325 -0.398 . . . . 17.350000000000001 109.947 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.401 ' O ' ' HB1' ' A' ' 192' ' ' ALA . . . 72.62 151.8 0.14 Allowed Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 114.771 -1.104 . . . . 19.100000000000001 111.785 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.01 -18.98 7.8 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 124.272 3.315 . . . . 19.350000000000001 114.538 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.7 t -163.99 32.21 0.08 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.591 0.71 . . . . 17.75 109.982 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.6 -79.1 0.85 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.468 -0.872 . . . . 17.960000000000001 111.438 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -114.49 69.19 0.71 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.548 -0.538 . . . . 19.420000000000002 109.548 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.607 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . -78.38 159.78 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.991 -0.549 . . . . 14.65 109.784 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.575 ' CB ' HD21 ' A' ' 197' ' ' LEU . 3.8 m-85 -144.45 159.96 41.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.851 0.357 . . . . 14.81 111.743 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.73 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.4 m -151.17 153.05 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.57 -0.741 . . . . 10.48 109.989 -176.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 61.0 t -106.45 111.17 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.582 -0.447 . . . . 10.1 110.593 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -88.4 105.49 17.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.238 -0.437 . . . . 12.0 110.769 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.971 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -83.72 -37.03 23.23 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.351 0.596 . . . . 11.880000000000001 109.987 -175.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.18 161.93 27.87 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.261 -0.881 . . . . 11.35 111.846 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -162.63 104.66 1.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.573 -0.529 . . . . 13.470000000000001 109.573 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 156' ' ' LYS . 1.5 pt? -153.26 165.64 35.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.309 0.576 . . . . 13.52 111.058 -176.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 82.3 mttt -98.44 7.1 46.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.255 -0.884 . . . . 17.600000000000001 110.914 -172.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -99.64 97.13 8.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.478 -0.783 . . . . 16.140000000000001 109.877 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.98 -27.29 68.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.326 0.584 . . . . 14.039999999999999 110.246 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.07 -37.22 66.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.931 -1.031 . . . . 16.57 110.551 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.555 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 66.1 mttm -90.5 -25.81 20.09 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.181 -0.918 . . . . 16.399999999999999 110.691 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' THR . 69.7 t -57.84 -40.46 76.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.437 0.637 . . . . 12.67 109.636 173.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -61.05 -33.4 73.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 15.32 112.183 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 12.6 pt-20 -83.91 -22.84 31.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.463 -0.495 . . . . 15.970000000000001 111.633 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 156' ' ' LYS . 16.8 mt -81.05 -49.68 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.345 0.593 . . . . 12.6 109.448 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 45.8 t -69.62 -32.71 53.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.26 -0.882 . . . . 12.539999999999999 110.449 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -56.74 -31.97 61.3 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.907 -0.664 . . . . 14.800000000000001 112.342 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -73.54 -62.13 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.781 0.324 . . . . 16.050000000000001 111.172 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.6 mm? -72.32 -50.37 27.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.085 0.402 . . . . 12.99 112.085 -173.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 31.2 ttm180 -64.13 -47.24 80.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.394 0.616 . . . . 15.06 110.098 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.23 -34.79 90.86 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.916 -1.038 . . . . 16.600000000000001 113.047 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -80.14 -7.39 58.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.973 0.416 . . . . 16.140000000000001 110.718 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.24 24.73 15.76 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.878 -0.677 . . . . 15.119999999999999 113.222 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -93.85 152.69 18.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.75 -0.463 . . . . 15.49 109.75 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -73.35 103.88 4.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.475 0.655 . . . . 13.869999999999999 110.162 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.78 139.1 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.832 -1.076 . . . . 10.82 110.051 -173.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.46 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -141.3 176.92 8.46 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.507 0.67 . . . . 11.130000000000001 110.806 171.213 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.2 p -113.55 -176.34 2.88 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.841 -1.072 . . . . 11.52 111.193 -172.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.82 149.74 16.06 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.405 -0.361 . . . . 12.75 111.111 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -39.32 -53.86 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.347 3.365 . . . . 14.640000000000001 115.674 -170.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.4 m -87.17 -64.71 1.11 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 119.515 -0.874 . . . . 16.68 113.133 -169.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.8 m -169.13 135.72 1.46 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 118.228 0.467 . . . . 16.039999999999999 111.346 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.549 ' HB3' HG21 ' A' ' 184' ' ' THR . 44.7 Cg_exo -65.74 123.95 12.08 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.577 2.184 . . . . 14.220000000000001 112.012 162.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.68 158.57 3.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.637 -0.505 . . . . 16.129999999999999 109.637 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.63 128.21 35.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.722 0.296 . . . . 16.699999999999999 110.54 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.6 -26.17 25.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.097 -0.573 . . . . 16.98 112.3 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.7 OUTLIER -102.67 154.76 18.83 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.716 -0.476 . . . . 18.73 109.716 178.333 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 183' ' ' ILE . 7.8 tp -73.38 109.65 5.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.6 0.714 . . . . 14.82 111.082 -175.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.549 HG21 ' HB3' ' A' ' 178' ' ' PRO . 50.9 m -99.34 119.32 37.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 12.779999999999999 109.804 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 60.8 mtt-85 -101.23 140.17 35.89 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.71 -0.677 . . . . 13.98 109.789 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.609 ' C ' HD12 ' A' ' 187' ' ' LEU . 2.1 mm -107.07 120.31 58.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.95 -0.759 . . . . 10.56 108.95 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.6 mp -128.77 121.86 29.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.521 0.677 . . . . 10.1 111.152 -173.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.971 HG23 HD21 ' A' ' 148' ' ' LEU . 40.3 t -101.44 142.99 15.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.072 -0.967 . . . . 9.7400000000000002 110.465 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.401 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 77.46 48.33 8.18 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.276 -0.875 . . . . 9.7599999999999998 113.77 174.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.73 ' HA ' HG12 ' A' ' 145' ' ' VAL . 13.6 Cg_endo -64.44 123.99 12.63 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 CA-C-N 119.667 1.734 . . . . 11.15 110.62 171.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -156.75 147.85 22.04 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.841 -0.618 . . . . 12.77 109.78 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.607 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -88.68 -4.97 58.42 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.788 -0.642 . . . . 14.6 111.971 -175.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.573 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 75.6 m -115.86 92.05 3.79 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.297 0.57 . . . . 14.300000000000001 110.608 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.427 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 30.4 ttpt -52.7 -48.4 66.63 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 114.726 -1.125 . . . . 15.970000000000001 111.016 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -55.57 -38.99 70.09 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.102 0.408 . . . . 15.6 112.102 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -74.65 -41.75 59.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.006 0.431 . . . . 14.220000000000001 110.539 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.575 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -81.19 -19.66 42.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.119 0.485 . . . . 11.949999999999999 110.69 -175.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.438 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 28.1 tptp -66.16 -38.13 87.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.371 0.605 . . . . 14.699999999999999 110.31 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.21 -12.5 82.21 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.51 -1.036 . . . . 13.09 110.51 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 75.5 m -83.74 -8.71 59.19 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.7 -0.75 . . . . 12.109999999999999 111.895 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 20.2 mt -67.2 -36.35 81.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.965 0.412 . . . . 12.720000000000001 110.6 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.08 95.97 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.709 -0.678 . . . . 14.66 112.322 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.443 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 10.9 pt-20 -85.74 -18.41 33.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.902 0.382 . . . . 13.890000000000001 110.807 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.4 tp -71.81 -35.05 69.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.558 -0.292 . . . . 12.550000000000001 111.196 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.428 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 0.1 OUTLIER -65.63 -15.3 62.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.11 0.481 . . . . 15.83 110.432 174.468 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -31.89 21.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.868 -0.606 . . . . 16.969999999999999 109.658 172.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.0 mt -81.92 -52.47 7.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.612 -0.722 . . . . 13.890000000000001 111.646 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.467 ' HB3' HD11 ' A' ' 164' ' ' LEU . 61.5 p -94.0 -43.79 8.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.218 0.533 . . . . 13.539999999999999 110.618 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 72.94 -1.04 41.92 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.082 -0.963 . . . . 14.67 112.288 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.58 155.34 18.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.188 -0.671 . . . . 13.039999999999999 109.188 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.2 t -92.07 109.0 20.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.967 0.413 . . . . 14.84 110.258 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -126.27 156.13 19.65 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.136 -1.03 . . . . 12.220000000000001 113.729 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 p -103.63 147.56 9.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.208 -0.496 . . . . 13.74 110.036 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.7 106.06 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 12.890000000000001 110.478 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 24.5 mmt -113.26 143.86 43.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.859 -0.61 . . . . 13.800000000000001 110.104 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -75.18 136.42 20.38 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.227 -0.987 . . . . 13.359999999999999 111.874 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.557 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 8.8 t80 -105.1 130.93 53.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.476 0.655 . . . . 14.24 110.052 -174.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 42.3 m -145.13 94.51 5.29 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 108.378 -0.971 . . . . 16.510000000000002 108.378 172.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.78 145.42 98.25 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.917 2.411 . . . . 17.420000000000002 113.189 -172.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 . . . . . 0 C--O 1.244 0.769 0 CA-C-O 118.35 -0.833 . . . . 19.190000000000001 109.879 179.051 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.97 -0.381 . . . . 18.390000000000001 109.97 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.3 147.26 5.47 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.202 -0.999 . . . . 17.77 112.718 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.468 ' CB ' ' HB3' ' A' ' 68' ' ' PRO . 19.9 tp60 74.78 -46.68 0.61 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.903 0.881 . . . . 17.690000000000001 112.062 175.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -56.39 -46.61 80.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.48 0.657 . . . . 19.93 110.189 176.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -109.35 170.23 8.19 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.284 -1.006 . . . . 17.43 108.284 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -78.53 55.11 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.595 0.712 . . . . 19.359999999999999 112.018 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -141.39 132.75 26.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.51 -1.292 . . . . 18.960000000000001 107.51 171.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 63.72 27.54 14.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.428 0.632 . . . . 18.239999999999998 110.029 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -102.45 -39.41 7.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.274 -0.876 . . . . 16.780000000000001 109.742 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -96.59 161.26 13.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.273 -0.876 . . . . 18.420000000000002 110.099 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.63 84.81 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.685 -0.689 . . . . 17.920000000000002 111.236 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 64.57 -76.34 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.762 0.825 . . . . 19.550000000000001 111.523 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.538 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . -163.41 141.92 8.01 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.51 -0.922 . . . . 20.309999999999999 108.51 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.401 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 7.6 mm -121.79 66.36 20.45 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 120.842 -0.343 . . . . 19.920000000000002 111.279 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.538 ' HD3' ' C ' ' A' ' 40' ' ' ALA . 38.5 Cg_endo -96.64 57.82 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.015 2.477 . . . . 21.640000000000001 111.286 174.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp 59.67 45.24 13.27 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.681 -0.691 . . . . 22.670000000000002 110.508 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.57 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 77.2 t -116.45 -59.99 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.644 -0.707 . . . . 21.34 111.568 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.57 ' HD2' ' H ' ' A' ' 44' ' ' VAL . 40.9 Cg_endo -68.78 119.56 6.54 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 121.636 1.557 . . . . 20.0 112.222 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -76.55 -33.56 58.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.031 -0.531 . . . . 21.079999999999998 109.992 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.43 -8.54 57.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.802 -0.635 . . . . 18.800000000000001 110.794 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.15 -168.37 46.66 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.044 -0.598 . . . . 17.510000000000002 112.494 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.93 127.63 32.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.539 0.209 . . . . 16.949999999999999 110.847 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.463 ' HD2' ' OD2' ' A' ' 51' ' ' ASP . 4.9 ttm105 -169.9 -157.36 0.16 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.364 . . . . 18.300000000000001 110.68 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' OD2' ' HD2' ' A' ' 50' ' ' ARG . 8.1 p-10 -70.45 154.46 41.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.642 -0.708 . . . . 18.170000000000002 111.145 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -87.27 116.83 67.42 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.49 -0.777 . . . . 18.82 111.119 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . 38.2 Cg_endo -67.37 -12.3 35.31 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.582 2.188 . . . . 19.870000000000001 111.952 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -83.95 -11.85 56.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.774 . . . . 21.100000000000001 111.051 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 87.6 mtp -107.34 -81.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 22.300000000000001 111.584 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 15.2 tpt -158.0 77.83 3.5 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.217 -0.661 . . . . 23.850000000000001 109.217 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.502 ' HG3' ' HA ' ' A' ' 53' ' ' PRO . 35.1 Cg_endo -88.4 39.07 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.33 2.687 . . . . 20.670000000000002 113.075 -173.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.13 100.66 13.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.022 -0.535 . . . . 20.489999999999998 109.914 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.498 ' O ' ' HB ' ' A' ' 60' ' ' THR . . . -68.8 78.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.039 0.447 . . . . 21.469999999999999 111.166 -177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 59' ' ' ALA . 10.8 t 170.29 -28.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.215 -0.902 . . . . 22.600000000000001 109.602 -178.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -150.65 38.04 0.67 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.265 0.555 . . . . 21.93 109.828 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.96 139.97 58.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.569 -0.741 . . . . 19.73 110.872 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.4 mt -122.8 79.5 49.26 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 19.579999999999998 110.447 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.505 ' O ' ' HD2' ' A' ' 67' ' ' PRO . 79.7 Cg_endo -93.65 15.04 1.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.957 2.438 . . . . 18.5 112.346 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.02 55.36 2.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.161 0.505 . . . . 17.609999999999999 111.323 -175.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.572 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 53.5 tp60 -132.24 -52.49 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.19 -0.459 . . . . 18.760000000000002 111.004 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 66' ' ' GLN . 50.9 Cg_exo -53.11 -49.33 17.91 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.497 1.465 . . . . 17.280000000000001 112.451 169.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.468 ' HB3' ' CB ' ' A' ' 30' ' ' GLN . 32.7 Cg_endo -66.05 143.94 74.02 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.665 1.576 . . . . 17.77 111.102 170.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.56 150.01 49.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.216 0.531 . . . . 18.699999999999999 110.371 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.49 -86.99 0.97 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.352 -0.84 . . . . 17.719999999999999 113.154 -171.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 57.68 73.37 0.47 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.249 0.547 . . . . 18.0 109.952 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.26 54.04 2.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.783 -0.644 . . . . 17.960000000000001 111.654 -174.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -160.34 65.01 0.33 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.509 0.671 . . . . 19.850000000000001 109.814 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -89.73 -5.34 57.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.348 0.594 . . . . 19.670000000000002 109.652 176.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.84 156.12 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.103 -0.953 . . . . 17.739999999999998 111.149 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.46 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 6.9 tpm_? -138.11 -33.73 0.68 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.193 -0.458 . . . . 19.949999999999999 110.915 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.39 72.1 7.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.754 0.311 . . . . 18.390000000000001 110.893 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.96 -34.83 61.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.006 -0.616 . . . . 17.66 112.403 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.12 -32.65 63.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.982 0.42 . . . . 17.68 110.604 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.6 31.49 21.13 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.353 -0.839 . . . . 17.800000000000001 111.375 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.71 69.13 5.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.125 0.488 . . . . 17.350000000000001 111.345 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.527 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . . . -84.91 -50.31 0.57 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.203 -0.453 . . . . 16.640000000000001 111.806 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 82' ' ' ALA . 27.2 Cg_exo -62.6 115.0 2.63 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 121.903 1.736 . . . . 17.23 111.977 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.5 t -105.32 -169.71 1.64 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.496 -0.775 . . . . 17.34 109.848 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mp 69.84 14.99 7.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.95 0.5 . . . . 18.41 111.316 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -82.9 133.54 48.44 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.189 -0.671 . . . . 17.449999999999999 109.189 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.43 -49.61 12.84 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.605 2.203 . . . . 18.890000000000001 112.551 -174.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 34.13 64.04 0.38 Allowed 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.484 1.115 . . . . 17.809999999999999 112.601 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.8 t -125.22 151.54 45.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.377 -0.374 . . . . 18.629999999999999 111.042 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 102' ' ' ALA . 64.7 mt 70.42 -68.51 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 123.839 0.712 . . . . 19.100000000000001 111.356 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.63 114.45 8.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.642 -0.503 . . . . 19.25 109.642 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -129.03 -63.02 0.98 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.297 -0.411 . . . . 18.789999999999999 110.989 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 53.8 t30 63.06 90.47 0.08 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.785 0.678 . . . . 18.949999999999999 110.34 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -113.47 46.16 1.31 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.162 -0.472 . . . . 20.309999999999999 111.092 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.0 t -73.43 -30.15 63.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.033 -0.531 . . . . 21.399999999999999 109.948 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.26 8.85 16.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.61 -0.723 . . . . 21.16 109.142 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.4 t80 58.55 55.31 4.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.27 -1.332 . . . . 22.18 111.045 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -105.64 109.82 63.58 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.268 -0.642 . . . . 19.449999999999999 109.268 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.14 71.39 3.6 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.702 2.268 . . . . 18.530000000000001 112.395 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.451 ' OE2' ' HD2' ' A' ' 101' ' ' PRO . 8.7 tp10 -87.91 115.81 64.22 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.772 -0.649 . . . . 17.449999999999999 109.727 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.451 ' HD2' ' OE2' ' A' ' 100' ' ' GLU . 32.3 Cg_exo -60.37 166.89 8.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.866 2.377 . . . . 17.420000000000002 111.996 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.404 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . . . -70.31 115.49 35.25 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.253 -0.43 . . . . 17.68 109.904 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.1 91.48 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.888 2.392 . . . . 16.289999999999999 113.052 -172.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.0 p -77.89 55.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.683 1.23 . . . . 17.260000000000002 109.834 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.669 ' HB1' ' HD2' ' A' ' 106' ' ' PRO . . . -137.81 178.87 1.51 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 114.816 -1.084 . . . . 15.800000000000001 110.081 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.669 ' HD2' ' HB1' ' A' ' 105' ' ' ALA . 49.5 Cg_exo -42.28 -39.54 6.32 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.013 2.475 . . . . 15.92 115.889 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 106' ' ' PRO . 1.5 Cg_endo -43.76 -30.6 3.0 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 123.24 2.627 . . . . 16.149999999999999 114.322 175.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -61.23 127.57 88.29 Favored Pre-proline 0 C--O 1.233 0.193 0 C-N-CA 121.17 -0.212 . . . . 17.629999999999999 110.631 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.92 106.08 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.255 2.637 . . . . 15.039999999999999 112.887 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.448 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 59.3 pttt -139.99 158.54 67.1 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.463 -0.94 . . . . 15.199999999999999 108.463 175.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 110' ' ' LYS . 9.9 Cg_endo -49.99 119.13 4.48 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.753 2.302 . . . . 14.08 112.415 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.501 HG12 ' ND2' ' A' ' 220' ' ' ASN . 7.7 p -81.6 64.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.86 0.838 . . . . 15.279999999999999 109.298 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 35.2 mm-40 80.92 126.78 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 114.284 -1.326 . . . . 16.84 110.266 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.04 145.07 65.77 Favored 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 122.758 2.306 . . . . 15.51 111.507 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.61 57.05 2.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.01 2.473 . . . . 16.039999999999999 112.888 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 7.1 ttpm? -78.33 -39.66 1.73 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.65 -0.704 . . . . 18.91 110.141 173.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 47.6 Cg_exo -59.56 120.4 8.21 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 121.139 1.226 . . . . 17.039999999999999 110.574 166.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . 29.1 mmmt 67.15 65.19 0.43 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.776 0.673 . . . . 17.52 110.759 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.2 115.2 5.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.644 0.259 . . . . 18.699999999999999 110.47 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 59.01 50.92 7.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.775 -0.648 . . . . 20.879999999999999 110.506 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . . . -53.79 114.1 5.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 18.890000000000001 110.849 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.04 135.28 61.65 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.556 2.171 . . . . 20.43 111.635 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.51 101.5 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.002 2.468 . . . . 21.100000000000001 112.294 -177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.39 147.35 98.17 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.656 -0.702 . . . . 21.149999999999999 110.268 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.34 73.98 0.38 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.806 2.337 . . . . 21.149999999999999 112.153 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 126' ' ' LYS . 17.4 pttp -55.38 112.59 4.35 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.189 -0.914 . . . . 21.879999999999999 111.808 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.29 -54.24 1.9 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.246 2.631 . . . . 20.190000000000001 112.332 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -143.43 88.06 8.15 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.991 0.424 . . . . 20.48 110.503 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.33 87.7 1.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.533 2.155 . . . . 21.170000000000002 111.183 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -64.26 116.81 30.99 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.706 -0.679 . . . . 23.18 110.734 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.29 107.29 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.494 2.13 . . . . 20.780000000000001 111.517 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.35 39.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 122.057 0.932 . . . . 19.75 110.526 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -157.53 133.69 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.493 -1.23 . . . . 21.050000000000001 109.867 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 136' ' ' LYS . 16.6 pt-20 -154.96 44.32 0.49 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.597 -0.89 . . . . 21.300000000000001 108.597 -178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 57.84 63.44 1.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.095 -0.957 . . . . 20.739999999999998 108.784 -166.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.607 ' HB3' ' CB ' ' A' ' 192' ' ' ALA . 67.4 mttm -92.47 87.67 6.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.892 -1.049 . . . . 17.969999999999999 109.128 -175.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . 56.8 42.12 27.1 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.131 -1.063 . . . . 17.350000000000001 108.131 -169.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 72.71 145.67 0.11 Allowed Pre-proline 0 C--N 1.341 0.219 0 CA-C-N 113.903 -1.499 . . . . 19.100000000000001 110.46 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -41.26 86.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.704 3.603 . . . . 19.350000000000001 114.634 -169.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.482 ' HB ' ' CG ' ' A' ' 219' ' ' PRO . 62.5 p 49.78 32.02 4.95 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.326 -0.852 . . . . 17.75 112.246 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.64 -59.22 1.45 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.783 -0.722 . . . . 17.960000000000001 111.449 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.46 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 65.1 mttm -94.78 71.16 3.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.002 0.43 . . . . 19.420000000000002 109.887 175.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.846 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . -104.61 158.41 16.52 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.669 -0.493 . . . . 14.65 109.669 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.64 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 16.1 m-85 -137.23 144.89 43.02 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.454 0.168 . . . . 14.81 111.233 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 190' ' ' PRO . 3.2 m -151.3 164.81 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 122.932 0.493 . . . . 10.48 110.827 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 44.4 t -114.72 108.98 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.778 0.323 . . . . 10.1 111.021 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.404 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 33.2 tt0 -84.84 111.55 19.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.541 -0.3 . . . . 12.0 110.796 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.996 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -91.29 -35.32 14.52 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.327 0.584 . . . . 11.880000000000001 109.804 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.39 166.52 27.66 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.667 -0.778 . . . . 11.35 112.475 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -167.33 101.31 0.51 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.117 -0.697 . . . . 13.470000000000001 109.117 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.71 159.32 42.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.323 0.582 . . . . 13.52 110.978 -171.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 181' ' ' GLY . 5.0 mmmm -98.02 5.29 48.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.892 -1.049 . . . . 17.600000000000001 110.027 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -112.61 106.67 15.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.979 -1.01 . . . . 16.140000000000001 110.041 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.41 ' HA ' ' CG2' ' A' ' 157' ' ' VAL . . . -61.5 -22.09 64.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.205 -0.452 . . . . 14.039999999999999 111.838 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.09 -35.52 73.54 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.814 0.816 . . . . 16.57 110.129 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.592 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 97.8 mttt -86.62 -25.71 24.76 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.609 -1.178 . . . . 16.399999999999999 110.289 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 184' ' ' THR . 90.0 t -61.61 -45.26 99.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.92 -0.582 . . . . 12.67 110.154 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -60.72 -33.83 73.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.628 -0.714 . . . . 15.32 112.007 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 15.7 pt-20 -78.25 -36.82 46.44 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.589 -0.444 . . . . 15.970000000000001 111.214 -175.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 156' ' ' LYS . 20.6 mt -72.02 -46.67 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.666 0.746 . . . . 12.6 109.756 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.97 -34.3 69.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.738 -1.119 . . . . 12.539999999999999 110.519 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.44 -27.0 67.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 14.800000000000001 112.281 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -71.99 -54.79 8.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.112 0.482 . . . . 16.050000000000001 111.068 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.473 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 4.3 mm? -85.7 -62.78 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 12.99 112.38 -174.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -63.18 -37.22 86.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.28 0.562 . . . . 15.06 109.925 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.71 -17.29 79.14 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.015 -0.993 . . . . 16.600000000000001 112.522 -176.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -100.71 -6.7 24.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.785 0.326 . . . . 16.140000000000001 110.982 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.87 25.66 19.39 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.382 -0.914 . . . . 15.119999999999999 113.153 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -93.72 150.91 20.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.3 0.55 . . . . 15.49 109.799 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 102.83 2.12 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.669 0.747 . . . . 13.869999999999999 110.058 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.83 144.23 24.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.342 -1.299 . . . . 10.82 109.337 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.63 177.18 8.2 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.768 0.794 . . . . 11.130000000000001 110.862 170.485 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 17.8 p -124.65 -175.17 3.2 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.173 -1.376 . . . . 11.52 110.0 -171.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 62.4 m -50.62 128.53 26.06 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.931 -0.308 . . . . 12.75 110.385 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.45 ' HG2' HG11 ' A' ' 112' ' ' VAL . 16.5 Cg_exo -15.7 -63.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.583 1 C-N-CA 126.908 5.072 . . . . 14.640000000000001 117.047 -175.108 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.5 t -83.81 -63.29 1.38 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.574 -0.851 . . . . 16.68 112.487 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 65.1 m -168.22 134.24 1.6 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 117.62 0.191 . . . . 16.039999999999999 110.919 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.514 ' HB3' HG21 ' A' ' 184' ' ' THR . 51.9 Cg_exo -60.68 124.67 15.5 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.383 2.056 . . . . 14.220000000000001 111.86 165.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 182' ' ' LYS . 32.2 m -137.58 160.75 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 109.042 -0.725 . . . . 16.129999999999999 109.042 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.48 120.87 22.3 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.26 -0.427 . . . . 16.699999999999999 110.317 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.441 ' O ' ' HE2' ' A' ' 152' ' ' LYS . . . 109.47 -26.45 14.69 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.966 -0.635 . . . . 16.98 113.106 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.508 ' HB2' ' CG2' ' A' ' 179' ' ' VAL . 4.3 mptp? -101.11 163.61 12.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.032 0.444 . . . . 18.73 110.884 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 183' ' ' ILE . 7.6 tp -73.13 108.03 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.835 0.826 . . . . 14.82 110.88 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.514 HG21 ' HB3' ' A' ' 178' ' ' PRO . 52.5 m -101.39 107.27 18.56 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.604 0.716 . . . . 12.779999999999999 109.758 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.519 ' HB3' HD11 ' A' ' 187' ' ' LEU . 81.5 mtt180 -86.92 138.54 31.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.782 -1.099 . . . . 13.98 109.579 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.576 ' O ' HD22 ' A' ' 148' ' ' LEU . 3.6 mm -110.5 116.8 53.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.49 -0.93 . . . . 10.56 108.49 177.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 185' ' ' ARG . 4.6 mp -129.27 128.83 44.01 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.478 0.656 . . . . 10.1 110.987 -173.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.996 HG23 HD21 ' A' ' 148' ' ' LEU . 54.8 t -104.01 142.39 17.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.903 -1.044 . . . . 9.7400000000000002 110.423 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.83 49.87 7.45 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.262 -0.881 . . . . 9.7599999999999998 113.308 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.828 ' HA ' HG12 ' A' ' 145' ' ' VAL . 11.2 Cg_endo -62.44 125.72 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 CA-C-N 119.548 1.674 . . . . 11.15 110.522 172.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -159.7 169.0 24.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.565 -0.743 . . . . 12.77 109.373 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.607 ' CB ' ' HB3' ' A' ' 136' ' ' LYS . . . -110.99 5.22 20.15 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.479 0.657 . . . . 14.6 110.237 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.1 m -120.68 103.2 8.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.545 -0.752 . . . . 14.300000000000001 111.396 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.617 ' HB2' ' CE1' ' A' ' 144' ' ' TYR . 37.5 ttpt -64.11 -47.96 77.96 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.775 -0.648 . . . . 15.970000000000001 109.982 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -57.09 -33.49 67.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.005 -0.543 . . . . 15.6 111.453 -177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -75.42 -54.19 7.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.052 -0.522 . . . . 14.220000000000001 110.023 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -72.85 -19.52 61.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.079 -0.509 . . . . 11.949999999999999 111.044 -173.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.463 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 2.0 mmmm -63.91 -33.67 76.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.526 0.679 . . . . 14.699999999999999 110.918 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.74 -12.75 81.04 Favored Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.415 -1.074 . . . . 13.09 110.415 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 74.0 m -83.71 -8.72 59.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.601 -0.799 . . . . 12.109999999999999 111.994 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 9.6 mt -71.84 -38.45 70.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.805 0.335 . . . . 12.720000000000001 110.632 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.54 -24.7 68.04 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.669 -0.972 . . . . 14.66 110.669 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.568 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 43.8 mt-10 -86.64 -24.2 25.4 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.175 -0.513 . . . . 13.890000000000001 110.328 174.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.403 ' CD2' HG11 ' A' ' 146' ' ' VAL . 6.0 tp -60.01 -46.29 89.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.415 -0.357 . . . . 12.550000000000001 111.106 -175.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -21.95 46.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.13 -0.486 . . . . 15.83 111.06 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -41.03 11.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.076 -0.511 . . . . 16.969999999999999 110.938 174.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.8 mt -67.9 -52.39 36.89 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.144 0.497 . . . . 13.890000000000001 111.437 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 66.0 p -104.23 -38.07 7.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.942 -0.572 . . . . 13.539999999999999 110.748 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.39 -0.55 54.3 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.103 -0.799 . . . . 14.67 111.103 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 58.7 mt -97.47 154.13 17.69 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 122.831 0.452 . . . . 13.039999999999999 110.336 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.1 m -84.85 107.34 16.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.904 -0.589 . . . . 14.84 110.555 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -127.83 158.8 21.5 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.282 -0.961 . . . . 12.220000000000001 113.325 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.49 142.58 21.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.763 -0.458 . . . . 13.74 109.763 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.4 105.53 4.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.077 -0.712 . . . . 12.890000000000001 109.077 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 92.8 mmm -114.09 142.39 46.26 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.444 -0.798 . . . . 13.800000000000001 109.383 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -69.94 109.08 2.71 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.11 -1.043 . . . . 13.359999999999999 111.726 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.846 ' CD2' ' HB1' ' A' ' 143' ' ' ALA . 5.4 t80 -64.38 127.03 29.73 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.113 0.965 . . . . 14.24 110.457 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.4 p -144.58 91.84 6.12 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 115.535 -0.757 . . . . 16.510000000000002 109.36 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.482 ' CG ' ' HB ' ' A' ' 140' ' ' THR . 19.0 Cg_endo -61.09 139.04 82.05 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.455 2.103 . . . . 17.420000000000002 112.169 -177.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.501 ' ND2' HG12 ' A' ' 112' ' ' VAL . 5.2 m-20 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.457 -0.782 . . . . 19.190000000000001 109.691 -177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 120.766 0.317 . . . . 18.390000000000001 110.839 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.17 64.09 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.365 -0.921 . . . . 17.77 112.801 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -77.36 98.6 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.999 -0.371 . . . . 17.690000000000001 109.999 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.456 ' HD2' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -136.87 121.53 18.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.2 0.524 . . . . 19.93 110.951 178.212 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.5 tptm -96.92 83.65 3.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.665 -0.865 . . . . 17.43 108.665 175.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -111.25 -76.39 0.6 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.15 -0.477 . . . . 19.359999999999999 110.673 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -155.37 22.51 0.42 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.946 0.35 . . . . 18.960000000000001 111.946 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -104.85 -116.07 0.23 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.507 -0.923 . . . . 18.239999999999998 108.507 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 66.38 -70.27 0.11 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.037 0.535 . . . . 16.780000000000001 111.604 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 60.04 55.06 3.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.241 0.544 . . . . 18.420000000000002 110.717 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 51' ' ' ASP . 49.6 m-85 -70.09 -49.56 49.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.164 -0.471 . . . . 17.920000000000002 110.814 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.06 33.97 5.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.535 -0.302 . . . . 19.550000000000001 110.844 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 68.85 -66.53 0.24 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.084 0.865 . . . . 20.309999999999999 111.723 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.511 HG22 ' HG2' ' A' ' 45' ' ' PRO . 35.7 pt 40.19 71.74 1.16 Allowed Pre-proline 0 N--CA 1.467 0.416 0 C-N-CA 124.12 0.968 . . . . 19.920000000000002 112.675 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.38 57.52 4.83 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.268 2.645 . . . . 21.640000000000001 111.891 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 43' ' ' LEU . 4.3 mm? 60.09 27.67 17.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.547 -0.751 . . . . 22.670000000000002 110.898 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.622 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 93.9 t -90.9 -54.77 0.27 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.94 -0.573 . . . . 21.34 111.081 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 30.8 Cg_endo -99.81 -177.95 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.888 2.392 . . . . 20.0 111.592 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -104.23 -1.08 27.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.988 0.423 . . . . 21.079999999999998 110.438 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.0 172.79 17.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.653 -0.703 . . . . 18.800000000000001 109.272 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.64 57.01 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.302 -0.951 . . . . 17.510000000000002 112.419 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.2 94.14 5.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.941 0.4 . . . . 16.949999999999999 110.224 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -80.14 -37.7 32.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 18.300000000000001 109.831 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.41 ' HB2' ' CD1' ' A' ' 38' ' ' PHE . 7.1 m-20 -97.7 110.37 22.95 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.1 -1.074 . . . . 18.170000000000002 108.1 169.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.561 ' HG3' ' HB2' ' A' ' 54' ' ' ASP . 14.0 tp10 -81.47 114.85 52.8 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.255 -0.43 . . . . 18.82 110.918 -172.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.28 44.51 1.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.904 2.402 . . . . 19.870000000000001 111.782 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.561 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 7.5 t70 -84.97 69.31 10.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.761 -0.654 . . . . 21.100000000000001 110.109 -177.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 88.4 mtp 70.26 -14.7 0.38 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.515 -0.766 . . . . 22.300000000000001 112.246 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 50.1 ttm -171.44 90.64 0.44 Allowed Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 108.953 -0.758 . . . . 23.850000000000001 108.953 -175.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -85.39 51.38 2.96 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.84 2.36 . . . . 20.670000000000002 112.11 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.18 113.6 6.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.317 -0.856 . . . . 20.489999999999998 109.876 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.99 -17.28 13.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.253 -0.43 . . . . 21.469999999999999 111.134 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.7 m -86.28 -27.21 24.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.25 0.548 . . . . 22.600000000000001 110.112 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -138.84 152.03 47.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.63 -0.714 . . . . 21.93 109.368 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.87 71.08 8.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.183 0.516 . . . . 19.73 110.011 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 98.3 mt -123.17 114.34 29.3 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.8 -0.636 . . . . 19.579999999999998 111.429 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.89 78.93 2.74 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.703 2.269 . . . . 18.5 111.119 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -60.76 -20.78 62.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.021 -0.536 . . . . 17.609999999999999 111.601 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -61.46 120.01 51.83 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.131 -0.486 . . . . 18.760000000000002 110.849 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -103.84 83.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.537 2.825 . . . . 17.280000000000001 113.437 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.74 -90.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.563 2.175 . . . . 17.77 112.763 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 67.16 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.825 0.703 . . . . 18.699999999999999 111.559 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.14 -159.92 32.45 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.761 -0.733 . . . . 17.719999999999999 111.916 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 61.47 49.0 5.47 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.859 0.464 . . . . 18.0 111.405 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 60.62 43.12 13.0 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.395 -0.82 . . . . 17.960000000000001 111.519 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 64.24 -90.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.3 -0.863 . . . . 19.850000000000001 111.325 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -90.94 91.35 8.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.873 -0.603 . . . . 19.670000000000002 109.943 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 p -78.17 106.94 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.278 0.561 . . . . 17.739999999999998 111.094 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -175.79 -53.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.829 -0.623 . . . . 19.949999999999999 110.529 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.68 137.43 44.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.129 -0.487 . . . . 18.390000000000001 111.134 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.02 179.48 45.35 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.228 -0.749 . . . . 17.66 111.228 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -139.55 -75.19 0.36 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.061 0.431 . . . . 17.68 110.706 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -159.09 19.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 17.800000000000001 111.234 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.31 -51.92 7.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 17.350000000000001 111.008 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' H ' ' HD2' ' A' ' 83' ' ' PRO . . . -172.26 -50.12 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.153 -0.476 . . . . 16.640000000000001 111.632 -176.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.499 ' HD2' ' H ' ' A' ' 82' ' ' ALA . 92.8 Cg_exo -41.55 107.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 123.207 2.605 . . . . 17.23 113.546 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -124.32 143.16 50.73 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.04 -0.982 . . . . 17.34 109.485 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.28 120.72 13.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.363 -0.38 . . . . 18.41 110.008 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.1 118.88 30.19 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.952 -0.567 . . . . 17.449999999999999 111.07 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.28 -14.18 18.56 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.889 2.392 . . . . 18.890000000000001 112.784 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.04 -3.77 56.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.006 0.431 . . . . 17.809999999999999 110.744 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.0 p 50.12 39.02 18.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.134 -0.939 . . . . 18.629999999999999 112.108 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.88 1.65 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.952 -0.567 . . . . 19.100000000000001 110.589 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.01 162.21 29.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.509 -0.769 . . . . 19.25 110.733 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.1 68.24 4.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.217 -0.447 . . . . 18.789999999999999 111.205 -176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -132.5 -56.41 0.95 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.591 . . . . 18.949999999999999 110.045 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -95.26 18.82 11.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.865 -0.607 . . . . 20.309999999999999 110.397 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -62.46 -45.7 91.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.545 -0.752 . . . . 21.399999999999999 110.934 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -118.29 25.69 10.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.101 0.477 . . . . 21.16 109.848 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.1 t80 57.77 71.03 0.6 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.908 -1.042 . . . . 22.18 111.205 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 63.75 100.33 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.719 -0.673 . . . . 19.449999999999999 110.993 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -44.83 106.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.716 2.944 . . . . 18.530000000000001 113.58 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.495 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 34.0 tt0 -173.49 -53.36 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.652 -0.704 . . . . 17.449999999999999 111.142 -178.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 100' ' ' GLU . 20.2 Cg_endo -60.93 -39.49 60.71 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 122.125 1.883 . . . . 17.420000000000002 112.438 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 46.87 76.71 0.52 Allowed Pre-proline 0 C--O 1.234 0.274 0 O-C-N 123.806 0.692 . . . . 17.68 112.502 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.96 116.02 2.87 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.934 2.422 . . . . 16.289999999999999 112.292 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 104' ' ' VAL . 5.0 m -86.04 82.12 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.074 -0.512 . . . . 17.260000000000002 111.075 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.15 83.19 0.21 Allowed Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 115.61 -0.723 . . . . 15.800000000000001 111.055 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 64.0 Cg_exo -52.26 117.05 3.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.292 2.661 . . . . 15.92 112.345 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 16.4 Cg_exo -68.3 -20.69 42.47 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.946 2.431 . . . . 16.149999999999999 112.635 -177.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -113.47 111.88 49.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.436 -0.347 . . . . 17.629999999999999 110.778 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 26.0 Cg_exo -64.37 172.11 7.0 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.953 2.436 . . . . 15.039999999999999 111.839 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 109' ' ' PRO . 24.9 mtpp 74.08 141.18 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 123.8 0.687 . . . . 15.199999999999999 111.334 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -59.87 146.99 94.37 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.645 2.23 . . . . 14.08 111.606 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.01 46.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.327 0.584 . . . . 15.279999999999999 111.874 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 51.21 84.83 0.2 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 114.653 -1.158 . . . . 16.84 111.552 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -67.15 164.13 31.45 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.774 2.316 . . . . 15.51 111.781 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -48.31 -49.31 14.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.585 2.19 . . . . 16.039999999999999 112.204 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -122.39 96.28 46.17 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.969 -0.56 . . . . 18.91 110.084 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.18 47.79 2.32 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.008 2.472 . . . . 17.039999999999999 111.55 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -160.07 99.96 1.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.468 -0.787 . . . . 17.52 109.278 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.38 90.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.558 0.694 . . . . 18.699999999999999 112.009 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -157.6 13.43 0.22 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.852 -1.067 . . . . 20.879999999999999 109.136 172.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.9 162.98 62.83 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 114.515 -1.221 . . . . 18.890000000000001 110.143 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.417 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 87.4 Cg_exo -41.83 -49.57 5.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.725 2.284 . . . . 20.43 113.552 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 122' ' ' PRO . 27.8 Cg_endo -63.03 111.67 1.46 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 121.778 1.652 . . . . 21.100000000000001 111.805 172.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.84 136.99 29.82 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.405 -0.361 . . . . 21.149999999999999 111.173 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.4 62.32 8.13 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.756 2.304 . . . . 21.149999999999999 112.294 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' A' ' 32' ' ' LYS . 12.6 mptt -123.26 68.84 38.97 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.975 -0.557 . . . . 21.879999999999999 111.183 176.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.01 44.47 1.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.228 1.952 . . . . 20.190000000000001 111.091 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.403 ' OE2' ' HG3' ' A' ' 131' ' ' PRO . 39.1 tt0 -163.68 99.41 0.97 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.7 -0.682 . . . . 20.48 110.516 -172.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.95 -55.8 0.29 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.849 2.366 . . . . 21.170000000000002 112.161 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -161.5 109.43 1.21 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 23.18 110.483 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.403 ' HG3' ' OE2' ' A' ' 128' ' ' GLU . 27.8 Cg_endo -95.28 179.04 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.339 2.693 . . . . 20.780000000000001 112.243 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.5 m -101.05 50.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.357 0.598 . . . . 19.75 109.396 172.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.9 t 57.04 76.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 114.944 -1.025 . . . . 21.050000000000001 109.589 -171.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -113.23 120.4 41.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.483 -0.781 . . . . 21.300000000000001 111.143 -174.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -108.99 175.47 5.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.674 -0.694 . . . . 20.739999999999998 109.882 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -92.33 48.29 1.39 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.894 -0.78 . . . . 17.969999999999999 108.894 176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 70.41 -4.12 1.69 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.651 -1.159 . . . . 17.350000000000001 111.582 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 64.31 166.72 0.11 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.902 -0.59 . . . . 19.100000000000001 110.514 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -71.95 1.07 6.25 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.707 2.271 . . . . 19.350000000000001 112.022 176.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 13.0 t 175.73 176.28 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.32 -0.992 . . . . 17.75 108.32 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.06 -64.35 3.35 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.371 -0.919 . . . . 17.960000000000001 112.361 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -92.76 38.58 1.02 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.476 0.655 . . . . 19.420000000000002 109.455 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.554 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -78.37 163.01 26.04 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.22 -0.9 . . . . 14.65 108.985 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.633 ' CB ' HD21 ' A' ' 197' ' ' LEU . 5.5 m-85 -145.53 153.79 41.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.515 0.198 . . . . 14.81 110.882 -175.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.861 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.7 t -149.51 161.64 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.622 -0.881 . . . . 10.48 108.622 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.548 HG11 HD22 ' A' ' 204' ' ' LEU . 17.7 t -106.39 108.19 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 122.129 -0.357 . . . . 10.1 111.715 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.554 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 30.0 tt0 -81.5 118.26 22.58 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.615 0.228 . . . . 12.0 111.615 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.938 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -91.62 -36.5 13.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.097 -0.641 . . . . 11.880000000000001 109.708 177.082 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.14 161.89 28.14 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.536 -0.84 . . . . 11.35 112.73 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -163.68 100.76 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.022 -0.733 . . . . 13.470000000000001 109.022 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.71 167.96 19.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.941 -0.572 . . . . 13.52 110.257 -174.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 4.9 mtpm? -104.83 20.85 18.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.325 -0.852 . . . . 17.600000000000001 109.662 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.403 ' O ' HG23 ' A' ' 157' ' ' VAL . 25.3 t-20 -130.76 118.48 20.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.847 -1.069 . . . . 16.140000000000001 109.689 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.42 -22.53 61.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.321 0.489 . . . . 14.039999999999999 112.321 -173.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.28 -34.78 78.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.935 0.874 . . . . 16.57 109.466 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.36 -29.27 34.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.338 -1.301 . . . . 16.399999999999999 110.093 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.533 ' HA ' HD11 ' A' ' 186' ' ' ILE . 97.8 t -65.82 -39.66 85.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.827 -0.624 . . . . 12.67 109.82 173.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.49 -34.57 72.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.022 -0.99 . . . . 15.32 112.13 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.86 -46.51 29.92 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 120.115 -0.634 . . . . 15.970000000000001 111.225 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.789 HD12 HD12 ' A' ' 186' ' ' ILE . 25.2 mt -59.01 -45.95 91.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.444 0.64 . . . . 12.6 109.868 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 82.2 t -68.61 -40.62 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.255 -0.884 . . . . 12.539999999999999 110.445 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.35 -34.31 88.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.045 -0.598 . . . . 14.800000000000001 112.544 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -73.61 -43.96 58.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.587 0.232 . . . . 16.050000000000001 111.046 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.643 ' HB3' HG21 ' A' ' 171' ' ' VAL . 8.5 mt -87.03 -59.15 2.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.386 0.884 . . . . 12.99 113.386 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.473 ' HG2' ' HB ' ' A' ' 171' ' ' VAL . 9.8 mtp180 -69.74 -30.05 67.56 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.848 -0.797 . . . . 15.06 108.848 -175.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.41 -31.7 77.52 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 114.633 -1.167 . . . . 16.600000000000001 111.57 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.3 -12.05 53.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.927 0.394 . . . . 16.140000000000001 110.555 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.0 23.24 13.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.892 -0.671 . . . . 15.119999999999999 113.317 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -87.79 152.54 22.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.078 0.439 . . . . 15.49 110.329 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.445 ' HG3' ' HD2' ' A' ' 190' ' ' PRO . 20.6 tpp180 -75.43 97.75 3.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.806 0.812 . . . . 13.869999999999999 109.589 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 188' ' ' VAL . 2.6 t -131.96 136.32 56.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.605 -1.18 . . . . 10.82 110.622 -173.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.424 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -135.26 174.83 10.18 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.759 0.79 . . . . 11.130000000000001 111.089 174.13 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 7.8 p -127.71 -174.52 3.21 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.165 -1.38 . . . . 11.52 110.809 -169.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 58.0 m -50.13 135.57 22.33 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 120.836 0.35 . . . . 12.75 110.477 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 30.5 Cg_exo -38.4 -44.85 2.17 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 124.714 3.609 . . . . 14.640000000000001 115.721 -169.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.6 m -87.01 -64.19 1.19 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 119.669 -0.812 . . . . 16.68 112.224 -173.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.7 m -168.52 129.13 1.08 Allowed Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 117.942 0.337 . . . . 16.039999999999999 111.861 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.522 ' HB3' HG21 ' A' ' 184' ' ' THR . 86.9 Cg_exo -58.33 125.16 17.61 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.772 2.315 . . . . 14.220000000000001 112.096 162.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.484 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.7 p -153.18 156.16 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 109.923 -0.399 . . . . 16.129999999999999 109.923 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -81.62 133.56 35.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.797 0.332 . . . . 16.699999999999999 110.202 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 102.86 -26.23 24.75 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.031 -0.604 . . . . 16.98 111.668 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -115.06 168.56 9.82 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.448 -0.575 . . . . 18.73 109.448 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 10.1 tp -76.48 126.26 36.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.471 0.653 . . . . 14.82 111.335 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.522 HG21 ' HB3' ' A' ' 178' ' ' PRO . 57.4 m -119.66 105.98 11.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.842 -0.617 . . . . 12.779999999999999 110.042 173.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 173' ' ' THR . 97.5 mtt180 -83.8 135.43 34.53 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.268 -0.878 . . . . 13.98 108.959 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.789 HD12 HD12 ' A' ' 160' ' ' ILE . 3.2 mt -119.8 120.5 63.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.577 -0.527 . . . . 10.56 109.577 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 187' ' ' LEU . 3.6 mp -129.16 142.1 50.97 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.344 -0.843 . . . . 10.1 111.114 -169.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.938 HG23 HD21 ' A' ' 148' ' ' LEU . 53.8 t -107.14 131.84 56.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.986 -1.006 . . . . 9.7400000000000002 110.926 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.86 49.62 4.73 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.19 -0.913 . . . . 9.7599999999999998 113.783 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.786 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -61.35 124.97 15.78 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 CA-C-N 119.624 1.712 . . . . 11.15 110.854 172.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -159.62 149.14 18.27 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.762 -0.458 . . . . 12.77 109.762 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -89.24 6.14 41.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.968 -0.56 . . . . 14.6 111.145 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.448 ' HB3' ' HB3' ' A' ' 196' ' ' LYS . 22.7 t -118.98 96.32 5.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.253 -0.647 . . . . 14.300000000000001 109.253 175.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.489 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 15.9 ptmt -63.03 -35.67 81.01 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.027 -0.988 . . . . 15.970000000000001 111.583 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -68.69 -44.42 74.01 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.996 0.427 . . . . 15.6 110.628 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 193' ' ' SER . 44.0 tttm -59.42 -44.07 92.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.765 -0.652 . . . . 14.220000000000001 110.698 176.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.633 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -82.54 -16.96 46.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.654 -0.703 . . . . 11.949999999999999 110.487 -176.307 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.622 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 25.3 tptp -64.57 -34.57 78.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 14.699999999999999 110.761 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -82.22 -12.56 80.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.391 -1.084 . . . . 13.09 110.391 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.516 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 70.9 m -79.58 -9.2 59.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.655 -0.772 . . . . 12.109999999999999 111.498 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 1.8 mt -74.11 -33.38 63.58 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.509 -0.552 . . . . 12.720000000000001 109.509 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -61.45 -28.23 69.18 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.551 -1.019 . . . . 14.66 110.551 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.545 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 41.8 mt-10 -85.85 -19.17 31.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.062 -0.569 . . . . 13.890000000000001 110.664 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.548 HD22 HG11 ' A' ' 146' ' ' VAL . 4.6 tp -60.59 -45.01 95.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.796 0.332 . . . . 12.550000000000001 111.553 -173.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -57.85 -23.88 54.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.302 -0.408 . . . . 15.83 111.224 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.38 -37.89 14.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.338 -0.392 . . . . 16.969999999999999 110.466 176.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 89.6 mt -70.9 -51.77 24.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.321 0.581 . . . . 13.890000000000001 111.052 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.564 ' CB ' HD21 ' A' ' 164' ' ' LEU . 28.4 t -110.11 -43.94 3.86 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.502 -0.772 . . . . 13.539999999999999 111.264 -173.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.34 -0.23 55.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.748 -0.739 . . . . 14.67 111.606 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.14 157.51 15.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.684 -0.487 . . . . 13.039999999999999 109.684 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 61.2 m -77.1 95.45 4.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.949 0.405 . . . . 14.84 111.1 -174.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -103.94 138.58 14.13 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.651 -0.704 . . . . 12.220000000000001 113.439 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.0 142.03 21.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.298 0.571 . . . . 13.74 110.066 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.6 t -78.68 105.94 8.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.434 -0.803 . . . . 12.890000000000001 110.419 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 90.1 mtp -120.31 142.59 48.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.073 -0.512 . . . . 13.800000000000001 110.258 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -69.22 136.03 28.12 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.624 -0.798 . . . . 13.359999999999999 112.416 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.861 ' HB2' HG23 ' A' ' 145' ' ' VAL . 10.5 t80 -100.67 124.61 46.52 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.396 -0.902 . . . . 14.24 110.102 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 219' ' ' PRO . 5.2 t -142.39 93.32 7.13 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 109.318 -0.623 . . . . 16.510000000000002 109.318 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 218' ' ' THR . 17.2 Cg_endo -59.36 138.6 85.3 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.744 2.296 . . . . 17.420000000000002 112.893 -174.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 33.2 t30 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.398 -0.811 . . . . 19.190000000000001 110.18 -179.299 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 30.3 t70 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.894 0.378 . . . . 18.390000000000001 110.349 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.05 153.74 25.54 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.36 -0.924 . . . . 17.77 111.786 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -82.36 65.71 7.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.944 0.402 . . . . 17.690000000000001 110.34 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? 58.73 26.07 14.19 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.544 -0.753 . . . . 19.93 110.946 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -97.61 77.54 2.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.682 -0.69 . . . . 17.43 110.637 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -86.82 95.07 9.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.672 -0.694 . . . . 19.359999999999999 110.173 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.5 t80 66.55 36.03 5.15 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.031 -0.986 . . . . 18.960000000000001 110.519 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -91.41 -42.06 10.53 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.952 -0.759 . . . . 18.239999999999998 108.952 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -153.51 128.82 9.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.017 -0.992 . . . . 16.780000000000001 109.585 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -98.77 31.73 2.84 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.986 -0.746 . . . . 18.420000000000002 108.986 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.46 ' CE2' ' HB2' ' A' ' 49' ' ' ASP . 7.5 m-30 68.14 -77.09 0.05 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.786 -1.097 . . . . 17.920000000000002 109.543 -173.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.18 -76.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.605 0.762 . . . . 19.550000000000001 112.942 174.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.83 -5.39 37.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.003 0.372 . . . . 20.309999999999999 112.003 -173.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.2 pt -127.2 64.77 62.64 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 111.97 0.359 . . . . 19.920000000000002 111.97 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.51 92.03 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.305 2.004 . . . . 21.640000000000001 111.666 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.1 mp 61.99 31.35 18.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.701 -0.681 . . . . 22.670000000000002 111.145 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.513 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 62.2 t -93.77 -50.86 0.26 Allowed Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 21.34 111.352 177.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.513 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 11.4 Cg_endo -88.03 -67.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.901 1.734 . . . . 20.0 112.499 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -152.67 69.06 0.85 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.028 -0.73 . . . . 21.079999999999998 109.028 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 70.18 -67.54 0.23 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.086 -0.961 . . . . 18.800000000000001 111.012 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -131.07 -120.71 2.22 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.822 -0.704 . . . . 17.510000000000002 112.739 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 22.8 t0 -80.19 122.06 26.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.971 0.415 . . . . 16.949999999999999 111.195 -173.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -166.86 -51.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.17 -0.678 . . . . 18.300000000000001 109.17 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -83.94 141.25 31.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.726 -0.67 . . . . 18.170000000000002 109.909 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -83.12 119.59 74.43 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.459 -0.337 . . . . 18.82 110.208 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.86 119.75 6.52 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.326 2.018 . . . . 19.870000000000001 111.141 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.78 -16.06 36.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 21.100000000000001 111.619 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.13 -28.8 69.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.541 -0.3 . . . . 22.300000000000001 110.671 176.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.3 tpt -172.84 79.99 0.42 Allowed Pre-proline 0 C--O 1.234 0.281 0 CA-C-O 120.808 0.337 . . . . 23.850000000000001 110.708 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -88.79 -167.69 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.852 2.368 . . . . 20.670000000000002 111.465 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.23 85.47 1.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.001 0.429 . . . . 20.489999999999998 111.308 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.97 156.73 48.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.16 -0.473 . . . . 21.469999999999999 110.952 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.4 m 65.35 -81.75 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.16 0.584 . . . . 22.600000000000001 111.323 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.401 ' H ' ' CD ' ' A' ' 61' ' ' GLN . 2.2 pm0 -89.47 -11.37 43.18 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.649 -0.5 . . . . 21.93 109.649 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.84 -78.55 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 114.892 -1.049 . . . . 19.73 112.04 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.1 mt 63.18 99.73 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.27 0 O-C-N 123.614 0.571 . . . . 19.579999999999998 110.222 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.59 132.53 20.63 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.142 2.561 . . . . 18.5 112.451 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.427 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 7.2 t -134.81 50.77 2.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.486 0.66 . . . . 17.609999999999999 110.877 -176.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.5 pm0 -79.89 108.7 9.77 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.511 . . . . 18.760000000000002 109.924 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 65' ' ' THR . 66.7 Cg_endo -83.75 116.89 2.26 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.527 2.151 . . . . 17.280000000000001 112.773 -175.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 73.4 Cg_endo -83.81 109.24 1.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.624 2.216 . . . . 17.77 111.02 174.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 68' ' ' PRO . 2.3 mp0 71.14 109.73 0.06 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.825 0.703 . . . . 18.699999999999999 110.283 -171.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.35 -34.55 22.86 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.677 -0.773 . . . . 17.719999999999999 111.938 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.44 55.29 2.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.05 0.453 . . . . 18.0 110.808 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . -70.77 -53.39 15.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.05 -0.523 . . . . 17.960000000000001 110.509 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -96.28 135.39 38.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.758 -0.656 . . . . 19.850000000000001 110.171 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -79.08 71.38 5.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.167 0.508 . . . . 19.670000000000002 110.128 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 m -72.94 128.55 35.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.639 -0.709 . . . . 17.739999999999998 111.241 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -97.12 -47.22 5.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.707 -0.679 . . . . 19.949999999999999 109.878 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.62 15.09 2.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.973 -0.558 . . . . 18.390000000000001 110.871 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.08 -103.91 0.87 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.818 -0.706 . . . . 17.66 111.526 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -129.14 17.8 6.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.315 -0.624 . . . . 17.68 109.315 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.68 -163.86 0.26 Allowed 'General case' 0 C--O 1.236 0.342 0 CA-C-N 114.914 -1.039 . . . . 17.800000000000001 109.882 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.11 31.65 19.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.187 0.518 . . . . 17.350000000000001 110.974 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -133.18 131.94 21.97 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.986 -0.552 . . . . 16.640000000000001 110.526 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.13 83.82 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.499 2.133 . . . . 17.23 112.312 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 p -103.33 -76.24 0.59 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.105 -0.952 . . . . 17.34 109.909 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -115.55 88.06 2.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.557 -0.905 . . . . 18.41 108.557 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -74.66 130.11 82.27 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.661 -0.7 . . . . 17.449999999999999 109.884 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.44 -18.61 49.5 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.867 2.378 . . . . 18.890000000000001 112.593 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.32 75.16 0.97 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.93 0.395 . . . . 17.809999999999999 110.563 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 m -64.51 -22.0 66.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.283 0.563 . . . . 18.629999999999999 110.322 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 24.7 pt -68.96 -16.33 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 19.100000000000001 110.912 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.43 35.93 4.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.33 0.586 . . . . 19.25 110.106 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 93' ' ' ASN . . . -73.01 -176.83 2.21 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.475 -0.784 . . . . 18.789999999999999 110.698 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 3.6 t-20 72.58 -66.39 0.31 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.092 0.557 . . . . 18.949999999999999 110.856 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -81.27 13.14 3.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.37 0.605 . . . . 20.309999999999999 111.295 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.8 t -94.83 -11.22 29.25 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.537 -0.756 . . . . 21.399999999999999 109.313 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -135.45 -32.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.628 -0.715 . . . . 21.16 111.611 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.479 ' CE1' ' HG2' ' A' ' 99' ' ' PRO . 3.0 t80 -172.25 79.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 22.18 110.172 -174.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.547 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 36.2 tt0 -53.16 -48.67 91.33 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 113.026 0.75 . . . . 19.449999999999999 113.026 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 98' ' ' GLU . 16.5 Cg_endo -58.29 -15.59 24.62 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.392 2.061 . . . . 18.530000000000001 113.933 -178.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -80.83 119.68 76.79 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.822 -0.436 . . . . 17.449999999999999 109.822 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.34 95.56 0.52 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.409 2.073 . . . . 17.420000000000002 112.078 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -61.19 130.9 91.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.851 -0.613 . . . . 17.68 110.538 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 54.4 Cg_exo -54.32 99.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.378 2.719 . . . . 16.289999999999999 113.154 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.87 112.13 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 121.774 0.797 . . . . 17.260000000000002 110.193 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.53 -50.02 90.51 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 114.838 -1.074 . . . . 15.800000000000001 112.8 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 55.2 Cg_endo -72.09 119.12 5.97 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.571 1.514 . . . . 15.92 111.496 172.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 13.9 Cg_exo -69.54 64.5 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.015 2.477 . . . . 16.149999999999999 112.683 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.425 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 8.5 mtmp? -80.4 -49.71 1.16 Allowed Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.01 -0.541 . . . . 17.629999999999999 111.398 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' A' ' 108' ' ' LYS . 88.7 Cg_endo -83.73 49.98 3.04 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.786 1.658 . . . . 15.039999999999999 112.567 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -93.21 130.72 34.91 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 120.832 0.348 . . . . 15.199999999999999 110.24 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.55 129.79 15.16 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.959 2.439 . . . . 14.08 113.119 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.5 p -94.72 40.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 122.819 1.295 . . . . 15.279999999999999 109.864 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -67.35 162.27 57.12 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.863 -1.517 . . . . 16.84 109.353 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.1 -49.71 9.67 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.506 2.137 . . . . 15.51 114.11 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 123' ' ' PRO . 56.8 Cg_endo -69.89 -17.27 37.08 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 121.729 1.619 . . . . 16.039999999999999 112.349 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm 53.41 68.39 2.95 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 122.863 0.465 . . . . 18.91 111.502 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -81.51 107.96 1.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.023 2.482 . . . . 17.039999999999999 111.452 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 56.6 mtmt -78.32 77.3 4.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.067 0.46 . . . . 17.52 111.12 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.5 t 69.9 -80.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.109 -0.95 . . . . 18.699999999999999 111.524 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -126.5 1.77 6.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.18 0.514 . . . . 20.879999999999999 110.483 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -85.52 132.35 44.96 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.436 -0.802 . . . . 18.890000000000001 110.611 -178.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 22.8 Cg_exo -65.21 134.33 38.85 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.58 2.187 . . . . 20.43 111.827 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.498 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 46.4 Cg_exo -57.81 113.1 1.37 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.762 2.308 . . . . 21.100000000000001 112.129 176.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.471 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . . . -143.17 141.64 19.88 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.253 -0.43 . . . . 21.149999999999999 110.64 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 124' ' ' ALA . 12.5 Cg_exo -70.8 94.35 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.855 2.37 . . . . 21.149999999999999 112.023 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -159.49 124.65 2.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.256 -0.429 . . . . 21.879999999999999 110.437 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.3 115.95 3.0 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.384 2.056 . . . . 20.190000000000001 110.878 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.69 124.51 89.51 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.782 -0.644 . . . . 20.48 111.752 -172.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.01 157.94 46.17 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.369 2.713 . . . . 21.170000000000002 112.443 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -157.07 146.34 15.1 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 23.18 110.446 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.43 125.97 10.0 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.237 1.958 . . . . 20.780000000000001 111.802 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.1 p -89.39 49.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 122.721 1.248 . . . . 19.75 110.373 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.6 m -86.26 20.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.675 -1.148 . . . . 21.050000000000001 110.353 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -129.31 155.67 45.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.404 -0.816 . . . . 21.300000000000001 109.756 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -81.08 64.14 5.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.16 0.505 . . . . 20.739999999999998 109.933 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -65.06 -68.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.376 -0.829 . . . . 17.969999999999999 109.608 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -112.03 9.57 20.39 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.858 -0.793 . . . . 17.350000000000001 108.858 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 73.89 148.44 0.12 Allowed Pre-proline 0 C--N 1.34 0.176 0 CA-C-N 114.076 -1.42 . . . . 19.100000000000001 110.796 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.88 -7.24 12.69 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.106 2.537 . . . . 19.350000000000001 113.135 -175.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 219' ' ' PRO . 9.6 t -155.0 173.19 16.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.297 -0.631 . . . . 17.75 109.297 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.53 -77.29 2.12 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.717 -0.754 . . . . 17.960000000000001 111.392 -174.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.54 73.81 2.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.492 0.663 . . . . 19.420000000000002 109.455 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.818 ' HB1' ' CD1' ' A' ' 217' ' ' TYR . . . -109.66 164.05 12.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.027 -0.988 . . . . 14.65 109.436 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.729 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 5.5 m-85 -138.6 141.12 39.17 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 111.455 0.168 . . . . 14.81 111.455 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 1.026 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.7 t -149.96 163.07 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 109.317 -0.623 . . . . 10.48 109.317 170.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 59.3 t -103.83 108.85 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 O-C-N 122.304 -0.248 . . . . 10.1 111.528 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.46 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 4.9 tt0 -76.72 111.78 12.59 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.21 0.204 . . . . 12.0 110.899 178.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.966 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -89.02 -35.66 16.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.26 -0.644 . . . . 11.880000000000001 109.26 176.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.52 167.61 27.49 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.35 -0.841 . . . . 11.35 112.45 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -165.35 101.27 0.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.123 -0.695 . . . . 13.470000000000001 109.123 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 158.08 45.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.669 -0.696 . . . . 13.52 110.499 -173.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 49.9 mttp -96.23 16.73 17.45 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.182 -0.917 . . . . 17.600000000000001 110.194 -175.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 157' ' ' VAL . 15.8 m120 -118.56 108.37 14.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.959 -1.019 . . . . 16.140000000000001 109.52 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.38 68.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.177 0.513 . . . . 14.039999999999999 110.557 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.68 -37.51 78.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.386 -0.824 . . . . 16.57 110.157 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 64.8 mttp -84.6 -23.3 29.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.621 -1.172 . . . . 16.399999999999999 110.132 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.46 HG13 ' CD1' ' A' ' 186' ' ' ILE . 77.0 t -65.64 -46.34 89.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.789 -0.641 . . . . 12.67 109.967 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -61.53 -29.49 70.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 15.32 112.04 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 14.8 pt-20 -77.4 -43.51 32.41 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.282 -0.567 . . . . 15.970000000000001 111.101 -177.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.465 HD12 HG13 ' A' ' 186' ' ' ILE . 21.7 mt -66.33 -46.73 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.762 0.792 . . . . 12.6 109.469 176.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.442 ' CG1' ' HD2' ' A' ' 165' ' ' ARG . 34.2 t -63.46 -32.9 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.538 -1.21 . . . . 12.539999999999999 110.588 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.76 -32.18 73.65 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.009 -0.615 . . . . 14.800000000000001 112.35 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -71.31 -53.96 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 16.050000000000001 110.967 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.481 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 4.0 mm? -83.84 -51.25 7.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.199 0.815 . . . . 12.99 113.199 -172.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.456 ' HG3' HG13 ' A' ' 171' ' ' VAL . 48.1 mtt180 -69.74 -37.52 76.49 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.838 -0.801 . . . . 15.06 108.838 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.87 -32.21 83.46 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 114.601 -1.181 . . . . 16.600000000000001 112.4 -175.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.78 -3.64 58.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 16.140000000000001 110.833 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.41 25.58 35.83 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 15.119999999999999 113.376 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.422 ' O ' HG12 ' A' ' 171' ' ' VAL . 35.5 m-85 -87.03 160.02 18.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.122 0.461 . . . . 15.49 110.658 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -76.29 97.3 4.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.608 0.718 . . . . 13.869999999999999 109.543 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.456 HG13 ' HG3' ' A' ' 165' ' ' ARG . 5.7 p -144.28 141.26 24.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.909 -1.041 . . . . 10.82 109.635 -174.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.585 ' CE1' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -140.2 176.57 8.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.717 0.77 . . . . 11.130000000000001 111.095 175.347 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.3 p -117.27 -175.22 2.76 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.44 -1.254 . . . . 11.52 110.696 -173.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.2 m -51.76 140.2 29.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 12.75 110.934 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -46.18 -36.77 17.33 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.136 3.224 . . . . 14.640000000000001 115.069 -169.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.1 m -87.19 -63.74 1.26 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 119.915 -0.714 . . . . 16.68 112.177 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 98.0 m -168.49 139.55 2.14 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 117.742 0.247 . . . . 16.039999999999999 111.19 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.437 ' HB3' HG11 ' A' ' 157' ' ' VAL . 27.8 Cg_exo -66.55 122.82 10.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 121.786 1.657 . . . . 14.220000000000001 110.115 163.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 7.8 p -153.01 156.79 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.363 -0.535 . . . . 16.129999999999999 111.251 -172.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -81.48 128.77 34.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.432 -0.804 . . . . 16.699999999999999 110.423 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.09 -25.03 29.79 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.704 -0.76 . . . . 16.98 112.433 176.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 9.0 mptt -112.32 158.93 19.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.636 -0.505 . . . . 18.73 109.636 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.4 tp -70.83 115.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.486 0.66 . . . . 14.82 111.36 -175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 36.3 m -112.05 113.18 25.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.648 -0.705 . . . . 12.779999999999999 109.826 175.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.551 ' CG ' HD11 ' A' ' 187' ' ' LEU . 21.0 ttm180 -89.49 140.93 29.04 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.04 -0.982 . . . . 13.98 110.112 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.521 ' O ' HD22 ' A' ' 148' ' ' LEU . 3.9 mm -111.21 117.51 55.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.878 -0.786 . . . . 10.56 108.878 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 187' ' ' LEU . 2.5 mp -130.33 135.02 47.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.306 0.574 . . . . 10.1 111.107 -173.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.966 HG23 HD21 ' A' ' 148' ' ' LEU . 41.1 t -108.59 135.62 46.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.241 -0.89 . . . . 9.7400000000000002 111.078 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.442 ' O ' HD22 ' A' ' 197' ' ' LEU . . . 82.8 49.3 5.15 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 114.999 -1.0 . . . . 9.7599999999999998 113.507 175.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.923 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -62.3 125.26 15.92 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 CA-C-N 119.552 1.676 . . . . 11.15 111.136 174.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -157.77 168.17 27.97 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.528 -0.545 . . . . 12.77 109.528 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -104.94 4.77 32.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.116 -0.493 . . . . 14.6 110.581 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 196' ' ' LYS . 21.0 t -120.67 117.7 28.21 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.036 0.446 . . . . 14.300000000000001 110.146 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.696 ' HB2' ' CE2' ' A' ' 144' ' ' TYR . 39.0 ttpt -67.8 -41.78 82.6 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-N 115.901 -0.591 . . . . 15.970000000000001 109.535 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -57.53 -50.19 73.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.667 0.27 . . . . 15.6 111.033 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 39.0 mtpt -52.85 -60.0 3.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.476 -0.784 . . . . 14.220000000000001 111.187 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -76.74 -28.83 55.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.912 -1.04 . . . . 11.949999999999999 111.617 -169.318 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.579 ' HD3' ' O ' ' A' ' 198' ' ' LYS . 12.9 tmtt? -73.45 -31.59 63.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.012 -0.736 . . . . 14.699999999999999 109.012 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.73 -12.55 84.36 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.227 -1.149 . . . . 13.09 110.227 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 58.5 m -88.37 -9.87 51.24 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.527 -0.837 . . . . 12.109999999999999 111.965 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 20.7 mt -66.28 -36.37 82.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.712 0.291 . . . . 12.720000000000001 111.055 -174.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -57.47 -44.25 93.76 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.026 -0.607 . . . . 14.66 111.829 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.429 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 13.0 pt-20 -86.07 -17.1 36.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.892 0.377 . . . . 13.890000000000001 110.519 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.56 HD11 HG12 ' A' ' 188' ' ' VAL . 15.5 tp -66.22 -31.91 73.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.028 0.442 . . . . 12.550000000000001 110.442 -177.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.492 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 6.1 mtpm? -58.98 -23.71 62.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.515 -0.766 . . . . 15.83 110.272 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 -36.96 15.05 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.863 -0.608 . . . . 16.969999999999999 110.236 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 92.6 mt -68.04 -52.65 33.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.043 -0.526 . . . . 13.890000000000001 111.5 -176.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.402 ' HB3' HD11 ' A' ' 164' ' ' LEU . 56.0 p -102.03 -44.12 5.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.119 0.485 . . . . 13.539999999999999 110.13 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.84 5.48 75.0 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.151 -0.931 . . . . 14.67 111.627 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.55 157.74 16.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 110.113 -0.329 . . . . 13.039999999999999 110.113 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.5 t -87.97 105.26 17.34 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.106 -0.497 . . . . 14.84 110.341 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -128.53 160.64 22.21 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.138 -1.03 . . . . 12.220000000000001 113.893 -176.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.14 143.53 20.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.137 -0.532 . . . . 13.74 110.026 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.62 105.27 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.38 -0.6 . . . . 12.890000000000001 109.38 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 64.1 mtt -120.99 145.96 47.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.019 -0.537 . . . . 13.800000000000001 110.226 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -71.91 110.36 3.18 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.365 -0.921 . . . . 13.359999999999999 112.803 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 1.026 ' HB2' HG23 ' A' ' 145' ' ' VAL . 4.4 t80 -64.05 134.68 55.43 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.243 -1.479 . . . . 14.24 110.287 175.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 27.1 m -147.09 93.34 4.75 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 120.881 -0.328 . . . . 16.510000000000002 110.935 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.435 ' HG2' ' OG1' ' A' ' 140' ' ' THR . 57.4 Cg_endo -73.66 118.86 5.64 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.865 1.71 . . . . 17.420000000000002 110.847 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 45.5 t30 . . . . . 0 C--O 1.244 0.797 0 CA-C-O 118.54 -0.743 . . . . 19.190000000000001 109.744 -176.181 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.699 0.285 . . . . 18.390000000000001 111.26 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.526 ' O ' ' HG2' ' A' ' 30' ' ' GLN . . . -97.66 32.38 6.84 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.056 -0.592 . . . . 17.77 113.452 -174.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 2.4 pt20 68.51 141.56 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.079 0.952 . . . . 17.690000000000001 112.467 174.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -84.08 118.91 24.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.314 -0.857 . . . . 19.93 109.68 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.536 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -161.57 142.92 11.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.332 0.586 . . . . 17.43 111.586 -174.337 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -79.17 -28.35 42.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.62 -0.718 . . . . 19.359999999999999 109.213 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 91.3 t80 -133.09 -69.52 0.56 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.225 -0.898 . . . . 18.960000000000001 109.461 176.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 53.4 tt0 175.73 -67.6 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.693 -0.685 . . . . 18.239999999999998 109.35 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -112.96 131.83 55.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 16.780000000000001 110.094 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -143.95 -53.92 0.35 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.166 -0.47 . . . . 18.420000000000002 110.061 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 t80 55.97 73.43 0.43 Allowed 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.853 0.721 . . . . 17.920000000000002 109.834 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 70.56 -63.16 0.42 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.108 -0.951 . . . . 19.550000000000001 111.112 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -168.26 -62.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.563 -0.289 . . . . 20.309999999999999 110.88 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.1 mt 55.57 73.54 0.84 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.825 -0.625 . . . . 19.920000000000002 111.067 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.26 46.59 2.14 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.931 2.421 . . . . 21.640000000000001 110.587 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mp 59.77 31.62 20.91 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.176 -0.92 . . . . 22.670000000000002 110.801 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.525 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 76.5 t -84.96 -58.44 0.35 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.554 -0.748 . . . . 21.34 110.667 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.525 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 73.3 Cg_endo -75.79 129.77 11.93 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.416 1.411 . . . . 20.0 111.301 172.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -68.54 -23.44 64.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 21.079999999999998 110.732 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.36 58.64 1.33 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.951 -0.568 . . . . 18.800000000000001 110.423 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.38 -25.86 60.5 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.743 -0.662 . . . . 17.510000000000002 112.104 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.55 95.5 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.785 -0.45 . . . . 16.949999999999999 109.785 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -75.35 -39.07 59.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.911 -0.586 . . . . 18.300000000000001 110.095 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.1 157.51 15.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.183 -0.673 . . . . 18.170000000000002 109.183 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.2 115.11 58.59 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.155 -0.313 . . . . 18.82 110.155 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.85 68.52 5.61 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.893 2.395 . . . . 19.870000000000001 112.052 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.76 152.4 26.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.772 -0.649 . . . . 21.100000000000001 110.064 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -66.85 -15.96 63.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.116 -0.493 . . . . 22.300000000000001 110.971 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 51.7 tpp -153.09 96.0 2.93 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.037 -0.529 . . . . 23.850000000000001 109.596 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -66.5 86.43 0.27 Allowed 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.683 2.255 . . . . 20.670000000000002 111.797 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 61' ' ' GLN . . . -168.83 131.68 1.34 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.913 -1.494 . . . . 20.489999999999998 109.822 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.85 -58.39 0.09 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.16 0.505 . . . . 21.469999999999999 109.775 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.9 p -105.8 -31.62 8.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.111 -0.7 . . . . 22.600000000000001 109.111 170.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.588 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 84.0 mm-40 -133.17 160.09 38.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.042 -0.981 . . . . 21.93 109.098 175.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.47 111.94 24.24 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.564 -0.532 . . . . 19.73 109.564 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.24 114.43 61.12 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.442 -0.344 . . . . 19.579999999999998 111.647 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -88.67 48.68 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.846 2.364 . . . . 18.5 111.003 172.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.7 p -81.09 -61.52 1.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.579 -0.737 . . . . 17.609999999999999 111.345 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.498 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 35.8 mt-30 -69.26 -53.42 13.43 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 119.501 -0.285 . . . . 18.760000000000002 110.414 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 30' ' ' GLN . 94.2 Cg_endo -87.97 103.02 0.48 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.995 1.797 . . . . 17.280000000000001 111.401 170.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 66' ' ' GLN . 23.0 Cg_exo -66.16 0.73 2.98 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.17 2.58 . . . . 17.77 113.179 -174.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.63 -57.92 0.63 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.657 -0.497 . . . . 18.699999999999999 109.657 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.08 161.97 12.44 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.71 -0.757 . . . . 17.719999999999999 111.849 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.28 93.99 3.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.949 0.404 . . . . 18.0 110.75 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.62 -45.5 17.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.262 -0.426 . . . . 17.960000000000001 110.149 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 4.3 tp10 65.59 172.86 0.22 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.338 -0.846 . . . . 19.850000000000001 110.829 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.513 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 2.5 mp0 63.37 35.4 12.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.494 0.664 . . . . 19.670000000000002 109.531 -175.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -93.95 -9.73 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.112 -0.949 . . . . 17.739999999999998 110.848 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -63.05 -30.83 71.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.222 -0.445 . . . . 19.949999999999999 110.974 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 60.93 -84.28 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.548 0.739 . . . . 18.390000000000001 112.012 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.09 130.1 4.34 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.25 -0.74 . . . . 17.66 111.25 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -73.16 107.61 5.58 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.513 -0.18 . . . . 17.68 110.513 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 71.79 -54.47 0.68 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.603 0.761 . . . . 17.800000000000001 111.78 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 57.38 56.8 4.81 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.379 0.609 . . . . 17.350000000000001 110.437 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.62 158.79 59.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.385 -0.825 . . . . 16.640000000000001 110.463 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -48.7 -59.11 1.37 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.864 2.376 . . . . 17.23 112.836 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.47 ' C ' HD12 ' A' ' 85' ' ' LEU . 19.1 p -171.31 -86.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 17.34 110.555 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.47 HD12 ' C ' ' A' ' 84' ' ' SER . 7.0 mp -135.66 50.31 2.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 18.41 110.185 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.47 145.91 99.01 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.593 -0.521 . . . . 17.449999999999999 109.593 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 -6.58 18.09 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.633 2.222 . . . . 18.890000000000001 113.603 -173.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 62.45 11.52 4.71 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.855 0.462 . . . . 17.809999999999999 111.544 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.0 p -146.38 -169.25 3.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.111 -0.495 . . . . 18.629999999999999 110.435 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.6 pt -91.29 136.13 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.144 0.497 . . . . 19.100000000000001 110.797 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.65 77.83 1.67 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.938 -0.574 . . . . 19.25 109.869 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.87 -28.84 64.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 18.789999999999999 110.739 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 65.1 -81.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.487 -0.779 . . . . 18.949999999999999 111.944 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.649 ' OD1' ' HA ' ' A' ' 97' ' ' PHE . 62.2 t30 -154.6 24.15 0.46 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.103 0.478 . . . . 20.309999999999999 110.414 -176.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.403 HG23 ' HG3' ' A' ' 96' ' ' GLU . 9.7 t -64.56 -27.77 69.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.032 -0.531 . . . . 21.399999999999999 110.985 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.403 ' HG3' HG23 ' A' ' 95' ' ' THR . 41.2 mt-10 -124.72 21.27 8.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.351 . . . . 21.16 110.665 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.649 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 95.4 m-85 65.58 87.1 0.12 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.371 -0.832 . . . . 22.18 111.239 175.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 62.08 101.37 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 115.552 -0.749 . . . . 19.449999999999999 111.316 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.0 98.25 0.1 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.535 2.157 . . . . 18.530000000000001 111.466 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 58.91 83.61 0.21 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.773 -0.649 . . . . 17.449999999999999 110.578 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.58 -8.95 17.25 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.76 2.307 . . . . 17.420000000000002 112.833 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -141.46 74.47 23.75 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.498 -0.319 . . . . 17.68 111.084 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.17 120.38 7.26 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.817 2.345 . . . . 16.289999999999999 111.64 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -100.99 20.52 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.178 0.436 . . . . 17.260000000000002 112.178 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.55 131.19 26.41 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.141 -0.481 . . . . 15.800000000000001 110.082 177.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 72.7 Cg_exo -46.53 117.71 2.18 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.556 2.837 . . . . 15.92 112.477 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 52.9 Cg_exo -53.48 -43.71 55.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.807 3.005 . . . . 16.149999999999999 113.246 -176.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -106.55 111.16 64.11 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.407 -0.361 . . . . 17.629999999999999 110.111 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.15 136.12 26.32 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.211 1.941 . . . . 15.039999999999999 111.774 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -94.56 108.07 34.4 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.487 -0.324 . . . . 15.199999999999999 110.143 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.46 138.99 17.98 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.38 2.053 . . . . 14.08 112.189 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.23 52.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.27 1.033 . . . . 15.279999999999999 109.164 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 62.35 88.6 0.12 Allowed Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 114.28 -1.327 . . . . 16.84 111.386 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.61 145.79 46.56 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.988 2.458 . . . . 15.51 111.884 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.425 ' HG2' ' CD1' ' A' ' 183' ' ' ILE . 85.8 Cg_exo -49.35 150.79 7.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.332 2.688 . . . . 16.039999999999999 113.184 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -66.38 115.29 22.43 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.155 -0.93 . . . . 18.91 111.356 -176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -75.41 166.86 27.86 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.714 2.276 . . . . 17.039999999999999 110.908 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -115.86 82.59 1.79 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.503 0.668 . . . . 17.52 110.993 -172.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.8 m -98.0 -27.51 3.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.095 -0.957 . . . . 18.699999999999999 110.543 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.471 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -101.35 12.96 36.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.544 -0.753 . . . . 20.879999999999999 110.18 -177.679 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.26 133.36 87.51 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.535 -0.757 . . . . 18.890000000000001 110.204 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 50.9 Cg_exo -54.35 134.25 60.16 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.78 2.32 . . . . 20.43 111.698 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 122' ' ' PRO . 15.7 Cg_exo -68.95 55.11 0.92 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.038 2.492 . . . . 21.100000000000001 112.589 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . . . -79.5 -48.8 1.44 Allowed Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.156 -0.475 . . . . 21.149999999999999 111.125 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 124' ' ' ALA . 6.1 Cg_exo -79.22 81.99 2.64 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.224 1.949 . . . . 21.149999999999999 111.486 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' A' ' 128' ' ' GLU . 59.5 tttp -73.99 120.39 81.06 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.013 -0.54 . . . . 21.879999999999999 109.691 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.19 -33.62 81.01 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.17 2.58 . . . . 20.190000000000001 113.008 -174.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.425 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 34.0 tt0 -153.62 118.59 2.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 121.174 -0.21 . . . . 20.48 110.881 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 128' ' ' GLU . 2.2 Cg_endo -81.22 146.19 15.63 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.783 2.322 . . . . 21.170000000000002 111.871 174.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt 55.97 77.69 0.41 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.883 -0.599 . . . . 23.18 111.649 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.73 137.71 46.58 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.38 2.053 . . . . 20.780000000000001 111.37 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.468 ' O ' ' HB ' ' A' ' 133' ' ' VAL . 15.7 m -114.36 54.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.041 0.448 . . . . 19.75 110.896 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 132' ' ' VAL . 73.2 t 72.52 111.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.219 -0.9 . . . . 21.050000000000001 110.364 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -80.39 148.92 30.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.347 -0.842 . . . . 21.300000000000001 111.165 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -57.69 -39.39 77.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.179 -0.919 . . . . 20.739999999999998 109.612 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -172.8 -66.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.109 -0.95 . . . . 17.969999999999999 108.509 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 142' ' ' LYS . . . -117.11 6.13 12.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.593 -0.73 . . . . 17.350000000000001 109.586 173.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . . . 72.65 143.69 0.1 OUTLIER Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 114.741 -1.118 . . . . 19.100000000000001 111.398 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.458 ' HA ' ' HB1' ' A' ' 192' ' ' ALA . 31.1 Cg_exo -60.18 -18.17 50.18 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.395 2.73 . . . . 19.350000000000001 113.294 -176.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 90.8 m -149.5 122.94 9.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.024 0.44 . . . . 17.75 111.017 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.93 -69.05 0.54 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.585 -0.817 . . . . 17.960000000000001 112.055 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 137' ' ' ALA . 0.0 OUTLIER -101.97 28.27 5.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.793 0.806 . . . . 19.420000000000002 109.98 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 217' ' ' TYR . . . -76.72 164.2 26.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.61 -1.177 . . . . 14.65 108.148 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.555 ' CE1' ' HD3' ' A' ' 194' ' ' LYS . 7.3 m-85 -138.23 153.48 49.12 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.695 0.628 . . . . 14.81 112.695 -176.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.8 m -151.99 151.97 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 114.842 -1.072 . . . . 10.48 109.76 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 80.5 t -110.79 108.02 24.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 120.3 -0.56 . . . . 10.1 111.434 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.515 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 19.0 tt0 -80.26 114.31 19.07 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.085 -0.507 . . . . 12.0 111.148 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 1.037 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -93.75 -33.73 13.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.509 0.671 . . . . 11.880000000000001 109.555 177.453 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.3 170.72 26.6 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.666 -0.778 . . . . 11.35 112.359 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -170.34 103.22 0.27 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.02 -0.733 . . . . 13.470000000000001 109.02 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.98 153.73 42.55 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.451 0.643 . . . . 13.52 110.435 -174.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 77.4 mttt -89.34 2.96 53.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.046 -0.979 . . . . 17.600000000000001 110.438 -175.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -101.82 109.44 21.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.419 -0.81 . . . . 16.140000000000001 109.597 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.409 ' HA ' ' CG2' ' A' ' 157' ' ' VAL . . . -69.88 -20.32 63.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.924 -0.58 . . . . 14.039999999999999 112.202 -175.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.13 -33.84 76.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 122.1 0.952 . . . . 16.57 109.257 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.482 ' O ' HG13 ' A' ' 160' ' ' ILE . 74.4 mmtt -83.54 -30.07 27.37 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.0 -1.454 . . . . 16.399999999999999 110.154 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.463 HG13 ' CD1' ' A' ' 186' ' ' ILE . 77.9 t -57.63 -40.17 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.73 -0.668 . . . . 12.67 110.273 173.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -68.55 -32.62 72.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.264 -0.88 . . . . 15.32 111.969 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.19 -38.09 31.95 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.061 -0.655 . . . . 15.970000000000001 111.2 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 156' ' ' LYS . 29.3 mt -63.28 -41.36 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 12.6 109.22 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.79 -35.66 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.01 -0.995 . . . . 12.539999999999999 110.17 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.64 -28.54 73.72 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.016 -0.612 . . . . 14.800000000000001 112.374 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -72.3 -61.96 1.61 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 16.050000000000001 110.977 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.719 ' HB3' HG21 ' A' ' 171' ' ' VAL . 1.8 mm? -79.5 -62.72 1.6 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.927 -0.579 . . . . 12.99 112.188 -175.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 165' ' ' ARG . 3.0 tmt_? -61.97 -38.25 87.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.381 -0.6 . . . . 15.06 109.381 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.95 85.22 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.258 -0.883 . . . . 16.600000000000001 112.506 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.28 -7.33 59.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.005 0.431 . . . . 16.140000000000001 110.523 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.43 25.1 9.58 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.807 -0.711 . . . . 15.119999999999999 112.624 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -96.31 145.24 25.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.182 -0.674 . . . . 15.49 109.182 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -70.25 107.32 3.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.611 0.72 . . . . 13.869999999999999 110.55 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 188' ' ' VAL . 11.0 t -138.62 135.71 43.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.773 -1.103 . . . . 10.82 110.324 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -137.85 175.39 9.63 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.78 0.8 . . . . 11.130000000000001 110.946 174.091 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 18.0 p -122.68 -172.68 2.53 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.135 -1.393 . . . . 11.52 110.56 -170.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.6 m -49.61 145.8 7.84 Favored Pre-proline 0 C--O 1.236 0.365 0 O-C-N 123.272 0.357 . . . . 12.75 110.739 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -38.25 -44.94 2.08 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 124.479 3.452 . . . . 14.640000000000001 115.302 -170.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.0 p -87.42 -63.53 1.29 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.735 -0.786 . . . . 16.68 113.089 -173.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.1 m -168.07 142.96 2.96 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 117.688 0.222 . . . . 16.039999999999999 110.86 -175.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.482 ' HG3' ' OG1' ' A' ' 173' ' ' THR . 25.0 Cg_exo -67.38 123.84 11.34 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.13 1.887 . . . . 14.220000000000001 111.066 165.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.427 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.9 p -153.61 156.49 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 120.826 0.346 . . . . 16.129999999999999 110.331 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.401 ' NE2' ' H ' ' A' ' 154' ' ' ALA . 6.2 tp-100 -80.31 128.46 33.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.121 -0.491 . . . . 16.699999999999999 110.193 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.17 -26.09 18.11 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.006 -0.616 . . . . 16.98 112.138 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 12.6 mptt -108.08 153.04 23.7 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.618 -0.512 . . . . 18.73 109.618 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.8 tp -69.17 109.58 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.76 0.791 . . . . 14.82 110.874 -176.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.436 ' HB ' HG21 ' A' ' 157' ' ' VAL . 26.8 m -103.57 109.02 20.53 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.956 0.884 . . . . 12.779999999999999 110.429 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 173' ' ' THR . 48.3 ttt180 -86.24 134.52 33.76 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.063 -1.426 . . . . 13.98 109.032 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.502 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.7 mm -109.4 117.19 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 N-CA-C 109.183 -0.673 . . . . 10.56 109.183 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 187' ' ' LEU . 2.1 mp -130.17 132.95 46.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.512 0.672 . . . . 10.1 111.034 -173.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.037 HG23 HD21 ' A' ' 148' ' ' LEU . 52.8 t -101.96 137.31 30.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.908 -1.042 . . . . 9.7400000000000002 110.208 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.97 51.49 5.8 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.344 -0.844 . . . . 9.7599999999999998 114.071 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.698 ' HA ' HG12 ' A' ' 145' ' ' VAL . 18.6 Cg_endo -67.06 125.71 14.02 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 CA-C-N 119.632 1.716 . . . . 11.15 110.813 170.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -157.88 153.63 26.62 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.598 -0.441 . . . . 12.77 110.274 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' A' ' 139' ' ' PRO . . . -98.83 0.54 44.5 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.948 -0.569 . . . . 14.6 111.473 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 68.8 m -118.48 93.66 4.2 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 121.37 0.605 . . . . 14.300000000000001 109.992 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.555 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 35.1 ttpt -57.12 -36.79 71.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.917 -1.038 . . . . 15.970000000000001 110.769 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.71 -39.29 80.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.976 0.417 . . . . 15.6 111.53 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -77.54 -42.84 33.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.62 0.724 . . . . 14.220000000000001 110.399 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -83.67 -19.19 35.78 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.251 -0.886 . . . . 11.949999999999999 110.977 -173.285 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -64.85 -40.12 94.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.193 0.52 . . . . 14.699999999999999 110.51 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.47 -13.73 82.92 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 110.328 -1.109 . . . . 13.09 110.328 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.472 ' HB2' ' HA ' ' A' ' 197' ' ' LEU . 58.4 m -83.35 -11.43 57.65 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.587 -0.807 . . . . 12.109999999999999 111.72 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 28.0 mt -66.88 -40.99 87.96 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.878 0.37 . . . . 12.720000000000001 110.399 -177.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.56 86.28 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.346 -0.931 . . . . 14.66 110.912 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.575 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 45.3 mt-10 -76.89 -26.94 54.74 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 120.81 0.338 . . . . 13.890000000000001 110.574 175.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 146' ' ' VAL . 4.7 tt -67.41 -38.75 85.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.056 -0.52 . . . . 12.550000000000001 110.422 -176.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 82.8 mttt -62.19 -21.02 64.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.392 -0.822 . . . . 15.83 110.261 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.16 -42.31 11.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.676 -0.693 . . . . 16.969999999999999 110.281 173.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 96.8 mt -66.9 -51.91 49.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.033 -0.53 . . . . 13.890000000000001 111.694 -176.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.446 ' HB3' HD11 ' A' ' 164' ' ' LEU . 71.4 p -100.16 -44.38 5.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.214 0.531 . . . . 13.539999999999999 110.821 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.34 12.22 57.86 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.301 -0.863 . . . . 14.67 111.698 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 91.6 mt -91.4 157.75 16.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.912 -0.403 . . . . 13.039999999999999 109.912 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 53.9 m -80.6 94.43 6.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.057 0.456 . . . . 14.84 110.777 -178.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -124.23 159.82 18.84 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.617 -0.802 . . . . 12.220000000000001 113.048 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.2 p -116.17 143.97 24.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.196 0.522 . . . . 13.74 110.541 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.429 HG21 HD13 ' A' ' 201' ' ' LEU . 39.6 t -80.03 106.79 11.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.218 -0.901 . . . . 12.890000000000001 110.343 -176.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 24.3 mmt -121.04 155.63 33.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.017 -0.538 . . . . 13.800000000000001 110.567 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -82.19 129.62 9.18 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.404 -0.903 . . . . 13.359999999999999 111.992 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.568 ' HB2' HG13 ' A' ' 145' ' ' VAL . 8.6 t80 -88.72 131.76 34.89 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 124.164 0.986 . . . . 14.24 109.975 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 78.6 m -144.91 92.25 5.83 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 109.506 -0.553 . . . . 16.510000000000002 109.506 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.28 140.92 91.12 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.409 2.072 . . . . 17.420000000000002 112.082 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.305 -0.855 . . . . 19.190000000000001 110.022 -177.888 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.784 0.326 . . . . 18.390000000000001 110.893 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.15 59.53 3.48 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.478 -0.868 . . . . 17.77 112.905 -176.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -66.3 126.48 28.89 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.337 -0.616 . . . . 17.690000000000001 109.337 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -98.97 139.27 34.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.824 -0.625 . . . . 19.93 111.196 -171.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -83.1 160.3 21.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 17.43 109.942 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -61.99 -57.65 10.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.029 0.443 . . . . 19.359999999999999 110.136 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -150.4 -67.89 0.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.91 -0.774 . . . . 18.960000000000001 108.91 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 47.15 45.81 16.21 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.986 0.804 . . . . 18.239999999999998 111.205 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -80.92 98.56 7.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.399 0.618 . . . . 16.780000000000001 110.646 -174.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -117.87 126.44 52.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.564 -0.744 . . . . 18.420000000000002 109.918 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -82.57 57.95 3.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.531 0.681 . . . . 17.920000000000002 110.363 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.41 39.27 1.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.72 -0.673 . . . . 19.550000000000001 110.028 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.4 167.12 29.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.259 -0.882 . . . . 20.309999999999999 109.214 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.421 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 17.0 pt 37.52 69.42 1.4 Allowed Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 124.237 0.96 . . . . 19.920000000000002 112.484 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.55 79.19 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.166 2.577 . . . . 21.640000000000001 112.976 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 43' ' ' LEU . 3.1 mm? 60.19 26.54 15.97 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.316 -0.856 . . . . 22.670000000000002 111.624 174.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.615 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 96.9 t -89.83 -55.2 0.29 Allowed Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.949 -0.569 . . . . 21.34 111.38 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.615 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 6.9 Cg_exo -77.13 149.36 28.34 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.98 1.787 . . . . 20.0 111.453 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -75.39 88.47 2.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.291 0.567 . . . . 21.079999999999998 109.643 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -159.7 -33.87 0.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.423 -0.808 . . . . 18.800000000000001 110.677 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.85 -60.43 4.88 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.887 -0.673 . . . . 17.510000000000002 111.662 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -102.02 178.6 4.56 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.072 -0.714 . . . . 16.949999999999999 109.072 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -80.54 171.68 14.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.18 0.514 . . . . 18.300000000000001 110.247 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -74.76 164.21 26.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.856 -0.611 . . . . 18.170000000000002 109.882 174.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 52' ' ' GLU . 1.6 pm0 -71.86 149.27 92.63 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.276 -0.42 . . . . 18.82 111.258 -173.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 57.4 Cg_endo -70.69 71.16 2.01 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.978 2.452 . . . . 19.870000000000001 113.1 -177.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.43 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 28.8 m-20 -132.24 165.98 22.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.349 -0.612 . . . . 21.100000000000001 109.349 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.46 ' HG3' ' HG2' ' A' ' 56' ' ' MET . 15.6 tpt -65.17 109.01 2.05 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.37 0.419 . . . . 22.300000000000001 110.81 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.46 ' HG2' ' HG3' ' A' ' 55' ' ' MET . 25.5 ptt? 40.81 73.65 0.84 Allowed Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 124.3 1.04 . . . . 23.850000000000001 112.497 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HG3' ' O ' ' A' ' 52' ' ' GLU . 86.9 Cg_endo -90.47 10.35 2.96 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.728 2.285 . . . . 20.670000000000002 112.337 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.53 149.76 30.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.979 -0.555 . . . . 20.489999999999998 110.305 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.11 -41.57 7.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.113 -0.494 . . . . 21.469999999999999 111.087 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.4 m -81.2 -48.06 12.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.313 -0.403 . . . . 22.600000000000001 110.522 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -100.27 -159.8 0.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.143 -0.481 . . . . 21.93 109.79 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.35 33.52 6.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.353 0.597 . . . . 19.73 110.311 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 2.6 tm? -72.35 -46.05 10.47 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.472 -0.785 . . . . 19.579999999999998 110.615 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 73.6 Cg_exo -52.69 119.5 6.07 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.933 1.755 . . . . 18.5 111.85 174.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 p -76.32 110.7 11.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.909 -0.587 . . . . 17.609999999999999 112.045 -174.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.526 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 23.3 mt-30 -66.96 -46.98 54.24 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.341 -0.845 . . . . 18.760000000000002 110.985 173.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 66' ' ' GLN . 51.5 Cg_endo -70.02 123.37 9.96 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.128 1.886 . . . . 17.280000000000001 112.3 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 67' ' ' PRO . 14.7 Cg_exo -70.92 -159.04 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.192 2.594 . . . . 17.77 112.504 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 73.31 -58.23 0.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.713 0.805 . . . . 18.699999999999999 112.296 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.3 -54.98 8.16 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.823 -0.703 . . . . 17.719999999999999 111.676 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -162.95 153.38 16.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.041 -0.355 . . . . 18.0 110.041 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.12 32.19 0.34 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.917 0.389 . . . . 17.960000000000001 110.952 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -124.13 -162.75 1.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.043 -0.526 . . . . 19.850000000000001 109.971 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 62.67 44.52 6.6 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.974 0.892 . . . . 19.670000000000002 109.357 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.46 140.47 8.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.996 -1.002 . . . . 17.739999999999998 109.437 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 73.57 -60.9 0.52 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.37 0.668 . . . . 19.949999999999999 111.05 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.16 34.41 4.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.054 0.454 . . . . 18.390000000000001 111.092 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.94 110.27 0.45 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.704 -0.76 . . . . 17.66 112.225 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 80' ' ' ALA . 10.3 t70 56.26 -151.36 0.41 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.702 0.401 . . . . 17.68 110.284 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.461 ' H ' ' CG ' ' A' ' 79' ' ' ASP . . . 58.78 29.27 18.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.083 0.468 . . . . 17.800000000000001 111.772 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.29 63.29 6.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.222 0.535 . . . . 17.350000000000001 110.882 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.17 98.24 25.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.702 -0.681 . . . . 16.640000000000001 110.018 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.5 129.51 26.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.969 2.446 . . . . 17.23 112.804 -177.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.3 m -84.82 -24.34 28.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.411 -0.813 . . . . 17.34 110.005 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.6 mt -78.7 -6.96 57.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.512 -0.767 . . . . 18.41 110.627 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.64 115.25 15.57 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 17.449999999999999 110.508 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.15 -6.7 18.28 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.019 2.48 . . . . 18.890000000000001 112.894 -175.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.439 ' HB1' HG23 ' A' ' 90' ' ' ILE . . . -86.92 -61.57 1.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.327 -0.397 . . . . 17.809999999999999 110.265 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.8 m 54.26 65.05 1.62 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.611 0.72 . . . . 18.629999999999999 109.542 -177.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.439 HG23 ' HB1' ' A' ' 88' ' ' ALA . 14.9 pt -103.09 61.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.332 -0.849 . . . . 19.100000000000001 112.232 -170.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.49 -23.29 40.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.193 -0.458 . . . . 19.25 110.2 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.08 124.22 23.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.651 -0.704 . . . . 18.789999999999999 110.788 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.603 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 48.4 m-80 -93.81 109.25 20.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.179 -0.464 . . . . 18.949999999999999 110.545 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -96.47 -178.75 4.38 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.976 -0.379 . . . . 20.309999999999999 109.976 177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.0 p 60.01 -43.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.898 1.279 . . . . 21.399999999999999 112.968 -174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -90.93 -25.7 19.65 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.188 -0.32 . . . . 21.16 111.282 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.603 ' HB3' ' O ' ' A' ' 93' ' ' ASN . 74.5 t80 -128.85 -0.31 5.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.692 0.758 . . . . 22.18 110.949 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -76.53 -45.26 3.33 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.472 -0.785 . . . . 19.449999999999999 112.364 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.74 71.35 4.06 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.148 1.899 . . . . 18.530000000000001 112.865 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -111.16 91.15 12.73 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.24 -0.437 . . . . 17.449999999999999 109.897 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.71 -21.59 9.73 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.547 2.165 . . . . 17.420000000000002 112.696 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 49.51 78.86 0.38 Allowed Pre-proline 0 N--CA 1.465 0.321 0 O-C-N 123.403 0.439 . . . . 17.68 111.454 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.27 113.39 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.088 2.525 . . . . 16.289999999999999 112.617 -177.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.6 t -82.25 104.99 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.876 -0.602 . . . . 17.260000000000002 110.7 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.97 113.3 62.73 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.352 -0.385 . . . . 15.800000000000001 110.953 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.18 154.73 46.92 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.751 2.301 . . . . 15.92 112.237 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.84 55.25 4.32 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.067 2.511 . . . . 16.149999999999999 112.753 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -167.63 121.01 0.77 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.561 . . . . 17.629999999999999 109.854 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.79 -39.06 0.54 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.439 2.093 . . . . 15.039999999999999 112.644 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.645 ' H ' ' HD2' ' A' ' 111' ' ' PRO . 62.1 mtpt -144.33 -58.87 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.256 -0.429 . . . . 15.199999999999999 111.655 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.645 ' HD2' ' H ' ' A' ' 110' ' ' LYS . 28.6 Cg_endo -62.63 119.25 6.26 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.842 1.695 . . . . 14.08 113.093 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.6 t -92.71 57.35 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.154 -0.684 . . . . 15.279999999999999 109.154 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 57.39 86.63 0.16 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.769 -1.105 . . . . 16.84 110.815 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.07 -48.46 20.93 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.415 2.743 . . . . 15.51 114.803 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.6 97.59 0.63 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.601 1.534 . . . . 16.039999999999999 112.755 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.573 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 32.1 mmmt -65.3 -51.08 55.74 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.171 -0.468 . . . . 18.91 111.086 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 116' ' ' LYS . 4.5 Cg_exo -77.94 -46.22 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.852 1.701 . . . . 17.039999999999999 111.16 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt 54.46 66.92 1.1 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.7 -0.682 . . . . 17.52 110.89 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.4 p -150.48 146.79 16.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.746 -0.661 . . . . 18.699999999999999 110.108 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 40.89 50.2 3.04 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.239 0.962 . . . . 20.879999999999999 112.231 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.88 135.57 96.36 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.814 -0.63 . . . . 18.890000000000001 110.386 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.27 115.14 2.32 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.866 2.377 . . . . 20.43 112.184 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.95 44.57 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.841 2.361 . . . . 21.100000000000001 112.111 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.14 142.87 64.46 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.165 -0.47 . . . . 21.149999999999999 110.474 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.31 60.26 3.99 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.806 2.337 . . . . 21.149999999999999 111.88 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -107.27 131.11 21.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.54 -0.754 . . . . 21.879999999999999 110.45 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.53 83.78 1.27 Allowed 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.843 2.362 . . . . 20.190000000000001 112.05 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -58.97 131.37 86.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 20.48 111.193 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.27 61.96 6.75 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.952 2.435 . . . . 21.170000000000002 112.369 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -138.66 143.43 37.9 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.73 -0.668 . . . . 23.18 109.77 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.82 96.43 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.539 2.159 . . . . 20.780000000000001 111.586 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.9 m -82.64 52.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.623 0.725 . . . . 19.75 110.845 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.4 m -83.84 0.79 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.392 -0.822 . . . . 21.050000000000001 111.02 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.77 17.23 11.9 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.8 -1.091 . . . . 21.300000000000001 108.891 174.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 65.73 -92.26 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.74 -1.118 . . . . 20.739999999999998 110.811 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 tttm 178.34 -45.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.024 -1.102 . . . . 17.969999999999999 108.024 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -87.3 -76.4 0.37 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.34 -0.846 . . . . 17.350000000000001 109.085 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.441 ' O ' ' HB1' ' A' ' 192' ' ' ALA . . . -177.17 149.45 0.8 Allowed Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.148 -0.933 . . . . 19.100000000000001 109.821 173.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.31 -42.59 27.49 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.918 2.412 . . . . 19.350000000000001 113.02 -174.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 39.0 p -130.63 23.57 5.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.956 -0.566 . . . . 17.75 110.469 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -125.02 121.79 4.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.969 -0.634 . . . . 17.960000000000001 111.86 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.5 mttm 58.15 32.46 22.05 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 122.842 0.457 . . . . 19.420000000000002 110.671 -176.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.517 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -70.77 162.59 28.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.338 -0.986 . . . . 14.65 108.338 174.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.695 ' CB ' HD21 ' A' ' 197' ' ' LEU . 3.3 m-85 -143.85 152.7 41.51 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.824 -0.351 . . . . 14.81 111.695 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.909 HG12 ' HA ' ' A' ' 190' ' ' PRO . 12.5 m -149.2 156.23 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.273 0.629 . . . . 10.48 109.846 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.411 HG21 HD13 ' A' ' 204' ' ' LEU . 60.9 t -109.7 109.55 28.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 O-C-N 121.84 -0.537 . . . . 10.1 111.111 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -86.71 109.55 19.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.566 -0.288 . . . . 12.0 111.478 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 1.04 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -88.97 -34.86 16.72 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.141 0.496 . . . . 11.880000000000001 109.965 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.02 161.56 28.12 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.499 -0.773 . . . . 11.35 112.457 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -161.44 101.49 1.2 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.316 -0.624 . . . . 13.470000000000001 109.316 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.75 164.18 28.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.808 -0.633 . . . . 13.52 110.332 -173.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 49.5 mtpt -105.71 0.55 26.36 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.032 -0.985 . . . . 17.600000000000001 109.782 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -97.79 108.33 21.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.231 -0.895 . . . . 16.140000000000001 109.373 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.53 -21.44 66.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.995 0.426 . . . . 14.039999999999999 110.876 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.88 -36.79 70.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.653 0.739 . . . . 16.57 110.036 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.524 ' N ' ' HD2' ' A' ' 156' ' ' LYS . 2.0 mptp? -83.87 -27.22 28.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.784 -1.098 . . . . 16.399999999999999 110.354 -178.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.65 -37.66 76.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.354 0.597 . . . . 12.67 109.801 174.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -68.99 -34.12 74.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.335 -0.848 . . . . 15.32 111.512 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.616 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.7 pt-20 -82.91 -21.35 34.23 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.964 -0.294 . . . . 15.970000000000001 111.589 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 156' ' ' LYS . 48.3 mt -85.06 -50.66 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.322 0.582 . . . . 12.6 110.046 174.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.1 -41.74 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.71 -0.677 . . . . 12.539999999999999 111.162 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.26 -25.27 62.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.868 -0.682 . . . . 14.800000000000001 112.462 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.616 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 13.5 mptt -78.09 -61.05 2.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.645 0.259 . . . . 16.050000000000001 110.595 176.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.68 ' HB3' HG21 ' A' ' 171' ' ' VAL . 2.4 mm? -78.18 -48.47 15.8 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.603 0.594 . . . . 12.99 112.603 -173.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.42 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 41.8 ttt180 -77.87 -26.01 49.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.911 -0.774 . . . . 15.06 108.911 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.15 -25.54 74.46 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.033 -0.985 . . . . 16.600000000000001 111.657 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.84 3.96 54.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.054 0.454 . . . . 16.140000000000001 110.65 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.87 22.11 47.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.901 -0.666 . . . . 15.119999999999999 113.701 174.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -89.11 156.85 18.56 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 117.493 0.647 . . . . 15.49 110.027 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.407 ' HB3' ' HD2' ' A' ' 190' ' ' PRO . 24.1 mmt180 -67.69 96.83 0.58 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.751 -0.463 . . . . 13.869999999999999 109.751 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.792 HG22 HG22 ' A' ' 188' ' ' VAL . 3.6 t -139.09 125.97 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 CA-C-N 115.546 -0.752 . . . . 10.82 110.2 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.489 ' CE1' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -138.63 175.68 9.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.608 -0.723 . . . . 11.130000000000001 110.462 173.423 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.3 p -115.68 -176.36 2.91 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.758 -1.11 . . . . 11.52 111.733 -168.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.626 ' HB2' ' H ' ' A' ' 185' ' ' ARG . 22.9 t -53.03 134.74 48.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.957 -0.565 . . . . 12.75 110.384 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -31.06 -55.31 0.23 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 125.198 3.932 . . . . 14.640000000000001 115.542 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.4 t -81.11 -64.39 1.2 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 119.75 -0.78 . . . . 16.68 112.574 -169.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 55.7 m -169.09 130.41 1.06 Allowed Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 118.028 0.376 . . . . 16.039999999999999 111.791 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.558 ' HB3' HG21 ' A' ' 184' ' ' THR . 52.3 Cg_exo -65.26 122.62 10.39 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.347 2.032 . . . . 14.220000000000001 112.125 162.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.408 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.8 p -154.91 156.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.303 -0.628 . . . . 16.129999999999999 109.303 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -77.65 127.75 32.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.07 0.462 . . . . 16.699999999999999 110.691 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.02 -26.47 15.3 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.51 -0.768 . . . . 16.98 111.819 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.6 OUTLIER -108.62 167.41 10.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.24 -0.652 . . . . 18.73 109.24 176.284 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.2 tp -81.51 118.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.553 0.692 . . . . 14.82 111.073 -175.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 178' ' ' PRO . 28.8 m -111.76 105.19 13.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.729 -0.669 . . . . 12.779999999999999 109.896 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.626 ' H ' ' HB2' ' A' ' 174' ' ' SER . 81.0 mtt-85 -84.61 144.44 28.61 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.332 -0.849 . . . . 13.98 110.156 176.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.57 ' C ' HD23 ' A' ' 187' ' ' LEU . 3.0 mm -115.74 117.83 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 108.698 -0.852 . . . . 10.56 108.698 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.57 HD23 ' C ' ' A' ' 186' ' ' ILE . 0.1 OUTLIER -129.94 128.16 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.748 0.785 . . . . 10.1 112.131 -175.237 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.04 HG23 HD21 ' A' ' 148' ' ' LEU . 55.1 t -95.45 146.37 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 114.205 -1.361 . . . . 9.7400000000000002 110.278 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 72.97 46.61 28.05 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.333 -0.849 . . . . 9.7599999999999998 114.203 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.909 ' HA ' HG12 ' A' ' 145' ' ' VAL . 11.3 Cg_endo -61.72 125.53 16.89 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 119.83 1.815 . . . . 11.15 110.52 170.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -159.48 154.71 25.26 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.927 -0.578 . . . . 12.77 109.877 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 138' ' ' ALA . . . -100.49 2.39 42.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.062 -0.517 . . . . 14.6 111.725 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.11 98.3 6.1 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.563 0.697 . . . . 14.300000000000001 110.759 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.487 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 18.4 ptmt -58.88 -39.6 81.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.551 -1.204 . . . . 15.970000000000001 112.557 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -67.41 -42.85 82.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.227 0.537 . . . . 15.6 110.393 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -62.9 -41.28 99.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.116 -0.947 . . . . 14.220000000000001 110.599 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.695 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -85.78 -16.79 37.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.865 -0.607 . . . . 11.949999999999999 111.085 -177.293 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 4.8 tppp? -64.04 -32.07 73.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.491 0.663 . . . . 14.699999999999999 110.023 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -83.88 -13.2 75.56 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.648 -0.981 . . . . 13.09 110.648 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 46.0 m -79.77 -9.17 59.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.008 -0.596 . . . . 12.109999999999999 111.523 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 9.8 mt -74.27 -37.25 63.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.939 0.399 . . . . 12.720000000000001 110.485 -176.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.41 -34.84 91.03 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.001 -0.618 . . . . 14.66 112.123 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.63 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 11.6 pt-20 -86.1 -19.84 29.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.797 0.332 . . . . 13.890000000000001 110.65 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 146' ' ' VAL . 5.3 tt -65.25 -42.98 92.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 12.550000000000001 111.209 -175.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.442 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 58.8 pttt -61.72 -17.63 56.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.058 -0.519 . . . . 15.83 111.414 176.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -89.23 -36.83 15.4 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.901 0.381 . . . . 16.969999999999999 109.993 172.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.6 mt -68.84 -52.16 32.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 13.890000000000001 110.6 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.636 ' HA ' HD11 ' A' ' 164' ' ' LEU . 3.8 m -101.92 -43.38 5.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.654 -0.703 . . . . 13.539999999999999 111.298 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 75.13 -2.45 51.41 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.554 -0.748 . . . . 14.67 111.816 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 40.7 mt -80.02 149.49 30.72 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.084 -0.71 . . . . 13.039999999999999 109.084 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.2 t -89.7 104.86 17.39 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.73 -0.47 . . . . 14.84 109.73 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.563 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -125.53 157.08 19.53 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.416 -0.897 . . . . 12.220000000000001 113.492 -174.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.96 143.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.109 0.48 . . . . 13.74 110.276 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 43.5 t -77.83 106.14 7.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.303 -0.862 . . . . 12.890000000000001 109.955 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 22.7 mmt -115.73 146.78 41.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.765 -0.652 . . . . 13.800000000000001 110.209 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -74.13 134.34 18.18 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.445 -0.883 . . . . 13.359999999999999 111.621 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.545 ' HB2' HG13 ' A' ' 145' ' ' VAL . 7.9 t80 -100.87 124.32 46.37 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.536 0.684 . . . . 14.24 110.26 -175.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 55.6 m -144.57 93.7 5.71 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 108.873 -0.788 . . . . 16.510000000000002 108.873 174.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.4 120.55 8.55 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.743 2.296 . . . . 17.420000000000002 112.496 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.1 p30 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.381 -0.819 . . . . 19.190000000000001 109.926 -178.042 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 t70 . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.683 0.278 . . . . 18.390000000000001 110.555 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.0 -36.12 4.32 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.843 -0.694 . . . . 17.77 112.158 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.535 ' HA ' ' CD1' ' A' ' 34' ' ' TYR . 13.9 pt20 39.86 71.11 0.19 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.074 0.95 . . . . 17.690000000000001 112.384 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -123.75 -96.88 0.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.064 -0.398 . . . . 19.93 111.857 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.573 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 24.9 ttmm -73.74 -23.68 59.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.194 0.442 . . . . 17.43 112.194 -169.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -82.79 -1.39 51.57 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.05 -0.26 . . . . 19.359999999999999 111.275 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.535 ' CD1' ' HA ' ' A' ' 30' ' ' GLN . 70.5 m-85 -135.06 -40.1 0.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.935 0.346 . . . . 18.960000000000001 111.935 -173.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.573 ' OE1' ' HA ' ' A' ' 32' ' ' LYS . 10.3 mm100 55.1 56.73 6.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.235 0.541 . . . . 18.239999999999998 110.098 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -92.1 -44.27 8.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.744 . . . . 16.780000000000001 112.556 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -87.31 -72.5 0.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.054 -0.258 . . . . 18.420000000000002 111.383 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -165.17 118.99 1.24 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.099 0.476 . . . . 17.920000000000002 110.386 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.47 161.86 21.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.842 -0.617 . . . . 19.550000000000001 110.783 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 62.93 25.91 15.28 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.795 0.685 . . . . 20.309999999999999 111.927 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.523 HG12 ' HB ' ' A' ' 44' ' ' VAL . 20.2 tt -164.59 65.17 1.2 Allowed Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 122.178 0.99 . . . . 19.920000000000002 109.679 177.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.602 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 24.4 Cg_exo -60.92 102.61 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.62 2.88 . . . . 21.640000000000001 113.053 -169.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 42' ' ' PRO . 0.6 OUTLIER 55.66 19.32 3.27 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.234 0.959 . . . . 22.670000000000002 111.771 174.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.523 ' HB ' HG12 ' A' ' 41' ' ' ILE . 93.5 t -83.55 -37.58 0.69 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 112.944 0.72 . . . . 21.34 112.944 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' HD3' HG12 ' A' ' 41' ' ' ILE . 5.2 Cg_exo -69.45 -28.18 27.04 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.224 1.283 . . . . 20.0 111.65 -174.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.09 -68.79 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.79 -0.641 . . . . 21.079999999999998 109.796 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.91 -26.76 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.223 -0.444 . . . . 18.800000000000001 111.182 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.75 -40.57 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.014 -0.834 . . . . 17.510000000000002 111.014 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -79.9 159.45 26.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.614 -0.513 . . . . 16.949999999999999 109.614 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -103.36 -51.02 3.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.366 0.603 . . . . 18.300000000000001 109.658 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -77.01 135.68 38.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.945 -1.025 . . . . 18.170000000000002 110.724 -172.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -85.51 115.45 61.51 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.363 -0.38 . . . . 18.82 110.369 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -89.0 88.46 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.095 2.53 . . . . 19.870000000000001 112.435 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -155.94 130.98 9.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 21.100000000000001 111.22 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.44 ' HG2' ' HG3' ' A' ' 56' ' ' MET . 20.5 ttt 70.49 -71.47 0.13 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.764 0.665 . . . . 22.300000000000001 111.793 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.685 ' H ' ' HD2' ' A' ' 57' ' ' PRO . 92.2 mtp -137.13 -53.91 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.172 -0.467 . . . . 23.850000000000001 110.569 -177.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.685 ' HD2' ' H ' ' A' ' 56' ' ' MET . 6.8 Cg_endo -48.99 123.93 10.64 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.295 1.997 . . . . 20.670000000000002 112.424 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 54.0 30.78 12.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.579 -0.737 . . . . 20.489999999999998 112.532 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.56 -62.47 1.49 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.892 0.377 . . . . 21.469999999999999 110.801 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.0 t -149.42 126.33 11.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.284 -0.416 . . . . 22.600000000000001 110.6 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 60.47 34.46 20.48 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.567 0.699 . . . . 21.93 110.554 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.24 -61.15 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.891 -0.595 . . . . 19.73 110.0 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.78 115.53 65.59 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.663 -0.866 . . . . 19.579999999999998 108.663 175.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -58.55 -37.02 96.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.758 2.305 . . . . 18.5 112.066 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.9 p 44.23 48.21 7.79 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.654 0.597 . . . . 17.609999999999999 112.239 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 98.1 mt-30 -80.55 133.78 55.53 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.077 -0.511 . . . . 18.760000000000002 110.064 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 66' ' ' GLN . 44.7 Cg_exo -54.72 114.25 1.76 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.832 2.354 . . . . 17.280000000000001 112.071 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.24 -4.92 15.69 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.79 2.327 . . . . 17.77 111.866 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -99.83 158.71 15.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.714 -0.676 . . . . 18.699999999999999 109.509 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.58 74.97 2.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.94 -0.647 . . . . 17.719999999999999 111.71 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.65 -51.83 6.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.121 0.486 . . . . 18.0 110.202 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.19 121.11 24.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.67 -0.695 . . . . 17.960000000000001 110.496 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.99 164.02 18.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.89 -0.595 . . . . 19.850000000000001 109.476 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -72.14 90.35 1.2 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.078 0.466 . . . . 19.670000000000002 111.183 -175.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.26 124.82 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.69 -0.686 . . . . 17.739999999999998 110.027 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.618 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -88.76 60.36 5.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.323 0.582 . . . . 19.949999999999999 109.813 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -97.97 28.44 3.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 18.390000000000001 111.043 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.52 100.15 0.46 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.182 -0.532 . . . . 17.66 111.876 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 59.12 42.75 18.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.541 0.686 . . . . 17.68 110.724 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.91 -8.62 57.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.326 -0.852 . . . . 17.800000000000001 110.58 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.64 -13.92 62.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.822 -0.626 . . . . 17.350000000000001 110.598 176.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.64 88.57 0.12 Allowed Pre-proline 0 N--CA 1.462 0.153 0 CA-C-N 115.382 -0.826 . . . . 16.640000000000001 111.621 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.23 160.61 46.74 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.444 2.096 . . . . 17.23 111.744 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.9 p -81.59 3.73 24.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.326 0.584 . . . . 17.34 110.413 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.12 -164.13 1.13 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.688 -0.687 . . . . 18.41 109.159 177.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.76 116.6 30.66 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.875 0.369 . . . . 17.449999999999999 110.781 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.58 -31.32 8.89 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.832 2.354 . . . . 18.890000000000001 113.076 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.64 115.03 2.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.171 -0.307 . . . . 17.809999999999999 110.171 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -74.52 89.26 2.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.28 0.562 . . . . 18.629999999999999 110.703 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.6 pt -111.15 128.59 67.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.609 -0.723 . . . . 19.100000000000001 110.647 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.74 140.85 30.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.188 -0.46 . . . . 19.25 110.565 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.12 55.71 2.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.137 0.494 . . . . 18.789999999999999 110.607 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 28.7 p30 -70.97 -19.79 62.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.831 -0.622 . . . . 18.949999999999999 110.806 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.1 164.08 20.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.006 -0.543 . . . . 20.309999999999999 109.682 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.6 m 71.4 -52.53 0.69 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.009 0.818 . . . . 21.399999999999999 109.884 -173.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -77.37 -40.68 42.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 21.16 110.439 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 93' ' ' ASN . 38.6 t80 -111.98 -79.1 0.58 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.453 -0.499 . . . . 22.18 110.443 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.416 ' O ' ' HD2' ' A' ' 101' ' ' PRO . 52.2 mt-10 -69.48 110.18 5.89 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 115.188 -0.914 . . . . 19.449999999999999 110.238 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.04 -15.98 16.11 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.636 2.224 . . . . 18.530000000000001 113.512 -175.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.58 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 6.9 tp10 -56.1 -53.47 63.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 111.653 0.242 . . . . 17.449999999999999 111.653 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 6.3 Cg_endo -91.55 31.5 0.32 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.619 2.212 . . . . 17.420000000000002 112.451 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.485 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . . . -69.71 -45.1 24.79 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.595 -0.275 . . . . 17.68 111.305 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 102' ' ' ALA . 23.6 Cg_exo -66.59 159.83 48.94 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.8 1.667 . . . . 16.289999999999999 111.262 173.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.85 20.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.458 0.647 . . . . 17.260000000000002 111.623 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.91 81.53 5.2 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.134 -0.939 . . . . 15.800000000000001 109.429 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.14 125.1 16.19 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.71 2.273 . . . . 15.92 112.249 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.93 96.88 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.478 2.118 . . . . 16.149999999999999 110.925 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -64.83 131.86 95.29 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.587 -0.733 . . . . 17.629999999999999 111.401 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.47 3.31 6.91 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.929 2.419 . . . . 15.039999999999999 111.942 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -114.59 79.09 5.33 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 15.199999999999999 109.992 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -83.69 136.5 7.34 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.426 2.084 . . . . 14.08 112.304 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -93.99 44.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 122.352 1.072 . . . . 15.279999999999999 109.467 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.92 122.38 2.63 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.216 -1.356 . . . . 16.84 110.5 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.32 134.98 13.1 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.37 2.047 . . . . 15.51 112.136 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.52 42.39 1.14 Allowed 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.796 2.331 . . . . 16.039999999999999 111.747 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.464 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 56.9 tttp -82.55 -48.68 0.84 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.363 -0.835 . . . . 18.91 111.389 -177.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 91.6 Cg_endo -84.97 6.14 5.88 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.002 1.801 . . . . 17.039999999999999 111.569 176.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -72.15 149.3 44.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.982 -1.008 . . . . 17.52 110.52 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 20.1 m -76.83 50.9 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.16 0.505 . . . . 18.699999999999999 112.268 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -89.83 68.82 7.51 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.689 -0.486 . . . . 20.879999999999999 109.689 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.98 122.41 41.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.361 -0.836 . . . . 18.890000000000001 111.865 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.31 145.93 61.33 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.69 2.26 . . . . 20.43 111.534 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.82 101.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.864 2.376 . . . . 21.100000000000001 111.978 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.482 ' N ' ' HD2' ' A' ' 125' ' ' PRO . . . -69.48 -49.05 23.62 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.839 -0.619 . . . . 21.149999999999999 112.246 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 124' ' ' ALA . 40.3 Cg_endo -67.65 85.16 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.062 1.841 . . . . 21.149999999999999 112.528 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 127' ' ' PRO . 68.2 mttm -68.36 -50.52 27.89 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.941 -0.572 . . . . 21.879999999999999 111.551 178.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 126' ' ' LYS . 61.2 Cg_endo -72.38 81.13 1.54 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.117 1.878 . . . . 20.190000000000001 112.102 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' A' ' 130' ' ' LYS . 10.1 pt-20 -95.35 153.08 39.69 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 20.48 110.968 -177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.74 27.02 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.106 2.538 . . . . 21.170000000000002 113.149 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 128' ' ' GLU . 31.2 mmmt -139.29 71.86 39.01 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.888 -0.597 . . . . 23.18 109.616 176.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.93 131.95 35.01 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.544 2.163 . . . . 20.780000000000001 111.874 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 132' ' ' VAL . 7.1 p -92.28 69.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 122.172 0.987 . . . . 19.75 110.117 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.74 147.03 8.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.37 -0.832 . . . . 21.050000000000001 109.949 176.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 40.85 63.09 1.24 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.611 0.764 . . . . 21.300000000000001 111.193 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -55.42 -62.0 1.96 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.861 -1.063 . . . . 20.739999999999998 111.691 -173.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 80.87 -14.87 0.79 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.099 0.874 . . . . 17.969999999999999 109.645 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . -132.86 23.21 4.24 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.961 -1.018 . . . . 17.350000000000001 109.004 175.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.409 ' HB1' ' HD2' ' A' ' 139' ' ' PRO . . . 68.85 158.16 0.15 Allowed Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 114.719 -1.128 . . . . 19.100000000000001 111.17 -177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' A' ' 138' ' ' ALA . 60.8 Cg_exo -43.0 -43.02 9.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.643 2.895 . . . . 19.350000000000001 114.174 -174.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.3 t -166.57 23.12 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.269 0.557 . . . . 17.75 110.878 175.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -83.69 -49.21 4.94 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.882 -0.675 . . . . 17.960000000000001 112.268 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.502 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 90.8 mttt -104.34 47.22 0.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.333 0.587 . . . . 19.420000000000002 110.06 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . -76.12 165.59 24.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.176 -0.92 . . . . 14.65 110.386 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.698 ' CD1' ' HG3' ' A' ' 194' ' ' LYS . 7.1 m-85 -144.17 156.99 44.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.802 0.297 . . . . 14.81 111.802 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.698 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.2 t -151.07 161.03 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.303 -0.999 . . . . 10.48 108.303 170.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.45 HG12 ' HA3' ' A' ' 212' ' ' GLY . 96.1 t -106.76 110.17 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.909 -0.494 . . . . 10.1 111.574 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.577 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 26.5 tt0 -81.14 115.5 20.59 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.785 -0.189 . . . . 12.0 111.39 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 1.035 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -94.76 -33.4 12.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.385 0.612 . . . . 11.880000000000001 110.298 -179.148 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.24 163.73 28.38 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.535 -0.84 . . . . 11.35 112.468 -175.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.53 ' HB1' HD11 ' A' ' 183' ' ' ILE . . . -161.6 100.02 1.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.356 -0.609 . . . . 13.470000000000001 109.356 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -127.61 163.24 24.65 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.263 0.554 . . . . 13.52 109.796 -174.073 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 22.0 mtpp -102.61 -9.42 20.13 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.943 -1.026 . . . . 17.600000000000001 109.37 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -94.63 111.54 23.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.909 -1.042 . . . . 16.140000000000001 109.301 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.75 -18.34 62.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.148 0.425 . . . . 14.039999999999999 112.148 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.4 -34.83 77.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.905 0.859 . . . . 16.57 109.978 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -83.55 -17.75 40.74 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.623 -1.171 . . . . 16.399999999999999 110.124 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.707 ' HA ' HD11 ' A' ' 186' ' ' ILE . 67.4 t -76.18 -33.84 24.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.701 -0.682 . . . . 12.67 109.244 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.89 -37.6 81.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.415 -0.812 . . . . 15.32 111.054 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.688 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.8 pt-20 -75.41 -26.67 58.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.729 0.3 . . . . 15.970000000000001 111.49 -175.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.797 HD12 HD12 ' A' ' 186' ' ' ILE . 69.1 mt -85.09 -49.07 16.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.149 0.499 . . . . 12.6 110.317 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.45 -46.58 69.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.83 -0.623 . . . . 12.539999999999999 111.156 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.53 62.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.958 -0.639 . . . . 14.800000000000001 112.568 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.688 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 2.1 mptm? -85.93 -57.08 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.683 0.278 . . . . 16.050000000000001 110.896 177.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.534 ' HB3' HG21 ' A' ' 171' ' ' VAL . 2.5 mm? -79.63 -56.84 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.167 0.432 . . . . 12.99 112.167 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.531 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 68.3 ttt180 -64.6 -39.6 94.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 15.06 109.983 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.25 -25.74 71.28 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.254 -0.885 . . . . 16.600000000000001 112.698 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.46 -7.3 58.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.929 0.395 . . . . 16.140000000000001 110.517 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.3 2.42 29.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.782 -0.723 . . . . 15.119999999999999 113.284 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -79.52 151.9 30.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.039 0.419 . . . . 15.49 110.479 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -70.23 99.06 1.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.868 -0.605 . . . . 13.869999999999999 110.316 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.701 HG22 HG22 ' A' ' 188' ' ' VAL . 13.7 t -132.06 132.61 61.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.106 0.479 . . . . 10.82 111.298 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.463 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -137.29 174.86 10.15 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.331 -0.849 . . . . 11.130000000000001 110.226 170.751 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 18.0 p -118.6 -176.57 3.11 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.964 -1.016 . . . . 11.52 111.849 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.2 OUTLIER -52.99 148.77 13.3 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.85 -0.614 . . . . 12.75 111.867 -178.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -23.93 -65.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.556 1 C-N-CA 125.969 4.446 . . . . 14.640000000000001 115.838 -176.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.6 m -88.56 -62.77 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.294 0.85 . . . . 16.68 113.294 -170.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.0 m -166.82 132.67 1.81 Allowed Pre-proline 0 C--O 1.234 0.285 0 N-CA-C 112.449 0.537 . . . . 16.039999999999999 112.449 -171.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.526 ' HB3' HG21 ' A' ' 184' ' ' THR . 53.0 Cg_exo -63.48 124.78 14.33 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.971 2.447 . . . . 14.220000000000001 111.6 162.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.4 p -152.14 158.46 4.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.42 -0.354 . . . . 16.129999999999999 110.261 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -80.49 120.06 23.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.315 -0.402 . . . . 16.699999999999999 110.81 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.96 -22.51 25.42 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.98 -0.629 . . . . 16.98 112.72 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -114.79 163.55 15.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.992 0.425 . . . . 18.73 110.062 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.53 HD11 ' HB1' ' A' ' 150' ' ' ALA . 10.1 tp -71.01 120.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.623 -0.717 . . . . 14.82 111.761 -173.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.526 HG21 ' HB3' ' A' ' 178' ' ' PRO . 56.8 m -114.05 105.87 13.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.754 -0.657 . . . . 12.779999999999999 109.704 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 63.5 mtt-85 -83.41 141.16 31.93 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.509 -0.769 . . . . 13.98 108.991 176.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.797 HD12 HD12 ' A' ' 160' ' ' ILE . 3.4 mt -120.91 123.57 70.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.443 -0.577 . . . . 10.56 109.443 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 147' ' ' GLN . 4.0 mp -128.73 135.92 49.87 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.324 -0.853 . . . . 10.1 110.661 -170.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 1.035 HG23 HD21 ' A' ' 148' ' ' LEU . 25.0 t -104.17 133.4 48.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.239 -0.892 . . . . 9.7400000000000002 110.835 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.02 47.37 5.3 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.0 -1.0 . . . . 9.7599999999999998 114.043 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.686 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -61.02 125.1 16.25 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 CA-C-N 119.68 1.74 . . . . 11.15 111.414 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -156.05 147.69 22.88 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.105 -0.498 . . . . 12.77 110.176 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.531 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -89.34 -8.99 52.08 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.559 -0.746 . . . . 14.6 111.267 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.4 t -100.67 94.44 6.1 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.449 -0.574 . . . . 14.300000000000001 109.449 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.698 ' HG3' ' CD1' ' A' ' 144' ' ' TYR . 18.1 ttmt -54.1 -41.08 67.88 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.142 -0.935 . . . . 15.970000000000001 110.101 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.07 -53.41 54.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 15.6 111.827 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -62.88 -46.21 88.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.138 0.494 . . . . 14.220000000000001 111.164 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -76.27 -20.76 57.04 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.841 -0.618 . . . . 11.949999999999999 110.864 -176.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 57.0 tptt -65.92 -39.25 90.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.448 0.642 . . . . 14.699999999999999 109.728 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.49 -11.3 85.43 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 114.984 -1.007 . . . . 13.09 110.667 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 204' ' ' LEU . 75.2 m -88.23 -8.97 54.45 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.101 -0.549 . . . . 12.109999999999999 112.377 -175.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 33.1 mt -68.34 -37.28 80.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.799 0.333 . . . . 12.720000000000001 110.956 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.05 -43.8 96.71 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.926 -0.654 . . . . 14.66 111.882 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 13.6 pt-20 -83.47 -18.03 39.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.795 0.331 . . . . 13.890000000000001 110.935 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 207' ' ' LEU . 15.2 tp -74.44 -34.74 63.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.086 0.47 . . . . 12.550000000000001 110.306 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 7.6 mtmp? -66.82 -15.63 63.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.775 -0.648 . . . . 15.83 110.015 174.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.01 -36.01 17.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.851 -0.613 . . . . 16.969999999999999 109.413 172.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 204' ' ' LEU . 66.3 mt -68.88 -51.4 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.787 -0.642 . . . . 13.890000000000001 111.127 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.463 ' HA ' HD11 ' A' ' 164' ' ' LEU . 22.2 p -102.67 -47.82 4.31 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.383 -0.527 . . . . 13.539999999999999 111.139 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 75.37 -0.17 60.6 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.824 -0.626 . . . . 14.67 112.183 -176.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.573 ' HB3' ' HB3' ' A' ' 148' ' ' LEU . 7.3 mp -74.92 158.98 32.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 110.048 -0.353 . . . . 13.039999999999999 110.048 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 57.1 p -77.09 93.35 3.86 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.082 -0.508 . . . . 14.84 110.44 -175.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -112.78 137.63 14.38 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.349 -0.929 . . . . 12.220000000000001 114.279 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 16.9 t -101.75 137.94 27.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.287 -0.634 . . . . 13.74 109.287 173.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 5.3 p -75.56 105.65 4.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.622 0.725 . . . . 12.890000000000001 109.936 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 91.2 mmm -117.35 133.79 55.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.869 -0.605 . . . . 13.800000000000001 110.546 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -67.74 139.31 34.71 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.526 -0.845 . . . . 13.359999999999999 111.546 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.698 ' HB2' HG23 ' A' ' 145' ' ' VAL . 9.9 t80 -108.98 131.61 54.9 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 123.703 0.801 . . . . 14.24 110.423 -170.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.2 t -146.56 94.75 4.71 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-O 121.091 0.472 . . . . 16.510000000000002 109.852 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.9 148.78 77.14 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.258 1.972 . . . . 17.420000000000002 111.823 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.695 -0.669 . . . . 19.190000000000001 109.959 -179.081 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.543 0.211 . . . . 18.390000000000001 110.459 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.42 163.29 29.4 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.747 -0.74 . . . . 17.77 112.14 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.432 HE21 ' HE3' ' A' ' 32' ' ' LYS . 51.4 tt0 60.25 80.82 0.2 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.426 0.632 . . . . 17.690000000000001 111.182 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -76.75 75.64 3.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.627 -0.715 . . . . 19.93 111.084 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.597 ' HG2' ' H ' ' A' ' 34' ' ' TYR . 41.2 ttmt -98.12 154.11 17.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.36 -0.607 . . . . 17.43 109.36 175.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.47 ' HE1' ' O ' ' A' ' 74' ' ' GLU . 85.4 m-70 -129.38 25.73 5.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.957 0.408 . . . . 19.359999999999999 111.355 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.597 ' H ' ' HG2' ' A' ' 32' ' ' LYS . 88.1 m-85 -132.92 176.81 8.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.325 -0.398 . . . . 18.960000000000001 110.512 -175.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 63.56 33.9 12.99 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.902 0.751 . . . . 18.239999999999998 109.473 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.4 t70 73.47 117.7 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.507 -1.224 . . . . 16.780000000000001 111.874 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.42 ' HA ' ' HB3' ' A' ' 71' ' ' ALA . 39.0 mt-10 -87.62 34.39 0.71 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.014 -0.539 . . . . 18.420000000000002 110.643 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.5 t80 62.35 -76.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.859 0.864 . . . . 17.920000000000002 111.447 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.06 141.5 11.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.775 0.321 . . . . 19.550000000000001 110.724 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.4 65.2 8.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.202 0.525 . . . . 20.309999999999999 110.332 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.429 HD12 ' O ' ' A' ' 47' ' ' ALA . 8.0 pt -121.8 83.1 42.63 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.822 -0.626 . . . . 19.920000000000002 111.543 -177.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.79 68.03 7.8 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.754 2.303 . . . . 21.640000000000001 111.897 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mp 62.88 34.53 14.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.907 -0.588 . . . . 22.670000000000002 111.468 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.579 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 57.9 t -90.69 -52.71 0.3 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.125 -0.488 . . . . 21.34 111.172 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 5.8 Cg_endo -92.22 172.25 2.46 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.777 2.318 . . . . 20.0 111.651 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -85.15 57.78 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.755 0.788 . . . . 21.079999999999998 109.154 174.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.429 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -168.36 137.94 2.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.839 -1.073 . . . . 18.800000000000001 109.253 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.11 -128.47 2.74 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.675 -0.774 . . . . 17.510000000000002 111.297 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.42 123.08 14.2 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.029 -0.36 . . . . 16.949999999999999 110.029 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -164.82 82.96 0.38 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.219 -0.66 . . . . 18.300000000000001 109.219 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.27 110.46 0.96 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.638 -0.71 . . . . 18.170000000000002 111.45 -172.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -85.48 115.4 61.28 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 109.12 -0.696 . . . . 18.82 109.12 171.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.72 7.18 2.45 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.856 2.371 . . . . 19.870000000000001 112.864 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -136.77 67.81 1.44 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.206 0.527 . . . . 21.100000000000001 110.355 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.3 ttt -166.68 -70.26 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.452 -0.795 . . . . 22.300000000000001 109.942 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.558 ' HB3' ' HD3' ' A' ' 57' ' ' PRO . 38.4 tpp -144.55 -48.57 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.966 -0.561 . . . . 23.850000000000001 110.656 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 56' ' ' MET . 14.0 Cg_exo -71.28 122.64 8.87 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.478 1.452 . . . . 20.670000000000002 110.712 172.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 62' ' ' ALA . . . -74.65 -47.51 31.57 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.009 -0.541 . . . . 20.489999999999998 110.183 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 177.81 -175.55 0.17 Allowed 'General case' 0 CA--C 1.522 -0.132 0 O-C-N 123.933 0.771 . . . . 21.469999999999999 109.663 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -67.23 -19.4 65.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.242 0.544 . . . . 22.600000000000001 110.117 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -82.53 -15.38 52.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.826 -0.625 . . . . 21.93 110.5 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 58' ' ' ALA . . . -147.64 87.92 1.66 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.131 -0.486 . . . . 19.73 110.872 -177.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.34 161.13 75.96 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.72 -0.673 . . . . 19.579999999999998 109.857 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.442 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 7.4 Cg_exo -73.64 69.76 4.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.775 2.317 . . . . 18.5 112.756 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m 59.57 42.08 17.95 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.387 0.613 . . . . 17.609999999999999 111.038 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 64' ' ' PRO . 12.0 pt20 -173.44 74.31 0.39 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.451 -0.795 . . . . 18.760000000000002 110.517 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.09 -45.19 37.46 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.305 2.67 . . . . 17.280000000000001 114.976 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.62 -46.73 31.37 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.235 1.957 . . . . 17.77 113.098 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -164.11 149.72 10.74 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.365 -0.605 . . . . 18.699999999999999 109.365 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 72' ' ' ALA . . . -90.6 58.8 3.36 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.848 -0.614 . . . . 17.719999999999999 112.391 -173.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . . . 70.15 -27.78 0.17 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.004 0.742 . . . . 18.0 113.004 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 70' ' ' GLY . . . -75.52 22.82 0.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.539 0.57 . . . . 17.960000000000001 112.539 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -83.39 -25.01 31.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.058 -1.09 . . . . 19.850000000000001 108.058 172.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' O ' ' HE1' ' A' ' 33' ' ' HIS . 30.0 tt0 -130.55 89.65 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.764 -1.107 . . . . 19.670000000000002 109.24 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 t -77.58 95.89 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 17.739999999999998 110.866 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -80.28 -41.76 24.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.139 -0.482 . . . . 19.949999999999999 110.131 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 66.5 -64.98 0.21 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.006 0.816 . . . . 18.390000000000001 112.697 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.64 ' HA2' ' HB2' ' A' ' 82' ' ' ALA . . . -98.72 -130.99 7.08 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.045 -0.597 . . . . 17.66 113.206 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 58.5 61.33 2.27 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.724 0.41 . . . . 17.68 110.442 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 74.11 -23.64 0.22 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.044 0.84 . . . . 17.800000000000001 112.311 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.73 -34.42 60.32 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.713 0.264 . . . . 17.350000000000001 111.713 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.64 ' HB2' ' HA2' ' A' ' 78' ' ' GLY . . . -56.47 -54.92 48.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 112.034 0.383 . . . . 16.640000000000001 112.034 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 82' ' ' ALA . 61.1 Cg_endo -74.15 -19.66 19.83 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.374 1.382 . . . . 17.23 112.254 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.8 t 69.29 -63.25 0.38 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.461 -0.79 . . . . 17.34 110.4 -175.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.6 mt -113.61 149.7 34.17 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.723 -0.473 . . . . 18.41 109.723 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -79.39 130.14 69.61 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.411 . . . . 17.449999999999999 110.918 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.45 -15.61 48.45 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.927 2.418 . . . . 18.890000000000001 112.222 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.22 102.62 2.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.05 -0.523 . . . . 17.809999999999999 110.807 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.1 p -75.91 -40.76 53.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.151 -0.477 . . . . 18.629999999999999 110.994 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 pt -121.43 -47.8 2.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.23 -0.441 . . . . 19.100000000000001 110.747 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -171.13 -91.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.328 -0.396 . . . . 19.25 110.332 174.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 174.34 -43.53 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.061 0.458 . . . . 18.789999999999999 111.295 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -94.08 47.03 1.19 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.982 -0.553 . . . . 18.949999999999999 112.24 -169.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -149.28 77.67 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.597 0.237 . . . . 20.309999999999999 110.587 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.8 m -67.19 -51.15 56.98 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.847 -0.797 . . . . 21.399999999999999 108.847 172.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -120.18 -26.5 5.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.948 -1.024 . . . . 21.16 108.83 168.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.406 ' H ' ' H ' ' A' ' 98' ' ' GLU . 27.4 p90 -179.6 -7.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.2 -0.909 . . . . 22.18 110.477 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.414 ' HB2' ' HD2' ' A' ' 99' ' ' PRO . 14.4 pt-20 -149.94 169.13 9.67 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.366 -0.834 . . . . 19.449999999999999 108.989 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 98' ' ' GLU . 35.8 Cg_exo -57.35 -64.72 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.981 1.788 . . . . 18.530000000000001 112.275 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 103' ' ' PRO . 34.7 tt0 -175.94 133.43 0.43 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 17.449999999999999 110.185 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.26 102.9 0.48 Allowed 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.586 2.191 . . . . 17.420000000000002 111.608 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 58.78 78.24 0.36 Allowed Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 115.584 -0.734 . . . . 17.68 110.292 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.49 ' HA ' ' OE1' ' A' ' 100' ' ' GLU . 36.3 Cg_exo -62.16 142.64 92.67 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.294 2.663 . . . . 16.289999999999999 112.926 -175.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.5 m -93.48 18.31 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 121.438 0.637 . . . . 17.260000000000002 111.23 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 106' ' ' PRO . . . -70.79 -50.3 13.06 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.24 -0.891 . . . . 15.800000000000001 111.982 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 105' ' ' ALA . 37.9 Cg_endo -65.51 156.78 61.75 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.982 1.788 . . . . 15.92 111.958 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.22 -13.02 25.73 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.723 2.282 . . . . 16.149999999999999 111.983 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 14.1 mptt -89.29 131.02 41.83 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.688 -0.687 . . . . 17.629999999999999 109.719 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 108' ' ' LYS . 35.5 Cg_exo -61.98 103.95 0.31 Allowed 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.729 2.286 . . . . 15.039999999999999 112.025 176.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.414 ' HB2' ' HD3' ' A' ' 111' ' ' PRO . 14.7 mmmm -84.29 -51.05 0.59 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.264 -0.426 . . . . 15.199999999999999 111.251 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 110' ' ' LYS . 64.9 Cg_endo -74.7 96.09 0.98 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.666 1.577 . . . . 14.08 112.701 177.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.8 53.78 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 122.376 1.084 . . . . 15.279999999999999 108.907 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.631 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 24.4 mm-40 -65.44 -41.62 51.67 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 113.84 -1.527 . . . . 16.84 112.425 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 113' ' ' GLU . 3.7 Cg_exo -40.87 126.97 2.53 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.968 2.445 . . . . 15.51 112.276 172.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.94 -172.65 1.49 Allowed 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.765 2.31 . . . . 16.039999999999999 112.515 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.1 tptt 64.83 71.95 0.52 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 115.765 -0.652 . . . . 18.91 110.48 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -96.57 -4.72 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.624 2.883 . . . . 17.039999999999999 111.465 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.3 tptt 60.04 51.66 5.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.264 -1.335 . . . . 17.52 110.722 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 m 37.45 -106.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 115.257 -0.883 . . . . 18.699999999999999 112.841 -176.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -113.12 68.87 0.68 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.974 0.416 . . . . 20.879999999999999 110.883 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.93 113.47 7.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 18.890000000000001 110.779 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.79 -50.26 10.92 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.118 2.545 . . . . 20.43 114.032 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -90.15 40.98 0.44 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.649 1.566 . . . . 21.100000000000001 112.259 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.45 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . . . -69.96 128.05 91.99 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.051 -0.522 . . . . 21.149999999999999 110.533 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 124' ' ' ALA . 24.9 Cg_exo -63.43 -18.93 66.82 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.759 2.306 . . . . 21.149999999999999 112.0 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -116.19 108.09 46.48 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.728 -0.669 . . . . 21.879999999999999 109.668 177.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.41 -38.75 89.45 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.297 2.665 . . . . 20.190000000000001 112.884 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -127.62 90.56 47.96 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.309 -0.405 . . . . 20.48 110.138 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.47 ' O ' ' HD3' ' A' ' 131' ' ' PRO . 7.6 Cg_exo -71.86 -65.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.994 2.463 . . . . 21.170000000000002 111.993 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -115.83 85.48 14.55 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.13 -0.693 . . . . 23.18 109.13 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 129' ' ' PRO . 2.6 Cg_exo -75.85 75.89 3.91 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.954 2.436 . . . . 20.780000000000001 112.425 -177.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.3 p -89.61 42.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 122.556 1.17 . . . . 19.75 109.292 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.44 136.3 7.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.637 -1.165 . . . . 21.050000000000001 110.861 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.88 -169.67 1.56 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.903 -0.589 . . . . 21.300000000000001 109.49 173.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.564 ' HG3' ' H ' ' A' ' 136' ' ' LYS . 2.0 pt-20 -47.06 -81.45 0.01 OUTLIER 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.751 0.648 . . . . 20.739999999999998 112.751 -174.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.564 ' H ' ' HG3' ' A' ' 135' ' ' GLU . 40.2 ttpt 70.3 -40.01 0.46 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.34 0.656 . . . . 17.969999999999999 111.127 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' A' ' 142' ' ' LYS . . . -68.68 -21.63 64.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.989 -0.55 . . . . 17.350000000000001 109.974 172.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 74.82 147.22 0.12 Allowed Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 114.467 -1.242 . . . . 19.100000000000001 111.347 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 192' ' ' ALA . 71.5 Cg_exo -51.51 -75.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.1 2.533 . . . . 19.350000000000001 113.586 -175.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.3 p -90.12 -11.98 39.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.888 0.375 . . . . 17.75 110.976 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.37 -54.6 31.11 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.18 -0.768 . . . . 17.960000000000001 111.18 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.548 ' HB3' ' HB1' ' A' ' 137' ' ' ALA . 58.6 tttm -144.56 79.58 1.61 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.814 0.816 . . . . 19.420000000000002 109.698 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.55 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -74.29 169.2 18.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.546 -1.206 . . . . 14.65 110.253 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.571 ' HB3' HD21 ' A' ' 197' ' ' LEU . 3.3 m-85 -128.6 156.15 43.83 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.813 0.672 . . . . 14.81 112.813 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.85 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.7 t -150.49 165.75 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 108.983 -0.747 . . . . 10.48 108.983 174.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 43.9 t -105.59 113.05 41.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 O-C-N 121.75 -0.594 . . . . 10.1 110.8 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.442 ' OE1' ' HD3' ' A' ' 185' ' ' ARG . 6.4 tt0 -87.72 105.16 17.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.715 -0.221 . . . . 12.0 111.161 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.931 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -85.66 -36.27 20.39 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.343 0.592 . . . . 11.880000000000001 110.198 -176.224 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.47 169.59 26.4 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.251 -0.976 . . . . 11.35 112.674 -173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.32 101.27 0.35 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.288 -0.634 . . . . 13.470000000000001 109.288 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.75 154.63 47.46 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.402 0.62 . . . . 13.52 110.724 -173.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 40.6 mtmt -95.44 -3.19 47.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.88 -1.055 . . . . 17.600000000000001 109.899 -176.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -97.92 104.15 16.15 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.025 . . . . 16.140000000000001 109.362 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.77 -19.01 65.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.371 0.605 . . . . 14.039999999999999 110.551 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -59.93 -34.34 73.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.235 -0.893 . . . . 16.57 110.189 174.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -90.42 -29.12 18.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.727 -1.124 . . . . 16.399999999999999 110.405 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' THR . 93.3 t -58.48 -38.73 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.368 0.604 . . . . 12.67 109.819 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -59.75 -29.48 68.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.148 -0.933 . . . . 15.32 111.243 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.74 -62.69 1.4 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.217 0.532 . . . . 15.970000000000001 110.03 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.458 HD12 HG13 ' A' ' 186' ' ' ILE . 7.6 mt -55.25 -43.51 71.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.885 -1.052 . . . . 12.6 110.757 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.5 t -74.59 -40.19 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.689 -0.687 . . . . 12.539999999999999 110.455 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.26 -33.95 86.33 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.373 -0.918 . . . . 14.800000000000001 111.487 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -68.23 -57.43 6.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.411 -0.394 . . . . 16.050000000000001 111.497 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -85.3 -52.35 5.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.353 0.501 . . . . 12.99 112.353 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -68.31 -37.59 80.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.15 0.5 . . . . 15.06 110.221 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.09 -23.9 77.63 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.41 -0.814 . . . . 16.600000000000001 112.552 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.5 1.39 55.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.951 0.405 . . . . 16.140000000000001 110.755 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.29 23.46 34.36 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.83 -0.7 . . . . 15.119999999999999 113.396 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -89.92 154.42 19.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.955 0.378 . . . . 15.49 110.208 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.474 ' HD2' ' N ' ' A' ' 170' ' ' ARG . 8.8 mpt_? -76.55 98.34 4.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.238 -0.653 . . . . 13.869999999999999 109.238 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.97 142.01 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.155 -0.929 . . . . 10.82 109.016 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.642 ' HH ' ' HD2' ' A' ' 217' ' ' TYR . 0.1 OUTLIER -138.98 176.8 8.38 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.554 0.693 . . . . 11.130000000000001 110.712 174.152 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 23.6 p -111.21 -175.95 2.83 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.508 -1.223 . . . . 11.52 111.353 -171.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.3 OUTLIER -53.81 148.94 18.22 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.212 -0.449 . . . . 12.75 111.031 176.599 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -32.09 -61.38 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 125.126 3.884 . . . . 14.640000000000001 115.337 -173.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.1 m -87.32 -63.0 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.371 0.878 . . . . 16.68 113.371 -168.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.7 m -167.82 129.22 1.2 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 118.434 0.561 . . . . 16.039999999999999 112.356 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.465 ' HB3' HG21 ' A' ' 184' ' ' THR . 72.1 Cg_exo -59.36 124.27 15.19 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.541 2.16 . . . . 14.220000000000001 111.705 163.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.3 p -153.32 160.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 109.646 -0.502 . . . . 16.129999999999999 109.646 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -80.13 122.57 26.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.457 -0.338 . . . . 16.699999999999999 110.56 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.75 -25.77 18.05 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.888 -0.672 . . . . 16.98 112.555 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -109.35 160.7 15.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.784 -0.451 . . . . 18.73 109.784 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.0 tp -73.19 109.4 5.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.747 0.784 . . . . 14.82 111.555 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 178' ' ' PRO . 56.9 m -100.05 112.53 24.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.449 -0.796 . . . . 12.779999999999999 109.625 174.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 46.1 mtt180 -93.61 144.77 25.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.691 -0.686 . . . . 13.98 109.938 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.519 ' O ' HD22 ' A' ' 148' ' ' LEU . 5.2 mm -114.85 120.41 64.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.108 -0.701 . . . . 10.56 109.108 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.499 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.9 mp -129.42 123.01 30.55 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.208 0.528 . . . . 10.1 111.041 -174.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.931 HG23 HD21 ' A' ' 148' ' ' LEU . 33.6 t -99.58 134.97 36.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.625 -0.716 . . . . 9.7400000000000002 111.159 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 84.5 47.98 5.2 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.96 -1.018 . . . . 9.7599999999999998 113.555 173.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.83 ' HA ' HG22 ' A' ' 145' ' ' VAL . 12.7 Cg_endo -62.74 125.82 16.88 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 119.476 1.638 . . . . 11.15 110.511 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -157.26 152.4 26.06 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.325 -0.55 . . . . 12.77 110.586 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 139' ' ' PRO . . . -88.74 2.62 53.11 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.608 -0.724 . . . . 14.6 111.34 -175.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 18.2 t -118.32 97.81 5.96 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.367 0.603 . . . . 14.300000000000001 109.685 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 198' ' ' LYS . 2.9 ptmm? -57.42 -40.5 78.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.899 -1.046 . . . . 15.970000000000001 111.821 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -71.75 -46.89 57.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.803 0.335 . . . . 15.6 111.461 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -59.55 -37.21 77.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.316 0.579 . . . . 14.220000000000001 110.243 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.571 HD21 ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -84.21 -24.18 30.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.749 -0.659 . . . . 11.949999999999999 110.412 -178.241 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 14.1 tmtt? -74.82 -34.46 62.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.313 0.578 . . . . 14.699999999999999 109.652 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.17 -13.28 82.89 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.157 -1.177 . . . . 13.09 110.157 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 45.5 m -90.17 -8.59 50.82 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.354 -0.923 . . . . 12.109999999999999 111.934 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 24.3 mt -65.31 -35.21 80.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.671 0.272 . . . . 12.720000000000001 111.043 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.2 -42.62 97.28 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.791 -0.718 . . . . 14.66 111.851 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 200' ' ' SER . 9.9 pt-20 -85.91 -19.7 30.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.664 0.268 . . . . 13.890000000000001 110.584 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 19.9 tp -68.65 -28.63 67.06 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.112 0.482 . . . . 12.550000000000001 110.085 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.543 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 90.8 mttt -60.92 -16.68 44.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.41 -0.814 . . . . 15.83 110.568 173.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -89.91 -43.01 10.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.42 -0.355 . . . . 16.969999999999999 110.424 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.13 -55.52 31.5 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.51 0.671 . . . . 13.890000000000001 112.204 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 55.9 p -97.38 -44.19 6.97 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.134 -0.939 . . . . 13.539999999999999 110.854 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 72.62 1.93 54.57 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.536 -0.756 . . . . 14.67 111.802 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.446 ' HB2' ' HG ' ' A' ' 148' ' ' LEU . 70.5 mt -85.53 152.14 23.4 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.738 -0.468 . . . . 13.039999999999999 109.738 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 p -90.32 104.84 17.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.256 -0.429 . . . . 14.84 110.591 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -130.32 160.7 23.09 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.148 -1.025 . . . . 12.220000000000001 114.142 -173.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.2 t -101.45 140.59 19.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.917 -0.641 . . . . 13.74 109.383 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.01 105.15 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.732 0.777 . . . . 12.890000000000001 109.614 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 1.8 mmt -122.07 168.85 11.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.48 -0.782 . . . . 13.800000000000001 110.564 -172.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -83.48 163.46 40.79 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.476 -0.868 . . . . 13.359999999999999 112.934 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.85 ' HB2' HG23 ' A' ' 145' ' ' VAL . 6.9 t80 -128.67 126.5 40.27 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.845 0.858 . . . . 14.24 110.166 -174.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 89.4 m -146.61 93.37 4.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 116.075 -0.511 . . . . 16.510000000000002 109.653 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.9 149.87 60.32 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.702 2.268 . . . . 17.420000000000002 112.541 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 47.8 t30 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.843 -0.599 . . . . 19.190000000000001 109.791 177.21 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.529 ' O ' ' HE2' ' A' ' 31' ' ' LYS . 28.7 m-20 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.706 -0.479 . . . . 18.390000000000001 109.706 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.0 162.75 54.1 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.851 -0.69 . . . . 17.77 112.687 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 65.71 -98.18 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.144 0.577 . . . . 17.690000000000001 111.747 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HE2' ' O ' ' A' ' 28' ' ' ASP . 57.6 mtmt 56.17 25.06 8.67 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 122.665 0.386 . . . . 19.93 111.154 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -167.51 -170.94 1.54 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.174 -0.676 . . . . 17.43 109.174 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m80 59.99 42.63 15.71 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.496 0.498 . . . . 19.359999999999999 110.771 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 66' ' ' GLN . 52.9 t80 -142.73 57.08 1.42 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.593 0.711 . . . . 18.960000000000001 110.065 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -89.49 46.05 1.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.741 0.781 . . . . 18.239999999999998 109.653 173.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -84.9 125.37 32.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.899 -1.046 . . . . 16.780000000000001 109.83 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -56.11 118.14 4.4 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.698 0.624 . . . . 18.420000000000002 110.95 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -73.28 86.75 1.46 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.08 0.467 . . . . 17.920000000000002 110.851 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.55 -13.29 26.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.686 -0.688 . . . . 19.550000000000001 109.65 175.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.79 -148.34 0.37 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.135 -0.938 . . . . 20.309999999999999 109.593 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 41' ' ' ILE . 4.4 mp 60.92 72.71 0.68 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 121.718 0.771 . . . . 19.920000000000002 110.411 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -81.18 54.02 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.068 2.512 . . . . 21.640000000000001 111.28 175.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 mp 62.24 26.4 15.82 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.39 -0.823 . . . . 22.670000000000002 111.336 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.551 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 83.9 t -79.81 -60.65 0.5 Allowed Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.301 -0.409 . . . . 21.34 110.593 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 96.1 Cg_endo -78.35 59.81 7.24 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.894 1.729 . . . . 20.0 111.537 172.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? 68.49 167.18 0.26 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.552 -0.749 . . . . 21.079999999999998 111.112 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.89 54.21 2.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 18.800000000000001 111.675 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.14 -8.93 83.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.903 -0.665 . . . . 17.510000000000002 112.052 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -80.55 131.07 35.48 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.409 -0.219 . . . . 16.949999999999999 110.409 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 60.59 39.11 18.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.758 -0.656 . . . . 18.300000000000001 110.415 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.11 127.67 33.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.634 -0.712 . . . . 18.170000000000002 109.286 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 57' ' ' PRO . 12.6 pt-20 -85.5 115.78 62.86 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.245 0.545 . . . . 18.82 112.366 -171.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.665 ' HA ' ' O ' ' A' ' 57' ' ' PRO . 88.1 Cg_endo -83.77 32.92 0.5 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.012 2.474 . . . . 19.870000000000001 112.038 176.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -93.65 -56.34 2.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.145 -0.479 . . . . 21.100000000000001 111.354 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 72.2 mtm -85.26 -85.25 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.413 -0.358 . . . . 22.300000000000001 111.586 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.636 ' H ' ' HD2' ' A' ' 57' ' ' PRO . 65.6 mtt -122.41 -41.28 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.297 0.48 . . . . 23.850000000000001 112.297 -176.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.665 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 88.0 Cg_exo -48.76 125.65 13.2 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.997 1.798 . . . . 20.670000000000002 112.168 171.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 66.13 8.99 5.91 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.333 -0.849 . . . . 20.489999999999998 111.877 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.97 -39.48 5.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.105 0.479 . . . . 21.469999999999999 109.863 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.6 m -80.52 -35.83 34.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 22.600000000000001 110.102 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -113.09 179.34 3.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.725 -0.67 . . . . 21.93 109.748 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.81 -80.98 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.852 0.358 . . . . 19.73 111.44 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.8 tp -134.98 89.82 23.33 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.043 0.449 . . . . 19.579999999999998 110.192 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -93.43 28.68 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.475 2.784 . . . . 18.5 113.222 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 p -68.25 -58.64 4.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.117 0.484 . . . . 17.609999999999999 110.311 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 84.0 mm-40 -135.6 76.26 55.17 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.825 -0.625 . . . . 18.760000000000002 109.683 172.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 83.7 Cg_endo -81.42 127.76 5.94 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.751 2.301 . . . . 17.280000000000001 112.267 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 67' ' ' PRO . 16.3 Cg_exo -68.41 -16.97 44.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.601 2.201 . . . . 17.77 112.306 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -124.56 163.13 22.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.547 -0.751 . . . . 18.699999999999999 109.906 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.9 -153.35 17.0 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.646 -0.787 . . . . 17.719999999999999 112.295 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 64.43 74.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.286 0.565 . . . . 18.0 110.824 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.8 152.97 20.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.469 -0.787 . . . . 17.960000000000001 109.738 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.81 124.76 39.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.632 0.254 . . . . 19.850000000000001 110.724 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 71.18 -59.43 0.54 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.462 0.705 . . . . 19.670000000000002 111.946 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.87 103.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.194 -0.457 . . . . 17.739999999999998 111.186 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? 66.98 17.0 10.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.439 -0.8 . . . . 19.949999999999999 111.242 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.85 -28.09 7.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.223 -0.444 . . . . 18.390000000000001 111.009 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.73 85.68 0.86 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.82 -0.705 . . . . 17.66 112.357 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -146.82 164.17 33.7 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.566 -0.531 . . . . 17.68 109.566 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.41 57.99 3.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.217 0.532 . . . . 17.800000000000001 110.79 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.76 71.79 1.25 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.761 -0.654 . . . . 17.350000000000001 110.393 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.34 105.84 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.338 0 O-C-N 123.87 0.731 . . . . 16.640000000000001 111.579 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.65 -22.31 59.99 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.994 2.463 . . . . 17.23 112.328 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.3 m 67.26 -176.5 0.2 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.434 -0.803 . . . . 17.34 111.187 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 85' ' ' LEU . 1.9 pt? -142.77 133.68 25.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.345 -0.388 . . . . 18.41 109.971 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -76.07 132.93 72.92 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.974 -0.557 . . . . 17.449999999999999 110.975 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.36 -6.39 18.3 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.689 2.259 . . . . 18.890000000000001 112.111 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 65.04 -85.32 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.422 -0.808 . . . . 17.809999999999999 111.425 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.6 p 49.33 -96.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.348 0.659 . . . . 18.629999999999999 112.309 -175.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mm -77.64 -36.13 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.146 0.498 . . . . 19.100000000000001 110.268 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.729 ' HA ' ' OG1' ' A' ' 95' ' ' THR . . . -104.9 81.96 1.81 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.845 -0.616 . . . . 19.25 110.822 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -99.33 -39.09 8.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.172 -0.467 . . . . 18.789999999999999 111.47 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -160.02 -69.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.972 0.415 . . . . 18.949999999999999 111.229 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -85.42 54.82 3.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.503 0.668 . . . . 20.309999999999999 111.373 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.729 ' OG1' ' HA ' ' A' ' 91' ' ' ALA . 6.9 m -103.26 -24.85 13.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.661 0.743 . . . . 21.399999999999999 109.287 172.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -143.13 30.14 1.44 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.769 -1.105 . . . . 21.16 109.301 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 56.18 52.95 9.54 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.752 -1.113 . . . . 22.18 111.48 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -79.74 120.23 79.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 19.449999999999999 110.14 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.417 ' C ' ' HD3' ' A' ' 101' ' ' PRO . 62.2 Cg_endo -74.29 147.56 37.46 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.294 1.996 . . . . 18.530000000000001 111.571 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.69 71.33 66.79 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 121.054 0.454 . . . . 17.449999999999999 110.542 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 99' ' ' PRO . 6.2 Cg_exo -74.05 -58.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.779 2.319 . . . . 17.420000000000002 111.719 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.58 116.95 8.5 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.901 -0.59 . . . . 17.68 109.889 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.05 132.79 33.2 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.616 2.21 . . . . 16.289999999999999 112.583 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 p -106.94 103.83 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.755 -0.657 . . . . 17.260000000000002 110.212 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 49.45 63.7 9.84 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-N 115.366 -0.834 . . . . 15.800000000000001 111.048 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.0 138.85 14.82 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.362 2.041 . . . . 15.92 112.891 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.54 -20.53 35.74 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.64 2.227 . . . . 16.149999999999999 110.811 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 87.2 tttt -117.88 115.43 36.86 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 114.909 -1.041 . . . . 17.629999999999999 108.446 173.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 108' ' ' LYS . 12.6 Cg_exo -70.62 53.5 1.4 Allowed 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.107 2.538 . . . . 15.039999999999999 113.259 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -77.0 115.46 48.73 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 15.199999999999999 110.274 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.76 117.61 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.147 1.898 . . . . 14.08 111.803 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.2 m -85.23 47.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.784 0.802 . . . . 15.279999999999999 110.486 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -139.4 165.33 32.45 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.915 -1.039 . . . . 16.84 110.043 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.83 170.53 1.37 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.811 2.341 . . . . 15.51 112.185 174.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.7 50.95 0.84 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.101 2.534 . . . . 16.039999999999999 112.172 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -174.53 69.57 0.3 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.746 -1.116 . . . . 18.91 108.512 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -38.07 -57.96 0.74 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.939 3.093 . . . . 17.039999999999999 113.187 -168.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -133.95 15.68 3.9 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.188 -0.671 . . . . 17.52 109.188 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.6 t 66.65 -69.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.167 -0.924 . . . . 18.699999999999999 110.235 -171.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.13 57.97 0.66 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.123 -0.49 . . . . 20.879999999999999 109.679 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.64 112.67 12.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 18.890000000000001 110.573 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.36 117.13 3.69 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.031 2.487 . . . . 20.43 112.512 -176.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.03 165.45 29.75 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.86 2.373 . . . . 21.100000000000001 111.645 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.451 ' C ' ' H ' ' A' ' 126' ' ' LYS . . . -70.13 141.41 89.01 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.29 -0.633 . . . . 21.149999999999999 109.29 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.85 21.25 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.619 2.213 . . . . 21.149999999999999 112.554 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 124' ' ' ALA . 12.2 mmmm -139.37 70.42 39.54 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.656 -0.702 . . . . 21.879999999999999 110.128 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.1 58.54 6.62 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.981 2.454 . . . . 20.190000000000001 111.779 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -73.19 136.27 79.18 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.496 -0.775 . . . . 20.48 110.566 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.04 72.06 2.75 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.738 2.292 . . . . 21.170000000000002 112.328 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -87.27 123.43 69.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.715 -0.675 . . . . 23.18 111.035 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.93 127.11 18.7 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.562 2.174 . . . . 20.780000000000001 110.97 173.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 m -85.91 51.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.081 0.467 . . . . 19.75 111.912 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 134' ' ' GLU . 31.5 t 66.54 172.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.313 -0.858 . . . . 21.050000000000001 110.239 178.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.521 ' N ' HG12 ' A' ' 133' ' ' VAL . 20.5 mt-10 73.39 78.05 0.13 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.33 0.586 . . . . 21.300000000000001 110.891 174.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -74.46 158.44 33.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.624 -0.717 . . . . 20.739999999999998 109.97 178.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -172.29 -27.85 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.137 -0.69 . . . . 17.969999999999999 109.137 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . -115.79 24.08 11.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.147 -0.933 . . . . 17.350000000000001 109.851 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 68.23 152.07 0.13 Allowed Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 115.154 -0.93 . . . . 19.100000000000001 111.779 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.37 94.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.129 2.553 . . . . 19.350000000000001 112.217 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.485 ' H ' ' HB1' ' A' ' 192' ' ' ALA . 1.4 p 51.48 26.97 3.49 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.886 0.875 . . . . 17.75 112.752 -176.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -83.24 -47.13 5.87 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.743 -0.943 . . . . 17.960000000000001 110.743 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.444 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 46.4 mtmt -127.89 56.93 1.56 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.122 -0.696 . . . . 19.420000000000002 109.122 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.485 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -77.32 164.55 25.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.13 -0.941 . . . . 14.65 110.37 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.557 ' HA ' ' H ' ' A' ' 217' ' ' TYR . 10.0 m-85 -143.95 151.17 39.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.912 0.387 . . . . 14.81 111.336 -177.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.88 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.3 t -146.81 153.11 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.58 -1.267 . . . . 10.48 107.58 170.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 17.1 t -98.23 121.73 49.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.304 -0.559 . . . . 10.1 110.815 -176.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.477 ' HG3' ' CG ' ' A' ' 185' ' ' ARG . 3.5 tt0 -83.98 101.73 11.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.579 -0.156 . . . . 12.0 110.579 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.775 HD13 ' N ' ' A' ' 212' ' ' GLY . 0.5 OUTLIER -87.58 -26.5 23.07 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.191 -0.67 . . . . 11.880000000000001 109.191 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -149.7 158.29 27.6 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.347 -0.842 . . . . 11.35 112.039 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.588 ' HB2' ' HG3' ' A' ' 185' ' ' ARG . . . -157.48 101.25 1.85 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.391 -0.596 . . . . 13.470000000000001 109.391 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -125.72 150.65 47.52 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.461 0.648 . . . . 13.52 110.296 -171.231 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 2.6 mttt -93.85 -1.84 54.29 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.738 -1.119 . . . . 17.600000000000001 108.431 176.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -104.87 107.27 18.15 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.205 -1.361 . . . . 16.140000000000001 109.238 175.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.76 -16.83 59.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.165 0.507 . . . . 14.039999999999999 111.022 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -54.98 -35.32 64.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.092 -0.958 . . . . 16.57 111.062 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.496 ' O ' HG13 ' A' ' 160' ' ' ILE . 83.6 tttt -90.53 -31.84 16.57 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.61 -0.723 . . . . 16.399999999999999 110.48 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.483 HG13 ' CD1' ' A' ' 186' ' ' ILE . 88.2 t -54.72 -43.26 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.239 -0.437 . . . . 12.67 110.472 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -62.0 -34.38 76.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.674 -0.694 . . . . 15.32 111.737 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.81 -59.05 2.9 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 120.911 0.386 . . . . 15.970000000000001 110.016 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 156' ' ' LYS . 21.8 mt -52.39 -45.07 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.846 -1.07 . . . . 12.6 110.788 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.445 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 89.6 t -71.16 -43.02 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.74 -0.663 . . . . 12.539999999999999 110.366 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.26 68.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.609 -0.805 . . . . 14.800000000000001 112.037 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -73.42 -61.79 1.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.257 0.223 . . . . 16.050000000000001 111.254 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 208' ' ' SER . 2.2 mm? -78.36 -45.8 21.6 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.415 0.524 . . . . 12.99 112.415 -174.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.476 ' HB2' ' CG1' ' A' ' 171' ' ' VAL . 25.8 ttm180 -65.17 -47.47 76.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.106 -0.702 . . . . 15.06 109.106 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.67 -20.59 68.3 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.048 -0.978 . . . . 16.600000000000001 113.456 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.2 -12.43 49.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.001 0.429 . . . . 16.140000000000001 110.385 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.41 20.86 11.32 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.937 -0.649 . . . . 15.119999999999999 113.222 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -95.74 154.91 16.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 117.337 0.568 . . . . 15.49 110.611 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -76.08 106.71 7.84 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.67 0.748 . . . . 13.869999999999999 110.151 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 165' ' ' ARG . 9.3 p -143.07 138.15 26.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.391 -1.277 . . . . 10.82 109.141 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.518 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.37 176.18 8.98 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.35 0.595 . . . . 11.130000000000001 110.583 171.484 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 24.8 p -105.78 -177.33 3.33 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.915 -1.039 . . . . 11.52 110.064 -174.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.23 142.73 36.96 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.305 -0.258 . . . . 12.75 110.305 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -38.92 -47.12 2.81 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 124.25 3.3 . . . . 14.640000000000001 115.145 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.9 t -85.74 -61.98 1.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 120.231 -0.588 . . . . 16.68 112.41 -171.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.8 m -167.65 137.66 2.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.607 0.595 . . . . 16.039999999999999 112.607 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.414 ' HB3' HG21 ' A' ' 184' ' ' THR . 30.6 Cg_exo -67.14 125.23 13.24 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.765 2.31 . . . . 14.220000000000001 111.315 160.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.563 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 8.8 p -145.63 152.33 14.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.092 0.472 . . . . 16.129999999999999 110.6 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -81.78 123.52 28.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 16.699999999999999 111.101 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 100.2 -12.1 60.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.836 -0.697 . . . . 16.98 112.612 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.563 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -123.31 161.5 24.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.301 -0.629 . . . . 18.73 109.301 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.8 tp -66.3 111.57 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.622 0.725 . . . . 14.82 111.858 -172.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.414 HG21 ' HB3' ' A' ' 178' ' ' PRO . 87.4 m -109.2 117.16 33.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.372 -0.603 . . . . 12.779999999999999 109.372 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.588 ' HG3' ' HB2' ' A' ' 150' ' ' ALA . 25.2 ttm180 -93.92 140.05 30.17 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.503 -0.771 . . . . 13.98 110.171 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.542 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.9 mm -109.31 115.53 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.417 -0.586 . . . . 10.56 109.417 176.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 4.8 mp -121.57 118.02 28.22 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.554 0.692 . . . . 10.1 110.824 -171.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.44 HG12 HD11 ' A' ' 204' ' ' LEU . 27.7 t -95.71 135.3 30.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 114.834 -1.075 . . . . 9.7400000000000002 110.61 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.19 48.93 5.49 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.248 -0.887 . . . . 9.7599999999999998 113.627 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.718 ' HA ' HG22 ' A' ' 145' ' ' VAL . 12.3 Cg_endo -63.84 125.3 15.11 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 CA-C-N 119.525 1.663 . . . . 11.15 111.05 174.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -156.88 161.12 39.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.001 -0.545 . . . . 12.77 110.102 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.485 ' HB1' ' H ' ' A' ' 140' ' ' THR . . . -102.73 0.09 32.41 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.943 -0.571 . . . . 14.6 111.363 -176.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 28.5 p -113.61 95.91 5.59 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.575 0.702 . . . . 14.300000000000001 110.13 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.426 ' HG3' ' CD2' ' A' ' 144' ' ' TYR . 31.6 ttpt -56.7 -53.62 55.58 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.062 -0.972 . . . . 15.970000000000001 111.146 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -61.76 -32.04 72.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.833 0.349 . . . . 15.6 111.686 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -73.39 -41.83 62.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.098 0.475 . . . . 14.220000000000001 110.539 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -82.66 -19.86 37.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.246 0.546 . . . . 11.949999999999999 110.649 -178.123 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 55.7 tptt -67.15 -36.39 81.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.835 -0.621 . . . . 14.699999999999999 110.455 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.61 -12.25 83.11 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.43 -1.068 . . . . 13.09 110.43 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 67.2 m -84.66 -8.08 59.0 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.873 -0.664 . . . . 12.109999999999999 111.902 -176.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 14.6 mt -70.58 -36.33 73.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 12.720000000000001 110.611 -177.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.7 92.65 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.987 -0.625 . . . . 14.66 112.219 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.422 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 12.8 pt-20 -85.79 -17.34 36.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.955 0.407 . . . . 13.890000000000001 110.441 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.44 HD11 HG12 ' A' ' 188' ' ' VAL . 17.6 tp -69.14 -34.91 75.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.278 -0.419 . . . . 12.550000000000001 111.438 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -63.72 -16.06 60.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.955 0.407 . . . . 15.83 110.604 173.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.442 ' N ' ' HD3' ' A' ' 205' ' ' LYS . 0.0 OUTLIER -88.93 -36.39 15.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.058 -0.519 . . . . 16.969999999999999 109.687 172.697 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 93.1 mt -71.47 -52.31 19.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.661 -0.699 . . . . 13.890000000000001 111.499 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.412 ' HB3' HD11 ' A' ' 164' ' ' LEU . 63.0 p -98.14 -43.6 6.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.397 0.618 . . . . 13.539999999999999 111.04 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.34 0.01 55.97 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.241 -0.89 . . . . 14.67 111.322 -174.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 148' ' ' LEU . 97.1 mt -80.0 162.23 24.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.701 -0.851 . . . . 13.039999999999999 108.701 175.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.0 m -111.41 109.46 19.44 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.201 0.445 . . . . 14.84 112.201 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.775 ' N ' HD13 ' A' ' 148' ' ' LEU . . . -121.9 173.67 15.87 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.844 -0.693 . . . . 12.220000000000001 114.17 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.4 p -117.1 146.39 21.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.839 -0.68 . . . . 13.74 109.267 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 25.6 t -82.35 115.33 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.905 -0.589 . . . . 12.890000000000001 110.505 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 74.8 mtp -125.96 149.83 48.47 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.123 0.487 . . . . 13.800000000000001 110.67 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.39 128.56 9.41 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.706 -0.759 . . . . 13.359999999999999 112.549 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.88 ' HB2' HG23 ' A' ' 145' ' ' VAL . 8.1 t80 -84.55 120.36 26.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.574 -0.813 . . . . 14.24 109.083 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 25.5 m -134.83 91.89 19.83 Favored Pre-proline 0 C--N 1.306 -1.295 0 C-N-CA 120.617 -0.433 . . . . 16.510000000000002 110.689 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.462 ' HG3' ' CZ ' ' A' ' 217' ' ' TYR . 9.5 Cg_exo -66.96 133.13 30.18 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.244 1.962 . . . . 17.420000000000002 111.138 173.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.1 t30 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.856 -0.592 . . . . 19.190000000000001 110.009 -178.096 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.499 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . . . . . . 0 CA--C 1.516 -0.358 0 N-CA-C 109.875 -0.417 . . . . 14.65 109.875 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.654 ' CE1' ' HG3' ' A' ' 194' ' ' LYS . 5.4 m-85 -137.55 156.51 48.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.162 0.43 . . . . 14.81 112.162 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.5 m -152.5 151.33 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.348 -0.842 . . . . 10.48 109.717 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.463 HG12 ' HA3' ' A' ' 212' ' ' GLY . 60.2 t -110.82 110.92 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 10.1 111.423 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.608 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 54.6 tt0 -84.85 113.52 21.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.516 -0.311 . . . . 12.0 111.688 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -92.01 -34.55 14.38 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.989 0.423 . . . . 11.880000000000001 110.341 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.62 174.21 25.69 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.189 -1.005 . . . . 11.35 112.855 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.557 ' HB2' HE21 ' A' ' 147' ' ' GLN . . . -170.76 103.39 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.636 -0.505 . . . . 13.470000000000001 109.636 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.81 157.07 43.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.304 0.573 . . . . 13.52 110.695 -175.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 86.1 mttt -98.12 14.3 28.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.134 -0.939 . . . . 17.600000000000001 110.612 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.432 ' OD1' ' HG3' ' A' ' 156' ' ' LYS . 4.1 t-20 -112.73 106.22 14.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.564 -0.744 . . . . 16.140000000000001 109.348 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.72 -26.48 68.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.901 0.381 . . . . 14.039999999999999 111.426 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.72 -38.87 76.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.539 0.685 . . . . 16.57 110.044 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.443 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 68.8 mttm -79.27 -33.44 43.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.671 -1.149 . . . . 16.399999999999999 110.292 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 184' ' ' THR . 79.6 t -58.02 -44.58 87.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.63 -0.714 . . . . 12.67 110.288 175.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -62.11 -30.43 71.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.299 -0.864 . . . . 15.32 110.823 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.576 ' O ' ' HG2' ' A' ' 163' ' ' LYS . 24.4 mt-10 -69.39 -61.95 1.58 Allowed 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 120.906 0.384 . . . . 15.970000000000001 110.167 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.428 HD12 HG13 ' A' ' 186' ' ' ILE . 27.8 mt -51.5 -46.22 35.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.045 -0.979 . . . . 12.6 111.143 -175.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.8 t -73.11 -34.51 45.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.724 -0.671 . . . . 12.539999999999999 110.288 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.8 -32.4 82.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.786 -0.721 . . . . 14.800000000000001 112.117 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 159' ' ' GLU . 48.7 mmtt -67.78 -51.05 53.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.266 0.555 . . . . 16.050000000000001 109.657 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.622 ' HB3' HG21 ' A' ' 171' ' ' VAL . 20.9 mt -87.03 -56.01 3.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.899 1.074 . . . . 12.99 113.899 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.407 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 47.2 ttp180 -70.13 -29.27 66.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.69 -0.855 . . . . 15.06 108.69 -174.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.7 -24.98 76.03 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.834 -1.076 . . . . 16.600000000000001 111.851 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.74 -5.05 59.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.213 0.53 . . . . 16.140000000000001 110.549 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.0 24.77 16.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.797 -0.716 . . . . 15.119999999999999 113.261 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -94.04 155.39 17.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.307 0.554 . . . . 15.49 110.783 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -71.63 98.24 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.621 -0.511 . . . . 13.869999999999999 109.621 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.799 HG22 HG22 ' A' ' 188' ' ' VAL . 6.7 t -133.17 125.69 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-N 115.589 -0.732 . . . . 10.82 111.123 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -135.33 175.24 9.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.265 -0.879 . . . . 11.130000000000001 110.602 176.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.4 p -117.09 -175.91 2.88 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.844 -1.071 . . . . 11.52 111.926 -169.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.78 153.65 5.62 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.633 -0.712 . . . . 12.75 111.598 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -42.13 -67.15 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.065 3.177 . . . . 14.640000000000001 115.19 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.1 m -76.55 -63.08 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.768 0.655 . . . . 16.68 112.768 -167.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.1 m -169.42 130.33 1.01 Allowed Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 112.226 0.454 . . . . 16.039999999999999 112.226 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.515 ' HB3' HG21 ' A' ' 184' ' ' THR . 50.1 Cg_exo -63.28 124.6 14.12 Favored 'Trans proline' 0 CA--C 1.519 -0.265 0 C-N-CA 122.771 2.314 . . . . 14.220000000000001 111.927 162.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.9 p -153.45 153.51 8.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.557 -0.534 . . . . 16.129999999999999 109.557 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -70.44 122.09 18.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.979 -0.555 . . . . 16.699999999999999 110.73 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.46 -26.45 14.71 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.621 -0.718 . . . . 16.98 112.407 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 13.2 mptt -108.18 156.28 19.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.961 0.41 . . . . 18.73 110.677 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.9 tp -71.2 117.28 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.681 -0.69 . . . . 14.82 111.462 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 178' ' ' PRO . 38.0 m -111.54 112.45 24.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.635 -0.711 . . . . 12.779999999999999 110.188 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 91.1 mtt180 -86.84 144.99 26.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.923 -0.581 . . . . 13.98 109.571 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.635 ' C ' HD12 ' A' ' 187' ' ' LEU . 5.2 mm -113.11 124.05 69.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.297 -0.631 . . . . 10.56 109.297 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.6 mp -129.15 129.08 44.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.487 0.661 . . . . 10.1 111.241 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 148' ' ' LEU . 39.8 t -100.58 142.18 16.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.991 -1.004 . . . . 9.7400000000000002 110.401 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.15 49.96 11.5 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.34 -0.845 . . . . 9.7599999999999998 113.932 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.674 ' HA ' HG12 ' A' ' 145' ' ' VAL . 13.7 Cg_endo -63.77 124.83 14.28 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 CA-C-N 119.915 1.857 . . . . 11.15 110.273 168.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.422 ' HB3' HD22 ' A' ' 197' ' ' LEU . 5.9 t70 -162.94 150.35 13.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.91 -0.586 . . . . 12.77 109.593 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.499 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -91.32 -9.3 45.47 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.919 -0.582 . . . . 14.6 110.944 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.3 t -97.37 102.32 14.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.173 0.511 . . . . 14.300000000000001 110.312 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.654 ' HG3' ' CE1' ' A' ' 144' ' ' TYR . 19.8 ttmt -64.54 -42.85 95.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.702 -0.681 . . . . 15.970000000000001 110.204 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.77 -51.91 67.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.127 0.489 . . . . 15.6 111.208 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -63.53 -51.47 65.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.602 -0.726 . . . . 14.220000000000001 111.431 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 191' ' ' ASP . 0.1 OUTLIER -87.01 -37.71 17.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.014 0.746 . . . . 11.949999999999999 113.014 -169.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.53 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 14.5 tmtt? -80.95 -20.51 41.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.499 0.666 . . . . 14.699999999999999 109.69 -168.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -82.84 -12.43 79.83 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.312 -1.115 . . . . 13.09 110.312 172.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 32.0 m -90.39 -7.62 52.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.825 -0.688 . . . . 12.109999999999999 112.547 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 15.8 mt -59.33 -36.58 75.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.592 0.234 . . . . 12.720000000000001 111.392 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -56.97 -46.69 90.92 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.909 -0.663 . . . . 14.66 112.189 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.37 -16.87 41.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.686 0.279 . . . . 13.890000000000001 110.701 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.538 HD12 HD12 ' A' ' 207' ' ' LEU . 2.6 tp -66.66 -26.95 67.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.048 0.451 . . . . 12.550000000000001 110.502 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.546 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 70.6 mmtt -61.08 -17.58 53.28 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.198 -0.455 . . . . 15.83 110.524 172.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -39.74 12.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.349 0.595 . . . . 16.969999999999999 109.521 170.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.538 HD12 HD12 ' A' ' 204' ' ' LEU . 84.5 mt -61.85 -52.95 62.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.227 -0.897 . . . . 13.890000000000001 111.642 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 23.0 p -99.96 -47.5 4.99 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.314 -0.555 . . . . 13.539999999999999 110.244 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.35 5.31 71.89 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.576 -0.738 . . . . 14.67 112.793 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.613 HD22 HD11 ' A' ' 164' ' ' LEU . 9.1 mp -95.64 158.47 15.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.18 -0.674 . . . . 13.039999999999999 109.18 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 19.4 t -76.5 93.44 3.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.085 0.469 . . . . 14.84 110.527 -173.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -114.12 140.8 16.6 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.713 -0.676 . . . . 12.220000000000001 113.264 -176.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 p -105.81 146.73 12.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.135 0.493 . . . . 13.74 110.265 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 5.5 p -73.17 114.01 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.153 -0.93 . . . . 12.890000000000001 111.406 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.53 141.75 51.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.028 -0.533 . . . . 13.800000000000001 110.202 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -81.49 126.94 7.65 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.246 -0.978 . . . . 13.359999999999999 111.603 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.502 ' HB2' HG22 ' A' ' 145' ' ' VAL . 4.8 t80 . . . . . 0 C--N 1.316 -0.868 0 C-N-CA 124.075 0.95 . . . . 14.24 110.561 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.582 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 108.904 -0.776 . . . . 14.65 108.904 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.608 ' CE1' ' HD3' ' A' ' 194' ' ' LYS . 7.6 m-85 -144.74 155.85 43.76 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.879 0.325 . . . . 14.81 111.879 -175.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.775 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.4 t -149.62 159.94 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.882 -0.784 . . . . 10.48 108.882 173.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 58.4 t -101.0 110.02 26.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 O-C-N 122.069 -0.394 . . . . 10.1 110.803 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -86.74 108.92 18.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.569 -0.287 . . . . 12.0 111.051 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.895 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -83.97 -40.55 18.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.228 0.537 . . . . 11.880000000000001 109.953 -176.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.38 165.85 28.22 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.544 -0.836 . . . . 11.35 112.526 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.481 ' C ' HD13 ' A' ' 151' ' ' LEU . . . -156.75 101.22 1.96 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.512 -0.551 . . . . 13.470000000000001 109.512 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.481 HD13 ' C ' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -119.57 159.25 24.71 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.38 0.609 . . . . 13.52 110.028 -174.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 39.3 mttm -101.56 24.49 9.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.888 -1.153 . . . . 17.600000000000001 107.888 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -136.37 110.86 8.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.724 -1.58 . . . . 16.140000000000001 109.114 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.407 ' HA ' ' CG2' ' A' ' 157' ' ' VAL . . . -70.76 -19.12 62.75 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.204 0.446 . . . . 14.039999999999999 112.204 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -64.32 -31.34 72.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.663 0.744 . . . . 16.57 109.563 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.462 ' HD2' HD11 ' A' ' 160' ' ' ILE . 3.8 tmtm? -77.87 -38.62 45.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.396 -1.275 . . . . 16.399999999999999 109.026 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.407 ' CG2' ' HA ' ' A' ' 154' ' ' ALA . 94.4 t -56.44 -42.74 75.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.955 -1.021 . . . . 12.67 110.517 176.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -58.68 -29.6 66.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.581 -0.736 . . . . 15.32 112.146 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.525 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 8.5 mm-40 -79.56 -60.81 2.21 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.6 -0.519 . . . . 15.970000000000001 109.6 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.462 HD11 ' HD2' ' A' ' 156' ' ' LYS . 11.4 mt -50.97 -44.3 27.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.278 -0.874 . . . . 12.6 110.673 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 84.9 t -76.49 -37.3 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.659 -0.7 . . . . 12.539999999999999 110.376 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.17 -28.79 71.29 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.669 -0.777 . . . . 14.800000000000001 112.053 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 1.0 OUTLIER -71.29 -52.27 19.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.66 0.266 . . . . 16.050000000000001 111.071 177.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.515 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 3.8 mm? -86.0 -55.59 3.87 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.043 0.386 . . . . 12.99 112.043 -175.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 24.5 ttt180 -61.7 -42.99 99.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.456 0.646 . . . . 15.06 109.82 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.82 -11.2 62.59 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.824 -1.08 . . . . 16.600000000000001 112.973 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.62 -2.19 22.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 16.140000000000001 110.714 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.94 56.13 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.233 -0.508 . . . . 15.119999999999999 113.569 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -82.58 155.44 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.241 -0.564 . . . . 15.49 110.369 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 170' ' ' ARG . 36.1 mmt180 -71.4 104.39 3.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.74 0.781 . . . . 13.869999999999999 110.211 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.19 141.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 114.454 -1.248 . . . . 10.82 109.48 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.37 175.49 9.55 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.635 0.731 . . . . 11.130000000000001 110.635 169.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.437 ' HB ' ' HG3' ' A' ' 178' ' ' PRO . 7.1 p -120.75 -173.96 2.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.625 -1.17 . . . . 11.52 112.294 -168.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.632 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -50.21 151.12 3.83 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 115.161 -0.927 . . . . 12.75 112.982 -177.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -23.9 -70.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 1 C-N-CA 126.093 4.529 . . . . 14.640000000000001 115.281 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.1 m -88.95 -62.12 1.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.242 -0.583 . . . . 16.68 112.313 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 97.6 m -167.58 132.08 1.53 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 111.453 0.168 . . . . 16.039999999999999 111.453 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.448 ' HB3' HG21 ' A' ' 184' ' ' THR . 73.4 Cg_exo -56.75 125.76 20.06 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.54 2.16 . . . . 14.220000000000001 111.741 166.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.3 p -148.71 160.26 6.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.643 -0.503 . . . . 16.129999999999999 109.643 -174.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -72.55 133.47 44.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.527 -0.306 . . . . 16.699999999999999 110.739 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.08 -25.61 11.8 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.213 -0.518 . . . . 16.98 114.116 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.501 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.3 OUTLIER -102.94 168.06 9.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.36 0.58 . . . . 18.73 110.67 -176.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.6 tp -76.29 110.5 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.973 0.892 . . . . 14.82 111.766 -174.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.448 HG21 ' HB3' ' A' ' 178' ' ' PRO . 48.8 m -104.9 107.59 18.64 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.496 -0.775 . . . . 12.779999999999999 109.464 173.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.632 ' H ' ' HB3' ' A' ' 174' ' ' SER . 6.4 ptm180 -90.42 133.71 34.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.408 -0.815 . . . . 13.98 109.675 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.556 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.3 mm -104.91 122.52 58.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.76 -0.459 . . . . 10.56 109.76 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.556 HD12 ' C ' ' A' ' 186' ' ' ILE . 5.1 mp -129.68 126.46 38.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.258 0.552 . . . . 10.1 111.153 -174.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.895 HG23 HD21 ' A' ' 148' ' ' LEU . 38.5 t -102.38 134.77 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.474 -0.784 . . . . 9.7400000000000002 110.997 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.06 49.86 4.83 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.001 -1.0 . . . . 9.7599999999999998 113.66 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.775 ' HA ' HG22 ' A' ' 145' ' ' VAL . 10.2 Cg_endo -58.86 125.09 17.22 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 119.441 1.621 . . . . 11.15 110.698 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -152.19 151.73 31.36 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.458 -0.497 . . . . 12.77 110.393 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -92.06 -7.0 49.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.824 -0.625 . . . . 14.6 111.706 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.4 p -118.29 104.98 11.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.341 0.591 . . . . 14.300000000000001 111.375 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.608 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 36.7 ttpt -58.47 -51.89 67.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.693 -1.139 . . . . 15.970000000000001 110.787 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.11 -44.97 83.75 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.158 -0.474 . . . . 15.6 111.191 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -62.63 -48.28 80.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.745 -0.661 . . . . 14.220000000000001 111.017 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -77.73 -20.39 53.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 11.949999999999999 110.935 -175.007 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.7 tptm -65.31 -39.02 91.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.516 0.674 . . . . 14.699999999999999 109.917 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -79.14 -12.43 84.04 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.498 -1.041 . . . . 13.09 110.498 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 59.0 m -84.08 -10.69 57.63 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.823 -0.689 . . . . 12.109999999999999 111.82 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 29.6 mt -64.77 -34.72 79.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.833 0.349 . . . . 12.720000000000001 110.995 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -61.68 -39.06 96.91 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.793 -0.718 . . . . 14.66 112.401 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.495 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 10.3 pt-20 -86.26 -22.2 26.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.876 0.369 . . . . 13.890000000000001 110.99 177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.6 tp -74.83 -31.47 61.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 12.550000000000001 111.272 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.582 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 20.2 ptmt -68.17 -15.09 63.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.111 0.481 . . . . 15.83 110.382 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.9 -30.67 17.71 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.177 0.513 . . . . 16.969999999999999 109.982 171.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 91.3 mt -76.44 -51.89 10.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.793 -0.64 . . . . 13.890000000000001 111.527 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.472 ' HB3' HD11 ' A' ' 164' ' ' LEU . 44.3 p -95.56 -43.93 7.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.354 0.597 . . . . 13.539999999999999 110.213 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 70.01 3.85 46.05 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 114.899 -1.046 . . . . 14.67 112.579 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.44 153.3 18.01 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 109.572 -0.529 . . . . 13.039999999999999 109.572 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 24.2 t -85.33 107.25 17.25 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.01 -0.541 . . . . 14.84 110.53 -175.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -127.48 163.27 21.29 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.346 -0.93 . . . . 12.220000000000001 113.435 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.87 145.8 12.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.039 -0.58 . . . . 13.74 109.748 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.61 104.85 3.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.104 -0.702 . . . . 12.890000000000001 109.104 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 92.8 mmm -117.06 141.8 47.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.168 -0.469 . . . . 13.800000000000001 110.447 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.21 155.09 51.31 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.494 -0.86 . . . . 13.359999999999999 111.698 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.704 ' HB2' HG23 ' A' ' 145' ' ' VAL . 10.9 t80 . . . . . 0 C--N 1.309 -1.185 0 C-N-CA 123.082 0.553 . . . . 14.24 110.286 -169.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 110.125 -0.324 . . . . 14.65 110.125 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CD2' ' HG3' ' A' ' 194' ' ' LYS . 4.7 m-85 -143.03 158.44 43.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.17 -0.468 . . . . 14.81 111.685 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.673 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.2 m -151.77 152.82 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.715 -0.675 . . . . 10.48 110.633 -176.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 60.3 t -108.73 108.35 25.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 120.862 0.363 . . . . 10.1 111.262 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -85.26 108.94 18.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.54 -0.3 . . . . 12.0 110.871 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -84.92 -36.64 21.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.138 0.494 . . . . 11.880000000000001 109.924 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.34 164.15 28.38 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.583 -0.818 . . . . 11.35 112.674 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -161.21 101.21 1.23 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.02 0.438 . . . . 13.470000000000001 109.822 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.8 168.37 18.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.293 0.568 . . . . 13.52 110.586 -174.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -100.39 -5.6 26.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.866 -1.061 . . . . 17.600000000000001 109.837 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -105.45 106.58 17.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.122 -0.945 . . . . 16.140000000000001 109.844 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.13 -19.42 65.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.798 -0.637 . . . . 14.039999999999999 111.266 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.93 -29.78 70.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.516 0.674 . . . . 16.57 110.24 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -89.85 -27.23 20.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.149 -0.932 . . . . 16.399999999999999 109.327 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.471 HG11 HG21 ' A' ' 184' ' ' THR . 74.2 t -60.7 -35.62 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.441 -0.799 . . . . 12.67 109.922 173.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.17 -26.81 66.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.437 -0.802 . . . . 15.32 111.59 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.468 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 3.9 mm-40 -70.95 -62.78 1.27 Allowed 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.48 -0.563 . . . . 15.970000000000001 109.48 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.819 HD12 HD12 ' A' ' 186' ' ' ILE . 13.8 mt -54.78 -46.49 74.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.622 -1.172 . . . . 12.6 110.514 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.474 HG23 HD13 ' A' ' 186' ' ' ILE . 85.0 t -72.04 -42.88 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.592 -0.731 . . . . 12.539999999999999 110.668 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.49 -27.77 66.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.627 -0.797 . . . . 14.800000000000001 111.804 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 159' ' ' GLU . 15.7 mttp -72.56 -57.93 3.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.491 -0.355 . . . . 16.050000000000001 111.021 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.7 mm? -82.87 -56.28 3.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.275 0.472 . . . . 12.99 112.275 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -62.53 -38.25 89.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.445 0.641 . . . . 15.06 109.7 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.08 -28.61 73.81 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.839 -1.073 . . . . 16.600000000000001 112.695 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.96 2.03 56.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.998 0.428 . . . . 16.140000000000001 110.879 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.83 23.59 55.32 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.979 -0.629 . . . . 15.119999999999999 113.313 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -85.66 154.59 21.57 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.645 -0.327 . . . . 15.49 110.22 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -68.52 99.34 0.96 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.366 0.603 . . . . 13.869999999999999 109.986 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.5 p -143.99 139.34 25.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 114.96 -1.018 . . . . 10.82 109.949 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.474 ' CE1' HG11 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -140.23 176.89 8.39 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.48 0.657 . . . . 11.130000000000001 110.508 172.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 p -126.49 -175.28 3.34 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.959 -1.019 . . . . 11.52 111.689 -169.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.519 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 2.9 p -52.24 149.51 9.81 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 115.94 -0.573 . . . . 12.75 111.876 -176.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -34.53 -58.07 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.797 3.664 . . . . 14.640000000000001 115.341 -171.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 31.7 t -87.91 -64.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.458 -0.897 . . . . 16.68 112.212 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 55.5 m -169.03 134.0 1.33 Allowed Pre-proline 0 CA--C 1.53 0.196 0 O-C-N 122.389 -0.195 . . . . 16.039999999999999 111.282 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.538 ' HB3' HG21 ' A' ' 184' ' ' THR . 72.5 Cg_exo -59.52 123.27 12.98 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.245 1.963 . . . . 14.220000000000001 111.58 165.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 8.6 p -153.92 159.87 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 109.767 -0.457 . . . . 16.129999999999999 109.767 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -80.51 122.42 27.0 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.935 -0.394 . . . . 16.699999999999999 109.935 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 110.02 -26.48 13.78 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.766 -0.652 . . . . 16.98 112.155 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.448 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.5 OUTLIER -106.93 158.44 17.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.411 -0.588 . . . . 18.73 109.411 175.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.6 tp -74.56 122.24 27.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.524 0.678 . . . . 14.82 111.156 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 56.0 m -111.34 105.0 13.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.81 -0.632 . . . . 12.779999999999999 110.202 174.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.519 ' H ' ' HB3' ' A' ' 174' ' ' SER . 97.3 mtt180 -84.03 138.05 33.28 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.984 -0.747 . . . . 13.98 108.984 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.819 HD12 HD12 ' A' ' 160' ' ' ILE . 4.2 mt -115.58 122.13 68.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.332 -0.618 . . . . 10.56 109.332 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 186' ' ' ILE . 3.8 mp -128.79 127.08 41.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.7 -0.682 . . . . 10.1 111.171 -168.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 148' ' ' LEU . 50.5 t -100.7 143.13 14.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.034 -0.985 . . . . 9.7400000000000002 110.418 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.99 48.43 7.71 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.192 -0.913 . . . . 9.7599999999999998 113.76 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.673 ' HA ' HG12 ' A' ' 145' ' ' VAL . 18.7 Cg_endo -66.24 123.62 11.45 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 CA-C-N 119.831 1.815 . . . . 11.15 110.568 172.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.1 158.55 36.6 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.548 -0.751 . . . . 12.77 109.386 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.479 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -92.6 -19.54 21.81 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.66 -0.7 . . . . 14.6 110.707 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 35.6 p -91.96 90.93 7.63 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.582 0.706 . . . . 14.300000000000001 110.863 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.52 ' HG3' ' CD2' ' A' ' 144' ' ' TYR . 27.7 ttpt -52.68 -51.88 58.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.562 -1.199 . . . . 15.970000000000001 110.905 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -57.71 -45.61 85.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.765 -0.652 . . . . 15.6 111.242 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -75.45 -38.03 59.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.903 -0.589 . . . . 14.220000000000001 111.591 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.1 OUTLIER -79.09 -20.07 49.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.263 0.554 . . . . 11.949999999999999 110.246 -178.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.434 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 54.1 tptt -64.97 -40.73 95.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.587 0.708 . . . . 14.699999999999999 110.219 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.24 -12.57 84.48 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.169 -0.923 . . . . 13.09 110.797 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.433 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 58.5 m -85.53 -9.04 57.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.716 -0.742 . . . . 12.109999999999999 112.236 -176.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.563 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 31.2 mt -65.91 -38.53 88.96 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.733 0.301 . . . . 12.720000000000001 111.361 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.34 -38.29 96.18 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.738 -0.744 . . . . 14.66 112.279 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 11.4 pt-20 -82.16 -18.63 42.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.096 0.474 . . . . 13.890000000000001 110.16 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.438 HD11 HG12 ' A' ' 188' ' ' VAL . 17.0 tp -74.02 -30.86 62.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.197 -0.456 . . . . 12.550000000000001 110.244 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 85.1 mttt -64.33 -19.96 65.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.284 0.564 . . . . 15.83 109.727 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.59 -29.99 18.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.512 -0.767 . . . . 16.969999999999999 110.288 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 82.4 mt -78.58 -53.04 7.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.827 -0.624 . . . . 13.890000000000001 111.701 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 164' ' ' LEU . 68.4 p -94.71 -44.0 8.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.418 0.628 . . . . 13.539999999999999 110.46 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 67.46 13.85 63.6 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.727 -1.124 . . . . 14.67 112.286 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.45 HD13 HG23 ' A' ' 160' ' ' ILE . 85.3 mt -103.85 152.72 21.58 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.188 -0.671 . . . . 13.039999999999999 109.188 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 10.9 t -88.69 108.84 19.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.106 0.479 . . . . 14.84 110.448 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -125.71 161.04 20.22 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.327 -0.939 . . . . 12.220000000000001 113.216 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.7 p -102.09 144.01 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.216 0.532 . . . . 13.74 110.433 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.78 105.8 8.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.26 -0.882 . . . . 12.890000000000001 110.263 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 84.2 mmm -115.35 148.64 39.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.931 -0.577 . . . . 13.800000000000001 110.404 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -78.26 132.65 11.94 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.225 -0.988 . . . . 13.359999999999999 111.698 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.592 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 7.3 t80 . . . . . 0 C--N 1.312 -1.064 0 C-N-CA 123.297 0.639 . . . . 14.24 109.607 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.772 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 109.535 -0.542 . . . . 14.65 109.535 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.695 ' CE2' ' HB2' ' A' ' 194' ' ' LYS . 4.4 m-85 -136.76 140.16 42.36 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 111.745 0.276 . . . . 14.81 111.745 -174.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 1.026 HG23 ' HB2' ' A' ' 217' ' ' TYR . 3.2 t -148.91 163.79 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.229 -0.656 . . . . 10.48 109.229 171.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.489 HG11 HD22 ' A' ' 204' ' ' LEU . 40.1 t -105.54 113.26 41.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 O-C-N 121.787 -0.571 . . . . 10.1 111.267 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.52 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 49.6 tt0 -86.01 116.83 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.636 -0.256 . . . . 12.0 111.551 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.984 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -93.35 -35.09 13.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.088 0.47 . . . . 11.880000000000001 110.21 -178.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -147.25 169.38 28.25 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.454 -0.879 . . . . 11.35 112.569 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -163.58 105.39 0.96 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.865 -0.791 . . . . 13.470000000000001 108.865 177.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -138.91 159.36 42.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.21 0.529 . . . . 13.52 110.909 -171.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 9.2 mmmm -96.93 -3.46 41.76 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.12 -0.945 . . . . 17.600000000000001 110.162 -174.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -111.91 115.87 29.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.371 -0.832 . . . . 16.140000000000001 110.338 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.6 65.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 14.039999999999999 111.007 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.14 -32.4 69.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.669 0.747 . . . . 16.57 110.199 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.528 ' HB3' HD22 ' A' ' 151' ' ' LEU . 32.5 mmtp -89.47 -31.27 17.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.739 -1.119 . . . . 16.399999999999999 110.368 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' THR . 94.9 t -61.89 -40.99 89.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.488 -0.778 . . . . 12.67 110.135 175.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -54.83 -36.38 64.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.078 -0.964 . . . . 15.32 111.056 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 18.5 mt-10 -69.13 -60.78 2.12 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.174 0.511 . . . . 15.970000000000001 110.057 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.55 HG23 HD13 ' A' ' 210' ' ' LEU . 7.9 mt -56.03 -45.19 80.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.074 -0.966 . . . . 12.6 110.971 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.3 t -74.74 -41.22 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.758 -0.656 . . . . 12.539999999999999 110.451 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.95 -28.54 66.27 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.547 -0.835 . . . . 14.800000000000001 111.763 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 159' ' ' GLU . 15.5 mttp -73.74 -56.73 4.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.612 0.244 . . . . 16.050000000000001 111.41 177.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.4 mm? -82.56 -51.73 7.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.093 0.405 . . . . 12.99 112.093 -174.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -65.84 -41.59 91.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.246 0.546 . . . . 15.06 109.653 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.23 -24.16 76.05 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.369 -0.832 . . . . 16.600000000000001 112.745 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.87 4.55 52.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.034 0.445 . . . . 16.140000000000001 110.877 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.61 25.11 47.88 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.956 -0.64 . . . . 15.119999999999999 113.54 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -89.65 160.12 16.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.159 0.48 . . . . 15.49 110.252 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.96 102.7 8.44 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.554 0.692 . . . . 13.869999999999999 109.379 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.84 139.8 27.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.753 -1.112 . . . . 10.82 109.87 -173.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.564 ' CE1' HG21 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -138.71 176.32 8.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.686 0.755 . . . . 11.130000000000001 110.723 172.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.421 ' HB ' ' HG3' ' A' ' 178' ' ' PRO . 4.5 p -123.3 -172.63 2.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.46 -1.245 . . . . 11.52 112.239 -167.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.669 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 0.9 OUTLIER -49.51 158.6 0.78 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.345 -0.843 . . . . 12.75 112.864 -177.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -47.36 -54.29 5.28 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.608 2.872 . . . . 14.640000000000001 113.904 -170.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.9 m -88.19 -64.09 1.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.705 -0.798 . . . . 16.68 112.227 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 42.1 m -169.26 137.93 1.63 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 122.336 0.255 . . . . 16.039999999999999 110.534 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.475 ' HB3' HG21 ' A' ' 184' ' ' THR . 76.1 Cg_exo -59.83 123.56 13.51 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.213 1.942 . . . . 14.220000000000001 111.306 165.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 12.2 p -154.66 159.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 116.177 -0.465 . . . . 16.129999999999999 110.487 -174.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -80.85 127.0 32.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.18 -0.464 . . . . 16.699999999999999 110.745 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 100.45 -16.45 57.87 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.981 -0.628 . . . . 16.98 112.221 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 8.5 mptt -120.84 162.5 19.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.787 -0.449 . . . . 18.73 109.787 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 152' ' ' LYS . 9.7 tp -73.38 120.11 21.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.69 0.757 . . . . 14.82 111.771 -172.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.482 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 37.8 m -113.16 105.37 13.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.432 -0.804 . . . . 12.779999999999999 109.747 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.669 ' H ' ' HB3' ' A' ' 174' ' ' SER . 15.8 ptt180 -88.18 136.25 33.06 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.362 -0.836 . . . . 13.98 109.584 176.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.537 ' C ' HD12 ' A' ' 187' ' ' LEU . 4.1 mm -110.39 123.1 65.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.677 -0.49 . . . . 10.56 109.677 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.555 ' HB3' ' CG1' ' A' ' 145' ' ' VAL . 4.5 mp -130.11 132.42 46.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.463 0.649 . . . . 10.1 111.441 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.984 HG23 HD21 ' A' ' 148' ' ' LEU . 26.4 t -107.57 132.72 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.053 -0.976 . . . . 9.7400000000000002 111.015 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.22 49.78 4.32 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.174 -0.921 . . . . 9.7599999999999998 113.58 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.929 ' HA ' HG22 ' A' ' 145' ' ' VAL . 9.3 Cg_endo -59.71 126.11 19.64 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 CA-C-N 119.515 1.657 . . . . 11.15 111.367 173.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -157.63 167.75 29.23 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.124 -0.695 . . . . 12.77 109.124 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -107.89 5.95 26.87 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.029 0.442 . . . . 14.6 110.706 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 48.1 m -120.4 107.37 12.83 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.153 -0.476 . . . . 14.300000000000001 111.254 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.695 ' HB2' ' CE2' ' A' ' 144' ' ' TYR . 35.1 ttpt -66.67 -40.4 88.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.81 -0.632 . . . . 15.970000000000001 110.023 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -62.49 -39.7 94.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.686 -0.688 . . . . 15.6 110.857 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -51.22 36.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.626 -0.715 . . . . 14.220000000000001 110.493 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.657 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -74.06 -18.85 60.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.484 . . . . 11.949999999999999 110.725 -175.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.54 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 17.4 tppt? -62.93 -39.57 95.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.197 0.522 . . . . 14.699999999999999 110.325 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.02 -17.38 79.85 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.09 -1.204 . . . . 13.09 110.09 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 31.0 m -79.39 -8.92 59.44 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.564 -0.818 . . . . 12.109999999999999 112.037 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 13.8 mt -70.81 -37.33 73.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.936 0.398 . . . . 12.720000000000001 110.378 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.23 -25.32 71.05 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.648 -0.981 . . . . 14.66 110.648 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.605 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 41.6 mt-10 -86.39 -24.43 25.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.941 -0.629 . . . . 13.890000000000001 110.534 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.489 HD22 HG11 ' A' ' 146' ' ' VAL . 3.0 tp -60.3 -48.25 82.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.425 -0.352 . . . . 12.550000000000001 111.103 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.0 -21.21 58.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 15.83 111.396 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -38.65 13.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 16.969999999999999 110.436 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 93.1 mt -72.75 -51.85 17.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.073 -0.512 . . . . 13.890000000000001 111.615 -176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.405 ' HB3' HD11 ' A' ' 164' ' ' LEU . 64.7 p -101.87 -43.32 5.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.222 0.534 . . . . 13.539999999999999 110.919 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.39 6.18 74.84 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.908 -0.877 . . . . 14.67 110.908 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.55 HD13 HG23 ' A' ' 160' ' ' ILE . 60.3 mt -97.74 157.91 15.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.787 -0.449 . . . . 13.039999999999999 109.787 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 17.7 p -81.12 95.61 6.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.011 0.434 . . . . 14.84 111.315 -176.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -108.23 142.34 15.95 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.727 -0.749 . . . . 12.220000000000001 114.127 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.1 142.39 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.526 -0.546 . . . . 13.74 109.526 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.38 107.02 4.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.109 -0.496 . . . . 12.890000000000001 110.512 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 23.9 mmt -109.0 141.54 40.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.741 -0.663 . . . . 13.800000000000001 109.817 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.55 107.34 2.34 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.169 -1.015 . . . . 13.359999999999999 111.748 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 1.026 ' HB2' HG23 ' A' ' 145' ' ' VAL . 6.1 t80 . . . . . 0 C--N 1.308 -1.212 0 CA-C-N 113.147 -1.526 . . . . 14.24 111.066 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.577 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 CA--C 1.518 -0.263 0 N-CA-C 109.133 -0.691 . . . . 14.65 109.133 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.595 ' CE2' ' HD3' ' A' ' 194' ' ' LYS . 4.3 m-85 -143.47 155.43 44.36 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.487 0.551 . . . . 14.81 112.487 -175.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.797 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.5 t -148.39 167.07 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.252 -1.018 . . . . 10.48 108.252 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 59.0 t -107.62 112.85 41.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 O-C-N 121.686 -0.633 . . . . 10.1 111.31 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.555 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 48.9 tt0 -84.52 114.54 22.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.355 -0.384 . . . . 12.0 111.381 -176.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.91 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -96.45 -33.07 12.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.391 0.615 . . . . 11.880000000000001 110.169 -178.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.29 168.39 27.18 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.47 -0.786 . . . . 11.35 112.169 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -170.93 101.49 0.22 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.0 -0.741 . . . . 13.470000000000001 109.0 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.81 164.65 35.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.86 -0.609 . . . . 13.52 110.785 -173.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 32.4 mtmm -101.6 15.32 29.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.128 -0.942 . . . . 17.600000000000001 110.389 -173.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -109.87 105.14 14.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.153 -0.93 . . . . 16.140000000000001 108.96 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.36 -22.13 63.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.199 -0.455 . . . . 14.039999999999999 111.682 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.48 -38.22 89.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.928 0.871 . . . . 16.57 109.292 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -75.43 -29.79 59.83 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.309 -1.314 . . . . 16.399999999999999 110.119 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 89.3 t -63.29 -40.84 90.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.627 -0.715 . . . . 12.67 109.867 172.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -64.17 -22.23 66.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.644 -0.707 . . . . 15.32 111.954 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.698 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 14.5 mt-10 -78.0 -62.9 1.53 Allowed 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.143 -0.688 . . . . 15.970000000000001 109.143 176.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.535 HD12 HG13 ' A' ' 186' ' ' ILE . 10.3 mt -54.48 -48.47 69.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.599 -0.728 . . . . 12.6 110.949 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.85 -40.01 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.762 -0.654 . . . . 12.539999999999999 110.555 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.88 -28.91 72.66 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.462 -0.875 . . . . 14.800000000000001 112.138 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.698 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.6 mptp? -80.95 -49.3 11.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.4 0.148 . . . . 16.050000000000001 111.4 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.42 HD21 ' HA ' ' A' ' 208' ' ' SER . 0.7 OUTLIER -79.87 -55.85 4.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 12.99 111.484 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.401 ' HB2' ' CG1' ' A' ' 171' ' ' VAL . 69.0 ttt180 -66.89 -40.8 87.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.249 0.547 . . . . 15.06 110.313 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.76 -19.87 73.69 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.222 -0.899 . . . . 16.600000000000001 112.66 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.05 -5.59 57.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.808 0.337 . . . . 16.140000000000001 110.916 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.71 24.97 12.36 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.651 -0.785 . . . . 15.119999999999999 112.806 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -94.8 148.3 22.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.933 -0.395 . . . . 15.49 109.933 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -76.67 96.55 4.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.164 -0.68 . . . . 13.869999999999999 109.164 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 165' ' ' ARG . 7.4 p -142.62 143.74 25.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.404 -0.816 . . . . 10.82 109.456 -176.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.471 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -139.08 176.49 8.66 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.69 0.757 . . . . 11.130000000000001 110.85 176.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 20.2 p -113.93 -176.4 2.89 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.477 -1.238 . . . . 11.52 111.004 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.5 OUTLIER -53.16 141.33 40.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 O-C-N 123.166 0.291 . . . . 12.75 110.778 178.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -40.14 -47.49 4.05 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 124.484 3.456 . . . . 14.640000000000001 115.553 -169.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.3 m -85.44 -63.68 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.522 -0.871 . . . . 16.68 112.696 -171.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 98.8 m -168.49 129.94 1.14 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 118.375 0.534 . . . . 16.039999999999999 112.096 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.465 ' HB3' HG21 ' A' ' 184' ' ' THR . 74.7 Cg_exo -62.63 123.97 13.31 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.519 2.146 . . . . 14.220000000000001 111.713 161.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.491 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 7.7 p -154.01 159.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.63 -0.507 . . . . 16.129999999999999 109.63 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -81.47 129.15 34.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.967 0.413 . . . . 16.699999999999999 110.721 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 104.81 -25.79 24.43 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.058 -0.591 . . . . 16.98 112.376 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.491 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 2.8 mptp? -114.35 157.69 22.48 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.557 -0.534 . . . . 18.73 109.557 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.6 tp -69.82 109.93 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.594 0.711 . . . . 14.82 111.815 -173.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 178' ' ' PRO . 54.0 m -101.79 111.39 23.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.786 -0.643 . . . . 12.779999999999999 109.562 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 74.1 mtp180 -92.22 139.57 30.48 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.39 -0.823 . . . . 13.98 109.755 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.535 HG13 HD12 ' A' ' 160' ' ' ILE . 4.1 mm -109.6 118.86 57.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.251 -0.648 . . . . 10.56 109.251 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 186' ' ' ILE . 5.2 mp -129.81 120.88 25.72 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.386 0.612 . . . . 10.1 111.386 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.91 HG23 HD21 ' A' ' 148' ' ' LEU . 38.0 t -95.38 136.02 27.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.508 -0.769 . . . . 9.7400000000000002 110.822 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.46 47.9 5.52 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.316 -0.856 . . . . 9.7599999999999998 113.943 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.772 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.5 Cg_endo -61.36 126.21 18.74 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 CA-C-N 119.732 1.766 . . . . 11.15 110.998 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -155.04 154.56 32.66 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.512 -0.475 . . . . 12.77 110.376 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -95.02 -4.51 46.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.649 -0.705 . . . . 14.6 111.312 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.1 m -112.5 100.57 8.85 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.487 0.661 . . . . 14.300000000000001 110.431 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.595 ' HD3' ' CE2' ' A' ' 144' ' ' TYR . 22.1 ttpp -55.66 -59.78 4.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.461 -1.245 . . . . 15.970000000000001 112.011 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.13 -27.96 68.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.686 -0.688 . . . . 15.6 111.81 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -72.51 -37.8 68.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.423 0.63 . . . . 14.220000000000001 110.154 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -85.55 -23.52 27.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.791 -0.64 . . . . 11.949999999999999 110.444 -175.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.557 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 36.8 mttt -74.66 -32.77 62.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.054 0.454 . . . . 14.699999999999999 110.634 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -73.81 -12.63 80.88 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.965 -1.254 . . . . 13.09 109.965 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 47.7 m -90.67 -8.89 48.73 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.365 -0.917 . . . . 12.109999999999999 112.24 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 22.7 mt -66.14 -33.37 75.61 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.186 -0.321 . . . . 12.720000000000001 110.989 -175.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.81 -44.16 97.28 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.807 -0.711 . . . . 14.66 111.94 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.62 -17.93 34.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.635 0.255 . . . . 13.890000000000001 111.037 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.43 HD12 HD12 ' A' ' 207' ' ' LEU . 24.5 tp -70.15 -29.32 66.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.05 0.453 . . . . 12.550000000000001 109.996 -176.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 61.3 mttp -60.92 -22.66 64.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.61 -0.723 . . . . 15.83 110.861 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.57 -35.34 30.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.291 0.567 . . . . 16.969999999999999 109.754 174.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.43 HD12 HD12 ' A' ' 204' ' ' LEU . 82.2 mt -75.45 -52.47 10.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.417 -0.81 . . . . 13.890000000000001 111.453 -175.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.42 ' HA ' HD21 ' A' ' 164' ' ' LEU . 31.9 p -98.64 -45.07 6.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.031 0.444 . . . . 13.539999999999999 110.717 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 60.59 21.79 58.31 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.598 -0.728 . . . . 14.67 111.868 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.436 ' HB2' ' HG ' ' A' ' 148' ' ' LEU . 79.8 mt -98.47 158.09 15.81 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.126 -0.694 . . . . 13.039999999999999 109.126 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 16.9 p -73.72 92.61 2.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.822 0.344 . . . . 14.84 110.756 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -111.33 146.33 17.76 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.486 -0.864 . . . . 12.220000000000001 114.256 -174.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 49.1 t -117.01 140.97 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.356 -0.979 . . . . 13.74 108.356 170.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.495 HG21 ' HE2' ' A' ' 198' ' ' LYS . 6.3 p -76.14 106.51 6.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.792 0.806 . . . . 12.890000000000001 110.314 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 23.0 mmt -113.18 145.99 40.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.152 -0.931 . . . . 13.800000000000001 110.797 -174.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.7 139.53 27.64 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.628 -0.796 . . . . 13.359999999999999 112.861 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.797 ' HB2' HG23 ' A' ' 145' ' ' VAL . 9.2 t80 . . . . . 0 C--N 1.315 -0.894 0 C-N-CA 124.332 1.053 . . . . 14.24 110.123 -175.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.538 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 120.27 0.081 . . . . 14.65 110.939 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.73 ' CB ' HD21 ' A' ' 197' ' ' LEU . 3.6 m-85 -146.79 160.66 41.99 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.333 0.396 . . . . 14.81 111.783 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.695 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.5 t -151.12 165.58 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 108.811 -0.811 . . . . 10.48 108.811 173.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 47.7 t -106.57 113.6 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.379 0.536 . . . . 10.1 111.524 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.478 ' OE1' ' HD2' ' A' ' 185' ' ' ARG . 48.5 tt0 -89.86 109.09 20.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.815 0.302 . . . . 12.0 111.815 -175.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -86.8 -36.04 18.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.29 0.566 . . . . 11.880000000000001 110.059 -177.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.59 170.18 26.29 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.603 -0.808 . . . . 11.35 112.456 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.67 107.59 0.39 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.468 -0.568 . . . . 13.470000000000001 109.468 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.89 43.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.392 0.615 . . . . 13.52 110.614 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 30.7 mtmm -97.82 8.24 45.04 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.951 -1.022 . . . . 17.600000000000001 109.94 -176.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.507 ' HA ' ' OE1' ' A' ' 180' ' ' GLN . 18.0 m120 -106.85 106.17 16.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.022 -0.99 . . . . 16.140000000000001 109.692 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.44 -26.17 68.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.067 -0.515 . . . . 14.039999999999999 111.067 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.61 -38.82 78.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.64 0.733 . . . . 16.57 109.969 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 160' ' ' ILE . 65.6 mttm -86.16 -17.92 33.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.783 -1.099 . . . . 16.399999999999999 110.305 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.447 HG11 HG21 ' A' ' 184' ' ' THR . 71.8 t -68.49 -44.14 83.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.063 -0.717 . . . . 12.67 109.063 170.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -63.1 -29.07 70.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.894 -1.048 . . . . 15.32 111.98 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.414 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.0 pt-20 -78.4 -48.48 15.4 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.641 -0.424 . . . . 15.970000000000001 110.866 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 156' ' ' LYS . 24.8 mt -60.17 -46.87 94.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.545 0.688 . . . . 12.6 109.713 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.477 HG13 ' CB ' ' A' ' 165' ' ' ARG . 43.4 t -63.85 -33.72 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.729 -1.123 . . . . 12.539999999999999 110.349 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.69 -34.6 82.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.209 -0.519 . . . . 14.800000000000001 112.616 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.1 mptp? -70.45 -52.23 23.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.4 . . . . 16.050000000000001 110.662 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.586 HD13 ' CG2' ' A' ' 188' ' ' VAL . 2.8 mt -87.87 -58.31 2.62 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.518 0.933 . . . . 12.99 113.518 -172.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.477 ' CB ' HG13 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -62.73 -37.04 85.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.394 0.616 . . . . 15.06 109.411 -176.227 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.08 -25.68 74.11 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.111 -0.95 . . . . 16.600000000000001 112.197 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.7 -2.98 58.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.948 0.404 . . . . 16.140000000000001 110.599 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.46 25.49 33.01 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.836 -0.697 . . . . 15.119999999999999 113.104 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -89.61 153.18 20.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.02 0.41 . . . . 15.49 110.462 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.52 100.48 1.42 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.198 0.523 . . . . 13.869999999999999 109.833 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.37 140.65 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.124 -0.944 . . . . 10.82 109.828 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.499 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.83 176.69 8.59 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.575 0.702 . . . . 11.130000000000001 110.935 172.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 20.3 p -122.47 -174.35 2.89 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.656 -1.156 . . . . 11.52 111.034 -171.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 67.4 m -51.83 142.29 25.26 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-O 121.218 0.533 . . . . 12.75 110.818 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 82.8 Cg_exo -49.22 -38.2 41.0 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 124.008 3.139 . . . . 14.640000000000001 115.179 -168.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 t -87.91 -65.68 0.99 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.813 -0.755 . . . . 16.68 112.261 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 70.7 m -170.17 128.5 0.81 Allowed Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 122.368 0.267 . . . . 16.039999999999999 110.94 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.531 ' HB3' HG21 ' A' ' 184' ' ' THR . 72.9 Cg_exo -60.02 121.88 10.52 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 121.848 1.699 . . . . 14.220000000000001 111.342 163.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.7 p -155.77 159.92 2.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.809 0.338 . . . . 16.129999999999999 110.538 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' A' ' 153' ' ' ASN . 9.2 mm100 -68.85 120.99 15.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.052 -0.522 . . . . 16.699999999999999 111.489 177.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.23 -26.22 17.58 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.805 -0.634 . . . . 16.98 112.798 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 13.6 mptt -103.07 154.65 19.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.977 -0.379 . . . . 18.73 109.977 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.7 tp -73.9 109.28 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.897 0.856 . . . . 14.82 110.836 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.531 HG21 ' HB3' ' A' ' 178' ' ' PRO . 29.2 m -101.91 107.06 18.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.605 0.717 . . . . 12.779999999999999 110.072 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.478 ' HD2' ' OE1' ' A' ' 147' ' ' GLN . 47.5 mtm180 -87.76 141.06 28.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.993 -1.003 . . . . 13.98 110.254 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.538 ' O ' HD22 ' A' ' 148' ' ' LEU . 4.4 mm -108.74 118.35 56.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.781 -0.822 . . . . 10.56 108.781 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.8 mp -128.9 130.85 47.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.487 0.661 . . . . 10.1 111.141 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 148' ' ' LEU . 43.9 t -107.24 136.52 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.102 -0.953 . . . . 9.7400000000000002 111.079 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 83.37 46.3 6.17 Favored Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 114.751 -1.113 . . . . 9.7599999999999998 113.432 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.695 ' HA ' HG22 ' A' ' 145' ' ' VAL . 10.9 Cg_endo -60.91 124.38 14.82 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 CA-C-N 119.674 1.737 . . . . 11.15 110.599 175.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -149.89 151.32 33.25 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.21 -0.663 . . . . 12.77 109.21 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.527 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -84.8 -11.91 54.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.367 -0.833 . . . . 14.6 111.581 -174.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.7 m -120.84 113.25 19.88 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.089 0.471 . . . . 14.300000000000001 110.954 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.657 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 20.8 ptmt -61.33 -36.29 79.75 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.504 -0.771 . . . . 15.970000000000001 111.305 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.35 -43.0 99.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.256 -0.429 . . . . 15.6 111.589 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -70.4 -39.01 74.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 14.220000000000001 110.531 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.73 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -84.37 -16.82 41.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.534 -0.757 . . . . 11.949999999999999 110.906 -176.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 0.8 OUTLIER -60.43 -34.96 74.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.661 0.743 . . . . 14.699999999999999 110.387 173.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.59 -12.87 81.12 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.712 -1.131 . . . . 13.09 110.494 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 69.7 m -82.2 -12.67 57.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.795 -0.702 . . . . 12.109999999999999 111.637 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 11.0 mt -69.44 -36.94 77.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.071 0.462 . . . . 12.720000000000001 109.934 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.09 -27.31 70.29 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.676 -0.773 . . . . 14.66 111.188 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.585 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 49.6 mt-10 -82.81 -27.32 30.99 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 110.142 -0.318 . . . . 13.890000000000001 110.142 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.76 -48.32 81.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.459 . . . . 12.550000000000001 111.621 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -56.76 -22.15 33.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.079 -0.51 . . . . 15.83 110.973 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -45.52 9.38 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.816 -0.629 . . . . 16.969999999999999 110.162 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 96.3 mt -65.3 -52.39 54.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.975 -0.557 . . . . 13.890000000000001 111.694 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.501 ' HB3' HD21 ' A' ' 164' ' ' LEU . 70.1 p -100.05 -44.76 5.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.282 0.563 . . . . 13.539999999999999 110.558 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.47 7.84 69.65 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.264 -0.88 . . . . 14.67 111.095 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.13 155.32 17.52 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.466 -0.568 . . . . 13.039999999999999 109.466 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 26.3 t -89.03 108.0 19.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.497 -0.319 . . . . 14.84 110.438 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -129.2 158.04 21.9 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.508 -0.853 . . . . 12.220000000000001 113.316 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.96 145.12 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.187 0.518 . . . . 13.74 109.997 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.88 110.18 5.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.47 -0.786 . . . . 12.890000000000001 110.227 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 93.4 mmm -117.88 141.23 48.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.848 -0.615 . . . . 13.800000000000001 110.569 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -66.9 152.73 52.76 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.777 -0.725 . . . . 13.359999999999999 112.158 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.68 ' HB2' HG23 ' A' ' 145' ' ' VAL . 10.9 t80 . . . . . 0 C--N 1.313 -1.009 0 C-N-CA 122.781 0.432 . . . . 14.24 109.954 -172.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.513 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . . . . . . 0 CA--C 1.51 -0.58 0 N-CA-C 109.635 -0.506 . . . . 14.65 109.635 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.553 ' HA ' ' H ' ' A' ' 217' ' ' TYR . 3.3 m-85 -135.79 152.76 51.42 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.109 0.48 . . . . 14.81 111.863 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' A' ' 187' ' ' LEU . 0.9 OUTLIER -152.91 145.69 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.166 -0.925 . . . . 10.48 109.922 -174.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 44.4 t -112.26 108.13 24.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-N 118.424 0.556 . . . . 10.1 111.035 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -88.11 111.08 21.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.491 -0.322 . . . . 12.0 111.334 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 1.002 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -86.42 -38.87 16.92 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.225 0.536 . . . . 11.880000000000001 109.721 -178.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.45 167.51 26.99 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.488 -0.863 . . . . 11.35 112.523 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -168.89 101.68 0.39 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.037 -0.727 . . . . 13.470000000000001 109.037 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.16 163.98 37.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.905 -0.589 . . . . 13.52 110.571 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 90.8 mttt -99.22 2.45 45.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.041 -0.981 . . . . 17.600000000000001 110.221 -173.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -93.37 98.64 11.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.78 -1.1 . . . . 16.140000000000001 108.68 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.85 -20.65 63.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.059 0.457 . . . . 14.039999999999999 111.193 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.14 -28.94 64.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.732 0.777 . . . . 16.57 109.183 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.403 ' O ' HG13 ' A' ' 160' ' ' ILE . 3.1 tppp? -80.49 -34.06 36.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.515 -1.22 . . . . 16.399999999999999 108.768 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 184' ' ' THR . 75.3 t -58.46 -36.61 59.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.085 -0.961 . . . . 12.67 109.806 172.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -62.02 -33.19 73.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.273 -0.876 . . . . 15.32 112.202 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.01 -35.86 28.42 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.051 -0.66 . . . . 15.970000000000001 110.996 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.738 HD12 HD12 ' A' ' 186' ' ' ILE . 14.0 mt -66.22 -47.45 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 12.6 109.437 176.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.59 -38.41 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.868 -1.06 . . . . 12.539999999999999 110.838 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -57.75 -30.23 62.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.016 -0.611 . . . . 14.800000000000001 112.4 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -70.61 -59.03 3.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.231 0.539 . . . . 16.050000000000001 111.081 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.427 HD11 ' HA ' ' A' ' 208' ' ' SER . 4.1 mm? -81.31 -59.79 2.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.709 -0.678 . . . . 12.99 112.101 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.428 ' HD3' ' C ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -64.05 -37.03 85.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.352 0.596 . . . . 15.06 109.632 -177.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.27 -19.48 77.48 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.043 -0.981 . . . . 16.600000000000001 112.691 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -97.42 -13.76 21.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.792 0.329 . . . . 16.140000000000001 110.758 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.5 24.92 9.68 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.703 -0.761 . . . . 15.119999999999999 113.177 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 207' ' ' LEU . 34.1 m-85 -88.26 158.38 18.49 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.793 -0.239 . . . . 15.49 110.536 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -67.39 97.68 0.58 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.374 0.607 . . . . 13.869999999999999 110.08 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.6 p -144.96 137.81 21.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.146 -0.934 . . . . 10.82 110.168 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.578 ' CE2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -142.12 176.72 8.74 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.454 0.645 . . . . 11.130000000000001 110.706 171.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.1 p -118.63 -177.05 3.22 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.785 -1.098 . . . . 11.52 110.713 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.1 OUTLIER -53.4 140.53 45.39 Favored Pre-proline 0 C--N 1.327 -0.405 0 O-C-N 123.256 0.347 . . . . 12.75 111.117 179.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -20.17 -67.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 1 C-N-CA 126.361 4.707 . . . . 14.640000000000001 116.048 -172.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.8 m -86.31 -61.66 1.69 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.981 0.734 . . . . 16.68 112.981 -170.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -166.69 133.8 2.02 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 122.021 -0.425 . . . . 16.039999999999999 111.795 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.487 ' HB3' HG21 ' A' ' 184' ' ' THR . 54.4 Cg_exo -60.97 125.02 16.1 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.716 2.277 . . . . 14.220000000000001 111.46 163.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 6.0 p -146.41 159.56 10.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.148 -0.686 . . . . 16.129999999999999 109.148 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -81.18 122.22 27.11 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.855 0.36 . . . . 16.699999999999999 110.862 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.13 -23.98 22.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 16.98 112.614 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.455 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 11.3 mptt -111.5 161.35 16.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.944 0.402 . . . . 18.73 110.327 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.6 tp -71.05 110.42 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.868 0.842 . . . . 14.82 112.114 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.487 HG21 ' HB3' ' A' ' 178' ' ' PRO . 62.1 m -99.34 106.46 18.56 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.583 -0.735 . . . . 12.779999999999999 109.715 172.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 89.8 mtt180 -89.22 136.76 32.84 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.452 -0.794 . . . . 13.98 109.159 176.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.738 HD12 HD12 ' A' ' 160' ' ' ILE . 2.8 mt -117.2 116.21 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 121.172 0.51 . . . . 10.56 109.696 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.578 HD12 ' CE2' ' A' ' 172' ' ' TYR . 0.1 OUTLIER -128.9 128.07 43.06 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.153 -0.931 . . . . 10.1 111.278 -172.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.002 HG23 HD21 ' A' ' 148' ' ' LEU . 43.1 t -99.91 149.17 5.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.287 -1.324 . . . . 9.7400000000000002 110.403 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 71.07 46.67 42.28 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 115.277 -0.874 . . . . 9.7599999999999998 113.895 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.436 ' HA ' ' CG2' ' A' ' 145' ' ' VAL . 19.2 Cg_endo -67.49 124.73 12.39 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 CA-C-N 119.903 1.851 . . . . 11.15 110.401 172.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -160.37 150.09 17.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.888 -0.596 . . . . 12.77 109.963 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.513 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -91.13 -6.34 53.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.497 -0.774 . . . . 14.6 110.58 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.548 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 43.2 t -100.44 103.87 15.25 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.087 -0.506 . . . . 14.300000000000001 110.274 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 198' ' ' LYS . 32.0 ttpt -60.56 -43.26 97.47 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.451 -0.795 . . . . 15.970000000000001 109.642 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.62 -55.49 30.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.217 -0.901 . . . . 15.6 112.398 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -65.51 -41.31 93.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.962 0.41 . . . . 14.220000000000001 111.147 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.548 ' HB3' ' O ' ' A' ' 193' ' ' SER . 0.2 OUTLIER -81.22 -18.29 46.62 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.103 -0.499 . . . . 11.949999999999999 110.849 -176.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 20.8 tptm -56.52 -55.34 34.95 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.684 0.754 . . . . 14.699999999999999 110.885 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -71.48 -13.18 74.05 Favored Glycine 0 CA--C 1.504 -0.64 0 CA-C-N 114.589 -1.187 . . . . 13.09 110.64 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.606 ' O ' ' HB2' ' A' ' 204' ' ' LEU . 72.9 m -78.45 -12.87 60.03 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.657 -0.771 . . . . 12.109999999999999 111.517 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 23.1 mt -76.66 -40.18 49.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.848 0.356 . . . . 12.720000000000001 110.477 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.1 -36.45 88.57 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.857 -0.687 . . . . 14.66 111.528 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.529 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 15.4 pt-20 -86.25 -16.89 36.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.888 0.375 . . . . 13.890000000000001 110.481 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 200' ' ' SER . 15.4 tp -71.34 -33.18 69.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.644 0.259 . . . . 12.550000000000001 111.166 -173.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.601 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 19.1 pttp -62.96 -16.16 58.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.186 0.517 . . . . 15.83 110.344 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -90.11 -42.02 11.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.811 -0.631 . . . . 16.969999999999999 110.081 170.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.8 mt -68.87 -52.79 25.93 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.788 -0.642 . . . . 13.890000000000001 111.505 -175.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.427 ' HA ' HD11 ' A' ' 164' ' ' LEU . 16.7 t -92.49 -44.11 8.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.433 0.635 . . . . 13.539999999999999 109.56 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 71.31 -2.13 22.52 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 114.837 -1.074 . . . . 14.67 112.164 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 53.3 mt -92.62 150.31 20.79 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.538 -0.541 . . . . 13.039999999999999 109.538 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 19.5 m -85.68 111.84 20.47 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.093 0.473 . . . . 14.84 110.59 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -130.51 163.83 23.11 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.479 -0.867 . . . . 12.220000000000001 112.491 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.9 p -100.29 135.39 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.348 0.594 . . . . 13.74 110.472 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 45.9 t -79.71 104.94 8.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.87 -1.059 . . . . 12.890000000000001 109.492 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 97.0 mmm -117.24 146.7 43.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.665 -0.698 . . . . 13.800000000000001 110.457 -175.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.64 106.33 2.16 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.41 -0.9 . . . . 13.359999999999999 111.733 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.553 ' H ' ' HA ' ' A' ' 144' ' ' TYR . 9.3 t80 . . . . . 0 C--N 1.316 -0.849 0 C-N-CA 123.446 0.699 . . . . 14.24 110.517 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.845 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.424 -0.584 . . . . 14.65 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.708 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 5.2 m-85 -143.7 141.94 30.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.261 0.224 . . . . 14.81 111.086 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.797 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.4 t -150.98 162.02 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 109.625 -0.509 . . . . 10.48 109.625 171.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 27.7 t -104.01 117.57 49.75 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 O-C-N 122.21 -0.306 . . . . 10.1 111.129 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.515 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 6.1 tt0 -91.02 111.4 22.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.649 0.24 . . . . 12.0 111.649 -176.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 1.018 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -94.47 -34.55 12.67 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.215 0.531 . . . . 11.880000000000001 110.313 -177.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.51 162.07 27.97 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.671 -0.776 . . . . 11.35 111.923 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -165.38 101.76 0.72 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.758 -0.46 . . . . 13.470000000000001 109.758 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.54 163.14 33.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.544 0.687 . . . . 13.52 111.127 -173.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 43.2 mttm -98.47 13.47 31.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.641 -1.163 . . . . 17.600000000000001 109.722 -177.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -117.64 104.01 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.31 -0.859 . . . . 16.140000000000001 110.277 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -22.71 67.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.204 0.526 . . . . 14.039999999999999 110.802 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.02 -37.94 55.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.063 -0.972 . . . . 16.57 111.002 175.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -89.64 -31.89 17.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.929 -1.032 . . . . 16.399999999999999 110.351 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 184' ' ' THR . 82.8 t -55.1 -44.31 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.831 -0.622 . . . . 12.67 110.783 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -58.6 -30.4 67.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.575 -0.739 . . . . 15.32 111.468 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.47 -56.43 4.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.829 -0.434 . . . . 15.970000000000001 109.829 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.413 HD12 HG13 ' A' ' 186' ' ' ILE . 19.4 mt -54.76 -40.71 53.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.295 -0.866 . . . . 12.6 110.601 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.6 t -73.83 -44.0 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.852 -0.613 . . . . 12.539999999999999 110.737 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.69 -32.4 73.93 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.633 -0.794 . . . . 14.800000000000001 111.861 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -67.41 -59.92 3.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.645 0.26 . . . . 16.050000000000001 111.214 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.551 ' HB3' HG21 ' A' ' 171' ' ' VAL . 2.1 mm? -85.98 -57.02 3.2 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.58 0.585 . . . . 12.99 112.58 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 165' ' ' ARG . 0.8 OUTLIER -64.45 -35.52 81.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.408 0.623 . . . . 15.06 109.549 -178.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.95 -15.22 76.18 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.349 -0.841 . . . . 16.600000000000001 112.313 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -96.17 7.25 46.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.295 0.569 . . . . 16.140000000000001 110.342 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.44 15.72 58.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.766 -0.652 . . . . 15.119999999999999 113.051 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 207' ' ' LEU . 53.1 m-85 -91.65 148.06 22.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 117.031 0.415 . . . . 15.49 110.574 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.427 ' HB3' ' HD2' ' A' ' 190' ' ' PRO . 22.9 mmm180 -62.56 98.98 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 13.869999999999999 110.512 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.669 HG22 HG22 ' A' ' 188' ' ' VAL . 10.2 t -133.83 133.46 56.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.038 0.447 . . . . 10.82 110.969 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -138.36 175.21 9.77 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.447 -0.797 . . . . 11.130000000000001 110.375 170.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 22.7 p -115.22 -176.11 2.84 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.878 -1.055 . . . . 11.52 111.173 -172.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.56 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.1 OUTLIER -53.51 143.51 36.75 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 123.16 0.288 . . . . 12.75 111.411 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -25.47 -57.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 1 C-N-CA 126.009 4.473 . . . . 14.640000000000001 116.239 -174.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.3 m -87.19 -64.34 1.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.682 -0.807 . . . . 16.68 113.0 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.5 m -170.38 135.57 1.16 Allowed Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 117.857 0.299 . . . . 16.039999999999999 111.68 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.462 ' HB3' HG21 ' A' ' 184' ' ' THR . 76.0 Cg_exo -60.13 124.76 15.91 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.139 2.559 . . . . 14.220000000000001 112.507 166.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.1 p -153.51 158.48 3.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.911 -0.586 . . . . 16.129999999999999 109.609 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.22 134.67 36.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.392 -0.367 . . . . 16.699999999999999 110.347 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 95.27 -25.9 22.03 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.85 -0.691 . . . . 16.98 112.422 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 9.8 mptt -106.95 168.94 8.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.18 -0.674 . . . . 18.73 109.18 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.439 HD11 ' HB1' ' A' ' 150' ' ' ALA . 10.3 tp -77.53 111.29 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.871 0.843 . . . . 14.82 111.84 -173.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.56 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 37.4 m -105.31 109.93 22.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.463 -0.79 . . . . 12.779999999999999 109.18 170.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 36.5 mtt180 -94.68 145.89 24.54 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.597 -0.729 . . . . 13.98 110.2 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.539 ' O ' HD22 ' A' ' 148' ' ' LEU . 3.0 mm -110.37 119.66 59.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.699 -0.852 . . . . 10.56 108.699 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.547 ' HB3' ' CG1' ' A' ' 145' ' ' VAL . 6.1 mp -128.79 131.37 47.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.376 0.608 . . . . 10.1 110.887 -175.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.018 HG23 HD21 ' A' ' 148' ' ' LEU . 39.8 t -104.01 133.74 47.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.995 -1.002 . . . . 9.7400000000000002 110.845 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.75 47.64 5.83 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 114.907 -1.042 . . . . 9.7599999999999998 113.731 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.797 ' HA ' HG22 ' A' ' 145' ' ' VAL . 10.9 Cg_endo -60.79 125.56 17.51 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 CA-C-N 119.629 1.715 . . . . 11.15 110.888 174.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -159.25 168.1 27.33 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.932 -0.576 . . . . 12.77 109.583 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . . . -106.9 13.69 27.43 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.296 0.569 . . . . 14.6 109.776 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 22.8 t -118.43 109.47 16.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.885 -0.598 . . . . 14.300000000000001 111.373 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.705 ' HB2' ' CZ ' ' A' ' 144' ' ' TYR . 38.3 ttpt -69.91 -42.35 73.45 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.67 -0.863 . . . . 15.970000000000001 108.67 171.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -56.6 -40.63 75.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 15.6 111.652 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -79.72 -48.25 13.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.374 -0.376 . . . . 14.220000000000001 111.196 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -79.66 -20.76 45.89 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.884 0.328 . . . . 11.949999999999999 111.884 -171.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.506 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 29.2 tptp -67.4 -44.6 78.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.236 0.541 . . . . 14.699999999999999 109.714 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.28 -13.62 76.84 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.678 -0.692 . . . . 13.09 111.547 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 73.9 m -75.32 -24.01 57.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.519 0.2 . . . . 12.109999999999999 111.367 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 15.8 mt -61.49 -31.14 71.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.349 . . . . 12.720000000000001 110.878 -175.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.48 -46.11 94.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.565 -0.826 . . . . 14.66 111.924 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 12.6 pt-20 -86.83 -19.64 28.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.429 . . . . 13.890000000000001 111.111 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.432 HD11 ' CG1' ' A' ' 188' ' ' VAL . 14.9 tp -68.63 -35.75 77.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.3 -0.409 . . . . 12.550000000000001 111.62 -172.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.44 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 6.3 ptpp? -64.37 -16.31 62.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.825 0.345 . . . . 15.83 110.765 174.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.42 -35.5 15.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.117 0.484 . . . . 16.969999999999999 110.04 172.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 82.5 mt -74.96 -53.18 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 13.890000000000001 111.36 -176.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.531 ' HA ' HD11 ' A' ' 164' ' ' LEU . 3.4 m -94.86 -43.68 8.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 13.539999999999999 110.592 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 71.35 1.02 40.92 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.318 -0.856 . . . . 14.67 112.383 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 59.5 mt -84.37 154.48 22.83 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.341 -0.615 . . . . 13.039999999999999 109.341 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 23.3 m -77.17 93.49 3.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.86 0.362 . . . . 14.84 110.104 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -111.13 136.54 13.67 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.641 -0.79 . . . . 12.220000000000001 113.348 -175.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.92 138.4 25.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.038 -0.727 . . . . 13.74 109.038 174.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 6.6 p -79.23 108.1 12.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.736 0.779 . . . . 12.890000000000001 109.378 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 67.2 mtt -122.42 152.52 40.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.369 -0.832 . . . . 13.800000000000001 110.13 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -75.26 143.61 30.89 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.004 -1.094 . . . . 13.359999999999999 111.616 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.845 ' CD2' ' HB1' ' A' ' 143' ' ' ALA . 4.3 t80 . . . . . 0 C--N 1.304 -1.384 0 CA-C-N 114.217 -0.992 . . . . 14.24 109.617 -170.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.826 ' HB1' ' CD1' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 110.387 -0.227 . . . . 14.65 110.387 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.683 ' CE2' ' HE3' ' A' ' 194' ' ' LYS . 36.6 m-85 -142.28 142.9 32.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.549 0.34 . . . . 14.81 111.67 -172.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.925 HG22 ' HA ' ' A' ' 190' ' ' PRO . 3.4 t -148.74 164.4 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 109.371 -0.603 . . . . 10.48 109.371 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.461 HG21 HD13 ' A' ' 204' ' ' LEU . 40.1 t -101.17 107.84 22.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 122.055 -0.403 . . . . 10.1 111.373 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.549 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 40.2 tt0 -78.68 115.94 18.71 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 122.617 0.367 . . . . 12.0 111.129 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 1.029 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -93.74 -33.31 13.66 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.424 0.631 . . . . 11.880000000000001 109.778 177.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.68 168.51 27.39 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.402 -0.817 . . . . 11.35 112.423 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -168.41 100.47 0.42 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.488 -0.93 . . . . 13.470000000000001 108.488 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.18 160.77 42.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.661 -0.7 . . . . 13.52 110.799 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 44.7 mtpt -99.35 -6.64 27.49 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.948 -1.024 . . . . 17.600000000000001 110.262 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.538 ' ND2' ' HG3' ' A' ' 156' ' ' LYS . 36.2 t30 -90.96 106.5 18.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.527 -0.76 . . . . 16.140000000000001 109.691 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.01 -21.38 64.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.969 -0.56 . . . . 14.039999999999999 111.697 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -59.52 -35.08 73.5 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.774 0.797 . . . . 16.57 109.878 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.538 ' HG3' ' ND2' ' A' ' 153' ' ' ASN . 28.3 mtpp -83.67 -33.35 25.24 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.561 -1.2 . . . . 16.399999999999999 110.753 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 178' ' ' PRO . 89.7 t -57.48 -39.14 67.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.404 0.621 . . . . 12.67 109.662 173.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -60.78 -30.32 69.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.106 -0.952 . . . . 15.32 111.743 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.614 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 6.0 mm-40 -77.24 -61.65 1.91 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.185 -0.672 . . . . 15.970000000000001 109.185 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 156' ' ' LYS . 12.3 mt -49.41 -46.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.357 -0.838 . . . . 12.6 110.793 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.3 t -73.75 -41.42 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.463 -0.789 . . . . 12.539999999999999 110.602 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.66 -28.88 70.61 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.611 -0.804 . . . . 14.800000000000001 112.137 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.614 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.6 mptp? -72.7 -52.44 15.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.703 0.287 . . . . 16.050000000000001 111.183 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.5 mm? -86.39 -55.86 3.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.272 0.471 . . . . 12.99 112.272 -176.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -63.45 -40.28 96.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.223 0.535 . . . . 15.06 109.752 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.68 -23.98 73.98 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.02 -0.991 . . . . 16.600000000000001 112.517 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.18 0.85 56.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.867 0.365 . . . . 16.140000000000001 110.723 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.56 17.3 58.76 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.927 -0.654 . . . . 15.119999999999999 113.237 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -83.86 153.85 23.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.979 0.39 . . . . 15.49 111.036 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.15 99.33 2.79 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.284 -0.636 . . . . 13.869999999999999 109.284 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.66 141.7 27.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 114.904 -1.044 . . . . 10.82 109.255 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.586 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -138.7 176.41 8.72 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.994 0.902 . . . . 11.130000000000001 111.31 170.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 14.2 p -123.34 -173.73 2.79 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.817 -1.538 . . . . 11.52 109.886 -171.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 19.5 m -50.01 137.58 19.97 Favored Pre-proline 0 C--O 1.234 0.278 0 N-CA-C 109.737 -0.468 . . . . 12.75 109.737 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -37.44 -50.38 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 124.572 3.515 . . . . 14.640000000000001 115.399 -167.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.0 t -82.93 -60.41 2.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.116 -0.634 . . . . 16.68 112.471 -172.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.3 m -166.81 135.43 2.24 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 117.891 0.314 . . . . 16.039999999999999 111.608 -175.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.47 ' HB3' HG11 ' A' ' 157' ' ' VAL . 34.4 Cg_exo -62.24 124.62 14.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.266 1.977 . . . . 14.220000000000001 111.063 165.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.463 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.8 p -153.57 154.56 7.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 110.084 -0.339 . . . . 16.129999999999999 110.084 -176.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -82.92 141.59 32.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.123 0.487 . . . . 16.699999999999999 110.887 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.93 -17.07 59.33 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.698 -0.683 . . . . 16.98 111.921 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 10.2 mptt -123.78 156.8 35.42 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.353 -0.61 . . . . 18.73 109.353 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 183' ' ' ILE . 7.7 tp -71.46 109.07 3.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.554 0.692 . . . . 14.82 111.049 -174.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.448 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 32.6 m -103.49 106.77 17.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.813 0.816 . . . . 12.779999999999999 110.438 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.751 ' HG2' HD11 ' A' ' 187' ' ' LEU . 22.1 ttp180 -85.39 133.29 34.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.317 -1.31 . . . . 13.98 109.367 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.533 ' O ' HD22 ' A' ' 148' ' ' LEU . 2.0 mm -112.98 118.6 58.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.057 -0.72 . . . . 10.56 109.057 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.751 HD11 ' HG2' ' A' ' 185' ' ' ARG . 1.5 mp -131.33 132.64 44.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.396 0.617 . . . . 10.1 111.278 -172.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.029 HG23 HD21 ' A' ' 148' ' ' LEU . 42.3 t -104.9 134.44 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.217 -0.902 . . . . 9.7400000000000002 111.009 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 84.57 50.41 4.24 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.443 -0.799 . . . . 9.7599999999999998 113.739 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.925 ' HA ' HG22 ' A' ' 145' ' ' VAL . 5.3 Cg_endo -55.88 125.51 19.32 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 119.277 1.538 . . . . 11.15 111.424 174.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -152.47 169.01 23.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.657 -0.702 . . . . 12.77 109.23 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.47 -1.88 22.63 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.81 0.338 . . . . 14.6 111.086 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 70.5 m -121.11 110.15 15.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.863 0.363 . . . . 14.300000000000001 111.351 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.683 ' HE3' ' CE2' ' A' ' 144' ' ' TYR . 37.5 ttmt -65.13 -53.44 45.13 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.968 -0.56 . . . . 15.970000000000001 110.014 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -51.34 -40.26 58.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.264 -0.88 . . . . 15.6 111.647 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -74.7 -42.07 59.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 14.220000000000001 110.947 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.2 OUTLIER -78.56 -20.25 51.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.022 0.439 . . . . 11.949999999999999 110.19 -177.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.462 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.4 tptm -67.06 -39.58 86.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.423 0.63 . . . . 14.699999999999999 110.305 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.75 -12.17 84.04 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.303 -1.119 . . . . 13.09 110.303 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 71.5 m -90.26 -9.29 48.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.528 -0.836 . . . . 12.109999999999999 112.454 -175.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 18.2 mt -65.2 -35.79 82.15 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.774 -0.37 . . . . 12.720000000000001 110.908 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.96 -44.08 97.52 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.915 -0.66 . . . . 14.66 112.331 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 200' ' ' SER . 11.1 pt-20 -81.06 -18.5 46.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.936 0.398 . . . . 13.890000000000001 110.457 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.461 HD13 HG21 ' A' ' 146' ' ' VAL . 1.2 tt -68.95 -32.17 71.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 12.550000000000001 109.958 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 25.2 mtpp -62.0 -19.84 63.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.572 -0.74 . . . . 15.83 110.37 173.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -40.01 13.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.174 0.511 . . . . 16.969999999999999 109.719 172.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.75 -52.54 59.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.63 -0.714 . . . . 13.890000000000001 111.339 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.495 ' HB3' HD11 ' A' ' 164' ' ' LEU . 62.8 p -103.84 -46.95 4.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.999 0.428 . . . . 13.539999999999999 110.802 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 82.27 -6.18 69.13 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.789 -0.641 . . . . 14.67 111.8 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.0 mp -86.61 158.37 19.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.82 -0.437 . . . . 13.039999999999999 109.82 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 16.1 m -80.13 94.73 6.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.851 -0.613 . . . . 14.84 110.594 -175.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -111.83 148.55 18.12 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.591 -0.814 . . . . 12.220000000000001 113.45 -176.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.4 141.97 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.963 0.411 . . . . 13.74 109.932 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.31 106.77 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.689 0.757 . . . . 12.890000000000001 110.372 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 96.6 mmm -117.87 168.55 10.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.464 -0.789 . . . . 13.800000000000001 110.376 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -84.76 151.31 26.17 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.356 -0.926 . . . . 13.359999999999999 112.462 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.913 ' HB2' HG23 ' A' ' 145' ' ' VAL . 3.9 t80 . . . . . 0 C--N 1.311 -1.085 0 CA-C-N 114.418 -0.891 . . . . 14.24 109.582 -171.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.845 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 110.449 -0.204 . . . . 14.65 110.449 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.67 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 37.9 m-85 -136.91 143.72 43.11 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.555 -0.293 . . . . 14.81 111.569 -173.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 190' ' ' PRO . 3.0 m -151.39 160.73 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.301 0.64 . . . . 10.48 110.036 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 12.4 t -114.59 122.04 67.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 120.754 -0.378 . . . . 10.1 110.021 176.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.529 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 27.2 tt0 -92.8 97.02 10.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.594 0.235 . . . . 12.0 110.917 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.781 HD13 ' N ' ' A' ' 212' ' ' GLY . 0.3 OUTLIER -83.41 -27.88 29.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.344 0.592 . . . . 11.880000000000001 109.691 -177.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.17 162.26 28.15 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.402 -0.904 . . . . 11.35 112.34 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.96 101.52 0.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.779 -0.452 . . . . 13.470000000000001 109.779 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.92 158.7 43.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.329 0.585 . . . . 13.52 110.748 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -99.45 4.97 46.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.096 -0.957 . . . . 17.600000000000001 109.808 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.404 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.1 t-20 -105.88 116.72 32.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.887 -1.051 . . . . 16.140000000000001 109.74 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -73.48 -23.45 60.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.169 -0.469 . . . . 14.039999999999999 112.17 -174.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.84 -35.31 79.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.891 0.853 . . . . 16.57 109.411 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.58 ' O ' HG13 ' A' ' 160' ' ' ILE . 32.3 mmtp -76.08 -38.55 56.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.127 -1.397 . . . . 16.399999999999999 110.205 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.528 HG11 HG21 ' A' ' 184' ' ' THR . 93.3 t -57.28 -47.69 83.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.307 0.575 . . . . 12.67 110.325 176.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -59.16 -35.56 73.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.986 -1.006 . . . . 15.32 111.985 -174.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.65 -39.25 27.64 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.626 -0.43 . . . . 15.970000000000001 111.65 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 156' ' ' LYS . 29.2 mt -62.7 -49.29 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.549 0.69 . . . . 12.6 109.523 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 91.8 t -66.08 -36.2 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.891 -1.05 . . . . 12.539999999999999 109.788 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -56.97 -32.67 62.72 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 14.800000000000001 112.187 176.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -71.8 -62.26 1.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.321 . . . . 16.050000000000001 111.452 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.7 mm? -78.02 -50.38 12.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.119 -0.491 . . . . 12.99 112.113 -172.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 3.9 tmt_? -64.84 -43.42 93.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.353 -0.61 . . . . 15.06 109.353 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.01 -27.23 73.36 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.043 -0.981 . . . . 16.600000000000001 112.874 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.27 -8.4 59.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.989 0.423 . . . . 16.140000000000001 110.625 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.21 19.82 27.21 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.053 -0.594 . . . . 15.119999999999999 113.197 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 207' ' ' LEU . 42.7 m-85 -88.22 157.13 18.88 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 117.23 0.515 . . . . 15.49 110.713 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -77.75 100.64 6.34 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.521 0.677 . . . . 13.869999999999999 109.279 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.6 p -142.06 137.98 30.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.687 -1.142 . . . . 10.82 109.477 -174.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.527 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.49 176.56 8.68 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.539 0.685 . . . . 11.130000000000001 110.585 174.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 10.0 p -121.82 -173.97 2.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.722 -1.126 . . . . 11.52 111.191 -169.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 74.7 m -50.45 143.05 14.27 Favored Pre-proline 0 C--O 1.236 0.35 0 O-C-N 123.465 0.478 . . . . 12.75 110.634 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -45.01 -45.43 14.18 Favored 'Trans proline' 0 CA--C 1.527 0.175 0 C-N-CA 124.006 3.138 . . . . 14.640000000000001 114.863 -170.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.2 p -86.97 -63.79 1.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.882 -0.727 . . . . 16.68 112.848 -172.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.9 m -168.54 130.04 1.14 Allowed Pre-proline 0 C--O 1.234 0.278 0 O-C-N 122.464 -0.148 . . . . 16.039999999999999 111.202 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.546 ' HB3' HG21 ' A' ' 184' ' ' THR . 78.2 Cg_exo -61.45 122.43 11.08 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.116 1.877 . . . . 14.220000000000001 111.493 162.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 182' ' ' LYS . 4.3 p -155.35 161.68 2.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.849 -0.426 . . . . 16.129999999999999 109.849 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -75.25 124.41 27.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.77 0.319 . . . . 16.699999999999999 110.681 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.16 -26.06 16.37 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.094 -0.574 . . . . 16.98 112.577 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.445 ' HB2' HG12 ' A' ' 179' ' ' VAL . 0.8 OUTLIER -107.16 154.61 20.94 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.703 -0.48 . . . . 18.73 109.703 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.1 tp -72.79 109.89 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.513 0.673 . . . . 14.82 111.071 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.546 HG21 ' HB3' ' A' ' 178' ' ' PRO . 31.4 m -98.8 109.41 22.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.624 0.726 . . . . 12.779999999999999 109.974 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 76.9 mtm180 -95.01 134.25 37.89 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.922 -1.036 . . . . 13.98 109.941 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.405 ' C ' HD12 ' A' ' 187' ' ' LEU . 4.5 mm -102.56 106.9 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 109.722 -0.473 . . . . 10.56 109.722 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.651 HD23 HG21 ' A' ' 145' ' ' VAL . 6.1 mp -110.85 114.84 28.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.582 0.706 . . . . 10.1 110.841 -174.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 41.9 t -95.08 140.89 15.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.856 -1.065 . . . . 9.7400000000000002 110.001 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 77.55 45.85 10.54 Favored Glycine 0 N--CA 1.434 -1.495 0 CA-C-N 115.292 -0.867 . . . . 9.7599999999999998 114.139 174.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.799 ' HA ' HG12 ' A' ' 145' ' ' VAL . 11.4 Cg_endo -61.92 126.38 18.72 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 CA-C-N 119.762 1.781 . . . . 11.15 110.83 171.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -161.54 167.87 24.62 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.987 -0.552 . . . . 12.77 109.721 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -103.9 7.49 36.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.255 -0.43 . . . . 14.6 110.427 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 36.4 t -120.6 116.57 25.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.918 -0.583 . . . . 14.300000000000001 110.921 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.657 ' HB2' ' CD2' ' A' ' 144' ' ' TYR . 31.5 ttmt -70.92 -47.75 57.33 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.022 -0.733 . . . . 15.970000000000001 109.022 172.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -46.24 -57.46 4.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.704 -1.134 . . . . 15.6 111.639 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -70.7 -39.66 73.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.459 -0.791 . . . . 14.220000000000001 111.995 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.548 HD23 ' HB2' ' A' ' 144' ' ' TYR . 0.1 OUTLIER -82.39 -30.99 29.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.645 0.239 . . . . 11.949999999999999 111.645 -174.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.573 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 13.3 tmtt? -79.32 -29.98 42.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.218 -0.66 . . . . 14.699999999999999 109.218 -177.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.51 -12.03 83.96 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.022 -1.231 . . . . 13.09 110.022 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 46.3 m -91.09 -8.07 49.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.592 -0.804 . . . . 12.109999999999999 112.272 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 23.2 mt -66.96 -35.12 79.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.922 -0.311 . . . . 12.720000000000001 111.244 -174.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -58.58 -42.95 96.35 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.735 -0.745 . . . . 14.66 111.905 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 200' ' ' SER . 10.7 pt-20 -83.62 -18.34 38.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.07 0.462 . . . . 13.890000000000001 110.412 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.36 -27.65 65.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.143 -0.481 . . . . 12.550000000000001 110.049 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 6.5 mtpm? -63.48 -20.88 65.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.786 -0.643 . . . . 15.83 110.496 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.84 -35.97 16.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.715 -0.476 . . . . 16.969999999999999 109.715 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.582 ' HB3' ' CE1' ' A' ' 169' ' ' TYR . 81.9 mt -73.41 -53.09 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.613 -0.722 . . . . 13.890000000000001 111.681 -175.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 164' ' ' LEU . 71.2 p -95.04 -42.64 8.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.271 0.557 . . . . 13.539999999999999 110.68 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 70.2 5.79 55.07 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.167 -0.924 . . . . 14.67 111.694 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.631 ' C ' HD12 ' A' ' 148' ' ' LEU . 96.1 mt -89.86 162.8 15.29 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.594 0.758 . . . . 13.039999999999999 109.84 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 66.1 m -102.24 99.89 10.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.13 0.419 . . . . 14.84 112.13 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.781 ' N ' HD13 ' A' ' 148' ' ' LEU . . . -116.55 157.43 15.05 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.303 -0.951 . . . . 12.220000000000001 114.559 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.76 146.15 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.779 -0.711 . . . . 13.74 109.796 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 24.0 t -74.53 117.69 19.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.857 -0.611 . . . . 12.890000000000001 110.057 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 87.6 mtp -128.83 153.81 47.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.089 -0.505 . . . . 13.800000000000001 110.277 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -86.71 111.1 3.59 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.308 -0.949 . . . . 13.359999999999999 112.208 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.845 ' CD2' ' HB1' ' A' ' 143' ' ' ALA . 5.2 t80 . . . . . 0 C--N 1.312 -1.027 0 C-N-CA 124.688 1.195 . . . . 14.24 110.472 178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.516 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 110.041 -0.355 . . . . 14.65 110.041 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.653 ' CD1' ' HG3' ' A' ' 194' ' ' LYS . 5.4 m-85 -146.72 159.82 43.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.685 0.279 . . . . 14.81 111.454 -177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.725 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.3 t -149.32 158.83 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.719 -0.845 . . . . 10.48 108.719 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.471 HG12 ' HA3' ' A' ' 212' ' ' GLY . 42.9 t -100.89 106.33 19.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 O-C-N 122.081 -0.387 . . . . 10.1 111.047 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.555 HE21 ' HB2' ' A' ' 150' ' ' ALA . 28.3 tt0 -78.85 110.23 13.85 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.526 0.331 . . . . 12.0 111.311 -177.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 1.013 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -87.94 -37.92 16.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.306 0.574 . . . . 11.880000000000001 109.568 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.3 164.28 28.02 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.374 -0.917 . . . . 11.35 112.559 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.555 ' HB2' HE21 ' A' ' 147' ' ' GLN . . . -164.43 104.25 0.84 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.695 -0.854 . . . . 13.470000000000001 108.695 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.99 166.19 24.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.956 -0.566 . . . . 13.52 110.406 -173.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 48.5 mtpt -102.77 -6.53 22.51 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.042 -0.981 . . . . 17.600000000000001 110.355 -174.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -99.38 109.68 22.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.556 -0.747 . . . . 16.140000000000001 109.61 173.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.0 -19.55 65.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.065 -0.516 . . . . 14.039999999999999 111.494 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.12 -35.51 75.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.813 0.816 . . . . 16.57 109.965 174.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.519 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.12 -26.98 33.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.564 -1.198 . . . . 16.399999999999999 110.12 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.531 ' HA ' HD11 ' A' ' 186' ' ' ILE . 69.5 t -66.0 -39.16 83.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.675 -0.693 . . . . 12.67 110.413 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.433 ' HA ' HG12 ' A' ' 161' ' ' VAL . 23.3 t-20 -68.05 -23.5 64.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.816 -0.629 . . . . 15.32 111.349 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.56 -61.85 1.7 Allowed 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.367 -0.605 . . . . 15.970000000000001 109.367 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.787 HD12 HD12 ' A' ' 186' ' ' ILE . 18.2 mt -53.74 -43.89 57.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.582 -1.19 . . . . 12.6 110.274 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 158' ' ' ASN . 0.3 OUTLIER -72.63 -37.11 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.601 -0.727 . . . . 12.539999999999999 110.197 -177.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -66.0 -29.76 75.65 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.768 -0.73 . . . . 14.800000000000001 111.505 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -70.23 -51.3 31.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.875 0.369 . . . . 16.050000000000001 110.152 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.507 HD13 ' CG2' ' A' ' 188' ' ' VAL . 16.3 mt -88.84 -59.26 2.28 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.133 0.79 . . . . 12.99 113.133 -173.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 55.2 ttp180 -60.86 -37.42 82.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.453 0.644 . . . . 15.06 109.768 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.2 -18.86 78.29 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.907 -1.042 . . . . 16.600000000000001 112.266 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -95.67 -0.93 51.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.881 0.372 . . . . 16.140000000000001 110.624 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.48 25.8 45.65 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.653 -0.784 . . . . 15.119999999999999 113.14 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -92.49 154.85 18.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.952 0.376 . . . . 15.49 110.968 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -67.55 104.23 1.54 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.426 0.631 . . . . 13.869999999999999 109.773 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.46 137.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.019 -0.991 . . . . 10.82 109.858 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.531 ' CE1' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -140.17 175.25 9.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.899 0.857 . . . . 11.130000000000001 111.211 169.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 15.0 p -121.96 -175.42 3.1 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.98 -1.464 . . . . 11.52 110.384 -172.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 7.3 m -50.38 125.6 20.44 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 109.115 -0.698 . . . . 12.75 109.115 173.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 89.6 Cg_exo -45.41 -35.51 11.99 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.349 3.366 . . . . 14.640000000000001 115.337 -167.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.9 p -79.85 -62.63 1.63 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.017 -0.673 . . . . 16.68 111.816 -175.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.2 m -167.68 135.01 1.87 Allowed Pre-proline 0 C--N 1.329 -0.298 0 C-N-CA 122.183 0.193 . . . . 16.039999999999999 110.771 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.01 123.2 11.53 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.634 1.556 . . . . 14.220000000000001 110.107 161.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.5 p -154.22 156.72 4.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.484 -0.487 . . . . 16.129999999999999 111.197 -172.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -81.78 133.82 35.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.82 -0.627 . . . . 16.699999999999999 110.875 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 99.81 -22.95 38.04 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.881 -0.599 . . . . 16.98 112.471 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 9.1 mptt -115.04 160.67 19.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.445 -0.576 . . . . 18.73 109.445 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 183' ' ' ILE . 9.1 tp -74.16 109.82 7.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.735 0.778 . . . . 14.82 111.28 -174.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 40.0 m -104.22 106.58 17.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.649 0.738 . . . . 12.779999999999999 110.208 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.55 ' HG2' HD11 ' A' ' 187' ' ' LEU . 31.1 ttm180 -86.77 136.58 32.94 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.637 -1.165 . . . . 13.98 109.54 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.787 HD12 HD12 ' A' ' 160' ' ' ILE . 3.6 mt -121.61 120.61 62.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.375 -0.602 . . . . 10.56 109.375 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -130.54 143.56 50.83 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.356 -0.838 . . . . 10.1 110.406 -169.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.013 HG23 HD21 ' A' ' 148' ' ' LEU . 42.5 t -107.69 136.23 43.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.461 -0.79 . . . . 9.7400000000000002 111.31 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 81.94 48.74 5.64 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.736 -1.12 . . . . 9.7599999999999998 113.533 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.725 ' HA ' HG22 ' A' ' 145' ' ' VAL . 9.9 Cg_endo -58.94 125.2 17.51 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 CA-C-N 119.472 1.636 . . . . 11.15 110.292 174.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.432 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 5.3 t70 -150.93 163.05 39.62 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 120.397 -0.521 . . . . 12.77 110.295 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -103.22 -4.17 24.72 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.304 -0.862 . . . . 14.6 111.281 -176.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 42.8 m -114.79 99.41 7.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.371 0.605 . . . . 14.300000000000001 110.449 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.653 ' HG3' ' CD1' ' A' ' 144' ' ' TYR . 25.3 ttpt -59.67 -54.51 45.58 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 114.984 -1.007 . . . . 15.970000000000001 111.881 -174.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.93 -40.88 97.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.004 0.43 . . . . 15.6 110.838 -172.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.39 -44.28 96.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 14.220000000000001 110.551 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -79.08 -22.54 45.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.049 -0.523 . . . . 11.949999999999999 110.567 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.3 tptm -69.15 -35.74 76.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.403 0.62 . . . . 14.699999999999999 109.92 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.02 -11.34 85.48 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.573 -1.011 . . . . 13.09 110.573 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 65.5 m -90.27 -8.96 49.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.89 -0.655 . . . . 12.109999999999999 112.624 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 18.4 mt -64.39 -34.52 78.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.001 -0.28 . . . . 12.720000000000001 111.409 -174.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.06 -42.92 96.41 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.831 -0.699 . . . . 14.66 112.135 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -79.31 -18.53 52.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 13.890000000000001 110.282 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.568 HD12 HD12 ' A' ' 207' ' ' LEU . 3.4 tp -76.27 -26.88 56.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.116 -0.493 . . . . 12.550000000000001 110.607 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 92.7 mttt -61.37 -22.47 64.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.145 0.498 . . . . 15.83 110.256 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -30.74 26.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.314 0.578 . . . . 16.969999999999999 109.58 173.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.568 HD12 HD12 ' A' ' 204' ' ' LEU . 88.9 mt -75.33 -53.76 8.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.503 -0.771 . . . . 13.890000000000001 111.84 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 p -99.58 -48.05 4.89 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.499 -0.481 . . . . 13.539999999999999 110.721 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 77.45 -0.64 68.62 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.706 -0.679 . . . . 14.67 112.675 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 164' ' ' LEU . 7.8 mp -90.14 158.1 17.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.328 -0.619 . . . . 13.039999999999999 109.328 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 35.8 m -84.06 102.57 12.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.159 -0.473 . . . . 14.84 110.877 -175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -122.43 150.06 16.95 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.28 -0.962 . . . . 12.220000000000001 113.61 -175.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.97 144.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.497 -0.557 . . . . 13.74 109.497 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.88 105.85 2.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.655 0.74 . . . . 12.890000000000001 109.767 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 98.0 mmm -119.27 139.72 51.45 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.677 -0.692 . . . . 13.800000000000001 110.674 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -68.92 155.42 53.54 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.587 -0.733 . . . . 13.359999999999999 112.425 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.656 ' HB2' HG23 ' A' ' 145' ' ' VAL . 16.0 t80 . . . . . 0 C--N 1.311 -1.071 0 CA-C-N 115.124 -0.538 . . . . 14.24 110.364 -171.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.607 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.784 -0.451 . . . . 14.65 109.784 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.575 ' CB ' HD21 ' A' ' 197' ' ' LEU . 3.8 m-85 -144.45 159.96 41.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.851 0.357 . . . . 14.81 111.743 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.73 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.4 m -151.17 153.05 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.57 -0.741 . . . . 10.48 109.989 -176.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 61.0 t -106.45 111.17 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.582 -0.447 . . . . 10.1 110.593 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -88.4 105.49 17.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.238 -0.437 . . . . 12.0 110.769 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.971 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -83.72 -37.03 23.23 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.351 0.596 . . . . 11.880000000000001 109.987 -175.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.18 161.93 27.87 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.261 -0.881 . . . . 11.35 111.846 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -162.63 104.66 1.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.573 -0.529 . . . . 13.470000000000001 109.573 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 156' ' ' LYS . 1.5 pt? -153.26 165.64 35.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.309 0.576 . . . . 13.52 111.058 -176.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 82.3 mttt -98.44 7.1 46.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.255 -0.884 . . . . 17.600000000000001 110.914 -172.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -99.64 97.13 8.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.478 -0.783 . . . . 16.140000000000001 109.877 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.98 -27.29 68.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.326 0.584 . . . . 14.039999999999999 110.246 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.07 -37.22 66.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.931 -1.031 . . . . 16.57 110.551 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.555 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 66.1 mttm -90.5 -25.81 20.09 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.181 -0.918 . . . . 16.399999999999999 110.691 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' THR . 69.7 t -57.84 -40.46 76.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.437 0.637 . . . . 12.67 109.636 173.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -61.05 -33.4 73.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 15.32 112.183 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 12.6 pt-20 -83.91 -22.84 31.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.463 -0.495 . . . . 15.970000000000001 111.633 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 156' ' ' LYS . 16.8 mt -81.05 -49.68 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.345 0.593 . . . . 12.6 109.448 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 45.8 t -69.62 -32.71 53.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.26 -0.882 . . . . 12.539999999999999 110.449 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -56.74 -31.97 61.3 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.907 -0.664 . . . . 14.800000000000001 112.342 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -73.54 -62.13 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.781 0.324 . . . . 16.050000000000001 111.172 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.6 mm? -72.32 -50.37 27.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.085 0.402 . . . . 12.99 112.085 -173.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 31.2 ttm180 -64.13 -47.24 80.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.394 0.616 . . . . 15.06 110.098 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.23 -34.79 90.86 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.916 -1.038 . . . . 16.600000000000001 113.047 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -80.14 -7.39 58.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.973 0.416 . . . . 16.140000000000001 110.718 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.24 24.73 15.76 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.878 -0.677 . . . . 15.119999999999999 113.222 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -93.85 152.69 18.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.75 -0.463 . . . . 15.49 109.75 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -73.35 103.88 4.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.475 0.655 . . . . 13.869999999999999 110.162 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.78 139.1 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.832 -1.076 . . . . 10.82 110.051 -173.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.46 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -141.3 176.92 8.46 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.507 0.67 . . . . 11.130000000000001 110.806 171.213 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.2 p -113.55 -176.34 2.88 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.841 -1.072 . . . . 11.52 111.193 -172.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.82 149.74 16.06 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.405 -0.361 . . . . 12.75 111.111 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -39.32 -53.86 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.347 3.365 . . . . 14.640000000000001 115.674 -170.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.4 m -87.17 -64.71 1.11 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 119.515 -0.874 . . . . 16.68 113.133 -169.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.8 m -169.13 135.72 1.46 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 118.228 0.467 . . . . 16.039999999999999 111.346 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.549 ' HB3' HG21 ' A' ' 184' ' ' THR . 44.7 Cg_exo -65.74 123.95 12.08 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.577 2.184 . . . . 14.220000000000001 112.012 162.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.68 158.57 3.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.637 -0.505 . . . . 16.129999999999999 109.637 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.63 128.21 35.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.722 0.296 . . . . 16.699999999999999 110.54 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.6 -26.17 25.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.097 -0.573 . . . . 16.98 112.3 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.7 OUTLIER -102.67 154.76 18.83 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.716 -0.476 . . . . 18.73 109.716 178.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 183' ' ' ILE . 7.8 tp -73.38 109.65 5.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.6 0.714 . . . . 14.82 111.082 -175.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.549 HG21 ' HB3' ' A' ' 178' ' ' PRO . 50.9 m -99.34 119.32 37.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 12.779999999999999 109.804 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 60.8 mtt-85 -101.23 140.17 35.89 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.71 -0.677 . . . . 13.98 109.789 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.609 ' C ' HD12 ' A' ' 187' ' ' LEU . 2.1 mm -107.07 120.31 58.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.95 -0.759 . . . . 10.56 108.95 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.6 mp -128.77 121.86 29.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.521 0.677 . . . . 10.1 111.152 -173.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.971 HG23 HD21 ' A' ' 148' ' ' LEU . 40.3 t -101.44 142.99 15.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.072 -0.967 . . . . 9.7400000000000002 110.465 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.401 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 77.46 48.33 8.18 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.276 -0.875 . . . . 9.7599999999999998 113.77 174.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.73 ' HA ' HG12 ' A' ' 145' ' ' VAL . 13.6 Cg_endo -64.44 123.99 12.63 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 CA-C-N 119.667 1.734 . . . . 11.15 110.62 171.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -156.75 147.85 22.04 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.841 -0.618 . . . . 12.77 109.78 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.607 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -88.68 -4.97 58.42 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.788 -0.642 . . . . 14.6 111.971 -175.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 75.6 m -115.86 92.05 3.79 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.297 0.57 . . . . 14.300000000000001 110.608 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.427 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 30.4 ttpt -52.7 -48.4 66.63 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 114.726 -1.125 . . . . 15.970000000000001 111.016 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -55.57 -38.99 70.09 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.102 0.408 . . . . 15.6 112.102 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -74.65 -41.75 59.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.006 0.431 . . . . 14.220000000000001 110.539 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.575 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -81.19 -19.66 42.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.119 0.485 . . . . 11.949999999999999 110.69 -175.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.438 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 28.1 tptp -66.16 -38.13 87.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.371 0.605 . . . . 14.699999999999999 110.31 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.21 -12.5 82.21 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.51 -1.036 . . . . 13.09 110.51 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 75.5 m -83.74 -8.71 59.19 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.7 -0.75 . . . . 12.109999999999999 111.895 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 20.2 mt -67.2 -36.35 81.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.965 0.412 . . . . 12.720000000000001 110.6 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.08 95.97 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.709 -0.678 . . . . 14.66 112.322 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.443 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 10.9 pt-20 -85.74 -18.41 33.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.902 0.382 . . . . 13.890000000000001 110.807 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.4 tp -71.81 -35.05 69.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.558 -0.292 . . . . 12.550000000000001 111.196 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.428 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 0.1 OUTLIER -65.63 -15.3 62.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.11 0.481 . . . . 15.83 110.432 174.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -31.89 21.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.868 -0.606 . . . . 16.969999999999999 109.658 172.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.0 mt -81.92 -52.47 7.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.612 -0.722 . . . . 13.890000000000001 111.646 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.467 ' HB3' HD11 ' A' ' 164' ' ' LEU . 61.5 p -94.0 -43.79 8.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.218 0.533 . . . . 13.539999999999999 110.618 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 72.94 -1.04 41.92 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.082 -0.963 . . . . 14.67 112.288 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.58 155.34 18.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.188 -0.671 . . . . 13.039999999999999 109.188 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.2 t -92.07 109.0 20.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.967 0.413 . . . . 14.84 110.258 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -126.27 156.13 19.65 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.136 -1.03 . . . . 12.220000000000001 113.729 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 p -103.63 147.56 9.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.208 -0.496 . . . . 13.74 110.036 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.7 106.06 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 12.890000000000001 110.478 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 24.5 mmt -113.26 143.86 43.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.859 -0.61 . . . . 13.800000000000001 110.104 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -75.18 136.42 20.38 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.227 -0.987 . . . . 13.359999999999999 111.874 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.557 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 8.8 t80 . . . . . 0 C--N 1.313 -1.009 0 CA-C-O 121.476 0.655 . . . . 14.24 110.052 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.846 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.444 -0.744 0 N-CA-C 109.669 -0.493 . . . . 14.65 109.669 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.64 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 16.1 m-85 -137.23 144.89 43.02 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.454 0.168 . . . . 14.81 111.233 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 190' ' ' PRO . 3.2 m -151.3 164.81 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 122.932 0.493 . . . . 10.48 110.827 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 44.4 t -114.72 108.98 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.778 0.323 . . . . 10.1 111.021 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.404 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 33.2 tt0 -84.84 111.55 19.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.541 -0.3 . . . . 12.0 110.796 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.996 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -91.29 -35.32 14.52 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.327 0.584 . . . . 11.880000000000001 109.804 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.39 166.52 27.66 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.667 -0.778 . . . . 11.35 112.475 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -167.33 101.31 0.51 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.117 -0.697 . . . . 13.470000000000001 109.117 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.71 159.32 42.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.323 0.582 . . . . 13.52 110.978 -171.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 181' ' ' GLY . 5.0 mmmm -98.02 5.29 48.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.892 -1.049 . . . . 17.600000000000001 110.027 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -112.61 106.67 15.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.979 -1.01 . . . . 16.140000000000001 110.041 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.41 ' HA ' ' CG2' ' A' ' 157' ' ' VAL . . . -61.5 -22.09 64.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.205 -0.452 . . . . 14.039999999999999 111.838 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.09 -35.52 73.54 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.814 0.816 . . . . 16.57 110.129 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.592 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 97.8 mttt -86.62 -25.71 24.76 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.609 -1.178 . . . . 16.399999999999999 110.289 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 184' ' ' THR . 90.0 t -61.61 -45.26 99.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.92 -0.582 . . . . 12.67 110.154 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -60.72 -33.83 73.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.628 -0.714 . . . . 15.32 112.007 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 15.7 pt-20 -78.25 -36.82 46.44 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.589 -0.444 . . . . 15.970000000000001 111.214 -175.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 156' ' ' LYS . 20.6 mt -72.02 -46.67 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.666 0.746 . . . . 12.6 109.756 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.97 -34.3 69.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.738 -1.119 . . . . 12.539999999999999 110.519 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.44 -27.0 67.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 14.800000000000001 112.281 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -71.99 -54.79 8.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.112 0.482 . . . . 16.050000000000001 111.068 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.473 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 4.3 mm? -85.7 -62.78 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 12.99 112.38 -174.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -63.18 -37.22 86.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.28 0.562 . . . . 15.06 109.925 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.71 -17.29 79.14 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.015 -0.993 . . . . 16.600000000000001 112.522 -176.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -100.71 -6.7 24.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.785 0.326 . . . . 16.140000000000001 110.982 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.87 25.66 19.39 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.382 -0.914 . . . . 15.119999999999999 113.153 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -93.72 150.91 20.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.3 0.55 . . . . 15.49 109.799 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 102.83 2.12 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.669 0.747 . . . . 13.869999999999999 110.058 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.83 144.23 24.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.342 -1.299 . . . . 10.82 109.337 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.63 177.18 8.2 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.768 0.794 . . . . 11.130000000000001 110.862 170.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 17.8 p -124.65 -175.17 3.2 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.173 -1.376 . . . . 11.52 110.0 -171.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 62.4 m -50.62 128.53 26.06 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.931 -0.308 . . . . 12.75 110.385 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -15.7 -63.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.583 1 C-N-CA 126.908 5.072 . . . . 14.640000000000001 117.047 -175.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.5 t -83.81 -63.29 1.38 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.574 -0.851 . . . . 16.68 112.487 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 65.1 m -168.22 134.24 1.6 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 117.62 0.191 . . . . 16.039999999999999 110.919 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.514 ' HB3' HG21 ' A' ' 184' ' ' THR . 51.9 Cg_exo -60.68 124.67 15.5 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.383 2.056 . . . . 14.220000000000001 111.86 165.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 182' ' ' LYS . 32.2 m -137.58 160.75 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 109.042 -0.725 . . . . 16.129999999999999 109.042 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.48 120.87 22.3 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.26 -0.427 . . . . 16.699999999999999 110.317 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . 0.441 ' O ' ' HE2' ' A' ' 152' ' ' LYS . . . 109.47 -26.45 14.69 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.966 -0.635 . . . . 16.98 113.106 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.508 ' HB2' ' CG2' ' A' ' 179' ' ' VAL . 4.3 mptp? -101.11 163.61 12.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.032 0.444 . . . . 18.73 110.884 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 183' ' ' ILE . 7.6 tp -73.13 108.03 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.835 0.826 . . . . 14.82 110.88 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.514 HG21 ' HB3' ' A' ' 178' ' ' PRO . 52.5 m -101.39 107.27 18.56 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.604 0.716 . . . . 12.779999999999999 109.758 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.519 ' HB3' HD11 ' A' ' 187' ' ' LEU . 81.5 mtt180 -86.92 138.54 31.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.782 -1.099 . . . . 13.98 109.579 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.576 ' O ' HD22 ' A' ' 148' ' ' LEU . 3.6 mm -110.5 116.8 53.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.49 -0.93 . . . . 10.56 108.49 177.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 185' ' ' ARG . 4.6 mp -129.27 128.83 44.01 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.478 0.656 . . . . 10.1 110.987 -173.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.996 HG23 HD21 ' A' ' 148' ' ' LEU . 54.8 t -104.01 142.39 17.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.903 -1.044 . . . . 9.7400000000000002 110.423 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.83 49.87 7.45 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.262 -0.881 . . . . 9.7599999999999998 113.308 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.828 ' HA ' HG12 ' A' ' 145' ' ' VAL . 11.2 Cg_endo -62.44 125.72 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 CA-C-N 119.548 1.674 . . . . 11.15 110.522 172.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -159.7 169.0 24.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.565 -0.743 . . . . 12.77 109.373 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . . . -110.99 5.22 20.15 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.479 0.657 . . . . 14.6 110.237 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.1 m -120.68 103.2 8.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.545 -0.752 . . . . 14.300000000000001 111.396 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.617 ' HB2' ' CE1' ' A' ' 144' ' ' TYR . 37.5 ttpt -64.11 -47.96 77.96 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.775 -0.648 . . . . 15.970000000000001 109.982 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -57.09 -33.49 67.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.005 -0.543 . . . . 15.6 111.453 -177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -75.42 -54.19 7.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.052 -0.522 . . . . 14.220000000000001 110.023 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -72.85 -19.52 61.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.079 -0.509 . . . . 11.949999999999999 111.044 -173.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.463 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 2.0 mmmm -63.91 -33.67 76.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.526 0.679 . . . . 14.699999999999999 110.918 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.74 -12.75 81.04 Favored Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.415 -1.074 . . . . 13.09 110.415 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 74.0 m -83.71 -8.72 59.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.601 -0.799 . . . . 12.109999999999999 111.994 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 9.6 mt -71.84 -38.45 70.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.805 0.335 . . . . 12.720000000000001 110.632 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.54 -24.7 68.04 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.669 -0.972 . . . . 14.66 110.669 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.568 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 43.8 mt-10 -86.64 -24.2 25.4 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.175 -0.513 . . . . 13.890000000000001 110.328 174.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.403 ' CD2' HG11 ' A' ' 146' ' ' VAL . 6.0 tp -60.01 -46.29 89.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.415 -0.357 . . . . 12.550000000000001 111.106 -175.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -21.95 46.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.13 -0.486 . . . . 15.83 111.06 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -41.03 11.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.076 -0.511 . . . . 16.969999999999999 110.938 174.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.8 mt -67.9 -52.39 36.89 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.144 0.497 . . . . 13.890000000000001 111.437 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 66.0 p -104.23 -38.07 7.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.942 -0.572 . . . . 13.539999999999999 110.748 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.39 -0.55 54.3 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.103 -0.799 . . . . 14.67 111.103 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 58.7 mt -97.47 154.13 17.69 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 122.831 0.452 . . . . 13.039999999999999 110.336 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.1 m -84.85 107.34 16.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.904 -0.589 . . . . 14.84 110.555 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -127.83 158.8 21.5 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.282 -0.961 . . . . 12.220000000000001 113.325 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.49 142.58 21.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.763 -0.458 . . . . 13.74 109.763 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.4 105.53 4.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.077 -0.712 . . . . 12.890000000000001 109.077 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 92.8 mmm -114.09 142.39 46.26 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.444 -0.798 . . . . 13.800000000000001 109.383 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -69.94 109.08 2.71 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.11 -1.043 . . . . 13.359999999999999 111.726 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.846 ' CD2' ' HB1' ' A' ' 143' ' ' ALA . 5.4 t80 . . . . . 0 C--N 1.313 -0.998 0 C-N-CA 124.113 0.965 . . . . 14.24 110.457 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.554 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.442 -0.856 0 N-CA-C 108.985 -0.746 . . . . 14.65 108.985 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.633 ' CB ' HD21 ' A' ' 197' ' ' LEU . 5.5 m-85 -145.53 153.79 41.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.515 0.198 . . . . 14.81 110.882 -175.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.861 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.7 t -149.51 161.64 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.622 -0.881 . . . . 10.48 108.622 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.548 HG11 HD22 ' A' ' 204' ' ' LEU . 17.7 t -106.39 108.19 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 122.129 -0.357 . . . . 10.1 111.715 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.554 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 30.0 tt0 -81.5 118.26 22.58 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.615 0.228 . . . . 12.0 111.615 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.938 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -91.62 -36.5 13.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.097 -0.641 . . . . 11.880000000000001 109.708 177.082 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.14 161.89 28.14 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.536 -0.84 . . . . 11.35 112.73 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -163.68 100.76 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.022 -0.733 . . . . 13.470000000000001 109.022 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.71 167.96 19.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.941 -0.572 . . . . 13.52 110.257 -174.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 4.9 mtpm? -104.83 20.85 18.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.325 -0.852 . . . . 17.600000000000001 109.662 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.403 ' O ' HG23 ' A' ' 157' ' ' VAL . 25.3 t-20 -130.76 118.48 20.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.847 -1.069 . . . . 16.140000000000001 109.689 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.42 -22.53 61.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.321 0.489 . . . . 14.039999999999999 112.321 -173.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.28 -34.78 78.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.935 0.874 . . . . 16.57 109.466 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.36 -29.27 34.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.338 -1.301 . . . . 16.399999999999999 110.093 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.533 ' HA ' HD11 ' A' ' 186' ' ' ILE . 97.8 t -65.82 -39.66 85.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.827 -0.624 . . . . 12.67 109.82 173.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.49 -34.57 72.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.022 -0.99 . . . . 15.32 112.13 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.86 -46.51 29.92 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 120.115 -0.634 . . . . 15.970000000000001 111.225 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.789 HD12 HD12 ' A' ' 186' ' ' ILE . 25.2 mt -59.01 -45.95 91.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.444 0.64 . . . . 12.6 109.868 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 82.2 t -68.61 -40.62 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.255 -0.884 . . . . 12.539999999999999 110.445 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.35 -34.31 88.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.045 -0.598 . . . . 14.800000000000001 112.544 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -73.61 -43.96 58.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.587 0.232 . . . . 16.050000000000001 111.046 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.643 ' HB3' HG21 ' A' ' 171' ' ' VAL . 8.5 mt -87.03 -59.15 2.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.386 0.884 . . . . 12.99 113.386 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.473 ' HG2' ' HB ' ' A' ' 171' ' ' VAL . 9.8 mtp180 -69.74 -30.05 67.56 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.848 -0.797 . . . . 15.06 108.848 -175.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.41 -31.7 77.52 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 114.633 -1.167 . . . . 16.600000000000001 111.57 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.3 -12.05 53.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.927 0.394 . . . . 16.140000000000001 110.555 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.0 23.24 13.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.892 -0.671 . . . . 15.119999999999999 113.317 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -87.79 152.54 22.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.078 0.439 . . . . 15.49 110.329 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.445 ' HG3' ' HD2' ' A' ' 190' ' ' PRO . 20.6 tpp180 -75.43 97.75 3.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.806 0.812 . . . . 13.869999999999999 109.589 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 188' ' ' VAL . 2.6 t -131.96 136.32 56.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.605 -1.18 . . . . 10.82 110.622 -173.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.424 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -135.26 174.83 10.18 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.759 0.79 . . . . 11.130000000000001 111.089 174.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 7.8 p -127.71 -174.52 3.21 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.165 -1.38 . . . . 11.52 110.809 -169.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 58.0 m -50.13 135.57 22.33 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 120.836 0.35 . . . . 12.75 110.477 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 30.5 Cg_exo -38.4 -44.85 2.17 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 124.714 3.609 . . . . 14.640000000000001 115.721 -169.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.6 m -87.01 -64.19 1.19 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 119.669 -0.812 . . . . 16.68 112.224 -173.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.7 m -168.52 129.13 1.08 Allowed Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 117.942 0.337 . . . . 16.039999999999999 111.861 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.522 ' HB3' HG21 ' A' ' 184' ' ' THR . 86.9 Cg_exo -58.33 125.16 17.61 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.772 2.315 . . . . 14.220000000000001 112.096 162.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.484 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.7 p -153.18 156.16 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 109.923 -0.399 . . . . 16.129999999999999 109.923 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -81.62 133.56 35.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.797 0.332 . . . . 16.699999999999999 110.202 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 102.86 -26.23 24.75 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.031 -0.604 . . . . 16.98 111.668 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -115.06 168.56 9.82 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.448 -0.575 . . . . 18.73 109.448 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 10.1 tp -76.48 126.26 36.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.471 0.653 . . . . 14.82 111.335 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.522 HG21 ' HB3' ' A' ' 178' ' ' PRO . 57.4 m -119.66 105.98 11.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.842 -0.617 . . . . 12.779999999999999 110.042 173.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 173' ' ' THR . 97.5 mtt180 -83.8 135.43 34.53 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.268 -0.878 . . . . 13.98 108.959 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.789 HD12 HD12 ' A' ' 160' ' ' ILE . 3.2 mt -119.8 120.5 63.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.577 -0.527 . . . . 10.56 109.577 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 187' ' ' LEU . 3.6 mp -129.16 142.1 50.97 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.344 -0.843 . . . . 10.1 111.114 -169.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.938 HG23 HD21 ' A' ' 148' ' ' LEU . 53.8 t -107.14 131.84 56.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.986 -1.006 . . . . 9.7400000000000002 110.926 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.86 49.62 4.73 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.19 -0.913 . . . . 9.7599999999999998 113.783 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.786 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -61.35 124.97 15.78 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 CA-C-N 119.624 1.712 . . . . 11.15 110.854 172.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -159.62 149.14 18.27 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.762 -0.458 . . . . 12.77 109.762 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -89.24 6.14 41.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.968 -0.56 . . . . 14.6 111.145 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.448 ' HB3' ' HB3' ' A' ' 196' ' ' LYS . 22.7 t -118.98 96.32 5.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.253 -0.647 . . . . 14.300000000000001 109.253 175.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.489 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 15.9 ptmt -63.03 -35.67 81.01 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.027 -0.988 . . . . 15.970000000000001 111.583 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -68.69 -44.42 74.01 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.996 0.427 . . . . 15.6 110.628 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 193' ' ' SER . 44.0 tttm -59.42 -44.07 92.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.765 -0.652 . . . . 14.220000000000001 110.698 176.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.633 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -82.54 -16.96 46.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.654 -0.703 . . . . 11.949999999999999 110.487 -176.307 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.622 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 25.3 tptp -64.57 -34.57 78.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 14.699999999999999 110.761 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -82.22 -12.56 80.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.391 -1.084 . . . . 13.09 110.391 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.516 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 70.9 m -79.58 -9.2 59.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.655 -0.772 . . . . 12.109999999999999 111.498 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 1.8 mt -74.11 -33.38 63.58 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.509 -0.552 . . . . 12.720000000000001 109.509 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -61.45 -28.23 69.18 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.551 -1.019 . . . . 14.66 110.551 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.545 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 41.8 mt-10 -85.85 -19.17 31.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.062 -0.569 . . . . 13.890000000000001 110.664 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.548 HD22 HG11 ' A' ' 146' ' ' VAL . 4.6 tp -60.59 -45.01 95.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.796 0.332 . . . . 12.550000000000001 111.553 -173.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -57.85 -23.88 54.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.302 -0.408 . . . . 15.83 111.224 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.38 -37.89 14.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.338 -0.392 . . . . 16.969999999999999 110.466 176.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 89.6 mt -70.9 -51.77 24.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.321 0.581 . . . . 13.890000000000001 111.052 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.564 ' CB ' HD21 ' A' ' 164' ' ' LEU . 28.4 t -110.11 -43.94 3.86 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.502 -0.772 . . . . 13.539999999999999 111.264 -173.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.34 -0.23 55.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.748 -0.739 . . . . 14.67 111.606 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.14 157.51 15.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.684 -0.487 . . . . 13.039999999999999 109.684 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 61.2 m -77.1 95.45 4.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.949 0.405 . . . . 14.84 111.1 -174.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -103.94 138.58 14.13 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.651 -0.704 . . . . 12.220000000000001 113.439 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.0 142.03 21.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.298 0.571 . . . . 13.74 110.066 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.6 t -78.68 105.94 8.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.434 -0.803 . . . . 12.890000000000001 110.419 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 90.1 mtp -120.31 142.59 48.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.073 -0.512 . . . . 13.800000000000001 110.258 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -69.22 136.03 28.12 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.624 -0.798 . . . . 13.359999999999999 112.416 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.861 ' HB2' HG23 ' A' ' 145' ' ' VAL . 10.5 t80 . . . . . 0 C--N 1.31 -1.121 0 CA-C-N 114.396 -0.902 . . . . 14.24 110.102 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.818 ' HB1' ' CD1' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 109.436 -0.579 . . . . 14.65 109.436 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.729 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 5.5 m-85 -138.6 141.12 39.17 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 111.455 0.168 . . . . 14.81 111.455 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 1.026 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.7 t -149.96 163.07 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 109.317 -0.623 . . . . 10.48 109.317 170.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 59.3 t -103.83 108.85 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 O-C-N 122.304 -0.248 . . . . 10.1 111.528 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.46 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 8.6 tt0 -76.72 111.78 12.59 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.21 0.204 . . . . 12.0 110.899 178.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.966 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -89.02 -35.66 16.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.26 -0.644 . . . . 11.880000000000001 109.26 176.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.52 167.61 27.49 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.35 -0.841 . . . . 11.35 112.45 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -165.35 101.27 0.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.123 -0.695 . . . . 13.470000000000001 109.123 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 158.08 45.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.669 -0.696 . . . . 13.52 110.499 -173.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 49.9 mttp -96.23 16.73 17.45 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.182 -0.917 . . . . 17.600000000000001 110.194 -175.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 157' ' ' VAL . 15.8 m120 -118.56 108.37 14.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.959 -1.019 . . . . 16.140000000000001 109.52 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.38 68.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.177 0.513 . . . . 14.039999999999999 110.557 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.68 -37.51 78.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.386 -0.824 . . . . 16.57 110.157 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 64.8 mttp -84.6 -23.3 29.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.621 -1.172 . . . . 16.399999999999999 110.132 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.46 HG13 ' CD1' ' A' ' 186' ' ' ILE . 77.0 t -65.64 -46.34 89.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.789 -0.641 . . . . 12.67 109.967 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -61.53 -29.49 70.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 15.32 112.04 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 14.8 pt-20 -77.4 -43.51 32.41 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.282 -0.567 . . . . 15.970000000000001 111.101 -177.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.465 HD12 HG13 ' A' ' 186' ' ' ILE . 21.7 mt -66.33 -46.73 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.762 0.792 . . . . 12.6 109.469 176.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.442 ' CG1' ' HD2' ' A' ' 165' ' ' ARG . 34.2 t -63.46 -32.9 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.538 -1.21 . . . . 12.539999999999999 110.588 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.76 -32.18 73.65 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.009 -0.615 . . . . 14.800000000000001 112.35 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -71.31 -53.96 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 16.050000000000001 110.967 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.481 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 4.0 mm? -83.84 -51.25 7.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.199 0.815 . . . . 12.99 113.199 -172.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.456 ' HG3' HG13 ' A' ' 171' ' ' VAL . 48.1 mtt180 -69.74 -37.52 76.49 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.838 -0.801 . . . . 15.06 108.838 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.87 -32.21 83.46 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 114.601 -1.181 . . . . 16.600000000000001 112.4 -175.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.78 -3.64 58.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 16.140000000000001 110.833 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.41 25.58 35.83 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 15.119999999999999 113.376 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.422 ' O ' HG12 ' A' ' 171' ' ' VAL . 35.5 m-85 -87.03 160.02 18.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.122 0.461 . . . . 15.49 110.658 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -76.29 97.3 4.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.608 0.718 . . . . 13.869999999999999 109.543 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.456 HG13 ' HG3' ' A' ' 165' ' ' ARG . 5.7 p -144.28 141.26 24.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.909 -1.041 . . . . 10.82 109.635 -174.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.585 ' CE1' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -140.2 176.57 8.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.717 0.77 . . . . 11.130000000000001 111.095 175.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.3 p -117.27 -175.22 2.76 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.44 -1.254 . . . . 11.52 110.696 -173.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.2 m -51.76 140.2 29.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 12.75 110.934 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -46.18 -36.77 17.33 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.136 3.224 . . . . 14.640000000000001 115.069 -169.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.1 m -87.19 -63.74 1.26 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 119.915 -0.714 . . . . 16.68 112.177 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 98.0 m -168.49 139.55 2.14 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 117.742 0.247 . . . . 16.039999999999999 111.19 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.437 ' HB3' HG11 ' A' ' 157' ' ' VAL . 27.8 Cg_exo -66.55 122.82 10.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 121.786 1.657 . . . . 14.220000000000001 110.115 163.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 7.8 p -153.01 156.79 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.363 -0.535 . . . . 16.129999999999999 111.251 -172.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -81.48 128.77 34.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.432 -0.804 . . . . 16.699999999999999 110.423 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.09 -25.03 29.79 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.704 -0.76 . . . . 16.98 112.433 176.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 9.0 mptt -112.32 158.93 19.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.636 -0.505 . . . . 18.73 109.636 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.4 tp -70.83 115.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.486 0.66 . . . . 14.82 111.36 -175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 36.3 m -112.05 113.18 25.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.648 -0.705 . . . . 12.779999999999999 109.826 175.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.551 ' CG ' HD11 ' A' ' 187' ' ' LEU . 21.0 ttm180 -89.49 140.93 29.04 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.04 -0.982 . . . . 13.98 110.112 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.521 ' O ' HD22 ' A' ' 148' ' ' LEU . 3.9 mm -111.21 117.51 55.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.878 -0.786 . . . . 10.56 108.878 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 187' ' ' LEU . 2.5 mp -130.33 135.02 47.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.306 0.574 . . . . 10.1 111.107 -173.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.966 HG23 HD21 ' A' ' 148' ' ' LEU . 41.1 t -108.59 135.62 46.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.241 -0.89 . . . . 9.7400000000000002 111.078 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.442 ' O ' HD22 ' A' ' 197' ' ' LEU . . . 82.8 49.3 5.15 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 114.999 -1.0 . . . . 9.7599999999999998 113.507 175.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.923 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -62.3 125.26 15.92 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 CA-C-N 119.552 1.676 . . . . 11.15 111.136 174.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -157.77 168.17 27.97 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.528 -0.545 . . . . 12.77 109.528 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -104.94 4.77 32.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.116 -0.493 . . . . 14.6 110.581 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 196' ' ' LYS . 21.0 t -120.67 117.7 28.21 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.036 0.446 . . . . 14.300000000000001 110.146 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.696 ' HB2' ' CE2' ' A' ' 144' ' ' TYR . 39.0 ttpt -67.8 -41.78 82.6 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-N 115.901 -0.591 . . . . 15.970000000000001 109.535 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -57.53 -50.19 73.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.667 0.27 . . . . 15.6 111.033 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 39.0 mtpt -52.85 -60.0 3.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.476 -0.784 . . . . 14.220000000000001 111.187 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -76.74 -28.83 55.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.912 -1.04 . . . . 11.949999999999999 111.617 -169.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.579 ' HD3' ' O ' ' A' ' 198' ' ' LYS . 12.9 tmtt? -73.45 -31.59 63.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.012 -0.736 . . . . 14.699999999999999 109.012 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.73 -12.55 84.36 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.227 -1.149 . . . . 13.09 110.227 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 58.5 m -88.37 -9.87 51.24 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.527 -0.837 . . . . 12.109999999999999 111.965 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 20.7 mt -66.28 -36.37 82.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.712 0.291 . . . . 12.720000000000001 111.055 -174.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -57.47 -44.25 93.76 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.026 -0.607 . . . . 14.66 111.829 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.429 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 13.0 pt-20 -86.07 -17.1 36.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.892 0.377 . . . . 13.890000000000001 110.519 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.56 HD11 HG12 ' A' ' 188' ' ' VAL . 15.5 tp -66.22 -31.91 73.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.028 0.442 . . . . 12.550000000000001 110.442 -177.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.492 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 6.1 mtpm? -58.98 -23.71 62.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.515 -0.766 . . . . 15.83 110.272 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.55 -36.96 15.05 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.863 -0.608 . . . . 16.969999999999999 110.236 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 92.6 mt -68.04 -52.65 33.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.043 -0.526 . . . . 13.890000000000001 111.5 -176.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.402 ' HB3' HD11 ' A' ' 164' ' ' LEU . 56.0 p -102.03 -44.12 5.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.119 0.485 . . . . 13.539999999999999 110.13 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.84 5.48 75.0 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.151 -0.931 . . . . 14.67 111.627 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.55 157.74 16.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 110.113 -0.329 . . . . 13.039999999999999 110.113 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.5 t -87.97 105.26 17.34 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.106 -0.497 . . . . 14.84 110.341 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -128.53 160.64 22.21 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.138 -1.03 . . . . 12.220000000000001 113.893 -176.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.14 143.53 20.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.137 -0.532 . . . . 13.74 110.026 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.62 105.27 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.38 -0.6 . . . . 12.890000000000001 109.38 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 64.1 mtt -120.99 145.96 47.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.019 -0.537 . . . . 13.800000000000001 110.226 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -71.91 110.36 3.18 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.365 -0.921 . . . . 13.359999999999999 112.803 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 1.026 ' HB2' HG23 ' A' ' 145' ' ' VAL . 4.4 t80 . . . . . 0 C--N 1.308 -1.237 0 CA-C-N 113.243 -1.479 . . . . 14.24 110.287 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 108.148 -1.056 . . . . 14.65 108.148 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.555 ' CE1' ' HD3' ' A' ' 194' ' ' LYS . 7.3 m-85 -138.23 153.48 49.12 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.695 0.628 . . . . 14.81 112.695 -176.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.8 m -151.99 151.97 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 114.842 -1.072 . . . . 10.48 109.76 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 80.5 t -110.79 108.02 24.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 120.3 -0.56 . . . . 10.1 111.434 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.515 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 19.0 tt0 -80.26 114.31 19.07 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.085 -0.507 . . . . 12.0 111.148 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 1.037 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -93.75 -33.73 13.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.509 0.671 . . . . 11.880000000000001 109.555 177.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.3 170.72 26.6 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.666 -0.778 . . . . 11.35 112.359 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -170.34 103.22 0.27 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.02 -0.733 . . . . 13.470000000000001 109.02 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.98 153.73 42.55 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.451 0.643 . . . . 13.52 110.435 -174.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 77.4 mttt -89.34 2.96 53.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.046 -0.979 . . . . 17.600000000000001 110.438 -175.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -101.82 109.44 21.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.419 -0.81 . . . . 16.140000000000001 109.597 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.409 ' HA ' ' CG2' ' A' ' 157' ' ' VAL . . . -69.88 -20.32 63.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.924 -0.58 . . . . 14.039999999999999 112.202 -175.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.13 -33.84 76.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 122.1 0.952 . . . . 16.57 109.257 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.482 ' O ' HG13 ' A' ' 160' ' ' ILE . 74.4 mmtt -83.54 -30.07 27.37 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.0 -1.454 . . . . 16.399999999999999 110.154 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.463 HG13 ' CD1' ' A' ' 186' ' ' ILE . 77.9 t -57.63 -40.17 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.73 -0.668 . . . . 12.67 110.273 173.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -68.55 -32.62 72.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.264 -0.88 . . . . 15.32 111.969 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.19 -38.09 31.95 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.061 -0.655 . . . . 15.970000000000001 111.2 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 156' ' ' LYS . 29.3 mt -63.28 -41.36 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 12.6 109.22 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.79 -35.66 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.01 -0.995 . . . . 12.539999999999999 110.17 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.64 -28.54 73.72 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.016 -0.612 . . . . 14.800000000000001 112.374 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -72.3 -61.96 1.61 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 16.050000000000001 110.977 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.719 ' HB3' HG21 ' A' ' 171' ' ' VAL . 1.8 mm? -79.5 -62.72 1.6 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.927 -0.579 . . . . 12.99 112.188 -175.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 165' ' ' ARG . 3.0 tmt_? -61.97 -38.25 87.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.381 -0.6 . . . . 15.06 109.381 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.95 85.22 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.258 -0.883 . . . . 16.600000000000001 112.506 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.28 -7.33 59.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.005 0.431 . . . . 16.140000000000001 110.523 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.43 25.1 9.58 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.807 -0.711 . . . . 15.119999999999999 112.624 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -96.31 145.24 25.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.182 -0.674 . . . . 15.49 109.182 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -70.25 107.32 3.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.611 0.72 . . . . 13.869999999999999 110.55 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 188' ' ' VAL . 11.0 t -138.62 135.71 43.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.773 -1.103 . . . . 10.82 110.324 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -137.85 175.39 9.63 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.78 0.8 . . . . 11.130000000000001 110.946 174.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 18.0 p -122.68 -172.68 2.53 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.135 -1.393 . . . . 11.52 110.56 -170.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.6 m -49.61 145.8 7.84 Favored Pre-proline 0 C--O 1.236 0.365 0 O-C-N 123.272 0.357 . . . . 12.75 110.739 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -38.25 -44.94 2.08 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 124.479 3.452 . . . . 14.640000000000001 115.302 -170.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.0 p -87.42 -63.53 1.29 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.735 -0.786 . . . . 16.68 113.089 -173.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.1 m -168.07 142.96 2.96 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 117.688 0.222 . . . . 16.039999999999999 110.86 -175.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.482 ' HG3' ' OG1' ' A' ' 173' ' ' THR . 25.0 Cg_exo -67.38 123.84 11.34 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.13 1.887 . . . . 14.220000000000001 111.066 165.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.427 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.9 p -153.61 156.49 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 120.826 0.346 . . . . 16.129999999999999 110.331 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.401 ' NE2' ' H ' ' A' ' 154' ' ' ALA . 6.2 tp-100 -80.31 128.46 33.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.121 -0.491 . . . . 16.699999999999999 110.193 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.17 -26.09 18.11 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.006 -0.616 . . . . 16.98 112.138 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 12.6 mptt -108.08 153.04 23.7 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.618 -0.512 . . . . 18.73 109.618 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.8 tp -69.17 109.58 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.76 0.791 . . . . 14.82 110.874 -176.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.436 ' HB ' HG21 ' A' ' 157' ' ' VAL . 26.8 m -103.57 109.02 20.53 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.956 0.884 . . . . 12.779999999999999 110.429 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 173' ' ' THR . 48.3 ttt180 -86.24 134.52 33.76 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.063 -1.426 . . . . 13.98 109.032 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.502 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.7 mm -109.4 117.19 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 N-CA-C 109.183 -0.673 . . . . 10.56 109.183 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 187' ' ' LEU . 2.1 mp -130.17 132.95 46.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.512 0.672 . . . . 10.1 111.034 -173.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.037 HG23 HD21 ' A' ' 148' ' ' LEU . 52.8 t -101.96 137.31 30.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.908 -1.042 . . . . 9.7400000000000002 110.208 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.97 51.49 5.8 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.344 -0.844 . . . . 9.7599999999999998 114.071 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.698 ' HA ' HG12 ' A' ' 145' ' ' VAL . 18.6 Cg_endo -67.06 125.71 14.02 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 CA-C-N 119.632 1.716 . . . . 11.15 110.813 170.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -157.88 153.63 26.62 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.598 -0.441 . . . . 12.77 110.274 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.412 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -98.83 0.54 44.5 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.948 -0.569 . . . . 14.6 111.473 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 68.8 m -118.48 93.66 4.2 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 121.37 0.605 . . . . 14.300000000000001 109.992 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.555 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 35.1 ttpt -57.12 -36.79 71.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.917 -1.038 . . . . 15.970000000000001 110.769 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.71 -39.29 80.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.976 0.417 . . . . 15.6 111.53 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -77.54 -42.84 33.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.62 0.724 . . . . 14.220000000000001 110.399 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -83.67 -19.19 35.78 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.251 -0.886 . . . . 11.949999999999999 110.977 -173.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -64.85 -40.12 94.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.193 0.52 . . . . 14.699999999999999 110.51 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.47 -13.73 82.92 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 110.328 -1.109 . . . . 13.09 110.328 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.472 ' HB2' ' HA ' ' A' ' 197' ' ' LEU . 58.4 m -83.35 -11.43 57.65 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.587 -0.807 . . . . 12.109999999999999 111.72 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 28.0 mt -66.88 -40.99 87.96 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.878 0.37 . . . . 12.720000000000001 110.399 -177.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.56 86.28 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.346 -0.931 . . . . 14.66 110.912 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.575 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 45.3 mt-10 -76.89 -26.94 54.74 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 120.81 0.338 . . . . 13.890000000000001 110.574 175.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 146' ' ' VAL . 4.7 tt -67.41 -38.75 85.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.056 -0.52 . . . . 12.550000000000001 110.422 -176.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 82.8 mttt -62.19 -21.02 64.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.392 -0.822 . . . . 15.83 110.261 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -42.31 11.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.676 -0.693 . . . . 16.969999999999999 110.281 173.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 96.8 mt -66.9 -51.91 49.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.033 -0.53 . . . . 13.890000000000001 111.694 -176.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.446 ' HB3' HD11 ' A' ' 164' ' ' LEU . 71.4 p -100.16 -44.38 5.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.214 0.531 . . . . 13.539999999999999 110.821 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.34 12.22 57.86 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.301 -0.863 . . . . 14.67 111.698 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 91.6 mt -91.4 157.75 16.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.912 -0.403 . . . . 13.039999999999999 109.912 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 53.9 m -80.6 94.43 6.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.057 0.456 . . . . 14.84 110.777 -178.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -124.23 159.82 18.84 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.617 -0.802 . . . . 12.220000000000001 113.048 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.2 p -116.17 143.97 24.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.196 0.522 . . . . 13.74 110.541 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . 0.429 HG21 HD13 ' A' ' 201' ' ' LEU . 39.6 t -80.03 106.79 11.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.218 -0.901 . . . . 12.890000000000001 110.343 -176.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 24.3 mmt -121.04 155.63 33.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.017 -0.538 . . . . 13.800000000000001 110.567 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -82.19 129.62 9.18 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.404 -0.903 . . . . 13.359999999999999 111.992 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.568 ' HB2' HG13 ' A' ' 145' ' ' VAL . 8.6 t80 . . . . . 0 C--N 1.314 -0.964 0 C-N-CA 124.164 0.986 . . . . 14.24 109.975 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.517 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 108.338 -0.986 . . . . 14.65 108.338 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.695 ' CB ' HD21 ' A' ' 197' ' ' LEU . 3.3 m-85 -143.85 152.7 41.51 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.824 -0.351 . . . . 14.81 111.695 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.909 HG12 ' HA ' ' A' ' 190' ' ' PRO . 12.5 m -149.2 156.23 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.273 0.629 . . . . 10.48 109.846 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.411 HG21 HD13 ' A' ' 204' ' ' LEU . 60.9 t -109.7 109.55 28.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 O-C-N 121.84 -0.537 . . . . 10.1 111.111 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -86.71 109.55 19.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.566 -0.288 . . . . 12.0 111.478 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 1.04 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -88.97 -34.86 16.72 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.141 0.496 . . . . 11.880000000000001 109.965 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.02 161.56 28.12 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.499 -0.773 . . . . 11.35 112.457 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -161.44 101.49 1.2 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.316 -0.624 . . . . 13.470000000000001 109.316 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.75 164.18 28.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.808 -0.633 . . . . 13.52 110.332 -173.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 49.5 mtpt -105.71 0.55 26.36 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.032 -0.985 . . . . 17.600000000000001 109.782 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -97.79 108.33 21.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.231 -0.895 . . . . 16.140000000000001 109.373 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.53 -21.44 66.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.995 0.426 . . . . 14.039999999999999 110.876 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.88 -36.79 70.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.653 0.739 . . . . 16.57 110.036 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.524 ' N ' ' HD2' ' A' ' 156' ' ' LYS . 2.0 mptp? -83.87 -27.22 28.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.784 -1.098 . . . . 16.399999999999999 110.354 -178.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.65 -37.66 76.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.354 0.597 . . . . 12.67 109.801 174.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -68.99 -34.12 74.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.335 -0.848 . . . . 15.32 111.512 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.616 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.7 pt-20 -82.91 -21.35 34.23 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.964 -0.294 . . . . 15.970000000000001 111.589 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 156' ' ' LYS . 48.3 mt -85.06 -50.66 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.322 0.582 . . . . 12.6 110.046 174.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.1 -41.74 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.71 -0.677 . . . . 12.539999999999999 111.162 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.26 -25.27 62.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.868 -0.682 . . . . 14.800000000000001 112.462 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.616 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 13.5 mptt -78.09 -61.05 2.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.645 0.259 . . . . 16.050000000000001 110.595 176.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.68 ' HB3' HG21 ' A' ' 171' ' ' VAL . 2.4 mm? -78.18 -48.47 15.8 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.603 0.594 . . . . 12.99 112.603 -173.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.42 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 41.8 ttt180 -77.87 -26.01 49.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.911 -0.774 . . . . 15.06 108.911 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.15 -25.54 74.46 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.033 -0.985 . . . . 16.600000000000001 111.657 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.84 3.96 54.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.054 0.454 . . . . 16.140000000000001 110.65 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.87 22.11 47.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.901 -0.666 . . . . 15.119999999999999 113.701 174.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -89.11 156.85 18.56 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 117.493 0.647 . . . . 15.49 110.027 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.407 ' HB3' ' HD2' ' A' ' 190' ' ' PRO . 24.1 mmt180 -67.69 96.83 0.58 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.751 -0.463 . . . . 13.869999999999999 109.751 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.792 HG22 HG22 ' A' ' 188' ' ' VAL . 3.6 t -139.09 125.97 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 CA-C-N 115.546 -0.752 . . . . 10.82 110.2 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.489 ' CE1' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -138.63 175.68 9.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.608 -0.723 . . . . 11.130000000000001 110.462 173.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.3 p -115.68 -176.36 2.91 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.758 -1.11 . . . . 11.52 111.733 -168.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.626 ' HB2' ' H ' ' A' ' 185' ' ' ARG . 22.9 t -53.03 134.74 48.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.957 -0.565 . . . . 12.75 110.384 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -31.06 -55.31 0.23 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 125.198 3.932 . . . . 14.640000000000001 115.542 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.4 t -81.11 -64.39 1.2 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 119.75 -0.78 . . . . 16.68 112.574 -169.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 55.7 m -169.09 130.41 1.06 Allowed Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 118.028 0.376 . . . . 16.039999999999999 111.791 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.558 ' HB3' HG21 ' A' ' 184' ' ' THR . 52.3 Cg_exo -65.26 122.62 10.39 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.347 2.032 . . . . 14.220000000000001 112.125 162.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.408 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.8 p -154.91 156.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.303 -0.628 . . . . 16.129999999999999 109.303 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -77.65 127.75 32.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.07 0.462 . . . . 16.699999999999999 110.691 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.02 -26.47 15.3 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.51 -0.768 . . . . 16.98 111.819 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.6 OUTLIER -108.62 167.41 10.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.24 -0.652 . . . . 18.73 109.24 176.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.2 tp -81.51 118.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.553 0.692 . . . . 14.82 111.073 -175.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 178' ' ' PRO . 28.8 m -111.76 105.19 13.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.729 -0.669 . . . . 12.779999999999999 109.896 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.626 ' H ' ' HB2' ' A' ' 174' ' ' SER . 81.0 mtt-85 -84.61 144.44 28.61 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.332 -0.849 . . . . 13.98 110.156 176.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.57 ' C ' HD23 ' A' ' 187' ' ' LEU . 3.0 mm -115.74 117.83 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 108.698 -0.852 . . . . 10.56 108.698 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.57 HD23 ' C ' ' A' ' 186' ' ' ILE . 0.1 OUTLIER -129.94 128.16 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.748 0.785 . . . . 10.1 112.131 -175.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.04 HG23 HD21 ' A' ' 148' ' ' LEU . 55.1 t -95.45 146.37 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 114.205 -1.361 . . . . 9.7400000000000002 110.278 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 72.97 46.61 28.05 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.333 -0.849 . . . . 9.7599999999999998 114.203 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.909 ' HA ' HG12 ' A' ' 145' ' ' VAL . 11.3 Cg_endo -61.72 125.53 16.89 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 119.83 1.815 . . . . 11.15 110.52 170.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -159.48 154.71 25.26 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.927 -0.578 . . . . 12.77 109.877 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -100.49 2.39 42.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.062 -0.517 . . . . 14.6 111.725 -174.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.11 98.3 6.1 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.563 0.697 . . . . 14.300000000000001 110.759 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.487 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 18.4 ptmt -58.88 -39.6 81.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.551 -1.204 . . . . 15.970000000000001 112.557 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -67.41 -42.85 82.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.227 0.537 . . . . 15.6 110.393 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -62.9 -41.28 99.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.116 -0.947 . . . . 14.220000000000001 110.599 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.695 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -85.78 -16.79 37.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.865 -0.607 . . . . 11.949999999999999 111.085 -177.293 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 4.8 tppp? -64.04 -32.07 73.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.491 0.663 . . . . 14.699999999999999 110.023 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -83.88 -13.2 75.56 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.648 -0.981 . . . . 13.09 110.648 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 46.0 m -79.77 -9.17 59.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.008 -0.596 . . . . 12.109999999999999 111.523 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 9.8 mt -74.27 -37.25 63.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.939 0.399 . . . . 12.720000000000001 110.485 -176.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.41 -34.84 91.03 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.001 -0.618 . . . . 14.66 112.123 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.63 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 11.6 pt-20 -86.1 -19.84 29.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.797 0.332 . . . . 13.890000000000001 110.65 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 146' ' ' VAL . 5.3 tt -65.25 -42.98 92.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 12.550000000000001 111.209 -175.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.442 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 58.8 pttt -61.72 -17.63 56.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.058 -0.519 . . . . 15.83 111.414 176.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -36.83 15.4 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.901 0.381 . . . . 16.969999999999999 109.993 172.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.6 mt -68.84 -52.16 32.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 13.890000000000001 110.6 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.636 ' HA ' HD11 ' A' ' 164' ' ' LEU . 3.8 m -101.92 -43.38 5.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.654 -0.703 . . . . 13.539999999999999 111.298 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 75.13 -2.45 51.41 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.554 -0.748 . . . . 14.67 111.816 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 40.7 mt -80.02 149.49 30.72 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.084 -0.71 . . . . 13.039999999999999 109.084 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.2 t -89.7 104.86 17.39 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.73 -0.47 . . . . 14.84 109.73 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.563 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -125.53 157.08 19.53 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.416 -0.897 . . . . 12.220000000000001 113.492 -174.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.96 143.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.109 0.48 . . . . 13.74 110.276 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 43.5 t -77.83 106.14 7.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.303 -0.862 . . . . 12.890000000000001 109.955 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 22.7 mmt -115.73 146.78 41.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.765 -0.652 . . . . 13.800000000000001 110.209 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -74.13 134.34 18.18 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.445 -0.883 . . . . 13.359999999999999 111.621 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.545 ' HB2' HG13 ' A' ' 145' ' ' VAL . 7.9 t80 . . . . . 0 C--N 1.308 -1.227 0 CA-C-O 121.536 0.684 . . . . 14.24 110.26 -175.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . . . . . . 0 CA--C 1.515 -0.395 0 N-CA-C 110.386 -0.228 . . . . 14.65 110.386 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.698 ' CD1' ' HG3' ' A' ' 194' ' ' LYS . 7.1 m-85 -144.17 156.99 44.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.802 0.297 . . . . 14.81 111.802 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.698 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.2 t -151.07 161.03 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.303 -0.999 . . . . 10.48 108.303 170.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.45 HG12 ' HA3' ' A' ' 212' ' ' GLY . 96.1 t -106.76 110.17 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.909 -0.494 . . . . 10.1 111.574 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.577 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 26.5 tt0 -81.14 115.5 20.59 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.785 -0.189 . . . . 12.0 111.39 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 1.035 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -94.76 -33.4 12.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.385 0.612 . . . . 11.880000000000001 110.298 -179.148 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.24 163.73 28.38 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.535 -0.84 . . . . 11.35 112.468 -175.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.53 ' HB1' HD11 ' A' ' 183' ' ' ILE . . . -161.6 100.02 1.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.356 -0.609 . . . . 13.470000000000001 109.356 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -127.61 163.24 24.65 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.263 0.554 . . . . 13.52 109.796 -174.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 22.0 mtpp -102.61 -9.42 20.13 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.943 -1.026 . . . . 17.600000000000001 109.37 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -94.63 111.54 23.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.909 -1.042 . . . . 16.140000000000001 109.301 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.75 -18.34 62.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.148 0.425 . . . . 14.039999999999999 112.148 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.4 -34.83 77.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.905 0.859 . . . . 16.57 109.978 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -83.55 -17.75 40.74 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.623 -1.171 . . . . 16.399999999999999 110.124 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.707 ' HA ' HD11 ' A' ' 186' ' ' ILE . 67.4 t -76.18 -33.84 24.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.701 -0.682 . . . . 12.67 109.244 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.89 -37.6 81.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.415 -0.812 . . . . 15.32 111.054 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.688 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.8 pt-20 -75.41 -26.67 58.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.729 0.3 . . . . 15.970000000000001 111.49 -175.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.797 HD12 HD12 ' A' ' 186' ' ' ILE . 69.1 mt -85.09 -49.07 16.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.149 0.499 . . . . 12.6 110.317 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.45 -46.58 69.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.83 -0.623 . . . . 12.539999999999999 111.156 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.53 62.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.958 -0.639 . . . . 14.800000000000001 112.568 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.688 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 2.1 mptm? -85.93 -57.08 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.683 0.278 . . . . 16.050000000000001 110.896 177.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.534 ' HB3' HG21 ' A' ' 171' ' ' VAL . 2.5 mm? -79.63 -56.84 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.167 0.432 . . . . 12.99 112.167 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.531 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 68.3 ttt180 -64.6 -39.6 94.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 15.06 109.983 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.25 -25.74 71.28 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.254 -0.885 . . . . 16.600000000000001 112.698 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.46 -7.3 58.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.929 0.395 . . . . 16.140000000000001 110.517 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.3 2.42 29.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.782 -0.723 . . . . 15.119999999999999 113.284 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -79.52 151.9 30.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.039 0.419 . . . . 15.49 110.479 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -70.23 99.06 1.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.868 -0.605 . . . . 13.869999999999999 110.316 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.701 HG22 HG22 ' A' ' 188' ' ' VAL . 13.7 t -132.06 132.61 61.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.106 0.479 . . . . 10.82 111.298 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.463 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -137.29 174.86 10.15 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.331 -0.849 . . . . 11.130000000000001 110.226 170.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 18.0 p -118.6 -176.57 3.11 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.964 -1.016 . . . . 11.52 111.849 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.2 OUTLIER -52.99 148.77 13.3 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.85 -0.614 . . . . 12.75 111.867 -178.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -23.93 -65.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.556 1 C-N-CA 125.969 4.446 . . . . 14.640000000000001 115.838 -176.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.6 m -88.56 -62.77 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.294 0.85 . . . . 16.68 113.294 -170.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.0 m -166.82 132.67 1.81 Allowed Pre-proline 0 C--O 1.234 0.285 0 N-CA-C 112.449 0.537 . . . . 16.039999999999999 112.449 -171.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.526 ' HB3' HG21 ' A' ' 184' ' ' THR . 53.0 Cg_exo -63.48 124.78 14.33 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.971 2.447 . . . . 14.220000000000001 111.6 162.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.4 p -152.14 158.46 4.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.42 -0.354 . . . . 16.129999999999999 110.261 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -80.49 120.06 23.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.315 -0.402 . . . . 16.699999999999999 110.81 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.96 -22.51 25.42 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.98 -0.629 . . . . 16.98 112.72 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -114.79 163.55 15.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.992 0.425 . . . . 18.73 110.062 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.53 HD11 ' HB1' ' A' ' 150' ' ' ALA . 10.1 tp -71.01 120.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.623 -0.717 . . . . 14.82 111.761 -173.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.526 HG21 ' HB3' ' A' ' 178' ' ' PRO . 56.8 m -114.05 105.87 13.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.754 -0.657 . . . . 12.779999999999999 109.704 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 63.5 mtt-85 -83.41 141.16 31.93 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.509 -0.769 . . . . 13.98 108.991 176.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.797 HD12 HD12 ' A' ' 160' ' ' ILE . 3.4 mt -120.91 123.57 70.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.443 -0.577 . . . . 10.56 109.443 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 147' ' ' GLN . 4.0 mp -128.73 135.92 49.87 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.324 -0.853 . . . . 10.1 110.661 -170.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 1.035 HG23 HD21 ' A' ' 148' ' ' LEU . 25.0 t -104.17 133.4 48.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.239 -0.892 . . . . 9.7400000000000002 110.835 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.02 47.37 5.3 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.0 -1.0 . . . . 9.7599999999999998 114.043 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.686 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -61.02 125.1 16.25 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 CA-C-N 119.68 1.74 . . . . 11.15 111.414 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -156.05 147.69 22.88 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.105 -0.498 . . . . 12.77 110.176 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.531 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -89.34 -8.99 52.08 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.559 -0.746 . . . . 14.6 111.267 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.4 t -100.67 94.44 6.1 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.449 -0.574 . . . . 14.300000000000001 109.449 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.698 ' HG3' ' CD1' ' A' ' 144' ' ' TYR . 18.1 ttmt -54.1 -41.08 67.88 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.142 -0.935 . . . . 15.970000000000001 110.101 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.07 -53.41 54.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 15.6 111.827 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -62.88 -46.21 88.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.138 0.494 . . . . 14.220000000000001 111.164 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -76.27 -20.76 57.04 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.841 -0.618 . . . . 11.949999999999999 110.864 -176.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 57.0 tptt -65.92 -39.25 90.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.448 0.642 . . . . 14.699999999999999 109.728 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.49 -11.3 85.43 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 114.984 -1.007 . . . . 13.09 110.667 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 204' ' ' LEU . 75.2 m -88.23 -8.97 54.45 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.101 -0.549 . . . . 12.109999999999999 112.377 -175.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 33.1 mt -68.34 -37.28 80.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.799 0.333 . . . . 12.720000000000001 110.956 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.05 -43.8 96.71 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.926 -0.654 . . . . 14.66 111.882 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 13.6 pt-20 -83.47 -18.03 39.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.795 0.331 . . . . 13.890000000000001 110.935 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 207' ' ' LEU . 15.2 tp -74.44 -34.74 63.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.086 0.47 . . . . 12.550000000000001 110.306 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 7.6 mtmp? -66.82 -15.63 63.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.775 -0.648 . . . . 15.83 110.015 174.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.01 -36.01 17.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.851 -0.613 . . . . 16.969999999999999 109.413 172.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 204' ' ' LEU . 66.3 mt -68.88 -51.4 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.787 -0.642 . . . . 13.890000000000001 111.127 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.463 ' HA ' HD11 ' A' ' 164' ' ' LEU . 22.2 p -102.67 -47.82 4.31 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.383 -0.527 . . . . 13.539999999999999 111.139 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 75.37 -0.17 60.6 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.824 -0.626 . . . . 14.67 112.183 -176.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.573 ' HB3' ' HB3' ' A' ' 148' ' ' LEU . 7.3 mp -74.92 158.98 32.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 110.048 -0.353 . . . . 13.039999999999999 110.048 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 57.1 p -77.09 93.35 3.86 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.082 -0.508 . . . . 14.84 110.44 -175.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -112.78 137.63 14.38 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.349 -0.929 . . . . 12.220000000000001 114.279 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 16.9 t -101.75 137.94 27.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.287 -0.634 . . . . 13.74 109.287 173.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 5.3 p -75.56 105.65 4.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.622 0.725 . . . . 12.890000000000001 109.936 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 91.2 mmm -117.35 133.79 55.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.869 -0.605 . . . . 13.800000000000001 110.546 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -67.74 139.31 34.71 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.526 -0.845 . . . . 13.359999999999999 111.546 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.698 ' HB2' HG23 ' A' ' 145' ' ' VAL . 9.9 t80 . . . . . 0 C--N 1.312 -1.031 0 C-N-CA 123.703 0.801 . . . . 14.24 110.423 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.55 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 110.253 -0.277 . . . . 14.65 110.253 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.571 ' HB3' HD21 ' A' ' 197' ' ' LEU . 3.3 m-85 -128.6 156.15 43.83 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.813 0.672 . . . . 14.81 112.813 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.85 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.7 t -150.49 165.75 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 108.983 -0.747 . . . . 10.48 108.983 174.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 43.9 t -105.59 113.05 41.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 O-C-N 121.75 -0.594 . . . . 10.1 110.8 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.442 ' OE1' ' HD3' ' A' ' 185' ' ' ARG . 6.4 tt0 -87.72 105.16 17.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.715 -0.221 . . . . 12.0 111.161 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.931 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -85.66 -36.27 20.39 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.343 0.592 . . . . 11.880000000000001 110.198 -176.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.47 169.59 26.4 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.251 -0.976 . . . . 11.35 112.674 -173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.32 101.27 0.35 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.288 -0.634 . . . . 13.470000000000001 109.288 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.75 154.63 47.46 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.402 0.62 . . . . 13.52 110.724 -173.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 40.6 mtmt -95.44 -3.19 47.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.88 -1.055 . . . . 17.600000000000001 109.899 -176.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -97.92 104.15 16.15 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.025 . . . . 16.140000000000001 109.362 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.77 -19.01 65.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.371 0.605 . . . . 14.039999999999999 110.551 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -59.93 -34.34 73.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.235 -0.893 . . . . 16.57 110.189 174.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -90.42 -29.12 18.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.727 -1.124 . . . . 16.399999999999999 110.405 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' THR . 93.3 t -58.48 -38.73 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.368 0.604 . . . . 12.67 109.819 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -59.75 -29.48 68.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.148 -0.933 . . . . 15.32 111.243 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.74 -62.69 1.4 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.217 0.532 . . . . 15.970000000000001 110.03 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.458 HD12 HG13 ' A' ' 186' ' ' ILE . 7.6 mt -55.25 -43.51 71.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.885 -1.052 . . . . 12.6 110.757 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.5 t -74.59 -40.19 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.689 -0.687 . . . . 12.539999999999999 110.455 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.26 -33.95 86.33 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.373 -0.918 . . . . 14.800000000000001 111.487 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -68.23 -57.43 6.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.411 -0.394 . . . . 16.050000000000001 111.497 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -85.3 -52.35 5.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.353 0.501 . . . . 12.99 112.353 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -68.31 -37.59 80.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.15 0.5 . . . . 15.06 110.221 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.09 -23.9 77.63 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.41 -0.814 . . . . 16.600000000000001 112.552 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.5 1.39 55.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.951 0.405 . . . . 16.140000000000001 110.755 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.29 23.46 34.36 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.83 -0.7 . . . . 15.119999999999999 113.396 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -89.92 154.42 19.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.955 0.378 . . . . 15.49 110.208 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.474 ' HD2' ' N ' ' A' ' 170' ' ' ARG . 8.8 mpt_? -76.55 98.34 4.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.238 -0.653 . . . . 13.869999999999999 109.238 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.97 142.01 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.155 -0.929 . . . . 10.82 109.016 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.642 ' HH ' ' HD2' ' A' ' 217' ' ' TYR . 0.1 OUTLIER -138.98 176.8 8.38 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.554 0.693 . . . . 11.130000000000001 110.712 174.152 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 23.6 p -111.21 -175.95 2.83 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.508 -1.223 . . . . 11.52 111.353 -171.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.3 OUTLIER -53.81 148.94 18.22 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.212 -0.449 . . . . 12.75 111.031 176.599 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -32.09 -61.38 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 125.126 3.884 . . . . 14.640000000000001 115.337 -173.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.1 m -87.32 -63.0 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.371 0.878 . . . . 16.68 113.371 -168.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.7 m -167.82 129.22 1.2 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 118.434 0.561 . . . . 16.039999999999999 112.356 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.465 ' HB3' HG21 ' A' ' 184' ' ' THR . 72.1 Cg_exo -59.36 124.27 15.19 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.541 2.16 . . . . 14.220000000000001 111.705 163.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.3 p -153.32 160.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 109.646 -0.502 . . . . 16.129999999999999 109.646 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -80.13 122.57 26.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.457 -0.338 . . . . 16.699999999999999 110.56 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.75 -25.77 18.05 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.888 -0.672 . . . . 16.98 112.555 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -109.35 160.7 15.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.784 -0.451 . . . . 18.73 109.784 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.0 tp -73.19 109.4 5.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.747 0.784 . . . . 14.82 111.555 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 178' ' ' PRO . 56.9 m -100.05 112.53 24.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.449 -0.796 . . . . 12.779999999999999 109.625 174.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 46.1 mtt180 -93.61 144.77 25.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.691 -0.686 . . . . 13.98 109.938 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.519 ' O ' HD22 ' A' ' 148' ' ' LEU . 5.2 mm -114.85 120.41 64.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.108 -0.701 . . . . 10.56 109.108 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.499 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.9 mp -129.42 123.01 30.55 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.208 0.528 . . . . 10.1 111.041 -174.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.931 HG23 HD21 ' A' ' 148' ' ' LEU . 33.6 t -99.58 134.97 36.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.625 -0.716 . . . . 9.7400000000000002 111.159 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 84.5 47.98 5.2 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.96 -1.018 . . . . 9.7599999999999998 113.555 173.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.83 ' HA ' HG22 ' A' ' 145' ' ' VAL . 12.7 Cg_endo -62.74 125.82 16.88 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 119.476 1.638 . . . . 11.15 110.511 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -157.26 152.4 26.06 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.325 -0.55 . . . . 12.77 110.586 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -88.74 2.62 53.11 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.608 -0.724 . . . . 14.6 111.34 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 18.2 t -118.32 97.81 5.96 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.367 0.603 . . . . 14.300000000000001 109.685 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 198' ' ' LYS . 2.9 ptmm? -57.42 -40.5 78.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.899 -1.046 . . . . 15.970000000000001 111.821 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -71.75 -46.89 57.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.803 0.335 . . . . 15.6 111.461 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -59.55 -37.21 77.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.316 0.579 . . . . 14.220000000000001 110.243 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.571 HD21 ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -84.21 -24.18 30.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.749 -0.659 . . . . 11.949999999999999 110.412 -178.241 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 14.1 tmtt? -74.82 -34.46 62.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.313 0.578 . . . . 14.699999999999999 109.652 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.17 -13.28 82.89 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.157 -1.177 . . . . 13.09 110.157 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 45.5 m -90.17 -8.59 50.82 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.354 -0.923 . . . . 12.109999999999999 111.934 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 24.3 mt -65.31 -35.21 80.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.671 0.272 . . . . 12.720000000000001 111.043 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.2 -42.62 97.28 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.791 -0.718 . . . . 14.66 111.851 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 200' ' ' SER . 9.9 pt-20 -85.91 -19.7 30.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.664 0.268 . . . . 13.890000000000001 110.584 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 19.9 tp -68.65 -28.63 67.06 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.112 0.482 . . . . 12.550000000000001 110.085 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.543 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 90.8 mttt -60.92 -16.68 44.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.41 -0.814 . . . . 15.83 110.568 173.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -89.91 -43.01 10.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.42 -0.355 . . . . 16.969999999999999 110.424 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.13 -55.52 31.5 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.51 0.671 . . . . 13.890000000000001 112.204 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 55.9 p -97.38 -44.19 6.97 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.134 -0.939 . . . . 13.539999999999999 110.854 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 72.62 1.93 54.57 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.536 -0.756 . . . . 14.67 111.802 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.446 ' HB2' ' HG ' ' A' ' 148' ' ' LEU . 70.5 mt -85.53 152.14 23.4 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.738 -0.468 . . . . 13.039999999999999 109.738 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 p -90.32 104.84 17.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.256 -0.429 . . . . 14.84 110.591 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -130.32 160.7 23.09 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.148 -1.025 . . . . 12.220000000000001 114.142 -173.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.2 t -101.45 140.59 19.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.917 -0.641 . . . . 13.74 109.383 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.01 105.15 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.732 0.777 . . . . 12.890000000000001 109.614 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 1.8 mmt -122.07 168.85 11.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.48 -0.782 . . . . 13.800000000000001 110.564 -172.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -83.48 163.46 40.79 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.476 -0.868 . . . . 13.359999999999999 112.934 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.85 ' HB2' HG23 ' A' ' 145' ' ' VAL . 6.9 t80 . . . . . 0 C--N 1.318 -0.8 0 C-N-CA 123.845 0.858 . . . . 14.24 110.166 -174.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.485 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . . . . . . 0 CA--C 1.509 -0.597 0 N-CA-C 110.37 -0.233 . . . . 14.65 110.37 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.557 ' HA ' ' H ' ' A' ' 217' ' ' TYR . 10.0 m-85 -143.95 151.17 39.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.912 0.387 . . . . 14.81 111.336 -177.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.88 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.3 t -146.81 153.11 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.58 -1.267 . . . . 10.48 107.58 170.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 17.1 t -98.23 121.73 49.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.304 -0.559 . . . . 10.1 110.815 -176.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.477 ' HG3' ' CG ' ' A' ' 185' ' ' ARG . 3.5 tt0 -83.98 101.73 11.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.579 -0.156 . . . . 12.0 110.579 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.775 HD13 ' N ' ' A' ' 212' ' ' GLY . 0.5 OUTLIER -87.58 -26.5 23.07 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.191 -0.67 . . . . 11.880000000000001 109.191 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -149.7 158.29 27.6 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.347 -0.842 . . . . 11.35 112.039 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.588 ' HB2' ' HG3' ' A' ' 185' ' ' ARG . . . -157.48 101.25 1.85 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.391 -0.596 . . . . 13.470000000000001 109.391 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -125.72 150.65 47.52 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.461 0.648 . . . . 13.52 110.296 -171.231 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 2.6 mttt -93.85 -1.84 54.29 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.738 -1.119 . . . . 17.600000000000001 108.431 176.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -104.87 107.27 18.15 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.205 -1.361 . . . . 16.140000000000001 109.238 175.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.76 -16.83 59.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.165 0.507 . . . . 14.039999999999999 111.022 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -54.98 -35.32 64.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.092 -0.958 . . . . 16.57 111.062 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.496 ' O ' HG13 ' A' ' 160' ' ' ILE . 83.6 tttt -90.53 -31.84 16.57 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.61 -0.723 . . . . 16.399999999999999 110.48 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.483 HG13 ' CD1' ' A' ' 186' ' ' ILE . 88.2 t -54.72 -43.26 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.239 -0.437 . . . . 12.67 110.472 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -62.0 -34.38 76.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.674 -0.694 . . . . 15.32 111.737 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.81 -59.05 2.9 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 120.911 0.386 . . . . 15.970000000000001 110.016 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 156' ' ' LYS . 21.8 mt -52.39 -45.07 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.846 -1.07 . . . . 12.6 110.788 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.445 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 89.6 t -71.16 -43.02 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.74 -0.663 . . . . 12.539999999999999 110.366 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.26 68.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.609 -0.805 . . . . 14.800000000000001 112.037 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -73.42 -61.79 1.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.257 0.223 . . . . 16.050000000000001 111.254 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 208' ' ' SER . 2.2 mm? -78.36 -45.8 21.6 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.415 0.524 . . . . 12.99 112.415 -174.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.476 ' HB2' ' CG1' ' A' ' 171' ' ' VAL . 25.8 ttm180 -65.17 -47.47 76.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.106 -0.702 . . . . 15.06 109.106 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.67 -20.59 68.3 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.048 -0.978 . . . . 16.600000000000001 113.456 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.2 -12.43 49.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.001 0.429 . . . . 16.140000000000001 110.385 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.41 20.86 11.32 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.937 -0.649 . . . . 15.119999999999999 113.222 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -95.74 154.91 16.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 117.337 0.568 . . . . 15.49 110.611 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -76.08 106.71 7.84 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.67 0.748 . . . . 13.869999999999999 110.151 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 165' ' ' ARG . 9.3 p -143.07 138.15 26.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.391 -1.277 . . . . 10.82 109.141 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.518 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.37 176.18 8.98 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.35 0.595 . . . . 11.130000000000001 110.583 171.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 24.8 p -105.78 -177.33 3.33 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.915 -1.039 . . . . 11.52 110.064 -174.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.23 142.73 36.96 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.305 -0.258 . . . . 12.75 110.305 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -38.92 -47.12 2.81 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 124.25 3.3 . . . . 14.640000000000001 115.145 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.9 t -85.74 -61.98 1.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 120.231 -0.588 . . . . 16.68 112.41 -171.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.8 m -167.65 137.66 2.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.607 0.595 . . . . 16.039999999999999 112.607 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.414 ' HB3' HG21 ' A' ' 184' ' ' THR . 30.6 Cg_exo -67.14 125.23 13.24 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.765 2.31 . . . . 14.220000000000001 111.315 160.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.563 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 8.8 p -145.63 152.33 14.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.092 0.472 . . . . 16.129999999999999 110.6 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -81.78 123.52 28.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 16.699999999999999 111.101 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 100.2 -12.1 60.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.836 -0.697 . . . . 16.98 112.612 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.563 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -123.31 161.5 24.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.301 -0.629 . . . . 18.73 109.301 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.8 tp -66.3 111.57 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.622 0.725 . . . . 14.82 111.858 -172.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.414 HG21 ' HB3' ' A' ' 178' ' ' PRO . 87.4 m -109.2 117.16 33.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.372 -0.603 . . . . 12.779999999999999 109.372 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.588 ' HG3' ' HB2' ' A' ' 150' ' ' ALA . 25.2 ttm180 -93.92 140.05 30.17 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.503 -0.771 . . . . 13.98 110.171 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.542 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.9 mm -109.31 115.53 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.417 -0.586 . . . . 10.56 109.417 176.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 4.8 mp -121.57 118.02 28.22 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.554 0.692 . . . . 10.1 110.824 -171.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.44 HG12 HD11 ' A' ' 204' ' ' LEU . 27.7 t -95.71 135.3 30.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 114.834 -1.075 . . . . 9.7400000000000002 110.61 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.19 48.93 5.49 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.248 -0.887 . . . . 9.7599999999999998 113.627 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.718 ' HA ' HG22 ' A' ' 145' ' ' VAL . 12.3 Cg_endo -63.84 125.3 15.11 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 CA-C-N 119.525 1.663 . . . . 11.15 111.05 174.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -156.88 161.12 39.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.001 -0.545 . . . . 12.77 110.102 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -102.73 0.09 32.41 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.943 -0.571 . . . . 14.6 111.363 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 28.5 p -113.61 95.91 5.59 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.575 0.702 . . . . 14.300000000000001 110.13 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.426 ' HG3' ' CD2' ' A' ' 144' ' ' TYR . 31.6 ttpt -56.7 -53.62 55.58 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.062 -0.972 . . . . 15.970000000000001 111.146 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -61.76 -32.04 72.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.833 0.349 . . . . 15.6 111.686 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -73.39 -41.83 62.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.098 0.475 . . . . 14.220000000000001 110.539 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -82.66 -19.86 37.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.246 0.546 . . . . 11.949999999999999 110.649 -178.123 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 55.7 tptt -67.15 -36.39 81.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.835 -0.621 . . . . 14.699999999999999 110.455 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.61 -12.25 83.11 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.43 -1.068 . . . . 13.09 110.43 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 67.2 m -84.66 -8.08 59.0 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.873 -0.664 . . . . 12.109999999999999 111.902 -176.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 14.6 mt -70.58 -36.33 73.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 12.720000000000001 110.611 -177.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.7 92.65 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.987 -0.625 . . . . 14.66 112.219 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.422 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 12.8 pt-20 -85.79 -17.34 36.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.955 0.407 . . . . 13.890000000000001 110.441 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.44 HD11 HG12 ' A' ' 188' ' ' VAL . 17.6 tp -69.14 -34.91 75.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.278 -0.419 . . . . 12.550000000000001 111.438 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -63.72 -16.06 60.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.955 0.407 . . . . 15.83 110.604 173.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.442 ' N ' ' HD3' ' A' ' 205' ' ' LYS . 0.8 OUTLIER -88.93 -36.39 15.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.058 -0.519 . . . . 16.969999999999999 109.687 172.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 93.1 mt -71.47 -52.31 19.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.661 -0.699 . . . . 13.890000000000001 111.499 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.412 ' HB3' HD11 ' A' ' 164' ' ' LEU . 63.0 p -98.14 -43.6 6.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.397 0.618 . . . . 13.539999999999999 111.04 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.34 0.01 55.97 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.241 -0.89 . . . . 14.67 111.322 -174.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 148' ' ' LEU . 97.1 mt -80.0 162.23 24.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.701 -0.851 . . . . 13.039999999999999 108.701 175.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.0 m -111.41 109.46 19.44 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.201 0.445 . . . . 14.84 112.201 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.775 ' N ' HD13 ' A' ' 148' ' ' LEU . . . -121.9 173.67 15.87 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.844 -0.693 . . . . 12.220000000000001 114.17 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.4 p -117.1 146.39 21.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.839 -0.68 . . . . 13.74 109.267 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 25.6 t -82.35 115.33 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.905 -0.589 . . . . 12.890000000000001 110.505 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 74.8 mtp -125.96 149.83 48.47 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.123 0.487 . . . . 13.800000000000001 110.67 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.39 128.56 9.41 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.706 -0.759 . . . . 13.359999999999999 112.549 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.88 ' HB2' HG23 ' A' ' 145' ' ' VAL . 8.1 t80 . . . . . 0 C--N 1.311 -1.071 0 CA-C-N 114.574 -0.813 . . . . 14.24 109.083 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 121.602 0.715 . . . . 18.390000000000001 110.207 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 69' ' ' GLU . . . -130.33 159.99 22.92 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.691 -0.686 . . . . 17.77 111.713 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -78.01 -20.43 52.55 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.152 -0.684 . . . . 17.690000000000001 109.152 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -132.37 105.48 7.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.125 -0.943 . . . . 19.93 109.57 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 26.3 tptp -62.35 -49.9 73.74 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.084 -0.71 . . . . 17.43 109.084 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.554 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 31.8 t-80 165.05 -65.5 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.514 -1.291 . . . . 19.359999999999999 107.514 174.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.507 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 31.9 t80 -175.59 100.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.693 -1.14 . . . . 18.960000000000001 108.248 173.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 74.8 mt-30 72.87 178.65 0.23 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.821 0.701 . . . . 18.239999999999998 110.002 -171.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -96.92 113.81 25.37 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.924 -0.399 . . . . 16.780000000000001 109.924 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -95.0 140.13 30.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.398 0.618 . . . . 18.420000000000002 111.23 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -147.04 -39.24 0.2 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.31 -0.859 . . . . 17.920000000000002 109.063 172.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.67 137.94 37.22 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.483 -0.78 . . . . 19.550000000000001 110.148 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 60.11 64.31 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.661 0.601 . . . . 20.309999999999999 112.042 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 pt -125.81 78.2 69.62 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.0 -0.545 . . . . 19.920000000000002 110.235 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.21 56.18 3.12 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.175 2.583 . . . . 21.640000000000001 112.09 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 60.25 32.12 20.69 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.718 -0.674 . . . . 22.670000000000002 110.402 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.609 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 96.0 t -87.87 -50.81 0.42 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.376 -0.829 . . . . 21.34 111.235 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.609 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 7.2 Cg_exo -75.2 173.6 14.23 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 121.618 1.545 . . . . 20.0 111.148 173.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.68 -46.86 87.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.207 0.527 . . . . 21.079999999999998 110.337 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.08 -31.8 1.25 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.842 -0.617 . . . . 18.800000000000001 110.959 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.23 -75.35 1.57 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.377 -0.689 . . . . 17.510000000000002 111.377 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.84 125.54 23.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.117 -0.327 . . . . 16.949999999999999 110.117 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -64.64 120.36 12.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.202 -0.454 . . . . 18.300000000000001 111.062 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.473 ' O ' HD22 ' A' ' 63' ' ' LEU . 16.6 t70 -76.73 111.61 12.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 18.170000000000002 109.673 178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.34 145.98 41.23 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.78 -0.646 . . . . 18.82 111.858 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.425 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 73.9 Cg_endo -77.73 -30.21 3.99 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.431 2.754 . . . . 19.870000000000001 114.237 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -174.34 112.04 0.16 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.443 -0.344 . . . . 21.100000000000001 111.188 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.5 ptp 176.63 -46.98 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.599 0.562 . . . . 22.300000000000001 110.332 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.554 ' HB3' ' HD3' ' A' ' 57' ' ' PRO . 60.1 ttp -144.25 -49.07 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.369 -0.378 . . . . 23.850000000000001 110.997 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 56' ' ' MET . 3.8 Cg_exo -78.52 94.05 1.08 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.787 1.658 . . . . 20.670000000000002 110.798 175.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.485 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . . . 64.95 179.61 0.18 Allowed 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.917 0.76 . . . . 20.489999999999998 110.785 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.93 151.51 44.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.98 0.419 . . . . 21.469999999999999 111.967 -174.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.4 m 70.94 -75.7 0.07 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.091 -0.959 . . . . 22.600000000000001 111.84 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.637 HE21 ' HA ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -122.96 72.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.635 0.731 . . . . 21.93 110.223 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 58' ' ' ALA . . . -92.5 -25.11 18.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.585 -0.734 . . . . 19.73 109.917 175.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 51' ' ' ASP . 44.0 tp -141.47 102.75 6.0 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.363 -0.835 . . . . 19.579999999999998 110.049 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -49.57 -39.72 45.92 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.26 2.64 . . . . 18.5 112.137 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m 61.81 91.64 0.06 Allowed 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.571 0.544 . . . . 17.609999999999999 111.465 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.642 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 7.8 tp-100 -91.44 -50.22 0.32 Allowed Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 120.813 -0.355 . . . . 18.760000000000002 110.391 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 66' ' ' GLN . 2.0 Cg_endo -87.25 153.07 8.06 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.482 2.121 . . . . 17.280000000000001 110.279 167.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.25 -19.18 66.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.079 2.519 . . . . 17.77 113.531 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 29' ' ' GLY . 12.1 tp10 62.51 -81.61 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.842 0.714 . . . . 18.699999999999999 111.017 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.89 -59.71 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.981 -0.628 . . . . 17.719999999999999 111.96 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 66.43 -71.06 0.1 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.369 0.668 . . . . 18.0 110.841 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -170.71 -55.05 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.89 -0.596 . . . . 17.960000000000001 109.849 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 67.36 -74.33 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.186 0.929 . . . . 19.850000000000001 111.153 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.53 -62.84 0.09 Allowed 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.324 -0.991 . . . . 19.670000000000002 108.324 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.6 t -96.59 91.3 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.078 -0.712 . . . . 17.739999999999998 109.078 172.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -66.55 -57.94 6.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.39 -0.823 . . . . 19.949999999999999 110.525 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.53 -75.67 0.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.309 -0.405 . . . . 18.390000000000001 110.716 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -98.61 52.17 1.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.959 -0.638 . . . . 17.66 111.528 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -98.97 122.48 42.28 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.105 -0.331 . . . . 17.68 110.105 -177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 67.04 -77.79 0.04 OUTLIER 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.961 0.788 . . . . 17.800000000000001 110.822 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 50.46 51.87 15.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.173 0.511 . . . . 17.350000000000001 111.199 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.33 123.89 22.64 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.848 -0.614 . . . . 16.640000000000001 111.004 -174.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.8 129.17 33.54 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.887 2.391 . . . . 17.23 111.881 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 m -84.06 -32.08 25.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.141 -0.481 . . . . 17.34 111.313 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.4 mt -84.08 -51.85 6.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.812 0.339 . . . . 18.41 110.684 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -83.82 115.16 58.37 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.005 -0.543 . . . . 17.449999999999999 110.833 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.88 -31.07 25.49 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.57 2.18 . . . . 18.890000000000001 111.585 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.27 92.94 1.01 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.652 -0.703 . . . . 17.809999999999999 109.825 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.5 m -59.51 -36.11 75.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.999 -0.546 . . . . 18.629999999999999 111.738 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 pt -77.87 -7.22 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.855 0.317 . . . . 19.100000000000001 111.855 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -113.94 -38.08 4.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.08 0.467 . . . . 19.25 110.878 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.93 -156.02 0.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.857 -0.61 . . . . 18.789999999999999 109.764 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER 68.07 -140.4 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.581 -0.282 . . . . 18.949999999999999 111.088 176.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.419 ' H ' ' HB3' ' A' ' 93' ' ' ASN . 22.1 t-20 -75.6 2.75 11.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.24 0.543 . . . . 20.309999999999999 111.403 -173.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.8 m -60.34 -35.43 75.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.918 -0.583 . . . . 21.399999999999999 110.391 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -142.53 30.72 1.51 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.973 -0.558 . . . . 21.16 110.351 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 63.83 88.53 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.178 -0.919 . . . . 22.18 111.369 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -119.8 88.39 39.75 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.701 -0.681 . . . . 19.449999999999999 109.916 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -91.24 133.99 1.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.49 2.793 . . . . 18.530000000000001 112.445 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.514 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 7.4 mp0 -84.14 -51.33 0.6 Allowed Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.445 -0.343 . . . . 17.449999999999999 111.89 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 100' ' ' GLU . 25.7 Cg_exo -64.3 -47.71 5.68 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.013 1.809 . . . . 17.420000000000002 112.483 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -123.48 79.03 54.53 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.435 -0.348 . . . . 17.68 110.815 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.54 140.42 91.16 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 123.05 2.5 . . . . 16.289999999999999 112.301 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.6 m -82.16 67.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.402 0.62 . . . . 17.260000000000002 111.042 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.75 144.95 88.96 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.537 -0.756 . . . . 15.800000000000001 111.125 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.419 ' HB2' ' HD3' ' A' ' 107' ' ' PRO . 56.3 Cg_exo -48.15 -51.29 10.3 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.881 2.387 . . . . 15.92 114.684 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 108' ' ' LYS . 46.8 Cg_exo -55.92 162.97 6.3 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.207 1.938 . . . . 16.149999999999999 113.31 -176.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 107' ' ' PRO . 75.4 mmtt 76.05 118.92 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.428 -0.806 . . . . 17.629999999999999 110.784 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.97 116.57 4.38 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.708 2.272 . . . . 15.039999999999999 112.047 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -140.31 118.65 8.4 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.82 -0.627 . . . . 15.199999999999999 110.639 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.02 165.04 17.46 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.387 2.058 . . . . 14.08 112.042 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.72 51.0 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 122.306 1.05 . . . . 15.279999999999999 108.993 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 61.35 85.49 0.17 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 114.211 -1.359 . . . . 16.84 110.35 -173.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.44 156.81 58.27 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.174 2.583 . . . . 15.51 112.087 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.81 58.17 5.92 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.133 2.556 . . . . 16.039999999999999 112.182 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 40.7 ttmt -70.66 -52.86 10.15 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.972 -0.558 . . . . 18.91 111.667 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 116' ' ' LYS . 29.9 Cg_endo -63.33 -33.24 71.18 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.163 1.909 . . . . 17.039999999999999 112.401 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.83 128.9 4.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 17.52 109.889 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 119' ' ' VAL . 5.7 p -115.52 101.74 12.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.385 0.612 . . . . 18.699999999999999 110.499 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.44 ' HG3' ' HA ' ' A' ' 203' ' ' GLU . 2.3 mp0 54.61 55.44 7.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.833 . . . . 20.879999999999999 110.718 -175.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.2 113.26 49.31 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.792 -0.64 . . . . 18.890000000000001 109.801 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.79 117.33 4.94 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.428 2.085 . . . . 20.43 111.76 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.81 114.2 1.97 Allowed 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 122.443 2.095 . . . . 21.100000000000001 111.518 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . . . -61.97 -50.38 81.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.961 -0.563 . . . . 21.149999999999999 110.382 176.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 124' ' ' ALA . 90.5 Cg_endo -86.44 142.2 7.04 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.575 1.516 . . . . 21.149999999999999 110.731 167.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -86.31 110.69 33.32 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.576 0.227 . . . . 21.879999999999999 110.399 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.75 139.77 15.97 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.446 2.097 . . . . 20.190000000000001 112.001 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -125.99 76.03 71.59 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.101 -0.5 . . . . 20.48 110.154 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.03 76.28 3.85 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.857 2.371 . . . . 21.170000000000002 111.074 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm 70.2 115.69 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.26 0 O-C-N 124.026 0.829 . . . . 23.18 110.293 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.17 133.11 46.23 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.777 2.318 . . . . 20.780000000000001 111.783 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.2 m -82.58 47.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.598 0.713 . . . . 19.75 111.491 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.9 m -89.8 17.62 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.193 -0.912 . . . . 21.050000000000001 110.26 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.85 -174.87 2.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.064 -0.971 . . . . 21.300000000000001 108.945 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 52.4 mt-10 -77.48 -81.32 0.09 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.513 -0.475 . . . . 20.739999999999998 109.768 177.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 135' ' ' GLU . 67.5 mttm 76.89 117.61 0.06 Allowed 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 124.089 0.868 . . . . 17.969999999999999 109.986 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . 65.49 -82.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.851 -1.068 . . . . 17.350000000000001 108.516 -164.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . . . 174.55 145.08 0.21 Allowed Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 123.921 0.763 . . . . 19.100000000000001 110.103 170.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 138' ' ' ALA . 12.5 Cg_exo -70.19 110.64 2.69 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.78 2.32 . . . . 19.350000000000001 111.271 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 28.0 m 76.87 -20.03 0.39 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.638 0.586 . . . . 17.75 111.17 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.06 -76.54 0.74 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.122 -0.561 . . . . 17.960000000000001 112.368 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.466 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 60.8 mttp -104.06 58.08 0.72 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.432 0.634 . . . . 19.420000000000002 110.777 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.499 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . -78.32 165.32 24.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.115 -0.948 . . . . 14.65 109.875 177.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.654 ' CE1' ' HG3' ' A' ' 194' ' ' LYS . 5.4 m-85 -137.55 156.51 48.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.162 0.43 . . . . 14.81 112.162 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.5 m -152.5 151.33 12.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.348 -0.842 . . . . 10.48 109.717 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.463 HG12 ' HA3' ' A' ' 212' ' ' GLY . 60.2 t -110.82 110.92 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 10.1 111.423 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.608 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 54.6 tt0 -84.85 113.52 21.42 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.516 -0.311 . . . . 12.0 111.688 -176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -92.01 -34.55 14.38 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.989 0.423 . . . . 11.880000000000001 110.341 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.62 174.21 25.69 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.189 -1.005 . . . . 11.35 112.855 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.557 ' HB2' HE21 ' A' ' 147' ' ' GLN . . . -170.76 103.39 0.24 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.636 -0.505 . . . . 13.470000000000001 109.636 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.81 157.07 43.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.304 0.573 . . . . 13.52 110.695 -175.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 86.1 mttt -98.12 14.3 28.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.134 -0.939 . . . . 17.600000000000001 110.612 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.432 ' OD1' ' HG3' ' A' ' 156' ' ' LYS . 4.1 t-20 -112.73 106.22 14.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.564 -0.744 . . . . 16.140000000000001 109.348 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.72 -26.48 68.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.901 0.381 . . . . 14.039999999999999 111.426 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.72 -38.87 76.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.539 0.685 . . . . 16.57 110.044 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.443 ' HA ' ' OE1' ' A' ' 159' ' ' GLU . 68.8 mttm -79.27 -33.44 43.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.671 -1.149 . . . . 16.399999999999999 110.292 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 184' ' ' THR . 79.6 t -58.02 -44.58 87.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.63 -0.714 . . . . 12.67 110.288 175.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -62.11 -30.43 71.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.299 -0.864 . . . . 15.32 110.823 -177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.576 ' O ' ' HG2' ' A' ' 163' ' ' LYS . 24.4 mt-10 -69.39 -61.95 1.58 Allowed 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 120.906 0.384 . . . . 15.970000000000001 110.167 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.428 HD12 HG13 ' A' ' 186' ' ' ILE . 27.8 mt -51.5 -46.22 35.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.045 -0.979 . . . . 12.6 111.143 -175.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.8 t -73.11 -34.51 45.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.724 -0.671 . . . . 12.539999999999999 110.288 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.8 -32.4 82.76 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.786 -0.721 . . . . 14.800000000000001 112.117 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 159' ' ' GLU . 48.7 mmtt -67.78 -51.05 53.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.266 0.555 . . . . 16.050000000000001 109.657 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.622 ' HB3' HG21 ' A' ' 171' ' ' VAL . 20.9 mt -87.03 -56.01 3.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.899 1.074 . . . . 12.99 113.899 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.407 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 47.2 ttp180 -70.13 -29.27 66.16 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.69 -0.855 . . . . 15.06 108.69 -174.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.7 -24.98 76.03 Favored Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 114.834 -1.076 . . . . 16.600000000000001 111.851 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.74 -5.05 59.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.213 0.53 . . . . 16.140000000000001 110.549 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.0 24.77 16.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.797 -0.716 . . . . 15.119999999999999 113.261 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -94.04 155.39 17.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 117.307 0.554 . . . . 15.49 110.783 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -71.63 98.24 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.621 -0.511 . . . . 13.869999999999999 109.621 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.799 HG22 HG22 ' A' ' 188' ' ' VAL . 6.7 t -133.17 125.69 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-N 115.589 -0.732 . . . . 10.82 111.123 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -135.33 175.24 9.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.265 -0.879 . . . . 11.130000000000001 110.602 176.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.4 p -117.09 -175.91 2.88 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.844 -1.071 . . . . 11.52 111.926 -169.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.78 153.65 5.62 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.633 -0.712 . . . . 12.75 111.598 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -42.13 -67.15 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.065 3.177 . . . . 14.640000000000001 115.19 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.1 m -76.55 -63.08 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.768 0.655 . . . . 16.68 112.768 -167.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.1 m -169.42 130.33 1.01 Allowed Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 112.226 0.454 . . . . 16.039999999999999 112.226 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.515 ' HB3' HG21 ' A' ' 184' ' ' THR . 50.1 Cg_exo -63.28 124.6 14.12 Favored 'Trans proline' 0 CA--C 1.519 -0.265 0 C-N-CA 122.771 2.314 . . . . 14.220000000000001 111.927 162.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.9 p -153.45 153.51 8.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.557 -0.534 . . . . 16.129999999999999 109.557 176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -70.44 122.09 18.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.979 -0.555 . . . . 16.699999999999999 110.73 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.46 -26.45 14.71 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.621 -0.718 . . . . 16.98 112.407 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 13.2 mptt -108.18 156.28 19.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.961 0.41 . . . . 18.73 110.677 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.9 tp -71.2 117.28 14.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.681 -0.69 . . . . 14.82 111.462 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 178' ' ' PRO . 38.0 m -111.54 112.45 24.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.635 -0.711 . . . . 12.779999999999999 110.188 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 91.1 mtt180 -86.84 144.99 26.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.923 -0.581 . . . . 13.98 109.571 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.635 ' C ' HD12 ' A' ' 187' ' ' LEU . 5.2 mm -113.11 124.05 69.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.297 -0.631 . . . . 10.56 109.297 178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.6 mp -129.15 129.08 44.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.487 0.661 . . . . 10.1 111.241 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 148' ' ' LEU . 39.8 t -100.58 142.18 16.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.991 -1.004 . . . . 9.7400000000000002 110.401 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.15 49.96 11.5 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.34 -0.845 . . . . 9.7599999999999998 113.932 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.674 ' HA ' HG12 ' A' ' 145' ' ' VAL . 13.7 Cg_endo -63.77 124.83 14.28 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 CA-C-N 119.915 1.857 . . . . 11.15 110.273 168.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.422 ' HB3' HD22 ' A' ' 197' ' ' LEU . 5.9 t70 -162.94 150.35 13.27 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.91 -0.586 . . . . 12.77 109.593 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.499 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -91.32 -9.3 45.47 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.919 -0.582 . . . . 14.6 110.944 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.3 t -97.37 102.32 14.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.173 0.511 . . . . 14.300000000000001 110.312 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.654 ' HG3' ' CE1' ' A' ' 144' ' ' TYR . 19.8 ttmt -64.54 -42.85 95.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.702 -0.681 . . . . 15.970000000000001 110.204 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.77 -51.91 67.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.127 0.489 . . . . 15.6 111.208 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -63.53 -51.47 65.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.602 -0.726 . . . . 14.220000000000001 111.431 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 191' ' ' ASP . 0.1 OUTLIER -87.01 -37.71 17.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.014 0.746 . . . . 11.949999999999999 113.014 -169.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.53 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 14.5 tmtt? -80.95 -20.51 41.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.499 0.666 . . . . 14.699999999999999 109.69 -168.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -82.84 -12.43 79.83 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.312 -1.115 . . . . 13.09 110.312 172.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 32.0 m -90.39 -7.62 52.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.825 -0.688 . . . . 12.109999999999999 112.547 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 15.8 mt -59.33 -36.58 75.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.592 0.234 . . . . 12.720000000000001 111.392 -174.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -56.97 -46.69 90.92 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.909 -0.663 . . . . 14.66 112.189 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.44 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . 11.9 pt-20 -84.37 -16.87 41.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.686 0.279 . . . . 13.890000000000001 110.701 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.538 HD12 HD12 ' A' ' 207' ' ' LEU . 2.6 tp -66.66 -26.95 67.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.048 0.451 . . . . 12.550000000000001 110.502 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.546 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 70.6 mmtt -61.08 -17.58 53.28 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.198 -0.455 . . . . 15.83 110.524 172.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -39.74 12.54 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.349 0.595 . . . . 16.969999999999999 109.521 170.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.538 HD12 HD12 ' A' ' 204' ' ' LEU . 84.5 mt -61.85 -52.95 62.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.227 -0.897 . . . . 13.890000000000001 111.642 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 23.0 p -99.96 -47.5 4.99 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.314 -0.555 . . . . 13.539999999999999 110.244 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.35 5.31 71.89 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.576 -0.738 . . . . 14.67 112.793 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.613 HD22 HD11 ' A' ' 164' ' ' LEU . 9.1 mp -95.64 158.47 15.44 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.18 -0.674 . . . . 13.039999999999999 109.18 177.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 19.4 t -76.5 93.44 3.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.085 0.469 . . . . 14.84 110.527 -173.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -114.12 140.8 16.6 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.713 -0.676 . . . . 12.220000000000001 113.264 -176.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.9 p -105.81 146.73 12.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.135 0.493 . . . . 13.74 110.265 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 5.5 p -73.17 114.01 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.153 -0.93 . . . . 12.890000000000001 111.406 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.53 141.75 51.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.028 -0.533 . . . . 13.800000000000001 110.202 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -81.49 126.94 7.65 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.246 -0.978 . . . . 13.359999999999999 111.603 176.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.529 ' CZ ' ' HG3' ' A' ' 219' ' ' PRO . 4.8 t80 -85.81 131.67 34.26 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.075 0.95 . . . . 14.24 110.561 -175.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 p -131.37 91.84 33.86 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.527 -0.546 . . . . 16.510000000000002 109.527 172.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.529 ' HG3' ' CZ ' ' A' ' 217' ' ' TYR . 37.9 Cg_exo -53.69 153.31 19.38 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 123.321 2.681 . . . . 17.420000000000002 114.218 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 C--O 1.251 1.153 0 CA-C-N 115.186 -0.915 . . . . 19.190000000000001 109.609 177.736 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.404 ' HA ' ' HG2' ' A' ' 69' ' ' GLU . 10.0 p-10 . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.613 0.245 . . . . 18.390000000000001 111.134 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.84 143.62 14.52 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.133 -1.032 . . . . 17.77 112.973 -173.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.4 pm0 -93.73 8.67 40.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.337 0.589 . . . . 17.690000000000001 110.178 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -92.7 130.1 38.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.553 -0.749 . . . . 19.93 109.552 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -64.94 -15.45 62.14 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.327 0.491 . . . . 17.43 112.327 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -63.29 -23.93 67.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.153 0.502 . . . . 19.359999999999999 109.896 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -110.31 131.01 55.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.952 -0.567 . . . . 18.960000000000001 109.857 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -89.32 126.89 35.71 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.092 -0.336 . . . . 18.239999999999998 110.092 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.86 144.73 56.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 16.780000000000001 109.835 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.613 ' HG2' ' H ' ' A' ' 39' ' ' ALA . 27.9 tt0 -117.17 124.55 49.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.073 0.463 . . . . 18.420000000000002 111.845 -171.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -102.81 5.52 38.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.774 -0.648 . . . . 17.920000000000002 110.413 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.613 ' H ' ' HG2' ' A' ' 37' ' ' GLU . . . -81.43 -76.69 0.24 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.215 -0.448 . . . . 19.550000000000001 111.74 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.76 -16.15 49.04 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.208 -0.197 . . . . 20.309999999999999 111.138 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.413 HG22 ' HG3' ' A' ' 45' ' ' PRO . 35.5 pt 37.12 67.76 1.74 Allowed Pre-proline 0 N--CA 1.472 0.674 0 O-C-N 124.223 0.952 . . . . 19.920000000000002 112.525 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.49 61.1 5.97 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.169 2.579 . . . . 21.640000000000001 111.941 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 mp 63.86 17.97 10.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.508 -0.769 . . . . 22.670000000000002 111.08 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.578 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 90.8 t -85.13 -67.5 0.18 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.206 -0.452 . . . . 21.34 110.43 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.578 ' CD ' ' HB ' ' A' ' 44' ' ' VAL . 56.7 Cg_endo -71.95 92.82 0.71 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.174 1.25 . . . . 20.0 110.594 172.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -77.95 53.33 1.16 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.768 -0.651 . . . . 21.079999999999998 110.753 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.26 9.23 0.64 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.339 -0.846 . . . . 18.800000000000001 110.093 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.89 -153.49 38.24 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.835 -0.698 . . . . 17.510000000000002 112.212 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -77.43 116.13 17.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.858 0.361 . . . . 16.949999999999999 110.445 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -134.78 44.79 2.61 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.651 0.739 . . . . 18.300000000000001 109.473 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -92.34 108.12 19.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.614 -0.721 . . . . 18.170000000000002 110.801 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.421 ' HB3' ' HG2' ' A' ' 57' ' ' PRO . 31.6 tt0 -88.66 137.6 30.18 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.516 -0.765 . . . . 18.82 108.944 172.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -42.0 136.26 3.59 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 123.185 2.59 . . . . 19.870000000000001 112.75 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -76.91 42.9 0.33 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.83 0.678 . . . . 21.100000000000001 112.83 -169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -82.27 -39.85 22.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.215 -0.661 . . . . 22.300000000000001 109.215 171.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.565 ' HB3' ' HD3' ' A' ' 57' ' ' PRO . 49.9 ttm -120.19 -50.66 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 23.850000000000001 111.304 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 56' ' ' MET . 89.1 Cg_exo -50.73 111.71 0.6 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 122.712 2.274 . . . . 20.670000000000002 113.267 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 70.12 -0.32 2.83 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.931 -1.031 . . . . 20.489999999999998 111.859 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.37 -86.08 0.33 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.593 -0.276 . . . . 21.469999999999999 110.457 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 56' ' ' MET . 9.0 t -91.72 -5.45 53.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.041 0.448 . . . . 22.600000000000001 110.314 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -141.06 114.18 8.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.941 -0.572 . . . . 21.93 109.632 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.93 145.31 56.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.23 -0.441 . . . . 19.73 111.299 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.2 mt -95.93 107.24 33.12 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.993 -0.549 . . . . 19.579999999999998 110.044 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.61 9.66 4.01 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.67 2.247 . . . . 18.5 112.257 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 p -70.48 -77.39 0.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 17.609999999999999 110.723 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 42.82 81.61 0.24 Allowed Pre-proline 0 N--CA 1.469 0.517 0 O-C-N 124.102 0.876 . . . . 18.760000000000002 112.236 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.4 111.28 0.67 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.081 2.521 . . . . 17.280000000000001 112.275 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -75.13 127.41 10.57 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.604 2.203 . . . . 17.77 112.581 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' A' ' 28' ' ' ASP . 17.8 mm-40 -106.22 -43.78 4.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.471 -0.937 . . . . 18.699999999999999 108.471 170.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.24 131.8 15.59 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.308 -0.86 . . . . 17.719999999999999 111.418 174.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 72.33 2.87 4.49 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.522 0.729 . . . . 18.0 111.508 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.73 -16.68 18.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.876 0.37 . . . . 17.960000000000001 110.435 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -72.94 81.61 1.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.799 -0.637 . . . . 19.850000000000001 109.752 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 67.57 177.57 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.669 -0.696 . . . . 19.670000000000002 111.044 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.2 t 67.28 -79.43 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.058 -0.519 . . . . 17.739999999999998 110.549 -176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mtm-85 54.1 40.15 31.36 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.249 0.547 . . . . 19.949999999999999 111.41 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.96 -163.74 0.87 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.877 -0.601 . . . . 18.390000000000001 110.341 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.06 89.59 0.4 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.021 -0.609 . . . . 17.66 112.337 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -112.22 172.5 6.88 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.342 -0.614 . . . . 17.68 109.342 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.09 8.95 21.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.868 0.365 . . . . 17.800000000000001 111.629 -173.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.75 -36.38 75.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 17.350000000000001 109.96 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.68 97.21 36.21 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.763 -0.653 . . . . 16.640000000000001 110.093 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.99 -30.89 80.06 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.995 2.464 . . . . 17.23 112.429 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 m 72.71 -45.53 0.62 Allowed 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.779 0.832 . . . . 17.34 112.245 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.2 mt -81.12 149.5 29.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.915 0.388 . . . . 18.41 110.611 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -79.46 131.85 63.92 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.851 -0.613 . . . . 17.449999999999999 110.414 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.22 -27.54 85.08 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.207 2.604 . . . . 18.890000000000001 112.414 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.39 63.1 7.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.289 0.566 . . . . 17.809999999999999 109.578 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.9 m -69.5 126.38 29.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.295 -0.866 . . . . 18.629999999999999 110.864 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.13 -44.44 49.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 19.100000000000001 111.106 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 57.56 81.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.378 0.423 . . . . 19.25 111.672 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.46 83.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.872 -0.604 . . . . 18.789999999999999 111.682 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -103.29 26.0 8.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.273 0.558 . . . . 18.949999999999999 109.891 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 57.03 37.99 29.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.589 -0.732 . . . . 20.309999999999999 111.689 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.0 t -70.07 -24.1 63.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.458 . . . . 21.399999999999999 110.415 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -111.37 3.16 18.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.611 0.719 . . . . 21.16 109.168 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 60.24 93.49 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 114.482 -1.235 . . . . 22.18 111.346 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.433 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 42.7 tt0 -68.07 -50.37 31.47 Favored Pre-proline 0 CA--C 1.539 0.558 0 N-CA-C 111.938 0.347 . . . . 19.449999999999999 111.938 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 98' ' ' GLU . 5.1 Cg_exo -77.78 57.76 6.18 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.59 2.194 . . . . 18.530000000000001 112.658 -176.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -93.46 143.39 26.58 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.063 -0.517 . . . . 17.449999999999999 110.105 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.76 3.41 3.27 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.894 2.396 . . . . 17.420000000000002 112.421 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.36 88.07 13.1 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.553 . . . . 17.68 110.223 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.91 143.38 85.37 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.787 2.324 . . . . 16.289999999999999 111.868 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.3 p -76.96 90.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-O 121.816 0.817 . . . . 17.260000000000002 110.503 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.97 144.35 9.8 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.144 -0.935 . . . . 15.800000000000001 109.804 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.401 ' O ' ' HD2' ' A' ' 109' ' ' PRO . 26.7 Cg_endo -62.59 152.63 76.66 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.649 2.233 . . . . 15.92 111.581 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.52 43.72 0.96 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.051 2.501 . . . . 16.149999999999999 112.819 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.559 ' H ' ' HD2' ' A' ' 109' ' ' PRO . 62.0 tttp -96.26 -57.56 0.19 Allowed Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 116.106 -0.497 . . . . 17.629999999999999 111.588 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.559 ' HD2' ' H ' ' A' ' 108' ' ' LYS . 10.0 Cg_endo -54.31 131.62 46.15 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.115 1.877 . . . . 15.039999999999999 112.361 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.459 ' HD3' ' HD2' ' A' ' 111' ' ' PRO . 4.2 tppp? -150.32 129.04 6.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.015 -0.539 . . . . 15.199999999999999 109.837 -176.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.459 ' HD2' ' HD3' ' A' ' 110' ' ' LYS . 26.1 Cg_endo -64.48 137.68 56.3 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.422 2.081 . . . . 14.08 112.192 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.8 t -90.51 51.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.865 0.841 . . . . 15.279999999999999 110.226 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 56.28 80.52 0.29 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.175 -1.375 . . . . 16.84 111.992 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.11 134.82 28.12 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.22 1.947 . . . . 15.51 111.028 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.11 129.64 18.65 Favored 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 122.383 2.055 . . . . 16.039999999999999 112.549 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -106.21 103.65 46.23 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.361 -0.381 . . . . 18.91 110.119 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 121' ' ' ALA . 14.9 Cg_exo -69.35 -52.11 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.695 2.263 . . . . 17.039999999999999 111.188 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -142.9 29.3 1.51 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.831 -0.622 . . . . 17.52 110.65 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 t 69.75 152.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.82 -0.627 . . . . 18.699999999999999 111.224 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 46.5 mm-40 68.84 34.59 3.23 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.118 0.567 . . . . 20.879999999999999 110.913 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.47 ' HB2' ' HD2' ' A' ' 117' ' ' PRO . . . -85.14 112.85 46.61 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.931 -0.577 . . . . 18.890000000000001 111.504 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 120' ' ' GLU . 41.8 Cg_endo -93.48 137.53 1.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.179 2.586 . . . . 20.43 112.153 175.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.58 58.92 6.05 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.769 2.313 . . . . 21.100000000000001 112.34 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.598 ' H ' ' HD2' ' A' ' 125' ' ' PRO . . . -140.96 -57.36 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.938 -0.574 . . . . 21.149999999999999 111.317 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.598 ' HD2' ' H ' ' A' ' 124' ' ' ALA . 19.9 Cg_endo -61.48 -34.75 85.23 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 121.907 1.738 . . . . 21.149999999999999 111.718 175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -127.15 94.65 38.46 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.902 -0.59 . . . . 21.879999999999999 109.649 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.61 151.75 74.92 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.766 2.311 . . . . 20.190000000000001 111.578 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.05 121.81 85.7 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 121.051 0.453 . . . . 20.48 110.753 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -88.53 -148.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.72 2.28 . . . . 21.170000000000002 110.931 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 130' ' ' LYS . 3.9 mppt? -85.29 133.81 41.84 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.312 -0.625 . . . . 23.18 109.312 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.97 111.69 1.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.256 1.971 . . . . 20.780000000000001 111.12 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.6 m -86.73 52.68 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.772 0.796 . . . . 19.75 110.941 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.1 m -75.5 151.96 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 115.096 -0.956 . . . . 21.050000000000001 110.146 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 69.39 -75.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.681 0.613 . . . . 21.300000000000001 111.218 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.553 ' HG3' ' H ' ' A' ' 138' ' ' ALA . 6.8 tp10 -170.7 174.48 4.95 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.382 -0.599 . . . . 20.739999999999998 109.382 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -140.16 -36.27 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.34 . . . . 17.969999999999999 111.121 -175.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 193' ' ' SER . . . -104.7 3.39 31.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.209 0.528 . . . . 17.350000000000001 110.164 176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.553 ' H ' ' HG3' ' A' ' 135' ' ' GLU . . . 68.19 141.92 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 114.534 -1.212 . . . . 19.100000000000001 111.927 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.69 -51.17 10.86 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.374 2.716 . . . . 19.350000000000001 113.917 -171.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.439 HG22 ' HG2' ' A' ' 219' ' ' PRO . 57.9 p -124.96 7.57 8.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.929 0.395 . . . . 17.75 110.869 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.07 -65.94 2.01 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.983 -0.627 . . . . 17.960000000000001 112.074 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -125.57 53.77 1.53 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.202 0.525 . . . . 19.420000000000002 110.366 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.582 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -73.01 163.2 28.53 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.904 -0.776 . . . . 14.65 108.904 175.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.608 ' CE1' ' HD3' ' A' ' 194' ' ' LYS . 7.6 m-85 -144.74 155.85 43.76 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 111.879 0.325 . . . . 14.81 111.879 -175.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.775 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.4 t -149.62 159.94 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.882 -0.784 . . . . 10.48 108.882 173.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 58.4 t -101.0 110.02 26.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 O-C-N 122.069 -0.394 . . . . 10.1 110.803 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -86.74 108.92 18.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.569 -0.287 . . . . 12.0 111.051 -177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.895 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -83.97 -40.55 18.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.228 0.537 . . . . 11.880000000000001 109.953 -176.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.38 165.85 28.22 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.544 -0.836 . . . . 11.35 112.526 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.481 ' C ' HD13 ' A' ' 151' ' ' LEU . . . -156.75 101.22 1.96 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.512 -0.551 . . . . 13.470000000000001 109.512 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.481 HD13 ' C ' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -119.57 159.25 24.71 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.38 0.609 . . . . 13.52 110.028 -174.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 39.3 mttm -101.56 24.49 9.66 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.888 -1.153 . . . . 17.600000000000001 107.888 175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -136.37 110.86 8.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 113.724 -1.58 . . . . 16.140000000000001 109.114 -176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.407 ' HA ' ' CG2' ' A' ' 157' ' ' VAL . . . -70.76 -19.12 62.75 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.204 0.446 . . . . 14.039999999999999 112.204 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -64.32 -31.34 72.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.663 0.744 . . . . 16.57 109.563 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.462 ' HD2' HD11 ' A' ' 160' ' ' ILE . 3.8 tmtm? -77.87 -38.62 45.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.396 -1.275 . . . . 16.399999999999999 109.026 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.407 ' CG2' ' HA ' ' A' ' 154' ' ' ALA . 94.4 t -56.44 -42.74 75.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.955 -1.021 . . . . 12.67 110.517 176.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -58.68 -29.6 66.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.581 -0.736 . . . . 15.32 112.146 -176.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.525 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 8.5 mm-40 -79.56 -60.81 2.21 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.6 -0.519 . . . . 15.970000000000001 109.6 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.462 HD11 ' HD2' ' A' ' 156' ' ' LYS . 11.4 mt -50.97 -44.3 27.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.278 -0.874 . . . . 12.6 110.673 -178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 84.9 t -76.49 -37.3 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.659 -0.7 . . . . 12.539999999999999 110.376 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.17 -28.79 71.29 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.669 -0.777 . . . . 14.800000000000001 112.053 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 1.0 OUTLIER -71.29 -52.27 19.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.66 0.266 . . . . 16.050000000000001 111.071 177.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.515 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 3.8 mm? -86.0 -55.59 3.87 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.043 0.386 . . . . 12.99 112.043 -175.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 24.5 ttt180 -61.7 -42.99 99.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.456 0.646 . . . . 15.06 109.82 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.82 -11.2 62.59 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.824 -1.08 . . . . 16.600000000000001 112.973 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.62 -2.19 22.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.97 0.414 . . . . 16.140000000000001 110.714 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.94 56.13 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.233 -0.508 . . . . 15.119999999999999 113.569 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -82.58 155.44 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 122.241 -0.564 . . . . 15.49 110.369 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 170' ' ' ARG . 36.1 mmt180 -71.4 104.39 3.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.74 0.781 . . . . 13.869999999999999 110.211 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.19 141.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 114.454 -1.248 . . . . 10.82 109.48 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.37 175.49 9.55 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.635 0.731 . . . . 11.130000000000001 110.635 169.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.437 ' HB ' ' HG3' ' A' ' 178' ' ' PRO . 7.1 p -120.75 -173.96 2.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.625 -1.17 . . . . 11.52 112.294 -168.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.632 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -50.21 151.12 3.83 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 115.161 -0.927 . . . . 12.75 112.982 -177.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -23.9 -70.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 1 C-N-CA 126.093 4.529 . . . . 14.640000000000001 115.281 -177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.1 m -88.95 -62.12 1.55 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.242 -0.583 . . . . 16.68 112.313 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 97.6 m -167.58 132.08 1.53 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 111.453 0.168 . . . . 16.039999999999999 111.453 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.448 ' HB3' HG21 ' A' ' 184' ' ' THR . 73.4 Cg_exo -56.75 125.76 20.06 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.54 2.16 . . . . 14.220000000000001 111.741 166.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.501 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.3 p -148.71 160.26 6.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.643 -0.503 . . . . 16.129999999999999 109.643 -174.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -72.55 133.47 44.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.527 -0.306 . . . . 16.699999999999999 110.739 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 90.08 -25.61 11.8 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.213 -0.518 . . . . 16.98 114.116 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.501 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.3 OUTLIER -102.94 168.06 9.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.36 0.58 . . . . 18.73 110.67 -176.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.6 tp -76.29 110.5 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.973 0.892 . . . . 14.82 111.766 -174.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.448 HG21 ' HB3' ' A' ' 178' ' ' PRO . 48.8 m -104.9 107.59 18.64 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.496 -0.775 . . . . 12.779999999999999 109.464 173.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.632 ' H ' ' HB3' ' A' ' 174' ' ' SER . 6.4 ptm180 -90.42 133.71 34.83 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.408 -0.815 . . . . 13.98 109.675 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.556 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.3 mm -104.91 122.52 58.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.76 -0.459 . . . . 10.56 109.76 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.556 HD12 ' C ' ' A' ' 186' ' ' ILE . 5.1 mp -129.68 126.46 38.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.258 0.552 . . . . 10.1 111.153 -174.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.895 HG23 HD21 ' A' ' 148' ' ' LEU . 38.5 t -102.38 134.77 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.474 -0.784 . . . . 9.7400000000000002 110.997 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.06 49.86 4.83 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.001 -1.0 . . . . 9.7599999999999998 113.66 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.775 ' HA ' HG22 ' A' ' 145' ' ' VAL . 10.2 Cg_endo -58.86 125.09 17.22 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 119.441 1.621 . . . . 11.15 110.698 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -152.19 151.73 31.36 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 120.458 -0.497 . . . . 12.77 110.393 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -92.06 -7.0 49.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.824 -0.625 . . . . 14.6 111.706 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.418 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 1.4 p -118.29 104.98 11.28 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.341 0.591 . . . . 14.300000000000001 111.375 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.608 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 36.7 ttpt -58.47 -51.89 67.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.693 -1.139 . . . . 15.970000000000001 110.787 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.11 -44.97 83.75 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.158 -0.474 . . . . 15.6 111.191 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -62.63 -48.28 80.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.745 -0.661 . . . . 14.220000000000001 111.017 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -77.73 -20.39 53.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 11.949999999999999 110.935 -175.007 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.7 tptm -65.31 -39.02 91.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.516 0.674 . . . . 14.699999999999999 109.917 177.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -79.14 -12.43 84.04 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.498 -1.041 . . . . 13.09 110.498 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 59.0 m -84.08 -10.69 57.63 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.823 -0.689 . . . . 12.109999999999999 111.82 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 29.6 mt -64.77 -34.72 79.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.833 0.349 . . . . 12.720000000000001 110.995 -175.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -61.68 -39.06 96.91 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.793 -0.718 . . . . 14.66 112.401 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.495 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 10.3 pt-20 -86.26 -22.2 26.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.876 0.369 . . . . 13.890000000000001 110.99 177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.6 tp -74.83 -31.47 61.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.386 -0.37 . . . . 12.550000000000001 111.272 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.582 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 20.2 ptmt -68.17 -15.09 63.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.111 0.481 . . . . 15.83 110.382 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.9 -30.67 17.71 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.177 0.513 . . . . 16.969999999999999 109.982 171.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 91.3 mt -76.44 -51.89 10.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.793 -0.64 . . . . 13.890000000000001 111.527 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.472 ' HB3' HD11 ' A' ' 164' ' ' LEU . 44.3 p -95.56 -43.93 7.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.354 0.597 . . . . 13.539999999999999 110.213 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 70.01 3.85 46.05 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 114.899 -1.046 . . . . 14.67 112.579 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.44 153.3 18.01 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 109.572 -0.529 . . . . 13.039999999999999 109.572 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 24.2 t -85.33 107.25 17.25 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.01 -0.541 . . . . 14.84 110.53 -175.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -127.48 163.27 21.29 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.346 -0.93 . . . . 12.220000000000001 113.435 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.87 145.8 12.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.039 -0.58 . . . . 13.74 109.748 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.61 104.85 3.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.104 -0.702 . . . . 12.890000000000001 109.104 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 92.8 mmm -117.06 141.8 47.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.168 -0.469 . . . . 13.800000000000001 110.447 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.21 155.09 51.31 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.494 -0.86 . . . . 13.359999999999999 111.698 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.704 ' HB2' HG23 ' A' ' 145' ' ' VAL . 10.9 t80 -132.03 132.06 43.05 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 123.082 0.553 . . . . 14.24 110.286 -169.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 31.5 m -146.71 93.4 4.88 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 109.161 -0.681 . . . . 16.510000000000002 109.161 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.439 ' HG2' HG22 ' A' ' 140' ' ' THR . 45.5 Cg_endo -67.04 147.23 79.43 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.735 2.29 . . . . 17.420000000000002 113.223 -173.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 C--O 1.244 0.805 0 CA-C-N 115.368 -0.833 . . . . 19.190000000000001 110.933 179.97 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 71' ' ' ALA . 10.0 p-10 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.485 -0.561 . . . . 18.390000000000001 109.485 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.491 ' N ' ' HB2' ' A' ' 69' ' ' GLU . . . -136.33 -98.11 0.52 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.187 -1.006 . . . . 17.77 113.271 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -115.76 -88.17 0.59 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.23 0.456 . . . . 17.690000000000001 112.23 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -142.16 168.85 18.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.631 0.253 . . . . 19.93 111.26 -173.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 33' ' ' HIS . 1.9 mptm? 59.73 -92.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.463 -0.79 . . . . 17.43 111.44 -177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 20.3 t-160 168.72 -55.23 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.691 -0.855 . . . . 19.359999999999999 108.691 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.502 ' HB2' ' O ' ' A' ' 33' ' ' HIS . 2.3 t80 170.84 -67.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.235 -0.893 . . . . 18.960000000000001 108.891 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.476 ' HG2' ' HB2' ' A' ' 38' ' ' PHE . 52.8 tt0 57.37 65.84 1.27 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.797 0.808 . . . . 18.239999999999998 109.229 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.63 118.5 13.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.715 -1.13 . . . . 16.780000000000001 112.311 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 55.9 43.35 27.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.416 -0.811 . . . . 18.420000000000002 112.695 173.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.476 ' HB2' ' HG2' ' A' ' 35' ' ' GLN . 52.4 m-85 -113.88 56.23 0.71 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.385 0.612 . . . . 17.920000000000002 109.87 174.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.72 25.5 11.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.547 -0.751 . . . . 19.550000000000001 111.001 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.3 -14.74 60.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.315 0.578 . . . . 20.309999999999999 110.317 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -127.59 65.04 65.65 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.567 -0.742 . . . . 19.920000000000002 110.779 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.06 65.03 8.39 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.271 1.981 . . . . 21.640000000000001 111.769 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mp 61.94 23.48 13.83 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.453 -0.794 . . . . 22.670000000000002 111.324 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.417 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 99.3 t -80.35 -57.06 0.66 Allowed Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.24 -0.436 . . . . 21.34 110.851 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.417 ' CD ' ' HB ' ' A' ' 44' ' ' VAL . 25.6 Cg_endo -64.07 -59.34 0.2 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.546 1.497 . . . . 20.0 111.267 174.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -175.37 -69.25 0.01 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.974 -0.557 . . . . 21.079999999999998 110.071 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.31 39.35 0.07 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.017 -0.538 . . . . 18.800000000000001 110.83 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.9 57.32 3.69 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.776 -0.726 . . . . 17.510000000000002 112.962 -176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.1 145.31 56.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.883 0.373 . . . . 16.949999999999999 110.841 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -67.37 106.05 1.97 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.789 -0.641 . . . . 18.300000000000001 110.81 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -96.68 121.48 38.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.264 0.554 . . . . 18.170000000000002 110.414 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -86.12 129.87 52.23 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.737 -0.665 . . . . 18.82 110.513 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.08 -7.34 21.18 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.977 2.451 . . . . 19.870000000000001 113.162 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -112.12 144.31 41.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.549 -0.296 . . . . 21.100000000000001 110.707 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 43.0 tpp 66.98 -77.11 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.518 -0.765 . . . . 22.300000000000001 112.322 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 91.0 mtp -143.67 129.05 9.83 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.718 0.294 . . . . 23.850000000000001 110.846 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.42 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 79.3 Cg_endo -85.07 163.48 11.57 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.864 2.376 . . . . 20.670000000000002 112.339 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.87 4.55 4.03 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.112 -0.494 . . . . 20.489999999999998 111.603 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.23 84.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.916 -0.402 . . . . 21.469999999999999 109.916 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.9 t -99.19 -32.01 11.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.074 -0.512 . . . . 22.600000000000001 110.908 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 57' ' ' PRO . 19.3 pt20 -106.15 49.78 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.057 0.456 . . . . 21.93 111.165 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.45 150.94 34.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.17 -0.468 . . . . 19.73 110.709 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . 7.7 mp 66.34 103.92 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.397 0 O-C-N 123.747 0.654 . . . . 19.579999999999998 110.85 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 63' ' ' LEU . 13.2 Cg_endo -56.49 145.47 79.77 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.056 2.504 . . . . 18.5 112.562 -174.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.486 ' OG1' ' HD2' ' A' ' 67' ' ' PRO . 6.9 t -155.35 168.12 28.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.323 -0.398 . . . . 17.609999999999999 110.416 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.452 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 63.3 tt0 -78.23 -48.26 1.99 Allowed Pre-proline 0 CA--C 1.541 0.618 0 CA-C-O 119.096 -0.478 . . . . 18.760000000000002 111.923 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.486 ' HD2' ' OG1' ' A' ' 65' ' ' THR . 36.6 Cg_exo -36.49 114.42 0.12 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 123.547 2.831 . . . . 17.280000000000001 113.928 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -88.41 145.52 5.98 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.838 2.359 . . . . 17.77 113.342 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.491 ' HB2' ' N ' ' A' ' 29' ' ' GLY . 15.1 mm-40 60.91 110.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.927 -1.033 . . . . 18.699999999999999 112.309 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.66 95.02 0.68 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.667 -0.697 . . . . 17.719999999999999 112.695 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 28' ' ' ASP . . . -110.35 52.02 0.74 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.19 0.519 . . . . 18.0 110.218 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -153.8 -49.67 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.883 -0.598 . . . . 17.960000000000001 111.419 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 60.82 38.65 17.84 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.157 0.98 . . . . 19.850000000000001 108.917 -174.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -119.13 -175.9 3.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.634 -1.166 . . . . 19.670000000000002 110.062 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.5 m 38.87 52.79 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 124.295 0.997 . . . . 17.739999999999998 111.787 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.6 ttp180 -112.38 -33.43 6.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.263 -0.88 . . . . 19.949999999999999 110.73 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.91 -87.16 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.96 0.355 . . . . 18.390000000000001 111.96 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.29 76.96 0.39 Allowed Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 111.362 -0.695 . . . . 17.66 111.362 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -107.49 146.31 31.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.88 0.372 . . . . 17.68 110.254 -174.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.02 -8.27 57.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.993 -0.548 . . . . 17.800000000000001 110.987 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.02 40.1 15.61 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.105 -0.952 . . . . 17.350000000000001 111.176 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.421 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . . . -142.85 95.23 6.31 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.846 -0.616 . . . . 16.640000000000001 110.788 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 82' ' ' ALA . 10.3 Cg_endo -52.71 112.57 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.767 2.311 . . . . 17.23 111.828 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 m -122.26 15.29 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 17.34 111.312 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -104.46 -63.75 1.18 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.28 0.562 . . . . 18.41 109.711 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 19.8 t70 -83.82 138.3 40.56 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.037 -0.727 . . . . 17.449999999999999 109.037 175.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 86' ' ' ASP . 42.6 Cg_exo -57.87 -20.04 42.19 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.997 2.464 . . . . 18.890000000000001 113.343 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 68.51 -59.93 0.44 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.631 0.772 . . . . 17.809999999999999 111.501 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.1 t -154.14 145.84 23.33 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.044 -0.525 . . . . 18.629999999999999 109.669 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.25 158.47 33.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.522 -0.547 . . . . 19.100000000000001 109.522 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.14 36.5 25.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.407 0.622 . . . . 19.25 109.997 -173.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.83 62.08 0.7 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.441 -0.8 . . . . 18.789999999999999 109.887 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.637 ' HA ' ' OE1' ' A' ' 98' ' ' GLU . 15.9 m120 -81.85 115.98 21.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.444 -0.798 . . . . 18.949999999999999 110.324 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.422 ' O ' ' HB ' ' A' ' 95' ' ' THR . 4.5 m-20 64.75 -154.97 0.29 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.782 0.676 . . . . 20.309999999999999 110.597 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 94' ' ' ASN . 54.8 m 74.65 -49.13 0.66 Allowed 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.34 0.4 . . . . 21.399999999999999 110.665 -176.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -113.55 21.21 15.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.401 -0.363 . . . . 21.16 111.029 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 70.18 83.11 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.316 0.579 . . . . 22.18 111.021 176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.637 ' OE1' ' HA ' ' A' ' 93' ' ' ASN . 48.7 tt0 -80.76 -52.85 0.87 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.88 -0.6 . . . . 19.449999999999999 111.345 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 98' ' ' GLU . 6.0 Cg_exo -79.44 85.44 1.85 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.363 2.042 . . . . 18.530000000000001 112.325 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 64.42 79.85 0.24 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.691 -0.686 . . . . 17.449999999999999 111.695 175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.07 -24.19 33.1 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.559 2.173 . . . . 17.420000000000002 112.406 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.482 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . . . -119.77 -52.29 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.16 0.43 . . . . 17.68 112.16 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 102' ' ' ALA . 1.9 Cg_endo -81.82 70.07 7.36 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.06 1.84 . . . . 16.289999999999999 111.846 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 t -77.34 110.78 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.257 -0.883 . . . . 17.260000000000002 110.365 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 56.41 65.39 4.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 O-C-N 123.816 0.698 . . . . 15.800000000000001 110.459 -175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.47 134.53 22.67 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.604 2.202 . . . . 15.92 112.363 -174.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.65 10.81 3.52 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.647 2.232 . . . . 16.149999999999999 111.949 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.8 tptm 68.61 110.03 0.03 OUTLIER Pre-proline 0 N--CA 1.462 0.128 0 CA-C-N 114.762 -1.108 . . . . 17.629999999999999 111.165 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.36 78.31 0.33 Allowed 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.705 2.27 . . . . 15.039999999999999 111.564 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -71.45 129.57 88.63 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.817 -0.629 . . . . 15.199999999999999 110.844 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.26 -175.83 2.17 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.149 2.566 . . . . 14.08 112.158 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.9 p -87.93 46.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.633 1.206 . . . . 15.279999999999999 109.502 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.559 ' HB2' ' HD3' ' A' ' 114' ' ' PRO . 52.5 mm-40 -96.4 -50.18 0.24 Allowed Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.267 -1.333 . . . . 16.84 111.445 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 113' ' ' GLU . 50.6 Cg_exo -54.0 -51.99 9.42 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 121.813 1.676 . . . . 15.51 113.915 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 114' ' ' PRO . 36.4 Cg_endo -64.62 107.66 0.91 Allowed 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 121.788 1.658 . . . . 16.039999999999999 112.336 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 30.5 mmmt -79.43 127.64 77.9 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 18.91 110.788 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 116' ' ' LYS . 12.9 Cg_exo -69.87 -54.19 0.23 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.961 2.44 . . . . 17.039999999999999 110.275 174.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? 70.27 157.67 0.17 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.498 -0.774 . . . . 17.52 112.038 172.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.26 167.33 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.969 -0.56 . . . . 18.699999999999999 109.596 170.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 42.6 44.8 3.78 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.796 0.808 . . . . 20.879999999999999 111.133 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -82.86 146.41 52.3 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.009 -0.996 . . . . 18.890000000000001 109.876 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.73 110.7 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.199 1.933 . . . . 20.43 111.285 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -84.5 -1.02 9.58 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.553 2.169 . . . . 21.100000000000001 112.387 -176.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 68.91 158.4 0.15 Allowed Pre-proline 0 C--O 1.235 0.325 0 O-C-N 124.246 0.966 . . . . 21.149999999999999 111.629 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.88 119.95 7.16 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.365 2.044 . . . . 21.149999999999999 110.313 171.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt 66.23 92.41 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 108.727 -0.842 . . . . 21.879999999999999 108.727 -170.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.74 157.24 33.65 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.073 2.515 . . . . 20.190000000000001 113.254 -170.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -51.38 116.43 7.63 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 115.177 -0.92 . . . . 20.48 111.104 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -75.91 -28.03 8.09 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.666 2.244 . . . . 21.170000000000002 112.745 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.48 ' HD2' ' CD ' ' A' ' 134' ' ' GLU . 86.2 mttt -110.75 161.56 24.29 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.119 -0.491 . . . . 23.18 109.944 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.41 -178.24 2.12 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.343 2.029 . . . . 20.780000000000001 111.026 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.7 m -75.74 49.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.495 0.664 . . . . 19.75 111.595 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.83 6.39 9.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 122.225 1.012 . . . . 21.050000000000001 109.275 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.48 ' CD ' ' HD2' ' A' ' 130' ' ' LYS . 41.9 mt-10 -116.31 18.27 15.3 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.552 -1.204 . . . . 21.300000000000001 109.817 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 61.42 -90.89 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.725 -0.67 . . . . 20.739999999999998 111.454 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.24 78.83 1.8 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.219 -0.66 . . . . 17.969999999999999 109.219 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.769 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . 53.45 30.91 11.24 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.344 0.592 . . . . 17.350000000000001 110.6 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . . . 67.91 137.57 0.05 OUTLIER Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 114.455 -1.248 . . . . 19.100000000000001 112.079 -176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.441 ' O ' ' HB ' ' A' ' 140' ' ' THR . 17.3 Cg_exo -64.6 117.53 4.59 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.799 2.333 . . . . 19.350000000000001 111.586 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 33.1 m 78.56 -17.44 0.58 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 123.522 0.514 . . . . 17.75 111.558 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -68.55 -75.86 0.48 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.966 -0.635 . . . . 17.960000000000001 112.655 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.769 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 68.5 mttm -102.68 42.9 1.11 Allowed 'General case' 0 C--N 1.319 -0.745 0 O-C-N 122.843 -0.21 . . . . 19.420000000000002 111.071 -177.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 217' ' ' TYR . . . -77.62 153.3 33.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.424 -0.511 . . . . 14.65 110.125 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.52 ' CD2' ' HG3' ' A' ' 194' ' ' LYS . 4.7 m-85 -143.03 158.44 43.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.17 -0.468 . . . . 14.81 111.685 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.673 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.2 m -151.77 152.82 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 115.715 -0.675 . . . . 10.48 110.633 -176.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 60.3 t -108.73 108.35 25.08 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.291 0 CA-C-O 120.862 0.363 . . . . 10.1 111.262 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -85.26 108.94 18.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.54 -0.3 . . . . 12.0 110.871 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -84.92 -36.64 21.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.138 0.494 . . . . 11.880000000000001 109.924 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.34 164.15 28.38 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.583 -0.818 . . . . 11.35 112.674 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -161.21 101.21 1.23 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.02 0.438 . . . . 13.470000000000001 109.822 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.8 168.37 18.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.293 0.568 . . . . 13.52 110.586 -174.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -100.39 -5.6 26.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.866 -1.061 . . . . 17.600000000000001 109.837 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -105.45 106.58 17.15 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.122 -0.945 . . . . 16.140000000000001 109.844 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.13 -19.42 65.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.798 -0.637 . . . . 14.039999999999999 111.266 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.93 -29.78 70.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.516 0.674 . . . . 16.57 110.24 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -89.85 -27.23 20.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.149 -0.932 . . . . 16.399999999999999 109.327 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.471 HG11 HG21 ' A' ' 184' ' ' THR . 74.2 t -60.7 -35.62 65.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.441 -0.799 . . . . 12.67 109.922 173.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.17 -26.81 66.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.437 -0.802 . . . . 15.32 111.59 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.468 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 3.9 mm-40 -70.95 -62.78 1.27 Allowed 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.48 -0.563 . . . . 15.970000000000001 109.48 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.819 HD12 HD12 ' A' ' 186' ' ' ILE . 13.8 mt -54.78 -46.49 74.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.622 -1.172 . . . . 12.6 110.514 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.474 HG23 HD13 ' A' ' 186' ' ' ILE . 85.0 t -72.04 -42.88 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.592 -0.731 . . . . 12.539999999999999 110.668 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.49 -27.77 66.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.627 -0.797 . . . . 14.800000000000001 111.804 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 159' ' ' GLU . 15.7 mttp -72.56 -57.93 3.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.491 -0.355 . . . . 16.050000000000001 111.021 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.7 mm? -82.87 -56.28 3.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.275 0.472 . . . . 12.99 112.275 -175.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -62.53 -38.25 89.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.445 0.641 . . . . 15.06 109.7 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -66.08 -28.61 73.81 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.839 -1.073 . . . . 16.600000000000001 112.695 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.96 2.03 56.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.998 0.428 . . . . 16.140000000000001 110.879 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.83 23.59 55.32 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.979 -0.629 . . . . 15.119999999999999 113.313 175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -85.66 154.59 21.57 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.645 -0.327 . . . . 15.49 110.22 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -68.52 99.34 0.96 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.366 0.603 . . . . 13.869999999999999 109.986 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.5 p -143.99 139.34 25.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 114.96 -1.018 . . . . 10.82 109.949 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.474 ' CE1' HG11 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -140.23 176.89 8.39 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.48 0.657 . . . . 11.130000000000001 110.508 172.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 12.0 p -126.49 -175.28 3.34 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.959 -1.019 . . . . 11.52 111.689 -169.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.519 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 2.9 p -52.24 149.51 9.81 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-N 115.94 -0.573 . . . . 12.75 111.876 -176.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -34.53 -58.07 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 124.797 3.664 . . . . 14.640000000000001 115.341 -171.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 31.7 t -87.91 -64.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.458 -0.897 . . . . 16.68 112.212 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 55.5 m -169.03 134.0 1.33 Allowed Pre-proline 0 CA--C 1.53 0.196 0 O-C-N 122.389 -0.195 . . . . 16.039999999999999 111.282 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.538 ' HB3' HG21 ' A' ' 184' ' ' THR . 72.5 Cg_exo -59.52 123.27 12.98 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.245 1.963 . . . . 14.220000000000001 111.58 165.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 8.6 p -153.92 159.87 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 109.767 -0.457 . . . . 16.129999999999999 109.767 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -80.51 122.42 27.0 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.935 -0.394 . . . . 16.699999999999999 109.935 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 110.02 -26.48 13.78 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.766 -0.652 . . . . 16.98 112.155 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.448 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.5 OUTLIER -106.93 158.44 17.02 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.411 -0.588 . . . . 18.73 109.411 175.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.6 tp -74.56 122.24 27.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.524 0.678 . . . . 14.82 111.156 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 56.0 m -111.34 105.0 13.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.81 -0.632 . . . . 12.779999999999999 110.202 174.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.519 ' H ' ' HB3' ' A' ' 174' ' ' SER . 97.3 mtt180 -84.03 138.05 33.28 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.984 -0.747 . . . . 13.98 108.984 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.819 HD12 HD12 ' A' ' 160' ' ' ILE . 4.2 mt -115.58 122.13 68.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.332 -0.618 . . . . 10.56 109.332 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 186' ' ' ILE . 3.8 mp -128.79 127.08 41.26 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.7 -0.682 . . . . 10.1 111.171 -168.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 148' ' ' LEU . 50.5 t -100.7 143.13 14.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.034 -0.985 . . . . 9.7400000000000002 110.418 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.99 48.43 7.71 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 115.192 -0.913 . . . . 9.7599999999999998 113.76 175.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.673 ' HA ' HG12 ' A' ' 145' ' ' VAL . 18.7 Cg_endo -66.24 123.62 11.45 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 CA-C-N 119.831 1.815 . . . . 11.15 110.568 172.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.1 158.55 36.6 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.548 -0.751 . . . . 12.77 109.386 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 137' ' ' ALA . . . -92.6 -19.54 21.81 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.66 -0.7 . . . . 14.6 110.707 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 35.6 p -91.96 90.93 7.63 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.582 0.706 . . . . 14.300000000000001 110.863 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.52 ' HG3' ' CD2' ' A' ' 144' ' ' TYR . 27.7 ttpt -52.68 -51.88 58.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.562 -1.199 . . . . 15.970000000000001 110.905 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -57.71 -45.61 85.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.765 -0.652 . . . . 15.6 111.242 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -75.45 -38.03 59.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.903 -0.589 . . . . 14.220000000000001 111.591 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.1 OUTLIER -79.09 -20.07 49.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.263 0.554 . . . . 11.949999999999999 110.246 -178.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.434 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 54.1 tptt -64.97 -40.73 95.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.587 0.708 . . . . 14.699999999999999 110.219 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.24 -12.57 84.48 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.169 -0.923 . . . . 13.09 110.797 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.433 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 58.5 m -85.53 -9.04 57.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.716 -0.742 . . . . 12.109999999999999 112.236 -176.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.563 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 31.2 mt -65.91 -38.53 88.96 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.733 0.301 . . . . 12.720000000000001 111.361 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.34 -38.29 96.18 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.738 -0.744 . . . . 14.66 112.279 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 11.4 pt-20 -82.16 -18.63 42.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.096 0.474 . . . . 13.890000000000001 110.16 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.438 HD11 HG12 ' A' ' 188' ' ' VAL . 17.0 tp -74.02 -30.86 62.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.197 -0.456 . . . . 12.550000000000001 110.244 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 85.1 mttt -64.33 -19.96 65.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.284 0.564 . . . . 15.83 109.727 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.59 -29.99 18.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.512 -0.767 . . . . 16.969999999999999 110.288 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 82.4 mt -78.58 -53.04 7.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.827 -0.624 . . . . 13.890000000000001 111.701 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 164' ' ' LEU . 68.4 p -94.71 -44.0 8.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.418 0.628 . . . . 13.539999999999999 110.46 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 67.46 13.85 63.6 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 114.727 -1.124 . . . . 14.67 112.286 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.45 HD13 HG23 ' A' ' 160' ' ' ILE . 85.3 mt -103.85 152.72 21.58 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.188 -0.671 . . . . 13.039999999999999 109.188 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 10.9 t -88.69 108.84 19.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.106 0.479 . . . . 14.84 110.448 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -125.71 161.04 20.22 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.327 -0.939 . . . . 12.220000000000001 113.216 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.7 p -102.09 144.01 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.216 0.532 . . . . 13.74 110.433 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.78 105.8 8.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.26 -0.882 . . . . 12.890000000000001 110.263 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 84.2 mmm -115.35 148.64 39.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.931 -0.577 . . . . 13.800000000000001 110.404 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -78.26 132.65 11.94 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 120.225 -0.988 . . . . 13.359999999999999 111.698 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.592 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 7.3 t80 -97.83 133.38 42.41 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.297 0.639 . . . . 14.24 109.607 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.4 t -147.2 93.05 4.77 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 109.167 -0.679 . . . . 16.510000000000002 109.167 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.61 145.62 97.5 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.451 2.101 . . . . 17.420000000000002 112.65 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.397 -0.811 . . . . 19.190000000000001 110.3 179.716 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.805 0.336 . . . . 18.390000000000001 110.552 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.58 -140.17 7.25 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.909 -0.877 . . . . 17.77 110.909 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -82.51 61.6 5.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.832 0.348 . . . . 17.690000000000001 110.771 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -140.52 30.95 1.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 19.93 110.649 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -110.62 -70.25 0.82 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.165 -0.47 . . . . 17.43 110.136 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 177.2 156.74 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 19.359999999999999 109.899 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -81.75 -67.57 0.77 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.76 0.314 . . . . 18.960000000000001 110.396 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -142.05 42.87 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.781 0.8 . . . . 18.239999999999998 109.528 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -76.88 -26.53 54.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.446 -0.797 . . . . 16.780000000000001 111.375 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.95 9.81 11.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.962 0.411 . . . . 18.420000000000002 110.956 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -76.04 -78.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.859 -0.61 . . . . 17.920000000000002 110.711 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.91 123.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 O-C-N 123.82 0.7 . . . . 19.550000000000001 111.197 -173.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.73 62.28 2.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.062 0.458 . . . . 20.309999999999999 111.01 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.8 mt 59.66 81.73 0.24 Allowed Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.307 -0.86 . . . . 19.920000000000002 110.676 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 94.7 Cg_endo -84.77 61.02 6.02 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.649 2.233 . . . . 21.640000000000001 109.887 175.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 11.2 mp 67.39 20.62 9.9 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.118 -0.946 . . . . 22.670000000000002 109.42 -171.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.09 80.8 40.41 Favored Pre-proline 0 C--O 1.234 0.27 0 CA-C-N 115.288 -0.869 . . . . 21.34 110.35 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -73.35 87.25 1.08 Allowed 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.518 2.145 . . . . 20.0 111.527 175.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -125.9 -75.52 0.59 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.907 -0.588 . . . . 21.079999999999998 110.017 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -167.44 -53.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.268 0.556 . . . . 18.800000000000001 110.328 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.21 -85.09 1.56 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.67 -0.695 . . . . 17.510000000000002 112.574 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -79.4 160.89 26.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.143 0.497 . . . . 16.949999999999999 110.673 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 50' ' ' ARG . 37.1 ttm180 -133.18 29.2 4.04 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.813 -0.81 . . . . 18.300000000000001 108.813 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -97.43 171.95 8.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.293 -0.867 . . . . 18.170000000000002 110.708 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.587 ' OE2' ' HD2' ' A' ' 53' ' ' PRO . 6.1 tp10 -61.66 146.33 90.49 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.945 -0.761 . . . . 18.82 108.945 173.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.587 ' HD2' ' OE2' ' A' ' 52' ' ' GLU . 13.4 Cg_exo -34.32 -62.85 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.006 3.138 . . . . 19.870000000000001 113.279 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -86.55 133.95 33.69 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.43 -0.582 . . . . 21.100000000000001 109.43 174.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 51.8 ttp -71.3 79.46 0.73 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.968 -0.56 . . . . 22.300000000000001 111.804 -173.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 25.9 ttt -160.16 67.76 2.77 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.861 -0.609 . . . . 23.850000000000001 109.375 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.89 2.4 8.28 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.916 2.411 . . . . 20.670000000000002 113.474 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.11 22.38 12.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.63 0.253 . . . . 20.489999999999998 111.271 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.95 -57.6 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.368 . . . . 21.469999999999999 110.8 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.1 t -100.59 6.54 44.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.432 0.634 . . . . 22.600000000000001 110.107 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 62.09 45.22 7.31 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.008 -0.996 . . . . 21.93 111.193 176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.64 -20.7 61.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.613 -0.721 . . . . 19.73 110.753 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.7 mp -103.62 133.15 20.44 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.732 -0.667 . . . . 19.579999999999998 109.95 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.3 134.38 36.05 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.66 2.24 . . . . 18.5 111.518 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.2 p -75.25 73.0 2.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.3 0.572 . . . . 17.609999999999999 111.243 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 3.8 pt20 -70.12 122.7 87.01 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.815 -0.63 . . . . 18.760000000000002 110.212 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 66' ' ' GLN . 23.5 Cg_exo -63.43 147.76 93.14 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.608 2.206 . . . . 17.280000000000001 111.783 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -59.33 134.52 59.36 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.378 2.052 . . . . 17.77 110.844 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.52 -39.49 88.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.378 -0.828 . . . . 18.699999999999999 111.532 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.57 -61.14 4.74 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.317 -0.713 . . . . 17.719999999999999 111.317 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -160.02 97.74 1.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 122.235 0.214 . . . . 18.0 110.607 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 67.46 -175.06 0.19 Allowed 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.718 0.636 . . . . 17.960000000000001 111.687 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -137.33 131.05 31.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.894 -0.594 . . . . 19.850000000000001 109.629 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -78.63 56.56 1.86 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 19.670000000000002 111.435 -174.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 m -118.58 93.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.567 0.698 . . . . 17.739999999999998 111.071 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -74.45 -29.8 61.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.628 -0.714 . . . . 19.949999999999999 110.126 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.81 113.58 7.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.694 -0.684 . . . . 18.390000000000001 110.084 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.79 -43.14 68.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.934 -0.65 . . . . 17.66 112.186 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -89.08 -13.68 38.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.992 0.425 . . . . 17.68 110.318 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 60.16 27.71 17.22 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.248 -0.887 . . . . 17.800000000000001 110.818 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.19 93.51 8.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.688 -0.687 . . . . 17.350000000000001 110.715 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.49 94.1 46.72 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 16.640000000000001 110.324 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.76 106.26 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.854 2.37 . . . . 17.23 111.964 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.6 p -136.57 40.98 2.58 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.182 -0.917 . . . . 17.34 110.293 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.1 tp -109.43 129.33 55.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.693 -0.685 . . . . 18.41 110.782 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -83.68 125.68 72.87 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.161 -0.472 . . . . 17.449999999999999 110.152 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.27 -6.38 19.07 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.83 2.353 . . . . 18.890000000000001 114.092 -174.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.81 -13.14 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.749 -0.38 . . . . 17.809999999999999 111.338 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.1 p -76.92 -80.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.624 -0.262 . . . . 18.629999999999999 111.061 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.8 mt 54.58 31.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.685 0.755 . . . . 19.100000000000001 110.322 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.31 27.71 12.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.095 -0.957 . . . . 19.25 112.15 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -94.03 99.93 12.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 18.789999999999999 110.773 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -163.02 162.77 26.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.764 -0.653 . . . . 18.949999999999999 109.899 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 63.56 22.84 13.36 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.485 0.49 . . . . 20.309999999999999 111.372 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.9 p -70.99 -41.01 71.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.659 0.742 . . . . 21.399999999999999 109.643 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -109.94 21.06 17.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.934 -1.03 . . . . 21.16 108.911 173.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 58.06 34.16 23.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 114.526 -1.216 . . . . 22.18 111.518 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 58.41 83.11 0.22 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 114.864 -1.062 . . . . 19.449999999999999 111.576 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.28 91.33 0.33 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.127 2.551 . . . . 18.530000000000001 111.944 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 67.64 139.39 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 115.626 -0.715 . . . . 17.449999999999999 111.582 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.01 55.28 4.94 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.674 2.249 . . . . 17.420000000000002 111.744 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -72.96 128.8 87.42 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.972 -0.558 . . . . 17.68 110.595 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 18.9 Cg_exo -67.58 79.51 0.47 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.685 2.257 . . . . 16.289999999999999 112.042 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.9 m -90.81 15.69 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-O 121.7 0.762 . . . . 17.260000000000002 110.497 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -139.55 109.97 7.41 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.762 -1.108 . . . . 15.800000000000001 109.927 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.25 155.22 70.14 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.626 2.217 . . . . 15.92 111.923 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -72.55 3.4 4.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.929 2.42 . . . . 16.149999999999999 112.077 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -126.98 148.35 65.29 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.476 -0.783 . . . . 17.629999999999999 109.217 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.73 7.94 2.53 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.613 2.209 . . . . 15.039999999999999 112.688 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.1 tttp 55.19 68.96 2.2 Favored Pre-proline 0 C--N 1.333 -0.116 0 CA-C-N 114.648 -1.16 . . . . 15.199999999999999 110.78 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.33 134.92 54.62 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.458 2.105 . . . . 14.08 112.251 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -82.68 54.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.597 1.189 . . . . 15.279999999999999 109.994 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.85 -52.78 39.45 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 114.541 -1.209 . . . . 16.84 110.61 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.15 135.69 25.5 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.487 1.458 . . . . 15.51 111.121 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 61.09 5.65 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.806 2.337 . . . . 16.039999999999999 112.417 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -104.66 127.19 29.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.962 -0.563 . . . . 18.91 110.821 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 16.4 Cg_exo -69.61 134.33 28.03 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.366 2.044 . . . . 17.039999999999999 110.323 169.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 117' ' ' PRO . 49.4 mmtm 70.49 123.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.654 0.596 . . . . 17.52 110.69 -175.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.2 m -69.3 -11.68 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.971 0.415 . . . . 18.699999999999999 111.093 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.27 13.09 20.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 20.879999999999999 110.816 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.67 146.07 97.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 18.890000000000001 110.594 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.18 125.83 20.36 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.99 2.46 . . . . 20.43 112.22 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.12 -40.34 85.52 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.296 2.664 . . . . 21.100000000000001 112.029 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.424 ' O ' ' HD2' ' A' ' 127' ' ' PRO . . . -113.09 126.26 28.5 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.914 -0.585 . . . . 21.149999999999999 109.693 176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 124' ' ' ALA . 7.8 Cg_exo -73.42 49.18 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.904 2.403 . . . . 21.149999999999999 112.054 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.55 ' H ' ' HD2' ' A' ' 127' ' ' PRO . 16.7 tppt? -98.24 -52.45 0.21 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.03 -0.532 . . . . 21.879999999999999 111.412 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.55 ' HD2' ' H ' ' A' ' 126' ' ' LYS . 56.5 Cg_endo -70.25 73.64 1.58 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.988 1.792 . . . . 20.190000000000001 112.349 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 30.6 tt0 -64.25 136.12 96.62 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 115.84 -0.618 . . . . 20.48 109.46 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 128' ' ' GLU . 19.2 Cg_exo -67.5 57.24 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.318 2.679 . . . . 21.170000000000002 114.132 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -134.51 115.76 12.68 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.172 -0.677 . . . . 23.18 109.172 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.72 121.92 9.42 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.369 2.046 . . . . 20.780000000000001 111.847 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.6 p -74.96 78.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 122.461 1.124 . . . . 19.75 110.544 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.1 m -83.04 -179.38 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 114.841 -1.072 . . . . 21.050000000000001 110.671 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 67.07 168.12 0.24 Allowed 'General case' 0 C--O 1.236 0.345 0 O-C-N 123.635 0.584 . . . . 21.300000000000001 110.108 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -81.47 68.24 7.73 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.343 -0.614 . . . . 20.739999999999998 109.343 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -100.38 -57.83 2.03 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.368 -0.833 . . . . 17.969999999999999 109.191 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 142' ' ' LYS . . . -62.14 -50.18 72.91 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.456 -1.313 . . . . 17.350000000000001 107.456 166.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 65.48 152.83 0.12 Allowed Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.55 -1.204 . . . . 19.100000000000001 110.996 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.487 ' HA ' ' CB ' ' A' ' 192' ' ' ALA . 8.3 Cg_exo -73.51 39.7 0.5 Allowed 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.624 2.216 . . . . 19.350000000000001 113.401 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 12.9 t 175.65 -14.87 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 111.931 0.345 . . . . 17.75 111.931 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -81.61 -89.41 0.61 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.452 -0.88 . . . . 17.960000000000001 111.814 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 137' ' ' ALA . 80.7 tttt -93.42 80.43 4.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.188 -1.042 . . . . 19.420000000000002 108.188 173.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.772 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . -91.17 165.56 13.41 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.27 -0.877 . . . . 14.65 109.535 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.695 ' CE2' ' HB2' ' A' ' 194' ' ' LYS . 4.4 m-85 -136.76 140.16 42.36 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 111.745 0.276 . . . . 14.81 111.745 -174.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 1.026 HG23 ' HB2' ' A' ' 217' ' ' TYR . 3.2 t -148.91 163.79 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.229 -0.656 . . . . 10.48 109.229 171.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.489 HG11 HD22 ' A' ' 204' ' ' LEU . 40.1 t -105.54 113.26 41.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 O-C-N 121.787 -0.571 . . . . 10.1 111.267 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.52 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 49.6 tt0 -86.01 116.83 24.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.636 -0.256 . . . . 12.0 111.551 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.984 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -93.35 -35.09 13.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.088 0.47 . . . . 11.880000000000001 110.21 -178.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -147.25 169.38 28.25 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.454 -0.879 . . . . 11.35 112.569 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -163.58 105.39 0.96 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.865 -0.791 . . . . 13.470000000000001 108.865 177.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -138.91 159.36 42.33 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.21 0.529 . . . . 13.52 110.909 -171.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 9.2 mmmm -96.93 -3.46 41.76 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.12 -0.945 . . . . 17.600000000000001 110.162 -174.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -111.91 115.87 29.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.371 -0.832 . . . . 16.140000000000001 110.338 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.57 -19.6 65.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 14.039999999999999 111.007 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.14 -32.4 69.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.669 0.747 . . . . 16.57 110.199 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.528 ' HB3' HD22 ' A' ' 151' ' ' LEU . 32.5 mmtp -89.47 -31.27 17.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.739 -1.119 . . . . 16.399999999999999 110.368 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' THR . 94.9 t -61.89 -40.99 89.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.488 -0.778 . . . . 12.67 110.135 175.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -54.83 -36.38 64.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.078 -0.964 . . . . 15.32 111.056 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 18.5 mt-10 -69.13 -60.78 2.12 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.174 0.511 . . . . 15.970000000000001 110.057 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.55 HG23 HD13 ' A' ' 210' ' ' LEU . 7.9 mt -56.03 -45.19 80.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.074 -0.966 . . . . 12.6 110.971 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.3 t -74.74 -41.22 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.758 -0.656 . . . . 12.539999999999999 110.451 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.95 -28.54 66.27 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.547 -0.835 . . . . 14.800000000000001 111.763 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 159' ' ' GLU . 15.5 mttp -73.74 -56.73 4.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.612 0.244 . . . . 16.050000000000001 111.41 177.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.4 mm? -82.56 -51.73 7.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.093 0.405 . . . . 12.99 112.093 -174.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -65.84 -41.59 91.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.246 0.546 . . . . 15.06 109.653 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -69.23 -24.16 76.05 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.369 -0.832 . . . . 16.600000000000001 112.745 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -91.87 4.55 52.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.034 0.445 . . . . 16.140000000000001 110.877 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.61 25.11 47.88 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.956 -0.64 . . . . 15.119999999999999 113.54 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -89.65 160.12 16.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.159 0.48 . . . . 15.49 110.252 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.96 102.7 8.44 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.554 0.692 . . . . 13.869999999999999 109.379 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.84 139.8 27.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.753 -1.112 . . . . 10.82 109.87 -173.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.564 ' CE1' HG21 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -138.71 176.32 8.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.686 0.755 . . . . 11.130000000000001 110.723 172.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.421 ' HB ' ' HG3' ' A' ' 178' ' ' PRO . 4.5 p -123.3 -172.63 2.55 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.46 -1.245 . . . . 11.52 112.239 -167.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.669 ' HB3' ' H ' ' A' ' 185' ' ' ARG . 0.9 OUTLIER -49.51 158.6 0.78 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.345 -0.843 . . . . 12.75 112.864 -177.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -47.36 -54.29 5.28 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.608 2.872 . . . . 14.640000000000001 113.904 -170.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.9 m -88.19 -64.09 1.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.705 -0.798 . . . . 16.68 112.227 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 42.1 m -169.26 137.93 1.63 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 122.336 0.255 . . . . 16.039999999999999 110.534 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.475 ' HB3' HG21 ' A' ' 184' ' ' THR . 76.1 Cg_exo -59.83 123.56 13.51 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.213 1.942 . . . . 14.220000000000001 111.306 165.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 12.2 p -154.66 159.42 3.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 116.177 -0.465 . . . . 16.129999999999999 110.487 -174.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -80.85 127.0 32.04 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.18 -0.464 . . . . 16.699999999999999 110.745 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 100.45 -16.45 57.87 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.981 -0.628 . . . . 16.98 112.221 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 8.5 mptt -120.84 162.5 19.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.787 -0.449 . . . . 18.73 109.787 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 152' ' ' LYS . 9.7 tp -73.38 120.11 21.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.69 0.757 . . . . 14.82 111.771 -172.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.482 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 37.8 m -113.16 105.37 13.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.432 -0.804 . . . . 12.779999999999999 109.747 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.669 ' H ' ' HB3' ' A' ' 174' ' ' SER . 15.8 ptt180 -88.18 136.25 33.06 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.362 -0.836 . . . . 13.98 109.584 176.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.537 ' C ' HD12 ' A' ' 187' ' ' LEU . 4.1 mm -110.39 123.1 65.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.677 -0.49 . . . . 10.56 109.677 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.555 ' HB3' ' CG1' ' A' ' 145' ' ' VAL . 4.5 mp -130.11 132.42 46.12 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.463 0.649 . . . . 10.1 111.441 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.984 HG23 HD21 ' A' ' 148' ' ' LEU . 26.4 t -107.57 132.72 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.053 -0.976 . . . . 9.7400000000000002 111.015 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.22 49.78 4.32 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.174 -0.921 . . . . 9.7599999999999998 113.58 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.929 ' HA ' HG22 ' A' ' 145' ' ' VAL . 9.3 Cg_endo -59.71 126.11 19.64 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 CA-C-N 119.515 1.657 . . . . 11.15 111.367 173.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -157.63 167.75 29.23 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.124 -0.695 . . . . 12.77 109.124 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.487 ' CB ' ' HA ' ' A' ' 139' ' ' PRO . . . -107.89 5.95 26.87 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.029 0.442 . . . . 14.6 110.706 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 48.1 m -120.4 107.37 12.83 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.153 -0.476 . . . . 14.300000000000001 111.254 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.695 ' HB2' ' CE2' ' A' ' 144' ' ' TYR . 35.1 ttpt -66.67 -40.4 88.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.81 -0.632 . . . . 15.970000000000001 110.023 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -62.49 -39.7 94.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.686 -0.688 . . . . 15.6 110.857 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.63 -51.22 36.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.626 -0.715 . . . . 14.220000000000001 110.493 178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.657 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -74.06 -18.85 60.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.484 . . . . 11.949999999999999 110.725 -175.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.54 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 17.4 tppt? -62.93 -39.57 95.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.197 0.522 . . . . 14.699999999999999 110.325 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.02 -17.38 79.85 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.09 -1.204 . . . . 13.09 110.09 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 31.0 m -79.39 -8.92 59.44 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.564 -0.818 . . . . 12.109999999999999 112.037 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 13.8 mt -70.81 -37.33 73.25 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.936 0.398 . . . . 12.720000000000001 110.378 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.23 -25.32 71.05 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.648 -0.981 . . . . 14.66 110.648 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.605 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 41.6 mt-10 -86.39 -24.43 25.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.941 -0.629 . . . . 13.890000000000001 110.534 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.489 HD22 HG11 ' A' ' 146' ' ' VAL . 3.0 tp -60.3 -48.25 82.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.425 -0.352 . . . . 12.550000000000001 111.103 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.0 -21.21 58.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 15.83 111.396 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.51 -38.65 13.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 16.969999999999999 110.436 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 93.1 mt -72.75 -51.85 17.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.073 -0.512 . . . . 13.890000000000001 111.615 -176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.405 ' HB3' HD11 ' A' ' 164' ' ' LEU . 64.7 p -101.87 -43.32 5.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.222 0.534 . . . . 13.539999999999999 110.919 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.39 6.18 74.84 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.908 -0.877 . . . . 14.67 110.908 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.55 HD13 HG23 ' A' ' 160' ' ' ILE . 60.3 mt -97.74 157.91 15.8 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.787 -0.449 . . . . 13.039999999999999 109.787 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 17.7 p -81.12 95.61 6.93 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.011 0.434 . . . . 14.84 111.315 -176.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -108.23 142.34 15.95 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.727 -0.749 . . . . 12.220000000000001 114.127 -173.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.1 142.39 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.526 -0.546 . . . . 13.74 109.526 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.8 t -74.38 107.02 4.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.109 -0.496 . . . . 12.890000000000001 110.512 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 23.9 mmt -109.0 141.54 40.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.741 -0.663 . . . . 13.800000000000001 109.817 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.55 107.34 2.34 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.169 -1.015 . . . . 13.359999999999999 111.748 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 1.026 ' HB2' HG23 ' A' ' 145' ' ' VAL . 6.1 t80 -63.85 133.66 53.76 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.147 -1.526 . . . . 14.24 111.066 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.9 p -141.89 91.91 7.99 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.229 -0.442 . . . . 16.510000000000002 110.246 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.35 133.47 28.4 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.306 2.004 . . . . 17.420000000000002 112.16 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--O 1.251 1.165 0 CA-C-N 115.608 -0.724 . . . . 19.190000000000001 111.247 178.043 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 120.507 0.194 . . . . 18.390000000000001 110.789 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.33 -72.48 1.12 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.292 -0.956 . . . . 17.77 113.017 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 58.25 54.48 5.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.407 0.622 . . . . 17.690000000000001 110.085 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -70.42 87.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.911 -1.04 . . . . 19.93 110.864 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -158.09 120.33 3.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.071 -0.513 . . . . 17.43 110.231 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -90.36 148.74 22.64 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.172 -0.467 . . . . 19.359999999999999 110.175 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -79.15 53.34 1.44 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.173 -0.467 . . . . 18.960000000000001 110.882 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -89.32 -44.4 10.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.034 -0.53 . . . . 18.239999999999998 109.771 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -137.02 176.89 8.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.398 -0.819 . . . . 16.780000000000001 109.803 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -86.75 -42.82 13.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.679 0.276 . . . . 18.420000000000002 111.241 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -146.29 26.5 1.19 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.041 0.386 . . . . 17.920000000000002 112.041 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.46 -16.65 30.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.361 . . . . 19.550000000000001 111.003 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.617 ' O ' ' HD3' ' A' ' 42' ' ' PRO . . . -107.21 114.1 27.93 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.871 -0.418 . . . . 20.309999999999999 109.871 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 41' ' ' ILE . 3.9 mp -102.5 96.27 7.14 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.176 -0.465 . . . . 19.920000000000002 109.85 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 40' ' ' ALA . 1.6 Cg_endo -83.54 61.16 6.95 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.968 2.445 . . . . 21.640000000000001 110.565 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.425 ' C ' ' HD3' ' A' ' 45' ' ' PRO . 11.1 mp 63.51 29.06 15.41 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 115.282 -0.872 . . . . 22.670000000000002 109.995 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.9 t -127.55 69.92 75.95 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 115.534 -0.757 . . . . 21.34 110.813 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 43' ' ' LEU . 3.1 Cg_exo -84.01 -5.56 10.46 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.918 2.412 . . . . 20.0 111.559 172.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -61.67 -35.92 79.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.495 -0.775 . . . . 21.079999999999998 110.902 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.18 169.48 22.89 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.865 -0.607 . . . . 18.800000000000001 109.697 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.84 -92.93 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.508 -0.853 . . . . 17.510000000000002 111.803 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -100.74 165.49 11.35 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.095 -0.705 . . . . 16.949999999999999 109.095 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -59.99 -40.53 89.48 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.562 -0.533 . . . . 18.300000000000001 109.562 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -99.36 153.04 19.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.685 -0.689 . . . . 18.170000000000002 109.792 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 7.6 mm-40 -78.61 145.42 67.15 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.633 -0.258 . . . . 18.82 110.736 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 52' ' ' GLU . 9.9 Cg_exo -72.41 72.67 2.89 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.1 2.534 . . . . 19.870000000000001 111.974 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 24.7 t70 -135.01 160.28 38.82 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.799 -0.637 . . . . 21.100000000000001 109.383 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.2 ttt -63.34 -25.39 68.27 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.169 0.293 . . . . 22.300000000000001 111.342 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 17.2 ptp -159.02 68.9 3.37 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.955 0.407 . . . . 23.850000000000001 111.051 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 54' ' ' ASP . 67.1 Cg_endo -83.38 -20.69 4.77 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.478 2.119 . . . . 20.670000000000002 112.024 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -149.23 92.04 1.91 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.57 -0.741 . . . . 20.489999999999998 109.361 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.88 -63.73 1.0 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 21.469999999999999 111.666 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.2 t -98.23 -23.47 15.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.848 0.356 . . . . 22.600000000000001 110.993 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -87.89 61.12 6.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.418 0.628 . . . . 21.93 110.27 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -108.71 14.82 24.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.742 -0.663 . . . . 19.73 110.358 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -81.59 117.14 67.07 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.206 -0.664 . . . . 19.579999999999998 109.206 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.34 108.06 1.11 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.551 2.167 . . . . 18.5 112.454 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.7 m -76.33 -22.69 54.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.329 0.585 . . . . 17.609999999999999 110.096 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -115.98 87.49 19.02 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.752 -0.658 . . . . 18.760000000000002 109.349 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.43 131.8 5.72 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.396 2.064 . . . . 17.280000000000001 112.899 -176.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.51 127.75 13.61 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.67 2.247 . . . . 17.77 111.798 173.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -84.42 166.97 16.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.246 -0.434 . . . . 18.699999999999999 110.466 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.8 129.32 13.22 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.972 -0.632 . . . . 17.719999999999999 112.3 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 60.81 41.26 14.92 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.093 0.557 . . . . 18.0 111.353 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.15 60.1 2.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.293 0.568 . . . . 17.960000000000001 110.958 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -124.27 52.31 1.51 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.041 -0.527 . . . . 19.850000000000001 110.434 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.91 -47.32 80.83 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.402 -0.817 . . . . 19.670000000000002 110.039 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 m -109.58 132.13 58.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.528 -0.76 . . . . 17.739999999999998 109.883 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -133.55 -61.39 0.81 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.223 -0.444 . . . . 19.949999999999999 110.01 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.93 98.24 8.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.114 -0.494 . . . . 18.390000000000001 110.394 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.85 -141.87 7.12 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.805 -0.712 . . . . 17.66 111.994 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -131.7 19.17 4.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.898 0.38 . . . . 17.68 110.246 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 56.76 41.54 28.01 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.339 -0.846 . . . . 17.800000000000001 111.729 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.51 31.4 1.54 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.177 0.513 . . . . 17.350000000000001 110.524 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.96 135.07 91.86 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 16.640000000000001 111.071 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.41 131.92 26.04 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.665 2.243 . . . . 17.23 112.117 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.1 m 64.87 35.29 8.55 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.335 -0.848 . . . . 17.34 111.056 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.8 tp -80.41 -21.09 42.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.018 -0.537 . . . . 18.41 109.703 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -61.46 128.08 89.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.497 -0.774 . . . . 17.449999999999999 109.953 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.66 -6.05 16.57 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.912 2.408 . . . . 18.890000000000001 113.547 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 67.19 94.66 0.07 Allowed 'General case' 0 N--CA 1.462 0.162 0 O-C-N 123.894 0.746 . . . . 17.809999999999999 111.196 -177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.6 p -80.31 67.98 6.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.4 0.619 . . . . 18.629999999999999 111.146 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.8 pt -99.67 24.42 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.761 -0.654 . . . . 19.100000000000001 110.701 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.6 -44.38 0.55 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.664 0.786 . . . . 19.25 111.52 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 71.84 -56.53 0.64 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.816 0.847 . . . . 18.789999999999999 111.984 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -77.78 -35.21 51.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.471 -0.331 . . . . 18.949999999999999 111.138 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 96' ' ' GLU . 87.3 m-20 -67.17 176.58 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.772 -0.195 . . . . 20.309999999999999 110.943 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.1 p 67.49 -36.16 0.28 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.931 1.292 . . . . 21.399999999999999 111.03 -171.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 94' ' ' ASN . 6.7 mm-40 -90.07 -5.58 56.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.208 0.528 . . . . 21.16 109.865 172.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 24.1 t80 61.54 47.98 6.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.754 -1.112 . . . . 22.18 109.886 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 63.05 97.75 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.266 0 CA-C-N 114.991 -1.004 . . . . 19.449999999999999 111.611 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -79.79 96.64 1.05 Allowed 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 123.188 2.592 . . . . 18.530000000000001 111.972 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -81.65 152.39 69.53 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.033 -0.53 . . . . 17.449999999999999 110.14 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.87 46.36 1.9 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.95 2.433 . . . . 17.420000000000002 112.591 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.481 ' N ' ' HD2' ' A' ' 103' ' ' PRO . . . -88.35 -50.82 0.4 Allowed Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 17.68 111.672 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 102' ' ' ALA . 37.0 Cg_endo -66.73 89.67 0.29 Allowed 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.165 1.91 . . . . 16.289999999999999 112.376 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.4 m -94.03 115.36 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 116.039 -0.528 . . . . 17.260000000000002 110.367 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.72 116.03 12.88 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.063 -0.517 . . . . 15.800000000000001 111.058 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.89 131.89 48.85 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.026 2.484 . . . . 15.92 112.359 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.48 137.55 60.51 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.908 2.405 . . . . 16.149999999999999 112.563 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.577 ' HG2' ' H ' ' A' ' 110' ' ' LYS . 41.5 ttmt -68.1 121.2 79.13 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 17.629999999999999 110.16 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -84.12 16.04 2.02 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.884 2.389 . . . . 15.039999999999999 112.765 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.577 ' H ' ' HG2' ' A' ' 108' ' ' LYS . 88.5 tttt 68.94 130.77 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 115.522 -0.763 . . . . 15.199999999999999 111.228 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.73 138.22 84.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.535 2.157 . . . . 14.08 111.684 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -88.26 49.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 122.162 0.982 . . . . 15.279999999999999 110.081 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -170.33 81.59 0.58 Allowed Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 114.12 -1.4 . . . . 16.84 110.104 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.88 125.85 20.51 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.005 2.47 . . . . 15.51 112.187 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.99 54.19 4.77 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 123.224 2.616 . . . . 16.039999999999999 112.327 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.4 tttm 57.4 80.57 0.28 Allowed Pre-proline 0 C--O 1.233 0.198 0 CA-C-N 115.645 -0.707 . . . . 18.91 110.402 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.31 -16.27 47.78 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.621 2.214 . . . . 17.039999999999999 111.799 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.12 75.29 9.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.803 -0.635 . . . . 17.52 110.197 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.4 t -92.66 -51.44 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.681 -0.69 . . . . 18.699999999999999 109.899 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 9.0 pt-20 -101.32 1.97 39.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 20.879999999999999 110.4 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.06 111.32 35.07 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.65 -0.705 . . . . 18.890000000000001 111.122 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 120' ' ' GLU . 88.9 Cg_endo -91.87 142.27 2.64 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.045 2.497 . . . . 20.43 112.174 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.01 -11.45 19.69 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.473 2.115 . . . . 21.100000000000001 111.607 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.48 153.37 26.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.501 -0.772 . . . . 21.149999999999999 109.228 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.68 -55.64 3.8 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.694 2.263 . . . . 21.149999999999999 112.552 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt 64.2 107.45 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.234 0 O-C-N 123.749 0.656 . . . . 21.879999999999999 111.538 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.23 57.49 4.07 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 122.755 2.303 . . . . 20.190000000000001 112.462 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -76.32 123.07 87.8 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.885 -0.598 . . . . 20.48 110.453 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.12 126.69 21.69 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.82 2.347 . . . . 21.170000000000002 111.645 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -69.99 -39.91 11.81 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 112.926 0.713 . . . . 23.18 112.926 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -71.04 84.49 0.86 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.761 1.641 . . . . 20.780000000000001 111.54 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.462 HG23 ' HD3' ' A' ' 136' ' ' LYS . 5.2 p -89.17 76.17 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.254 1.026 . . . . 19.75 110.281 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.4 t -100.02 -3.9 9.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.944 0.878 . . . . 21.050000000000001 109.901 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -109.94 174.47 5.85 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.58 -1.191 . . . . 21.300000000000001 110.541 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -67.26 -62.38 1.45 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.05 -0.352 . . . . 20.739999999999998 110.05 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.462 ' HD3' HG23 ' A' ' 132' ' ' VAL . 29.7 mtpp 75.1 -48.7 0.64 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.975 0.797 . . . . 17.969999999999999 111.701 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.414 ' HB2' ' HE3' ' A' ' 194' ' ' LYS . . . -75.51 -21.98 57.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.312 -0.404 . . . . 17.350000000000001 110.061 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 73.02 146.55 0.12 Allowed Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 114.829 -1.078 . . . . 19.100000000000001 111.607 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.599 ' HA ' ' HB1' ' A' ' 192' ' ' ALA . 71.5 Cg_exo -49.64 -60.95 0.66 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.348 2.698 . . . . 19.350000000000001 114.043 -173.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.2 m -109.44 0.88 19.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.258 0.551 . . . . 17.75 110.549 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.27 -61.65 2.59 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.805 -0.712 . . . . 17.960000000000001 111.98 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -130.91 58.2 1.72 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.196 0.522 . . . . 19.420000000000002 110.772 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.577 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -71.37 165.32 23.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.442 -0.799 . . . . 14.65 109.133 173.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.595 ' CE2' ' HD3' ' A' ' 194' ' ' LYS . 4.3 m-85 -143.47 155.43 44.36 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.487 0.551 . . . . 14.81 112.487 -175.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.797 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.5 t -148.39 167.07 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.252 -1.018 . . . . 10.48 108.252 174.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 59.0 t -107.62 112.85 41.9 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 O-C-N 121.686 -0.633 . . . . 10.1 111.31 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.555 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 48.9 tt0 -84.52 114.54 22.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.355 -0.384 . . . . 12.0 111.381 -176.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.91 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -96.45 -33.07 12.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.391 0.615 . . . . 11.880000000000001 110.169 -178.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.29 168.39 27.18 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.47 -0.786 . . . . 11.35 112.169 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -170.93 101.49 0.22 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.0 -0.741 . . . . 13.470000000000001 109.0 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.81 164.65 35.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.86 -0.609 . . . . 13.52 110.785 -173.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 32.4 mtmm -101.6 15.32 29.27 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.128 -0.942 . . . . 17.600000000000001 110.389 -173.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -109.87 105.14 14.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.153 -0.93 . . . . 16.140000000000001 108.96 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.36 -22.13 63.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.199 -0.455 . . . . 14.039999999999999 111.682 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -65.48 -38.22 89.14 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.928 0.871 . . . . 16.57 109.292 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -75.43 -29.79 59.83 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.309 -1.314 . . . . 16.399999999999999 110.119 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 89.3 t -63.29 -40.84 90.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.627 -0.715 . . . . 12.67 109.867 172.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -64.17 -22.23 66.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.644 -0.707 . . . . 15.32 111.954 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.698 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 14.5 mt-10 -78.0 -62.9 1.53 Allowed 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 109.143 -0.688 . . . . 15.970000000000001 109.143 176.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.535 HD12 HG13 ' A' ' 186' ' ' ILE . 10.3 mt -54.48 -48.47 69.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.599 -0.728 . . . . 12.6 110.949 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.85 -40.01 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.762 -0.654 . . . . 12.539999999999999 110.555 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.88 -28.91 72.66 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.462 -0.875 . . . . 14.800000000000001 112.138 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.698 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.6 mptp? -80.95 -49.3 11.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.4 0.148 . . . . 16.050000000000001 111.4 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.42 HD21 ' HA ' ' A' ' 208' ' ' SER . 0.7 OUTLIER -79.87 -55.85 4.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 12.99 111.484 -179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.401 ' HB2' ' CG1' ' A' ' 171' ' ' VAL . 69.0 ttt180 -66.89 -40.8 87.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.249 0.547 . . . . 15.06 110.313 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.76 -19.87 73.69 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.222 -0.899 . . . . 16.600000000000001 112.66 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.05 -5.59 57.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.808 0.337 . . . . 16.140000000000001 110.916 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.71 24.97 12.36 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.651 -0.785 . . . . 15.119999999999999 112.806 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -94.8 148.3 22.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.933 -0.395 . . . . 15.49 109.933 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -76.67 96.55 4.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.164 -0.68 . . . . 13.869999999999999 109.164 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 165' ' ' ARG . 7.4 p -142.62 143.74 25.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.404 -0.816 . . . . 10.82 109.456 -176.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.471 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -139.08 176.49 8.66 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.69 0.757 . . . . 11.130000000000001 110.85 176.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 20.2 p -113.93 -176.4 2.89 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.477 -1.238 . . . . 11.52 111.004 -173.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.5 OUTLIER -53.16 141.33 40.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 O-C-N 123.166 0.291 . . . . 12.75 110.778 178.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -40.14 -47.49 4.05 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 124.484 3.456 . . . . 14.640000000000001 115.553 -169.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.3 m -85.44 -63.68 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.522 -0.871 . . . . 16.68 112.696 -171.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 98.8 m -168.49 129.94 1.14 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 118.375 0.534 . . . . 16.039999999999999 112.096 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.465 ' HB3' HG21 ' A' ' 184' ' ' THR . 74.7 Cg_exo -62.63 123.97 13.31 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.519 2.146 . . . . 14.220000000000001 111.713 161.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.491 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 7.7 p -154.01 159.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 109.63 -0.507 . . . . 16.129999999999999 109.63 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -81.47 129.15 34.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.967 0.413 . . . . 16.699999999999999 110.721 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 104.81 -25.79 24.43 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.058 -0.591 . . . . 16.98 112.376 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.491 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 2.8 mptp? -114.35 157.69 22.48 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.557 -0.534 . . . . 18.73 109.557 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.6 tp -69.82 109.93 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.594 0.711 . . . . 14.82 111.815 -173.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 178' ' ' PRO . 54.0 m -101.79 111.39 23.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.786 -0.643 . . . . 12.779999999999999 109.562 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 74.1 mtp180 -92.22 139.57 30.48 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.39 -0.823 . . . . 13.98 109.755 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.535 HG13 HD12 ' A' ' 160' ' ' ILE . 4.1 mm -109.6 118.86 57.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.251 -0.648 . . . . 10.56 109.251 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 186' ' ' ILE . 5.2 mp -129.81 120.88 25.72 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.386 0.612 . . . . 10.1 111.386 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.91 HG23 HD21 ' A' ' 148' ' ' LEU . 38.0 t -95.38 136.02 27.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.508 -0.769 . . . . 9.7400000000000002 110.822 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.46 47.9 5.52 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.316 -0.856 . . . . 9.7599999999999998 113.943 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.772 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.5 Cg_endo -61.36 126.21 18.74 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 CA-C-N 119.732 1.766 . . . . 11.15 110.998 175.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -155.04 154.56 32.66 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.512 -0.475 . . . . 12.77 110.376 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.599 ' HB1' ' HA ' ' A' ' 139' ' ' PRO . . . -95.02 -4.51 46.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.649 -0.705 . . . . 14.6 111.312 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 73.1 m -112.5 100.57 8.85 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.487 0.661 . . . . 14.300000000000001 110.431 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.595 ' HD3' ' CE2' ' A' ' 144' ' ' TYR . 22.1 ttpp -55.66 -59.78 4.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.461 -1.245 . . . . 15.970000000000001 112.011 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.13 -27.96 68.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.686 -0.688 . . . . 15.6 111.81 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -72.51 -37.8 68.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.423 0.63 . . . . 14.220000000000001 110.154 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -85.55 -23.52 27.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.791 -0.64 . . . . 11.949999999999999 110.444 -175.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.557 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 36.8 mttt -74.66 -32.77 62.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.054 0.454 . . . . 14.699999999999999 110.634 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -73.81 -12.63 80.88 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.965 -1.254 . . . . 13.09 109.965 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 47.7 m -90.67 -8.89 48.73 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.365 -0.917 . . . . 12.109999999999999 112.24 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 22.7 mt -66.14 -33.37 75.61 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.186 -0.321 . . . . 12.720000000000001 110.989 -175.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.81 -44.16 97.28 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.807 -0.711 . . . . 14.66 111.94 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -85.62 -17.93 34.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.635 0.255 . . . . 13.890000000000001 111.037 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.43 HD12 HD12 ' A' ' 207' ' ' LEU . 24.5 tp -70.15 -29.32 66.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.05 0.453 . . . . 12.550000000000001 109.996 -176.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 61.3 mttp -60.92 -22.66 64.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.61 -0.723 . . . . 15.83 110.861 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.57 -35.34 30.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.291 0.567 . . . . 16.969999999999999 109.754 174.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.43 HD12 HD12 ' A' ' 204' ' ' LEU . 82.2 mt -75.45 -52.47 10.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.417 -0.81 . . . . 13.890000000000001 111.453 -175.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.42 ' HA ' HD21 ' A' ' 164' ' ' LEU . 31.9 p -98.64 -45.07 6.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.031 0.444 . . . . 13.539999999999999 110.717 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 60.59 21.79 58.31 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.598 -0.728 . . . . 14.67 111.868 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.436 ' HB2' ' HG ' ' A' ' 148' ' ' LEU . 79.8 mt -98.47 158.09 15.81 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.126 -0.694 . . . . 13.039999999999999 109.126 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 16.9 p -73.72 92.61 2.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.822 0.344 . . . . 14.84 110.756 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -111.33 146.33 17.76 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.486 -0.864 . . . . 12.220000000000001 114.256 -174.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 49.1 t -117.01 140.97 37.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.356 -0.979 . . . . 13.74 108.356 170.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.495 HG21 ' HE2' ' A' ' 198' ' ' LYS . 6.3 p -76.14 106.51 6.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.792 0.806 . . . . 12.890000000000001 110.314 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 23.0 mmt -113.18 145.99 40.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.152 -0.931 . . . . 13.800000000000001 110.797 -174.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.7 139.53 27.64 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.628 -0.796 . . . . 13.359999999999999 112.861 -177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.797 ' HB2' HG23 ' A' ' 145' ' ' VAL . 9.2 t80 -106.54 126.12 51.87 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 124.332 1.053 . . . . 14.24 110.123 -175.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 16.8 p -136.33 92.78 15.26 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 120.808 0.337 . . . . 16.510000000000002 110.582 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.565 ' HG3' ' CZ ' ' A' ' 217' ' ' TYR . 14.5 Cg_exo -63.15 120.15 7.5 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.374 2.049 . . . . 17.420000000000002 111.925 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.243 -0.884 . . . . 19.190000000000001 109.418 -176.752 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.806 -0.442 . . . . 18.390000000000001 109.806 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 35' ' ' GLN . . . 144.5 -11.34 1.98 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.312 -0.946 . . . . 17.77 113.16 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 68.61 -66.22 0.25 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.258 0.623 . . . . 17.690000000000001 110.893 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -99.29 -69.24 0.77 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.297 -0.631 . . . . 19.93 109.297 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -128.32 -69.31 0.73 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.968 -0.56 . . . . 17.43 110.681 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -168.17 -3.32 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.779 0.323 . . . . 19.359999999999999 111.805 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -79.35 -9.08 59.51 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 122.002 -0.436 . . . . 18.960000000000001 111.444 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.522 ' O ' ' HA2' ' A' ' 29' ' ' GLY . 27.3 mt-30 -138.56 166.3 24.68 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.464 -0.569 . . . . 18.239999999999998 109.464 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.421 ' HA ' ' OG1' ' A' ' 65' ' ' THR . 3.1 m-20 56.11 78.03 0.22 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.898 0.749 . . . . 16.780000000000001 112.22 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.535 ' HG2' ' H ' ' A' ' 38' ' ' PHE . 21.0 tt0 -129.12 170.36 13.62 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.61 -0.885 . . . . 18.420000000000002 108.61 176.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.535 ' H ' ' HG2' ' A' ' 37' ' ' GLU . 81.6 m-85 -75.08 39.11 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.834 0.349 . . . . 17.920000000000002 111.742 -176.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -110.86 -10.76 14.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.238 0.542 . . . . 19.550000000000001 109.983 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.71 132.47 39.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.585 -0.734 . . . . 20.309999999999999 110.447 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.46 HG22 ' HG2' ' A' ' 45' ' ' PRO . 14.0 pt -134.07 79.93 55.26 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.173 0.511 . . . . 19.920000000000002 111.259 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -76.74 51.88 3.51 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.591 2.194 . . . . 21.640000000000001 111.045 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 60.76 32.67 20.21 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.741 -0.663 . . . . 22.670000000000002 110.41 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.63 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 89.2 t -110.25 -62.96 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.932 -0.576 . . . . 21.34 112.337 -176.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 5.8 Cg_exo -81.92 126.31 5.07 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.329 2.019 . . . . 20.0 112.4 -172.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -86.8 105.7 17.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.062 -0.517 . . . . 21.079999999999998 110.822 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 53.07 52.32 14.0 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.997 -0.547 . . . . 18.800000000000001 111.12 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -142.99 31.72 1.96 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.638 -0.791 . . . . 17.510000000000002 112.265 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -100.36 138.92 36.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.01 0.433 . . . . 16.949999999999999 110.558 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -109.74 49.12 0.85 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.782 0.801 . . . . 18.300000000000001 108.846 171.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.98 127.65 43.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.974 -1.012 . . . . 18.170000000000002 109.638 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -78.12 113.06 30.09 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.571 -0.286 . . . . 18.82 110.291 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 91.2 Cg_endo -85.4 30.06 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.837 2.358 . . . . 19.870000000000001 112.782 -175.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -141.33 -60.95 0.48 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.469 -0.332 . . . . 21.100000000000001 111.395 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.478 ' HG3' ' N ' ' A' ' 56' ' ' MET . 24.8 ptp -70.27 -54.29 13.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.902 0.334 . . . . 22.300000000000001 111.902 -175.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.478 ' N ' ' HG3' ' A' ' 55' ' ' MET . 57.4 mtt -161.55 76.05 2.36 Favored Pre-proline 0 CA--C 1.517 -0.321 0 N-CA-C 109.555 -0.535 . . . . 23.850000000000001 109.555 -173.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 53' ' ' PRO . 85.3 Cg_endo -78.9 124.3 6.11 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.07 1.846 . . . . 20.670000000000002 111.46 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 68.23 -53.6 0.53 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.359 -0.837 . . . . 20.489999999999998 110.96 -171.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 56.83 65.59 1.37 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.128 0.489 . . . . 21.469999999999999 110.071 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.6 m 62.12 52.37 3.27 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.222 -0.899 . . . . 22.600000000000001 109.757 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 67.7 131.08 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.831 -1.077 . . . . 21.93 111.442 -176.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 63' ' ' LEU . . . -87.43 37.49 0.78 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.841 -0.618 . . . . 19.73 110.671 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 3.5 mm? 68.78 140.5 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.285 -0.87 . . . . 19.579999999999998 111.195 -177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.59 83.31 0.67 Allowed 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.327 2.018 . . . . 18.5 111.84 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' A' ' 36' ' ' ASP . 29.6 m -75.36 117.58 17.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.897 -0.592 . . . . 17.609999999999999 110.775 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.541 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 34.9 tt0 -177.82 -52.32 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 115.905 -0.589 . . . . 18.760000000000002 111.614 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 66' ' ' GLN . 75.6 Cg_exo -50.88 -50.18 14.64 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.322 2.014 . . . . 17.280000000000001 115.011 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.26 142.92 34.53 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.489 1.459 . . . . 17.77 113.504 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 65.87 -89.14 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.048 -0.978 . . . . 18.699999999999999 112.628 171.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.9 55.44 5.32 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.516 -0.85 . . . . 17.719999999999999 111.547 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.36 143.32 40.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.573 0.225 . . . . 18.0 111.047 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -175.94 -60.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.819 -0.628 . . . . 17.960000000000001 110.141 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -112.26 79.24 1.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.709 -0.678 . . . . 19.850000000000001 110.34 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.33 -8.41 53.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.524 . . . . 19.670000000000002 110.303 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.0 p -91.24 127.67 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.872 -0.604 . . . . 17.739999999999998 109.543 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -126.38 -19.75 4.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.142 -0.481 . . . . 19.949999999999999 111.229 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.56 54.3 3.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.103 0.478 . . . . 18.390000000000001 110.185 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.29 -106.9 1.97 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.598 -0.728 . . . . 17.66 112.218 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -173.49 -60.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.218 -0.66 . . . . 17.68 109.218 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -158.7 36.79 0.22 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.274 -0.876 . . . . 17.800000000000001 109.668 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.54 67.38 8.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.741 -0.663 . . . . 17.350000000000001 111.381 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.84 89.12 45.14 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.935 -0.575 . . . . 16.640000000000001 109.886 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.94 79.23 1.33 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.167 2.578 . . . . 17.23 112.445 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.6 m 71.68 132.34 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.624 -0.716 . . . . 17.34 111.498 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.405 ' N ' HD22 ' A' ' 85' ' ' LEU . 3.2 mm? -98.62 3.6 47.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.767 -0.651 . . . . 18.41 110.347 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.49 111.5 21.41 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.536 -0.757 . . . . 17.449999999999999 110.973 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.15 -42.06 0.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.694 2.263 . . . . 18.890000000000001 112.062 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.26 -61.3 1.84 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.289 -0.414 . . . . 17.809999999999999 110.992 -176.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.7 t -100.26 58.63 0.98 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.555 0.693 . . . . 18.629999999999999 110.615 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.8 tp -66.77 -25.68 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.672 -0.695 . . . . 19.100000000000001 109.81 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.61 142.04 40.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.67 -0.695 . . . . 19.25 110.378 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.32 166.63 24.25 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.228 -0.442 . . . . 18.789999999999999 110.088 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.63 68.5 6.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.887 0.375 . . . . 18.949999999999999 110.211 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -177.9 -159.11 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.34 -0.846 . . . . 20.309999999999999 109.389 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 66.6 p 65.67 -53.33 0.37 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.007 1.323 . . . . 21.399999999999999 112.11 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -119.18 20.47 12.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.628 0.252 . . . . 21.16 110.516 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 60.72 69.91 0.65 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.631 -0.713 . . . . 22.18 110.749 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 67.18 112.04 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.185 -0.916 . . . . 19.449999999999999 111.116 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -71.79 69.7 2.89 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.973 2.449 . . . . 18.530000000000001 113.292 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -95.08 133.86 25.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.622 -0.51 . . . . 17.449999999999999 109.622 172.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.53 108.56 1.86 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.69 2.26 . . . . 17.420000000000002 112.583 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.64 131.64 94.26 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.813 -0.631 . . . . 17.68 110.805 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.39 72.95 3.44 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.707 2.272 . . . . 16.289999999999999 111.638 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.3 m -86.82 39.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.061 -0.518 . . . . 17.260000000000002 111.248 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . . . -83.51 122.34 76.84 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.98 -0.555 . . . . 15.800000000000001 110.749 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 105' ' ' ALA . 37.8 Cg_exo -61.23 109.64 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.254 2.636 . . . . 15.92 112.577 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.4 -55.46 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.937 2.425 . . . . 16.149999999999999 112.649 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.484 ' HB3' ' HD3' ' A' ' 109' ' ' PRO . 88.1 tttt -76.2 -50.26 2.97 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 112.431 0.53 . . . . 17.629999999999999 112.431 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 108' ' ' LYS . 31.9 Cg_exo -60.49 -21.58 68.71 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.065 1.844 . . . . 15.039999999999999 113.241 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -112.62 103.81 55.67 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.081 -0.34 . . . . 15.199999999999999 110.081 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.77 107.92 1.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.085 1.857 . . . . 14.08 111.738 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.9 p -80.87 53.35 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 122.726 1.251 . . . . 15.279999999999999 110.088 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.498 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 49.1 mt-10 -94.73 136.97 22.58 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.611 -1.177 . . . . 16.84 110.147 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 117' ' ' PRO . 72.1 Cg_endo -80.01 100.07 1.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.75 2.3 . . . . 15.51 111.125 172.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 16.3 Cg_exo -67.21 -38.09 16.55 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.893 2.395 . . . . 16.039999999999999 113.728 -170.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 27.5 ttpp -77.05 -48.68 2.54 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.544 0.572 . . . . 18.91 112.544 -176.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 11.2 Cg_exo -73.4 -34.89 5.4 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.178 1.918 . . . . 17.039999999999999 112.174 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -102.4 85.88 2.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.999 -0.546 . . . . 17.52 110.326 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.7 m -97.85 -23.17 4.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.012 -0.54 . . . . 18.699999999999999 110.876 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.87 125.61 36.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.371 -0.377 . . . . 20.879999999999999 110.625 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.69 120.2 74.85 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.697 -0.683 . . . . 18.890000000000001 111.254 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.481 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 53.4 Cg_exo -53.04 -44.44 48.79 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.447 2.765 . . . . 20.43 114.203 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 122' ' ' PRO . 40.2 Cg_endo -67.66 -15.84 45.43 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 121.75 1.633 . . . . 21.100000000000001 112.845 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -125.34 77.43 68.23 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.868 0.366 . . . . 21.149999999999999 110.887 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.497 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 74.2 Cg_endo -80.77 -172.92 1.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.427 2.085 . . . . 21.149999999999999 112.234 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.456 ' O ' ' HD2' ' A' ' 129' ' ' PRO . 52.9 tptt -52.26 -43.11 89.96 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 113.03 0.752 . . . . 21.879999999999999 113.03 -177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.4 ' HA ' ' HD2' ' A' ' 130' ' ' LYS . 35.9 Cg_exo -60.4 -14.7 31.43 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.29 1.993 . . . . 20.190000000000001 114.386 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.588 ' HB3' ' HD3' ' A' ' 129' ' ' PRO . 16.3 tp10 -78.6 -55.68 1.01 Allowed Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.234 0.457 . . . . 20.48 112.234 -175.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 128' ' ' GLU . 19.1 Cg_endo -94.81 87.0 0.12 Allowed 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.412 2.074 . . . . 21.170000000000002 111.778 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 127' ' ' PRO . 28.2 mtpp -117.52 83.09 16.42 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.376 -0.374 . . . . 23.18 111.511 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 129' ' ' PRO . 8.5 Cg_endo -90.77 11.75 2.55 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.973 2.449 . . . . 20.780000000000001 112.144 176.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.2 t 51.72 33.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 112.921 -1.945 . . . . 19.75 110.207 -173.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.8 t 65.5 158.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 114.255 -1.339 . . . . 21.050000000000001 110.835 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 78.02 -77.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.335 0.654 . . . . 21.300000000000001 111.743 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -161.59 144.45 12.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.087 0.47 . . . . 20.739999999999998 111.141 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -129.67 -48.05 1.15 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.774 -0.824 . . . . 17.969999999999999 108.774 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.573 ' CB ' ' HG2' ' A' ' 194' ' ' LYS . . . -91.78 5.32 50.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.917 -0.583 . . . . 17.350000000000001 110.74 173.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 70.48 160.05 0.16 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.136 -0.938 . . . . 19.100000000000001 111.976 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' A' ' 140' ' ' THR . 2.8 Cg_exo -78.39 92.6 1.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.963 2.442 . . . . 19.350000000000001 111.727 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.64 ' N ' ' HB1' ' A' ' 192' ' ' ALA . 36.2 m 84.11 140.55 0.06 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.627 -0.715 . . . . 17.75 111.049 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 117.08 -67.83 0.31 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.621 -0.991 . . . . 17.960000000000001 110.621 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -99.75 54.13 0.93 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.798 0.809 . . . . 19.420000000000002 109.262 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.538 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -87.27 163.01 17.1 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.61 -1.177 . . . . 14.65 110.939 -175.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.73 ' CB ' HD21 ' A' ' 197' ' ' LEU . 3.6 m-85 -146.79 160.66 41.99 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.333 0.396 . . . . 14.81 111.783 -177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.695 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.5 t -151.12 165.58 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 108.811 -0.811 . . . . 10.48 108.811 173.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 47.7 t -106.57 113.6 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 118.379 0.536 . . . . 10.1 111.524 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.478 ' OE1' ' HD2' ' A' ' 185' ' ' ARG . 48.5 tt0 -89.86 109.09 20.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.815 0.302 . . . . 12.0 111.815 -175.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -86.8 -36.04 18.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.29 0.566 . . . . 11.880000000000001 110.059 -177.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.59 170.18 26.29 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.603 -0.808 . . . . 11.35 112.456 -176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.67 107.59 0.39 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.468 -0.568 . . . . 13.470000000000001 109.468 -178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.89 43.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.392 0.615 . . . . 13.52 110.614 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 30.7 mtmm -97.82 8.24 45.04 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.951 -1.022 . . . . 17.600000000000001 109.94 -176.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.507 ' HA ' ' OE1' ' A' ' 180' ' ' GLN . 18.0 m120 -106.85 106.17 16.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.022 -0.99 . . . . 16.140000000000001 109.692 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.44 -26.17 68.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.067 -0.515 . . . . 14.039999999999999 111.067 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.61 -38.82 78.84 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.64 0.733 . . . . 16.57 109.969 175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 160' ' ' ILE . 65.6 mttm -86.16 -17.92 33.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.783 -1.099 . . . . 16.399999999999999 110.305 -178.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.447 HG11 HG21 ' A' ' 184' ' ' THR . 71.8 t -68.49 -44.14 83.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.063 -0.717 . . . . 12.67 109.063 170.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -63.1 -29.07 70.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.894 -1.048 . . . . 15.32 111.98 -175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.414 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.0 pt-20 -78.4 -48.48 15.4 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.641 -0.424 . . . . 15.970000000000001 110.866 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 156' ' ' LYS . 24.8 mt -60.17 -46.87 94.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.545 0.688 . . . . 12.6 109.713 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.477 HG13 ' CB ' ' A' ' 165' ' ' ARG . 43.4 t -63.85 -33.72 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.729 -1.123 . . . . 12.539999999999999 110.349 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.69 -34.6 82.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.209 -0.519 . . . . 14.800000000000001 112.616 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.1 mptp? -70.45 -52.23 23.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.4 . . . . 16.050000000000001 110.662 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.586 HD13 ' CG2' ' A' ' 188' ' ' VAL . 2.8 mt -87.87 -58.31 2.62 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.518 0.933 . . . . 12.99 113.518 -172.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.477 ' CB ' HG13 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -62.73 -37.04 85.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.394 0.616 . . . . 15.06 109.411 -176.227 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.08 -25.68 74.11 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.111 -0.95 . . . . 16.600000000000001 112.197 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.7 -2.98 58.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.948 0.404 . . . . 16.140000000000001 110.599 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.46 25.49 33.01 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.836 -0.697 . . . . 15.119999999999999 113.104 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -89.61 153.18 20.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.02 0.41 . . . . 15.49 110.462 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.52 100.48 1.42 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.198 0.523 . . . . 13.869999999999999 109.833 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.37 140.65 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.124 -0.944 . . . . 10.82 109.828 -175.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.499 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.83 176.69 8.59 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.575 0.702 . . . . 11.130000000000001 110.935 172.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 20.3 p -122.47 -174.35 2.89 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.656 -1.156 . . . . 11.52 111.034 -171.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 67.4 m -51.83 142.29 25.26 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-O 121.218 0.533 . . . . 12.75 110.818 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 82.8 Cg_exo -49.22 -38.2 41.0 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 124.008 3.139 . . . . 14.640000000000001 115.179 -168.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 t -87.91 -65.68 0.99 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.813 -0.755 . . . . 16.68 112.261 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 70.7 m -170.17 128.5 0.81 Allowed Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 122.368 0.267 . . . . 16.039999999999999 110.94 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.531 ' HB3' HG21 ' A' ' 184' ' ' THR . 72.9 Cg_exo -60.02 121.88 10.52 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 121.848 1.699 . . . . 14.220000000000001 111.342 163.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.7 p -155.77 159.92 2.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.809 0.338 . . . . 16.129999999999999 110.538 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.507 ' OE1' ' HA ' ' A' ' 153' ' ' ASN . 9.2 mm100 -68.85 120.99 15.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.052 -0.522 . . . . 16.699999999999999 111.489 177.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.23 -26.22 17.58 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.805 -0.634 . . . . 16.98 112.798 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 13.6 mptt -103.07 154.65 19.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.977 -0.379 . . . . 18.73 109.977 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.7 tp -73.9 109.28 6.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.897 0.856 . . . . 14.82 110.836 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.531 HG21 ' HB3' ' A' ' 178' ' ' PRO . 29.2 m -101.91 107.06 18.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.605 0.717 . . . . 12.779999999999999 110.072 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.478 ' HD2' ' OE1' ' A' ' 147' ' ' GLN . 47.5 mtm180 -87.76 141.06 28.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.993 -1.003 . . . . 13.98 110.254 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.538 ' O ' HD22 ' A' ' 148' ' ' LEU . 4.4 mm -108.74 118.35 56.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.781 -0.822 . . . . 10.56 108.781 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.521 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.8 mp -128.9 130.85 47.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.487 0.661 . . . . 10.1 111.141 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 148' ' ' LEU . 43.9 t -107.24 136.52 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.102 -0.953 . . . . 9.7400000000000002 111.079 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 83.37 46.3 6.17 Favored Glycine 0 N--CA 1.435 -1.422 0 CA-C-N 114.751 -1.113 . . . . 9.7599999999999998 113.432 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.695 ' HA ' HG22 ' A' ' 145' ' ' VAL . 10.9 Cg_endo -60.91 124.38 14.82 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 CA-C-N 119.674 1.737 . . . . 11.15 110.599 175.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -149.89 151.32 33.25 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.21 -0.663 . . . . 12.77 109.21 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.64 ' HB1' ' N ' ' A' ' 140' ' ' THR . . . -84.8 -11.91 54.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.367 -0.833 . . . . 14.6 111.581 -174.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.7 m -120.84 113.25 19.88 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.089 0.471 . . . . 14.300000000000001 110.954 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.657 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 20.8 ptmt -61.33 -36.29 79.75 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.504 -0.771 . . . . 15.970000000000001 111.305 177.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.35 -43.0 99.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.256 -0.429 . . . . 15.6 111.589 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -70.4 -39.01 74.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.167 0.508 . . . . 14.220000000000001 110.531 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.73 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -84.37 -16.82 41.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.534 -0.757 . . . . 11.949999999999999 110.906 -176.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 0.8 OUTLIER -60.43 -34.96 74.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.661 0.743 . . . . 14.699999999999999 110.387 173.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.59 -12.87 81.12 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.712 -1.131 . . . . 13.09 110.494 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 69.7 m -82.2 -12.67 57.97 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.795 -0.702 . . . . 12.109999999999999 111.637 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 11.0 mt -69.44 -36.94 77.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.071 0.462 . . . . 12.720000000000001 109.934 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.09 -27.31 70.29 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.676 -0.773 . . . . 14.66 111.188 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.585 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 49.6 mt-10 -82.81 -27.32 30.99 Favored 'General case' 0 C--O 1.221 -0.396 0 N-CA-C 110.142 -0.318 . . . . 13.890000000000001 110.142 175.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.76 -48.32 81.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.459 . . . . 12.550000000000001 111.621 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -56.76 -22.15 33.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.079 -0.51 . . . . 15.83 110.973 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -45.52 9.38 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.816 -0.629 . . . . 16.969999999999999 110.162 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 96.3 mt -65.3 -52.39 54.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.975 -0.557 . . . . 13.890000000000001 111.694 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.501 ' HB3' HD21 ' A' ' 164' ' ' LEU . 70.1 p -100.05 -44.76 5.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.282 0.563 . . . . 13.539999999999999 110.558 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 72.47 7.84 69.65 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.264 -0.88 . . . . 14.67 111.095 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.13 155.32 17.52 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.466 -0.568 . . . . 13.039999999999999 109.466 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 26.3 t -89.03 108.0 19.35 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.497 -0.319 . . . . 14.84 110.438 -174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -129.2 158.04 21.9 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.508 -0.853 . . . . 12.220000000000001 113.316 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.96 145.12 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.187 0.518 . . . . 13.74 109.997 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.88 110.18 5.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.47 -0.786 . . . . 12.890000000000001 110.227 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 93.4 mmm -117.88 141.23 48.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.848 -0.615 . . . . 13.800000000000001 110.569 -175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -66.9 152.73 52.76 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.777 -0.725 . . . . 13.359999999999999 112.158 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.68 ' HB2' HG23 ' A' ' 145' ' ' VAL . 10.9 t80 -129.43 131.51 46.77 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 122.781 0.432 . . . . 14.24 109.954 -172.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.3 t -143.55 93.19 6.37 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-O 121.535 0.683 . . . . 16.510000000000002 109.51 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.33 140.35 19.39 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.603 2.202 . . . . 17.420000000000002 112.855 -177.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 21.1 m120 . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.502 -0.772 . . . . 19.190000000000001 109.58 176.917 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.942 0.401 . . . . 18.390000000000001 110.968 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.29 134.46 1.83 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.111 -0.566 . . . . 17.77 111.756 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.03 9.29 17.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.927 0.363 . . . . 17.690000000000001 111.582 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -77.42 -31.19 53.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.029 0.442 . . . . 19.93 110.451 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -118.6 -176.31 3.06 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.047 -0.524 . . . . 17.43 110.061 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -111.69 -103.16 0.4 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.087 -0.338 . . . . 19.359999999999999 110.087 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 58.64 -87.49 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.246 0.618 . . . . 18.960000000000001 112.056 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -129.56 13.55 5.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.874 0.368 . . . . 18.239999999999998 111.122 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.9 54.68 0.93 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.914 0.387 . . . . 16.780000000000001 111.527 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -177.72 119.62 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.585 -0.734 . . . . 18.420000000000002 110.005 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' A' ' 49' ' ' ASP . 40.5 p90 -58.38 134.67 56.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 17.920000000000002 110.921 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.69 -178.35 6.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.162 -0.472 . . . . 19.550000000000001 111.184 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.95 -47.45 68.61 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.32 -0.252 . . . . 20.309999999999999 110.32 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.457 HG23 ' HD2' ' A' ' 45' ' ' PRO . 44.8 mm 61.49 73.59 0.57 Allowed Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 115.904 -0.589 . . . . 19.920000000000002 110.956 177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.86 56.89 6.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.399 2.066 . . . . 21.640000000000001 111.668 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mp 62.42 33.64 16.09 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.336 -0.847 . . . . 22.670000000000002 111.362 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 89.2 t -80.69 -59.75 0.48 Allowed Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.14 -0.482 . . . . 21.34 110.248 176.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.512 ' CD ' ' HB ' ' A' ' 44' ' ' VAL . 56.2 Cg_endo -74.15 179.43 5.79 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.818 1.679 . . . . 20.0 111.498 169.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -87.16 15.13 6.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.397 -0.365 . . . . 21.079999999999998 111.504 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.3 -169.18 1.36 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.538 -0.542 . . . . 18.800000000000001 109.538 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.35 -154.46 8.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.393 -0.908 . . . . 17.510000000000002 111.665 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . 7.9 t0 -102.11 93.02 5.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.029 -0.73 . . . . 16.949999999999999 109.029 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 61.19 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.874 0.734 . . . . 18.300000000000001 110.949 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -97.67 172.61 7.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.143 -0.48 . . . . 18.170000000000002 110.696 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 6.5 pt-20 -85.98 131.36 47.08 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.775 -0.648 . . . . 18.82 110.527 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 25.1 Cg_endo -60.96 162.26 19.65 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.843 3.028 . . . . 19.870000000000001 113.884 -173.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -74.65 38.39 0.12 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.407 -0.815 . . . . 21.100000000000001 112.314 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 65.9 mtt -90.32 -41.3 11.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.888 0.375 . . . . 22.300000000000001 110.094 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.584 ' H ' ' CD ' ' A' ' 57' ' ' PRO . 25.5 mmt -132.65 -48.71 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.614 -0.721 . . . . 23.850000000000001 111.534 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.584 ' CD ' ' H ' ' A' ' 56' ' ' MET . 53.8 Cg_exo -54.19 132.46 50.51 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 122.593 2.196 . . . . 20.670000000000002 113.557 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -168.92 -50.29 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.962 -1.017 . . . . 20.489999999999998 110.356 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 64.45 -82.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.424 -0.807 . . . . 21.469999999999999 111.765 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.6 p -134.06 51.88 2.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.315 -0.402 . . . . 22.600000000000001 110.13 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 64.8 26.22 12.96 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.705 -0.68 . . . . 21.93 110.647 -175.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.92 74.12 2.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.752 -0.658 . . . . 19.73 110.157 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 61.0 mt -78.45 116.52 59.94 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.515 -0.766 . . . . 19.579999999999998 110.579 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -86.25 -9.19 7.29 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.891 2.394 . . . . 18.5 113.189 -176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 p -79.04 63.43 3.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.189 0.519 . . . . 17.609999999999999 111.895 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 16.9 mm-40 -84.31 114.81 57.06 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.985 -0.552 . . . . 18.760000000000002 109.558 175.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.63 -52.82 8.01 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.615 2.876 . . . . 17.280000000000001 114.378 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.41 149.41 80.53 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.155 1.237 . . . . 17.77 112.238 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 28' ' ' ASP . 32.8 mt-10 75.81 168.03 0.27 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.993 0.808 . . . . 18.699999999999999 111.538 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.34 -78.22 0.28 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.931 -0.652 . . . . 17.719999999999999 112.29 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -149.44 40.44 0.85 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.273 0.559 . . . . 18.0 110.197 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -134.0 56.02 1.87 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.9 -0.591 . . . . 17.960000000000001 110.619 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -111.77 -35.61 5.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.762 -0.654 . . . . 19.850000000000001 110.828 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -88.63 61.56 6.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.981 -0.554 . . . . 19.670000000000002 109.974 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -92.57 138.4 20.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.863 -0.608 . . . . 17.739999999999998 110.933 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -89.46 59.4 4.77 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.294 -0.632 . . . . 19.949999999999999 109.294 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.52 80.53 4.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.489 -0.778 . . . . 18.390000000000001 110.529 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -153.81 81.43 0.18 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.627 -0.715 . . . . 17.66 111.849 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -72.49 -35.55 68.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.693 -0.484 . . . . 17.68 109.693 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 49.74 53.62 12.45 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.333 0.587 . . . . 17.800000000000001 110.243 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -142.39 -73.24 0.31 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.337 -0.847 . . . . 17.350000000000001 110.65 -175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 45.3 63.88 8.58 Favored Pre-proline 0 N--CA 1.465 0.288 0 O-C-N 123.639 0.587 . . . . 16.640000000000001 111.754 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -62.18 -50.26 5.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.543 2.162 . . . . 17.23 112.092 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.8 m 60.81 -90.21 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 O-C-N 123.83 0.706 . . . . 17.34 111.453 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.92 -14.07 14.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.668 0.271 . . . . 18.41 110.611 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.24 115.35 46.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 17.449999999999999 110.683 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.59 -9.62 15.96 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.501 2.134 . . . . 18.890000000000001 111.705 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 71.16 -62.53 0.45 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.382 -0.826 . . . . 17.809999999999999 111.055 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.6 m -77.91 104.33 8.41 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.824 -0.435 . . . . 18.629999999999999 109.824 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.5 mm -75.44 -31.29 23.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.209 0.528 . . . . 19.100000000000001 111.385 -174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.88 27.66 14.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.224 -0.898 . . . . 19.25 112.546 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 58.9 73.83 0.46 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.903 -0.59 . . . . 18.789999999999999 111.604 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -79.13 -7.66 58.36 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.123 -0.489 . . . . 18.949999999999999 111.078 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 97' ' ' PHE . 17.4 m120 -89.76 19.1 4.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.98 0.419 . . . . 20.309999999999999 111.129 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.5 p -68.13 -48.04 66.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.389 0.614 . . . . 21.399999999999999 109.94 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -105.7 5.81 31.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.557 -0.747 . . . . 21.16 109.238 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 94' ' ' ASN . 91.6 m-85 61.27 64.57 1.07 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.753 -1.112 . . . . 22.18 110.229 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 64.24 89.66 0.1 Allowed Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 115.344 -0.844 . . . . 19.449999999999999 110.649 -175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.93 105.6 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.082 2.521 . . . . 18.530000000000001 111.999 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.45 136.47 19.18 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.013 0.435 . . . . 17.449999999999999 111.055 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.9 160.14 19.13 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.947 2.431 . . . . 17.420000000000002 111.762 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.69 112.49 24.85 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.344 -0.389 . . . . 17.68 110.725 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -79.58 132.15 9.78 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.454 2.103 . . . . 16.289999999999999 112.42 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 6.0 p -79.89 73.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 122.251 1.024 . . . . 17.260000000000002 110.132 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.471 ' HB3' ' HD3' ' A' ' 106' ' ' PRO . . . -89.19 -48.52 0.41 Allowed Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.199 -0.909 . . . . 15.800000000000001 112.386 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 105' ' ' ALA . 27.3 Cg_exo -63.12 118.12 5.03 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.851 1.701 . . . . 15.92 112.145 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.91 121.81 9.43 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.026 2.484 . . . . 16.149999999999999 112.166 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -69.23 -50.02 21.9 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.947 -0.569 . . . . 17.629999999999999 111.78 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.16 48.84 2.64 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.025 1.816 . . . . 15.039999999999999 112.713 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -95.21 116.2 66.12 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.96 -0.564 . . . . 15.199999999999999 110.743 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.95 107.86 2.31 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.285 1.99 . . . . 14.08 111.426 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.7 m -94.31 45.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 121.755 0.788 . . . . 15.279999999999999 110.873 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -131.97 108.6 14.02 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.887 -1.051 . . . . 16.84 110.793 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.34 125.42 9.08 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.754 2.303 . . . . 15.51 111.456 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.63 147.34 76.01 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.262 1.974 . . . . 16.039999999999999 111.647 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 63.86 85.43 0.16 Allowed Pre-proline 0 N--CA 1.466 0.333 0 O-C-N 123.613 0.571 . . . . 18.91 110.889 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.47 118.78 5.76 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.701 2.267 . . . . 17.039999999999999 111.467 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 64.22 -93.82 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.494 0.664 . . . . 17.52 109.939 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.2 t -133.4 -57.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 114.957 -1.019 . . . . 18.699999999999999 109.002 172.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.77 99.35 2.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.002 -0.999 . . . . 20.879999999999999 109.024 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.7 111.99 30.65 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.24 -0.436 . . . . 18.890000000000001 110.674 -176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.91 160.02 43.96 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.571 2.181 . . . . 20.43 111.511 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.8 -17.02 58.22 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.932 2.421 . . . . 21.100000000000001 112.115 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.39 118.03 14.7 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.616 -0.72 . . . . 21.149999999999999 109.569 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.454 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 32.4 Cg_exo -58.32 139.27 89.92 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.601 2.201 . . . . 21.149999999999999 111.969 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -89.68 110.95 43.09 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.355 -0.384 . . . . 21.879999999999999 110.932 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 125' ' ' PRO . 7.8 Cg_exo -72.71 109.19 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.695 2.263 . . . . 20.190000000000001 111.336 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -98.22 112.31 61.76 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.906 -0.588 . . . . 20.48 110.327 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.6 -37.52 96.7 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.772 2.315 . . . . 21.170000000000002 111.195 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.43 ' NZ ' ' HB3' ' A' ' 130' ' ' LYS . 6.9 ttpm? -123.71 87.49 52.5 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.229 -0.896 . . . . 23.18 108.806 173.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.4 104.66 1.46 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.82 2.346 . . . . 20.780000000000001 112.544 -175.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.4 t -81.74 56.19 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 122.154 0.978 . . . . 19.75 109.025 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.403 HG22 ' HE2' ' A' ' 136' ' ' LYS . 11.8 p -133.31 15.24 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.693 -1.14 . . . . 21.050000000000001 108.921 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -90.24 -33.71 16.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.759 -1.11 . . . . 21.300000000000001 111.088 -175.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.14 81.9 2.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.64 0.734 . . . . 20.739999999999998 110.955 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 137' ' ' ALA . 66.7 mttm -125.59 83.12 2.13 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.096 -1.076 . . . . 17.969999999999999 108.096 173.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . 72.35 36.35 1.06 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.532 -0.914 . . . . 17.350000000000001 108.532 -165.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . . . 72.76 143.08 0.09 OUTLIER Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 113.971 -1.468 . . . . 19.100000000000001 110.759 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 138' ' ' ALA . 48.4 Cg_exo -57.77 95.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.156 2.571 . . . . 19.350000000000001 112.536 -176.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.446 ' HA ' ' HB1' ' A' ' 192' ' ' ALA . 3.9 m 57.67 33.68 23.54 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.701 0.762 . . . . 17.75 110.124 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -93.46 -70.84 1.14 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.525 -0.761 . . . . 17.960000000000001 111.246 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 13.1 mptt -98.4 60.99 1.39 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.523 -0.547 . . . . 19.420000000000002 109.523 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.513 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . -72.46 162.47 29.43 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.378 -0.828 . . . . 14.65 109.635 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.553 ' HA ' ' H ' ' A' ' 217' ' ' TYR . 3.3 m-85 -135.79 152.76 51.42 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.109 0.48 . . . . 14.81 111.863 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' A' ' 187' ' ' LEU . 0.9 OUTLIER -152.91 145.69 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.166 -0.925 . . . . 10.48 109.922 -174.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 44.4 t -112.26 108.13 24.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-N 118.424 0.556 . . . . 10.1 111.035 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -88.11 111.08 21.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.491 -0.322 . . . . 12.0 111.334 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 1.002 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -86.42 -38.87 16.92 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.225 0.536 . . . . 11.880000000000001 109.721 -178.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.45 167.51 26.99 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.488 -0.863 . . . . 11.35 112.523 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -168.89 101.68 0.39 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.037 -0.727 . . . . 13.470000000000001 109.037 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.16 163.98 37.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.905 -0.589 . . . . 13.52 110.571 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 90.8 mttt -99.22 2.45 45.7 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.041 -0.981 . . . . 17.600000000000001 110.221 -173.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -93.37 98.64 11.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.78 -1.1 . . . . 16.140000000000001 108.68 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.85 -20.65 63.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.059 0.457 . . . . 14.039999999999999 111.193 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.14 -28.94 64.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.732 0.777 . . . . 16.57 109.183 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.403 ' O ' HG13 ' A' ' 160' ' ' ILE . 3.1 tppp? -80.49 -34.06 36.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.515 -1.22 . . . . 16.399999999999999 108.768 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.456 HG11 HG21 ' A' ' 184' ' ' THR . 75.3 t -58.46 -36.61 59.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.085 -0.961 . . . . 12.67 109.806 172.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -62.02 -33.19 73.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.273 -0.876 . . . . 15.32 112.202 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.01 -35.86 28.42 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.051 -0.66 . . . . 15.970000000000001 110.996 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.738 HD12 HD12 ' A' ' 186' ' ' ILE . 14.0 mt -66.22 -47.45 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 12.6 109.437 176.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.59 -38.41 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 114.868 -1.06 . . . . 12.539999999999999 110.838 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -57.75 -30.23 62.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.016 -0.611 . . . . 14.800000000000001 112.4 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -70.61 -59.03 3.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.231 0.539 . . . . 16.050000000000001 111.081 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.427 HD11 ' HA ' ' A' ' 208' ' ' SER . 4.1 mm? -81.31 -59.79 2.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.709 -0.678 . . . . 12.99 112.101 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.428 ' HD3' ' C ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -64.05 -37.03 85.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.352 0.596 . . . . 15.06 109.632 -177.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.27 -19.48 77.48 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.043 -0.981 . . . . 16.600000000000001 112.691 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -97.42 -13.76 21.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.792 0.329 . . . . 16.140000000000001 110.758 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.5 24.92 9.68 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.703 -0.761 . . . . 15.119999999999999 113.177 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 207' ' ' LEU . 34.1 m-85 -88.26 158.38 18.49 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.793 -0.239 . . . . 15.49 110.536 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -67.39 97.68 0.58 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.374 0.607 . . . . 13.869999999999999 110.08 177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.6 p -144.96 137.81 21.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.146 -0.934 . . . . 10.82 110.168 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.578 ' CE2' HD12 ' A' ' 187' ' ' LEU . 0.0 OUTLIER -142.12 176.72 8.74 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.454 0.645 . . . . 11.130000000000001 110.706 171.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 17.1 p -118.63 -177.05 3.22 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.785 -1.098 . . . . 11.52 110.713 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.1 OUTLIER -53.4 140.53 45.39 Favored Pre-proline 0 C--N 1.327 -0.405 0 O-C-N 123.256 0.347 . . . . 12.75 111.117 179.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -20.17 -67.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 1 C-N-CA 126.361 4.707 . . . . 14.640000000000001 116.048 -172.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.8 m -86.31 -61.66 1.69 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.981 0.734 . . . . 16.68 112.981 -170.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.9 m -166.69 133.8 2.02 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 122.021 -0.425 . . . . 16.039999999999999 111.795 -174.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.487 ' HB3' HG21 ' A' ' 184' ' ' THR . 54.4 Cg_exo -60.97 125.02 16.1 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.716 2.277 . . . . 14.220000000000001 111.46 163.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 6.0 p -146.41 159.56 10.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 109.148 -0.686 . . . . 16.129999999999999 109.148 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -81.18 122.22 27.11 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.855 0.36 . . . . 16.699999999999999 110.862 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.13 -23.98 22.01 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 16.98 112.614 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.455 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 11.3 mptt -111.5 161.35 16.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.944 0.402 . . . . 18.73 110.327 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.6 tp -71.05 110.42 4.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.868 0.842 . . . . 14.82 112.114 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.487 HG21 ' HB3' ' A' ' 178' ' ' PRO . 62.1 m -99.34 106.46 18.56 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.583 -0.735 . . . . 12.779999999999999 109.715 172.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 89.8 mtt180 -89.22 136.76 32.84 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.452 -0.794 . . . . 13.98 109.159 176.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.738 HD12 HD12 ' A' ' 160' ' ' ILE . 2.8 mt -117.2 116.21 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 121.172 0.51 . . . . 10.56 109.696 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.578 HD12 ' CE2' ' A' ' 172' ' ' TYR . 0.1 OUTLIER -128.9 128.07 43.06 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.153 -0.931 . . . . 10.1 111.278 -172.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.002 HG23 HD21 ' A' ' 148' ' ' LEU . 43.1 t -99.91 149.17 5.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.287 -1.324 . . . . 9.7400000000000002 110.403 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.4 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 71.07 46.67 42.28 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 115.277 -0.874 . . . . 9.7599999999999998 113.895 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.436 ' HA ' ' CG2' ' A' ' 145' ' ' VAL . 19.2 Cg_endo -67.49 124.73 12.39 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 CA-C-N 119.903 1.851 . . . . 11.15 110.401 172.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -160.37 150.09 17.77 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.888 -0.596 . . . . 12.77 109.963 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.513 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -91.13 -6.34 53.75 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.497 -0.774 . . . . 14.6 110.58 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.548 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 43.2 t -100.44 103.87 15.25 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 116.087 -0.506 . . . . 14.300000000000001 110.274 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 198' ' ' LYS . 32.0 ttpt -60.56 -43.26 97.47 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.451 -0.795 . . . . 15.970000000000001 109.642 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.62 -55.49 30.1 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.217 -0.901 . . . . 15.6 112.398 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -65.51 -41.31 93.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.962 0.41 . . . . 14.220000000000001 111.147 -175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.548 ' HB3' ' O ' ' A' ' 193' ' ' SER . 0.2 OUTLIER -81.22 -18.29 46.62 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.103 -0.499 . . . . 11.949999999999999 110.849 -176.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 20.8 tptm -56.52 -55.34 34.95 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.684 0.754 . . . . 14.699999999999999 110.885 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -71.48 -13.18 74.05 Favored Glycine 0 CA--C 1.504 -0.64 0 CA-C-N 114.589 -1.187 . . . . 13.09 110.64 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.606 ' O ' ' HB2' ' A' ' 204' ' ' LEU . 72.9 m -78.45 -12.87 60.03 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.657 -0.771 . . . . 12.109999999999999 111.517 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 23.1 mt -76.66 -40.18 49.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.848 0.356 . . . . 12.720000000000001 110.477 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.1 -36.45 88.57 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.857 -0.687 . . . . 14.66 111.528 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.529 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 15.4 pt-20 -86.25 -16.89 36.22 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.888 0.375 . . . . 13.890000000000001 110.481 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 200' ' ' SER . 15.4 tp -71.34 -33.18 69.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.644 0.259 . . . . 12.550000000000001 111.166 -173.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.601 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 19.1 pttp -62.96 -16.16 58.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.186 0.517 . . . . 15.83 110.344 172.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -90.11 -42.02 11.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.811 -0.631 . . . . 16.969999999999999 110.081 170.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.8 mt -68.87 -52.79 25.93 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.788 -0.642 . . . . 13.890000000000001 111.505 -175.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.427 ' HA ' HD11 ' A' ' 164' ' ' LEU . 16.7 t -92.49 -44.11 8.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.433 0.635 . . . . 13.539999999999999 109.56 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.601 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 71.31 -2.13 22.52 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 114.837 -1.074 . . . . 14.67 112.164 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 53.3 mt -92.62 150.31 20.79 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.538 -0.541 . . . . 13.039999999999999 109.538 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 19.5 m -85.68 111.84 20.47 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.093 0.473 . . . . 14.84 110.59 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -130.51 163.83 23.11 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.479 -0.867 . . . . 12.220000000000001 112.491 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.9 p -100.29 135.39 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.348 0.594 . . . . 13.74 110.472 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 45.9 t -79.71 104.94 8.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.87 -1.059 . . . . 12.890000000000001 109.492 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 97.0 mmm -117.24 146.7 43.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.665 -0.698 . . . . 13.800000000000001 110.457 -175.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.64 106.33 2.16 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.41 -0.9 . . . . 13.359999999999999 111.733 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.553 ' H ' ' HA ' ' A' ' 144' ' ' TYR . 9.3 t80 -64.59 124.29 21.47 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.446 0.699 . . . . 14.24 110.517 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 29.8 m -138.66 93.64 10.81 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 109.274 -0.639 . . . . 16.510000000000002 109.274 174.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.23 153.46 51.2 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.494 2.129 . . . . 17.420000000000002 112.29 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 44.3 t30 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.488 -0.768 . . . . 19.190000000000001 109.723 178.088 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.5 t70 . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.578 0.227 . . . . 18.390000000000001 110.465 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.44 -87.05 0.18 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.827 -0.702 . . . . 17.77 112.013 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 62.1 -163.56 0.26 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.031 0.532 . . . . 17.690000000000001 110.337 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -102.99 -58.69 1.83 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.841 -0.8 . . . . 19.93 108.841 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 166.04 25.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.49 -1.232 . . . . 17.43 107.718 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -81.6 83.44 7.04 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.509 0.671 . . . . 19.359999999999999 110.478 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -74.52 113.21 11.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.567 -0.742 . . . . 18.960000000000001 110.531 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -129.3 6.81 5.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.553 -0.748 . . . . 18.239999999999998 110.149 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -77.43 170.82 15.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.912 -0.585 . . . . 16.780000000000001 111.783 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' A' ' 62' ' ' ALA . 31.1 tt0 73.16 -52.35 0.71 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.127 -0.942 . . . . 18.420000000000002 110.416 -176.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -106.94 31.55 5.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.024 0.44 . . . . 17.920000000000002 110.417 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.18 -40.56 71.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.99 -0.55 . . . . 19.550000000000001 111.164 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.18 -0.01 3.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.973 -0.558 . . . . 20.309999999999999 110.619 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.447 HG21 ' HB2' ' A' ' 49' ' ' ASP . 22.3 pt 33.93 64.45 1.57 Allowed Pre-proline 0 N--CA 1.476 0.854 0 O-C-N 124.192 0.932 . . . . 19.920000000000002 113.486 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 41' ' ' ILE . 2.8 Cg_endo -84.88 55.13 4.2 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.85 2.367 . . . . 21.640000000000001 111.269 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 mp 60.57 38.7 18.68 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.452 -0.795 . . . . 22.670000000000002 110.527 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.534 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 72.9 t -105.48 -66.22 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.779 -0.646 . . . . 21.34 110.458 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.534 ' CD ' ' HB ' ' A' ' 44' ' ' VAL . 92.3 Cg_endo -80.12 118.8 3.75 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.296 1.33 . . . . 20.0 111.505 170.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -69.88 103.3 2.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.363 -0.381 . . . . 21.079999999999998 110.247 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 58.26 39.38 25.74 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.666 -0.697 . . . . 18.800000000000001 110.764 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.15 -18.94 63.73 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.684 -0.689 . . . . 17.510000000000002 112.273 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.447 ' HB2' HG21 ' A' ' 41' ' ' ILE . 19.7 t70 -78.22 127.99 33.07 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.447 -0.205 . . . . 16.949999999999999 110.447 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 64.4 95.89 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.953 0.783 . . . . 18.300000000000001 111.244 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.32 128.63 38.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.059 -0.519 . . . . 18.170000000000002 109.972 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 33.0 tt0 -60.25 118.67 35.47 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.023 -0.535 . . . . 18.82 109.994 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 54' ' ' ASP . 59.4 Cg_endo -71.8 -169.35 0.43 Allowed 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.14 2.56 . . . . 19.870000000000001 113.205 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 22.0 m-20 71.28 -174.26 0.17 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.281 -0.872 . . . . 21.100000000000001 110.949 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.33 40.58 0.72 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.779 -0.646 . . . . 22.300000000000001 111.494 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 25.7 ttt -166.62 78.93 1.06 Allowed Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.223 -0.658 . . . . 23.850000000000001 109.223 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 52' ' ' GLU . 91.7 Cg_endo -78.02 155.91 30.13 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.935 2.423 . . . . 20.670000000000002 112.785 -174.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.76 136.08 57.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.611 -1.177 . . . . 20.489999999999998 111.171 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.81 17.43 2.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.206 -0.452 . . . . 21.469999999999999 111.22 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -66.62 130.73 44.14 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.677 -0.49 . . . . 22.600000000000001 109.677 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -73.94 -0.7 16.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.78 0.324 . . . . 21.93 111.608 -175.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.525 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . . . -61.64 -41.93 98.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.256 -0.646 . . . . 19.73 109.256 171.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.508 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 92.3 mt 45.36 77.64 0.44 Allowed Pre-proline 0 N--CA 1.464 0.25 0 O-C-N 124.389 1.056 . . . . 19.579999999999998 111.967 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.17 -19.56 66.15 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.76 2.307 . . . . 18.5 112.261 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 m -80.71 58.61 3.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.727 0.775 . . . . 17.609999999999999 110.796 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.584 ' H ' ' HD2' ' A' ' 67' ' ' PRO . 78.0 mt-30 -93.43 -50.64 0.27 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.726 -0.67 . . . . 18.760000000000002 111.014 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HD2' ' H ' ' A' ' 66' ' ' GLN . 50.5 Cg_endo -67.82 148.31 76.7 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 121.92 1.747 . . . . 17.280000000000001 112.037 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.83 -11.3 25.67 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.776 2.317 . . . . 17.77 112.395 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -108.73 114.79 28.88 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.632 -0.713 . . . . 18.699999999999999 109.667 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 158.79 33.15 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.387 -0.911 . . . . 17.719999999999999 113.4 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.78 -60.51 2.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.215 0.531 . . . . 18.0 110.027 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -117.1 7.85 13.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.829 -0.623 . . . . 17.960000000000001 110.142 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.68 115.39 15.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.643 -0.708 . . . . 19.850000000000001 110.759 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -112.84 24.48 12.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.185 0.517 . . . . 19.670000000000002 110.0 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 t -121.32 47.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.898 -0.592 . . . . 17.739999999999998 110.076 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.8 tpp180 -126.92 5.02 6.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.949 0.404 . . . . 19.949999999999999 110.537 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.34 89.08 2.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.884 0.373 . . . . 18.390000000000001 110.666 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -163.85 -147.62 5.14 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.442 -0.885 . . . . 17.66 112.445 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.74 -75.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.8 0.333 . . . . 17.68 110.723 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.19 -44.53 9.7 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.635 -0.506 . . . . 17.800000000000001 109.635 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 56.33 55.2 6.85 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.405 0.621 . . . . 17.350000000000001 111.104 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.04 85.65 3.88 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.122 -0.944 . . . . 16.640000000000001 109.709 177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -46.79 -52.99 6.76 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.391 2.728 . . . . 17.23 112.132 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.4 p 39.92 -91.31 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.138 0.975 . . . . 17.34 113.292 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.9 tp 64.57 82.78 0.18 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.261 0.553 . . . . 18.41 110.379 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -77.48 115.98 54.02 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.712 -0.676 . . . . 17.449999999999999 110.488 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.1 -25.22 36.26 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.247 2.632 . . . . 18.890000000000001 112.553 177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -126.75 81.15 1.99 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.949 -0.568 . . . . 17.809999999999999 109.84 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 m -76.5 101.39 5.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.006 -0.543 . . . . 18.629999999999999 110.38 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.425 HD12 HD21 ' A' ' 93' ' ' ASN . 33.7 pt -93.02 -16.69 7.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.23 -0.441 . . . . 19.100000000000001 111.083 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 68.65 -73.9 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.862 0.726 . . . . 19.25 111.563 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -151.15 177.88 9.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.465 -0.198 . . . . 18.789999999999999 110.465 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.425 HD21 HD12 ' A' ' 90' ' ' ILE . 44.8 m-80 -134.23 129.6 35.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.561 -0.29 . . . . 18.949999999999999 110.967 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 97' ' ' PHE . 4.4 m-20 58.25 24.34 11.37 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.759 -0.655 . . . . 20.309999999999999 112.586 177.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.9 p -84.74 -43.88 13.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.466 0.651 . . . . 21.399999999999999 109.53 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -110.47 -17.81 13.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.359 -0.837 . . . . 21.16 109.991 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.421 ' HB3' ' HA ' ' A' ' 94' ' ' ASN . 77.0 t80 -80.24 -23.03 41.14 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.69 0.757 . . . . 22.18 110.791 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -137.86 84.17 22.29 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.084 -0.962 . . . . 19.449999999999999 110.805 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -89.41 -79.84 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.995 2.463 . . . . 18.530000000000001 111.252 172.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.636 ' H ' ' HD2' ' A' ' 101' ' ' PRO . 40.2 mt-10 -144.16 -54.88 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.72 -0.673 . . . . 17.449999999999999 110.503 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.636 ' HD2' ' H ' ' A' ' 100' ' ' GLU . 75.3 Cg_endo -76.88 157.92 34.84 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.661 1.574 . . . . 17.420000000000002 112.191 175.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.449 ' N ' ' HD3' ' A' ' 103' ' ' PRO . . . 51.22 64.17 8.49 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.578 -0.737 . . . . 17.68 112.155 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 102' ' ' ALA . 13.0 Cg_endo -92.79 121.03 0.46 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.914 2.409 . . . . 16.289999999999999 111.822 177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.6 m -87.17 29.39 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.214 0.531 . . . . 17.260000000000002 110.937 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.29 119.86 74.74 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.61 -0.723 . . . . 15.800000000000001 110.241 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.438 ' O ' ' HD2' ' A' ' 109' ' ' PRO . 56.8 Cg_endo -70.24 150.85 65.92 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.327 2.018 . . . . 15.92 111.835 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.87 47.81 1.55 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.008 2.472 . . . . 16.149999999999999 112.707 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.486 ' H ' ' HD2' ' A' ' 109' ' ' PRO . 68.0 mttm -96.23 -56.36 0.2 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.959 -0.564 . . . . 17.629999999999999 110.051 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' A' ' 108' ' ' LYS . 73.5 Cg_endo -75.01 141.29 26.43 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.768 1.646 . . . . 15.039999999999999 111.02 171.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -76.0 -48.57 3.52 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.175 -0.466 . . . . 15.199999999999999 111.776 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -76.11 101.21 1.47 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.364 1.376 . . . . 14.08 112.392 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.9 t -89.68 59.66 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.352 -0.981 . . . . 15.279999999999999 108.352 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 68.99 86.3 0.12 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 114.086 -1.415 . . . . 16.84 109.736 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 32.4 Cg_exo -58.66 142.76 98.77 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.365 2.71 . . . . 15.51 112.456 -176.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 114' ' ' PRO . 31.5 Cg_exo -58.89 137.44 79.86 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.813 2.342 . . . . 16.039999999999999 111.768 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 5.0 tppp? -68.69 120.19 74.07 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.459 . . . . 18.91 110.255 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 116' ' ' LYS . 15.3 Cg_exo -69.36 70.5 1.37 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.925 2.416 . . . . 17.039999999999999 112.355 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.07 142.13 47.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.936 -0.574 . . . . 17.52 110.652 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.45 HG11 ' HG3' ' A' ' 142' ' ' LYS . 24.3 m -90.46 -22.98 6.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.262 -0.426 . . . . 18.699999999999999 111.566 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 119' ' ' VAL . 10.1 pt-20 -148.98 64.43 1.04 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.513 0.673 . . . . 20.879999999999999 110.167 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -61.17 142.78 93.08 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.126 -0.943 . . . . 18.890000000000001 110.934 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 12.8 Cg_exo -69.3 112.57 3.03 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.844 2.363 . . . . 20.43 111.883 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.34 52.17 4.21 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.808 2.339 . . . . 21.100000000000001 112.228 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.6 -51.98 1.78 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.856 -0.611 . . . . 21.149999999999999 111.208 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.47 98.31 0.84 Allowed 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.481 1.454 . . . . 21.149999999999999 110.917 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? 65.86 101.45 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.961 -0.563 . . . . 21.879999999999999 109.819 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.426 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 24.4 Cg_exo -62.67 90.88 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.944 2.429 . . . . 20.190000000000001 113.498 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -113.39 75.35 2.35 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.73 -0.668 . . . . 20.48 109.768 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 96.2 Cg_endo -92.3 152.36 3.08 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.788 2.326 . . . . 21.170000000000002 113.523 -173.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.448 ' HD2' ' HD2' ' A' ' 131' ' ' PRO . 26.9 tptp -137.37 111.47 9.12 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.413 -0.812 . . . . 23.18 109.321 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.448 ' HD2' ' HD2' ' A' ' 130' ' ' LYS . 52.8 Cg_exo -55.57 119.58 6.8 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.449 2.099 . . . . 20.780000000000001 111.891 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 m -102.61 45.24 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.799 0.809 . . . . 19.75 110.053 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.1 t -95.24 154.84 3.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.63 -1.168 . . . . 21.050000000000001 108.626 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 66.79 26.35 9.45 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.223 0.535 . . . . 21.300000000000001 109.649 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -109.83 149.0 30.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.532 -0.758 . . . . 20.739999999999998 110.804 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.404 ' NZ ' ' HB2' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -92.69 -49.05 6.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.802 -0.814 . . . . 17.969999999999999 108.802 176.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . -151.82 16.28 0.67 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.081 -0.963 . . . . 17.350000000000001 109.472 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 75.75 146.11 0.11 Allowed Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 114.361 -1.291 . . . . 19.100000000000001 111.406 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -47.31 -55.09 4.23 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.763 2.975 . . . . 19.350000000000001 114.416 -172.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.9 t -120.76 -16.43 8.2 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.956 -0.298 . . . . 17.75 111.272 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.95 -58.65 11.85 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.973 -0.632 . . . . 17.960000000000001 111.843 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.641 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 67.7 mttm -129.95 82.51 2.07 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.196 0.522 . . . . 19.420000000000002 110.069 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.845 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . -107.43 162.05 14.28 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.826 -0.624 . . . . 14.65 109.424 176.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.708 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 5.2 m-85 -143.7 141.94 30.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.261 0.224 . . . . 14.81 111.086 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.797 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.4 t -150.98 162.02 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 109.625 -0.509 . . . . 10.48 109.625 171.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 27.7 t -104.01 117.57 49.75 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 O-C-N 122.21 -0.306 . . . . 10.1 111.129 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.515 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 6.1 tt0 -91.02 111.4 22.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.649 0.24 . . . . 12.0 111.649 -176.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 1.018 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -94.47 -34.55 12.67 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.215 0.531 . . . . 11.880000000000001 110.313 -177.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.51 162.07 27.97 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.671 -0.776 . . . . 11.35 111.923 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -165.38 101.76 0.72 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.758 -0.46 . . . . 13.470000000000001 109.758 -178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.54 163.14 33.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.544 0.687 . . . . 13.52 111.127 -173.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 43.2 mttm -98.47 13.47 31.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.641 -1.163 . . . . 17.600000000000001 109.722 -177.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -117.64 104.01 10.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.31 -0.859 . . . . 16.140000000000001 110.277 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -22.71 67.04 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.204 0.526 . . . . 14.039999999999999 110.802 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -52.02 -37.94 55.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.063 -0.972 . . . . 16.57 111.002 175.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -89.64 -31.89 17.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.929 -1.032 . . . . 16.399999999999999 110.351 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 184' ' ' THR . 82.8 t -55.1 -44.31 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.831 -0.622 . . . . 12.67 110.783 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -58.6 -30.4 67.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.575 -0.739 . . . . 15.32 111.468 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.47 -56.43 4.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.829 -0.434 . . . . 15.970000000000001 109.829 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.413 HD12 HG13 ' A' ' 186' ' ' ILE . 19.4 mt -54.76 -40.71 53.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.295 -0.866 . . . . 12.6 110.601 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.6 t -73.83 -44.0 52.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.852 -0.613 . . . . 12.539999999999999 110.737 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.69 -32.4 73.93 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.633 -0.794 . . . . 14.800000000000001 111.861 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -67.41 -59.92 3.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.645 0.26 . . . . 16.050000000000001 111.214 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.551 ' HB3' HG21 ' A' ' 171' ' ' VAL . 2.1 mm? -85.98 -57.02 3.2 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.58 0.585 . . . . 12.99 112.58 -175.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 165' ' ' ARG . 0.8 OUTLIER -64.45 -35.52 81.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.408 0.623 . . . . 15.06 109.549 -178.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.95 -15.22 76.18 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.349 -0.841 . . . . 16.600000000000001 112.313 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -96.17 7.25 46.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.295 0.569 . . . . 16.140000000000001 110.342 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.44 15.72 58.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.766 -0.652 . . . . 15.119999999999999 113.051 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 207' ' ' LEU . 53.1 m-85 -91.65 148.06 22.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 117.031 0.415 . . . . 15.49 110.574 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.427 ' HB3' ' HD2' ' A' ' 190' ' ' PRO . 22.9 mmm180 -62.56 98.98 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 13.869999999999999 110.512 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.669 HG22 HG22 ' A' ' 188' ' ' VAL . 10.2 t -133.83 133.46 56.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.038 0.447 . . . . 10.82 110.969 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -138.36 175.21 9.77 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.447 -0.797 . . . . 11.130000000000001 110.375 170.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 22.7 p -115.22 -176.11 2.84 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.878 -1.055 . . . . 11.52 111.173 -172.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.56 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.1 OUTLIER -53.51 143.51 36.75 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 123.16 0.288 . . . . 12.75 111.411 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -25.47 -57.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 1 C-N-CA 126.009 4.473 . . . . 14.640000000000001 116.239 -174.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.3 m -87.19 -64.34 1.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.682 -0.807 . . . . 16.68 113.0 -169.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.5 m -170.38 135.57 1.16 Allowed Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 117.857 0.299 . . . . 16.039999999999999 111.68 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.462 ' HB3' HG21 ' A' ' 184' ' ' THR . 76.0 Cg_exo -60.13 124.76 15.91 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.139 2.559 . . . . 14.220000000000001 112.507 166.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.1 p -153.51 158.48 3.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.911 -0.586 . . . . 16.129999999999999 109.609 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.22 134.67 36.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.392 -0.367 . . . . 16.699999999999999 110.347 -176.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 95.27 -25.9 22.03 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.85 -0.691 . . . . 16.98 112.422 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.533 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 9.8 mptt -106.95 168.94 8.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.18 -0.674 . . . . 18.73 109.18 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.439 HD11 ' HB1' ' A' ' 150' ' ' ALA . 10.3 tp -77.53 111.29 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.871 0.843 . . . . 14.82 111.84 -173.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.56 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 37.4 m -105.31 109.93 22.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.463 -0.79 . . . . 12.779999999999999 109.18 170.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 36.5 mtt180 -94.68 145.89 24.54 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.597 -0.729 . . . . 13.98 110.2 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.539 ' O ' HD22 ' A' ' 148' ' ' LEU . 3.0 mm -110.37 119.66 59.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.699 -0.852 . . . . 10.56 108.699 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.547 ' HB3' ' CG1' ' A' ' 145' ' ' VAL . 6.1 mp -128.79 131.37 47.78 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.376 0.608 . . . . 10.1 110.887 -175.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.018 HG23 HD21 ' A' ' 148' ' ' LEU . 39.8 t -104.01 133.74 47.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.995 -1.002 . . . . 9.7400000000000002 110.845 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.75 47.64 5.83 Favored Glycine 0 N--CA 1.438 -1.217 0 CA-C-N 114.907 -1.042 . . . . 9.7599999999999998 113.731 174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.797 ' HA ' HG22 ' A' ' 145' ' ' VAL . 10.9 Cg_endo -60.79 125.56 17.51 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 CA-C-N 119.629 1.715 . . . . 11.15 110.888 174.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -159.25 168.1 27.33 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.932 -0.576 . . . . 12.77 109.583 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 143' ' ' ALA . . . -106.9 13.69 27.43 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.296 0.569 . . . . 14.6 109.776 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 22.8 t -118.43 109.47 16.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.885 -0.598 . . . . 14.300000000000001 111.373 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.705 ' HB2' ' CZ ' ' A' ' 144' ' ' TYR . 38.3 ttpt -69.91 -42.35 73.45 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.67 -0.863 . . . . 15.970000000000001 108.67 171.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -56.6 -40.63 75.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 15.6 111.652 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -79.72 -48.25 13.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.374 -0.376 . . . . 14.220000000000001 111.196 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.633 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -79.66 -20.76 45.89 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.884 0.328 . . . . 11.949999999999999 111.884 -171.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.506 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 29.2 tptp -67.4 -44.6 78.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.236 0.541 . . . . 14.699999999999999 109.714 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.28 -13.62 76.84 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.678 -0.692 . . . . 13.09 111.547 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 73.9 m -75.32 -24.01 57.37 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.519 0.2 . . . . 12.109999999999999 111.367 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 15.8 mt -61.49 -31.14 71.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.349 . . . . 12.720000000000001 110.878 -175.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.48 -46.11 94.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.565 -0.826 . . . . 14.66 111.924 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 12.6 pt-20 -86.83 -19.64 28.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.0 0.429 . . . . 13.890000000000001 111.111 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.432 HD11 ' CG1' ' A' ' 188' ' ' VAL . 14.9 tp -68.63 -35.75 77.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.3 -0.409 . . . . 12.550000000000001 111.62 -172.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.44 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 6.3 ptpp? -64.37 -16.31 62.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.825 0.345 . . . . 15.83 110.765 174.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.42 -35.5 15.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.117 0.484 . . . . 16.969999999999999 110.04 172.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 82.5 mt -74.96 -53.18 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 13.890000000000001 111.36 -176.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.531 ' HA ' HD11 ' A' ' 164' ' ' LEU . 3.4 m -94.86 -43.68 8.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.247 0.546 . . . . 13.539999999999999 110.592 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 71.35 1.02 40.92 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.318 -0.856 . . . . 14.67 112.383 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 59.5 mt -84.37 154.48 22.83 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.341 -0.615 . . . . 13.039999999999999 109.341 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 23.3 m -77.17 93.49 3.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.86 0.362 . . . . 14.84 110.104 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -111.13 136.54 13.67 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.641 -0.79 . . . . 12.220000000000001 113.348 -175.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.6 t -100.92 138.4 25.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.038 -0.727 . . . . 13.74 109.038 174.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 6.6 p -79.23 108.1 12.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.736 0.779 . . . . 12.890000000000001 109.378 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 67.2 mtt -122.42 152.52 40.16 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.369 -0.832 . . . . 13.800000000000001 110.13 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -75.26 143.61 30.89 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.004 -1.094 . . . . 13.359999999999999 111.616 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.845 ' CD2' ' HB1' ' A' ' 143' ' ' ALA . 4.3 t80 -110.21 133.89 52.78 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.217 -0.992 . . . . 14.24 109.617 -170.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.8 t -147.7 93.66 4.52 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-O 121.229 0.537 . . . . 16.510000000000002 110.802 177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.429 ' HD3' ' CE1' ' A' ' 217' ' ' TYR . 58.4 Cg_endo -72.71 123.78 9.26 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.244 1.962 . . . . 17.420000000000002 111.201 174.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.8 p30 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.377 -0.82 . . . . 19.190000000000001 109.77 -179.284 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.883 0.373 . . . . 18.390000000000001 110.692 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -115.01 107.25 1.75 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.761 -0.733 . . . . 17.77 111.674 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -81.08 48.91 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.257 0.551 . . . . 17.690000000000001 112.022 -175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -85.94 -25.22 26.21 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.149 -0.686 . . . . 19.93 109.149 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -86.98 140.06 29.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.303 -0.862 . . . . 17.43 109.709 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -88.47 174.61 8.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.285 -0.416 . . . . 19.359999999999999 110.604 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -53.56 -64.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.833 -0.621 . . . . 18.960000000000001 112.178 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -172.94 -64.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.062 0.458 . . . . 18.239999999999998 110.294 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -155.41 128.49 8.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.511 -0.768 . . . . 16.780000000000001 109.112 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.33 111.36 2.25 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.337 0.589 . . . . 18.420000000000002 111.059 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -58.23 118.78 5.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.219 -0.901 . . . . 17.920000000000002 111.466 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.79 71.95 3.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.719 -0.673 . . . . 19.550000000000001 110.398 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 71.05 -49.5 0.68 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.982 0.801 . . . . 20.309999999999999 111.791 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.8 pt 39.27 65.72 3.27 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.249 1.019 . . . . 19.920000000000002 112.53 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.14 76.49 4.45 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.137 2.558 . . . . 21.640000000000001 112.35 -176.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 62.72 48.86 4.01 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.427 -0.806 . . . . 22.670000000000002 111.519 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.553 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 88.9 t -122.44 -62.5 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 116.322 -0.399 . . . . 21.34 111.343 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 44' ' ' VAL . 59.3 Cg_endo -69.81 150.54 68.02 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.089 1.859 . . . . 20.0 112.816 178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -79.49 -28.99 41.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.778 -0.646 . . . . 21.079999999999998 110.632 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.77 -168.5 2.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.068 -0.515 . . . . 18.800000000000001 110.533 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.77 175.54 19.06 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.991 -0.624 . . . . 17.510000000000002 111.669 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.49 95.03 1.02 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.369 0.604 . . . . 16.949999999999999 110.303 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -122.31 119.91 32.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.45 -0.796 . . . . 18.300000000000001 109.582 -177.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -67.75 134.88 51.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.317 -0.623 . . . . 18.170000000000002 109.317 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 9.4 pt-20 -85.51 119.41 72.15 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 121.038 0.447 . . . . 18.82 112.149 -172.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.53 -23.51 4.91 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.329 2.019 . . . . 19.870000000000001 110.151 167.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 52' ' ' GLU . 17.2 m-20 -142.17 157.73 44.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.088 -1.415 . . . . 21.100000000000001 107.925 176.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.2 ttt -72.06 80.56 0.94 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.332 0.586 . . . . 22.300000000000001 110.815 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.558 ' HB2' ' HD3' ' A' ' 57' ' ' PRO . 66.0 mtt -131.85 -49.84 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.616 -0.72 . . . . 23.850000000000001 111.214 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.558 ' HD3' ' HB2' ' A' ' 56' ' ' MET . 51.2 Cg_exo -58.9 136.54 74.22 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.862 1.708 . . . . 20.670000000000002 111.846 174.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 68.63 -64.97 0.29 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.918 0.761 . . . . 20.489999999999998 111.427 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.68 -82.52 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.674 0.79 . . . . 21.469999999999999 112.304 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 t -79.74 -16.52 55.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.068 0.461 . . . . 22.600000000000001 110.322 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -94.76 130.7 41.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.896 -0.593 . . . . 21.93 110.485 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.58 100.6 12.53 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.862 -0.422 . . . . 19.73 109.862 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.15 101.44 45.06 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.315 -0.402 . . . . 19.579999999999998 110.004 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.85 -69.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.631 2.221 . . . . 18.5 111.964 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.0 m -154.03 -63.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.946 0.403 . . . . 17.609999999999999 111.007 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.441 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 25.5 tp60 -130.91 94.66 27.74 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.252 -0.431 . . . . 18.760000000000002 110.459 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -96.8 93.95 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.272 2.648 . . . . 17.280000000000001 112.224 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 66' ' ' GLN . 97.4 Cg_endo -76.11 -23.25 12.2 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.426 2.084 . . . . 17.77 111.924 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -138.91 177.04 8.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.956 -1.02 . . . . 18.699999999999999 109.194 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.87 -49.85 4.28 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.81 -0.709 . . . . 17.719999999999999 112.121 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -110.95 8.92 22.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.053 0.454 . . . . 18.0 110.254 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.63 74.53 8.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.903 -0.589 . . . . 17.960000000000001 110.811 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -78.43 0.71 24.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.887 -0.597 . . . . 19.850000000000001 111.289 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -112.77 91.04 3.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.255 -0.43 . . . . 19.670000000000002 109.985 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.5 m -80.97 53.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.469 0.652 . . . . 17.739999999999998 111.292 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -69.41 -38.7 78.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.548 -0.751 . . . . 19.949999999999999 110.204 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.3 56.1 3.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.616 . . . . 18.390000000000001 110.448 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.73 -90.43 0.96 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.845 -0.616 . . . . 17.66 112.212 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -132.12 -8.7 3.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.063 0.459 . . . . 17.68 110.544 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.9 18.77 11.39 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.337 -0.847 . . . . 17.800000000000001 110.943 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -155.8 143.99 19.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.715 -0.675 . . . . 17.350000000000001 109.649 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.411 ' N ' ' HD3' ' A' ' 83' ' ' PRO . . . 53.52 64.24 7.06 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 123.521 0.513 . . . . 16.640000000000001 111.117 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 82' ' ' ALA . 17.9 Cg_exo -66.93 96.42 0.37 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.631 2.221 . . . . 17.23 111.053 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -84.52 51.42 2.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.826 -0.624 . . . . 17.34 111.1 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.69 6.82 39.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.957 -0.565 . . . . 18.41 110.096 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.99 120.85 61.26 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.563 -0.744 . . . . 17.449999999999999 110.496 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.51 -31.34 94.15 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.137 2.558 . . . . 18.890000000000001 111.542 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -101.01 69.81 1.33 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.765 -0.652 . . . . 17.809999999999999 109.775 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 m -66.58 -46.56 75.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.037 -0.528 . . . . 18.629999999999999 109.871 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.4 tt -130.12 86.36 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 122.084 0.945 . . . . 19.100000000000001 110.16 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -121.66 156.42 33.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.359 -0.837 . . . . 19.25 110.077 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 70.87 -52.57 0.68 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.87 0.731 . . . . 18.789999999999999 111.576 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -91.11 99.83 12.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.522 0.201 . . . . 18.949999999999999 110.614 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 68.33 171.56 0.28 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.914 -0.585 . . . . 20.309999999999999 110.681 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.2 m 74.68 -43.83 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.057 0.543 . . . . 21.399999999999999 110.878 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -131.07 21.06 4.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.012 -0.54 . . . . 21.16 110.881 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.517 ' CD2' ' HG2' ' A' ' 98' ' ' GLU . 13.9 t80 -130.15 -79.97 0.55 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.448 0.642 . . . . 22.18 110.759 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.517 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 7.7 pt-20 -154.22 142.52 14.29 Favored Pre-proline 0 C--N 1.305 -1.367 0 CA-C-N 114.798 -1.092 . . . . 19.449999999999999 109.889 176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.76 135.39 59.69 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.643 2.229 . . . . 18.530000000000001 112.08 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -101.4 140.71 21.48 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.817 -0.629 . . . . 17.449999999999999 110.609 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.68 143.72 99.59 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.695 2.263 . . . . 17.420000000000002 111.474 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -116.09 90.99 30.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.728 0.299 . . . . 17.68 111.142 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.64 92.36 0.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.743 2.296 . . . . 16.289999999999999 111.458 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.0 m -84.66 16.16 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.661 0.743 . . . . 17.260000000000002 111.047 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.98 141.66 12.72 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 114.817 -1.083 . . . . 15.800000000000001 109.083 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.98 116.58 3.23 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.985 2.457 . . . . 15.92 112.881 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.01 -32.54 93.38 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.016 2.477 . . . . 16.149999999999999 111.977 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.78 82.67 54.79 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.18 -0.464 . . . . 17.629999999999999 110.08 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.05 49.57 2.84 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.919 2.413 . . . . 15.039999999999999 111.837 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -153.82 151.06 24.17 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.527 -0.761 . . . . 15.199999999999999 109.745 -177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.25 107.66 1.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.264 1.976 . . . . 14.08 111.139 173.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 m -83.24 50.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 121.372 0.606 . . . . 15.279999999999999 111.16 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 58.51 83.63 0.21 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 114.572 -1.194 . . . . 16.84 111.172 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.62 109.41 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.252 1.968 . . . . 15.51 111.636 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.54 52.89 4.43 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.92 2.413 . . . . 16.039999999999999 112.142 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -72.96 117.11 57.01 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.495 -0.775 . . . . 18.91 109.803 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.26 60.17 6.81 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.909 2.406 . . . . 17.039999999999999 112.133 -175.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 60.8 mttm 63.35 -132.17 0.43 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.493 -0.776 . . . . 17.52 110.724 177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.3 t 70.27 -67.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 O-C-N 123.57 0.543 . . . . 18.699999999999999 111.299 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -105.11 30.59 5.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.864 0.364 . . . . 20.879999999999999 110.406 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.35 146.59 99.05 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.469 -0.332 . . . . 18.890000000000001 110.56 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.434 ' HB2' ' HD3' ' A' ' 123' ' ' PRO . 71.6 Cg_exo -46.13 -52.63 6.87 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.232 2.622 . . . . 20.43 115.174 -174.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 122' ' ' PRO . 67.9 Cg_endo -84.28 26.56 0.64 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.663 1.575 . . . . 21.100000000000001 113.903 -173.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 58.56 84.69 0.2 Allowed Pre-proline 0 N--CA 1.466 0.333 0 C-N-CA 123.074 0.549 . . . . 21.149999999999999 111.294 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.86 98.22 1.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.507 2.138 . . . . 21.149999999999999 112.754 -173.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 127' ' ' PRO . 87.3 tttt -70.95 -48.66 14.01 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.004 -0.544 . . . . 21.879999999999999 110.966 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 126' ' ' LYS . 39.7 Cg_endo -66.27 154.8 72.81 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.012 1.808 . . . . 20.190000000000001 112.499 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -97.02 164.27 18.23 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.602 -0.726 . . . . 20.48 110.272 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.49 76.75 0.52 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.979 2.453 . . . . 21.170000000000002 112.094 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -161.07 162.13 22.78 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.465 -0.789 . . . . 23.18 108.984 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.95 95.46 0.49 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.065 1.843 . . . . 20.780000000000001 111.169 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.58 59.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.926 0.869 . . . . 19.75 110.487 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 95.3 t 63.18 96.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 114.966 -1.015 . . . . 21.050000000000001 111.417 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -78.03 -17.08 57.5 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.764 -0.653 . . . . 21.300000000000001 110.419 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.23 171.3 5.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.854 -0.612 . . . . 20.739999999999998 109.518 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.489 ' NZ ' ' HB2' ' A' ' 136' ' ' LYS . 1.0 OUTLIER -164.52 21.66 0.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.794 0.806 . . . . 17.969999999999999 109.428 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 176.48 -78.72 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.11 -1.405 . . . . 17.350000000000001 108.043 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.638 ' HB3' ' H ' ' A' ' 142' ' ' LYS . . . 174.95 148.76 0.25 Allowed Pre-proline 0 C--N 1.327 -0.385 0 O-C-N 124.683 1.239 . . . . 19.100000000000001 109.927 168.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.8 -60.79 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 122.477 2.118 . . . . 19.350000000000001 113.486 -175.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.402 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 12.5 p -111.63 -24.62 9.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.101 0.408 . . . . 17.75 112.101 -173.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.5 -74.67 0.75 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.691 -0.766 . . . . 17.960000000000001 112.104 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.638 ' H ' ' HB3' ' A' ' 138' ' ' ALA . 0.4 OUTLIER -89.77 78.3 6.91 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.746 -0.464 . . . . 19.420000000000002 109.746 177.093 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.826 ' HB1' ' CD1' ' A' ' 217' ' ' TYR . . . -105.56 162.57 13.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.027 -0.533 . . . . 14.65 110.387 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.683 ' CE2' ' HE3' ' A' ' 194' ' ' LYS . 36.6 m-85 -142.28 142.9 32.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.549 0.34 . . . . 14.81 111.67 -172.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.925 HG22 ' HA ' ' A' ' 190' ' ' PRO . 3.4 t -148.74 164.4 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 109.371 -0.603 . . . . 10.48 109.371 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.461 HG21 HD13 ' A' ' 204' ' ' LEU . 40.1 t -101.17 107.84 22.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 122.055 -0.403 . . . . 10.1 111.373 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.549 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 40.2 tt0 -78.68 115.94 18.71 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 122.617 0.367 . . . . 12.0 111.129 -178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 1.029 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -93.74 -33.31 13.66 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.424 0.631 . . . . 11.880000000000001 109.778 177.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.68 168.51 27.39 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.402 -0.817 . . . . 11.35 112.423 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -168.41 100.47 0.42 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.488 -0.93 . . . . 13.470000000000001 108.488 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.18 160.77 42.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.661 -0.7 . . . . 13.52 110.799 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 44.7 mtpt -99.35 -6.64 27.49 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.948 -1.024 . . . . 17.600000000000001 110.262 -173.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.538 ' ND2' ' HG3' ' A' ' 156' ' ' LYS . 36.2 t30 -90.96 106.5 18.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.527 -0.76 . . . . 16.140000000000001 109.691 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.01 -21.38 64.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.969 -0.56 . . . . 14.039999999999999 111.697 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -59.52 -35.08 73.5 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.774 0.797 . . . . 16.57 109.878 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.538 ' HG3' ' ND2' ' A' ' 153' ' ' ASN . 28.3 mtpp -83.67 -33.35 25.24 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.561 -1.2 . . . . 16.399999999999999 110.753 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 178' ' ' PRO . 89.7 t -57.48 -39.14 67.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.404 0.621 . . . . 12.67 109.662 173.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -60.78 -30.32 69.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.106 -0.952 . . . . 15.32 111.743 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.614 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 6.0 mm-40 -77.24 -61.65 1.91 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.185 -0.672 . . . . 15.970000000000001 109.185 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 156' ' ' LYS . 12.3 mt -49.41 -46.09 19.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.357 -0.838 . . . . 12.6 110.793 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 69.3 t -73.75 -41.42 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.463 -0.789 . . . . 12.539999999999999 110.602 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.66 -28.88 70.61 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.611 -0.804 . . . . 14.800000000000001 112.137 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.614 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 5.6 mptp? -72.7 -52.44 15.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.703 0.287 . . . . 16.050000000000001 111.183 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.5 mm? -86.39 -55.86 3.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.272 0.471 . . . . 12.99 112.272 -176.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -63.45 -40.28 96.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.223 0.535 . . . . 15.06 109.752 -177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.68 -23.98 73.98 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.02 -0.991 . . . . 16.600000000000001 112.517 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.18 0.85 56.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.867 0.365 . . . . 16.140000000000001 110.723 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.56 17.3 58.76 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.927 -0.654 . . . . 15.119999999999999 113.237 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -83.86 153.85 23.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.979 0.39 . . . . 15.49 111.036 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.15 99.33 2.79 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.284 -0.636 . . . . 13.869999999999999 109.284 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.5 p -142.66 141.7 27.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 114.904 -1.044 . . . . 10.82 109.255 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.586 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -138.7 176.41 8.72 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.994 0.902 . . . . 11.130000000000001 111.31 170.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 14.2 p -123.34 -173.73 2.79 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.817 -1.538 . . . . 11.52 109.886 -171.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 19.5 m -50.01 137.58 19.97 Favored Pre-proline 0 C--O 1.234 0.278 0 N-CA-C 109.737 -0.468 . . . . 12.75 109.737 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -37.44 -50.38 1.75 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 124.572 3.515 . . . . 14.640000000000001 115.399 -167.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.0 t -82.93 -60.41 2.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 120.116 -0.634 . . . . 16.68 112.471 -172.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.3 m -166.81 135.43 2.24 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 117.891 0.314 . . . . 16.039999999999999 111.608 -175.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.47 ' HB3' HG11 ' A' ' 157' ' ' VAL . 34.4 Cg_exo -62.24 124.62 14.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.266 1.977 . . . . 14.220000000000001 111.063 165.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.463 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.8 p -153.57 154.56 7.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 110.084 -0.339 . . . . 16.129999999999999 110.084 -176.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -82.92 141.59 32.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.123 0.487 . . . . 16.699999999999999 110.887 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.93 -17.07 59.33 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.698 -0.683 . . . . 16.98 111.921 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 10.2 mptt -123.78 156.8 35.42 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.353 -0.61 . . . . 18.73 109.353 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 183' ' ' ILE . 7.7 tp -71.46 109.07 3.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.554 0.692 . . . . 14.82 111.049 -174.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.448 ' HA ' ' OG ' ' A' ' 174' ' ' SER . 32.6 m -103.49 106.77 17.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.813 0.816 . . . . 12.779999999999999 110.438 178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.751 ' HG2' HD11 ' A' ' 187' ' ' LEU . 22.1 ttp180 -85.39 133.29 34.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.317 -1.31 . . . . 13.98 109.367 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.533 ' O ' HD22 ' A' ' 148' ' ' LEU . 2.0 mm -112.98 118.6 58.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.057 -0.72 . . . . 10.56 109.057 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.751 HD11 ' HG2' ' A' ' 185' ' ' ARG . 1.5 mp -131.33 132.64 44.63 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.396 0.617 . . . . 10.1 111.278 -172.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.029 HG23 HD21 ' A' ' 148' ' ' LEU . 42.3 t -104.9 134.44 46.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.217 -0.902 . . . . 9.7400000000000002 111.009 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 84.57 50.41 4.24 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.443 -0.799 . . . . 9.7599999999999998 113.739 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.925 ' HA ' HG22 ' A' ' 145' ' ' VAL . 5.3 Cg_endo -55.88 125.51 19.32 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 119.277 1.538 . . . . 11.15 111.424 174.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -152.47 169.01 23.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.657 -0.702 . . . . 12.77 109.23 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -106.47 -1.88 22.63 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 120.81 0.338 . . . . 14.6 111.086 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 70.5 m -121.11 110.15 15.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.863 0.363 . . . . 14.300000000000001 111.351 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.683 ' HE3' ' CE2' ' A' ' 144' ' ' TYR . 37.5 ttmt -65.13 -53.44 45.13 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.968 -0.56 . . . . 15.970000000000001 110.014 177.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -51.34 -40.26 58.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.264 -0.88 . . . . 15.6 111.647 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -74.7 -42.07 59.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.197 -0.456 . . . . 14.220000000000001 110.947 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.2 OUTLIER -78.56 -20.25 51.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.022 0.439 . . . . 11.949999999999999 110.19 -177.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.462 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.4 tptm -67.06 -39.58 86.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.423 0.63 . . . . 14.699999999999999 110.305 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.75 -12.17 84.04 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.303 -1.119 . . . . 13.09 110.303 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 71.5 m -90.26 -9.29 48.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.528 -0.836 . . . . 12.109999999999999 112.454 -175.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 18.2 mt -65.2 -35.79 82.15 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.774 -0.37 . . . . 12.720000000000001 110.908 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.96 -44.08 97.52 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.915 -0.66 . . . . 14.66 112.331 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 200' ' ' SER . 11.1 pt-20 -81.06 -18.5 46.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.936 0.398 . . . . 13.890000000000001 110.457 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.461 HD13 HG21 ' A' ' 146' ' ' VAL . 1.2 tt -68.95 -32.17 71.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 12.550000000000001 109.958 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 25.2 mtpp -62.0 -19.84 63.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.572 -0.74 . . . . 15.83 110.37 173.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -40.01 13.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.174 0.511 . . . . 16.969999999999999 109.719 172.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.75 -52.54 59.99 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.63 -0.714 . . . . 13.890000000000001 111.339 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.495 ' HB3' HD11 ' A' ' 164' ' ' LEU . 62.8 p -103.84 -46.95 4.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.999 0.428 . . . . 13.539999999999999 110.802 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 82.27 -6.18 69.13 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.789 -0.641 . . . . 14.67 111.8 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.0 mp -86.61 158.37 19.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.82 -0.437 . . . . 13.039999999999999 109.82 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 16.1 m -80.13 94.73 6.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.851 -0.613 . . . . 14.84 110.594 -175.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -111.83 148.55 18.12 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.591 -0.814 . . . . 12.220000000000001 113.45 -176.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.4 141.97 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.963 0.411 . . . . 13.74 109.932 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.31 106.77 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.689 0.757 . . . . 12.890000000000001 110.372 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 96.6 mmm -117.87 168.55 10.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.464 -0.789 . . . . 13.800000000000001 110.376 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -84.76 151.31 26.17 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.356 -0.926 . . . . 13.359999999999999 112.462 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.913 ' HB2' HG23 ' A' ' 145' ' ' VAL . 3.9 t80 -123.87 133.01 53.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.418 -0.891 . . . . 14.24 109.582 -171.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 26.5 p -139.84 92.33 9.99 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 116.396 -0.365 . . . . 16.510000000000002 110.204 177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 140' ' ' THR . 43.9 Cg_endo -69.64 120.77 7.53 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.242 1.962 . . . . 17.420000000000002 111.501 177.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 13.7 m120 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.628 -0.701 . . . . 19.190000000000001 110.155 -178.73 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 9.4 p-10 . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 109.903 -0.406 . . . . 18.390000000000001 109.903 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.59 -38.94 94.43 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.806 -0.711 . . . . 17.77 111.68 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.495 ' OE1' ' HD2' ' A' ' 68' ' ' PRO . 19.3 tp60 55.61 74.76 0.36 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.601 0.715 . . . . 17.690000000000001 110.892 177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -122.17 -63.22 1.31 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.533 -0.758 . . . . 19.93 111.194 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -152.29 160.72 43.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.958 -0.386 . . . . 17.43 109.958 -173.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.5 m80 66.98 35.51 4.66 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.889 0.476 . . . . 19.359999999999999 111.303 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.556 ' CD2' ' HG2' ' A' ' 35' ' ' GLN . 39.9 p90 -74.41 -29.24 61.43 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.939 -0.305 . . . . 18.960000000000001 110.976 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.556 ' HG2' ' CD2' ' A' ' 34' ' ' TYR . 11.5 pt20 -160.29 22.15 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.215 0.531 . . . . 18.239999999999998 110.06 173.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.76 -67.78 0.8 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.519 -0.764 . . . . 16.780000000000001 110.505 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -148.75 162.45 39.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.639 -0.71 . . . . 18.420000000000002 109.271 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -137.85 166.37 24.19 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.782 0.325 . . . . 17.920000000000002 110.851 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.52 159.92 25.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.076 -0.511 . . . . 19.550000000000001 110.313 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.09 50.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.607 0.242 . . . . 20.309999999999999 110.756 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.411 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 22.9 pt 36.63 64.94 2.4 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 124.41 1.069 . . . . 19.920000000000002 113.14 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 41' ' ' ILE . 8.3 Cg_exo -72.27 72.96 2.76 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.746 2.297 . . . . 21.640000000000001 111.423 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mp 69.08 7.85 6.48 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.5 -0.773 . . . . 22.670000000000002 111.526 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.561 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 47.8 t -64.3 -53.89 42.97 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.428 -0.351 . . . . 21.34 111.64 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.561 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 84.0 Cg_endo -80.79 14.49 2.04 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 121.791 1.66 . . . . 20.0 112.073 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 60.62 29.37 18.96 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.385 0.612 . . . . 21.079999999999998 110.276 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.99 155.6 39.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.355 -0.839 . . . . 18.800000000000001 109.62 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.62 168.55 16.29 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.769 -0.729 . . . . 17.510000000000002 112.155 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -81.87 164.11 21.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.639 -0.134 . . . . 16.949999999999999 110.639 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 73.24 -55.71 0.67 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.932 0.77 . . . . 18.300000000000001 111.71 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.84 115.17 9.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.852 0.358 . . . . 18.170000000000002 110.62 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.406 ' HB3' ' HG2' ' A' ' 57' ' ' PRO . 35.3 mt-10 -86.11 147.36 44.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.15 -0.477 . . . . 18.82 110.922 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.82 141.87 67.19 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.524 2.149 . . . . 19.870000000000001 111.716 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -76.91 63.51 2.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.091 0.472 . . . . 21.100000000000001 111.512 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.4 mmt -105.75 -33.36 8.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.95 -0.568 . . . . 22.300000000000001 109.833 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.605 ' H ' ' HD2' ' A' ' 57' ' ' PRO . 68.4 mtt -146.22 -50.72 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 115.506 -0.77 . . . . 23.850000000000001 111.842 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.605 ' HD2' ' H ' ' A' ' 56' ' ' MET . 84.6 Cg_exo -48.79 121.63 6.89 Favored 'Trans proline' 0 C--N 1.363 1.315 0 C-N-CA 122.374 2.049 . . . . 20.670000000000002 112.849 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.26 -26.5 42.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.587 -0.733 . . . . 20.489999999999998 110.868 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 68.58 -71.36 0.12 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.982 0.801 . . . . 21.469999999999999 111.745 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.8 t -75.51 124.06 26.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.098 0.475 . . . . 22.600000000000001 110.993 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 55.45 42.14 30.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.495 -0.775 . . . . 21.93 110.77 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.74 134.37 37.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.913 -0.585 . . . . 19.73 110.427 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.3 mt -111.97 96.77 35.44 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.362 -0.381 . . . . 19.579999999999998 110.432 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.84 39.97 0.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.741 2.294 . . . . 18.5 112.069 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.408 HG23 ' HG3' ' A' ' 66' ' ' GLN . 4.1 t -68.29 -30.66 69.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.764 -0.653 . . . . 17.609999999999999 110.597 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' A' ' 65' ' ' THR . 48.6 mt-30 -108.4 152.84 42.2 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.146 -0.479 . . . . 18.760000000000002 109.988 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.78 110.02 2.46 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.736 2.291 . . . . 17.280000000000001 111.655 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' OE1' ' A' ' 30' ' ' GLN . 46.3 Cg_exo -57.37 113.74 1.63 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.035 2.49 . . . . 17.77 112.218 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 20.9 mt-10 66.8 -73.26 0.08 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.625 0.77 . . . . 18.699999999999999 111.19 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.55 46.61 14.32 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.709 -0.757 . . . . 17.719999999999999 111.36 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.21 86.38 1.97 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.139 0.495 . . . . 18.0 111.368 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.05 58.65 3.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.145 0.497 . . . . 17.960000000000001 109.773 176.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.57 -1.46 37.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 19.850000000000001 111.825 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -89.41 -160.68 0.7 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.651 0.262 . . . . 19.670000000000002 110.692 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.9 t -74.25 81.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.216 0.532 . . . . 17.739999999999998 110.485 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -74.09 -22.13 59.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.857 -0.61 . . . . 19.949999999999999 110.826 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.21 36.33 1.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.167 0.508 . . . . 18.390000000000001 110.48 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.85 101.16 2.55 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.948 -0.644 . . . . 17.66 112.083 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -71.57 -64.61 0.89 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.996 0.427 . . . . 17.68 110.082 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.14 -15.15 14.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.955 -0.566 . . . . 17.800000000000001 110.014 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.76 40.94 0.93 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.662 -0.699 . . . . 17.350000000000001 111.084 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.6 133.61 21.54 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.86 -0.609 . . . . 16.640000000000001 110.279 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -88.98 45.57 0.89 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.095 2.53 . . . . 17.23 112.747 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.7 m 58.45 -97.5 0.07 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.002 -0.545 . . . . 17.34 111.538 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.55 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 95.9 mt -133.29 10.9 4.15 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.494 0.187 . . . . 18.41 111.223 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.48 112.01 36.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.627 -0.261 . . . . 17.449999999999999 111.461 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 85' ' ' LEU . 24.2 Cg_exo -63.79 -47.23 7.3 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.567 2.178 . . . . 18.890000000000001 110.668 172.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 45.72 49.55 11.27 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 124.099 0.874 . . . . 17.809999999999999 112.352 174.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.4 t -163.07 141.05 8.02 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.08 -0.509 . . . . 18.629999999999999 110.128 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.431 ' HA ' ' ND2' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -135.52 22.17 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.069 -0.514 . . . . 19.100000000000001 109.617 177.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.66 73.61 3.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.556 -0.747 . . . . 19.25 111.42 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 63.87 54.26 1.8 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.665 -0.698 . . . . 18.789999999999999 111.929 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 90' ' ' ILE . 45.4 m-20 -76.79 65.03 2.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.08 0.466 . . . . 18.949999999999999 109.961 176.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -82.43 37.65 0.52 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.49 0.552 . . . . 20.309999999999999 112.49 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.1 p -73.21 -33.9 65.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.507 0.67 . . . . 21.399999999999999 109.318 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -107.57 17.22 22.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.252 -0.885 . . . . 21.16 108.737 172.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 15.1 t80 62.85 24.02 14.31 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.912 -1.04 . . . . 22.18 111.099 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.48 ' OE2' ' HA ' ' A' ' 101' ' ' PRO . 10.0 pt-20 -155.9 128.32 4.08 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.81 -0.632 . . . . 19.449999999999999 109.561 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 93' ' ' ASN . 35.4 Cg_endo -65.09 -23.18 61.0 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.952 2.434 . . . . 18.530000000000001 112.864 -175.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -154.31 140.78 12.97 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.682 -0.69 . . . . 17.449999999999999 109.424 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.48 ' HA ' ' OE2' ' A' ' 98' ' ' GLU . 52.4 Cg_endo -68.12 -18.64 45.55 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.021 2.481 . . . . 17.420000000000002 112.79 -176.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -84.14 142.48 41.27 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.018 -0.537 . . . . 17.68 109.945 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.3 83.42 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.545 2.163 . . . . 16.289999999999999 111.534 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 104' ' ' VAL . 9.5 p 41.82 47.9 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 122.363 1.077 . . . . 17.260000000000002 111.837 -176.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -132.16 91.83 30.8 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.125 -0.943 . . . . 15.800000000000001 110.852 -175.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -88.48 103.31 0.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.189 2.592 . . . . 15.92 111.968 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.37 -18.45 34.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.291 1.994 . . . . 16.149999999999999 111.726 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 75.3 mmtt -91.44 126.92 52.8 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.825 -0.625 . . . . 17.629999999999999 109.825 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 108' ' ' LYS . 6.7 Cg_exo -73.28 54.9 2.89 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.931 2.42 . . . . 15.039999999999999 111.706 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -84.12 118.11 70.42 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.733 -0.667 . . . . 15.199999999999999 110.571 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.48 123.51 9.56 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.355 2.037 . . . . 14.08 111.627 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.8 p -84.7 49.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 122.584 1.183 . . . . 15.279999999999999 110.242 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.649 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 43.9 mt-10 -105.53 -46.91 0.13 Allowed Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.778 -1.101 . . . . 16.84 112.16 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 113' ' ' GLU . 65.3 Cg_endo -97.04 95.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.434 2.089 . . . . 15.51 112.728 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.649 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 86.1 Cg_endo -91.2 -177.11 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.769 2.313 . . . . 16.039999999999999 111.584 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -131.37 69.48 81.91 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 120.931 0.396 . . . . 18.91 111.217 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.499 ' HB2' ' OD1' ' A' ' 220' ' ' ASN . 4.0 Cg_exo -79.01 -81.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.065 1.843 . . . . 17.039999999999999 110.493 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 56.58 -158.7 0.24 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.953 0.406 . . . . 17.52 110.602 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 22.7 t -87.01 -19.05 8.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.786 -0.82 . . . . 18.699999999999999 108.786 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -90.13 33.59 0.88 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.144 -0.935 . . . . 20.879999999999999 110.516 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.34 130.67 93.35 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.676 -0.693 . . . . 18.890000000000001 111.418 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 39.3 Cg_exo -59.31 127.85 25.41 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.544 2.162 . . . . 20.43 111.14 174.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 122' ' ' PRO . 15.3 Cg_exo -69.86 52.46 1.03 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.994 2.462 . . . . 21.100000000000001 112.663 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.69 118.81 66.45 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.05 -0.523 . . . . 21.149999999999999 109.757 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.457 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 12.1 Cg_endo -56.29 117.62 4.3 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.919 2.413 . . . . 21.149999999999999 112.39 -175.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -99.91 103.65 23.58 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.539 -0.755 . . . . 21.879999999999999 110.151 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.487 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 90.1 Cg_endo -87.25 -161.22 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.858 2.372 . . . . 20.190000000000001 110.888 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -114.68 74.13 3.18 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.634 0.254 . . . . 20.48 110.556 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.487 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 93.8 Cg_endo -92.39 -168.3 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.916 2.411 . . . . 21.170000000000002 111.72 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -127.41 77.44 75.78 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.764 -0.458 . . . . 23.18 109.764 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.2 96.57 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.97 2.447 . . . . 20.780000000000001 111.697 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.6 m -91.39 43.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.767 0.794 . . . . 19.75 110.416 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 134' ' ' GLU . 12.4 p -135.7 163.41 35.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.766 -1.106 . . . . 21.050000000000001 109.173 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 133' ' ' VAL . 46.1 mt-10 72.73 -175.08 0.16 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.121 0.569 . . . . 21.300000000000001 110.177 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.07 -84.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.727 0.269 . . . . 20.739999999999998 111.727 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -139.83 -73.14 0.37 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.826 0.346 . . . . 17.969999999999999 110.23 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . -97.66 -3.71 38.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.13 -0.486 . . . . 17.350000000000001 110.121 177.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . 80.35 142.39 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 114.632 -1.167 . . . . 19.100000000000001 111.552 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.33 -57.79 2.14 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.707 2.938 . . . . 19.350000000000001 114.155 -172.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.2 t -113.65 -13.61 12.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.861 0.362 . . . . 17.75 110.604 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.09 -51.7 55.82 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.99 -0.624 . . . . 17.960000000000001 111.565 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.474 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 32.9 mtmm -143.28 94.08 2.57 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.192 -0.67 . . . . 19.420000000000002 109.192 175.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.845 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . -108.13 159.87 16.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.86 -0.609 . . . . 14.65 110.449 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.67 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 37.9 m-85 -136.91 143.72 43.11 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.555 -0.293 . . . . 14.81 111.569 -173.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 190' ' ' PRO . 3.0 m -151.39 160.73 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.301 0.64 . . . . 10.48 110.036 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 12.4 t -114.59 122.04 67.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 C-N-CA 120.754 -0.378 . . . . 10.1 110.021 176.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.529 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 27.2 tt0 -92.8 97.02 10.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.594 0.235 . . . . 12.0 110.917 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.781 HD13 ' N ' ' A' ' 212' ' ' GLY . 0.3 OUTLIER -83.41 -27.88 29.27 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.344 0.592 . . . . 11.880000000000001 109.691 -177.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.17 162.26 28.15 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.402 -0.904 . . . . 11.35 112.34 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.96 101.52 0.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.779 -0.452 . . . . 13.470000000000001 109.779 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.92 158.7 43.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.329 0.585 . . . . 13.52 110.748 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -99.45 4.97 46.35 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.096 -0.957 . . . . 17.600000000000001 109.808 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.404 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.1 t-20 -105.88 116.72 32.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.887 -1.051 . . . . 16.140000000000001 109.74 176.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -73.48 -23.45 60.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.169 -0.469 . . . . 14.039999999999999 112.17 -174.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.84 -35.31 79.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.891 0.853 . . . . 16.57 109.411 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.58 ' O ' HG13 ' A' ' 160' ' ' ILE . 32.3 mmtp -76.08 -38.55 56.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.127 -1.397 . . . . 16.399999999999999 110.205 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.528 HG11 HG21 ' A' ' 184' ' ' THR . 93.3 t -57.28 -47.69 83.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.307 0.575 . . . . 12.67 110.325 176.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -59.16 -35.56 73.74 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.986 -1.006 . . . . 15.32 111.985 -174.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -80.65 -39.25 27.64 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.626 -0.43 . . . . 15.970000000000001 111.65 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 156' ' ' LYS . 29.2 mt -62.7 -49.29 84.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.549 0.69 . . . . 12.6 109.523 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 91.8 t -66.08 -36.2 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.891 -1.05 . . . . 12.539999999999999 109.788 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -56.97 -32.67 62.72 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.884 -0.674 . . . . 14.800000000000001 112.187 176.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -71.8 -62.26 1.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.321 . . . . 16.050000000000001 111.452 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.7 mm? -78.02 -50.38 12.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.119 -0.491 . . . . 12.99 112.113 -172.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 3.9 tmt_? -64.84 -43.42 93.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.353 -0.61 . . . . 15.06 109.353 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.01 -27.23 73.36 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.043 -0.981 . . . . 16.600000000000001 112.874 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.27 -8.4 59.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.989 0.423 . . . . 16.140000000000001 110.625 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.21 19.82 27.21 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.053 -0.594 . . . . 15.119999999999999 113.197 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 207' ' ' LEU . 42.7 m-85 -88.22 157.13 18.88 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 117.23 0.515 . . . . 15.49 110.713 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -77.75 100.64 6.34 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.521 0.677 . . . . 13.869999999999999 109.279 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.6 p -142.06 137.98 30.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.687 -1.142 . . . . 10.82 109.477 -174.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.527 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.49 176.56 8.68 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.539 0.685 . . . . 11.130000000000001 110.585 174.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 10.0 p -121.82 -173.97 2.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.722 -1.126 . . . . 11.52 111.191 -169.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 74.7 m -50.45 143.05 14.27 Favored Pre-proline 0 C--O 1.236 0.35 0 O-C-N 123.465 0.478 . . . . 12.75 110.634 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -45.01 -45.43 14.18 Favored 'Trans proline' 0 CA--C 1.527 0.175 0 C-N-CA 124.006 3.138 . . . . 14.640000000000001 114.863 -170.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.2 p -86.97 -63.79 1.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.882 -0.727 . . . . 16.68 112.848 -172.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 89.9 m -168.54 130.04 1.14 Allowed Pre-proline 0 C--O 1.234 0.278 0 O-C-N 122.464 -0.148 . . . . 16.039999999999999 111.202 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.546 ' HB3' HG21 ' A' ' 184' ' ' THR . 78.2 Cg_exo -61.45 122.43 11.08 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.116 1.877 . . . . 14.220000000000001 111.493 162.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' A' ' 182' ' ' LYS . 4.3 p -155.35 161.68 2.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.849 -0.426 . . . . 16.129999999999999 109.849 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -75.25 124.41 27.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.77 0.319 . . . . 16.699999999999999 110.681 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.16 -26.06 16.37 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.094 -0.574 . . . . 16.98 112.577 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.445 ' HB2' HG12 ' A' ' 179' ' ' VAL . 0.8 OUTLIER -107.16 154.61 20.94 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.703 -0.48 . . . . 18.73 109.703 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.1 tp -72.79 109.89 5.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.513 0.673 . . . . 14.82 111.071 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.546 HG21 ' HB3' ' A' ' 178' ' ' PRO . 31.4 m -98.8 109.41 22.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.624 0.726 . . . . 12.779999999999999 109.974 175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 76.9 mtm180 -95.01 134.25 37.89 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.922 -1.036 . . . . 13.98 109.941 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.405 ' C ' HD12 ' A' ' 187' ' ' LEU . 4.5 mm -102.56 106.9 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 109.722 -0.473 . . . . 10.56 109.722 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.651 HD23 HG21 ' A' ' 145' ' ' VAL . 6.1 mp -110.85 114.84 28.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.582 0.706 . . . . 10.1 110.841 -174.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 41.9 t -95.08 140.89 15.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.856 -1.065 . . . . 9.7400000000000002 110.001 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.421 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 77.55 45.85 10.54 Favored Glycine 0 N--CA 1.434 -1.495 0 CA-C-N 115.292 -0.867 . . . . 9.7599999999999998 114.139 174.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.799 ' HA ' HG12 ' A' ' 145' ' ' VAL . 11.4 Cg_endo -61.92 126.38 18.72 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 CA-C-N 119.762 1.781 . . . . 11.15 110.83 171.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -161.54 167.87 24.62 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.987 -0.552 . . . . 12.77 109.721 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -103.9 7.49 36.83 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.255 -0.43 . . . . 14.6 110.427 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 197' ' ' LEU . 36.4 t -120.6 116.57 25.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.918 -0.583 . . . . 14.300000000000001 110.921 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.657 ' HB2' ' CD2' ' A' ' 144' ' ' TYR . 31.5 ttmt -70.92 -47.75 57.33 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 109.022 -0.733 . . . . 15.970000000000001 109.022 172.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -46.24 -57.46 4.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.704 -1.134 . . . . 15.6 111.639 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -70.7 -39.66 73.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.459 -0.791 . . . . 14.220000000000001 111.995 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.548 HD23 ' HB2' ' A' ' 144' ' ' TYR . 0.1 OUTLIER -82.39 -30.99 29.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.645 0.239 . . . . 11.949999999999999 111.645 -174.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.573 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 13.3 tmtt? -79.32 -29.98 42.58 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.218 -0.66 . . . . 14.699999999999999 109.218 -177.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.51 -12.03 83.96 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.022 -1.231 . . . . 13.09 110.022 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 46.3 m -91.09 -8.07 49.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.592 -0.804 . . . . 12.109999999999999 112.272 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 23.2 mt -66.96 -35.12 79.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.922 -0.311 . . . . 12.720000000000001 111.244 -174.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -58.58 -42.95 96.35 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.735 -0.745 . . . . 14.66 111.905 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 200' ' ' SER . 10.7 pt-20 -83.62 -18.34 38.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.07 0.462 . . . . 13.890000000000001 110.412 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.36 -27.65 65.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.143 -0.481 . . . . 12.550000000000001 110.049 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 6.5 mtpm? -63.48 -20.88 65.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.786 -0.643 . . . . 15.83 110.496 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.84 -35.97 16.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.715 -0.476 . . . . 16.969999999999999 109.715 173.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.582 ' HB3' ' CE1' ' A' ' 169' ' ' TYR . 81.9 mt -73.41 -53.09 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.613 -0.722 . . . . 13.890000000000001 111.681 -175.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.439 ' HB3' HD11 ' A' ' 164' ' ' LEU . 71.2 p -95.04 -42.64 8.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.271 0.557 . . . . 13.539999999999999 110.68 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 70.2 5.79 55.07 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.167 -0.924 . . . . 14.67 111.694 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.631 ' C ' HD12 ' A' ' 148' ' ' LEU . 96.1 mt -89.86 162.8 15.29 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.594 0.758 . . . . 13.039999999999999 109.84 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 66.1 m -102.24 99.89 10.03 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.13 0.419 . . . . 14.84 112.13 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.781 ' N ' HD13 ' A' ' 148' ' ' LEU . . . -116.55 157.43 15.05 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.303 -0.951 . . . . 12.220000000000001 114.559 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.76 146.15 13.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.779 -0.711 . . . . 13.74 109.796 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 24.0 t -74.53 117.69 19.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.857 -0.611 . . . . 12.890000000000001 110.057 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 87.6 mtp -128.83 153.81 47.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.089 -0.505 . . . . 13.800000000000001 110.277 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -86.71 111.1 3.59 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.308 -0.949 . . . . 13.359999999999999 112.208 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.845 ' CD2' ' HB1' ' A' ' 143' ' ' ALA . 5.2 t80 -63.82 142.71 58.31 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 124.688 1.195 . . . . 14.24 110.472 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 20.5 m -145.78 93.57 5.21 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 110.205 -0.294 . . . . 16.510000000000002 110.205 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.56 ' HG3' ' CZ ' ' A' ' 217' ' ' TYR . 19.3 Cg_exo -60.43 118.99 5.92 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.259 1.973 . . . . 17.420000000000002 111.373 175.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.499 ' OD1' ' HB2' ' A' ' 117' ' ' PRO . 90.9 m-20 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.475 -0.774 . . . . 19.190000000000001 110.68 -175.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.757 0.313 . . . . 18.390000000000001 111.147 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -99.91 -110.36 3.16 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.354 -0.927 . . . . 17.77 112.624 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 67.2 -67.31 0.17 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.509 0.723 . . . . 17.690000000000001 111.24 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -72.67 -38.25 67.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.277 0.56 . . . . 19.93 110.357 177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 60.95 23.21 13.34 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.806 -1.088 . . . . 17.43 112.65 173.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -73.2 -45.03 58.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.053 -0.721 . . . . 19.359999999999999 109.053 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 36' ' ' ASP . 35.4 t80 -153.59 89.75 1.35 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.441 -0.948 . . . . 18.960000000000001 108.441 172.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -68.13 -10.4 53.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.791 -0.64 . . . . 18.239999999999998 111.999 -174.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 35.9 t70 -89.63 5.45 45.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.45 0.643 . . . . 16.780000000000001 110.187 177.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -75.48 86.55 2.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 18.420000000000002 110.162 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.1 t80 57.86 59.47 3.16 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.42 0.629 . . . . 17.920000000000002 109.32 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.36 96.73 1.92 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.554 -0.748 . . . . 19.550000000000001 111.123 -176.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 68.52 -74.0 0.08 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.144 0.903 . . . . 20.309999999999999 111.199 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.42 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 33.6 mm 54.6 66.07 4.49 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 121.308 0.575 . . . . 19.920000000000002 111.367 178.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HD3' ' N ' ' A' ' 41' ' ' ILE . 3.6 Cg_exo -81.41 71.84 6.7 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.065 2.51 . . . . 21.640000000000001 111.617 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mp 58.79 37.6 24.91 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.467 0.651 . . . . 22.670000000000002 109.884 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.479 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 7.7 p -96.88 -29.39 0.26 Allowed Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 114.41 1.263 . . . . 21.34 114.41 -173.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 44' ' ' VAL . 96.5 Cg_endo -88.96 178.22 2.75 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 121.481 1.454 . . . . 20.0 112.824 -172.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -92.29 -18.44 23.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.886 -0.597 . . . . 21.079999999999998 110.977 -178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.47 -48.22 0.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.301 -0.409 . . . . 18.800000000000001 110.846 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.14 -113.57 0.62 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.994 -0.622 . . . . 17.510000000000002 111.752 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.06 149.67 29.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.682 -0.488 . . . . 16.949999999999999 109.682 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 50' ' ' ARG . 4.8 mpt_? -83.18 125.48 31.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.954 0.407 . . . . 18.300000000000001 109.992 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -78.83 150.09 32.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 18.170000000000002 111.548 -173.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -77.16 133.5 68.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.234 -0.894 . . . . 18.82 111.237 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.86 152.64 52.56 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.951 2.434 . . . . 19.870000000000001 112.458 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -77.1 75.38 3.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.546 . . . . 21.100000000000001 110.74 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 54.9 ttm -165.34 -40.12 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.512 -0.767 . . . . 22.300000000000001 109.826 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.2 tpt -160.88 74.78 2.66 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.797 -0.638 . . . . 23.850000000000001 109.475 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.45 123.44 1.86 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.51 2.14 . . . . 20.670000000000002 112.35 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.44 88.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.053 -0.976 . . . . 20.489999999999998 111.481 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.23 136.24 15.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.145 -0.479 . . . . 21.469999999999999 110.347 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.3 p -80.78 -10.09 59.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.168 0.509 . . . . 22.600000000000001 111.033 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -109.06 27.73 9.21 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.056 -0.52 . . . . 21.93 109.833 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.462 ' O ' ' HD3' ' A' ' 64' ' ' PRO . . . 68.71 171.63 0.29 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.337 -0.847 . . . . 19.73 111.544 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.2 100.54 5.9 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.637 -0.71 . . . . 19.579999999999998 109.161 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 62' ' ' ALA . 96.1 Cg_endo -81.53 40.69 1.02 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.737 2.291 . . . . 18.5 112.75 -174.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m 60.02 78.87 0.25 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.651 -0.704 . . . . 17.609999999999999 110.738 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.551 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 50.1 tt0 -67.67 -47.63 44.71 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.007 -0.542 . . . . 18.760000000000002 111.305 178.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 66' ' ' GLN . 38.1 Cg_endo -65.55 137.11 49.12 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 121.952 1.768 . . . . 17.280000000000001 111.465 174.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.6 114.57 2.19 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.028 1.818 . . . . 17.77 111.384 174.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.74 -53.01 3.69 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.726 -0.842 . . . . 18.699999999999999 108.726 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 177.26 164.06 30.29 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.451 -0.795 . . . . 17.719999999999999 111.28 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -109.72 144.15 38.52 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.034 -0.358 . . . . 18.0 110.034 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.31 103.11 1.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.201 -0.454 . . . . 17.960000000000001 110.476 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -70.09 -54.56 12.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.417 0.627 . . . . 19.850000000000001 109.74 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -120.96 -77.17 0.58 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.121 -0.945 . . . . 19.670000000000002 109.166 175.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.2 m -145.47 143.92 21.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.871 -0.604 . . . . 17.739999999999998 109.767 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -111.82 -21.82 11.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.928 0.394 . . . . 19.949999999999999 110.232 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.05 167.36 22.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.826 -0.624 . . . . 18.390000000000001 110.311 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.33 177.17 32.17 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.978 -0.629 . . . . 17.66 111.7 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -116.84 162.81 17.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.927 -0.397 . . . . 17.68 109.927 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.98 -42.16 99.76 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.579 -0.156 . . . . 17.800000000000001 110.579 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 50.03 78.83 0.09 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.633 0.583 . . . . 17.350000000000001 111.492 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 112.52 5.06 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 16.640000000000001 111.322 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.98 -24.58 8.24 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.485 2.123 . . . . 17.23 113.067 -176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.2 p -136.79 143.03 42.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.756 0.312 . . . . 17.34 111.346 -177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.3 mt -98.03 71.4 2.15 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.221 -0.659 . . . . 18.41 109.221 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -53.33 120.91 22.88 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.268 -0.878 . . . . 17.449999999999999 111.641 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.0 -6.26 18.68 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.954 2.436 . . . . 18.890000000000001 112.94 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 69.77 36.9 1.96 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.557 -0.747 . . . . 17.809999999999999 111.791 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m 65.36 97.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.662 -0.699 . . . . 18.629999999999999 111.743 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.6 mt 67.66 96.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.257 0.551 . . . . 19.100000000000001 111.504 175.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.6 -17.14 60.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.117 -0.492 . . . . 19.25 110.651 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.477 ' H ' ' HG2' ' A' ' 98' ' ' GLU . . . 65.07 12.84 8.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.436 -0.802 . . . . 18.789999999999999 112.018 176.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.83 165.32 11.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.086 0.469 . . . . 18.949999999999999 110.777 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -94.77 36.41 1.18 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.997 -0.547 . . . . 20.309999999999999 110.421 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.5 m -84.95 -42.4 14.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.807 -0.633 . . . . 21.399999999999999 109.321 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -122.78 27.27 7.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.354 -0.839 . . . . 21.16 109.511 175.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 46.9 t80 52.65 77.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.989 -1.005 . . . . 22.18 111.215 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.477 ' HG2' ' H ' ' A' ' 92' ' ' ALA . 6.9 tp10 -115.71 81.59 9.46 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 108.792 -0.818 . . . . 19.449999999999999 108.792 174.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.11 -69.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.517 2.145 . . . . 18.530000000000001 113.512 -172.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 58.49 69.91 1.34 Allowed Pre-proline 0 N--CA 1.462 0.16 0 O-C-N 123.263 0.352 . . . . 17.449999999999999 110.389 -172.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.89 -35.4 67.4 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.518 2.146 . . . . 17.420000000000002 112.004 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 50.06 70.99 1.71 Allowed Pre-proline 0 C--O 1.238 0.453 0 O-C-N 123.808 0.693 . . . . 17.68 111.498 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.2 48.39 2.68 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.595 2.197 . . . . 16.289999999999999 111.928 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.71 41.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.974 -1.012 . . . . 17.260000000000002 111.179 -176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -134.9 87.94 28.71 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.703 -0.68 . . . . 15.800000000000001 110.39 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.515 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 73.2 Cg_exo -49.48 -47.68 21.69 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.054 2.503 . . . . 15.92 113.417 176.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 106' ' ' PRO . 13.9 Cg_endo -57.05 127.54 26.19 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.968 1.779 . . . . 16.149999999999999 112.249 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -85.3 160.03 55.17 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.586 -0.733 . . . . 17.629999999999999 109.979 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.5 74.72 0.81 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.736 2.29 . . . . 15.039999999999999 110.83 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -109.84 134.63 20.59 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.335 -0.848 . . . . 15.199999999999999 110.338 -172.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.71 147.87 93.51 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.67 2.247 . . . . 14.08 111.848 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.7 m -85.33 54.56 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 121.72 0.772 . . . . 15.279999999999999 111.353 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.12 129.34 94.43 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.033 -0.985 . . . . 16.84 110.136 176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 40.3 Cg_exo -57.7 119.09 6.12 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.046 2.498 . . . . 15.51 112.244 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 114' ' ' PRO . 22.0 Cg_exo -66.25 175.81 4.56 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.838 2.358 . . . . 16.039999999999999 112.136 177.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp 56.47 71.07 1.25 Allowed Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 116.064 -0.516 . . . . 18.91 109.861 -175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.58 35.88 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.175 2.583 . . . . 17.039999999999999 113.999 -170.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -111.08 40.65 2.0 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.881 0.372 . . . . 17.52 111.145 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.48 -11.63 12.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.191 0.519 . . . . 18.699999999999999 110.502 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.92 16.42 19.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.62 -0.718 . . . . 20.879999999999999 110.913 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.48 131.4 86.47 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.601 -0.727 . . . . 18.890000000000001 110.022 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 75.6 Cg_exo -50.12 120.65 6.42 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.138 2.558 . . . . 20.43 112.073 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 122' ' ' PRO . 51.8 Cg_exo -55.52 102.52 0.09 OUTLIER 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.348 2.699 . . . . 21.100000000000001 112.865 -177.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.402 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . . . -150.99 99.79 3.07 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 21.149999999999999 110.35 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 124' ' ' ALA . 32.4 Cg_endo -64.68 -32.13 57.88 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.757 2.304 . . . . 21.149999999999999 112.709 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -121.12 103.31 42.54 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.973 -0.38 . . . . 21.879999999999999 109.973 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.69 142.44 76.9 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.713 2.275 . . . . 20.190000000000001 111.459 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 16.0 pt-20 -71.98 141.35 84.11 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.143 -0.481 . . . . 20.48 110.546 -176.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 128' ' ' GLU . 23.5 Cg_exo -65.55 -18.03 58.44 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.095 2.53 . . . . 21.170000000000002 113.149 -177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -129.47 84.06 63.08 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.742 0.306 . . . . 23.18 111.17 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.25 160.35 49.28 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.746 2.297 . . . . 20.780000000000001 111.076 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 t -81.23 50.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.882 0.849 . . . . 19.75 109.977 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.5 t -136.44 83.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.922 -1.035 . . . . 21.050000000000001 109.333 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -107.84 -23.47 12.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.592 0.711 . . . . 21.300000000000001 109.111 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.7 141.32 58.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.587 -1.188 . . . . 20.739999999999998 109.735 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -112.45 -51.39 2.84 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.026 -0.534 . . . . 17.969999999999999 110.131 -173.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 192' ' ' ALA . . . -89.39 6.29 41.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.329 0.585 . . . . 17.350000000000001 109.57 174.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 74.12 148.71 0.12 Allowed Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 114.123 -1.399 . . . . 19.100000000000001 112.411 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -44.22 -45.62 12.07 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.873 3.048 . . . . 19.350000000000001 114.403 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.4 m -130.5 22.34 5.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.405 0.622 . . . . 17.75 110.056 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.63 -79.48 0.72 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.947 -0.861 . . . . 17.960000000000001 110.947 178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.437 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 68.3 mttm -129.27 59.28 1.59 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.333 0.587 . . . . 19.420000000000002 109.552 173.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.516 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -73.37 161.0 30.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.272 -0.876 . . . . 14.65 110.041 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.653 ' CD1' ' HG3' ' A' ' 194' ' ' LYS . 5.4 m-85 -146.72 159.82 43.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.685 0.279 . . . . 14.81 111.454 -177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.725 HG22 ' HA ' ' A' ' 190' ' ' PRO . 2.3 t -149.32 158.83 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.719 -0.845 . . . . 10.48 108.719 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.471 HG12 ' HA3' ' A' ' 212' ' ' GLY . 42.9 t -100.89 106.33 19.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 O-C-N 122.081 -0.387 . . . . 10.1 111.047 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.555 HE21 ' HB2' ' A' ' 150' ' ' ALA . 28.3 tt0 -78.85 110.23 13.85 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.526 0.331 . . . . 12.0 111.311 -177.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 1.013 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -87.94 -37.92 16.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.306 0.574 . . . . 11.880000000000001 109.568 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.3 164.28 28.02 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.374 -0.917 . . . . 11.35 112.559 -177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.555 ' HB2' HE21 ' A' ' 147' ' ' GLN . . . -164.43 104.25 0.84 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.695 -0.854 . . . . 13.470000000000001 108.695 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.99 166.19 24.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.956 -0.566 . . . . 13.52 110.406 -173.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 48.5 mtpt -102.77 -6.53 22.51 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.042 -0.981 . . . . 17.600000000000001 110.355 -174.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -99.38 109.68 22.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.556 -0.747 . . . . 16.140000000000001 109.61 173.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.0 -19.55 65.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.065 -0.516 . . . . 14.039999999999999 111.494 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.12 -35.51 75.42 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.813 0.816 . . . . 16.57 109.965 174.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.519 ' HA ' ' HE3' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -82.12 -26.98 33.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.564 -1.198 . . . . 16.399999999999999 110.12 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.531 ' HA ' HD11 ' A' ' 186' ' ' ILE . 69.5 t -66.0 -39.16 83.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.675 -0.693 . . . . 12.67 110.413 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.433 ' HA ' HG12 ' A' ' 161' ' ' VAL . 23.3 t-20 -68.05 -23.5 64.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.816 -0.629 . . . . 15.32 111.349 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.56 -61.85 1.7 Allowed 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.367 -0.605 . . . . 15.970000000000001 109.367 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.787 HD12 HD12 ' A' ' 186' ' ' ILE . 18.2 mt -53.74 -43.89 57.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.582 -1.19 . . . . 12.6 110.274 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 158' ' ' ASN . 0.3 OUTLIER -72.63 -37.11 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.601 -0.727 . . . . 12.539999999999999 110.197 -177.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -66.0 -29.76 75.65 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.768 -0.73 . . . . 14.800000000000001 111.505 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -70.23 -51.3 31.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.875 0.369 . . . . 16.050000000000001 110.152 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.507 HD13 ' CG2' ' A' ' 188' ' ' VAL . 16.3 mt -88.84 -59.26 2.28 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.133 0.79 . . . . 12.99 113.133 -173.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 55.2 ttp180 -60.86 -37.42 82.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.453 0.644 . . . . 15.06 109.768 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.2 -18.86 78.29 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.907 -1.042 . . . . 16.600000000000001 112.266 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -95.67 -0.93 51.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.881 0.372 . . . . 16.140000000000001 110.624 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.48 25.8 45.65 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.653 -0.784 . . . . 15.119999999999999 113.14 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -92.49 154.85 18.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.952 0.376 . . . . 15.49 110.968 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -67.55 104.23 1.54 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.426 0.631 . . . . 13.869999999999999 109.773 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.46 137.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.019 -0.991 . . . . 10.82 109.858 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.531 ' CE1' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -140.17 175.25 9.74 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.899 0.857 . . . . 11.130000000000001 111.211 169.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 15.0 p -121.96 -175.42 3.1 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.98 -1.464 . . . . 11.52 110.384 -172.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 7.3 m -50.38 125.6 20.44 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 109.115 -0.698 . . . . 12.75 109.115 173.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 89.6 Cg_exo -45.41 -35.51 11.99 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.349 3.366 . . . . 14.640000000000001 115.337 -167.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.9 p -79.85 -62.63 1.63 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.017 -0.673 . . . . 16.68 111.816 -175.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 26.2 m -167.68 135.01 1.87 Allowed Pre-proline 0 C--N 1.329 -0.298 0 C-N-CA 122.183 0.193 . . . . 16.039999999999999 110.771 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.01 123.2 11.53 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.634 1.556 . . . . 14.220000000000001 110.107 161.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.5 p -154.22 156.72 4.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 C-N-CA 120.484 -0.487 . . . . 16.129999999999999 111.197 -172.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -81.78 133.82 35.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.82 -0.627 . . . . 16.699999999999999 110.875 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 99.81 -22.95 38.04 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.881 -0.599 . . . . 16.98 112.471 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 182' ' ' LYS . 9.1 mptt -115.04 160.67 19.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.445 -0.576 . . . . 18.73 109.445 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 183' ' ' ILE . 9.1 tp -74.16 109.82 7.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.735 0.778 . . . . 14.82 111.28 -174.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 150' ' ' ALA . 40.0 m -104.22 106.58 17.13 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.649 0.738 . . . . 12.779999999999999 110.208 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.55 ' HG2' HD11 ' A' ' 187' ' ' LEU . 31.1 ttm180 -86.77 136.58 32.94 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.637 -1.165 . . . . 13.98 109.54 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.787 HD12 HD12 ' A' ' 160' ' ' ILE . 3.6 mt -121.61 120.61 62.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.375 -0.602 . . . . 10.56 109.375 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -130.54 143.56 50.83 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.356 -0.838 . . . . 10.1 110.406 -169.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.013 HG23 HD21 ' A' ' 148' ' ' LEU . 42.5 t -107.69 136.23 43.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.461 -0.79 . . . . 9.7400000000000002 111.31 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 81.94 48.74 5.64 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 114.736 -1.12 . . . . 9.7599999999999998 113.533 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.725 ' HA ' HG22 ' A' ' 145' ' ' VAL . 9.9 Cg_endo -58.94 125.2 17.51 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 CA-C-N 119.472 1.636 . . . . 11.15 110.292 174.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.432 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 5.3 t70 -150.93 163.05 39.62 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 120.397 -0.521 . . . . 12.77 110.295 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 137' ' ' ALA . . . -103.22 -4.17 24.72 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.304 -0.862 . . . . 14.6 111.281 -176.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 42.8 m -114.79 99.41 7.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.371 0.605 . . . . 14.300000000000001 110.449 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.653 ' HG3' ' CD1' ' A' ' 144' ' ' TYR . 25.3 ttpt -59.67 -54.51 45.58 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 114.984 -1.007 . . . . 15.970000000000001 111.881 -174.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -63.93 -40.88 97.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.004 0.43 . . . . 15.6 110.838 -172.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.39 -44.28 96.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 14.220000000000001 110.551 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -79.08 -22.54 45.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.049 -0.523 . . . . 11.949999999999999 110.567 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 23.3 tptm -69.15 -35.74 76.67 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.403 0.62 . . . . 14.699999999999999 109.92 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.02 -11.34 85.48 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.573 -1.011 . . . . 13.09 110.573 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 65.5 m -90.27 -8.96 49.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.89 -0.655 . . . . 12.109999999999999 112.624 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 18.4 mt -64.39 -34.52 78.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.001 -0.28 . . . . 12.720000000000001 111.409 -174.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -65.06 -42.92 96.41 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.831 -0.699 . . . . 14.66 112.135 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -79.31 -18.53 52.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 13.890000000000001 110.282 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.568 HD12 HD12 ' A' ' 207' ' ' LEU . 3.4 tp -76.27 -26.88 56.39 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.116 -0.493 . . . . 12.550000000000001 110.607 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 92.7 mttt -61.37 -22.47 64.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.145 0.498 . . . . 15.83 110.256 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -30.74 26.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.314 0.578 . . . . 16.969999999999999 109.58 173.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.568 HD12 HD12 ' A' ' 204' ' ' LEU . 88.9 mt -75.33 -53.76 8.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.503 -0.771 . . . . 13.890000000000001 111.84 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 25.0 p -99.58 -48.05 4.89 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.499 -0.481 . . . . 13.539999999999999 110.721 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 77.45 -0.64 68.62 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.706 -0.679 . . . . 14.67 112.675 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 164' ' ' LEU . 7.8 mp -90.14 158.1 17.43 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.328 -0.619 . . . . 13.039999999999999 109.328 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 35.8 m -84.06 102.57 12.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.159 -0.473 . . . . 14.84 110.877 -175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -122.43 150.06 16.95 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 120.28 -0.962 . . . . 12.220000000000001 113.61 -175.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.97 144.02 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.497 -0.557 . . . . 13.74 109.497 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.88 105.85 2.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.655 0.74 . . . . 12.890000000000001 109.767 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 98.0 mmm -119.27 139.72 51.45 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.677 -0.692 . . . . 13.800000000000001 110.674 -174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -68.92 155.42 53.54 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.587 -0.733 . . . . 13.359999999999999 112.425 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.656 ' HB2' HG23 ' A' ' 145' ' ' VAL . 16.0 t80 -135.06 127.76 31.0 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.124 -0.538 . . . . 14.24 110.364 -171.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.8 p -141.45 92.49 8.18 Favored Pre-proline 0 C--N 1.317 -0.845 0 N-CA-C 109.608 -0.516 . . . . 16.510000000000002 109.608 172.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -64.36 160.79 37.37 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.628 2.218 . . . . 17.420000000000002 112.457 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 6.1 t30 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.377 -0.821 . . . . 19.190000000000001 109.817 -178.44 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.653 -0.499 . . . . 18.390000000000001 109.653 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.84 -152.29 21.62 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.091 -0.804 . . . . 17.77 111.091 170.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -155.69 -45.25 0.08 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.811 0.305 . . . . 17.690000000000001 110.842 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -84.14 -50.77 7.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.003 0.43 . . . . 19.93 110.374 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 37.5 tptt -86.55 133.69 33.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.789 -0.641 . . . . 17.43 109.847 -175.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -144.64 147.24 32.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.241 0.46 . . . . 19.359999999999999 112.241 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.41 ' CZ ' ' HA ' ' A' ' 76' ' ' ARG . 95.1 m-85 56.45 41.08 29.29 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.29 -0.868 . . . . 18.960000000000001 111.894 175.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -160.38 39.01 0.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.68 0.752 . . . . 18.239999999999998 109.338 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.416 ' HB3' ' HA3' ' A' ' 78' ' ' GLY . 4.7 p-10 -65.08 144.03 57.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.248 -0.887 . . . . 16.780000000000001 111.303 -177.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -150.35 90.94 1.7 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.849 -0.614 . . . . 18.420000000000002 110.244 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -120.03 4.74 10.88 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.675 -0.693 . . . . 17.920000000000002 110.353 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.09 -42.2 5.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.624 . . . . 19.550000000000001 111.106 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.0 38.8 1.0 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.126 0.489 . . . . 20.309999999999999 111.137 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 41' ' ' ILE . 28.2 pt -127.72 90.2 48.76 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 121.353 0.597 . . . . 19.920000000000002 110.712 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.76 59.27 4.96 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.134 2.556 . . . . 21.640000000000001 111.742 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.3 mp 57.1 32.31 21.48 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.498 -0.774 . . . . 22.670000000000002 110.772 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.517 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 79.1 t -84.44 -57.19 0.4 Allowed Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.577 -0.738 . . . . 21.34 110.706 177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 97.0 Cg_endo -77.4 137.0 16.29 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.889 1.726 . . . . 20.0 112.054 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.17 -31.9 11.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.393 0.616 . . . . 21.079999999999998 109.523 176.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' A' ' 84' ' ' SER . . . -105.69 136.76 44.72 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.512 -0.767 . . . . 18.800000000000001 109.041 172.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.446 ' HA2' ' HD3' ' A' ' 53' ' ' PRO . . . 119.8 -22.21 8.74 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.785 -0.926 . . . . 17.510000000000002 110.785 -171.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 50' ' ' ARG . 12.0 t70 -80.57 99.62 8.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.041 -0.726 . . . . 16.949999999999999 109.041 175.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 87.7 mtt180 70.69 -56.69 0.61 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.445 0.698 . . . . 18.300000000000001 111.473 -175.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -88.24 122.67 32.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.123 -0.49 . . . . 18.170000000000002 110.431 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.86 135.5 96.03 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.205 -0.452 . . . . 18.82 111.487 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.545 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 96.3 Cg_endo -86.03 53.78 3.28 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.004 2.469 . . . . 19.870000000000001 112.104 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.03 172.58 17.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.846 -0.616 . . . . 21.100000000000001 109.797 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 47.8 tpp -80.86 82.23 6.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.427 0.632 . . . . 22.300000000000001 109.836 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.562 ' H ' ' HD2' ' A' ' 57' ' ' PRO . 47.4 tpp -150.17 -54.4 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.568 -0.742 . . . . 23.850000000000001 109.475 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 56' ' ' MET . 13.6 Cg_endo -57.44 105.45 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.218 1.945 . . . . 20.670000000000002 112.304 172.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.76 116.57 21.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.819 -0.628 . . . . 20.489999999999998 110.105 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.71 12.5 16.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.998 -0.546 . . . . 21.469999999999999 111.194 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 p -95.26 64.05 2.65 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.045 0.45 . . . . 22.600000000000001 111.04 177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 63.58 20.32 12.18 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.565 -0.743 . . . . 21.93 111.966 178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.96 -29.52 14.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.112 0.482 . . . . 19.73 110.01 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.6 mt -125.68 77.75 69.42 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.747 -0.66 . . . . 19.579999999999998 111.236 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -82.87 -10.08 10.62 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.932 2.421 . . . . 18.5 110.716 172.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.8 p -107.48 166.54 10.58 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.022 -0.99 . . . . 17.609999999999999 110.017 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.9 116.14 59.01 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.436 -0.579 . . . . 18.760000000000002 109.436 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -42.22 123.31 2.59 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.99 3.126 . . . . 17.280000000000001 113.2 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -29.86 113.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 1 C-N-CA 125.314 4.01 . . . . 17.77 114.66 -173.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -123.2 -52.85 1.84 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.697 -0.683 . . . . 18.699999999999999 109.717 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 74' ' ' GLU . . . 133.69 -151.67 20.25 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.306 -0.861 . . . . 17.719999999999999 111.454 -177.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.93 -70.64 0.12 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.708 0.289 . . . . 18.0 110.783 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.12 -69.55 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.397 -0.365 . . . . 17.960000000000001 110.636 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -88.21 -16.49 33.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.259 0.552 . . . . 19.850000000000001 109.948 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.51 ' O ' ' HA3' ' A' ' 70' ' ' GLY . 38.8 tt0 -97.04 120.89 38.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.897 -0.592 . . . . 19.670000000000002 110.547 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.31 138.35 15.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.938 -1.134 . . . . 17.739999999999998 107.938 172.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.41 ' HA ' ' CZ ' ' A' ' 34' ' ' TYR . 10.4 ptm180 -146.22 -50.21 0.22 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.556 0.947 . . . . 19.949999999999999 113.556 -171.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.85 166.82 22.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.325 0.583 . . . . 18.390000000000001 112.293 -168.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 36' ' ' ASP . . . 153.18 113.55 0.53 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.34 -0.845 . . . . 17.66 111.572 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.466 ' HA ' ' HG2' ' A' ' 32' ' ' LYS . 33.4 t70 -93.23 150.36 20.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.934 0.397 . . . . 17.68 110.562 -177.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.93 -8.46 58.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.511 -0.768 . . . . 17.800000000000001 111.719 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.27 33.45 20.93 Favored 'General case' 0 N--CA 1.461 0.079 0 O-C-N 123.96 0.788 . . . . 17.350000000000001 111.501 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.429 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . . . -98.39 -51.79 0.21 Allowed Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 115.684 -0.689 . . . . 16.640000000000001 112.641 -177.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 53' ' ' PRO . 6.0 Cg_exo -78.29 57.79 6.38 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.334 2.023 . . . . 17.23 112.801 -175.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 29.5 t -75.03 78.66 2.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.072 0.463 . . . . 17.34 110.428 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 85' ' ' LEU . 2.7 pt? -77.69 -35.46 52.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 18.41 110.419 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 6.3 m-20 -83.71 121.62 76.27 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.235 -0.439 . . . . 17.449999999999999 110.802 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 86' ' ' ASP . 7.9 Cg_exo -72.95 -8.55 22.45 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.787 2.324 . . . . 18.890000000000001 111.814 176.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 68.22 -64.1 0.31 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.611 0.764 . . . . 17.809999999999999 110.97 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.6 m -94.16 110.0 21.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.21 -0.663 . . . . 18.629999999999999 109.21 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.6 mt -77.26 75.68 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.443 0.639 . . . . 19.100000000000001 110.283 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.96 11.1 7.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.484 -0.78 . . . . 19.25 110.475 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 69.9 -66.78 0.26 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.471 -0.786 . . . . 18.789999999999999 111.78 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -157.84 161.36 38.33 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.434 -0.58 . . . . 18.949999999999999 109.434 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 98' ' ' GLU . 2.2 t-20 -80.76 61.83 4.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.298 0.57 . . . . 20.309999999999999 111.435 -176.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.489 HG23 ' HG2' ' A' ' 96' ' ' GLU . 3.4 t -87.11 -42.28 13.16 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.886 -0.783 . . . . 21.399999999999999 108.886 169.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.489 ' HG2' HG23 ' A' ' 95' ' ' THR . 25.7 mm-40 -107.27 -43.69 4.52 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.295 -0.411 . . . . 21.16 111.076 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.0 t80 178.13 95.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.975 0.416 . . . . 22.18 110.925 -172.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.423 ' H ' ' ND2' ' A' ' 94' ' ' ASN . 33.5 tt0 -95.25 -46.22 0.27 Allowed Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 115.905 -0.589 . . . . 19.449999999999999 112.032 176.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.06 75.2 3.31 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.188 1.925 . . . . 18.530000000000001 112.847 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.408 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 10.9 tp10 -68.07 -49.67 34.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.016 -0.538 . . . . 17.449999999999999 111.532 175.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 98.1 Cg_endo -76.94 45.12 1.6 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.091 1.861 . . . . 17.420000000000002 112.509 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.0 138.4 32.04 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 115.944 -0.571 . . . . 17.68 110.685 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.38 78.73 3.56 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.549 2.166 . . . . 16.289999999999999 111.272 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 104' ' ' VAL . 11.1 m -86.35 46.89 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.626 -0.715 . . . . 17.260000000000002 111.293 -177.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.6 87.42 0.13 Allowed Pre-proline 0 C--O 1.232 0.16 0 CA-C-N 115.426 -0.806 . . . . 15.800000000000001 111.799 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.79 114.75 3.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.385 2.057 . . . . 15.92 110.396 173.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.4 -28.27 62.86 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.555 2.17 . . . . 16.149999999999999 112.666 -173.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -148.21 91.92 4.7 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.208 -0.451 . . . . 17.629999999999999 110.12 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.38 -33.63 57.65 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.369 2.046 . . . . 15.039999999999999 111.687 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -140.64 125.86 11.15 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.61 -0.723 . . . . 15.199999999999999 110.636 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -74.65 118.28 5.26 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.178 1.918 . . . . 14.08 110.776 170.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.3 p -83.32 52.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 122.667 1.222 . . . . 15.279999999999999 110.416 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -86.61 131.26 46.14 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.682 -1.145 . . . . 16.84 109.529 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -56.72 115.45 2.49 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.481 2.12 . . . . 15.51 111.713 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.412 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 58.0 Cg_endo -72.2 155.97 55.84 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.437 2.091 . . . . 16.039999999999999 112.391 -176.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -109.22 91.56 9.79 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 18.91 109.572 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 115' ' ' PRO . 61.6 Cg_endo -89.74 36.32 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.802 2.335 . . . . 17.039999999999999 112.843 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.6 pttm 45.48 101.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.692 1.197 . . . . 17.52 113.108 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.2 m -62.97 -28.96 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.851 -0.613 . . . . 18.699999999999999 111.471 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.21 84.93 2.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.514 0.673 . . . . 20.879999999999999 109.889 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.32 116.7 62.4 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.488 -0.778 . . . . 18.890000000000001 111.069 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -88.63 166.19 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.981 2.454 . . . . 20.43 111.687 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.56 67.43 6.39 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.598 2.199 . . . . 21.100000000000001 111.331 176.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -135.65 132.11 19.52 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.911 -0.586 . . . . 21.149999999999999 110.797 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.08 142.81 88.88 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.737 2.291 . . . . 21.149999999999999 111.501 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.515 ' O ' ' HD2' ' A' ' 129' ' ' PRO . 52.1 mtmt -55.57 -38.5 68.68 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 114.812 1.412 . . . . 21.879999999999999 114.812 -171.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.88 -23.61 35.06 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.022 1.815 . . . . 20.190000000000001 114.581 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.5 ' HB2' ' HD3' ' A' ' 129' ' ' PRO . 30.5 mt-10 -70.62 -52.82 10.33 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 119.006 -0.521 . . . . 20.48 111.979 -177.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 126' ' ' LYS . 77.1 Cg_exo -52.75 103.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.11 1.873 . . . . 21.170000000000002 112.225 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.401 ' HB2' ' HD3' ' A' ' 131' ' ' PRO . 24.7 mtpp -83.32 -43.64 0.84 Allowed Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 112.234 0.457 . . . . 23.18 112.234 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' A' ' 130' ' ' LYS . 78.0 Cg_exo -54.03 112.96 1.12 Allowed 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.048 1.832 . . . . 20.780000000000001 111.917 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.6 m -81.49 36.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.786 0.803 . . . . 19.75 111.91 -173.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 10.6 p -131.76 -2.42 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.824 -1.08 . . . . 21.050000000000001 109.865 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -100.28 -7.44 24.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.737 -1.119 . . . . 21.300000000000001 110.04 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -121.68 -162.16 0.96 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.424 -0.807 . . . . 20.739999999999998 109.873 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 136' ' ' LYS . 8.3 mptt -95.36 -75.96 0.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.688 -0.405 . . . . 17.969999999999999 110.283 -172.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' A' ' 193' ' ' SER . . . -109.79 18.6 20.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.325 -0.398 . . . . 17.350000000000001 109.947 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.401 ' O ' ' HB1' ' A' ' 192' ' ' ALA . . . 72.62 151.8 0.14 Allowed Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 114.771 -1.104 . . . . 19.100000000000001 111.785 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.01 -18.98 7.8 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 124.272 3.315 . . . . 19.350000000000001 114.538 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.7 t -163.99 32.21 0.08 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.591 0.71 . . . . 17.75 109.982 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -79.6 -79.1 0.85 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.468 -0.872 . . . . 17.960000000000001 111.438 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -114.49 69.19 0.71 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.548 -0.538 . . . . 19.420000000000002 109.548 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.607 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . -78.38 159.78 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.991 -0.549 . . . . 14.65 109.784 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.575 ' CB ' HD21 ' A' ' 197' ' ' LEU . 3.8 m-85 -144.45 159.96 41.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.851 0.357 . . . . 14.81 111.743 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.73 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.4 m -151.17 153.05 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.57 -0.741 . . . . 10.48 109.989 -176.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 61.0 t -106.45 111.17 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.582 -0.447 . . . . 10.1 110.593 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -88.4 105.49 17.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.238 -0.437 . . . . 12.0 110.769 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.971 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -83.72 -37.03 23.23 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.351 0.596 . . . . 11.880000000000001 109.987 -175.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.18 161.93 27.87 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.261 -0.881 . . . . 11.35 111.846 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -162.63 104.66 1.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.573 -0.529 . . . . 13.470000000000001 109.573 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 156' ' ' LYS . 1.5 pt? -153.26 165.64 35.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.309 0.576 . . . . 13.52 111.058 -176.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 82.3 mttt -98.44 7.1 46.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.255 -0.884 . . . . 17.600000000000001 110.914 -172.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -99.64 97.13 8.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.478 -0.783 . . . . 16.140000000000001 109.877 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.98 -27.29 68.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.326 0.584 . . . . 14.039999999999999 110.246 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -55.07 -37.22 66.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.931 -1.031 . . . . 16.57 110.551 174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.555 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 66.1 mttm -90.5 -25.81 20.09 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.181 -0.918 . . . . 16.399999999999999 110.691 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' THR . 69.7 t -57.84 -40.46 76.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.437 0.637 . . . . 12.67 109.636 173.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -61.05 -33.4 73.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.038 -0.983 . . . . 15.32 112.183 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 12.6 pt-20 -83.91 -22.84 31.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.463 -0.495 . . . . 15.970000000000001 111.633 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 156' ' ' LYS . 16.8 mt -81.05 -49.68 17.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.345 0.593 . . . . 12.6 109.448 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 45.8 t -69.62 -32.71 53.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.26 -0.882 . . . . 12.539999999999999 110.449 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -56.74 -31.97 61.3 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.907 -0.664 . . . . 14.800000000000001 112.342 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -73.54 -62.13 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.781 0.324 . . . . 16.050000000000001 111.172 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 208' ' ' SER . 3.6 mm? -72.32 -50.37 27.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.085 0.402 . . . . 12.99 112.085 -173.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 31.2 ttm180 -64.13 -47.24 80.71 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.394 0.616 . . . . 15.06 110.098 -178.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.23 -34.79 90.86 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 114.916 -1.038 . . . . 16.600000000000001 113.047 -174.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -80.14 -7.39 58.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.973 0.416 . . . . 16.140000000000001 110.718 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 95.24 24.73 15.76 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.878 -0.677 . . . . 15.119999999999999 113.222 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -93.85 152.69 18.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.75 -0.463 . . . . 15.49 109.75 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -73.35 103.88 4.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.475 0.655 . . . . 13.869999999999999 110.162 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.78 139.1 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 114.832 -1.076 . . . . 10.82 110.051 -173.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.46 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -141.3 176.92 8.46 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.507 0.67 . . . . 11.130000000000001 110.806 171.213 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.2 p -113.55 -176.34 2.88 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.841 -1.072 . . . . 11.52 111.193 -172.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.82 149.74 16.06 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.405 -0.361 . . . . 12.75 111.111 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -39.32 -53.86 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.347 3.365 . . . . 14.640000000000001 115.674 -170.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.4 m -87.17 -64.71 1.11 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 119.515 -0.874 . . . . 16.68 113.133 -169.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.8 m -169.13 135.72 1.46 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 118.228 0.467 . . . . 16.039999999999999 111.346 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.549 ' HB3' HG21 ' A' ' 184' ' ' THR . 44.7 Cg_exo -65.74 123.95 12.08 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.577 2.184 . . . . 14.220000000000001 112.012 162.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.9 p -154.68 158.57 3.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.637 -0.505 . . . . 16.129999999999999 109.637 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.63 128.21 35.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.722 0.296 . . . . 16.699999999999999 110.54 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.6 -26.17 25.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.097 -0.573 . . . . 16.98 112.3 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.7 OUTLIER -102.67 154.76 18.83 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.716 -0.476 . . . . 18.73 109.716 178.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 183' ' ' ILE . 7.8 tp -73.38 109.65 5.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.6 0.714 . . . . 14.82 111.082 -175.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.549 HG21 ' HB3' ' A' ' 178' ' ' PRO . 50.9 m -99.34 119.32 37.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.872 -0.604 . . . . 12.779999999999999 109.804 174.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 60.8 mtt-85 -101.23 140.17 35.89 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.71 -0.677 . . . . 13.98 109.789 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.609 ' C ' HD12 ' A' ' 187' ' ' LEU . 2.1 mm -107.07 120.31 58.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.95 -0.759 . . . . 10.56 108.95 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.6 mp -128.77 121.86 29.32 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.521 0.677 . . . . 10.1 111.152 -173.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.971 HG23 HD21 ' A' ' 148' ' ' LEU . 40.3 t -101.44 142.99 15.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.072 -0.967 . . . . 9.7400000000000002 110.465 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.401 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 77.46 48.33 8.18 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 115.276 -0.875 . . . . 9.7599999999999998 113.77 174.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.73 ' HA ' HG12 ' A' ' 145' ' ' VAL . 13.6 Cg_endo -64.44 123.99 12.63 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 CA-C-N 119.667 1.734 . . . . 11.15 110.62 171.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -156.75 147.85 22.04 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.841 -0.618 . . . . 12.77 109.78 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.607 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -88.68 -4.97 58.42 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.788 -0.642 . . . . 14.6 111.971 -175.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.573 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 75.6 m -115.86 92.05 3.79 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.297 0.57 . . . . 14.300000000000001 110.608 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.427 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 30.4 ttpt -52.7 -48.4 66.63 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 114.726 -1.125 . . . . 15.970000000000001 111.016 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -55.57 -38.99 70.09 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.102 0.408 . . . . 15.6 112.102 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -74.65 -41.75 59.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.006 0.431 . . . . 14.220000000000001 110.539 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.575 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -81.19 -19.66 42.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.119 0.485 . . . . 11.949999999999999 110.69 -175.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.438 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 28.1 tptp -66.16 -38.13 87.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.371 0.605 . . . . 14.699999999999999 110.31 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.21 -12.5 82.21 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.51 -1.036 . . . . 13.09 110.51 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 75.5 m -83.74 -8.71 59.19 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.7 -0.75 . . . . 12.109999999999999 111.895 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 20.2 mt -67.2 -36.35 81.54 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.965 0.412 . . . . 12.720000000000001 110.6 -177.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.57 -39.08 95.97 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.709 -0.678 . . . . 14.66 112.322 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.443 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 10.9 pt-20 -85.74 -18.41 33.11 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.902 0.382 . . . . 13.890000000000001 110.807 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.4 tp -71.81 -35.05 69.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.558 -0.292 . . . . 12.550000000000001 111.196 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.428 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 0.1 OUTLIER -65.63 -15.3 62.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.11 0.481 . . . . 15.83 110.432 174.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -31.89 21.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.868 -0.606 . . . . 16.969999999999999 109.658 172.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.0 mt -81.92 -52.47 7.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.612 -0.722 . . . . 13.890000000000001 111.646 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.467 ' HB3' HD11 ' A' ' 164' ' ' LEU . 61.5 p -94.0 -43.79 8.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.218 0.533 . . . . 13.539999999999999 110.618 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 72.94 -1.04 41.92 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.082 -0.963 . . . . 14.67 112.288 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.58 155.34 18.94 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.188 -0.671 . . . . 13.039999999999999 109.188 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.2 t -92.07 109.0 20.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.967 0.413 . . . . 14.84 110.258 -174.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -126.27 156.13 19.65 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.136 -1.03 . . . . 12.220000000000001 113.729 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.7 p -103.63 147.56 9.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.208 -0.496 . . . . 13.74 110.036 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.7 106.06 6.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 12.890000000000001 110.478 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 24.5 mmt -113.26 143.86 43.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.859 -0.61 . . . . 13.800000000000001 110.104 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -75.18 136.42 20.38 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.227 -0.987 . . . . 13.359999999999999 111.874 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.557 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 8.8 t80 -105.1 130.93 53.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.476 0.655 . . . . 14.24 110.052 -174.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 42.3 m -145.13 94.51 5.29 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 108.378 -0.971 . . . . 16.510000000000002 108.378 172.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.78 145.42 98.25 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.917 2.411 . . . . 17.420000000000002 113.189 -172.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 . . . . . 0 C--O 1.244 0.769 0 CA-C-O 118.35 -0.833 . . . . 19.190000000000001 109.879 179.051 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.97 -0.381 . . . . 18.390000000000001 109.97 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.3 147.26 5.47 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.202 -0.999 . . . . 17.77 112.718 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.468 ' CB ' ' HB3' ' A' ' 68' ' ' PRO . 19.9 tp60 74.78 -46.68 0.61 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.903 0.881 . . . . 17.690000000000001 112.062 175.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -56.39 -46.61 80.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.48 0.657 . . . . 19.93 110.189 176.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -109.35 170.23 8.19 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.284 -1.006 . . . . 17.43 108.284 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -78.53 55.11 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.595 0.712 . . . . 19.359999999999999 112.018 -175.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -141.39 132.75 26.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.51 -1.292 . . . . 18.960000000000001 107.51 171.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 63.72 27.54 14.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.428 0.632 . . . . 18.239999999999998 110.029 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -102.45 -39.41 7.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.274 -0.876 . . . . 16.780000000000001 109.742 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -96.59 161.26 13.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.273 -0.876 . . . . 18.420000000000002 110.099 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.63 84.81 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.685 -0.689 . . . . 17.920000000000002 111.236 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 64.57 -76.34 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.762 0.825 . . . . 19.550000000000001 111.523 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.538 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . -163.41 141.92 8.01 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.51 -0.922 . . . . 20.309999999999999 108.51 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.401 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 7.6 mm -121.79 66.36 20.45 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 120.842 -0.343 . . . . 19.920000000000002 111.279 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.538 ' HD3' ' C ' ' A' ' 40' ' ' ALA . 38.5 Cg_endo -96.64 57.82 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.015 2.477 . . . . 21.640000000000001 111.286 174.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp 59.67 45.24 13.27 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.681 -0.691 . . . . 22.670000000000002 110.508 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.57 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 77.2 t -116.45 -59.99 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.644 -0.707 . . . . 21.34 111.568 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.57 ' HD2' ' H ' ' A' ' 44' ' ' VAL . 40.9 Cg_endo -68.78 119.56 6.54 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 121.636 1.557 . . . . 20.0 112.222 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -76.55 -33.56 58.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.031 -0.531 . . . . 21.079999999999998 109.992 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.43 -8.54 57.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.802 -0.635 . . . . 18.800000000000001 110.794 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.15 -168.37 46.66 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.044 -0.598 . . . . 17.510000000000002 112.494 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -78.93 127.63 32.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.539 0.209 . . . . 16.949999999999999 110.847 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.463 ' HD2' ' OD2' ' A' ' 51' ' ' ASP . 4.9 ttm105 -169.9 -157.36 0.16 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.364 . . . . 18.300000000000001 110.68 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' OD2' ' HD2' ' A' ' 50' ' ' ARG . 8.1 p-10 -70.45 154.46 41.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.642 -0.708 . . . . 18.170000000000002 111.145 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -87.27 116.83 67.42 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.49 -0.777 . . . . 18.82 111.119 -177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HA ' ' HG3' ' A' ' 57' ' ' PRO . 38.2 Cg_endo -67.37 -12.3 35.31 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.582 2.188 . . . . 19.870000000000001 111.952 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -83.95 -11.85 56.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.774 . . . . 21.100000000000001 111.051 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 87.6 mtp -107.34 -81.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 22.300000000000001 111.584 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 15.2 tpt -158.0 77.83 3.5 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.217 -0.661 . . . . 23.850000000000001 109.217 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.502 ' HG3' ' HA ' ' A' ' 53' ' ' PRO . 35.1 Cg_endo -88.4 39.07 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.33 2.687 . . . . 20.670000000000002 113.075 -173.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.13 100.66 13.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.022 -0.535 . . . . 20.489999999999998 109.914 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.498 ' O ' ' HB ' ' A' ' 60' ' ' THR . . . -68.8 78.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.039 0.447 . . . . 21.469999999999999 111.166 -177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 59' ' ' ALA . 10.8 t 170.29 -28.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.215 -0.902 . . . . 22.600000000000001 109.602 -178.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -150.65 38.04 0.67 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.265 0.555 . . . . 21.93 109.828 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.96 139.97 58.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.569 -0.741 . . . . 19.73 110.872 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.4 mt -122.8 79.5 49.26 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.14 -0.482 . . . . 19.579999999999998 110.447 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.505 ' O ' ' HD2' ' A' ' 67' ' ' PRO . 79.7 Cg_endo -93.65 15.04 1.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.957 2.438 . . . . 18.5 112.346 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.02 55.36 2.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.161 0.505 . . . . 17.609999999999999 111.323 -175.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.572 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 53.5 tp60 -132.24 -52.49 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.19 -0.459 . . . . 18.760000000000002 111.004 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 66' ' ' GLN . 50.9 Cg_exo -53.11 -49.33 17.91 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.497 1.465 . . . . 17.280000000000001 112.451 169.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.468 ' HB3' ' CB ' ' A' ' 30' ' ' GLN . 32.7 Cg_endo -66.05 143.94 74.02 Favored 'Trans proline' 0 C--N 1.361 1.211 0 C-N-CA 121.665 1.576 . . . . 17.77 111.102 170.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.56 150.01 49.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.216 0.531 . . . . 18.699999999999999 110.371 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -120.49 -86.99 0.97 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.352 -0.84 . . . . 17.719999999999999 113.154 -171.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 57.68 73.37 0.47 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.249 0.547 . . . . 18.0 109.952 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.26 54.04 2.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.783 -0.644 . . . . 17.960000000000001 111.654 -174.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -160.34 65.01 0.33 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.509 0.671 . . . . 19.850000000000001 109.814 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -89.73 -5.34 57.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.348 0.594 . . . . 19.670000000000002 109.652 176.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.84 156.12 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.103 -0.953 . . . . 17.739999999999998 111.149 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.46 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 6.9 tpm_? -138.11 -33.73 0.68 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.193 -0.458 . . . . 19.949999999999999 110.915 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.39 72.1 7.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.754 0.311 . . . . 18.390000000000001 110.893 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.96 -34.83 61.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.006 -0.616 . . . . 17.66 112.403 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.12 -32.65 63.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.982 0.42 . . . . 17.68 110.604 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 58.6 31.49 21.13 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.353 -0.839 . . . . 17.800000000000001 111.375 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.71 69.13 5.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.125 0.488 . . . . 17.350000000000001 111.345 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.527 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . . . -84.91 -50.31 0.57 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.203 -0.453 . . . . 16.640000000000001 111.806 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 82' ' ' ALA . 27.2 Cg_exo -62.6 115.0 2.63 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 121.903 1.736 . . . . 17.23 111.977 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.5 t -105.32 -169.71 1.64 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.496 -0.775 . . . . 17.34 109.848 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mp 69.84 14.99 7.98 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.95 0.5 . . . . 18.41 111.316 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -82.9 133.54 48.44 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 109.189 -0.671 . . . . 17.449999999999999 109.189 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -47.43 -49.61 12.84 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.605 2.203 . . . . 18.890000000000001 112.551 -174.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 34.13 64.04 0.38 Allowed 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.484 1.115 . . . . 17.809999999999999 112.601 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.8 t -125.22 151.54 45.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.377 -0.374 . . . . 18.629999999999999 111.042 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 102' ' ' ALA . 64.7 mt 70.42 -68.51 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 123.839 0.712 . . . . 19.100000000000001 111.356 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -142.63 114.45 8.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.642 -0.503 . . . . 19.25 109.642 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -129.03 -63.02 0.98 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.297 -0.411 . . . . 18.789999999999999 110.989 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 53.8 t30 63.06 90.47 0.08 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.785 0.678 . . . . 18.949999999999999 110.34 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.47 46.16 1.31 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.162 -0.472 . . . . 20.309999999999999 111.092 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.0 t -73.43 -30.15 63.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.033 -0.531 . . . . 21.399999999999999 109.948 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.26 8.85 16.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.61 -0.723 . . . . 21.16 109.142 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 38.4 t80 58.55 55.31 4.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.27 -1.332 . . . . 22.18 111.045 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -105.64 109.82 63.58 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.268 -0.642 . . . . 19.449999999999999 109.268 171.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.14 71.39 3.6 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.702 2.268 . . . . 18.530000000000001 112.395 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.451 ' OE2' ' HD2' ' A' ' 101' ' ' PRO . 8.7 tp10 -87.91 115.81 64.22 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.772 -0.649 . . . . 17.449999999999999 109.727 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.451 ' HD2' ' OE2' ' A' ' 100' ' ' GLU . 32.3 Cg_exo -60.37 166.89 8.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.866 2.377 . . . . 17.420000000000002 111.996 177.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.404 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . . . -70.31 115.49 35.25 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.253 -0.43 . . . . 17.68 109.904 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.1 91.48 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.888 2.392 . . . . 16.289999999999999 113.052 -172.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.0 p -77.89 55.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.683 1.23 . . . . 17.260000000000002 109.834 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.669 ' HB1' ' HD2' ' A' ' 106' ' ' PRO . . . -137.81 178.87 1.51 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 114.816 -1.084 . . . . 15.800000000000001 110.081 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.669 ' HD2' ' HB1' ' A' ' 105' ' ' ALA . 49.5 Cg_exo -42.28 -39.54 6.32 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.013 2.475 . . . . 15.92 115.889 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 106' ' ' PRO . 1.5 Cg_endo -43.76 -30.6 3.0 Favored 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 123.24 2.627 . . . . 16.149999999999999 114.322 175.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -61.23 127.57 88.29 Favored Pre-proline 0 C--O 1.233 0.193 0 C-N-CA 121.17 -0.212 . . . . 17.629999999999999 110.631 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.92 106.08 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.255 2.637 . . . . 15.039999999999999 112.887 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.448 ' HB2' ' HD2' ' A' ' 111' ' ' PRO . 59.3 pttt -139.99 158.54 67.1 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.463 -0.94 . . . . 15.199999999999999 108.463 175.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 110' ' ' LYS . 9.9 Cg_endo -49.99 119.13 4.48 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.753 2.302 . . . . 14.08 112.415 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 113' ' ' GLU . 7.7 p -81.6 64.72 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.86 0.838 . . . . 15.279999999999999 109.298 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 35.2 mm-40 80.92 126.78 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.312 0 CA-C-N 114.284 -1.326 . . . . 16.84 110.266 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.04 145.07 65.77 Favored 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 122.758 2.306 . . . . 15.51 111.507 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.61 57.05 2.36 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.01 2.473 . . . . 16.039999999999999 112.888 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 7.1 ttpm? -78.33 -39.66 1.73 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.65 -0.704 . . . . 18.91 110.141 173.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 47.6 Cg_exo -59.56 120.4 8.21 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 121.139 1.226 . . . . 17.039999999999999 110.574 166.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . 29.1 mmmt 67.15 65.19 0.43 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.776 0.673 . . . . 17.52 110.759 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.2 115.2 5.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 120.644 0.259 . . . . 18.699999999999999 110.47 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 59.01 50.92 7.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.775 -0.648 . . . . 20.879999999999999 110.506 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . . . -53.79 114.1 5.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 18.890000000000001 110.849 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.04 135.28 61.65 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.556 2.171 . . . . 20.43 111.635 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.51 101.5 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.002 2.468 . . . . 21.100000000000001 112.294 -177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.39 147.35 98.17 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.656 -0.702 . . . . 21.149999999999999 110.268 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.34 73.98 0.38 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.806 2.337 . . . . 21.149999999999999 112.153 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 126' ' ' LYS . 17.4 pttp -55.38 112.59 4.35 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.189 -0.914 . . . . 21.879999999999999 111.808 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.29 -54.24 1.9 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.246 2.631 . . . . 20.190000000000001 112.332 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -143.43 88.06 8.15 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.991 0.424 . . . . 20.48 110.503 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.33 87.7 1.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.533 2.155 . . . . 21.170000000000002 111.183 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -64.26 116.81 30.99 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.706 -0.679 . . . . 23.18 110.734 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.29 107.29 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.494 2.13 . . . . 20.780000000000001 111.517 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.0 m -86.35 39.61 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 122.057 0.932 . . . . 19.75 110.526 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -157.53 133.69 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.493 -1.23 . . . . 21.050000000000001 109.867 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 136' ' ' LYS . 16.6 pt-20 -154.96 44.32 0.49 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.597 -0.89 . . . . 21.300000000000001 108.597 -178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 57.84 63.44 1.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.095 -0.957 . . . . 20.739999999999998 108.784 -166.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.607 ' HB3' ' CB ' ' A' ' 192' ' ' ALA . 67.4 mttm -92.47 87.67 6.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.892 -1.049 . . . . 17.969999999999999 109.128 -175.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . 56.8 42.12 27.1 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.131 -1.063 . . . . 17.350000000000001 108.131 -169.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 72.71 145.67 0.11 Allowed Pre-proline 0 C--N 1.341 0.219 0 CA-C-N 113.903 -1.499 . . . . 19.100000000000001 110.46 -170.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -41.26 86.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.704 3.603 . . . . 19.350000000000001 114.634 -169.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.482 ' HB ' ' CG ' ' A' ' 219' ' ' PRO . 62.5 p 49.78 32.02 4.95 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.326 -0.852 . . . . 17.75 112.246 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.64 -59.22 1.45 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.783 -0.722 . . . . 17.960000000000001 111.449 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.46 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 65.1 mttm -94.78 71.16 3.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.002 0.43 . . . . 19.420000000000002 109.887 175.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.846 ' HB1' ' CD2' ' A' ' 217' ' ' TYR . . . -104.61 158.41 16.52 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.669 -0.493 . . . . 14.65 109.669 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.64 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 16.1 m-85 -137.23 144.89 43.02 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.454 0.168 . . . . 14.81 111.233 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 190' ' ' PRO . 3.2 m -151.3 164.81 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 122.932 0.493 . . . . 10.48 110.827 -178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 44.4 t -114.72 108.98 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.778 0.323 . . . . 10.1 111.021 174.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.404 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 33.2 tt0 -84.84 111.55 19.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.541 -0.3 . . . . 12.0 110.796 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.996 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -91.29 -35.32 14.52 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.327 0.584 . . . . 11.880000000000001 109.804 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.39 166.52 27.66 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.667 -0.778 . . . . 11.35 112.475 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -167.33 101.31 0.51 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.117 -0.697 . . . . 13.470000000000001 109.117 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.71 159.32 42.18 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.323 0.582 . . . . 13.52 110.978 -171.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 181' ' ' GLY . 5.0 mmmm -98.02 5.29 48.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.892 -1.049 . . . . 17.600000000000001 110.027 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -112.61 106.67 15.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.979 -1.01 . . . . 16.140000000000001 110.041 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.41 ' HA ' ' CG2' ' A' ' 157' ' ' VAL . . . -61.5 -22.09 64.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.205 -0.452 . . . . 14.039999999999999 111.838 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.09 -35.52 73.54 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.814 0.816 . . . . 16.57 110.129 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.592 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 97.8 mttt -86.62 -25.71 24.76 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.609 -1.178 . . . . 16.399999999999999 110.289 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 184' ' ' THR . 90.0 t -61.61 -45.26 99.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.92 -0.582 . . . . 12.67 110.154 175.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -60.72 -33.83 73.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.628 -0.714 . . . . 15.32 112.007 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 15.7 pt-20 -78.25 -36.82 46.44 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.589 -0.444 . . . . 15.970000000000001 111.214 -175.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 156' ' ' LYS . 20.6 mt -72.02 -46.67 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.666 0.746 . . . . 12.6 109.756 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.97 -34.3 69.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.738 -1.119 . . . . 12.539999999999999 110.519 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.44 -27.0 67.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 14.800000000000001 112.281 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -71.99 -54.79 8.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.112 0.482 . . . . 16.050000000000001 111.068 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.473 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 4.3 mm? -85.7 -62.78 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 12.99 112.38 -174.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -63.18 -37.22 86.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.28 0.562 . . . . 15.06 109.925 -175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.71 -17.29 79.14 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.015 -0.993 . . . . 16.600000000000001 112.522 -176.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -100.71 -6.7 24.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.785 0.326 . . . . 16.140000000000001 110.982 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.87 25.66 19.39 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.382 -0.914 . . . . 15.119999999999999 113.153 177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -93.72 150.91 20.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.3 0.55 . . . . 15.49 109.799 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.04 102.83 2.12 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.669 0.747 . . . . 13.869999999999999 110.058 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.8 p -142.83 144.23 24.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.342 -1.299 . . . . 10.82 109.337 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.63 177.18 8.2 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.768 0.794 . . . . 11.130000000000001 110.862 170.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 17.8 p -124.65 -175.17 3.2 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.173 -1.376 . . . . 11.52 110.0 -171.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 62.4 m -50.62 128.53 26.06 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.931 -0.308 . . . . 12.75 110.385 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.45 ' HG2' HG11 ' A' ' 112' ' ' VAL . 16.5 Cg_exo -15.7 -63.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.583 1 C-N-CA 126.908 5.072 . . . . 14.640000000000001 117.047 -175.108 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.5 t -83.81 -63.29 1.38 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.574 -0.851 . . . . 16.68 112.487 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 65.1 m -168.22 134.24 1.6 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 117.62 0.191 . . . . 16.039999999999999 110.919 -176.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.514 ' HB3' HG21 ' A' ' 184' ' ' THR . 51.9 Cg_exo -60.68 124.67 15.5 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.383 2.056 . . . . 14.220000000000001 111.86 165.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 182' ' ' LYS . 32.2 m -137.58 160.75 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 109.042 -0.725 . . . . 16.129999999999999 109.042 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.48 120.87 22.3 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.26 -0.427 . . . . 16.699999999999999 110.317 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.441 ' O ' ' HE2' ' A' ' 152' ' ' LYS . . . 109.47 -26.45 14.69 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.966 -0.635 . . . . 16.98 113.106 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.508 ' HB2' ' CG2' ' A' ' 179' ' ' VAL . 4.3 mptp? -101.11 163.61 12.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.032 0.444 . . . . 18.73 110.884 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 183' ' ' ILE . 7.6 tp -73.13 108.03 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.835 0.826 . . . . 14.82 110.88 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.514 HG21 ' HB3' ' A' ' 178' ' ' PRO . 52.5 m -101.39 107.27 18.56 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.604 0.716 . . . . 12.779999999999999 109.758 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.519 ' HB3' HD11 ' A' ' 187' ' ' LEU . 81.5 mtt180 -86.92 138.54 31.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.782 -1.099 . . . . 13.98 109.579 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.576 ' O ' HD22 ' A' ' 148' ' ' LEU . 3.6 mm -110.5 116.8 53.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.49 -0.93 . . . . 10.56 108.49 177.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 185' ' ' ARG . 4.6 mp -129.27 128.83 44.01 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.478 0.656 . . . . 10.1 110.987 -173.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.996 HG23 HD21 ' A' ' 148' ' ' LEU . 54.8 t -104.01 142.39 17.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.903 -1.044 . . . . 9.7400000000000002 110.423 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.83 49.87 7.45 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-N 115.262 -0.881 . . . . 9.7599999999999998 113.308 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.828 ' HA ' HG12 ' A' ' 145' ' ' VAL . 11.2 Cg_endo -62.44 125.72 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 CA-C-N 119.548 1.674 . . . . 11.15 110.522 172.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -159.7 169.0 24.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.565 -0.743 . . . . 12.77 109.373 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.607 ' CB ' ' HB3' ' A' ' 136' ' ' LYS . . . -110.99 5.22 20.15 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.479 0.657 . . . . 14.6 110.237 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 50.1 m -120.68 103.2 8.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.545 -0.752 . . . . 14.300000000000001 111.396 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.617 ' HB2' ' CE1' ' A' ' 144' ' ' TYR . 37.5 ttpt -64.11 -47.96 77.96 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 115.775 -0.648 . . . . 15.970000000000001 109.982 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -57.09 -33.49 67.35 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.005 -0.543 . . . . 15.6 111.453 -177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -75.42 -54.19 7.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.052 -0.522 . . . . 14.220000000000001 110.023 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.652 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -72.85 -19.52 61.29 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.079 -0.509 . . . . 11.949999999999999 111.044 -173.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.463 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 2.0 mmmm -63.91 -33.67 76.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.526 0.679 . . . . 14.699999999999999 110.918 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -81.74 -12.75 81.04 Favored Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.415 -1.074 . . . . 13.09 110.415 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 74.0 m -83.71 -8.72 59.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.601 -0.799 . . . . 12.109999999999999 111.994 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 9.6 mt -71.84 -38.45 70.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.805 0.335 . . . . 12.720000000000001 110.632 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.54 -24.7 68.04 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.669 -0.972 . . . . 14.66 110.669 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.568 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 43.8 mt-10 -86.64 -24.2 25.4 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.175 -0.513 . . . . 13.890000000000001 110.328 174.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.403 ' CD2' HG11 ' A' ' 146' ' ' VAL . 6.0 tp -60.01 -46.29 89.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.415 -0.357 . . . . 12.550000000000001 111.106 -175.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -21.95 46.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.13 -0.486 . . . . 15.83 111.06 177.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -41.03 11.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.076 -0.511 . . . . 16.969999999999999 110.938 174.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.8 mt -67.9 -52.39 36.89 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.144 0.497 . . . . 13.890000000000001 111.437 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 66.0 p -104.23 -38.07 7.03 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.942 -0.572 . . . . 13.539999999999999 110.748 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.39 -0.55 54.3 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.103 -0.799 . . . . 14.67 111.103 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 58.7 mt -97.47 154.13 17.69 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 122.831 0.452 . . . . 13.039999999999999 110.336 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.1 m -84.85 107.34 16.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.904 -0.589 . . . . 14.84 110.555 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -127.83 158.8 21.5 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.282 -0.961 . . . . 12.220000000000001 113.325 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.49 142.58 21.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.763 -0.458 . . . . 13.74 109.763 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.4 105.53 4.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.077 -0.712 . . . . 12.890000000000001 109.077 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 92.8 mmm -114.09 142.39 46.26 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.444 -0.798 . . . . 13.800000000000001 109.383 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -69.94 109.08 2.71 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.11 -1.043 . . . . 13.359999999999999 111.726 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.846 ' CD2' ' HB1' ' A' ' 143' ' ' ALA . 5.4 t80 -64.38 127.03 29.73 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.113 0.965 . . . . 14.24 110.457 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.4 p -144.58 91.84 6.12 Favored Pre-proline 0 C--N 1.312 -1.036 0 CA-C-N 115.535 -0.757 . . . . 16.510000000000002 109.36 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.482 ' CG ' ' HB ' ' A' ' 140' ' ' THR . 19.0 Cg_endo -61.09 139.04 82.05 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.455 2.103 . . . . 17.420000000000002 112.169 -177.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.466 HD22 ' N ' ' A' ' 220' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.457 -0.782 . . . . 19.190000000000001 109.691 -177.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 120.766 0.317 . . . . 18.390000000000001 110.839 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.17 64.09 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.365 -0.921 . . . . 17.77 112.801 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -77.36 98.6 5.29 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.999 -0.371 . . . . 17.690000000000001 109.999 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.456 ' HD2' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -136.87 121.53 18.5 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.2 0.524 . . . . 19.93 110.951 178.212 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.463 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 21.5 tptm -96.92 83.65 3.43 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.665 -0.865 . . . . 17.43 108.665 175.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -111.25 -76.39 0.6 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.15 -0.477 . . . . 19.359999999999999 110.673 -174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -155.37 22.51 0.42 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.946 0.35 . . . . 18.960000000000001 111.946 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -104.85 -116.07 0.23 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.507 -0.923 . . . . 18.239999999999998 108.507 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 66.38 -70.27 0.11 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.037 0.535 . . . . 16.780000000000001 111.604 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 60.04 55.06 3.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.241 0.544 . . . . 18.420000000000002 110.717 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 51' ' ' ASP . 49.6 m-85 -70.09 -49.56 49.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.164 -0.471 . . . . 17.920000000000002 110.814 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.06 33.97 5.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.535 -0.302 . . . . 19.550000000000001 110.844 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 68.85 -66.53 0.24 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.084 0.865 . . . . 20.309999999999999 111.723 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.511 HG22 ' HG2' ' A' ' 45' ' ' PRO . 35.7 pt 40.19 71.74 1.16 Allowed Pre-proline 0 N--CA 1.467 0.416 0 C-N-CA 124.12 0.968 . . . . 19.920000000000002 112.675 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.38 57.52 4.83 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.268 2.645 . . . . 21.640000000000001 111.891 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 43' ' ' LEU . 4.3 mm? 60.09 27.67 17.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.547 -0.751 . . . . 22.670000000000002 110.898 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.622 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 93.9 t -90.9 -54.77 0.27 Allowed Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.94 -0.573 . . . . 21.34 111.081 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 30.8 Cg_endo -99.81 -177.95 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.888 2.392 . . . . 20.0 111.592 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -104.23 -1.08 27.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.988 0.423 . . . . 21.079999999999998 110.438 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.0 172.79 17.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.653 -0.703 . . . . 18.800000000000001 109.272 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.64 57.01 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.302 -0.951 . . . . 17.510000000000002 112.419 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.2 94.14 5.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.941 0.4 . . . . 16.949999999999999 110.224 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -80.14 -37.7 32.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 18.300000000000001 109.831 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.41 ' HB2' ' CD1' ' A' ' 38' ' ' PHE . 7.1 m-20 -97.7 110.37 22.95 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.1 -1.074 . . . . 18.170000000000002 108.1 169.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.561 ' HG3' ' HB2' ' A' ' 54' ' ' ASP . 14.0 tp10 -81.47 114.85 52.8 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.255 -0.43 . . . . 18.82 110.918 -172.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.28 44.51 1.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.904 2.402 . . . . 19.870000000000001 111.782 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.561 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 7.5 t70 -84.97 69.31 10.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.761 -0.654 . . . . 21.100000000000001 110.109 -177.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 88.4 mtp 70.26 -14.7 0.38 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.515 -0.766 . . . . 22.300000000000001 112.246 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 50.1 ttm -171.44 90.64 0.44 Allowed Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 108.953 -0.758 . . . . 23.850000000000001 108.953 -175.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -85.39 51.38 2.96 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.84 2.36 . . . . 20.670000000000002 112.11 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.18 113.6 6.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.317 -0.856 . . . . 20.489999999999998 109.876 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.99 -17.28 13.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.253 -0.43 . . . . 21.469999999999999 111.134 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.7 m -86.28 -27.21 24.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.25 0.548 . . . . 22.600000000000001 110.112 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -138.84 152.03 47.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.63 -0.714 . . . . 21.93 109.368 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.87 71.08 8.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.183 0.516 . . . . 19.73 110.011 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 98.3 mt -123.17 114.34 29.3 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.8 -0.636 . . . . 19.579999999999998 111.429 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.89 78.93 2.74 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.703 2.269 . . . . 18.5 111.119 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -60.76 -20.78 62.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.021 -0.536 . . . . 17.609999999999999 111.601 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -61.46 120.01 51.83 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.131 -0.486 . . . . 18.760000000000002 110.849 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -103.84 83.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.537 2.825 . . . . 17.280000000000001 113.437 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.74 -90.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.563 2.175 . . . . 17.77 112.763 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 67.16 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.825 0.703 . . . . 18.699999999999999 111.559 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 163.14 -159.92 32.45 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.761 -0.733 . . . . 17.719999999999999 111.916 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 61.47 49.0 5.47 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.859 0.464 . . . . 18.0 111.405 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 60.62 43.12 13.0 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.395 -0.82 . . . . 17.960000000000001 111.519 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 64.24 -90.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.3 -0.863 . . . . 19.850000000000001 111.325 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -90.94 91.35 8.29 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.873 -0.603 . . . . 19.670000000000002 109.943 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 p -78.17 106.94 9.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.278 0.561 . . . . 17.739999999999998 111.094 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -175.79 -53.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.829 -0.623 . . . . 19.949999999999999 110.529 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.68 137.43 44.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.129 -0.487 . . . . 18.390000000000001 111.134 -178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.02 179.48 45.35 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.228 -0.749 . . . . 17.66 111.228 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -139.55 -75.19 0.36 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.061 0.431 . . . . 17.68 110.706 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -159.09 19.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 17.800000000000001 111.234 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.31 -51.92 7.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 17.350000000000001 111.008 -177.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' H ' ' HD2' ' A' ' 83' ' ' PRO . . . -172.26 -50.12 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.153 -0.476 . . . . 16.640000000000001 111.632 -176.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.499 ' HD2' ' H ' ' A' ' 82' ' ' ALA . 92.8 Cg_exo -41.55 107.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 123.207 2.605 . . . . 17.23 113.546 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -124.32 143.16 50.73 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.04 -0.982 . . . . 17.34 109.485 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.3 mp -65.28 120.72 13.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.363 -0.38 . . . . 18.41 110.008 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.1 118.88 30.19 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.952 -0.567 . . . . 17.449999999999999 111.07 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.28 -14.18 18.56 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.889 2.392 . . . . 18.890000000000001 112.784 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.04 -3.77 56.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.006 0.431 . . . . 17.809999999999999 110.744 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.0 p 50.12 39.02 18.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.134 -0.939 . . . . 18.629999999999999 112.108 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.88 1.65 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.952 -0.567 . . . . 19.100000000000001 110.589 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.01 162.21 29.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.509 -0.769 . . . . 19.25 110.733 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.1 68.24 4.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.217 -0.447 . . . . 18.789999999999999 111.205 -176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -132.5 -56.41 0.95 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.899 -0.591 . . . . 18.949999999999999 110.045 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -95.26 18.82 11.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.865 -0.607 . . . . 20.309999999999999 110.397 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 p -62.46 -45.7 91.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.545 -0.752 . . . . 21.399999999999999 110.934 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -118.29 25.69 10.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.101 0.477 . . . . 21.16 109.848 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.1 t80 57.77 71.03 0.6 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.908 -1.042 . . . . 22.18 111.205 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 63.75 100.33 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.719 -0.673 . . . . 19.449999999999999 110.993 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -44.83 106.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.716 2.944 . . . . 18.530000000000001 113.58 -176.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.495 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 34.0 tt0 -173.49 -53.36 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.652 -0.704 . . . . 17.449999999999999 111.142 -178.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 100' ' ' GLU . 20.2 Cg_endo -60.93 -39.49 60.71 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 122.125 1.883 . . . . 17.420000000000002 112.438 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 46.87 76.71 0.52 Allowed Pre-proline 0 C--O 1.234 0.274 0 O-C-N 123.806 0.692 . . . . 17.68 112.502 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.96 116.02 2.87 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.934 2.422 . . . . 16.289999999999999 112.292 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 104' ' ' VAL . 5.0 m -86.04 82.12 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.074 -0.512 . . . . 17.260000000000002 111.075 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 60.15 83.19 0.21 Allowed Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 115.61 -0.723 . . . . 15.800000000000001 111.055 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 64.0 Cg_exo -52.26 117.05 3.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.292 2.661 . . . . 15.92 112.345 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 16.4 Cg_exo -68.3 -20.69 42.47 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.946 2.431 . . . . 16.149999999999999 112.635 -177.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -113.47 111.88 49.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.436 -0.347 . . . . 17.629999999999999 110.778 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 26.0 Cg_exo -64.37 172.11 7.0 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.953 2.436 . . . . 15.039999999999999 111.839 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 109' ' ' PRO . 24.9 mtpp 74.08 141.18 0.08 OUTLIER Pre-proline 0 N--CA 1.469 0.497 0 O-C-N 123.8 0.687 . . . . 15.199999999999999 111.334 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -59.87 146.99 94.37 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.645 2.23 . . . . 14.08 111.606 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.01 46.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.327 0.584 . . . . 15.279999999999999 111.874 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 51.21 84.83 0.2 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 114.653 -1.158 . . . . 16.84 111.552 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -67.15 164.13 31.45 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.774 2.316 . . . . 15.51 111.781 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -48.31 -49.31 14.6 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.585 2.19 . . . . 16.039999999999999 112.204 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -122.39 96.28 46.17 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.969 -0.56 . . . . 18.91 110.084 175.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.18 47.79 2.32 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.008 2.472 . . . . 17.039999999999999 111.55 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -160.07 99.96 1.38 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.468 -0.787 . . . . 17.52 109.278 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.38 90.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.558 0.694 . . . . 18.699999999999999 112.009 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -157.6 13.43 0.22 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.852 -1.067 . . . . 20.879999999999999 109.136 172.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.9 162.98 62.83 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 114.515 -1.221 . . . . 18.890000000000001 110.143 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.417 ' N ' ' HD2' ' A' ' 123' ' ' PRO . 87.4 Cg_exo -41.83 -49.57 5.45 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.725 2.284 . . . . 20.43 113.552 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 122' ' ' PRO . 27.8 Cg_endo -63.03 111.67 1.46 Allowed 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 121.778 1.652 . . . . 21.100000000000001 111.805 172.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.84 136.99 29.82 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.405 -0.361 . . . . 21.149999999999999 111.173 -177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.4 62.32 8.13 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.756 2.304 . . . . 21.149999999999999 112.294 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' A' ' 32' ' ' LYS . 12.6 mptt -123.26 68.84 38.97 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.975 -0.557 . . . . 21.879999999999999 111.183 176.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -82.01 44.47 1.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.228 1.952 . . . . 20.190000000000001 111.091 175.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.403 ' OE2' ' HG3' ' A' ' 131' ' ' PRO . 39.1 tt0 -163.68 99.41 0.97 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.7 -0.682 . . . . 20.48 110.516 -172.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.95 -55.8 0.29 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.849 2.366 . . . . 21.170000000000002 112.161 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -161.5 109.43 1.21 Allowed Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 23.18 110.483 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.403 ' HG3' ' OE2' ' A' ' 128' ' ' GLU . 27.8 Cg_endo -95.28 179.04 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.339 2.693 . . . . 20.780000000000001 112.243 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.5 m -101.05 50.36 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.357 0.598 . . . . 19.75 109.396 172.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.9 t 57.04 76.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 114.944 -1.025 . . . . 21.050000000000001 109.589 -171.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -113.23 120.4 41.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.483 -0.781 . . . . 21.300000000000001 111.143 -174.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -108.99 175.47 5.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.674 -0.694 . . . . 20.739999999999998 109.882 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -92.33 48.29 1.39 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.894 -0.78 . . . . 17.969999999999999 108.894 176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . 70.41 -4.12 1.69 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 114.651 -1.159 . . . . 17.350000000000001 111.582 -174.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 64.31 166.72 0.11 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.902 -0.59 . . . . 19.100000000000001 110.514 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -71.95 1.07 6.25 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.707 2.271 . . . . 19.350000000000001 112.022 176.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 13.0 t 175.73 176.28 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.32 -0.992 . . . . 17.75 108.32 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.06 -64.35 3.35 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.371 -0.919 . . . . 17.960000000000001 112.361 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -92.76 38.58 1.02 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.476 0.655 . . . . 19.420000000000002 109.455 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.554 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -78.37 163.01 26.04 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.22 -0.9 . . . . 14.65 108.985 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.633 ' CB ' HD21 ' A' ' 197' ' ' LEU . 5.5 m-85 -145.53 153.79 41.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.515 0.198 . . . . 14.81 110.882 -175.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.861 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.7 t -149.51 161.64 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 108.622 -0.881 . . . . 10.48 108.622 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.548 HG11 HD22 ' A' ' 204' ' ' LEU . 17.7 t -106.39 108.19 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 122.129 -0.357 . . . . 10.1 111.715 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.554 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 30.0 tt0 -81.5 118.26 22.58 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.615 0.228 . . . . 12.0 111.615 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.938 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -91.62 -36.5 13.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.097 -0.641 . . . . 11.880000000000001 109.708 177.082 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.14 161.89 28.14 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.536 -0.84 . . . . 11.35 112.73 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 184' ' ' THR . . . -163.68 100.76 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.022 -0.733 . . . . 13.470000000000001 109.022 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.71 167.96 19.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.941 -0.572 . . . . 13.52 110.257 -174.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 4.9 mtpm? -104.83 20.85 18.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.325 -0.852 . . . . 17.600000000000001 109.662 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.403 ' O ' HG23 ' A' ' 157' ' ' VAL . 25.3 t-20 -130.76 118.48 20.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.847 -1.069 . . . . 16.140000000000001 109.689 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.42 -22.53 61.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.321 0.489 . . . . 14.039999999999999 112.321 -173.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.28 -34.78 78.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.935 0.874 . . . . 16.57 109.466 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.36 -29.27 34.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.338 -1.301 . . . . 16.399999999999999 110.093 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.533 ' HA ' HD11 ' A' ' 186' ' ' ILE . 97.8 t -65.82 -39.66 85.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.827 -0.624 . . . . 12.67 109.82 173.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.49 -34.57 72.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.022 -0.99 . . . . 15.32 112.13 -175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.86 -46.51 29.92 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 120.115 -0.634 . . . . 15.970000000000001 111.225 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.789 HD12 HD12 ' A' ' 186' ' ' ILE . 25.2 mt -59.01 -45.95 91.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.444 0.64 . . . . 12.6 109.868 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 82.2 t -68.61 -40.62 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.255 -0.884 . . . . 12.539999999999999 110.445 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -62.35 -34.31 88.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.045 -0.598 . . . . 14.800000000000001 112.544 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -73.61 -43.96 58.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.587 0.232 . . . . 16.050000000000001 111.046 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.643 ' HB3' HG21 ' A' ' 171' ' ' VAL . 8.5 mt -87.03 -59.15 2.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.386 0.884 . . . . 12.99 113.386 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.473 ' HG2' ' HB ' ' A' ' 171' ' ' VAL . 9.8 mtp180 -69.74 -30.05 67.56 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 108.848 -0.797 . . . . 15.06 108.848 -175.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -67.41 -31.7 77.52 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 114.633 -1.167 . . . . 16.600000000000001 111.57 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.3 -12.05 53.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.927 0.394 . . . . 16.140000000000001 110.555 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.0 23.24 13.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.892 -0.671 . . . . 15.119999999999999 113.317 174.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -87.79 152.54 22.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.078 0.439 . . . . 15.49 110.329 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.445 ' HG3' ' HD2' ' A' ' 190' ' ' PRO . 20.6 tpp180 -75.43 97.75 3.73 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.806 0.812 . . . . 13.869999999999999 109.589 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 188' ' ' VAL . 2.6 t -131.96 136.32 56.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.605 -1.18 . . . . 10.82 110.622 -173.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.424 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -135.26 174.83 10.18 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.759 0.79 . . . . 11.130000000000001 111.089 174.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 7.8 p -127.71 -174.52 3.21 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.165 -1.38 . . . . 11.52 110.809 -169.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 175' ' ' PRO . 58.0 m -50.13 135.57 22.33 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-O 120.836 0.35 . . . . 12.75 110.477 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 174' ' ' SER . 30.5 Cg_exo -38.4 -44.85 2.17 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 124.714 3.609 . . . . 14.640000000000001 115.721 -169.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.6 m -87.01 -64.19 1.19 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 119.669 -0.812 . . . . 16.68 112.224 -173.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 93.7 m -168.52 129.13 1.08 Allowed Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 117.942 0.337 . . . . 16.039999999999999 111.861 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.522 ' HB3' HG21 ' A' ' 184' ' ' THR . 86.9 Cg_exo -58.33 125.16 17.61 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.772 2.315 . . . . 14.220000000000001 112.096 162.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.484 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.7 p -153.18 156.16 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 109.923 -0.399 . . . . 16.129999999999999 109.923 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -81.62 133.56 35.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.797 0.332 . . . . 16.699999999999999 110.202 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 102.86 -26.23 24.75 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.031 -0.604 . . . . 16.98 111.668 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -115.06 168.56 9.82 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.448 -0.575 . . . . 18.73 109.448 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 10.1 tp -76.48 126.26 36.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.471 0.653 . . . . 14.82 111.335 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.522 HG21 ' HB3' ' A' ' 178' ' ' PRO . 57.4 m -119.66 105.98 11.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.842 -0.617 . . . . 12.779999999999999 110.042 173.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 173' ' ' THR . 97.5 mtt180 -83.8 135.43 34.53 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.268 -0.878 . . . . 13.98 108.959 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.789 HD12 HD12 ' A' ' 160' ' ' ILE . 3.2 mt -119.8 120.5 63.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.577 -0.527 . . . . 10.56 109.577 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 187' ' ' LEU . 3.6 mp -129.16 142.1 50.97 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.344 -0.843 . . . . 10.1 111.114 -169.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.938 HG23 HD21 ' A' ' 148' ' ' LEU . 53.8 t -107.14 131.84 56.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.986 -1.006 . . . . 9.7400000000000002 110.926 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.86 49.62 4.73 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.19 -0.913 . . . . 9.7599999999999998 113.783 173.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.786 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -61.35 124.97 15.78 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 CA-C-N 119.624 1.712 . . . . 11.15 110.854 172.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -159.62 149.14 18.27 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.762 -0.458 . . . . 12.77 109.762 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -89.24 6.14 41.61 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.968 -0.56 . . . . 14.6 111.145 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.448 ' HB3' ' HB3' ' A' ' 196' ' ' LYS . 22.7 t -118.98 96.32 5.19 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 109.253 -0.647 . . . . 14.300000000000001 109.253 175.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.489 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 15.9 ptmt -63.03 -35.67 81.01 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.027 -0.988 . . . . 15.970000000000001 111.583 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -68.69 -44.42 74.01 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.996 0.427 . . . . 15.6 110.628 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 193' ' ' SER . 44.0 tttm -59.42 -44.07 92.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.765 -0.652 . . . . 14.220000000000001 110.698 176.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.633 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -82.54 -16.96 46.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.654 -0.703 . . . . 11.949999999999999 110.487 -176.307 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.622 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 25.3 tptp -64.57 -34.57 78.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 14.699999999999999 110.761 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -82.22 -12.56 80.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.391 -1.084 . . . . 13.09 110.391 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.516 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 70.9 m -79.58 -9.2 59.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.655 -0.772 . . . . 12.109999999999999 111.498 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 1.8 mt -74.11 -33.38 63.58 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.509 -0.552 . . . . 12.720000000000001 109.509 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -61.45 -28.23 69.18 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.551 -1.019 . . . . 14.66 110.551 173.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.545 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 41.8 mt-10 -85.85 -19.17 31.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.062 -0.569 . . . . 13.890000000000001 110.664 175.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.548 HD22 HG11 ' A' ' 146' ' ' VAL . 4.6 tp -60.59 -45.01 95.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.796 0.332 . . . . 12.550000000000001 111.553 -173.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -57.85 -23.88 54.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.302 -0.408 . . . . 15.83 111.224 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.38 -37.89 14.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.338 -0.392 . . . . 16.969999999999999 110.466 176.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 89.6 mt -70.9 -51.77 24.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.321 0.581 . . . . 13.890000000000001 111.052 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.564 ' CB ' HD21 ' A' ' 164' ' ' LEU . 28.4 t -110.11 -43.94 3.86 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.502 -0.772 . . . . 13.539999999999999 111.264 -173.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 74.34 -0.23 55.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.748 -0.739 . . . . 14.67 111.606 -174.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.14 157.51 15.86 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.684 -0.487 . . . . 13.039999999999999 109.684 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 61.2 m -77.1 95.45 4.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.949 0.405 . . . . 14.84 111.1 -174.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -103.94 138.58 14.13 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.651 -0.704 . . . . 12.220000000000001 113.439 -176.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.0 142.03 21.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.298 0.571 . . . . 13.74 110.066 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.6 t -78.68 105.94 8.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.434 -0.803 . . . . 12.890000000000001 110.419 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 90.1 mtp -120.31 142.59 48.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.073 -0.512 . . . . 13.800000000000001 110.258 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -69.22 136.03 28.12 Favored Glycine 0 N--CA 1.439 -1.13 0 C-N-CA 120.624 -0.798 . . . . 13.359999999999999 112.416 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.861 ' HB2' HG23 ' A' ' 145' ' ' VAL . 10.5 t80 -100.67 124.61 46.52 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.396 -0.902 . . . . 14.24 110.102 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 219' ' ' PRO . 5.2 t -142.39 93.32 7.13 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 109.318 -0.623 . . . . 16.510000000000002 109.318 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 218' ' ' THR . 17.2 Cg_endo -59.36 138.6 85.3 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.744 2.296 . . . . 17.420000000000002 112.893 -174.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 33.2 t30 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.398 -0.811 . . . . 19.190000000000001 110.18 -179.299 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 30.3 t70 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.894 0.378 . . . . 18.390000000000001 110.349 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -147.05 153.74 25.54 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.36 -0.924 . . . . 17.77 111.786 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -82.36 65.71 7.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.944 0.402 . . . . 17.690000000000001 110.34 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? 58.73 26.07 14.19 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.544 -0.753 . . . . 19.93 110.946 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -97.61 77.54 2.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.682 -0.69 . . . . 17.43 110.637 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -86.82 95.07 9.73 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.672 -0.694 . . . . 19.359999999999999 110.173 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.5 t80 66.55 36.03 5.15 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.031 -0.986 . . . . 18.960000000000001 110.519 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -91.41 -42.06 10.53 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.952 -0.759 . . . . 18.239999999999998 108.952 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -153.51 128.82 9.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.017 -0.992 . . . . 16.780000000000001 109.585 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -98.77 31.73 2.84 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.986 -0.746 . . . . 18.420000000000002 108.986 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.46 ' CE2' ' HB2' ' A' ' 49' ' ' ASP . 7.5 m-30 68.14 -77.09 0.05 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.786 -1.097 . . . . 17.920000000000002 109.543 -173.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.18 -76.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.605 0.762 . . . . 19.550000000000001 112.942 174.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.83 -5.39 37.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.003 0.372 . . . . 20.309999999999999 112.003 -173.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.2 pt -127.2 64.77 62.64 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 111.97 0.359 . . . . 19.920000000000002 111.97 178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.51 92.03 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.305 2.004 . . . . 21.640000000000001 111.666 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.1 mp 61.99 31.35 18.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.701 -0.681 . . . . 22.670000000000002 111.145 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.513 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 62.2 t -93.77 -50.86 0.26 Allowed Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 21.34 111.352 177.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.513 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 11.4 Cg_endo -88.03 -67.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.901 1.734 . . . . 20.0 112.499 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -152.67 69.06 0.85 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.028 -0.73 . . . . 21.079999999999998 109.028 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 70.18 -67.54 0.23 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.086 -0.961 . . . . 18.800000000000001 111.012 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -131.07 -120.71 2.22 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.822 -0.704 . . . . 17.510000000000002 112.739 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 22.8 t0 -80.19 122.06 26.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.971 0.415 . . . . 16.949999999999999 111.195 -173.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -166.86 -51.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.17 -0.678 . . . . 18.300000000000001 109.17 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -83.94 141.25 31.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.726 -0.67 . . . . 18.170000000000002 109.909 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -83.12 119.59 74.43 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.459 -0.337 . . . . 18.82 110.208 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.86 119.75 6.52 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.326 2.018 . . . . 19.870000000000001 111.141 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.78 -16.06 36.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 21.100000000000001 111.619 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -61.13 -28.8 69.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.541 -0.3 . . . . 22.300000000000001 110.671 176.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.3 tpt -172.84 79.99 0.42 Allowed Pre-proline 0 C--O 1.234 0.281 0 CA-C-O 120.808 0.337 . . . . 23.850000000000001 110.708 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -88.79 -167.69 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.852 2.368 . . . . 20.670000000000002 111.465 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.23 85.47 1.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.001 0.429 . . . . 20.489999999999998 111.308 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.97 156.73 48.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.16 -0.473 . . . . 21.469999999999999 110.952 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.4 m 65.35 -81.75 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.16 0.584 . . . . 22.600000000000001 111.323 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.401 ' H ' ' CD ' ' A' ' 61' ' ' GLN . 2.2 pm0 -89.47 -11.37 43.18 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.649 -0.5 . . . . 21.93 109.649 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 68.84 -78.55 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 114.892 -1.049 . . . . 19.73 112.04 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 87.1 mt 63.18 99.73 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.27 0 O-C-N 123.614 0.571 . . . . 19.579999999999998 110.222 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.59 132.53 20.63 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.142 2.561 . . . . 18.5 112.451 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.427 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 7.2 t -134.81 50.77 2.14 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.486 0.66 . . . . 17.609999999999999 110.877 -176.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.5 pm0 -79.89 108.7 9.77 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.077 -0.511 . . . . 18.760000000000002 109.924 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 65' ' ' THR . 66.7 Cg_endo -83.75 116.89 2.26 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.527 2.151 . . . . 17.280000000000001 112.773 -175.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 69' ' ' GLU . 73.4 Cg_endo -83.81 109.24 1.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.624 2.216 . . . . 17.77 111.02 174.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 68' ' ' PRO . 2.3 mp0 71.14 109.73 0.06 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.825 0.703 . . . . 18.699999999999999 110.283 -171.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.35 -34.55 22.86 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.677 -0.773 . . . . 17.719999999999999 111.938 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.44 55.29 2.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.05 0.453 . . . . 18.0 110.808 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 28' ' ' ASP . . . -70.77 -53.39 15.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.05 -0.523 . . . . 17.960000000000001 110.509 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -96.28 135.39 38.18 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.758 -0.656 . . . . 19.850000000000001 110.171 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -79.08 71.38 5.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.167 0.508 . . . . 19.670000000000002 110.128 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.5 m -72.94 128.55 35.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.639 -0.709 . . . . 17.739999999999998 111.241 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -97.12 -47.22 5.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.707 -0.679 . . . . 19.949999999999999 109.878 177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.62 15.09 2.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.973 -0.558 . . . . 18.390000000000001 110.871 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.08 -103.91 0.87 Allowed Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.818 -0.706 . . . . 17.66 111.526 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -129.14 17.8 6.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.315 -0.624 . . . . 17.68 109.315 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.68 -163.86 0.26 Allowed 'General case' 0 C--O 1.236 0.342 0 CA-C-N 114.914 -1.039 . . . . 17.800000000000001 109.882 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.11 31.65 19.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.187 0.518 . . . . 17.350000000000001 110.974 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -133.18 131.94 21.97 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.986 -0.552 . . . . 16.640000000000001 110.526 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -74.13 83.82 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.499 2.133 . . . . 17.23 112.312 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 p -103.33 -76.24 0.59 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.105 -0.952 . . . . 17.34 109.909 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -115.55 88.06 2.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.557 -0.905 . . . . 18.41 108.557 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -74.66 130.11 82.27 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.661 -0.7 . . . . 17.449999999999999 109.884 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.44 -18.61 49.5 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.867 2.378 . . . . 18.890000000000001 112.593 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.32 75.16 0.97 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.93 0.395 . . . . 17.809999999999999 110.563 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 m -64.51 -22.0 66.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.283 0.563 . . . . 18.629999999999999 110.322 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 24.7 pt -68.96 -16.33 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 19.100000000000001 110.912 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -120.43 35.93 4.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.33 0.586 . . . . 19.25 110.106 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 93' ' ' ASN . . . -73.01 -176.83 2.21 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.475 -0.784 . . . . 18.789999999999999 110.698 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 3.6 t-20 72.58 -66.39 0.31 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.092 0.557 . . . . 18.949999999999999 110.856 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -81.27 13.14 3.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.37 0.605 . . . . 20.309999999999999 111.295 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.8 t -94.83 -11.22 29.25 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.537 -0.756 . . . . 21.399999999999999 109.313 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -135.45 -32.79 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.628 -0.715 . . . . 21.16 111.611 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.479 ' CE1' ' HG2' ' A' ' 99' ' ' PRO . 3.0 t80 -172.25 79.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 22.18 110.172 -174.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.547 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 36.2 tt0 -53.16 -48.67 91.33 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 113.026 0.75 . . . . 19.449999999999999 113.026 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 98' ' ' GLU . 16.5 Cg_endo -58.29 -15.59 24.62 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.392 2.061 . . . . 18.530000000000001 113.933 -178.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -80.83 119.68 76.79 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.822 -0.436 . . . . 17.449999999999999 109.822 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.34 95.56 0.52 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.409 2.073 . . . . 17.420000000000002 112.078 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . . . -61.19 130.9 91.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.851 -0.613 . . . . 17.68 110.538 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 102' ' ' ALA . 54.4 Cg_exo -54.32 99.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.378 2.719 . . . . 16.289999999999999 113.154 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.87 112.13 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 121.774 0.797 . . . . 17.260000000000002 110.193 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.53 -50.02 90.51 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 114.838 -1.074 . . . . 15.800000000000001 112.8 -177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 55.2 Cg_endo -72.09 119.12 5.97 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.571 1.514 . . . . 15.92 111.496 172.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 13.9 Cg_exo -69.54 64.5 1.67 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.015 2.477 . . . . 16.149999999999999 112.683 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.425 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 8.5 mtmp? -80.4 -49.71 1.16 Allowed Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.01 -0.541 . . . . 17.629999999999999 111.398 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' A' ' 108' ' ' LYS . 88.7 Cg_endo -83.73 49.98 3.04 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.786 1.658 . . . . 15.039999999999999 112.567 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -93.21 130.72 34.91 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 120.832 0.348 . . . . 15.199999999999999 110.24 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.55 129.79 15.16 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.959 2.439 . . . . 14.08 113.119 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.5 p -94.72 40.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 122.819 1.295 . . . . 15.279999999999999 109.864 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -67.35 162.27 57.12 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.863 -1.517 . . . . 16.84 109.353 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.1 -49.71 9.67 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.506 2.137 . . . . 15.51 114.11 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 123' ' ' PRO . 56.8 Cg_endo -69.89 -17.27 37.08 Favored 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 121.729 1.619 . . . . 16.039999999999999 112.349 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm 53.41 68.39 2.95 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 122.863 0.465 . . . . 18.91 111.502 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -81.51 107.96 1.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.023 2.482 . . . . 17.039999999999999 111.452 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 56.6 mtmt -78.32 77.3 4.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.067 0.46 . . . . 17.52 111.12 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.5 t 69.9 -80.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.109 -0.95 . . . . 18.699999999999999 111.524 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -126.5 1.77 6.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.18 0.514 . . . . 20.879999999999999 110.483 -177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -85.52 132.35 44.96 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.436 -0.802 . . . . 18.890000000000001 110.611 -178.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 22.8 Cg_exo -65.21 134.33 38.85 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.58 2.187 . . . . 20.43 111.827 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.498 ' HB3' ' O ' ' A' ' 115' ' ' PRO . 46.4 Cg_exo -57.81 113.1 1.37 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.762 2.308 . . . . 21.100000000000001 112.129 176.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.471 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . . . -143.17 141.64 19.88 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.253 -0.43 . . . . 21.149999999999999 110.64 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 124' ' ' ALA . 12.5 Cg_exo -70.8 94.35 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.855 2.37 . . . . 21.149999999999999 112.023 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -159.49 124.65 2.24 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.256 -0.429 . . . . 21.879999999999999 110.437 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.3 115.95 3.0 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.384 2.056 . . . . 20.190000000000001 110.878 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.69 124.51 89.51 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.782 -0.644 . . . . 20.48 111.752 -172.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.01 157.94 46.17 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.369 2.713 . . . . 21.170000000000002 112.443 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -157.07 146.34 15.1 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 23.18 110.446 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.43 125.97 10.0 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.237 1.958 . . . . 20.780000000000001 111.802 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.1 p -89.39 49.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 122.721 1.248 . . . . 19.75 110.373 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.6 m -86.26 20.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 114.675 -1.148 . . . . 21.050000000000001 110.353 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -129.31 155.67 45.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.404 -0.816 . . . . 21.300000000000001 109.756 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -81.08 64.14 5.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.16 0.505 . . . . 20.739999999999998 109.933 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -65.06 -68.68 0.34 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.376 -0.829 . . . . 17.969999999999999 109.608 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -112.03 9.57 20.39 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.858 -0.793 . . . . 17.350000000000001 108.858 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 73.89 148.44 0.12 Allowed Pre-proline 0 C--N 1.34 0.176 0 CA-C-N 114.076 -1.42 . . . . 19.100000000000001 110.796 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.88 -7.24 12.69 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.106 2.537 . . . . 19.350000000000001 113.135 -175.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 219' ' ' PRO . 9.6 t -155.0 173.19 16.92 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.297 -0.631 . . . . 17.75 109.297 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.53 -77.29 2.12 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.717 -0.754 . . . . 17.960000000000001 111.392 -174.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -98.54 73.81 2.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.492 0.663 . . . . 19.420000000000002 109.455 175.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.818 ' HB1' ' CD1' ' A' ' 217' ' ' TYR . . . -109.66 164.05 12.91 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.027 -0.988 . . . . 14.65 109.436 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.729 ' N ' ' HB3' ' A' ' 217' ' ' TYR . 5.5 m-85 -138.6 141.12 39.17 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 111.455 0.168 . . . . 14.81 111.455 -174.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 1.026 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.7 t -149.96 163.07 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 109.317 -0.623 . . . . 10.48 109.317 170.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 59.3 t -103.83 108.85 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 O-C-N 122.304 -0.248 . . . . 10.1 111.528 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.46 ' HA ' ' HG ' ' A' ' 187' ' ' LEU . 8.6 tt0 -76.72 111.78 12.59 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.21 0.204 . . . . 12.0 110.899 178.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.966 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -89.02 -35.66 16.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.26 -0.644 . . . . 11.880000000000001 109.26 176.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.52 167.61 27.49 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.35 -0.841 . . . . 11.35 112.45 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -165.35 101.27 0.72 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.123 -0.695 . . . . 13.470000000000001 109.123 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 158.08 45.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.669 -0.696 . . . . 13.52 110.499 -173.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 49.9 mttp -96.23 16.73 17.45 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.182 -0.917 . . . . 17.600000000000001 110.194 -175.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.424 ' O ' HG23 ' A' ' 157' ' ' VAL . 15.8 m120 -118.56 108.37 14.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.959 -1.019 . . . . 16.140000000000001 109.52 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.82 -25.38 68.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.177 0.513 . . . . 14.039999999999999 110.557 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -59.68 -37.51 78.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.386 -0.824 . . . . 16.57 110.157 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' A' ' 159' ' ' GLU . 64.8 mttp -84.6 -23.3 29.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.621 -1.172 . . . . 16.399999999999999 110.132 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.46 HG13 ' CD1' ' A' ' 186' ' ' ILE . 77.0 t -65.64 -46.34 89.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.789 -0.641 . . . . 12.67 109.967 174.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -61.53 -29.49 70.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.751 -0.659 . . . . 15.32 112.04 -176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 14.8 pt-20 -77.4 -43.51 32.41 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.282 -0.567 . . . . 15.970000000000001 111.101 -177.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.465 HD12 HG13 ' A' ' 186' ' ' ILE . 21.7 mt -66.33 -46.73 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.762 0.792 . . . . 12.6 109.469 176.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.442 ' CG1' ' HD2' ' A' ' 165' ' ' ARG . 34.2 t -63.46 -32.9 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 114.538 -1.21 . . . . 12.539999999999999 110.588 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -59.76 -32.18 73.65 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.009 -0.615 . . . . 14.800000000000001 112.35 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? -71.31 -53.96 12.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 16.050000000000001 110.967 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.481 ' HG ' ' CG2' ' A' ' 188' ' ' VAL . 4.0 mm? -83.84 -51.25 7.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.199 0.815 . . . . 12.99 113.199 -172.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.456 ' HG3' HG13 ' A' ' 171' ' ' VAL . 48.1 mtt180 -69.74 -37.52 76.49 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.838 -0.801 . . . . 15.06 108.838 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.87 -32.21 83.46 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 114.601 -1.181 . . . . 16.600000000000001 112.4 -175.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -87.78 -3.64 58.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.974 0.416 . . . . 16.140000000000001 110.833 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.41 25.58 35.83 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.703 -0.761 . . . . 15.119999999999999 113.376 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.422 ' O ' HG12 ' A' ' 171' ' ' VAL . 35.5 m-85 -87.03 160.02 18.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.122 0.461 . . . . 15.49 110.658 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -76.29 97.3 4.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.608 0.718 . . . . 13.869999999999999 109.543 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.456 HG13 ' HG3' ' A' ' 165' ' ' ARG . 5.7 p -144.28 141.26 24.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 114.909 -1.041 . . . . 10.82 109.635 -174.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.585 ' CE1' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -140.2 176.57 8.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.717 0.77 . . . . 11.130000000000001 111.095 175.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 22.3 p -117.27 -175.22 2.76 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.44 -1.254 . . . . 11.52 110.696 -173.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.2 m -51.76 140.2 29.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 12.75 110.934 177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -46.18 -36.77 17.33 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.136 3.224 . . . . 14.640000000000001 115.069 -169.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.1 m -87.19 -63.74 1.26 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 119.915 -0.714 . . . . 16.68 112.177 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 98.0 m -168.49 139.55 2.14 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 117.742 0.247 . . . . 16.039999999999999 111.19 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.437 ' HB3' HG11 ' A' ' 157' ' ' VAL . 27.8 Cg_exo -66.55 122.82 10.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 121.786 1.657 . . . . 14.220000000000001 110.115 163.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 7.8 p -153.01 156.79 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.363 -0.535 . . . . 16.129999999999999 111.251 -172.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -81.48 128.77 34.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.432 -0.804 . . . . 16.699999999999999 110.423 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.09 -25.03 29.79 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.704 -0.76 . . . . 16.98 112.433 176.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 9.0 mptt -112.32 158.93 19.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.636 -0.505 . . . . 18.73 109.636 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.4 tp -70.83 115.58 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.486 0.66 . . . . 14.82 111.36 -175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 178' ' ' PRO . 36.3 m -112.05 113.18 25.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.648 -0.705 . . . . 12.779999999999999 109.826 175.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.551 ' CG ' HD11 ' A' ' 187' ' ' LEU . 21.0 ttm180 -89.49 140.93 29.04 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.04 -0.982 . . . . 13.98 110.112 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.521 ' O ' HD22 ' A' ' 148' ' ' LEU . 3.9 mm -111.21 117.51 55.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.878 -0.786 . . . . 10.56 108.878 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 187' ' ' LEU . 2.5 mp -130.33 135.02 47.62 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.306 0.574 . . . . 10.1 111.107 -173.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.966 HG23 HD21 ' A' ' 148' ' ' LEU . 41.1 t -108.59 135.62 46.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.241 -0.89 . . . . 9.7400000000000002 111.078 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.442 ' O ' HD22 ' A' ' 197' ' ' LEU . . . 82.8 49.3 5.15 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 114.999 -1.0 . . . . 9.7599999999999998 113.507 175.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.923 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -62.3 125.26 15.92 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 CA-C-N 119.552 1.676 . . . . 11.15 111.136 174.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -157.77 168.17 27.97 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.528 -0.545 . . . . 12.77 109.528 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -104.94 4.77 32.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.116 -0.493 . . . . 14.6 110.581 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 196' ' ' LYS . 21.0 t -120.67 117.7 28.21 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.036 0.446 . . . . 14.300000000000001 110.146 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.696 ' HB2' ' CE2' ' A' ' 144' ' ' TYR . 39.0 ttpt -67.8 -41.78 82.6 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-N 115.901 -0.591 . . . . 15.970000000000001 109.535 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -57.53 -50.19 73.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.667 0.27 . . . . 15.6 111.033 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 193' ' ' SER . 39.0 mtpt -52.85 -60.0 3.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.476 -0.784 . . . . 14.220000000000001 111.187 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -76.74 -28.83 55.92 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.912 -1.04 . . . . 11.949999999999999 111.617 -169.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.579 ' HD3' ' O ' ' A' ' 198' ' ' LYS . 12.9 tmtt? -73.45 -31.59 63.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.012 -0.736 . . . . 14.699999999999999 109.012 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.73 -12.55 84.36 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.227 -1.149 . . . . 13.09 110.227 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 58.5 m -88.37 -9.87 51.24 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.527 -0.837 . . . . 12.109999999999999 111.965 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 20.7 mt -66.28 -36.37 82.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.712 0.291 . . . . 12.720000000000001 111.055 -174.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -57.47 -44.25 93.76 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.026 -0.607 . . . . 14.66 111.829 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.429 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 13.0 pt-20 -86.07 -17.1 36.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.892 0.377 . . . . 13.890000000000001 110.519 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.56 HD11 HG12 ' A' ' 188' ' ' VAL . 15.5 tp -66.22 -31.91 73.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.028 0.442 . . . . 12.550000000000001 110.442 -177.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.492 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 6.1 mtpm? -58.98 -23.71 62.04 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.515 -0.766 . . . . 15.83 110.272 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.55 -36.96 15.05 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.863 -0.608 . . . . 16.969999999999999 110.236 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 92.6 mt -68.04 -52.65 33.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.043 -0.526 . . . . 13.890000000000001 111.5 -176.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.402 ' HB3' HD11 ' A' ' 164' ' ' LEU . 56.0 p -102.03 -44.12 5.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.119 0.485 . . . . 13.539999999999999 110.13 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.84 5.48 75.0 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.151 -0.931 . . . . 14.67 111.627 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.55 157.74 16.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 110.113 -0.329 . . . . 13.039999999999999 110.113 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.5 t -87.97 105.26 17.34 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.106 -0.497 . . . . 14.84 110.341 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -128.53 160.64 22.21 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.138 -1.03 . . . . 12.220000000000001 113.893 -176.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.14 143.53 20.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.137 -0.532 . . . . 13.74 110.026 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.62 105.27 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.38 -0.6 . . . . 12.890000000000001 109.38 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 64.1 mtt -120.99 145.96 47.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.019 -0.537 . . . . 13.800000000000001 110.226 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -71.91 110.36 3.18 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.365 -0.921 . . . . 13.359999999999999 112.803 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 1.026 ' HB2' HG23 ' A' ' 145' ' ' VAL . 4.4 t80 -64.05 134.68 55.43 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.243 -1.479 . . . . 14.24 110.287 175.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 27.1 m -147.09 93.34 4.75 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 120.881 -0.328 . . . . 16.510000000000002 110.935 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.435 ' HG2' ' OG1' ' A' ' 140' ' ' THR . 57.4 Cg_endo -73.66 118.86 5.64 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 121.865 1.71 . . . . 17.420000000000002 110.847 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 45.5 t30 . . . . . 0 C--O 1.244 0.797 0 CA-C-O 118.54 -0.743 . . . . 19.190000000000001 109.744 -176.181 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.699 0.285 . . . . 18.390000000000001 111.26 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.526 ' O ' ' HG2' ' A' ' 30' ' ' GLN . . . -97.66 32.38 6.84 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.056 -0.592 . . . . 17.77 113.452 -174.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 2.4 pt20 68.51 141.56 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.079 0.952 . . . . 17.690000000000001 112.467 174.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -84.08 118.91 24.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.314 -0.857 . . . . 19.93 109.68 178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.536 ' HD2' ' O ' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -161.57 142.92 11.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.332 0.586 . . . . 17.43 111.586 -174.337 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -79.17 -28.35 42.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.62 -0.718 . . . . 19.359999999999999 109.213 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 35' ' ' GLN . 91.3 t80 -133.09 -69.52 0.56 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.225 -0.898 . . . . 18.960000000000001 109.461 176.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 8.3 tt0 175.73 -67.6 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.693 -0.685 . . . . 18.239999999999998 109.35 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -112.96 131.83 55.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.321 -0.854 . . . . 16.780000000000001 110.094 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -143.95 -53.92 0.35 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.166 -0.47 . . . . 18.420000000000002 110.061 178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.9 t80 55.97 73.43 0.43 Allowed 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.853 0.721 . . . . 17.920000000000002 109.834 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 70.56 -63.16 0.42 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.108 -0.951 . . . . 19.550000000000001 111.112 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -168.26 -62.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.563 -0.289 . . . . 20.309999999999999 110.88 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.1 mt 55.57 73.54 0.84 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.825 -0.625 . . . . 19.920000000000002 111.067 -175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.26 46.59 2.14 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.931 2.421 . . . . 21.640000000000001 110.587 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.1 mp 59.77 31.62 20.91 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.176 -0.92 . . . . 22.670000000000002 110.801 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.525 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 76.5 t -84.96 -58.44 0.35 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.554 -0.748 . . . . 21.34 110.667 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.525 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 73.3 Cg_endo -75.79 129.77 11.93 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.416 1.411 . . . . 20.0 111.301 172.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -68.54 -23.44 64.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 21.079999999999998 110.732 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.36 58.64 1.33 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.951 -0.568 . . . . 18.800000000000001 110.423 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.38 -25.86 60.5 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.743 -0.662 . . . . 17.510000000000002 112.104 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.55 95.5 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.785 -0.45 . . . . 16.949999999999999 109.785 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -75.35 -39.07 59.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.911 -0.586 . . . . 18.300000000000001 110.095 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.1 157.51 15.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.183 -0.673 . . . . 18.170000000000002 109.183 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -84.2 115.11 58.59 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.155 -0.313 . . . . 18.82 110.155 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.85 68.52 5.61 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.893 2.395 . . . . 19.870000000000001 112.052 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.76 152.4 26.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.772 -0.649 . . . . 21.100000000000001 110.064 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -66.85 -15.96 63.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.116 -0.493 . . . . 22.300000000000001 110.971 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 51.7 tpp -153.09 96.0 2.93 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.037 -0.529 . . . . 23.850000000000001 109.596 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -66.5 86.43 0.27 Allowed 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.683 2.255 . . . . 20.670000000000002 111.797 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 61' ' ' GLN . . . -168.83 131.68 1.34 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.913 -1.494 . . . . 20.489999999999998 109.822 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -156.85 -58.39 0.09 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.16 0.505 . . . . 21.469999999999999 109.775 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.9 p -105.8 -31.62 8.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.111 -0.7 . . . . 22.600000000000001 109.111 170.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.588 ' O ' ' HA ' ' A' ' 58' ' ' ALA . 84.0 mm-40 -133.17 160.09 38.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.042 -0.981 . . . . 21.93 109.098 175.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.47 111.94 24.24 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.564 -0.532 . . . . 19.73 109.564 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.24 114.43 61.12 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.442 -0.344 . . . . 19.579999999999998 111.647 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -88.67 48.68 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.846 2.364 . . . . 18.5 111.003 172.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.7 p -81.09 -61.52 1.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.579 -0.737 . . . . 17.609999999999999 111.345 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.498 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 35.8 mt-30 -69.26 -53.42 13.43 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 119.501 -0.285 . . . . 18.760000000000002 110.414 174.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 30' ' ' GLN . 94.2 Cg_endo -87.97 103.02 0.48 Allowed 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.995 1.797 . . . . 17.280000000000001 111.401 170.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 66' ' ' GLN . 23.0 Cg_exo -66.16 0.73 2.98 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.17 2.58 . . . . 17.77 113.179 -174.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -138.63 -57.92 0.63 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.657 -0.497 . . . . 18.699999999999999 109.657 176.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.08 161.97 12.44 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.71 -0.757 . . . . 17.719999999999999 111.849 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.28 93.99 3.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.949 0.404 . . . . 18.0 110.75 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.62 -45.5 17.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.262 -0.426 . . . . 17.960000000000001 110.149 177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 74' ' ' GLU . 4.3 tp10 65.59 172.86 0.22 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.338 -0.846 . . . . 19.850000000000001 110.829 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.513 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 2.5 mp0 63.37 35.4 12.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.494 0.664 . . . . 19.670000000000002 109.531 -175.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -93.95 -9.73 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.112 -0.949 . . . . 17.739999999999998 110.848 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -63.05 -30.83 71.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.222 -0.445 . . . . 19.949999999999999 110.974 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 60.93 -84.28 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.548 0.739 . . . . 18.390000000000001 112.012 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -141.09 130.1 4.34 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.25 -0.74 . . . . 17.66 111.25 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -73.16 107.61 5.58 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.513 -0.18 . . . . 17.68 110.513 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 71.79 -54.47 0.68 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.603 0.761 . . . . 17.800000000000001 111.78 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 57.38 56.8 4.81 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.379 0.609 . . . . 17.350000000000001 110.437 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.62 158.79 59.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.385 -0.825 . . . . 16.640000000000001 110.463 -176.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -48.7 -59.11 1.37 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.864 2.376 . . . . 17.23 112.836 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.47 ' C ' HD12 ' A' ' 85' ' ' LEU . 19.1 p -171.31 -86.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 17.34 110.555 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.47 HD12 ' C ' ' A' ' 84' ' ' SER . 7.0 mp -135.66 50.31 2.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 18.41 110.185 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.47 145.91 99.01 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.593 -0.521 . . . . 17.449999999999999 109.593 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 -6.58 18.09 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.633 2.222 . . . . 18.890000000000001 113.603 -173.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 62.45 11.52 4.71 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.855 0.462 . . . . 17.809999999999999 111.544 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.0 p -146.38 -169.25 3.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.111 -0.495 . . . . 18.629999999999999 110.435 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.6 pt -91.29 136.13 25.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.144 0.497 . . . . 19.100000000000001 110.797 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.65 77.83 1.67 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.938 -0.574 . . . . 19.25 109.869 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.87 -28.84 64.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.666 -0.697 . . . . 18.789999999999999 110.739 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 65.1 -81.92 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.487 -0.779 . . . . 18.949999999999999 111.944 175.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.649 ' OD1' ' HA ' ' A' ' 97' ' ' PHE . 62.2 t30 -154.6 24.15 0.46 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.103 0.478 . . . . 20.309999999999999 110.414 -176.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.403 HG23 ' HG3' ' A' ' 96' ' ' GLU . 9.7 t -64.56 -27.77 69.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.032 -0.531 . . . . 21.399999999999999 110.985 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.403 ' HG3' HG23 ' A' ' 95' ' ' THR . 41.2 mt-10 -124.72 21.27 8.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.429 -0.351 . . . . 21.16 110.665 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.649 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 95.4 m-85 65.58 87.1 0.12 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.371 -0.832 . . . . 22.18 111.239 175.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 62.08 101.37 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.252 0 CA-C-N 115.552 -0.749 . . . . 19.449999999999999 111.316 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.0 98.25 0.1 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.535 2.157 . . . . 18.530000000000001 111.466 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 58.91 83.61 0.21 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.773 -0.649 . . . . 17.449999999999999 110.578 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.58 -8.95 17.25 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.76 2.307 . . . . 17.420000000000002 112.833 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -141.46 74.47 23.75 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.498 -0.319 . . . . 17.68 111.084 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.17 120.38 7.26 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.817 2.345 . . . . 16.289999999999999 111.64 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.5 m -100.99 20.52 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.178 0.436 . . . . 17.260000000000002 112.178 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.55 131.19 26.41 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.141 -0.481 . . . . 15.800000000000001 110.082 177.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 72.7 Cg_exo -46.53 117.71 2.18 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.556 2.837 . . . . 15.92 112.477 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 106' ' ' PRO . 52.9 Cg_exo -53.48 -43.71 55.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.807 3.005 . . . . 16.149999999999999 113.246 -176.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -106.55 111.16 64.11 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.407 -0.361 . . . . 17.629999999999999 110.111 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.15 136.12 26.32 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.211 1.941 . . . . 15.039999999999999 111.774 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -94.56 108.07 34.4 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.487 -0.324 . . . . 15.199999999999999 110.143 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.46 138.99 17.98 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.38 2.053 . . . . 14.08 112.189 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.23 52.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.27 1.033 . . . . 15.279999999999999 109.164 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 62.35 88.6 0.12 Allowed Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 114.28 -1.327 . . . . 16.84 111.386 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.61 145.79 46.56 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.988 2.458 . . . . 15.51 111.884 177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.425 ' HG2' ' CD1' ' A' ' 183' ' ' ILE . 85.8 Cg_exo -49.35 150.79 7.5 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.332 2.688 . . . . 16.039999999999999 113.184 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -66.38 115.29 22.43 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.155 -0.93 . . . . 18.91 111.356 -176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -75.41 166.86 27.86 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.714 2.276 . . . . 17.039999999999999 110.908 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -115.86 82.59 1.79 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.503 0.668 . . . . 17.52 110.993 -172.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.8 m -98.0 -27.51 3.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.095 -0.957 . . . . 18.699999999999999 110.543 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.471 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -101.35 12.96 36.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.544 -0.753 . . . . 20.879999999999999 110.18 -177.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.26 133.36 87.51 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.535 -0.757 . . . . 18.890000000000001 110.204 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 50.9 Cg_exo -54.35 134.25 60.16 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.78 2.32 . . . . 20.43 111.698 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 122' ' ' PRO . 15.7 Cg_exo -68.95 55.11 0.92 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.038 2.492 . . . . 21.100000000000001 112.589 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . . . -79.5 -48.8 1.44 Allowed Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.156 -0.475 . . . . 21.149999999999999 111.125 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 124' ' ' ALA . 6.1 Cg_exo -79.22 81.99 2.64 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.224 1.949 . . . . 21.149999999999999 111.486 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' A' ' 128' ' ' GLU . 59.5 tttp -73.99 120.39 81.06 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.013 -0.54 . . . . 21.879999999999999 109.691 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.19 -33.62 81.01 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.17 2.58 . . . . 20.190000000000001 113.008 -174.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.425 ' O ' ' HE3' ' A' ' 126' ' ' LYS . 34.0 tt0 -153.62 118.59 2.78 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 121.174 -0.21 . . . . 20.48 110.881 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 128' ' ' GLU . 2.2 Cg_endo -81.22 146.19 15.63 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.783 2.322 . . . . 21.170000000000002 111.871 174.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt 55.97 77.69 0.41 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.883 -0.599 . . . . 23.18 111.649 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.73 137.71 46.58 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.38 2.053 . . . . 20.780000000000001 111.37 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.468 ' O ' ' HB ' ' A' ' 133' ' ' VAL . 15.7 m -114.36 54.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.041 0.448 . . . . 19.75 110.896 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 132' ' ' VAL . 73.2 t 72.52 111.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.219 -0.9 . . . . 21.050000000000001 110.364 -175.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -80.39 148.92 30.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.347 -0.842 . . . . 21.300000000000001 111.165 -175.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -57.69 -39.39 77.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.179 -0.919 . . . . 20.739999999999998 109.612 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -172.8 -66.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.109 -0.95 . . . . 17.969999999999999 108.509 174.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 142' ' ' LYS . . . -117.11 6.13 12.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.593 -0.73 . . . . 17.350000000000001 109.586 173.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . . . 72.65 143.69 0.1 OUTLIER Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 114.741 -1.118 . . . . 19.100000000000001 111.398 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.458 ' HA ' ' HB1' ' A' ' 192' ' ' ALA . 31.1 Cg_exo -60.18 -18.17 50.18 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.395 2.73 . . . . 19.350000000000001 113.294 -176.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 90.8 m -149.5 122.94 9.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.024 0.44 . . . . 17.75 111.017 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.93 -69.05 0.54 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.585 -0.817 . . . . 17.960000000000001 112.055 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 137' ' ' ALA . 0.0 OUTLIER -101.97 28.27 5.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.793 0.806 . . . . 19.420000000000002 109.98 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 217' ' ' TYR . . . -76.72 164.2 26.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.61 -1.177 . . . . 14.65 108.148 173.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.555 ' CE1' ' HD3' ' A' ' 194' ' ' LYS . 7.3 m-85 -138.23 153.48 49.12 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.695 0.628 . . . . 14.81 112.695 -176.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 190' ' ' PRO . 2.8 m -151.99 151.97 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 114.842 -1.072 . . . . 10.48 109.76 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 80.5 t -110.79 108.02 24.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 120.3 -0.56 . . . . 10.1 111.434 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.515 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 19.0 tt0 -80.26 114.31 19.07 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.085 -0.507 . . . . 12.0 111.148 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 1.037 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -93.75 -33.73 13.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.509 0.671 . . . . 11.880000000000001 109.555 177.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.3 170.72 26.6 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.666 -0.778 . . . . 11.35 112.359 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -170.34 103.22 0.27 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.02 -0.733 . . . . 13.470000000000001 109.02 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.98 153.73 42.55 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.451 0.643 . . . . 13.52 110.435 -174.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 77.4 mttt -89.34 2.96 53.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.046 -0.979 . . . . 17.600000000000001 110.438 -175.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -101.82 109.44 21.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.419 -0.81 . . . . 16.140000000000001 109.597 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.409 ' HA ' ' CG2' ' A' ' 157' ' ' VAL . . . -69.88 -20.32 63.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.924 -0.58 . . . . 14.039999999999999 112.202 -175.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.13 -33.84 76.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 122.1 0.952 . . . . 16.57 109.257 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.482 ' O ' HG13 ' A' ' 160' ' ' ILE . 74.4 mmtt -83.54 -30.07 27.37 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.0 -1.454 . . . . 16.399999999999999 110.154 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.463 HG13 ' CD1' ' A' ' 186' ' ' ILE . 77.9 t -57.63 -40.17 73.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.73 -0.668 . . . . 12.67 110.273 173.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -68.55 -32.62 72.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.264 -0.88 . . . . 15.32 111.969 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.19 -38.09 31.95 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.061 -0.655 . . . . 15.970000000000001 111.2 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 156' ' ' LYS . 29.3 mt -63.28 -41.36 92.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 12.6 109.22 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.79 -35.66 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.01 -0.995 . . . . 12.539999999999999 110.17 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -65.64 -28.54 73.72 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.016 -0.612 . . . . 14.800000000000001 112.374 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -72.3 -61.96 1.61 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 16.050000000000001 110.977 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.719 ' HB3' HG21 ' A' ' 171' ' ' VAL . 1.8 mm? -79.5 -62.72 1.6 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.927 -0.579 . . . . 12.99 112.188 -175.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 165' ' ' ARG . 3.0 tmt_? -61.97 -38.25 87.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.381 -0.6 . . . . 15.06 109.381 -178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.95 85.22 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.258 -0.883 . . . . 16.600000000000001 112.506 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.28 -7.33 59.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.005 0.431 . . . . 16.140000000000001 110.523 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.43 25.1 9.58 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.807 -0.711 . . . . 15.119999999999999 112.624 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -96.31 145.24 25.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.182 -0.674 . . . . 15.49 109.182 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -70.25 107.32 3.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.611 0.72 . . . . 13.869999999999999 110.55 -175.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 188' ' ' VAL . 11.0 t -138.62 135.71 43.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.773 -1.103 . . . . 10.82 110.324 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -137.85 175.39 9.63 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.78 0.8 . . . . 11.130000000000001 110.946 174.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 18.0 p -122.68 -172.68 2.53 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.135 -1.393 . . . . 11.52 110.56 -170.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.6 m -49.61 145.8 7.84 Favored Pre-proline 0 C--O 1.236 0.365 0 O-C-N 123.272 0.357 . . . . 12.75 110.739 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -38.25 -44.94 2.08 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 124.479 3.452 . . . . 14.640000000000001 115.302 -170.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.0 p -87.42 -63.53 1.29 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.735 -0.786 . . . . 16.68 113.089 -173.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.1 m -168.07 142.96 2.96 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 117.688 0.222 . . . . 16.039999999999999 110.86 -175.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.482 ' HG3' ' OG1' ' A' ' 173' ' ' THR . 25.0 Cg_exo -67.38 123.84 11.34 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.13 1.887 . . . . 14.220000000000001 111.066 165.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.427 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.9 p -153.61 156.49 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-O 120.826 0.346 . . . . 16.129999999999999 110.331 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.401 ' NE2' ' H ' ' A' ' 154' ' ' ALA . 6.2 tp-100 -80.31 128.46 33.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.121 -0.491 . . . . 16.699999999999999 110.193 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.17 -26.09 18.11 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.006 -0.616 . . . . 16.98 112.138 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 12.6 mptt -108.08 153.04 23.7 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.618 -0.512 . . . . 18.73 109.618 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.8 tp -69.17 109.58 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.76 0.791 . . . . 14.82 110.874 -176.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.436 ' HB ' HG21 ' A' ' 157' ' ' VAL . 26.8 m -103.57 109.02 20.53 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.956 0.884 . . . . 12.779999999999999 110.429 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 173' ' ' THR . 48.3 ttt180 -86.24 134.52 33.76 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.063 -1.426 . . . . 13.98 109.032 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.502 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.7 mm -109.4 117.19 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 N-CA-C 109.183 -0.673 . . . . 10.56 109.183 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 187' ' ' LEU . 2.1 mp -130.17 132.95 46.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.512 0.672 . . . . 10.1 111.034 -173.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.037 HG23 HD21 ' A' ' 148' ' ' LEU . 52.8 t -101.96 137.31 30.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.908 -1.042 . . . . 9.7400000000000002 110.208 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.97 51.49 5.8 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.344 -0.844 . . . . 9.7599999999999998 114.071 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.698 ' HA ' HG12 ' A' ' 145' ' ' VAL . 18.6 Cg_endo -67.06 125.71 14.02 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 CA-C-N 119.632 1.716 . . . . 11.15 110.813 170.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -157.88 153.63 26.62 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.598 -0.441 . . . . 12.77 110.274 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' A' ' 139' ' ' PRO . . . -98.83 0.54 44.5 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.948 -0.569 . . . . 14.6 111.473 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 68.8 m -118.48 93.66 4.2 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 121.37 0.605 . . . . 14.300000000000001 109.992 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.555 ' HD3' ' CE1' ' A' ' 144' ' ' TYR . 35.1 ttpt -57.12 -36.79 71.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.917 -1.038 . . . . 15.970000000000001 110.769 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.71 -39.29 80.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.976 0.417 . . . . 15.6 111.53 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -77.54 -42.84 33.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.62 0.724 . . . . 14.220000000000001 110.399 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -83.67 -19.19 35.78 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.251 -0.886 . . . . 11.949999999999999 110.977 -173.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -64.85 -40.12 94.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.193 0.52 . . . . 14.699999999999999 110.51 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.47 -13.73 82.92 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 110.328 -1.109 . . . . 13.09 110.328 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.472 ' HB2' ' HA ' ' A' ' 197' ' ' LEU . 58.4 m -83.35 -11.43 57.65 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.587 -0.807 . . . . 12.109999999999999 111.72 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 28.0 mt -66.88 -40.99 87.96 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 120.878 0.37 . . . . 12.720000000000001 110.399 -177.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -62.16 -33.56 86.28 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.346 -0.931 . . . . 14.66 110.912 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.575 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 45.3 mt-10 -76.89 -26.94 54.74 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-O 120.81 0.338 . . . . 13.890000000000001 110.574 175.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.433 HD13 HG21 ' A' ' 146' ' ' VAL . 4.7 tt -67.41 -38.75 85.12 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.056 -0.52 . . . . 12.550000000000001 110.422 -176.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 82.8 mttt -62.19 -21.02 64.77 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.392 -0.822 . . . . 15.83 110.261 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -42.31 11.74 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.676 -0.693 . . . . 16.969999999999999 110.281 173.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 96.8 mt -66.9 -51.91 49.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.033 -0.53 . . . . 13.890000000000001 111.694 -176.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.446 ' HB3' HD11 ' A' ' 164' ' ' LEU . 71.4 p -100.16 -44.38 5.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.214 0.531 . . . . 13.539999999999999 110.821 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.34 12.22 57.86 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.301 -0.863 . . . . 14.67 111.698 -175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 91.6 mt -91.4 157.75 16.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.912 -0.403 . . . . 13.039999999999999 109.912 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 53.9 m -80.6 94.43 6.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.057 0.456 . . . . 14.84 110.777 -178.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -124.23 159.82 18.84 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.617 -0.802 . . . . 12.220000000000001 113.048 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 5.2 p -116.17 143.97 24.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.196 0.522 . . . . 13.74 110.541 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.429 HG21 HD13 ' A' ' 201' ' ' LEU . 39.6 t -80.03 106.79 11.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.218 -0.901 . . . . 12.890000000000001 110.343 -176.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 24.3 mmt -121.04 155.63 33.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.017 -0.538 . . . . 13.800000000000001 110.567 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -82.19 129.62 9.18 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.404 -0.903 . . . . 13.359999999999999 111.992 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.568 ' HB2' HG13 ' A' ' 145' ' ' VAL . 8.6 t80 -88.72 131.76 34.89 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 124.164 0.986 . . . . 14.24 109.975 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 78.6 m -144.91 92.25 5.83 Favored Pre-proline 0 C--N 1.314 -0.963 0 N-CA-C 109.506 -0.553 . . . . 16.510000000000002 109.506 174.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.28 140.92 91.12 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.409 2.072 . . . . 17.420000000000002 112.082 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.305 -0.855 . . . . 19.190000000000001 110.022 -177.888 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.784 0.326 . . . . 18.390000000000001 110.893 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.15 59.53 3.48 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.478 -0.868 . . . . 17.77 112.905 -176.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -66.3 126.48 28.89 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.337 -0.616 . . . . 17.690000000000001 109.337 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -98.97 139.27 34.88 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.824 -0.625 . . . . 19.93 111.196 -171.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -83.1 160.3 21.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.117 -0.492 . . . . 17.43 109.942 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -61.99 -57.65 10.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.029 0.443 . . . . 19.359999999999999 110.136 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -150.4 -67.89 0.19 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.91 -0.774 . . . . 18.960000000000001 108.91 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 47.15 45.81 16.21 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.986 0.804 . . . . 18.239999999999998 111.205 175.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -80.92 98.56 7.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.399 0.618 . . . . 16.780000000000001 110.646 -174.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -117.87 126.44 52.39 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.564 -0.744 . . . . 18.420000000000002 109.918 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -82.57 57.95 3.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.531 0.681 . . . . 17.920000000000002 110.363 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.41 39.27 1.38 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.72 -0.673 . . . . 19.550000000000001 110.028 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.4 167.12 29.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.259 -0.882 . . . . 20.309999999999999 109.214 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.421 ' HB ' ' CD ' ' A' ' 45' ' ' PRO . 17.0 pt 37.52 69.42 1.4 Allowed Pre-proline 0 N--CA 1.475 0.816 0 O-C-N 124.237 0.96 . . . . 19.920000000000002 112.484 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.55 79.19 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.166 2.577 . . . . 21.640000000000001 112.976 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 43' ' ' LEU . 3.1 mm? 60.19 26.54 15.97 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.316 -0.856 . . . . 22.670000000000002 111.624 174.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.615 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 96.9 t -89.83 -55.2 0.29 Allowed Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.949 -0.569 . . . . 21.34 111.38 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.615 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 6.9 Cg_exo -77.13 149.36 28.34 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.98 1.787 . . . . 20.0 111.453 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -75.39 88.47 2.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.291 0.567 . . . . 21.079999999999998 109.643 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -159.7 -33.87 0.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.423 -0.808 . . . . 18.800000000000001 110.677 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.85 -60.43 4.88 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.887 -0.673 . . . . 17.510000000000002 111.662 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -102.02 178.6 4.56 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.072 -0.714 . . . . 16.949999999999999 109.072 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -80.54 171.68 14.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.18 0.514 . . . . 18.300000000000001 110.247 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -74.76 164.21 26.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.856 -0.611 . . . . 18.170000000000002 109.882 174.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 52' ' ' GLU . 1.6 pm0 -71.86 149.27 92.63 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.276 -0.42 . . . . 18.82 111.258 -173.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HA ' ' OE1' ' A' ' 66' ' ' GLN . 57.4 Cg_endo -70.69 71.16 2.01 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.978 2.452 . . . . 19.870000000000001 113.1 -177.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.43 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 28.8 m-20 -132.24 165.98 22.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.349 -0.612 . . . . 21.100000000000001 109.349 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.46 ' HG3' ' HG2' ' A' ' 56' ' ' MET . 15.6 tpt -65.17 109.01 2.05 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.37 0.419 . . . . 22.300000000000001 110.81 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.46 ' HG2' ' HG3' ' A' ' 55' ' ' MET . 25.5 ptt? 40.81 73.65 0.84 Allowed Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 124.3 1.04 . . . . 23.850000000000001 112.497 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HG3' ' O ' ' A' ' 52' ' ' GLU . 86.9 Cg_endo -90.47 10.35 2.96 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.728 2.285 . . . . 20.670000000000002 112.337 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -150.53 149.76 30.36 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.979 -0.555 . . . . 20.489999999999998 110.305 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.11 -41.57 7.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.113 -0.494 . . . . 21.469999999999999 111.087 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.4 m -81.2 -48.06 12.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.313 -0.403 . . . . 22.600000000000001 110.522 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -100.27 -159.8 0.76 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.143 -0.481 . . . . 21.93 109.79 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.35 33.52 6.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.353 0.597 . . . . 19.73 110.311 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 2.6 tm? -72.35 -46.05 10.47 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.472 -0.785 . . . . 19.579999999999998 110.615 176.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 63' ' ' LEU . 73.6 Cg_exo -52.69 119.5 6.07 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 121.933 1.755 . . . . 18.5 111.85 174.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 p -76.32 110.7 11.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.909 -0.587 . . . . 17.609999999999999 112.045 -174.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.526 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 23.3 mt-30 -66.96 -46.98 54.24 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.341 -0.845 . . . . 18.760000000000002 110.985 173.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 66' ' ' GLN . 51.5 Cg_endo -70.02 123.37 9.96 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.128 1.886 . . . . 17.280000000000001 112.3 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 67' ' ' PRO . 14.7 Cg_exo -70.92 -159.04 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.192 2.594 . . . . 17.77 112.504 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 73.31 -58.23 0.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.713 0.805 . . . . 18.699999999999999 112.296 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.3 -54.98 8.16 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.823 -0.703 . . . . 17.719999999999999 111.676 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -162.95 153.38 16.43 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.041 -0.355 . . . . 18.0 110.041 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -156.12 32.19 0.34 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.917 0.389 . . . . 17.960000000000001 110.952 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -124.13 -162.75 1.09 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.043 -0.526 . . . . 19.850000000000001 109.971 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 62.67 44.52 6.6 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.974 0.892 . . . . 19.670000000000002 109.357 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.46 140.47 8.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.996 -1.002 . . . . 17.739999999999998 109.437 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 73.57 -60.9 0.52 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.37 0.668 . . . . 19.949999999999999 111.05 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.16 34.41 4.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.054 0.454 . . . . 18.390000000000001 111.092 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.94 110.27 0.45 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.704 -0.76 . . . . 17.66 112.225 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 80' ' ' ALA . 10.3 t70 56.26 -151.36 0.41 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.702 0.401 . . . . 17.68 110.284 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.461 ' H ' ' CG ' ' A' ' 79' ' ' ASP . . . 58.78 29.27 18.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.083 0.468 . . . . 17.800000000000001 111.772 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.29 63.29 6.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.222 0.535 . . . . 17.350000000000001 110.882 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.17 98.24 25.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.702 -0.681 . . . . 16.640000000000001 110.018 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.5 129.51 26.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.969 2.446 . . . . 17.23 112.804 -177.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.3 m -84.82 -24.34 28.7 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.411 -0.813 . . . . 17.34 110.005 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.6 mt -78.7 -6.96 57.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.512 -0.767 . . . . 18.41 110.627 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.64 115.25 15.57 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 17.449999999999999 110.508 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.15 -6.7 18.28 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.019 2.48 . . . . 18.890000000000001 112.894 -175.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.439 ' HB1' HG23 ' A' ' 90' ' ' ILE . . . -86.92 -61.57 1.7 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.327 -0.397 . . . . 17.809999999999999 110.265 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.8 m 54.26 65.05 1.62 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.611 0.72 . . . . 18.629999999999999 109.542 -177.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.439 HG23 ' HB1' ' A' ' 88' ' ' ALA . 14.9 pt -103.09 61.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.332 -0.849 . . . . 19.100000000000001 112.232 -170.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.49 -23.29 40.24 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.193 -0.458 . . . . 19.25 110.2 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.08 124.22 23.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.651 -0.704 . . . . 18.789999999999999 110.788 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.603 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 48.4 m-80 -93.81 109.25 20.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.179 -0.464 . . . . 18.949999999999999 110.545 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -96.47 -178.75 4.38 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.976 -0.379 . . . . 20.309999999999999 109.976 177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.0 p 60.01 -43.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.898 1.279 . . . . 21.399999999999999 112.968 -174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -90.93 -25.7 19.65 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.188 -0.32 . . . . 21.16 111.282 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.603 ' HB3' ' O ' ' A' ' 93' ' ' ASN . 74.5 t80 -128.85 -0.31 5.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.692 0.758 . . . . 22.18 110.949 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -76.53 -45.26 3.33 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.472 -0.785 . . . . 19.449999999999999 112.364 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.74 71.35 4.06 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.148 1.899 . . . . 18.530000000000001 112.865 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -111.16 91.15 12.73 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.24 -0.437 . . . . 17.449999999999999 109.897 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.71 -21.59 9.73 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.547 2.165 . . . . 17.420000000000002 112.696 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 49.51 78.86 0.38 Allowed Pre-proline 0 N--CA 1.465 0.321 0 O-C-N 123.403 0.439 . . . . 17.68 111.454 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.27 113.39 1.74 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 123.088 2.525 . . . . 16.289999999999999 112.617 -177.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.6 t -82.25 104.99 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.876 -0.602 . . . . 17.260000000000002 110.7 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -106.97 113.3 62.73 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.352 -0.385 . . . . 15.800000000000001 110.953 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.18 154.73 46.92 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.751 2.301 . . . . 15.92 112.237 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.84 55.25 4.32 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.067 2.511 . . . . 16.149999999999999 112.753 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -167.63 121.01 0.77 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.561 . . . . 17.629999999999999 109.854 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.79 -39.06 0.54 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.439 2.093 . . . . 15.039999999999999 112.644 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.645 ' H ' ' HD2' ' A' ' 111' ' ' PRO . 62.1 mtpt -144.33 -58.87 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.256 -0.429 . . . . 15.199999999999999 111.655 -177.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.645 ' HD2' ' H ' ' A' ' 110' ' ' LYS . 28.6 Cg_endo -62.63 119.25 6.26 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.842 1.695 . . . . 14.08 113.093 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.6 t -92.71 57.35 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.154 -0.684 . . . . 15.279999999999999 109.154 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 57.39 86.63 0.16 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.769 -1.105 . . . . 16.84 110.815 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.07 -48.46 20.93 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.415 2.743 . . . . 15.51 114.803 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.6 97.59 0.63 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 121.601 1.534 . . . . 16.039999999999999 112.755 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.573 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 32.1 mmmt -65.3 -51.08 55.74 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.171 -0.468 . . . . 18.91 111.086 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 116' ' ' LYS . 4.5 Cg_exo -77.94 -46.22 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.852 1.701 . . . . 17.039999999999999 111.16 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt 54.46 66.92 1.1 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.7 -0.682 . . . . 17.52 110.89 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.4 p -150.48 146.79 16.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.746 -0.661 . . . . 18.699999999999999 110.108 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 40.89 50.2 3.04 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.239 0.962 . . . . 20.879999999999999 112.231 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.88 135.57 96.36 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.814 -0.63 . . . . 18.890000000000001 110.386 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.27 115.14 2.32 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.866 2.377 . . . . 20.43 112.184 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.95 44.57 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.841 2.361 . . . . 21.100000000000001 112.111 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.14 142.87 64.46 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.165 -0.47 . . . . 21.149999999999999 110.474 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.31 60.26 3.99 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.806 2.337 . . . . 21.149999999999999 111.88 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -107.27 131.11 21.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.54 -0.754 . . . . 21.879999999999999 110.45 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.53 83.78 1.27 Allowed 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.843 2.362 . . . . 20.190000000000001 112.05 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -58.97 131.37 86.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 20.48 111.193 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.27 61.96 6.75 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.952 2.435 . . . . 21.170000000000002 112.369 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -138.66 143.43 37.9 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.73 -0.668 . . . . 23.18 109.77 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.82 96.43 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.539 2.159 . . . . 20.780000000000001 111.586 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.9 m -82.64 52.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.623 0.725 . . . . 19.75 110.845 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.4 m -83.84 0.79 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.392 -0.822 . . . . 21.050000000000001 111.02 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.77 17.23 11.9 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.8 -1.091 . . . . 21.300000000000001 108.891 174.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 65.73 -92.26 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.74 -1.118 . . . . 20.739999999999998 110.811 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 tttm 178.34 -45.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.024 -1.102 . . . . 17.969999999999999 108.024 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -87.3 -76.4 0.37 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.34 -0.846 . . . . 17.350000000000001 109.085 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.441 ' O ' ' HB1' ' A' ' 192' ' ' ALA . . . -177.17 149.45 0.8 Allowed Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.148 -0.933 . . . . 19.100000000000001 109.821 173.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.31 -42.59 27.49 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.918 2.412 . . . . 19.350000000000001 113.02 -174.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 39.0 p -130.63 23.57 5.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.956 -0.566 . . . . 17.75 110.469 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -125.02 121.79 4.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.969 -0.634 . . . . 17.960000000000001 111.86 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.5 mttm 58.15 32.46 22.05 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 122.842 0.457 . . . . 19.420000000000002 110.671 -176.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.517 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -70.77 162.59 28.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.338 -0.986 . . . . 14.65 108.338 174.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.695 ' CB ' HD21 ' A' ' 197' ' ' LEU . 3.3 m-85 -143.85 152.7 41.51 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.824 -0.351 . . . . 14.81 111.695 -175.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.909 HG12 ' HA ' ' A' ' 190' ' ' PRO . 12.5 m -149.2 156.23 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.273 0.629 . . . . 10.48 109.846 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.411 HG21 HD13 ' A' ' 204' ' ' LEU . 60.9 t -109.7 109.55 28.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 O-C-N 121.84 -0.537 . . . . 10.1 111.111 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -86.71 109.55 19.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.566 -0.288 . . . . 12.0 111.478 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 1.04 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -88.97 -34.86 16.72 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.141 0.496 . . . . 11.880000000000001 109.965 -177.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -145.02 161.56 28.12 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.499 -0.773 . . . . 11.35 112.457 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -161.44 101.49 1.2 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.316 -0.624 . . . . 13.470000000000001 109.316 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.75 164.18 28.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.808 -0.633 . . . . 13.52 110.332 -173.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 49.5 mtpt -105.71 0.55 26.36 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.032 -0.985 . . . . 17.600000000000001 109.782 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -97.79 108.33 21.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.231 -0.895 . . . . 16.140000000000001 109.373 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.53 -21.44 66.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.995 0.426 . . . . 14.039999999999999 110.876 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -56.88 -36.79 70.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.653 0.739 . . . . 16.57 110.036 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.524 ' N ' ' HD2' ' A' ' 156' ' ' LYS . 2.0 mptp? -83.87 -27.22 28.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.784 -1.098 . . . . 16.399999999999999 110.354 -178.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.65 -37.66 76.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.354 0.597 . . . . 12.67 109.801 174.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -68.99 -34.12 74.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.335 -0.848 . . . . 15.32 111.512 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.616 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.7 pt-20 -82.91 -21.35 34.23 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.964 -0.294 . . . . 15.970000000000001 111.589 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 156' ' ' LYS . 48.3 mt -85.06 -50.66 14.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.322 0.582 . . . . 12.6 110.046 174.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 74.3 t -69.1 -41.74 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.71 -0.677 . . . . 12.539999999999999 111.162 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.26 -25.27 62.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.868 -0.682 . . . . 14.800000000000001 112.462 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.616 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 13.5 mptt -78.09 -61.05 2.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.645 0.259 . . . . 16.050000000000001 110.595 176.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.68 ' HB3' HG21 ' A' ' 171' ' ' VAL . 2.4 mm? -78.18 -48.47 15.8 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.603 0.594 . . . . 12.99 112.603 -173.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.42 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 41.8 ttt180 -77.87 -26.01 49.0 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.911 -0.774 . . . . 15.06 108.911 -177.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -68.15 -25.54 74.46 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.033 -0.985 . . . . 16.600000000000001 111.657 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.84 3.96 54.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.054 0.454 . . . . 16.140000000000001 110.65 176.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.87 22.11 47.36 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.901 -0.666 . . . . 15.119999999999999 113.701 174.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -89.11 156.85 18.56 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 117.493 0.647 . . . . 15.49 110.027 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.407 ' HB3' ' HD2' ' A' ' 190' ' ' PRO . 24.1 mmt180 -67.69 96.83 0.58 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.751 -0.463 . . . . 13.869999999999999 109.751 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.792 HG22 HG22 ' A' ' 188' ' ' VAL . 3.6 t -139.09 125.97 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 CA-C-N 115.546 -0.752 . . . . 10.82 110.2 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.489 ' CE1' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -138.63 175.68 9.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.608 -0.723 . . . . 11.130000000000001 110.462 173.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.3 p -115.68 -176.36 2.91 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.758 -1.11 . . . . 11.52 111.733 -168.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.626 ' HB2' ' H ' ' A' ' 185' ' ' ARG . 22.9 t -53.03 134.74 48.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.957 -0.565 . . . . 12.75 110.384 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -31.06 -55.31 0.23 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 125.198 3.932 . . . . 14.640000000000001 115.542 -176.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.4 t -81.11 -64.39 1.2 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 119.75 -0.78 . . . . 16.68 112.574 -169.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 55.7 m -169.09 130.41 1.06 Allowed Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 118.028 0.376 . . . . 16.039999999999999 111.791 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.558 ' HB3' HG21 ' A' ' 184' ' ' THR . 52.3 Cg_exo -65.26 122.62 10.39 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.347 2.032 . . . . 14.220000000000001 112.125 162.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.408 ' CG1' ' HD3' ' A' ' 182' ' ' LYS . 9.8 p -154.91 156.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.303 -0.628 . . . . 16.129999999999999 109.303 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -77.65 127.75 32.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.07 0.462 . . . . 16.699999999999999 110.691 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 109.02 -26.47 15.3 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.51 -0.768 . . . . 16.98 111.819 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.6 OUTLIER -108.62 167.41 10.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.24 -0.652 . . . . 18.73 109.24 176.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.2 tp -81.51 118.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.553 0.692 . . . . 14.82 111.073 -175.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 178' ' ' PRO . 28.8 m -111.76 105.19 13.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.729 -0.669 . . . . 12.779999999999999 109.896 174.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.626 ' H ' ' HB2' ' A' ' 174' ' ' SER . 81.0 mtt-85 -84.61 144.44 28.61 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.332 -0.849 . . . . 13.98 110.156 176.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.57 ' C ' HD23 ' A' ' 187' ' ' LEU . 3.0 mm -115.74 117.83 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 108.698 -0.852 . . . . 10.56 108.698 177.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.57 HD23 ' C ' ' A' ' 186' ' ' ILE . 0.1 OUTLIER -129.94 128.16 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.748 0.785 . . . . 10.1 112.131 -175.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.04 HG23 HD21 ' A' ' 148' ' ' LEU . 55.1 t -95.45 146.37 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 114.205 -1.361 . . . . 9.7400000000000002 110.278 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 190' ' ' PRO . . . 72.97 46.61 28.05 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.333 -0.849 . . . . 9.7599999999999998 114.203 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.909 ' HA ' HG12 ' A' ' 145' ' ' VAL . 11.3 Cg_endo -61.72 125.53 16.89 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 119.83 1.815 . . . . 11.15 110.52 170.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -159.48 154.71 25.26 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.927 -0.578 . . . . 12.77 109.877 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 138' ' ' ALA . . . -100.49 2.39 42.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.062 -0.517 . . . . 14.6 111.725 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.11 98.3 6.1 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.563 0.697 . . . . 14.300000000000001 110.759 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.487 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 18.4 ptmt -58.88 -39.6 81.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.551 -1.204 . . . . 15.970000000000001 112.557 -176.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -67.41 -42.85 82.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.227 0.537 . . . . 15.6 110.393 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -62.9 -41.28 99.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.116 -0.947 . . . . 14.220000000000001 110.599 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.695 HD21 ' CB ' ' A' ' 144' ' ' TYR . 0.3 OUTLIER -85.78 -16.79 37.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.865 -0.607 . . . . 11.949999999999999 111.085 -177.293 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 4.8 tppp? -64.04 -32.07 73.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.491 0.663 . . . . 14.699999999999999 110.023 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -83.88 -13.2 75.56 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.648 -0.981 . . . . 13.09 110.648 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 46.0 m -79.77 -9.17 59.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.008 -0.596 . . . . 12.109999999999999 111.523 -177.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 9.8 mt -74.27 -37.25 63.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.939 0.399 . . . . 12.720000000000001 110.485 -176.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -63.41 -34.84 91.03 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.001 -0.618 . . . . 14.66 112.123 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.63 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 11.6 pt-20 -86.1 -19.84 29.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.797 0.332 . . . . 13.890000000000001 110.65 176.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 146' ' ' VAL . 5.3 tt -65.25 -42.98 92.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 12.550000000000001 111.209 -175.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.442 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 58.8 pttt -61.72 -17.63 56.55 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.058 -0.519 . . . . 15.83 111.414 176.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.23 -36.83 15.4 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.901 0.381 . . . . 16.969999999999999 109.993 172.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 83.6 mt -68.84 -52.16 32.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.946 -0.57 . . . . 13.890000000000001 110.6 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.636 ' HA ' HD11 ' A' ' 164' ' ' LEU . 3.8 m -101.92 -43.38 5.82 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.654 -0.703 . . . . 13.539999999999999 111.298 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 75.13 -2.45 51.41 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.554 -0.748 . . . . 14.67 111.816 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 40.7 mt -80.02 149.49 30.72 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.084 -0.71 . . . . 13.039999999999999 109.084 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.2 t -89.7 104.86 17.39 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.73 -0.47 . . . . 14.84 109.73 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.563 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -125.53 157.08 19.53 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.416 -0.897 . . . . 12.220000000000001 113.492 -174.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.96 143.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.109 0.48 . . . . 13.74 110.276 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 43.5 t -77.83 106.14 7.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.303 -0.862 . . . . 12.890000000000001 109.955 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 22.7 mmt -115.73 146.78 41.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.765 -0.652 . . . . 13.800000000000001 110.209 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -74.13 134.34 18.18 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.445 -0.883 . . . . 13.359999999999999 111.621 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.545 ' HB2' HG13 ' A' ' 145' ' ' VAL . 7.9 t80 -100.87 124.32 46.37 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.536 0.684 . . . . 14.24 110.26 -175.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 55.6 m -144.57 93.7 5.71 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 108.873 -0.788 . . . . 16.510000000000002 108.873 174.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.4 120.55 8.55 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.743 2.296 . . . . 17.420000000000002 112.496 -175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.1 p30 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.381 -0.819 . . . . 19.190000000000001 109.926 -178.042 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 t70 . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.683 0.278 . . . . 18.390000000000001 110.555 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.0 -36.12 4.32 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.843 -0.694 . . . . 17.77 112.158 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.535 ' HA ' ' CD1' ' A' ' 34' ' ' TYR . 13.9 pt20 39.86 71.11 0.19 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.074 0.95 . . . . 17.690000000000001 112.384 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -123.75 -96.88 0.45 Allowed 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.064 -0.398 . . . . 19.93 111.857 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.573 ' HA ' ' OE1' ' A' ' 35' ' ' GLN . 24.9 ttmm -73.74 -23.68 59.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.194 0.442 . . . . 17.43 112.194 -169.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -82.79 -1.39 51.57 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 121.05 -0.26 . . . . 19.359999999999999 111.275 -177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.535 ' CD1' ' HA ' ' A' ' 30' ' ' GLN . 70.5 m-85 -135.06 -40.1 0.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.935 0.346 . . . . 18.960000000000001 111.935 -173.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.573 ' OE1' ' HA ' ' A' ' 32' ' ' LYS . 10.3 mm100 55.1 56.73 6.22 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.235 0.541 . . . . 18.239999999999998 110.098 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -92.1 -44.27 8.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.744 . . . . 16.780000000000001 112.556 -173.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -87.31 -72.5 0.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.054 -0.258 . . . . 18.420000000000002 111.383 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -165.17 118.99 1.24 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.099 0.476 . . . . 17.920000000000002 110.386 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.47 161.86 21.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.842 -0.617 . . . . 19.550000000000001 110.783 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 62.93 25.91 15.28 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.795 0.685 . . . . 20.309999999999999 111.927 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.523 HG12 ' HB ' ' A' ' 44' ' ' VAL . 20.2 tt -164.59 65.17 1.2 Allowed Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 122.178 0.99 . . . . 19.920000000000002 109.679 177.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.602 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 24.4 Cg_exo -60.92 102.61 0.21 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.62 2.88 . . . . 21.640000000000001 113.053 -169.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 42' ' ' PRO . 0.6 OUTLIER 55.66 19.32 3.27 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.234 0.959 . . . . 22.670000000000002 111.771 174.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.523 ' HB ' HG12 ' A' ' 41' ' ' ILE . 93.5 t -83.55 -37.58 0.69 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 112.944 0.72 . . . . 21.34 112.944 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' HD3' HG12 ' A' ' 41' ' ' ILE . 5.2 Cg_exo -69.45 -28.18 27.04 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 121.224 1.283 . . . . 20.0 111.65 -174.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.09 -68.79 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.79 -0.641 . . . . 21.079999999999998 109.796 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.91 -26.76 0.54 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.223 -0.444 . . . . 18.800000000000001 111.182 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.75 -40.57 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.014 -0.834 . . . . 17.510000000000002 111.014 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -79.9 159.45 26.38 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.614 -0.513 . . . . 16.949999999999999 109.614 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -103.36 -51.02 3.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.366 0.603 . . . . 18.300000000000001 109.658 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -77.01 135.68 38.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.945 -1.025 . . . . 18.170000000000002 110.724 -172.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -85.51 115.45 61.51 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.363 -0.38 . . . . 18.82 110.369 176.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -89.0 88.46 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.095 2.53 . . . . 19.870000000000001 112.435 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -155.94 130.98 9.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 21.100000000000001 111.22 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.44 ' HG2' ' HG3' ' A' ' 56' ' ' MET . 20.5 ttt 70.49 -71.47 0.13 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.764 0.665 . . . . 22.300000000000001 111.793 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.685 ' H ' ' HD2' ' A' ' 57' ' ' PRO . 92.2 mtp -137.13 -53.91 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.172 -0.467 . . . . 23.850000000000001 110.569 -177.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.685 ' HD2' ' H ' ' A' ' 56' ' ' MET . 6.8 Cg_endo -48.99 123.93 10.64 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.295 1.997 . . . . 20.670000000000002 112.424 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 54.0 30.78 12.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.579 -0.737 . . . . 20.489999999999998 112.532 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.56 -62.47 1.49 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.892 0.377 . . . . 21.469999999999999 110.801 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.0 t -149.42 126.33 11.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.284 -0.416 . . . . 22.600000000000001 110.6 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 60.47 34.46 20.48 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.567 0.699 . . . . 21.93 110.554 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.24 -61.15 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.891 -0.595 . . . . 19.73 110.0 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.78 115.53 65.59 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.663 -0.866 . . . . 19.579999999999998 108.663 175.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -58.55 -37.02 96.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.758 2.305 . . . . 18.5 112.066 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.9 p 44.23 48.21 7.79 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.654 0.597 . . . . 17.609999999999999 112.239 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 26.2 mt-30 -80.55 133.78 55.53 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.077 -0.511 . . . . 18.760000000000002 110.064 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 66' ' ' GLN . 44.7 Cg_exo -54.72 114.25 1.76 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.832 2.354 . . . . 17.280000000000001 112.071 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.24 -4.92 15.69 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.79 2.327 . . . . 17.77 111.866 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -99.83 158.71 15.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.714 -0.676 . . . . 18.699999999999999 109.509 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.58 74.97 2.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.94 -0.647 . . . . 17.719999999999999 111.71 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.65 -51.83 6.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.121 0.486 . . . . 18.0 110.202 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.19 121.11 24.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.67 -0.695 . . . . 17.960000000000001 110.496 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.99 164.02 18.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.89 -0.595 . . . . 19.850000000000001 109.476 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -72.14 90.35 1.2 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.078 0.466 . . . . 19.670000000000002 111.183 -175.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.26 124.82 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.69 -0.686 . . . . 17.739999999999998 110.027 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.618 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -88.76 60.36 5.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.323 0.582 . . . . 19.949999999999999 109.813 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -97.97 28.44 3.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 18.390000000000001 111.043 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.52 100.15 0.46 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.182 -0.532 . . . . 17.66 111.876 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 59.12 42.75 18.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.541 0.686 . . . . 17.68 110.724 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.91 -8.62 57.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.326 -0.852 . . . . 17.800000000000001 110.58 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.64 -13.92 62.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.822 -0.626 . . . . 17.350000000000001 110.598 176.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 63.64 88.57 0.12 Allowed Pre-proline 0 N--CA 1.462 0.153 0 CA-C-N 115.382 -0.826 . . . . 16.640000000000001 111.621 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.23 160.61 46.74 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.444 2.096 . . . . 17.23 111.744 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.9 p -81.59 3.73 24.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.326 0.584 . . . . 17.34 110.413 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.12 -164.13 1.13 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.688 -0.687 . . . . 18.41 109.159 177.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.76 116.6 30.66 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.875 0.369 . . . . 17.449999999999999 110.781 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.58 -31.32 8.89 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.832 2.354 . . . . 18.890000000000001 113.076 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.64 115.03 2.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.171 -0.307 . . . . 17.809999999999999 110.171 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -74.52 89.26 2.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.28 0.562 . . . . 18.629999999999999 110.703 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.6 pt -111.15 128.59 67.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.609 -0.723 . . . . 19.100000000000001 110.647 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.74 140.85 30.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.188 -0.46 . . . . 19.25 110.565 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.12 55.71 2.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.137 0.494 . . . . 18.789999999999999 110.607 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 97' ' ' PHE . 28.7 p30 -70.97 -19.79 62.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.831 -0.622 . . . . 18.949999999999999 110.806 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -124.1 164.08 20.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.006 -0.543 . . . . 20.309999999999999 109.682 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.6 m 71.4 -52.53 0.69 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 124.009 0.818 . . . . 21.399999999999999 109.884 -173.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -77.37 -40.68 42.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 21.16 110.439 175.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 93' ' ' ASN . 38.6 t80 -111.98 -79.1 0.58 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.453 -0.499 . . . . 22.18 110.443 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.416 ' O ' ' HD2' ' A' ' 101' ' ' PRO . 52.2 mt-10 -69.48 110.18 5.89 Favored Pre-proline 0 C--N 1.309 -1.195 0 CA-C-N 115.188 -0.914 . . . . 19.449999999999999 110.238 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.04 -15.98 16.11 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.636 2.224 . . . . 18.530000000000001 113.512 -175.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.58 ' HB3' ' HD3' ' A' ' 101' ' ' PRO . 6.9 tp10 -56.1 -53.47 63.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 111.653 0.242 . . . . 17.449999999999999 111.653 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 6.3 Cg_endo -91.55 31.5 0.32 Allowed 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.619 2.212 . . . . 17.420000000000002 112.451 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.485 ' HB3' ' HD3' ' A' ' 103' ' ' PRO . . . -69.71 -45.1 24.79 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.595 -0.275 . . . . 17.68 111.305 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 102' ' ' ALA . 23.6 Cg_exo -66.59 159.83 48.94 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.8 1.667 . . . . 16.289999999999999 111.262 173.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.85 20.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.458 0.647 . . . . 17.260000000000002 111.623 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.91 81.53 5.2 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.134 -0.939 . . . . 15.800000000000001 109.429 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.14 125.1 16.19 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.71 2.273 . . . . 15.92 112.249 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.93 96.88 0.62 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.478 2.118 . . . . 16.149999999999999 110.925 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -64.83 131.86 95.29 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.587 -0.733 . . . . 17.629999999999999 111.401 -174.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.47 3.31 6.91 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.929 2.419 . . . . 15.039999999999999 111.942 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -114.59 79.09 5.33 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.842 -0.617 . . . . 15.199999999999999 109.992 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -83.69 136.5 7.34 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.426 2.084 . . . . 14.08 112.304 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 t -93.99 44.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 122.352 1.072 . . . . 15.279999999999999 109.467 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -155.92 122.38 2.63 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 114.216 -1.356 . . . . 16.84 110.5 -174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.32 134.98 13.1 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.37 2.047 . . . . 15.51 112.136 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.52 42.39 1.14 Allowed 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 122.796 2.331 . . . . 16.039999999999999 111.747 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.464 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 56.9 tttp -82.55 -48.68 0.84 Allowed Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.363 -0.835 . . . . 18.91 111.389 -177.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 116' ' ' LYS . 91.6 Cg_endo -84.97 6.14 5.88 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.002 1.801 . . . . 17.039999999999999 111.569 176.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -72.15 149.3 44.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.982 -1.008 . . . . 17.52 110.52 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 20.1 m -76.83 50.9 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.16 0.505 . . . . 18.699999999999999 112.268 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -89.83 68.82 7.51 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.689 -0.486 . . . . 20.879999999999999 109.689 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.98 122.41 41.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.361 -0.836 . . . . 18.890000000000001 111.865 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.31 145.93 61.33 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.69 2.26 . . . . 20.43 111.534 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.82 101.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.864 2.376 . . . . 21.100000000000001 111.978 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.482 ' N ' ' HD2' ' A' ' 125' ' ' PRO . . . -69.48 -49.05 23.62 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.839 -0.619 . . . . 21.149999999999999 112.246 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 124' ' ' ALA . 40.3 Cg_endo -67.65 85.16 0.38 Allowed 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.062 1.841 . . . . 21.149999999999999 112.528 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 127' ' ' PRO . 68.2 mttm -68.36 -50.52 27.89 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.941 -0.572 . . . . 21.879999999999999 111.551 178.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 126' ' ' LYS . 61.2 Cg_endo -72.38 81.13 1.54 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.117 1.878 . . . . 20.190000000000001 112.102 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' A' ' 130' ' ' LYS . 10.1 pt-20 -95.35 153.08 39.69 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 20.48 110.968 -177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.74 27.02 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.106 2.538 . . . . 21.170000000000002 113.149 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 128' ' ' GLU . 31.2 mmmt -139.29 71.86 39.01 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.888 -0.597 . . . . 23.18 109.616 176.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.93 131.95 35.01 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.544 2.163 . . . . 20.780000000000001 111.874 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 132' ' ' VAL . 7.1 p -92.28 69.93 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 122.172 0.987 . . . . 19.75 110.117 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.74 147.03 8.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.37 -0.832 . . . . 21.050000000000001 109.949 176.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 40.85 63.09 1.24 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.611 0.764 . . . . 21.300000000000001 111.193 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -55.42 -62.0 1.96 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.861 -1.063 . . . . 20.739999999999998 111.691 -173.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? 80.87 -14.87 0.79 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.099 0.874 . . . . 17.969999999999999 109.645 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . -132.86 23.21 4.24 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.961 -1.018 . . . . 17.350000000000001 109.004 175.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.409 ' HB1' ' HD2' ' A' ' 139' ' ' PRO . . . 68.85 158.16 0.15 Allowed Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 114.719 -1.128 . . . . 19.100000000000001 111.17 -177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' A' ' 138' ' ' ALA . 60.8 Cg_exo -43.0 -43.02 9.49 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.643 2.895 . . . . 19.350000000000001 114.174 -174.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.3 t -166.57 23.12 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.269 0.557 . . . . 17.75 110.878 175.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -83.69 -49.21 4.94 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.882 -0.675 . . . . 17.960000000000001 112.268 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.502 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 90.8 mttt -104.34 47.22 0.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.333 0.587 . . . . 19.420000000000002 110.06 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 192' ' ' ALA . . . -76.12 165.59 24.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.176 -0.92 . . . . 14.65 110.386 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.698 ' CD1' ' HG3' ' A' ' 194' ' ' LYS . 7.1 m-85 -144.17 156.99 44.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.802 0.297 . . . . 14.81 111.802 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.698 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.2 t -151.07 161.03 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.303 -0.999 . . . . 10.48 108.303 170.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.45 HG12 ' HA3' ' A' ' 212' ' ' GLY . 96.1 t -106.76 110.17 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.909 -0.494 . . . . 10.1 111.574 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.577 ' O ' ' HA2' ' A' ' 212' ' ' GLY . 26.5 tt0 -81.14 115.5 20.59 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.785 -0.189 . . . . 12.0 111.39 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 1.035 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -94.76 -33.4 12.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.385 0.612 . . . . 11.880000000000001 110.298 -179.148 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -146.24 163.73 28.38 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.535 -0.84 . . . . 11.35 112.468 -175.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.53 ' HB1' HD11 ' A' ' 183' ' ' ILE . . . -161.6 100.02 1.15 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.356 -0.609 . . . . 13.470000000000001 109.356 176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -127.61 163.24 24.65 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.263 0.554 . . . . 13.52 109.796 -174.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 22.0 mtpp -102.61 -9.42 20.13 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.943 -1.026 . . . . 17.600000000000001 109.37 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -94.63 111.54 23.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.909 -1.042 . . . . 16.140000000000001 109.301 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.75 -18.34 62.45 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.148 0.425 . . . . 14.039999999999999 112.148 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.4 -34.83 77.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.905 0.859 . . . . 16.57 109.978 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -83.55 -17.75 40.74 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.623 -1.171 . . . . 16.399999999999999 110.124 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.707 ' HA ' HD11 ' A' ' 186' ' ' ILE . 67.4 t -76.18 -33.84 24.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.701 -0.682 . . . . 12.67 109.244 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.89 -37.6 81.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.415 -0.812 . . . . 15.32 111.054 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.688 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 12.8 pt-20 -75.41 -26.67 58.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.729 0.3 . . . . 15.970000000000001 111.49 -175.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.797 HD12 HD12 ' A' ' 186' ' ' ILE . 69.1 mt -85.09 -49.07 16.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.149 0.499 . . . . 12.6 110.317 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.45 -46.58 69.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.83 -0.623 . . . . 12.539999999999999 111.156 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.53 62.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.958 -0.639 . . . . 14.800000000000001 112.568 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.688 ' HD3' ' O ' ' A' ' 159' ' ' GLU . 2.1 mptm? -85.93 -57.08 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.683 0.278 . . . . 16.050000000000001 110.896 177.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.534 ' HB3' HG21 ' A' ' 171' ' ' VAL . 2.5 mm? -79.63 -56.84 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.167 0.432 . . . . 12.99 112.167 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.531 ' HB2' ' HB ' ' A' ' 171' ' ' VAL . 68.3 ttt180 -64.6 -39.6 94.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 15.06 109.983 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.25 -25.74 71.28 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.254 -0.885 . . . . 16.600000000000001 112.698 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.46 -7.3 58.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.929 0.395 . . . . 16.140000000000001 110.517 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.3 2.42 29.57 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.782 -0.723 . . . . 15.119999999999999 113.284 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -79.52 151.9 30.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.039 0.419 . . . . 15.49 110.479 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -70.23 99.06 1.46 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.868 -0.605 . . . . 13.869999999999999 110.316 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.701 HG22 HG22 ' A' ' 188' ' ' VAL . 13.7 t -132.06 132.61 61.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.106 0.479 . . . . 10.82 111.298 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.463 ' CE2' HG21 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -137.29 174.86 10.15 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.331 -0.849 . . . . 11.130000000000001 110.226 170.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 18.0 p -118.6 -176.57 3.11 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.964 -1.016 . . . . 11.52 111.849 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.2 OUTLIER -52.99 148.77 13.3 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.85 -0.614 . . . . 12.75 111.867 -178.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -23.93 -65.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.556 1 C-N-CA 125.969 4.446 . . . . 14.640000000000001 115.838 -176.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.6 m -88.56 -62.77 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.294 0.85 . . . . 16.68 113.294 -170.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 86.0 m -166.82 132.67 1.81 Allowed Pre-proline 0 C--O 1.234 0.285 0 N-CA-C 112.449 0.537 . . . . 16.039999999999999 112.449 -171.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.526 ' HB3' HG21 ' A' ' 184' ' ' THR . 53.0 Cg_exo -63.48 124.78 14.33 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.971 2.447 . . . . 14.220000000000001 111.6 162.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 9.4 p -152.14 158.46 4.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.42 -0.354 . . . . 16.129999999999999 110.261 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -80.49 120.06 23.99 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.315 -0.402 . . . . 16.699999999999999 110.81 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.96 -22.51 25.42 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.98 -0.629 . . . . 16.98 112.72 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -114.79 163.55 15.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.992 0.425 . . . . 18.73 110.062 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.53 HD11 ' HB1' ' A' ' 150' ' ' ALA . 10.1 tp -71.01 120.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.623 -0.717 . . . . 14.82 111.761 -173.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.526 HG21 ' HB3' ' A' ' 178' ' ' PRO . 56.8 m -114.05 105.87 13.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.754 -0.657 . . . . 12.779999999999999 109.704 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 63.5 mtt-85 -83.41 141.16 31.93 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.509 -0.769 . . . . 13.98 108.991 176.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.797 HD12 HD12 ' A' ' 160' ' ' ILE . 3.4 mt -120.91 123.57 70.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.443 -0.577 . . . . 10.56 109.443 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 147' ' ' GLN . 4.0 mp -128.73 135.92 49.87 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.324 -0.853 . . . . 10.1 110.661 -170.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 1.035 HG23 HD21 ' A' ' 148' ' ' LEU . 25.0 t -104.17 133.4 48.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.239 -0.892 . . . . 9.7400000000000002 110.835 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.02 47.37 5.3 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.0 -1.0 . . . . 9.7599999999999998 114.043 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.686 ' HA ' HG22 ' A' ' 145' ' ' VAL . 11.0 Cg_endo -61.02 125.1 16.25 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 CA-C-N 119.68 1.74 . . . . 11.15 111.414 175.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -156.05 147.69 22.88 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.105 -0.498 . . . . 12.77 110.176 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.531 ' HA ' ' CB ' ' A' ' 143' ' ' ALA . . . -89.34 -8.99 52.08 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.559 -0.746 . . . . 14.6 111.267 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.4 t -100.67 94.44 6.1 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.449 -0.574 . . . . 14.300000000000001 109.449 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.698 ' HG3' ' CD1' ' A' ' 144' ' ' TYR . 18.1 ttmt -54.1 -41.08 67.88 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.142 -0.935 . . . . 15.970000000000001 110.101 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.07 -53.41 54.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.158 -0.474 . . . . 15.6 111.827 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -62.88 -46.21 88.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.138 0.494 . . . . 14.220000000000001 111.164 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -76.27 -20.76 57.04 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.841 -0.618 . . . . 11.949999999999999 110.864 -176.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 194' ' ' LYS . 57.0 tptt -65.92 -39.25 90.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.448 0.642 . . . . 14.699999999999999 109.728 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -78.49 -11.3 85.43 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 114.984 -1.007 . . . . 13.09 110.667 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 204' ' ' LEU . 75.2 m -88.23 -8.97 54.45 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.101 -0.549 . . . . 12.109999999999999 112.377 -175.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 33.1 mt -68.34 -37.28 80.38 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.799 0.333 . . . . 12.720000000000001 110.956 -175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.05 -43.8 96.71 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.926 -0.654 . . . . 14.66 111.882 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.458 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 13.6 pt-20 -83.47 -18.03 39.98 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.795 0.331 . . . . 13.890000000000001 110.935 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 207' ' ' LEU . 15.2 tp -74.44 -34.74 63.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.086 0.47 . . . . 12.550000000000001 110.306 -176.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 201' ' ' LEU . 7.6 mtmp? -66.82 -15.63 63.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.775 -0.648 . . . . 15.83 110.015 174.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.01 -36.01 17.26 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.851 -0.613 . . . . 16.969999999999999 109.413 172.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 204' ' ' LEU . 66.3 mt -68.88 -51.4 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.787 -0.642 . . . . 13.890000000000001 111.127 -178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.463 ' HA ' HD11 ' A' ' 164' ' ' LEU . 22.2 p -102.67 -47.82 4.31 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.383 -0.527 . . . . 13.539999999999999 111.139 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 75.37 -0.17 60.6 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.824 -0.626 . . . . 14.67 112.183 -176.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.573 ' HB3' ' HB3' ' A' ' 148' ' ' LEU . 7.3 mp -74.92 158.98 32.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 110.048 -0.353 . . . . 13.039999999999999 110.048 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 57.1 p -77.09 93.35 3.86 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.082 -0.508 . . . . 14.84 110.44 -175.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 147' ' ' GLN . . . -112.78 137.63 14.38 Favored Glycine 0 N--CA 1.439 -1.104 0 C-N-CA 120.349 -0.929 . . . . 12.220000000000001 114.279 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 16.9 t -101.75 137.94 27.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.287 -0.634 . . . . 13.74 109.287 173.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 5.3 p -75.56 105.65 4.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.622 0.725 . . . . 12.890000000000001 109.936 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 91.2 mmm -117.35 133.79 55.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.869 -0.605 . . . . 13.800000000000001 110.546 -175.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -67.74 139.31 34.71 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.526 -0.845 . . . . 13.359999999999999 111.546 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.698 ' HB2' HG23 ' A' ' 145' ' ' VAL . 9.9 t80 -108.98 131.61 54.9 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 123.703 0.801 . . . . 14.24 110.423 -170.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.2 t -146.56 94.75 4.71 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-O 121.091 0.472 . . . . 16.510000000000002 109.852 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.9 148.78 77.14 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.258 1.972 . . . . 17.420000000000002 111.823 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.695 -0.669 . . . . 19.190000000000001 109.959 -179.081 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.543 0.211 . . . . 18.390000000000001 110.459 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.42 163.29 29.4 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.747 -0.74 . . . . 17.77 112.14 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.432 HE21 ' HE3' ' A' ' 32' ' ' LYS . 51.4 tt0 60.25 80.82 0.2 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.426 0.632 . . . . 17.690000000000001 111.182 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -76.75 75.64 3.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.627 -0.715 . . . . 19.93 111.084 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.597 ' HG2' ' H ' ' A' ' 34' ' ' TYR . 41.2 ttmt -98.12 154.11 17.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.36 -0.607 . . . . 17.43 109.36 175.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.47 ' HE1' ' O ' ' A' ' 74' ' ' GLU . 85.4 m-70 -129.38 25.73 5.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.957 0.408 . . . . 19.359999999999999 111.355 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.597 ' H ' ' HG2' ' A' ' 32' ' ' LYS . 88.1 m-85 -132.92 176.81 8.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.325 -0.398 . . . . 18.960000000000001 110.512 -175.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 63.56 33.9 12.99 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 123.902 0.751 . . . . 18.239999999999998 109.473 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.4 t70 73.47 117.7 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.507 -1.224 . . . . 16.780000000000001 111.874 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.42 ' HA ' ' HB3' ' A' ' 71' ' ' ALA . 39.0 mt-10 -87.62 34.39 0.71 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.014 -0.539 . . . . 18.420000000000002 110.643 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 74.5 t80 62.35 -76.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.859 0.864 . . . . 17.920000000000002 111.447 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.06 141.5 11.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.775 0.321 . . . . 19.550000000000001 110.724 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.4 65.2 8.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.202 0.525 . . . . 20.309999999999999 110.332 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.429 HD12 ' O ' ' A' ' 47' ' ' ALA . 8.0 pt -121.8 83.1 42.63 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.822 -0.626 . . . . 19.920000000000002 111.543 -177.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.79 68.03 7.8 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.754 2.303 . . . . 21.640000000000001 111.897 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mp 62.88 34.53 14.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.907 -0.588 . . . . 22.670000000000002 111.468 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.579 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 57.9 t -90.69 -52.71 0.3 Allowed Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.125 -0.488 . . . . 21.34 111.172 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 5.8 Cg_endo -92.22 172.25 2.46 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.777 2.318 . . . . 20.0 111.651 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -85.15 57.78 4.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.755 0.788 . . . . 21.079999999999998 109.154 174.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.429 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -168.36 137.94 2.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.839 -1.073 . . . . 18.800000000000001 109.253 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.11 -128.47 2.74 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.675 -0.774 . . . . 17.510000000000002 111.297 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.42 123.08 14.2 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.029 -0.36 . . . . 16.949999999999999 110.029 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -164.82 82.96 0.38 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.219 -0.66 . . . . 18.300000000000001 109.219 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -58.27 110.46 0.96 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.638 -0.71 . . . . 18.170000000000002 111.45 -172.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -85.48 115.4 61.28 Favored Pre-proline 0 N--CA 1.447 -0.612 0 N-CA-C 109.12 -0.696 . . . . 18.82 109.12 171.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.72 7.18 2.45 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.856 2.371 . . . . 19.870000000000001 112.864 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -136.77 67.81 1.44 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.206 0.527 . . . . 21.100000000000001 110.355 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.3 ttt -166.68 -70.26 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.452 -0.795 . . . . 22.300000000000001 109.942 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.558 ' HB3' ' HD3' ' A' ' 57' ' ' PRO . 38.4 tpp -144.55 -48.57 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.966 -0.561 . . . . 23.850000000000001 110.656 177.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 56' ' ' MET . 14.0 Cg_exo -71.28 122.64 8.87 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 121.478 1.452 . . . . 20.670000000000002 110.712 172.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 62' ' ' ALA . . . -74.65 -47.51 31.57 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.009 -0.541 . . . . 20.489999999999998 110.183 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 177.81 -175.55 0.17 Allowed 'General case' 0 CA--C 1.522 -0.132 0 O-C-N 123.933 0.771 . . . . 21.469999999999999 109.663 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -67.23 -19.4 65.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.242 0.544 . . . . 22.600000000000001 110.117 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -82.53 -15.38 52.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.826 -0.625 . . . . 21.93 110.5 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 58' ' ' ALA . . . -147.64 87.92 1.66 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.131 -0.486 . . . . 19.73 110.872 -177.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.34 161.13 75.96 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.72 -0.673 . . . . 19.579999999999998 109.857 177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.442 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 7.4 Cg_exo -73.64 69.76 4.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.775 2.317 . . . . 18.5 112.756 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m 59.57 42.08 17.95 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.387 0.613 . . . . 17.609999999999999 111.038 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 64' ' ' PRO . 12.0 pt20 -173.44 74.31 0.39 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.451 -0.795 . . . . 18.760000000000002 110.517 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.09 -45.19 37.46 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.305 2.67 . . . . 17.280000000000001 114.976 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.62 -46.73 31.37 Favored 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 122.235 1.957 . . . . 17.77 113.098 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -164.11 149.72 10.74 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.365 -0.605 . . . . 18.699999999999999 109.365 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 72' ' ' ALA . . . -90.6 58.8 3.36 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.848 -0.614 . . . . 17.719999999999999 112.391 -173.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 37' ' ' GLU . . . 70.15 -27.78 0.17 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.004 0.742 . . . . 18.0 113.004 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 70' ' ' GLY . . . -75.52 22.82 0.12 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.539 0.57 . . . . 17.960000000000001 112.539 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -83.39 -25.01 31.74 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.058 -1.09 . . . . 19.850000000000001 108.058 172.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' O ' ' HE1' ' A' ' 33' ' ' HIS . 30.0 tt0 -130.55 89.65 2.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.764 -1.107 . . . . 19.670000000000002 109.24 176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 t -77.58 95.89 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.971 0.415 . . . . 17.739999999999998 110.866 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -80.28 -41.76 24.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.139 -0.482 . . . . 19.949999999999999 110.131 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 66.5 -64.98 0.21 Allowed 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.006 0.816 . . . . 18.390000000000001 112.697 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.64 ' HA2' ' HB2' ' A' ' 82' ' ' ALA . . . -98.72 -130.99 7.08 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.045 -0.597 . . . . 17.66 113.206 -174.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 58.5 61.33 2.27 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.724 0.41 . . . . 17.68 110.442 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 74.11 -23.64 0.22 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.044 0.84 . . . . 17.800000000000001 112.311 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.73 -34.42 60.32 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.713 0.264 . . . . 17.350000000000001 111.713 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.64 ' HB2' ' HA2' ' A' ' 78' ' ' GLY . . . -56.47 -54.92 48.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 112.034 0.383 . . . . 16.640000000000001 112.034 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 82' ' ' ALA . 61.1 Cg_endo -74.15 -19.66 19.83 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.374 1.382 . . . . 17.23 112.254 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.8 t 69.29 -63.25 0.38 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.461 -0.79 . . . . 17.34 110.4 -175.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.6 mt -113.61 149.7 34.17 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.723 -0.473 . . . . 18.41 109.723 177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -79.39 130.14 69.61 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.411 . . . . 17.449999999999999 110.918 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.45 -15.61 48.45 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.927 2.418 . . . . 18.890000000000001 112.222 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.22 102.62 2.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.05 -0.523 . . . . 17.809999999999999 110.807 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.1 p -75.91 -40.76 53.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.151 -0.477 . . . . 18.629999999999999 110.994 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.7 pt -121.43 -47.8 2.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.23 -0.441 . . . . 19.100000000000001 110.747 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -171.13 -91.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.328 -0.396 . . . . 19.25 110.332 174.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 174.34 -43.53 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.061 0.458 . . . . 18.789999999999999 111.295 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -94.08 47.03 1.19 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.982 -0.553 . . . . 18.949999999999999 112.24 -169.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -149.28 77.67 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.597 0.237 . . . . 20.309999999999999 110.587 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 59.8 m -67.19 -51.15 56.98 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.847 -0.797 . . . . 21.399999999999999 108.847 172.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -120.18 -26.5 5.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.948 -1.024 . . . . 21.16 108.83 168.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.406 ' H ' ' H ' ' A' ' 98' ' ' GLU . 27.4 p90 -179.6 -7.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.2 -0.909 . . . . 22.18 110.477 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.414 ' HB2' ' HD2' ' A' ' 99' ' ' PRO . 14.4 pt-20 -149.94 169.13 9.67 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.366 -0.834 . . . . 19.449999999999999 108.989 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 98' ' ' GLU . 35.8 Cg_exo -57.35 -64.72 0.12 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 121.981 1.788 . . . . 18.530000000000001 112.275 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 103' ' ' PRO . 34.7 tt0 -175.94 133.43 0.43 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.428 . . . . 17.449999999999999 110.185 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.26 102.9 0.48 Allowed 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.586 2.191 . . . . 17.420000000000002 111.608 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 58.78 78.24 0.36 Allowed Pre-proline 0 C--O 1.235 0.337 0 CA-C-N 115.584 -0.734 . . . . 17.68 110.292 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.49 ' HA ' ' OE1' ' A' ' 100' ' ' GLU . 36.3 Cg_exo -62.16 142.64 92.67 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.294 2.663 . . . . 16.289999999999999 112.926 -175.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.5 m -93.48 18.31 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 121.438 0.637 . . . . 17.260000000000002 111.23 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 106' ' ' PRO . . . -70.79 -50.3 13.06 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.24 -0.891 . . . . 15.800000000000001 111.982 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 105' ' ' ALA . 37.9 Cg_endo -65.51 156.78 61.75 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.982 1.788 . . . . 15.92 111.958 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.22 -13.02 25.73 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.723 2.282 . . . . 16.149999999999999 111.983 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 14.1 mptt -89.29 131.02 41.83 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.688 -0.687 . . . . 17.629999999999999 109.719 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 108' ' ' LYS . 35.5 Cg_exo -61.98 103.95 0.31 Allowed 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.729 2.286 . . . . 15.039999999999999 112.025 176.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.414 ' HB2' ' HD3' ' A' ' 111' ' ' PRO . 14.7 mmmm -84.29 -51.05 0.59 Allowed Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.264 -0.426 . . . . 15.199999999999999 111.251 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 110' ' ' LYS . 64.9 Cg_endo -74.7 96.09 0.98 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.666 1.577 . . . . 14.08 112.701 177.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.8 53.78 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 122.376 1.084 . . . . 15.279999999999999 108.907 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.631 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 24.4 mm-40 -65.44 -41.62 51.67 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 113.84 -1.527 . . . . 16.84 112.425 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 113' ' ' GLU . 3.7 Cg_exo -40.87 126.97 2.53 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.968 2.445 . . . . 15.51 112.276 172.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.94 -172.65 1.49 Allowed 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.765 2.31 . . . . 16.039999999999999 112.515 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 52.1 tptt 64.83 71.95 0.52 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 115.765 -0.652 . . . . 18.91 110.48 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -96.57 -4.72 1.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.624 2.883 . . . . 17.039999999999999 111.465 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.3 tptt 60.04 51.66 5.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.264 -1.335 . . . . 17.52 110.722 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.1 m 37.45 -106.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 115.257 -0.883 . . . . 18.699999999999999 112.841 -176.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -113.12 68.87 0.68 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.974 0.416 . . . . 20.879999999999999 110.883 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.93 113.47 7.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 18.890000000000001 110.779 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.79 -50.26 10.92 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.118 2.545 . . . . 20.43 114.032 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -90.15 40.98 0.44 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.649 1.566 . . . . 21.100000000000001 112.259 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.45 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . . . -69.96 128.05 91.99 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.051 -0.522 . . . . 21.149999999999999 110.533 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 124' ' ' ALA . 24.9 Cg_exo -63.43 -18.93 66.82 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.759 2.306 . . . . 21.149999999999999 112.0 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -116.19 108.09 46.48 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.728 -0.669 . . . . 21.879999999999999 109.668 177.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.41 -38.75 89.45 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.297 2.665 . . . . 20.190000000000001 112.884 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -127.62 90.56 47.96 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.309 -0.405 . . . . 20.48 110.138 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.47 ' O ' ' HD3' ' A' ' 131' ' ' PRO . 7.6 Cg_exo -71.86 -65.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.994 2.463 . . . . 21.170000000000002 111.993 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -115.83 85.48 14.55 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.13 -0.693 . . . . 23.18 109.13 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 129' ' ' PRO . 2.6 Cg_exo -75.85 75.89 3.91 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.954 2.436 . . . . 20.780000000000001 112.425 -177.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.3 p -89.61 42.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 122.556 1.17 . . . . 19.75 109.292 177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.44 136.3 7.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.637 -1.165 . . . . 21.050000000000001 110.861 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.88 -169.67 1.56 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.903 -0.589 . . . . 21.300000000000001 109.49 173.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.564 ' HG3' ' H ' ' A' ' 136' ' ' LYS . 2.0 pt-20 -47.06 -81.45 0.01 OUTLIER 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.751 0.648 . . . . 20.739999999999998 112.751 -174.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.564 ' H ' ' HG3' ' A' ' 135' ' ' GLU . 40.2 ttpt 70.3 -40.01 0.46 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.34 0.656 . . . . 17.969999999999999 111.127 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' A' ' 142' ' ' LYS . . . -68.68 -21.63 64.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.989 -0.55 . . . . 17.350000000000001 109.974 172.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 74.82 147.22 0.12 Allowed Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 114.467 -1.242 . . . . 19.100000000000001 111.347 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 192' ' ' ALA . 71.5 Cg_exo -51.51 -75.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.1 2.533 . . . . 19.350000000000001 113.586 -175.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.3 p -90.12 -11.98 39.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.888 0.375 . . . . 17.75 110.976 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.37 -54.6 31.11 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.18 -0.768 . . . . 17.960000000000001 111.18 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.548 ' HB3' ' HB1' ' A' ' 137' ' ' ALA . 58.6 tttm -144.56 79.58 1.61 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.814 0.816 . . . . 19.420000000000002 109.698 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.55 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -74.29 169.2 18.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.546 -1.206 . . . . 14.65 110.253 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.571 ' HB3' HD21 ' A' ' 197' ' ' LEU . 3.3 m-85 -128.6 156.15 43.83 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.813 0.672 . . . . 14.81 112.813 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.85 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.7 t -150.49 165.75 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 108.983 -0.747 . . . . 10.48 108.983 174.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 43.9 t -105.59 113.05 41.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 O-C-N 121.75 -0.594 . . . . 10.1 110.8 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.442 ' OE1' ' HD3' ' A' ' 185' ' ' ARG . 6.4 tt0 -87.72 105.16 17.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.715 -0.221 . . . . 12.0 111.161 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.931 HD21 HG23 ' A' ' 188' ' ' VAL . 0.0 OUTLIER -85.66 -36.27 20.39 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.343 0.592 . . . . 11.880000000000001 110.198 -176.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -144.47 169.59 26.4 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.251 -0.976 . . . . 11.35 112.674 -173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 185' ' ' ARG . . . -169.32 101.27 0.35 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.288 -0.634 . . . . 13.470000000000001 109.288 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.75 154.63 47.46 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.402 0.62 . . . . 13.52 110.724 -173.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 40.6 mtmt -95.44 -3.19 47.33 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.88 -1.055 . . . . 17.600000000000001 109.899 -176.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -97.92 104.15 16.15 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.946 -1.025 . . . . 16.140000000000001 109.362 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.77 -19.01 65.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.371 0.605 . . . . 14.039999999999999 110.551 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -59.93 -34.34 73.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.235 -0.893 . . . . 16.57 110.189 174.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -90.42 -29.12 18.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.727 -1.124 . . . . 16.399999999999999 110.405 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' THR . 93.3 t -58.48 -38.73 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.368 0.604 . . . . 12.67 109.819 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -59.75 -29.48 68.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.148 -0.933 . . . . 15.32 111.243 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.74 -62.69 1.4 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 121.217 0.532 . . . . 15.970000000000001 110.03 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.458 HD12 HG13 ' A' ' 186' ' ' ILE . 7.6 mt -55.25 -43.51 71.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.885 -1.052 . . . . 12.6 110.757 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.5 t -74.59 -40.19 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.689 -0.687 . . . . 12.539999999999999 110.455 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -61.26 -33.95 86.33 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.373 -0.918 . . . . 14.800000000000001 111.487 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -68.23 -57.43 6.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.411 -0.394 . . . . 16.050000000000001 111.497 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -85.3 -52.35 5.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.353 0.501 . . . . 12.99 112.353 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -68.31 -37.59 80.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.15 0.5 . . . . 15.06 110.221 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.09 -23.9 77.63 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.41 -0.814 . . . . 16.600000000000001 112.552 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -89.5 1.39 55.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.951 0.405 . . . . 16.140000000000001 110.755 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.29 23.46 34.36 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.83 -0.7 . . . . 15.119999999999999 113.396 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -89.92 154.42 19.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.955 0.378 . . . . 15.49 110.208 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.474 ' HD2' ' N ' ' A' ' 170' ' ' ARG . 8.8 mpt_? -76.55 98.34 4.63 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.238 -0.653 . . . . 13.869999999999999 109.238 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.97 142.01 26.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.155 -0.929 . . . . 10.82 109.016 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.642 ' HH ' ' HD2' ' A' ' 217' ' ' TYR . 0.1 OUTLIER -138.98 176.8 8.38 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.554 0.693 . . . . 11.130000000000001 110.712 174.152 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 23.6 p -111.21 -175.95 2.83 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.508 -1.223 . . . . 11.52 111.353 -171.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' A' ' 184' ' ' THR . 0.3 OUTLIER -53.81 148.94 18.22 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.212 -0.449 . . . . 12.75 111.031 176.599 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -32.09 -61.38 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 125.126 3.884 . . . . 14.640000000000001 115.337 -173.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.1 m -87.32 -63.0 1.37 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.371 0.878 . . . . 16.68 113.371 -168.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 85.7 m -167.82 129.22 1.2 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 118.434 0.561 . . . . 16.039999999999999 112.356 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.465 ' HB3' HG21 ' A' ' 184' ' ' THR . 72.1 Cg_exo -59.36 124.27 15.19 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.541 2.16 . . . . 14.220000000000001 111.705 163.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.48 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 10.3 p -153.32 160.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 109.646 -0.502 . . . . 16.129999999999999 109.646 -176.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -80.13 122.57 26.97 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.457 -0.338 . . . . 16.699999999999999 110.56 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 108.75 -25.77 18.05 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.888 -0.672 . . . . 16.98 112.555 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -109.35 160.7 15.94 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.784 -0.451 . . . . 18.73 109.784 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.0 tp -73.19 109.4 5.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.747 0.784 . . . . 14.82 111.555 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 178' ' ' PRO . 56.9 m -100.05 112.53 24.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.449 -0.796 . . . . 12.779999999999999 109.625 174.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 150' ' ' ALA . 46.1 mtt180 -93.61 144.77 25.07 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.691 -0.686 . . . . 13.98 109.938 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.519 ' O ' HD22 ' A' ' 148' ' ' LEU . 5.2 mm -114.85 120.41 64.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.108 -0.701 . . . . 10.56 109.108 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.499 HD12 ' C ' ' A' ' 186' ' ' ILE . 4.9 mp -129.42 123.01 30.55 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.208 0.528 . . . . 10.1 111.041 -174.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.931 HG23 HD21 ' A' ' 148' ' ' LEU . 33.6 t -99.58 134.97 36.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.625 -0.716 . . . . 9.7400000000000002 111.159 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 84.5 47.98 5.2 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.96 -1.018 . . . . 9.7599999999999998 113.555 173.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.83 ' HA ' HG22 ' A' ' 145' ' ' VAL . 12.7 Cg_endo -62.74 125.82 16.88 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 119.476 1.638 . . . . 11.15 110.511 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -157.26 152.4 26.06 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.325 -0.55 . . . . 12.77 110.586 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 139' ' ' PRO . . . -88.74 2.62 53.11 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.608 -0.724 . . . . 14.6 111.34 -175.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 18.2 t -118.32 97.81 5.96 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.367 0.603 . . . . 14.300000000000001 109.685 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 198' ' ' LYS . 2.9 ptmm? -57.42 -40.5 78.47 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 114.899 -1.046 . . . . 15.970000000000001 111.821 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -71.75 -46.89 57.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.803 0.335 . . . . 15.6 111.461 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -59.55 -37.21 77.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.316 0.579 . . . . 14.220000000000001 110.243 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.571 HD21 ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -84.21 -24.18 30.19 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.749 -0.659 . . . . 11.949999999999999 110.412 -178.241 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.578 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 14.1 tmtt? -74.82 -34.46 62.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.313 0.578 . . . . 14.699999999999999 109.652 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -75.17 -13.28 82.89 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.157 -1.177 . . . . 13.09 110.157 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' A' ' 203' ' ' GLU . 45.5 m -90.17 -8.59 50.82 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 114.354 -0.923 . . . . 12.109999999999999 111.934 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 24.3 mt -65.31 -35.21 80.32 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.671 0.272 . . . . 12.720000000000001 111.043 -176.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -59.2 -42.62 97.28 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.791 -0.718 . . . . 14.66 111.851 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 200' ' ' SER . 9.9 pt-20 -85.91 -19.7 30.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.664 0.268 . . . . 13.890000000000001 110.584 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 19.9 tp -68.65 -28.63 67.06 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.112 0.482 . . . . 12.550000000000001 110.085 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.543 ' O ' ' HA2' ' A' ' 209' ' ' GLY . 90.8 mttt -60.92 -16.68 44.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.41 -0.814 . . . . 15.83 110.568 173.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -89.91 -43.01 10.87 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.42 -0.355 . . . . 16.969999999999999 110.424 172.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.13 -55.52 31.5 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.51 0.671 . . . . 13.890000000000001 112.204 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 55.9 p -97.38 -44.19 6.97 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.134 -0.939 . . . . 13.539999999999999 110.854 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 72.62 1.93 54.57 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.536 -0.756 . . . . 14.67 111.802 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.446 ' HB2' ' HG ' ' A' ' 148' ' ' LEU . 70.5 mt -85.53 152.14 23.4 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.738 -0.468 . . . . 13.039999999999999 109.738 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.9 p -90.32 104.84 17.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.256 -0.429 . . . . 14.84 110.591 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 148' ' ' LEU . . . -130.32 160.7 23.09 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.148 -1.025 . . . . 12.220000000000001 114.142 -173.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.2 t -101.45 140.59 19.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 114.917 -0.641 . . . . 13.74 109.383 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.01 105.15 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.732 0.777 . . . . 12.890000000000001 109.614 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 1.8 mmt -122.07 168.85 11.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.48 -0.782 . . . . 13.800000000000001 110.564 -172.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -83.48 163.46 40.79 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.476 -0.868 . . . . 13.359999999999999 112.934 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.85 ' HB2' HG23 ' A' ' 145' ' ' VAL . 6.9 t80 -128.67 126.5 40.27 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.845 0.858 . . . . 14.24 110.166 -174.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 89.4 m -146.61 93.37 4.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 116.075 -0.511 . . . . 16.510000000000002 109.653 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.9 149.87 60.32 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.702 2.268 . . . . 17.420000000000002 112.541 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 47.8 t30 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.843 -0.599 . . . . 19.190000000000001 109.791 177.21 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.529 ' O ' ' HE2' ' A' ' 31' ' ' LYS . 28.7 m-20 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.706 -0.479 . . . . 18.390000000000001 109.706 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.0 162.75 54.1 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.851 -0.69 . . . . 17.77 112.687 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 65.71 -98.18 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.144 0.577 . . . . 17.690000000000001 111.747 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HE2' ' O ' ' A' ' 28' ' ' ASP . 57.6 mtmt 56.17 25.06 8.67 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 122.665 0.386 . . . . 19.93 111.154 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -167.51 -170.94 1.54 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.174 -0.676 . . . . 17.43 109.174 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m80 59.99 42.63 15.71 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.496 0.498 . . . . 19.359999999999999 110.771 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 66' ' ' GLN . 52.9 t80 -142.73 57.08 1.42 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.593 0.711 . . . . 18.960000000000001 110.065 178.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -89.49 46.05 1.34 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.741 0.781 . . . . 18.239999999999998 109.653 173.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -84.9 125.37 32.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.899 -1.046 . . . . 16.780000000000001 109.83 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -56.11 118.14 4.4 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.698 0.624 . . . . 18.420000000000002 110.95 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -73.28 86.75 1.46 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.08 0.467 . . . . 17.920000000000002 110.851 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.55 -13.29 26.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.686 -0.688 . . . . 19.550000000000001 109.65 175.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.79 -148.34 0.37 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.135 -0.938 . . . . 20.309999999999999 109.593 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 41' ' ' ILE . 4.4 mp 60.92 72.71 0.68 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 121.718 0.771 . . . . 19.920000000000002 110.411 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -81.18 54.02 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.068 2.512 . . . . 21.640000000000001 111.28 175.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 mp 62.24 26.4 15.82 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.39 -0.823 . . . . 22.670000000000002 111.336 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.551 ' HB ' ' HD3' ' A' ' 45' ' ' PRO . 83.9 t -79.81 -60.65 0.5 Allowed Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 116.301 -0.409 . . . . 21.34 110.593 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 44' ' ' VAL . 96.1 Cg_endo -78.35 59.81 7.24 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.894 1.729 . . . . 20.0 111.537 172.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? 68.49 167.18 0.26 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.552 -0.749 . . . . 21.079999999999998 111.112 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.89 54.21 2.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.939 -0.573 . . . . 18.800000000000001 111.675 -175.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.14 -8.93 83.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.903 -0.665 . . . . 17.510000000000002 112.052 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -80.55 131.07 35.48 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.409 -0.219 . . . . 16.949999999999999 110.409 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 60.59 39.11 18.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.758 -0.656 . . . . 18.300000000000001 110.415 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.11 127.67 33.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.634 -0.712 . . . . 18.170000000000002 109.286 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 57' ' ' PRO . 12.6 pt-20 -85.5 115.78 62.86 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.245 0.545 . . . . 18.82 112.366 -171.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.665 ' HA ' ' O ' ' A' ' 57' ' ' PRO . 88.1 Cg_endo -83.77 32.92 0.5 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.012 2.474 . . . . 19.870000000000001 112.038 176.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -93.65 -56.34 2.94 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.145 -0.479 . . . . 21.100000000000001 111.354 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 72.2 mtm -85.26 -85.25 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.413 -0.358 . . . . 22.300000000000001 111.586 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.636 ' H ' ' HD2' ' A' ' 57' ' ' PRO . 65.6 mtt -122.41 -41.28 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.297 0.48 . . . . 23.850000000000001 112.297 -176.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.665 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 88.0 Cg_exo -48.76 125.65 13.2 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.997 1.798 . . . . 20.670000000000002 112.168 171.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . 66.13 8.99 5.91 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.333 -0.849 . . . . 20.489999999999998 111.877 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.97 -39.48 5.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.105 0.479 . . . . 21.469999999999999 109.863 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.6 m -80.52 -35.83 34.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.838 -0.619 . . . . 22.600000000000001 110.102 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -113.09 179.34 3.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.725 -0.67 . . . . 21.93 109.748 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.81 -80.98 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.852 0.358 . . . . 19.73 111.44 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.8 tp -134.98 89.82 23.33 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.043 0.449 . . . . 19.579999999999998 110.192 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -93.43 28.68 0.31 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.475 2.784 . . . . 18.5 113.222 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 p -68.25 -58.64 4.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.117 0.484 . . . . 17.609999999999999 110.311 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 84.0 mm-40 -135.6 76.26 55.17 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.825 -0.625 . . . . 18.760000000000002 109.683 172.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 83.7 Cg_endo -81.42 127.76 5.94 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.751 2.301 . . . . 17.280000000000001 112.267 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 67' ' ' PRO . 16.3 Cg_exo -68.41 -16.97 44.04 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.601 2.201 . . . . 17.77 112.306 178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -124.56 163.13 22.56 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.547 -0.751 . . . . 18.699999999999999 109.906 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.9 -153.35 17.0 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.646 -0.787 . . . . 17.719999999999999 112.295 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 64.43 74.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.286 0.565 . . . . 18.0 110.824 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.8 152.97 20.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.469 -0.787 . . . . 17.960000000000001 109.738 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.81 124.76 39.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.632 0.254 . . . . 19.850000000000001 110.724 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 71.18 -59.43 0.54 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.462 0.705 . . . . 19.670000000000002 111.946 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.87 103.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.194 -0.457 . . . . 17.739999999999998 111.186 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? 66.98 17.0 10.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.439 -0.8 . . . . 19.949999999999999 111.242 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.85 -28.09 7.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.223 -0.444 . . . . 18.390000000000001 111.009 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.73 85.68 0.86 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.82 -0.705 . . . . 17.66 112.357 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -146.82 164.17 33.7 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.566 -0.531 . . . . 17.68 109.566 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.41 57.99 3.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.217 0.532 . . . . 17.800000000000001 110.79 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.76 71.79 1.25 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.761 -0.654 . . . . 17.350000000000001 110.393 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 68.34 105.84 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.338 0 O-C-N 123.87 0.731 . . . . 16.640000000000001 111.579 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.65 -22.31 59.99 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.994 2.463 . . . . 17.23 112.328 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.3 m 67.26 -176.5 0.2 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.434 -0.803 . . . . 17.34 111.187 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 85' ' ' LEU . 1.9 pt? -142.77 133.68 25.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.345 -0.388 . . . . 18.41 109.971 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -76.07 132.93 72.92 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.974 -0.557 . . . . 17.449999999999999 110.975 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.36 -6.39 18.3 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.689 2.259 . . . . 18.890000000000001 112.111 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 65.04 -85.32 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.422 -0.808 . . . . 17.809999999999999 111.425 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.6 p 49.33 -96.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.348 0.659 . . . . 18.629999999999999 112.309 -175.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.4 mm -77.64 -36.13 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.146 0.498 . . . . 19.100000000000001 110.268 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.729 ' HA ' ' OG1' ' A' ' 95' ' ' THR . . . -104.9 81.96 1.81 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.845 -0.616 . . . . 19.25 110.822 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -99.33 -39.09 8.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.172 -0.467 . . . . 18.789999999999999 111.47 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -160.02 -69.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.972 0.415 . . . . 18.949999999999999 111.229 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -85.42 54.82 3.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.503 0.668 . . . . 20.309999999999999 111.373 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.729 ' OG1' ' HA ' ' A' ' 91' ' ' ALA . 6.9 m -103.26 -24.85 13.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.661 0.743 . . . . 21.399999999999999 109.287 172.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -143.13 30.14 1.44 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.769 -1.105 . . . . 21.16 109.301 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 56.18 52.95 9.54 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.752 -1.113 . . . . 22.18 111.48 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -79.74 120.23 79.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.349 -0.387 . . . . 19.449999999999999 110.14 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.417 ' C ' ' HD3' ' A' ' 101' ' ' PRO . 62.2 Cg_endo -74.29 147.56 37.46 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.294 1.996 . . . . 18.530000000000001 111.571 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -125.69 71.33 66.79 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 121.054 0.454 . . . . 17.449999999999999 110.542 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 99' ' ' PRO . 6.2 Cg_exo -74.05 -58.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.779 2.319 . . . . 17.420000000000002 111.719 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.58 116.95 8.5 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.901 -0.59 . . . . 17.68 109.889 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.05 132.79 33.2 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.616 2.21 . . . . 16.289999999999999 112.583 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 p -106.94 103.83 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.755 -0.657 . . . . 17.260000000000002 110.212 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 49.45 63.7 9.84 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-N 115.366 -0.834 . . . . 15.800000000000001 111.048 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.0 138.85 14.82 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.362 2.041 . . . . 15.92 112.891 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.54 -20.53 35.74 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.64 2.227 . . . . 16.149999999999999 110.811 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 87.2 tttt -117.88 115.43 36.86 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 114.909 -1.041 . . . . 17.629999999999999 108.446 173.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 108' ' ' LYS . 12.6 Cg_exo -70.62 53.5 1.4 Allowed 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.107 2.538 . . . . 15.039999999999999 113.259 -176.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -77.0 115.46 48.73 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.25 -0.432 . . . . 15.199999999999999 110.274 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.76 117.61 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.147 1.898 . . . . 14.08 111.803 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.2 m -85.23 47.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.784 0.802 . . . . 15.279999999999999 110.486 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -139.4 165.33 32.45 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.915 -1.039 . . . . 16.84 110.043 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.83 170.53 1.37 Allowed 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.811 2.341 . . . . 15.51 112.185 174.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.7 50.95 0.84 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.101 2.534 . . . . 16.039999999999999 112.172 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -174.53 69.57 0.3 Allowed Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 114.746 -1.116 . . . . 18.91 108.512 -178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -38.07 -57.96 0.74 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.939 3.093 . . . . 17.039999999999999 113.187 -168.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -133.95 15.68 3.9 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.188 -0.671 . . . . 17.52 109.188 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.6 t 66.65 -69.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.167 -0.924 . . . . 18.699999999999999 110.235 -171.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.13 57.97 0.66 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.123 -0.49 . . . . 20.879999999999999 109.679 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.64 112.67 12.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 18.890000000000001 110.573 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.36 117.13 3.69 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.031 2.487 . . . . 20.43 112.512 -176.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.03 165.45 29.75 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.86 2.373 . . . . 21.100000000000001 111.645 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.451 ' C ' ' H ' ' A' ' 126' ' ' LYS . . . -70.13 141.41 89.01 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.29 -0.633 . . . . 21.149999999999999 109.29 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.85 21.25 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.619 2.213 . . . . 21.149999999999999 112.554 -178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 124' ' ' ALA . 12.2 mmmm -139.37 70.42 39.54 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.656 -0.702 . . . . 21.879999999999999 110.128 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.1 58.54 6.62 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.981 2.454 . . . . 20.190000000000001 111.779 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -73.19 136.27 79.18 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.496 -0.775 . . . . 20.48 110.566 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.04 72.06 2.75 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.738 2.292 . . . . 21.170000000000002 112.328 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -87.27 123.43 69.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.715 -0.675 . . . . 23.18 111.035 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.93 127.11 18.7 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.562 2.174 . . . . 20.780000000000001 110.97 173.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 m -85.91 51.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.081 0.467 . . . . 19.75 111.912 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 134' ' ' GLU . 31.5 t 66.54 172.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.313 -0.858 . . . . 21.050000000000001 110.239 178.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.521 ' N ' HG12 ' A' ' 133' ' ' VAL . 20.5 mt-10 73.39 78.05 0.13 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.33 0.586 . . . . 21.300000000000001 110.891 174.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -74.46 158.44 33.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.624 -0.717 . . . . 20.739999999999998 109.97 178.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -172.29 -27.85 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.137 -0.69 . . . . 17.969999999999999 109.137 -175.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 142' ' ' LYS . . . -115.79 24.08 11.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.147 -0.933 . . . . 17.350000000000001 109.851 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . 68.23 152.07 0.13 Allowed Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 115.154 -0.93 . . . . 19.100000000000001 111.779 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.37 94.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.129 2.553 . . . . 19.350000000000001 112.217 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.485 ' H ' ' HB1' ' A' ' 192' ' ' ALA . 1.4 p 51.48 26.97 3.49 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.886 0.875 . . . . 17.75 112.752 -176.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -83.24 -47.13 5.87 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.743 -0.943 . . . . 17.960000000000001 110.743 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.444 ' HB2' ' HB1' ' A' ' 137' ' ' ALA . 46.4 mtmt -127.89 56.93 1.56 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.122 -0.696 . . . . 19.420000000000002 109.122 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.485 ' C ' ' HB3' ' A' ' 217' ' ' TYR . . . -77.32 164.55 25.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.13 -0.941 . . . . 14.65 110.37 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.557 ' HA ' ' H ' ' A' ' 217' ' ' TYR . 10.0 m-85 -143.95 151.17 39.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.912 0.387 . . . . 14.81 111.336 -177.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.88 HG23 ' HB2' ' A' ' 217' ' ' TYR . 2.3 t -146.81 153.11 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.58 -1.267 . . . . 10.48 107.58 170.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 187' ' ' LEU . 17.1 t -98.23 121.73 49.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.304 -0.559 . . . . 10.1 110.815 -176.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.477 ' HG3' ' CG ' ' A' ' 185' ' ' ARG . 3.5 tt0 -83.98 101.73 11.94 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.579 -0.156 . . . . 12.0 110.579 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.775 HD13 ' N ' ' A' ' 212' ' ' GLY . 0.5 OUTLIER -87.58 -26.5 23.07 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.191 -0.67 . . . . 11.880000000000001 109.191 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -149.7 158.29 27.6 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.347 -0.842 . . . . 11.35 112.039 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.588 ' HB2' ' HG3' ' A' ' 185' ' ' ARG . . . -157.48 101.25 1.85 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.391 -0.596 . . . . 13.470000000000001 109.391 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -125.72 150.65 47.52 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.461 0.648 . . . . 13.52 110.296 -171.231 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 182' ' ' LYS . 2.6 mttt -93.85 -1.84 54.29 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.738 -1.119 . . . . 17.600000000000001 108.431 176.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -104.87 107.27 18.15 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.205 -1.361 . . . . 16.140000000000001 109.238 175.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.76 -16.83 59.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.165 0.507 . . . . 14.039999999999999 111.022 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -54.98 -35.32 64.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.092 -0.958 . . . . 16.57 111.062 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.496 ' O ' HG13 ' A' ' 160' ' ' ILE . 83.6 tttt -90.53 -31.84 16.57 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.61 -0.723 . . . . 16.399999999999999 110.48 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.483 HG13 ' CD1' ' A' ' 186' ' ' ILE . 88.2 t -54.72 -43.26 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.239 -0.437 . . . . 12.67 110.472 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -62.0 -34.38 76.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.674 -0.694 . . . . 15.32 111.737 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.81 -59.05 2.9 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 120.911 0.386 . . . . 15.970000000000001 110.016 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 156' ' ' LYS . 21.8 mt -52.39 -45.07 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.846 -1.07 . . . . 12.6 110.788 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.445 ' O ' ' HB3' ' A' ' 165' ' ' ARG . 89.6 t -71.16 -43.02 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.74 -0.663 . . . . 12.539999999999999 110.366 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.26 68.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.609 -0.805 . . . . 14.800000000000001 112.037 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -73.42 -61.79 1.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.257 0.223 . . . . 16.050000000000001 111.254 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 208' ' ' SER . 2.2 mm? -78.36 -45.8 21.6 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.415 0.524 . . . . 12.99 112.415 -174.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.476 ' HB2' ' CG1' ' A' ' 171' ' ' VAL . 25.8 ttm180 -65.17 -47.47 76.9 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.106 -0.702 . . . . 15.06 109.106 178.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.67 -20.59 68.3 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.048 -0.978 . . . . 16.600000000000001 113.456 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.2 -12.43 49.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.001 0.429 . . . . 16.140000000000001 110.385 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 102.41 20.86 11.32 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.937 -0.649 . . . . 15.119999999999999 113.222 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -95.74 154.91 16.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 117.337 0.568 . . . . 15.49 110.611 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -76.08 106.71 7.84 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.67 0.748 . . . . 13.869999999999999 110.151 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 165' ' ' ARG . 9.3 p -143.07 138.15 26.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.391 -1.277 . . . . 10.82 109.141 -176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.518 ' CE2' ' HB2' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -140.37 176.18 8.98 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.35 0.595 . . . . 11.130000000000001 110.583 171.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 185' ' ' ARG . 24.8 p -105.78 -177.33 3.33 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.915 -1.039 . . . . 11.52 110.064 -174.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.23 142.73 36.96 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.305 -0.258 . . . . 12.75 110.305 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -38.92 -47.12 2.81 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 124.25 3.3 . . . . 14.640000000000001 115.145 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.9 t -85.74 -61.98 1.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 120.231 -0.588 . . . . 16.68 112.41 -171.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 99.8 m -167.65 137.66 2.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 112.607 0.595 . . . . 16.039999999999999 112.607 -173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.414 ' HB3' HG21 ' A' ' 184' ' ' THR . 30.6 Cg_exo -67.14 125.23 13.24 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.765 2.31 . . . . 14.220000000000001 111.315 160.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.563 ' CG1' ' HB2' ' A' ' 182' ' ' LYS . 8.8 p -145.63 152.33 14.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.092 0.472 . . . . 16.129999999999999 110.6 -176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -81.78 123.52 28.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 16.699999999999999 111.101 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 100.2 -12.1 60.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.836 -0.697 . . . . 16.98 112.612 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.563 ' HB2' ' CG1' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -123.31 161.5 24.51 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.301 -0.629 . . . . 18.73 109.301 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 183' ' ' ILE . 8.8 tp -66.3 111.57 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.622 0.725 . . . . 14.82 111.858 -172.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.414 HG21 ' HB3' ' A' ' 178' ' ' PRO . 87.4 m -109.2 117.16 33.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.372 -0.603 . . . . 12.779999999999999 109.372 173.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.588 ' HG3' ' HB2' ' A' ' 150' ' ' ALA . 25.2 ttm180 -93.92 140.05 30.17 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.503 -0.771 . . . . 13.98 110.171 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.542 ' C ' HD12 ' A' ' 187' ' ' LEU . 3.9 mm -109.31 115.53 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.417 -0.586 . . . . 10.56 109.417 176.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 4.8 mp -121.57 118.02 28.22 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.554 0.692 . . . . 10.1 110.824 -171.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.44 HG12 HD11 ' A' ' 204' ' ' LEU . 27.7 t -95.71 135.3 30.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 114.834 -1.075 . . . . 9.7400000000000002 110.61 -179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.19 48.93 5.49 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.248 -0.887 . . . . 9.7599999999999998 113.627 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.718 ' HA ' HG22 ' A' ' 145' ' ' VAL . 12.3 Cg_endo -63.84 125.3 15.11 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 CA-C-N 119.525 1.663 . . . . 11.15 111.05 174.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -156.88 161.12 39.69 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.001 -0.545 . . . . 12.77 110.102 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.485 ' HB1' ' H ' ' A' ' 140' ' ' THR . . . -102.73 0.09 32.41 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.943 -0.571 . . . . 14.6 111.363 -176.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 28.5 p -113.61 95.91 5.59 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.575 0.702 . . . . 14.300000000000001 110.13 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.426 ' HG3' ' CD2' ' A' ' 144' ' ' TYR . 31.6 ttpt -56.7 -53.62 55.58 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.062 -0.972 . . . . 15.970000000000001 111.146 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -61.76 -32.04 72.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.833 0.349 . . . . 15.6 111.686 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -73.39 -41.83 62.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.098 0.475 . . . . 14.220000000000001 110.539 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 197' ' ' LEU . 0.1 OUTLIER -82.66 -19.86 37.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.246 0.546 . . . . 11.949999999999999 110.649 -178.123 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 55.7 tptt -67.15 -36.39 81.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.835 -0.621 . . . . 14.699999999999999 110.455 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -80.61 -12.25 83.11 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.43 -1.068 . . . . 13.09 110.43 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 197' ' ' LEU . 67.2 m -84.66 -8.08 59.0 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.873 -0.664 . . . . 12.109999999999999 111.902 -176.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 198' ' ' LYS . 14.6 mt -70.58 -36.33 73.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 12.720000000000001 110.611 -177.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.7 92.65 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.987 -0.625 . . . . 14.66 112.219 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.422 ' O ' ' HG ' ' A' ' 207' ' ' LEU . 12.8 pt-20 -85.79 -17.34 36.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.955 0.407 . . . . 13.890000000000001 110.441 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.44 HD11 HG12 ' A' ' 188' ' ' VAL . 17.6 tp -69.14 -34.91 75.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.278 -0.419 . . . . 12.550000000000001 111.438 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -63.72 -16.06 60.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.955 0.407 . . . . 15.83 110.604 173.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.442 ' N ' ' HD3' ' A' ' 205' ' ' LYS . 0.8 OUTLIER -88.93 -36.39 15.93 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.058 -0.519 . . . . 16.969999999999999 109.687 172.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 203' ' ' GLU . 93.1 mt -71.47 -52.31 19.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.661 -0.699 . . . . 13.890000000000001 111.499 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.412 ' HB3' HD11 ' A' ' 164' ' ' LEU . 63.0 p -98.14 -43.6 6.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.397 0.618 . . . . 13.539999999999999 111.04 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 205' ' ' LYS . . . 74.34 0.01 55.97 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.241 -0.89 . . . . 14.67 111.322 -174.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 148' ' ' LEU . 97.1 mt -80.0 162.23 24.99 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.701 -0.851 . . . . 13.039999999999999 108.701 175.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.0 m -111.41 109.46 19.44 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.201 0.445 . . . . 14.84 112.201 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.775 ' N ' HD13 ' A' ' 148' ' ' LEU . . . -121.9 173.67 15.87 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.844 -0.693 . . . . 12.220000000000001 114.17 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 3.4 p -117.1 146.39 21.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.839 -0.68 . . . . 13.74 109.267 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 25.6 t -82.35 115.33 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.905 -0.589 . . . . 12.890000000000001 110.505 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . . . . . . . . . 74.8 mtp -125.96 149.83 48.47 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.123 0.487 . . . . 13.800000000000001 110.67 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.39 128.56 9.41 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.706 -0.759 . . . . 13.359999999999999 112.549 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.88 ' HB2' HG23 ' A' ' 145' ' ' VAL . 8.1 t80 -84.55 120.36 26.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.574 -0.813 . . . . 14.24 109.083 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 25.5 m -134.83 91.89 19.83 Favored Pre-proline 0 C--N 1.306 -1.295 0 C-N-CA 120.617 -0.433 . . . . 16.510000000000002 110.689 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.462 ' HG3' ' CZ ' ' A' ' 217' ' ' TYR . 9.5 Cg_exo -66.96 133.13 30.18 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.244 1.962 . . . . 17.420000000000002 111.138 173.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.1 t30 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.856 -0.592 . . . . 19.190000000000001 110.009 -178.096 . . . . . . . . 0 0 . 1 stop_ save_